data_2rmn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rmn _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.6 t . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.12 0.486 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.9 p-10 -96.15 25.86 4.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.652 -0.655 . . . . 0.0 110.601 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 51.0 m -71.04 125.19 26.2 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.573 -0.704 . . . . 0.0 110.27 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -71.42 144.98 49.59 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.661 -0.649 . . . . 0.0 110.443 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -153.87 99.05 2.59 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.742 -0.599 . . . . 0.0 110.073 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -59.39 -39.94 72.11 Favored 'Trans proline' 0 N--CA 1.487 1.147 0 O-C-N 123.175 1.092 . . . . 0.0 110.705 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.45 -155.16 48.36 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -75.75 -42.03 0.48 Allowed 'Trans proline' 0 C--N 1.316 -1.155 0 O-C-N 123.34 1.179 . . . . 0.0 110.993 -174.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -87.65 6.63 33.76 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.559 -0.713 . . . . 0.0 111.509 -173.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.69 60.97 3.33 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.98 -1.075 . . . . 0.0 110.672 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -77.89 118.87 20.62 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.63 -0.669 . . . . 0.0 109.955 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -130.04 161.42 31.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.81 -0.556 . . . . 0.0 110.068 -178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 62.9 t -126.48 145.74 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.696 -0.628 . . . . 0.0 109.893 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 78.4 p -155.43 160.29 40.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.802 -0.561 . . . . 0.0 110.043 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.498 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 71.7 m-85 . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.849 -0.532 . . . . 0.0 109.885 -175.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 121.154 0.502 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.403 ' OG1' ' CD1' ' A' ' 153' ' ' TRP . 43.5 p -60.1 -34.0 72.88 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.795 -0.565 . . . . 0.0 110.072 176.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.426 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -171.44 144.52 1.96 Allowed 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.397 0.617 . . . . 0.0 110.331 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.6 t -142.08 142.51 32.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.929 -0.482 . . . . 0.0 109.878 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.498 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 64.7 t80 -125.65 140.04 53.05 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.509 -0.744 . . . . 0.0 110.787 -171.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.2 t -111.7 124.88 53.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.8 -0.562 . . . . 0.0 109.958 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 59.2 m -70.95 -37.02 72.81 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.749 -0.595 . . . . 0.0 110.571 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -59.01 -34.75 72.24 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.573 -0.704 . . . . 0.0 110.444 -177.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.0 mt -104.83 -12.04 16.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.662 -0.649 . . . . 0.0 110.88 -176.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 82.3 tttt 59.73 51.62 6.1 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.074 -1.017 . . . . 0.0 109.673 178.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -145.09 153.07 41.04 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.594 -173.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.6 tp -126.56 137.73 53.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.779 -0.576 . . . . 0.0 110.24 -175.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -116.0 135.4 54.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.674 -0.641 . . . . 0.0 109.288 173.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.9 p -138.36 158.42 44.31 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.705 -0.622 . . . . 0.0 110.899 -175.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -104.5 144.07 32.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.64 -0.662 . . . . 0.0 110.277 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 17.2 tt -52.81 146.05 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-O 121.592 0.711 . . . . 0.0 111.802 -173.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 64.5 10.0 5.46 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.554 -0.716 . . . . 0.0 112.484 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -96.61 155.06 16.93 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.995 -1.066 . . . . 0.0 110.867 175.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 85.0 m -84.5 126.13 33.01 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.689 -0.632 . . . . 0.0 110.668 -177.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 44.7 t -115.37 90.19 24.12 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.576 -0.702 . . . . 0.0 110.202 174.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.426 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 21.2 Cg_exo -62.59 131.1 32.17 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.216 1.114 . . . . 0.0 110.691 173.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.421 HG12 ' CE2' ' A' ' 142' ' ' PHE . 95.1 mt -125.08 143.82 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.659 -0.651 . . . . 0.0 109.279 175.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -109.47 135.36 50.61 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.496 -0.753 . . . . 0.0 110.813 -175.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 48.7 mm -95.29 135.01 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.604 -0.685 . . . . 0.0 109.584 168.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -116.11 128.0 55.3 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.608 -0.683 . . . . 0.0 110.406 175.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.1 m -136.57 159.72 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.674 -0.641 . . . . 0.0 109.892 175.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.7 mmm -74.46 -40.44 61.89 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.704 -0.622 . . . . 0.0 110.094 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 77.5 p -135.87 143.23 43.56 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.752 -0.593 . . . . 0.0 109.825 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -55.34 139.9 81.72 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 O-C-N 123.17 1.089 . . . . 0.0 110.861 -173.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.427 ' HG3' ' CE2' ' A' ' 251' ' ' TYR . 18.0 Cg_endo -61.97 166.9 11.46 Favored 'Trans proline' 0 N--CA 1.487 1.145 0 O-C-N 123.217 1.114 . . . . 0.0 110.72 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -61.06 155.68 49.09 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 O-C-N 123.382 1.201 . . . . 0.0 110.41 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -73.55 138.66 45.11 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.652 -0.655 . . . . 0.0 109.93 176.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.57 -24.94 29.36 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -174.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.14 150.94 2.18 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.367 -1.078 . . . . 0.0 111.426 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.78 155.94 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.735 -0.603 . . . . 0.0 109.906 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.402 HD12 ' CD2' ' A' ' 251' ' ' TYR . 53.4 mt -109.61 135.57 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -114.95 145.97 41.67 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.674 -0.641 . . . . 0.0 109.292 -174.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -140.54 127.74 21.01 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.546 -0.721 . . . . 0.0 110.312 173.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 41.3 ttp -137.25 139.91 29.35 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.766 -0.584 . . . . 0.0 111.061 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -91.12 138.2 2.28 Favored 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 121.051 1.167 . . . . 0.0 110.789 177.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.8 m -147.38 154.85 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.539 -0.725 . . . . 0.0 110.06 174.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.417 ' CE2' HG21 ' A' ' 202' ' ' VAL . 78.3 m-85 -63.02 167.69 4.64 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.457 -0.777 . . . . 0.0 110.517 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -85.05 -60.12 2.14 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.657 -0.652 . . . . 0.0 110.834 -173.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -80.11 152.33 29.35 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.593 -0.692 . . . . 0.0 110.284 -175.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.67 -38.68 72.54 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.364 -0.835 . . . . 0.0 110.664 -175.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -56.58 -24.77 49.66 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.499 -0.751 . . . . 0.0 110.558 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.406 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 98.7 m-70 -109.71 -20.49 12.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.534 -0.729 . . . . 0.0 111.167 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.2 p -67.65 -20.22 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.12 -0.987 . . . . 0.0 110.581 -176.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 67.8 p -79.42 -16.85 55.48 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.544 -0.723 . . . . 0.0 110.856 174.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.35 136.41 33.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.303 -0.873 . . . . 0.0 110.086 175.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.1 t -73.0 143.26 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.661 -0.649 . . . . 0.0 110.267 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.417 HG21 ' CE2' ' A' ' 192' ' ' TYR . 60.8 t -84.94 136.39 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.625 -0.672 . . . . 0.0 109.224 171.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.8 pttt -134.89 -170.22 2.52 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.453 -0.779 . . . . 0.0 111.137 -168.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -95.3 158.96 15.23 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.776 -0.578 . . . . 0.0 110.34 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.619 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 56.9 m . . . . . 0 N--CA 1.497 1.91 0 O-C-N 121.551 -0.718 . . . . 0.0 109.304 175.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 39.5 tp . . . . . 0 N--CA 1.497 1.887 0 CA-C-O 120.795 0.331 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 83.2 mt -101.42 136.77 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.795 -0.566 . . . . 0.0 109.84 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -131.69 156.98 44.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.688 -0.633 . . . . 0.0 110.328 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 88.3 t -103.13 146.65 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.749 -0.595 . . . . 0.0 109.941 176.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -118.24 126.76 52.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.721 -0.612 . . . . 0.0 110.368 171.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 96.98 21.4 20.91 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 168.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -139.4 105.23 5.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.3 -1.118 . . . . 0.0 110.038 174.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 91.6 p -63.65 -15.1 57.42 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.604 -0.685 . . . . 0.0 111.232 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -97.02 9.97 40.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.245 -0.909 . . . . 0.0 111.235 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.75 130.49 46.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.127 -0.983 . . . . 0.0 110.09 175.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -139.74 157.96 44.89 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.668 -0.645 . . . . 0.0 109.862 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -118.58 150.81 39.03 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.576 -0.702 . . . . 0.0 110.646 -176.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.11 159.9 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.776 -0.578 . . . . 0.0 110.128 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -120.38 130.04 54.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.738 -0.601 . . . . 0.0 110.262 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.27 119.08 46.3 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.625 -0.672 . . . . 0.0 109.669 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.16 -27.7 78.93 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 O-C-N 123.059 1.031 . . . . 0.0 110.874 -172.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 84.0 mt -102.99 -50.32 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.434 -0.792 . . . . 0.0 110.952 -170.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 18.6 p -105.33 12.23 31.92 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.379 -0.826 . . . . 0.0 111.975 -171.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 82.95 -25.04 4.9 Favored Glycine 0 N--CA 1.497 2.737 0 O-C-N 121.009 -1.057 . . . . 0.0 111.825 168.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -45.89 142.13 2.75 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 118.598 1.199 . . . . 0.0 112.627 -168.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -105.22 146.9 28.65 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.659 -0.651 . . . . 0.0 110.036 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.2 p -154.74 159.92 40.99 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.576 -0.703 . . . . 0.0 110.35 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 8.4 p -122.92 148.1 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.729 -0.607 . . . . 0.0 109.814 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 81.9 mt -129.71 154.61 46.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.738 -0.601 . . . . 0.0 109.891 -175.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 33.8 m -151.3 151.84 29.91 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.878 -0.514 . . . . 0.0 109.935 175.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -71.04 138.95 34.81 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 O-C-N 123.269 1.142 . . . . 0.0 109.95 177.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.427 ' CE2' ' HG3' ' A' ' 180' ' ' PRO . 10.0 t80 -78.69 126.51 30.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.496 -0.753 . . . . 0.0 110.21 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -99.97 160.05 28.22 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.695 -0.628 . . . . 0.0 110.059 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -59.17 159.53 22.01 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.234 1.123 . . . . 0.0 110.423 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.38 149.96 78.02 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 O-C-N 123.261 1.137 . . . . 0.0 110.536 -177.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -61.3 148.09 42.4 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.679 -0.638 . . . . 0.0 110.2 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.9 t -69.84 127.2 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.563 -0.711 . . . . 0.0 110.178 -170.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.03 -10.14 55.23 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.405 ' OG1' ' CE2' ' A' ' 260' ' ' PHE . 10.0 t -144.5 173.25 11.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.169 -1.195 . . . . 0.0 110.642 175.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -106.9 13.22 27.98 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.674 -0.641 . . . . 0.0 111.743 -168.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . 0.405 ' CE2' ' OG1' ' A' ' 258' ' ' THR . 14.8 p90 -119.99 168.06 11.54 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.159 -0.963 . . . . 0.0 111.092 -175.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 84.1 m -117.75 145.69 44.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.813 -0.554 . . . . 0.0 109.837 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 52.2 m -114.94 135.54 54.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.594 -0.691 . . . . 0.0 110.934 -174.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.6 t -130.12 137.24 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 72.1 mt -104.73 119.07 38.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.581 -0.7 . . . . 0.0 109.863 -172.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -105.89 151.24 24.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.675 -0.64 . . . . 0.0 110.614 -177.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -136.6 142.91 43.35 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -112.23 131.06 55.7 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.518 -0.739 . . . . 0.0 110.437 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -100.23 7.43 44.48 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.683 -0.636 . . . . 0.0 111.972 -175.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -144.76 164.95 29.48 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.075 -1.016 . . . . 0.0 109.834 171.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -120.7 161.94 20.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.651 -0.656 . . . . 0.0 110.456 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 22.5 m -58.08 -33.42 69.05 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.48 -0.762 . . . . 0.0 111.082 -163.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 48.8 p -99.4 11.5 38.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.466 -0.771 . . . . 0.0 112.011 -163.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . 0.619 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 30.2 p -94.48 118.01 31.0 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.124 -0.985 . . . . 0.0 110.672 178.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.7 t -64.12 140.04 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.504 -0.748 . . . . 0.0 110.412 -169.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.46 -5.21 58.63 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -125.46 -100.43 1.25 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 170.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 93.3 mmm -64.28 -31.44 72.65 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.687 -0.89 . . . . 0.0 110.319 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.7 p30 43.38 51.51 5.98 Favored 'General case' 0 N--CA 1.505 2.301 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 175.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 54.81 27.05 8.39 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.275 -0.891 . . . . 0.0 111.145 175.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -118.32 105.91 45.72 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.575 -0.703 . . . . 0.0 110.057 176.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.51 147.27 92.27 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 O-C-N 123.119 1.063 . . . . 0.0 110.6 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 45.7 pt -131.88 178.32 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 121.744 0.783 . . . . 0.0 110.832 -177.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 31.3 mt -124.4 149.87 46.22 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.422 ' HB ' ' CZ ' ' A' ' 301' ' ' PHE . 81.2 mt -115.27 130.34 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 82.0 mt -109.74 126.26 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -176.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 59.7 t -118.9 126.71 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.6 p -125.26 152.76 44.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.637 -0.665 . . . . 0.0 110.665 -174.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 19.8 tp -102.59 126.17 49.58 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 168.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -131.78 149.13 52.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.814 -0.554 . . . . 0.0 110.003 -172.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 19.0 p -89.98 161.11 16.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.706 -0.621 . . . . 0.0 110.115 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -55.95 -26.12 46.52 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.603 -0.686 . . . . 0.0 111.094 -176.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 46.0 p30 -90.18 9.66 27.57 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.399 -0.813 . . . . 0.0 111.889 -173.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 88.79 20.19 48.23 Favored Glycine 0 N--CA 1.494 2.542 0 O-C-N 121.12 -0.987 . . . . 0.0 110.655 171.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -107.98 140.15 41.56 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.267 -1.137 . . . . 0.0 110.025 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 60.8 t -88.74 132.23 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.65 -0.656 . . . . 0.0 110.234 -172.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 96.2 mt -99.88 -40.08 7.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.707 -0.62 . . . . 0.0 110.532 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -162.61 150.83 20.33 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 78.5 mtm180 -135.15 134.77 40.52 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.686 -0.89 . . . . 0.0 110.566 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -137.34 158.69 43.87 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.676 -0.64 . . . . 0.0 109.982 172.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 97.7 m -142.56 155.69 45.03 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.424 -0.797 . . . . 0.0 110.713 -175.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.422 ' CZ ' ' HB ' ' A' ' 284' ' ' ILE . 47.9 p90 -144.94 163.73 33.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.72 -0.612 . . . . 0.0 110.113 175.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -104.91 135.37 46.39 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.496 -0.752 . . . . 0.0 110.151 -177.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -124.29 143.5 50.52 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.677 -170.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -138.67 139.01 38.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.843 -0.536 . . . . 0.0 109.806 173.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 74.5 mt -105.82 122.93 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.549 -0.72 . . . . 0.0 109.59 175.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.9 p -145.18 168.24 20.85 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.558 -0.714 . . . . 0.0 110.968 -170.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -68.8 -39.97 79.81 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.686 -0.633 . . . . 0.0 110.636 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 4.1 t -131.25 88.54 44.2 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.534 -0.729 . . . . 0.0 110.496 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.33 -29.35 67.3 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 O-C-N 123.185 1.098 . . . . 0.0 110.914 174.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.36 -37.77 93.07 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -73.25 -40.63 64.48 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.689 -0.889 . . . . 0.0 109.875 -173.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -69.47 -39.96 77.4 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.164 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -61.01 -44.15 97.83 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.456 -0.777 . . . . 0.0 110.289 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -64.68 -40.14 94.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.557 -0.714 . . . . 0.0 110.495 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.57 -50.05 74.2 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.499 -0.751 . . . . 0.0 110.486 -173.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 N--CA 1.495 1.817 0 O-C-N 121.501 -0.749 . . . . 0.0 110.084 -178.283 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.5 t . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.05 0.453 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.5 p-10 -94.06 23.22 5.11 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.69 -0.631 . . . . 0.0 110.915 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 50.4 m -75.4 125.16 28.44 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.445 -0.785 . . . . 0.0 110.233 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -69.61 144.97 52.84 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.639 -0.663 . . . . 0.0 110.478 -177.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -153.18 100.59 2.65 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.647 -0.658 . . . . 0.0 110.118 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -59.14 -39.96 74.3 Favored 'Trans proline' 0 N--CA 1.489 1.206 0 O-C-N 123.129 1.068 . . . . 0.0 110.774 -175.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.3 -155.17 48.59 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -75.47 -43.57 0.35 Allowed 'Trans proline' 0 C--N 1.317 -1.095 0 O-C-N 123.303 1.159 . . . . 0.0 110.978 -174.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -86.77 8.1 24.12 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.529 -0.732 . . . . 0.0 111.412 -173.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.39 59.67 4.23 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.997 -1.064 . . . . 0.0 110.72 -176.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -77.82 117.25 19.01 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.572 -0.705 . . . . 0.0 109.933 -178.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -130.05 160.01 35.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.855 -0.528 . . . . 0.0 110.141 -178.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 63.8 t -126.41 146.42 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.681 -0.637 . . . . 0.0 109.816 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 78.4 p -155.26 161.4 41.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.765 -0.584 . . . . 0.0 110.069 177.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.497 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 67.1 m-85 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.8 -0.562 . . . . 0.0 109.851 -176.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 121.142 0.496 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 82.1 p -60.03 -32.92 71.34 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.715 -0.616 . . . . 0.0 109.99 175.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.418 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.8 p-90 -171.04 143.74 2.02 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.329 0.585 . . . . 0.0 110.059 177.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.0 t -142.15 142.63 32.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.88 -0.513 . . . . 0.0 110.072 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.497 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 44.7 t80 -125.49 140.06 53.09 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.551 -0.718 . . . . 0.0 110.514 -172.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.8 t -111.79 124.94 53.41 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 120.383 -0.527 . . . . 0.0 109.878 176.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 56.5 m -70.68 -37.07 73.61 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.789 -0.569 . . . . 0.0 110.483 -177.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -59.49 -33.86 71.86 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.645 -0.659 . . . . 0.0 110.441 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 57.1 mt -104.77 -12.04 16.52 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.678 -0.639 . . . . 0.0 110.88 -175.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 30.5 tttt 59.77 50.3 7.19 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.051 -1.031 . . . . 0.0 109.675 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -146.42 153.09 40.07 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.74 -0.6 . . . . 0.0 110.612 -174.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.6 tp -126.55 137.85 53.4 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.833 -0.542 . . . . 0.0 110.209 -176.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -114.94 135.2 54.47 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.1 p -138.34 158.5 44.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.72 -0.612 . . . . 0.0 111.044 -175.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -104.45 140.94 37.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.628 -0.67 . . . . 0.0 110.021 172.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 17.1 tt -52.25 148.67 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.502 -0.749 . . . . 0.0 111.917 -172.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 64.79 10.05 5.77 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.539 -0.726 . . . . 0.0 112.509 176.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt -95.35 155.11 16.87 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.924 -1.11 . . . . 0.0 110.955 174.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 87.3 m -84.68 126.25 33.22 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.721 -0.612 . . . . 0.0 110.552 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 29.9 t -115.15 90.36 23.62 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.572 -0.705 . . . . 0.0 110.178 176.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.418 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 22.6 Cg_endo -65.83 130.82 25.59 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 O-C-N 123.271 1.143 . . . . 0.0 110.597 176.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.417 HG12 ' CE2' ' A' ' 142' ' ' PHE . 96.9 mt -123.51 142.06 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.692 -0.63 . . . . 0.0 109.306 176.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -109.08 134.7 51.34 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.552 -0.718 . . . . 0.0 110.713 -176.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.1 mm -95.29 134.76 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.67 -0.644 . . . . 0.0 109.66 169.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -115.16 127.27 55.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.593 -0.692 . . . . 0.0 110.452 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.0 m -136.66 159.77 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.639 -0.663 . . . . 0.0 109.852 174.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.6 mmm -76.32 -40.69 50.73 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.658 -0.651 . . . . 0.0 110.092 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 77.5 p -134.45 143.28 46.09 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.763 -0.586 . . . . 0.0 109.9 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -55.5 139.92 82.64 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 O-C-N 123.173 1.091 . . . . 0.0 110.947 -173.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.423 ' HG3' ' CE2' ' A' ' 251' ' ' TYR . 19.3 Cg_endo -59.95 165.2 10.67 Favored 'Trans proline' 0 C--N 1.316 -1.167 0 O-C-N 123.17 1.09 . . . . 0.0 110.656 177.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -62.04 154.86 59.25 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 O-C-N 123.312 1.164 . . . . 0.0 110.446 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -64.67 137.54 57.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.65 -0.656 . . . . 0.0 110.117 173.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 96.8 -24.96 28.67 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.861 -1.295 . . . . 0.0 109.861 -177.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.15 149.21 2.96 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.324 -1.104 . . . . 0.0 111.423 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.74 155.95 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.72 -0.612 . . . . 0.0 109.831 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.423 HD11 ' CD2' ' A' ' 251' ' ' TYR . 64.0 mt -108.79 135.21 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -114.95 145.85 41.8 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -174.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -140.54 126.53 19.51 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.534 -0.729 . . . . 0.0 110.212 173.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 32.9 ttp -137.22 139.0 26.76 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.804 -0.56 . . . . 0.0 110.98 -176.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -91.11 138.25 2.29 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 O-C-N 123.204 1.107 . . . . 0.0 110.81 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 35.9 m -146.22 154.87 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.554 -0.716 . . . . 0.0 110.118 173.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.45 ' CE2' ' CG2' ' A' ' 202' ' ' VAL . 83.4 m-85 -60.73 161.32 8.07 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.467 -0.771 . . . . 0.0 110.402 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 33.7 tttt -77.6 -60.07 2.52 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.632 -0.668 . . . . 0.0 110.827 -174.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -80.13 151.02 30.02 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.558 -0.713 . . . . 0.0 110.34 -175.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.54 -37.81 71.0 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.421 -0.8 . . . . 0.0 110.695 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -56.61 -24.78 50.28 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.529 -0.732 . . . . 0.0 110.573 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.404 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 64.2 m170 -109.49 -20.51 12.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.531 -0.731 . . . . 0.0 111.165 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.2 p -67.72 -20.22 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.174 -0.954 . . . . 0.0 110.574 -176.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 67.7 p -79.36 -16.98 55.4 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.562 -0.711 . . . . 0.0 110.735 174.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -88.36 137.3 32.45 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.349 -0.845 . . . . 0.0 110.092 173.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.9 t -73.0 142.0 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.626 -0.671 . . . . 0.0 110.299 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.45 ' CG2' ' CE2' ' A' ' 192' ' ' TYR . 75.8 t -84.96 139.7 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.542 -0.724 . . . . 0.0 109.344 170.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 14.7 pttt -134.86 -170.08 2.49 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.553 -0.717 . . . . 0.0 110.883 -170.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -95.13 154.72 17.05 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.741 -0.599 . . . . 0.0 110.286 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.723 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 42.0 m . . . . . 0 N--CA 1.497 1.88 0 O-C-N 121.632 -0.668 . . . . 0.0 109.271 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 30.1 tp . . . . . 0 N--CA 1.496 1.84 0 CA-C-O 120.925 0.393 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 84.8 mt -103.94 136.76 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.746 -0.596 . . . . 0.0 109.917 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -131.6 156.7 45.34 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.667 -0.646 . . . . 0.0 110.318 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 89.4 t -102.28 146.62 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.772 -0.58 . . . . 0.0 109.974 176.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -117.96 130.03 55.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.722 -0.611 . . . . 0.0 110.431 171.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 93.15 21.55 29.81 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 167.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -136.73 107.24 6.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.319 -1.107 . . . . 0.0 110.048 173.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 94.5 p -63.43 -15.14 56.79 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.651 -0.656 . . . . 0.0 111.192 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -97.27 10.05 40.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.272 -0.892 . . . . 0.0 111.189 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.81 126.58 27.84 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.174 -0.954 . . . . 0.0 110.092 176.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -139.75 154.39 47.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.762 -0.586 . . . . 0.0 109.785 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.401 ' CD1' ' HB ' ' A' ' 247' ' ' VAL . 86.3 m-85 -116.95 150.7 38.11 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.596 -0.69 . . . . 0.0 110.538 -176.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.17 159.89 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.762 -0.587 . . . . 0.0 110.118 176.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -122.86 130.0 52.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.75 -0.594 . . . . 0.0 110.177 177.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -64.98 109.98 3.6 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.649 -0.657 . . . . 0.0 109.741 176.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -59.98 -24.46 76.51 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.083 1.044 . . . . 0.0 111.032 -172.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 84.3 mt -99.87 -50.39 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.488 -0.757 . . . . 0.0 110.766 -171.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 6.2 p -105.3 12.09 32.13 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.365 -0.834 . . . . 0.0 111.984 -173.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 81.97 -24.98 4.3 Favored Glycine 0 N--CA 1.496 2.7 0 O-C-N 120.982 -1.074 . . . . 0.0 111.888 169.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 -45.88 142.08 2.76 Favored 'General case' 0 N--CA 1.505 2.282 0 CA-C-N 118.59 1.195 . . . . 0.0 112.614 -168.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -108.8 144.58 36.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.629 -0.669 . . . . 0.0 110.063 174.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 78.8 p -154.83 159.96 40.91 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.62 -0.675 . . . . 0.0 110.48 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.401 ' HB ' ' CD1' ' A' ' 236' ' ' TYR . 8.3 p -123.07 148.12 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.77 -0.581 . . . . 0.0 109.695 177.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 81.3 mt -129.71 154.64 46.97 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.896 -176.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 35.9 m -150.57 151.84 31.48 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.807 -0.558 . . . . 0.0 109.944 175.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -71.11 138.81 34.31 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 O-C-N 123.188 1.099 . . . . 0.0 109.844 177.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.423 ' CD2' HD11 ' A' ' 186' ' ' ILE . 9.0 t80 -78.45 126.06 30.23 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.454 -0.779 . . . . 0.0 110.04 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -100.0 160.11 28.06 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.719 -0.613 . . . . 0.0 110.02 177.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -59.11 159.62 21.48 Favored 'Trans proline' 0 C--N 1.316 -1.157 0 O-C-N 123.276 1.145 . . . . 0.0 110.401 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.36 149.98 77.8 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.268 1.141 . . . . 0.0 110.521 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -60.53 148.42 37.95 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.681 -0.637 . . . . 0.0 110.241 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.82 127.17 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.516 -0.74 . . . . 0.0 110.154 -170.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.99 -10.17 55.39 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.401 ' OG1' ' CD2' ' A' ' 260' ' ' PHE . 10.0 t -144.66 173.31 11.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.177 -1.19 . . . . 0.0 110.586 175.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -107.19 13.14 27.6 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.63 -0.669 . . . . 0.0 111.783 -168.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . 0.401 ' CD2' ' OG1' ' A' ' 258' ' ' THR . 15.2 p90 -119.99 168.05 11.54 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.11 -0.994 . . . . 0.0 111.083 -175.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 83.6 m -117.72 145.83 44.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.729 -0.607 . . . . 0.0 109.876 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 42.8 m -115.59 135.72 53.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.622 -0.674 . . . . 0.0 110.885 -175.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.4 t -129.7 137.32 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 62.8 mt -104.63 118.57 36.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.511 -0.743 . . . . 0.0 109.73 -172.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -105.56 151.31 24.48 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.694 -0.629 . . . . 0.0 110.578 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -136.53 142.9 43.48 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -112.53 129.26 56.42 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.608 -0.682 . . . . 0.0 110.458 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -98.23 -1.84 41.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.741 -0.6 . . . . 0.0 111.95 -176.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.73 159.11 43.38 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.117 -0.989 . . . . 0.0 109.839 174.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -113.95 153.49 29.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.732 -0.605 . . . . 0.0 110.059 178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 89.1 p -56.54 -26.51 55.09 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.43 -0.794 . . . . 0.0 111.189 -168.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 49.8 p -94.4 8.09 43.22 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.396 -0.815 . . . . 0.0 112.095 -166.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . 0.723 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 28.8 p -92.98 116.61 29.21 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.009 -1.057 . . . . 0.0 110.584 178.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.39 143.3 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.482 -0.761 . . . . 0.0 110.414 -166.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.55 -5.33 58.55 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.96 -93.13 0.66 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 170.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 94.3 mmm -66.31 -29.06 69.19 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.731 -0.864 . . . . 0.0 110.36 176.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.8 p30 45.1 52.46 8.41 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 172.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 54.91 33.14 19.33 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.255 -0.903 . . . . 0.0 111.227 174.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -113.97 104.95 54.84 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.511 -0.743 . . . . 0.0 110.245 173.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -61.1 145.49 98.81 Favored 'Trans proline' 0 N--CA 1.488 1.171 0 O-C-N 123.107 1.056 . . . . 0.0 110.293 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 44.0 pt -131.97 176.82 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.943 0.878 . . . . 0.0 111.244 -174.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 31.4 mt -124.29 149.86 46.05 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.423 HD12 ' CE1' ' A' ' 301' ' ' PHE . 81.6 mt -114.85 129.4 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.253 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 80.4 mt -109.8 126.26 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -176.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 58.3 t -118.96 126.77 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.3 p -125.27 152.24 44.9 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.621 -174.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 21.1 tp -101.44 125.29 48.06 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 167.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -131.17 150.84 51.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.85 -0.531 . . . . 0.0 109.979 -172.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 68.9 p -89.96 159.88 16.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.606 -0.684 . . . . 0.0 109.908 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -55.95 -26.1 46.48 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.523 -0.735 . . . . 0.0 110.809 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -87.5 9.69 20.12 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.477 -0.764 . . . . 0.0 111.862 -174.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 86.9 20.16 54.23 Favored Glycine 0 N--CA 1.495 2.567 0 C-N-CA 120.195 -1.002 . . . . 0.0 110.733 170.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -106.84 140.14 40.14 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.293 -1.122 . . . . 0.0 110.267 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 59.9 t -88.32 130.15 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.65 -0.656 . . . . 0.0 110.034 -175.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 96.0 mt -99.94 -40.15 7.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.681 -0.637 . . . . 0.0 110.46 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -160.14 147.9 15.56 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -135.09 134.4 40.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.644 -0.915 . . . . 0.0 110.565 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -137.47 158.95 43.28 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.654 -0.654 . . . . 0.0 110.036 172.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 92.8 m -142.26 155.73 45.25 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.467 -0.771 . . . . 0.0 110.745 -175.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.423 ' CE1' HD12 ' A' ' 284' ' ' ILE . 48.9 p90 -144.98 160.54 41.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.701 -0.625 . . . . 0.0 110.074 174.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -104.88 135.92 45.33 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.539 -0.726 . . . . 0.0 110.178 -177.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -118.41 143.74 46.45 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.812 -169.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -138.57 138.07 37.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.819 -0.551 . . . . 0.0 109.759 173.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 34.8 mt -110.8 122.85 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.538 -0.726 . . . . 0.0 109.495 178.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.3 p -145.25 171.9 13.9 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.561 -0.712 . . . . 0.0 111.035 -169.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -70.32 -40.06 74.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.681 -0.637 . . . . 0.0 110.653 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 4.5 t -132.37 89.98 35.23 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.574 -0.704 . . . . 0.0 110.525 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.18 -30.08 69.5 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.15 1.079 . . . . 0.0 111.032 174.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.03 -37.48 93.19 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -73.66 -40.59 63.6 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.701 -0.882 . . . . 0.0 109.895 -173.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -69.56 -39.99 77.05 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 120.084 -0.647 . . . . 0.0 110.236 -177.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -61.26 -43.77 98.34 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.382 177.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -64.86 -38.36 90.71 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.524 -0.735 . . . . 0.0 110.461 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.84 -49.76 75.0 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.539 -0.726 . . . . 0.0 110.539 -173.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 2.8 p30 . . . . . 0 N--CA 1.495 1.79 0 O-C-N 121.488 -0.758 . . . . 0.0 110.138 -178.674 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.9 t . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.011 0.434 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -95.05 24.79 4.6 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.717 -0.614 . . . . 0.0 110.756 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 52.0 m -74.96 125.23 28.45 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.587 -0.696 . . . . 0.0 110.263 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -69.88 144.93 52.34 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.675 -0.64 . . . . 0.0 110.496 -177.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -156.96 102.33 1.93 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.675 -0.64 . . . . 0.0 110.048 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.97 -39.98 66.09 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 O-C-N 123.138 1.073 . . . . 0.0 110.699 -175.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.39 -155.15 43.35 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -72.65 -48.97 0.28 Allowed 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.318 1.168 . . . . 0.0 110.813 -175.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -83.77 4.64 28.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.537 -0.727 . . . . 0.0 111.369 -175.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 t 54.12 61.22 3.15 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.908 -1.12 . . . . 0.0 110.664 -176.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.423 ' CE1' ' HB2' ' A' ' 288' ' ' LEU . 63.0 t80 -77.96 119.92 22.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.522 -0.736 . . . . 0.0 110.04 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -129.98 160.01 34.93 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.778 -0.576 . . . . 0.0 110.072 -176.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.2 t -124.55 146.34 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.789 -0.57 . . . . 0.0 109.754 177.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.3 p -155.12 162.96 40.86 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.325 0.583 . . . . 0.0 109.941 177.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.492 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 71.2 m-85 . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.74 -0.6 . . . . 0.0 109.762 -176.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 121.169 0.509 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.402 ' OG1' ' CD1' ' A' ' 153' ' ' TRP . 65.2 p -60.13 -34.02 72.95 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.742 -0.599 . . . . 0.0 109.967 175.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.424 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -171.33 143.48 1.86 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.399 0.618 . . . . 0.0 110.406 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 13.4 t -142.16 142.68 32.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.899 -0.5 . . . . 0.0 109.892 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.492 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 62.3 t80 -125.56 140.03 53.09 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.399 -0.813 . . . . 0.0 110.646 -171.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.8 t -110.38 124.92 52.61 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.878 176.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 54.6 m -70.84 -37.0 73.12 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.838 -0.539 . . . . 0.0 110.414 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -59.36 -33.9 71.73 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.652 -0.655 . . . . 0.0 110.47 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.0 mt -104.79 -12.02 16.51 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.691 -0.631 . . . . 0.0 110.838 -175.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt 59.69 49.27 8.39 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.076 -1.015 . . . . 0.0 109.699 177.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.416 ' HE3' ' CZ ' ' A' ' 163' ' ' TYR . 34.2 ttpt -147.15 153.26 39.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.714 -0.616 . . . . 0.0 110.563 -173.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.5 tp -126.44 138.06 53.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.686 -0.633 . . . . 0.0 110.315 -173.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.416 ' CZ ' ' HE3' ' A' ' 161' ' ' LYS . 54.0 m-85 -114.72 133.75 55.64 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.36 158.46 44.24 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.65 -0.656 . . . . 0.0 110.824 -175.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -104.62 141.9 35.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.595 -0.691 . . . . 0.0 110.275 172.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 16.6 tt -51.42 147.38 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 CA-C-O 121.624 0.726 . . . . 0.0 111.989 -174.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 64.26 10.06 5.3 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.521 -0.737 . . . . 0.0 112.534 176.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 30.5 mmtm -96.28 155.04 16.93 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.899 -1.126 . . . . 0.0 110.838 175.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 86.5 m -84.37 126.22 33.02 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.707 -0.621 . . . . 0.0 110.525 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 44.0 t -115.22 90.19 23.37 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.62 -0.675 . . . . 0.0 110.199 174.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.424 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 23.1 Cg_exo -61.85 130.75 32.27 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 O-C-N 123.278 1.146 . . . . 0.0 110.677 173.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.418 HG12 ' CE2' ' A' ' 142' ' ' PHE . 93.2 mt -124.97 142.16 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.626 -0.671 . . . . 0.0 109.219 175.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -107.93 136.3 47.87 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.475 -0.766 . . . . 0.0 110.826 -174.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.417 HD11 ' CZ ' ' A' ' 138' ' ' PHE . 48.6 mm -95.22 135.07 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.757 -0.589 . . . . 0.0 109.691 169.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -118.09 128.99 55.27 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.415 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 17.3 m -136.24 159.82 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.63 -0.669 . . . . 0.0 109.979 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 81.2 mmm -77.75 -40.49 40.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.713 -0.617 . . . . 0.0 110.085 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 77.1 p -135.21 143.27 44.97 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.797 -0.564 . . . . 0.0 109.788 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -55.57 139.8 82.96 Favored 'Trans proline' 0 N--CA 1.489 1.264 0 O-C-N 123.245 1.129 . . . . 0.0 110.871 -172.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.436 ' CG ' ' CE1' ' A' ' 251' ' ' TYR . 23.8 Cg_endo -64.47 169.38 11.23 Favored 'Trans proline' 0 N--CA 1.488 1.151 0 O-C-N 123.181 1.095 . . . . 0.0 110.704 178.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -61.19 158.26 35.87 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 O-C-N 123.321 1.169 . . . . 0.0 110.469 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -78.7 138.18 38.15 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.602 -0.686 . . . . 0.0 109.969 175.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.5 -24.84 30.6 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -174.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.2 151.09 2.17 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.35 -1.088 . . . . 0.0 111.322 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.7 155.95 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.727 -0.608 . . . . 0.0 109.762 176.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 66.5 mt -108.13 137.0 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.406 ' HG2' ' CD2' ' A' ' 248' ' ' LEU . 37.8 mtp180 -114.87 146.79 40.72 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -175.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -140.85 126.07 18.54 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.483 -0.761 . . . . 0.0 110.4 171.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 48.5 ttp -137.33 140.69 31.49 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.775 -0.578 . . . . 0.0 111.052 -176.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -89.85 138.25 2.95 Favored 'Trans proline' 0 C--N 1.32 -0.96 0 O-C-N 123.24 1.126 . . . . 0.0 110.843 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.7 m -146.39 154.82 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.547 -0.721 . . . . 0.0 110.085 173.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.451 ' CE2' ' CG2' ' A' ' 202' ' ' VAL . 88.3 m-85 -62.92 162.9 10.46 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.522 -0.736 . . . . 0.0 110.468 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -78.93 -60.04 2.54 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.659 -0.65 . . . . 0.0 110.815 -175.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 38.9 mttp -80.1 150.77 30.16 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.62 -0.675 . . . . 0.0 110.34 -175.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.52 -37.69 70.8 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.371 -0.831 . . . . 0.0 110.728 -176.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -56.44 -24.83 48.0 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.536 -0.727 . . . . 0.0 110.642 -176.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.407 ' HB3' ' CG ' ' A' ' 192' ' ' TYR . 77.7 m80 -110.09 -20.51 12.67 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.174 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.1 p -67.07 -20.28 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.15 -0.969 . . . . 0.0 110.544 -176.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 71.9 p -79.29 -16.99 55.52 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.491 -0.756 . . . . 0.0 110.651 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -88.34 137.19 32.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.34 -0.85 . . . . 0.0 110.041 172.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.3 t -73.1 141.58 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.645 -0.659 . . . . 0.0 110.248 177.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.451 ' CG2' ' CE2' ' A' ' 192' ' ' TYR . 64.7 t -84.93 137.8 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.618 -0.676 . . . . 0.0 109.405 171.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 12.1 pttt -134.92 -170.29 2.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.543 -0.723 . . . . 0.0 111.035 -171.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 83.5 mtm-85 -95.26 158.7 15.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.781 -0.575 . . . . 0.0 110.34 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.697 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 56.5 m . . . . . 0 N--CA 1.497 1.878 0 O-C-N 121.679 -0.638 . . . . 0.0 109.513 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 54.0 tp . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 120.941 0.4 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 82.6 mt -104.06 136.75 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.843 -0.536 . . . . 0.0 109.685 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -134.16 158.81 42.72 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.714 -0.616 . . . . 0.0 110.389 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 83.9 t -103.85 146.72 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.66 -0.65 . . . . 0.0 110.099 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -117.27 128.13 54.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.817 -0.552 . . . . 0.0 110.368 171.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.05 22.96 23.92 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 167.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -135.24 106.42 6.72 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.394 -1.062 . . . . 0.0 110.09 173.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 27.6 t -62.93 -15.12 54.3 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.649 -0.657 . . . . 0.0 111.24 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -100.13 5.02 44.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.198 -0.939 . . . . 0.0 111.61 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.4 131.16 49.33 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.039 -1.038 . . . . 0.0 110.276 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -139.76 157.74 45.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.782 -0.574 . . . . 0.0 109.62 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -115.72 150.63 36.52 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.592 -0.693 . . . . 0.0 110.497 -177.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.14 159.98 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.759 -0.588 . . . . 0.0 110.263 177.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -116.53 129.95 56.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.804 -0.56 . . . . 0.0 110.003 174.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -63.31 117.45 33.98 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.649 -0.657 . . . . 0.0 109.76 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.84 -27.18 80.09 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.096 1.051 . . . . 0.0 110.878 -172.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 84.2 mt -101.85 -50.34 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.439 -0.788 . . . . 0.0 110.907 -170.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 7.5 p -105.37 12.25 31.84 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.431 -0.793 . . . . 0.0 111.987 -172.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 81.25 -25.06 3.82 Favored Glycine 0 N--CA 1.498 2.787 0 O-C-N 121.006 -1.059 . . . . 0.0 111.868 170.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -45.71 142.09 2.61 Favored 'General case' 0 N--CA 1.505 2.285 0 CA-C-N 118.641 1.22 . . . . 0.0 112.726 -166.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -97.8 145.17 26.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.583 -0.698 . . . . 0.0 109.838 171.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 77.5 p -154.8 159.91 40.92 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.528 -0.732 . . . . 0.0 110.588 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 8.2 p -123.23 148.03 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.722 -0.611 . . . . 0.0 109.72 176.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.406 ' CD2' ' HG2' ' A' ' 187' ' ' ARG . 79.2 mt -129.78 154.76 46.9 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.833 -175.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 35.8 m -150.44 151.78 31.69 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.843 -0.536 . . . . 0.0 109.898 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -71.11 138.99 34.69 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 O-C-N 123.24 1.126 . . . . 0.0 109.923 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.436 ' CE1' ' CG ' ' A' ' 180' ' ' PRO . 9.9 t80 -80.05 123.43 27.84 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.543 -0.723 . . . . 0.0 110.188 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -99.99 160.1 28.1 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.717 -0.614 . . . . 0.0 110.07 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -58.83 160.1 19.03 Favored 'Trans proline' 0 N--CA 1.487 1.12 0 O-C-N 123.228 1.12 . . . . 0.0 110.414 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -58.67 149.91 73.55 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 O-C-N 123.171 1.09 . . . . 0.0 110.567 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -62.46 146.94 50.21 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.693 -0.629 . . . . 0.0 110.261 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.9 127.26 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.496 -0.752 . . . . 0.0 110.232 -171.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.65 -10.08 55.86 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.4 ' OG1' ' CE2' ' A' ' 260' ' ' PHE . 7.3 t -143.84 166.46 24.86 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.165 -1.197 . . . . 0.0 110.6 177.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -101.87 13.07 35.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.717 -0.615 . . . . 0.0 111.846 -168.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . 0.4 ' CE2' ' OG1' ' A' ' 258' ' ' THR . 9.6 p90 -127.57 168.13 15.4 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.098 -1.001 . . . . 0.0 111.126 -176.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 83.2 m -117.67 147.31 43.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.701 -0.624 . . . . 0.0 109.912 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 31.1 m -116.32 135.9 53.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.592 -0.693 . . . . 0.0 110.922 -174.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.5 t -128.57 137.21 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 171.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 70.2 mt -104.74 119.84 39.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.457 -0.777 . . . . 0.0 109.849 -172.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 6.1 m-30 -105.97 151.3 24.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.683 -0.636 . . . . 0.0 110.639 -176.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -136.63 142.98 43.28 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -114.07 130.6 56.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.513 -0.742 . . . . 0.0 110.407 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -99.12 1.4 45.04 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.708 -0.62 . . . . 0.0 111.963 -176.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -144.72 158.51 43.75 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.109 -0.994 . . . . 0.0 109.928 173.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -113.97 154.26 27.92 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.666 -0.646 . . . . 0.0 110.073 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 90.7 p -56.6 -26.97 57.0 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.373 -0.829 . . . . 0.0 111.096 -167.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 46.7 p -95.19 6.97 47.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.401 -0.812 . . . . 0.0 112.146 -165.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . 0.697 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 29.0 p -92.95 118.08 30.76 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.029 -1.044 . . . . 0.0 110.675 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.8 t -69.84 142.75 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.556 -0.715 . . . . 0.0 110.531 -168.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.4 -5.26 58.75 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.14 -95.45 0.74 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 169.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 95.3 mmm -64.7 -28.15 69.4 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.746 -0.855 . . . . 0.0 110.277 176.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 10.0 p30 44.73 50.92 8.51 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 172.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 54.76 34.12 21.08 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.375 -0.828 . . . . 0.0 111.316 174.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -115.94 104.93 52.03 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.548 -0.72 . . . . 0.0 110.141 172.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -60.26 145.03 99.43 Favored 'Trans proline' 0 N--CA 1.489 1.264 0 O-C-N 123.139 1.073 . . . . 0.0 110.374 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 42.8 pt -132.57 178.45 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 122.029 0.919 . . . . 0.0 111.373 -174.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 34.5 mt -124.3 149.86 46.06 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.43 ' HB ' ' CZ ' ' A' ' 301' ' ' PHE . 79.4 mt -112.24 128.71 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 77.8 mt -109.68 125.67 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -175.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 58.5 t -118.87 126.65 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.4 p -125.35 154.81 41.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.661 -0.649 . . . . 0.0 110.567 -174.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.423 ' HB2' ' CE1' ' A' ' 138' ' ' PHE . 24.4 tp -105.59 125.85 51.47 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 169.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -132.04 149.5 52.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.858 -0.526 . . . . 0.0 109.911 -173.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 25.4 p -89.98 161.28 15.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.703 -0.623 . . . . 0.0 110.031 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 69.7 ttp85 -55.94 -26.13 46.51 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.566 -0.708 . . . . 0.0 111.139 -175.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 44.7 p30 -90.87 9.82 28.82 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.444 -0.785 . . . . 0.0 111.963 -173.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.55 20.23 45.38 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.15 -1.024 . . . . 0.0 110.732 171.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -107.52 140.23 40.81 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.33 -1.1 . . . . 0.0 109.988 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 62.1 t -90.28 132.0 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.572 -0.705 . . . . 0.0 110.236 -172.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 96.0 mt -99.84 -40.29 7.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.767 -0.583 . . . . 0.0 110.545 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -162.05 153.17 23.78 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -135.06 135.19 41.09 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.598 -0.942 . . . . 0.0 110.521 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -138.03 156.0 48.25 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.611 -0.681 . . . . 0.0 110.028 172.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 98.3 m -143.23 155.7 44.57 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.379 -0.826 . . . . 0.0 110.844 -175.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.43 ' CZ ' ' HB ' ' A' ' 284' ' ' ILE . 47.8 p90 -145.3 162.62 36.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.643 -0.661 . . . . 0.0 110.156 174.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -104.77 137.34 42.71 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.591 -0.693 . . . . 0.0 110.219 -178.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -118.94 144.66 46.32 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.766 -170.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -136.99 138.51 40.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.799 -0.563 . . . . 0.0 109.725 173.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 61.6 mt -112.02 122.86 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.572 -0.705 . . . . 0.0 109.63 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.1 p -145.42 173.73 11.75 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.589 -0.695 . . . . 0.0 110.683 -171.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -74.17 -40.12 62.77 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.573 -0.704 . . . . 0.0 110.639 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.8 t -127.25 86.86 57.75 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.494 -0.754 . . . . 0.0 110.475 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -55.81 -28.65 68.43 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.117 1.062 . . . . 0.0 110.768 174.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.88 -37.45 92.23 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -73.38 -41.05 63.86 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.643 -0.916 . . . . 0.0 109.889 -173.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -69.41 -40.33 77.38 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 120.076 -0.649 . . . . 0.0 110.153 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -61.28 -44.19 97.65 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.482 -0.762 . . . . 0.0 110.258 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 23.6 ttpt -63.73 -39.63 94.77 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.641 -0.662 . . . . 0.0 110.432 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.86 -51.9 66.34 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.517 -0.74 . . . . 0.0 110.396 -173.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.4 p30 . . . . . 0 N--CA 1.494 1.772 0 O-C-N 121.437 -0.789 . . . . 0.0 110.15 -177.551 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.6 t . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.035 0.445 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.6 p-10 -93.91 22.5 5.63 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.644 -0.66 . . . . 0.0 110.877 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 52.0 m -79.14 125.18 29.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.466 -0.771 . . . . 0.0 110.177 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -68.78 144.95 54.18 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.585 -0.697 . . . . 0.0 110.444 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -156.54 101.2 2.03 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.727 -0.608 . . . . 0.0 110.098 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.65 -39.89 78.48 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 O-C-N 123.126 1.066 . . . . 0.0 110.857 -175.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.3 -155.16 39.66 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 178.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -72.88 -48.33 0.29 Allowed 'Trans proline' 0 N--CA 1.486 1.079 0 O-C-N 123.402 1.212 . . . . 0.0 110.983 -174.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -86.47 8.36 22.19 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.614 -0.679 . . . . 0.0 111.351 -174.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.8 58.3 5.23 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.983 -1.073 . . . . 0.0 110.6 -176.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.451 ' CE1' ' CG2' ' A' ' 174' ' ' ILE . 71.7 t80 -79.38 115.81 19.25 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.604 -0.685 . . . . 0.0 109.877 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -130.05 160.04 34.9 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.28 0.562 . . . . 0.0 110.41 -174.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 78.8 t -122.01 150.32 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.831 -0.543 . . . . 0.0 109.807 174.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 78.2 p -154.91 169.21 24.58 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.012 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.494 ' CD2' ' CE2' ' A' ' 155' ' ' TYR . 97.3 m-85 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.884 -0.51 . . . . 0.0 109.938 -176.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 121.124 0.488 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 77.8 p -60.05 -32.21 70.71 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.653 -0.655 . . . . 0.0 109.922 174.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.424 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -171.46 143.78 1.84 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.403 0.621 . . . . 0.0 110.132 178.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.3 t -142.1 142.56 32.81 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.863 -0.523 . . . . 0.0 109.916 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.494 ' CE2' ' CD2' ' A' ' 142' ' ' PHE . 62.6 t80 -125.56 140.01 53.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.533 -0.729 . . . . 0.0 110.673 -172.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.5 t -111.3 124.01 51.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.829 -0.545 . . . . 0.0 109.775 175.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 62.0 m -70.88 -37.09 73.02 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.819 -0.55 . . . . 0.0 110.359 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -59.09 -33.05 70.37 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.555 -0.716 . . . . 0.0 110.447 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 55.1 mt -104.8 -12.03 16.5 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.77 -176.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt 59.76 47.76 9.96 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.039 -1.038 . . . . 0.0 109.728 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.422 ' HE3' ' CZ ' ' A' ' 163' ' ' TYR . 20.7 ttpt -148.21 153.23 38.48 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 120.161 -0.615 . . . . 0.0 110.803 -173.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.5 tp -126.49 137.93 53.44 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.731 -0.605 . . . . 0.0 110.437 -173.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.422 ' CZ ' ' HE3' ' A' ' 161' ' ' LYS . 98.7 m-85 -114.85 134.38 55.19 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.9 p -138.39 158.44 44.28 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.61 -0.681 . . . . 0.0 111.194 -176.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -104.47 142.18 35.06 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.663 -0.648 . . . . 0.0 110.336 173.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 18.0 tt -55.04 148.22 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.548 -0.72 . . . . 0.0 111.613 -173.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 64.37 10.01 5.36 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.544 -0.723 . . . . 0.0 112.511 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -97.09 155.08 16.96 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.984 -1.073 . . . . 0.0 110.773 174.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 74.5 m -80.16 126.04 30.59 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.674 -0.641 . . . . 0.0 110.573 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 31.4 t -117.1 90.37 33.21 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.625 -0.672 . . . . 0.0 110.182 174.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.424 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 26.1 Cg_endo -66.97 128.25 18.38 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 O-C-N 123.337 1.177 . . . . 0.0 110.756 176.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.425 HG12 ' CE1' ' A' ' 142' ' ' PHE . 83.7 mt -122.51 141.64 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.675 -0.641 . . . . 0.0 109.362 172.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -109.48 136.95 48.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.54 -0.725 . . . . 0.0 110.755 -173.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.451 ' CG2' ' CE1' ' A' ' 138' ' ' PHE . 50.4 mm -95.24 135.01 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.779 -0.576 . . . . 0.0 109.744 172.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 17.0 tptp -117.57 130.81 56.64 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.606 -0.684 . . . . 0.0 110.492 176.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 17.6 m -136.34 159.76 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.579 -0.701 . . . . 0.0 110.04 174.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 79.8 mmm -77.63 -39.79 44.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.724 -0.61 . . . . 0.0 110.029 176.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 77.3 p -135.66 143.24 44.0 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.831 -0.543 . . . . 0.0 109.709 177.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -55.63 139.86 83.33 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 O-C-N 123.146 1.077 . . . . 0.0 110.821 -173.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.446 ' CG ' ' CE1' ' A' ' 251' ' ' TYR . 26.6 Cg_endo -65.19 169.61 11.94 Favored 'Trans proline' 0 N--CA 1.487 1.115 0 O-C-N 123.165 1.087 . . . . 0.0 110.684 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -61.27 156.7 44.17 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 O-C-N 123.37 1.195 . . . . 0.0 110.46 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -77.53 140.24 39.71 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.616 -0.677 . . . . 0.0 109.913 175.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.79 -24.91 29.62 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -175.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.16 151.64 1.97 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.363 -1.081 . . . . 0.0 111.319 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 33.8 m -129.77 155.89 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.766 -0.584 . . . . 0.0 109.597 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 79.3 mt -107.25 136.6 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.406 ' HG2' ' CD2' ' A' ' 248' ' ' LEU . 73.3 mtp180 -114.79 142.82 46.03 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -175.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -140.69 123.46 16.26 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.486 -0.759 . . . . 0.0 110.501 177.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 30.7 ttp -137.43 139.01 26.21 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.76 -0.587 . . . . 0.0 110.969 -175.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -90.62 138.18 2.53 Favored 'Trans proline' 0 C--N 1.318 -1.03 0 O-C-N 123.246 1.13 . . . . 0.0 110.418 176.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.6 m -146.47 154.81 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.596 -0.69 . . . . 0.0 110.196 175.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.423 ' CE1' HG23 ' A' ' 202' ' ' VAL . 89.1 m-85 -59.82 160.35 7.73 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.495 -0.753 . . . . 0.0 110.495 178.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 34.1 tttt -74.04 -59.45 2.72 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.598 -0.688 . . . . 0.0 110.729 -175.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -80.01 148.78 30.98 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.57 -0.706 . . . . 0.0 110.398 -174.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.86 -38.11 72.26 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.355 -0.84 . . . . 0.0 110.695 -175.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -56.41 -24.94 48.34 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.441 -0.787 . . . . 0.0 110.629 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.404 ' O ' ' CD1' ' A' ' 192' ' ' TYR . 94.3 m-70 -109.99 -20.51 12.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.597 -0.69 . . . . 0.0 111.188 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.2 p -67.25 -20.09 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.272 -0.892 . . . . 0.0 110.598 -176.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 69.2 p -79.27 -16.11 56.94 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.558 -0.714 . . . . 0.0 110.714 175.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -88.2 137.59 32.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.915 . . . . 0.0 110.049 172.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.7 t -73.01 142.36 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.606 -0.684 . . . . 0.0 110.25 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.423 HG23 ' CE1' ' A' ' 192' ' ' TYR . 77.0 t -84.81 139.11 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.514 -0.741 . . . . 0.0 109.339 170.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 14.1 pttt -134.81 -170.05 2.48 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.406 -0.809 . . . . 0.0 111.205 -165.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -95.13 154.4 17.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.783 -0.573 . . . . 0.0 110.62 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.614 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 61.0 m . . . . . 0 N--CA 1.496 1.867 0 O-C-N 121.668 -0.645 . . . . 0.0 109.303 172.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 32.2 tp . . . . . 0 N--CA 1.496 1.871 0 CA-C-O 120.936 0.398 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 83.6 mt -98.17 136.78 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-O 121.232 0.539 . . . . 0.0 109.896 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 -131.14 159.38 37.85 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.735 -0.603 . . . . 0.0 110.084 175.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 73.7 t -105.62 146.68 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.425 0.631 . . . . 0.0 110.204 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -121.5 130.04 53.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.725 -0.609 . . . . 0.0 110.311 171.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 96.61 20.42 24.61 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 169.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -140.01 103.7 4.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.36 -1.082 . . . . 0.0 109.944 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 93.5 p -63.62 -15.21 57.59 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.657 -0.652 . . . . 0.0 111.15 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -97.43 9.86 41.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.29 -0.881 . . . . 0.0 111.17 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -62.07 132.71 53.77 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.235 -0.915 . . . . 0.0 110.102 176.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -139.65 157.96 44.9 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.691 -0.631 . . . . 0.0 109.826 177.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -114.2 150.68 33.91 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.516 -0.74 . . . . 0.0 110.576 -177.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.18 159.92 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.73 -0.606 . . . . 0.0 110.124 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -119.76 130.06 54.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.741 -0.6 . . . . 0.0 110.209 176.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -63.44 130.07 94.04 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.65 -0.656 . . . . 0.0 109.792 177.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -64.77 -27.66 59.81 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 O-C-N 123.118 1.062 . . . . 0.0 111.045 -170.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.2 mt -101.4 -50.5 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.411 -0.806 . . . . 0.0 111.108 -167.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 75.7 p -105.46 12.18 31.74 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.315 -0.865 . . . . 0.0 111.881 -174.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.93 -4.97 14.35 Favored Glycine 0 N--CA 1.496 2.645 0 O-C-N 121.1 -1.0 . . . . 0.0 111.837 174.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -45.99 142.09 2.86 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 119.088 1.444 . . . . 0.0 112.334 -173.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -102.74 142.27 34.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.662 -0.649 . . . . 0.0 110.294 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 77.3 p -154.8 159.93 40.93 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.642 -0.661 . . . . 0.0 110.301 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 8.3 p -122.96 148.16 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.708 -0.62 . . . . 0.0 109.754 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.406 ' CD2' ' HG2' ' A' ' 187' ' ' ARG . 79.7 mt -129.69 154.63 46.96 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.763 -174.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 33.8 m -150.9 151.74 30.5 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.873 -0.517 . . . . 0.0 109.901 174.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -70.96 137.67 32.44 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 O-C-N 123.273 1.144 . . . . 0.0 109.92 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.446 ' CE1' ' CG ' ' A' ' 180' ' ' PRO . 11.7 t80 -77.9 122.85 26.04 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.552 -0.717 . . . . 0.0 110.183 179.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -100.01 160.01 28.32 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.753 -0.592 . . . . 0.0 110.15 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.92 160.02 19.57 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 123.233 1.123 . . . . 0.0 110.403 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -58.56 150.06 71.67 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 123.29 1.153 . . . . 0.0 110.666 -177.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -61.13 147.31 44.44 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.672 -0.643 . . . . 0.0 110.184 -177.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.81 127.2 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.485 -0.759 . . . . 0.0 110.167 -170.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.87 -10.13 55.54 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.415 ' OG1' ' CD2' ' A' ' 260' ' ' PHE . 10.2 t -144.31 174.2 11.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.177 -1.19 . . . . 0.0 110.614 175.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -108.18 13.14 26.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.603 -0.686 . . . . 0.0 111.854 -167.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . 0.415 ' CD2' ' OG1' ' A' ' 258' ' ' THR . 43.5 p90 -124.59 168.13 13.55 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.178 -0.951 . . . . 0.0 111.189 -176.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 94.2 m -117.79 145.95 44.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.737 -0.602 . . . . 0.0 109.862 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 44.4 m -116.57 136.29 53.1 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.535 -0.728 . . . . 0.0 110.937 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 60.1 t -127.05 137.08 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 60.2 mt -104.82 121.21 43.19 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.603 -0.685 . . . . 0.0 109.747 -173.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . 0.411 ' CE2' HD12 ' A' ' 172' ' ' ILE . 3.4 m-85 -99.95 156.71 17.0 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.578 -0.701 . . . . 0.0 110.88 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -136.41 142.94 43.72 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 171.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -110.4 128.97 55.84 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.551 -0.718 . . . . 0.0 110.27 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -95.29 -0.11 53.22 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.712 -0.618 . . . . 0.0 112.019 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -144.77 165.06 29.15 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.158 -0.964 . . . . 0.0 110.076 176.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -121.98 163.48 19.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.69 -0.631 . . . . 0.0 110.593 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 19.0 m -57.62 -34.15 69.0 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.414 -0.803 . . . . 0.0 111.136 -164.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 51.4 p -104.17 15.06 29.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.374 -0.829 . . . . 0.0 111.911 -163.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . 0.614 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 29.7 p -95.77 118.07 31.73 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.079 -1.013 . . . . 0.0 110.712 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 58.0 t -63.16 138.93 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.477 -0.764 . . . . 0.0 110.253 -171.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.04 -5.18 59.27 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.11 -98.33 0.83 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 171.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 93.2 mmm -63.17 -32.35 73.72 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.726 -0.867 . . . . 0.0 110.235 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.3 p30 44.21 48.84 7.79 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 174.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 54.76 30.27 13.27 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.377 -0.827 . . . . 0.0 111.306 174.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 15.4 mtt85 -119.45 107.04 41.58 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.59 -0.694 . . . . 0.0 110.08 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.58 148.0 89.29 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 O-C-N 123.127 1.067 . . . . 0.0 110.529 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 44.7 pt -131.9 177.52 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.709 0.766 . . . . 0.0 110.987 -176.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 34.3 mt -124.38 150.02 46.03 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 177.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.42 ' HB ' ' CZ ' ' A' ' 301' ' ' PHE . 77.7 mt -112.65 128.29 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.562 -0.711 . . . . 0.0 109.089 176.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 81.3 mt -109.86 125.57 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 59.1 t -118.87 126.63 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.5 p -125.31 154.66 41.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.581 -0.699 . . . . 0.0 110.623 -175.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.427 ' HB2' ' CE1' ' A' ' 138' ' ' PHE . 22.8 tp -105.22 126.41 52.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.819 -0.551 . . . . 0.0 109.539 169.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -132.47 150.99 52.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.863 -0.523 . . . . 0.0 109.902 -174.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 68.6 p -89.89 159.47 16.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.619 -0.675 . . . . 0.0 109.648 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -55.86 -26.11 45.43 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.532 -0.73 . . . . 0.0 110.81 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -87.52 9.14 21.97 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.489 -0.757 . . . . 0.0 111.855 -174.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 87.22 20.26 53.05 Favored Glycine 0 N--CA 1.495 2.59 0 O-C-N 121.053 -1.03 . . . . 0.0 110.704 170.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -106.81 140.12 40.15 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.262 -1.14 . . . . 0.0 110.206 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 59.4 t -88.33 131.32 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.666 -0.646 . . . . 0.0 110.194 -173.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 95.6 mt -99.91 -40.14 7.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.733 -0.604 . . . . 0.0 110.544 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -165.23 153.12 23.04 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -134.96 136.17 42.03 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.721 -0.87 . . . . 0.0 110.748 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -133.28 153.66 51.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.578 -0.701 . . . . 0.0 110.106 172.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 99.8 m -142.76 151.63 41.46 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.486 -0.759 . . . . 0.0 110.659 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.42 ' CZ ' ' HB ' ' A' ' 284' ' ' ILE . 49.8 p90 -145.43 166.7 24.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.701 -0.625 . . . . 0.0 110.029 173.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -104.78 136.1 44.93 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.449 -0.782 . . . . 0.0 110.277 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -123.3 144.5 49.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.682 -0.636 . . . . 0.0 110.548 -170.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -137.66 137.87 38.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.844 -0.535 . . . . 0.0 109.796 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 66.3 mt -106.34 123.0 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.581 -0.699 . . . . 0.0 109.556 175.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.0 p -145.17 167.28 23.15 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.56 -0.713 . . . . 0.0 110.89 -170.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -67.31 -40.1 85.96 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.675 -0.641 . . . . 0.0 110.616 -177.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 3.9 t -132.05 89.58 37.7 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.545 -0.722 . . . . 0.0 110.53 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -55.77 -29.04 69.95 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 O-C-N 123.23 1.121 . . . . 0.0 110.74 174.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.51 -37.94 93.02 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -72.56 -40.04 66.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.622 -0.928 . . . . 0.0 109.837 -173.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -69.51 -38.47 77.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.67 -0.644 . . . . 0.0 110.198 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -61.51 -43.21 99.28 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.228 178.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 14.5 ttpp -65.01 -38.73 91.88 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.586 -0.696 . . . . 0.0 110.419 176.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.22 -49.95 75.07 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.493 -0.755 . . . . 0.0 110.578 -173.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 N--CA 1.495 1.784 0 O-C-N 121.463 -0.773 . . . . 0.0 110.113 -178.839 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.085 0.469 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -95.28 24.73 4.81 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.632 -0.667 . . . . 0.0 110.779 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 51.6 m -74.6 125.23 28.2 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.554 -0.716 . . . . 0.0 110.286 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -69.78 144.94 52.54 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.763 -0.586 . . . . 0.0 110.482 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -154.18 98.86 2.54 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.617 -0.677 . . . . 0.0 110.156 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -59.27 -39.95 73.1 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 O-C-N 123.261 1.137 . . . . 0.0 110.782 -176.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 73.76 -155.15 49.38 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -73.82 -45.65 0.37 Allowed 'Trans proline' 0 C--N 1.317 -1.096 0 O-C-N 123.38 1.2 . . . . 0.0 111.044 -174.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -86.24 8.07 22.69 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.474 -0.766 . . . . 0.0 111.383 -173.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.69 60.22 3.81 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.987 -1.071 . . . . 0.0 110.655 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.416 ' CE1' HG22 ' A' ' 174' ' ' ILE . 56.5 t80 -77.8 118.77 20.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.584 -0.697 . . . . 0.0 109.851 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -130.0 160.02 34.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.887 -0.508 . . . . 0.0 110.182 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 80.6 t -125.16 146.92 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.729 -0.607 . . . . 0.0 109.785 176.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.4 p -157.73 171.03 21.04 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.88 176.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.413 ' CE1' HG12 ' A' ' 172' ' ' ILE . 57.7 m-85 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 121.118 0.485 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 69.0 p -60.03 -34.03 72.82 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.769 -0.582 . . . . 0.0 110.093 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -170.75 148.08 2.89 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.834 -0.541 . . . . 0.0 109.964 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.4 t -141.7 142.44 33.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.749 -0.594 . . . . 0.0 109.884 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -125.54 140.07 53.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.52 -0.738 . . . . 0.0 110.589 -172.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 30.1 t -109.86 122.81 48.39 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.297 -0.561 . . . . 0.0 109.734 174.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 67.6 m -70.75 -36.98 73.38 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.353 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -59.38 -31.77 69.54 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.615 -0.678 . . . . 0.0 110.453 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.3 mt -104.78 -12.04 16.51 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.682 -0.636 . . . . 0.0 110.79 -175.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 32.5 tttt 59.68 48.52 9.27 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.007 -1.058 . . . . 0.0 109.682 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -146.93 153.06 39.65 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.736 -0.602 . . . . 0.0 110.638 -174.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.6 tp -126.43 137.8 53.46 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.759 -0.588 . . . . 0.0 110.164 -175.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -115.85 132.67 56.57 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 175.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.1 p -138.36 158.43 44.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.663 -0.648 . . . . 0.0 111.046 -174.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -104.62 140.13 38.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.662 -0.649 . . . . 0.0 110.205 171.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 17.5 tt -52.61 149.14 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-O 121.619 0.723 . . . . 0.0 111.799 -174.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 66.06 8.35 5.41 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.489 -0.757 . . . . 0.0 112.483 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -96.6 155.09 16.92 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.904 -1.123 . . . . 0.0 110.949 174.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 87.8 m -84.24 126.41 33.13 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.668 -0.645 . . . . 0.0 110.635 -177.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 43.1 t -112.94 90.25 15.26 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.569 -0.707 . . . . 0.0 109.995 174.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -65.32 131.67 29.01 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.199 1.105 . . . . 0.0 110.484 176.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.413 HG12 ' CE1' ' A' ' 142' ' ' PHE . 92.5 mt -125.84 142.29 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.6 -0.688 . . . . 0.0 109.541 175.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -110.83 135.59 51.16 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.601 -0.687 . . . . 0.0 110.697 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.416 HG22 ' CE1' ' A' ' 138' ' ' PHE . 49.7 mm -95.33 134.91 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.556 -0.715 . . . . 0.0 109.579 169.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -116.21 128.47 55.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.602 -0.686 . . . . 0.0 110.445 176.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.5 m -136.29 159.77 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.548 -0.72 . . . . 0.0 109.886 174.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 81.9 mmm -75.45 -40.4 57.57 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.703 -0.623 . . . . 0.0 110.068 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 75.5 p -134.75 143.18 45.32 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.769 -0.582 . . . . 0.0 109.768 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -54.95 139.79 79.34 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 O-C-N 123.138 1.073 . . . . 0.0 110.883 -172.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.421 ' CG ' ' CE1' ' A' ' 251' ' ' TYR . 20.5 Cg_endo -63.26 167.63 12.42 Favored 'Trans proline' 0 N--CA 1.487 1.099 0 O-C-N 123.191 1.1 . . . . 0.0 110.59 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -61.38 155.04 54.55 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.353 1.186 . . . . 0.0 110.321 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -72.99 139.0 46.38 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.591 -0.693 . . . . 0.0 109.853 175.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.71 -25.01 29.15 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -175.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.1 148.71 3.21 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.377 -1.072 . . . . 0.0 111.303 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.8 155.96 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.692 -0.63 . . . . 0.0 109.743 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 85.6 mt -106.57 137.91 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.698 -0.626 . . . . 0.0 109.457 176.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.406 ' HG2' ' CD2' ' A' ' 248' ' ' LEU . 70.8 mtp180 -114.85 141.96 47.2 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -176.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -137.39 125.83 23.45 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.471 -0.768 . . . . 0.0 110.353 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 39.4 ttm -137.27 139.11 26.95 Favored Pre-proline 0 N--CA 1.497 1.901 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.977 -176.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -90.39 138.21 2.66 Favored 'Trans proline' 0 C--N 1.319 -0.982 0 C-N-CA 120.936 1.091 . . . . 0.0 110.858 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.9 m -147.26 154.86 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.493 -0.755 . . . . 0.0 110.009 174.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.424 ' CE2' HG22 ' A' ' 202' ' ' VAL . 80.4 m-85 -61.49 165.0 5.17 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.431 -0.793 . . . . 0.0 110.448 -177.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -84.69 -60.06 2.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.605 -0.685 . . . . 0.0 110.841 -173.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 42.7 mttt -80.01 152.52 29.4 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.667 -0.646 . . . . 0.0 110.311 -174.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.68 -39.18 73.34 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.387 -0.821 . . . . 0.0 110.66 -174.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -56.62 -24.79 50.46 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.438 -0.789 . . . . 0.0 110.67 -177.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.419 ' CE1' ' NH1' ' A' ' 280' ' ' ARG . 99.3 m-70 -109.23 -20.46 12.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.604 -0.685 . . . . 0.0 111.197 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.2 p -68.36 -20.28 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.144 -0.973 . . . . 0.0 110.639 -175.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 68.3 p -79.45 -17.15 54.85 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.551 -0.718 . . . . 0.0 110.858 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -88.36 137.7 32.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.302 -0.874 . . . . 0.0 110.186 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 57.7 t -72.95 146.49 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.587 -0.696 . . . . 0.0 110.146 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.424 HG22 ' CE2' ' A' ' 192' ' ' TYR . 60.0 t -84.82 140.06 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.575 -0.703 . . . . 0.0 109.203 172.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -134.83 -170.23 2.52 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.395 -0.815 . . . . 0.0 111.131 -167.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -95.21 154.14 17.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.771 -0.581 . . . . 0.0 110.461 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.871 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 63.3 m . . . . . 0 N--CA 1.496 1.847 0 O-C-N 121.649 -0.657 . . . . 0.0 109.274 173.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 56.4 tp . . . . . 0 N--CA 1.498 1.972 0 CA-C-O 120.773 0.321 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 84.7 mt -106.06 136.82 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 120.309 -0.557 . . . . 0.0 109.867 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -132.84 158.23 43.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.785 -0.572 . . . . 0.0 110.171 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 94.0 t -105.22 146.68 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.693 -0.629 . . . . 0.0 110.122 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -119.45 127.97 53.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.768 -0.582 . . . . 0.0 110.352 170.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.17 21.1 21.34 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 168.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -140.2 105.54 5.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.381 -1.07 . . . . 0.0 110.048 174.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 95.2 p -63.58 -15.13 57.24 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.625 -0.672 . . . . 0.0 111.217 -178.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -96.74 9.93 40.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -0.834 . . . . 0.0 111.219 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -62.2 127.83 33.21 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.246 -0.908 . . . . 0.0 110.056 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -139.84 157.35 45.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.719 -0.613 . . . . 0.0 109.734 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 247' ' ' VAL . 83.6 m-85 -117.98 150.61 38.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.599 -0.688 . . . . 0.0 110.627 -176.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.16 159.96 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.837 -0.54 . . . . 0.0 110.213 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -116.49 130.07 56.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.765 -0.584 . . . . 0.0 110.111 175.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -63.12 130.07 93.9 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.634 -0.667 . . . . 0.0 109.867 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -65.73 -29.31 51.23 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 123.197 1.104 . . . . 0.0 110.952 -171.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 82.5 mt -103.9 -50.45 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.484 -0.76 . . . . 0.0 111.071 -168.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 7.3 p -105.29 12.08 32.18 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.376 -0.827 . . . . 0.0 111.927 -173.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 73.66 -6.97 15.13 Favored Glycine 0 N--CA 1.497 2.701 0 O-C-N 121.077 -1.014 . . . . 0.0 112.125 171.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -45.89 142.09 2.76 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-N 119.095 1.448 . . . . 0.0 112.312 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -105.91 143.89 33.4 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.671 -0.643 . . . . 0.0 110.09 174.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 78.9 p -154.73 159.93 41.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.554 -0.716 . . . . 0.0 110.571 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.416 ' HB ' ' CD1' ' A' ' 236' ' ' TYR . 8.3 p -122.97 148.18 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.732 -0.605 . . . . 0.0 109.636 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.406 ' CD2' ' HG2' ' A' ' 187' ' ' ARG . 75.2 mt -129.68 154.6 46.98 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.71 -174.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 35.9 m -150.63 151.75 31.19 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.811 -0.555 . . . . 0.0 109.96 174.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -71.21 137.42 31.25 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.264 1.139 . . . . 0.0 109.913 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.421 ' CE1' ' CG ' ' A' ' 180' ' ' PRO . 8.9 t80 -76.95 125.5 29.41 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.509 -0.744 . . . . 0.0 109.984 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -99.98 160.12 28.05 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.658 -0.651 . . . . 0.0 110.145 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -58.81 159.64 20.37 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 O-C-N 123.284 1.15 . . . . 0.0 110.343 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.38 149.94 78.15 Favored 'Trans proline' 0 C--N 1.316 -1.132 0 O-C-N 123.177 1.093 . . . . 0.0 110.538 -176.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -61.14 149.75 36.34 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.695 -0.628 . . . . 0.0 110.146 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.0 t -69.83 127.09 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.552 -0.718 . . . . 0.0 110.198 -170.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.11 -10.06 56.68 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.406 ' OG1' ' CD1' ' A' ' 260' ' ' PHE . 9.6 t -145.39 175.39 10.35 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.182 -1.187 . . . . 0.0 110.604 175.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -110.52 13.23 22.71 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.531 -0.73 . . . . 0.0 111.93 -166.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . 0.406 ' CD1' ' OG1' ' A' ' 258' ' ' THR . 49.4 p90 -120.04 168.01 11.61 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.074 -1.016 . . . . 0.0 111.16 -177.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 78.1 m -117.74 146.09 44.01 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.81 -0.556 . . . . 0.0 109.914 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 32.2 m -116.88 135.57 53.62 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.594 -0.691 . . . . 0.0 110.981 -175.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 65.1 t -131.42 137.27 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 74.0 mt -104.68 122.02 44.78 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.538 -0.726 . . . . 0.0 109.944 -171.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 6.1 m-30 -106.35 149.32 27.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.709 -0.62 . . . . 0.0 110.591 -177.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -136.63 142.99 43.28 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -113.57 130.7 56.32 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.47 -0.769 . . . . 0.0 110.395 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.87 -0.62 39.27 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.782 -0.574 . . . . 0.0 111.844 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . 0.548 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 7.0 t -144.78 158.05 43.94 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.147 -0.971 . . . . 0.0 109.009 176.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -119.0 152.32 36.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.678 -0.639 . . . . 0.0 110.262 -175.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 90.0 p -57.64 -25.39 60.09 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.481 -0.762 . . . . 0.0 111.148 -170.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 49.3 p -89.24 2.1 54.76 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.328 -0.858 . . . . 0.0 112.094 -167.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . 0.871 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 28.6 p -85.23 118.0 24.51 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.014 -1.053 . . . . 0.0 110.618 -178.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.63 140.17 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.457 -0.777 . . . . 0.0 110.445 -171.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 101.04 -5.18 56.07 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 177.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.11 -98.55 0.84 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 171.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 91.7 mmm -63.6 -30.96 72.0 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.73 -0.865 . . . . 0.0 110.332 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.1 p30 44.91 53.18 7.72 Favored 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 121.427 0.632 . . . . 0.0 112.338 173.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 17.1 mtt-85 54.89 34.97 23.31 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.336 -0.852 . . . . 0.0 111.328 175.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' ARG . . . . . 0.419 ' NH1' ' CE1' ' A' ' 197' ' ' HIS . 31.7 mtt-85 -112.43 104.94 56.22 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.575 -0.703 . . . . 0.0 110.085 169.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -60.13 148.95 87.54 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 O-C-N 123.12 1.063 . . . . 0.0 110.558 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 28.7 pt -131.97 179.16 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.811 0.815 . . . . 0.0 111.014 -177.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 32.2 mt -124.37 149.96 46.07 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.419 HD12 ' CE1' ' A' ' 301' ' ' PHE . 80.6 mt -114.01 129.29 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.183 177.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 80.7 mt -109.73 125.92 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -175.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 60.0 t -118.89 126.72 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 44.8 p -125.3 153.09 43.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.652 -0.655 . . . . 0.0 110.642 -175.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 23.8 tp -102.85 126.03 49.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.799 -0.563 . . . . 0.0 109.509 170.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -132.78 150.59 52.14 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.79 -0.569 . . . . 0.0 109.967 -172.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 72.6 p -90.01 159.19 17.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.593 -0.692 . . . . 0.0 109.96 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -56.05 -26.12 47.85 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.533 -0.729 . . . . 0.0 110.935 -177.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -92.32 11.65 25.2 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.45 -0.781 . . . . 0.0 111.729 -173.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 90.05 20.12 44.02 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.11 -1.043 . . . . 0.0 110.932 167.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -105.49 140.14 39.04 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.28 -1.129 . . . . 0.0 110.154 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 59.4 t -90.66 130.9 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.63 -0.669 . . . . 0.0 110.159 -174.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 95.8 mt -99.92 -40.21 7.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.768 -0.582 . . . . 0.0 110.781 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -161.64 154.71 25.76 Favored Glycine 0 N--CA 1.497 2.719 0 C-N-CA 119.987 -1.101 . . . . 0.0 110.359 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 41.1 mtt180 -135.15 135.92 41.48 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.642 -0.916 . . . . 0.0 110.383 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -141.54 158.65 43.58 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.491 -0.755 . . . . 0.0 110.095 169.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 94.8 m -143.59 157.91 44.06 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.407 -0.808 . . . . 0.0 110.701 -174.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.419 ' CE1' HD12 ' A' ' 284' ' ' ILE . 49.6 p90 -145.59 161.03 40.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.658 -0.651 . . . . 0.0 110.073 175.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -104.9 136.71 43.88 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.548 -0.72 . . . . 0.0 110.178 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -119.01 143.5 47.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.645 -0.659 . . . . 0.0 110.833 -169.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -138.5 138.25 37.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.772 -0.58 . . . . 0.0 109.601 172.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 65.7 mt -111.21 122.84 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.52 -0.738 . . . . 0.0 109.719 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.0 p -145.34 173.38 12.03 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.707 -0.621 . . . . 0.0 110.654 -172.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -74.13 -40.11 62.86 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.655 -0.653 . . . . 0.0 110.696 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.9 t -127.35 86.75 57.92 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.581 -0.699 . . . . 0.0 110.547 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -55.66 -28.62 66.81 Favored 'Trans proline' 0 N--CA 1.488 1.2 0 O-C-N 123.156 1.082 . . . . 0.0 110.813 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.97 -37.76 92.35 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -72.83 -40.48 65.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.692 -0.887 . . . . 0.0 109.881 -173.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -69.61 -38.25 77.18 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.283 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -62.08 -42.75 99.53 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.196 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -64.88 -37.43 87.62 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.5 -0.75 . . . . 0.0 110.342 175.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.63 -49.42 76.63 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.548 -0.72 . . . . 0.0 110.608 -173.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 2.8 p30 . . . . . 0 N--CA 1.495 1.778 0 O-C-N 121.448 -0.782 . . . . 0.0 110.098 -178.588 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 27.8 t . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.037 0.446 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.6 p-10 -99.93 24.85 7.96 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.718 -0.614 . . . . 0.0 110.731 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 53.1 m -78.14 125.19 29.0 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.53 -0.731 . . . . 0.0 110.25 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -71.04 144.95 50.22 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.739 -0.6 . . . . 0.0 110.403 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -158.57 101.83 1.66 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.675 -0.641 . . . . 0.0 110.07 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -59.21 -40.0 73.3 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.151 1.08 . . . . 0.0 110.729 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.08 -155.19 40.13 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -74.67 -43.29 0.47 Allowed 'Trans proline' 0 C--N 1.317 -1.116 0 O-C-N 123.315 1.166 . . . . 0.0 110.846 -175.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -88.65 4.41 47.24 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.577 -0.702 . . . . 0.0 111.437 -174.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 t 54.05 61.79 2.89 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.995 -1.066 . . . . 0.0 110.669 -176.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.432 ' CE1' ' CG2' ' A' ' 174' ' ' ILE . 59.5 t80 -78.0 120.77 23.31 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.606 -0.683 . . . . 0.0 110.111 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -130.01 160.01 34.96 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.8 -0.563 . . . . 0.0 110.129 -177.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 74.6 t -123.13 146.75 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.423 0.63 . . . . 0.0 110.046 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.0 p -157.3 171.08 21.04 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.126 0.489 . . . . 0.0 109.688 175.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.426 ' CE2' HG12 ' A' ' 172' ' ' ILE . 52.7 m-85 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.827 -0.545 . . . . 0.0 109.656 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 121.177 0.513 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 76.6 p -60.08 -34.04 72.9 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.71 -0.619 . . . . 0.0 109.928 177.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.415 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 67.2 p-90 -170.59 147.88 2.96 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.878 -0.514 . . . . 0.0 109.788 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 14.0 t -142.08 142.43 32.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.768 -0.583 . . . . 0.0 109.963 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -125.63 140.08 53.02 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.494 -0.754 . . . . 0.0 110.45 -172.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 30.7 t -109.72 122.5 47.62 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 120.324 -0.551 . . . . 0.0 109.748 175.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 63.6 m -70.77 -37.0 73.34 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.71 -0.619 . . . . 0.0 110.443 -177.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -60.46 -32.25 71.22 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.605 -0.684 . . . . 0.0 110.357 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 60.3 mt -104.79 -12.06 16.5 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.726 -0.609 . . . . 0.0 110.852 -176.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.5 tttm 59.84 50.75 6.63 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.081 -1.012 . . . . 0.0 109.702 177.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -146.34 153.0 40.03 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.598 -176.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.5 tp -126.63 137.87 53.36 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.791 -0.568 . . . . 0.0 110.24 -175.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -115.47 134.05 55.45 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.9 p -138.28 158.39 44.39 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.637 -0.664 . . . . 0.0 111.005 -175.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -104.55 143.04 33.59 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.499 0.666 . . . . 0.0 110.347 172.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 17.3 tt -52.53 147.68 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-O 121.583 0.706 . . . . 0.0 111.842 -173.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 64.36 9.98 5.33 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.638 -0.664 . . . . 0.0 112.461 177.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -96.82 155.1 16.92 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.975 -1.078 . . . . 0.0 110.811 175.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 87.3 m -82.78 126.17 32.11 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.709 -0.619 . . . . 0.0 110.607 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 42.6 t -112.93 90.29 15.29 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.647 -0.658 . . . . 0.0 110.082 172.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.415 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 15.8 Cg_exo -65.1 128.65 21.07 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 O-C-N 123.264 1.139 . . . . 0.0 110.394 176.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.426 HG12 ' CE2' ' A' ' 142' ' ' PHE . 94.7 mt -122.38 139.42 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.621 -0.674 . . . . 0.0 109.393 177.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -108.69 137.0 47.33 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.645 -0.659 . . . . 0.0 110.488 -177.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.432 ' CG2' ' CE1' ' A' ' 138' ' ' PHE . 48.5 mm -95.23 132.77 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.66 -0.65 . . . . 0.0 109.562 171.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -115.93 128.95 56.17 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.699 -0.626 . . . . 0.0 110.352 176.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 17.0 m -136.74 159.71 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.575 -0.703 . . . . 0.0 110.012 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.5 mmm -75.45 -40.19 57.8 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.723 -0.611 . . . . 0.0 110.056 177.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 76.4 p -136.82 143.23 41.8 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.788 -0.57 . . . . 0.0 109.729 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -55.4 139.91 82.06 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 O-C-N 123.21 1.11 . . . . 0.0 110.898 -171.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.43 ' HG2' ' CD1' ' A' ' 251' ' ' TYR . 33.4 Cg_endo -68.05 170.08 15.15 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 O-C-N 123.119 1.063 . . . . 0.0 110.558 178.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -60.5 155.04 49.66 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 O-C-N 123.289 1.152 . . . . 0.0 110.516 -178.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -77.55 140.2 39.68 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.598 -0.689 . . . . 0.0 109.931 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.67 -24.93 29.48 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -174.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.19 153.33 1.48 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.307 -1.114 . . . . 0.0 111.387 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.84 155.93 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.665 -0.647 . . . . 0.0 109.841 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 87.4 mt -109.25 137.92 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.662 -0.649 . . . . 0.0 109.652 176.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 40.4 mtm180 -114.97 146.95 40.67 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -176.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -140.59 127.72 20.91 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.503 -0.748 . . . . 0.0 110.343 173.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 21.1 ttm -137.31 139.71 28.61 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.811 -0.555 . . . . 0.0 110.978 -177.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -91.98 138.17 1.93 Allowed 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 121.061 1.174 . . . . 0.0 110.778 177.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.7 m -147.06 154.86 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.445 -0.784 . . . . 0.0 110.178 173.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.45 ' CE2' ' CG2' ' A' ' 202' ' ' VAL . 83.7 m-85 -60.7 164.56 4.56 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.425 -0.797 . . . . 0.0 110.441 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -80.74 -60.03 2.46 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.601 -0.687 . . . . 0.0 110.827 -174.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -80.12 151.25 29.91 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.587 -0.696 . . . . 0.0 110.385 -175.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.57 -37.94 71.27 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.392 -0.817 . . . . 0.0 110.684 -176.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -56.84 -24.91 54.67 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.488 -0.757 . . . . 0.0 110.542 -176.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.402 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 63.3 m170 -109.27 -20.58 12.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.52 -0.738 . . . . 0.0 111.125 -178.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.1 p -68.0 -20.25 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.199 -0.938 . . . . 0.0 110.623 -176.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 72.3 p -79.43 -17.04 55.11 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.62 174.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -88.35 135.66 33.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.417 -0.802 . . . . 0.0 110.067 174.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.8 t -73.05 141.21 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.73 -0.606 . . . . 0.0 110.223 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.45 ' CG2' ' CE2' ' A' ' 192' ' ' TYR . 64.3 t -84.98 138.28 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.632 -0.667 . . . . 0.0 109.233 170.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -134.82 -170.25 2.52 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.536 -0.727 . . . . 0.0 111.229 -167.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 73.0 mtm-85 -95.25 154.68 17.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.853 -0.529 . . . . 0.0 110.389 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.571 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 57.0 m . . . . . 0 N--CA 1.496 1.827 0 O-C-N 121.62 -0.675 . . . . 0.0 109.247 174.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 37.6 tp . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 120.884 0.373 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 83.3 mt -102.44 136.88 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.814 -0.554 . . . . 0.0 109.883 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 50.0 mtt-85 -130.92 159.44 37.44 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.689 -0.632 . . . . 0.0 110.326 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 81.3 t -103.96 146.65 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.728 -0.607 . . . . 0.0 110.0 176.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -118.25 128.12 54.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.696 -0.627 . . . . 0.0 110.349 170.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 96.67 21.39 21.69 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 168.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -139.38 106.24 5.41 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.348 -1.089 . . . . 0.0 109.95 174.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 90.9 p -63.66 -15.09 57.4 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.64 -0.663 . . . . 0.0 111.201 -177.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -97.12 9.93 40.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.341 -0.849 . . . . 0.0 111.236 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.75 128.78 37.87 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.111 -0.993 . . . . 0.0 110.114 175.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -139.76 155.75 47.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.76 -0.587 . . . . 0.0 109.607 177.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.421 ' CD1' ' HB ' ' A' ' 247' ' ' VAL . 80.9 m-85 -119.12 150.74 39.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.568 -0.708 . . . . 0.0 110.61 -175.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.16 159.97 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.778 -0.576 . . . . 0.0 110.242 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -117.76 130.01 56.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.766 -0.584 . . . . 0.0 110.181 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -62.52 130.19 93.24 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.623 -0.673 . . . . 0.0 109.789 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -64.82 -28.04 59.3 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 O-C-N 123.135 1.071 . . . . 0.0 111.003 -170.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.0 mt -102.0 -50.43 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.344 -0.848 . . . . 0.0 111.014 -168.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 17.9 p -105.43 12.14 31.84 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.31 -0.869 . . . . 0.0 111.913 -174.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 72.17 -4.92 16.01 Favored Glycine 0 N--CA 1.497 2.723 0 O-C-N 121.074 -1.016 . . . . 0.0 112.022 172.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -45.86 142.01 2.77 Favored 'General case' 0 N--CA 1.505 2.309 0 CA-C-N 119.119 1.46 . . . . 0.0 112.388 -175.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -103.54 143.36 32.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.618 -0.676 . . . . 0.0 110.119 175.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.2 p -154.81 159.94 40.92 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.595 -0.69 . . . . 0.0 110.348 176.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.421 ' HB ' ' CD1' ' A' ' 236' ' ' TYR . 8.6 p -123.17 148.23 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.836 -0.54 . . . . 0.0 109.814 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 81.8 mt -129.62 154.61 46.93 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.079 -0.649 . . . . 0.0 109.638 -177.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 34.4 m -151.1 151.67 29.95 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.813 -0.554 . . . . 0.0 110.001 175.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -71.05 139.0 34.88 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 O-C-N 123.368 1.194 . . . . 0.0 110.08 177.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.43 ' CD1' ' HG2' ' A' ' 180' ' ' PRO . 58.9 t80 -75.9 124.47 27.39 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.099 175.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -99.99 160.11 28.07 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.694 -0.628 . . . . 0.0 109.953 176.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -58.37 158.49 22.59 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 O-C-N 123.294 1.155 . . . . 0.0 110.517 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -59.09 149.98 76.35 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 O-C-N 123.219 1.115 . . . . 0.0 110.511 -177.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -60.73 148.27 39.42 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.65 -0.656 . . . . 0.0 110.295 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.84 127.19 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.538 -0.726 . . . . 0.0 110.168 -171.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.96 -10.14 55.41 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.409 ' OG1' ' CD2' ' A' ' 260' ' ' PHE . 10.0 t -144.65 173.43 11.83 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.175 -1.191 . . . . 0.0 110.63 175.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -107.28 13.09 27.51 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.617 -0.677 . . . . 0.0 111.78 -168.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . 0.409 ' CD2' ' OG1' ' A' ' 258' ' ' THR . 15.6 p90 -119.92 168.01 11.56 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.181 -0.95 . . . . 0.0 111.168 -175.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 92.6 m -117.73 146.76 43.54 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.744 -0.597 . . . . 0.0 109.986 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 46.4 m -118.24 135.67 54.13 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.604 -0.685 . . . . 0.0 110.952 -174.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 60.2 t -132.56 137.23 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 172.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 75.1 mt -104.78 123.8 48.3 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.437 -0.789 . . . . 0.0 110.054 -171.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 6.1 m-30 -106.85 151.51 25.12 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.644 -0.66 . . . . 0.0 110.683 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -136.49 142.92 43.55 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -113.47 133.11 55.39 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.538 -0.726 . . . . 0.0 110.55 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 2.3 ppp? -97.68 2.66 49.97 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.709 -0.62 . . . . 0.0 112.164 -175.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -144.73 165.07 29.1 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.131 -0.981 . . . . 0.0 110.195 176.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -120.68 162.8 19.07 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.43 0.633 . . . . 0.0 110.407 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 25.2 m -58.8 -33.53 70.45 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.407 -0.808 . . . . 0.0 110.927 -163.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 49.9 p -100.75 12.17 38.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.466 -0.771 . . . . 0.0 112.018 -163.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . 0.571 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 30.4 p -94.54 118.1 31.15 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.03 -1.043 . . . . 0.0 110.742 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.2 t -63.2 139.78 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.431 -0.793 . . . . 0.0 110.393 -171.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.83 -5.28 58.08 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.08 -99.78 0.88 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 171.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 93.7 mmm -62.71 -31.53 72.46 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.773 -0.84 . . . . 0.0 110.308 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.3 p30 44.47 49.32 8.3 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 174.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 21.3 mtt180 54.79 31.71 16.1 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.331 -0.855 . . . . 0.0 111.179 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -119.31 104.96 45.04 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.508 -0.745 . . . . 0.0 110.07 174.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -59.98 145.26 98.79 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 O-C-N 123.162 1.085 . . . . 0.0 110.466 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 46.5 pt -131.98 176.38 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.874 0.845 . . . . 0.0 111.186 -174.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 29.4 mt -124.37 149.86 46.18 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.423 HD13 ' CE1' ' A' ' 301' ' ' PHE . 79.0 mt -115.66 130.11 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.595 -0.69 . . . . 0.0 109.174 178.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 79.0 mt -109.86 126.06 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 57.8 t -118.86 126.93 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.2 p -125.27 152.91 44.01 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.592 -0.692 . . . . 0.0 110.614 -173.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.417 ' HB2' ' CE1' ' A' ' 138' ' ' PHE . 23.2 tp -103.54 126.68 50.83 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.754 -0.591 . . . . 0.0 109.434 168.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -130.52 152.03 50.34 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.892 -0.505 . . . . 0.0 109.876 -173.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 68.6 p -89.83 159.91 16.76 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.699 -0.625 . . . . 0.0 109.735 176.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -55.97 -26.1 46.76 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.515 -0.741 . . . . 0.0 110.772 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -86.96 9.18 20.27 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.521 -0.737 . . . . 0.0 111.845 -174.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 86.6 20.16 54.84 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 120.183 -1.008 . . . . 0.0 110.766 170.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -107.55 140.24 40.84 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.282 -1.128 . . . . 0.0 110.196 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 61.5 t -86.21 132.9 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.656 -0.653 . . . . 0.0 110.091 -174.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 80.3 mt -99.89 -40.1 7.85 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.722 -0.611 . . . . 0.0 110.424 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -165.27 153.28 23.3 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -133.49 136.46 45.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.686 -0.891 . . . . 0.0 110.751 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -135.59 158.29 44.74 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.634 -0.666 . . . . 0.0 109.862 172.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 95.0 m -143.0 155.1 44.59 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.34 -0.85 . . . . 0.0 110.772 -175.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.423 ' CE1' HD13 ' A' ' 284' ' ' ILE . 49.4 p90 -144.97 162.76 36.11 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.734 -0.604 . . . . 0.0 110.052 175.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -104.75 135.06 46.83 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.544 -0.723 . . . . 0.0 110.217 -177.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -122.84 143.18 50.03 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.701 -169.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -138.3 139.2 39.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.74 -0.6 . . . . 0.0 109.704 173.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 70.5 mt -108.02 122.8 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.537 -0.727 . . . . 0.0 109.605 176.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.9 p -145.27 169.34 18.43 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.629 -0.67 . . . . 0.0 110.676 -171.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -71.32 -40.1 70.98 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.631 -0.668 . . . . 0.0 110.64 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.9 t -127.5 86.05 59.42 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.468 -0.77 . . . . 0.0 110.47 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -55.87 -28.36 67.41 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 O-C-N 123.122 1.064 . . . . 0.0 110.812 174.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -67.59 -36.73 88.62 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -73.35 -39.83 64.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.72 -0.871 . . . . 0.0 109.822 -173.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -69.56 -40.94 76.51 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.137 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -61.88 -43.46 98.81 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.477 -0.765 . . . . 0.0 110.24 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -64.79 -39.06 92.97 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.532 -0.73 . . . . 0.0 110.478 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.2 -50.5 72.88 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.439 -0.788 . . . . 0.0 110.427 -173.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.1 p30 . . . . . 0 N--CA 1.496 1.839 0 O-C-N 121.455 -0.778 . . . . 0.0 110.1 -178.996 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.973 0.416 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -92.8 21.2 5.78 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.675 -0.641 . . . . 0.0 111.004 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 54.9 m -72.07 125.11 26.44 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.371 -0.831 . . . . 0.0 110.223 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -69.99 144.89 52.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.679 -0.638 . . . . 0.0 110.558 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -153.64 102.41 2.53 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.744 -0.597 . . . . 0.0 110.182 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -58.53 -39.95 78.56 Favored 'Trans proline' 0 N--CA 1.487 1.142 0 O-C-N 123.096 1.051 . . . . 0.0 110.922 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.43 -155.13 45.04 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -74.69 -46.12 0.27 Allowed 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.366 1.193 . . . . 0.0 111.007 -173.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -89.66 12.12 17.78 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.557 -0.715 . . . . 0.0 111.285 -172.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.5 60.93 3.38 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.017 -1.052 . . . . 0.0 110.709 -176.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -77.82 118.32 20.05 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.643 -0.661 . . . . 0.0 109.73 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -129.98 159.94 35.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.784 -0.573 . . . . 0.0 110.196 -177.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 64.3 t -125.76 146.75 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.802 -0.561 . . . . 0.0 109.716 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.2 p -155.27 162.43 40.89 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.276 0.56 . . . . 0.0 110.108 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.501 ' CD2' ' CE2' ' A' ' 155' ' ' TYR . 72.7 m-85 . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.837 -0.54 . . . . 0.0 109.708 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 121.139 0.495 . . . . 0.0 110.036 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.401 ' OG1' ' CD1' ' A' ' 153' ' ' TRP . 75.5 p -60.11 -34.05 72.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.768 -0.583 . . . . 0.0 109.96 176.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.421 ' CZ2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -171.65 143.66 1.75 Allowed 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.497 0.665 . . . . 0.0 110.489 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 9.9 t -142.16 142.53 32.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.817 -0.552 . . . . 0.0 110.042 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.501 ' CE2' ' CD2' ' A' ' 142' ' ' PHE . 43.8 t80 -125.47 140.09 53.07 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.534 -0.729 . . . . 0.0 110.529 -173.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 30.6 t -111.47 125.66 54.13 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 120.431 -0.507 . . . . 0.0 109.871 176.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 59.4 m -70.78 -37.08 73.3 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.866 -0.521 . . . . 0.0 110.469 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -59.51 -32.99 70.8 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.601 -0.687 . . . . 0.0 110.36 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 55.9 mt -104.74 -12.15 16.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.771 -0.58 . . . . 0.0 110.806 -175.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.1 ttpt 59.81 47.23 10.46 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.025 -1.047 . . . . 0.0 109.693 176.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -148.31 153.26 38.41 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.786 -172.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.6 tp -126.5 137.87 53.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.799 -0.563 . . . . 0.0 110.246 -173.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -114.83 132.84 56.36 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 174.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.32 158.38 44.39 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 120.109 -0.636 . . . . 0.0 111.024 -175.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -104.55 143.6 32.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.553 -0.717 . . . . 0.0 110.481 173.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 17.7 tt -53.69 146.58 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 CA-C-O 121.586 0.708 . . . . 0.0 111.687 -173.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 64.27 10.0 5.26 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.601 -0.687 . . . . 0.0 112.448 176.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp -95.19 154.99 16.92 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.964 -1.085 . . . . 0.0 110.666 175.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 87.4 m -83.1 126.17 32.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.728 -0.607 . . . . 0.0 110.523 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 49.5 t -114.33 90.08 19.58 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.635 -0.666 . . . . 0.0 110.041 172.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.421 ' HD2' ' CZ2' ' A' ' 153' ' ' TRP . 21.7 Cg_exo -62.2 129.48 27.19 Favored 'Trans proline' 0 C--N 1.316 -1.158 0 O-C-N 123.225 1.119 . . . . 0.0 110.562 173.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.422 HG12 ' CE1' ' A' ' 142' ' ' PHE . 97.3 mt -124.39 141.96 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 176.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -109.69 135.45 50.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.443 -0.785 . . . . 0.0 110.789 -175.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.3 mm -95.22 134.99 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.68 -0.638 . . . . 0.0 109.669 169.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -116.54 129.03 55.96 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.618 -0.676 . . . . 0.0 110.455 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.1 m -136.77 159.78 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.566 -0.709 . . . . 0.0 109.868 174.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 81.3 mmm -78.22 -42.45 31.27 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.738 -0.601 . . . . 0.0 110.148 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 77.2 p -131.7 143.2 48.14 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.799 -0.563 . . . . 0.0 109.702 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -55.55 139.8 82.81 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 O-C-N 123.181 1.095 . . . . 0.0 110.876 -171.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.422 ' HD2' ' CE1' ' A' ' 251' ' ' TYR . 35.3 Cg_endo -67.6 170.03 14.63 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 O-C-N 123.168 1.088 . . . . 0.0 110.627 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -60.81 157.11 39.53 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 123.419 1.22 . . . . 0.0 110.514 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -78.73 139.13 38.5 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.647 -0.658 . . . . 0.0 110.024 175.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.06 -25.05 29.76 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -174.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -49.98 150.44 2.28 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.334 -1.098 . . . . 0.0 111.443 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.76 155.99 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.794 -0.566 . . . . 0.0 109.736 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 79.7 mt -108.27 137.1 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.667 -0.646 . . . . 0.0 109.437 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 61.6 mtt180 -114.99 143.09 45.72 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -176.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -137.35 127.25 25.7 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.46 -0.775 . . . . 0.0 110.28 176.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 23.9 ttm -137.22 139.91 29.41 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.787 -0.571 . . . . 0.0 111.086 -176.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -91.97 138.22 1.94 Allowed 'Trans proline' 0 C--N 1.319 -0.992 0 C-N-CA 121.051 1.167 . . . . 0.0 110.643 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.9 m -146.52 154.9 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.548 -0.72 . . . . 0.0 110.093 174.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.424 ' CE2' HG23 ' A' ' 202' ' ' VAL . 86.1 m-85 -63.56 159.39 18.86 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.483 -0.761 . . . . 0.0 110.578 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -75.39 -56.6 4.55 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.709 -0.619 . . . . 0.0 110.697 -175.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -79.98 147.61 31.5 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.554 -0.716 . . . . 0.0 110.29 -174.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.54 -38.51 71.97 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.38 -0.825 . . . . 0.0 110.716 -175.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 20.2 mp0 -56.55 -25.16 51.33 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.441 -0.787 . . . . 0.0 110.55 -176.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.409 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 77.4 m80 -109.84 -20.54 12.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.528 -0.733 . . . . 0.0 111.19 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.2 p -67.29 -20.24 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.202 -0.936 . . . . 0.0 110.527 -175.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 71.3 p -79.43 -16.87 55.43 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.551 -0.718 . . . . 0.0 110.578 175.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -88.38 137.77 32.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.316 -0.865 . . . . 0.0 110.027 172.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.1 t -72.98 144.35 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.651 -0.656 . . . . 0.0 110.184 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.424 HG23 ' CE2' ' A' ' 192' ' ' TYR . 61.8 t -84.91 138.89 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.569 -0.707 . . . . 0.0 109.175 173.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -134.87 -170.37 2.55 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.401 -0.812 . . . . 0.0 111.326 -167.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -95.37 159.13 15.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.818 -0.551 . . . . 0.0 110.617 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.598 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 60.7 m . . . . . 0 N--CA 1.497 1.9 0 O-C-N 121.605 -0.684 . . . . 0.0 109.324 174.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 43.3 tp . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 120.87 0.367 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 83.7 mt -102.82 136.79 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.785 -0.572 . . . . 0.0 109.744 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -134.05 159.84 39.58 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.749 -0.594 . . . . 0.0 110.187 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 97.2 t -105.72 146.71 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.71 -0.618 . . . . 0.0 110.09 178.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -118.08 123.91 46.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.738 -0.601 . . . . 0.0 110.444 172.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 95.71 24.05 16.72 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 167.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 33.5 t-20 -135.34 107.61 7.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.323 -1.104 . . . . 0.0 110.057 174.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 32.5 t -62.94 -15.14 54.56 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.677 -0.639 . . . . 0.0 111.309 -177.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -99.98 7.06 45.05 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.196 -0.94 . . . . 0.0 111.591 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.35 128.33 35.84 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.036 -1.04 . . . . 0.0 110.236 177.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -139.73 156.71 46.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.794 -0.566 . . . . 0.0 109.656 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.423 ' CD1' ' HB ' ' A' ' 247' ' ' VAL . 82.1 m-85 -118.72 150.76 39.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.601 -0.687 . . . . 0.0 110.685 -176.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.13 159.92 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.717 -0.614 . . . . 0.0 110.334 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -120.82 130.09 53.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.761 -0.587 . . . . 0.0 110.133 176.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -62.48 122.96 76.87 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.678 -0.639 . . . . 0.0 109.71 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.89 -28.08 67.09 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 O-C-N 123.047 1.025 . . . . 0.0 110.812 -173.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.7 mt -103.9 -50.25 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.469 -0.769 . . . . 0.0 110.899 -170.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 5.6 p -105.34 12.23 31.89 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.364 -0.835 . . . . 0.0 112.014 -170.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 81.09 -21.32 5.89 Favored Glycine 0 N--CA 1.497 2.72 0 O-C-N 121.004 -1.06 . . . . 0.0 111.795 170.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 -45.95 142.05 2.83 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-N 118.673 1.236 . . . . 0.0 112.429 -169.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -108.66 145.45 34.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.575 -0.703 . . . . 0.0 110.151 174.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.9 p -154.85 159.88 40.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.655 -0.653 . . . . 0.0 110.598 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.423 ' HB ' ' CD1' ' A' ' 236' ' ' TYR . 8.6 p -122.95 148.28 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.791 -0.568 . . . . 0.0 109.657 177.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 81.2 mt -129.58 154.61 46.9 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.829 -175.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 35.8 m -150.85 151.69 30.53 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.851 -0.531 . . . . 0.0 110.02 175.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -71.19 138.74 33.95 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 O-C-N 123.385 1.203 . . . . 0.0 109.988 176.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.422 ' CE1' ' HD2' ' A' ' 180' ' ' PRO . 60.9 t80 -75.0 127.31 32.94 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.487 -0.758 . . . . 0.0 110.224 174.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -100.0 160.12 28.05 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.738 -0.601 . . . . 0.0 109.983 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.94 157.81 27.46 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.266 1.14 . . . . 0.0 110.432 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.02 149.96 76.16 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 O-C-N 123.218 1.115 . . . . 0.0 110.499 -177.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -61.62 148.63 41.8 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.718 -0.614 . . . . 0.0 110.108 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.84 127.23 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.502 -0.749 . . . . 0.0 110.208 -170.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.16 -10.16 56.65 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.413 ' OG1' ' CD2' ' A' ' 260' ' ' PHE . 10.0 t -144.86 174.23 11.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.185 -1.185 . . . . 0.0 110.527 175.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -109.34 13.18 24.36 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.489 -0.757 . . . . 0.0 111.923 -166.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . 0.413 ' CD2' ' OG1' ' A' ' 258' ' ' THR . 46.2 p90 -120.0 168.06 11.54 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.113 -0.992 . . . . 0.0 111.219 -175.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 83.1 m -117.7 145.62 44.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.793 -0.567 . . . . 0.0 109.87 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 41.5 m -116.92 135.43 53.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.622 -0.674 . . . . 0.0 110.88 -175.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 60.3 t -131.54 137.31 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 173.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 75.0 mt -104.6 121.07 42.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.533 -0.729 . . . . 0.0 109.953 -171.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -105.39 153.02 22.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.661 -0.649 . . . . 0.0 110.789 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -136.55 142.95 43.44 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 177.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -113.58 131.87 55.94 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.536 -0.728 . . . . 0.0 110.388 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -101.01 9.06 42.65 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.624 -0.672 . . . . 0.0 112.011 -175.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -144.7 164.99 29.32 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.079 -1.013 . . . . 0.0 110.146 172.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -123.06 163.98 19.47 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.391 0.615 . . . . 0.0 110.547 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 23.9 m -57.82 -33.93 69.13 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.479 -0.763 . . . . 0.0 111.104 -164.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 50.0 p -102.18 13.05 35.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.395 -0.816 . . . . 0.0 112.029 -163.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . 0.598 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 29.9 p -96.03 118.04 31.86 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.066 -1.021 . . . . 0.0 110.735 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.75 139.82 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.519 -0.738 . . . . 0.0 110.319 -171.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.04 -5.2 59.28 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.07 -96.75 0.78 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 170.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 15.7 mmt -64.33 -35.23 80.18 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.673 -0.898 . . . . 0.0 110.475 177.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.3 p30 42.63 50.66 4.96 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 33.3 mtp180 54.8 29.5 11.97 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.402 -0.811 . . . . 0.0 111.193 176.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -120.0 104.93 43.35 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.599 -0.688 . . . . 0.0 110.177 175.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -60.39 148.82 89.14 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 O-C-N 123.131 1.069 . . . . 0.0 110.518 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 45.8 pt -131.88 177.42 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.788 0.804 . . . . 0.0 111.087 -176.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 21.7 mt -124.44 149.89 46.28 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.421 HD13 ' CE1' ' A' ' 301' ' ' PHE . 82.0 mt -117.98 129.71 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.353 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 81.0 mt -109.81 126.91 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -176.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 57.3 t -118.91 126.81 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.6 p -125.28 152.79 44.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.596 -0.69 . . . . 0.0 110.659 -174.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 24.0 tp -102.22 126.16 49.12 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.748 -0.595 . . . . 0.0 109.473 169.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -130.43 150.1 51.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.875 -0.516 . . . . 0.0 109.855 -173.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.4 ' CG2' ' CD1' ' A' ' 296' ' ' LEU . 22.1 p -89.85 160.89 16.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.619 -0.676 . . . . 0.0 109.897 176.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -55.84 -26.21 45.62 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.574 -0.704 . . . . 0.0 111.03 -176.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 45.3 p30 -90.59 9.7 28.51 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.491 -0.756 . . . . 0.0 111.937 -173.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.87 20.18 44.44 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 120.163 -1.018 . . . . 0.0 110.799 170.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -106.98 140.22 40.14 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.238 -1.154 . . . . 0.0 110.106 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 64.1 t -86.55 131.61 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.641 -0.662 . . . . 0.0 110.226 -173.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.4 ' CD1' ' CG2' ' A' ' 290' ' ' THR . 96.3 mt -99.97 -40.08 7.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.724 -0.61 . . . . 0.0 110.694 177.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -164.14 153.5 23.87 Favored Glycine 0 N--CA 1.497 2.736 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.298 -177.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -135.2 136.44 41.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.749 -0.853 . . . . 0.0 110.719 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -139.38 156.91 46.69 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.622 -0.674 . . . . 0.0 110.001 169.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 80.6 m -141.8 157.23 45.26 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.459 -0.776 . . . . 0.0 110.622 -174.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.421 ' CE1' HD13 ' A' ' 284' ' ' ILE . 49.6 p90 -144.94 162.31 37.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.637 -0.664 . . . . 0.0 110.144 176.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -104.88 134.97 47.11 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.596 -0.69 . . . . 0.0 110.184 -177.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -121.05 142.79 49.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.578 -0.702 . . . . 0.0 110.867 -169.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -137.06 138.95 40.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.792 -0.567 . . . . 0.0 109.622 172.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 77.0 mt -108.28 122.81 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.549 -0.719 . . . . 0.0 109.763 177.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.1 p -145.29 168.88 19.38 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.64 -0.662 . . . . 0.0 110.615 -171.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -71.53 -40.07 70.32 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.695 -0.628 . . . . 0.0 110.664 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.8 t -127.25 85.34 61.2 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.532 -0.73 . . . . 0.0 110.568 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -55.39 -27.23 57.2 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 O-C-N 123.224 1.118 . . . . 0.0 110.728 174.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -68.39 -37.72 86.26 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -71.14 -38.36 72.26 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.605 -0.938 . . . . 0.0 109.74 -174.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -69.36 -35.39 75.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.68 -0.637 . . . . 0.0 110.11 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -58.52 -46.25 87.14 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.55 -0.719 . . . . 0.0 110.43 174.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -64.53 -38.01 89.52 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.647 -0.658 . . . . 0.0 110.345 178.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -62.65 -51.79 65.89 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.484 -0.76 . . . . 0.0 110.578 -173.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.8 p30 . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.457 -0.777 . . . . 0.0 110.031 -176.98 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.8 t . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.075 0.465 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -101.42 25.8 7.95 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.617 -0.677 . . . . 0.0 110.634 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 54.4 m -78.85 125.22 29.08 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.554 -0.716 . . . . 0.0 110.231 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -70.33 144.86 51.55 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.632 -0.667 . . . . 0.0 110.396 -178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -158.37 101.21 1.71 Allowed Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.684 -0.635 . . . . 0.0 110.182 178.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -58.76 -39.96 77.12 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 O-C-N 123.086 1.045 . . . . 0.0 110.844 -175.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.82 -155.08 40.49 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -73.11 -49.05 0.24 Allowed 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.308 1.162 . . . . 0.0 110.911 -174.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -85.43 6.99 24.32 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.617 -0.677 . . . . 0.0 111.425 -175.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.97 61.92 2.84 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.949 -1.095 . . . . 0.0 110.608 -176.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.439 ' CE1' ' CG2' ' A' ' 174' ' ' ILE . 60.2 t80 -77.97 120.48 22.88 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.525 -0.735 . . . . 0.0 109.983 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -129.79 159.92 35.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.835 -0.541 . . . . 0.0 110.124 -176.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.2 t -124.96 145.8 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.792 -0.568 . . . . 0.0 109.889 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.9 p -155.01 162.25 41.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.81 -0.556 . . . . 0.0 109.92 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.472 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 75.3 m-85 . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.808 -0.558 . . . . 0.0 109.799 -175.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.781 0 CA-C-O 121.206 0.527 . . . . 0.0 110.026 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.404 ' OG1' ' CD1' ' A' ' 153' ' ' TRP . 82.3 p -60.02 -34.05 72.84 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.751 -0.593 . . . . 0.0 109.944 176.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.423 ' CZ2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -172.04 144.02 1.63 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.763 -0.585 . . . . 0.0 110.164 178.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 13.3 t -142.17 142.57 32.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.84 -0.538 . . . . 0.0 109.947 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.472 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 63.7 t80 -125.56 140.06 53.06 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.548 -0.72 . . . . 0.0 110.553 -172.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.9 t -110.23 124.26 51.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.837 -0.539 . . . . 0.0 109.827 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 58.5 m -70.66 -37.03 73.67 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.772 -0.58 . . . . 0.0 110.481 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -59.66 -34.7 73.16 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.553 -0.717 . . . . 0.0 110.43 -177.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 57.5 mt -104.86 -11.75 16.6 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.662 -0.649 . . . . 0.0 110.864 -175.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 26.2 tttp 59.83 52.03 5.69 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.02 -1.05 . . . . 0.0 109.715 178.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -144.96 152.77 40.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.74 -0.6 . . . . 0.0 110.587 -175.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.5 tp -126.61 137.81 53.36 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.758 -0.589 . . . . 0.0 110.338 -176.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -115.18 135.45 54.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.616 -0.677 . . . . 0.0 109.243 173.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.8 p -138.28 158.38 44.41 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.922 -175.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -104.53 143.02 33.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.593 -0.692 . . . . 0.0 110.131 173.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 16.8 tt -52.54 146.28 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.499 -0.751 . . . . 0.0 111.895 -173.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 64.81 10.04 5.78 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.579 -0.7 . . . . 0.0 112.471 176.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 53.4 mmtt -95.64 155.08 16.89 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.961 -1.087 . . . . 0.0 110.897 174.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 90.5 m -82.94 126.17 32.21 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.628 -0.67 . . . . 0.0 110.689 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 43.6 t -114.23 90.09 19.29 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.657 -0.652 . . . . 0.0 110.108 172.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.423 ' HD2' ' CZ2' ' A' ' 153' ' ' TRP . 17.4 Cg_exo -63.79 129.41 24.7 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 123.248 1.13 . . . . 0.0 110.581 173.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.412 HG12 ' CE2' ' A' ' 142' ' ' PHE . 97.5 mt -123.12 141.35 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 175.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -108.13 136.39 47.89 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.476 -0.765 . . . . 0.0 110.737 -175.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.439 ' CG2' ' CE1' ' A' ' 138' ' ' PHE . 48.6 mm -95.37 135.02 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.719 -0.613 . . . . 0.0 109.633 170.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -117.18 129.31 55.86 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.662 -0.649 . . . . 0.0 110.426 176.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 17.0 m -136.63 159.77 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.478 -0.764 . . . . 0.0 110.047 175.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 80.8 mmm -77.59 -40.24 42.85 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.745 -0.597 . . . . 0.0 110.007 177.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 77.9 p -135.51 143.28 44.45 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.832 -0.542 . . . . 0.0 109.675 177.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -55.57 139.89 83.04 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 O-C-N 123.14 1.074 . . . . 0.0 110.887 -172.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.43 ' HG2' ' CD1' ' A' ' 251' ' ' TYR . 31.3 Cg_endo -67.35 170.04 14.26 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 O-C-N 123.25 1.132 . . . . 0.0 110.633 177.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -60.45 154.98 49.75 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.431 1.227 . . . . 0.0 110.546 -178.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -77.43 140.08 39.8 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.581 -0.699 . . . . 0.0 109.95 175.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.73 -25.06 28.96 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -174.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.22 153.08 1.56 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.363 -1.08 . . . . 0.0 111.41 178.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 33.9 m -129.66 155.93 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.661 -0.649 . . . . 0.0 109.686 176.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 82.6 mt -107.85 137.21 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.688 -0.633 . . . . 0.0 109.462 175.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 32.1 mtm180 -115.06 143.37 45.29 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 -176.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -136.62 126.48 25.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.568 -0.707 . . . . 0.0 110.235 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 23.8 ttp -137.24 137.14 21.8 Favored Pre-proline 0 N--CA 1.497 1.884 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.934 -176.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -90.74 138.21 2.47 Favored 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 123.169 1.089 . . . . 0.0 110.706 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.9 m -147.48 154.84 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.467 -0.771 . . . . 0.0 110.191 174.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.444 ' CZ ' ' NH2' ' A' ' 280' ' ' ARG . 79.4 m-85 -63.8 162.81 12.82 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.546 -0.721 . . . . 0.0 110.487 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -79.35 -60.04 2.52 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.669 -0.644 . . . . 0.0 110.905 -173.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -80.11 150.66 30.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.574 -0.704 . . . . 0.0 110.281 -174.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.58 -38.12 71.53 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.424 -0.797 . . . . 0.0 110.686 -175.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -56.77 -24.91 53.54 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.494 -0.754 . . . . 0.0 110.565 -176.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.4 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 81.0 m-70 -109.68 -20.55 12.79 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.954 -0.699 . . . . 0.0 111.102 -178.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.2 p -67.71 -20.25 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.223 -0.923 . . . . 0.0 110.447 -176.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 67.2 p -79.37 -17.12 55.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.496 -0.752 . . . . 0.0 110.7 175.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -88.25 134.17 33.86 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.336 -0.853 . . . . 0.0 109.945 172.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.0 t -72.84 141.84 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.63 -0.669 . . . . 0.0 110.211 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.422 HG23 ' CZ ' ' A' ' 192' ' ' TYR . 58.4 t -84.86 140.05 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.571 -0.706 . . . . 0.0 109.153 171.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -134.71 -170.57 2.58 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.471 -0.768 . . . . 0.0 111.054 -170.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 13.6 mmp_? -95.62 157.35 15.94 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.732 -0.605 . . . . 0.0 110.106 178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 49.8 m . . . . . 0 N--CA 1.496 1.854 0 O-C-N 121.539 -0.726 . . . . 0.0 109.263 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 48.8 tp . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 120.978 0.418 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 86.2 mt -101.39 136.75 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.803 -0.561 . . . . 0.0 109.889 -175.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -135.18 159.72 40.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.71 -0.619 . . . . 0.0 110.317 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 94.6 t -105.18 146.82 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.704 -0.622 . . . . 0.0 110.138 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -120.99 124.51 45.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.777 -0.577 . . . . 0.0 110.27 172.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.78 24.16 11.09 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 169.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 -140.6 106.42 5.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.397 -1.06 . . . . 0.0 109.976 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 43.2 m -63.19 -15.28 56.46 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.519 -0.738 . . . . 0.0 111.341 -175.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -99.98 7.53 44.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 111.675 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.74 130.64 46.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.192 -0.942 . . . . 0.0 110.172 177.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -139.79 158.0 44.81 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.784 -0.572 . . . . 0.0 109.715 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -116.03 150.66 36.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.569 -0.707 . . . . 0.0 110.435 -177.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.16 159.88 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.79 -0.569 . . . . 0.0 110.26 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -123.43 128.25 49.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.73 -0.607 . . . . 0.0 110.08 174.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -65.12 130.05 94.68 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.669 -0.644 . . . . 0.0 109.85 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -67.07 -27.4 42.22 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 O-C-N 123.128 1.067 . . . . 0.0 111.008 -173.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 84.2 mt -100.57 -50.35 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.369 -0.832 . . . . 0.0 110.923 -168.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.3 p -105.28 12.13 32.12 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.338 -0.852 . . . . 0.0 111.831 -174.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.92 -5.43 12.82 Favored Glycine 0 N--CA 1.497 2.709 0 O-C-N 121.137 -0.977 . . . . 0.0 111.909 173.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 68.3 mmt-85 -46.04 142.0 2.94 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-N 119.192 1.496 . . . . 0.0 112.296 -175.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -109.24 140.8 42.4 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.682 -0.636 . . . . 0.0 110.037 172.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 78.5 p -154.75 159.99 41.02 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.591 -0.693 . . . . 0.0 110.689 178.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 8.2 p -124.17 148.32 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.798 -0.564 . . . . 0.0 109.657 176.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 84.4 mt -129.57 154.58 46.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.638 -0.664 . . . . 0.0 109.963 -175.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 35.9 m -151.28 151.71 29.72 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.794 -0.566 . . . . 0.0 109.947 176.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -71.08 138.95 34.7 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 O-C-N 123.275 1.145 . . . . 0.0 110.15 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.43 ' CD1' ' HG2' ' A' ' 180' ' ' PRO . 58.3 t80 -74.88 126.06 30.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.525 -0.734 . . . . 0.0 110.233 175.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -99.99 160.07 28.17 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.683 -0.635 . . . . 0.0 109.993 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.83 159.02 22.34 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 O-C-N 123.211 1.111 . . . . 0.0 110.529 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.38 149.98 77.93 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 O-C-N 123.251 1.132 . . . . 0.0 110.471 -178.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -61.31 146.94 46.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.737 -0.602 . . . . 0.0 110.233 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.94 127.25 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.517 -0.74 . . . . 0.0 110.164 -171.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.03 -10.15 55.25 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.405 ' OG1' ' CE2' ' A' ' 260' ' ' PHE . 10.0 t -144.0 173.44 11.71 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.168 -1.195 . . . . 0.0 110.625 175.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -106.83 13.15 28.19 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.612 -0.68 . . . . 0.0 111.756 -168.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . 0.405 ' CE2' ' OG1' ' A' ' 258' ' ' THR . 14.8 p90 -119.93 167.96 11.61 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.227 -0.921 . . . . 0.0 111.192 -175.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 94.1 m -117.75 146.31 43.87 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.762 -0.586 . . . . 0.0 109.868 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 39.7 m -116.74 135.77 53.5 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.577 -0.702 . . . . 0.0 110.941 -175.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.0 t -130.78 137.19 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 172.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 69.8 mt -104.53 121.6 43.82 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.49 -0.756 . . . . 0.0 109.94 -172.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -106.56 154.84 20.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.65 -0.656 . . . . 0.0 110.824 -177.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -136.19 142.94 44.17 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -112.86 127.2 56.12 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.737 -0.602 . . . . 0.0 110.057 176.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 4.5 ppp? -95.74 7.3 46.7 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.705 -0.622 . . . . 0.0 111.898 -176.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -144.87 164.98 29.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.12 -0.987 . . . . 0.0 109.883 174.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -120.37 160.82 22.29 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.722 -0.611 . . . . 0.0 110.236 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 24.0 m -58.99 -31.72 69.03 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.458 -0.776 . . . . 0.0 110.908 -163.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 72.9 m -94.99 8.93 41.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.602 -0.686 . . . . 0.0 112.098 -164.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 31.9 p -95.42 118.18 31.69 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.03 -1.044 . . . . 0.0 110.869 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.11 141.05 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.467 -0.771 . . . . 0.0 110.324 -172.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 100.78 -5.22 56.56 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.0 -105.39 1.13 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 169.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 97.0 mmm -61.35 -36.93 81.57 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.691 -0.888 . . . . 0.0 110.15 178.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 40.45 55.04 2.9 Favored 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 121.42 0.629 . . . . 0.0 112.664 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 55.62 34.09 22.53 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.456 -0.777 . . . . 0.0 111.523 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' ARG . . . . . 0.444 ' NH2' ' CZ ' ' A' ' 192' ' ' TYR . 35.6 mtm180 -120.12 106.09 41.44 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.295 -0.878 . . . . 0.0 110.161 165.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -60.7 147.98 93.13 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 O-C-N 123.073 1.039 . . . . 0.0 110.416 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 43.9 pt -131.94 179.52 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-O 121.798 0.808 . . . . 0.0 111.001 -176.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 33.0 mt -124.4 149.93 46.16 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.423 HD12 ' CE1' ' A' ' 301' ' ' PHE . 82.6 mt -115.17 129.9 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 77.7 mt -109.76 126.9 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -176.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 57.6 t -118.93 126.66 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.0 p -125.21 152.95 43.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.618 -0.676 . . . . 0.0 110.692 -174.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.426 ' HB2' ' CE1' ' A' ' 138' ' ' PHE . 26.3 tp -101.52 126.94 48.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.66 -0.65 . . . . 0.0 109.483 168.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -131.61 150.88 52.0 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -173.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 80.0 p -89.92 159.4 16.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.623 -0.673 . . . . 0.0 109.726 177.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 68.4 ttp85 -55.96 -26.02 46.31 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.619 -0.676 . . . . 0.0 110.796 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -87.62 9.72 20.36 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.5 -0.75 . . . . 0.0 111.841 -174.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 87.31 20.13 53.15 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 120.159 -1.02 . . . . 0.0 110.779 170.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -107.22 140.19 40.48 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.364 -1.08 . . . . 0.0 110.238 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 60.7 t -88.1 132.33 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.619 -0.676 . . . . 0.0 110.194 -174.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 95.8 mt -99.94 -40.18 7.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.635 -0.666 . . . . 0.0 110.5 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -165.25 153.45 23.58 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 78.5 mtm180 -134.72 136.24 42.55 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.672 -0.899 . . . . 0.0 110.908 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -134.0 158.5 43.37 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.572 -0.705 . . . . 0.0 109.77 170.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 93.6 m -142.91 154.2 43.86 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.444 -0.785 . . . . 0.0 110.772 -175.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.423 ' CE1' HD12 ' A' ' 284' ' ' ILE . 46.0 p90 -145.0 162.1 37.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.702 -0.624 . . . . 0.0 110.017 175.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -104.93 136.15 44.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.537 -0.727 . . . . 0.0 110.116 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -122.55 144.05 49.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.647 -0.658 . . . . 0.0 110.769 -169.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -138.52 137.14 36.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.832 -0.543 . . . . 0.0 109.757 173.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 67.5 mt -105.88 122.84 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.582 -0.699 . . . . 0.0 109.423 175.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.1 p -145.14 169.45 18.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.559 -0.713 . . . . 0.0 111.038 -169.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -69.63 -40.02 76.82 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.673 -0.642 . . . . 0.0 110.626 -178.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 4.2 t -131.39 88.34 44.22 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.578 -0.702 . . . . 0.0 110.5 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -55.25 -29.45 67.07 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 O-C-N 123.207 1.109 . . . . 0.0 111.023 174.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.43 -37.91 93.1 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.4 ttm-85 -73.47 -40.28 64.26 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.684 -0.892 . . . . 0.0 109.795 -173.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -69.43 -40.45 77.24 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.077 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -61.27 -44.54 97.07 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.271 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 28.9 tttp -64.01 -40.45 96.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.552 -0.717 . . . . 0.0 110.498 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.55 -50.6 71.99 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.487 -0.758 . . . . 0.0 110.476 -173.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 N--CA 1.494 1.763 0 O-C-N 121.449 -0.782 . . . . 0.0 110.127 -177.979 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.0 t . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 121.062 0.458 . . . . 0.0 110.261 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.5 p-10 -95.15 24.63 4.8 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.655 -0.653 . . . . 0.0 110.794 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 50.4 m -73.33 125.17 27.22 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.573 -0.705 . . . . 0.0 110.263 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -72.67 145.05 47.5 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.614 -0.679 . . . . 0.0 110.346 -178.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -154.8 101.41 2.34 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.747 -0.596 . . . . 0.0 110.24 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -58.92 -39.97 76.14 Favored 'Trans proline' 0 N--CA 1.488 1.18 0 O-C-N 123.151 1.079 . . . . 0.0 110.803 -177.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.31 -155.12 48.52 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -72.78 -46.88 0.38 Allowed 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 123.399 1.21 . . . . 0.0 111.066 -173.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -87.59 9.83 19.93 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.523 -0.736 . . . . 0.0 111.396 -173.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.81 59.69 4.13 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.983 -1.073 . . . . 0.0 110.58 -175.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.416 ' CE1' HG22 ' A' ' 174' ' ' ILE . 67.8 t80 -77.83 118.36 20.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.714 -0.616 . . . . 0.0 109.861 -179.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -130.02 159.89 35.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.781 -0.575 . . . . 0.0 110.193 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 70.9 t -124.22 147.34 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.704 -0.622 . . . . 0.0 109.857 174.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 76.5 p -154.91 162.76 40.99 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 120.378 -0.529 . . . . 0.0 109.956 177.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.49 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 74.9 m-85 . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.81 -0.556 . . . . 0.0 109.897 -175.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.114 0.483 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.403 ' OG1' ' CD1' ' A' ' 153' ' ' TRP . 73.1 p -60.13 -33.76 72.59 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.678 -0.639 . . . . 0.0 109.974 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.421 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.6 p-90 -171.03 144.68 2.16 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.356 0.598 . . . . 0.0 110.289 178.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 9.5 t -142.2 142.65 32.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.846 -0.534 . . . . 0.0 110.064 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.49 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 62.7 t80 -125.42 140.02 53.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.522 -0.736 . . . . 0.0 110.483 -172.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.4 t -110.09 124.94 52.41 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 120.386 -0.526 . . . . 0.0 109.872 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 49.5 m -70.73 -37.05 73.46 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.391 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -60.28 -32.27 71.03 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.635 -0.666 . . . . 0.0 110.323 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 59.2 mt -104.76 -12.12 16.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.73 -0.606 . . . . 0.0 110.835 -174.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 71.4 tttt 59.78 47.47 10.27 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.019 -1.051 . . . . 0.0 109.58 177.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.7 tttp -146.68 153.15 39.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.706 -0.621 . . . . 0.0 110.666 -172.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.6 tp -126.41 137.79 53.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.776 -0.577 . . . . 0.0 110.307 -176.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -114.92 131.62 56.82 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 175.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.3 158.48 44.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.69 -0.631 . . . . 0.0 110.941 -173.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -104.69 141.47 36.4 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.47 0.652 . . . . 0.0 110.351 172.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 16.7 tt -52.19 148.06 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 121.622 0.725 . . . . 0.0 111.857 -174.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 64.29 10.01 5.29 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.558 -0.714 . . . . 0.0 112.516 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -96.65 155.08 16.92 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.892 -1.13 . . . . 0.0 110.889 174.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 86.8 m -83.5 126.2 32.54 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.73 -0.606 . . . . 0.0 110.602 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 44.4 t -114.85 90.1 21.44 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.55 -0.719 . . . . 0.0 110.222 173.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.421 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 19.3 Cg_exo -63.27 130.09 27.54 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 O-C-N 123.228 1.12 . . . . 0.0 110.753 173.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.413 HG12 ' CE2' ' A' ' 142' ' ' PHE . 97.0 mt -123.52 143.35 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.664 -0.647 . . . . 0.0 109.317 173.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -109.35 135.48 50.35 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.491 -0.756 . . . . 0.0 110.824 -175.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.416 HG22 ' CE1' ' A' ' 138' ' ' PHE . 48.9 mm -95.29 135.03 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.685 -0.634 . . . . 0.0 109.65 169.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 44.5 tttm -116.43 129.53 56.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.62 -0.675 . . . . 0.0 110.482 176.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.5 m -136.69 159.76 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.552 -0.718 . . . . 0.0 109.873 174.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.4 mmm -78.44 -41.63 32.33 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.692 -0.63 . . . . 0.0 110.15 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 76.9 p -133.81 143.2 46.58 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.773 -0.579 . . . . 0.0 109.634 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -55.21 139.79 80.94 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 O-C-N 123.191 1.101 . . . . 0.0 110.925 -171.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.429 ' HG2' ' CD1' ' A' ' 251' ' ' TYR . 30.7 Cg_endo -66.81 170.1 13.39 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.17 1.09 . . . . 0.0 110.588 177.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -60.65 155.06 50.45 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.363 1.191 . . . . 0.0 110.537 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -78.08 140.59 39.09 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.619 -0.676 . . . . 0.0 109.91 175.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.83 -24.92 29.6 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -174.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.2 152.06 1.86 Allowed 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.348 -1.09 . . . . 0.0 111.436 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.79 156.3 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.814 -0.554 . . . . 0.0 109.805 176.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 52.4 mt -109.75 135.56 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -114.97 145.48 42.2 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -174.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -139.74 126.58 20.75 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.509 -0.744 . . . . 0.0 110.332 173.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 37.5 ttp -137.39 138.55 25.17 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.78 -0.575 . . . . 0.0 111.093 -176.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -90.75 138.15 2.45 Favored 'Trans proline' 0 C--N 1.32 -0.941 0 O-C-N 123.207 1.109 . . . . 0.0 110.808 176.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.8 m -147.31 154.78 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.487 -0.758 . . . . 0.0 110.109 173.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.453 ' CE1' ' CG2' ' A' ' 202' ' ' VAL . 90.4 m-85 -62.18 166.43 4.85 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.41 -0.806 . . . . 0.0 110.477 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -83.09 -60.04 2.28 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.671 -0.643 . . . . 0.0 110.824 -175.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 39.6 mttp -80.06 151.14 30.06 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.609 -0.682 . . . . 0.0 110.328 -175.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.55 -38.07 71.41 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.404 -0.81 . . . . 0.0 110.802 -175.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -56.75 -24.92 53.37 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.556 -0.715 . . . . 0.0 110.599 -176.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -109.7 -20.53 12.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.519 -0.738 . . . . 0.0 111.144 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.1 p -67.73 -20.23 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.181 -0.95 . . . . 0.0 110.518 -176.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 78.5 p -79.43 -17.01 55.19 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.779 175.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -88.28 137.86 31.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.367 -0.833 . . . . 0.0 110.089 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.7 t -73.13 140.89 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.614 -0.679 . . . . 0.0 110.295 177.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.453 ' CG2' ' CE1' ' A' ' 192' ' ' TYR . 62.0 t -85.0 138.57 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.552 -0.718 . . . . 0.0 109.345 170.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 14.2 pttt -134.92 -170.26 2.53 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.575 -0.703 . . . . 0.0 111.01 -171.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 84.7 mtm-85 -95.27 157.49 15.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.747 -0.596 . . . . 0.0 110.212 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.735 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 53.4 m . . . . . 0 N--CA 1.496 1.862 0 O-C-N 121.677 -0.64 . . . . 0.0 109.558 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 54.9 tp . . . . . 0 N--CA 1.497 1.875 0 CA-C-O 120.946 0.403 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 83.0 mt -105.51 136.8 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.747 -0.596 . . . . 0.0 109.735 177.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -132.35 157.13 45.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.677 -0.639 . . . . 0.0 110.264 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 75.2 t -102.52 146.58 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.727 -0.608 . . . . 0.0 110.022 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -117.83 130.08 56.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.7 -0.625 . . . . 0.0 110.386 170.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 95.65 20.71 25.97 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.559 -1.017 . . . . 0.0 110.559 168.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -138.84 105.88 5.45 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -1.119 . . . . 0.0 110.005 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 43.2 m -63.21 -15.23 56.32 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.596 -0.69 . . . . 0.0 111.285 -177.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -100.0 8.9 43.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.19 -0.944 . . . . 0.0 111.53 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.37 131.42 50.21 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.072 -1.018 . . . . 0.0 110.196 176.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -139.76 158.06 44.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.752 -0.592 . . . . 0.0 109.805 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -111.69 150.63 29.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.614 -0.679 . . . . 0.0 110.484 -177.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.17 159.92 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.732 -0.605 . . . . 0.0 110.216 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -121.03 130.1 53.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.813 -0.555 . . . . 0.0 110.154 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -63.23 130.0 93.89 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.664 -0.648 . . . . 0.0 109.853 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -65.23 -28.63 55.74 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 O-C-N 123.186 1.098 . . . . 0.0 110.968 -170.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.6 mt -102.15 -50.47 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.467 -0.77 . . . . 0.0 111.07 -168.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 14.1 p -105.3 12.18 32.04 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.392 -0.818 . . . . 0.0 111.942 -174.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 72.56 -4.89 18.57 Favored Glycine 0 N--CA 1.496 2.669 0 O-C-N 120.988 -1.07 . . . . 0.0 111.955 172.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -45.92 142.02 2.83 Favored 'General case' 0 N--CA 1.506 2.328 0 CA-C-N 119.101 1.451 . . . . 0.0 112.339 -175.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -103.94 141.72 35.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.616 -0.678 . . . . 0.0 110.219 176.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.4 p -154.73 159.95 41.02 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.623 -0.673 . . . . 0.0 110.299 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 8.3 p -122.95 148.08 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.674 -0.641 . . . . 0.0 109.796 178.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 80.1 mt -129.63 154.62 46.93 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.816 -175.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 35.8 m -150.98 151.76 30.34 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.808 -0.558 . . . . 0.0 109.907 175.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -71.01 140.5 38.11 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 O-C-N 123.251 1.132 . . . . 0.0 110.003 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.429 ' CD1' ' HG2' ' A' ' 180' ' ' PRO . 60.6 t80 -76.06 125.41 29.08 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.459 -0.775 . . . . 0.0 110.155 177.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -100.05 160.14 27.96 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.739 -0.6 . . . . 0.0 109.998 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -59.0 159.13 22.58 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 O-C-N 123.284 1.149 . . . . 0.0 110.445 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -59.11 149.93 76.79 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 O-C-N 123.248 1.131 . . . . 0.0 110.515 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -60.36 147.45 40.6 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.627 -0.671 . . . . 0.0 110.319 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.7 t -69.83 127.25 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.619 -0.675 . . . . 0.0 110.22 -170.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.99 -10.09 55.33 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.407 ' OG1' ' CD2' ' A' ' 260' ' ' PHE . 9.6 t -144.35 173.27 11.92 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.224 -1.162 . . . . 0.0 110.558 175.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -106.92 13.21 27.95 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.651 -0.656 . . . . 0.0 111.804 -168.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . 0.407 ' CD2' ' OG1' ' A' ' 258' ' ' THR . 15.3 p90 -120.03 168.05 11.57 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.115 -0.991 . . . . 0.0 111.152 -175.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 82.3 m -117.75 146.25 43.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.729 -0.607 . . . . 0.0 109.788 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 35.6 m -116.72 136.61 52.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.636 -0.665 . . . . 0.0 110.917 -175.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 59.3 t -128.56 137.13 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 66.4 mt -104.78 119.49 39.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.497 -0.752 . . . . 0.0 109.831 -173.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 6.5 m-30 -105.69 151.06 24.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.62 -0.675 . . . . 0.0 110.718 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -136.53 143.01 43.49 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -115.0 131.97 56.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.527 -0.733 . . . . 0.0 110.501 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -100.24 1.16 41.57 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.654 -0.654 . . . . 0.0 111.9 -177.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.65 159.6 42.55 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.085 -1.009 . . . . 0.0 109.982 173.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -115.13 153.89 29.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.74 -0.6 . . . . 0.0 110.161 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 92.7 p -56.64 -26.7 56.76 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.404 -0.81 . . . . 0.0 111.155 -167.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 46.0 p -95.04 8.19 43.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.387 -0.821 . . . . 0.0 112.086 -165.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . 0.735 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 28.9 p -93.96 117.96 30.82 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.98 -1.075 . . . . 0.0 110.727 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 60.2 t -69.68 143.34 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.561 -0.712 . . . . 0.0 110.533 -167.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.53 -5.28 58.55 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.04 -95.35 0.74 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 169.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 95.2 mmm -64.78 -28.61 69.69 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.74 -0.859 . . . . 0.0 110.386 176.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.9 p30 44.95 51.56 8.6 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 121.325 0.583 . . . . 0.0 112.507 172.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 37.9 mtt180 54.7 33.4 19.35 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.321 -0.862 . . . . 0.0 111.289 174.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -114.89 105.01 53.74 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.499 -0.751 . . . . 0.0 110.092 173.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -60.8 144.97 99.65 Favored 'Trans proline' 0 N--CA 1.488 1.175 0 O-C-N 123.138 1.073 . . . . 0.0 110.371 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 43.6 pt -132.58 177.84 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 121.943 0.878 . . . . 0.0 111.253 -174.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 35.0 mt -124.34 149.9 46.09 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.421 ' HB ' ' CZ ' ' A' ' 301' ' ' PHE . 80.8 mt -114.21 130.51 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.63 -0.669 . . . . 0.0 109.312 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 81.0 mt -109.78 125.91 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -176.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 75.8 t -118.98 126.71 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.7 p -125.28 153.01 43.89 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.717 -0.614 . . . . 0.0 110.72 -174.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.405 ' HB2' ' CE1' ' A' ' 138' ' ' PHE . 19.1 tp -100.29 126.95 46.68 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 166.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -132.69 149.72 52.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.756 -0.59 . . . . 0.0 110.01 -172.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 77.2 p -89.93 158.28 17.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.667 -0.646 . . . . 0.0 110.013 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -55.98 -26.16 47.19 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.559 -0.713 . . . . 0.0 111.009 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -92.93 12.86 22.37 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.47 -0.769 . . . . 0.0 111.697 -173.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.94 20.18 44.17 Favored Glycine 0 N--CA 1.494 2.539 0 C-N-CA 120.118 -1.039 . . . . 0.0 110.962 167.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -107.43 140.14 40.83 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.216 -1.167 . . . . 0.0 110.18 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 58.7 t -90.1 130.9 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.626 -0.671 . . . . 0.0 110.054 -175.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 96.3 mt -99.97 -40.07 7.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.716 -0.615 . . . . 0.0 110.569 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -160.35 149.36 18.66 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -135.19 136.24 41.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.678 -0.895 . . . . 0.0 110.575 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -138.13 157.82 45.55 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.608 -0.682 . . . . 0.0 110.301 170.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 82.2 m -141.88 154.96 45.5 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.493 -0.754 . . . . 0.0 110.643 -175.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.421 ' CZ ' ' HB ' ' A' ' 284' ' ' ILE . 47.3 p90 -144.95 160.97 40.49 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.703 -0.623 . . . . 0.0 110.194 175.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -104.93 136.89 43.56 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.571 -0.706 . . . . 0.0 110.125 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -117.94 143.73 46.1 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.821 -169.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -137.1 138.57 40.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.822 -0.549 . . . . 0.0 109.713 172.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 56.2 mt -112.7 122.86 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.512 -0.743 . . . . 0.0 109.757 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.2 p -145.32 170.56 16.08 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.642 -0.662 . . . . 0.0 110.664 -171.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -71.97 -40.11 68.86 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.694 -0.629 . . . . 0.0 110.641 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.8 t -127.12 86.51 58.66 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.59 -0.694 . . . . 0.0 110.506 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -56.24 -28.2 70.14 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.169 1.089 . . . . 0.0 110.533 173.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -67.53 -37.57 89.86 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -70.5 -38.33 74.3 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.643 -0.916 . . . . 0.0 109.749 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -69.45 -35.42 75.64 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.085 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 37.7 ttt85 -57.16 -47.3 81.55 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.533 -0.73 . . . . 0.0 110.593 174.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -64.56 -39.02 92.98 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.575 -0.703 . . . . 0.0 110.401 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -62.44 -51.41 67.62 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.529 -0.732 . . . . 0.0 110.56 -173.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.5 p30 . . . . . 0 N--CA 1.495 1.777 0 O-C-N 121.472 -0.767 . . . . 0.0 110.096 -176.928 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.5 t . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.057 0.456 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -94.65 24.25 4.77 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.691 -0.63 . . . . 0.0 110.878 -178.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 50.9 m -72.33 125.18 26.72 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.496 -0.753 . . . . 0.0 110.148 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -68.5 144.94 54.45 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.614 -0.679 . . . . 0.0 110.388 -176.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -155.55 101.65 2.2 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.802 -0.561 . . . . 0.0 110.058 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -59.54 -39.87 71.25 Favored 'Trans proline' 0 N--CA 1.489 1.222 0 O-C-N 123.152 1.08 . . . . 0.0 110.677 -175.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.04 -155.17 42.1 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -73.29 -43.86 0.64 Allowed 'Trans proline' 0 C--N 1.316 -1.142 0 O-C-N 123.422 1.222 . . . . 0.0 110.89 -175.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -89.28 5.64 44.01 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.543 -0.723 . . . . 0.0 111.497 -174.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 t 53.99 59.43 4.26 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.978 -1.076 . . . . 0.0 110.729 -176.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.443 ' CE1' ' CG2' ' A' ' 174' ' ' ILE . 64.6 t80 -78.15 118.78 20.72 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.571 -0.706 . . . . 0.0 110.019 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -130.06 160.02 34.98 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.34 0.591 . . . . 0.0 110.321 -176.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.0 t -124.83 148.42 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.692 -0.63 . . . . 0.0 109.87 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.6 p -155.87 166.9 32.09 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.313 0.578 . . . . 0.0 110.088 176.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.496 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 66.3 m-85 . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.782 -0.574 . . . . 0.0 109.84 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 121.173 0.511 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.4 ' OG1' ' CD1' ' A' ' 153' ' ' TRP . 42.5 p -60.09 -34.08 72.98 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.643 -0.661 . . . . 0.0 110.094 176.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.423 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.8 p-90 -171.22 144.27 2.02 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.331 0.586 . . . . 0.0 110.224 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.0 t -142.09 142.6 32.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.897 -0.502 . . . . 0.0 109.985 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.496 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 64.7 t80 -125.61 139.98 53.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.486 -0.759 . . . . 0.0 110.775 -171.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.0 t -111.96 123.85 51.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.851 -0.531 . . . . 0.0 109.92 177.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 59.0 m -70.93 -37.01 72.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.806 -0.559 . . . . 0.0 110.568 -176.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -59.21 -35.36 73.48 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.505 -0.747 . . . . 0.0 110.522 -177.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.2 mt -104.86 -11.05 16.94 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.683 -0.636 . . . . 0.0 110.981 -176.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt 59.76 52.64 5.34 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.14 -0.975 . . . . 0.0 109.743 177.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -145.25 153.07 40.92 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.779 -0.576 . . . . 0.0 110.625 -175.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.6 tp -126.58 137.76 53.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.758 -0.588 . . . . 0.0 110.206 -175.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -116.04 135.89 53.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.63 -0.669 . . . . 0.0 109.381 173.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.1 p -138.49 158.49 44.17 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.68 -0.638 . . . . 0.0 110.767 -177.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -104.61 144.49 31.64 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.505 -0.747 . . . . 0.0 109.882 171.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 16.3 tt -51.71 147.48 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.502 -0.749 . . . . 0.0 111.95 -174.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 65.11 10.0 5.99 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.637 -0.665 . . . . 0.0 112.702 174.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -96.12 155.11 16.9 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.955 -1.091 . . . . 0.0 111.074 172.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 91.3 m -80.33 126.18 30.83 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.719 -0.613 . . . . 0.0 110.569 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 48.6 t -116.32 90.03 28.34 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.604 -0.685 . . . . 0.0 110.126 174.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.423 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 15.2 Cg_exo -65.78 131.08 26.39 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 O-C-N 123.264 1.139 . . . . 0.0 110.756 174.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.414 HG12 ' CE2' ' A' ' 142' ' ' PHE . 78.2 mt -123.91 144.69 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.596 -0.69 . . . . 0.0 109.496 172.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . 0.405 ' OE1' ' CD1' ' A' ' 260' ' ' PHE . 70.5 mm-40 -108.42 133.05 53.12 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.52 -0.738 . . . . 0.0 110.361 -173.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.443 ' CG2' ' CE1' ' A' ' 138' ' ' PHE . 49.0 mm -95.35 135.0 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.652 -0.655 . . . . 0.0 109.657 170.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.0 tttp -119.3 130.28 55.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.531 -0.73 . . . . 0.0 110.529 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 17.4 m -136.2 159.73 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.605 -0.684 . . . . 0.0 109.905 175.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 81.6 mmm -77.13 -40.3 46.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.695 -0.628 . . . . 0.0 110.045 177.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 77.3 p -135.87 143.27 43.72 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.764 -0.585 . . . . 0.0 109.795 177.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -55.69 139.89 83.68 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 O-C-N 123.217 1.114 . . . . 0.0 110.886 -172.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.441 ' CG ' ' CE1' ' A' ' 251' ' ' TYR . 23.4 Cg_endo -64.28 169.71 10.45 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.238 1.125 . . . . 0.0 110.69 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -61.06 156.54 44.02 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.35 1.184 . . . . 0.0 110.497 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -77.06 139.61 40.07 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.629 -0.669 . . . . 0.0 109.908 175.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.9 -25.02 29.24 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -175.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.12 152.97 1.53 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.296 -1.12 . . . . 0.0 111.325 176.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.77 155.98 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.748 -0.595 . . . . 0.0 109.774 176.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.413 HD12 ' CD2' ' A' ' 251' ' ' TYR . 72.4 mt -106.13 133.7 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 177.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -115.01 140.94 48.64 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -174.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -138.52 124.47 20.02 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.49 -0.757 . . . . 0.0 110.53 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 20.3 ttm -137.35 139.31 27.32 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.808 -0.558 . . . . 0.0 111.145 -175.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -90.29 138.13 2.69 Favored 'Trans proline' 0 C--N 1.32 -0.948 0 O-C-N 123.185 1.097 . . . . 0.0 110.519 175.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.8 m -147.07 154.92 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.577 -0.702 . . . . 0.0 110.211 174.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.426 ' CE2' HG21 ' A' ' 202' ' ' VAL . 82.3 m-85 -60.97 161.1 8.76 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.477 -0.764 . . . . 0.0 110.348 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -78.46 -60.04 2.53 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.635 -0.666 . . . . 0.0 110.812 -173.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -80.02 151.88 29.73 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.605 -0.685 . . . . 0.0 110.447 -174.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.41 -38.94 72.23 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.353 -0.842 . . . . 0.0 110.74 -176.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -56.37 -24.57 45.25 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.533 -0.73 . . . . 0.0 110.624 -176.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.412 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 60.4 m170 -110.01 -20.56 12.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.509 -0.744 . . . . 0.0 111.101 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.1 p -66.88 -20.34 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.111 -0.993 . . . . 0.0 110.639 -176.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 73.7 p -79.3 -16.96 55.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.522 -0.736 . . . . 0.0 110.78 175.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -88.41 134.62 33.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.338 -0.851 . . . . 0.0 110.064 173.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.3 t -73.16 143.69 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.612 -0.68 . . . . 0.0 110.269 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.426 HG21 ' CE2' ' A' ' 192' ' ' TYR . 78.9 t -84.9 139.56 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.527 -0.733 . . . . 0.0 109.326 170.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 9.3 pttt -134.9 -170.06 2.49 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.477 -0.765 . . . . 0.0 111.035 -167.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -95.07 154.2 17.28 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.712 -0.617 . . . . 0.0 110.317 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.579 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 56.3 m . . . . . 0 N--CA 1.496 1.865 0 O-C-N 121.647 -0.658 . . . . 0.0 109.249 174.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 45.8 tp . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 120.938 0.399 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 79.3 mt -99.21 136.79 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.836 -0.54 . . . . 0.0 109.659 175.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -135.05 157.61 46.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.737 -0.602 . . . . 0.0 109.971 176.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 72.6 t -103.52 146.65 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.712 -0.618 . . . . 0.0 110.161 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -122.06 130.01 52.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.746 -0.596 . . . . 0.0 110.285 170.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 99.12 19.51 21.19 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 170.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -140.7 104.52 4.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.267 -1.137 . . . . 0.0 110.028 174.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 45.8 m -63.42 -15.31 57.27 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.666 -0.646 . . . . 0.0 111.276 -176.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -100.01 7.63 44.59 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.22 -0.925 . . . . 0.0 111.55 -177.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.61 133.37 55.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.088 -1.007 . . . . 0.0 110.21 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -139.83 157.98 44.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.735 -0.603 . . . . 0.0 109.809 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.42 ' CD1' ' HB ' ' A' ' 247' ' ' VAL . 84.3 m-85 -114.37 150.65 34.27 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.552 -0.717 . . . . 0.0 110.497 -178.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.22 159.92 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.76 -0.588 . . . . 0.0 110.266 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -119.22 130.04 55.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.769 -0.582 . . . . 0.0 110.163 175.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -65.09 130.11 94.72 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.676 -0.64 . . . . 0.0 109.838 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -66.36 -27.66 47.37 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 O-C-N 123.172 1.09 . . . . 0.0 111.021 -171.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 82.6 mt -100.49 -50.54 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.399 -0.813 . . . . 0.0 110.942 -167.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.3 p -105.3 12.04 32.21 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.322 -0.861 . . . . 0.0 111.887 -175.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.88 -5.11 13.57 Favored Glycine 0 N--CA 1.495 2.582 0 O-C-N 121.08 -1.012 . . . . 0.0 111.916 173.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 22.2 mmt85 -46.14 142.02 3.02 Favored 'General case' 0 N--CA 1.505 2.276 0 CA-C-N 119.108 1.454 . . . . 0.0 112.321 -174.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -106.27 139.91 40.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.628 -0.67 . . . . 0.0 110.123 175.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 78.7 p -154.74 159.98 41.03 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.635 -0.665 . . . . 0.0 110.518 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.42 ' HB ' ' CD1' ' A' ' 236' ' ' TYR . 8.3 p -122.96 148.17 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.78 -0.575 . . . . 0.0 109.666 177.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 83.0 mt -129.64 154.52 47.04 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.045 -175.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 35.4 m -151.12 151.76 30.09 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.812 -0.555 . . . . 0.0 109.84 175.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -70.57 137.16 32.5 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 O-C-N 123.237 1.125 . . . . 0.0 109.979 177.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.441 ' CE1' ' CG ' ' A' ' 180' ' ' PRO . 13.9 t80 -77.23 124.29 27.63 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.572 -0.705 . . . . 0.0 110.201 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -100.01 160.06 28.2 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.719 -0.613 . . . . 0.0 110.177 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -59.26 159.99 20.9 Favored 'Trans proline' 0 C--N 1.316 -1.163 0 O-C-N 123.244 1.129 . . . . 0.0 110.434 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.88 150.22 73.3 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 O-C-N 123.194 1.102 . . . . 0.0 110.567 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -60.02 148.11 36.72 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.575 -0.703 . . . . 0.0 110.323 -178.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.84 127.25 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.457 -0.777 . . . . 0.0 110.068 -170.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.92 -10.12 55.46 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.405 ' OG1' ' CD2' ' A' ' 260' ' ' PHE . 9.5 t -144.68 173.71 11.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.163 -1.198 . . . . 0.0 110.601 175.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -106.94 13.18 27.96 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.66 -0.65 . . . . 0.0 111.768 -168.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . 0.405 ' CD2' ' OG1' ' A' ' 258' ' ' THR . 13.8 p90 -119.94 168.02 11.56 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.212 -0.93 . . . . 0.0 111.233 -175.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 86.4 m -117.86 147.78 42.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.768 -0.583 . . . . 0.0 109.841 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 40.6 m -115.95 137.54 52.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.553 -0.717 . . . . 0.0 110.91 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 57.9 t -128.62 136.87 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 170.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 64.7 mt -104.87 120.12 40.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.494 -0.754 . . . . 0.0 109.815 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . 0.41 ' CE2' HD12 ' A' ' 172' ' ' ILE . 3.3 m-85 -99.19 156.4 16.98 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.796 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -136.42 142.99 43.7 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 171.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -113.41 129.58 56.51 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.61 -0.681 . . . . 0.0 110.163 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.98 5.85 46.98 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.636 -0.665 . . . . 0.0 111.724 -176.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -144.78 161.33 39.52 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.141 -0.975 . . . . 0.0 110.069 173.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -116.27 158.71 22.95 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.731 -0.605 . . . . 0.0 109.822 176.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 19.2 m -58.6 -32.65 69.19 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.376 -0.827 . . . . 0.0 110.947 -163.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 73.1 m -93.93 10.7 32.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.601 -0.687 . . . . 0.0 111.986 -165.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . 0.579 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 31.7 p -93.8 118.19 31.1 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.069 -1.019 . . . . 0.0 110.593 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.3 t -61.34 139.9 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.389 -0.819 . . . . 0.0 110.218 -171.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 101.0 -5.11 56.16 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -124.89 -115.87 2.12 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 170.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 26.9 ttt -60.27 -24.94 65.32 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.613 -0.934 . . . . 0.0 110.409 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 43.87 55.07 5.41 Favored 'General case' 0 N--CA 1.504 2.241 0 CA-C-O 121.434 0.635 . . . . 0.0 112.584 172.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 54.94 30.36 13.87 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.401 -0.812 . . . . 0.0 111.317 175.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -116.81 116.42 38.35 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.468 -0.77 . . . . 0.0 110.128 170.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -59.68 145.66 97.54 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 O-C-N 123.042 1.022 . . . . 0.0 110.495 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 45.4 pt -131.97 175.73 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 121.762 0.791 . . . . 0.0 110.89 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 32.0 mt -124.42 149.92 46.21 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.413 ' HB ' ' CZ ' ' A' ' 301' ' ' PHE . 79.1 mt -112.58 127.95 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.057 176.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 76.5 mt -109.85 126.34 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.436 -175.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 59.1 t -118.92 126.55 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.3 p -125.4 153.93 42.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.643 -0.661 . . . . 0.0 110.536 -174.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.424 ' HB2' ' CE1' ' A' ' 138' ' ' PHE . 24.3 tp -103.55 126.57 50.78 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 169.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -132.15 150.24 52.2 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.996 -173.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 76.5 p -89.96 159.21 17.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.732 -0.605 . . . . 0.0 109.907 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -55.95 -26.16 46.8 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.534 -0.729 . . . . 0.0 110.905 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -93.07 12.95 22.33 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.479 -0.763 . . . . 0.0 111.697 -174.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.41 20.16 46.22 Favored Glycine 0 N--CA 1.495 2.62 0 C-N-CA 120.132 -1.033 . . . . 0.0 110.972 167.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -105.64 140.16 39.13 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.203 -1.175 . . . . 0.0 110.231 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 59.4 t -87.52 131.32 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.678 -0.639 . . . . 0.0 110.008 -176.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 96.9 mt -99.87 -40.11 7.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.718 -0.614 . . . . 0.0 110.484 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -162.7 151.6 21.48 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -135.01 134.35 40.36 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.719 -0.871 . . . . 0.0 110.469 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -136.3 152.81 51.09 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.558 -0.713 . . . . 0.0 110.236 172.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 90.7 m -142.49 153.18 43.41 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.415 -0.803 . . . . 0.0 110.772 -175.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.413 ' CZ ' ' HB ' ' A' ' 284' ' ' ILE . 51.1 p90 -145.82 166.77 24.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.671 -0.643 . . . . 0.0 109.97 174.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -104.84 136.91 43.45 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.527 -0.733 . . . . 0.0 110.225 -177.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -119.4 145.47 46.19 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.626 -171.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 40.0 tpt85 -138.09 134.01 34.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.71 -0.619 . . . . 0.0 109.699 174.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 80.5 mt -105.75 122.87 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.504 -0.748 . . . . 0.0 109.583 176.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.4 p -145.21 173.23 12.12 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.535 -0.728 . . . . 0.0 110.648 -171.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -72.46 -40.13 67.23 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.704 -0.623 . . . . 0.0 110.582 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.7 t -131.04 89.37 42.52 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.544 -0.722 . . . . 0.0 110.467 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.13 -30.52 60.99 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 O-C-N 123.188 1.099 . . . . 0.0 111.03 172.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -65.4 -37.15 93.51 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -73.26 -40.44 64.63 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.669 -0.901 . . . . 0.0 109.802 -173.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -69.52 -41.33 76.15 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 120.084 -0.647 . . . . 0.0 110.092 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 72.4 ttt-85 -61.21 -41.8 97.48 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.564 -0.71 . . . . 0.0 110.346 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -64.17 -38.61 91.66 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.49 -0.757 . . . . 0.0 110.451 178.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -62.7 -52.85 61.68 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.486 -0.759 . . . . 0.0 110.541 -173.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.4 p30 . . . . . 0 N--CA 1.496 1.839 0 O-C-N 121.464 -0.773 . . . . 0.0 110.158 -176.992 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.3 t . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.108 0.48 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 p-10 -95.58 25.17 4.68 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.664 -0.647 . . . . 0.0 110.775 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 55.1 m -72.3 125.25 26.88 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.511 -0.743 . . . . 0.0 110.242 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -72.3 144.88 48.18 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.705 -0.622 . . . . 0.0 110.437 -178.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.412 ' CE1' ' HA2' ' A' ' 134' ' ' GLY . 65.0 t80 -159.64 100.62 1.5 Allowed Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.671 -0.643 . . . . 0.0 110.129 178.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -58.72 -39.93 77.61 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 O-C-N 123.182 1.096 . . . . 0.0 110.818 -176.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.412 ' HA2' ' CE1' ' A' ' 132' ' ' TYR . . . 79.95 -155.16 38.37 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -73.3 -48.31 0.27 Allowed 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.385 1.203 . . . . 0.0 110.901 -174.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -85.05 6.28 26.02 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.557 -0.714 . . . . 0.0 111.341 -174.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.92 59.79 4.04 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.983 -1.073 . . . . 0.0 110.669 -176.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.447 ' CE1' ' CG2' ' A' ' 174' ' ' ILE . 64.5 t80 -78.35 118.75 20.83 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.54 -0.725 . . . . 0.0 109.959 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -130.1 159.98 35.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.811 -0.556 . . . . 0.0 110.289 -175.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 66.7 t -124.01 146.29 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 121.272 0.558 . . . . 0.0 110.087 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.0 p -156.95 169.09 25.59 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.218 0.532 . . . . 0.0 109.757 174.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.427 ' CE2' HG12 ' A' ' 172' ' ' ILE . 36.4 m-85 . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.7 -0.625 . . . . 0.0 109.792 -177.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.883 0 CA-C-O 121.227 0.537 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 46.6 p -60.12 -34.05 72.98 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.698 -0.626 . . . . 0.0 110.117 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.41 ' CE3' HD13 ' A' ' 162' ' ' LEU . 64.3 p-90 -170.54 148.0 3.01 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.817 -0.552 . . . . 0.0 109.867 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 15.1 t -142.12 142.41 32.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.777 -0.577 . . . . 0.0 110.063 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -125.52 140.08 53.07 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.487 -0.758 . . . . 0.0 110.538 -172.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.2 t -110.01 123.09 49.04 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.863 176.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 61.6 m -70.58 -37.11 73.89 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.763 -0.586 . . . . 0.0 110.503 -176.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -59.28 -34.23 72.03 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.516 -0.74 . . . . 0.0 110.533 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.6 mt -104.75 -11.02 17.04 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.628 -0.67 . . . . 0.0 110.889 -175.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 62.8 tttt 59.86 52.52 5.32 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.063 -1.023 . . . . 0.0 109.735 177.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -145.72 152.99 40.48 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.632 -175.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.41 HD13 ' CE3' ' A' ' 153' ' ' TRP . 14.6 tp -126.61 137.73 53.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.744 -0.598 . . . . 0.0 110.203 -176.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -117.27 132.81 56.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.54 -0.725 . . . . 0.0 109.283 175.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.1 p -138.31 158.47 44.22 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.983 -175.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -104.53 142.77 34.03 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.456 0.646 . . . . 0.0 110.11 172.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 17.2 tt -51.28 147.48 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 CA-C-O 121.655 0.74 . . . . 0.0 112.117 -173.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 64.47 9.89 5.36 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.543 -0.723 . . . . 0.0 112.481 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -96.51 155.12 16.9 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.996 -1.065 . . . . 0.0 110.93 175.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 84.1 m -84.03 126.19 32.81 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.646 -0.659 . . . . 0.0 110.841 -176.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 42.8 t -113.38 90.23 16.68 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.603 -0.685 . . . . 0.0 110.137 174.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.409 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 15.3 Cg_exo -65.9 130.81 25.46 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.298 1.157 . . . . 0.0 110.449 177.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.427 HG12 ' CE2' ' A' ' 142' ' ' PHE . 93.8 mt -124.21 139.39 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.696 -0.628 . . . . 0.0 109.408 176.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 10.3 mp0 -108.95 134.35 51.74 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.613 -0.68 . . . . 0.0 110.664 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.447 ' CG2' ' CE1' ' A' ' 138' ' ' PHE . 49.6 mm -95.3 135.14 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.637 -0.664 . . . . 0.0 109.612 172.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -118.62 130.36 55.83 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.461 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 17.5 m -136.36 159.72 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.523 -0.736 . . . . 0.0 109.971 175.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 80.7 mmm -77.23 -40.21 45.75 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.751 -0.593 . . . . 0.0 110.054 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 77.5 p -135.15 143.26 45.05 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.79 -0.569 . . . . 0.0 109.826 177.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -55.58 139.92 83.08 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 O-C-N 123.145 1.076 . . . . 0.0 110.859 -172.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.445 ' CG ' ' CE1' ' A' ' 251' ' ' TYR . 25.5 Cg_endo -64.88 169.16 12.17 Favored 'Trans proline' 0 N--CA 1.487 1.095 0 O-C-N 123.127 1.067 . . . . 0.0 110.687 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -61.12 155.85 48.43 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 O-C-N 123.379 1.199 . . . . 0.0 110.496 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -75.3 139.4 42.46 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.656 -0.652 . . . . 0.0 109.931 175.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.76 -25.05 28.99 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 -175.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.14 150.81 2.24 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.355 -1.085 . . . . 0.0 111.391 178.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.79 155.92 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.665 -0.647 . . . . 0.0 109.897 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 74.0 mt -108.78 135.25 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 54.1 mtt180 -114.97 147.71 39.7 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -174.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -141.36 128.14 20.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.386 -0.821 . . . . 0.0 110.405 173.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 31.6 ttp -137.23 140.25 30.4 Favored Pre-proline 0 N--CA 1.496 1.864 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.062 -177.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -91.5 138.2 2.13 Favored 'Trans proline' 0 C--N 1.32 -0.957 0 C-N-CA 121.08 1.187 . . . . 0.0 110.858 177.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 35.0 m -147.91 154.9 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.546 -0.721 . . . . 0.0 109.924 174.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.417 ' CE1' HG23 ' A' ' 202' ' ' VAL . 82.5 m-85 -60.4 168.52 2.05 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.395 -0.816 . . . . 0.0 110.513 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 68.8 tttt -84.08 -60.11 2.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.588 -0.695 . . . . 0.0 110.76 -175.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 43.1 mttp -80.16 151.68 29.62 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.54 -0.725 . . . . 0.0 110.305 -175.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.76 -38.36 72.34 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.384 -0.823 . . . . 0.0 110.633 -176.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -56.39 -24.52 45.22 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.386 -0.821 . . . . 0.0 110.584 -177.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.407 ' HB3' ' CG ' ' A' ' 192' ' ' TYR . 96.6 m-70 -109.97 -20.52 12.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.466 -0.771 . . . . 0.0 111.21 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.2 p -67.41 -20.2 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.194 -0.941 . . . . 0.0 110.595 -176.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 74.4 p -79.38 -16.92 55.46 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.524 -0.735 . . . . 0.0 110.767 175.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.45 135.1 33.64 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.348 -0.845 . . . . 0.0 110.064 173.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.0 t -73.38 140.97 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.564 -0.71 . . . . 0.0 110.348 178.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.417 HG23 ' CE1' ' A' ' 192' ' ' TYR . 65.7 t -84.89 140.05 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.594 -0.691 . . . . 0.0 109.506 172.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -134.91 -170.28 2.53 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.53 -0.731 . . . . 0.0 110.99 -169.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 81.3 mtm-85 -95.36 157.06 16.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.842 -0.536 . . . . 0.0 110.424 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 58.8 m . . . . . 0 N--CA 1.497 1.909 0 O-C-N 121.651 -0.656 . . . . 0.0 109.475 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 61.9 tp . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 120.875 0.369 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 82.2 mt -102.21 136.75 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 120.329 -0.548 . . . . 0.0 109.685 177.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 22.2 mtp-105 -131.75 157.23 44.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.758 -0.589 . . . . 0.0 110.157 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 99.3 t -104.8 146.5 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.737 -0.602 . . . . 0.0 110.042 176.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -118.9 123.65 45.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.768 -0.583 . . . . 0.0 110.473 172.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 96.31 23.32 17.1 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 168.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -135.0 108.82 8.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.369 -1.077 . . . . 0.0 110.142 174.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 27.3 t -62.88 -15.14 53.73 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.609 -0.682 . . . . 0.0 111.318 -177.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -99.35 9.91 42.42 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.29 -0.881 . . . . 0.0 111.552 -177.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.46 124.49 20.51 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.092 -1.005 . . . . 0.0 110.235 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -139.78 158.05 44.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.794 -0.566 . . . . 0.0 109.678 177.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -117.98 150.72 38.79 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.546 -0.721 . . . . 0.0 110.793 -175.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.07 159.95 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.819 -0.551 . . . . 0.0 110.108 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -120.0 130.03 54.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.792 -0.567 . . . . 0.0 110.299 177.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -63.77 130.07 94.18 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.653 -0.655 . . . . 0.0 109.784 178.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -65.97 -28.35 49.94 Favored 'Trans proline' 0 C--N 1.316 -1.168 0 O-C-N 123.042 1.022 . . . . 0.0 110.97 -170.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.8 mt -101.14 -50.5 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.465 -0.772 . . . . 0.0 111.019 -168.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 13.0 p -105.34 12.15 32.0 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.338 -0.851 . . . . 0.0 111.872 -175.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 72.37 -4.92 17.22 Favored Glycine 0 N--CA 1.496 2.667 0 O-C-N 121.013 -1.055 . . . . 0.0 111.968 172.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -46.0 142.07 2.87 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 119.163 1.482 . . . . 0.0 112.389 -175.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -104.25 143.35 33.08 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.674 -0.641 . . . . 0.0 110.204 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.1 p -154.71 160.04 41.1 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.608 -0.682 . . . . 0.0 110.213 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 8.5 p -123.01 148.19 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.707 -0.621 . . . . 0.0 109.779 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 83.0 mt -129.82 154.69 47.0 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 120.204 -0.599 . . . . 0.0 109.931 -174.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 32.1 m -150.69 151.81 31.15 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.783 -0.573 . . . . 0.0 109.816 174.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -70.94 139.46 36.19 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 O-C-N 123.267 1.141 . . . . 0.0 110.029 177.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.445 ' CE1' ' CG ' ' A' ' 180' ' ' PRO . 10.2 t80 -79.59 122.16 26.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.519 -0.738 . . . . 0.0 110.07 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -100.08 160.09 28.08 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.706 -0.621 . . . . 0.0 110.184 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -58.95 160.08 19.46 Favored 'Trans proline' 0 N--CA 1.488 1.174 0 O-C-N 123.285 1.15 . . . . 0.0 110.457 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.17 150.05 76.32 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 O-C-N 123.276 1.145 . . . . 0.0 110.613 -177.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -60.95 149.56 36.15 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.609 -0.682 . . . . 0.0 110.189 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.84 127.21 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.496 -0.752 . . . . 0.0 110.148 -170.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.29 -10.18 56.46 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.407 ' OG1' ' CE1' ' A' ' 260' ' ' PHE . 9.4 t -145.41 175.39 10.35 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.25 -1.147 . . . . 0.0 110.619 175.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -110.03 13.09 23.42 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.617 -0.677 . . . . 0.0 111.883 -167.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . 0.407 ' CE1' ' OG1' ' A' ' 258' ' ' THR . 48.1 p90 -120.84 168.03 11.89 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.141 -0.974 . . . . 0.0 111.177 -177.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 93.4 m -117.87 147.56 42.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.793 -0.567 . . . . 0.0 109.837 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 32.7 m -117.78 136.14 53.59 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.567 -0.708 . . . . 0.0 110.945 -175.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 57.9 t -130.44 137.18 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 171.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 74.0 mt -104.88 120.94 42.63 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.512 -0.742 . . . . 0.0 110.004 -173.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 -105.55 150.62 25.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.688 -0.633 . . . . 0.0 110.662 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -136.56 142.99 43.42 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -113.31 131.93 55.76 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.584 -0.697 . . . . 0.0 110.48 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -101.28 9.43 41.75 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.657 -0.652 . . . . 0.0 111.963 -176.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -144.6 163.45 33.88 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.115 -0.991 . . . . 0.0 110.076 171.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 27.9 p30 -121.34 163.97 17.8 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.442 0.639 . . . . 0.0 110.434 -177.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 50.4 m -58.22 -34.07 70.0 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.44 -0.788 . . . . 0.0 111.058 -163.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 49.6 p -103.62 15.05 29.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.39 -0.819 . . . . 0.0 111.844 -163.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 30.5 p -94.86 118.09 31.21 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.11 -0.994 . . . . 0.0 110.585 177.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 60.1 t -64.24 139.9 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.42 -0.8 . . . . 0.0 110.332 -169.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.22 -5.17 58.98 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.0 -95.6 0.75 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 172.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 15.9 mmt -63.04 -34.12 76.89 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.699 -0.883 . . . . 0.0 110.304 177.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.4 p30 43.38 48.1 5.92 Favored 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 176.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 36.2 mtt180 54.73 29.46 11.76 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.356 -0.84 . . . . 0.0 111.2 175.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -120.07 105.06 43.0 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.58 -0.7 . . . . 0.0 110.078 175.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.77 147.6 91.62 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 O-C-N 123.128 1.067 . . . . 0.0 110.481 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 45.4 pt -132.02 178.0 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.779 0.8 . . . . 0.0 111.011 -175.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 30.4 mt -124.42 149.88 46.26 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.42 HD11 ' CE1' ' A' ' 301' ' ' PHE . 79.9 mt -115.33 130.1 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.245 177.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 80.9 mt -109.76 126.39 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -176.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 57.5 t -118.86 126.78 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.6 p -125.25 153.71 42.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.603 -0.686 . . . . 0.0 110.579 -173.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.419 ' HB2' ' CE1' ' A' ' 138' ' ' PHE . 25.0 tp -103.97 125.87 50.67 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 169.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -131.24 149.92 52.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.885 -0.509 . . . . 0.0 109.882 -173.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 74.4 p -89.86 159.36 17.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.629 -0.669 . . . . 0.0 109.774 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -55.96 -26.07 46.53 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.582 -0.699 . . . . 0.0 110.823 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -87.27 9.68 19.53 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.519 -0.738 . . . . 0.0 111.783 -174.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 87.51 20.19 52.32 Favored Glycine 0 N--CA 1.495 2.606 0 O-C-N 121.089 -1.007 . . . . 0.0 110.731 170.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -108.02 140.26 41.44 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.283 -1.127 . . . . 0.0 110.175 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 60.0 t -89.55 132.56 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.587 -0.696 . . . . 0.0 110.067 -174.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 96.2 mt -99.97 -40.1 7.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.671 -0.643 . . . . 0.0 110.489 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -161.67 154.83 25.91 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -178.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 47.7 mtp180 -134.9 135.15 41.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.669 -0.9 . . . . 0.0 110.746 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 -135.18 158.03 45.4 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.609 -0.682 . . . . 0.0 109.958 172.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 85.9 m -144.29 153.83 42.43 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.504 -0.747 . . . . 0.0 110.745 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.42 ' CE1' HD11 ' A' ' 284' ' ' ILE . 49.3 p90 -144.96 162.17 37.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.705 -0.622 . . . . 0.0 110.05 174.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -104.84 135.36 46.35 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.479 -0.763 . . . . 0.0 110.198 -176.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -120.06 142.93 48.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.626 -0.671 . . . . 0.0 110.687 -170.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -138.49 138.82 38.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.795 -0.565 . . . . 0.0 109.795 173.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 78.7 mt -108.75 122.89 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.544 -0.723 . . . . 0.0 109.619 177.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.9 p -145.36 170.56 16.1 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.66 -0.65 . . . . 0.0 110.69 -171.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -72.52 -40.12 67.05 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.613 -0.68 . . . . 0.0 110.708 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.8 t -127.95 86.43 58.17 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.591 -0.693 . . . . 0.0 110.484 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -55.91 -29.21 71.97 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 O-C-N 123.134 1.07 . . . . 0.0 110.899 174.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.48 -37.98 93.09 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.014 -1.635 . . . . 0.0 109.014 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -73.28 -40.02 64.9 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.748 -0.854 . . . . 0.0 109.751 -173.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -69.44 -39.78 77.6 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.163 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -61.86 -45.56 93.23 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.306 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 23.7 ttpt -64.11 -39.22 93.58 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.585 -0.697 . . . . 0.0 110.47 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.66 -50.71 71.4 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.495 -0.753 . . . . 0.0 110.426 -174.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 2.9 p30 . . . . . 0 N--CA 1.495 1.789 0 O-C-N 121.45 -0.781 . . . . 0.0 110.105 -178.254 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.4 t . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 121.099 0.476 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -95.42 24.39 5.17 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.68 -0.637 . . . . 0.0 110.64 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 54.6 m -72.71 125.18 26.88 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.567 -0.708 . . . . 0.0 110.337 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -70.97 144.98 50.33 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.723 -0.611 . . . . 0.0 110.291 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -158.28 102.07 1.71 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.603 -0.686 . . . . 0.0 110.164 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -58.77 -39.96 77.1 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 O-C-N 123.177 1.093 . . . . 0.0 110.691 -178.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.12 -155.15 45.6 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 177.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -72.75 -45.93 0.47 Allowed 'Trans proline' 0 N--CA 1.486 1.067 0 O-C-N 123.33 1.174 . . . . 0.0 111.004 -174.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -89.1 9.1 26.65 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.615 -0.678 . . . . 0.0 111.453 -172.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.71 61.63 3.01 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.975 -1.078 . . . . 0.0 110.732 -176.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -77.92 118.2 20.0 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.648 -0.657 . . . . 0.0 109.83 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -130.04 160.04 34.9 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.312 0.577 . . . . 0.0 110.178 -177.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 78.6 t -124.31 148.78 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.69 -0.631 . . . . 0.0 109.775 176.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.4 p -157.1 171.02 21.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.813 -0.554 . . . . 0.0 109.928 176.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.425 ' CE1' HG12 ' A' ' 172' ' ' ILE . 64.8 m-85 . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.821 -0.549 . . . . 0.0 109.64 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 121.145 0.497 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 76.1 p -60.06 -33.88 72.67 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.668 -0.645 . . . . 0.0 109.928 174.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 67.5 p-90 -170.06 148.02 3.33 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.964 -0.46 . . . . 0.0 109.784 178.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.9 t -142.04 142.37 32.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.789 -0.57 . . . . 0.0 109.974 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -125.76 140.12 52.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.513 -0.742 . . . . 0.0 110.559 -172.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 31.2 t -110.43 121.07 44.41 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.727 174.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 69.4 m -71.42 -36.45 71.31 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.702 -0.624 . . . . 0.0 110.489 -176.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -58.76 -33.83 70.72 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.586 -0.696 . . . . 0.0 110.526 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 53.9 mt -104.82 -11.33 16.84 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.734 -0.604 . . . . 0.0 110.851 -176.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt 59.87 51.84 5.76 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.045 -1.034 . . . . 0.0 109.825 176.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -147.14 152.86 39.13 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.696 -0.628 . . . . 0.0 110.714 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.6 tp -126.65 137.88 53.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.793 -0.567 . . . . 0.0 110.375 -173.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -117.54 133.32 56.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.537 -0.727 . . . . 0.0 109.462 175.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.1 p -138.3 158.31 44.54 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 120.111 -0.636 . . . . 0.0 111.104 -175.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -104.69 141.59 36.19 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.588 -0.695 . . . . 0.0 110.33 172.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 18.0 tt -54.6 149.43 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.529 -0.732 . . . . 0.0 111.552 -173.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 64.22 10.01 5.22 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.593 -0.692 . . . . 0.0 112.515 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -96.4 155.13 16.89 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.958 -1.089 . . . . 0.0 110.784 174.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 70.2 m -79.96 126.09 30.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.702 -0.624 . . . . 0.0 110.61 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 42.3 t -115.43 90.23 24.54 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.624 -0.673 . . . . 0.0 110.22 174.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -69.99 125.41 11.99 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.266 1.14 . . . . 0.0 110.521 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.425 HG12 ' CE1' ' A' ' 142' ' ' PHE . 86.4 mt -122.22 143.43 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.594 -0.692 . . . . 0.0 109.575 173.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . 0.422 ' NE2' ' CE1' ' A' ' 260' ' ' PHE . 95.4 mt-30 -109.14 136.64 48.3 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.611 -0.681 . . . . 0.0 110.707 -175.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.3 mm -95.23 135.02 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.674 -0.641 . . . . 0.0 109.744 169.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 35.2 tttm -117.05 130.27 56.55 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.509 -0.745 . . . . 0.0 110.581 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 17.0 m -136.01 159.8 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.63 -0.669 . . . . 0.0 109.797 174.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 79.0 mmm -81.3 -45.4 16.27 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.62 -0.675 . . . . 0.0 110.151 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 77.0 p -126.52 143.18 45.37 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.724 -0.61 . . . . 0.0 109.684 177.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -55.5 139.74 82.54 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 O-C-N 123.205 1.108 . . . . 0.0 110.902 -171.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.43 ' CG ' ' CE1' ' A' ' 251' ' ' TYR . 36.0 Cg_endo -67.51 170.01 14.53 Favored 'Trans proline' 0 N--CA 1.487 1.128 0 O-C-N 123.226 1.119 . . . . 0.0 110.542 177.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -60.26 155.77 44.2 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 123.326 1.172 . . . . 0.0 110.622 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -78.16 138.26 38.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.599 -0.688 . . . . 0.0 109.931 175.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.24 -24.97 30.08 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -174.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.13 151.2 2.09 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.381 -1.07 . . . . 0.0 111.48 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 35.4 m -129.75 156.03 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.777 -0.577 . . . . 0.0 109.853 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 53.7 mt -107.34 134.9 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -114.94 141.34 48.09 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -174.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -138.51 123.72 19.21 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.456 178.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 44.5 ttp -137.34 140.61 31.22 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.773 -0.579 . . . . 0.0 111.222 -175.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -90.98 138.22 2.34 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 O-C-N 123.243 1.128 . . . . 0.0 110.717 176.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.7 m -147.48 154.84 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.51 -0.744 . . . . 0.0 110.134 173.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.421 ' CD1' ' HB3' ' A' ' 197' ' ' HIS . 88.3 m-85 -61.33 166.67 3.71 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.488 -0.758 . . . . 0.0 110.429 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -84.67 -59.96 2.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.678 -0.639 . . . . 0.0 110.849 -175.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -80.08 152.24 29.44 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.656 -0.653 . . . . 0.0 110.319 -175.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.81 -38.58 72.78 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.333 -0.854 . . . . 0.0 110.72 -175.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -56.58 -24.57 48.28 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.539 -0.726 . . . . 0.0 110.567 -177.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.421 ' HB3' ' CD1' ' A' ' 192' ' ' TYR . 47.8 m80 -109.89 -20.46 12.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.565 -0.71 . . . . 0.0 111.116 -178.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.1 p -67.56 -20.19 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.145 -0.972 . . . . 0.0 110.606 -176.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 69.2 p -79.35 -17.01 55.37 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.535 -0.728 . . . . 0.0 110.678 174.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.41 136.93 32.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.357 -0.84 . . . . 0.0 110.029 174.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.8 t -73.02 146.03 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.623 -0.673 . . . . 0.0 110.228 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.421 HG23 ' CE2' ' A' ' 192' ' ' TYR . 60.8 t -84.95 136.16 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.595 -0.69 . . . . 0.0 109.191 172.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.0 pttp -134.95 -170.18 2.51 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.508 -0.745 . . . . 0.0 111.073 -167.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -95.1 159.32 15.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.75 -0.594 . . . . 0.0 110.501 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.661 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 59.9 m . . . . . 0 N--CA 1.497 1.888 0 O-C-N 121.627 -0.67 . . . . 0.0 109.281 175.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 55.9 tp . . . . . 0 N--CA 1.497 1.878 0 CA-C-O 120.831 0.348 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 80.9 mt -104.17 136.75 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.821 -0.549 . . . . 0.0 109.818 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -132.56 159.17 40.23 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.716 -0.615 . . . . 0.0 110.111 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 70.5 t -105.59 146.74 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.663 -0.648 . . . . 0.0 110.144 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -121.78 130.05 53.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.715 -0.616 . . . . 0.0 110.303 171.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.8 20.58 21.19 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.526 -1.029 . . . . 0.0 110.526 170.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -141.27 105.16 4.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.307 -1.114 . . . . 0.0 109.988 174.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 93.1 p -63.6 -15.13 57.3 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.603 -0.686 . . . . 0.0 111.224 -177.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -97.24 9.96 40.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.303 -0.873 . . . . 0.0 111.187 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.97 130.35 45.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.205 -0.934 . . . . 0.0 110.081 176.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -139.77 156.25 46.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.774 -0.579 . . . . 0.0 109.719 177.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.418 ' CD1' ' HB ' ' A' ' 247' ' ' VAL . 90.4 m-85 -117.96 150.66 38.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.513 -0.742 . . . . 0.0 110.617 -176.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.08 159.89 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.902 -0.499 . . . . 0.0 110.224 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -119.65 130.08 54.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.771 -0.581 . . . . 0.0 110.113 176.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -61.72 126.04 86.09 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.657 -0.652 . . . . 0.0 109.754 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -65.01 -29.15 57.27 Favored 'Trans proline' 0 C--N 1.317 -1.123 0 O-C-N 123.201 1.106 . . . . 0.0 110.782 -172.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.9 mt -104.15 -50.25 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.553 -0.717 . . . . 0.0 110.943 -170.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 20.3 p -105.26 12.25 32.02 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.372 -0.83 . . . . 0.0 111.945 -170.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 82.31 -23.24 5.55 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 120.97 -1.081 . . . . 0.0 111.85 168.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -45.79 142.07 2.69 Favored 'General case' 0 N--CA 1.505 2.325 0 CA-C-N 118.572 1.186 . . . . 0.0 112.569 -168.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -105.12 146.17 29.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.637 -0.664 . . . . 0.0 110.093 174.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 78.8 p -154.79 159.92 40.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.584 -0.698 . . . . 0.0 110.404 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.418 ' HB ' ' CD1' ' A' ' 236' ' ' TYR . 8.3 p -122.95 148.1 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.746 -0.596 . . . . 0.0 109.69 178.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 81.6 mt -129.69 154.58 47.02 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.797 -175.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 35.4 m -151.07 151.75 30.14 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.822 -0.549 . . . . 0.0 110.008 175.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -71.09 139.08 34.9 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 O-C-N 123.237 1.125 . . . . 0.0 109.999 177.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.43 ' CE1' ' CG ' ' A' ' 180' ' ' PRO . 61.8 t80 -76.04 123.9 26.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.488 -0.758 . . . . 0.0 110.219 176.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -99.95 160.09 28.15 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.668 -0.645 . . . . 0.0 110.029 176.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -58.76 159.72 19.96 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 O-C-N 123.154 1.081 . . . . 0.0 110.42 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.03 149.98 76.06 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 O-C-N 123.26 1.137 . . . . 0.0 110.522 -176.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -61.71 148.2 43.56 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.648 -0.658 . . . . 0.0 110.138 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.9 t -69.81 127.18 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.586 -0.696 . . . . 0.0 110.233 -170.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.93 -10.13 55.45 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.415 ' OG1' ' CD2' ' A' ' 260' ' ' PHE . 10.2 t -144.63 174.42 10.98 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.148 -1.207 . . . . 0.0 110.648 175.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -108.27 13.14 25.97 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.613 -0.679 . . . . 0.0 111.83 -167.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . 0.422 ' CE1' ' NE2' ' A' ' 173' ' ' GLN . 40.2 p90 -123.88 168.17 13.13 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.096 -1.003 . . . . 0.0 111.148 -175.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 71.9 m -117.73 145.23 44.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.799 -0.563 . . . . 0.0 109.75 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 28.4 m -115.28 137.41 52.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.615 -0.678 . . . . 0.0 110.882 -174.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 57.8 t -128.78 136.99 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 172.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 63.9 mt -104.73 120.47 41.43 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.534 -0.729 . . . . 0.0 109.873 -174.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . 0.408 ' CE2' HD12 ' A' ' 172' ' ' ILE . 3.8 m-85 -98.41 156.19 16.87 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.627 -0.67 . . . . 0.0 110.842 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -136.49 142.89 43.56 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 171.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -111.89 132.02 54.99 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.61 -0.681 . . . . 0.0 110.397 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -102.73 6.77 39.63 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.659 -0.651 . . . . 0.0 111.874 -177.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -144.73 160.45 41.2 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.985 -1.072 . . . . 0.0 109.908 171.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -119.77 163.49 17.38 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.459 0.647 . . . . 0.0 110.506 -178.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 50.1 m -58.63 -33.09 69.66 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.482 -0.761 . . . . 0.0 111.028 -163.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 50.0 p -100.77 12.68 37.03 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.431 -0.793 . . . . 0.0 111.954 -163.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . 0.661 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 29.6 p -94.69 117.99 31.02 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.091 -1.006 . . . . 0.0 110.625 177.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.4 t -64.42 139.78 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.561 -0.712 . . . . 0.0 110.356 -169.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.37 -5.02 60.5 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -125.06 -100.33 1.28 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 170.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 93.4 mmm -64.87 -31.44 72.67 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.693 -0.887 . . . . 0.0 110.355 176.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.8 p30 43.1 52.11 5.45 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 175.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 54.85 27.0 8.37 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.328 -0.858 . . . . 0.0 111.182 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 36.6 mtt180 -118.77 106.36 44.08 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.56 -0.712 . . . . 0.0 110.046 175.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.38 149.19 82.9 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 O-C-N 123.015 1.008 . . . . 0.0 110.691 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 44.6 pt -131.93 -179.7 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-O 121.752 0.786 . . . . 0.0 110.742 -177.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 34.7 mt -124.33 149.93 46.03 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.414 HD11 ' CE1' ' A' ' 301' ' ' PHE . 77.7 mt -113.83 128.75 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.125 176.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 80.0 mt -109.84 126.46 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -175.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 59.2 t -118.88 126.69 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.2 p -125.36 154.7 41.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.683 -0.635 . . . . 0.0 110.516 -175.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 28.8 tp -102.61 126.42 49.68 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 168.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -131.61 150.3 52.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.845 -0.534 . . . . 0.0 109.937 -171.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 76.8 p -90.03 157.43 17.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.67 -0.644 . . . . 0.0 109.909 177.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -56.08 -26.1 48.12 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.587 -0.696 . . . . 0.0 110.932 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -91.03 11.86 21.65 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.451 -0.78 . . . . 0.0 111.745 -174.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 90.25 20.15 43.15 Favored Glycine 0 N--CA 1.494 2.541 0 C-N-CA 120.139 -1.029 . . . . 0.0 110.922 168.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -109.15 140.17 43.09 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.3 -1.118 . . . . 0.0 110.062 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 59.2 t -91.64 133.39 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.558 -0.714 . . . . 0.0 110.234 -174.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 93.9 mt -99.97 -40.0 7.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.757 -0.589 . . . . 0.0 110.586 -179.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -159.29 155.41 26.5 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 57.2 mtt85 -135.06 136.28 41.91 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.764 -0.845 . . . . 0.0 110.349 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -136.58 153.99 50.81 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.44 -0.787 . . . . 0.0 110.19 168.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 95.8 m -143.29 154.01 43.35 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.545 -0.722 . . . . 0.0 110.626 -175.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.414 ' CE1' HD11 ' A' ' 284' ' ' ILE . 51.7 p90 -145.77 166.8 24.82 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.647 -0.658 . . . . 0.0 109.962 173.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -104.92 135.62 45.93 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.421 -0.8 . . . . 0.0 110.193 -177.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -122.67 144.26 49.25 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.722 -169.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -138.08 138.94 39.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.747 -0.596 . . . . 0.0 109.694 173.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 74.0 mt -107.42 122.83 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.548 -0.72 . . . . 0.0 109.735 176.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.8 p -145.27 169.71 17.7 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.7 -0.625 . . . . 0.0 110.647 -172.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -71.55 -40.11 70.24 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.626 -0.671 . . . . 0.0 110.648 -178.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.7 t -127.16 86.07 59.61 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.476 -0.765 . . . . 0.0 110.468 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -55.94 -28.16 67.15 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 O-C-N 123.251 1.132 . . . . 0.0 110.766 174.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -67.05 -37.8 92.11 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 177.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -72.76 -40.84 65.69 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.737 -0.86 . . . . 0.0 109.845 -173.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -69.5 -38.91 77.82 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.162 -178.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -61.81 -43.22 99.28 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.195 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 21.0 ttpp -64.18 -38.53 91.39 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.582 -0.699 . . . . 0.0 110.446 178.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -60.74 -50.52 73.13 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.507 -0.746 . . . . 0.0 110.46 -173.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 2.8 p30 . . . . . 0 N--CA 1.495 1.775 0 O-C-N 121.482 -0.761 . . . . 0.0 110.087 -179.12 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.7 t . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.097 0.475 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.7 p-10 -94.31 23.54 5.07 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.658 -0.651 . . . . 0.0 110.885 -178.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 54.0 m -72.35 125.15 26.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.471 -0.768 . . . . 0.0 110.212 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -70.53 144.92 51.17 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.602 -0.686 . . . . 0.0 110.401 -177.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.409 ' CE1' ' HA2' ' A' ' 134' ' ' GLY . 52.6 t80 -157.33 101.22 1.89 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.618 -0.676 . . . . 0.0 110.101 178.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.51 -39.94 78.76 Favored 'Trans proline' 0 N--CA 1.488 1.204 0 O-C-N 123.153 1.081 . . . . 0.0 110.952 -174.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.409 ' HA2' ' CE1' ' A' ' 132' ' ' TYR . . . 79.84 -155.11 38.52 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -74.18 -47.61 0.24 Allowed 'Trans proline' 0 C--N 1.317 -1.085 0 O-C-N 123.313 1.165 . . . . 0.0 110.846 -175.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -84.19 5.16 27.45 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.525 -0.734 . . . . 0.0 111.431 -175.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 54.01 59.97 3.92 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.898 -1.126 . . . . 0.0 110.681 -176.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.446 ' CE1' ' CG2' ' A' ' 174' ' ' ILE . 64.6 t80 -77.96 118.94 20.74 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.57 -0.706 . . . . 0.0 110.008 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -129.96 159.92 35.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.785 -0.572 . . . . 0.0 110.215 -175.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 71.9 t -123.65 146.66 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-O 121.443 0.639 . . . . 0.0 110.174 177.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 76.8 p -157.06 171.16 20.95 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 175.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.421 ' CE2' HG12 ' A' ' 172' ' ' ILE . 64.8 m-85 . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.706 -0.622 . . . . 0.0 109.916 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 121.117 0.484 . . . . 0.0 109.943 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 57.9 p -60.15 -34.09 73.07 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.773 -0.579 . . . . 0.0 110.118 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 -170.46 148.14 3.09 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.636 -0.665 . . . . 0.0 109.752 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 13.7 t -141.52 142.36 33.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.717 -0.614 . . . . 0.0 110.031 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -125.65 140.04 53.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.482 -0.761 . . . . 0.0 110.532 -172.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 32.8 t -109.82 122.31 47.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.783 -0.573 . . . . 0.0 109.785 175.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 65.1 m -70.66 -36.8 73.56 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.689 -0.632 . . . . 0.0 110.482 -177.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -58.79 -34.28 71.29 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.615 -0.678 . . . . 0.0 110.582 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 53.8 mt -104.8 -11.71 16.66 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.61 -0.681 . . . . 0.0 110.804 -176.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.0 tttm 59.82 52.18 5.59 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.14 -0.975 . . . . 0.0 109.732 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -145.86 152.88 40.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.714 -0.616 . . . . 0.0 110.562 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.5 tp -126.66 137.83 53.34 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.863 -0.523 . . . . 0.0 110.256 -175.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -116.96 133.86 55.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.557 -0.714 . . . . 0.0 109.319 174.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.9 p -138.29 158.46 44.25 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 120.036 -0.665 . . . . 0.0 110.979 -174.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -104.52 143.9 32.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.62 -0.675 . . . . 0.0 110.398 172.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 16.9 tt -52.47 147.77 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 CA-C-O 121.64 0.733 . . . . 0.0 111.841 -173.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 64.16 10.01 5.18 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.628 -0.67 . . . . 0.0 112.539 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 32.3 mmtt -96.52 155.13 16.9 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.04 -1.037 . . . . 0.0 110.788 175.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 85.6 m -84.31 126.21 32.98 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.666 -0.646 . . . . 0.0 110.676 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 42.6 t -112.63 90.31 14.67 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.514 -0.741 . . . . 0.0 110.082 173.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -64.75 129.28 23.03 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 123.339 1.179 . . . . 0.0 110.445 176.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.421 HG12 ' CE2' ' A' ' 142' ' ' PHE . 95.4 mt -123.17 138.67 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.665 -0.647 . . . . 0.0 109.36 176.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -108.72 133.97 52.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.546 -0.722 . . . . 0.0 110.637 -176.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.446 ' CG2' ' CE1' ' A' ' 138' ' ' PHE . 49.5 mm -95.37 135.07 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.641 -0.662 . . . . 0.0 109.674 172.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -118.08 129.93 55.85 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.583 -0.698 . . . . 0.0 110.597 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 17.3 m -136.3 159.74 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.475 -0.766 . . . . 0.0 109.957 175.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 79.7 mmm -77.46 -40.37 43.43 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.745 -0.597 . . . . 0.0 110.018 177.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 77.0 p -134.1 143.21 46.22 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.78 -0.575 . . . . 0.0 109.793 177.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -55.67 139.88 83.6 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 O-C-N 123.2 1.105 . . . . 0.0 110.86 -173.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.447 ' CG ' ' CE1' ' A' ' 251' ' ' TYR . 23.5 Cg_endo -64.5 168.18 13.54 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 O-C-N 123.23 1.121 . . . . 0.0 110.635 178.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -61.53 158.21 37.72 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 O-C-N 123.353 1.186 . . . . 0.0 110.413 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -77.76 137.9 38.71 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.667 -0.645 . . . . 0.0 109.889 175.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.53 -24.97 30.08 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -174.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.1 149.98 2.58 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.367 -1.078 . . . . 0.0 111.373 177.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.71 155.99 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.654 -0.654 . . . . 0.0 109.816 176.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 69.8 mt -108.46 136.21 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.403 ' HG2' ' CD2' ' A' ' 248' ' ' LEU . 36.5 mtp180 -114.89 146.11 41.46 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -175.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -140.6 127.56 20.68 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.439 -0.788 . . . . 0.0 110.337 172.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 25.0 ttm -137.2 139.36 27.87 Favored Pre-proline 0 N--CA 1.495 1.811 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.031 -177.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -91.34 138.29 2.21 Favored 'Trans proline' 0 C--N 1.32 -0.972 0 O-C-N 123.288 1.152 . . . . 0.0 110.772 177.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.7 m -147.24 154.89 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.518 -0.739 . . . . 0.0 110.059 174.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.417 ' CE2' HG21 ' A' ' 202' ' ' VAL . 77.3 m-85 -61.6 164.78 5.58 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.47 -0.769 . . . . 0.0 110.545 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -80.33 -60.02 2.48 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.625 -0.672 . . . . 0.0 110.843 -174.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -80.04 151.2 30.06 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.601 -0.687 . . . . 0.0 110.372 -175.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.44 -38.52 71.74 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.368 -0.832 . . . . 0.0 110.736 -175.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -56.49 -24.92 49.34 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.525 -0.735 . . . . 0.0 110.58 -176.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.407 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 63.2 m170 -110.05 -20.49 12.69 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.094 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.2 p -67.14 -20.22 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.157 -0.964 . . . . 0.0 110.564 -176.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 81.3 p -79.35 -17.08 55.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.502 -0.749 . . . . 0.0 110.777 175.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.25 135.65 33.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.342 -0.849 . . . . 0.0 110.09 173.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.99 142.97 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.682 -0.636 . . . . 0.0 110.22 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.417 HG21 ' CE2' ' A' ' 192' ' ' TYR . 60.2 t -84.93 138.82 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.529 -0.732 . . . . 0.0 109.257 172.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 14.0 pttt -134.77 -170.29 2.53 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.412 -0.805 . . . . 0.0 111.345 -168.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 74.4 mtm-85 -95.3 156.05 16.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.807 -0.558 . . . . 0.0 110.319 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 48.7 m . . . . . 0 N--CA 1.496 1.849 0 O-C-N 121.571 -0.706 . . . . 0.0 109.237 173.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 41.3 tp . . . . . 0 N--CA 1.497 1.879 0 CA-C-O 120.824 0.345 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 84.3 mt -101.81 136.75 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.767 -0.583 . . . . 0.0 110.034 -176.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -125.65 158.11 35.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.692 -0.63 . . . . 0.0 110.135 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 90.3 t -104.44 146.6 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.701 -0.625 . . . . 0.0 109.844 172.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -118.74 128.13 54.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.629 -0.67 . . . . 0.0 110.4 170.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.11 20.93 21.99 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 168.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -139.37 105.05 5.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.313 -1.11 . . . . 0.0 110.034 174.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 44.2 m -63.49 -15.21 57.2 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.547 -0.721 . . . . 0.0 111.24 -176.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -100.01 8.02 44.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.223 -0.923 . . . . 0.0 111.621 -177.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.68 133.22 55.33 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.108 -0.995 . . . . 0.0 110.175 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -139.8 158.06 44.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.756 -0.59 . . . . 0.0 109.83 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -113.87 150.6 33.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.596 -0.69 . . . . 0.0 110.556 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.06 159.98 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.771 -0.58 . . . . 0.0 110.233 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -122.7 130.05 52.51 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.743 -0.598 . . . . 0.0 110.201 177.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -65.04 112.36 7.99 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.672 -0.643 . . . . 0.0 109.714 177.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -60.23 -25.55 80.37 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.107 1.056 . . . . 0.0 110.998 -172.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.8 mt -101.14 -50.32 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.368 -0.832 . . . . 0.0 110.824 -171.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 6.6 p -105.33 12.16 31.99 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.341 -0.85 . . . . 0.0 111.998 -172.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 82.29 -24.85 4.58 Favored Glycine 0 N--CA 1.497 2.742 0 O-C-N 121.007 -1.058 . . . . 0.0 111.813 170.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 23.8 mmt85 -45.81 142.13 2.67 Favored 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 118.54 1.17 . . . . 0.0 112.544 -168.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -108.51 145.08 35.28 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.626 -0.671 . . . . 0.0 110.047 174.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 77.3 p -154.84 159.91 40.87 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.572 -0.705 . . . . 0.0 110.487 178.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 8.5 p -123.01 148.07 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.77 -0.581 . . . . 0.0 109.655 178.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.403 ' CD2' ' HG2' ' A' ' 187' ' ' ARG . 78.8 mt -129.69 154.62 46.97 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.872 -173.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 35.9 m -150.69 151.82 31.16 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.819 -0.55 . . . . 0.0 109.858 174.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -71.02 139.49 35.99 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.173 1.091 . . . . 0.0 110.012 177.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.447 ' CE1' ' CG ' ' A' ' 180' ' ' PRO . 9.4 t80 -79.82 123.37 27.66 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.463 -0.773 . . . . 0.0 110.05 178.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -100.1 160.05 28.19 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.677 -0.64 . . . . 0.0 110.095 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -58.91 159.97 19.7 Favored 'Trans proline' 0 N--CA 1.487 1.118 0 O-C-N 123.298 1.157 . . . . 0.0 110.425 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -59.15 149.95 76.85 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.245 1.129 . . . . 0.0 110.614 -176.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -61.21 148.94 39.19 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.692 -0.63 . . . . 0.0 110.166 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.78 127.22 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.469 -0.769 . . . . 0.0 110.158 -170.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.92 -10.11 55.46 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.402 ' OG1' ' CD2' ' A' ' 260' ' ' PHE . 9.9 t -145.02 173.33 11.98 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.245 -1.15 . . . . 0.0 110.607 175.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -107.35 13.14 27.35 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.586 -0.696 . . . . 0.0 111.743 -168.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . 0.402 ' CD2' ' OG1' ' A' ' 258' ' ' THR . 14.7 p90 -120.01 168.0 11.61 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.167 -0.958 . . . . 0.0 111.164 -175.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 93.2 m -117.71 147.01 43.34 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.781 -0.574 . . . . 0.0 109.859 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 38.5 m -116.83 135.0 54.08 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.541 -0.724 . . . . 0.0 110.927 -175.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.4 t -129.66 137.12 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 171.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 70.1 mt -104.83 122.09 45.03 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.582 -0.699 . . . . 0.0 109.903 -173.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -106.92 149.4 27.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.637 -0.664 . . . . 0.0 110.633 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -136.63 142.95 43.27 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -111.04 131.55 54.97 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.575 -0.703 . . . . 0.0 110.499 -176.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -96.79 2.87 52.38 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.708 -0.62 . . . . 0.0 112.119 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -144.67 165.03 29.2 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.055 -1.028 . . . . 0.0 110.11 174.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -119.86 162.37 19.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.72 -0.612 . . . . 0.0 110.303 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 23.1 m -58.29 -33.47 69.49 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.468 -0.77 . . . . 0.0 110.983 -163.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 49.2 p -97.9 9.88 41.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.458 -0.776 . . . . 0.0 112.07 -163.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 31.2 p -93.79 118.07 30.94 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.09 -1.006 . . . . 0.0 110.691 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 60.4 t -64.42 140.52 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.442 -0.786 . . . . 0.0 110.305 -170.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 100.74 -5.21 56.62 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 177.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.62 -99.16 0.88 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 170.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 93.2 mmm -63.85 -31.59 72.82 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.639 -0.918 . . . . 0.0 110.3 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.5 p30 43.84 50.56 6.92 Favored 'General case' 0 N--CA 1.504 2.234 0 CA-C-O 121.286 0.565 . . . . 0.0 112.521 175.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 22.0 mtt180 54.81 29.67 12.31 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.29 -0.881 . . . . 0.0 111.17 175.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -119.28 104.97 45.08 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.517 -0.739 . . . . 0.0 110.149 175.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.85 145.95 96.96 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 123.077 1.04 . . . . 0.0 110.522 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 45.6 pt -131.98 177.59 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 121.79 0.805 . . . . 0.0 111.132 -175.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 30.1 mt -124.34 149.9 46.1 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.421 HD12 ' CE1' ' A' ' 301' ' ' PHE . 77.6 mt -115.03 129.91 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.213 177.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 82.3 mt -109.71 127.17 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -176.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 58.7 t -118.83 126.73 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.5 p -125.21 153.8 42.57 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.466 -174.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.424 ' HB2' ' CE1' ' A' ' 138' ' ' PHE . 27.1 tp -105.32 126.08 51.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.73 -0.606 . . . . 0.0 109.535 169.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -131.79 148.86 52.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.955 -0.466 . . . . 0.0 109.768 -174.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.4 ' CG2' ' CD1' ' A' ' 296' ' ' LEU . 54.4 p -89.88 161.68 15.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.641 -0.662 . . . . 0.0 109.98 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -55.99 -26.09 46.89 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.544 -0.723 . . . . 0.0 111.112 -174.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 40.8 p30 -91.6 10.25 28.85 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.379 -0.826 . . . . 0.0 111.923 -173.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.85 20.19 44.47 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 120.14 -1.028 . . . . 0.0 110.725 171.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -106.0 140.15 39.44 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.256 -1.144 . . . . 0.0 110.001 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 58.5 t -89.21 132.09 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.634 -0.666 . . . . 0.0 110.282 -172.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.4 ' CD1' ' CG2' ' A' ' 290' ' ' THR . 95.9 mt -99.92 -40.2 7.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.682 -0.636 . . . . 0.0 110.694 178.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -169.34 158.54 31.01 Favored Glycine 0 N--CA 1.496 2.686 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.612 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -134.6 138.89 44.93 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.619 -0.93 . . . . 0.0 110.957 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -132.76 159.27 40.21 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.639 -0.663 . . . . 0.0 109.727 169.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 87.6 m -144.06 154.38 43.16 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.409 -0.807 . . . . 0.0 110.76 -176.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.421 ' CE1' HD12 ' A' ' 284' ' ' ILE . 48.7 p90 -145.78 161.86 38.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.614 -0.679 . . . . 0.0 110.087 174.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -104.83 136.81 43.64 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.619 -0.676 . . . . 0.0 110.224 -176.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -124.3 142.75 51.01 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.779 -170.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -138.11 140.91 40.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.793 -0.567 . . . . 0.0 109.684 172.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 74.5 mt -108.29 122.78 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.462 -0.774 . . . . 0.0 109.688 176.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.0 p -145.31 170.28 16.61 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.605 -0.684 . . . . 0.0 110.676 -171.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -72.47 -40.18 67.17 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.662 -0.649 . . . . 0.0 110.648 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.7 t -126.83 85.75 60.18 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.471 -0.768 . . . . 0.0 110.485 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -55.69 -28.19 64.91 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 O-C-N 123.121 1.064 . . . . 0.0 110.856 174.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.95 -38.18 92.66 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 177.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 57.5 ttt85 -72.61 -40.37 66.54 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.621 -0.929 . . . . 0.0 109.875 -173.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -69.53 -38.91 77.71 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.137 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -61.25 -43.28 99.13 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.52 -0.738 . . . . 0.0 110.251 178.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -64.51 -40.82 96.34 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.567 -0.708 . . . . 0.0 110.604 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -60.73 -49.88 75.71 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.478 -0.764 . . . . 0.0 110.559 -173.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 2.9 p30 . . . . . 0 N--CA 1.495 1.816 0 O-C-N 121.418 -0.802 . . . . 0.0 110.045 -179.456 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 27.5 t . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.115 0.483 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.4 p-10 -101.89 25.22 8.91 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.586 -0.696 . . . . 0.0 110.699 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 49.1 m -79.17 125.23 29.17 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.617 -0.677 . . . . 0.0 110.262 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -68.86 144.93 54.1 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.696 -0.628 . . . . 0.0 110.418 -177.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -154.3 99.81 2.48 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.76 -0.587 . . . . 0.0 110.038 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.47 -39.99 78.58 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 O-C-N 123.181 1.095 . . . . 0.0 110.823 -175.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.94 -155.19 47.65 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -73.72 -46.31 0.34 Allowed 'Trans proline' 0 C--N 1.316 -1.155 0 O-C-N 123.354 1.186 . . . . 0.0 110.959 -173.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -87.38 9.08 21.76 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.509 -0.745 . . . . 0.0 111.376 -173.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.61 61.28 3.18 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.991 -1.068 . . . . 0.0 110.727 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -77.86 119.22 21.03 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.587 -0.696 . . . . 0.0 109.869 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -130.08 160.43 33.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.829 -0.545 . . . . 0.0 110.154 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 63.2 t -125.76 145.57 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.82 -0.55 . . . . 0.0 109.767 177.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 78.4 p -155.46 160.51 40.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.734 -0.603 . . . . 0.0 110.067 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.434 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 67.8 m-85 . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.854 -0.529 . . . . 0.0 109.788 -176.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.196 0.522 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 75.8 p -60.09 -33.09 71.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.716 -0.615 . . . . 0.0 109.932 176.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.418 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.6 p-90 -170.95 142.6 1.88 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.309 0.576 . . . . 0.0 110.026 178.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 13.2 t -142.2 142.57 32.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.942 -0.474 . . . . 0.0 109.952 -176.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.434 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 64.1 t80 -125.51 140.03 53.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.523 -0.736 . . . . 0.0 110.544 -172.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 28.5 t -110.24 124.41 51.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.861 -0.525 . . . . 0.0 109.845 176.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 58.6 m -70.76 -36.94 73.33 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.789 -0.569 . . . . 0.0 110.556 -177.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -59.43 -34.66 72.77 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.561 -0.712 . . . . 0.0 110.464 -177.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 57.4 mt -104.88 -11.98 16.47 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.672 -0.642 . . . . 0.0 110.88 -175.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 59.8 tttt 59.79 52.01 5.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.065 -1.022 . . . . 0.0 109.746 178.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -145.35 152.99 40.74 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.707 -0.621 . . . . 0.0 110.556 -175.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.6 tp -126.55 137.79 53.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.69 -0.631 . . . . 0.0 110.344 -176.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -116.19 134.2 55.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.675 -0.641 . . . . 0.0 109.382 174.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.3 158.39 44.39 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.939 -175.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -104.61 143.38 33.15 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.469 0.652 . . . . 0.0 110.396 173.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 16.7 tt -52.0 146.51 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.608 -0.682 . . . . 0.0 111.813 -175.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 65.2 10.01 6.06 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.665 -0.647 . . . . 0.0 112.415 177.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -96.63 155.13 16.9 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.068 -1.02 . . . . 0.0 110.832 174.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 62.3 m -88.53 126.22 35.15 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.662 -0.648 . . . . 0.0 110.669 -177.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 44.2 t -113.71 90.08 17.45 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.59 -0.694 . . . . 0.0 110.19 175.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.418 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 23.7 Cg_exo -60.75 130.26 32.45 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 O-C-N 123.268 1.141 . . . . 0.0 110.678 172.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.409 HG12 ' CE2' ' A' ' 142' ' ' PHE . 97.5 mt -124.9 141.66 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 176.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -109.5 135.43 50.51 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.464 -0.772 . . . . 0.0 110.879 -175.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.5 mm -95.29 133.58 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.713 -0.617 . . . . 0.0 109.624 169.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 40.2 tttp -114.49 128.77 56.51 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.579 -0.701 . . . . 0.0 110.449 176.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.1 m -136.72 159.88 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.588 -0.695 . . . . 0.0 109.86 175.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.7 mmm -76.57 -41.4 46.53 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.666 -0.646 . . . . 0.0 110.1 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 77.0 p -134.78 143.27 45.65 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.763 -0.586 . . . . 0.0 109.695 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -55.45 139.74 82.24 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 O-C-N 123.156 1.082 . . . . 0.0 110.889 -171.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.432 ' HG2' ' CD1' ' A' ' 251' ' ' TYR . 34.9 Cg_endo -67.63 169.99 14.76 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 O-C-N 123.157 1.082 . . . . 0.0 110.608 177.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -60.81 155.28 50.05 Favored 'Trans proline' 0 C--N 1.316 -1.152 0 O-C-N 123.327 1.172 . . . . 0.0 110.521 -178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -77.46 141.09 39.88 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.519 -0.738 . . . . 0.0 109.879 174.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.8 -24.88 29.76 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -174.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.19 150.74 2.31 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.412 -1.052 . . . . 0.0 111.4 177.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.7 156.04 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.762 -0.586 . . . . 0.0 109.688 176.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 84.2 mt -109.16 141.49 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.752 -0.592 . . . . 0.0 109.599 177.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.409 ' HG2' ' CD2' ' A' ' 248' ' ' LEU . 70.6 mtp180 -114.78 145.2 42.37 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -176.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -140.03 126.29 19.98 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.339 173.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 41.9 ttm -137.24 139.9 29.37 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.81 -0.557 . . . . 0.0 111.059 -176.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -91.19 138.23 2.26 Favored 'Trans proline' 0 C--N 1.32 -0.964 0 O-C-N 123.3 1.158 . . . . 0.0 110.812 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.8 m -147.7 154.9 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.574 -0.704 . . . . 0.0 109.988 173.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.419 ' CE2' HG21 ' A' ' 202' ' ' VAL . 87.2 m-85 -61.49 165.76 4.59 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.462 -0.774 . . . . 0.0 110.447 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -83.99 -60.05 2.22 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.626 -0.671 . . . . 0.0 110.799 -173.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 48.3 mttt -80.04 152.49 29.37 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.639 -0.663 . . . . 0.0 110.332 -175.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.56 -38.75 72.36 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.462 -0.774 . . . . 0.0 110.698 -175.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -56.48 -24.91 49.25 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.519 -0.738 . . . . 0.0 110.621 -176.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.404 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 77.8 m80 -109.7 -20.5 12.8 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.137 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.2 p -67.6 -20.23 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.123 -0.986 . . . . 0.0 110.576 -175.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 71.7 p -79.48 -16.91 55.25 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.763 174.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -88.37 134.93 33.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.359 -0.838 . . . . 0.0 110.1 173.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 60.9 t -72.97 145.91 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.615 -0.678 . . . . 0.0 110.27 178.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.419 HG21 ' CE2' ' A' ' 192' ' ' TYR . 60.6 t -84.72 139.79 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.564 -0.71 . . . . 0.0 109.223 172.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.8 pttp -134.85 -170.16 2.51 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.422 -0.799 . . . . 0.0 111.295 -166.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -95.21 152.59 18.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.789 -0.57 . . . . 0.0 110.102 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.534 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 36.5 m . . . . . 0 N--CA 1.498 1.938 0 O-C-N 121.471 -0.768 . . . . 0.0 109.025 173.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 58.8 tp . . . . . 0 N--CA 1.497 1.902 0 CA-C-O 120.879 0.371 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 83.7 mt -104.94 136.81 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.834 -0.541 . . . . 0.0 109.801 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -132.47 157.82 43.65 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.797 -0.564 . . . . 0.0 110.292 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 94.1 t -102.67 146.56 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.722 -0.611 . . . . 0.0 109.909 175.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -117.26 124.14 48.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.722 -0.611 . . . . 0.0 110.428 172.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 95.79 24.33 15.77 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 167.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -137.27 107.07 6.23 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.5 -1.0 . . . . 0.0 110.015 174.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 28.0 t -63.03 -15.2 55.66 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.611 -0.68 . . . . 0.0 111.203 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -100.0 9.34 43.06 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.289 -0.882 . . . . 0.0 111.588 -177.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.37 127.91 33.77 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.129 -0.982 . . . . 0.0 110.179 176.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -139.75 158.01 44.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.707 -0.62 . . . . 0.0 109.868 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -114.67 150.66 34.85 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.604 -0.685 . . . . 0.0 110.576 -176.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.13 160.0 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.742 -0.599 . . . . 0.0 110.173 177.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -119.17 130.06 55.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.703 -0.623 . . . . 0.0 110.227 176.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -64.18 130.04 94.36 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.66 -0.65 . . . . 0.0 109.833 178.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -65.41 -28.34 54.39 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.187 1.098 . . . . 0.0 111.024 -170.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.8 mt -101.74 -50.5 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.425 -0.797 . . . . 0.0 111.051 -167.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 11.1 p -105.4 12.18 31.86 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.446 -0.784 . . . . 0.0 111.843 -174.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 72.3 -5.01 16.43 Favored Glycine 0 N--CA 1.496 2.688 0 O-C-N 121.102 -0.999 . . . . 0.0 112.007 173.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -45.91 142.05 2.8 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-N 119.134 1.467 . . . . 0.0 112.36 -174.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -103.61 143.43 32.77 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.715 -0.616 . . . . 0.0 110.117 175.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 76.5 p -154.74 159.95 41.0 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.637 -0.664 . . . . 0.0 110.332 177.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 8.2 p -123.0 148.2 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.789 -0.569 . . . . 0.0 109.699 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.409 ' CD2' ' HG2' ' A' ' 187' ' ' ARG . 79.9 mt -129.51 154.56 46.9 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.615 -175.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 32.5 m -151.13 151.78 30.09 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.776 -0.577 . . . . 0.0 109.955 175.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -71.14 139.59 35.81 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 O-C-N 123.333 1.175 . . . . 0.0 110.009 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.432 ' CD1' ' HG2' ' A' ' 180' ' ' PRO . 59.2 t80 -75.76 127.22 32.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.539 -0.726 . . . . 0.0 110.123 175.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -100.11 160.09 28.06 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.765 -0.584 . . . . 0.0 109.979 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -58.77 158.34 24.71 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.213 1.112 . . . . 0.0 110.496 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.25 149.95 77.43 Favored 'Trans proline' 0 N--CA 1.487 1.145 0 O-C-N 123.206 1.109 . . . . 0.0 110.549 -177.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -61.87 147.73 45.69 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.603 -0.686 . . . . 0.0 110.146 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.92 127.25 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.537 -0.727 . . . . 0.0 110.161 -170.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.95 -10.17 55.43 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.416 ' OG1' ' CD2' ' A' ' 260' ' ' PHE . 9.2 t -144.46 174.14 11.19 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.253 -1.145 . . . . 0.0 110.566 175.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -108.08 13.22 26.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.622 -0.674 . . . . 0.0 111.839 -167.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . 0.416 ' CD2' ' OG1' ' A' ' 258' ' ' THR . 38.6 p90 -120.0 168.09 11.51 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.15 -0.969 . . . . 0.0 111.101 -175.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 76.9 m -117.75 145.87 44.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.756 -0.59 . . . . 0.0 109.836 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 55.8 m -116.64 134.81 54.37 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.478 0.656 . . . . 0.0 110.91 -174.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 64.0 t -130.35 137.32 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 172.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 76.1 mt -104.73 120.47 41.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.518 -0.739 . . . . 0.0 109.89 -171.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -106.51 151.67 24.68 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.693 -0.63 . . . . 0.0 110.486 -177.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -136.54 142.89 43.46 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -113.48 131.73 55.93 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.6 -0.688 . . . . 0.0 110.259 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -104.17 9.68 36.11 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.582 -0.699 . . . . 0.0 111.897 -175.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -144.62 160.37 41.29 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.035 -1.041 . . . . 0.0 109.861 170.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -117.49 162.43 17.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.682 -0.636 . . . . 0.0 110.31 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 20.1 m -58.78 -32.28 69.15 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.582 -0.699 . . . . 0.0 110.925 -163.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 48.0 p -99.79 12.89 35.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.507 -0.746 . . . . 0.0 111.962 -164.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . 0.534 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 32.0 p -94.54 118.15 31.24 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.552 177.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 60.1 t -64.02 139.54 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.46 -0.775 . . . . 0.0 110.399 -167.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.56 -5.16 58.44 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 176.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -124.46 -100.05 1.33 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 170.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 93.2 mmm -63.96 -31.98 73.36 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.654 -0.909 . . . . 0.0 110.207 176.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.5 p30 43.53 51.15 6.31 Favored 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 175.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 54.78 27.42 8.85 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.394 -0.816 . . . . 0.0 111.163 175.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 77.2 mtt180 -117.67 106.42 46.23 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.476 -0.765 . . . . 0.0 110.09 175.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.56 146.71 94.43 Favored 'Trans proline' 0 N--CA 1.488 1.171 0 O-C-N 123.137 1.072 . . . . 0.0 110.577 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 45.4 pt -131.96 178.34 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.761 0.791 . . . . 0.0 110.773 -176.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 28.0 mt -124.41 149.84 46.28 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.422 ' HB ' ' CZ ' ' A' ' 301' ' ' PHE . 80.3 mt -115.82 130.44 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.617 -0.677 . . . . 0.0 109.239 177.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 85.3 mt -109.79 126.22 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -176.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 58.5 t -118.91 126.7 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.4 p -125.25 154.69 41.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.673 -0.642 . . . . 0.0 110.795 -175.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 23.6 tp -104.82 126.83 52.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.816 -0.553 . . . . 0.0 109.575 170.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -132.44 149.83 52.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.897 -0.502 . . . . 0.0 109.912 -172.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 26.1 p -90.42 160.88 15.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.639 -0.663 . . . . 0.0 110.015 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -55.95 -26.14 46.7 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.506 -0.746 . . . . 0.0 111.002 -175.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 44.8 p30 -89.72 9.77 25.88 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.414 -0.804 . . . . 0.0 111.9 -172.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.7 20.17 45.08 Favored Glycine 0 N--CA 1.495 2.6 0 C-N-CA 120.143 -1.027 . . . . 0.0 110.677 171.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -108.98 140.13 42.91 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.32 -1.106 . . . . 0.0 109.921 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 60.3 t -91.83 133.3 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.527 -0.733 . . . . 0.0 110.217 -172.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 71.6 mt -99.87 -40.24 7.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.792 -0.567 . . . . 0.0 110.59 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -158.36 154.87 25.93 Favored Glycine 0 N--CA 1.496 2.697 0 C-N-CA 119.917 -1.135 . . . . 0.0 110.516 -177.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 55.5 mtt85 -135.03 136.32 42.0 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.722 -0.869 . . . . 0.0 110.211 178.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -140.69 157.26 45.69 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.487 -0.758 . . . . 0.0 110.152 169.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 95.3 m -142.52 156.63 45.15 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.512 -0.743 . . . . 0.0 110.632 -175.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.422 ' CZ ' ' HB ' ' A' ' 284' ' ' ILE . 48.5 p90 -145.0 162.88 35.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.681 -0.637 . . . . 0.0 110.199 176.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -104.96 136.15 44.97 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.526 -0.734 . . . . 0.0 110.11 -177.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -121.66 144.21 48.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.614 -0.679 . . . . 0.0 110.814 -169.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -139.23 139.51 37.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.857 -0.527 . . . . 0.0 109.744 172.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 82.6 mt -108.71 122.84 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.465 -0.772 . . . . 0.0 109.726 176.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.8 p -145.31 171.02 15.17 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.609 -0.682 . . . . 0.0 110.606 -172.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -73.2 -40.09 65.02 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.589 -0.694 . . . . 0.0 110.7 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.7 t -127.12 85.66 60.55 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.524 -0.735 . . . . 0.0 110.49 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -55.88 -27.85 64.95 Favored 'Trans proline' 0 C--N 1.314 -1.259 0 O-C-N 123.226 1.119 . . . . 0.0 110.772 174.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -67.6 -38.1 89.99 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -72.89 -40.46 65.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.674 -0.897 . . . . 0.0 109.803 -173.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -69.59 -39.35 77.35 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.061 -178.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -61.38 -44.66 96.78 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.219 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -64.04 -40.16 95.7 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.606 -0.684 . . . . 0.0 110.459 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.6 -50.73 71.43 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.548 -0.72 . . . . 0.0 110.419 -173.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.1 p30 . . . . . 0 N--CA 1.496 1.843 0 O-C-N 121.509 -0.744 . . . . 0.0 110.107 -178.214 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.2 t . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.035 0.445 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 p-10 -96.33 24.34 5.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.637 -0.664 . . . . 0.0 110.721 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 49.9 m -77.8 125.16 28.92 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.577 -0.702 . . . . 0.0 110.274 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -71.16 144.96 50.03 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.686 -0.634 . . . . 0.0 110.414 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -157.78 101.48 1.8 Allowed Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.746 -0.596 . . . . 0.0 110.077 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -59.73 -39.87 69.46 Favored 'Trans proline' 0 N--CA 1.488 1.167 0 O-C-N 123.179 1.094 . . . . 0.0 110.681 -175.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.08 -155.12 43.9 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -73.6 -44.85 0.46 Allowed 'Trans proline' 0 C--N 1.317 -1.09 0 O-C-N 123.344 1.181 . . . . 0.0 110.855 -175.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -86.92 4.34 41.93 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.585 -0.697 . . . . 0.0 111.498 -174.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.82 61.6 3.01 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.888 -1.133 . . . . 0.0 110.716 -176.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.416 ' CE1' ' CG2' ' A' ' 174' ' ' ILE . 63.1 t80 -78.04 120.46 22.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.643 -0.661 . . . . 0.0 110.106 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -129.98 159.97 35.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.763 -0.586 . . . . 0.0 110.261 -177.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 64.5 t -126.28 146.3 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.789 -0.57 . . . . 0.0 109.831 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.9 p -154.98 162.75 41.0 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.947 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.423 ' CE2' HG12 ' A' ' 172' ' ' ILE . 76.2 m-85 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.771 -0.581 . . . . 0.0 109.944 -175.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 121.163 0.506 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.401 ' OG1' ' CD1' ' A' ' 153' ' ' TRP . 65.4 p -60.1 -34.08 72.98 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.613 -0.68 . . . . 0.0 110.055 176.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.405 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -171.83 144.15 1.74 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.43 0.633 . . . . 0.0 110.158 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.3 t -142.11 142.59 32.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.788 -0.57 . . . . 0.0 109.943 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -125.52 140.07 53.07 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.532 -0.73 . . . . 0.0 110.579 -172.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.7 t -110.43 123.56 50.11 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 120.366 -0.533 . . . . 0.0 109.641 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 63.1 m -70.82 -37.11 73.21 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.755 -0.591 . . . . 0.0 110.42 -177.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -58.94 -32.76 69.88 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.582 -0.699 . . . . 0.0 110.275 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 37.7 mt -104.8 -12.11 16.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.71 -0.619 . . . . 0.0 110.712 -175.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 31.6 tttm 59.68 47.92 9.97 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.971 -1.08 . . . . 0.0 109.761 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.415 ' HE3' ' CZ ' ' A' ' 163' ' ' TYR . 33.9 ttpt -147.19 153.16 39.5 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 120.114 -0.635 . . . . 0.0 110.725 -174.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.6 tp -126.6 138.18 53.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.763 -0.585 . . . . 0.0 110.374 -173.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.415 ' CZ ' ' HE3' ' A' ' 161' ' ' LYS . 52.3 m-85 -114.7 135.04 54.59 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 174.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.9 p -138.33 158.4 44.36 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.034 -176.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -104.55 142.86 33.89 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.611 -0.681 . . . . 0.0 110.211 173.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 17.2 tt -52.41 147.42 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.461 -0.774 . . . . 0.0 111.837 -174.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 64.89 9.97 5.78 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.539 -0.726 . . . . 0.0 112.487 176.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -95.68 155.09 16.89 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.994 -1.067 . . . . 0.0 110.906 174.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 88.2 m -84.49 126.17 33.04 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.725 -0.609 . . . . 0.0 110.59 -178.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 48.9 t -114.22 90.32 19.91 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.59 -0.694 . . . . 0.0 110.18 175.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.405 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 21.3 Cg_endo -65.94 129.65 22.52 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 O-C-N 123.261 1.137 . . . . 0.0 110.59 176.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.423 HG12 ' CE2' ' A' ' 142' ' ' PHE . 93.9 mt -123.15 141.69 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.62 -0.675 . . . . 0.0 109.329 176.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -109.06 135.35 50.37 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.519 -0.738 . . . . 0.0 110.761 -175.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.416 ' CG2' ' CE1' ' A' ' 138' ' ' PHE . 48.3 mm -95.24 135.03 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.652 -0.655 . . . . 0.0 109.642 170.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -117.84 128.84 55.24 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.42 175.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 17.1 m -136.47 159.75 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.532 -0.73 . . . . 0.0 109.949 175.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.0 mmm -77.07 -40.47 46.04 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.683 -0.635 . . . . 0.0 110.113 178.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 77.4 p -135.3 143.18 44.43 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.746 -0.596 . . . . 0.0 109.849 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -55.94 139.87 85.09 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 O-C-N 123.181 1.095 . . . . 0.0 110.828 -173.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.429 ' HG3' ' CE2' ' A' ' 251' ' ' TYR . 20.8 Cg_endo -63.49 169.1 10.25 Favored 'Trans proline' 0 N--CA 1.488 1.18 0 O-C-N 123.204 1.107 . . . . 0.0 110.728 176.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -61.16 157.5 39.42 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.376 1.198 . . . . 0.0 110.482 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -76.61 137.45 39.49 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.635 -0.666 . . . . 0.0 109.898 175.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.51 -25.09 29.62 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -174.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.08 151.98 1.81 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.335 -1.097 . . . . 0.0 111.396 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.77 155.95 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.698 -0.627 . . . . 0.0 109.935 177.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.413 HD13 ' CD2' ' A' ' 251' ' ' TYR . 72.4 mt -108.47 135.51 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -115.05 147.13 40.54 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.702 -0.623 . . . . 0.0 109.376 -175.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -140.12 128.7 22.93 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.536 -0.728 . . . . 0.0 110.138 172.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 22.6 ttp -137.29 137.18 21.82 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.796 -0.565 . . . . 0.0 111.083 -176.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -91.43 138.19 2.15 Favored 'Trans proline' 0 C--N 1.32 -0.959 0 C-N-CA 121.038 1.159 . . . . 0.0 110.773 177.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 35.0 m -146.99 154.86 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.486 -0.759 . . . . 0.0 110.022 173.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.426 ' CE2' HG23 ' A' ' 202' ' ' VAL . 87.6 m-85 -61.48 160.02 11.85 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.464 -0.773 . . . . 0.0 110.397 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -76.21 -60.04 2.5 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.664 -0.647 . . . . 0.0 110.832 -173.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -80.01 150.7 30.32 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.58 -0.7 . . . . 0.0 110.356 -174.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.44 -38.86 72.2 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.385 -0.822 . . . . 0.0 110.728 -175.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -56.33 -25.04 47.58 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.555 -0.716 . . . . 0.0 110.668 -176.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.408 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 97.3 m-70 -110.03 -20.57 12.67 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.934 -0.706 . . . . 0.0 111.147 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.1 p -66.78 -20.25 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.154 -0.966 . . . . 0.0 110.573 -175.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 68.1 p -79.35 -17.05 55.29 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.713 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -88.27 136.39 33.0 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.353 -0.842 . . . . 0.0 109.951 172.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 56.9 t -73.02 146.48 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.61 -0.681 . . . . 0.0 110.133 178.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.426 HG23 ' CE2' ' A' ' 192' ' ' TYR . 79.5 t -84.92 139.65 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.598 -0.689 . . . . 0.0 109.261 172.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.7 pttp -134.82 -170.07 2.48 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.557 -0.715 . . . . 0.0 111.038 -166.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -95.12 154.04 17.37 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.744 -0.597 . . . . 0.0 110.442 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.644 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 58.7 m . . . . . 0 N--CA 1.496 1.857 0 O-C-N 121.641 -0.662 . . . . 0.0 109.272 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 59.5 tp . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 120.968 0.413 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 83.4 mt -103.97 136.79 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.729 -0.607 . . . . 0.0 109.949 -178.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -127.26 157.54 39.56 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.748 -0.595 . . . . 0.0 110.176 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 90.7 t -102.32 146.6 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.787 -0.571 . . . . 0.0 109.81 173.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -118.59 129.97 55.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.698 -0.626 . . . . 0.0 110.4 170.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.96 21.08 26.56 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 168.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 35.7 t-20 -138.45 105.65 5.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.305 -1.115 . . . . 0.0 110.054 174.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 43.7 m -63.28 -15.33 56.87 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.656 -0.653 . . . . 0.0 111.306 -176.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -99.92 7.58 44.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.214 -0.929 . . . . 0.0 111.597 -177.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.64 132.27 52.73 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.114 -0.991 . . . . 0.0 110.24 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -139.76 157.97 44.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.79 -0.569 . . . . 0.0 109.674 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -116.36 150.64 37.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.542 -0.724 . . . . 0.0 110.573 -177.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.19 159.89 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.824 -0.548 . . . . 0.0 110.24 177.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -123.71 128.21 49.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.76 -0.587 . . . . 0.0 110.05 174.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -65.09 130.05 94.69 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.678 -0.639 . . . . 0.0 109.893 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -66.8 -26.48 44.93 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 O-C-N 123.036 1.019 . . . . 0.0 111.029 -172.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.2 mt -99.06 -50.45 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.371 -0.831 . . . . 0.0 110.916 -168.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.0 p -105.33 12.07 32.11 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.406 -0.809 . . . . 0.0 111.835 -175.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.89 -5.08 13.77 Favored Glycine 0 N--CA 1.496 2.691 0 O-C-N 121.058 -1.027 . . . . 0.0 111.709 174.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 69.5 mmt-85 -46.18 141.98 3.07 Favored 'General case' 0 N--CA 1.505 2.278 0 CA-C-N 119.07 1.435 . . . . 0.0 112.363 -172.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -108.13 139.55 42.63 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.651 -0.655 . . . . 0.0 110.091 174.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 77.8 p -154.76 159.94 40.98 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.569 -0.707 . . . . 0.0 110.619 177.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 8.4 p -123.67 148.1 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.706 -0.621 . . . . 0.0 109.713 177.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 83.0 mt -129.67 154.71 46.86 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.032 -174.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 36.0 m -150.77 151.76 30.87 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.855 -0.528 . . . . 0.0 109.878 175.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -70.6 139.4 37.22 Favored 'Trans proline' 0 C--N 1.315 -1.184 0 O-C-N 123.292 1.154 . . . . 0.0 110.055 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.429 ' CE2' ' HG3' ' A' ' 180' ' ' PRO . 10.0 t80 -79.66 123.29 27.5 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.539 -0.726 . . . . 0.0 110.16 178.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -100.04 160.1 28.07 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.693 -0.629 . . . . 0.0 110.19 178.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -59.08 160.05 20.05 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.362 1.191 . . . . 0.0 110.472 178.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.87 150.01 74.63 Favored 'Trans proline' 0 N--CA 1.489 1.244 0 O-C-N 123.293 1.154 . . . . 0.0 110.501 -177.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -60.91 147.94 41.41 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.626 -0.671 . . . . 0.0 110.184 -178.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.85 127.24 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.557 -0.715 . . . . 0.0 110.168 -170.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.88 -10.23 55.59 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.413 ' OG1' ' CD2' ' A' ' 260' ' ' PHE . 10.2 t -144.62 174.42 10.98 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.187 -1.184 . . . . 0.0 110.613 175.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -108.71 13.06 25.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.57 -0.706 . . . . 0.0 111.85 -167.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . 0.413 ' CD2' ' OG1' ' A' ' 258' ' ' THR . 43.2 p90 -122.41 168.07 12.54 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.125 -0.984 . . . . 0.0 111.149 -176.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 87.2 m -117.69 145.56 44.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.748 -0.595 . . . . 0.0 109.849 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 38.6 m -116.22 135.73 53.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.557 -0.715 . . . . 0.0 110.939 -175.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 57.6 t -129.03 137.29 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 172.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 62.7 mt -104.72 119.97 40.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.525 -0.734 . . . . 0.0 109.793 -172.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 -106.67 150.97 25.7 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.63 -0.669 . . . . 0.0 110.664 -178.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -136.47 142.91 43.59 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -113.15 132.67 55.37 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.56 -0.713 . . . . 0.0 110.48 -176.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -103.21 8.52 38.46 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.711 -0.618 . . . . 0.0 112.172 -175.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -144.68 165.1 29.0 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.045 -1.034 . . . . 0.0 109.906 171.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 27.9 p30 -121.68 161.61 22.21 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.394 0.616 . . . . 0.0 110.38 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 26.7 m -58.36 -33.56 69.7 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.465 -0.772 . . . . 0.0 111.09 -163.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 70.6 m -97.56 10.54 39.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.494 -0.754 . . . . 0.0 112.089 -164.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . 0.644 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 30.5 p -93.9 118.1 31.0 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.027 -1.045 . . . . 0.0 110.644 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.81 139.87 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.505 -0.747 . . . . 0.0 110.349 -169.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.57 -5.13 60.16 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 178.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -125.18 -100.2 1.26 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 170.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 93.4 mmm -65.55 -32.77 74.54 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.614 -0.933 . . . . 0.0 110.419 176.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.6 p30 42.47 53.11 4.7 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 176.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 54.8 27.44 8.9 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.328 -0.858 . . . . 0.0 111.184 176.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -119.12 105.15 45.21 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.484 -0.76 . . . . 0.0 110.098 175.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -59.45 151.02 71.73 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 O-C-N 123.135 1.071 . . . . 0.0 110.686 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 46.3 pt -131.81 177.63 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.766 0.793 . . . . 0.0 110.922 -177.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 24.4 mt -124.33 149.81 46.17 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.424 HD11 ' CE1' ' A' ' 301' ' ' PHE . 80.2 mt -118.1 129.12 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.232 178.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 84.7 mt -109.79 127.55 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 120.251 -0.579 . . . . 0.0 109.448 -175.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 59.5 t -118.87 126.79 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.4 p -125.23 153.66 42.81 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 120.136 -0.625 . . . . 0.0 110.55 -174.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.41 ' HB2' ' CD1' ' A' ' 138' ' ' PHE . 20.7 tp -104.09 125.59 50.55 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 168.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -131.8 150.43 52.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.855 -0.528 . . . . 0.0 109.851 -171.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.4 ' CG2' ' CD1' ' A' ' 296' ' ' LEU . 68.4 p -89.86 159.54 16.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.632 -0.668 . . . . 0.0 109.708 177.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 28.7 tpt180 -56.03 -25.98 46.96 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.521 -0.737 . . . . 0.0 110.761 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -86.65 8.96 20.18 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.482 -0.762 . . . . 0.0 111.706 -174.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 86.95 20.13 54.22 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 120.186 -1.007 . . . . 0.0 110.673 170.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -107.86 140.12 41.44 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.214 -1.168 . . . . 0.0 110.252 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 60.5 t -88.86 131.4 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.683 -0.635 . . . . 0.0 110.133 -174.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.4 ' CD1' ' CG2' ' A' ' 290' ' ' THR . 76.8 mt -99.78 -40.18 7.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.753 -0.592 . . . . 0.0 110.504 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -159.68 151.77 22.58 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -135.08 134.29 40.16 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.643 -0.916 . . . . 0.0 110.606 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -136.76 157.88 45.73 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.568 -0.707 . . . . 0.0 109.848 172.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 94.7 m -143.18 156.69 44.83 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.358 -0.838 . . . . 0.0 110.846 -175.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.424 ' CE1' HD11 ' A' ' 284' ' ' ILE . 47.1 p90 -145.21 162.17 37.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.653 -0.654 . . . . 0.0 110.12 175.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -104.85 135.36 46.36 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.515 -0.741 . . . . 0.0 110.16 -178.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -123.6 142.99 50.5 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.736 -170.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 53.4 ttt85 -139.04 140.33 38.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.853 -0.53 . . . . 0.0 109.769 173.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 73.6 mt -107.78 123.0 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.611 -0.68 . . . . 0.0 109.602 176.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.9 p -145.13 167.56 22.45 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.592 -0.692 . . . . 0.0 110.929 -170.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -67.8 -40.07 83.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.633 -0.667 . . . . 0.0 110.628 -177.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 3.9 t -132.09 89.49 37.77 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.592 -0.693 . . . . 0.0 110.448 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.54 -29.86 71.57 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 O-C-N 123.089 1.047 . . . . 0.0 110.853 174.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.26 -37.28 92.76 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -73.25 -40.37 64.69 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.752 -0.852 . . . . 0.0 109.779 -173.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -69.53 -40.14 77.07 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.183 -178.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -61.72 -43.19 99.34 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.301 178.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -65.06 -39.74 93.7 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.494 -0.754 . . . . 0.0 110.445 177.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.37 -49.86 75.21 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.515 -0.74 . . . . 0.0 110.551 -173.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.2 p30 . . . . . 0 N--CA 1.494 1.73 0 O-C-N 121.389 -0.82 . . . . 0.0 110.09 -178.807 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.0 t . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.029 0.442 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.5 p-10 -94.38 23.2 5.35 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.713 -0.617 . . . . 0.0 110.845 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 50.5 m -75.47 125.1 28.33 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.454 -0.779 . . . . 0.0 110.171 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -70.44 144.88 51.33 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.584 -0.697 . . . . 0.0 110.43 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.413 ' CE2' ' HA2' ' A' ' 134' ' ' GLY . 65.4 t80 -155.92 102.51 2.12 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.635 -0.666 . . . . 0.0 110.055 178.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -58.95 -39.87 76.84 Favored 'Trans proline' 0 N--CA 1.488 1.161 0 O-C-N 123.129 1.068 . . . . 0.0 110.792 -174.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.413 ' HA2' ' CE2' ' A' ' 132' ' ' TYR . . . 81.13 -155.14 36.05 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 178.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -73.04 -49.92 0.22 Allowed 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.361 1.19 . . . . 0.0 110.914 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -87.88 9.89 20.53 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.55 -0.719 . . . . 0.0 111.36 -173.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.71 61.51 3.06 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.922 -1.111 . . . . 0.0 110.705 -177.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.454 ' CE1' ' CG2' ' A' ' 174' ' ' ILE . 64.3 t80 -79.85 118.81 21.97 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.663 -0.648 . . . . 0.0 110.07 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -130.01 160.04 34.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.787 -0.571 . . . . 0.0 110.316 -175.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 72.3 t -123.99 147.09 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.751 -0.593 . . . . 0.0 109.764 177.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.9 p -155.17 163.65 39.93 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.251 0.548 . . . . 0.0 109.932 176.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.494 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 67.3 m-85 . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.723 -0.611 . . . . 0.0 109.844 -176.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 121.229 0.538 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 61.6 p -60.09 -33.22 71.79 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.753 -0.592 . . . . 0.0 110.005 175.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.418 ' CZ2' ' HD2' ' A' ' 171' ' ' PRO . 68.5 p-90 -171.28 143.48 1.88 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.784 -0.572 . . . . 0.0 110.063 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.5 t -142.03 142.54 32.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.83 -0.544 . . . . 0.0 110.011 -177.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.494 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 64.9 t80 -125.62 140.03 53.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.534 -0.729 . . . . 0.0 110.646 -172.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 40.6 t -109.59 124.46 51.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.863 -0.523 . . . . 0.0 109.944 176.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 56.1 m -71.12 -37.1 72.35 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.794 -0.566 . . . . 0.0 110.513 -177.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -59.9 -34.29 72.99 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.604 -0.685 . . . . 0.0 110.364 -178.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 58.0 mt -104.82 -11.99 16.51 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.656 -0.653 . . . . 0.0 110.871 -175.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.6 tttp 59.81 51.31 6.21 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.112 -0.992 . . . . 0.0 109.734 177.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -145.71 153.06 40.57 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.562 -174.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.5 tp -126.65 137.8 53.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.772 -0.58 . . . . 0.0 110.416 -175.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -117.15 134.28 54.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.683 -0.635 . . . . 0.0 109.414 174.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.28 158.37 44.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.615 -0.678 . . . . 0.0 111.0 -174.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -104.56 144.9 31.06 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.568 0.699 . . . . 0.0 110.491 173.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 16.8 tt -52.1 146.25 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.551 -0.718 . . . . 0.0 111.894 -174.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 63.96 10.17 5.11 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.629 -0.67 . . . . 0.0 112.448 176.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -96.12 155.04 16.93 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.987 -1.071 . . . . 0.0 110.705 175.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 90.5 m -84.63 126.18 33.13 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.709 -0.619 . . . . 0.0 110.537 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 42.9 t -114.3 90.08 19.49 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.627 -0.671 . . . . 0.0 110.046 172.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.418 ' HD2' ' CZ2' ' A' ' 153' ' ' TRP . 22.6 Cg_exo -61.78 129.29 27.12 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 O-C-N 123.334 1.176 . . . . 0.0 110.548 172.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.421 HG12 ' CE2' ' A' ' 142' ' ' PHE . 95.2 mt -123.26 139.38 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 175.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -106.77 135.92 47.49 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.559 -0.713 . . . . 0.0 110.753 -175.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.454 ' CG2' ' CE1' ' A' ' 138' ' ' PHE . 49.8 mm -95.3 135.01 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.75 -0.594 . . . . 0.0 109.715 171.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 31.7 tptt -117.21 130.57 56.67 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.679 -0.638 . . . . 0.0 110.518 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.5 m -136.87 159.78 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.518 -0.739 . . . . 0.0 109.977 175.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 80.3 mmm -78.4 -40.29 36.47 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.716 -0.615 . . . . 0.0 110.008 177.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 76.7 p -135.09 143.21 44.95 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.805 -0.559 . . . . 0.0 109.686 177.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -55.51 139.79 82.6 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 O-C-N 123.177 1.093 . . . . 0.0 110.92 -172.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.428 ' HG2' ' CD1' ' A' ' 251' ' ' TYR . 34.2 Cg_endo -68.12 169.99 15.46 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.211 1.111 . . . . 0.0 110.616 177.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -60.28 157.92 33.25 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 O-C-N 123.317 1.167 . . . . 0.0 110.685 -178.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -80.21 139.2 36.84 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.663 -0.648 . . . . 0.0 110.034 175.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.04 -24.94 30.22 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 -174.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.07 152.64 1.61 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.365 -1.08 . . . . 0.0 111.429 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.73 155.95 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.686 -0.634 . . . . 0.0 109.841 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 86.7 mt -109.04 137.97 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.629 -0.669 . . . . 0.0 109.539 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -115.03 146.24 41.47 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -176.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -139.97 127.94 22.16 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.454 -0.779 . . . . 0.0 110.327 174.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 30.6 ttp -137.26 139.95 29.45 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.752 -0.593 . . . . 0.0 111.19 -176.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -92.46 138.14 1.73 Allowed 'Trans proline' 0 C--N 1.32 -0.961 0 C-N-CA 121.15 1.233 . . . . 0.0 110.702 177.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 35.0 m -148.05 154.9 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.507 -0.746 . . . . 0.0 110.133 174.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.422 ' CE2' HG23 ' A' ' 202' ' ' VAL . 71.2 m-85 -60.3 164.96 3.84 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.529 -0.732 . . . . 0.0 110.487 178.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 36.8 tttt -79.86 -60.03 2.5 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.607 -0.683 . . . . 0.0 110.805 -174.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -80.1 150.73 30.16 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.525 -0.734 . . . . 0.0 110.293 -174.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.5 -38.68 72.12 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.334 -0.854 . . . . 0.0 110.749 -174.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -56.31 -25.12 47.51 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.487 -0.758 . . . . 0.0 110.633 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -110.01 -20.52 12.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.605 -0.684 . . . . 0.0 111.218 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.1 p -66.78 -20.24 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.153 -0.967 . . . . 0.0 110.604 -176.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 71.0 p -79.43 -15.44 57.81 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.577 -0.702 . . . . 0.0 110.813 175.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.22 135.18 33.56 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.355 -0.84 . . . . 0.0 110.031 173.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.9 t -72.89 143.98 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.661 -0.65 . . . . 0.0 110.221 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.422 HG23 ' CE2' ' A' ' 192' ' ' TYR . 63.1 t -84.97 136.31 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.583 -0.698 . . . . 0.0 109.318 171.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 9.2 pttt -134.91 -170.14 2.5 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.464 -0.773 . . . . 0.0 111.067 -166.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -95.15 159.34 15.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.715 -0.616 . . . . 0.0 110.426 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.656 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 59.6 m . . . . . 0 N--CA 1.495 1.812 0 O-C-N 121.644 -0.66 . . . . 0.0 109.425 176.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 30.7 tp . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 120.824 0.345 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 80.8 mt -98.96 136.78 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.757 -0.59 . . . . 0.0 109.867 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -132.53 158.01 43.23 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.704 -0.622 . . . . 0.0 110.381 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 86.3 t -103.45 146.68 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.694 -0.629 . . . . 0.0 110.034 177.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -118.79 129.62 55.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.727 -0.608 . . . . 0.0 110.329 170.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.12 24.18 20.32 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 167.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -139.7 107.29 5.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.427 -1.043 . . . . 0.0 110.104 174.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 93.5 p -63.36 -15.12 56.51 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.641 -0.662 . . . . 0.0 111.197 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -97.02 9.99 40.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.266 -0.896 . . . . 0.0 111.265 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.87 126.2 26.52 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.185 -0.947 . . . . 0.0 110.112 176.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -139.69 155.2 47.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.794 -0.566 . . . . 0.0 109.759 176.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.417 ' CD2' ' HB ' ' A' ' 247' ' ' VAL . 77.2 m-85 -118.77 150.67 39.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.506 -0.746 . . . . 0.0 110.558 -176.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.19 159.88 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.817 -0.552 . . . . 0.0 110.3 178.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -120.1 129.78 54.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.667 -0.645 . . . . 0.0 110.063 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -65.01 130.01 94.71 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.626 -0.671 . . . . 0.0 109.886 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -66.36 -27.66 47.4 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.164 1.086 . . . . 0.0 111.111 -171.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.5 mt -100.35 -50.49 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.377 -0.827 . . . . 0.0 110.978 -168.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.7 p -105.38 12.16 31.91 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.37 -0.831 . . . . 0.0 111.846 -175.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.87 -5.16 13.4 Favored Glycine 0 N--CA 1.497 2.736 0 O-C-N 121.055 -1.028 . . . . 0.0 111.898 173.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 23.1 mmt85 -46.19 142.12 3.01 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-N 119.125 1.462 . . . . 0.0 112.265 -174.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -107.29 141.67 38.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.637 -0.664 . . . . 0.0 110.143 175.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 80.0 p -154.77 159.89 40.94 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.547 -0.721 . . . . 0.0 110.609 177.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.417 ' HB ' ' CD2' ' A' ' 236' ' ' TYR . 8.4 p -123.28 148.25 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.739 -0.601 . . . . 0.0 109.696 178.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 82.4 mt -129.57 154.58 46.92 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.878 -175.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 34.7 m -151.15 151.73 29.97 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.823 -0.548 . . . . 0.0 109.943 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -71.07 140.11 37.1 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.303 1.159 . . . . 0.0 110.084 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.428 ' CD1' ' HG2' ' A' ' 180' ' ' PRO . 58.9 t80 -76.6 125.0 28.47 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.435 -0.791 . . . . 0.0 110.168 174.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -100.0 160.16 27.94 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.795 -0.565 . . . . 0.0 109.907 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -58.68 159.8 19.47 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 O-C-N 123.305 1.161 . . . . 0.0 110.48 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.02 149.92 76.42 Favored 'Trans proline' 0 N--CA 1.487 1.126 0 O-C-N 123.218 1.115 . . . . 0.0 110.539 -177.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -61.98 148.1 44.92 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.689 -0.632 . . . . 0.0 110.21 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.5 t -69.9 127.24 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.496 -0.752 . . . . 0.0 110.124 -170.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.01 -10.1 55.27 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.406 ' OG1' ' CD2' ' A' ' 260' ' ' PHE . 9.9 t -144.59 173.12 12.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.177 -1.19 . . . . 0.0 110.604 174.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -106.88 13.05 28.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.657 -0.652 . . . . 0.0 111.728 -168.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . 0.406 ' CD2' ' OG1' ' A' ' 258' ' ' THR . 14.7 p90 -119.95 168.02 11.56 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.149 -0.969 . . . . 0.0 111.136 -175.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 92.4 m -117.8 146.89 43.52 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.768 -0.583 . . . . 0.0 109.861 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 47.5 m -117.73 134.9 54.42 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.599 -0.688 . . . . 0.0 110.942 -175.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 59.6 t -131.02 137.36 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 71.9 mt -104.7 121.88 44.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.422 -0.799 . . . . 0.0 109.958 -171.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -106.38 151.8 24.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.709 -0.619 . . . . 0.0 110.616 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -136.61 142.93 43.31 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -111.26 130.02 55.79 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.54 -0.725 . . . . 0.0 110.426 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -96.85 3.85 51.98 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.682 -0.636 . . . . 0.0 112.052 -175.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.79 165.02 29.27 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.053 -1.03 . . . . 0.0 109.961 174.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -119.43 159.82 23.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.643 -0.661 . . . . 0.0 110.187 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 29.5 m -59.31 -32.39 70.01 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.356 -0.84 . . . . 0.0 110.912 -163.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 47.1 p -97.58 11.47 36.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.405 -0.809 . . . . 0.0 111.978 -164.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . 0.656 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 30.0 p -95.07 118.07 31.26 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.116 -0.99 . . . . 0.0 110.631 178.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.15 139.16 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.462 -0.774 . . . . 0.0 110.189 -172.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 100.87 -5.12 56.38 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -123.74 -113.98 2.1 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 170.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 26.6 ttt -64.16 -23.71 67.42 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.62 -0.93 . . . . 0.0 110.489 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 10.2 p30 44.52 54.46 6.39 Favored 'General case' 0 N--CA 1.504 2.273 0 CA-C-O 121.331 0.586 . . . . 0.0 112.58 172.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 22.8 mtp85 54.74 26.93 8.11 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.312 -0.867 . . . . 0.0 111.365 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 82.0 mtt-85 -115.02 114.6 43.62 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.388 -0.82 . . . . 0.0 109.956 173.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.45 145.39 98.09 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 O-C-N 122.969 0.984 . . . . 0.0 110.614 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 44.9 pt -131.92 174.72 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-O 121.758 0.79 . . . . 0.0 110.862 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 29.2 mt -124.44 149.88 46.28 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.43 HD12 ' CE1' ' A' ' 301' ' ' PHE . 81.3 mt -118.33 128.68 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.218 178.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 85.4 mt -109.72 127.38 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -174.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 61.8 t -119.0 126.79 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.6 p -125.26 154.07 42.23 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.664 -0.647 . . . . 0.0 110.624 -173.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.428 ' HB2' ' CE1' ' A' ' 138' ' ' PHE . 29.7 tp -105.19 126.16 51.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.697 -0.627 . . . . 0.0 109.503 169.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -130.96 149.62 52.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.916 -0.49 . . . . 0.0 109.681 -173.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 23.4 p -89.93 160.37 16.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.6 -0.688 . . . . 0.0 109.999 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -55.89 -26.15 45.94 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.568 -0.707 . . . . 0.0 111.082 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 45.4 p30 -90.14 9.52 27.99 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.467 -0.771 . . . . 0.0 111.931 -173.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.61 20.21 45.27 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 120.182 -1.008 . . . . 0.0 110.755 171.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -107.93 140.21 41.4 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.274 -1.133 . . . . 0.0 110.002 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 61.1 t -87.63 133.12 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.551 -0.718 . . . . 0.0 110.278 -172.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 96.1 mt -99.86 -40.19 7.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.697 -0.627 . . . . 0.0 110.522 178.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -167.54 154.97 25.57 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -133.86 136.9 44.68 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.616 -0.932 . . . . 0.0 110.791 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -135.01 155.84 50.07 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.661 -0.65 . . . . 0.0 109.874 172.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 98.1 m -142.52 153.18 43.38 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.399 -0.813 . . . . 0.0 110.781 -175.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.43 ' CE1' HD12 ' A' ' 284' ' ' ILE . 46.2 p90 -145.02 164.15 32.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.608 -0.683 . . . . 0.0 110.071 176.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -104.84 136.1 44.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.609 -0.682 . . . . 0.0 110.173 -177.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -124.48 143.84 50.42 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.715 -169.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 61.8 ttm-85 -138.13 141.88 40.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.712 -0.617 . . . . 0.0 109.744 173.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 77.2 mt -108.74 122.94 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.577 -0.702 . . . . 0.0 109.671 175.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.8 p -145.39 168.89 19.43 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.53 -0.731 . . . . 0.0 110.645 -172.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -71.28 -40.05 71.14 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.674 -0.642 . . . . 0.0 110.77 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.8 t -127.14 85.37 61.19 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.454 -0.779 . . . . 0.0 110.514 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -56.03 -27.79 66.15 Favored 'Trans proline' 0 N--CA 1.489 1.257 0 O-C-N 123.231 1.122 . . . . 0.0 110.674 174.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -68.14 -37.06 86.62 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.126 -1.589 . . . . 0.0 109.126 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -72.85 -39.92 66.14 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.647 -0.913 . . . . 0.0 109.749 -173.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -69.49 -40.51 77.0 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 120.067 -0.653 . . . . 0.0 109.934 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -62.06 -42.83 99.6 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.557 -0.715 . . . . 0.0 110.122 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -63.87 -40.27 96.15 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.599 -0.688 . . . . 0.0 110.563 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.19 -51.97 66.79 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.503 -0.748 . . . . 0.0 110.392 -174.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.6 p30 . . . . . 0 N--CA 1.494 1.77 0 O-C-N 121.458 -0.776 . . . . 0.0 110.029 -178.437 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.6 t . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.082 0.467 . . . . 0.0 110.342 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.9 p-10 -94.97 24.95 4.43 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.644 -0.66 . . . . 0.0 110.797 -178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 52.1 m -72.09 125.21 26.71 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.593 -0.692 . . . . 0.0 110.248 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -71.09 144.9 50.16 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.754 -0.591 . . . . 0.0 110.538 -177.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -152.18 101.02 2.81 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.732 -0.605 . . . . 0.0 110.134 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -59.07 -39.96 75.11 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.042 1.022 . . . . 0.0 110.792 -174.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.42 -155.12 46.75 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -76.36 -44.0 0.27 Allowed 'Trans proline' 0 C--N 1.317 -1.08 0 O-C-N 123.38 1.2 . . . . 0.0 110.991 -174.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -86.91 8.84 21.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.503 -0.748 . . . . 0.0 111.425 -173.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 t 53.62 60.54 3.62 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.956 -1.09 . . . . 0.0 110.772 -176.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -77.84 118.41 20.14 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.585 -0.697 . . . . 0.0 109.871 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -130.03 159.99 35.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.862 -0.523 . . . . 0.0 110.124 -178.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.8 t -125.98 146.07 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.797 -0.564 . . . . 0.0 109.726 177.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.8 p -155.31 161.12 41.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.772 -0.58 . . . . 0.0 110.03 177.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.415 ' CE2' HG12 ' A' ' 172' ' ' ILE . 71.5 m-85 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.769 -0.582 . . . . 0.0 109.772 -176.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 121.113 0.482 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.401 ' OG1' ' CD1' ' A' ' 153' ' ' TRP . 44.9 p -60.07 -34.12 73.01 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.7 -0.625 . . . . 0.0 110.243 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.416 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -170.87 144.35 2.2 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.435 0.636 . . . . 0.0 110.237 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.4 t -142.09 142.66 32.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.863 -0.523 . . . . 0.0 109.971 -176.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -125.44 140.12 53.06 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.499 -0.751 . . . . 0.0 110.553 -172.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.2 t -110.69 124.5 52.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.852 -0.53 . . . . 0.0 109.773 176.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 60.6 m -70.63 -36.99 73.73 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.808 -0.558 . . . . 0.0 110.417 -177.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -59.54 -33.59 71.59 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.587 -0.695 . . . . 0.0 110.43 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 57.0 mt -104.85 -12.06 16.45 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.711 -0.618 . . . . 0.0 110.826 -175.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 78.8 tttt 59.84 50.25 7.14 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.126 -0.984 . . . . 0.0 109.678 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -145.84 153.1 40.51 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.571 -174.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.5 tp -126.5 137.83 53.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.739 -0.601 . . . . 0.0 110.25 -176.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -115.81 134.51 54.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.668 -0.645 . . . . 0.0 109.33 175.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.47 158.57 44.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.646 -0.659 . . . . 0.0 110.808 -176.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -104.54 144.56 31.52 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.668 171.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 17.2 tt -51.46 147.43 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 CA-C-O 121.572 0.701 . . . . 0.0 112.107 -173.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 64.99 9.99 5.89 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.555 -0.715 . . . . 0.0 112.734 174.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -94.22 155.15 17.19 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.951 -1.093 . . . . 0.0 111.045 173.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 87.3 m -81.28 126.22 31.28 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.767 -0.583 . . . . 0.0 110.596 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 43.9 t -114.13 90.04 18.8 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.602 -0.686 . . . . 0.0 110.175 173.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.416 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 18.4 Cg_exo -63.38 128.83 23.55 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 O-C-N 123.281 1.148 . . . . 0.0 110.598 173.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.415 HG12 ' CE2' ' A' ' 142' ' ' PHE . 97.5 mt -123.34 143.43 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.597 -0.689 . . . . 0.0 109.36 175.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -110.47 134.82 51.99 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.453 -0.779 . . . . 0.0 110.857 -175.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.5 mm -95.26 135.03 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.644 -0.66 . . . . 0.0 109.7 169.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.9 tttt -115.21 128.29 56.06 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.466 175.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.9 m -136.64 159.71 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.69 -0.631 . . . . 0.0 109.832 174.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.7 mmm -75.22 -40.51 59.04 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.771 -0.581 . . . . 0.0 110.166 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 76.8 p -135.71 143.25 43.96 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.834 -0.541 . . . . 0.0 109.725 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -55.31 139.85 81.55 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 O-C-N 123.106 1.056 . . . . 0.0 110.921 -172.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.428 ' HG3' ' CE2' ' A' ' 251' ' ' TYR . 19.6 Cg_endo -63.05 167.85 11.67 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.226 1.119 . . . . 0.0 110.637 178.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -61.04 156.71 42.95 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 O-C-N 123.395 1.208 . . . . 0.0 110.509 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -74.5 139.01 43.55 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.672 -0.642 . . . . 0.0 109.858 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.69 -24.97 29.29 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 -175.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.2 150.36 2.49 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.317 -1.107 . . . . 0.0 111.323 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 33.6 m -129.79 155.92 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.765 -0.585 . . . . 0.0 109.664 176.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 83.3 mt -106.93 138.31 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.747 -0.595 . . . . 0.0 109.435 175.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 56.6 mtp85 -114.95 144.99 42.71 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -176.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -137.8 128.03 26.11 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.426 -0.796 . . . . 0.0 110.324 174.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 1.6 ttp -137.3 135.84 19.97 Favored Pre-proline 0 N--CA 1.495 1.816 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.957 -175.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -91.19 138.18 2.25 Favored 'Trans proline' 0 C--N 1.32 -0.951 0 O-C-N 123.196 1.103 . . . . 0.0 110.777 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 35.5 m -148.21 154.95 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.578 -0.702 . . . . 0.0 109.904 173.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.444 ' CE2' ' CG2' ' A' ' 202' ' ' VAL . 89.6 m-85 -60.91 163.24 5.98 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.379 -0.826 . . . . 0.0 110.385 -178.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 39.6 tttm -78.64 -60.02 2.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.622 -0.674 . . . . 0.0 110.71 -175.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -80.05 150.33 30.38 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.597 -0.69 . . . . 0.0 110.356 -175.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.42 -37.88 70.8 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.404 -0.81 . . . . 0.0 110.713 -175.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -56.37 -25.24 48.79 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.562 -0.711 . . . . 0.0 110.56 -175.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.441 ' CD2' ' NH1' ' A' ' 280' ' ' ARG . 62.9 m170 -109.94 -20.64 12.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.577 -0.702 . . . . 0.0 111.112 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.2 p -67.05 -20.2 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.244 -0.91 . . . . 0.0 110.62 -176.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 82.3 p -79.42 -16.96 55.3 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.55 -0.719 . . . . 0.0 110.705 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -88.3 138.52 31.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.359 -0.838 . . . . 0.0 110.058 173.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.9 t -72.87 139.85 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.606 -0.684 . . . . 0.0 110.428 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.444 ' CG2' ' CE2' ' A' ' 192' ' ' TYR . 63.9 t -84.93 138.92 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.561 -0.712 . . . . 0.0 109.421 170.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 10.6 pttt -134.9 -170.45 2.57 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.463 -0.773 . . . . 0.0 110.993 -171.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -95.47 156.82 16.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.77 -0.581 . . . . 0.0 110.321 174.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.542 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 60.7 m . . . . . 0 N--CA 1.498 1.935 0 O-C-N 121.554 -0.716 . . . . 0.0 109.07 171.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 58.6 tp . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 120.836 0.35 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 83.0 mt -102.85 136.76 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.85 -0.531 . . . . 0.0 109.642 177.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -136.95 162.96 31.84 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.746 -0.596 . . . . 0.0 110.341 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 94.5 t -109.09 146.79 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.826 -0.546 . . . . 0.0 110.129 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -120.81 121.54 38.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.809 -0.557 . . . . 0.0 110.348 174.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.98 24.09 10.88 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 169.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -137.23 106.74 6.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.413 -1.051 . . . . 0.0 109.988 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 46.0 m -63.16 -15.34 56.54 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.582 -0.699 . . . . 0.0 111.325 -176.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -99.94 5.59 45.25 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.275 -0.89 . . . . 0.0 111.608 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.94 131.4 49.58 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.039 -1.038 . . . . 0.0 110.16 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -139.72 158.07 44.71 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.797 -0.565 . . . . 0.0 109.811 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -112.35 150.64 30.78 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.618 -0.677 . . . . 0.0 110.361 -178.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.26 159.91 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.737 -0.602 . . . . 0.0 110.174 176.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -122.62 129.96 52.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.787 -0.57 . . . . 0.0 110.094 175.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -64.96 130.07 94.72 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.654 -0.654 . . . . 0.0 109.87 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -66.42 -27.92 46.67 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 O-C-N 123.193 1.102 . . . . 0.0 111.049 -170.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.0 mt -100.51 -50.46 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.423 -0.798 . . . . 0.0 110.879 -168.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.1 p -105.32 12.06 32.14 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.396 -0.815 . . . . 0.0 111.875 -175.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.9 -6.23 10.29 Favored Glycine 0 N--CA 1.496 2.69 0 O-C-N 121.034 -1.041 . . . . 0.0 111.941 172.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -46.12 142.03 3.0 Favored 'General case' 0 N--CA 1.506 2.327 0 CA-C-N 119.081 1.441 . . . . 0.0 112.258 -173.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -104.7 141.57 36.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.559 -0.713 . . . . 0.0 110.218 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 72.4 p -154.76 159.93 40.97 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.61 -0.682 . . . . 0.0 110.476 176.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 8.2 p -125.31 148.21 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.788 -0.57 . . . . 0.0 109.643 177.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 71.4 mt -129.5 154.7 46.75 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.633 -174.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 35.8 m -150.86 151.7 30.52 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.769 -0.582 . . . . 0.0 110.042 176.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -71.09 137.99 32.7 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 O-C-N 123.298 1.157 . . . . 0.0 109.994 177.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.428 ' CE2' ' HG3' ' A' ' 180' ' ' PRO . 10.5 t80 -76.54 126.02 30.25 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.573 -0.704 . . . . 0.0 110.221 176.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -100.01 160.07 28.16 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.771 -0.581 . . . . 0.0 109.979 176.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.88 159.11 22.25 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.199 1.105 . . . . 0.0 110.419 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.01 150.04 75.59 Favored 'Trans proline' 0 N--CA 1.488 1.187 0 O-C-N 123.26 1.137 . . . . 0.0 110.525 -177.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -61.16 147.46 44.05 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.669 -0.645 . . . . 0.0 110.139 -178.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.7 t -69.9 127.14 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.485 -0.759 . . . . 0.0 110.168 -170.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.53 -10.11 56.05 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.402 ' OG1' ' CD2' ' A' ' 260' ' ' PHE . 9.8 t -144.36 174.34 11.0 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.147 -1.208 . . . . 0.0 110.6 176.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -109.21 13.09 24.59 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.527 -0.733 . . . . 0.0 111.918 -166.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . 0.402 ' CD2' ' OG1' ' A' ' 258' ' ' THR . 47.1 p90 -120.95 168.06 11.89 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.081 -1.012 . . . . 0.0 111.193 -176.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 76.2 m -117.68 144.3 45.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.797 -0.564 . . . . 0.0 109.865 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 35.7 m -115.71 135.59 53.89 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.612 -0.68 . . . . 0.0 110.867 -175.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 62.9 t -131.18 137.28 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 174.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 72.4 mt -104.63 120.34 41.08 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.42 -0.8 . . . . 0.0 109.908 -171.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -105.03 155.39 19.02 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.741 -0.599 . . . . 0.0 110.825 -176.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -136.32 142.9 43.89 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -114.89 128.97 56.6 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.616 -0.677 . . . . 0.0 110.266 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -98.57 9.27 43.61 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.712 -0.617 . . . . 0.0 111.982 -175.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -144.58 161.32 39.43 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.178 -0.951 . . . . 0.0 110.112 173.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -119.91 164.06 16.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.786 -0.571 . . . . 0.0 110.286 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 27.6 m -57.6 -33.93 68.73 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.449 -0.782 . . . . 0.0 110.983 -164.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 67.6 m -105.21 14.95 28.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.497 -0.752 . . . . 0.0 112.042 -164.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . 0.542 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 30.1 p -95.17 118.06 31.31 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.103 -0.998 . . . . 0.0 110.677 178.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 51.9 t -63.19 138.86 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.482 -0.761 . . . . 0.0 110.203 -171.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.76 -5.13 59.78 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 178.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.12 -99.3 0.86 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 172.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 93.4 mmm -63.29 -32.59 74.04 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.796 -0.826 . . . . 0.0 110.328 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.4 p30 44.05 48.75 7.45 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 175.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 54.95 29.97 13.17 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.392 -0.818 . . . . 0.0 111.146 175.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' ARG . . . . . 0.441 ' NH1' ' CD2' ' A' ' 197' ' ' HIS . 74.0 mtt180 -119.96 105.0 43.36 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.475 -0.766 . . . . 0.0 110.208 175.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -60.53 145.78 98.15 Favored 'Trans proline' 0 N--CA 1.487 1.115 0 O-C-N 123.094 1.049 . . . . 0.0 110.402 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 46.2 pt -131.95 177.63 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.856 0.836 . . . . 0.0 111.249 -175.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 24.8 mt -124.5 149.91 46.36 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.426 HD11 ' CE1' ' A' ' 301' ' ' PHE . 81.2 mt -117.83 130.33 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.318 179.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 80.8 mt -109.79 127.38 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 57.5 t -118.94 126.83 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.4 p -125.33 153.1 43.83 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.745 . . . . 0.0 110.632 -173.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 21.7 tp -104.5 124.39 49.19 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.726 -0.609 . . . . 0.0 109.468 169.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -132.16 151.72 51.64 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.87 -0.519 . . . . 0.0 109.806 -173.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 77.8 p -89.88 159.58 16.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.558 -0.714 . . . . 0.0 109.768 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -55.94 -26.11 46.43 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.564 -0.71 . . . . 0.0 110.789 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -88.34 9.76 22.19 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.552 -0.717 . . . . 0.0 111.808 -174.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 87.25 20.22 53.07 Favored Glycine 0 N--CA 1.495 2.583 0 O-C-N 121.083 -1.011 . . . . 0.0 110.687 170.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -106.21 140.15 39.61 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.218 -1.166 . . . . 0.0 110.231 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 59.1 t -89.59 130.97 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.592 -0.692 . . . . 0.0 110.29 -173.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 95.6 mt -100.11 -40.08 7.77 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.781 -0.574 . . . . 0.0 110.528 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -166.25 154.67 25.38 Favored Glycine 0 N--CA 1.497 2.719 0 C-N-CA 119.898 -1.144 . . . . 0.0 110.391 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -135.09 137.46 42.87 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.692 -0.887 . . . . 0.0 110.667 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -137.67 157.82 45.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.684 -0.635 . . . . 0.0 109.963 170.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 78.7 m -141.33 156.81 45.8 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.43 -0.794 . . . . 0.0 110.684 -175.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.426 ' CE1' HD11 ' A' ' 284' ' ' ILE . 47.8 p90 -144.91 162.14 37.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.681 -0.637 . . . . 0.0 110.164 175.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -104.94 134.5 47.95 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.501 -0.749 . . . . 0.0 110.051 -177.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -118.78 143.99 46.57 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.728 -169.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 55.7 ttt85 -138.3 136.79 36.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.766 -0.584 . . . . 0.0 109.792 172.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 78.9 mt -108.27 123.0 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.608 -0.682 . . . . 0.0 109.542 177.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.4 p -145.07 172.82 12.53 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.571 -0.706 . . . . 0.0 110.769 -171.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -72.21 -40.09 68.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.676 -0.64 . . . . 0.0 110.566 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.8 t -131.26 89.08 42.45 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.627 -0.671 . . . . 0.0 110.53 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.3 -29.57 58.2 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 O-C-N 123.162 1.085 . . . . 0.0 110.996 173.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -65.95 -37.81 93.57 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -72.5 -41.04 66.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.758 -0.848 . . . . 0.0 109.829 -173.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -69.45 -39.61 77.68 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 120.056 -0.657 . . . . 0.0 110.076 -178.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -61.6 -43.23 99.25 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.284 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -64.27 -40.12 95.32 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.613 -0.679 . . . . 0.0 110.503 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.64 -50.95 70.49 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.502 -0.749 . . . . 0.0 110.512 -173.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.4 p30 . . . . . 0 N--CA 1.495 1.792 0 O-C-N 121.507 -0.746 . . . . 0.0 110.142 -177.944 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 30.4 t . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 121.043 0.449 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 p-10 -96.31 26.06 4.56 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.636 -0.665 . . . . 0.0 110.598 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 47.6 m -73.94 125.13 27.52 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.575 -0.703 . . . . 0.0 110.395 -178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -73.36 144.98 46.25 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.689 -0.632 . . . . 0.0 110.462 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.407 ' CE2' ' HA2' ' A' ' 134' ' ' GLY . 62.8 t80 -157.01 101.78 1.94 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.7 -0.625 . . . . 0.0 110.137 178.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -58.64 -39.9 78.42 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 O-C-N 123.094 1.049 . . . . 0.0 110.948 -175.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.407 ' HA2' ' CE2' ' A' ' 132' ' ' TYR . . . 78.76 -155.12 40.66 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 178.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -73.14 -49.1 0.24 Allowed 'Trans proline' 0 C--N 1.317 -1.116 0 O-C-N 123.337 1.177 . . . . 0.0 110.874 -174.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -85.18 6.67 24.88 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.626 -0.672 . . . . 0.0 111.432 -174.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 t 54.17 62.09 2.75 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.964 -1.085 . . . . 0.0 110.675 -176.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.433 ' CE2' ' CG2' ' A' ' 174' ' ' ILE . 59.3 t80 -77.87 120.86 23.34 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.655 -0.653 . . . . 0.0 109.993 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -130.06 159.95 35.19 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.309 0.576 . . . . 0.0 110.134 -177.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 64.8 t -124.97 145.23 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.76 -0.588 . . . . 0.0 109.897 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 80.0 p -155.41 160.94 41.05 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.345 0.593 . . . . 0.0 109.937 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.49 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 59.8 m-85 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.728 -0.608 . . . . 0.0 109.848 -176.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.871 0 CA-C-O 121.193 0.521 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 82.1 p -60.06 -33.99 72.81 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.689 -0.632 . . . . 0.0 109.933 176.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.416 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.8 p-90 -170.74 143.5 2.14 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.366 0.603 . . . . 0.0 110.238 177.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.6 t -142.11 142.58 32.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.9 -0.5 . . . . 0.0 109.978 -176.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.49 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 60.9 t80 -125.58 140.01 53.11 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.496 -0.753 . . . . 0.0 110.771 -172.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 31.5 t -112.2 125.02 53.69 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.007 177.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 54.1 m -70.81 -37.12 73.22 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.724 -0.61 . . . . 0.0 110.534 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -59.25 -34.55 72.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.618 -0.676 . . . . 0.0 110.502 -177.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.1 mt -104.84 -12.0 16.49 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.933 -175.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 49.7 tttt 59.83 51.37 6.14 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.991 -1.068 . . . . 0.0 109.637 178.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -145.15 153.13 41.05 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.571 -173.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.9 tp -126.54 137.71 53.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.788 -0.57 . . . . 0.0 110.208 -176.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -115.59 134.42 55.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.64 -0.662 . . . . 0.0 109.292 173.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.43 158.62 43.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.736 -0.602 . . . . 0.0 110.85 -177.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -104.42 143.08 33.49 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.553 -0.717 . . . . 0.0 109.795 171.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 17.3 tt -52.44 148.45 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.538 -0.727 . . . . 0.0 111.851 -173.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 66.38 9.13 6.2 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.624 -0.672 . . . . 0.0 112.596 175.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -94.41 155.13 17.11 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.933 -1.105 . . . . 0.0 110.983 172.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 88.5 m -84.07 126.21 32.85 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.719 -0.613 . . . . 0.0 110.433 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 48.5 t -113.09 90.19 15.58 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.658 -0.652 . . . . 0.0 110.075 174.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.416 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 22.5 Cg_exo -61.33 130.52 32.4 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.276 1.145 . . . . 0.0 110.704 173.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.42 HG12 ' CE2' ' A' ' 142' ' ' PHE . 94.5 mt -124.61 141.91 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.639 -0.663 . . . . 0.0 109.28 175.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . 0.436 ' NE2' ' CE1' ' A' ' 260' ' ' PHE . 98.4 mt-30 -108.9 136.45 48.43 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.524 -0.735 . . . . 0.0 110.826 -175.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.433 ' CG2' ' CE2' ' A' ' 138' ' ' PHE . 48.5 mm -95.24 135.06 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.694 -0.629 . . . . 0.0 109.64 169.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -117.65 129.37 55.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.606 -0.684 . . . . 0.0 110.405 176.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 17.1 m -136.67 159.75 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.538 -0.726 . . . . 0.0 110.057 175.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 80.7 mmm -77.46 -40.3 43.64 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.703 -0.623 . . . . 0.0 110.122 177.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 75.6 p -135.48 143.24 44.37 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.744 -0.597 . . . . 0.0 109.693 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -55.49 139.89 82.56 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 O-C-N 123.114 1.06 . . . . 0.0 110.911 -172.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.43 ' HG2' ' CD1' ' A' ' 251' ' ' TYR . 32.1 Cg_endo -67.67 169.98 14.84 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 O-C-N 123.211 1.111 . . . . 0.0 110.565 177.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -60.49 155.32 47.98 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.35 1.184 . . . . 0.0 110.551 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -77.8 140.61 39.43 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.591 -0.693 . . . . 0.0 109.925 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.65 -24.93 29.47 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -174.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.16 152.78 1.61 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.337 -1.096 . . . . 0.0 111.404 178.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.8 155.89 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.713 -0.617 . . . . 0.0 109.765 176.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 81.1 mt -108.89 138.17 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.645 -0.659 . . . . 0.0 109.49 176.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -115.08 146.05 41.7 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -175.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -139.03 128.48 24.34 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.535 -0.728 . . . . 0.0 110.226 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 26.3 ttp -137.27 136.37 20.64 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.788 -0.57 . . . . 0.0 110.905 -176.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -91.86 138.08 1.96 Allowed 'Trans proline' 0 C--N 1.32 -0.953 0 O-C-N 123.164 1.086 . . . . 0.0 110.643 177.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 35.2 m -148.42 154.95 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.528 -0.733 . . . . 0.0 109.907 174.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.447 ' CE2' ' CG2' ' A' ' 202' ' ' VAL . 91.3 m-85 -60.6 163.92 5.01 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.447 -0.783 . . . . 0.0 110.413 -178.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -79.93 -59.99 2.51 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.661 -0.65 . . . . 0.0 110.785 -174.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 35.0 mttm -80.03 150.68 30.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.628 -0.67 . . . . 0.0 110.395 -175.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.43 -38.3 71.39 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.435 -0.791 . . . . 0.0 110.718 -175.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -56.49 -25.04 49.96 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.518 -0.739 . . . . 0.0 110.594 -175.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -110.01 -20.56 12.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.58 -0.7 . . . . 0.0 111.088 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.1 p -67.02 -20.27 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.137 -0.977 . . . . 0.0 110.592 -176.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 81.6 p -79.34 -17.06 55.29 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.545 -0.722 . . . . 0.0 110.753 175.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -88.39 138.79 31.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.38 -0.825 . . . . 0.0 110.041 173.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 57.6 t -73.24 142.73 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.585 -0.697 . . . . 0.0 110.156 176.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.447 ' CG2' ' CE2' ' A' ' 192' ' ' TYR . 77.8 t -84.9 140.15 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.552 -0.718 . . . . 0.0 109.443 171.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.2 pttp -134.84 -170.27 2.53 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.539 -0.726 . . . . 0.0 110.873 -169.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -95.28 156.38 16.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.735 -0.603 . . . . 0.0 110.52 178.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.624 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 60.1 m . . . . . 0 N--CA 1.497 1.887 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 172.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 40.7 tp . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 120.887 0.375 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 91.3 mt -107.67 136.77 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 121.159 0.504 . . . . 0.0 110.111 -176.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 71.9 mtm-85 -140.53 167.92 21.02 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.638 -0.664 . . . . 0.0 110.1 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 82.9 t -105.28 146.73 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.37 0.605 . . . . 0.0 110.211 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -116.39 130.0 56.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.729 -0.607 . . . . 0.0 110.356 169.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.36 25.26 16.65 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 167.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -140.9 107.45 5.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.443 -1.034 . . . . 0.0 110.061 175.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 27.2 t -62.89 -15.26 54.4 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.588 -0.695 . . . . 0.0 111.329 -177.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 63.1 m170 -99.77 6.38 45.47 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.21 -0.931 . . . . 0.0 111.612 -177.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.32 128.51 36.71 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.081 -1.012 . . . . 0.0 110.241 176.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -139.75 158.05 44.74 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.785 -0.572 . . . . 0.0 109.681 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -116.86 150.6 38.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.574 -0.704 . . . . 0.0 110.686 -176.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.14 159.94 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.81 -0.556 . . . . 0.0 110.167 177.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -120.59 130.0 54.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.775 -0.578 . . . . 0.0 110.193 176.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -65.09 130.1 94.71 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.706 -0.621 . . . . 0.0 109.878 177.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -66.37 -27.62 47.35 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 O-C-N 123.128 1.068 . . . . 0.0 111.038 -171.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 82.9 mt -100.43 -50.41 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.292 -0.88 . . . . 0.0 111.013 -167.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.7 p -105.38 12.14 31.93 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.326 -0.859 . . . . 0.0 111.828 -175.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.86 -5.63 11.93 Favored Glycine 0 N--CA 1.496 2.678 0 O-C-N 121.131 -0.981 . . . . 0.0 111.832 174.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 22.9 mmt85 -46.09 142.0 2.99 Favored 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 119.194 1.497 . . . . 0.0 112.23 -173.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -105.59 145.43 30.99 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.607 -0.683 . . . . 0.0 110.091 175.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.0 p -154.74 159.92 40.99 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.623 -0.673 . . . . 0.0 110.534 176.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 8.2 p -123.82 148.1 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.731 -0.606 . . . . 0.0 109.695 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 81.7 mt -129.76 154.57 47.07 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.867 -176.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 35.7 m -150.69 151.67 30.89 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.813 -0.554 . . . . 0.0 109.986 174.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -71.1 140.03 36.85 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 O-C-N 123.329 1.173 . . . . 0.0 110.085 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.43 ' CD1' ' HG2' ' A' ' 180' ' ' PRO . 58.7 t80 -76.6 126.1 30.39 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.505 -0.747 . . . . 0.0 110.194 174.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -100.08 160.09 28.09 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.687 -0.633 . . . . 0.0 109.887 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.88 159.84 20.01 Favored 'Trans proline' 0 N--CA 1.488 1.188 0 O-C-N 123.204 1.107 . . . . 0.0 110.403 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.07 150.03 75.97 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 O-C-N 123.274 1.144 . . . . 0.0 110.501 -177.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -61.6 146.76 47.88 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.674 -0.641 . . . . 0.0 110.123 -178.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.84 127.2 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.517 -0.739 . . . . 0.0 110.145 -170.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.02 -10.2 55.32 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.4 ' OG1' ' CD2' ' A' ' 260' ' ' PHE . 9.8 t -144.23 174.39 10.93 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.105 -1.233 . . . . 0.0 110.641 176.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -108.84 13.13 25.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.595 -0.691 . . . . 0.0 111.948 -167.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . 0.436 ' CE1' ' NE2' ' A' ' 173' ' ' GLN . 46.6 p90 -121.76 168.11 12.2 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.155 -0.965 . . . . 0.0 111.122 -176.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 85.5 m -117.77 145.86 44.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.778 -0.576 . . . . 0.0 109.87 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 55.3 m -116.02 135.58 53.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.633 -0.667 . . . . 0.0 110.903 -174.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.9 t -131.77 137.27 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 173.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 77.2 mt -104.69 121.6 43.91 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.477 -0.764 . . . . 0.0 110.005 -170.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -107.94 149.24 28.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.705 -0.622 . . . . 0.0 110.556 -176.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -136.55 143.01 43.45 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.674 -0.642 . . . . 0.0 109.545 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -120.2 136.99 54.45 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.638 -0.664 . . . . 0.0 110.452 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.43 12.53 31.41 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 120.179 -0.608 . . . . 0.0 112.195 -176.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -144.6 159.16 43.26 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.075 -1.016 . . . . 0.0 109.838 176.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -120.31 163.42 17.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.651 -0.656 . . . . 0.0 110.401 -177.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 43.4 m -57.11 -34.18 68.1 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.46 -0.775 . . . . 0.0 111.1 -165.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 65.5 m -104.6 15.02 28.84 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.411 -0.806 . . . . 0.0 111.967 -164.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . 0.624 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 30.3 p -93.61 118.03 30.85 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.088 -1.007 . . . . 0.0 110.581 178.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.2 t -63.58 139.45 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.442 -0.786 . . . . 0.0 110.419 -169.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.47 -5.09 60.35 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.97 -99.33 0.87 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 173.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 93.5 mmm -61.42 -31.87 71.81 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.614 -0.933 . . . . 0.0 110.109 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 23.6 p30 42.25 47.02 4.02 Favored 'General case' 0 N--CA 1.507 2.38 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 174.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 22.9 mtt180 54.87 31.58 16.04 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.274 -0.891 . . . . 0.0 111.207 176.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 -120.1 104.94 43.11 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.458 -0.776 . . . . 0.0 110.056 173.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -59.99 148.24 89.75 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 O-C-N 123.094 1.049 . . . . 0.0 110.468 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 46.7 pt -131.86 176.74 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.806 0.812 . . . . 0.0 111.118 -175.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 27.5 mt -124.37 149.83 46.23 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.425 HD12 ' CE1' ' A' ' 301' ' ' PHE . 81.4 mt -116.89 130.76 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.21 178.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 79.4 mt -109.8 126.37 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 58.7 t -118.92 126.75 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 46.1 p -125.21 153.54 42.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.554 -0.716 . . . . 0.0 110.721 -173.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.422 ' HB2' ' CE2' ' A' ' 138' ' ' PHE . 26.3 tp -104.08 126.42 51.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.785 -0.572 . . . . 0.0 109.5 169.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -130.44 150.25 51.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.91 -0.494 . . . . 0.0 109.861 -173.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.402 ' CG2' ' CD1' ' A' ' 296' ' ' LEU . 22.8 p -89.87 161.73 15.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.687 -0.633 . . . . 0.0 109.928 177.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -55.89 -26.15 45.96 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.641 -0.662 . . . . 0.0 111.042 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 45.6 p30 -89.87 9.19 28.53 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.408 -0.807 . . . . 0.0 112.004 -173.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.61 20.19 45.36 Favored Glycine 0 N--CA 1.494 2.522 0 O-C-N 121.09 -1.006 . . . . 0.0 110.725 171.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -107.03 140.21 40.2 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.295 -1.121 . . . . 0.0 110.163 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 72.1 t -85.24 132.79 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.588 -0.695 . . . . 0.0 110.228 -174.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.402 ' CD1' ' CG2' ' A' ' 290' ' ' THR . 95.2 mt -100.01 -40.15 7.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.621 -0.674 . . . . 0.0 110.399 176.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -163.64 153.44 23.88 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -133.87 136.19 44.18 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.609 -0.936 . . . . 0.0 110.648 -178.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -134.73 157.81 45.75 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.611 -0.681 . . . . 0.0 110.026 172.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 95.3 m -143.02 153.25 42.78 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.474 -0.766 . . . . 0.0 110.629 -176.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.425 ' CE1' HD12 ' A' ' 284' ' ' ILE . 47.8 p90 -145.01 162.38 37.06 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.631 -0.668 . . . . 0.0 110.174 176.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -104.86 135.11 46.82 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.543 -0.723 . . . . 0.0 110.238 -176.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -120.09 143.61 48.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.62 -0.675 . . . . 0.0 110.737 -170.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -138.28 138.29 38.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.786 -0.571 . . . . 0.0 109.74 173.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 73.9 mt -109.01 122.96 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.541 -0.724 . . . . 0.0 109.667 176.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.3 p -145.17 171.56 14.35 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.625 -0.672 . . . . 0.0 110.657 -172.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -70.89 -40.11 72.4 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.658 -0.651 . . . . 0.0 110.494 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.8 t -130.44 89.11 45.23 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.524 -0.735 . . . . 0.0 110.467 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.25 -29.27 56.34 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 O-C-N 123.146 1.077 . . . . 0.0 111.025 173.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -65.63 -37.81 93.96 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 177.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 37.6 ttp180 -72.82 -42.1 64.18 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.714 -0.874 . . . . 0.0 109.938 -173.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -69.53 -40.47 76.89 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.172 -178.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 73.2 ttt-85 -60.23 -43.38 96.1 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.449 -0.782 . . . . 0.0 110.351 178.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -64.42 -41.02 96.84 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.585 -0.697 . . . . 0.0 110.522 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -60.94 -50.14 74.62 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.506 -0.746 . . . . 0.0 110.462 -173.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.2 p30 . . . . . 0 N--CA 1.494 1.772 0 O-C-N 121.433 -0.792 . . . . 0.0 110.06 -178.703 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.6 t . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.133 0.492 . . . . 0.0 110.313 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -93.85 22.92 5.19 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.614 -0.679 . . . . 0.0 110.893 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 48.2 m -71.67 125.14 26.34 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.542 -0.724 . . . . 0.0 110.226 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -70.74 144.9 50.78 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.715 -0.615 . . . . 0.0 110.461 -177.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.416 ' CE1' ' HA2' ' A' ' 134' ' ' GLY . 64.9 t80 -154.93 101.37 2.32 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.72 -0.613 . . . . 0.0 110.061 178.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -58.79 -39.88 77.67 Favored 'Trans proline' 0 N--CA 1.488 1.153 0 O-C-N 123.115 1.061 . . . . 0.0 110.799 -174.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.416 ' HA2' ' CE1' ' A' ' 132' ' ' TYR . . . 81.64 -155.2 35.22 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 177.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -74.27 -48.89 0.2 Allowed 'Trans proline' 0 C--N 1.316 -1.156 0 O-C-N 123.385 1.203 . . . . 0.0 110.873 -174.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -86.98 9.03 20.76 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.635 -0.665 . . . . 0.0 111.403 -173.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.57 62.11 2.79 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.99 -1.069 . . . . 0.0 110.686 -177.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.444 ' CE1' ' CG2' ' A' ' 174' ' ' ILE . 65.2 t80 -79.27 119.3 22.15 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.559 -0.713 . . . . 0.0 110.048 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -130.05 159.94 35.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.785 -0.572 . . . . 0.0 110.37 -175.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 59.4 t -125.11 146.54 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.698 -0.626 . . . . 0.0 109.819 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.6 p -155.18 161.55 41.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.736 -0.602 . . . . 0.0 110.024 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.422 ' CE2' HG12 ' A' ' 172' ' ' ILE . 41.2 m-85 . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.789 -0.57 . . . . 0.0 109.923 -176.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.111 0.481 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 44.1 p -60.12 -34.09 73.03 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.682 -0.636 . . . . 0.0 110.229 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.429 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.0 p-90 -171.26 144.29 2.0 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.62 -0.675 . . . . 0.0 110.117 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.4 t -142.13 142.7 32.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.882 -0.511 . . . . 0.0 109.992 -176.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.403 ' CG ' ' HB2' ' A' ' 142' ' ' PHE . 63.2 t80 -125.41 140.06 53.12 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.54 -0.725 . . . . 0.0 110.423 -173.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.8 t -110.56 123.96 50.94 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 120.379 -0.529 . . . . 0.0 109.811 176.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 56.1 m -70.71 -37.1 73.53 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.872 -0.518 . . . . 0.0 110.376 -177.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -59.75 -33.28 71.46 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.58 -0.7 . . . . 0.0 110.478 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 57.7 mt -104.81 -11.96 16.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.666 -0.646 . . . . 0.0 110.81 -175.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 79.9 tttt 59.79 49.65 7.81 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.978 -1.076 . . . . 0.0 109.704 177.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -146.58 153.03 39.88 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.8 -174.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.6 tp -126.58 137.84 53.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.841 -0.537 . . . . 0.0 110.413 -175.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -117.66 134.27 55.07 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.645 -0.659 . . . . 0.0 109.487 175.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.35 158.4 44.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.671 -0.643 . . . . 0.0 111.173 -174.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -104.63 141.3 36.67 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.585 -0.697 . . . . 0.0 110.525 172.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 18.8 tt -55.39 149.9 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.594 -0.691 . . . . 0.0 111.444 -175.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 64.79 10.08 5.78 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.559 -0.713 . . . . 0.0 112.481 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -96.18 155.07 16.91 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.959 -1.088 . . . . 0.0 110.611 172.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 77.4 m -81.16 126.07 31.03 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.631 -0.668 . . . . 0.0 110.325 177.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 43.5 t -115.13 89.64 21.04 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.652 -0.655 . . . . 0.0 110.273 175.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.429 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 15.5 Cg_exo -65.8 124.94 13.42 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 O-C-N 123.281 1.148 . . . . 0.0 110.675 173.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.422 HG12 ' CE2' ' A' ' 142' ' ' PHE . 97.3 mt -119.87 140.83 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.634 -0.667 . . . . 0.0 109.246 172.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -106.79 135.46 48.29 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.454 -0.779 . . . . 0.0 110.74 -174.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.444 ' CG2' ' CE1' ' A' ' 138' ' ' PHE . 49.6 mm -95.27 134.97 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.708 -0.62 . . . . 0.0 109.687 170.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -117.48 130.69 56.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.557 -0.714 . . . . 0.0 110.44 176.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.6 m -136.67 159.75 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.573 -0.704 . . . . 0.0 109.99 175.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 80.6 mmm -78.75 -40.56 33.03 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.67 -0.644 . . . . 0.0 110.068 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 76.8 p -135.02 143.24 45.22 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.735 -0.603 . . . . 0.0 109.722 177.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -55.84 139.89 84.57 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 O-C-N 123.161 1.085 . . . . 0.0 110.855 -172.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.426 ' HG2' ' CD1' ' A' ' 251' ' ' TYR . 32.5 Cg_endo -67.47 170.03 14.44 Favored 'Trans proline' 0 N--CA 1.487 1.113 0 O-C-N 123.131 1.069 . . . . 0.0 110.619 177.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -60.75 157.39 37.92 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 O-C-N 123.293 1.154 . . . . 0.0 110.53 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -79.8 140.87 36.7 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.574 -0.704 . . . . 0.0 109.949 175.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.7 -24.91 29.57 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -174.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.14 153.78 1.34 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.378 -1.072 . . . . 0.0 111.398 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.8 155.95 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.751 -0.593 . . . . 0.0 109.779 176.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 52.4 mt -108.06 135.59 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 -114.78 143.88 44.38 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -176.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -139.47 123.75 18.04 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.598 -0.689 . . . . 0.0 110.408 177.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 26.8 ttm -137.36 138.05 23.96 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.797 -0.564 . . . . 0.0 111.073 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -91.13 138.17 2.27 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 O-C-N 123.187 1.098 . . . . 0.0 110.643 176.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.8 m -146.79 154.85 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.471 -0.768 . . . . 0.0 110.212 173.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.425 ' CE2' HG21 ' A' ' 202' ' ' VAL . 87.1 m-85 -58.49 167.55 1.4 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.511 -0.743 . . . . 0.0 110.679 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -84.94 -60.08 2.15 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.639 -0.663 . . . . 0.0 110.863 -174.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -80.08 152.11 29.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.544 -0.722 . . . . 0.0 110.286 -175.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.67 -38.06 71.68 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.332 -0.855 . . . . 0.0 110.713 -176.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.4 mp0 -56.5 -24.81 48.8 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.483 -0.76 . . . . 0.0 110.616 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.415 ' HB3' ' CD1' ' A' ' 192' ' ' TYR . 99.5 m-70 -109.53 -20.51 12.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.586 -0.696 . . . . 0.0 111.14 -178.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.2 p -68.05 -20.24 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.119 -0.988 . . . . 0.0 110.628 -176.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 78.8 p -79.45 -17.08 55.02 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.577 -0.702 . . . . 0.0 110.649 175.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -88.35 136.34 33.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.386 -0.821 . . . . 0.0 110.017 173.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 60.5 t -73.07 143.76 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.584 -0.698 . . . . 0.0 110.13 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.425 HG21 ' CE2' ' A' ' 192' ' ' TYR . 84.0 t -84.82 139.13 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.538 -0.726 . . . . 0.0 109.217 171.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -134.76 -170.04 2.48 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.508 -0.745 . . . . 0.0 111.157 -165.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -95.2 152.99 17.88 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.795 -0.565 . . . . 0.0 110.206 -176.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 56.5 m . . . . . 0 N--CA 1.497 1.897 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 172.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 57.5 tp . . . . . 0 N--CA 1.497 1.901 0 CA-C-O 120.922 0.392 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 83.9 mt -106.31 136.65 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.905 -0.497 . . . . 0.0 109.707 176.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 40.6 mtm105 -133.52 157.78 44.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.693 -0.629 . . . . 0.0 110.129 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 79.2 t -102.41 146.58 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.649 -0.657 . . . . 0.0 110.098 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -120.76 130.01 53.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.857 -0.527 . . . . 0.0 110.332 171.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.39 20.69 19.29 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 169.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -140.99 107.06 5.18 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.276 -1.132 . . . . 0.0 110.08 174.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 42.8 m -63.3 -15.26 56.7 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.56 -0.712 . . . . 0.0 111.269 -175.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -100.05 8.1 44.21 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.219 -0.925 . . . . 0.0 111.59 -177.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.2 129.4 41.09 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.104 -0.998 . . . . 0.0 110.345 177.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -139.79 158.1 44.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.826 -0.546 . . . . 0.0 109.709 177.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -112.16 150.57 30.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.522 -0.736 . . . . 0.0 110.539 -177.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.21 159.9 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.804 -0.56 . . . . 0.0 110.155 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -122.53 130.04 52.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.68 -0.638 . . . . 0.0 110.194 176.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -65.08 130.12 94.72 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.625 -0.672 . . . . 0.0 109.823 178.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -66.48 -27.79 46.34 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 O-C-N 123.155 1.082 . . . . 0.0 111.006 -171.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 82.8 mt -100.55 -50.39 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.471 -0.768 . . . . 0.0 110.99 -167.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.1 p -105.47 12.11 31.82 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.41 -0.806 . . . . 0.0 111.877 -174.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.82 -5.11 13.24 Favored Glycine 0 N--CA 1.496 2.638 0 O-C-N 121.128 -0.982 . . . . 0.0 111.9 173.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -46.11 142.02 3.0 Favored 'General case' 0 N--CA 1.504 2.234 0 CA-C-N 119.104 1.452 . . . . 0.0 112.3 -174.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.6 mp0 -106.09 141.62 37.15 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.577 -0.702 . . . . 0.0 110.156 176.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 80.0 p -154.84 159.96 40.9 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.585 -0.697 . . . . 0.0 110.45 177.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 8.4 p -123.72 148.22 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.735 -0.603 . . . . 0.0 109.793 178.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 82.9 mt -129.57 154.63 46.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.644 -0.66 . . . . 0.0 110.094 -175.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 35.9 m -151.51 151.83 29.53 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.781 -0.574 . . . . 0.0 109.934 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -71.14 139.33 35.3 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 O-C-N 123.254 1.133 . . . . 0.0 109.993 176.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.426 ' CD1' ' HG2' ' A' ' 180' ' ' PRO . 60.6 t80 -75.06 124.48 27.07 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.42 -0.8 . . . . 0.0 110.21 176.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -100.04 160.12 28.03 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.665 -0.647 . . . . 0.0 110.072 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -59.53 159.95 22.05 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 O-C-N 123.241 1.127 . . . . 0.0 110.448 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -59.45 149.92 78.63 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 O-C-N 123.243 1.128 . . . . 0.0 110.426 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -60.91 147.63 42.44 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.612 -0.68 . . . . 0.0 110.19 -178.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.9 t -69.87 127.24 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.557 -0.715 . . . . 0.0 110.212 -170.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.97 -10.05 55.35 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.407 ' OG1' ' CD2' ' A' ' 260' ' ' PHE . 10.1 t -144.42 173.81 11.46 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.078 -1.248 . . . . 0.0 110.664 175.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -107.05 13.21 27.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.662 -0.649 . . . . 0.0 111.764 -168.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . 0.407 ' CD2' ' OG1' ' A' ' 258' ' ' THR . 14.1 p90 -119.98 168.04 11.55 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.154 -0.966 . . . . 0.0 111.118 -175.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 93.3 m -117.79 146.73 43.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.761 -0.587 . . . . 0.0 109.887 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 45.3 m -116.46 136.41 53.01 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.524 -0.735 . . . . 0.0 110.857 -175.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.2 t -128.39 136.02 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 172.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 71.3 mt -104.94 120.75 42.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.565 -0.709 . . . . 0.0 110.015 -174.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . 0.421 ' CE2' HD13 ' A' ' 172' ' ' ILE . 2.9 m-30 -95.5 157.37 15.92 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.642 -0.661 . . . . 0.0 110.605 176.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -136.47 142.83 43.59 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 168.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -114.32 133.16 55.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.498 -0.751 . . . . 0.0 110.459 -177.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.25 3.31 35.38 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.685 -0.634 . . . . 0.0 111.975 -178.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -144.63 159.95 41.97 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.102 -0.999 . . . . 0.0 109.929 174.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -119.78 163.54 17.31 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.435 0.636 . . . . 0.0 110.484 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 32.4 m -58.22 -32.62 68.48 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.465 -0.772 . . . . 0.0 110.975 -164.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 49.1 p -101.51 13.05 36.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.47 -0.769 . . . . 0.0 111.941 -164.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 30.7 p -94.26 118.08 31.06 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.077 -1.014 . . . . 0.0 110.612 178.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 61.2 t -63.82 139.92 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.44 -0.788 . . . . 0.0 110.351 -170.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 100.13 -5.11 57.54 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 177.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.81 -99.05 0.87 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 171.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 93.3 mmm -62.91 -32.1 73.31 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.7 -0.882 . . . . 0.0 110.287 178.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.3 p30 44.31 49.88 7.89 Favored 'General case' 0 N--CA 1.504 2.243 0 CA-C-O 121.262 0.553 . . . . 0.0 112.449 174.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 21.3 mtt180 54.85 28.64 10.69 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.29 -0.881 . . . . 0.0 111.197 175.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -116.82 106.01 48.67 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.561 -0.712 . . . . 0.0 109.995 174.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.37 147.71 89.92 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 O-C-N 123.029 1.015 . . . . 0.0 110.609 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 45.2 pt -131.87 177.34 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.646 0.736 . . . . 0.0 110.876 -177.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 35.3 mt -124.3 149.85 46.08 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.417 ' HB ' ' CE2' ' A' ' 301' ' ' PHE . 81.2 mt -112.02 129.94 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 79.4 mt -109.81 125.26 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.423 HG22 ' CE1' ' A' ' 301' ' ' PHE . 63.1 t -118.99 126.78 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.9 p -125.24 152.16 44.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.631 -0.668 . . . . 0.0 110.594 -173.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.414 ' HB2' ' CE1' ' A' ' 138' ' ' PHE . 26.2 tp -101.03 127.14 47.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.715 -0.615 . . . . 0.0 109.5 167.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -130.27 150.32 51.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.856 -0.528 . . . . 0.0 109.926 -173.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 8.2 p -89.99 161.14 16.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.579 -0.701 . . . . 0.0 109.971 177.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -55.89 -26.14 45.96 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.502 -0.749 . . . . 0.0 111.043 -176.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 49.1 p30 -87.61 8.28 25.99 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.424 -0.797 . . . . 0.0 111.904 -174.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 88.19 20.19 50.17 Favored Glycine 0 N--CA 1.494 2.548 0 O-C-N 121.067 -1.021 . . . . 0.0 110.648 172.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -107.6 140.21 40.96 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.323 -1.104 . . . . 0.0 110.111 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 58.6 t -83.91 133.56 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.563 -0.711 . . . . 0.0 110.15 -174.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 95.7 mt -99.93 -40.15 7.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.711 -0.618 . . . . 0.0 110.283 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -167.26 150.41 17.02 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -133.47 137.29 45.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.612 -0.934 . . . . 0.0 110.718 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -130.61 155.21 46.93 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.619 -0.676 . . . . 0.0 110.229 172.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 79.5 m -139.15 146.73 40.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.469 -0.769 . . . . 0.0 110.831 -174.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.423 ' CE1' HG22 ' A' ' 286' ' ' VAL . 9.2 p90 -147.76 162.08 39.93 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.782 -0.574 . . . . 0.0 109.979 177.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -104.77 138.44 41.05 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.542 -0.724 . . . . 0.0 110.331 -175.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -125.14 143.63 50.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.651 -0.655 . . . . 0.0 110.596 -171.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -138.19 140.77 39.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.75 -0.594 . . . . 0.0 109.755 174.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 63.8 mt -108.88 122.87 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.501 -0.749 . . . . 0.0 109.645 176.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.9 p -145.24 168.66 19.88 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.636 -0.665 . . . . 0.0 110.657 -172.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -70.03 -40.18 75.33 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.64 -0.663 . . . . 0.0 110.638 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.8 t -127.99 86.55 57.87 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.522 -0.736 . . . . 0.0 110.457 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -56.23 -27.69 67.51 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 O-C-N 123.198 1.104 . . . . 0.0 110.573 174.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -68.47 -36.79 84.63 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -72.18 -39.95 68.29 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.708 -0.877 . . . . 0.0 109.873 -173.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -69.58 -39.26 77.43 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.062 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 -61.61 -44.01 97.8 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.301 178.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -65.12 -39.42 93.05 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.569 -0.707 . . . . 0.0 110.476 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.32 -49.95 74.94 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.599 -0.688 . . . . 0.0 110.44 -173.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.1 p30 . . . . . 0 N--CA 1.495 1.799 0 O-C-N 121.487 -0.758 . . . . 0.0 110.02 -178.669 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.2 t . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.02 0.438 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -94.69 25.0 4.26 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.611 -0.681 . . . . 0.0 110.824 -178.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 51.0 m -70.06 125.21 26.09 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.613 -0.679 . . . . 0.0 110.249 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -70.06 144.94 52.02 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.616 -0.678 . . . . 0.0 110.432 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.421 ' CE1' ' HA2' ' A' ' 134' ' ' GLY . 43.2 t80 -155.47 101.4 2.22 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.587 -0.696 . . . . 0.0 110.018 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -59.29 -39.97 72.78 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 O-C-N 123.185 1.097 . . . . 0.0 110.762 -173.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.421 ' HA2' ' CE1' ' A' ' 132' ' ' TYR . . . 82.67 -155.1 33.28 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -73.8 -50.01 0.18 Allowed 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.382 1.201 . . . . 0.0 110.881 -174.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -87.75 9.68 20.85 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.576 -0.702 . . . . 0.0 111.337 -173.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 t 53.81 61.69 2.97 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.961 -1.087 . . . . 0.0 110.632 -176.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.447 ' CE1' ' CG2' ' A' ' 174' ' ' ILE . 64.4 t80 -80.27 118.69 22.15 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.651 -0.656 . . . . 0.0 109.932 -178.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -129.98 163.21 26.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.768 -0.582 . . . . 0.0 110.413 -174.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 62.9 t -125.16 147.73 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.729 -0.607 . . . . 0.0 109.773 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.7 p -155.16 163.32 40.38 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.942 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.438 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 73.1 m-85 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.784 -0.573 . . . . 0.0 109.855 -176.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 121.191 0.519 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.403 ' OG1' ' CD1' ' A' ' 153' ' ' TRP . 44.6 p -60.07 -33.99 72.83 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.674 -0.641 . . . . 0.0 110.204 177.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.418 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -171.45 145.94 2.17 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.709 -0.62 . . . . 0.0 110.001 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.7 t -142.12 142.65 32.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.8 -0.563 . . . . 0.0 110.082 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.438 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 61.7 t80 -125.57 140.09 53.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.646 -0.659 . . . . 0.0 110.483 -172.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.4 t -109.78 124.07 50.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.842 -0.536 . . . . 0.0 109.785 175.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 48.7 m -71.35 -37.11 71.7 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.357 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -60.75 -31.64 70.97 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.605 -0.684 . . . . 0.0 110.25 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 58.2 mt -104.79 -12.19 16.43 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.612 -0.68 . . . . 0.0 110.786 -174.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 46.5 tttt 59.73 47.56 10.28 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.05 -1.031 . . . . 0.0 109.751 176.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -147.68 153.12 38.91 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.627 -0.671 . . . . 0.0 110.89 -173.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.6 tp -126.61 137.86 53.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.771 -0.581 . . . . 0.0 110.408 -176.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -115.51 132.94 56.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.646 -0.659 . . . . 0.0 109.231 174.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.37 158.41 44.32 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.659 -0.651 . . . . 0.0 111.134 -173.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -104.58 144.08 32.19 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.494 0.664 . . . . 0.0 110.316 173.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 17.2 tt -52.06 147.22 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.52 -0.737 . . . . 0.0 111.871 -174.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 64.42 10.0 5.39 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.614 -0.679 . . . . 0.0 112.544 175.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -95.36 155.08 16.89 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.001 -1.062 . . . . 0.0 110.894 175.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 84.9 m -83.23 126.1 32.29 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.708 -0.62 . . . . 0.0 110.522 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 43.3 t -115.14 90.29 23.34 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.615 -0.678 . . . . 0.0 110.12 174.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.418 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 18.9 Cg_endo -64.41 131.44 29.98 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.239 1.126 . . . . 0.0 110.45 176.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.408 HG12 ' CE2' ' A' ' 142' ' ' PHE . 93.6 mt -123.78 141.56 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . 0.4 ' OE1' ' CD1' ' A' ' 260' ' ' PHE . 67.1 mm-40 -109.17 133.72 52.65 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.566 -0.709 . . . . 0.0 110.408 -173.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.447 ' CG2' ' CE1' ' A' ' 138' ' ' PHE . 49.4 mm -95.38 135.01 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.574 -0.704 . . . . 0.0 109.725 171.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 32.2 tttt -119.52 131.13 55.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.594 -0.691 . . . . 0.0 110.453 177.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.7 m -136.83 159.72 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.59 -0.694 . . . . 0.0 110.05 175.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 78.8 mmm -78.32 -40.3 37.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.726 -0.609 . . . . 0.0 110.019 176.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 77.0 p -134.15 143.21 46.2 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.735 -0.603 . . . . 0.0 109.718 177.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -55.3 139.85 81.45 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 O-C-N 123.076 1.04 . . . . 0.0 110.892 -172.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.423 ' HG2' ' CD1' ' A' ' 251' ' ' TYR . 36.8 Cg_endo -68.56 170.06 15.91 Favored 'Trans proline' 0 N--CA 1.487 1.099 0 O-C-N 123.153 1.081 . . . . 0.0 110.629 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -60.4 155.41 47.04 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.404 1.213 . . . . 0.0 110.602 -178.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -78.69 138.47 38.29 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.58 -0.7 . . . . 0.0 109.981 175.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.28 -24.78 30.85 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -174.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.14 151.91 1.87 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.364 -1.08 . . . . 0.0 111.452 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.0 m -129.71 155.97 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.707 -0.62 . . . . 0.0 109.625 176.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 81.6 mt -108.43 139.3 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.685 -0.635 . . . . 0.0 109.537 176.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 38.9 mtm180 -114.87 146.81 40.69 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -176.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -140.55 127.61 20.83 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.372 174.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 33.3 ttm -137.34 139.04 26.55 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.805 -0.56 . . . . 0.0 110.938 -177.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -91.44 138.15 2.14 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 120.983 1.122 . . . . 0.0 110.702 176.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.9 m -147.22 154.94 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.599 -0.688 . . . . 0.0 110.14 174.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.442 ' CE2' ' CG2' ' A' ' 202' ' ' VAL . 90.4 m-85 -60.32 165.9 3.31 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.478 -0.764 . . . . 0.0 110.399 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -82.99 -60.1 2.27 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.621 -0.675 . . . . 0.0 110.832 -174.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -80.11 151.96 29.55 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.501 -0.749 . . . . 0.0 110.373 -175.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.67 -38.31 72.05 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.36 -0.838 . . . . 0.0 110.709 -175.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -56.5 -24.92 49.51 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.48 -0.763 . . . . 0.0 110.652 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.405 ' HB3' ' CG ' ' A' ' 192' ' ' TYR . 98.9 m-70 -109.69 -20.49 12.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.53 -0.732 . . . . 0.0 111.167 -178.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.1 p -67.74 -20.3 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.086 -1.008 . . . . 0.0 110.655 -176.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 67.0 p -79.35 -17.1 55.17 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.537 -0.727 . . . . 0.0 110.742 175.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -88.31 137.24 32.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.292 -0.88 . . . . 0.0 110.097 173.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 54.1 t -74.09 142.01 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.612 -0.68 . . . . 0.0 110.262 177.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.442 ' CG2' ' CE2' ' A' ' 192' ' ' TYR . 67.8 t -84.84 138.8 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.579 -0.701 . . . . 0.0 109.331 170.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.9 pttp -134.86 -170.16 2.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.482 -0.761 . . . . 0.0 111.185 -168.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -95.27 153.9 17.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.794 -0.567 . . . . 0.0 110.499 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.628 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 60.3 m . . . . . 0 N--CA 1.497 1.887 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 174.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 55.2 tp . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 120.939 0.399 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 82.1 mt -101.01 136.75 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.786 -0.571 . . . . 0.0 109.85 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 -133.28 158.71 42.26 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.646 -0.659 . . . . 0.0 110.254 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 93.0 t -103.93 146.7 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.725 -0.61 . . . . 0.0 110.137 178.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -118.5 130.0 55.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.73 -0.606 . . . . 0.0 110.477 170.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 92.42 25.02 22.47 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 167.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -138.86 108.1 6.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.433 -1.04 . . . . 0.0 110.017 174.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 92.6 p -63.35 -15.14 56.51 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.675 -0.641 . . . . 0.0 111.287 -177.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -97.28 9.36 42.46 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.299 -0.876 . . . . 0.0 111.155 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -62.24 125.44 23.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.222 -0.924 . . . . 0.0 110.156 176.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -139.72 154.81 47.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.798 -0.564 . . . . 0.0 109.74 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.42 ' CD1' ' HB ' ' A' ' 247' ' ' VAL . 91.1 m-85 -117.36 150.73 38.36 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.605 -176.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.19 160.03 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.782 -0.574 . . . . 0.0 110.234 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -114.69 130.05 56.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.768 -0.583 . . . . 0.0 110.038 174.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -63.78 130.11 94.21 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.71 -0.619 . . . . 0.0 109.741 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -64.98 -28.69 57.76 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.232 1.122 . . . . 0.0 111.045 -170.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.9 mt -102.16 -50.53 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.387 -0.821 . . . . 0.0 111.041 -167.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 9.3 p -105.5 12.27 31.58 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.327 -0.858 . . . . 0.0 111.917 -176.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 72.14 -5.01 15.46 Favored Glycine 0 N--CA 1.497 2.737 0 O-C-N 121.057 -1.027 . . . . 0.0 112.001 171.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -45.82 142.14 2.68 Favored 'General case' 0 N--CA 1.505 2.324 0 CA-C-N 119.137 1.469 . . . . 0.0 112.509 -174.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -96.01 143.55 27.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.551 -0.718 . . . . 0.0 110.099 172.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 77.9 p -154.7 159.87 41.0 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.579 -0.7 . . . . 0.0 110.483 174.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.42 ' HB ' ' CD1' ' A' ' 236' ' ' TYR . 8.6 p -125.12 148.33 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.78 -0.575 . . . . 0.0 109.781 179.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 81.6 mt -129.64 154.55 47.0 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.651 -177.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 34.1 m -151.53 151.68 29.22 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.789 -0.569 . . . . 0.0 109.985 176.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -71.07 139.04 34.89 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 123.297 1.156 . . . . 0.0 110.018 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.423 ' CD1' ' HG2' ' A' ' 180' ' ' PRO . 59.9 t80 -75.96 125.61 29.44 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.491 -0.756 . . . . 0.0 110.123 174.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -100.06 160.01 28.3 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.725 -0.609 . . . . 0.0 109.996 177.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -58.94 159.93 19.9 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.268 1.141 . . . . 0.0 110.417 178.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.38 149.91 78.32 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 O-C-N 123.187 1.098 . . . . 0.0 110.493 -177.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -61.82 148.48 43.07 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.681 -0.637 . . . . 0.0 110.138 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.2 t -69.92 127.2 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.534 -0.729 . . . . 0.0 110.12 -170.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.98 -10.14 55.37 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.407 ' OG1' ' CD2' ' A' ' 260' ' ' PHE . 9.9 t -144.73 174.11 11.26 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.124 -1.221 . . . . 0.0 110.616 175.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -107.26 13.16 27.47 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.612 -0.68 . . . . 0.0 111.707 -168.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . 0.407 ' CD2' ' OG1' ' A' ' 258' ' ' THR . 13.5 p90 -119.86 168.08 11.46 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.152 -0.967 . . . . 0.0 111.135 -174.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 88.4 m -117.77 147.49 42.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.741 -0.599 . . . . 0.0 109.905 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 47.0 m -118.14 136.28 53.71 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.56 -0.712 . . . . 0.0 111.048 -174.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.8 t -131.92 137.26 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 172.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 67.8 mt -104.62 120.73 42.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.467 -0.77 . . . . 0.0 109.826 -172.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -106.29 151.2 25.13 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.678 -0.639 . . . . 0.0 110.604 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -136.58 142.86 43.39 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -112.0 130.08 55.98 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.595 -0.69 . . . . 0.0 110.453 -177.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -96.16 3.0 53.54 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.633 -0.667 . . . . 0.0 111.973 -176.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.81 165.04 29.24 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.076 -1.015 . . . . 0.0 110.123 175.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -121.7 163.4 19.1 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.646 -0.659 . . . . 0.0 110.417 -178.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 29.6 m -58.42 -35.14 71.62 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.427 -0.796 . . . . 0.0 110.986 -163.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 51.3 p -103.46 15.0 30.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.409 -0.807 . . . . 0.0 111.949 -163.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . 0.628 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 29.7 p -93.96 118.05 30.95 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.063 -1.023 . . . . 0.0 110.712 178.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 60.0 t -62.75 138.82 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.519 -0.738 . . . . 0.0 110.352 -171.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.08 -5.21 61.2 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 178.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.13 -101.66 0.95 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 172.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 93.4 mmm -60.93 -29.95 69.91 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.657 -0.908 . . . . 0.0 110.124 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 22.6 p30 42.86 44.74 4.03 Favored 'General case' 0 N--CA 1.505 2.312 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 173.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 55.02 34.66 22.96 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.355 -0.841 . . . . 0.0 111.11 175.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -120.04 105.74 42.12 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.54 -0.725 . . . . 0.0 109.98 172.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -58.93 144.94 98.74 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 O-C-N 123.112 1.059 . . . . 0.0 110.573 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 46.2 pt -131.97 175.36 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 122.006 0.908 . . . . 0.0 111.244 -173.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 26.0 mt -124.44 149.84 46.34 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.426 HD12 ' CE1' ' A' ' 301' ' ' PHE . 82.4 mt -115.83 129.63 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.173 178.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 82.1 mt -109.74 125.52 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 -176.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 60.4 t -118.9 126.76 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.5 p -125.29 155.0 40.88 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.655 -0.653 . . . . 0.0 110.614 -172.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 30.5 tp -107.02 126.13 51.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.803 -0.561 . . . . 0.0 109.564 170.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -131.77 151.41 51.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.855 -0.528 . . . . 0.0 109.853 -174.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 71.4 p -89.9 157.8 17.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.605 -0.684 . . . . 0.0 109.779 178.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -56.12 -26.02 48.36 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.506 -0.746 . . . . 0.0 110.739 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -87.14 9.55 19.61 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.55 -0.719 . . . . 0.0 111.789 -174.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 87.63 20.09 52.26 Favored Glycine 0 N--CA 1.493 2.49 0 O-C-N 121.068 -1.02 . . . . 0.0 110.76 170.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -108.53 140.22 42.17 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.294 -1.121 . . . . 0.0 110.208 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 59.5 t -86.76 134.98 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.571 -0.706 . . . . 0.0 110.043 -173.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 96.4 mt -99.87 -40.14 7.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.658 -0.651 . . . . 0.0 110.457 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -175.35 162.42 31.92 Favored Glycine 0 N--CA 1.496 2.674 0 C-N-CA 119.922 -1.132 . . . . 0.0 110.384 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -130.73 139.83 50.3 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.672 -0.899 . . . . 0.0 110.567 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -136.59 155.07 50.42 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.479 -0.763 . . . . 0.0 109.869 170.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 89.1 m -143.56 154.76 43.92 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.327 -0.858 . . . . 0.0 110.874 -175.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.426 ' CE1' HD12 ' A' ' 284' ' ' ILE . 48.7 p90 -145.72 163.91 33.44 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.717 -0.614 . . . . 0.0 110.108 176.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -104.89 135.84 45.5 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.457 -0.777 . . . . 0.0 110.325 -177.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -123.84 144.42 49.74 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.633 -0.667 . . . . 0.0 110.729 -170.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -138.67 137.0 36.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.815 -0.553 . . . . 0.0 109.812 173.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 75.0 mt -105.8 123.56 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.58 -0.7 . . . . 0.0 109.584 176.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.2 p -145.15 164.9 29.87 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.569 -0.707 . . . . 0.0 110.948 -169.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -66.43 -39.92 89.2 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.671 -0.643 . . . . 0.0 110.615 -177.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.9 t -131.31 89.06 42.31 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.534 -0.729 . . . . 0.0 110.576 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -56.71 -29.3 79.67 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 123.136 1.072 . . . . 0.0 110.477 173.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.15 -37.93 93.46 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 176.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -70.23 -38.41 75.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.536 -0.979 . . . . 0.0 109.779 -175.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -69.4 -36.13 76.45 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.986 178.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 47.7 ttt-85 -57.04 -48.39 78.63 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.529 -0.732 . . . . 0.0 110.57 175.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -64.99 -38.54 91.28 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.72 -0.613 . . . . 0.0 110.448 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.85 -52.16 65.26 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.501 -0.749 . . . . 0.0 110.475 -173.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.6 p30 . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.434 -0.791 . . . . 0.0 110.155 -177.123 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 27.8 t . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.031 0.443 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.9 p-10 -96.33 24.62 5.61 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.722 -0.611 . . . . 0.0 110.681 -179.227 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 51.6 m -76.63 125.17 28.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.54 -0.725 . . . . 0.0 110.279 -179.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -70.14 144.91 51.89 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.672 -0.642 . . . . 0.0 110.41 -177.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -154.25 99.41 2.5 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.774 -0.579 . . . . 0.0 110.153 178.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -58.8 -39.91 77.37 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 O-C-N 123.202 1.106 . . . . 0.0 110.774 -176.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.69 -155.11 47.93 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 178.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -73.29 -46.19 0.38 Allowed 'Trans proline' 0 C--N 1.316 -1.176 0 O-C-N 123.363 1.191 . . . . 0.0 110.922 -174.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -85.9 6.7 27.22 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.531 -0.731 . . . . 0.0 111.382 -173.679 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.72 61.18 3.22 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.853 -1.154 . . . . 0.0 110.656 -175.519 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.417 ' CE1' HG22 ' A' ' 174' ' ' ILE . 54.6 t80 -77.82 119.29 21.1 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.64 -0.662 . . . . 0.0 109.852 -178.678 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -130.07 159.93 35.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.826 -0.546 . . . . 0.0 110.189 -178.419 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 68.5 t -124.57 147.65 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.694 -0.629 . . . . 0.0 109.902 176.131 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.9 p -155.04 164.23 39.17 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.075 177.132 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.486 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 88.0 m-85 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.84 -0.537 . . . . 0.0 109.894 -176.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.803 0 CA-C-O 121.153 0.501 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 80.9 p -59.99 -32.49 70.9 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.641 -0.662 . . . . 0.0 109.868 174.197 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.422 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -171.34 142.8 1.75 Allowed 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.319 0.581 . . . . 0.0 110.253 176.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.7 t -142.12 142.72 32.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.935 -0.478 . . . . 0.0 109.997 -177.318 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.486 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 52.0 t80 -125.52 140.06 53.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.545 -0.722 . . . . 0.0 110.524 -172.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.5 t -111.84 124.31 52.08 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 120.401 -0.52 . . . . 0.0 109.789 176.118 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 62.3 m -70.58 -37.05 73.9 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.771 -0.581 . . . . 0.0 110.45 -177.658 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -59.1 -33.03 70.36 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.529 -0.732 . . . . 0.0 110.53 -178.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.1 mt -104.84 -11.99 16.5 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.688 -0.632 . . . . 0.0 110.787 -175.805 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 70.7 tttt 59.74 49.54 8.03 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.046 -1.034 . . . . 0.0 109.653 177.703 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 40.5 tttt -146.56 153.11 39.98 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.754 -0.591 . . . . 0.0 110.668 -174.054 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.5 tp -126.52 137.76 53.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.805 -0.559 . . . . 0.0 110.171 -177.333 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -115.16 134.78 54.85 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.8 p -138.42 158.61 43.95 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 120.114 -0.635 . . . . 0.0 111.114 -174.029 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -104.42 141.99 35.38 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.557 -0.714 . . . . 0.0 110.209 173.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 18.3 tt -54.85 146.23 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.562 -0.712 . . . . 0.0 111.561 -171.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 64.36 9.98 5.33 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.552 -0.718 . . . . 0.0 112.479 177.017 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -96.13 155.08 16.91 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.896 -1.128 . . . . 0.0 110.747 175.114 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 86.7 m -81.12 126.2 31.17 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.738 -0.601 . . . . 0.0 110.634 -177.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 46.9 t -115.53 90.23 25.07 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.702 -0.624 . . . . 0.0 110.11 172.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.422 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 22.0 Cg_exo -62.37 130.89 31.78 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 O-C-N 123.276 1.145 . . . . 0.0 110.624 174.079 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.415 HG12 ' CE2' ' A' ' 142' ' ' PHE . 94.5 mt -125.41 142.92 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.655 -0.653 . . . . 0.0 109.299 175.593 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -108.44 136.21 48.45 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.517 -0.739 . . . . 0.0 110.739 -176.209 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.417 HG22 ' CE1' ' A' ' 138' ' ' PHE . 48.5 mm -95.27 131.55 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.724 -0.61 . . . . 0.0 109.613 169.241 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -112.99 128.28 56.45 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.607 -0.683 . . . . 0.0 110.447 176.28 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.2 m -136.59 159.79 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.594 -0.691 . . . . 0.0 109.903 175.104 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.5 mmm -76.47 -40.81 49.35 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.632 -0.668 . . . . 0.0 110.104 178.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 77.5 p -135.44 143.15 44.05 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.782 -0.574 . . . . 0.0 109.65 178.356 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -55.22 139.8 81.02 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 O-C-N 123.142 1.075 . . . . 0.0 110.841 -171.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.431 ' HG2' ' CD1' ' A' ' 251' ' ' TYR . 29.8 Cg_endo -66.58 170.0 13.25 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 O-C-N 123.212 1.111 . . . . 0.0 110.618 178.411 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -60.85 156.25 44.68 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.358 1.189 . . . . 0.0 110.5 -178.293 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -79.1 139.32 38.1 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.651 -0.656 . . . . 0.0 109.954 176.118 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 98.53 -24.94 29.94 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -174.167 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.18 152.35 1.76 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.359 -1.083 . . . . 0.0 111.426 177.684 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 33.8 m -129.78 155.95 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.766 -0.584 . . . . 0.0 109.649 176.293 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 80.4 mt -109.17 138.78 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.676 -0.64 . . . . 0.0 109.51 176.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 30.8 mtm180 -114.9 147.27 40.18 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -175.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -140.13 127.18 20.89 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.501 -0.749 . . . . 0.0 110.259 173.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 3.2 ttp -137.24 138.33 24.93 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.777 -0.577 . . . . 0.0 110.926 -176.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -91.9 138.09 1.95 Allowed 'Trans proline' 0 C--N 1.32 -0.949 0 C-N-CA 121.023 1.149 . . . . 0.0 110.771 177.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.7 m -147.43 154.82 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.505 -0.747 . . . . 0.0 110.101 174.089 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.42 ' CE2' HG21 ' A' ' 202' ' ' VAL . 63.3 m-85 -60.05 162.06 6.12 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.409 -0.807 . . . . 0.0 110.55 -179.155 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 29.0 tttp -79.19 -60.02 2.54 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.665 -0.647 . . . . 0.0 110.878 -173.092 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -80.15 152.04 29.44 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.587 -0.695 . . . . 0.0 110.425 -175.373 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.52 -37.95 71.16 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.376 -0.827 . . . . 0.0 110.674 -177.084 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -56.86 -25.02 55.67 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.548 -0.72 . . . . 0.0 110.572 -177.438 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.407 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 65.0 m170 -108.81 -20.58 13.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.598 -0.689 . . . . 0.0 111.116 -178.816 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.2 p -68.45 -20.28 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.148 -0.97 . . . . 0.0 110.581 -175.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 67.3 p -79.42 -17.03 55.18 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.516 -0.74 . . . . 0.0 110.678 174.37 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.39 136.54 32.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.366 -0.834 . . . . 0.0 110.025 173.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.9 t -72.92 145.08 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.569 -0.707 . . . . 0.0 110.269 178.354 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.42 HG21 ' CE2' ' A' ' 192' ' ' TYR . 57.8 t -84.88 139.9 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 170.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 11.9 pttt -134.72 -170.46 2.56 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.509 -0.744 . . . . 0.0 111.195 -169.34 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 63.8 mmt-85 -95.37 150.92 19.75 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.827 -0.546 . . . . 0.0 110.423 -176.23 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.658 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 60.9 m . . . . . 0 N--CA 1.497 1.894 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 169.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 57.2 tp . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 120.93 0.395 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 85.5 mt -104.7 136.72 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -134.57 159.52 40.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.701 -0.624 . . . . 0.0 110.189 -178.401 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 91.2 t -104.46 146.74 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.766 -0.584 . . . . 0.0 110.103 178.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -118.1 124.4 47.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.732 -0.605 . . . . 0.0 110.361 172.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.05 23.82 14.15 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 168.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -137.17 107.6 6.48 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.464 -1.021 . . . . 0.0 110.028 174.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 26.3 t -62.89 -15.18 53.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.67 -0.643 . . . . 0.0 111.322 -178.001 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -100.02 7.98 44.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.246 -0.909 . . . . 0.0 111.524 -177.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.06 130.76 47.99 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.191 -0.943 . . . . 0.0 110.213 176.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -139.76 157.95 44.9 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.75 -0.594 . . . . 0.0 109.807 177.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -115.01 150.73 35.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.596 -0.69 . . . . 0.0 110.658 -176.394 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.16 159.93 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.827 -0.546 . . . . 0.0 110.081 176.38 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -121.46 130.11 53.38 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.69 -0.631 . . . . 0.0 110.344 178.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -64.74 110.34 3.97 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.636 -0.665 . . . . 0.0 109.697 176.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -59.76 -25.11 78.2 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.141 1.074 . . . . 0.0 111.078 -171.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.8 mt -100.72 -50.41 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.409 -0.807 . . . . 0.0 110.853 -171.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 17.4 p -105.43 12.16 31.83 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.41 -0.807 . . . . 0.0 111.96 -173.211 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 82.32 -25.07 4.48 Favored Glycine 0 N--CA 1.498 2.781 0 O-C-N 120.997 -1.064 . . . . 0.0 111.885 169.169 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -45.83 142.14 2.69 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-N 118.652 1.226 . . . . 0.0 112.678 -168.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -104.41 146.08 29.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.7 -0.625 . . . . 0.0 109.93 173.681 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 77.9 p -154.74 159.98 41.03 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.609 -0.682 . . . . 0.0 110.39 178.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 8.6 p -123.23 148.25 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.75 -0.593 . . . . 0.0 109.816 179.535 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 83.9 mt -129.57 154.62 46.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.653 -0.655 . . . . 0.0 109.662 -176.506 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 35.1 m -151.35 151.73 29.63 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.769 -0.582 . . . . 0.0 110.045 175.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -71.1 138.6 33.92 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 O-C-N 123.232 1.122 . . . . 0.0 109.991 177.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.431 ' CD1' ' HG2' ' A' ' 180' ' ' PRO . 57.1 t80 -74.07 127.16 32.2 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.53 -0.731 . . . . 0.0 110.194 175.376 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -99.95 160.09 28.13 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.697 -0.627 . . . . 0.0 109.974 175.111 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -58.55 157.86 25.61 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 O-C-N 123.291 1.153 . . . . 0.0 110.518 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.15 149.92 77.06 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 O-C-N 123.203 1.107 . . . . 0.0 110.514 -177.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -60.64 147.65 41.17 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.569 -0.707 . . . . 0.0 110.254 -178.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.87 127.2 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.508 -0.745 . . . . 0.0 110.219 -170.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.06 -10.27 55.18 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.405 ' OG1' ' CE2' ' A' ' 260' ' ' PHE . 10.1 t -144.12 174.12 11.15 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.115 -1.227 . . . . 0.0 110.676 176.027 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -107.39 13.17 27.27 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.647 -0.658 . . . . 0.0 111.812 -168.325 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . 0.405 ' CE2' ' OG1' ' A' ' 258' ' ' THR . 14.6 p90 -119.92 168.01 11.56 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.116 -0.99 . . . . 0.0 111.155 -175.184 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 82.2 m -117.77 145.75 44.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.791 -0.568 . . . . 0.0 109.854 179.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 42.2 m -116.62 135.93 53.39 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.582 -0.699 . . . . 0.0 110.78 -176.55 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.9 t -132.31 137.33 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 175.094 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 76.6 mt -104.59 120.92 42.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.493 -0.755 . . . . 0.0 109.991 -170.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -105.29 153.64 21.33 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.672 -0.643 . . . . 0.0 110.823 -176.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -136.54 142.92 43.46 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -114.99 133.82 55.71 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.463 -0.773 . . . . 0.0 110.47 -179.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -102.44 9.42 39.66 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.606 -0.684 . . . . 0.0 112.053 -175.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -144.61 159.05 43.44 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.083 -1.011 . . . . 0.0 110.108 173.06 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -119.27 163.11 17.62 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.752 -0.593 . . . . 0.0 110.423 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 25.1 m -57.95 -31.48 66.88 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.44 -0.788 . . . . 0.0 110.843 -166.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 51.1 p -105.72 14.95 27.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.352 -0.843 . . . . 0.0 111.965 -165.222 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . 0.658 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 29.6 p -94.18 118.1 31.07 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.139 -0.975 . . . . 0.0 110.539 177.571 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.89 139.23 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.436 -0.79 . . . . 0.0 110.177 -170.5 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.6 -5.13 60.12 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 178.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.05 -97.69 0.81 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 173.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 93.0 mmm -64.03 -33.76 76.46 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.74 -0.859 . . . . 0.0 110.41 178.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.1 p30 43.72 50.77 6.69 Favored 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 175.486 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 54.86 31.86 16.6 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.294 -0.879 . . . . 0.0 111.188 176.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -120.02 104.94 43.3 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.498 -0.751 . . . . 0.0 110.148 174.247 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -60.37 148.16 91.42 Favored 'Trans proline' 0 N--CA 1.487 1.139 0 O-C-N 123.104 1.055 . . . . 0.0 110.528 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 45.5 pt -131.99 177.42 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 CA-C-O 121.79 0.805 . . . . 0.0 111.037 -176.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 28.1 mt -124.34 149.9 46.09 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.425 ' HB ' ' CZ ' ' A' ' 301' ' ' PHE . 81.4 mt -115.79 130.19 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.931 -0.707 . . . . 0.0 109.315 177.705 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 83.3 mt -109.88 126.19 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.483 -177.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 57.8 t -118.96 126.84 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.5 p -125.24 151.61 45.68 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.581 -0.7 . . . . 0.0 110.736 -173.467 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 21.8 tp -101.3 125.67 47.96 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 167.427 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -130.58 150.54 51.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.845 -0.534 . . . . 0.0 110.005 -172.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.4 ' CG2' ' CD1' ' A' ' 296' ' ' LEU . 17.1 p -89.96 161.13 16.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.678 -0.639 . . . . 0.0 109.967 177.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -55.95 -26.07 46.33 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.579 -0.701 . . . . 0.0 110.98 -176.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 47.0 p30 -90.36 9.36 29.23 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.373 -0.829 . . . . 0.0 111.908 -173.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.41 20.15 46.23 Favored Glycine 0 N--CA 1.494 2.546 0 C-N-CA 120.169 -1.015 . . . . 0.0 110.841 171.055 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -107.58 140.16 41.01 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.357 -1.084 . . . . 0.0 110.075 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 59.8 t -87.68 132.14 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.543 -0.723 . . . . 0.0 110.164 -173.35 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.4 ' CD1' ' CG2' ' A' ' 290' ' ' THR . 96.1 mt -99.97 -40.2 7.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.667 -0.646 . . . . 0.0 110.44 178.15 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -159.97 148.62 17.35 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -178.14 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -135.09 133.14 38.97 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.73 -0.864 . . . . 0.0 110.566 -178.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -135.03 156.17 49.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.705 -0.622 . . . . 0.0 109.976 172.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 83.0 m -141.77 154.21 45.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.431 -0.793 . . . . 0.0 110.541 -176.269 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.425 ' CZ ' ' HB ' ' A' ' 284' ' ' ILE . 49.3 p90 -144.96 164.62 30.57 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.694 -0.628 . . . . 0.0 110.247 177.14 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -104.87 134.58 47.76 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.548 -0.72 . . . . 0.0 110.048 -177.137 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -121.77 143.68 49.24 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.704 -169.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 64.5 ttt-85 -139.82 134.86 32.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.761 -0.587 . . . . 0.0 109.633 173.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 33.5 mt -106.79 122.86 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.585 -0.697 . . . . 0.0 109.67 178.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.2 p -145.12 170.92 15.29 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.594 -0.691 . . . . 0.0 110.975 -169.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -70.23 -40.05 74.72 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.752 -0.593 . . . . 0.0 110.604 -178.481 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 3.7 t -131.15 88.85 43.65 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.591 -0.693 . . . . 0.0 110.422 179.139 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -55.85 -29.04 70.72 Favored 'Trans proline' 0 N--CA 1.488 1.187 0 O-C-N 123.176 1.092 . . . . 0.0 110.82 174.48 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.6 -37.83 92.83 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 177.136 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 72.2 ttt-85 -72.4 -40.49 67.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.67 -0.9 . . . . 0.0 109.77 -173.327 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -69.43 -38.35 77.8 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.256 -178.347 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -61.23 -43.7 98.46 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.467 -0.77 . . . . 0.0 110.226 178.227 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 52.5 tttt -64.9 -39.41 93.48 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.509 -0.744 . . . . 0.0 110.469 177.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.44 -49.82 75.27 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.515 -0.74 . . . . 0.0 110.573 -173.342 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.1 p30 . . . . . 0 N--CA 1.496 1.84 0 O-C-N 121.564 -0.71 . . . . 0.0 110.075 -178.691 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.8 t -82.2 -25.82 33.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.67 -0.9 . . . . 0.0 110.468 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.9 m -58.36 -33.32 69.44 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.536 -0.727 . . . . 0.0 110.46 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.0 t 40.29 41.82 1.09 Allowed 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 52.01 -172.06 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.436 -0.79 . . . . 0.0 111.035 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 53.63 44.51 29.66 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.441 -0.787 . . . . 0.0 110.809 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -168.09 115.54 0.71 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.682 -0.637 . . . . 0.0 110.173 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 28.3 tp 55.8 -87.14 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.633 -0.667 . . . . 0.0 110.754 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.5 p -137.1 167.16 22.13 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.153 -0.967 . . . . 0.0 110.221 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -66.29 153.03 81.56 Favored 'Cis proline' 0 N--CA 1.495 1.573 0 C-N-CA 123.039 -1.65 . . . . 0.0 110.35 -17.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 71.1 m -82.21 145.58 52.75 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.648 -0.657 . . . . 0.0 110.146 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -59.55 146.11 96.12 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 O-C-N 123.179 1.094 . . . . 0.0 110.639 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.86 144.88 40.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.67 -0.644 . . . . 0.0 110.119 178.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 51.1 mm -120.71 99.95 46.98 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.624 -0.672 . . . . 0.0 110.029 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -60.81 148.38 92.26 Favored 'Trans proline' 0 N--CA 1.488 1.169 0 O-C-N 123.208 1.11 . . . . 0.0 110.531 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.6 t -117.25 145.6 43.83 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.657 -0.652 . . . . 0.0 110.289 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.9 p-10 -96.15 25.86 4.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.652 -0.655 . . . . 0.0 110.601 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 51.0 m -71.04 125.19 26.2 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.573 -0.704 . . . . 0.0 110.27 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -71.42 144.98 49.59 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.661 -0.649 . . . . 0.0 110.443 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -153.87 99.05 2.59 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.742 -0.599 . . . . 0.0 110.073 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -59.39 -39.94 72.11 Favored 'Trans proline' 0 N--CA 1.487 1.147 0 O-C-N 123.175 1.092 . . . . 0.0 110.705 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.45 -155.16 48.36 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -75.75 -42.03 0.48 Allowed 'Trans proline' 0 C--N 1.316 -1.155 0 O-C-N 123.34 1.179 . . . . 0.0 110.993 -174.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -87.65 6.63 33.76 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.559 -0.713 . . . . 0.0 111.509 -173.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.69 60.97 3.33 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.98 -1.075 . . . . 0.0 110.672 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -77.89 118.87 20.62 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.63 -0.669 . . . . 0.0 109.955 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -130.04 161.42 31.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.81 -0.556 . . . . 0.0 110.068 -178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 62.9 t -126.48 145.74 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.696 -0.628 . . . . 0.0 109.893 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 78.4 p -155.43 160.29 40.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.802 -0.561 . . . . 0.0 110.043 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.498 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 71.7 m-85 -126.7 125.31 41.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.849 -0.532 . . . . 0.0 109.885 -175.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -56.79 147.91 21.94 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.551 -0.718 . . . . 0.0 110.587 -173.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -100.8 146.42 27.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.7 -0.625 . . . . 0.0 110.312 -177.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 83.9 p -143.4 163.21 33.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.669 -0.644 . . . . 0.0 110.163 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 43.9 m -61.37 157.75 16.02 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.684 -0.635 . . . . 0.0 110.186 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.4 p -72.37 63.85 0.56 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.6 -0.687 . . . . 0.0 110.083 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.95 152.68 43.38 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.536 -0.727 . . . . 0.0 110.189 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -76.21 155.49 34.43 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.66 -0.65 . . . . 0.0 110.026 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 34.9 t 53.24 29.15 8.02 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.454 -0.779 . . . . 0.0 110.903 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -60.38 132.13 52.95 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.66 -0.65 . . . . 0.0 110.241 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.403 ' OG1' ' CD1' ' A' ' 153' ' ' TRP . 43.5 p -60.1 -34.0 72.88 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.795 -0.565 . . . . 0.0 110.072 176.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.426 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -171.44 144.52 1.96 Allowed 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.397 0.617 . . . . 0.0 110.331 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.6 t -142.08 142.51 32.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.929 -0.482 . . . . 0.0 109.878 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.498 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 64.7 t80 -125.65 140.04 53.05 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.509 -0.744 . . . . 0.0 110.787 -171.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.2 t -111.7 124.88 53.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.8 -0.562 . . . . 0.0 109.958 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 59.2 m -70.95 -37.02 72.81 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.749 -0.595 . . . . 0.0 110.571 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -59.01 -34.75 72.24 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.573 -0.704 . . . . 0.0 110.444 -177.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.0 mt -104.83 -12.04 16.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.662 -0.649 . . . . 0.0 110.88 -176.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 82.3 tttt 59.73 51.62 6.1 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.074 -1.017 . . . . 0.0 109.673 178.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -145.09 153.07 41.04 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.594 -173.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.6 tp -126.56 137.73 53.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.779 -0.576 . . . . 0.0 110.24 -175.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -116.0 135.4 54.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.674 -0.641 . . . . 0.0 109.288 173.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.9 p -138.36 158.42 44.31 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.705 -0.622 . . . . 0.0 110.899 -175.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -104.5 144.07 32.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.64 -0.662 . . . . 0.0 110.277 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 17.2 tt -52.81 146.05 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-O 121.592 0.711 . . . . 0.0 111.802 -173.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 64.5 10.0 5.46 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.554 -0.716 . . . . 0.0 112.484 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -96.61 155.06 16.93 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.995 -1.066 . . . . 0.0 110.867 175.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 85.0 m -84.5 126.13 33.01 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.689 -0.632 . . . . 0.0 110.668 -177.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 44.7 t -115.37 90.19 24.12 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.576 -0.702 . . . . 0.0 110.202 174.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.426 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 21.2 Cg_exo -62.59 131.1 32.17 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.216 1.114 . . . . 0.0 110.691 173.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.421 HG12 ' CE2' ' A' ' 142' ' ' PHE . 95.1 mt -125.08 143.82 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.659 -0.651 . . . . 0.0 109.279 175.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -109.47 135.36 50.61 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.496 -0.753 . . . . 0.0 110.813 -175.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 48.7 mm -95.29 135.01 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.604 -0.685 . . . . 0.0 109.584 168.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -116.11 128.0 55.3 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.608 -0.683 . . . . 0.0 110.406 175.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.1 m -136.57 159.72 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.674 -0.641 . . . . 0.0 109.892 175.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.7 mmm -74.46 -40.44 61.89 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.704 -0.622 . . . . 0.0 110.094 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 77.5 p -135.87 143.23 43.56 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.752 -0.593 . . . . 0.0 109.825 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -55.34 139.9 81.72 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 O-C-N 123.17 1.089 . . . . 0.0 110.861 -173.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.427 ' HG3' ' CE2' ' A' ' 251' ' ' TYR . 18.0 Cg_endo -61.97 166.9 11.46 Favored 'Trans proline' 0 N--CA 1.487 1.145 0 O-C-N 123.217 1.114 . . . . 0.0 110.72 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -61.06 155.68 49.09 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 O-C-N 123.382 1.201 . . . . 0.0 110.41 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -73.55 138.66 45.11 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.652 -0.655 . . . . 0.0 109.93 176.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.57 -24.94 29.36 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -174.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.14 150.94 2.18 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.367 -1.078 . . . . 0.0 111.426 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.78 155.94 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.735 -0.603 . . . . 0.0 109.906 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.402 HD12 ' CD2' ' A' ' 251' ' ' TYR . 53.4 mt -109.61 135.57 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -114.95 145.97 41.67 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.674 -0.641 . . . . 0.0 109.292 -174.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -140.54 127.74 21.01 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.546 -0.721 . . . . 0.0 110.312 173.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 41.3 ttp -137.25 139.91 29.35 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.766 -0.584 . . . . 0.0 111.061 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -91.12 138.2 2.28 Favored 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 121.051 1.167 . . . . 0.0 110.789 177.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.8 m -147.38 154.85 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.539 -0.725 . . . . 0.0 110.06 174.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.417 ' CE2' HG21 ' A' ' 202' ' ' VAL . 78.3 m-85 -63.02 167.69 4.64 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.457 -0.777 . . . . 0.0 110.517 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -85.05 -60.12 2.14 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.657 -0.652 . . . . 0.0 110.834 -173.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -80.11 152.33 29.35 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.593 -0.692 . . . . 0.0 110.284 -175.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.67 -38.68 72.54 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.364 -0.835 . . . . 0.0 110.664 -175.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -56.58 -24.77 49.66 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.499 -0.751 . . . . 0.0 110.558 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.406 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 98.7 m-70 -109.71 -20.49 12.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.534 -0.729 . . . . 0.0 111.167 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.2 p -67.65 -20.22 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.12 -0.987 . . . . 0.0 110.581 -176.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 67.8 p -79.42 -16.85 55.48 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.544 -0.723 . . . . 0.0 110.856 174.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.35 136.41 33.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.303 -0.873 . . . . 0.0 110.086 175.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.1 t -73.0 143.26 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.661 -0.649 . . . . 0.0 110.267 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.417 HG21 ' CE2' ' A' ' 192' ' ' TYR . 60.8 t -84.94 136.39 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.625 -0.672 . . . . 0.0 109.224 171.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.8 pttt -134.89 -170.22 2.52 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.453 -0.779 . . . . 0.0 111.137 -168.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -95.3 158.96 15.23 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.776 -0.578 . . . . 0.0 110.34 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 56.9 m -77.26 157.42 80.79 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.551 -0.718 . . . . 0.0 109.304 175.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -63.37 -47.31 7.96 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 123.122 1.064 . . . . 0.0 109.97 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.431 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.3 p-10 -65.44 -43.74 89.5 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.549 -0.719 . . . . 0.0 111.091 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . 0.431 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 53.6 m170 -81.75 -27.99 33.53 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.459 -0.775 . . . . 0.0 111.266 -175.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -69.15 -38.87 79.0 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.384 -0.822 . . . . 0.0 110.402 172.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 26.7 tp -56.43 -35.91 68.38 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.57 -0.706 . . . . 0.0 110.836 -176.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 30.2 t -48.42 140.4 7.86 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.472 -0.767 . . . . 0.0 111.313 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.418 ' HB2' ' CE2' ' A' ' 214' ' ' PHE . 92.3 mtt-85 -60.33 141.08 56.71 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.575 -0.703 . . . . 0.0 110.274 -176.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -65.51 -32.81 74.62 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.692 -0.63 . . . . 0.0 110.518 -176.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.418 ' CE2' ' HB2' ' A' ' 212' ' ' ARG . 52.2 m-85 51.2 47.54 24.66 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.534 -0.729 . . . . 0.0 110.975 -175.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -73.38 -10.15 59.44 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.737 -0.602 . . . . 0.0 111.346 -175.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -58.5 113.03 1.8 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.206 -0.934 . . . . 0.0 110.743 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 73.97 19.98 79.74 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 174.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -114.89 140.15 49.21 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.303 -1.116 . . . . 0.0 110.471 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.8 mt -84.91 -25.06 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.688 -0.632 . . . . 0.0 110.416 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -124.99 93.95 44.83 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.462 -0.774 . . . . 0.0 110.586 -176.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.41 ' HD2' ' CE2' ' A' ' 236' ' ' TYR . 24.7 Cg_endo -67.21 144.29 68.15 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 O-C-N 123.323 1.17 . . . . 0.0 110.445 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -57.49 -19.59 37.05 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 O-C-N 123.124 1.065 . . . . 0.0 111.528 -177.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 27.4 m -51.26 -26.95 8.07 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.187 -0.946 . . . . 0.0 111.444 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -102.58 130.53 49.47 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.458 -0.776 . . . . 0.0 110.269 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 39.5 tp -60.58 -38.14 83.63 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.641 -0.662 . . . . 0.0 110.285 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 83.2 mt -101.42 136.77 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.795 -0.566 . . . . 0.0 109.84 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -131.69 156.98 44.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.688 -0.633 . . . . 0.0 110.328 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 88.3 t -103.13 146.65 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.749 -0.595 . . . . 0.0 109.941 176.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -118.24 126.76 52.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.721 -0.612 . . . . 0.0 110.368 171.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 96.98 21.4 20.91 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 168.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -139.4 105.23 5.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.3 -1.118 . . . . 0.0 110.038 174.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 91.6 p -63.65 -15.1 57.42 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.604 -0.685 . . . . 0.0 111.232 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -97.02 9.97 40.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.245 -0.909 . . . . 0.0 111.235 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.75 130.49 46.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.127 -0.983 . . . . 0.0 110.09 175.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -139.74 157.96 44.89 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.668 -0.645 . . . . 0.0 109.862 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.41 ' CE2' ' HD2' ' A' ' 221' ' ' PRO . 88.0 m-85 -118.58 150.81 39.03 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.576 -0.702 . . . . 0.0 110.646 -176.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.11 159.9 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.776 -0.578 . . . . 0.0 110.128 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -120.38 130.04 54.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.738 -0.601 . . . . 0.0 110.262 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.27 119.08 46.3 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.625 -0.672 . . . . 0.0 109.669 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.16 -27.7 78.93 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 O-C-N 123.059 1.031 . . . . 0.0 110.874 -172.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 84.0 mt -102.99 -50.32 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.434 -0.792 . . . . 0.0 110.952 -170.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 18.6 p -105.33 12.23 31.92 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.379 -0.826 . . . . 0.0 111.975 -171.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 82.95 -25.04 4.9 Favored Glycine 0 N--CA 1.497 2.737 0 O-C-N 121.009 -1.057 . . . . 0.0 111.825 168.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -45.89 142.13 2.75 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 118.598 1.199 . . . . 0.0 112.627 -168.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -105.22 146.9 28.65 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.659 -0.651 . . . . 0.0 110.036 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.2 p -154.74 159.92 40.99 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.576 -0.703 . . . . 0.0 110.35 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 8.4 p -122.92 148.1 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.729 -0.607 . . . . 0.0 109.814 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 81.9 mt -129.71 154.61 46.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.738 -0.601 . . . . 0.0 109.891 -175.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 33.8 m -151.3 151.84 29.91 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.878 -0.514 . . . . 0.0 109.935 175.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -71.04 138.95 34.81 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 O-C-N 123.269 1.142 . . . . 0.0 109.95 177.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.427 ' CE2' ' HG3' ' A' ' 180' ' ' PRO . 10.0 t80 -78.69 126.51 30.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.496 -0.753 . . . . 0.0 110.21 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -99.97 160.05 28.22 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.695 -0.628 . . . . 0.0 110.059 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -59.17 159.53 22.01 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.234 1.123 . . . . 0.0 110.423 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.38 149.96 78.02 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 O-C-N 123.261 1.137 . . . . 0.0 110.536 -177.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -61.3 148.09 42.4 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.679 -0.638 . . . . 0.0 110.2 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.9 t -69.84 127.2 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.563 -0.711 . . . . 0.0 110.178 -170.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.03 -10.14 55.23 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.405 ' OG1' ' CE2' ' A' ' 260' ' ' PHE . 10.0 t -144.5 173.25 11.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.169 -1.195 . . . . 0.0 110.642 175.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -106.9 13.22 27.98 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.674 -0.641 . . . . 0.0 111.743 -168.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . 0.405 ' CE2' ' OG1' ' A' ' 258' ' ' THR . 14.8 p90 -119.99 168.06 11.54 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.159 -0.963 . . . . 0.0 111.092 -175.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 84.1 m -117.75 145.69 44.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.813 -0.554 . . . . 0.0 109.837 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 52.2 m -114.94 135.54 54.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.594 -0.691 . . . . 0.0 110.934 -174.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.6 t -130.12 137.24 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 72.1 mt -104.73 119.07 38.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.581 -0.7 . . . . 0.0 109.863 -172.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -105.89 151.24 24.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.675 -0.64 . . . . 0.0 110.614 -177.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -136.6 142.91 43.35 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -112.23 131.06 55.7 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.518 -0.739 . . . . 0.0 110.437 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -100.23 7.43 44.48 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.683 -0.636 . . . . 0.0 111.972 -175.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -144.76 164.95 29.48 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.075 -1.016 . . . . 0.0 109.834 171.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -120.7 161.94 20.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.651 -0.656 . . . . 0.0 110.456 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 22.5 m -58.08 -33.42 69.05 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.48 -0.762 . . . . 0.0 111.082 -163.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 48.8 p -99.4 11.5 38.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.466 -0.771 . . . . 0.0 112.011 -163.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 30.2 p -94.48 118.01 31.0 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.124 -0.985 . . . . 0.0 110.672 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.7 t -64.12 140.04 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.504 -0.748 . . . . 0.0 110.412 -169.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.46 -5.21 58.63 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -125.46 -100.43 1.25 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 170.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 93.3 mmm -64.28 -31.44 72.65 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.687 -0.89 . . . . 0.0 110.319 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.7 p30 43.38 51.51 5.98 Favored 'General case' 0 N--CA 1.505 2.301 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 175.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 54.81 27.05 8.39 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.275 -0.891 . . . . 0.0 111.145 175.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -118.32 105.91 45.72 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.575 -0.703 . . . . 0.0 110.057 176.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.51 147.27 92.27 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 O-C-N 123.119 1.063 . . . . 0.0 110.6 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 45.7 pt -131.88 178.32 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 121.744 0.783 . . . . 0.0 110.832 -177.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 31.3 mt -124.4 149.87 46.22 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.422 ' HB ' ' CZ ' ' A' ' 301' ' ' PHE . 81.2 mt -115.27 130.34 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 82.0 mt -109.74 126.26 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -176.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 59.7 t -118.9 126.71 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.6 p -125.26 152.76 44.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.637 -0.665 . . . . 0.0 110.665 -174.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 19.8 tp -102.59 126.17 49.58 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 168.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -131.78 149.13 52.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.814 -0.554 . . . . 0.0 110.003 -172.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 19.0 p -89.98 161.11 16.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.706 -0.621 . . . . 0.0 110.115 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -55.95 -26.12 46.52 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.603 -0.686 . . . . 0.0 111.094 -176.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 46.0 p30 -90.18 9.66 27.57 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.399 -0.813 . . . . 0.0 111.889 -173.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 88.79 20.19 48.23 Favored Glycine 0 N--CA 1.494 2.542 0 O-C-N 121.12 -0.987 . . . . 0.0 110.655 171.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -107.98 140.15 41.56 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.267 -1.137 . . . . 0.0 110.025 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 60.8 t -88.74 132.23 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.65 -0.656 . . . . 0.0 110.234 -172.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 96.2 mt -99.88 -40.08 7.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.707 -0.62 . . . . 0.0 110.532 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -162.61 150.83 20.33 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 78.5 mtm180 -135.15 134.77 40.52 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.686 -0.89 . . . . 0.0 110.566 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -137.34 158.69 43.87 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.676 -0.64 . . . . 0.0 109.982 172.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 97.7 m -142.56 155.69 45.03 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.424 -0.797 . . . . 0.0 110.713 -175.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.422 ' CZ ' ' HB ' ' A' ' 284' ' ' ILE . 47.9 p90 -144.94 163.73 33.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.72 -0.612 . . . . 0.0 110.113 175.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -104.91 135.37 46.39 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.496 -0.752 . . . . 0.0 110.151 -177.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -124.29 143.5 50.52 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.677 -170.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -138.67 139.01 38.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.843 -0.536 . . . . 0.0 109.806 173.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 74.5 mt -105.82 122.93 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.549 -0.72 . . . . 0.0 109.59 175.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.9 p -145.18 168.24 20.85 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.558 -0.714 . . . . 0.0 110.968 -170.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -68.8 -39.97 79.81 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.686 -0.633 . . . . 0.0 110.636 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 4.1 t -131.25 88.54 44.2 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.534 -0.729 . . . . 0.0 110.496 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.33 -29.35 67.3 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 O-C-N 123.185 1.098 . . . . 0.0 110.914 174.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.36 -37.77 93.07 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -73.25 -40.63 64.48 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.689 -0.889 . . . . 0.0 109.875 -173.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -69.47 -39.96 77.4 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.164 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -61.01 -44.15 97.83 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.456 -0.777 . . . . 0.0 110.289 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -64.68 -40.14 94.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.557 -0.714 . . . . 0.0 110.495 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.57 -50.05 74.2 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.499 -0.751 . . . . 0.0 110.486 -173.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -61.3 -37.82 84.58 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.501 -0.749 . . . . 0.0 110.084 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -63.49 -40.53 97.32 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.625 -0.672 . . . . 0.0 110.166 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -62.48 -35.2 78.58 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.603 -0.685 . . . . 0.0 109.977 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 23.8 m -62.8 -33.66 75.66 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.719 -0.613 . . . . 0.0 110.228 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 83.5 mt -78.34 -44.41 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.606 -0.684 . . . . 0.0 109.936 -177.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -58.95 -40.64 85.27 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.658 -0.651 . . . . 0.0 110.503 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -61.39 -44.33 97.33 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.613 -0.679 . . . . 0.0 110.185 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -63.9 -33.77 76.45 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.66 -0.65 . . . . 0.0 110.236 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -98.09 125.12 42.94 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.675 -0.64 . . . . 0.0 110.411 -176.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.53 130.05 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.65 -0.656 . . . . 0.0 109.783 178.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 29.4 t -95.06 139.98 30.65 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.595 -0.69 . . . . 0.0 110.39 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -84.65 124.41 31.44 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.668 -0.645 . . . . 0.0 110.207 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 11.0 t -61.17 148.27 41.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.566 -0.709 . . . . 0.0 110.175 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 76.9 p -99.83 22.01 11.71 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.62 -0.675 . . . . 0.0 110.901 -176.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -60.09 -36.53 77.6 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.464 -0.772 . . . . 0.0 110.226 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -111.66 138.59 48.03 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.67 -0.644 . . . . 0.0 110.145 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -60.26 -36.04 89.76 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -160.44 160.03 31.66 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.655 -0.909 . . . . 0.0 110.366 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -87.88 130.86 34.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.63 -0.669 . . . . 0.0 110.17 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -72.33 -44.92 61.96 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.685 -0.634 . . . . 0.0 110.397 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -85.85 -37.24 19.4 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.637 -0.664 . . . . 0.0 110.506 -176.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 53.72 46.73 25.29 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.395 -0.815 . . . . 0.0 110.744 -178.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -101.34 133.32 46.11 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.649 -0.657 . . . . 0.0 110.439 -177.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 76.4 p -97.0 26.27 4.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.626 -0.671 . . . . 0.0 110.398 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -68.71 154.07 42.63 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.568 -0.708 . . . . 0.0 110.239 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 97.7 168.81 32.48 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 50.9 mm -94.14 136.1 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.604 -0.939 . . . . 0.0 110.089 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -84.94 -38.04 19.82 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.602 -0.686 . . . . 0.0 110.382 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 23.0 ptt? -138.83 55.05 1.73 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.58 -0.7 . . . . 0.0 110.443 -177.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 51.0 m . . . . . 0 N--CA 1.5 2.047 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.823 179.426 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 75.2 m -86.28 9.31 18.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.587 -0.949 . . . . 0.0 111.361 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 86.8 p -61.64 -28.36 69.32 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.212 -0.93 . . . . 0.0 110.257 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.9 p -122.44 161.67 23.09 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.643 -0.66 . . . . 0.0 110.295 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -133.51 151.74 51.8 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.655 -0.653 . . . . 0.0 110.33 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -88.67 119.46 29.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.633 -0.667 . . . . 0.0 110.45 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 50.1 83.36 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.543 -0.723 . . . . 0.0 111.404 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 88.7 mt 51.38 -176.23 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.345 -0.847 . . . . 0.0 111.111 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.3 p -130.47 161.04 63.05 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.601 -0.687 . . . . 0.0 110.245 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -61.76 151.86 78.04 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 O-C-N 123.273 1.144 . . . . 0.0 110.333 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 79.1 p -81.47 141.56 49.14 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.632 -0.667 . . . . 0.0 110.078 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.73 144.97 85.63 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 O-C-N 123.244 1.128 . . . . 0.0 110.533 -177.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.43 141.4 41.4 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.665 -0.647 . . . . 0.0 110.03 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 50.4 mm -123.52 99.95 38.86 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.698 -0.626 . . . . 0.0 110.062 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -61.13 152.99 67.82 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 O-C-N 123.236 1.124 . . . . 0.0 110.461 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.5 t -108.4 148.64 29.84 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.667 -0.645 . . . . 0.0 110.233 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.5 p-10 -94.06 23.22 5.11 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.69 -0.631 . . . . 0.0 110.915 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 50.4 m -75.4 125.16 28.44 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.445 -0.785 . . . . 0.0 110.233 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -69.61 144.97 52.84 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.639 -0.663 . . . . 0.0 110.478 -177.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -153.18 100.59 2.65 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.647 -0.658 . . . . 0.0 110.118 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -59.14 -39.96 74.3 Favored 'Trans proline' 0 N--CA 1.489 1.206 0 O-C-N 123.129 1.068 . . . . 0.0 110.774 -175.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.3 -155.17 48.59 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -75.47 -43.57 0.35 Allowed 'Trans proline' 0 C--N 1.317 -1.095 0 O-C-N 123.303 1.159 . . . . 0.0 110.978 -174.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -86.77 8.1 24.12 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.529 -0.732 . . . . 0.0 111.412 -173.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.39 59.67 4.23 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.997 -1.064 . . . . 0.0 110.72 -176.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -77.82 117.25 19.01 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.572 -0.705 . . . . 0.0 109.933 -178.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -130.05 160.01 35.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.855 -0.528 . . . . 0.0 110.141 -178.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 63.8 t -126.41 146.42 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.681 -0.637 . . . . 0.0 109.816 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 78.4 p -155.26 161.4 41.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.765 -0.584 . . . . 0.0 110.069 177.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.497 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 67.1 m-85 -126.74 125.24 41.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.8 -0.562 . . . . 0.0 109.851 -176.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -57.47 144.05 38.17 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.594 -0.691 . . . . 0.0 110.267 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -120.05 156.18 31.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.608 -0.682 . . . . 0.0 110.747 -173.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 23.2 t -148.21 165.74 30.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.725 -0.609 . . . . 0.0 109.994 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 54.5 p -61.43 162.74 7.56 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.585 -0.697 . . . . 0.0 110.058 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 71.7 p -59.96 92.44 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.563 -0.71 . . . . 0.0 110.263 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.06 148.86 22.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.734 -0.604 . . . . 0.0 110.256 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -72.81 137.22 45.62 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.686 -0.634 . . . . 0.0 110.132 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.3 m 53.41 51.43 15.37 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.492 -0.755 . . . . 0.0 110.96 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.98 132.96 46.73 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.623 -0.673 . . . . 0.0 110.172 177.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 82.1 p -60.03 -32.92 71.34 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.715 -0.616 . . . . 0.0 109.99 175.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.418 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.8 p-90 -171.04 143.74 2.02 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.329 0.585 . . . . 0.0 110.059 177.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.0 t -142.15 142.63 32.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.88 -0.513 . . . . 0.0 110.072 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.497 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 44.7 t80 -125.49 140.06 53.09 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.551 -0.718 . . . . 0.0 110.514 -172.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.8 t -111.79 124.94 53.41 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 120.383 -0.527 . . . . 0.0 109.878 176.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 56.5 m -70.68 -37.07 73.61 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.789 -0.569 . . . . 0.0 110.483 -177.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -59.49 -33.86 71.86 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.645 -0.659 . . . . 0.0 110.441 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 57.1 mt -104.77 -12.04 16.52 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.678 -0.639 . . . . 0.0 110.88 -175.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 30.5 tttt 59.77 50.3 7.19 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.051 -1.031 . . . . 0.0 109.675 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -146.42 153.09 40.07 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.74 -0.6 . . . . 0.0 110.612 -174.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.6 tp -126.55 137.85 53.4 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.833 -0.542 . . . . 0.0 110.209 -176.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -114.94 135.2 54.47 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.1 p -138.34 158.5 44.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.72 -0.612 . . . . 0.0 111.044 -175.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -104.45 140.94 37.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.628 -0.67 . . . . 0.0 110.021 172.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 17.1 tt -52.25 148.67 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.502 -0.749 . . . . 0.0 111.917 -172.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 64.79 10.05 5.77 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.539 -0.726 . . . . 0.0 112.509 176.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt -95.35 155.11 16.87 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.924 -1.11 . . . . 0.0 110.955 174.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 87.3 m -84.68 126.25 33.22 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.721 -0.612 . . . . 0.0 110.552 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 29.9 t -115.15 90.36 23.62 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.572 -0.705 . . . . 0.0 110.178 176.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.418 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 22.6 Cg_endo -65.83 130.82 25.59 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 O-C-N 123.271 1.143 . . . . 0.0 110.597 176.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.417 HG12 ' CE2' ' A' ' 142' ' ' PHE . 96.9 mt -123.51 142.06 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.692 -0.63 . . . . 0.0 109.306 176.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -109.08 134.7 51.34 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.552 -0.718 . . . . 0.0 110.713 -176.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.1 mm -95.29 134.76 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.67 -0.644 . . . . 0.0 109.66 169.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -115.16 127.27 55.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.593 -0.692 . . . . 0.0 110.452 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.0 m -136.66 159.77 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.639 -0.663 . . . . 0.0 109.852 174.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.6 mmm -76.32 -40.69 50.73 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.658 -0.651 . . . . 0.0 110.092 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 77.5 p -134.45 143.28 46.09 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.763 -0.586 . . . . 0.0 109.9 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -55.5 139.92 82.64 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 O-C-N 123.173 1.091 . . . . 0.0 110.947 -173.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.423 ' HG3' ' CE2' ' A' ' 251' ' ' TYR . 19.3 Cg_endo -59.95 165.2 10.67 Favored 'Trans proline' 0 C--N 1.316 -1.167 0 O-C-N 123.17 1.09 . . . . 0.0 110.656 177.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -62.04 154.86 59.25 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 O-C-N 123.312 1.164 . . . . 0.0 110.446 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -64.67 137.54 57.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.65 -0.656 . . . . 0.0 110.117 173.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 96.8 -24.96 28.67 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.861 -1.295 . . . . 0.0 109.861 -177.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.15 149.21 2.96 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.324 -1.104 . . . . 0.0 111.423 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.74 155.95 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.72 -0.612 . . . . 0.0 109.831 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.423 HD11 ' CD2' ' A' ' 251' ' ' TYR . 64.0 mt -108.79 135.21 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -114.95 145.85 41.8 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -174.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -140.54 126.53 19.51 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.534 -0.729 . . . . 0.0 110.212 173.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 32.9 ttp -137.22 139.0 26.76 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.804 -0.56 . . . . 0.0 110.98 -176.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -91.11 138.25 2.29 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 O-C-N 123.204 1.107 . . . . 0.0 110.81 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 35.9 m -146.22 154.87 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.554 -0.716 . . . . 0.0 110.118 173.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.45 ' CE2' ' CG2' ' A' ' 202' ' ' VAL . 83.4 m-85 -60.73 161.32 8.07 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.467 -0.771 . . . . 0.0 110.402 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 33.7 tttt -77.6 -60.07 2.52 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.632 -0.668 . . . . 0.0 110.827 -174.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -80.13 151.02 30.02 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.558 -0.713 . . . . 0.0 110.34 -175.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.54 -37.81 71.0 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.421 -0.8 . . . . 0.0 110.695 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -56.61 -24.78 50.28 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.529 -0.732 . . . . 0.0 110.573 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.404 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 64.2 m170 -109.49 -20.51 12.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.531 -0.731 . . . . 0.0 111.165 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.2 p -67.72 -20.22 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.174 -0.954 . . . . 0.0 110.574 -176.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 67.7 p -79.36 -16.98 55.4 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.562 -0.711 . . . . 0.0 110.735 174.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -88.36 137.3 32.45 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.349 -0.845 . . . . 0.0 110.092 173.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.9 t -73.0 142.0 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.626 -0.671 . . . . 0.0 110.299 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.45 ' CG2' ' CE2' ' A' ' 192' ' ' TYR . 75.8 t -84.96 139.7 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.542 -0.724 . . . . 0.0 109.344 170.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 14.7 pttt -134.86 -170.08 2.49 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.553 -0.717 . . . . 0.0 110.883 -170.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -95.13 154.72 17.05 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.741 -0.599 . . . . 0.0 110.286 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 42.0 m -72.75 154.75 91.19 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.632 -0.668 . . . . 0.0 109.271 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -62.52 -47.31 9.68 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 O-C-N 123.123 1.065 . . . . 0.0 110.048 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.414 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.6 p-10 -65.45 -44.16 88.11 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.599 -0.688 . . . . 0.0 111.223 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . 0.414 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 52.1 m170 -82.23 -28.0 32.19 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.453 -0.779 . . . . 0.0 111.171 -174.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -69.08 -37.24 78.36 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.395 -0.815 . . . . 0.0 110.297 172.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 26.4 tp -55.52 -33.61 63.92 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.558 -0.714 . . . . 0.0 110.898 -177.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 31.1 t -48.29 145.73 3.16 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.535 -0.728 . . . . 0.0 111.292 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -59.95 142.19 54.21 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.585 -0.697 . . . . 0.0 110.388 -175.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -61.12 -39.84 91.53 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.62 -0.675 . . . . 0.0 110.174 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.404 ' O ' ' CD2' ' A' ' 214' ' ' PHE . 55.2 t80 50.52 50.69 18.35 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.486 -0.759 . . . . 0.0 111.091 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -75.13 -10.18 59.23 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.633 -0.667 . . . . 0.0 111.334 -178.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -58.96 114.06 2.38 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.116 -0.99 . . . . 0.0 110.731 -177.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 74.63 20.06 79.67 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 173.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -114.85 139.93 49.36 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.334 -1.098 . . . . 0.0 110.469 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 83.8 mt -88.27 -25.21 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.6 -0.688 . . . . 0.0 110.364 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -126.7 97.55 33.01 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.497 -0.752 . . . . 0.0 110.472 -177.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -64.21 144.28 86.16 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 O-C-N 123.368 1.193 . . . . 0.0 110.48 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -57.47 -20.02 38.89 Favored 'Trans proline' 0 N--CA 1.489 1.246 0 O-C-N 123.153 1.081 . . . . 0.0 111.449 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 87.5 p -53.78 -22.49 9.54 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.192 -0.943 . . . . 0.0 111.283 -176.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . 0.406 ' CD2' ' HB3' ' A' ' 236' ' ' TYR . 77.4 m80 -103.74 130.4 51.25 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.493 -0.754 . . . . 0.0 110.352 178.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 30.1 tp -61.0 -37.69 83.41 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.673 -0.642 . . . . 0.0 110.289 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 84.8 mt -103.94 136.76 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.746 -0.596 . . . . 0.0 109.917 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -131.6 156.7 45.34 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.667 -0.646 . . . . 0.0 110.318 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 89.4 t -102.28 146.62 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.772 -0.58 . . . . 0.0 109.974 176.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -117.96 130.03 55.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.722 -0.611 . . . . 0.0 110.431 171.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 93.15 21.55 29.81 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 167.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -136.73 107.24 6.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.319 -1.107 . . . . 0.0 110.048 173.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 94.5 p -63.43 -15.14 56.79 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.651 -0.656 . . . . 0.0 111.192 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -97.27 10.05 40.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.272 -0.892 . . . . 0.0 111.189 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.81 126.58 27.84 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.174 -0.954 . . . . 0.0 110.092 176.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -139.75 154.39 47.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.762 -0.586 . . . . 0.0 109.785 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.406 ' HB3' ' CD2' ' A' ' 224' ' ' HIS . 86.3 m-85 -116.95 150.7 38.11 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.596 -0.69 . . . . 0.0 110.538 -176.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.17 159.89 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.762 -0.587 . . . . 0.0 110.118 176.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -122.86 130.0 52.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.75 -0.594 . . . . 0.0 110.177 177.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -64.98 109.98 3.6 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.649 -0.657 . . . . 0.0 109.741 176.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -59.98 -24.46 76.51 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.083 1.044 . . . . 0.0 111.032 -172.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 84.3 mt -99.87 -50.39 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.488 -0.757 . . . . 0.0 110.766 -171.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 6.2 p -105.3 12.09 32.13 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.365 -0.834 . . . . 0.0 111.984 -173.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 81.97 -24.98 4.3 Favored Glycine 0 N--CA 1.496 2.7 0 O-C-N 120.982 -1.074 . . . . 0.0 111.888 169.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 -45.88 142.08 2.76 Favored 'General case' 0 N--CA 1.505 2.282 0 CA-C-N 118.59 1.195 . . . . 0.0 112.614 -168.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -108.8 144.58 36.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.629 -0.669 . . . . 0.0 110.063 174.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 78.8 p -154.83 159.96 40.91 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.62 -0.675 . . . . 0.0 110.48 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.401 ' HB ' ' CD1' ' A' ' 236' ' ' TYR . 8.3 p -123.07 148.12 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.77 -0.581 . . . . 0.0 109.695 177.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 81.3 mt -129.71 154.64 46.97 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.896 -176.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 35.9 m -150.57 151.84 31.48 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.807 -0.558 . . . . 0.0 109.944 175.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -71.11 138.81 34.31 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 O-C-N 123.188 1.099 . . . . 0.0 109.844 177.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.423 ' CD2' HD11 ' A' ' 186' ' ' ILE . 9.0 t80 -78.45 126.06 30.23 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.454 -0.779 . . . . 0.0 110.04 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -100.0 160.11 28.06 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.719 -0.613 . . . . 0.0 110.02 177.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -59.11 159.62 21.48 Favored 'Trans proline' 0 C--N 1.316 -1.157 0 O-C-N 123.276 1.145 . . . . 0.0 110.401 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.36 149.98 77.8 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.268 1.141 . . . . 0.0 110.521 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -60.53 148.42 37.95 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.681 -0.637 . . . . 0.0 110.241 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.82 127.17 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.516 -0.74 . . . . 0.0 110.154 -170.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.99 -10.17 55.39 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.401 ' OG1' ' CD2' ' A' ' 260' ' ' PHE . 10.0 t -144.66 173.31 11.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.177 -1.19 . . . . 0.0 110.586 175.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -107.19 13.14 27.6 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.63 -0.669 . . . . 0.0 111.783 -168.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . 0.401 ' CD2' ' OG1' ' A' ' 258' ' ' THR . 15.2 p90 -119.99 168.05 11.54 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.11 -0.994 . . . . 0.0 111.083 -175.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 83.6 m -117.72 145.83 44.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.729 -0.607 . . . . 0.0 109.876 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 42.8 m -115.59 135.72 53.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.622 -0.674 . . . . 0.0 110.885 -175.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.4 t -129.7 137.32 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 62.8 mt -104.63 118.57 36.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.511 -0.743 . . . . 0.0 109.73 -172.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -105.56 151.31 24.48 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.694 -0.629 . . . . 0.0 110.578 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -136.53 142.9 43.48 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -112.53 129.26 56.42 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.608 -0.682 . . . . 0.0 110.458 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -98.23 -1.84 41.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.741 -0.6 . . . . 0.0 111.95 -176.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.73 159.11 43.38 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.117 -0.989 . . . . 0.0 109.839 174.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -113.95 153.49 29.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.732 -0.605 . . . . 0.0 110.059 178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 89.1 p -56.54 -26.51 55.09 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.43 -0.794 . . . . 0.0 111.189 -168.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 49.8 p -94.4 8.09 43.22 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.396 -0.815 . . . . 0.0 112.095 -166.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 28.8 p -92.98 116.61 29.21 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.009 -1.057 . . . . 0.0 110.584 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.39 143.3 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.482 -0.761 . . . . 0.0 110.414 -166.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.55 -5.33 58.55 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.96 -93.13 0.66 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 170.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 94.3 mmm -66.31 -29.06 69.19 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.731 -0.864 . . . . 0.0 110.36 176.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.8 p30 45.1 52.46 8.41 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 172.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 54.91 33.14 19.33 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.255 -0.903 . . . . 0.0 111.227 174.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -113.97 104.95 54.84 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.511 -0.743 . . . . 0.0 110.245 173.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -61.1 145.49 98.81 Favored 'Trans proline' 0 N--CA 1.488 1.171 0 O-C-N 123.107 1.056 . . . . 0.0 110.293 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 44.0 pt -131.97 176.82 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.943 0.878 . . . . 0.0 111.244 -174.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 31.4 mt -124.29 149.86 46.05 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.423 HD12 ' CE1' ' A' ' 301' ' ' PHE . 81.6 mt -114.85 129.4 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.253 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 80.4 mt -109.8 126.26 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -176.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 58.3 t -118.96 126.77 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.3 p -125.27 152.24 44.9 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.621 -174.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 21.1 tp -101.44 125.29 48.06 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 167.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -131.17 150.84 51.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.85 -0.531 . . . . 0.0 109.979 -172.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 68.9 p -89.96 159.88 16.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.606 -0.684 . . . . 0.0 109.908 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -55.95 -26.1 46.48 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.523 -0.735 . . . . 0.0 110.809 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -87.5 9.69 20.12 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.477 -0.764 . . . . 0.0 111.862 -174.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 86.9 20.16 54.23 Favored Glycine 0 N--CA 1.495 2.567 0 C-N-CA 120.195 -1.002 . . . . 0.0 110.733 170.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -106.84 140.14 40.14 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.293 -1.122 . . . . 0.0 110.267 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 59.9 t -88.32 130.15 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.65 -0.656 . . . . 0.0 110.034 -175.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 96.0 mt -99.94 -40.15 7.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.681 -0.637 . . . . 0.0 110.46 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -160.14 147.9 15.56 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -135.09 134.4 40.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.644 -0.915 . . . . 0.0 110.565 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -137.47 158.95 43.28 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.654 -0.654 . . . . 0.0 110.036 172.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 92.8 m -142.26 155.73 45.25 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.467 -0.771 . . . . 0.0 110.745 -175.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.423 ' CE1' HD12 ' A' ' 284' ' ' ILE . 48.9 p90 -144.98 160.54 41.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.701 -0.625 . . . . 0.0 110.074 174.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -104.88 135.92 45.33 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.539 -0.726 . . . . 0.0 110.178 -177.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -118.41 143.74 46.45 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.812 -169.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -138.57 138.07 37.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.819 -0.551 . . . . 0.0 109.759 173.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 34.8 mt -110.8 122.85 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.538 -0.726 . . . . 0.0 109.495 178.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.3 p -145.25 171.9 13.9 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.561 -0.712 . . . . 0.0 111.035 -169.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -70.32 -40.06 74.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.681 -0.637 . . . . 0.0 110.653 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 4.5 t -132.37 89.98 35.23 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.574 -0.704 . . . . 0.0 110.525 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.18 -30.08 69.5 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.15 1.079 . . . . 0.0 111.032 174.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.03 -37.48 93.19 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -73.66 -40.59 63.6 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.701 -0.882 . . . . 0.0 109.895 -173.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -69.56 -39.99 77.05 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 120.084 -0.647 . . . . 0.0 110.236 -177.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -61.26 -43.77 98.34 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.382 177.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -64.86 -38.36 90.71 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.524 -0.735 . . . . 0.0 110.461 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.84 -49.76 75.0 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.539 -0.726 . . . . 0.0 110.539 -173.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -60.84 -37.68 82.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.488 -0.758 . . . . 0.0 110.138 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -63.29 -40.69 98.07 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.622 -0.674 . . . . 0.0 110.11 177.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -62.62 -35.15 78.66 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.705 -0.622 . . . . 0.0 109.929 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 23.8 m -62.01 -33.44 74.34 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.74 -0.6 . . . . 0.0 110.183 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 83.5 mt -77.78 -45.62 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.607 -0.683 . . . . 0.0 110.014 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -60.52 -38.02 83.04 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.616 -0.678 . . . . 0.0 110.441 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 34.8 tttm -60.48 -39.94 89.48 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.589 -0.694 . . . . 0.0 110.189 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -60.52 -33.17 72.25 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.726 -0.609 . . . . 0.0 110.094 176.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -98.32 125.05 43.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.727 -0.608 . . . . 0.0 110.339 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 61.8 t -114.86 130.02 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.557 -0.715 . . . . 0.0 109.995 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 65.3 p -95.11 140.1 30.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.59 -0.694 . . . . 0.0 110.225 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -74.23 136.68 42.73 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.681 -0.637 . . . . 0.0 110.153 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 58.4 p -80.55 157.54 26.05 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.616 -0.678 . . . . 0.0 110.21 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 77.3 p -102.12 19.91 17.67 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.688 -0.632 . . . . 0.0 110.871 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 20.0 mtpp -60.42 -38.0 82.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.346 -0.846 . . . . 0.0 110.279 -178.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -60.42 -34.83 74.51 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.669 -0.644 . . . . 0.0 110.312 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 98.55 -27.43 19.63 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 59.46 79.89 0.21 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.437 -1.037 . . . . 0.0 110.257 175.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -92.57 119.67 32.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.622 -0.674 . . . . 0.0 110.193 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -61.09 -44.27 97.61 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.657 -0.652 . . . . 0.0 110.27 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 55.99 161.98 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.566 -0.709 . . . . 0.0 110.869 -175.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -61.12 -35.77 77.94 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.5 -0.75 . . . . 0.0 110.23 179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -105.43 129.9 53.64 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.615 -0.678 . . . . 0.0 110.297 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 9.2 t -130.99 157.38 43.13 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.711 -0.618 . . . . 0.0 110.403 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -122.68 145.4 48.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.659 -0.65 . . . . 0.0 110.264 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -73.05 64.47 1.59 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 82.6 mt -92.95 138.95 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.662 -0.905 . . . . 0.0 110.006 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -90.76 135.34 33.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.617 -0.677 . . . . 0.0 110.224 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 71.0 mtm -60.42 -35.34 75.56 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.665 -0.647 . . . . 0.0 110.33 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 30.0 p . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.239 -179.831 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 82.5 p -81.86 -24.33 35.85 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.657 -0.908 . . . . 0.0 110.508 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.8 m -119.18 148.71 42.8 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.493 -0.755 . . . . 0.0 110.287 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 46.3 m -120.74 142.39 49.58 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.71 -0.619 . . . . 0.0 110.222 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -114.13 149.57 35.43 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.656 -0.653 . . . . 0.0 110.212 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 55.7 p30 -88.25 11.49 16.37 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.647 -0.658 . . . . 0.0 111.515 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 58.16 -82.97 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.223 -0.923 . . . . 0.0 110.731 -175.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 34.4 tp 56.1 -85.78 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.444 -0.785 . . . . 0.0 110.801 -176.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 59.5 p -73.41 150.97 89.58 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.117 -0.99 . . . . 0.0 109.977 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.65 154.96 39.38 Favored 'Cis proline' 0 N--CA 1.494 1.543 0 C-N-CA 123.215 -1.577 . . . . 0.0 110.317 -22.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 2.4 m -80.39 147.28 63.71 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.672 -0.643 . . . . 0.0 110.341 -176.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -61.43 146.02 97.53 Favored 'Trans proline' 0 C--N 1.318 -1.069 0 O-C-N 123.264 1.139 . . . . 0.0 110.526 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.9 141.97 42.21 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.666 -0.646 . . . . 0.0 110.097 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 50.6 mm -123.01 99.94 40.53 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.623 -0.673 . . . . 0.0 110.026 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -60.93 151.26 79.07 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 O-C-N 123.287 1.151 . . . . 0.0 110.538 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.9 t -110.08 147.69 33.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.655 -0.653 . . . . 0.0 110.338 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -95.05 24.79 4.6 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.717 -0.614 . . . . 0.0 110.756 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 52.0 m -74.96 125.23 28.45 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.587 -0.696 . . . . 0.0 110.263 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -69.88 144.93 52.34 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.675 -0.64 . . . . 0.0 110.496 -177.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -156.96 102.33 1.93 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.675 -0.64 . . . . 0.0 110.048 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.97 -39.98 66.09 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 O-C-N 123.138 1.073 . . . . 0.0 110.699 -175.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.39 -155.15 43.35 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -72.65 -48.97 0.28 Allowed 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.318 1.168 . . . . 0.0 110.813 -175.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -83.77 4.64 28.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.537 -0.727 . . . . 0.0 111.369 -175.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 t 54.12 61.22 3.15 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.908 -1.12 . . . . 0.0 110.664 -176.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.423 ' CE1' ' HB2' ' A' ' 288' ' ' LEU . 63.0 t80 -77.96 119.92 22.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.522 -0.736 . . . . 0.0 110.04 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -129.98 160.01 34.93 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.778 -0.576 . . . . 0.0 110.072 -176.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.2 t -124.55 146.34 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.789 -0.57 . . . . 0.0 109.754 177.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.3 p -155.12 162.96 40.86 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.325 0.583 . . . . 0.0 109.941 177.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.492 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 71.2 m-85 -126.74 125.2 41.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.74 -0.6 . . . . 0.0 109.762 -176.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -55.96 144.21 29.31 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.577 -0.702 . . . . 0.0 110.752 -173.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -97.01 134.08 40.84 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.703 -0.623 . . . . 0.0 110.38 -176.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 50.8 m -126.01 151.77 46.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.637 -0.665 . . . . 0.0 110.162 178.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 43.4 m -60.43 159.61 10.03 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.533 -0.729 . . . . 0.0 110.137 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.8 p -64.13 84.65 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.624 -0.673 . . . . 0.0 110.206 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.11 155.24 19.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.751 -0.593 . . . . 0.0 110.198 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -80.74 149.01 29.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.682 -0.636 . . . . 0.0 110.078 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 41.4 t 52.71 35.25 17.95 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.344 -0.847 . . . . 0.0 111.018 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.04 132.92 55.37 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.621 -0.674 . . . . 0.0 110.205 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.402 ' OG1' ' CD1' ' A' ' 153' ' ' TRP . 65.2 p -60.13 -34.02 72.95 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.742 -0.599 . . . . 0.0 109.967 175.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.424 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -171.33 143.48 1.86 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.399 0.618 . . . . 0.0 110.406 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 13.4 t -142.16 142.68 32.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.899 -0.5 . . . . 0.0 109.892 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.492 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 62.3 t80 -125.56 140.03 53.09 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.399 -0.813 . . . . 0.0 110.646 -171.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.8 t -110.38 124.92 52.61 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.878 176.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 54.6 m -70.84 -37.0 73.12 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.838 -0.539 . . . . 0.0 110.414 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -59.36 -33.9 71.73 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.652 -0.655 . . . . 0.0 110.47 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.0 mt -104.79 -12.02 16.51 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.691 -0.631 . . . . 0.0 110.838 -175.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt 59.69 49.27 8.39 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.076 -1.015 . . . . 0.0 109.699 177.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.416 ' HE3' ' CZ ' ' A' ' 163' ' ' TYR . 34.2 ttpt -147.15 153.26 39.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.714 -0.616 . . . . 0.0 110.563 -173.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.5 tp -126.44 138.06 53.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.686 -0.633 . . . . 0.0 110.315 -173.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.416 ' CZ ' ' HE3' ' A' ' 161' ' ' LYS . 54.0 m-85 -114.72 133.75 55.64 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.36 158.46 44.24 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.65 -0.656 . . . . 0.0 110.824 -175.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -104.62 141.9 35.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.595 -0.691 . . . . 0.0 110.275 172.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 16.6 tt -51.42 147.38 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 CA-C-O 121.624 0.726 . . . . 0.0 111.989 -174.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 64.26 10.06 5.3 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.521 -0.737 . . . . 0.0 112.534 176.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 30.5 mmtm -96.28 155.04 16.93 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.899 -1.126 . . . . 0.0 110.838 175.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 86.5 m -84.37 126.22 33.02 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.707 -0.621 . . . . 0.0 110.525 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 44.0 t -115.22 90.19 23.37 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.62 -0.675 . . . . 0.0 110.199 174.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.424 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 23.1 Cg_exo -61.85 130.75 32.27 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 O-C-N 123.278 1.146 . . . . 0.0 110.677 173.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.418 HG12 ' CE2' ' A' ' 142' ' ' PHE . 93.2 mt -124.97 142.16 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.626 -0.671 . . . . 0.0 109.219 175.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -107.93 136.3 47.87 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.475 -0.766 . . . . 0.0 110.826 -174.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.417 HD11 ' CZ ' ' A' ' 138' ' ' PHE . 48.6 mm -95.22 135.07 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.757 -0.589 . . . . 0.0 109.691 169.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -118.09 128.99 55.27 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.415 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 17.3 m -136.24 159.82 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.63 -0.669 . . . . 0.0 109.979 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 81.2 mmm -77.75 -40.49 40.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.713 -0.617 . . . . 0.0 110.085 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 77.1 p -135.21 143.27 44.97 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.797 -0.564 . . . . 0.0 109.788 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -55.57 139.8 82.96 Favored 'Trans proline' 0 N--CA 1.489 1.264 0 O-C-N 123.245 1.129 . . . . 0.0 110.871 -172.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.436 ' CG ' ' CE1' ' A' ' 251' ' ' TYR . 23.8 Cg_endo -64.47 169.38 11.23 Favored 'Trans proline' 0 N--CA 1.488 1.151 0 O-C-N 123.181 1.095 . . . . 0.0 110.704 178.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -61.19 158.26 35.87 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 O-C-N 123.321 1.169 . . . . 0.0 110.469 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -78.7 138.18 38.15 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.602 -0.686 . . . . 0.0 109.969 175.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.5 -24.84 30.6 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -174.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.2 151.09 2.17 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.35 -1.088 . . . . 0.0 111.322 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.7 155.95 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.727 -0.608 . . . . 0.0 109.762 176.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 66.5 mt -108.13 137.0 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.406 ' HG2' ' CD2' ' A' ' 248' ' ' LEU . 37.8 mtp180 -114.87 146.79 40.72 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -175.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -140.85 126.07 18.54 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.483 -0.761 . . . . 0.0 110.4 171.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 48.5 ttp -137.33 140.69 31.49 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.775 -0.578 . . . . 0.0 111.052 -176.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -89.85 138.25 2.95 Favored 'Trans proline' 0 C--N 1.32 -0.96 0 O-C-N 123.24 1.126 . . . . 0.0 110.843 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.7 m -146.39 154.82 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.547 -0.721 . . . . 0.0 110.085 173.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.451 ' CE2' ' CG2' ' A' ' 202' ' ' VAL . 88.3 m-85 -62.92 162.9 10.46 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.522 -0.736 . . . . 0.0 110.468 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -78.93 -60.04 2.54 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.659 -0.65 . . . . 0.0 110.815 -175.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 38.9 mttp -80.1 150.77 30.16 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.62 -0.675 . . . . 0.0 110.34 -175.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.52 -37.69 70.8 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.371 -0.831 . . . . 0.0 110.728 -176.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -56.44 -24.83 48.0 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.536 -0.727 . . . . 0.0 110.642 -176.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.407 ' HB3' ' CG ' ' A' ' 192' ' ' TYR . 77.7 m80 -110.09 -20.51 12.67 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.174 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.1 p -67.07 -20.28 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.15 -0.969 . . . . 0.0 110.544 -176.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 71.9 p -79.29 -16.99 55.52 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.491 -0.756 . . . . 0.0 110.651 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -88.34 137.19 32.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.34 -0.85 . . . . 0.0 110.041 172.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.3 t -73.1 141.58 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.645 -0.659 . . . . 0.0 110.248 177.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.451 ' CG2' ' CE2' ' A' ' 192' ' ' TYR . 64.7 t -84.93 137.8 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.618 -0.676 . . . . 0.0 109.405 171.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 12.1 pttt -134.92 -170.29 2.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.543 -0.723 . . . . 0.0 111.035 -171.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 83.5 mtm-85 -95.26 158.7 15.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.781 -0.575 . . . . 0.0 110.34 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 56.5 m -75.81 157.42 83.84 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.679 -0.638 . . . . 0.0 109.513 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -63.34 -47.33 7.97 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.247 1.13 . . . . 0.0 109.99 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.443 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.4 p-10 -65.41 -43.96 88.95 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.579 -0.701 . . . . 0.0 111.159 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . 0.443 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 54.9 m170 -81.12 -27.87 35.37 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.423 -0.798 . . . . 0.0 111.196 -175.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -69.16 -39.82 78.53 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.374 -0.829 . . . . 0.0 110.21 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 26.6 tp -58.12 -34.79 70.61 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.66 -0.65 . . . . 0.0 110.697 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 29.0 t -48.46 143.98 4.48 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.481 -0.762 . . . . 0.0 111.347 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.419 ' HD3' ' CE1' ' A' ' 214' ' ' PHE . 53.8 ttt85 -61.92 139.8 58.35 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.654 -0.654 . . . . 0.0 110.023 -176.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -63.04 -32.49 73.87 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.751 -0.593 . . . . 0.0 110.589 -176.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.419 ' CE1' ' HD3' ' A' ' 212' ' ' ARG . 60.6 m-85 52.05 47.9 23.82 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.553 -0.717 . . . . 0.0 110.836 -175.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -74.0 -10.13 59.33 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.796 -0.565 . . . . 0.0 111.313 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -58.53 113.86 2.19 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.17 -0.956 . . . . 0.0 110.766 -177.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 75.16 20.04 79.39 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 173.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -114.79 139.89 49.36 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.307 -1.114 . . . . 0.0 110.522 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.7 mt -85.66 -25.05 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.712 -0.618 . . . . 0.0 110.466 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -124.95 96.09 40.83 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.439 -0.788 . . . . 0.0 110.371 -173.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.403 ' HD2' ' CE2' ' A' ' 236' ' ' TYR . 15.3 Cg_exo -65.11 140.13 63.94 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.326 1.172 . . . . 0.0 110.621 -177.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -60.87 -17.33 50.2 Favored 'Trans proline' 0 N--CA 1.488 1.172 0 O-C-N 123.043 1.023 . . . . 0.0 111.325 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 30.2 m -51.81 -24.08 5.57 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.159 -0.963 . . . . 0.0 111.29 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . 0.491 ' CD2' ' CG ' ' A' ' 236' ' ' TYR . 97.6 m-70 -103.02 132.65 49.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.448 -0.783 . . . . 0.0 110.286 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 54.0 tp -59.83 -40.33 88.12 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.558 -0.714 . . . . 0.0 110.283 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 82.6 mt -104.06 136.75 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.843 -0.536 . . . . 0.0 109.685 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -134.16 158.81 42.72 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.714 -0.616 . . . . 0.0 110.389 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 83.9 t -103.85 146.72 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.66 -0.65 . . . . 0.0 110.099 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -117.27 128.13 54.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.817 -0.552 . . . . 0.0 110.368 171.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.05 22.96 23.92 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 167.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -135.24 106.42 6.72 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.394 -1.062 . . . . 0.0 110.09 173.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 27.6 t -62.93 -15.12 54.3 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.649 -0.657 . . . . 0.0 111.24 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -100.13 5.02 44.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.198 -0.939 . . . . 0.0 111.61 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.4 131.16 49.33 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.039 -1.038 . . . . 0.0 110.276 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -139.76 157.74 45.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.782 -0.574 . . . . 0.0 109.62 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.491 ' CG ' ' CD2' ' A' ' 224' ' ' HIS . 93.1 m-85 -115.72 150.63 36.52 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.592 -0.693 . . . . 0.0 110.497 -177.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.14 159.98 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.759 -0.588 . . . . 0.0 110.263 177.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -116.53 129.95 56.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.804 -0.56 . . . . 0.0 110.003 174.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -63.31 117.45 33.98 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.649 -0.657 . . . . 0.0 109.76 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.84 -27.18 80.09 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.096 1.051 . . . . 0.0 110.878 -172.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 84.2 mt -101.85 -50.34 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.439 -0.788 . . . . 0.0 110.907 -170.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 7.5 p -105.37 12.25 31.84 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.431 -0.793 . . . . 0.0 111.987 -172.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 81.25 -25.06 3.82 Favored Glycine 0 N--CA 1.498 2.787 0 O-C-N 121.006 -1.059 . . . . 0.0 111.868 170.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -45.71 142.09 2.61 Favored 'General case' 0 N--CA 1.505 2.285 0 CA-C-N 118.641 1.22 . . . . 0.0 112.726 -166.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -97.8 145.17 26.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.583 -0.698 . . . . 0.0 109.838 171.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 77.5 p -154.8 159.91 40.92 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.528 -0.732 . . . . 0.0 110.588 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 8.2 p -123.23 148.03 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.722 -0.611 . . . . 0.0 109.72 176.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.406 ' CD2' ' HG2' ' A' ' 187' ' ' ARG . 79.2 mt -129.78 154.76 46.9 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.833 -175.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 35.8 m -150.44 151.78 31.69 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.843 -0.536 . . . . 0.0 109.898 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -71.11 138.99 34.69 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 O-C-N 123.24 1.126 . . . . 0.0 109.923 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.436 ' CE1' ' CG ' ' A' ' 180' ' ' PRO . 9.9 t80 -80.05 123.43 27.84 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.543 -0.723 . . . . 0.0 110.188 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -99.99 160.1 28.1 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.717 -0.614 . . . . 0.0 110.07 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -58.83 160.1 19.03 Favored 'Trans proline' 0 N--CA 1.487 1.12 0 O-C-N 123.228 1.12 . . . . 0.0 110.414 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -58.67 149.91 73.55 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 O-C-N 123.171 1.09 . . . . 0.0 110.567 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -62.46 146.94 50.21 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.693 -0.629 . . . . 0.0 110.261 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.9 127.26 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.496 -0.752 . . . . 0.0 110.232 -171.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.65 -10.08 55.86 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.4 ' OG1' ' CE2' ' A' ' 260' ' ' PHE . 7.3 t -143.84 166.46 24.86 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.165 -1.197 . . . . 0.0 110.6 177.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -101.87 13.07 35.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.717 -0.615 . . . . 0.0 111.846 -168.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . 0.4 ' CE2' ' OG1' ' A' ' 258' ' ' THR . 9.6 p90 -127.57 168.13 15.4 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.098 -1.001 . . . . 0.0 111.126 -176.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 83.2 m -117.67 147.31 43.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.701 -0.624 . . . . 0.0 109.912 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 31.1 m -116.32 135.9 53.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.592 -0.693 . . . . 0.0 110.922 -174.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.5 t -128.57 137.21 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 171.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 70.2 mt -104.74 119.84 39.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.457 -0.777 . . . . 0.0 109.849 -172.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 6.1 m-30 -105.97 151.3 24.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.683 -0.636 . . . . 0.0 110.639 -176.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -136.63 142.98 43.28 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -114.07 130.6 56.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.513 -0.742 . . . . 0.0 110.407 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -99.12 1.4 45.04 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.708 -0.62 . . . . 0.0 111.963 -176.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -144.72 158.51 43.75 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.109 -0.994 . . . . 0.0 109.928 173.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -113.97 154.26 27.92 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.666 -0.646 . . . . 0.0 110.073 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 90.7 p -56.6 -26.97 57.0 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.373 -0.829 . . . . 0.0 111.096 -167.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 46.7 p -95.19 6.97 47.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.401 -0.812 . . . . 0.0 112.146 -165.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 29.0 p -92.95 118.08 30.76 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.029 -1.044 . . . . 0.0 110.675 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.8 t -69.84 142.75 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.556 -0.715 . . . . 0.0 110.531 -168.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.4 -5.26 58.75 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.14 -95.45 0.74 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 169.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 95.3 mmm -64.7 -28.15 69.4 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.746 -0.855 . . . . 0.0 110.277 176.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 10.0 p30 44.73 50.92 8.51 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 172.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 54.76 34.12 21.08 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.375 -0.828 . . . . 0.0 111.316 174.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -115.94 104.93 52.03 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.548 -0.72 . . . . 0.0 110.141 172.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -60.26 145.03 99.43 Favored 'Trans proline' 0 N--CA 1.489 1.264 0 O-C-N 123.139 1.073 . . . . 0.0 110.374 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 42.8 pt -132.57 178.45 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 122.029 0.919 . . . . 0.0 111.373 -174.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 34.5 mt -124.3 149.86 46.06 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.43 ' HB ' ' CZ ' ' A' ' 301' ' ' PHE . 79.4 mt -112.24 128.71 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 77.8 mt -109.68 125.67 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -175.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 58.5 t -118.87 126.65 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.4 p -125.35 154.81 41.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.661 -0.649 . . . . 0.0 110.567 -174.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.423 ' HB2' ' CE1' ' A' ' 138' ' ' PHE . 24.4 tp -105.59 125.85 51.47 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 169.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -132.04 149.5 52.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.858 -0.526 . . . . 0.0 109.911 -173.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 25.4 p -89.98 161.28 15.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.703 -0.623 . . . . 0.0 110.031 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 69.7 ttp85 -55.94 -26.13 46.51 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.566 -0.708 . . . . 0.0 111.139 -175.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 44.7 p30 -90.87 9.82 28.82 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.444 -0.785 . . . . 0.0 111.963 -173.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.55 20.23 45.38 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.15 -1.024 . . . . 0.0 110.732 171.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -107.52 140.23 40.81 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.33 -1.1 . . . . 0.0 109.988 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 62.1 t -90.28 132.0 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.572 -0.705 . . . . 0.0 110.236 -172.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 96.0 mt -99.84 -40.29 7.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.767 -0.583 . . . . 0.0 110.545 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -162.05 153.17 23.78 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -135.06 135.19 41.09 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.598 -0.942 . . . . 0.0 110.521 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -138.03 156.0 48.25 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.611 -0.681 . . . . 0.0 110.028 172.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 98.3 m -143.23 155.7 44.57 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.379 -0.826 . . . . 0.0 110.844 -175.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.43 ' CZ ' ' HB ' ' A' ' 284' ' ' ILE . 47.8 p90 -145.3 162.62 36.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.643 -0.661 . . . . 0.0 110.156 174.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -104.77 137.34 42.71 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.591 -0.693 . . . . 0.0 110.219 -178.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -118.94 144.66 46.32 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.766 -170.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -136.99 138.51 40.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.799 -0.563 . . . . 0.0 109.725 173.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 61.6 mt -112.02 122.86 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.572 -0.705 . . . . 0.0 109.63 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.1 p -145.42 173.73 11.75 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.589 -0.695 . . . . 0.0 110.683 -171.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -74.17 -40.12 62.77 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.573 -0.704 . . . . 0.0 110.639 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.8 t -127.25 86.86 57.75 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.494 -0.754 . . . . 0.0 110.475 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -55.81 -28.65 68.43 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.117 1.062 . . . . 0.0 110.768 174.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.88 -37.45 92.23 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -73.38 -41.05 63.86 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.643 -0.916 . . . . 0.0 109.889 -173.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -69.41 -40.33 77.38 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 120.076 -0.649 . . . . 0.0 110.153 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -61.28 -44.19 97.65 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.482 -0.762 . . . . 0.0 110.258 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 23.6 ttpt -63.73 -39.63 94.77 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.641 -0.662 . . . . 0.0 110.432 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.86 -51.9 66.34 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.517 -0.74 . . . . 0.0 110.396 -173.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -61.53 -37.74 84.86 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.437 -0.789 . . . . 0.0 110.15 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -65.29 -39.9 93.14 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.272 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -62.46 -35.13 78.33 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.537 -0.727 . . . . 0.0 110.021 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 22.9 t -62.75 -34.32 76.98 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.632 -0.667 . . . . 0.0 110.171 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 79.9 mt -79.61 -42.66 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.696 -0.627 . . . . 0.0 109.95 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -58.56 -38.83 78.68 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.639 -0.663 . . . . 0.0 110.522 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 37.4 tttp -59.19 -41.44 88.5 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.555 -0.715 . . . . 0.0 110.286 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -62.73 -33.25 74.75 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.634 -0.666 . . . . 0.0 110.067 176.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -92.31 125.13 36.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.738 -0.601 . . . . 0.0 110.388 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 62.3 t -103.3 130.11 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.648 -0.657 . . . . 0.0 109.858 178.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 28.7 t -94.95 140.07 30.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.61 -0.681 . . . . 0.0 110.277 -177.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -82.77 120.61 25.84 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.687 -0.633 . . . . 0.0 110.301 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 29.6 t -94.03 152.62 18.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.619 -0.676 . . . . 0.0 110.158 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 71.7 p -90.27 -25.83 20.34 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.646 -0.659 . . . . 0.0 110.226 -178.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -61.27 -36.22 79.43 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.451 -0.781 . . . . 0.0 110.096 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -112.78 142.36 45.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.718 -0.614 . . . . 0.0 110.078 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -58.89 -37.91 91.65 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -178.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 59.41 79.98 0.21 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.564 -0.962 . . . . 0.0 110.224 175.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -79.91 121.72 25.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.531 -0.73 . . . . 0.0 110.123 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -63.38 -35.66 81.14 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.654 -0.654 . . . . 0.0 110.215 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 77.1 mtt85 51.97 178.15 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.478 -0.763 . . . . 0.0 111.019 -177.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -60.31 -36.42 77.87 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.573 -0.704 . . . . 0.0 110.328 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 54.5 t30 53.29 45.7 27.95 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.486 -0.759 . . . . 0.0 110.928 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 73.3 p -65.06 -33.54 76.29 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.63 -0.669 . . . . 0.0 110.119 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -131.15 127.64 38.45 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.677 -0.64 . . . . 0.0 110.222 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -87.17 176.91 47.35 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 45.3 pt -147.36 158.92 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.624 -0.927 . . . . 0.0 110.209 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -90.57 5.39 48.07 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.729 -0.607 . . . . 0.0 111.322 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 64.7 mtt -61.05 -35.25 76.43 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.118 -0.989 . . . . 0.0 110.241 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 7.4 t . . . . . 0 N--CA 1.495 1.8 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.305 -179.823 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 60.3 p -84.3 160.28 20.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.631 -0.923 . . . . 0.0 110.282 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 46.8 m -63.96 153.65 36.46 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.678 -0.639 . . . . 0.0 110.218 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 44.9 m -60.32 -37.61 81.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.629 -0.669 . . . . 0.0 110.342 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -117.62 154.45 31.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.649 -0.657 . . . . 0.0 110.283 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -85.38 123.33 30.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.757 -0.59 . . . . 0.0 110.412 -178.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 53.16 43.24 31.85 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.452 -0.78 . . . . 0.0 111.043 177.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 21.8 tp -85.36 134.48 34.09 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.594 -0.691 . . . . 0.0 110.191 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.64 178.69 0.25 Allowed Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.696 -0.628 . . . . 0.0 110.088 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -64.08 151.54 72.57 Favored 'Cis proline' 0 N--CA 1.496 1.654 0 C-N-CA 123.303 -1.54 . . . . 0.0 110.501 -12.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 57.5 p -81.46 153.0 70.9 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.655 -0.653 . . . . 0.0 110.298 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -59.57 153.84 52.4 Favored 'Trans proline' 0 N--CA 1.488 1.187 0 O-C-N 123.338 1.178 . . . . 0.0 110.5 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.31 150.03 40.37 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.696 -0.628 . . . . 0.0 110.097 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 50.0 mm -119.9 140.39 29.62 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.643 -0.661 . . . . 0.0 109.955 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -62.2 153.62 68.56 Favored 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.164 1.086 . . . . 0.0 110.362 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.6 t -107.27 144.89 33.43 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.605 -0.684 . . . . 0.0 110.156 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.6 p-10 -93.91 22.5 5.63 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.644 -0.66 . . . . 0.0 110.877 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 52.0 m -79.14 125.18 29.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.466 -0.771 . . . . 0.0 110.177 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -68.78 144.95 54.18 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.585 -0.697 . . . . 0.0 110.444 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -156.54 101.2 2.03 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.727 -0.608 . . . . 0.0 110.098 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.65 -39.89 78.48 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 O-C-N 123.126 1.066 . . . . 0.0 110.857 -175.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.3 -155.16 39.66 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 178.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -72.88 -48.33 0.29 Allowed 'Trans proline' 0 N--CA 1.486 1.079 0 O-C-N 123.402 1.212 . . . . 0.0 110.983 -174.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -86.47 8.36 22.19 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.614 -0.679 . . . . 0.0 111.351 -174.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.8 58.3 5.23 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.983 -1.073 . . . . 0.0 110.6 -176.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.451 ' CE1' ' CG2' ' A' ' 174' ' ' ILE . 71.7 t80 -79.38 115.81 19.25 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.604 -0.685 . . . . 0.0 109.877 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -130.05 160.04 34.9 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.28 0.562 . . . . 0.0 110.41 -174.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 78.8 t -122.01 150.32 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.831 -0.543 . . . . 0.0 109.807 174.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 78.2 p -154.91 169.21 24.58 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.012 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.494 ' CD2' ' CE2' ' A' ' 155' ' ' TYR . 97.3 m-85 -126.63 125.26 41.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.884 -0.51 . . . . 0.0 109.938 -176.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -57.56 144.45 37.18 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.663 -0.648 . . . . 0.0 110.415 -177.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -94.69 140.99 29.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.658 -0.651 . . . . 0.0 110.579 -174.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 28.1 t -141.74 152.21 43.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.681 -0.637 . . . . 0.0 110.137 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 54.0 p -62.81 163.76 8.94 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.671 -0.643 . . . . 0.0 110.07 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.2 p -72.74 63.95 0.64 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.649 -0.657 . . . . 0.0 110.097 -178.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.58 150.07 49.03 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.617 -0.677 . . . . 0.0 110.186 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.8 tptm -65.1 140.31 58.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.725 -0.61 . . . . 0.0 110.164 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.4 p 51.2 48.09 23.66 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.579 -0.701 . . . . 0.0 111.216 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.44 137.18 57.29 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.689 -0.632 . . . . 0.0 110.182 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 77.8 p -60.05 -32.21 70.71 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.653 -0.655 . . . . 0.0 109.922 174.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.424 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -171.46 143.78 1.84 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.403 0.621 . . . . 0.0 110.132 178.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.3 t -142.1 142.56 32.81 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.863 -0.523 . . . . 0.0 109.916 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.494 ' CE2' ' CD2' ' A' ' 142' ' ' PHE . 62.6 t80 -125.56 140.01 53.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.533 -0.729 . . . . 0.0 110.673 -172.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.5 t -111.3 124.01 51.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.829 -0.545 . . . . 0.0 109.775 175.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 62.0 m -70.88 -37.09 73.02 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.819 -0.55 . . . . 0.0 110.359 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -59.09 -33.05 70.37 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.555 -0.716 . . . . 0.0 110.447 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 55.1 mt -104.8 -12.03 16.5 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.77 -176.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt 59.76 47.76 9.96 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.039 -1.038 . . . . 0.0 109.728 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.422 ' HE3' ' CZ ' ' A' ' 163' ' ' TYR . 20.7 ttpt -148.21 153.23 38.48 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 120.161 -0.615 . . . . 0.0 110.803 -173.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.5 tp -126.49 137.93 53.44 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.731 -0.605 . . . . 0.0 110.437 -173.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.422 ' CZ ' ' HE3' ' A' ' 161' ' ' LYS . 98.7 m-85 -114.85 134.38 55.19 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.9 p -138.39 158.44 44.28 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.61 -0.681 . . . . 0.0 111.194 -176.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -104.47 142.18 35.06 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.663 -0.648 . . . . 0.0 110.336 173.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 18.0 tt -55.04 148.22 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.548 -0.72 . . . . 0.0 111.613 -173.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 64.37 10.01 5.36 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.544 -0.723 . . . . 0.0 112.511 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -97.09 155.08 16.96 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.984 -1.073 . . . . 0.0 110.773 174.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 74.5 m -80.16 126.04 30.59 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.674 -0.641 . . . . 0.0 110.573 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 31.4 t -117.1 90.37 33.21 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.625 -0.672 . . . . 0.0 110.182 174.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.424 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 26.1 Cg_endo -66.97 128.25 18.38 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 O-C-N 123.337 1.177 . . . . 0.0 110.756 176.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.425 HG12 ' CE1' ' A' ' 142' ' ' PHE . 83.7 mt -122.51 141.64 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.675 -0.641 . . . . 0.0 109.362 172.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -109.48 136.95 48.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.54 -0.725 . . . . 0.0 110.755 -173.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.451 ' CG2' ' CE1' ' A' ' 138' ' ' PHE . 50.4 mm -95.24 135.01 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.779 -0.576 . . . . 0.0 109.744 172.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 17.0 tptp -117.57 130.81 56.64 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.606 -0.684 . . . . 0.0 110.492 176.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 17.6 m -136.34 159.76 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.579 -0.701 . . . . 0.0 110.04 174.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 79.8 mmm -77.63 -39.79 44.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.724 -0.61 . . . . 0.0 110.029 176.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 77.3 p -135.66 143.24 44.0 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.831 -0.543 . . . . 0.0 109.709 177.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -55.63 139.86 83.33 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 O-C-N 123.146 1.077 . . . . 0.0 110.821 -173.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.446 ' CG ' ' CE1' ' A' ' 251' ' ' TYR . 26.6 Cg_endo -65.19 169.61 11.94 Favored 'Trans proline' 0 N--CA 1.487 1.115 0 O-C-N 123.165 1.087 . . . . 0.0 110.684 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -61.27 156.7 44.17 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 O-C-N 123.37 1.195 . . . . 0.0 110.46 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -77.53 140.24 39.71 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.616 -0.677 . . . . 0.0 109.913 175.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.79 -24.91 29.62 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -175.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.16 151.64 1.97 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.363 -1.081 . . . . 0.0 111.319 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 33.8 m -129.77 155.89 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.766 -0.584 . . . . 0.0 109.597 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 79.3 mt -107.25 136.6 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.406 ' HG2' ' CD2' ' A' ' 248' ' ' LEU . 73.3 mtp180 -114.79 142.82 46.03 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -175.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -140.69 123.46 16.26 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.486 -0.759 . . . . 0.0 110.501 177.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 30.7 ttp -137.43 139.01 26.21 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.76 -0.587 . . . . 0.0 110.969 -175.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -90.62 138.18 2.53 Favored 'Trans proline' 0 C--N 1.318 -1.03 0 O-C-N 123.246 1.13 . . . . 0.0 110.418 176.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.6 m -146.47 154.81 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.596 -0.69 . . . . 0.0 110.196 175.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.423 ' CE1' HG23 ' A' ' 202' ' ' VAL . 89.1 m-85 -59.82 160.35 7.73 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.495 -0.753 . . . . 0.0 110.495 178.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 34.1 tttt -74.04 -59.45 2.72 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.598 -0.688 . . . . 0.0 110.729 -175.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -80.01 148.78 30.98 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.57 -0.706 . . . . 0.0 110.398 -174.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.86 -38.11 72.26 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.355 -0.84 . . . . 0.0 110.695 -175.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -56.41 -24.94 48.34 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.441 -0.787 . . . . 0.0 110.629 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.404 ' O ' ' CD1' ' A' ' 192' ' ' TYR . 94.3 m-70 -109.99 -20.51 12.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.597 -0.69 . . . . 0.0 111.188 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.2 p -67.25 -20.09 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.272 -0.892 . . . . 0.0 110.598 -176.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 69.2 p -79.27 -16.11 56.94 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.558 -0.714 . . . . 0.0 110.714 175.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -88.2 137.59 32.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.915 . . . . 0.0 110.049 172.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.7 t -73.01 142.36 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.606 -0.684 . . . . 0.0 110.25 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.423 HG23 ' CE1' ' A' ' 192' ' ' TYR . 77.0 t -84.81 139.11 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.514 -0.741 . . . . 0.0 109.339 170.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 14.1 pttt -134.81 -170.05 2.48 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.406 -0.809 . . . . 0.0 111.205 -165.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -95.13 154.4 17.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.783 -0.573 . . . . 0.0 110.62 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 61.0 m -76.17 160.94 76.94 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.668 -0.645 . . . . 0.0 109.303 172.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -64.21 -47.33 6.36 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 O-C-N 123.217 1.114 . . . . 0.0 109.811 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.445 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.7 p-10 -65.47 -44.44 87.14 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.641 -0.662 . . . . 0.0 111.318 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . 0.445 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 55.4 m170 -80.71 -27.85 36.82 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.391 -0.818 . . . . 0.0 111.41 -174.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -69.02 -42.11 76.82 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.385 -0.822 . . . . 0.0 110.175 173.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 23.9 tp -69.7 -30.33 67.95 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.694 -0.629 . . . . 0.0 110.5 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.8 t -48.39 -36.46 14.69 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.682 -0.636 . . . . 0.0 111.843 -175.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -126.86 139.08 53.35 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.547 -0.721 . . . . 0.0 110.411 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -140.42 -177.18 4.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.673 -0.642 . . . . 0.0 110.114 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 54.07 75.13 0.29 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.422 -0.799 . . . . 0.0 110.848 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -64.76 -10.34 26.9 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.642 -0.661 . . . . 0.0 111.345 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -58.65 121.78 11.86 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.07 -1.019 . . . . 0.0 110.362 174.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 94.89 1.51 63.27 Favored Glycine 0 N--CA 1.492 2.413 0 C-N-CA 120.414 -0.898 . . . . 0.0 110.977 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -114.7 140.1 49.13 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.088 -1.242 . . . . 0.0 110.392 178.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.6 mt -85.0 -25.11 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.607 -0.683 . . . . 0.0 110.446 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -125.03 95.41 41.98 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.414 -0.804 . . . . 0.0 110.311 -177.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.42 ' HD2' ' CE1' ' A' ' 236' ' ' TYR . 17.1 Cg_exo -63.42 136.96 57.62 Favored 'Trans proline' 0 C--N 1.316 -1.152 0 O-C-N 123.27 1.142 . . . . 0.0 110.365 -177.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.6 -21.88 48.94 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 O-C-N 123.064 1.034 . . . . 0.0 111.244 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 86.8 p -53.77 -22.89 10.34 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.412 -0.805 . . . . 0.0 111.226 -175.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . 0.485 ' CD2' ' CD2' ' A' ' 236' ' ' TYR . 88.9 m-70 -103.45 126.0 50.36 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.459 -0.776 . . . . 0.0 110.155 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 32.2 tp -60.98 -36.26 78.96 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.675 -0.641 . . . . 0.0 110.166 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 83.6 mt -98.17 136.78 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-O 121.232 0.539 . . . . 0.0 109.896 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 -131.14 159.38 37.85 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.735 -0.603 . . . . 0.0 110.084 175.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 73.7 t -105.62 146.68 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.425 0.631 . . . . 0.0 110.204 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -121.5 130.04 53.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.725 -0.609 . . . . 0.0 110.311 171.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 96.61 20.42 24.61 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 169.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -140.01 103.7 4.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.36 -1.082 . . . . 0.0 109.944 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 93.5 p -63.62 -15.21 57.59 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.657 -0.652 . . . . 0.0 111.15 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -97.43 9.86 41.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.29 -0.881 . . . . 0.0 111.17 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -62.07 132.71 53.77 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.235 -0.915 . . . . 0.0 110.102 176.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -139.65 157.96 44.9 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.691 -0.631 . . . . 0.0 109.826 177.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.485 ' CD2' ' CD2' ' A' ' 224' ' ' HIS . 87.0 m-85 -114.2 150.68 33.91 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.516 -0.74 . . . . 0.0 110.576 -177.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.18 159.92 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.73 -0.606 . . . . 0.0 110.124 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -119.76 130.06 54.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.741 -0.6 . . . . 0.0 110.209 176.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -63.44 130.07 94.04 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.65 -0.656 . . . . 0.0 109.792 177.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -64.77 -27.66 59.81 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 O-C-N 123.118 1.062 . . . . 0.0 111.045 -170.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.2 mt -101.4 -50.5 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.411 -0.806 . . . . 0.0 111.108 -167.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 75.7 p -105.46 12.18 31.74 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.315 -0.865 . . . . 0.0 111.881 -174.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.93 -4.97 14.35 Favored Glycine 0 N--CA 1.496 2.645 0 O-C-N 121.1 -1.0 . . . . 0.0 111.837 174.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -45.99 142.09 2.86 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 119.088 1.444 . . . . 0.0 112.334 -173.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -102.74 142.27 34.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.662 -0.649 . . . . 0.0 110.294 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 77.3 p -154.8 159.93 40.93 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.642 -0.661 . . . . 0.0 110.301 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 8.3 p -122.96 148.16 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.708 -0.62 . . . . 0.0 109.754 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.406 ' CD2' ' HG2' ' A' ' 187' ' ' ARG . 79.7 mt -129.69 154.63 46.96 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.763 -174.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 33.8 m -150.9 151.74 30.5 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.873 -0.517 . . . . 0.0 109.901 174.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -70.96 137.67 32.44 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 O-C-N 123.273 1.144 . . . . 0.0 109.92 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.446 ' CE1' ' CG ' ' A' ' 180' ' ' PRO . 11.7 t80 -77.9 122.85 26.04 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.552 -0.717 . . . . 0.0 110.183 179.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -100.01 160.01 28.32 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.753 -0.592 . . . . 0.0 110.15 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.92 160.02 19.57 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 123.233 1.123 . . . . 0.0 110.403 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -58.56 150.06 71.67 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 123.29 1.153 . . . . 0.0 110.666 -177.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -61.13 147.31 44.44 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.672 -0.643 . . . . 0.0 110.184 -177.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.81 127.2 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.485 -0.759 . . . . 0.0 110.167 -170.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.87 -10.13 55.54 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.415 ' OG1' ' CD2' ' A' ' 260' ' ' PHE . 10.2 t -144.31 174.2 11.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.177 -1.19 . . . . 0.0 110.614 175.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -108.18 13.14 26.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.603 -0.686 . . . . 0.0 111.854 -167.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . 0.415 ' CD2' ' OG1' ' A' ' 258' ' ' THR . 43.5 p90 -124.59 168.13 13.55 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.178 -0.951 . . . . 0.0 111.189 -176.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 94.2 m -117.79 145.95 44.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.737 -0.602 . . . . 0.0 109.862 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 44.4 m -116.57 136.29 53.1 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.535 -0.728 . . . . 0.0 110.937 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 60.1 t -127.05 137.08 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 60.2 mt -104.82 121.21 43.19 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.603 -0.685 . . . . 0.0 109.747 -173.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . 0.411 ' CE2' HD12 ' A' ' 172' ' ' ILE . 3.4 m-85 -99.95 156.71 17.0 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.578 -0.701 . . . . 0.0 110.88 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -136.41 142.94 43.72 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 171.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -110.4 128.97 55.84 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.551 -0.718 . . . . 0.0 110.27 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -95.29 -0.11 53.22 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.712 -0.618 . . . . 0.0 112.019 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -144.77 165.06 29.15 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.158 -0.964 . . . . 0.0 110.076 176.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -121.98 163.48 19.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.69 -0.631 . . . . 0.0 110.593 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 19.0 m -57.62 -34.15 69.0 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.414 -0.803 . . . . 0.0 111.136 -164.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 51.4 p -104.17 15.06 29.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.374 -0.829 . . . . 0.0 111.911 -163.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 29.7 p -95.77 118.07 31.73 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.079 -1.013 . . . . 0.0 110.712 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 58.0 t -63.16 138.93 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.477 -0.764 . . . . 0.0 110.253 -171.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.04 -5.18 59.27 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.11 -98.33 0.83 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 171.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 93.2 mmm -63.17 -32.35 73.72 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.726 -0.867 . . . . 0.0 110.235 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.3 p30 44.21 48.84 7.79 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 174.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 54.76 30.27 13.27 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.377 -0.827 . . . . 0.0 111.306 174.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 15.4 mtt85 -119.45 107.04 41.58 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.59 -0.694 . . . . 0.0 110.08 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.58 148.0 89.29 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 O-C-N 123.127 1.067 . . . . 0.0 110.529 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 44.7 pt -131.9 177.52 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.709 0.766 . . . . 0.0 110.987 -176.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 34.3 mt -124.38 150.02 46.03 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 177.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.42 ' HB ' ' CZ ' ' A' ' 301' ' ' PHE . 77.7 mt -112.65 128.29 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.562 -0.711 . . . . 0.0 109.089 176.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 81.3 mt -109.86 125.57 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 59.1 t -118.87 126.63 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.5 p -125.31 154.66 41.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.581 -0.699 . . . . 0.0 110.623 -175.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.427 ' HB2' ' CE1' ' A' ' 138' ' ' PHE . 22.8 tp -105.22 126.41 52.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.819 -0.551 . . . . 0.0 109.539 169.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -132.47 150.99 52.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.863 -0.523 . . . . 0.0 109.902 -174.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 68.6 p -89.89 159.47 16.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.619 -0.675 . . . . 0.0 109.648 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -55.86 -26.11 45.43 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.532 -0.73 . . . . 0.0 110.81 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -87.52 9.14 21.97 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.489 -0.757 . . . . 0.0 111.855 -174.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 87.22 20.26 53.05 Favored Glycine 0 N--CA 1.495 2.59 0 O-C-N 121.053 -1.03 . . . . 0.0 110.704 170.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -106.81 140.12 40.15 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.262 -1.14 . . . . 0.0 110.206 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 59.4 t -88.33 131.32 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.666 -0.646 . . . . 0.0 110.194 -173.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 95.6 mt -99.91 -40.14 7.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.733 -0.604 . . . . 0.0 110.544 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -165.23 153.12 23.04 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -134.96 136.17 42.03 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.721 -0.87 . . . . 0.0 110.748 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -133.28 153.66 51.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.578 -0.701 . . . . 0.0 110.106 172.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 99.8 m -142.76 151.63 41.46 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.486 -0.759 . . . . 0.0 110.659 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.42 ' CZ ' ' HB ' ' A' ' 284' ' ' ILE . 49.8 p90 -145.43 166.7 24.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.701 -0.625 . . . . 0.0 110.029 173.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -104.78 136.1 44.93 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.449 -0.782 . . . . 0.0 110.277 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -123.3 144.5 49.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.682 -0.636 . . . . 0.0 110.548 -170.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -137.66 137.87 38.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.844 -0.535 . . . . 0.0 109.796 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 66.3 mt -106.34 123.0 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.581 -0.699 . . . . 0.0 109.556 175.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.0 p -145.17 167.28 23.15 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.56 -0.713 . . . . 0.0 110.89 -170.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -67.31 -40.1 85.96 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.675 -0.641 . . . . 0.0 110.616 -177.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 3.9 t -132.05 89.58 37.7 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.545 -0.722 . . . . 0.0 110.53 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -55.77 -29.04 69.95 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 O-C-N 123.23 1.121 . . . . 0.0 110.74 174.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.51 -37.94 93.02 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -72.56 -40.04 66.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.622 -0.928 . . . . 0.0 109.837 -173.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -69.51 -38.47 77.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.67 -0.644 . . . . 0.0 110.198 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -61.51 -43.21 99.28 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.228 178.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 14.5 ttpp -65.01 -38.73 91.88 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.586 -0.696 . . . . 0.0 110.419 176.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.22 -49.95 75.07 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.493 -0.755 . . . . 0.0 110.578 -173.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -61.29 -37.69 84.1 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.463 -0.773 . . . . 0.0 110.113 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -61.58 -40.88 96.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.606 -0.684 . . . . 0.0 110.146 177.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -62.5 -35.17 78.54 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.586 -0.696 . . . . 0.0 109.956 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 23.8 m -62.09 -33.34 74.26 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.758 -0.589 . . . . 0.0 110.173 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 83.6 mt -77.42 -44.21 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.619 -0.675 . . . . 0.0 109.965 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -58.84 -39.58 81.69 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.575 -0.703 . . . . 0.0 110.492 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -61.05 -40.26 92.97 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.655 -0.653 . . . . 0.0 110.163 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -60.91 -31.89 71.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.677 -0.639 . . . . 0.0 110.204 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -105.11 125.07 50.58 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.702 -0.624 . . . . 0.0 110.495 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 61.7 t -120.5 130.04 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.54 -0.725 . . . . 0.0 109.923 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 29.9 t -95.15 139.96 30.75 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.683 -0.636 . . . . 0.0 110.204 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -100.97 142.68 32.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.609 -0.682 . . . . 0.0 110.356 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 78.6 p -94.05 155.05 17.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.675 -0.641 . . . . 0.0 110.276 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 75.0 p -96.35 -21.89 17.52 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.606 -0.684 . . . . 0.0 110.765 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -60.45 -33.94 73.27 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.448 -0.782 . . . . 0.0 110.443 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 42.2 p-10 -89.14 13.97 11.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.592 -0.692 . . . . 0.0 111.337 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -157.05 114.26 0.6 Allowed Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -85.52 117.35 24.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.589 -0.948 . . . . 0.0 110.313 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -145.48 152.38 39.69 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.656 -0.652 . . . . 0.0 110.252 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -119.99 151.9 38.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.571 -0.706 . . . . 0.0 110.241 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 51.63 94.82 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.497 -0.752 . . . . 0.0 111.142 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -60.74 -34.34 74.29 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.621 -0.675 . . . . 0.0 110.22 178.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -58.97 -30.91 68.28 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.675 -0.641 . . . . 0.0 110.47 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 74.4 p -96.17 26.3 4.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.594 -0.692 . . . . 0.0 110.476 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -104.63 160.7 14.74 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.581 -0.7 . . . . 0.0 110.185 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -79.49 -177.23 49.97 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -177.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 51.4 mm -92.62 141.19 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.7 -0.883 . . . . 0.0 110.129 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -82.19 -31.99 30.11 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.677 -0.639 . . . . 0.0 110.133 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 93.3 mmm -100.67 142.25 32.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.597 -0.689 . . . . 0.0 110.271 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 117.917 -1.039 . . . . 0.0 110.347 179.962 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 27.3 t -156.31 148.74 23.56 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.642 -0.917 . . . . 0.0 110.212 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.5 m -59.69 -34.45 72.9 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.645 -0.66 . . . . 0.0 110.359 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 44.9 m -59.81 -37.21 78.51 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.657 -0.652 . . . . 0.0 110.277 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -106.35 137.29 44.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.573 -0.704 . . . . 0.0 110.234 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -83.46 141.0 31.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.578 -0.701 . . . . 0.0 110.243 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -165.46 153.83 11.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.723 -0.61 . . . . 0.0 110.144 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.9 mt 52.11 -179.0 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.487 -0.758 . . . . 0.0 111.091 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.9 m -76.97 160.96 75.18 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.741 -0.599 . . . . 0.0 110.213 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -66.21 151.94 80.59 Favored 'Cis proline' 0 N--CA 1.496 1.65 0 C-N-CA 123.133 -1.611 . . . . 0.0 110.421 -16.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 7.6 m -81.5 149.42 64.81 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.68 -0.638 . . . . 0.0 110.27 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -59.51 158.46 27.41 Favored 'Trans proline' 0 N--CA 1.488 1.169 0 O-C-N 123.309 1.163 . . . . 0.0 110.502 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -73.98 135.5 43.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.656 -0.653 . . . . 0.0 110.119 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 50.2 mm -124.94 106.13 29.01 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.69 -0.631 . . . . 0.0 109.991 -177.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -60.02 148.22 89.95 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 O-C-N 123.104 1.055 . . . . 0.0 110.467 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.3 t -110.56 147.09 34.9 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.707 -0.621 . . . . 0.0 110.378 -177.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -95.28 24.73 4.81 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.632 -0.667 . . . . 0.0 110.779 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 51.6 m -74.6 125.23 28.2 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.554 -0.716 . . . . 0.0 110.286 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -69.78 144.94 52.54 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.763 -0.586 . . . . 0.0 110.482 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -154.18 98.86 2.54 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.617 -0.677 . . . . 0.0 110.156 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -59.27 -39.95 73.1 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 O-C-N 123.261 1.137 . . . . 0.0 110.782 -176.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 73.76 -155.15 49.38 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -73.82 -45.65 0.37 Allowed 'Trans proline' 0 C--N 1.317 -1.096 0 O-C-N 123.38 1.2 . . . . 0.0 111.044 -174.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -86.24 8.07 22.69 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.474 -0.766 . . . . 0.0 111.383 -173.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.69 60.22 3.81 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.987 -1.071 . . . . 0.0 110.655 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.416 ' CE1' HG22 ' A' ' 174' ' ' ILE . 56.5 t80 -77.8 118.77 20.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.584 -0.697 . . . . 0.0 109.851 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -130.0 160.02 34.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.887 -0.508 . . . . 0.0 110.182 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 80.6 t -125.16 146.92 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.729 -0.607 . . . . 0.0 109.785 176.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.4 p -157.73 171.03 21.04 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.88 176.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.413 ' CE1' HG12 ' A' ' 172' ' ' ILE . 57.7 m-85 -126.41 125.06 41.55 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.05 150.02 17.96 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.585 -0.697 . . . . 0.0 110.437 -176.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -69.99 136.22 50.22 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.584 -0.698 . . . . 0.0 110.391 -170.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 28.0 t -133.15 145.58 50.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.707 -0.62 . . . . 0.0 110.1 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 60.8 p -69.87 166.41 19.52 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.634 -0.666 . . . . 0.0 110.231 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 74.8 p -97.27 28.55 3.6 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.724 -0.61 . . . . 0.0 110.133 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.08 159.09 12.34 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.689 -0.632 . . . . 0.0 110.262 -176.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -58.94 157.63 9.61 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.699 -0.625 . . . . 0.0 110.394 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 75.5 m 53.6 33.64 16.88 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.496 -0.753 . . . . 0.0 111.008 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -70.44 126.68 30.32 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.702 -0.624 . . . . 0.0 109.854 173.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 69.0 p -60.03 -34.03 72.82 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.769 -0.582 . . . . 0.0 110.093 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -170.75 148.08 2.89 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.834 -0.541 . . . . 0.0 109.964 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.4 t -141.7 142.44 33.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.749 -0.594 . . . . 0.0 109.884 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -125.54 140.07 53.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.52 -0.738 . . . . 0.0 110.589 -172.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 30.1 t -109.86 122.81 48.39 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.297 -0.561 . . . . 0.0 109.734 174.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 67.6 m -70.75 -36.98 73.38 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.353 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -59.38 -31.77 69.54 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.615 -0.678 . . . . 0.0 110.453 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.3 mt -104.78 -12.04 16.51 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.682 -0.636 . . . . 0.0 110.79 -175.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 32.5 tttt 59.68 48.52 9.27 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.007 -1.058 . . . . 0.0 109.682 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -146.93 153.06 39.65 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.736 -0.602 . . . . 0.0 110.638 -174.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.6 tp -126.43 137.8 53.46 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.759 -0.588 . . . . 0.0 110.164 -175.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -115.85 132.67 56.57 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 175.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.1 p -138.36 158.43 44.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.663 -0.648 . . . . 0.0 111.046 -174.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -104.62 140.13 38.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.662 -0.649 . . . . 0.0 110.205 171.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 17.5 tt -52.61 149.14 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-O 121.619 0.723 . . . . 0.0 111.799 -174.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 66.06 8.35 5.41 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.489 -0.757 . . . . 0.0 112.483 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -96.6 155.09 16.92 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.904 -1.123 . . . . 0.0 110.949 174.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 87.8 m -84.24 126.41 33.13 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.668 -0.645 . . . . 0.0 110.635 -177.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 43.1 t -112.94 90.25 15.26 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.569 -0.707 . . . . 0.0 109.995 174.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -65.32 131.67 29.01 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.199 1.105 . . . . 0.0 110.484 176.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.413 HG12 ' CE1' ' A' ' 142' ' ' PHE . 92.5 mt -125.84 142.29 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.6 -0.688 . . . . 0.0 109.541 175.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -110.83 135.59 51.16 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.601 -0.687 . . . . 0.0 110.697 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.416 HG22 ' CE1' ' A' ' 138' ' ' PHE . 49.7 mm -95.33 134.91 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.556 -0.715 . . . . 0.0 109.579 169.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -116.21 128.47 55.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.602 -0.686 . . . . 0.0 110.445 176.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.5 m -136.29 159.77 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.548 -0.72 . . . . 0.0 109.886 174.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 81.9 mmm -75.45 -40.4 57.57 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.703 -0.623 . . . . 0.0 110.068 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 75.5 p -134.75 143.18 45.32 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.769 -0.582 . . . . 0.0 109.768 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -54.95 139.79 79.34 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 O-C-N 123.138 1.073 . . . . 0.0 110.883 -172.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.421 ' CG ' ' CE1' ' A' ' 251' ' ' TYR . 20.5 Cg_endo -63.26 167.63 12.42 Favored 'Trans proline' 0 N--CA 1.487 1.099 0 O-C-N 123.191 1.1 . . . . 0.0 110.59 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -61.38 155.04 54.55 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.353 1.186 . . . . 0.0 110.321 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -72.99 139.0 46.38 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.591 -0.693 . . . . 0.0 109.853 175.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.71 -25.01 29.15 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -175.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.1 148.71 3.21 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.377 -1.072 . . . . 0.0 111.303 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.8 155.96 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.692 -0.63 . . . . 0.0 109.743 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 85.6 mt -106.57 137.91 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.698 -0.626 . . . . 0.0 109.457 176.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.406 ' HG2' ' CD2' ' A' ' 248' ' ' LEU . 70.8 mtp180 -114.85 141.96 47.2 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -176.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -137.39 125.83 23.45 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.471 -0.768 . . . . 0.0 110.353 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 39.4 ttm -137.27 139.11 26.95 Favored Pre-proline 0 N--CA 1.497 1.901 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.977 -176.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -90.39 138.21 2.66 Favored 'Trans proline' 0 C--N 1.319 -0.982 0 C-N-CA 120.936 1.091 . . . . 0.0 110.858 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.9 m -147.26 154.86 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.493 -0.755 . . . . 0.0 110.009 174.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.424 ' CE2' HG22 ' A' ' 202' ' ' VAL . 80.4 m-85 -61.49 165.0 5.17 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.431 -0.793 . . . . 0.0 110.448 -177.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -84.69 -60.06 2.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.605 -0.685 . . . . 0.0 110.841 -173.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 42.7 mttt -80.01 152.52 29.4 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.667 -0.646 . . . . 0.0 110.311 -174.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.68 -39.18 73.34 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.387 -0.821 . . . . 0.0 110.66 -174.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -56.62 -24.79 50.46 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.438 -0.789 . . . . 0.0 110.67 -177.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.419 ' CE1' ' NH1' ' A' ' 280' ' ' ARG . 99.3 m-70 -109.23 -20.46 12.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.604 -0.685 . . . . 0.0 111.197 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.2 p -68.36 -20.28 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.144 -0.973 . . . . 0.0 110.639 -175.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 68.3 p -79.45 -17.15 54.85 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.551 -0.718 . . . . 0.0 110.858 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -88.36 137.7 32.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.302 -0.874 . . . . 0.0 110.186 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 57.7 t -72.95 146.49 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.587 -0.696 . . . . 0.0 110.146 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.424 HG22 ' CE2' ' A' ' 192' ' ' TYR . 60.0 t -84.82 140.06 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.575 -0.703 . . . . 0.0 109.203 172.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -134.83 -170.23 2.52 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.395 -0.815 . . . . 0.0 111.131 -167.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -95.21 154.14 17.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.771 -0.581 . . . . 0.0 110.461 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 63.3 m -77.52 162.75 67.45 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.649 -0.657 . . . . 0.0 109.274 173.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -63.9 -47.39 6.84 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 O-C-N 123.092 1.048 . . . . 0.0 109.849 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.449 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.8 p-10 -65.55 -44.55 86.47 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.62 -0.675 . . . . 0.0 111.257 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . 0.449 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 55.8 m170 -81.4 -27.94 34.56 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.349 -0.845 . . . . 0.0 111.526 -174.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -69.17 -39.37 78.78 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.31 -0.868 . . . . 0.0 110.359 173.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 23.1 tp -55.99 -34.84 66.13 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.533 -0.729 . . . . 0.0 110.866 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 28.0 t -48.34 132.77 16.39 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.447 -0.783 . . . . 0.0 111.404 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -61.19 143.63 55.19 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.728 -0.608 . . . . 0.0 110.248 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -60.84 -40.36 92.54 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.685 -0.634 . . . . 0.0 110.253 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 57.5 t80 50.6 50.7 18.38 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.425 -0.797 . . . . 0.0 111.145 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -75.3 -10.21 59.26 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.734 -0.604 . . . . 0.0 111.18 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -59.98 117.3 4.9 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.231 -0.918 . . . . 0.0 110.498 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 77.78 20.02 74.5 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.491 -1.043 . . . . 0.0 110.491 176.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -143.16 139.96 30.58 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.311 -1.111 . . . . 0.0 110.101 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.8 mt -88.21 -25.09 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.741 -0.6 . . . . 0.0 110.456 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -124.98 89.96 51.8 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.415 -0.803 . . . . 0.0 110.459 -175.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -62.58 145.24 95.31 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 O-C-N 123.24 1.126 . . . . 0.0 110.537 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -59.36 -18.52 46.14 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.201 1.106 . . . . 0.0 111.293 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 24.4 m -53.03 -28.38 24.14 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.157 -0.964 . . . . 0.0 111.168 -178.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -89.69 129.75 36.07 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.496 -0.752 . . . . 0.0 110.117 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 56.4 tp -57.19 -42.53 81.41 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.573 -0.705 . . . . 0.0 110.576 -175.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 84.7 mt -106.06 136.82 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 120.309 -0.557 . . . . 0.0 109.867 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -132.84 158.23 43.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.785 -0.572 . . . . 0.0 110.171 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 94.0 t -105.22 146.68 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.693 -0.629 . . . . 0.0 110.122 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -119.45 127.97 53.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.768 -0.582 . . . . 0.0 110.352 170.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.17 21.1 21.34 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 168.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -140.2 105.54 5.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.381 -1.07 . . . . 0.0 110.048 174.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 95.2 p -63.58 -15.13 57.24 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.625 -0.672 . . . . 0.0 111.217 -178.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -96.74 9.93 40.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -0.834 . . . . 0.0 111.219 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -62.2 127.83 33.21 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.246 -0.908 . . . . 0.0 110.056 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -139.84 157.35 45.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.719 -0.613 . . . . 0.0 109.734 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 247' ' ' VAL . 83.6 m-85 -117.98 150.61 38.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.599 -0.688 . . . . 0.0 110.627 -176.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.16 159.96 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.837 -0.54 . . . . 0.0 110.213 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -116.49 130.07 56.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.765 -0.584 . . . . 0.0 110.111 175.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -63.12 130.07 93.9 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.634 -0.667 . . . . 0.0 109.867 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -65.73 -29.31 51.23 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 123.197 1.104 . . . . 0.0 110.952 -171.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 82.5 mt -103.9 -50.45 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.484 -0.76 . . . . 0.0 111.071 -168.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 7.3 p -105.29 12.08 32.18 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.376 -0.827 . . . . 0.0 111.927 -173.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 73.66 -6.97 15.13 Favored Glycine 0 N--CA 1.497 2.701 0 O-C-N 121.077 -1.014 . . . . 0.0 112.125 171.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -45.89 142.09 2.76 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-N 119.095 1.448 . . . . 0.0 112.312 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -105.91 143.89 33.4 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.671 -0.643 . . . . 0.0 110.09 174.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 78.9 p -154.73 159.93 41.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.554 -0.716 . . . . 0.0 110.571 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.416 ' HB ' ' CD1' ' A' ' 236' ' ' TYR . 8.3 p -122.97 148.18 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.732 -0.605 . . . . 0.0 109.636 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.406 ' CD2' ' HG2' ' A' ' 187' ' ' ARG . 75.2 mt -129.68 154.6 46.98 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.71 -174.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 35.9 m -150.63 151.75 31.19 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.811 -0.555 . . . . 0.0 109.96 174.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -71.21 137.42 31.25 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.264 1.139 . . . . 0.0 109.913 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.421 ' CE1' ' CG ' ' A' ' 180' ' ' PRO . 8.9 t80 -76.95 125.5 29.41 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.509 -0.744 . . . . 0.0 109.984 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -99.98 160.12 28.05 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.658 -0.651 . . . . 0.0 110.145 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -58.81 159.64 20.37 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 O-C-N 123.284 1.15 . . . . 0.0 110.343 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.38 149.94 78.15 Favored 'Trans proline' 0 C--N 1.316 -1.132 0 O-C-N 123.177 1.093 . . . . 0.0 110.538 -176.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -61.14 149.75 36.34 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.695 -0.628 . . . . 0.0 110.146 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.0 t -69.83 127.09 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.552 -0.718 . . . . 0.0 110.198 -170.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.11 -10.06 56.68 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.406 ' OG1' ' CD1' ' A' ' 260' ' ' PHE . 9.6 t -145.39 175.39 10.35 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.182 -1.187 . . . . 0.0 110.604 175.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -110.52 13.23 22.71 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.531 -0.73 . . . . 0.0 111.93 -166.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . 0.406 ' CD1' ' OG1' ' A' ' 258' ' ' THR . 49.4 p90 -120.04 168.01 11.61 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.074 -1.016 . . . . 0.0 111.16 -177.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 78.1 m -117.74 146.09 44.01 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.81 -0.556 . . . . 0.0 109.914 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 32.2 m -116.88 135.57 53.62 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.594 -0.691 . . . . 0.0 110.981 -175.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 65.1 t -131.42 137.27 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 74.0 mt -104.68 122.02 44.78 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.538 -0.726 . . . . 0.0 109.944 -171.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 6.1 m-30 -106.35 149.32 27.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.709 -0.62 . . . . 0.0 110.591 -177.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -136.63 142.99 43.28 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -113.57 130.7 56.32 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.47 -0.769 . . . . 0.0 110.395 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.87 -0.62 39.27 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.782 -0.574 . . . . 0.0 111.844 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 7.0 t -144.78 158.05 43.94 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.147 -0.971 . . . . 0.0 109.009 176.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -119.0 152.32 36.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.678 -0.639 . . . . 0.0 110.262 -175.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 90.0 p -57.64 -25.39 60.09 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.481 -0.762 . . . . 0.0 111.148 -170.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 49.3 p -89.24 2.1 54.76 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.328 -0.858 . . . . 0.0 112.094 -167.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 28.6 p -85.23 118.0 24.51 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.014 -1.053 . . . . 0.0 110.618 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.63 140.17 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.457 -0.777 . . . . 0.0 110.445 -171.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 101.04 -5.18 56.07 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 177.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.11 -98.55 0.84 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 171.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 91.7 mmm -63.6 -30.96 72.0 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.73 -0.865 . . . . 0.0 110.332 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.1 p30 44.91 53.18 7.72 Favored 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 121.427 0.632 . . . . 0.0 112.338 173.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 17.1 mtt-85 54.89 34.97 23.31 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.336 -0.852 . . . . 0.0 111.328 175.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . 0.419 ' NH1' ' CE1' ' A' ' 197' ' ' HIS . 31.7 mtt-85 -112.43 104.94 56.22 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.575 -0.703 . . . . 0.0 110.085 169.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -60.13 148.95 87.54 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 O-C-N 123.12 1.063 . . . . 0.0 110.558 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 28.7 pt -131.97 179.16 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.811 0.815 . . . . 0.0 111.014 -177.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 32.2 mt -124.37 149.96 46.07 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.419 HD12 ' CE1' ' A' ' 301' ' ' PHE . 80.6 mt -114.01 129.29 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.183 177.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 80.7 mt -109.73 125.92 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -175.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 60.0 t -118.89 126.72 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 44.8 p -125.3 153.09 43.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.652 -0.655 . . . . 0.0 110.642 -175.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 23.8 tp -102.85 126.03 49.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.799 -0.563 . . . . 0.0 109.509 170.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -132.78 150.59 52.14 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.79 -0.569 . . . . 0.0 109.967 -172.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 72.6 p -90.01 159.19 17.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.593 -0.692 . . . . 0.0 109.96 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -56.05 -26.12 47.85 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.533 -0.729 . . . . 0.0 110.935 -177.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -92.32 11.65 25.2 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.45 -0.781 . . . . 0.0 111.729 -173.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 90.05 20.12 44.02 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.11 -1.043 . . . . 0.0 110.932 167.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -105.49 140.14 39.04 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.28 -1.129 . . . . 0.0 110.154 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 59.4 t -90.66 130.9 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.63 -0.669 . . . . 0.0 110.159 -174.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 95.8 mt -99.92 -40.21 7.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.768 -0.582 . . . . 0.0 110.781 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -161.64 154.71 25.76 Favored Glycine 0 N--CA 1.497 2.719 0 C-N-CA 119.987 -1.101 . . . . 0.0 110.359 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 41.1 mtt180 -135.15 135.92 41.48 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.642 -0.916 . . . . 0.0 110.383 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -141.54 158.65 43.58 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.491 -0.755 . . . . 0.0 110.095 169.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 94.8 m -143.59 157.91 44.06 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.407 -0.808 . . . . 0.0 110.701 -174.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.419 ' CE1' HD12 ' A' ' 284' ' ' ILE . 49.6 p90 -145.59 161.03 40.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.658 -0.651 . . . . 0.0 110.073 175.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -104.9 136.71 43.88 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.548 -0.72 . . . . 0.0 110.178 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -119.01 143.5 47.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.645 -0.659 . . . . 0.0 110.833 -169.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -138.5 138.25 37.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.772 -0.58 . . . . 0.0 109.601 172.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 65.7 mt -111.21 122.84 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.52 -0.738 . . . . 0.0 109.719 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.0 p -145.34 173.38 12.03 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.707 -0.621 . . . . 0.0 110.654 -172.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -74.13 -40.11 62.86 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.655 -0.653 . . . . 0.0 110.696 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.9 t -127.35 86.75 57.92 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.581 -0.699 . . . . 0.0 110.547 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -55.66 -28.62 66.81 Favored 'Trans proline' 0 N--CA 1.488 1.2 0 O-C-N 123.156 1.082 . . . . 0.0 110.813 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.97 -37.76 92.35 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -72.83 -40.48 65.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.692 -0.887 . . . . 0.0 109.881 -173.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -69.61 -38.25 77.18 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.283 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -62.08 -42.75 99.53 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.196 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -64.88 -37.43 87.62 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.5 -0.75 . . . . 0.0 110.342 175.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.63 -49.42 76.63 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.548 -0.72 . . . . 0.0 110.608 -173.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -61.08 -37.69 83.6 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.448 -0.782 . . . . 0.0 110.098 -178.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -62.98 -41.2 99.49 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.035 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -62.84 -35.14 78.97 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.67 -0.644 . . . . 0.0 109.876 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 23.9 m -63.42 -32.36 73.78 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.792 -0.567 . . . . 0.0 110.173 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 83.4 mt -76.79 -48.15 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.61 -0.681 . . . . 0.0 109.986 -177.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -61.03 -39.74 90.92 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.635 -0.666 . . . . 0.0 110.437 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -60.66 -43.78 97.24 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.57 -0.706 . . . . 0.0 110.329 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -62.1 -33.15 73.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.607 -0.683 . . . . 0.0 110.082 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -93.55 124.96 37.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.643 -0.66 . . . . 0.0 110.385 -178.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.23 130.19 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.643 -0.66 . . . . 0.0 109.808 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 59.9 p -93.43 140.03 30.03 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.702 -0.624 . . . . 0.0 110.278 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -88.64 121.8 31.4 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.686 -0.634 . . . . 0.0 110.262 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 29.8 t -69.49 144.17 53.28 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.601 -0.687 . . . . 0.0 109.992 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 67.5 p -132.63 164.72 26.07 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.624 -0.672 . . . . 0.0 110.287 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 31.4 mmtm -88.09 155.04 20.0 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.642 -0.661 . . . . 0.0 110.133 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -58.66 -27.98 65.28 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.621 -0.675 . . . . 0.0 110.63 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -170.44 -178.9 41.54 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 59.51 79.85 0.22 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.502 -0.999 . . . . 0.0 110.236 176.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -165.83 103.8 0.68 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.669 -0.644 . . . . 0.0 110.266 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -117.25 148.18 41.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.65 -0.656 . . . . 0.0 110.308 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 51.61 95.85 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.484 -0.76 . . . . 0.0 111.156 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -115.47 143.49 45.23 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.56 -0.712 . . . . 0.0 110.264 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 53.71 42.63 31.77 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.429 -0.794 . . . . 0.0 110.903 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 74.6 p -67.69 -33.26 74.56 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.669 -0.645 . . . . 0.0 110.255 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -59.56 -41.98 91.38 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.619 -0.676 . . . . 0.0 110.383 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 76.06 28.02 61.21 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 15.9 tt -148.17 146.55 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.631 -0.923 . . . . 0.0 110.253 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -92.69 124.28 36.58 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.689 -0.632 . . . . 0.0 110.222 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 65.1 mtt -60.4 -35.3 75.44 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.579 -0.701 . . . . 0.0 110.292 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.19 -179.894 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 60.3 p -84.4 160.71 20.56 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.701 -0.882 . . . . 0.0 110.262 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 96.6 p -122.72 153.99 38.71 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.609 -0.682 . . . . 0.0 110.15 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.7 t -131.82 25.1 4.67 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.631 -0.668 . . . . 0.0 110.757 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -60.61 -37.65 82.11 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.496 -0.753 . . . . 0.0 110.198 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -81.01 -29.02 35.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.642 -0.661 . . . . 0.0 110.203 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 50.55 -163.39 0.05 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.367 -0.833 . . . . 0.0 111.148 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 6.7 tt 63.04 -70.21 0.06 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.6 -0.688 . . . . 0.0 111.035 -175.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.8 t -63.54 158.14 60.76 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.391 -0.818 . . . . 0.0 110.159 -176.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -62.25 150.59 62.1 Favored 'Cis proline' 0 N--CA 1.496 1.651 0 C-N-CA 123.086 -1.631 . . . . 0.0 110.33 -19.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 26.7 t -81.19 144.77 54.86 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.604 -0.685 . . . . 0.0 110.21 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -64.42 147.15 90.61 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 O-C-N 123.253 1.133 . . . . 0.0 110.297 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.77 139.5 41.86 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.621 -0.674 . . . . 0.0 110.032 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 50.2 mm -121.69 139.4 29.95 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.67 -0.644 . . . . 0.0 109.958 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.83 152.71 79.45 Favored 'Trans proline' 0 N--CA 1.487 1.12 0 O-C-N 123.148 1.078 . . . . 0.0 110.376 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 27.8 t -112.49 142.67 44.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.656 -0.653 . . . . 0.0 110.322 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.6 p-10 -99.93 24.85 7.96 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.718 -0.614 . . . . 0.0 110.731 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 53.1 m -78.14 125.19 29.0 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.53 -0.731 . . . . 0.0 110.25 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -71.04 144.95 50.22 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.739 -0.6 . . . . 0.0 110.403 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -158.57 101.83 1.66 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.675 -0.641 . . . . 0.0 110.07 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -59.21 -40.0 73.3 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.151 1.08 . . . . 0.0 110.729 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.08 -155.19 40.13 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -74.67 -43.29 0.47 Allowed 'Trans proline' 0 C--N 1.317 -1.116 0 O-C-N 123.315 1.166 . . . . 0.0 110.846 -175.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -88.65 4.41 47.24 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.577 -0.702 . . . . 0.0 111.437 -174.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 t 54.05 61.79 2.89 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.995 -1.066 . . . . 0.0 110.669 -176.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.432 ' CE1' ' CG2' ' A' ' 174' ' ' ILE . 59.5 t80 -78.0 120.77 23.31 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.606 -0.683 . . . . 0.0 110.111 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -130.01 160.01 34.96 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.8 -0.563 . . . . 0.0 110.129 -177.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 74.6 t -123.13 146.75 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.423 0.63 . . . . 0.0 110.046 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.0 p -157.3 171.08 21.04 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.126 0.489 . . . . 0.0 109.688 175.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.426 ' CE2' HG12 ' A' ' 172' ' ' ILE . 52.7 m-85 -126.48 125.16 41.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.827 -0.545 . . . . 0.0 109.656 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -57.38 139.47 52.97 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.591 -0.693 . . . . 0.0 110.378 -175.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -78.63 144.13 35.73 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.552 -0.718 . . . . 0.0 110.656 -169.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 83.2 p -142.84 161.82 37.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.721 -0.612 . . . . 0.0 110.067 177.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 47.5 m -62.72 161.78 11.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.61 -0.681 . . . . 0.0 110.228 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 77.8 p -92.61 44.44 1.16 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.618 -0.676 . . . . 0.0 110.178 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.11 156.12 36.95 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.735 -0.603 . . . . 0.0 110.243 -176.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -63.21 162.12 12.5 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.691 -0.631 . . . . 0.0 110.063 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 60.3 m 53.24 26.96 5.53 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.434 -0.791 . . . . 0.0 111.018 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.88 131.7 49.65 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.556 -0.715 . . . . 0.0 109.923 175.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 76.6 p -60.08 -34.04 72.9 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.71 -0.619 . . . . 0.0 109.928 177.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.415 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 67.2 p-90 -170.59 147.88 2.96 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.878 -0.514 . . . . 0.0 109.788 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 14.0 t -142.08 142.43 32.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.768 -0.583 . . . . 0.0 109.963 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -125.63 140.08 53.02 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.494 -0.754 . . . . 0.0 110.45 -172.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 30.7 t -109.72 122.5 47.62 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 120.324 -0.551 . . . . 0.0 109.748 175.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 63.6 m -70.77 -37.0 73.34 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.71 -0.619 . . . . 0.0 110.443 -177.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -60.46 -32.25 71.22 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.605 -0.684 . . . . 0.0 110.357 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 60.3 mt -104.79 -12.06 16.5 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.726 -0.609 . . . . 0.0 110.852 -176.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.5 tttm 59.84 50.75 6.63 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.081 -1.012 . . . . 0.0 109.702 177.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -146.34 153.0 40.03 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.598 -176.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.5 tp -126.63 137.87 53.36 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.791 -0.568 . . . . 0.0 110.24 -175.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -115.47 134.05 55.45 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.9 p -138.28 158.39 44.39 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.637 -0.664 . . . . 0.0 111.005 -175.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -104.55 143.04 33.59 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.499 0.666 . . . . 0.0 110.347 172.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 17.3 tt -52.53 147.68 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-O 121.583 0.706 . . . . 0.0 111.842 -173.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 64.36 9.98 5.33 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.638 -0.664 . . . . 0.0 112.461 177.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -96.82 155.1 16.92 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.975 -1.078 . . . . 0.0 110.811 175.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 87.3 m -82.78 126.17 32.11 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.709 -0.619 . . . . 0.0 110.607 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 42.6 t -112.93 90.29 15.29 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.647 -0.658 . . . . 0.0 110.082 172.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.415 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 15.8 Cg_exo -65.1 128.65 21.07 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 O-C-N 123.264 1.139 . . . . 0.0 110.394 176.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.426 HG12 ' CE2' ' A' ' 142' ' ' PHE . 94.7 mt -122.38 139.42 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.621 -0.674 . . . . 0.0 109.393 177.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -108.69 137.0 47.33 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.645 -0.659 . . . . 0.0 110.488 -177.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.432 ' CG2' ' CE1' ' A' ' 138' ' ' PHE . 48.5 mm -95.23 132.77 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.66 -0.65 . . . . 0.0 109.562 171.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -115.93 128.95 56.17 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.699 -0.626 . . . . 0.0 110.352 176.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 17.0 m -136.74 159.71 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.575 -0.703 . . . . 0.0 110.012 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.5 mmm -75.45 -40.19 57.8 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.723 -0.611 . . . . 0.0 110.056 177.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 76.4 p -136.82 143.23 41.8 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.788 -0.57 . . . . 0.0 109.729 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -55.4 139.91 82.06 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 O-C-N 123.21 1.11 . . . . 0.0 110.898 -171.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.43 ' HG2' ' CD1' ' A' ' 251' ' ' TYR . 33.4 Cg_endo -68.05 170.08 15.15 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 O-C-N 123.119 1.063 . . . . 0.0 110.558 178.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -60.5 155.04 49.66 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 O-C-N 123.289 1.152 . . . . 0.0 110.516 -178.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -77.55 140.2 39.68 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.598 -0.689 . . . . 0.0 109.931 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.67 -24.93 29.48 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -174.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.19 153.33 1.48 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.307 -1.114 . . . . 0.0 111.387 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.84 155.93 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.665 -0.647 . . . . 0.0 109.841 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 87.4 mt -109.25 137.92 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.662 -0.649 . . . . 0.0 109.652 176.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 40.4 mtm180 -114.97 146.95 40.67 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -176.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -140.59 127.72 20.91 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.503 -0.748 . . . . 0.0 110.343 173.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 21.1 ttm -137.31 139.71 28.61 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.811 -0.555 . . . . 0.0 110.978 -177.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -91.98 138.17 1.93 Allowed 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 121.061 1.174 . . . . 0.0 110.778 177.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.7 m -147.06 154.86 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.445 -0.784 . . . . 0.0 110.178 173.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.45 ' CE2' ' CG2' ' A' ' 202' ' ' VAL . 83.7 m-85 -60.7 164.56 4.56 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.425 -0.797 . . . . 0.0 110.441 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -80.74 -60.03 2.46 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.601 -0.687 . . . . 0.0 110.827 -174.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -80.12 151.25 29.91 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.587 -0.696 . . . . 0.0 110.385 -175.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.57 -37.94 71.27 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.392 -0.817 . . . . 0.0 110.684 -176.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -56.84 -24.91 54.67 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.488 -0.757 . . . . 0.0 110.542 -176.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.402 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 63.3 m170 -109.27 -20.58 12.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.52 -0.738 . . . . 0.0 111.125 -178.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.1 p -68.0 -20.25 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.199 -0.938 . . . . 0.0 110.623 -176.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 72.3 p -79.43 -17.04 55.11 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.62 174.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -88.35 135.66 33.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.417 -0.802 . . . . 0.0 110.067 174.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.8 t -73.05 141.21 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.73 -0.606 . . . . 0.0 110.223 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.45 ' CG2' ' CE2' ' A' ' 192' ' ' TYR . 64.3 t -84.98 138.28 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.632 -0.667 . . . . 0.0 109.233 170.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -134.82 -170.25 2.52 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.536 -0.727 . . . . 0.0 111.229 -167.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 73.0 mtm-85 -95.25 154.68 17.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.853 -0.529 . . . . 0.0 110.389 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 57.0 m -76.0 156.82 84.03 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.62 -0.675 . . . . 0.0 109.247 174.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -63.48 -47.4 7.61 Favored 'Trans proline' 0 C--N 1.315 -1.234 0 O-C-N 123.192 1.101 . . . . 0.0 109.96 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.43 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.6 p-10 -65.44 -44.49 87.14 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.649 -0.657 . . . . 0.0 111.312 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . 0.43 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 52.6 m170 -81.34 -27.94 34.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.367 -0.833 . . . . 0.0 111.253 -174.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -68.99 -42.07 77.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.416 -0.802 . . . . 0.0 110.221 173.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 26.3 tp -63.61 -36.68 84.63 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.634 -0.666 . . . . 0.0 110.268 178.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.0 t -48.46 -41.44 29.6 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.551 -0.718 . . . . 0.0 111.608 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 49.93 -167.28 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.435 -0.791 . . . . 0.0 111.202 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -167.95 48.65 0.05 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.614 -0.679 . . . . 0.0 110.073 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 52.16 75.03 0.24 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.405 -0.809 . . . . 0.0 110.928 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -66.74 -10.27 45.31 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.633 -0.667 . . . . 0.0 111.238 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -60.09 118.27 6.12 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.192 -0.943 . . . . 0.0 110.333 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 79.08 20.16 70.76 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -114.75 146.69 40.69 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.251 -1.146 . . . . 0.0 110.4 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.9 mt -84.81 -25.03 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.674 -0.642 . . . . 0.0 110.564 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.43 ' CB ' ' CE2' ' A' ' 236' ' ' TYR . . . -124.9 97.45 38.38 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.414 -0.804 . . . . 0.0 110.544 -175.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -65.66 157.51 58.26 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.348 1.183 . . . . 0.0 110.415 177.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -56.44 -20.92 35.07 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 O-C-N 123.226 1.119 . . . . 0.0 111.492 -174.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 25.7 m -52.79 -28.35 22.14 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.268 -0.895 . . . . 0.0 111.432 -176.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . 0.419 ' CD2' ' HB3' ' A' ' 236' ' ' TYR . 47.0 m80 -96.0 124.03 39.85 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.357 -0.839 . . . . 0.0 110.653 -174.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 37.6 tp -66.11 -36.04 82.1 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.609 -0.682 . . . . 0.0 110.388 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 83.3 mt -102.44 136.88 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.814 -0.554 . . . . 0.0 109.883 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 50.0 mtt-85 -130.92 159.44 37.44 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.689 -0.632 . . . . 0.0 110.326 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 81.3 t -103.96 146.65 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.728 -0.607 . . . . 0.0 110.0 176.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -118.25 128.12 54.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.696 -0.627 . . . . 0.0 110.349 170.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 96.67 21.39 21.69 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 168.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -139.38 106.24 5.41 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.348 -1.089 . . . . 0.0 109.95 174.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 90.9 p -63.66 -15.09 57.4 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.64 -0.663 . . . . 0.0 111.201 -177.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -97.12 9.93 40.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.341 -0.849 . . . . 0.0 111.236 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.75 128.78 37.87 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.111 -0.993 . . . . 0.0 110.114 175.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -139.76 155.75 47.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.76 -0.587 . . . . 0.0 109.607 177.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.43 ' CE2' ' CB ' ' A' ' 220' ' ' ALA . 80.9 m-85 -119.12 150.74 39.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.568 -0.708 . . . . 0.0 110.61 -175.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.16 159.97 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.778 -0.576 . . . . 0.0 110.242 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -117.76 130.01 56.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.766 -0.584 . . . . 0.0 110.181 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -62.52 130.19 93.24 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.623 -0.673 . . . . 0.0 109.789 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -64.82 -28.04 59.3 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 O-C-N 123.135 1.071 . . . . 0.0 111.003 -170.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.0 mt -102.0 -50.43 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.344 -0.848 . . . . 0.0 111.014 -168.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 17.9 p -105.43 12.14 31.84 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.31 -0.869 . . . . 0.0 111.913 -174.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 72.17 -4.92 16.01 Favored Glycine 0 N--CA 1.497 2.723 0 O-C-N 121.074 -1.016 . . . . 0.0 112.022 172.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -45.86 142.01 2.77 Favored 'General case' 0 N--CA 1.505 2.309 0 CA-C-N 119.119 1.46 . . . . 0.0 112.388 -175.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -103.54 143.36 32.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.618 -0.676 . . . . 0.0 110.119 175.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.2 p -154.81 159.94 40.92 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.595 -0.69 . . . . 0.0 110.348 176.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.421 ' HB ' ' CD1' ' A' ' 236' ' ' TYR . 8.6 p -123.17 148.23 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.836 -0.54 . . . . 0.0 109.814 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 81.8 mt -129.62 154.61 46.93 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.079 -0.649 . . . . 0.0 109.638 -177.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 34.4 m -151.1 151.67 29.95 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.813 -0.554 . . . . 0.0 110.001 175.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -71.05 139.0 34.88 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 O-C-N 123.368 1.194 . . . . 0.0 110.08 177.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.43 ' CD1' ' HG2' ' A' ' 180' ' ' PRO . 58.9 t80 -75.9 124.47 27.39 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.099 175.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -99.99 160.11 28.07 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.694 -0.628 . . . . 0.0 109.953 176.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -58.37 158.49 22.59 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 O-C-N 123.294 1.155 . . . . 0.0 110.517 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -59.09 149.98 76.35 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 O-C-N 123.219 1.115 . . . . 0.0 110.511 -177.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -60.73 148.27 39.42 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.65 -0.656 . . . . 0.0 110.295 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.84 127.19 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.538 -0.726 . . . . 0.0 110.168 -171.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.96 -10.14 55.41 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.409 ' OG1' ' CD2' ' A' ' 260' ' ' PHE . 10.0 t -144.65 173.43 11.83 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.175 -1.191 . . . . 0.0 110.63 175.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -107.28 13.09 27.51 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.617 -0.677 . . . . 0.0 111.78 -168.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . 0.409 ' CD2' ' OG1' ' A' ' 258' ' ' THR . 15.6 p90 -119.92 168.01 11.56 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.181 -0.95 . . . . 0.0 111.168 -175.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 92.6 m -117.73 146.76 43.54 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.744 -0.597 . . . . 0.0 109.986 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 46.4 m -118.24 135.67 54.13 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.604 -0.685 . . . . 0.0 110.952 -174.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 60.2 t -132.56 137.23 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 172.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 75.1 mt -104.78 123.8 48.3 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.437 -0.789 . . . . 0.0 110.054 -171.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 6.1 m-30 -106.85 151.51 25.12 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.644 -0.66 . . . . 0.0 110.683 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -136.49 142.92 43.55 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -113.47 133.11 55.39 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.538 -0.726 . . . . 0.0 110.55 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 2.3 ppp? -97.68 2.66 49.97 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.709 -0.62 . . . . 0.0 112.164 -175.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -144.73 165.07 29.1 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.131 -0.981 . . . . 0.0 110.195 176.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -120.68 162.8 19.07 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.43 0.633 . . . . 0.0 110.407 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 25.2 m -58.8 -33.53 70.45 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.407 -0.808 . . . . 0.0 110.927 -163.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 49.9 p -100.75 12.17 38.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.466 -0.771 . . . . 0.0 112.018 -163.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 30.4 p -94.54 118.1 31.15 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.03 -1.043 . . . . 0.0 110.742 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.2 t -63.2 139.78 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.431 -0.793 . . . . 0.0 110.393 -171.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.83 -5.28 58.08 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.08 -99.78 0.88 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 171.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 93.7 mmm -62.71 -31.53 72.46 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.773 -0.84 . . . . 0.0 110.308 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.3 p30 44.47 49.32 8.3 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 174.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 21.3 mtt180 54.79 31.71 16.1 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.331 -0.855 . . . . 0.0 111.179 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -119.31 104.96 45.04 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.508 -0.745 . . . . 0.0 110.07 174.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -59.98 145.26 98.79 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 O-C-N 123.162 1.085 . . . . 0.0 110.466 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 46.5 pt -131.98 176.38 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.874 0.845 . . . . 0.0 111.186 -174.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 29.4 mt -124.37 149.86 46.18 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.423 HD13 ' CE1' ' A' ' 301' ' ' PHE . 79.0 mt -115.66 130.11 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.595 -0.69 . . . . 0.0 109.174 178.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 79.0 mt -109.86 126.06 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 57.8 t -118.86 126.93 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.2 p -125.27 152.91 44.01 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.592 -0.692 . . . . 0.0 110.614 -173.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.417 ' HB2' ' CE1' ' A' ' 138' ' ' PHE . 23.2 tp -103.54 126.68 50.83 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.754 -0.591 . . . . 0.0 109.434 168.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -130.52 152.03 50.34 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.892 -0.505 . . . . 0.0 109.876 -173.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 68.6 p -89.83 159.91 16.76 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.699 -0.625 . . . . 0.0 109.735 176.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -55.97 -26.1 46.76 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.515 -0.741 . . . . 0.0 110.772 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -86.96 9.18 20.27 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.521 -0.737 . . . . 0.0 111.845 -174.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 86.6 20.16 54.84 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 120.183 -1.008 . . . . 0.0 110.766 170.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -107.55 140.24 40.84 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.282 -1.128 . . . . 0.0 110.196 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 61.5 t -86.21 132.9 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.656 -0.653 . . . . 0.0 110.091 -174.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 80.3 mt -99.89 -40.1 7.85 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.722 -0.611 . . . . 0.0 110.424 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -165.27 153.28 23.3 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -133.49 136.46 45.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.686 -0.891 . . . . 0.0 110.751 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -135.59 158.29 44.74 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.634 -0.666 . . . . 0.0 109.862 172.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 95.0 m -143.0 155.1 44.59 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.34 -0.85 . . . . 0.0 110.772 -175.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.423 ' CE1' HD13 ' A' ' 284' ' ' ILE . 49.4 p90 -144.97 162.76 36.11 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.734 -0.604 . . . . 0.0 110.052 175.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -104.75 135.06 46.83 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.544 -0.723 . . . . 0.0 110.217 -177.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -122.84 143.18 50.03 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.701 -169.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -138.3 139.2 39.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.74 -0.6 . . . . 0.0 109.704 173.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 70.5 mt -108.02 122.8 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.537 -0.727 . . . . 0.0 109.605 176.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.9 p -145.27 169.34 18.43 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.629 -0.67 . . . . 0.0 110.676 -171.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -71.32 -40.1 70.98 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.631 -0.668 . . . . 0.0 110.64 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.9 t -127.5 86.05 59.42 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.468 -0.77 . . . . 0.0 110.47 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -55.87 -28.36 67.41 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 O-C-N 123.122 1.064 . . . . 0.0 110.812 174.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -67.59 -36.73 88.62 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -73.35 -39.83 64.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.72 -0.871 . . . . 0.0 109.822 -173.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -69.56 -40.94 76.51 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.137 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -61.88 -43.46 98.81 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.477 -0.765 . . . . 0.0 110.24 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -64.79 -39.06 92.97 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.532 -0.73 . . . . 0.0 110.478 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.2 -50.5 72.88 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.439 -0.788 . . . . 0.0 110.427 -173.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -61.42 -37.72 84.52 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.455 -0.778 . . . . 0.0 110.1 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -61.56 -40.68 95.59 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.601 -0.687 . . . . 0.0 110.132 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -62.34 -35.18 78.3 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.646 -0.659 . . . . 0.0 109.938 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 23.1 m -62.27 -33.74 75.22 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.665 -0.647 . . . . 0.0 110.223 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 83.6 mt -78.12 -43.08 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.692 -0.63 . . . . 0.0 109.953 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -58.64 -39.82 81.64 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.576 -0.702 . . . . 0.0 110.544 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -60.99 -42.14 97.85 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.672 -0.643 . . . . 0.0 110.131 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -61.59 -34.55 75.81 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.643 -0.661 . . . . 0.0 110.15 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -97.66 125.13 42.26 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.716 -0.615 . . . . 0.0 110.355 -176.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 62.2 t -110.86 130.08 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.698 -0.626 . . . . 0.0 109.849 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 50.1 m -95.1 140.19 30.39 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.683 -0.636 . . . . 0.0 110.265 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -68.49 144.88 54.49 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.76 -0.587 . . . . 0.0 110.142 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 55.0 p -68.65 162.34 26.21 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.665 -0.647 . . . . 0.0 110.152 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 71.6 p -92.82 -24.1 18.62 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.648 -0.658 . . . . 0.0 110.465 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -60.14 -36.15 76.89 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.452 -0.78 . . . . 0.0 110.254 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -110.04 137.65 47.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.652 -0.655 . . . . 0.0 110.218 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -84.15 -177.55 51.42 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -75.46 128.14 34.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.609 -0.936 . . . . 0.0 110.254 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -146.42 155.03 42.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.64 -0.662 . . . . 0.0 110.325 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -139.77 166.16 25.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.577 -0.702 . . . . 0.0 110.35 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 56.84 -84.4 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.745 -0.597 . . . . 0.0 111.052 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -57.31 -37.35 72.34 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.151 -0.968 . . . . 0.0 110.681 -174.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -104.91 137.04 43.29 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.67 -0.644 . . . . 0.0 110.274 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 52.4 m -121.31 144.78 48.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.65 -0.656 . . . . 0.0 110.292 -178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -57.23 -34.81 68.96 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.632 -0.668 . . . . 0.0 110.587 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 101.72 -24.35 31.77 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 16.3 tt -92.37 150.18 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.452 -1.028 . . . . 0.0 110.324 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -92.2 127.3 37.62 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.653 -0.654 . . . . 0.0 110.241 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 93.4 mmm -59.93 -35.49 75.03 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.697 -0.627 . . . . 0.0 110.329 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 25.0 m . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.205 179.729 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 31.5 m -80.79 -30.97 35.88 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.656 -0.908 . . . . 0.0 110.249 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.6 m -59.95 -36.97 78.24 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.606 -0.684 . . . . 0.0 110.345 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 64.1 p -67.29 -29.65 69.3 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.649 -0.657 . . . . 0.0 110.157 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -59.71 -43.21 94.22 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.596 -0.69 . . . . 0.0 110.433 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -86.94 6.59 31.36 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.659 -0.65 . . . . 0.0 111.438 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 50.02 -161.04 0.06 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.084 -1.01 . . . . 0.0 111.267 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.4 tt 51.69 91.13 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.491 -0.756 . . . . 0.0 111.153 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 27.0 m -127.87 164.24 38.13 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.666 -0.646 . . . . 0.0 110.269 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -61.04 153.67 62.49 Favored 'Trans proline' 0 N--CA 1.488 1.161 0 O-C-N 123.302 1.159 . . . . 0.0 110.289 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.9 m -81.53 136.35 48.88 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.645 -0.66 . . . . 0.0 110.138 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -65.97 148.11 85.45 Favored 'Trans proline' 0 N--CA 1.487 1.126 0 O-C-N 123.11 1.058 . . . . 0.0 110.426 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.91 139.49 41.65 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.653 -0.654 . . . . 0.0 110.026 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 50.7 mm -126.05 99.96 30.88 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.648 -0.658 . . . . 0.0 110.128 -177.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -61.64 154.89 56.9 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 O-C-N 123.248 1.13 . . . . 0.0 110.437 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 32.4 t -108.89 150.6 27.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.64 -0.662 . . . . 0.0 110.274 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -92.8 21.2 5.78 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.675 -0.641 . . . . 0.0 111.004 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 54.9 m -72.07 125.11 26.44 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.371 -0.831 . . . . 0.0 110.223 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -69.99 144.89 52.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.679 -0.638 . . . . 0.0 110.558 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -153.64 102.41 2.53 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.744 -0.597 . . . . 0.0 110.182 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -58.53 -39.95 78.56 Favored 'Trans proline' 0 N--CA 1.487 1.142 0 O-C-N 123.096 1.051 . . . . 0.0 110.922 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.43 -155.13 45.04 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -74.69 -46.12 0.27 Allowed 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.366 1.193 . . . . 0.0 111.007 -173.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -89.66 12.12 17.78 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.557 -0.715 . . . . 0.0 111.285 -172.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.5 60.93 3.38 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.017 -1.052 . . . . 0.0 110.709 -176.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -77.82 118.32 20.05 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.643 -0.661 . . . . 0.0 109.73 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -129.98 159.94 35.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.784 -0.573 . . . . 0.0 110.196 -177.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 64.3 t -125.76 146.75 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.802 -0.561 . . . . 0.0 109.716 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.2 p -155.27 162.43 40.89 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.276 0.56 . . . . 0.0 110.108 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.501 ' CD2' ' CE2' ' A' ' 155' ' ' TYR . 72.7 m-85 -126.67 125.2 41.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.837 -0.54 . . . . 0.0 109.708 -177.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -57.08 145.31 31.29 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.59 -0.694 . . . . 0.0 110.527 -174.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -99.04 135.8 39.92 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.675 -0.641 . . . . 0.0 110.413 -175.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 49.5 m -125.68 154.72 41.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.675 -0.641 . . . . 0.0 110.029 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.0 m -59.23 157.36 10.79 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.504 -0.747 . . . . 0.0 110.264 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 64.6 p -68.22 75.83 0.24 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.729 -0.607 . . . . 0.0 110.148 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.07 156.72 18.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.537 -0.727 . . . . 0.0 110.264 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -76.59 156.92 32.39 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.619 -0.676 . . . . 0.0 110.087 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.9 p 50.99 31.1 5.89 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.571 -0.706 . . . . 0.0 111.277 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.02 131.37 49.39 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.608 -0.683 . . . . 0.0 110.036 176.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.401 ' OG1' ' CD1' ' A' ' 153' ' ' TRP . 75.5 p -60.11 -34.05 72.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.768 -0.583 . . . . 0.0 109.96 176.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.421 ' CZ2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -171.65 143.66 1.75 Allowed 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.497 0.665 . . . . 0.0 110.489 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 9.9 t -142.16 142.53 32.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.817 -0.552 . . . . 0.0 110.042 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.501 ' CE2' ' CD2' ' A' ' 142' ' ' PHE . 43.8 t80 -125.47 140.09 53.07 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.534 -0.729 . . . . 0.0 110.529 -173.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 30.6 t -111.47 125.66 54.13 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 120.431 -0.507 . . . . 0.0 109.871 176.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 59.4 m -70.78 -37.08 73.3 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.866 -0.521 . . . . 0.0 110.469 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -59.51 -32.99 70.8 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.601 -0.687 . . . . 0.0 110.36 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 55.9 mt -104.74 -12.15 16.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.771 -0.58 . . . . 0.0 110.806 -175.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.1 ttpt 59.81 47.23 10.46 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.025 -1.047 . . . . 0.0 109.693 176.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -148.31 153.26 38.41 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.786 -172.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.6 tp -126.5 137.87 53.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.799 -0.563 . . . . 0.0 110.246 -173.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -114.83 132.84 56.36 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 174.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.32 158.38 44.39 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 120.109 -0.636 . . . . 0.0 111.024 -175.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -104.55 143.6 32.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.553 -0.717 . . . . 0.0 110.481 173.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 17.7 tt -53.69 146.58 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 CA-C-O 121.586 0.708 . . . . 0.0 111.687 -173.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 64.27 10.0 5.26 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.601 -0.687 . . . . 0.0 112.448 176.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp -95.19 154.99 16.92 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.964 -1.085 . . . . 0.0 110.666 175.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 87.4 m -83.1 126.17 32.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.728 -0.607 . . . . 0.0 110.523 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 49.5 t -114.33 90.08 19.58 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.635 -0.666 . . . . 0.0 110.041 172.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.421 ' HD2' ' CZ2' ' A' ' 153' ' ' TRP . 21.7 Cg_exo -62.2 129.48 27.19 Favored 'Trans proline' 0 C--N 1.316 -1.158 0 O-C-N 123.225 1.119 . . . . 0.0 110.562 173.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.422 HG12 ' CE1' ' A' ' 142' ' ' PHE . 97.3 mt -124.39 141.96 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 176.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -109.69 135.45 50.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.443 -0.785 . . . . 0.0 110.789 -175.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.3 mm -95.22 134.99 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.68 -0.638 . . . . 0.0 109.669 169.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -116.54 129.03 55.96 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.618 -0.676 . . . . 0.0 110.455 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.1 m -136.77 159.78 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.566 -0.709 . . . . 0.0 109.868 174.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 81.3 mmm -78.22 -42.45 31.27 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.738 -0.601 . . . . 0.0 110.148 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 77.2 p -131.7 143.2 48.14 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.799 -0.563 . . . . 0.0 109.702 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -55.55 139.8 82.81 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 O-C-N 123.181 1.095 . . . . 0.0 110.876 -171.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.422 ' HG2' ' CD1' ' A' ' 251' ' ' TYR . 35.3 Cg_endo -67.6 170.03 14.63 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 O-C-N 123.168 1.088 . . . . 0.0 110.627 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -60.81 157.11 39.53 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 123.419 1.22 . . . . 0.0 110.514 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -78.73 139.13 38.5 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.647 -0.658 . . . . 0.0 110.024 175.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.06 -25.05 29.76 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -174.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -49.98 150.44 2.28 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.334 -1.098 . . . . 0.0 111.443 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.76 155.99 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.794 -0.566 . . . . 0.0 109.736 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 79.7 mt -108.27 137.1 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.667 -0.646 . . . . 0.0 109.437 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 61.6 mtt180 -114.99 143.09 45.72 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -176.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -137.35 127.25 25.7 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.46 -0.775 . . . . 0.0 110.28 176.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 23.9 ttm -137.22 139.91 29.41 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.787 -0.571 . . . . 0.0 111.086 -176.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -91.97 138.22 1.94 Allowed 'Trans proline' 0 C--N 1.319 -0.992 0 C-N-CA 121.051 1.167 . . . . 0.0 110.643 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.9 m -146.52 154.9 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.548 -0.72 . . . . 0.0 110.093 174.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.424 ' CE2' HG23 ' A' ' 202' ' ' VAL . 86.1 m-85 -63.56 159.39 18.86 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.483 -0.761 . . . . 0.0 110.578 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -75.39 -56.6 4.55 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.709 -0.619 . . . . 0.0 110.697 -175.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -79.98 147.61 31.5 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.554 -0.716 . . . . 0.0 110.29 -174.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.54 -38.51 71.97 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.38 -0.825 . . . . 0.0 110.716 -175.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 20.2 mp0 -56.55 -25.16 51.33 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.441 -0.787 . . . . 0.0 110.55 -176.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.409 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 77.4 m80 -109.84 -20.54 12.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.528 -0.733 . . . . 0.0 111.19 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.2 p -67.29 -20.24 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.202 -0.936 . . . . 0.0 110.527 -175.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 71.3 p -79.43 -16.87 55.43 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.551 -0.718 . . . . 0.0 110.578 175.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -88.38 137.77 32.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.316 -0.865 . . . . 0.0 110.027 172.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.1 t -72.98 144.35 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.651 -0.656 . . . . 0.0 110.184 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.424 HG23 ' CE2' ' A' ' 192' ' ' TYR . 61.8 t -84.91 138.89 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.569 -0.707 . . . . 0.0 109.175 173.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -134.87 -170.37 2.55 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.401 -0.812 . . . . 0.0 111.326 -167.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -95.37 159.13 15.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.818 -0.551 . . . . 0.0 110.617 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 60.7 m -78.82 160.92 70.74 Favored Pre-proline 0 N--CA 1.497 1.9 0 O-C-N 121.605 -0.684 . . . . 0.0 109.324 174.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -64.09 -47.39 6.5 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 O-C-N 123.17 1.089 . . . . 0.0 109.929 177.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.441 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.3 p-10 -65.44 -43.86 89.11 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.577 -0.702 . . . . 0.0 111.106 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . 0.441 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 55.5 m170 -80.43 -27.71 37.91 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.54 -0.725 . . . . 0.0 111.363 -175.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -69.06 -42.08 76.73 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.447 -0.783 . . . . 0.0 110.177 174.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 22.7 tp -60.56 -39.98 89.95 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.627 -0.67 . . . . 0.0 110.289 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 28.6 t -48.45 138.44 10.25 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.512 -0.742 . . . . 0.0 111.225 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -121.7 130.23 53.3 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.661 -0.649 . . . . 0.0 110.298 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -100.68 24.33 9.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.624 -0.673 . . . . 0.0 110.343 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 52.48 75.05 0.24 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.445 -0.784 . . . . 0.0 110.747 -176.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -66.01 -10.3 38.5 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.685 -0.634 . . . . 0.0 111.365 -174.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -59.29 118.64 6.17 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.165 -0.959 . . . . 0.0 110.366 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 79.31 20.06 70.37 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -114.67 140.65 48.67 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.321 -1.105 . . . . 0.0 110.426 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.1 mt -84.92 -25.06 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.633 -0.667 . . . . 0.0 110.557 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -124.94 90.01 51.71 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.37 -0.831 . . . . 0.0 110.49 -174.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.422 ' HD2' ' CE2' ' A' ' 236' ' ' TYR . 17.7 Cg_endo -65.06 141.38 69.83 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.283 1.149 . . . . 0.0 110.642 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -61.14 -17.5 52.64 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 O-C-N 123.136 1.072 . . . . 0.0 111.392 -177.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 88.1 p -54.35 -22.25 11.67 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.152 -0.968 . . . . 0.0 111.251 -176.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . 0.408 ' CD2' ' HB3' ' A' ' 236' ' ' TYR . 76.3 m80 -103.58 131.73 50.45 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.441 -0.787 . . . . 0.0 110.252 178.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 43.3 tp -60.43 -38.0 82.7 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.637 -0.665 . . . . 0.0 110.306 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 83.7 mt -102.82 136.79 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.785 -0.572 . . . . 0.0 109.744 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -134.05 159.84 39.58 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.749 -0.594 . . . . 0.0 110.187 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 97.2 t -105.72 146.71 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.71 -0.618 . . . . 0.0 110.09 178.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -118.08 123.91 46.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.738 -0.601 . . . . 0.0 110.444 172.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 95.71 24.05 16.72 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 167.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 33.5 t-20 -135.34 107.61 7.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.323 -1.104 . . . . 0.0 110.057 174.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 32.5 t -62.94 -15.14 54.56 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.677 -0.639 . . . . 0.0 111.309 -177.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -99.98 7.06 45.05 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.196 -0.94 . . . . 0.0 111.591 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.35 128.33 35.84 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.036 -1.04 . . . . 0.0 110.236 177.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -139.73 156.71 46.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.794 -0.566 . . . . 0.0 109.656 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.423 ' CD1' ' HB ' ' A' ' 247' ' ' VAL . 82.1 m-85 -118.72 150.76 39.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.601 -0.687 . . . . 0.0 110.685 -176.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.13 159.92 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.717 -0.614 . . . . 0.0 110.334 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -120.82 130.09 53.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.761 -0.587 . . . . 0.0 110.133 176.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -62.48 122.96 76.87 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.678 -0.639 . . . . 0.0 109.71 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.89 -28.08 67.09 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 O-C-N 123.047 1.025 . . . . 0.0 110.812 -173.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.7 mt -103.9 -50.25 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.469 -0.769 . . . . 0.0 110.899 -170.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 5.6 p -105.34 12.23 31.89 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.364 -0.835 . . . . 0.0 112.014 -170.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 81.09 -21.32 5.89 Favored Glycine 0 N--CA 1.497 2.72 0 O-C-N 121.004 -1.06 . . . . 0.0 111.795 170.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 -45.95 142.05 2.83 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-N 118.673 1.236 . . . . 0.0 112.429 -169.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -108.66 145.45 34.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.575 -0.703 . . . . 0.0 110.151 174.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.9 p -154.85 159.88 40.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.655 -0.653 . . . . 0.0 110.598 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.423 ' HB ' ' CD1' ' A' ' 236' ' ' TYR . 8.6 p -122.95 148.28 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.791 -0.568 . . . . 0.0 109.657 177.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 81.2 mt -129.58 154.61 46.9 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.829 -175.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 35.8 m -150.85 151.69 30.53 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.851 -0.531 . . . . 0.0 110.02 175.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -71.19 138.74 33.95 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 O-C-N 123.385 1.203 . . . . 0.0 109.988 176.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.422 ' CD1' ' HG2' ' A' ' 180' ' ' PRO . 60.9 t80 -75.0 127.31 32.94 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.487 -0.758 . . . . 0.0 110.224 174.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -100.0 160.12 28.05 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.738 -0.601 . . . . 0.0 109.983 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.94 157.81 27.46 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.266 1.14 . . . . 0.0 110.432 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.02 149.96 76.16 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 O-C-N 123.218 1.115 . . . . 0.0 110.499 -177.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -61.62 148.63 41.8 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.718 -0.614 . . . . 0.0 110.108 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.84 127.23 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.502 -0.749 . . . . 0.0 110.208 -170.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.16 -10.16 56.65 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.413 ' OG1' ' CD2' ' A' ' 260' ' ' PHE . 10.0 t -144.86 174.23 11.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.185 -1.185 . . . . 0.0 110.527 175.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -109.34 13.18 24.36 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.489 -0.757 . . . . 0.0 111.923 -166.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . 0.413 ' CD2' ' OG1' ' A' ' 258' ' ' THR . 46.2 p90 -120.0 168.06 11.54 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.113 -0.992 . . . . 0.0 111.219 -175.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 83.1 m -117.7 145.62 44.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.793 -0.567 . . . . 0.0 109.87 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 41.5 m -116.92 135.43 53.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.622 -0.674 . . . . 0.0 110.88 -175.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 60.3 t -131.54 137.31 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 173.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 75.0 mt -104.6 121.07 42.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.533 -0.729 . . . . 0.0 109.953 -171.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -105.39 153.02 22.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.661 -0.649 . . . . 0.0 110.789 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -136.55 142.95 43.44 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 177.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -113.58 131.87 55.94 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.536 -0.728 . . . . 0.0 110.388 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -101.01 9.06 42.65 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.624 -0.672 . . . . 0.0 112.011 -175.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -144.7 164.99 29.32 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.079 -1.013 . . . . 0.0 110.146 172.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -123.06 163.98 19.47 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.391 0.615 . . . . 0.0 110.547 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 23.9 m -57.82 -33.93 69.13 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.479 -0.763 . . . . 0.0 111.104 -164.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 50.0 p -102.18 13.05 35.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.395 -0.816 . . . . 0.0 112.029 -163.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 29.9 p -96.03 118.04 31.86 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.066 -1.021 . . . . 0.0 110.735 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.75 139.82 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.519 -0.738 . . . . 0.0 110.319 -171.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.04 -5.2 59.28 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.07 -96.75 0.78 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 170.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 15.7 mmt -64.33 -35.23 80.18 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.673 -0.898 . . . . 0.0 110.475 177.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.3 p30 42.63 50.66 4.96 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 33.3 mtp180 54.8 29.5 11.97 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.402 -0.811 . . . . 0.0 111.193 176.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -120.0 104.93 43.35 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.599 -0.688 . . . . 0.0 110.177 175.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -60.39 148.82 89.14 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 O-C-N 123.131 1.069 . . . . 0.0 110.518 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 45.8 pt -131.88 177.42 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.788 0.804 . . . . 0.0 111.087 -176.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 21.7 mt -124.44 149.89 46.28 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.421 HD13 ' CE1' ' A' ' 301' ' ' PHE . 82.0 mt -117.98 129.71 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.353 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 81.0 mt -109.81 126.91 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -176.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 57.3 t -118.91 126.81 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.6 p -125.28 152.79 44.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.596 -0.69 . . . . 0.0 110.659 -174.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 24.0 tp -102.22 126.16 49.12 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.748 -0.595 . . . . 0.0 109.473 169.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -130.43 150.1 51.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.875 -0.516 . . . . 0.0 109.855 -173.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.4 ' CG2' ' CD1' ' A' ' 296' ' ' LEU . 22.1 p -89.85 160.89 16.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.619 -0.676 . . . . 0.0 109.897 176.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -55.84 -26.21 45.62 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.574 -0.704 . . . . 0.0 111.03 -176.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 45.3 p30 -90.59 9.7 28.51 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.491 -0.756 . . . . 0.0 111.937 -173.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.87 20.18 44.44 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 120.163 -1.018 . . . . 0.0 110.799 170.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -106.98 140.22 40.14 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.238 -1.154 . . . . 0.0 110.106 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 64.1 t -86.55 131.61 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.641 -0.662 . . . . 0.0 110.226 -173.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.4 ' CD1' ' CG2' ' A' ' 290' ' ' THR . 96.3 mt -99.97 -40.08 7.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.724 -0.61 . . . . 0.0 110.694 177.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -164.14 153.5 23.87 Favored Glycine 0 N--CA 1.497 2.736 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.298 -177.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -135.2 136.44 41.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.749 -0.853 . . . . 0.0 110.719 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -139.38 156.91 46.69 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.622 -0.674 . . . . 0.0 110.001 169.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 80.6 m -141.8 157.23 45.26 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.459 -0.776 . . . . 0.0 110.622 -174.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.421 ' CE1' HD13 ' A' ' 284' ' ' ILE . 49.6 p90 -144.94 162.31 37.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.637 -0.664 . . . . 0.0 110.144 176.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -104.88 134.97 47.11 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.596 -0.69 . . . . 0.0 110.184 -177.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -121.05 142.79 49.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.578 -0.702 . . . . 0.0 110.867 -169.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -137.06 138.95 40.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.792 -0.567 . . . . 0.0 109.622 172.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 77.0 mt -108.28 122.81 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.549 -0.719 . . . . 0.0 109.763 177.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.1 p -145.29 168.88 19.38 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.64 -0.662 . . . . 0.0 110.615 -171.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -71.53 -40.07 70.32 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.695 -0.628 . . . . 0.0 110.664 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.8 t -127.25 85.34 61.2 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.532 -0.73 . . . . 0.0 110.568 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -55.39 -27.23 57.2 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 O-C-N 123.224 1.118 . . . . 0.0 110.728 174.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -68.39 -37.72 86.26 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -71.14 -38.36 72.26 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.605 -0.938 . . . . 0.0 109.74 -174.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -69.36 -35.39 75.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.68 -0.637 . . . . 0.0 110.11 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -58.52 -46.25 87.14 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.55 -0.719 . . . . 0.0 110.43 174.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -64.53 -38.01 89.52 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.647 -0.658 . . . . 0.0 110.345 178.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -62.65 -51.79 65.89 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.484 -0.76 . . . . 0.0 110.578 -173.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -61.44 -37.74 84.66 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.457 -0.777 . . . . 0.0 110.031 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -64.67 -41.1 96.32 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.236 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -62.47 -35.08 78.2 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.693 -0.63 . . . . 0.0 110.058 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 24.3 m -62.76 -32.62 73.81 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.742 -0.599 . . . . 0.0 110.209 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 83.4 mt -78.46 -46.5 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.72 -0.612 . . . . 0.0 109.919 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -59.49 -42.41 92.08 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.621 -0.674 . . . . 0.0 110.459 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -66.3 -47.07 74.78 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.689 -0.632 . . . . 0.0 110.201 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -63.62 -36.65 84.53 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.727 -0.608 . . . . 0.0 110.295 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -104.95 124.99 50.46 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.64 -0.663 . . . . 0.0 110.492 -175.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 62.6 t -121.14 130.11 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.678 -0.639 . . . . 0.0 109.793 177.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 30.4 t -95.09 138.18 33.16 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.608 -0.682 . . . . 0.0 110.263 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -87.98 115.46 25.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.673 -0.642 . . . . 0.0 110.177 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 51.2 m -80.06 150.92 30.16 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.59 -0.694 . . . . 0.0 110.186 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 9.7 t -143.29 152.31 41.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.663 -0.648 . . . . 0.0 110.386 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -60.83 -40.4 92.65 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.693 -0.629 . . . . 0.0 110.584 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -107.92 145.72 33.39 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.653 -0.654 . . . . 0.0 110.271 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -59.07 -36.8 90.12 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . 0.401 ' OD2' ' CZ ' ' A' ' 335' ' ' PHE . 18.4 t70 -87.07 114.51 23.75 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.61 -0.935 . . . . 0.0 110.123 177.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -109.4 146.6 34.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.536 -0.728 . . . . 0.0 110.364 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . 0.401 ' CZ ' ' OD2' ' A' ' 333' ' ' ASP . 99.2 m-85 -115.49 146.64 41.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.726 -0.609 . . . . 0.0 110.146 177.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 51.78 -166.7 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.422 -0.799 . . . . 0.0 110.968 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -142.37 159.14 42.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.685 -0.635 . . . . 0.0 110.448 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -91.92 13.51 18.35 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.689 -0.632 . . . . 0.0 111.151 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 41.5 m -59.77 -37.03 77.9 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.319 -0.863 . . . . 0.0 110.342 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 83.5 t60 52.79 26.07 4.28 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.475 -0.766 . . . . 0.0 111.074 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 94.72 -44.2 2.25 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 178.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 82.2 mt -94.31 129.82 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.574 -0.956 . . . . 0.0 110.124 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -85.02 -30.06 24.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.682 -0.636 . . . . 0.0 110.196 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 10.9 tpt -98.01 135.43 39.73 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.658 -0.651 . . . . 0.0 110.281 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.225 -179.973 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 76.7 p -156.17 164.51 38.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.595 -0.944 . . . . 0.0 110.247 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 29.5 t -119.74 141.5 49.37 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.648 -0.657 . . . . 0.0 110.225 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.8 p -124.25 163.32 21.86 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.655 -0.653 . . . . 0.0 110.139 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -131.97 156.55 45.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.662 -0.648 . . . . 0.0 110.294 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -85.81 143.83 28.07 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.655 -0.653 . . . . 0.0 110.362 -178.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 50.69 -158.73 0.09 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.473 -0.767 . . . . 0.0 111.167 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 26.3 tp 56.77 158.93 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.67 -0.644 . . . . 0.0 110.831 -175.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.3 m -82.9 171.86 10.76 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.534 -0.729 . . . . 0.0 110.27 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -66.68 152.22 82.49 Favored 'Cis proline' 0 N--CA 1.496 1.635 0 C-N-CA 123.128 -1.613 . . . . 0.0 110.501 -13.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.3 m -81.59 146.82 57.81 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.651 -0.656 . . . . 0.0 110.127 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -59.83 145.01 99.34 Favored 'Trans proline' 0 N--CA 1.487 1.128 0 O-C-N 123.194 1.102 . . . . 0.0 110.569 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.97 145.59 40.21 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.597 -0.689 . . . . 0.0 110.202 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 50.4 mm -120.0 139.99 29.12 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.632 -0.667 . . . . 0.0 109.909 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -61.72 149.83 88.31 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 O-C-N 123.134 1.071 . . . . 0.0 110.353 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.8 t -114.24 143.07 45.44 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.629 -0.669 . . . . 0.0 110.275 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -101.42 25.8 7.95 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.617 -0.677 . . . . 0.0 110.634 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 54.4 m -78.85 125.22 29.08 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.554 -0.716 . . . . 0.0 110.231 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -70.33 144.86 51.55 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.632 -0.667 . . . . 0.0 110.396 -178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -158.37 101.21 1.71 Allowed Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.684 -0.635 . . . . 0.0 110.182 178.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -58.76 -39.96 77.12 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 O-C-N 123.086 1.045 . . . . 0.0 110.844 -175.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.82 -155.08 40.49 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -73.11 -49.05 0.24 Allowed 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.308 1.162 . . . . 0.0 110.911 -174.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -85.43 6.99 24.32 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.617 -0.677 . . . . 0.0 111.425 -175.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.97 61.92 2.84 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.949 -1.095 . . . . 0.0 110.608 -176.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.439 ' CE1' ' CG2' ' A' ' 174' ' ' ILE . 60.2 t80 -77.97 120.48 22.88 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.525 -0.735 . . . . 0.0 109.983 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -129.79 159.92 35.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.835 -0.541 . . . . 0.0 110.124 -176.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.2 t -124.96 145.8 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.792 -0.568 . . . . 0.0 109.889 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.9 p -155.01 162.25 41.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.81 -0.556 . . . . 0.0 109.92 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.472 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 75.3 m-85 -126.66 125.23 41.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.808 -0.558 . . . . 0.0 109.799 -175.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -58.06 144.6 39.37 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.655 -0.653 . . . . 0.0 110.394 -174.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -93.61 138.96 31.32 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.617 -0.677 . . . . 0.0 110.35 -175.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 28.5 t -131.06 148.34 52.73 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.754 -0.591 . . . . 0.0 110.09 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 41.7 m -60.58 158.43 12.42 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.609 -0.682 . . . . 0.0 110.133 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.7 t -70.91 67.51 0.4 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.734 -0.604 . . . . 0.0 110.283 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -78.13 149.61 33.8 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.605 -0.684 . . . . 0.0 110.161 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -58.59 145.14 40.56 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.62 -0.675 . . . . 0.0 110.473 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.8 p 50.8 49.1 21.69 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.581 -0.699 . . . . 0.0 111.315 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.74 130.74 43.7 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.676 -0.64 . . . . 0.0 110.026 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.404 ' OG1' ' CD1' ' A' ' 153' ' ' TRP . 82.3 p -60.02 -34.05 72.84 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.751 -0.593 . . . . 0.0 109.944 176.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.423 ' CZ2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -172.04 144.02 1.63 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.763 -0.585 . . . . 0.0 110.164 178.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 13.3 t -142.17 142.57 32.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.84 -0.538 . . . . 0.0 109.947 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.472 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 63.7 t80 -125.56 140.06 53.06 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.548 -0.72 . . . . 0.0 110.553 -172.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.9 t -110.23 124.26 51.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.837 -0.539 . . . . 0.0 109.827 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 58.5 m -70.66 -37.03 73.67 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.772 -0.58 . . . . 0.0 110.481 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -59.66 -34.7 73.16 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.553 -0.717 . . . . 0.0 110.43 -177.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 57.5 mt -104.86 -11.75 16.6 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.662 -0.649 . . . . 0.0 110.864 -175.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 26.2 tttp 59.83 52.03 5.69 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.02 -1.05 . . . . 0.0 109.715 178.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -144.96 152.77 40.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.74 -0.6 . . . . 0.0 110.587 -175.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.5 tp -126.61 137.81 53.36 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.758 -0.589 . . . . 0.0 110.338 -176.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -115.18 135.45 54.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.616 -0.677 . . . . 0.0 109.243 173.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.8 p -138.28 158.38 44.41 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.922 -175.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -104.53 143.02 33.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.593 -0.692 . . . . 0.0 110.131 173.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 16.8 tt -52.54 146.28 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.499 -0.751 . . . . 0.0 111.895 -173.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 64.81 10.04 5.78 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.579 -0.7 . . . . 0.0 112.471 176.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 53.4 mmtt -95.64 155.08 16.89 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.961 -1.087 . . . . 0.0 110.897 174.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 90.5 m -82.94 126.17 32.21 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.628 -0.67 . . . . 0.0 110.689 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 43.6 t -114.23 90.09 19.29 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.657 -0.652 . . . . 0.0 110.108 172.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.423 ' HD2' ' CZ2' ' A' ' 153' ' ' TRP . 17.4 Cg_exo -63.79 129.41 24.7 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 123.248 1.13 . . . . 0.0 110.581 173.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.412 HG12 ' CE2' ' A' ' 142' ' ' PHE . 97.5 mt -123.12 141.35 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 175.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -108.13 136.39 47.89 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.476 -0.765 . . . . 0.0 110.737 -175.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.439 ' CG2' ' CE1' ' A' ' 138' ' ' PHE . 48.6 mm -95.37 135.02 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.719 -0.613 . . . . 0.0 109.633 170.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -117.18 129.31 55.86 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.662 -0.649 . . . . 0.0 110.426 176.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 17.0 m -136.63 159.77 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.478 -0.764 . . . . 0.0 110.047 175.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 80.8 mmm -77.59 -40.24 42.85 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.745 -0.597 . . . . 0.0 110.007 177.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 77.9 p -135.51 143.28 44.45 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.832 -0.542 . . . . 0.0 109.675 177.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -55.57 139.89 83.04 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 O-C-N 123.14 1.074 . . . . 0.0 110.887 -172.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.43 ' HG2' ' CD1' ' A' ' 251' ' ' TYR . 31.3 Cg_endo -67.35 170.04 14.26 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 O-C-N 123.25 1.132 . . . . 0.0 110.633 177.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -60.45 154.98 49.75 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.431 1.227 . . . . 0.0 110.546 -178.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -77.43 140.08 39.8 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.581 -0.699 . . . . 0.0 109.95 175.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.73 -25.06 28.96 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -174.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.22 153.08 1.56 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.363 -1.08 . . . . 0.0 111.41 178.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 33.9 m -129.66 155.93 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.661 -0.649 . . . . 0.0 109.686 176.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 82.6 mt -107.85 137.21 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.688 -0.633 . . . . 0.0 109.462 175.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 32.1 mtm180 -115.06 143.37 45.29 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 -176.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -136.62 126.48 25.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.568 -0.707 . . . . 0.0 110.235 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 23.8 ttp -137.24 137.14 21.8 Favored Pre-proline 0 N--CA 1.497 1.884 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.934 -176.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -90.74 138.21 2.47 Favored 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 123.169 1.089 . . . . 0.0 110.706 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.9 m -147.48 154.84 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.467 -0.771 . . . . 0.0 110.191 174.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.444 ' CZ ' ' NH2' ' A' ' 280' ' ' ARG . 79.4 m-85 -63.8 162.81 12.82 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.546 -0.721 . . . . 0.0 110.487 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -79.35 -60.04 2.52 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.669 -0.644 . . . . 0.0 110.905 -173.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -80.11 150.66 30.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.574 -0.704 . . . . 0.0 110.281 -174.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.58 -38.12 71.53 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.424 -0.797 . . . . 0.0 110.686 -175.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -56.77 -24.91 53.54 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.494 -0.754 . . . . 0.0 110.565 -176.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.4 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 81.0 m-70 -109.68 -20.55 12.79 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.954 -0.699 . . . . 0.0 111.102 -178.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.2 p -67.71 -20.25 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.223 -0.923 . . . . 0.0 110.447 -176.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 67.2 p -79.37 -17.12 55.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.496 -0.752 . . . . 0.0 110.7 175.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -88.25 134.17 33.86 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.336 -0.853 . . . . 0.0 109.945 172.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.0 t -72.84 141.84 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.63 -0.669 . . . . 0.0 110.211 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.422 HG23 ' CZ ' ' A' ' 192' ' ' TYR . 58.4 t -84.86 140.05 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.571 -0.706 . . . . 0.0 109.153 171.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -134.71 -170.57 2.58 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.471 -0.768 . . . . 0.0 111.054 -170.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 13.6 mmp_? -95.62 157.35 15.94 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.732 -0.605 . . . . 0.0 110.106 178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 49.8 m -75.15 154.72 86.41 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.539 -0.726 . . . . 0.0 109.263 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -62.74 -47.44 8.96 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 O-C-N 123.181 1.095 . . . . 0.0 110.067 177.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.442 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.7 p-10 -65.46 -44.45 87.17 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.573 -0.705 . . . . 0.0 111.232 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . 0.442 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 53.9 m170 -81.04 -27.83 35.6 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.413 -0.805 . . . . 0.0 111.346 -174.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -69.13 -42.07 76.51 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.429 -0.794 . . . . 0.0 110.027 171.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 27.3 tp -70.05 -32.79 71.08 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.666 -0.646 . . . . 0.0 110.373 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.4 t -48.46 -33.03 8.66 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.671 -0.643 . . . . 0.0 111.75 -176.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -116.35 125.46 52.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.575 -0.703 . . . . 0.0 110.209 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -127.38 164.07 22.63 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.727 -0.608 . . . . 0.0 110.394 -177.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 53.17 75.13 0.26 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.42 -0.8 . . . . 0.0 110.854 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -83.32 8.1 14.56 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.597 -0.689 . . . . 0.0 111.358 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -60.21 122.86 15.5 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.037 -1.039 . . . . 0.0 110.11 173.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 95.01 2.28 62.57 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -177.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -114.56 146.41 40.8 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.05 -1.265 . . . . 0.0 110.404 175.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.4 mt -84.87 -24.33 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.706 -0.621 . . . . 0.0 110.764 -174.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -124.8 94.47 44.2 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.335 -0.853 . . . . 0.0 110.622 -173.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.413 ' HD2' ' CE2' ' A' ' 236' ' ' TYR . 17.3 Cg_exo -63.52 139.17 68.92 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 O-C-N 123.335 1.176 . . . . 0.0 110.514 -178.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -60.79 -18.38 55.87 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 O-C-N 123.035 1.018 . . . . 0.0 111.23 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 86.5 p -56.19 -21.22 21.7 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.282 -0.886 . . . . 0.0 111.216 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . 0.416 ' CE1' ' HB3' ' A' ' 236' ' ' TYR . 98.5 m-70 -107.08 130.21 54.71 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.479 -0.763 . . . . 0.0 110.496 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 48.8 tp -61.6 -38.04 86.12 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.731 -0.606 . . . . 0.0 110.253 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 86.2 mt -101.39 136.75 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.803 -0.561 . . . . 0.0 109.889 -175.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -135.18 159.72 40.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.71 -0.619 . . . . 0.0 110.317 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 94.6 t -105.18 146.82 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.704 -0.622 . . . . 0.0 110.138 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -120.99 124.51 45.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.777 -0.577 . . . . 0.0 110.27 172.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.78 24.16 11.09 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 169.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 -140.6 106.42 5.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.397 -1.06 . . . . 0.0 109.976 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 43.2 m -63.19 -15.28 56.46 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.519 -0.738 . . . . 0.0 111.341 -175.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -99.98 7.53 44.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 111.675 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.74 130.64 46.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.192 -0.942 . . . . 0.0 110.172 177.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -139.79 158.0 44.81 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.784 -0.572 . . . . 0.0 109.715 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.416 ' HB3' ' CE1' ' A' ' 224' ' ' HIS . 80.4 m-85 -116.03 150.66 36.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.569 -0.707 . . . . 0.0 110.435 -177.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.16 159.88 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.79 -0.569 . . . . 0.0 110.26 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -123.43 128.25 49.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.73 -0.607 . . . . 0.0 110.08 174.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -65.12 130.05 94.68 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.669 -0.644 . . . . 0.0 109.85 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -67.07 -27.4 42.22 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 O-C-N 123.128 1.067 . . . . 0.0 111.008 -173.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 84.2 mt -100.57 -50.35 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.369 -0.832 . . . . 0.0 110.923 -168.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.3 p -105.28 12.13 32.12 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.338 -0.852 . . . . 0.0 111.831 -174.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.92 -5.43 12.82 Favored Glycine 0 N--CA 1.497 2.709 0 O-C-N 121.137 -0.977 . . . . 0.0 111.909 173.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 68.3 mmt-85 -46.04 142.0 2.94 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-N 119.192 1.496 . . . . 0.0 112.296 -175.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -109.24 140.8 42.4 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.682 -0.636 . . . . 0.0 110.037 172.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 78.5 p -154.75 159.99 41.02 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.591 -0.693 . . . . 0.0 110.689 178.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 8.2 p -124.17 148.32 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.798 -0.564 . . . . 0.0 109.657 176.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 84.4 mt -129.57 154.58 46.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.638 -0.664 . . . . 0.0 109.963 -175.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 35.9 m -151.28 151.71 29.72 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.794 -0.566 . . . . 0.0 109.947 176.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -71.08 138.95 34.7 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 O-C-N 123.275 1.145 . . . . 0.0 110.15 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.43 ' CD1' ' HG2' ' A' ' 180' ' ' PRO . 58.3 t80 -74.88 126.06 30.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.525 -0.734 . . . . 0.0 110.233 175.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -99.99 160.07 28.17 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.683 -0.635 . . . . 0.0 109.993 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.83 159.02 22.34 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 O-C-N 123.211 1.111 . . . . 0.0 110.529 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.38 149.98 77.93 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 O-C-N 123.251 1.132 . . . . 0.0 110.471 -178.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -61.31 146.94 46.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.737 -0.602 . . . . 0.0 110.233 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.94 127.25 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.517 -0.74 . . . . 0.0 110.164 -171.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.03 -10.15 55.25 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.405 ' OG1' ' CE2' ' A' ' 260' ' ' PHE . 10.0 t -144.0 173.44 11.71 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.168 -1.195 . . . . 0.0 110.625 175.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -106.83 13.15 28.19 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.612 -0.68 . . . . 0.0 111.756 -168.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . 0.405 ' CE2' ' OG1' ' A' ' 258' ' ' THR . 14.8 p90 -119.93 167.96 11.61 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.227 -0.921 . . . . 0.0 111.192 -175.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 94.1 m -117.75 146.31 43.87 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.762 -0.586 . . . . 0.0 109.868 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 39.7 m -116.74 135.77 53.5 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.577 -0.702 . . . . 0.0 110.941 -175.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.0 t -130.78 137.19 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 172.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 69.8 mt -104.53 121.6 43.82 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.49 -0.756 . . . . 0.0 109.94 -172.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -106.56 154.84 20.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.65 -0.656 . . . . 0.0 110.824 -177.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -136.19 142.94 44.17 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -112.86 127.2 56.12 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.737 -0.602 . . . . 0.0 110.057 176.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 4.5 ppp? -95.74 7.3 46.7 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.705 -0.622 . . . . 0.0 111.898 -176.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -144.87 164.98 29.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.12 -0.987 . . . . 0.0 109.883 174.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -120.37 160.82 22.29 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.722 -0.611 . . . . 0.0 110.236 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 24.0 m -58.99 -31.72 69.03 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.458 -0.776 . . . . 0.0 110.908 -163.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 72.9 m -94.99 8.93 41.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.602 -0.686 . . . . 0.0 112.098 -164.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 31.9 p -95.42 118.18 31.69 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.03 -1.044 . . . . 0.0 110.869 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.11 141.05 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.467 -0.771 . . . . 0.0 110.324 -172.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 100.78 -5.22 56.56 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.0 -105.39 1.13 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 169.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 97.0 mmm -61.35 -36.93 81.57 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.691 -0.888 . . . . 0.0 110.15 178.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 40.45 55.04 2.9 Favored 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 121.42 0.629 . . . . 0.0 112.664 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 55.62 34.09 22.53 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.456 -0.777 . . . . 0.0 111.523 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . 0.444 ' NH2' ' CZ ' ' A' ' 192' ' ' TYR . 35.6 mtm180 -120.12 106.09 41.44 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.295 -0.878 . . . . 0.0 110.161 165.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -60.7 147.98 93.13 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 O-C-N 123.073 1.039 . . . . 0.0 110.416 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 43.9 pt -131.94 179.52 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-O 121.798 0.808 . . . . 0.0 111.001 -176.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 33.0 mt -124.4 149.93 46.16 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.423 HD12 ' CE1' ' A' ' 301' ' ' PHE . 82.6 mt -115.17 129.9 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 77.7 mt -109.76 126.9 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -176.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 57.6 t -118.93 126.66 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.0 p -125.21 152.95 43.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.618 -0.676 . . . . 0.0 110.692 -174.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.426 ' HB2' ' CE1' ' A' ' 138' ' ' PHE . 26.3 tp -101.52 126.94 48.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.66 -0.65 . . . . 0.0 109.483 168.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -131.61 150.88 52.0 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -173.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 80.0 p -89.92 159.4 16.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.623 -0.673 . . . . 0.0 109.726 177.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 68.4 ttp85 -55.96 -26.02 46.31 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.619 -0.676 . . . . 0.0 110.796 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -87.62 9.72 20.36 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.5 -0.75 . . . . 0.0 111.841 -174.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 87.31 20.13 53.15 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 120.159 -1.02 . . . . 0.0 110.779 170.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -107.22 140.19 40.48 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.364 -1.08 . . . . 0.0 110.238 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 60.7 t -88.1 132.33 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.619 -0.676 . . . . 0.0 110.194 -174.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 95.8 mt -99.94 -40.18 7.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.635 -0.666 . . . . 0.0 110.5 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -165.25 153.45 23.58 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 78.5 mtm180 -134.72 136.24 42.55 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.672 -0.899 . . . . 0.0 110.908 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -134.0 158.5 43.37 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.572 -0.705 . . . . 0.0 109.77 170.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 93.6 m -142.91 154.2 43.86 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.444 -0.785 . . . . 0.0 110.772 -175.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.423 ' CE1' HD12 ' A' ' 284' ' ' ILE . 46.0 p90 -145.0 162.1 37.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.702 -0.624 . . . . 0.0 110.017 175.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -104.93 136.15 44.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.537 -0.727 . . . . 0.0 110.116 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -122.55 144.05 49.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.647 -0.658 . . . . 0.0 110.769 -169.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -138.52 137.14 36.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.832 -0.543 . . . . 0.0 109.757 173.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 67.5 mt -105.88 122.84 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.582 -0.699 . . . . 0.0 109.423 175.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.1 p -145.14 169.45 18.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.559 -0.713 . . . . 0.0 111.038 -169.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -69.63 -40.02 76.82 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.673 -0.642 . . . . 0.0 110.626 -178.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 4.2 t -131.39 88.34 44.22 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.578 -0.702 . . . . 0.0 110.5 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -55.25 -29.45 67.07 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 O-C-N 123.207 1.109 . . . . 0.0 111.023 174.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.43 -37.91 93.1 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.4 ttm-85 -73.47 -40.28 64.26 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.684 -0.892 . . . . 0.0 109.795 -173.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -69.43 -40.45 77.24 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.077 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -61.27 -44.54 97.07 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.271 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 28.9 tttp -64.01 -40.45 96.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.552 -0.717 . . . . 0.0 110.498 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.55 -50.6 71.99 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.487 -0.758 . . . . 0.0 110.476 -173.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -61.57 -37.83 85.27 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.449 -0.782 . . . . 0.0 110.127 -177.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -63.72 -40.56 97.07 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.646 -0.659 . . . . 0.0 110.178 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -62.61 -35.25 78.97 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.678 -0.639 . . . . 0.0 109.967 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 22.8 t -63.1 -32.51 73.9 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.647 -0.658 . . . . 0.0 110.206 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 83.8 mt -79.51 -44.07 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.647 -0.658 . . . . 0.0 109.894 -177.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -58.4 -41.3 84.61 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.657 -0.652 . . . . 0.0 110.537 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -63.05 -41.91 99.58 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.631 -0.668 . . . . 0.0 110.257 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -63.77 -32.6 74.15 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.645 -0.659 . . . . 0.0 110.273 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -105.15 125.14 50.65 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.665 -0.647 . . . . 0.0 110.637 -175.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 61.6 t -109.02 130.09 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.6 -0.688 . . . . 0.0 109.766 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 53.1 p -80.91 140.01 35.56 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.67 -0.644 . . . . 0.0 110.417 -177.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -117.6 141.8 47.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.632 -0.667 . . . . 0.0 110.216 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 54.3 p -65.1 160.45 21.07 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.669 -0.644 . . . . 0.0 110.214 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 77.1 p -138.72 28.2 2.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.696 -0.627 . . . . 0.0 110.297 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -83.08 146.56 28.63 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.672 -0.642 . . . . 0.0 110.173 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -87.47 10.67 16.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.664 -0.647 . . . . 0.0 111.278 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -84.23 -178.71 51.58 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -84.47 119.21 24.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.698 -0.884 . . . . 0.0 110.217 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -92.69 138.6 31.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.634 -0.666 . . . . 0.0 110.207 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -60.54 -38.69 85.29 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.676 -0.64 . . . . 0.0 110.303 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 51.37 90.54 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.362 -0.836 . . . . 0.0 111.128 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -60.66 -34.85 74.92 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.617 -0.677 . . . . 0.0 110.239 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -105.45 142.71 34.74 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.672 -0.643 . . . . 0.0 110.22 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 75.4 p -101.2 24.02 10.06 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.599 -0.688 . . . . 0.0 110.672 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -119.79 131.72 55.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.486 -0.759 . . . . 0.0 110.254 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -85.33 -176.69 50.6 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 26.9 pt -96.7 151.78 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.657 -0.908 . . . . 0.0 110.364 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -91.35 143.81 26.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.627 -0.671 . . . . 0.0 110.267 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 88.3 mtp -60.1 -35.21 74.71 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.592 -0.693 . . . . 0.0 110.344 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 10.3 m . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.288 -179.889 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 29.1 t -156.43 150.02 24.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.643 -0.916 . . . . 0.0 110.215 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 45.1 m -62.11 157.12 19.8 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.673 -0.642 . . . . 0.0 110.106 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.2 t -64.93 146.79 54.48 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.687 -0.633 . . . . 0.0 110.343 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -63.5 -43.06 98.35 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.716 -0.615 . . . . 0.0 110.553 -177.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -78.93 -36.05 42.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.631 -0.668 . . . . 0.0 110.284 -174.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 57.01 -84.59 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.664 -0.648 . . . . 0.0 110.761 -176.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.36 134.23 34.1 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.255 -0.903 . . . . 0.0 110.051 -178.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.9 m -76.15 110.56 11.49 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.678 -0.639 . . . . 0.0 110.17 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -61.02 151.99 74.42 Favored 'Trans proline' 0 N--CA 1.488 1.149 0 O-C-N 123.072 1.038 . . . . 0.0 110.432 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.0 m -81.71 150.95 67.24 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.62 -0.675 . . . . 0.0 110.163 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -61.65 147.79 94.53 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.334 1.176 . . . . 0.0 110.385 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.6 142.54 42.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.672 -0.642 . . . . 0.0 110.152 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 50.8 mm -122.76 100.03 41.16 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.667 -0.645 . . . . 0.0 109.953 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -60.79 151.0 80.06 Favored 'Trans proline' 0 C--N 1.317 -1.122 0 O-C-N 123.213 1.112 . . . . 0.0 110.53 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.0 t -114.57 148.03 38.6 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.631 -0.668 . . . . 0.0 110.261 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.5 p-10 -95.15 24.63 4.8 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.655 -0.653 . . . . 0.0 110.794 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 50.4 m -73.33 125.17 27.22 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.573 -0.705 . . . . 0.0 110.263 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -72.67 145.05 47.5 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.614 -0.679 . . . . 0.0 110.346 -178.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -154.8 101.41 2.34 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.747 -0.596 . . . . 0.0 110.24 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -58.92 -39.97 76.14 Favored 'Trans proline' 0 N--CA 1.488 1.18 0 O-C-N 123.151 1.079 . . . . 0.0 110.803 -177.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.31 -155.12 48.52 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -72.78 -46.88 0.38 Allowed 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 123.399 1.21 . . . . 0.0 111.066 -173.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -87.59 9.83 19.93 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.523 -0.736 . . . . 0.0 111.396 -173.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.81 59.69 4.13 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.983 -1.073 . . . . 0.0 110.58 -175.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.416 ' CE1' HG22 ' A' ' 174' ' ' ILE . 67.8 t80 -77.83 118.36 20.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.714 -0.616 . . . . 0.0 109.861 -179.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -130.02 159.89 35.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.781 -0.575 . . . . 0.0 110.193 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 70.9 t -124.22 147.34 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.704 -0.622 . . . . 0.0 109.857 174.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 76.5 p -154.91 162.76 40.99 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 120.378 -0.529 . . . . 0.0 109.956 177.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.49 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 74.9 m-85 -126.66 125.27 41.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.81 -0.556 . . . . 0.0 109.897 -175.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -56.83 140.81 46.86 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.618 -0.676 . . . . 0.0 110.554 -174.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -101.83 130.0 48.18 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.727 -0.608 . . . . 0.0 110.45 -175.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 51.1 m -122.03 150.68 41.76 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.677 -0.64 . . . . 0.0 110.153 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.9 m -60.55 160.76 8.52 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.604 -0.685 . . . . 0.0 110.164 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 68.8 p -62.35 86.49 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.716 -0.615 . . . . 0.0 110.231 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.02 158.38 17.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.687 -0.633 . . . . 0.0 110.266 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -78.51 142.37 37.47 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.647 -0.658 . . . . 0.0 110.042 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.76 55.29 9.22 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.332 -0.855 . . . . 0.0 110.942 -178.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.7 129.88 35.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.6 -0.688 . . . . 0.0 110.137 177.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.403 ' OG1' ' CD1' ' A' ' 153' ' ' TRP . 73.1 p -60.13 -33.76 72.59 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.678 -0.639 . . . . 0.0 109.974 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.421 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.6 p-90 -171.03 144.68 2.16 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.356 0.598 . . . . 0.0 110.289 178.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 9.5 t -142.2 142.65 32.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.846 -0.534 . . . . 0.0 110.064 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.49 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 62.7 t80 -125.42 140.02 53.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.522 -0.736 . . . . 0.0 110.483 -172.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.4 t -110.09 124.94 52.41 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 120.386 -0.526 . . . . 0.0 109.872 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 49.5 m -70.73 -37.05 73.46 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.391 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -60.28 -32.27 71.03 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.635 -0.666 . . . . 0.0 110.323 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 59.2 mt -104.76 -12.12 16.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.73 -0.606 . . . . 0.0 110.835 -174.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 71.4 tttt 59.78 47.47 10.27 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.019 -1.051 . . . . 0.0 109.58 177.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.7 tttp -146.68 153.15 39.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.706 -0.621 . . . . 0.0 110.666 -172.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.6 tp -126.41 137.79 53.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.776 -0.577 . . . . 0.0 110.307 -176.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -114.92 131.62 56.82 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 175.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.3 158.48 44.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.69 -0.631 . . . . 0.0 110.941 -173.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -104.69 141.47 36.4 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.47 0.652 . . . . 0.0 110.351 172.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 16.7 tt -52.19 148.06 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 121.622 0.725 . . . . 0.0 111.857 -174.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 64.29 10.01 5.29 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.558 -0.714 . . . . 0.0 112.516 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -96.65 155.08 16.92 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.892 -1.13 . . . . 0.0 110.889 174.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 86.8 m -83.5 126.2 32.54 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.73 -0.606 . . . . 0.0 110.602 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 44.4 t -114.85 90.1 21.44 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.55 -0.719 . . . . 0.0 110.222 173.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.421 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 19.3 Cg_exo -63.27 130.09 27.54 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 O-C-N 123.228 1.12 . . . . 0.0 110.753 173.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.413 HG12 ' CE2' ' A' ' 142' ' ' PHE . 97.0 mt -123.52 143.35 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.664 -0.647 . . . . 0.0 109.317 173.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -109.35 135.48 50.35 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.491 -0.756 . . . . 0.0 110.824 -175.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.416 HG22 ' CE1' ' A' ' 138' ' ' PHE . 48.9 mm -95.29 135.03 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.685 -0.634 . . . . 0.0 109.65 169.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 44.5 tttm -116.43 129.53 56.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.62 -0.675 . . . . 0.0 110.482 176.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.5 m -136.69 159.76 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.552 -0.718 . . . . 0.0 109.873 174.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.4 mmm -78.44 -41.63 32.33 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.692 -0.63 . . . . 0.0 110.15 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 76.9 p -133.81 143.2 46.58 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.773 -0.579 . . . . 0.0 109.634 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -55.21 139.79 80.94 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 O-C-N 123.191 1.101 . . . . 0.0 110.925 -171.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.429 ' HG2' ' CD1' ' A' ' 251' ' ' TYR . 30.7 Cg_endo -66.81 170.1 13.39 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.17 1.09 . . . . 0.0 110.588 177.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -60.65 155.06 50.45 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.363 1.191 . . . . 0.0 110.537 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -78.08 140.59 39.09 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.619 -0.676 . . . . 0.0 109.91 175.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.83 -24.92 29.6 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -174.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.2 152.06 1.86 Allowed 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.348 -1.09 . . . . 0.0 111.436 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.79 156.3 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.814 -0.554 . . . . 0.0 109.805 176.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 52.4 mt -109.75 135.56 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -114.97 145.48 42.2 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -174.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -139.74 126.58 20.75 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.509 -0.744 . . . . 0.0 110.332 173.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 37.5 ttp -137.39 138.55 25.17 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.78 -0.575 . . . . 0.0 111.093 -176.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -90.75 138.15 2.45 Favored 'Trans proline' 0 C--N 1.32 -0.941 0 O-C-N 123.207 1.109 . . . . 0.0 110.808 176.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.8 m -147.31 154.78 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.487 -0.758 . . . . 0.0 110.109 173.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.453 ' CE1' ' CG2' ' A' ' 202' ' ' VAL . 90.4 m-85 -62.18 166.43 4.85 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.41 -0.806 . . . . 0.0 110.477 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -83.09 -60.04 2.28 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.671 -0.643 . . . . 0.0 110.824 -175.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 39.6 mttp -80.06 151.14 30.06 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.609 -0.682 . . . . 0.0 110.328 -175.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.55 -38.07 71.41 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.404 -0.81 . . . . 0.0 110.802 -175.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -56.75 -24.92 53.37 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.556 -0.715 . . . . 0.0 110.599 -176.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -109.7 -20.53 12.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.519 -0.738 . . . . 0.0 111.144 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.1 p -67.73 -20.23 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.181 -0.95 . . . . 0.0 110.518 -176.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 78.5 p -79.43 -17.01 55.19 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.779 175.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -88.28 137.86 31.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.367 -0.833 . . . . 0.0 110.089 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.7 t -73.13 140.89 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.614 -0.679 . . . . 0.0 110.295 177.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.453 ' CG2' ' CE1' ' A' ' 192' ' ' TYR . 62.0 t -85.0 138.57 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.552 -0.718 . . . . 0.0 109.345 170.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 14.2 pttt -134.92 -170.26 2.53 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.575 -0.703 . . . . 0.0 111.01 -171.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 84.7 mtm-85 -95.27 157.49 15.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.747 -0.596 . . . . 0.0 110.212 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 53.4 m -73.74 156.37 88.4 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.677 -0.64 . . . . 0.0 109.558 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -62.95 -47.34 8.7 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.201 1.106 . . . . 0.0 110.074 176.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.443 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.4 p-10 -65.45 -44.05 88.49 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.541 -0.724 . . . . 0.0 111.149 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . 0.443 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 55.0 m170 -81.24 -27.93 35.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.342 -0.849 . . . . 0.0 111.18 -175.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -69.01 -41.96 77.08 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.441 -0.787 . . . . 0.0 110.263 172.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 27.3 tp -59.15 -34.65 72.33 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.547 -0.721 . . . . 0.0 110.518 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 29.4 t -48.3 145.29 3.4 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.526 -0.734 . . . . 0.0 111.424 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 62.9 mtm180 -59.79 143.72 50.32 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.612 -0.68 . . . . 0.0 110.385 -177.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -61.24 -37.26 82.42 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.72 -0.613 . . . . 0.0 110.403 -176.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 52.28 50.15 18.99 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.431 -0.793 . . . . 0.0 110.916 -176.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -74.27 -10.18 59.34 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.64 -0.662 . . . . 0.0 111.174 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -59.49 118.89 6.56 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.167 -0.958 . . . . 0.0 110.48 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 75.01 19.96 79.67 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 176.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -114.74 139.93 49.3 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.276 -1.132 . . . . 0.0 110.396 178.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 85.3 mt -84.92 -25.22 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.619 -0.675 . . . . 0.0 110.338 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -130.94 129.96 22.71 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.515 -0.741 . . . . 0.0 110.199 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.413 ' HD2' ' CE2' ' A' ' 236' ' ' TYR . 44.1 Cg_endo -74.55 138.36 24.11 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 O-C-N 123.101 1.053 . . . . 0.0 110.748 -177.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -58.96 -18.33 42.21 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 O-C-N 123.036 1.019 . . . . 0.0 111.413 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 30.7 m -50.73 -24.27 3.29 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.248 -0.907 . . . . 0.0 111.587 -177.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -104.06 133.75 48.48 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.454 -0.779 . . . . 0.0 110.4 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 54.9 tp -59.7 -39.7 85.47 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.626 -0.671 . . . . 0.0 110.324 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 83.0 mt -105.51 136.8 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.747 -0.596 . . . . 0.0 109.735 177.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -132.35 157.13 45.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.677 -0.639 . . . . 0.0 110.264 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 75.2 t -102.52 146.58 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.727 -0.608 . . . . 0.0 110.022 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -117.83 130.08 56.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.7 -0.625 . . . . 0.0 110.386 170.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 95.65 20.71 25.97 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.559 -1.017 . . . . 0.0 110.559 168.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -138.84 105.88 5.45 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -1.119 . . . . 0.0 110.005 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 43.2 m -63.21 -15.23 56.32 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.596 -0.69 . . . . 0.0 111.285 -177.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -100.0 8.9 43.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.19 -0.944 . . . . 0.0 111.53 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.37 131.42 50.21 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.072 -1.018 . . . . 0.0 110.196 176.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -139.76 158.06 44.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.752 -0.592 . . . . 0.0 109.805 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.413 ' CE2' ' HD2' ' A' ' 221' ' ' PRO . 72.7 m-85 -111.69 150.63 29.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.614 -0.679 . . . . 0.0 110.484 -177.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.17 159.92 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.732 -0.605 . . . . 0.0 110.216 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -121.03 130.1 53.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.813 -0.555 . . . . 0.0 110.154 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -63.23 130.0 93.89 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.664 -0.648 . . . . 0.0 109.853 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -65.23 -28.63 55.74 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 O-C-N 123.186 1.098 . . . . 0.0 110.968 -170.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.6 mt -102.15 -50.47 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.467 -0.77 . . . . 0.0 111.07 -168.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 14.1 p -105.3 12.18 32.04 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.392 -0.818 . . . . 0.0 111.942 -174.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 72.56 -4.89 18.57 Favored Glycine 0 N--CA 1.496 2.669 0 O-C-N 120.988 -1.07 . . . . 0.0 111.955 172.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -45.92 142.02 2.83 Favored 'General case' 0 N--CA 1.506 2.328 0 CA-C-N 119.101 1.451 . . . . 0.0 112.339 -175.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -103.94 141.72 35.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.616 -0.678 . . . . 0.0 110.219 176.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.4 p -154.73 159.95 41.02 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.623 -0.673 . . . . 0.0 110.299 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 8.3 p -122.95 148.08 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.674 -0.641 . . . . 0.0 109.796 178.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 80.1 mt -129.63 154.62 46.93 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.816 -175.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 35.8 m -150.98 151.76 30.34 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.808 -0.558 . . . . 0.0 109.907 175.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -71.01 140.5 38.11 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 O-C-N 123.251 1.132 . . . . 0.0 110.003 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.429 ' CD1' ' HG2' ' A' ' 180' ' ' PRO . 60.6 t80 -76.06 125.41 29.08 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.459 -0.775 . . . . 0.0 110.155 177.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -100.05 160.14 27.96 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.739 -0.6 . . . . 0.0 109.998 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -59.0 159.13 22.58 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 O-C-N 123.284 1.149 . . . . 0.0 110.445 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -59.11 149.93 76.79 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 O-C-N 123.248 1.131 . . . . 0.0 110.515 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -60.36 147.45 40.6 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.627 -0.671 . . . . 0.0 110.319 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.7 t -69.83 127.25 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.619 -0.675 . . . . 0.0 110.22 -170.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.99 -10.09 55.33 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.407 ' OG1' ' CD2' ' A' ' 260' ' ' PHE . 9.6 t -144.35 173.27 11.92 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.224 -1.162 . . . . 0.0 110.558 175.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -106.92 13.21 27.95 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.651 -0.656 . . . . 0.0 111.804 -168.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . 0.407 ' CD2' ' OG1' ' A' ' 258' ' ' THR . 15.3 p90 -120.03 168.05 11.57 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.115 -0.991 . . . . 0.0 111.152 -175.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 82.3 m -117.75 146.25 43.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.729 -0.607 . . . . 0.0 109.788 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 35.6 m -116.72 136.61 52.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.636 -0.665 . . . . 0.0 110.917 -175.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 59.3 t -128.56 137.13 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 66.4 mt -104.78 119.49 39.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.497 -0.752 . . . . 0.0 109.831 -173.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 6.5 m-30 -105.69 151.06 24.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.62 -0.675 . . . . 0.0 110.718 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -136.53 143.01 43.49 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -115.0 131.97 56.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.527 -0.733 . . . . 0.0 110.501 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -100.24 1.16 41.57 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.654 -0.654 . . . . 0.0 111.9 -177.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.65 159.6 42.55 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.085 -1.009 . . . . 0.0 109.982 173.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -115.13 153.89 29.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.74 -0.6 . . . . 0.0 110.161 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 92.7 p -56.64 -26.7 56.76 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.404 -0.81 . . . . 0.0 111.155 -167.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 46.0 p -95.04 8.19 43.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.387 -0.821 . . . . 0.0 112.086 -165.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 28.9 p -93.96 117.96 30.82 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.98 -1.075 . . . . 0.0 110.727 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 60.2 t -69.68 143.34 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.561 -0.712 . . . . 0.0 110.533 -167.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.53 -5.28 58.55 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.04 -95.35 0.74 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 169.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 95.2 mmm -64.78 -28.61 69.69 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.74 -0.859 . . . . 0.0 110.386 176.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.9 p30 44.95 51.56 8.6 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 121.325 0.583 . . . . 0.0 112.507 172.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 37.9 mtt180 54.7 33.4 19.35 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.321 -0.862 . . . . 0.0 111.289 174.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -114.89 105.01 53.74 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.499 -0.751 . . . . 0.0 110.092 173.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -60.8 144.97 99.65 Favored 'Trans proline' 0 N--CA 1.488 1.175 0 O-C-N 123.138 1.073 . . . . 0.0 110.371 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 43.6 pt -132.58 177.84 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 121.943 0.878 . . . . 0.0 111.253 -174.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 35.0 mt -124.34 149.9 46.09 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.421 ' HB ' ' CZ ' ' A' ' 301' ' ' PHE . 80.8 mt -114.21 130.51 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.63 -0.669 . . . . 0.0 109.312 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 81.0 mt -109.78 125.91 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -176.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 75.8 t -118.98 126.71 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.7 p -125.28 153.01 43.89 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.717 -0.614 . . . . 0.0 110.72 -174.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.405 ' HB2' ' CE1' ' A' ' 138' ' ' PHE . 19.1 tp -100.29 126.95 46.68 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 166.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -132.69 149.72 52.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.756 -0.59 . . . . 0.0 110.01 -172.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 77.2 p -89.93 158.28 17.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.667 -0.646 . . . . 0.0 110.013 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -55.98 -26.16 47.19 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.559 -0.713 . . . . 0.0 111.009 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -92.93 12.86 22.37 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.47 -0.769 . . . . 0.0 111.697 -173.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.94 20.18 44.17 Favored Glycine 0 N--CA 1.494 2.539 0 C-N-CA 120.118 -1.039 . . . . 0.0 110.962 167.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -107.43 140.14 40.83 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.216 -1.167 . . . . 0.0 110.18 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 58.7 t -90.1 130.9 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.626 -0.671 . . . . 0.0 110.054 -175.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 96.3 mt -99.97 -40.07 7.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.716 -0.615 . . . . 0.0 110.569 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -160.35 149.36 18.66 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -135.19 136.24 41.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.678 -0.895 . . . . 0.0 110.575 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -138.13 157.82 45.55 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.608 -0.682 . . . . 0.0 110.301 170.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 82.2 m -141.88 154.96 45.5 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.493 -0.754 . . . . 0.0 110.643 -175.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.421 ' CZ ' ' HB ' ' A' ' 284' ' ' ILE . 47.3 p90 -144.95 160.97 40.49 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.703 -0.623 . . . . 0.0 110.194 175.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -104.93 136.89 43.56 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.571 -0.706 . . . . 0.0 110.125 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -117.94 143.73 46.1 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.821 -169.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -137.1 138.57 40.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.822 -0.549 . . . . 0.0 109.713 172.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 56.2 mt -112.7 122.86 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.512 -0.743 . . . . 0.0 109.757 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.2 p -145.32 170.56 16.08 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.642 -0.662 . . . . 0.0 110.664 -171.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -71.97 -40.11 68.86 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.694 -0.629 . . . . 0.0 110.641 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.8 t -127.12 86.51 58.66 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.59 -0.694 . . . . 0.0 110.506 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -56.24 -28.2 70.14 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.169 1.089 . . . . 0.0 110.533 173.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -67.53 -37.57 89.86 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -70.5 -38.33 74.3 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.643 -0.916 . . . . 0.0 109.749 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -69.45 -35.42 75.64 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.085 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 37.7 ttt85 -57.16 -47.3 81.55 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.533 -0.73 . . . . 0.0 110.593 174.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -64.56 -39.02 92.98 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.575 -0.703 . . . . 0.0 110.401 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -62.44 -51.41 67.62 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.529 -0.732 . . . . 0.0 110.56 -173.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -61.16 -37.77 84.08 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.472 -0.767 . . . . 0.0 110.096 -176.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -66.06 -40.58 91.03 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.257 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -62.86 -35.22 79.28 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.568 -0.707 . . . . 0.0 110.136 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 59.8 p -64.59 -29.66 70.68 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.679 -0.638 . . . . 0.0 110.097 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 83.9 mt -81.26 -45.82 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.641 -0.662 . . . . 0.0 110.047 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -59.47 -39.56 84.09 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.686 -0.633 . . . . 0.0 110.546 -177.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -63.57 -43.13 97.89 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.574 -0.704 . . . . 0.0 110.224 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -66.15 -35.8 81.43 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.669 -0.644 . . . . 0.0 110.339 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -105.07 125.06 50.57 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.647 -0.658 . . . . 0.0 110.952 -174.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 61.8 t -105.5 130.08 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.487 -0.758 . . . . 0.0 109.706 176.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 49.6 m -95.16 140.11 30.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.63 -0.669 . . . . 0.0 110.476 -176.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -80.0 150.05 30.55 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.678 -0.638 . . . . 0.0 110.192 176.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 30.9 t -75.81 137.97 40.86 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.693 -0.629 . . . . 0.0 110.266 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 40.1 m -94.92 -25.53 16.51 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.657 -0.652 . . . . 0.0 110.543 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -58.58 -34.52 71.18 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.503 -0.748 . . . . 0.0 110.567 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -89.07 107.57 19.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.615 -0.678 . . . . 0.0 110.238 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -61.29 -33.69 85.38 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -147.97 160.04 43.24 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.571 -0.959 . . . . 0.0 110.358 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -139.95 159.69 41.61 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.598 -0.689 . . . . 0.0 110.294 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -104.73 139.82 38.98 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.669 -0.644 . . . . 0.0 110.216 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 52.58 -166.59 0.06 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.424 -0.797 . . . . 0.0 110.787 -178.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -97.75 129.07 44.8 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.668 -0.645 . . . . 0.0 110.306 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -116.75 130.47 56.74 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.737 -0.602 . . . . 0.0 110.177 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 66.5 p -119.31 158.22 26.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.696 -0.627 . . . . 0.0 110.262 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -131.72 154.51 48.94 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.699 -0.626 . . . . 0.0 110.318 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 78.67 30.07 49.9 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 27.2 pt -96.37 147.5 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.628 -0.925 . . . . 0.0 110.389 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -143.95 160.67 40.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.586 -0.696 . . . . 0.0 110.055 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 64.6 mtt 52.67 26.55 4.49 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.414 -0.804 . . . . 0.0 110.967 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 117.957 -1.021 . . . . 0.0 110.279 -179.885 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 29.7 t -86.96 144.17 27.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.621 -0.929 . . . . 0.0 110.28 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 86.3 p -61.65 -28.77 69.62 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.659 -0.651 . . . . 0.0 110.247 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 49.6 m -122.49 139.04 54.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.65 -0.656 . . . . 0.0 110.284 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -103.56 134.13 47.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.668 -0.645 . . . . 0.0 110.21 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -155.97 94.34 1.53 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.737 -0.602 . . . . 0.0 110.269 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.12 -28.73 62.43 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.682 -0.636 . . . . 0.0 110.317 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 29.7 tp 56.77 -85.81 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.72 -0.613 . . . . 0.0 110.739 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 21.0 p -70.52 159.5 84.75 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.169 -0.957 . . . . 0.0 110.198 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -66.47 153.04 82.26 Favored 'Cis proline' 0 N--CA 1.496 1.626 0 C-N-CA 123.147 -1.606 . . . . 0.0 110.509 -15.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.7 m -82.13 161.72 59.23 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.691 -0.631 . . . . 0.0 110.219 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -60.69 147.31 95.29 Favored 'Trans proline' 0 C--N 1.316 -1.147 0 O-C-N 123.316 1.166 . . . . 0.0 110.494 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.82 142.32 42.26 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.641 -0.662 . . . . 0.0 110.25 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 49.4 mm -119.96 107.8 39.51 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.676 -0.64 . . . . 0.0 109.885 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -59.7 150.54 76.17 Favored 'Trans proline' 0 N--CA 1.487 1.136 0 O-C-N 123.117 1.062 . . . . 0.0 110.597 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.5 t -114.43 148.3 37.95 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.632 -0.668 . . . . 0.0 110.252 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -94.65 24.25 4.77 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.691 -0.63 . . . . 0.0 110.878 -178.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 50.9 m -72.33 125.18 26.72 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.496 -0.753 . . . . 0.0 110.148 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -68.5 144.94 54.45 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.614 -0.679 . . . . 0.0 110.388 -176.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -155.55 101.65 2.2 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.802 -0.561 . . . . 0.0 110.058 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -59.54 -39.87 71.25 Favored 'Trans proline' 0 N--CA 1.489 1.222 0 O-C-N 123.152 1.08 . . . . 0.0 110.677 -175.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.04 -155.17 42.1 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -73.29 -43.86 0.64 Allowed 'Trans proline' 0 C--N 1.316 -1.142 0 O-C-N 123.422 1.222 . . . . 0.0 110.89 -175.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -89.28 5.64 44.01 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.543 -0.723 . . . . 0.0 111.497 -174.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 t 53.99 59.43 4.26 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.978 -1.076 . . . . 0.0 110.729 -176.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.443 ' CE1' ' CG2' ' A' ' 174' ' ' ILE . 64.6 t80 -78.15 118.78 20.72 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.571 -0.706 . . . . 0.0 110.019 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -130.06 160.02 34.98 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.34 0.591 . . . . 0.0 110.321 -176.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.0 t -124.83 148.42 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.692 -0.63 . . . . 0.0 109.87 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.6 p -155.87 166.9 32.09 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.313 0.578 . . . . 0.0 110.088 176.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.496 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 66.3 m-85 -126.58 125.16 41.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.782 -0.574 . . . . 0.0 109.84 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -56.77 141.88 42.65 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.603 -0.686 . . . . 0.0 110.44 -175.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -95.81 125.77 40.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.646 -0.658 . . . . 0.0 110.542 -173.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 49.7 m -122.97 149.22 44.56 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.703 -0.623 . . . . 0.0 110.101 177.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 42.4 m -61.18 160.24 10.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.622 -0.674 . . . . 0.0 110.197 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.7 t -67.77 75.42 0.19 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.66 -0.65 . . . . 0.0 110.237 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.7 162.01 25.45 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.632 -0.668 . . . . 0.0 110.205 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -75.48 143.58 42.51 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.6 -0.687 . . . . 0.0 110.031 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.81 56.05 8.14 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.409 -0.807 . . . . 0.0 110.914 -177.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -79.88 129.25 34.34 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.634 -0.666 . . . . 0.0 110.194 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.4 ' OG1' ' CD1' ' A' ' 153' ' ' TRP . 42.5 p -60.09 -34.08 72.98 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.643 -0.661 . . . . 0.0 110.094 176.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.423 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.8 p-90 -171.22 144.27 2.02 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.331 0.586 . . . . 0.0 110.224 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.0 t -142.09 142.6 32.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.897 -0.502 . . . . 0.0 109.985 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.496 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 64.7 t80 -125.61 139.98 53.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.486 -0.759 . . . . 0.0 110.775 -171.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.0 t -111.96 123.85 51.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.851 -0.531 . . . . 0.0 109.92 177.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 59.0 m -70.93 -37.01 72.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.806 -0.559 . . . . 0.0 110.568 -176.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -59.21 -35.36 73.48 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.505 -0.747 . . . . 0.0 110.522 -177.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.2 mt -104.86 -11.05 16.94 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.683 -0.636 . . . . 0.0 110.981 -176.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt 59.76 52.64 5.34 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.14 -0.975 . . . . 0.0 109.743 177.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -145.25 153.07 40.92 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.779 -0.576 . . . . 0.0 110.625 -175.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.6 tp -126.58 137.76 53.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.758 -0.588 . . . . 0.0 110.206 -175.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -116.04 135.89 53.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.63 -0.669 . . . . 0.0 109.381 173.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.1 p -138.49 158.49 44.17 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.68 -0.638 . . . . 0.0 110.767 -177.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -104.61 144.49 31.64 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.505 -0.747 . . . . 0.0 109.882 171.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 16.3 tt -51.71 147.48 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.502 -0.749 . . . . 0.0 111.95 -174.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 65.11 10.0 5.99 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.637 -0.665 . . . . 0.0 112.702 174.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -96.12 155.11 16.9 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.955 -1.091 . . . . 0.0 111.074 172.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 91.3 m -80.33 126.18 30.83 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.719 -0.613 . . . . 0.0 110.569 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 48.6 t -116.32 90.03 28.34 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.604 -0.685 . . . . 0.0 110.126 174.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.423 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 15.2 Cg_exo -65.78 131.08 26.39 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 O-C-N 123.264 1.139 . . . . 0.0 110.756 174.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.414 HG12 ' CE2' ' A' ' 142' ' ' PHE . 78.2 mt -123.91 144.69 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.596 -0.69 . . . . 0.0 109.496 172.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . 0.405 ' OE1' ' CD1' ' A' ' 260' ' ' PHE . 70.5 mm-40 -108.42 133.05 53.12 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.52 -0.738 . . . . 0.0 110.361 -173.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.443 ' CG2' ' CE1' ' A' ' 138' ' ' PHE . 49.0 mm -95.35 135.0 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.652 -0.655 . . . . 0.0 109.657 170.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.0 tttp -119.3 130.28 55.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.531 -0.73 . . . . 0.0 110.529 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 17.4 m -136.2 159.73 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.605 -0.684 . . . . 0.0 109.905 175.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 81.6 mmm -77.13 -40.3 46.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.695 -0.628 . . . . 0.0 110.045 177.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 77.3 p -135.87 143.27 43.72 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.764 -0.585 . . . . 0.0 109.795 177.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -55.69 139.89 83.68 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 O-C-N 123.217 1.114 . . . . 0.0 110.886 -172.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.441 ' CG ' ' CE1' ' A' ' 251' ' ' TYR . 23.4 Cg_endo -64.28 169.71 10.45 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.238 1.125 . . . . 0.0 110.69 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -61.06 156.54 44.02 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.35 1.184 . . . . 0.0 110.497 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -77.06 139.61 40.07 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.629 -0.669 . . . . 0.0 109.908 175.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.9 -25.02 29.24 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -175.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.12 152.97 1.53 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.296 -1.12 . . . . 0.0 111.325 176.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.77 155.98 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.748 -0.595 . . . . 0.0 109.774 176.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.413 HD12 ' CD2' ' A' ' 251' ' ' TYR . 72.4 mt -106.13 133.7 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 177.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -115.01 140.94 48.64 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -174.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -138.52 124.47 20.02 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.49 -0.757 . . . . 0.0 110.53 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 20.3 ttm -137.35 139.31 27.32 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.808 -0.558 . . . . 0.0 111.145 -175.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -90.29 138.13 2.69 Favored 'Trans proline' 0 C--N 1.32 -0.948 0 O-C-N 123.185 1.097 . . . . 0.0 110.519 175.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.8 m -147.07 154.92 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.577 -0.702 . . . . 0.0 110.211 174.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.426 ' CE2' HG21 ' A' ' 202' ' ' VAL . 82.3 m-85 -60.97 161.1 8.76 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.477 -0.764 . . . . 0.0 110.348 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -78.46 -60.04 2.53 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.635 -0.666 . . . . 0.0 110.812 -173.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -80.02 151.88 29.73 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.605 -0.685 . . . . 0.0 110.447 -174.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.41 -38.94 72.23 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.353 -0.842 . . . . 0.0 110.74 -176.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -56.37 -24.57 45.25 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.533 -0.73 . . . . 0.0 110.624 -176.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.412 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 60.4 m170 -110.01 -20.56 12.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.509 -0.744 . . . . 0.0 111.101 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.1 p -66.88 -20.34 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.111 -0.993 . . . . 0.0 110.639 -176.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 73.7 p -79.3 -16.96 55.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.522 -0.736 . . . . 0.0 110.78 175.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -88.41 134.62 33.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.338 -0.851 . . . . 0.0 110.064 173.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.3 t -73.16 143.69 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.612 -0.68 . . . . 0.0 110.269 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.426 HG21 ' CE2' ' A' ' 192' ' ' TYR . 78.9 t -84.9 139.56 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.527 -0.733 . . . . 0.0 109.326 170.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 9.3 pttt -134.9 -170.06 2.49 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.477 -0.765 . . . . 0.0 111.035 -167.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -95.07 154.2 17.28 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.712 -0.617 . . . . 0.0 110.317 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 56.3 m -76.04 157.29 83.55 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.647 -0.658 . . . . 0.0 109.249 174.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -63.11 -47.31 8.44 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 O-C-N 123.088 1.046 . . . . 0.0 110.023 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.415 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.6 p-10 -65.48 -44.36 87.36 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.639 -0.663 . . . . 0.0 111.169 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . 0.415 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 51.9 m170 -81.93 -28.04 33.01 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.461 -0.775 . . . . 0.0 111.279 -174.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -69.05 -38.78 79.3 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.323 -0.861 . . . . 0.0 110.314 172.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 25.3 tp -57.38 -31.97 66.33 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.62 -0.675 . . . . 0.0 110.786 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 31.3 t -48.41 138.23 10.4 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.532 -0.73 . . . . 0.0 111.442 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 34.8 ptt-85 -58.82 126.16 26.53 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.668 -0.645 . . . . 0.0 110.572 -175.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -75.51 -54.67 6.64 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.557 -0.715 . . . . 0.0 110.599 -175.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 51.46 54.55 10.87 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.442 -0.786 . . . . 0.0 111.208 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -69.23 -10.36 57.39 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.619 -0.675 . . . . 0.0 111.001 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -61.29 121.12 11.78 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.264 -0.897 . . . . 0.0 110.162 175.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 78.17 20.02 73.46 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -138.36 139.85 39.2 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.251 -1.146 . . . . 0.0 110.004 177.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 81.8 mt -85.59 -25.18 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.705 -0.622 . . . . 0.0 110.522 -177.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -124.94 89.9 51.87 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.483 -0.761 . . . . 0.0 110.592 -173.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.42 ' HD2' ' CE2' ' A' ' 236' ' ' TYR . 35.5 Cg_endo -70.67 145.72 52.64 Favored 'Trans proline' 0 N--CA 1.487 1.124 0 O-C-N 123.278 1.146 . . . . 0.0 110.673 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -59.4 -17.94 43.22 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 O-C-N 123.222 1.117 . . . . 0.0 111.454 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 27.3 t -51.81 -23.95 5.4 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.163 -0.96 . . . . 0.0 111.393 -178.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . 0.414 ' CE1' ' HB3' ' A' ' 236' ' ' TYR . 99.2 m-70 -104.32 132.4 50.61 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.441 -0.787 . . . . 0.0 110.245 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 45.8 tp -60.27 -40.31 89.94 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.55 -0.719 . . . . 0.0 110.089 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 79.3 mt -99.21 136.79 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.836 -0.54 . . . . 0.0 109.659 175.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -135.05 157.61 46.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.737 -0.602 . . . . 0.0 109.971 176.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 72.6 t -103.52 146.65 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.712 -0.618 . . . . 0.0 110.161 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -122.06 130.01 52.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.746 -0.596 . . . . 0.0 110.285 170.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 99.12 19.51 21.19 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 170.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -140.7 104.52 4.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.267 -1.137 . . . . 0.0 110.028 174.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 45.8 m -63.42 -15.31 57.27 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.666 -0.646 . . . . 0.0 111.276 -176.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -100.01 7.63 44.59 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.22 -0.925 . . . . 0.0 111.55 -177.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.61 133.37 55.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.088 -1.007 . . . . 0.0 110.21 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -139.83 157.98 44.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.735 -0.603 . . . . 0.0 109.809 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.42 ' CE2' ' HD2' ' A' ' 221' ' ' PRO . 84.3 m-85 -114.37 150.65 34.27 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.552 -0.717 . . . . 0.0 110.497 -178.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.22 159.92 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.76 -0.588 . . . . 0.0 110.266 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -119.22 130.04 55.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.769 -0.582 . . . . 0.0 110.163 175.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -65.09 130.11 94.72 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.676 -0.64 . . . . 0.0 109.838 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -66.36 -27.66 47.37 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 O-C-N 123.172 1.09 . . . . 0.0 111.021 -171.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 82.6 mt -100.49 -50.54 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.399 -0.813 . . . . 0.0 110.942 -167.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.3 p -105.3 12.04 32.21 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.322 -0.861 . . . . 0.0 111.887 -175.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.88 -5.11 13.57 Favored Glycine 0 N--CA 1.495 2.582 0 O-C-N 121.08 -1.012 . . . . 0.0 111.916 173.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 22.2 mmt85 -46.14 142.02 3.02 Favored 'General case' 0 N--CA 1.505 2.276 0 CA-C-N 119.108 1.454 . . . . 0.0 112.321 -174.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -106.27 139.91 40.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.628 -0.67 . . . . 0.0 110.123 175.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 78.7 p -154.74 159.98 41.03 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.635 -0.665 . . . . 0.0 110.518 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.42 ' HB ' ' CD1' ' A' ' 236' ' ' TYR . 8.3 p -122.96 148.17 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.78 -0.575 . . . . 0.0 109.666 177.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 83.0 mt -129.64 154.52 47.04 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.045 -175.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 35.4 m -151.12 151.76 30.09 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.812 -0.555 . . . . 0.0 109.84 175.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -70.57 137.16 32.5 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 O-C-N 123.237 1.125 . . . . 0.0 109.979 177.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.441 ' CE1' ' CG ' ' A' ' 180' ' ' PRO . 13.9 t80 -77.23 124.29 27.63 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.572 -0.705 . . . . 0.0 110.201 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -100.01 160.06 28.2 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.719 -0.613 . . . . 0.0 110.177 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -59.26 159.99 20.9 Favored 'Trans proline' 0 C--N 1.316 -1.163 0 O-C-N 123.244 1.129 . . . . 0.0 110.434 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.88 150.22 73.3 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 O-C-N 123.194 1.102 . . . . 0.0 110.567 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -60.02 148.11 36.72 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.575 -0.703 . . . . 0.0 110.323 -178.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.84 127.25 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.457 -0.777 . . . . 0.0 110.068 -170.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.92 -10.12 55.46 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.405 ' OG1' ' CD2' ' A' ' 260' ' ' PHE . 9.5 t -144.68 173.71 11.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.163 -1.198 . . . . 0.0 110.601 175.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -106.94 13.18 27.96 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.66 -0.65 . . . . 0.0 111.768 -168.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . 0.405 ' CD2' ' OG1' ' A' ' 258' ' ' THR . 13.8 p90 -119.94 168.02 11.56 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.212 -0.93 . . . . 0.0 111.233 -175.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 86.4 m -117.86 147.78 42.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.768 -0.583 . . . . 0.0 109.841 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 40.6 m -115.95 137.54 52.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.553 -0.717 . . . . 0.0 110.91 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 57.9 t -128.62 136.87 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 170.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 64.7 mt -104.87 120.12 40.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.494 -0.754 . . . . 0.0 109.815 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . 0.41 ' CE2' HD12 ' A' ' 172' ' ' ILE . 3.3 m-85 -99.19 156.4 16.98 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.796 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -136.42 142.99 43.7 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 171.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -113.41 129.58 56.51 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.61 -0.681 . . . . 0.0 110.163 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.98 5.85 46.98 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.636 -0.665 . . . . 0.0 111.724 -176.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -144.78 161.33 39.52 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.141 -0.975 . . . . 0.0 110.069 173.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -116.27 158.71 22.95 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.731 -0.605 . . . . 0.0 109.822 176.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 19.2 m -58.6 -32.65 69.19 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.376 -0.827 . . . . 0.0 110.947 -163.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 73.1 m -93.93 10.7 32.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.601 -0.687 . . . . 0.0 111.986 -165.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 31.7 p -93.8 118.19 31.1 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.069 -1.019 . . . . 0.0 110.593 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.3 t -61.34 139.9 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.389 -0.819 . . . . 0.0 110.218 -171.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 101.0 -5.11 56.16 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -124.89 -115.87 2.12 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 170.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 26.9 ttt -60.27 -24.94 65.32 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.613 -0.934 . . . . 0.0 110.409 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 43.87 55.07 5.41 Favored 'General case' 0 N--CA 1.504 2.241 0 CA-C-O 121.434 0.635 . . . . 0.0 112.584 172.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 54.94 30.36 13.87 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.401 -0.812 . . . . 0.0 111.317 175.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -116.81 116.42 38.35 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.468 -0.77 . . . . 0.0 110.128 170.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -59.68 145.66 97.54 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 O-C-N 123.042 1.022 . . . . 0.0 110.495 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 45.4 pt -131.97 175.73 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 121.762 0.791 . . . . 0.0 110.89 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 32.0 mt -124.42 149.92 46.21 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.413 ' HB ' ' CZ ' ' A' ' 301' ' ' PHE . 79.1 mt -112.58 127.95 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.057 176.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 76.5 mt -109.85 126.34 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.436 -175.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 59.1 t -118.92 126.55 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.3 p -125.4 153.93 42.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.643 -0.661 . . . . 0.0 110.536 -174.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.424 ' HB2' ' CE1' ' A' ' 138' ' ' PHE . 24.3 tp -103.55 126.57 50.78 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 169.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -132.15 150.24 52.2 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.996 -173.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 76.5 p -89.96 159.21 17.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.732 -0.605 . . . . 0.0 109.907 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -55.95 -26.16 46.8 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.534 -0.729 . . . . 0.0 110.905 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -93.07 12.95 22.33 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.479 -0.763 . . . . 0.0 111.697 -174.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.41 20.16 46.22 Favored Glycine 0 N--CA 1.495 2.62 0 C-N-CA 120.132 -1.033 . . . . 0.0 110.972 167.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -105.64 140.16 39.13 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.203 -1.175 . . . . 0.0 110.231 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 59.4 t -87.52 131.32 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.678 -0.639 . . . . 0.0 110.008 -176.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 96.9 mt -99.87 -40.11 7.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.718 -0.614 . . . . 0.0 110.484 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -162.7 151.6 21.48 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -135.01 134.35 40.36 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.719 -0.871 . . . . 0.0 110.469 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -136.3 152.81 51.09 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.558 -0.713 . . . . 0.0 110.236 172.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 90.7 m -142.49 153.18 43.41 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.415 -0.803 . . . . 0.0 110.772 -175.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.413 ' CZ ' ' HB ' ' A' ' 284' ' ' ILE . 51.1 p90 -145.82 166.77 24.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.671 -0.643 . . . . 0.0 109.97 174.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -104.84 136.91 43.45 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.527 -0.733 . . . . 0.0 110.225 -177.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -119.4 145.47 46.19 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.626 -171.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 40.0 tpt85 -138.09 134.01 34.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.71 -0.619 . . . . 0.0 109.699 174.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 80.5 mt -105.75 122.87 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.504 -0.748 . . . . 0.0 109.583 176.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.4 p -145.21 173.23 12.12 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.535 -0.728 . . . . 0.0 110.648 -171.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -72.46 -40.13 67.23 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.704 -0.623 . . . . 0.0 110.582 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.7 t -131.04 89.37 42.52 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.544 -0.722 . . . . 0.0 110.467 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.13 -30.52 60.99 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 O-C-N 123.188 1.099 . . . . 0.0 111.03 172.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -65.4 -37.15 93.51 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -73.26 -40.44 64.63 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.669 -0.901 . . . . 0.0 109.802 -173.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -69.52 -41.33 76.15 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 120.084 -0.647 . . . . 0.0 110.092 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 72.4 ttt-85 -61.21 -41.8 97.48 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.564 -0.71 . . . . 0.0 110.346 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -64.17 -38.61 91.66 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.49 -0.757 . . . . 0.0 110.451 178.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -62.7 -52.85 61.68 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.486 -0.759 . . . . 0.0 110.541 -173.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -61.39 -37.79 84.71 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.464 -0.773 . . . . 0.0 110.158 -176.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -65.94 -39.6 90.64 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.687 -0.633 . . . . 0.0 110.227 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -62.49 -35.3 78.91 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.583 -0.698 . . . . 0.0 109.969 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 23.4 m -62.16 -33.35 74.33 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.615 -0.678 . . . . 0.0 110.198 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 83.7 mt -79.19 -44.57 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.578 -0.701 . . . . 0.0 109.993 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 55.4 ttt85 -58.85 -39.94 82.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.596 -0.69 . . . . 0.0 110.546 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 49.9 mttt -66.16 -46.86 75.95 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.633 -0.667 . . . . 0.0 110.178 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -69.04 -42.04 76.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.669 -0.644 . . . . 0.0 110.238 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -105.12 125.03 50.53 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.722 -0.611 . . . . 0.0 110.479 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.12 128.51 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.581 -0.699 . . . . 0.0 109.916 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 65.9 p -95.12 140.14 30.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.608 -0.683 . . . . 0.0 110.186 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -89.24 112.89 24.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.598 -0.689 . . . . 0.0 110.199 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 50.4 m -71.88 149.66 44.96 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.575 -0.703 . . . . 0.0 110.096 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 74.2 m -104.0 117.2 33.72 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.668 -0.645 . . . . 0.0 110.304 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 64.3 mttt -68.58 -40.4 80.56 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.66 -0.65 . . . . 0.0 110.31 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 -152.72 -164.66 2.0 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.626 -0.671 . . . . 0.0 110.386 -177.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -60.17 145.62 46.31 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -82.8 117.38 22.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.645 -0.915 . . . . 0.0 110.31 -176.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -147.14 149.7 33.52 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.775 -0.578 . . . . 0.0 110.066 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 52.91 26.53 4.73 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.438 -0.789 . . . . 0.0 110.872 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 52.88 26.56 4.72 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.469 -0.769 . . . . 0.0 110.938 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 53.73 40.54 31.61 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.532 -0.73 . . . . 0.0 110.836 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 53.22 42.11 32.13 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.44 -0.787 . . . . 0.0 110.887 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 48.3 m -124.1 137.09 54.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.577 -0.702 . . . . 0.0 110.365 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -60.76 -40.84 94.01 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.697 -0.627 . . . . 0.0 110.255 178.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 99.63 123.91 5.11 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 15.8 tt -147.45 147.32 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.652 -0.911 . . . . 0.0 110.202 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -92.39 127.77 38.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.631 -0.668 . . . . 0.0 110.266 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 88.4 mtp -59.86 -35.43 74.77 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.62 -0.675 . . . . 0.0 110.384 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.352 179.803 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 60.3 p -84.38 161.23 20.45 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.687 -0.89 . . . . 0.0 110.233 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 29.4 t -118.03 143.37 46.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.611 -0.68 . . . . 0.0 110.251 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 67.4 p -122.6 161.96 22.75 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.689 -0.632 . . . . 0.0 110.272 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -102.03 133.52 46.72 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.654 -0.653 . . . . 0.0 110.26 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -157.73 163.44 38.13 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.61 -0.681 . . . . 0.0 110.308 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 51.43 -169.87 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.474 -0.767 . . . . 0.0 111.104 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.1 mp 52.64 -171.08 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.512 -0.742 . . . . 0.0 111.0 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.1 t -108.21 165.34 12.9 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.658 -0.651 . . . . 0.0 110.162 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -63.37 151.7 70.01 Favored 'Cis proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.138 -1.609 . . . . 0.0 110.505 -18.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 2.2 m -81.66 149.58 64.56 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.621 -0.675 . . . . 0.0 110.241 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -61.73 150.46 85.69 Favored 'Trans proline' 0 C--N 1.316 -1.155 0 O-C-N 123.393 1.207 . . . . 0.0 110.384 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.07 143.41 43.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.614 -0.678 . . . . 0.0 110.102 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 51.5 mm -121.93 100.09 43.5 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.668 -0.645 . . . . 0.0 109.96 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -60.22 149.39 85.57 Favored 'Trans proline' 0 N--CA 1.487 1.118 0 O-C-N 123.232 1.122 . . . . 0.0 110.66 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.3 t -114.58 147.31 39.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.691 -0.631 . . . . 0.0 110.306 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 p-10 -95.58 25.17 4.68 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.664 -0.647 . . . . 0.0 110.775 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 55.1 m -72.3 125.25 26.88 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.511 -0.743 . . . . 0.0 110.242 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -72.3 144.88 48.18 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.705 -0.622 . . . . 0.0 110.437 -178.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.412 ' CE1' ' HA2' ' A' ' 134' ' ' GLY . 65.0 t80 -159.64 100.62 1.5 Allowed Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.671 -0.643 . . . . 0.0 110.129 178.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -58.72 -39.93 77.61 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 O-C-N 123.182 1.096 . . . . 0.0 110.818 -176.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.412 ' HA2' ' CE1' ' A' ' 132' ' ' TYR . . . 79.95 -155.16 38.37 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -73.3 -48.31 0.27 Allowed 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.385 1.203 . . . . 0.0 110.901 -174.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -85.05 6.28 26.02 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.557 -0.714 . . . . 0.0 111.341 -174.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.92 59.79 4.04 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.983 -1.073 . . . . 0.0 110.669 -176.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.447 ' CE1' ' CG2' ' A' ' 174' ' ' ILE . 64.5 t80 -78.35 118.75 20.83 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.54 -0.725 . . . . 0.0 109.959 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -130.1 159.98 35.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.811 -0.556 . . . . 0.0 110.289 -175.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 66.7 t -124.01 146.29 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 121.272 0.558 . . . . 0.0 110.087 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.0 p -156.95 169.09 25.59 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.218 0.532 . . . . 0.0 109.757 174.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.427 ' CE2' HG12 ' A' ' 172' ' ' ILE . 36.4 m-85 -126.6 125.09 41.38 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.7 -0.625 . . . . 0.0 109.792 -177.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -59.18 140.13 56.22 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.541 -0.724 . . . . 0.0 110.178 -178.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -105.8 152.14 23.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.55 -0.719 . . . . 0.0 110.853 -166.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 82.9 p -146.05 166.86 24.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.742 -0.599 . . . . 0.0 109.901 176.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 56.3 p -63.77 164.18 10.43 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.578 -0.701 . . . . 0.0 110.108 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.8 t -71.2 65.02 0.38 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.56 -0.713 . . . . 0.0 110.297 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.13 152.04 46.48 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.596 -0.69 . . . . 0.0 110.132 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -73.31 155.7 39.18 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.667 -0.646 . . . . 0.0 110.046 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.6 t 53.23 29.62 8.72 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.432 -0.793 . . . . 0.0 110.91 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -60.16 129.98 44.43 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.568 -0.707 . . . . 0.0 110.245 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 46.6 p -60.12 -34.05 72.98 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.698 -0.626 . . . . 0.0 110.117 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.41 ' CE3' HD13 ' A' ' 162' ' ' LEU . 64.3 p-90 -170.54 148.0 3.01 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.817 -0.552 . . . . 0.0 109.867 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 15.1 t -142.12 142.41 32.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.777 -0.577 . . . . 0.0 110.063 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -125.52 140.08 53.07 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.487 -0.758 . . . . 0.0 110.538 -172.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.2 t -110.01 123.09 49.04 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.863 176.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 61.6 m -70.58 -37.11 73.89 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.763 -0.586 . . . . 0.0 110.503 -176.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -59.28 -34.23 72.03 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.516 -0.74 . . . . 0.0 110.533 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.6 mt -104.75 -11.02 17.04 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.628 -0.67 . . . . 0.0 110.889 -175.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 62.8 tttt 59.86 52.52 5.32 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.063 -1.023 . . . . 0.0 109.735 177.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -145.72 152.99 40.48 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.632 -175.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.41 HD13 ' CE3' ' A' ' 153' ' ' TRP . 14.6 tp -126.61 137.73 53.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.744 -0.598 . . . . 0.0 110.203 -176.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -117.27 132.81 56.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.54 -0.725 . . . . 0.0 109.283 175.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.1 p -138.31 158.47 44.22 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.983 -175.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -104.53 142.77 34.03 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.456 0.646 . . . . 0.0 110.11 172.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 17.2 tt -51.28 147.48 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 CA-C-O 121.655 0.74 . . . . 0.0 112.117 -173.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 64.47 9.89 5.36 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.543 -0.723 . . . . 0.0 112.481 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -96.51 155.12 16.9 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.996 -1.065 . . . . 0.0 110.93 175.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 84.1 m -84.03 126.19 32.81 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.646 -0.659 . . . . 0.0 110.841 -176.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 42.8 t -113.38 90.23 16.68 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.603 -0.685 . . . . 0.0 110.137 174.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.409 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 15.3 Cg_exo -65.9 130.81 25.46 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.298 1.157 . . . . 0.0 110.449 177.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.427 HG12 ' CE2' ' A' ' 142' ' ' PHE . 93.8 mt -124.21 139.39 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.696 -0.628 . . . . 0.0 109.408 176.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 10.3 mp0 -108.95 134.35 51.74 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.613 -0.68 . . . . 0.0 110.664 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.447 ' CG2' ' CE1' ' A' ' 138' ' ' PHE . 49.6 mm -95.3 135.14 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.637 -0.664 . . . . 0.0 109.612 172.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -118.62 130.36 55.83 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.461 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 17.5 m -136.36 159.72 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.523 -0.736 . . . . 0.0 109.971 175.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 80.7 mmm -77.23 -40.21 45.75 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.751 -0.593 . . . . 0.0 110.054 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 77.5 p -135.15 143.26 45.05 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.79 -0.569 . . . . 0.0 109.826 177.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -55.58 139.92 83.08 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 O-C-N 123.145 1.076 . . . . 0.0 110.859 -172.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.445 ' CG ' ' CE1' ' A' ' 251' ' ' TYR . 25.5 Cg_endo -64.88 169.16 12.17 Favored 'Trans proline' 0 N--CA 1.487 1.095 0 O-C-N 123.127 1.067 . . . . 0.0 110.687 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -61.12 155.85 48.43 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 O-C-N 123.379 1.199 . . . . 0.0 110.496 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -75.3 139.4 42.46 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.656 -0.652 . . . . 0.0 109.931 175.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.76 -25.05 28.99 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 -175.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.14 150.81 2.24 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.355 -1.085 . . . . 0.0 111.391 178.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.79 155.92 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.665 -0.647 . . . . 0.0 109.897 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 74.0 mt -108.78 135.25 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 54.1 mtt180 -114.97 147.71 39.7 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -174.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -141.36 128.14 20.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.386 -0.821 . . . . 0.0 110.405 173.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 31.6 ttp -137.23 140.25 30.4 Favored Pre-proline 0 N--CA 1.496 1.864 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.062 -177.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -91.5 138.2 2.13 Favored 'Trans proline' 0 C--N 1.32 -0.957 0 C-N-CA 121.08 1.187 . . . . 0.0 110.858 177.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 35.0 m -147.91 154.9 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.546 -0.721 . . . . 0.0 109.924 174.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.417 ' CE1' HG23 ' A' ' 202' ' ' VAL . 82.5 m-85 -60.4 168.52 2.05 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.395 -0.816 . . . . 0.0 110.513 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 68.8 tttt -84.08 -60.11 2.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.588 -0.695 . . . . 0.0 110.76 -175.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 43.1 mttp -80.16 151.68 29.62 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.54 -0.725 . . . . 0.0 110.305 -175.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.76 -38.36 72.34 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.384 -0.823 . . . . 0.0 110.633 -176.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -56.39 -24.52 45.22 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.386 -0.821 . . . . 0.0 110.584 -177.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.407 ' HB3' ' CG ' ' A' ' 192' ' ' TYR . 96.6 m-70 -109.97 -20.52 12.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.466 -0.771 . . . . 0.0 111.21 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.2 p -67.41 -20.2 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.194 -0.941 . . . . 0.0 110.595 -176.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 74.4 p -79.38 -16.92 55.46 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.524 -0.735 . . . . 0.0 110.767 175.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.45 135.1 33.64 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.348 -0.845 . . . . 0.0 110.064 173.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.0 t -73.38 140.97 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.564 -0.71 . . . . 0.0 110.348 178.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.417 HG23 ' CE1' ' A' ' 192' ' ' TYR . 65.7 t -84.89 140.05 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.594 -0.691 . . . . 0.0 109.506 172.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -134.91 -170.28 2.53 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.53 -0.731 . . . . 0.0 110.99 -169.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 81.3 mtm-85 -95.36 157.06 16.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.842 -0.536 . . . . 0.0 110.424 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 58.8 m -75.39 159.4 82.09 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.651 -0.656 . . . . 0.0 109.475 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -64.0 -47.36 6.7 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 O-C-N 123.146 1.077 . . . . 0.0 109.985 176.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.438 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.1 p-10 -65.39 -43.4 90.79 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.575 -0.703 . . . . 0.0 111.045 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . 0.438 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 55.1 m170 -81.12 -27.85 35.39 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.49 -0.757 . . . . 0.0 111.245 -175.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -69.07 -38.76 79.23 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.387 -0.82 . . . . 0.0 110.321 172.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 23.5 tp -56.5 -36.13 68.8 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.504 -0.747 . . . . 0.0 110.785 -176.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 29.6 t -48.35 138.9 9.42 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.558 -0.714 . . . . 0.0 111.306 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 214' ' ' PHE . 27.1 mmt85 -61.04 145.84 49.35 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.61 -0.682 . . . . 0.0 110.18 -177.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -64.42 -32.69 74.42 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.691 -0.631 . . . . 0.0 110.454 -177.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.419 ' CZ ' ' HB2' ' A' ' 212' ' ' ARG . 63.0 m-85 51.78 46.73 26.09 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.461 -0.774 . . . . 0.0 110.883 -176.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -75.7 -10.21 59.25 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.14 -177.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -61.14 117.9 6.13 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.132 -0.98 . . . . 0.0 110.255 177.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 77.18 20.1 75.96 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -139.64 140.03 36.84 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.316 -1.108 . . . . 0.0 110.057 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 86.5 mt -84.95 -25.06 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.728 -0.607 . . . . 0.0 110.587 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -124.85 98.16 37.22 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.362 -0.836 . . . . 0.0 110.644 -172.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -70.58 153.26 65.28 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.346 1.182 . . . . 0.0 110.591 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -60.69 -16.29 42.53 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 O-C-N 123.236 1.124 . . . . 0.0 111.419 -177.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 32.0 m -50.42 -23.96 2.76 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.127 -0.983 . . . . 0.0 111.333 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . 0.444 ' CE1' ' CB ' ' A' ' 236' ' ' TYR . 98.7 m-70 -100.71 128.37 46.79 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.545 -0.722 . . . . 0.0 110.141 176.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 61.9 tp -60.25 -39.15 85.73 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.606 -0.684 . . . . 0.0 110.235 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 82.2 mt -102.21 136.75 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 120.329 -0.548 . . . . 0.0 109.685 177.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 22.2 mtp-105 -131.75 157.23 44.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.758 -0.589 . . . . 0.0 110.157 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 99.3 t -104.8 146.5 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.737 -0.602 . . . . 0.0 110.042 176.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -118.9 123.65 45.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.768 -0.583 . . . . 0.0 110.473 172.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 96.31 23.32 17.1 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 168.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -135.0 108.82 8.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.369 -1.077 . . . . 0.0 110.142 174.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 27.3 t -62.88 -15.14 53.73 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.609 -0.682 . . . . 0.0 111.318 -177.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -99.35 9.91 42.42 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.29 -0.881 . . . . 0.0 111.552 -177.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.46 124.49 20.51 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.092 -1.005 . . . . 0.0 110.235 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -139.78 158.05 44.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.794 -0.566 . . . . 0.0 109.678 177.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.444 ' CB ' ' CE1' ' A' ' 224' ' ' HIS . 97.4 m-85 -117.98 150.72 38.79 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.546 -0.721 . . . . 0.0 110.793 -175.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.07 159.95 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.819 -0.551 . . . . 0.0 110.108 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -120.0 130.03 54.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.792 -0.567 . . . . 0.0 110.299 177.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -63.77 130.07 94.18 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.653 -0.655 . . . . 0.0 109.784 178.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -65.97 -28.35 49.94 Favored 'Trans proline' 0 C--N 1.316 -1.168 0 O-C-N 123.042 1.022 . . . . 0.0 110.97 -170.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.8 mt -101.14 -50.5 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.465 -0.772 . . . . 0.0 111.019 -168.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 13.0 p -105.34 12.15 32.0 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.338 -0.851 . . . . 0.0 111.872 -175.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 72.37 -4.92 17.22 Favored Glycine 0 N--CA 1.496 2.667 0 O-C-N 121.013 -1.055 . . . . 0.0 111.968 172.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -46.0 142.07 2.87 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 119.163 1.482 . . . . 0.0 112.389 -175.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -104.25 143.35 33.08 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.674 -0.641 . . . . 0.0 110.204 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.1 p -154.71 160.04 41.1 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.608 -0.682 . . . . 0.0 110.213 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 8.5 p -123.01 148.19 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.707 -0.621 . . . . 0.0 109.779 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 83.0 mt -129.82 154.69 47.0 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 120.204 -0.599 . . . . 0.0 109.931 -174.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 32.1 m -150.69 151.81 31.15 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.783 -0.573 . . . . 0.0 109.816 174.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -70.94 139.46 36.19 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 O-C-N 123.267 1.141 . . . . 0.0 110.029 177.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.445 ' CE1' ' CG ' ' A' ' 180' ' ' PRO . 10.2 t80 -79.59 122.16 26.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.519 -0.738 . . . . 0.0 110.07 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -100.08 160.09 28.08 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.706 -0.621 . . . . 0.0 110.184 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -58.95 160.08 19.46 Favored 'Trans proline' 0 N--CA 1.488 1.174 0 O-C-N 123.285 1.15 . . . . 0.0 110.457 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.17 150.05 76.32 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 O-C-N 123.276 1.145 . . . . 0.0 110.613 -177.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -60.95 149.56 36.15 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.609 -0.682 . . . . 0.0 110.189 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.84 127.21 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.496 -0.752 . . . . 0.0 110.148 -170.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.29 -10.18 56.46 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.407 ' OG1' ' CE1' ' A' ' 260' ' ' PHE . 9.4 t -145.41 175.39 10.35 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.25 -1.147 . . . . 0.0 110.619 175.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -110.03 13.09 23.42 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.617 -0.677 . . . . 0.0 111.883 -167.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . 0.407 ' CE1' ' OG1' ' A' ' 258' ' ' THR . 48.1 p90 -120.84 168.03 11.89 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.141 -0.974 . . . . 0.0 111.177 -177.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 93.4 m -117.87 147.56 42.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.793 -0.567 . . . . 0.0 109.837 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 32.7 m -117.78 136.14 53.59 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.567 -0.708 . . . . 0.0 110.945 -175.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 57.9 t -130.44 137.18 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 171.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 74.0 mt -104.88 120.94 42.63 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.512 -0.742 . . . . 0.0 110.004 -173.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 -105.55 150.62 25.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.688 -0.633 . . . . 0.0 110.662 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -136.56 142.99 43.42 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -113.31 131.93 55.76 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.584 -0.697 . . . . 0.0 110.48 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -101.28 9.43 41.75 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.657 -0.652 . . . . 0.0 111.963 -176.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -144.6 163.45 33.88 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.115 -0.991 . . . . 0.0 110.076 171.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 27.9 p30 -121.34 163.97 17.8 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.442 0.639 . . . . 0.0 110.434 -177.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 50.4 m -58.22 -34.07 70.0 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.44 -0.788 . . . . 0.0 111.058 -163.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 49.6 p -103.62 15.05 29.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.39 -0.819 . . . . 0.0 111.844 -163.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 30.5 p -94.86 118.09 31.21 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.11 -0.994 . . . . 0.0 110.585 177.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 60.1 t -64.24 139.9 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.42 -0.8 . . . . 0.0 110.332 -169.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.22 -5.17 58.98 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.0 -95.6 0.75 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 172.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 15.9 mmt -63.04 -34.12 76.89 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.699 -0.883 . . . . 0.0 110.304 177.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.4 p30 43.38 48.1 5.92 Favored 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 176.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 36.2 mtt180 54.73 29.46 11.76 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.356 -0.84 . . . . 0.0 111.2 175.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -120.07 105.06 43.0 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.58 -0.7 . . . . 0.0 110.078 175.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.77 147.6 91.62 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 O-C-N 123.128 1.067 . . . . 0.0 110.481 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 45.4 pt -132.02 178.0 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.779 0.8 . . . . 0.0 111.011 -175.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 30.4 mt -124.42 149.88 46.26 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.42 HD11 ' CE1' ' A' ' 301' ' ' PHE . 79.9 mt -115.33 130.1 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.245 177.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 80.9 mt -109.76 126.39 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -176.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 57.5 t -118.86 126.78 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.6 p -125.25 153.71 42.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.603 -0.686 . . . . 0.0 110.579 -173.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.419 ' HB2' ' CE1' ' A' ' 138' ' ' PHE . 25.0 tp -103.97 125.87 50.67 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 169.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -131.24 149.92 52.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.885 -0.509 . . . . 0.0 109.882 -173.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 74.4 p -89.86 159.36 17.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.629 -0.669 . . . . 0.0 109.774 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -55.96 -26.07 46.53 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.582 -0.699 . . . . 0.0 110.823 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -87.27 9.68 19.53 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.519 -0.738 . . . . 0.0 111.783 -174.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 87.51 20.19 52.32 Favored Glycine 0 N--CA 1.495 2.606 0 O-C-N 121.089 -1.007 . . . . 0.0 110.731 170.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -108.02 140.26 41.44 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.283 -1.127 . . . . 0.0 110.175 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 60.0 t -89.55 132.56 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.587 -0.696 . . . . 0.0 110.067 -174.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 96.2 mt -99.97 -40.1 7.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.671 -0.643 . . . . 0.0 110.489 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -161.67 154.83 25.91 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -178.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 47.7 mtp180 -134.9 135.15 41.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.669 -0.9 . . . . 0.0 110.746 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 -135.18 158.03 45.4 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.609 -0.682 . . . . 0.0 109.958 172.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 85.9 m -144.29 153.83 42.43 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.504 -0.747 . . . . 0.0 110.745 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.42 ' CE1' HD11 ' A' ' 284' ' ' ILE . 49.3 p90 -144.96 162.17 37.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.705 -0.622 . . . . 0.0 110.05 174.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -104.84 135.36 46.35 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.479 -0.763 . . . . 0.0 110.198 -176.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -120.06 142.93 48.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.626 -0.671 . . . . 0.0 110.687 -170.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -138.49 138.82 38.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.795 -0.565 . . . . 0.0 109.795 173.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 78.7 mt -108.75 122.89 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.544 -0.723 . . . . 0.0 109.619 177.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.9 p -145.36 170.56 16.1 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.66 -0.65 . . . . 0.0 110.69 -171.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -72.52 -40.12 67.05 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.613 -0.68 . . . . 0.0 110.708 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.8 t -127.95 86.43 58.17 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.591 -0.693 . . . . 0.0 110.484 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -55.91 -29.21 71.97 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 O-C-N 123.134 1.07 . . . . 0.0 110.899 174.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.48 -37.98 93.09 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.014 -1.635 . . . . 0.0 109.014 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -73.28 -40.02 64.9 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.748 -0.854 . . . . 0.0 109.751 -173.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -69.44 -39.78 77.6 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.163 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -61.86 -45.56 93.23 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.306 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 23.7 ttpt -64.11 -39.22 93.58 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.585 -0.697 . . . . 0.0 110.47 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.66 -50.71 71.4 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.495 -0.753 . . . . 0.0 110.426 -174.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -61.56 -37.77 85.05 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.45 -0.781 . . . . 0.0 110.105 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -62.3 -40.13 95.27 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.635 -0.665 . . . . 0.0 110.016 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -62.39 -35.18 78.39 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.619 -0.676 . . . . 0.0 109.957 178.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 22.6 t -62.76 -32.06 73.14 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.658 -0.651 . . . . 0.0 110.32 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 51.3 mm -78.38 -45.98 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.593 -0.692 . . . . 0.0 109.964 -177.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -59.09 -42.08 89.6 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.629 -0.669 . . . . 0.0 110.536 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -65.63 -46.29 79.78 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.628 -0.67 . . . . 0.0 110.339 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -66.11 -36.28 82.74 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.68 -0.638 . . . . 0.0 110.349 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -105.03 125.08 50.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.629 -0.669 . . . . 0.0 110.474 -175.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 62.5 t -122.1 130.04 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.586 -0.696 . . . . 0.0 109.789 176.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 48.9 m -95.18 140.05 30.65 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.575 -0.703 . . . . 0.0 110.342 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -106.37 144.25 33.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.693 -0.629 . . . . 0.0 110.15 177.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 50.4 m -65.99 148.51 51.69 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.638 -0.664 . . . . 0.0 110.147 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 74.1 p -96.21 -26.74 15.32 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.687 -0.633 . . . . 0.0 110.497 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -60.35 -41.04 92.8 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.501 -0.75 . . . . 0.0 110.395 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -60.31 -36.08 77.08 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.635 -0.666 . . . . 0.0 110.362 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -92.97 134.27 12.1 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -147.57 82.35 1.53 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.67 -0.9 . . . . 0.0 110.155 178.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -152.53 149.35 28.42 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.693 -0.629 . . . . 0.0 110.201 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -125.59 153.86 43.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.553 -0.717 . . . . 0.0 110.469 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 53.23 46.0 27.4 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.473 -0.767 . . . . 0.0 111.282 175.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -117.77 139.09 51.55 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.55 -0.719 . . . . 0.0 110.288 173.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -119.44 136.85 54.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.666 -0.646 . . . . 0.0 110.245 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 9.8 t -134.33 152.74 51.98 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.69 -0.631 . . . . 0.0 110.44 178.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -60.99 -41.94 97.46 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.704 -0.622 . . . . 0.0 110.212 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 84.58 -170.52 46.37 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 82.4 mt -94.0 133.81 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.634 -0.921 . . . . 0.0 109.97 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -154.12 -50.21 0.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.704 -0.622 . . . . 0.0 110.27 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 65.0 mtt -59.86 -35.44 74.79 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.679 -0.638 . . . . 0.0 110.365 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 7.4 t . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 118.035 -0.984 . . . . 0.0 110.364 179.954 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 75.2 m -86.77 10.37 16.11 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.703 -0.881 . . . . 0.0 111.363 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 86.6 p -61.52 -29.88 70.27 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.135 -0.978 . . . . 0.0 110.263 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 43.4 m -61.13 -38.69 87.26 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.611 -0.681 . . . . 0.0 110.566 -177.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -59.19 -40.95 87.35 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.595 -0.69 . . . . 0.0 110.585 -175.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -85.7 -162.56 0.74 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.644 -0.66 . . . . 0.0 110.336 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 54.61 28.0 9.31 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.325 -0.859 . . . . 0.0 110.798 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 88.4 mt 51.76 32.07 9.01 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.374 -0.829 . . . . 0.0 111.194 176.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.2 m -117.79 154.82 51.21 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.625 -0.672 . . . . 0.0 110.079 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -58.36 150.45 36.99 Favored 'Cis proline' 0 N--CA 1.496 1.623 0 C-N-CA 123.066 -1.639 . . . . 0.0 110.258 -23.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 66.3 m -81.69 141.14 47.88 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.583 -0.698 . . . . 0.0 110.296 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -68.04 152.61 76.46 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 O-C-N 123.207 1.109 . . . . 0.0 110.552 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.94 144.49 43.2 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.652 -0.655 . . . . 0.0 109.996 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 50.1 mm -121.19 100.85 45.01 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.663 -0.648 . . . . 0.0 110.186 -176.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -61.25 154.01 61.11 Favored 'Trans proline' 0 N--CA 1.487 1.118 0 O-C-N 123.189 1.099 . . . . 0.0 110.364 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.4 t -109.97 146.88 34.49 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.67 -0.644 . . . . 0.0 110.43 -177.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -95.42 24.39 5.17 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.68 -0.637 . . . . 0.0 110.64 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 54.6 m -72.71 125.18 26.88 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.567 -0.708 . . . . 0.0 110.337 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -70.97 144.98 50.33 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.723 -0.611 . . . . 0.0 110.291 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -158.28 102.07 1.71 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.603 -0.686 . . . . 0.0 110.164 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -58.77 -39.96 77.1 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 O-C-N 123.177 1.093 . . . . 0.0 110.691 -178.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.12 -155.15 45.6 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 177.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -72.75 -45.93 0.47 Allowed 'Trans proline' 0 N--CA 1.486 1.067 0 O-C-N 123.33 1.174 . . . . 0.0 111.004 -174.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -89.1 9.1 26.65 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.615 -0.678 . . . . 0.0 111.453 -172.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.71 61.63 3.01 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.975 -1.078 . . . . 0.0 110.732 -176.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -77.92 118.2 20.0 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.648 -0.657 . . . . 0.0 109.83 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -130.04 160.04 34.9 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.312 0.577 . . . . 0.0 110.178 -177.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 78.6 t -124.31 148.78 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.69 -0.631 . . . . 0.0 109.775 176.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.4 p -157.1 171.02 21.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.813 -0.554 . . . . 0.0 109.928 176.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.425 ' CE1' HG12 ' A' ' 172' ' ' ILE . 64.8 m-85 -126.36 125.14 41.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.821 -0.549 . . . . 0.0 109.64 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -57.28 142.04 44.65 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.574 -0.704 . . . . 0.0 110.497 -175.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -76.33 144.97 39.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.589 -0.695 . . . . 0.0 110.687 -169.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 83.1 p -145.44 162.63 36.86 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.74 -0.6 . . . . 0.0 110.027 176.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 24.1 t -77.2 157.03 31.11 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.53 -0.731 . . . . 0.0 110.123 179.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 66.6 p -79.12 59.49 2.75 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.682 -0.636 . . . . 0.0 110.145 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.92 158.88 32.58 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.663 -0.648 . . . . 0.0 110.242 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 68.3 mttt -75.22 162.25 28.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.62 -0.675 . . . . 0.0 110.162 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 27.7 t 53.18 25.97 4.69 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.494 -0.754 . . . . 0.0 111.054 -177.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.68 134.32 56.14 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.602 -0.686 . . . . 0.0 110.158 177.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 76.1 p -60.06 -33.88 72.67 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.668 -0.645 . . . . 0.0 109.928 174.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 67.5 p-90 -170.06 148.02 3.33 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.964 -0.46 . . . . 0.0 109.784 178.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.9 t -142.04 142.37 32.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.789 -0.57 . . . . 0.0 109.974 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -125.76 140.12 52.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.513 -0.742 . . . . 0.0 110.559 -172.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 31.2 t -110.43 121.07 44.41 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.727 174.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 69.4 m -71.42 -36.45 71.31 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.702 -0.624 . . . . 0.0 110.489 -176.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -58.76 -33.83 70.72 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.586 -0.696 . . . . 0.0 110.526 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 53.9 mt -104.82 -11.33 16.84 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.734 -0.604 . . . . 0.0 110.851 -176.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt 59.87 51.84 5.76 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.045 -1.034 . . . . 0.0 109.825 176.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -147.14 152.86 39.13 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.696 -0.628 . . . . 0.0 110.714 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.6 tp -126.65 137.88 53.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.793 -0.567 . . . . 0.0 110.375 -173.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -117.54 133.32 56.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.537 -0.727 . . . . 0.0 109.462 175.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.1 p -138.3 158.31 44.54 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 120.111 -0.636 . . . . 0.0 111.104 -175.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -104.69 141.59 36.19 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.588 -0.695 . . . . 0.0 110.33 172.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 18.0 tt -54.6 149.43 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.529 -0.732 . . . . 0.0 111.552 -173.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 64.22 10.01 5.22 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.593 -0.692 . . . . 0.0 112.515 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -96.4 155.13 16.89 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.958 -1.089 . . . . 0.0 110.784 174.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 70.2 m -79.96 126.09 30.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.702 -0.624 . . . . 0.0 110.61 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 42.3 t -115.43 90.23 24.54 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.624 -0.673 . . . . 0.0 110.22 174.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -69.99 125.41 11.99 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.266 1.14 . . . . 0.0 110.521 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.425 HG12 ' CE1' ' A' ' 142' ' ' PHE . 86.4 mt -122.22 143.43 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.594 -0.692 . . . . 0.0 109.575 173.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . 0.422 ' NE2' ' CE1' ' A' ' 260' ' ' PHE . 95.4 mt-30 -109.14 136.64 48.3 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.611 -0.681 . . . . 0.0 110.707 -175.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.3 mm -95.23 135.02 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.674 -0.641 . . . . 0.0 109.744 169.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 35.2 tttm -117.05 130.27 56.55 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.509 -0.745 . . . . 0.0 110.581 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 17.0 m -136.01 159.8 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.63 -0.669 . . . . 0.0 109.797 174.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 79.0 mmm -81.3 -45.4 16.27 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.62 -0.675 . . . . 0.0 110.151 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 77.0 p -126.52 143.18 45.37 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.724 -0.61 . . . . 0.0 109.684 177.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -55.5 139.74 82.54 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 O-C-N 123.205 1.108 . . . . 0.0 110.902 -171.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.43 ' CG ' ' CE1' ' A' ' 251' ' ' TYR . 36.0 Cg_endo -67.51 170.01 14.53 Favored 'Trans proline' 0 N--CA 1.487 1.128 0 O-C-N 123.226 1.119 . . . . 0.0 110.542 177.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -60.26 155.77 44.2 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 123.326 1.172 . . . . 0.0 110.622 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -78.16 138.26 38.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.599 -0.688 . . . . 0.0 109.931 175.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.24 -24.97 30.08 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -174.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.13 151.2 2.09 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.381 -1.07 . . . . 0.0 111.48 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 35.4 m -129.75 156.03 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.777 -0.577 . . . . 0.0 109.853 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 53.7 mt -107.34 134.9 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -114.94 141.34 48.09 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -174.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -138.51 123.72 19.21 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.456 178.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 44.5 ttp -137.34 140.61 31.22 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.773 -0.579 . . . . 0.0 111.222 -175.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -90.98 138.22 2.34 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 O-C-N 123.243 1.128 . . . . 0.0 110.717 176.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.7 m -147.48 154.84 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.51 -0.744 . . . . 0.0 110.134 173.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.421 ' CD1' ' HB3' ' A' ' 197' ' ' HIS . 88.3 m-85 -61.33 166.67 3.71 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.488 -0.758 . . . . 0.0 110.429 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -84.67 -59.96 2.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.678 -0.639 . . . . 0.0 110.849 -175.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -80.08 152.24 29.44 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.656 -0.653 . . . . 0.0 110.319 -175.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.81 -38.58 72.78 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.333 -0.854 . . . . 0.0 110.72 -175.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -56.58 -24.57 48.28 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.539 -0.726 . . . . 0.0 110.567 -177.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.421 ' HB3' ' CD1' ' A' ' 192' ' ' TYR . 47.8 m80 -109.89 -20.46 12.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.565 -0.71 . . . . 0.0 111.116 -178.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.1 p -67.56 -20.19 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.145 -0.972 . . . . 0.0 110.606 -176.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 69.2 p -79.35 -17.01 55.37 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.535 -0.728 . . . . 0.0 110.678 174.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.41 136.93 32.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.357 -0.84 . . . . 0.0 110.029 174.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.8 t -73.02 146.03 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.623 -0.673 . . . . 0.0 110.228 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.421 HG23 ' CE2' ' A' ' 192' ' ' TYR . 60.8 t -84.95 136.16 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.595 -0.69 . . . . 0.0 109.191 172.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.0 pttp -134.95 -170.18 2.51 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.508 -0.745 . . . . 0.0 111.073 -167.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -95.1 159.32 15.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.75 -0.594 . . . . 0.0 110.501 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 59.9 m -80.05 160.48 68.44 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.627 -0.67 . . . . 0.0 109.281 175.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -64.14 -47.33 6.5 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.171 1.09 . . . . 0.0 109.841 176.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.442 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.5 p-10 -65.42 -44.38 87.57 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.556 -0.715 . . . . 0.0 111.162 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . 0.442 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 55.0 m170 -81.42 -27.96 34.48 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.438 -0.789 . . . . 0.0 111.391 -174.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -69.13 -41.35 77.45 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.387 -0.821 . . . . 0.0 110.243 172.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 26.4 tp -58.48 -34.1 70.52 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.58 -0.7 . . . . 0.0 110.695 -178.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 29.1 t -48.37 142.81 5.28 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.549 -0.719 . . . . 0.0 111.404 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -62.83 130.62 45.64 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.634 -0.666 . . . . 0.0 110.163 -176.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -63.68 -34.89 78.86 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.718 -0.614 . . . . 0.0 110.206 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.406 ' CD2' ' O ' ' A' ' 214' ' ' PHE . 56.6 t80 52.64 50.48 18.06 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.381 -0.824 . . . . 0.0 110.772 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -72.49 -10.09 59.36 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.691 -0.63 . . . . 0.0 111.264 -177.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -59.81 119.63 8.05 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.136 -0.978 . . . . 0.0 110.434 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 75.73 20.0 78.53 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 177.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -114.85 140.45 48.94 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.284 -1.127 . . . . 0.0 110.362 178.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.2 mt -84.86 -25.16 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.602 -0.686 . . . . 0.0 110.401 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -127.56 127.57 24.07 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.476 -0.765 . . . . 0.0 110.33 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.421 ' HD2' ' CE2' ' A' ' 236' ' ' TYR . 21.0 Cg_endo -66.6 123.32 10.94 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 O-C-N 123.082 1.043 . . . . 0.0 110.479 178.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -59.18 -19.35 49.18 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 O-C-N 122.977 0.988 . . . . 0.0 111.424 -176.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 86.9 p -54.35 -22.32 11.86 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.257 -0.902 . . . . 0.0 111.35 -175.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . 0.418 ' CE1' ' HG2' ' A' ' 221' ' ' PRO . 80.2 m80 -84.08 133.42 34.64 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.414 -0.803 . . . . 0.0 110.226 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 55.9 tp -59.52 -39.21 83.16 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.563 -0.711 . . . . 0.0 110.325 -177.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 80.9 mt -104.17 136.75 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.821 -0.549 . . . . 0.0 109.818 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -132.56 159.17 40.23 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.716 -0.615 . . . . 0.0 110.111 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 70.5 t -105.59 146.74 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.663 -0.648 . . . . 0.0 110.144 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -121.78 130.05 53.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.715 -0.616 . . . . 0.0 110.303 171.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.8 20.58 21.19 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.526 -1.029 . . . . 0.0 110.526 170.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -141.27 105.16 4.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.307 -1.114 . . . . 0.0 109.988 174.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 93.1 p -63.6 -15.13 57.3 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.603 -0.686 . . . . 0.0 111.224 -177.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -97.24 9.96 40.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.303 -0.873 . . . . 0.0 111.187 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.97 130.35 45.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.205 -0.934 . . . . 0.0 110.081 176.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -139.77 156.25 46.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.774 -0.579 . . . . 0.0 109.719 177.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.421 ' CE2' ' HD2' ' A' ' 221' ' ' PRO . 90.4 m-85 -117.96 150.66 38.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.513 -0.742 . . . . 0.0 110.617 -176.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.08 159.89 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.902 -0.499 . . . . 0.0 110.224 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -119.65 130.08 54.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.771 -0.581 . . . . 0.0 110.113 176.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -61.72 126.04 86.09 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.657 -0.652 . . . . 0.0 109.754 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -65.01 -29.15 57.27 Favored 'Trans proline' 0 C--N 1.317 -1.123 0 O-C-N 123.201 1.106 . . . . 0.0 110.782 -172.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.9 mt -104.15 -50.25 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.553 -0.717 . . . . 0.0 110.943 -170.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 20.3 p -105.26 12.25 32.02 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.372 -0.83 . . . . 0.0 111.945 -170.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 82.31 -23.24 5.55 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 120.97 -1.081 . . . . 0.0 111.85 168.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -45.79 142.07 2.69 Favored 'General case' 0 N--CA 1.505 2.325 0 CA-C-N 118.572 1.186 . . . . 0.0 112.569 -168.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -105.12 146.17 29.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.637 -0.664 . . . . 0.0 110.093 174.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 78.8 p -154.79 159.92 40.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.584 -0.698 . . . . 0.0 110.404 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.418 ' HB ' ' CD1' ' A' ' 236' ' ' TYR . 8.3 p -122.95 148.1 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.746 -0.596 . . . . 0.0 109.69 178.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 81.6 mt -129.69 154.58 47.02 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.797 -175.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 35.4 m -151.07 151.75 30.14 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.822 -0.549 . . . . 0.0 110.008 175.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -71.09 139.08 34.9 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 O-C-N 123.237 1.125 . . . . 0.0 109.999 177.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.43 ' CE1' ' CG ' ' A' ' 180' ' ' PRO . 61.8 t80 -76.04 123.9 26.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.488 -0.758 . . . . 0.0 110.219 176.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -99.95 160.09 28.15 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.668 -0.645 . . . . 0.0 110.029 176.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -58.76 159.72 19.96 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 O-C-N 123.154 1.081 . . . . 0.0 110.42 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.03 149.98 76.06 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 O-C-N 123.26 1.137 . . . . 0.0 110.522 -176.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -61.71 148.2 43.56 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.648 -0.658 . . . . 0.0 110.138 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.9 t -69.81 127.18 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.586 -0.696 . . . . 0.0 110.233 -170.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.93 -10.13 55.45 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.415 ' OG1' ' CD2' ' A' ' 260' ' ' PHE . 10.2 t -144.63 174.42 10.98 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.148 -1.207 . . . . 0.0 110.648 175.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -108.27 13.14 25.97 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.613 -0.679 . . . . 0.0 111.83 -167.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . 0.422 ' CE1' ' NE2' ' A' ' 173' ' ' GLN . 40.2 p90 -123.88 168.17 13.13 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.096 -1.003 . . . . 0.0 111.148 -175.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 71.9 m -117.73 145.23 44.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.799 -0.563 . . . . 0.0 109.75 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 28.4 m -115.28 137.41 52.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.615 -0.678 . . . . 0.0 110.882 -174.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 57.8 t -128.78 136.99 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 172.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 63.9 mt -104.73 120.47 41.43 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.534 -0.729 . . . . 0.0 109.873 -174.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . 0.408 ' CE2' HD12 ' A' ' 172' ' ' ILE . 3.8 m-85 -98.41 156.19 16.87 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.627 -0.67 . . . . 0.0 110.842 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -136.49 142.89 43.56 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 171.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -111.89 132.02 54.99 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.61 -0.681 . . . . 0.0 110.397 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -102.73 6.77 39.63 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.659 -0.651 . . . . 0.0 111.874 -177.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -144.73 160.45 41.2 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.985 -1.072 . . . . 0.0 109.908 171.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -119.77 163.49 17.38 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.459 0.647 . . . . 0.0 110.506 -178.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 50.1 m -58.63 -33.09 69.66 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.482 -0.761 . . . . 0.0 111.028 -163.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 50.0 p -100.77 12.68 37.03 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.431 -0.793 . . . . 0.0 111.954 -163.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 29.6 p -94.69 117.99 31.02 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.091 -1.006 . . . . 0.0 110.625 177.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.4 t -64.42 139.78 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.561 -0.712 . . . . 0.0 110.356 -169.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.37 -5.02 60.5 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -125.06 -100.33 1.28 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 170.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 93.4 mmm -64.87 -31.44 72.67 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.693 -0.887 . . . . 0.0 110.355 176.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.8 p30 43.1 52.11 5.45 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 175.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 54.85 27.0 8.37 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.328 -0.858 . . . . 0.0 111.182 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 36.6 mtt180 -118.77 106.36 44.08 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.56 -0.712 . . . . 0.0 110.046 175.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.38 149.19 82.9 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 O-C-N 123.015 1.008 . . . . 0.0 110.691 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 44.6 pt -131.93 -179.7 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-O 121.752 0.786 . . . . 0.0 110.742 -177.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 34.7 mt -124.33 149.93 46.03 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.414 HD11 ' CE1' ' A' ' 301' ' ' PHE . 77.7 mt -113.83 128.75 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.125 176.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 80.0 mt -109.84 126.46 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -175.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 59.2 t -118.88 126.69 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.2 p -125.36 154.7 41.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.683 -0.635 . . . . 0.0 110.516 -175.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 28.8 tp -102.61 126.42 49.68 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 168.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -131.61 150.3 52.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.845 -0.534 . . . . 0.0 109.937 -171.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 76.8 p -90.03 157.43 17.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.67 -0.644 . . . . 0.0 109.909 177.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -56.08 -26.1 48.12 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.587 -0.696 . . . . 0.0 110.932 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -91.03 11.86 21.65 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.451 -0.78 . . . . 0.0 111.745 -174.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 90.25 20.15 43.15 Favored Glycine 0 N--CA 1.494 2.541 0 C-N-CA 120.139 -1.029 . . . . 0.0 110.922 168.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -109.15 140.17 43.09 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.3 -1.118 . . . . 0.0 110.062 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 59.2 t -91.64 133.39 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.558 -0.714 . . . . 0.0 110.234 -174.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 93.9 mt -99.97 -40.0 7.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.757 -0.589 . . . . 0.0 110.586 -179.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -159.29 155.41 26.5 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 57.2 mtt85 -135.06 136.28 41.91 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.764 -0.845 . . . . 0.0 110.349 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -136.58 153.99 50.81 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.44 -0.787 . . . . 0.0 110.19 168.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 95.8 m -143.29 154.01 43.35 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.545 -0.722 . . . . 0.0 110.626 -175.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.414 ' CE1' HD11 ' A' ' 284' ' ' ILE . 51.7 p90 -145.77 166.8 24.82 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.647 -0.658 . . . . 0.0 109.962 173.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -104.92 135.62 45.93 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.421 -0.8 . . . . 0.0 110.193 -177.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -122.67 144.26 49.25 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.722 -169.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -138.08 138.94 39.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.747 -0.596 . . . . 0.0 109.694 173.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 74.0 mt -107.42 122.83 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.548 -0.72 . . . . 0.0 109.735 176.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.8 p -145.27 169.71 17.7 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.7 -0.625 . . . . 0.0 110.647 -172.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -71.55 -40.11 70.24 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.626 -0.671 . . . . 0.0 110.648 -178.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.7 t -127.16 86.07 59.61 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.476 -0.765 . . . . 0.0 110.468 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -55.94 -28.16 67.15 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 O-C-N 123.251 1.132 . . . . 0.0 110.766 174.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -67.05 -37.8 92.11 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 177.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -72.76 -40.84 65.69 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.737 -0.86 . . . . 0.0 109.845 -173.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -69.5 -38.91 77.82 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.162 -178.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -61.81 -43.22 99.28 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.195 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 21.0 ttpp -64.18 -38.53 91.39 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.582 -0.699 . . . . 0.0 110.446 178.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -60.74 -50.52 73.13 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.507 -0.746 . . . . 0.0 110.46 -173.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -61.55 -37.81 85.15 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.482 -0.761 . . . . 0.0 110.087 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -62.07 -39.56 92.84 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.634 -0.666 . . . . 0.0 110.137 177.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -62.38 -35.17 78.34 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.601 -0.687 . . . . 0.0 109.926 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 24.5 m -62.57 -32.49 73.48 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.728 -0.608 . . . . 0.0 110.176 178.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 51.4 mm -77.56 -45.32 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.686 -0.634 . . . . 0.0 109.943 -178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -59.11 -40.33 85.03 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.637 -0.664 . . . . 0.0 110.541 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -65.17 -43.3 92.19 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.645 -0.659 . . . . 0.0 110.07 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -65.65 -38.34 89.05 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.708 -0.62 . . . . 0.0 110.377 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -105.15 125.04 50.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.619 -0.675 . . . . 0.0 110.484 -175.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 62.9 t -116.41 130.07 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.6 -0.687 . . . . 0.0 109.834 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 29.3 t -95.11 137.13 34.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.624 -0.673 . . . . 0.0 110.332 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -114.43 116.74 29.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.649 -0.657 . . . . 0.0 110.228 177.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 49.4 m -94.09 142.63 27.17 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.595 -0.691 . . . . 0.0 110.301 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 67.9 p -135.68 157.33 47.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.624 -0.673 . . . . 0.0 109.994 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -61.29 -46.86 88.57 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.58 -0.7 . . . . 0.0 110.285 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -67.42 -46.85 71.97 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.555 -0.716 . . . . 0.0 110.291 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 96.1 -26.77 19.43 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -101.48 160.06 14.76 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.521 -0.988 . . . . 0.0 110.44 -177.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . 57.59 109.69 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.585 -0.697 . . . . 0.0 110.711 -177.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -58.45 -45.95 87.53 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.608 -0.682 . . . . 0.0 110.379 -178.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 55.2 mmm-85 51.41 58.91 5.0 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.43 -0.794 . . . . 0.0 111.048 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -58.72 -41.51 86.56 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.561 -0.712 . . . . 0.0 110.384 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 27.7 t30 52.43 42.77 31.3 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.428 -0.795 . . . . 0.0 111.064 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 28.2 m -125.57 138.16 53.94 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.576 -0.702 . . . . 0.0 110.261 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -58.78 -38.97 79.7 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.574 -0.704 . . . . 0.0 110.489 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -148.01 -173.71 19.21 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 51.6 mm -91.96 132.43 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.601 -0.94 . . . . 0.0 110.075 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -93.09 148.66 21.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.625 -0.672 . . . . 0.0 110.348 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 93.3 mmm -59.96 -34.86 73.84 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.59 -0.694 . . . . 0.0 110.333 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 59.1 m . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.25 179.9 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 35.9 m -80.77 -29.28 36.2 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.676 -0.896 . . . . 0.0 110.18 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 57.6 p -71.77 163.26 28.12 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.649 -0.657 . . . . 0.0 110.181 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.7 t -130.86 153.93 48.6 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.598 -0.689 . . . . 0.0 110.513 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -62.94 -37.68 88.02 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.671 -0.643 . . . . 0.0 110.696 -175.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -78.94 -31.91 45.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.504 -0.748 . . . . 0.0 110.226 -175.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 49.72 70.48 0.49 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.456 -0.777 . . . . 0.0 111.272 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.3 mt 55.75 -85.43 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.757 -0.589 . . . . 0.0 111.063 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 74.3 p -105.16 164.93 14.1 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.204 -0.935 . . . . 0.0 110.174 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -63.26 152.35 70.14 Favored 'Cis proline' 0 N--CA 1.495 1.563 0 C-N-CA 123.194 -1.586 . . . . 0.0 110.44 -18.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.9 m -82.01 158.97 66.62 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.638 -0.664 . . . . 0.0 110.274 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -59.04 147.11 91.79 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.333 1.175 . . . . 0.0 110.643 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.59 144.02 42.03 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.666 -0.646 . . . . 0.0 110.136 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 50.7 mm -121.88 100.02 43.7 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.711 -0.618 . . . . 0.0 109.998 -178.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -60.34 151.21 75.8 Favored 'Trans proline' 0 N--CA 1.487 1.147 0 O-C-N 123.185 1.097 . . . . 0.0 110.623 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.7 t -112.3 149.77 31.93 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.641 -0.662 . . . . 0.0 110.219 -178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.7 p-10 -94.31 23.54 5.07 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.658 -0.651 . . . . 0.0 110.885 -178.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 54.0 m -72.35 125.15 26.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.471 -0.768 . . . . 0.0 110.212 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -70.53 144.92 51.17 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.602 -0.686 . . . . 0.0 110.401 -177.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.409 ' CE1' ' HA2' ' A' ' 134' ' ' GLY . 52.6 t80 -157.33 101.22 1.89 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.618 -0.676 . . . . 0.0 110.101 178.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.51 -39.94 78.76 Favored 'Trans proline' 0 N--CA 1.488 1.204 0 O-C-N 123.153 1.081 . . . . 0.0 110.952 -174.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.409 ' HA2' ' CE1' ' A' ' 132' ' ' TYR . . . 79.84 -155.11 38.52 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -74.18 -47.61 0.24 Allowed 'Trans proline' 0 C--N 1.317 -1.085 0 O-C-N 123.313 1.165 . . . . 0.0 110.846 -175.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -84.19 5.16 27.45 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.525 -0.734 . . . . 0.0 111.431 -175.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 54.01 59.97 3.92 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.898 -1.126 . . . . 0.0 110.681 -176.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.446 ' CE1' ' CG2' ' A' ' 174' ' ' ILE . 64.6 t80 -77.96 118.94 20.74 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.57 -0.706 . . . . 0.0 110.008 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -129.96 159.92 35.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.785 -0.572 . . . . 0.0 110.215 -175.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 71.9 t -123.65 146.66 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-O 121.443 0.639 . . . . 0.0 110.174 177.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 76.8 p -157.06 171.16 20.95 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 175.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.421 ' CE2' HG12 ' A' ' 172' ' ' ILE . 64.8 m-85 -126.57 125.08 41.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.706 -0.622 . . . . 0.0 109.916 -177.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -57.15 150.1 18.19 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.614 -0.679 . . . . 0.0 110.537 -177.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -69.99 133.56 47.39 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.652 -0.655 . . . . 0.0 110.542 -170.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.8 t -128.83 147.44 50.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.761 -0.587 . . . . 0.0 110.043 178.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 56.3 p -67.06 162.92 21.13 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.631 -0.668 . . . . 0.0 110.307 -178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 73.3 p -101.84 26.31 7.63 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.682 -0.636 . . . . 0.0 110.178 178.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.02 162.06 28.9 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.601 -0.687 . . . . 0.0 110.208 -177.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -55.51 170.55 0.24 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.577 -0.702 . . . . 0.0 110.724 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 68.0 m 52.83 26.38 4.54 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.548 -0.72 . . . . 0.0 111.091 -178.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -77.26 120.63 22.56 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.594 -0.691 . . . . 0.0 109.943 176.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 57.9 p -60.15 -34.09 73.07 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.773 -0.579 . . . . 0.0 110.118 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 -170.46 148.14 3.09 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.636 -0.665 . . . . 0.0 109.752 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 13.7 t -141.52 142.36 33.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.717 -0.614 . . . . 0.0 110.031 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -125.65 140.04 53.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.482 -0.761 . . . . 0.0 110.532 -172.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 32.8 t -109.82 122.31 47.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.783 -0.573 . . . . 0.0 109.785 175.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 65.1 m -70.66 -36.8 73.56 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.689 -0.632 . . . . 0.0 110.482 -177.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -58.79 -34.28 71.29 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.615 -0.678 . . . . 0.0 110.582 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 53.8 mt -104.8 -11.71 16.66 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.61 -0.681 . . . . 0.0 110.804 -176.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.0 tttm 59.82 52.18 5.59 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.14 -0.975 . . . . 0.0 109.732 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -145.86 152.88 40.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.714 -0.616 . . . . 0.0 110.562 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.5 tp -126.66 137.83 53.34 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.863 -0.523 . . . . 0.0 110.256 -175.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -116.96 133.86 55.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.557 -0.714 . . . . 0.0 109.319 174.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.9 p -138.29 158.46 44.25 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 120.036 -0.665 . . . . 0.0 110.979 -174.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -104.52 143.9 32.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.62 -0.675 . . . . 0.0 110.398 172.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 16.9 tt -52.47 147.77 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 CA-C-O 121.64 0.733 . . . . 0.0 111.841 -173.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 64.16 10.01 5.18 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.628 -0.67 . . . . 0.0 112.539 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 32.3 mmtt -96.52 155.13 16.9 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.04 -1.037 . . . . 0.0 110.788 175.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 85.6 m -84.31 126.21 32.98 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.666 -0.646 . . . . 0.0 110.676 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 42.6 t -112.63 90.31 14.67 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.514 -0.741 . . . . 0.0 110.082 173.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -64.75 129.28 23.03 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 123.339 1.179 . . . . 0.0 110.445 176.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.421 HG12 ' CE2' ' A' ' 142' ' ' PHE . 95.4 mt -123.17 138.67 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.665 -0.647 . . . . 0.0 109.36 176.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -108.72 133.97 52.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.546 -0.722 . . . . 0.0 110.637 -176.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.446 ' CG2' ' CE1' ' A' ' 138' ' ' PHE . 49.5 mm -95.37 135.07 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.641 -0.662 . . . . 0.0 109.674 172.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -118.08 129.93 55.85 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.583 -0.698 . . . . 0.0 110.597 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 17.3 m -136.3 159.74 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.475 -0.766 . . . . 0.0 109.957 175.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 79.7 mmm -77.46 -40.37 43.43 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.745 -0.597 . . . . 0.0 110.018 177.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 77.0 p -134.1 143.21 46.22 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.78 -0.575 . . . . 0.0 109.793 177.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -55.67 139.88 83.6 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 O-C-N 123.2 1.105 . . . . 0.0 110.86 -173.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.447 ' CG ' ' CE1' ' A' ' 251' ' ' TYR . 23.5 Cg_endo -64.5 168.18 13.54 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 O-C-N 123.23 1.121 . . . . 0.0 110.635 178.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -61.53 158.21 37.72 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 O-C-N 123.353 1.186 . . . . 0.0 110.413 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -77.76 137.9 38.71 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.667 -0.645 . . . . 0.0 109.889 175.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.53 -24.97 30.08 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -174.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.1 149.98 2.58 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.367 -1.078 . . . . 0.0 111.373 177.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.71 155.99 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.654 -0.654 . . . . 0.0 109.816 176.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 69.8 mt -108.46 136.21 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.403 ' HG2' ' CD2' ' A' ' 248' ' ' LEU . 36.5 mtp180 -114.89 146.11 41.46 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -175.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -140.6 127.56 20.68 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.439 -0.788 . . . . 0.0 110.337 172.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 25.0 ttm -137.2 139.36 27.87 Favored Pre-proline 0 N--CA 1.495 1.811 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.031 -177.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -91.34 138.29 2.21 Favored 'Trans proline' 0 C--N 1.32 -0.972 0 O-C-N 123.288 1.152 . . . . 0.0 110.772 177.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.7 m -147.24 154.89 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.518 -0.739 . . . . 0.0 110.059 174.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.417 ' CE2' HG21 ' A' ' 202' ' ' VAL . 77.3 m-85 -61.6 164.78 5.58 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.47 -0.769 . . . . 0.0 110.545 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -80.33 -60.02 2.48 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.625 -0.672 . . . . 0.0 110.843 -174.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -80.04 151.2 30.06 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.601 -0.687 . . . . 0.0 110.372 -175.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.44 -38.52 71.74 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.368 -0.832 . . . . 0.0 110.736 -175.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -56.49 -24.92 49.34 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.525 -0.735 . . . . 0.0 110.58 -176.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.407 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 63.2 m170 -110.05 -20.49 12.69 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.094 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.2 p -67.14 -20.22 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.157 -0.964 . . . . 0.0 110.564 -176.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 81.3 p -79.35 -17.08 55.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.502 -0.749 . . . . 0.0 110.777 175.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.25 135.65 33.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.342 -0.849 . . . . 0.0 110.09 173.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.99 142.97 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.682 -0.636 . . . . 0.0 110.22 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.417 HG21 ' CE2' ' A' ' 192' ' ' TYR . 60.2 t -84.93 138.82 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.529 -0.732 . . . . 0.0 109.257 172.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 14.0 pttt -134.77 -170.29 2.53 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.412 -0.805 . . . . 0.0 111.345 -168.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 74.4 mtm-85 -95.3 156.05 16.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.807 -0.558 . . . . 0.0 110.319 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 48.7 m -75.64 154.75 85.48 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.571 -0.706 . . . . 0.0 109.237 173.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -62.83 -47.35 8.95 Favored 'Trans proline' 0 C--N 1.315 -1.231 0 O-C-N 123.147 1.077 . . . . 0.0 110.056 176.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.412 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.7 p-10 -65.44 -44.1 88.37 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.566 -0.709 . . . . 0.0 111.245 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . 0.412 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 51.2 m170 -82.06 -28.27 32.52 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.411 -0.805 . . . . 0.0 111.171 -174.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 59.4 tt0 -69.2 -37.8 78.3 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.424 -0.798 . . . . 0.0 110.313 172.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 27.1 tp -55.62 -34.56 64.99 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.509 -0.745 . . . . 0.0 110.946 -175.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 28.6 t -48.4 137.51 11.25 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.477 -0.764 . . . . 0.0 111.392 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.421 ' HB2' ' CE2' ' A' ' 214' ' ' PHE . 88.7 mtt180 -60.52 144.26 51.81 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.667 -0.646 . . . . 0.0 110.336 -176.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -63.69 -37.34 86.99 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.727 -0.608 . . . . 0.0 110.328 -178.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.421 ' CE2' ' HB2' ' A' ' 212' ' ' ARG . 8.1 m-85 51.36 50.74 18.29 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.394 -0.816 . . . . 0.0 110.967 -177.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -67.67 -10.39 51.89 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.605 -0.684 . . . . 0.0 111.161 -176.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.63 119.73 9.24 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.202 -0.936 . . . . 0.0 110.208 177.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 74.15 20.12 79.71 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -140.56 153.48 46.15 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.314 -1.11 . . . . 0.0 110.024 -177.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.2 mt -114.97 -8.65 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.678 -0.639 . . . . 0.0 111.143 -177.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -124.94 93.15 46.4 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.18 -0.95 . . . . 0.0 110.474 -173.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.407 ' HD2' ' CE2' ' A' ' 236' ' ' TYR . 28.7 Cg_endo -67.96 150.92 78.27 Favored 'Trans proline' 0 C--N 1.316 -1.168 0 O-C-N 123.355 1.187 . . . . 0.0 110.608 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -60.37 -16.77 43.42 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 O-C-N 123.183 1.097 . . . . 0.0 111.432 -176.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 26.3 m -51.77 -27.1 11.11 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.173 -0.954 . . . . 0.0 111.303 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . 0.405 ' CD2' ' HB3' ' A' ' 245' ' ' GLN . 12.9 t-80 -109.64 129.28 55.61 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.497 -0.752 . . . . 0.0 110.46 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 41.3 tp -60.53 -36.43 78.39 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.617 -0.677 . . . . 0.0 110.341 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 84.3 mt -101.81 136.75 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.767 -0.583 . . . . 0.0 110.034 -176.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -125.65 158.11 35.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.692 -0.63 . . . . 0.0 110.135 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 90.3 t -104.44 146.6 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.701 -0.625 . . . . 0.0 109.844 172.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -118.74 128.13 54.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.629 -0.67 . . . . 0.0 110.4 170.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.11 20.93 21.99 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 168.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -139.37 105.05 5.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.313 -1.11 . . . . 0.0 110.034 174.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 44.2 m -63.49 -15.21 57.2 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.547 -0.721 . . . . 0.0 111.24 -176.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -100.01 8.02 44.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.223 -0.923 . . . . 0.0 111.621 -177.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.68 133.22 55.33 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.108 -0.995 . . . . 0.0 110.175 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -139.8 158.06 44.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.756 -0.59 . . . . 0.0 109.83 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.407 ' CE2' ' HD2' ' A' ' 221' ' ' PRO . 90.4 m-85 -113.87 150.6 33.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.596 -0.69 . . . . 0.0 110.556 -177.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.06 159.98 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.771 -0.58 . . . . 0.0 110.233 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -122.7 130.05 52.51 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.743 -0.598 . . . . 0.0 110.201 177.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -65.04 112.36 7.99 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.672 -0.643 . . . . 0.0 109.714 177.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -60.23 -25.55 80.37 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.107 1.056 . . . . 0.0 110.998 -172.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.8 mt -101.14 -50.32 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.368 -0.832 . . . . 0.0 110.824 -171.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 6.6 p -105.33 12.16 31.99 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.341 -0.85 . . . . 0.0 111.998 -172.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 82.29 -24.85 4.58 Favored Glycine 0 N--CA 1.497 2.742 0 O-C-N 121.007 -1.058 . . . . 0.0 111.813 170.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 23.8 mmt85 -45.81 142.13 2.67 Favored 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 118.54 1.17 . . . . 0.0 112.544 -168.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.405 ' HB3' ' CD2' ' A' ' 224' ' ' HIS . 18.2 mp0 -108.51 145.08 35.28 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.626 -0.671 . . . . 0.0 110.047 174.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 77.3 p -154.84 159.91 40.87 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.572 -0.705 . . . . 0.0 110.487 178.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 8.5 p -123.01 148.07 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.77 -0.581 . . . . 0.0 109.655 178.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.403 ' CD2' ' HG2' ' A' ' 187' ' ' ARG . 78.8 mt -129.69 154.62 46.97 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.872 -173.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 35.9 m -150.69 151.82 31.16 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.819 -0.55 . . . . 0.0 109.858 174.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -71.02 139.49 35.99 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.173 1.091 . . . . 0.0 110.012 177.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.447 ' CE1' ' CG ' ' A' ' 180' ' ' PRO . 9.4 t80 -79.82 123.37 27.66 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.463 -0.773 . . . . 0.0 110.05 178.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -100.1 160.05 28.19 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.677 -0.64 . . . . 0.0 110.095 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -58.91 159.97 19.7 Favored 'Trans proline' 0 N--CA 1.487 1.118 0 O-C-N 123.298 1.157 . . . . 0.0 110.425 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -59.15 149.95 76.85 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.245 1.129 . . . . 0.0 110.614 -176.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -61.21 148.94 39.19 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.692 -0.63 . . . . 0.0 110.166 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.78 127.22 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.469 -0.769 . . . . 0.0 110.158 -170.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.92 -10.11 55.46 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.402 ' OG1' ' CD2' ' A' ' 260' ' ' PHE . 9.9 t -145.02 173.33 11.98 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.245 -1.15 . . . . 0.0 110.607 175.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -107.35 13.14 27.35 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.586 -0.696 . . . . 0.0 111.743 -168.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . 0.402 ' CD2' ' OG1' ' A' ' 258' ' ' THR . 14.7 p90 -120.01 168.0 11.61 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.167 -0.958 . . . . 0.0 111.164 -175.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 93.2 m -117.71 147.01 43.34 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.781 -0.574 . . . . 0.0 109.859 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 38.5 m -116.83 135.0 54.08 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.541 -0.724 . . . . 0.0 110.927 -175.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.4 t -129.66 137.12 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 171.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 70.1 mt -104.83 122.09 45.03 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.582 -0.699 . . . . 0.0 109.903 -173.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -106.92 149.4 27.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.637 -0.664 . . . . 0.0 110.633 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -136.63 142.95 43.27 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -111.04 131.55 54.97 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.575 -0.703 . . . . 0.0 110.499 -176.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -96.79 2.87 52.38 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.708 -0.62 . . . . 0.0 112.119 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -144.67 165.03 29.2 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.055 -1.028 . . . . 0.0 110.11 174.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -119.86 162.37 19.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.72 -0.612 . . . . 0.0 110.303 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 23.1 m -58.29 -33.47 69.49 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.468 -0.77 . . . . 0.0 110.983 -163.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 49.2 p -97.9 9.88 41.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.458 -0.776 . . . . 0.0 112.07 -163.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 31.2 p -93.79 118.07 30.94 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.09 -1.006 . . . . 0.0 110.691 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 60.4 t -64.42 140.52 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.442 -0.786 . . . . 0.0 110.305 -170.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 100.74 -5.21 56.62 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 177.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.62 -99.16 0.88 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 170.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 93.2 mmm -63.85 -31.59 72.82 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.639 -0.918 . . . . 0.0 110.3 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.5 p30 43.84 50.56 6.92 Favored 'General case' 0 N--CA 1.504 2.234 0 CA-C-O 121.286 0.565 . . . . 0.0 112.521 175.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 22.0 mtt180 54.81 29.67 12.31 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.29 -0.881 . . . . 0.0 111.17 175.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -119.28 104.97 45.08 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.517 -0.739 . . . . 0.0 110.149 175.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.85 145.95 96.96 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 123.077 1.04 . . . . 0.0 110.522 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 45.6 pt -131.98 177.59 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 121.79 0.805 . . . . 0.0 111.132 -175.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 30.1 mt -124.34 149.9 46.1 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.421 HD12 ' CE1' ' A' ' 301' ' ' PHE . 77.6 mt -115.03 129.91 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.213 177.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 82.3 mt -109.71 127.17 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -176.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 58.7 t -118.83 126.73 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.5 p -125.21 153.8 42.57 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.466 -174.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.424 ' HB2' ' CE1' ' A' ' 138' ' ' PHE . 27.1 tp -105.32 126.08 51.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.73 -0.606 . . . . 0.0 109.535 169.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -131.79 148.86 52.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.955 -0.466 . . . . 0.0 109.768 -174.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.4 ' CG2' ' CD1' ' A' ' 296' ' ' LEU . 54.4 p -89.88 161.68 15.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.641 -0.662 . . . . 0.0 109.98 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -55.99 -26.09 46.89 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.544 -0.723 . . . . 0.0 111.112 -174.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 40.8 p30 -91.6 10.25 28.85 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.379 -0.826 . . . . 0.0 111.923 -173.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.85 20.19 44.47 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 120.14 -1.028 . . . . 0.0 110.725 171.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -106.0 140.15 39.44 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.256 -1.144 . . . . 0.0 110.001 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 58.5 t -89.21 132.09 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.634 -0.666 . . . . 0.0 110.282 -172.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.4 ' CD1' ' CG2' ' A' ' 290' ' ' THR . 95.9 mt -99.92 -40.2 7.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.682 -0.636 . . . . 0.0 110.694 178.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -169.34 158.54 31.01 Favored Glycine 0 N--CA 1.496 2.686 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.612 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -134.6 138.89 44.93 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.619 -0.93 . . . . 0.0 110.957 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -132.76 159.27 40.21 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.639 -0.663 . . . . 0.0 109.727 169.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 87.6 m -144.06 154.38 43.16 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.409 -0.807 . . . . 0.0 110.76 -176.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.421 ' CE1' HD12 ' A' ' 284' ' ' ILE . 48.7 p90 -145.78 161.86 38.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.614 -0.679 . . . . 0.0 110.087 174.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -104.83 136.81 43.64 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.619 -0.676 . . . . 0.0 110.224 -176.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -124.3 142.75 51.01 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.779 -170.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -138.11 140.91 40.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.793 -0.567 . . . . 0.0 109.684 172.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 74.5 mt -108.29 122.78 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.462 -0.774 . . . . 0.0 109.688 176.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.0 p -145.31 170.28 16.61 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.605 -0.684 . . . . 0.0 110.676 -171.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -72.47 -40.18 67.17 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.662 -0.649 . . . . 0.0 110.648 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.7 t -126.83 85.75 60.18 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.471 -0.768 . . . . 0.0 110.485 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -55.69 -28.19 64.91 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 O-C-N 123.121 1.064 . . . . 0.0 110.856 174.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.95 -38.18 92.66 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 177.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 57.5 ttt85 -72.61 -40.37 66.54 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.621 -0.929 . . . . 0.0 109.875 -173.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -69.53 -38.91 77.71 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.137 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -61.25 -43.28 99.13 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.52 -0.738 . . . . 0.0 110.251 178.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -64.51 -40.82 96.34 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.567 -0.708 . . . . 0.0 110.604 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -60.73 -49.88 75.71 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.478 -0.764 . . . . 0.0 110.559 -173.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -61.27 -37.72 84.16 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.418 -0.802 . . . . 0.0 110.045 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -61.31 -40.57 94.69 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.557 -0.714 . . . . 0.0 110.171 177.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -63.05 -35.28 79.73 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.671 -0.643 . . . . 0.0 110.249 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 37.0 p -66.65 -28.58 68.59 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.661 -0.65 . . . . 0.0 110.318 -178.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 50.9 mm -78.85 -44.37 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.61 -0.681 . . . . 0.0 109.956 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -59.14 -39.76 83.4 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.626 -0.671 . . . . 0.0 110.452 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 20.0 mtpp -61.79 -42.43 98.99 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.186 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -64.49 -32.95 74.8 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.63 -0.669 . . . . 0.0 110.276 178.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -84.55 125.02 32.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.669 -0.644 . . . . 0.0 110.396 -176.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 61.8 t -117.26 130.15 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.587 -0.696 . . . . 0.0 109.787 178.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 28.9 t -60.19 140.05 57.19 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.63 -0.669 . . . . 0.0 110.277 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -72.38 143.46 48.57 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.701 -0.625 . . . . 0.0 110.244 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 63.7 m -94.05 159.22 15.26 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.674 -0.641 . . . . 0.0 110.173 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 4.6 m -139.85 27.45 2.21 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.591 -0.693 . . . . 0.0 110.401 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -96.22 21.68 8.63 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.54 -0.725 . . . . 0.0 110.624 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 41.5 p-10 -84.83 -165.65 1.25 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.456 -0.777 . . . . 0.0 110.453 -178.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 92.63 -161.68 26.19 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -80.18 121.21 25.3 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.672 -0.899 . . . . 0.0 110.269 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -140.01 157.37 45.77 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.689 -0.632 . . . . 0.0 110.18 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -120.94 160.71 22.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.681 -0.637 . . . . 0.0 110.46 -177.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 56.45 -85.39 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.766 -0.584 . . . . 0.0 111.146 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 53.16 48.07 23.03 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.122 -0.986 . . . . 0.0 110.878 -176.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -58.1 -36.76 73.35 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.58 -0.7 . . . . 0.0 110.535 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 68.5 p -123.59 158.54 31.2 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.664 -0.647 . . . . 0.0 110.19 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -128.98 145.86 51.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.609 -0.682 . . . . 0.0 110.286 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -97.67 27.24 19.74 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 82.3 mt -93.77 135.27 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.556 -0.967 . . . . 0.0 109.866 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -90.72 16.5 9.1 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.648 -0.658 . . . . 0.0 111.148 -177.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 70.1 mtm -125.8 157.03 38.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.276 -0.89 . . . . 0.0 110.236 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.236 -179.992 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 74.9 m -86.09 9.22 17.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.689 -0.889 . . . . 0.0 111.332 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.6 m -120.02 147.05 45.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.183 -0.948 . . . . 0.0 110.294 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 49.1 m -123.66 140.9 52.53 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.733 -0.605 . . . . 0.0 110.238 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -115.62 148.57 39.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.618 -0.677 . . . . 0.0 110.242 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -80.36 -31.97 37.79 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.659 -0.651 . . . . 0.0 110.215 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 56.45 -84.69 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.646 -0.659 . . . . 0.0 110.843 -176.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 30.3 tp 55.85 -86.66 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.23 -0.919 . . . . 0.0 110.857 -177.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.9 p -131.55 162.58 55.26 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.132 -0.98 . . . . 0.0 110.305 -177.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -64.84 151.48 75.4 Favored 'Cis proline' 0 N--CA 1.496 1.618 0 C-N-CA 123.101 -1.625 . . . . 0.0 110.31 -17.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.8 t -81.27 144.06 53.29 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.631 -0.668 . . . . 0.0 110.153 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -64.23 146.78 90.85 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.297 1.156 . . . . 0.0 110.362 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.5 149.01 38.53 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.663 -0.648 . . . . 0.0 109.991 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 49.9 mm -119.99 138.34 26.86 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.573 -0.705 . . . . 0.0 109.982 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -65.61 154.47 73.64 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 123.141 1.074 . . . . 0.0 110.418 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 27.5 t -114.22 142.88 45.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.612 -0.68 . . . . 0.0 110.238 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.4 p-10 -101.89 25.22 8.91 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.586 -0.696 . . . . 0.0 110.699 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 49.1 m -79.17 125.23 29.17 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.617 -0.677 . . . . 0.0 110.262 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -68.86 144.93 54.1 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.696 -0.628 . . . . 0.0 110.418 -177.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -154.3 99.81 2.48 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.76 -0.587 . . . . 0.0 110.038 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.47 -39.99 78.58 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 O-C-N 123.181 1.095 . . . . 0.0 110.823 -175.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.94 -155.19 47.65 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -73.72 -46.31 0.34 Allowed 'Trans proline' 0 C--N 1.316 -1.155 0 O-C-N 123.354 1.186 . . . . 0.0 110.959 -173.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -87.38 9.08 21.76 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.509 -0.745 . . . . 0.0 111.376 -173.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.61 61.28 3.18 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.991 -1.068 . . . . 0.0 110.727 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -77.86 119.22 21.03 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.587 -0.696 . . . . 0.0 109.869 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -130.08 160.43 33.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.829 -0.545 . . . . 0.0 110.154 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 63.2 t -125.76 145.57 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.82 -0.55 . . . . 0.0 109.767 177.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 78.4 p -155.46 160.51 40.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.734 -0.603 . . . . 0.0 110.067 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.434 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 67.8 m-85 -126.75 125.23 41.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.854 -0.529 . . . . 0.0 109.788 -176.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -58.1 137.48 56.9 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.623 -0.673 . . . . 0.0 110.287 -175.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -120.14 155.54 32.86 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.683 -0.635 . . . . 0.0 110.517 -176.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 23.2 t -149.29 171.74 16.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.697 -0.627 . . . . 0.0 110.05 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 43.9 m -59.62 156.33 13.81 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.58 -0.7 . . . . 0.0 110.179 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.1 p -59.11 98.93 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.619 -0.676 . . . . 0.0 110.351 -176.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.12 149.08 22.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.735 -0.603 . . . . 0.0 110.224 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -69.4 133.58 47.95 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.583 -0.698 . . . . 0.0 109.961 178.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.0 t 52.49 74.93 0.25 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.411 -0.806 . . . . 0.0 110.87 -177.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -93.31 132.52 37.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.589 -0.694 . . . . 0.0 110.149 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 75.8 p -60.09 -33.09 71.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.716 -0.615 . . . . 0.0 109.932 176.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.418 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.6 p-90 -170.95 142.6 1.88 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.309 0.576 . . . . 0.0 110.026 178.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 13.2 t -142.2 142.57 32.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.942 -0.474 . . . . 0.0 109.952 -176.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.434 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 64.1 t80 -125.51 140.03 53.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.523 -0.736 . . . . 0.0 110.544 -172.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 28.5 t -110.24 124.41 51.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.861 -0.525 . . . . 0.0 109.845 176.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 58.6 m -70.76 -36.94 73.33 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.789 -0.569 . . . . 0.0 110.556 -177.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -59.43 -34.66 72.77 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.561 -0.712 . . . . 0.0 110.464 -177.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 57.4 mt -104.88 -11.98 16.47 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.672 -0.642 . . . . 0.0 110.88 -175.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 59.8 tttt 59.79 52.01 5.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.065 -1.022 . . . . 0.0 109.746 178.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -145.35 152.99 40.74 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.707 -0.621 . . . . 0.0 110.556 -175.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.6 tp -126.55 137.79 53.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.69 -0.631 . . . . 0.0 110.344 -176.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -116.19 134.2 55.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.675 -0.641 . . . . 0.0 109.382 174.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.3 158.39 44.39 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.939 -175.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -104.61 143.38 33.15 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.469 0.652 . . . . 0.0 110.396 173.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 16.7 tt -52.0 146.51 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.608 -0.682 . . . . 0.0 111.813 -175.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 65.2 10.01 6.06 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.665 -0.647 . . . . 0.0 112.415 177.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -96.63 155.13 16.9 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.068 -1.02 . . . . 0.0 110.832 174.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 62.3 m -88.53 126.22 35.15 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.662 -0.648 . . . . 0.0 110.669 -177.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 44.2 t -113.71 90.08 17.45 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.59 -0.694 . . . . 0.0 110.19 175.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.418 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 23.7 Cg_exo -60.75 130.26 32.45 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 O-C-N 123.268 1.141 . . . . 0.0 110.678 172.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.409 HG12 ' CE2' ' A' ' 142' ' ' PHE . 97.5 mt -124.9 141.66 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 176.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -109.5 135.43 50.51 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.464 -0.772 . . . . 0.0 110.879 -175.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.5 mm -95.29 133.58 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.713 -0.617 . . . . 0.0 109.624 169.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 40.2 tttp -114.49 128.77 56.51 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.579 -0.701 . . . . 0.0 110.449 176.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.1 m -136.72 159.88 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.588 -0.695 . . . . 0.0 109.86 175.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.7 mmm -76.57 -41.4 46.53 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.666 -0.646 . . . . 0.0 110.1 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 77.0 p -134.78 143.27 45.65 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.763 -0.586 . . . . 0.0 109.695 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -55.45 139.74 82.24 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 O-C-N 123.156 1.082 . . . . 0.0 110.889 -171.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.432 ' HG2' ' CD1' ' A' ' 251' ' ' TYR . 34.9 Cg_endo -67.63 169.99 14.76 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 O-C-N 123.157 1.082 . . . . 0.0 110.608 177.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -60.81 155.28 50.05 Favored 'Trans proline' 0 C--N 1.316 -1.152 0 O-C-N 123.327 1.172 . . . . 0.0 110.521 -178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -77.46 141.09 39.88 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.519 -0.738 . . . . 0.0 109.879 174.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.8 -24.88 29.76 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -174.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.19 150.74 2.31 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.412 -1.052 . . . . 0.0 111.4 177.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.7 156.04 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.762 -0.586 . . . . 0.0 109.688 176.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 84.2 mt -109.16 141.49 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.752 -0.592 . . . . 0.0 109.599 177.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.409 ' HG2' ' CD2' ' A' ' 248' ' ' LEU . 70.6 mtp180 -114.78 145.2 42.37 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -176.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -140.03 126.29 19.98 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.339 173.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 41.9 ttm -137.24 139.9 29.37 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.81 -0.557 . . . . 0.0 111.059 -176.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -91.19 138.23 2.26 Favored 'Trans proline' 0 C--N 1.32 -0.964 0 O-C-N 123.3 1.158 . . . . 0.0 110.812 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.8 m -147.7 154.9 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.574 -0.704 . . . . 0.0 109.988 173.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.419 ' CE2' HG21 ' A' ' 202' ' ' VAL . 87.2 m-85 -61.49 165.76 4.59 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.462 -0.774 . . . . 0.0 110.447 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -83.99 -60.05 2.22 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.626 -0.671 . . . . 0.0 110.799 -173.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 48.3 mttt -80.04 152.49 29.37 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.639 -0.663 . . . . 0.0 110.332 -175.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.56 -38.75 72.36 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.462 -0.774 . . . . 0.0 110.698 -175.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -56.48 -24.91 49.25 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.519 -0.738 . . . . 0.0 110.621 -176.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.404 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 77.8 m80 -109.7 -20.5 12.8 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.137 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.2 p -67.6 -20.23 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.123 -0.986 . . . . 0.0 110.576 -175.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 71.7 p -79.48 -16.91 55.25 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.763 174.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -88.37 134.93 33.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.359 -0.838 . . . . 0.0 110.1 173.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 60.9 t -72.97 145.91 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.615 -0.678 . . . . 0.0 110.27 178.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.419 HG21 ' CE2' ' A' ' 192' ' ' TYR . 60.6 t -84.72 139.79 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.564 -0.71 . . . . 0.0 109.223 172.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.8 pttp -134.85 -170.16 2.51 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.422 -0.799 . . . . 0.0 111.295 -166.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -95.21 152.59 18.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.789 -0.57 . . . . 0.0 110.102 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 36.5 m -73.5 152.16 89.67 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.471 -0.768 . . . . 0.0 109.025 173.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -61.8 -47.31 11.25 Favored 'Trans proline' 0 C--N 1.315 -1.231 0 O-C-N 123.071 1.037 . . . . 0.0 110.243 177.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.408 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.6 p-10 -65.38 -44.1 88.64 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.615 -0.678 . . . . 0.0 111.236 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . 0.408 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 52.0 m170 -82.82 -27.93 30.56 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.442 -0.786 . . . . 0.0 111.191 -174.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -69.05 -39.24 79.26 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.341 -0.849 . . . . 0.0 110.302 174.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 25.9 tp -57.11 -35.93 70.02 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.493 -0.755 . . . . 0.0 110.75 -177.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 30.6 t -48.28 141.03 6.87 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.504 -0.748 . . . . 0.0 111.376 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -60.76 141.54 56.84 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.595 -0.691 . . . . 0.0 110.248 -177.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -64.04 -37.06 86.06 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.736 -0.603 . . . . 0.0 110.143 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.406 ' CD2' ' O ' ' A' ' 214' ' ' PHE . 59.1 t80 51.21 51.32 17.2 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.521 -0.737 . . . . 0.0 111.038 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -73.34 -10.22 59.52 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.711 -0.618 . . . . 0.0 111.16 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -60.41 118.55 6.6 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.254 -0.904 . . . . 0.0 110.326 177.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 78.0 20.04 73.86 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 177.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -139.52 140.02 37.06 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.292 -1.122 . . . . 0.0 110.139 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.1 mt -84.91 -24.89 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.689 -0.632 . . . . 0.0 110.529 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -124.83 99.35 35.32 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.429 -0.794 . . . . 0.0 110.482 -173.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -66.08 149.49 85.78 Favored 'Trans proline' 0 C--N 1.316 -1.132 0 O-C-N 123.211 1.111 . . . . 0.0 110.645 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -57.5 -19.57 37.07 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 O-C-N 123.285 1.15 . . . . 0.0 111.484 -178.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 25.9 m -51.14 -27.06 7.62 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.153 -0.967 . . . . 0.0 111.467 -177.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -101.92 129.93 48.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.517 -0.739 . . . . 0.0 110.433 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.72 -39.42 88.54 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.69 -0.631 . . . . 0.0 110.202 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 83.7 mt -104.94 136.81 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.834 -0.541 . . . . 0.0 109.801 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -132.47 157.82 43.65 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.797 -0.564 . . . . 0.0 110.292 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 94.1 t -102.67 146.56 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.722 -0.611 . . . . 0.0 109.909 175.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -117.26 124.14 48.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.722 -0.611 . . . . 0.0 110.428 172.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 95.79 24.33 15.77 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 167.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -137.27 107.07 6.23 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.5 -1.0 . . . . 0.0 110.015 174.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 28.0 t -63.03 -15.2 55.66 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.611 -0.68 . . . . 0.0 111.203 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -100.0 9.34 43.06 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.289 -0.882 . . . . 0.0 111.588 -177.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.37 127.91 33.77 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.129 -0.982 . . . . 0.0 110.179 176.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -139.75 158.01 44.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.707 -0.62 . . . . 0.0 109.868 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -114.67 150.66 34.85 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.604 -0.685 . . . . 0.0 110.576 -176.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.13 160.0 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.742 -0.599 . . . . 0.0 110.173 177.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -119.17 130.06 55.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.703 -0.623 . . . . 0.0 110.227 176.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -64.18 130.04 94.36 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.66 -0.65 . . . . 0.0 109.833 178.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -65.41 -28.34 54.39 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.187 1.098 . . . . 0.0 111.024 -170.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.8 mt -101.74 -50.5 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.425 -0.797 . . . . 0.0 111.051 -167.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 11.1 p -105.4 12.18 31.86 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.446 -0.784 . . . . 0.0 111.843 -174.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 72.3 -5.01 16.43 Favored Glycine 0 N--CA 1.496 2.688 0 O-C-N 121.102 -0.999 . . . . 0.0 112.007 173.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -45.91 142.05 2.8 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-N 119.134 1.467 . . . . 0.0 112.36 -174.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -103.61 143.43 32.77 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.715 -0.616 . . . . 0.0 110.117 175.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 76.5 p -154.74 159.95 41.0 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.637 -0.664 . . . . 0.0 110.332 177.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 8.2 p -123.0 148.2 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.789 -0.569 . . . . 0.0 109.699 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.409 ' CD2' ' HG2' ' A' ' 187' ' ' ARG . 79.9 mt -129.51 154.56 46.9 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.615 -175.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 32.5 m -151.13 151.78 30.09 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.776 -0.577 . . . . 0.0 109.955 175.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -71.14 139.59 35.81 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 O-C-N 123.333 1.175 . . . . 0.0 110.009 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.432 ' CD1' ' HG2' ' A' ' 180' ' ' PRO . 59.2 t80 -75.76 127.22 32.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.539 -0.726 . . . . 0.0 110.123 175.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -100.11 160.09 28.06 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.765 -0.584 . . . . 0.0 109.979 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -58.77 158.34 24.71 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.213 1.112 . . . . 0.0 110.496 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.25 149.95 77.43 Favored 'Trans proline' 0 N--CA 1.487 1.145 0 O-C-N 123.206 1.109 . . . . 0.0 110.549 -177.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -61.87 147.73 45.69 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.603 -0.686 . . . . 0.0 110.146 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.92 127.25 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.537 -0.727 . . . . 0.0 110.161 -170.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.95 -10.17 55.43 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.416 ' OG1' ' CD2' ' A' ' 260' ' ' PHE . 9.2 t -144.46 174.14 11.19 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.253 -1.145 . . . . 0.0 110.566 175.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -108.08 13.22 26.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.622 -0.674 . . . . 0.0 111.839 -167.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . 0.416 ' CD2' ' OG1' ' A' ' 258' ' ' THR . 38.6 p90 -120.0 168.09 11.51 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.15 -0.969 . . . . 0.0 111.101 -175.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 76.9 m -117.75 145.87 44.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.756 -0.59 . . . . 0.0 109.836 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 55.8 m -116.64 134.81 54.37 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.478 0.656 . . . . 0.0 110.91 -174.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 64.0 t -130.35 137.32 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 172.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 76.1 mt -104.73 120.47 41.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.518 -0.739 . . . . 0.0 109.89 -171.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -106.51 151.67 24.68 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.693 -0.63 . . . . 0.0 110.486 -177.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -136.54 142.89 43.46 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -113.48 131.73 55.93 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.6 -0.688 . . . . 0.0 110.259 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -104.17 9.68 36.11 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.582 -0.699 . . . . 0.0 111.897 -175.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -144.62 160.37 41.29 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.035 -1.041 . . . . 0.0 109.861 170.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -117.49 162.43 17.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.682 -0.636 . . . . 0.0 110.31 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 20.1 m -58.78 -32.28 69.15 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.582 -0.699 . . . . 0.0 110.925 -163.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 48.0 p -99.79 12.89 35.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.507 -0.746 . . . . 0.0 111.962 -164.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 32.0 p -94.54 118.15 31.24 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.552 177.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 60.1 t -64.02 139.54 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.46 -0.775 . . . . 0.0 110.399 -167.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.56 -5.16 58.44 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 176.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -124.46 -100.05 1.33 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 170.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 93.2 mmm -63.96 -31.98 73.36 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.654 -0.909 . . . . 0.0 110.207 176.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.5 p30 43.53 51.15 6.31 Favored 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 175.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 54.78 27.42 8.85 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.394 -0.816 . . . . 0.0 111.163 175.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 77.2 mtt180 -117.67 106.42 46.23 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.476 -0.765 . . . . 0.0 110.09 175.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.56 146.71 94.43 Favored 'Trans proline' 0 N--CA 1.488 1.171 0 O-C-N 123.137 1.072 . . . . 0.0 110.577 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 45.4 pt -131.96 178.34 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.761 0.791 . . . . 0.0 110.773 -176.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 28.0 mt -124.41 149.84 46.28 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.422 ' HB ' ' CZ ' ' A' ' 301' ' ' PHE . 80.3 mt -115.82 130.44 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.617 -0.677 . . . . 0.0 109.239 177.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 85.3 mt -109.79 126.22 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -176.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 58.5 t -118.91 126.7 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.4 p -125.25 154.69 41.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.673 -0.642 . . . . 0.0 110.795 -175.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 23.6 tp -104.82 126.83 52.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.816 -0.553 . . . . 0.0 109.575 170.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -132.44 149.83 52.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.897 -0.502 . . . . 0.0 109.912 -172.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 26.1 p -90.42 160.88 15.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.639 -0.663 . . . . 0.0 110.015 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -55.95 -26.14 46.7 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.506 -0.746 . . . . 0.0 111.002 -175.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 44.8 p30 -89.72 9.77 25.88 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.414 -0.804 . . . . 0.0 111.9 -172.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.7 20.17 45.08 Favored Glycine 0 N--CA 1.495 2.6 0 C-N-CA 120.143 -1.027 . . . . 0.0 110.677 171.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -108.98 140.13 42.91 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.32 -1.106 . . . . 0.0 109.921 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 60.3 t -91.83 133.3 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.527 -0.733 . . . . 0.0 110.217 -172.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 71.6 mt -99.87 -40.24 7.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.792 -0.567 . . . . 0.0 110.59 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -158.36 154.87 25.93 Favored Glycine 0 N--CA 1.496 2.697 0 C-N-CA 119.917 -1.135 . . . . 0.0 110.516 -177.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 55.5 mtt85 -135.03 136.32 42.0 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.722 -0.869 . . . . 0.0 110.211 178.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -140.69 157.26 45.69 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.487 -0.758 . . . . 0.0 110.152 169.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 95.3 m -142.52 156.63 45.15 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.512 -0.743 . . . . 0.0 110.632 -175.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.422 ' CZ ' ' HB ' ' A' ' 284' ' ' ILE . 48.5 p90 -145.0 162.88 35.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.681 -0.637 . . . . 0.0 110.199 176.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -104.96 136.15 44.97 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.526 -0.734 . . . . 0.0 110.11 -177.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -121.66 144.21 48.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.614 -0.679 . . . . 0.0 110.814 -169.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -139.23 139.51 37.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.857 -0.527 . . . . 0.0 109.744 172.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 82.6 mt -108.71 122.84 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.465 -0.772 . . . . 0.0 109.726 176.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.8 p -145.31 171.02 15.17 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.609 -0.682 . . . . 0.0 110.606 -172.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -73.2 -40.09 65.02 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.589 -0.694 . . . . 0.0 110.7 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.7 t -127.12 85.66 60.55 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.524 -0.735 . . . . 0.0 110.49 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -55.88 -27.85 64.95 Favored 'Trans proline' 0 C--N 1.314 -1.259 0 O-C-N 123.226 1.119 . . . . 0.0 110.772 174.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -67.6 -38.1 89.99 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -72.89 -40.46 65.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.674 -0.897 . . . . 0.0 109.803 -173.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -69.59 -39.35 77.35 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.061 -178.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -61.38 -44.66 96.78 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.219 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -64.04 -40.16 95.7 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.606 -0.684 . . . . 0.0 110.459 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.6 -50.73 71.43 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.548 -0.72 . . . . 0.0 110.419 -173.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -61.62 -37.76 85.12 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.509 -0.744 . . . . 0.0 110.107 -178.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -62.93 -39.61 95.11 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.646 -0.659 . . . . 0.0 110.138 178.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -62.25 -35.22 78.28 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.647 -0.658 . . . . 0.0 109.949 178.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 23.9 m -63.13 -33.38 75.34 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.686 -0.634 . . . . 0.0 110.322 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 51.0 mm -77.82 -43.51 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.61 -0.681 . . . . 0.0 110.012 -177.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -58.73 -41.17 85.79 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.639 -0.663 . . . . 0.0 110.444 178.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 32.4 tttp -61.76 -41.75 98.09 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.652 -0.655 . . . . 0.0 110.088 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -61.38 -33.8 74.27 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.63 -0.669 . . . . 0.0 110.136 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -85.97 125.03 33.08 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.699 -0.626 . . . . 0.0 110.397 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 62.3 t -118.6 130.17 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.699 -0.626 . . . . 0.0 109.803 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 29.4 t -95.09 139.98 30.67 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.669 -0.645 . . . . 0.0 110.239 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -106.55 150.09 26.5 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.682 -0.636 . . . . 0.0 110.442 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 29.7 t -94.05 146.05 24.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.646 -0.659 . . . . 0.0 110.238 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 48.6 m -97.89 134.39 41.09 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.689 -0.632 . . . . 0.0 110.267 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -100.02 146.29 26.91 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.687 -0.633 . . . . 0.0 110.245 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -59.26 -33.2 70.76 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.625 -0.672 . . . . 0.0 110.298 178.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -142.3 179.96 19.7 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 46.8 p30 -146.19 160.02 42.52 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.698 -0.883 . . . . 0.0 110.475 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -147.17 155.88 42.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.674 -0.641 . . . . 0.0 110.278 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . 0.444 ' CD2' ' NE2' ' A' ' 337' ' ' GLN . 66.1 t80 -59.32 -38.51 80.48 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.671 -0.643 . . . . 0.0 110.365 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 53.3 99.35 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.51 -0.744 . . . . 0.0 110.994 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' GLN . . . . . 0.444 ' NE2' ' CD2' ' A' ' 335' ' ' PHE . 98.8 mm-40 -60.2 -33.24 71.97 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.598 -0.689 . . . . 0.0 110.3 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . 0.402 ' OD1' ' CE1' ' A' ' 340' ' ' HIS . 22.7 t-20 -89.13 128.02 35.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.603 -0.686 . . . . 0.0 110.264 -178.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 51.2 m -118.32 141.99 47.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.626 -0.671 . . . . 0.0 110.286 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . 0.402 ' CE1' ' OD1' ' A' ' 338' ' ' ASN . 99.4 m-70 -116.6 144.41 44.41 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.558 -0.714 . . . . 0.0 110.282 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -59.46 -30.43 68.23 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 26.4 pt -94.33 147.67 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.637 -0.919 . . . . 0.0 110.322 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -83.54 -34.74 25.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.673 -0.642 . . . . 0.0 110.186 -179.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 70.3 mtm -120.37 152.44 37.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.622 -0.674 . . . . 0.0 110.256 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 7.4 t . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.315 -179.92 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 29.4 t -156.24 148.19 23.11 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.644 -0.915 . . . . 0.0 110.289 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 29.0 t -119.86 142.9 48.24 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.619 -0.676 . . . . 0.0 110.243 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 49.6 m -121.69 140.11 52.72 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.562 -0.711 . . . . 0.0 110.295 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -118.76 153.04 35.06 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.714 -0.617 . . . . 0.0 110.207 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -80.15 -30.44 38.95 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.667 -0.646 . . . . 0.0 110.119 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 50.78 -165.57 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.368 -0.832 . . . . 0.0 111.159 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.4 mt 52.75 -165.56 0.07 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.434 -0.791 . . . . 0.0 110.922 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.82 174.45 2.39 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.638 -0.664 . . . . 0.0 110.081 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -64.27 152.55 73.91 Favored 'Cis proline' 0 N--CA 1.496 1.623 0 C-N-CA 123.304 -1.54 . . . . 0.0 110.493 -14.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.0 156.48 69.64 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.682 -0.636 . . . . 0.0 110.213 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -59.08 145.04 98.99 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 O-C-N 123.28 1.147 . . . . 0.0 110.666 -178.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.86 150.09 37.69 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.776 -0.578 . . . . 0.0 110.121 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 50.0 mm -119.94 139.52 28.35 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.579 -0.701 . . . . 0.0 109.845 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -61.56 150.04 87.12 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 O-C-N 123.134 1.071 . . . . 0.0 110.383 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.2 t -114.8 143.42 45.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.731 -0.606 . . . . 0.0 110.219 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 p-10 -96.33 24.34 5.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.637 -0.664 . . . . 0.0 110.721 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 49.9 m -77.8 125.16 28.92 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.577 -0.702 . . . . 0.0 110.274 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -71.16 144.96 50.03 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.686 -0.634 . . . . 0.0 110.414 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -157.78 101.48 1.8 Allowed Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.746 -0.596 . . . . 0.0 110.077 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -59.73 -39.87 69.46 Favored 'Trans proline' 0 N--CA 1.488 1.167 0 O-C-N 123.179 1.094 . . . . 0.0 110.681 -175.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.08 -155.12 43.9 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -73.6 -44.85 0.46 Allowed 'Trans proline' 0 C--N 1.317 -1.09 0 O-C-N 123.344 1.181 . . . . 0.0 110.855 -175.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -86.92 4.34 41.93 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.585 -0.697 . . . . 0.0 111.498 -174.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.82 61.6 3.01 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.888 -1.133 . . . . 0.0 110.716 -176.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.416 ' CE1' ' CG2' ' A' ' 174' ' ' ILE . 63.1 t80 -78.04 120.46 22.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.643 -0.661 . . . . 0.0 110.106 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -129.98 159.97 35.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.763 -0.586 . . . . 0.0 110.261 -177.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 64.5 t -126.28 146.3 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.789 -0.57 . . . . 0.0 109.831 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.9 p -154.98 162.75 41.0 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.947 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.423 ' CE2' HG12 ' A' ' 172' ' ' ILE . 76.2 m-85 -126.66 125.26 41.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.771 -0.581 . . . . 0.0 109.944 -175.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -57.11 145.97 29.27 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.568 -0.708 . . . . 0.0 110.516 -174.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -106.61 148.28 28.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.598 -0.688 . . . . 0.0 110.466 -175.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 83.8 p -143.37 163.44 33.04 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.702 -0.624 . . . . 0.0 110.049 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 44.8 m -61.24 154.85 22.45 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.569 -0.707 . . . . 0.0 110.121 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 73.9 p -67.78 78.4 0.2 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.616 -0.677 . . . . 0.0 110.033 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.11 142.23 27.91 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.692 -0.63 . . . . 0.0 110.25 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -60.02 157.85 12.08 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.629 -0.67 . . . . 0.0 110.464 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 66.1 m 52.31 31.77 9.93 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.426 -0.796 . . . . 0.0 111.093 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.2 129.62 41.61 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.628 -0.67 . . . . 0.0 110.049 177.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.401 ' OG1' ' CD1' ' A' ' 153' ' ' TRP . 65.4 p -60.1 -34.08 72.98 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.613 -0.68 . . . . 0.0 110.055 176.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.405 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -171.83 144.15 1.74 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.43 0.633 . . . . 0.0 110.158 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.3 t -142.11 142.59 32.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.788 -0.57 . . . . 0.0 109.943 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -125.52 140.07 53.07 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.532 -0.73 . . . . 0.0 110.579 -172.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.7 t -110.43 123.56 50.11 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 120.366 -0.533 . . . . 0.0 109.641 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 63.1 m -70.82 -37.11 73.21 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.755 -0.591 . . . . 0.0 110.42 -177.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -58.94 -32.76 69.88 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.582 -0.699 . . . . 0.0 110.275 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 37.7 mt -104.8 -12.11 16.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.71 -0.619 . . . . 0.0 110.712 -175.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 31.6 tttm 59.68 47.92 9.97 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.971 -1.08 . . . . 0.0 109.761 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.415 ' HE3' ' CZ ' ' A' ' 163' ' ' TYR . 33.9 ttpt -147.19 153.16 39.5 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 120.114 -0.635 . . . . 0.0 110.725 -174.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.6 tp -126.6 138.18 53.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.763 -0.585 . . . . 0.0 110.374 -173.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.415 ' CZ ' ' HE3' ' A' ' 161' ' ' LYS . 52.3 m-85 -114.7 135.04 54.59 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 174.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.9 p -138.33 158.4 44.36 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.034 -176.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -104.55 142.86 33.89 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.611 -0.681 . . . . 0.0 110.211 173.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 17.2 tt -52.41 147.42 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.461 -0.774 . . . . 0.0 111.837 -174.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 64.89 9.97 5.78 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.539 -0.726 . . . . 0.0 112.487 176.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -95.68 155.09 16.89 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.994 -1.067 . . . . 0.0 110.906 174.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 88.2 m -84.49 126.17 33.04 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.725 -0.609 . . . . 0.0 110.59 -178.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 48.9 t -114.22 90.32 19.91 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.59 -0.694 . . . . 0.0 110.18 175.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.405 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 21.3 Cg_endo -65.94 129.65 22.52 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 O-C-N 123.261 1.137 . . . . 0.0 110.59 176.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.423 HG12 ' CE2' ' A' ' 142' ' ' PHE . 93.9 mt -123.15 141.69 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.62 -0.675 . . . . 0.0 109.329 176.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -109.06 135.35 50.37 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.519 -0.738 . . . . 0.0 110.761 -175.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.416 ' CG2' ' CE1' ' A' ' 138' ' ' PHE . 48.3 mm -95.24 135.03 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.652 -0.655 . . . . 0.0 109.642 170.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -117.84 128.84 55.24 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.42 175.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 17.1 m -136.47 159.75 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.532 -0.73 . . . . 0.0 109.949 175.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.0 mmm -77.07 -40.47 46.04 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.683 -0.635 . . . . 0.0 110.113 178.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 77.4 p -135.3 143.18 44.43 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.746 -0.596 . . . . 0.0 109.849 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -55.94 139.87 85.09 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 O-C-N 123.181 1.095 . . . . 0.0 110.828 -173.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.429 ' HG3' ' CE2' ' A' ' 251' ' ' TYR . 20.8 Cg_endo -63.49 169.1 10.25 Favored 'Trans proline' 0 N--CA 1.488 1.18 0 O-C-N 123.204 1.107 . . . . 0.0 110.728 176.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -61.16 157.5 39.42 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.376 1.198 . . . . 0.0 110.482 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -76.61 137.45 39.49 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.635 -0.666 . . . . 0.0 109.898 175.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.51 -25.09 29.62 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -174.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.08 151.98 1.81 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.335 -1.097 . . . . 0.0 111.396 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.77 155.95 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.698 -0.627 . . . . 0.0 109.935 177.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.413 HD13 ' CD2' ' A' ' 251' ' ' TYR . 72.4 mt -108.47 135.51 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -115.05 147.13 40.54 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.702 -0.623 . . . . 0.0 109.376 -175.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -140.12 128.7 22.93 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.536 -0.728 . . . . 0.0 110.138 172.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 22.6 ttp -137.29 137.18 21.82 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.796 -0.565 . . . . 0.0 111.083 -176.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -91.43 138.19 2.15 Favored 'Trans proline' 0 C--N 1.32 -0.959 0 C-N-CA 121.038 1.159 . . . . 0.0 110.773 177.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 35.0 m -146.99 154.86 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.486 -0.759 . . . . 0.0 110.022 173.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.426 ' CE2' HG23 ' A' ' 202' ' ' VAL . 87.6 m-85 -61.48 160.02 11.85 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.464 -0.773 . . . . 0.0 110.397 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -76.21 -60.04 2.5 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.664 -0.647 . . . . 0.0 110.832 -173.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -80.01 150.7 30.32 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.58 -0.7 . . . . 0.0 110.356 -174.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.44 -38.86 72.2 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.385 -0.822 . . . . 0.0 110.728 -175.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -56.33 -25.04 47.58 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.555 -0.716 . . . . 0.0 110.668 -176.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.408 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 97.3 m-70 -110.03 -20.57 12.67 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.934 -0.706 . . . . 0.0 111.147 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.1 p -66.78 -20.25 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.154 -0.966 . . . . 0.0 110.573 -175.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 68.1 p -79.35 -17.05 55.29 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.713 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -88.27 136.39 33.0 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.353 -0.842 . . . . 0.0 109.951 172.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 56.9 t -73.02 146.48 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.61 -0.681 . . . . 0.0 110.133 178.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.426 HG23 ' CE2' ' A' ' 192' ' ' TYR . 79.5 t -84.92 139.65 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.598 -0.689 . . . . 0.0 109.261 172.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.7 pttp -134.82 -170.07 2.48 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.557 -0.715 . . . . 0.0 111.038 -166.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -95.12 154.04 17.37 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.744 -0.597 . . . . 0.0 110.442 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 58.7 m -74.86 159.42 83.07 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.641 -0.662 . . . . 0.0 109.272 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -63.74 -47.41 7.12 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.179 1.094 . . . . 0.0 109.851 176.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.423 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.4 p-10 -65.46 -44.09 88.26 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.549 -0.719 . . . . 0.0 111.165 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . 0.423 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 52.8 m170 -81.84 -29.41 32.59 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.431 -0.793 . . . . 0.0 111.437 -174.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -69.19 -36.15 77.0 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.309 -0.869 . . . . 0.0 110.392 172.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 26.3 tp -54.32 -34.41 60.94 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.591 -0.693 . . . . 0.0 111.087 -175.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 29.1 t -48.38 142.96 5.15 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.437 -0.789 . . . . 0.0 111.252 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -59.24 143.9 47.79 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.655 -0.653 . . . . 0.0 110.445 -175.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -60.57 -41.95 95.64 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.716 -0.615 . . . . 0.0 110.128 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 20.1 t80 50.56 50.52 18.7 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.467 -0.77 . . . . 0.0 111.017 177.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -80.2 -10.1 59.75 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.586 -0.696 . . . . 0.0 111.31 -177.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -59.33 115.25 3.11 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.114 -0.991 . . . . 0.0 110.698 -177.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 73.13 20.16 79.86 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 173.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -114.89 140.04 49.29 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.284 -1.127 . . . . 0.0 110.47 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.2 mt -84.98 -25.09 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.686 -0.633 . . . . 0.0 110.411 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -124.96 92.87 46.87 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.499 -0.75 . . . . 0.0 110.485 -175.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -64.49 145.46 87.65 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 O-C-N 123.362 1.19 . . . . 0.0 110.543 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -59.75 -18.4 48.36 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 O-C-N 123.238 1.125 . . . . 0.0 111.586 -174.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 85.9 p -55.28 -22.94 20.54 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.161 -0.962 . . . . 0.0 111.276 -176.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . 0.423 ' CE1' ' CB ' ' A' ' 236' ' ' TYR . 55.2 m80 -102.05 130.9 48.74 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.339 -0.851 . . . . 0.0 110.614 -177.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 59.5 tp -62.18 -36.76 82.87 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.695 -0.628 . . . . 0.0 110.338 177.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 83.4 mt -103.97 136.79 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.729 -0.607 . . . . 0.0 109.949 -178.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -127.26 157.54 39.56 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.748 -0.595 . . . . 0.0 110.176 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 90.7 t -102.32 146.6 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.787 -0.571 . . . . 0.0 109.81 173.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -118.59 129.97 55.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.698 -0.626 . . . . 0.0 110.4 170.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.96 21.08 26.56 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 168.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 35.7 t-20 -138.45 105.65 5.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.305 -1.115 . . . . 0.0 110.054 174.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 43.7 m -63.28 -15.33 56.87 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.656 -0.653 . . . . 0.0 111.306 -176.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -99.92 7.58 44.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.214 -0.929 . . . . 0.0 111.597 -177.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.64 132.27 52.73 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.114 -0.991 . . . . 0.0 110.24 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -139.76 157.97 44.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.79 -0.569 . . . . 0.0 109.674 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.423 ' CB ' ' CE1' ' A' ' 224' ' ' HIS . 75.3 m-85 -116.36 150.64 37.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.542 -0.724 . . . . 0.0 110.573 -177.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.19 159.89 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.824 -0.548 . . . . 0.0 110.24 177.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -123.71 128.21 49.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.76 -0.587 . . . . 0.0 110.05 174.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -65.09 130.05 94.69 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.678 -0.639 . . . . 0.0 109.893 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -66.8 -26.48 44.93 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 O-C-N 123.036 1.019 . . . . 0.0 111.029 -172.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.2 mt -99.06 -50.45 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.371 -0.831 . . . . 0.0 110.916 -168.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.0 p -105.33 12.07 32.11 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.406 -0.809 . . . . 0.0 111.835 -175.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.89 -5.08 13.77 Favored Glycine 0 N--CA 1.496 2.691 0 O-C-N 121.058 -1.027 . . . . 0.0 111.709 174.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 69.5 mmt-85 -46.18 141.98 3.07 Favored 'General case' 0 N--CA 1.505 2.278 0 CA-C-N 119.07 1.435 . . . . 0.0 112.363 -172.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -108.13 139.55 42.63 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.651 -0.655 . . . . 0.0 110.091 174.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 77.8 p -154.76 159.94 40.98 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.569 -0.707 . . . . 0.0 110.619 177.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 8.4 p -123.67 148.1 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.706 -0.621 . . . . 0.0 109.713 177.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 83.0 mt -129.67 154.71 46.86 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.032 -174.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 36.0 m -150.77 151.76 30.87 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.855 -0.528 . . . . 0.0 109.878 175.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -70.6 139.4 37.22 Favored 'Trans proline' 0 C--N 1.315 -1.184 0 O-C-N 123.292 1.154 . . . . 0.0 110.055 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.429 ' CE2' ' HG3' ' A' ' 180' ' ' PRO . 10.0 t80 -79.66 123.29 27.5 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.539 -0.726 . . . . 0.0 110.16 178.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -100.04 160.1 28.07 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.693 -0.629 . . . . 0.0 110.19 178.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -59.08 160.05 20.05 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.362 1.191 . . . . 0.0 110.472 178.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.87 150.01 74.63 Favored 'Trans proline' 0 N--CA 1.489 1.244 0 O-C-N 123.293 1.154 . . . . 0.0 110.501 -177.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -60.91 147.94 41.41 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.626 -0.671 . . . . 0.0 110.184 -178.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.85 127.24 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.557 -0.715 . . . . 0.0 110.168 -170.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.88 -10.23 55.59 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.413 ' OG1' ' CD2' ' A' ' 260' ' ' PHE . 10.2 t -144.62 174.42 10.98 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.187 -1.184 . . . . 0.0 110.613 175.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -108.71 13.06 25.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.57 -0.706 . . . . 0.0 111.85 -167.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . 0.413 ' CD2' ' OG1' ' A' ' 258' ' ' THR . 43.2 p90 -122.41 168.07 12.54 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.125 -0.984 . . . . 0.0 111.149 -176.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 87.2 m -117.69 145.56 44.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.748 -0.595 . . . . 0.0 109.849 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 38.6 m -116.22 135.73 53.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.557 -0.715 . . . . 0.0 110.939 -175.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 57.6 t -129.03 137.29 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 172.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 62.7 mt -104.72 119.97 40.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.525 -0.734 . . . . 0.0 109.793 -172.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 -106.67 150.97 25.7 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.63 -0.669 . . . . 0.0 110.664 -178.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -136.47 142.91 43.59 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -113.15 132.67 55.37 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.56 -0.713 . . . . 0.0 110.48 -176.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -103.21 8.52 38.46 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.711 -0.618 . . . . 0.0 112.172 -175.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -144.68 165.1 29.0 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.045 -1.034 . . . . 0.0 109.906 171.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 27.9 p30 -121.68 161.61 22.21 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.394 0.616 . . . . 0.0 110.38 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 26.7 m -58.36 -33.56 69.7 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.465 -0.772 . . . . 0.0 111.09 -163.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 70.6 m -97.56 10.54 39.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.494 -0.754 . . . . 0.0 112.089 -164.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 30.5 p -93.9 118.1 31.0 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.027 -1.045 . . . . 0.0 110.644 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.81 139.87 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.505 -0.747 . . . . 0.0 110.349 -169.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.57 -5.13 60.16 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 178.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -125.18 -100.2 1.26 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 170.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 93.4 mmm -65.55 -32.77 74.54 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.614 -0.933 . . . . 0.0 110.419 176.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.6 p30 42.47 53.11 4.7 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 176.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 54.8 27.44 8.9 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.328 -0.858 . . . . 0.0 111.184 176.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -119.12 105.15 45.21 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.484 -0.76 . . . . 0.0 110.098 175.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -59.45 151.02 71.73 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 O-C-N 123.135 1.071 . . . . 0.0 110.686 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 46.3 pt -131.81 177.63 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.766 0.793 . . . . 0.0 110.922 -177.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 24.4 mt -124.33 149.81 46.17 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.424 HD11 ' CE1' ' A' ' 301' ' ' PHE . 80.2 mt -118.1 129.12 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.232 178.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 84.7 mt -109.79 127.55 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 120.251 -0.579 . . . . 0.0 109.448 -175.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 59.5 t -118.87 126.79 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.4 p -125.23 153.66 42.81 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 120.136 -0.625 . . . . 0.0 110.55 -174.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.41 ' HB2' ' CD1' ' A' ' 138' ' ' PHE . 20.7 tp -104.09 125.59 50.55 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 168.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -131.8 150.43 52.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.855 -0.528 . . . . 0.0 109.851 -171.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.4 ' CG2' ' CD1' ' A' ' 296' ' ' LEU . 68.4 p -89.86 159.54 16.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.632 -0.668 . . . . 0.0 109.708 177.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 28.7 tpt180 -56.03 -25.98 46.96 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.521 -0.737 . . . . 0.0 110.761 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -86.65 8.96 20.18 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.482 -0.762 . . . . 0.0 111.706 -174.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 86.95 20.13 54.22 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 120.186 -1.007 . . . . 0.0 110.673 170.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -107.86 140.12 41.44 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.214 -1.168 . . . . 0.0 110.252 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 60.5 t -88.86 131.4 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.683 -0.635 . . . . 0.0 110.133 -174.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.4 ' CD1' ' CG2' ' A' ' 290' ' ' THR . 76.8 mt -99.78 -40.18 7.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.753 -0.592 . . . . 0.0 110.504 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -159.68 151.77 22.58 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -135.08 134.29 40.16 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.643 -0.916 . . . . 0.0 110.606 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -136.76 157.88 45.73 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.568 -0.707 . . . . 0.0 109.848 172.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 94.7 m -143.18 156.69 44.83 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.358 -0.838 . . . . 0.0 110.846 -175.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.424 ' CE1' HD11 ' A' ' 284' ' ' ILE . 47.1 p90 -145.21 162.17 37.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.653 -0.654 . . . . 0.0 110.12 175.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -104.85 135.36 46.36 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.515 -0.741 . . . . 0.0 110.16 -178.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -123.6 142.99 50.5 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.736 -170.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 53.4 ttt85 -139.04 140.33 38.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.853 -0.53 . . . . 0.0 109.769 173.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 73.6 mt -107.78 123.0 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.611 -0.68 . . . . 0.0 109.602 176.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.9 p -145.13 167.56 22.45 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.592 -0.692 . . . . 0.0 110.929 -170.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -67.8 -40.07 83.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.633 -0.667 . . . . 0.0 110.628 -177.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 3.9 t -132.09 89.49 37.77 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.592 -0.693 . . . . 0.0 110.448 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.54 -29.86 71.57 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 O-C-N 123.089 1.047 . . . . 0.0 110.853 174.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.26 -37.28 92.76 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -73.25 -40.37 64.69 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.752 -0.852 . . . . 0.0 109.779 -173.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -69.53 -40.14 77.07 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.183 -178.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -61.72 -43.19 99.34 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.301 178.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -65.06 -39.74 93.7 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.494 -0.754 . . . . 0.0 110.445 177.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.37 -49.86 75.21 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.515 -0.74 . . . . 0.0 110.551 -173.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -61.39 -37.66 84.22 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.389 -0.82 . . . . 0.0 110.09 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -62.3 -41.27 98.38 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.59 -0.694 . . . . 0.0 110.026 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -62.48 -35.2 78.61 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.7 -0.625 . . . . 0.0 109.917 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 24.6 m -62.14 -32.62 73.24 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.726 -0.609 . . . . 0.0 110.113 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 84.0 mt -78.95 -42.8 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.714 -0.616 . . . . 0.0 109.925 -177.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -58.48 -41.62 85.69 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.683 -0.636 . . . . 0.0 110.53 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -62.58 -42.69 99.71 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.687 -0.633 . . . . 0.0 110.249 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -63.85 -33.64 76.15 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.646 -0.659 . . . . 0.0 110.275 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -96.9 125.04 41.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.714 -0.616 . . . . 0.0 110.367 -177.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 61.5 t -121.45 130.08 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.643 -0.66 . . . . 0.0 109.849 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 49.5 m -95.11 140.01 30.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.696 -0.627 . . . . 0.0 110.329 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -82.04 136.85 35.18 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.694 -0.629 . . . . 0.0 110.29 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 52.1 m -94.08 151.3 19.61 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.642 -0.661 . . . . 0.0 110.403 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 99.5 m 55.57 -87.02 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.695 -0.628 . . . . 0.0 110.957 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -91.94 147.35 23.03 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.058 -1.026 . . . . 0.0 110.271 -176.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -58.69 -38.39 78.13 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.64 -0.663 . . . . 0.0 110.421 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -149.87 166.69 29.87 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -101.95 147.63 26.31 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.698 -0.884 . . . . 0.0 110.188 178.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -144.91 150.7 37.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.653 -0.655 . . . . 0.0 110.323 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . 0.402 ' O ' ' CD2' ' A' ' 335' ' ' PHE . 64.2 t80 -168.3 32.99 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.629 -0.67 . . . . 0.0 110.089 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 55.55 -85.83 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.689 -0.632 . . . . 0.0 111.086 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -58.85 -37.48 76.59 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.146 -0.971 . . . . 0.0 110.481 -176.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -105.03 140.38 38.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.581 -0.699 . . . . 0.0 110.235 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 66.7 p -121.86 162.08 21.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.679 -0.638 . . . . 0.0 110.316 -179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -60.08 -35.38 75.05 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.613 -0.68 . . . . 0.0 110.364 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -58.66 -33.32 71.94 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -177.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 82.1 mt -92.95 128.57 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.675 -0.897 . . . . 0.0 109.96 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -84.98 -36.39 21.37 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.615 -0.678 . . . . 0.0 110.138 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 59.9 ttp -122.43 147.38 46.38 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.631 -0.668 . . . . 0.0 110.294 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.319 179.886 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.9 t -156.31 148.51 23.32 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.627 -0.925 . . . . 0.0 110.24 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 90.7 p -123.41 155.99 36.34 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.714 -0.616 . . . . 0.0 110.215 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 45.0 m -59.51 -40.37 86.85 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.576 -0.703 . . . . 0.0 110.358 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -119.26 125.1 48.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.65 -0.656 . . . . 0.0 110.285 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -88.32 113.57 24.06 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.591 -0.693 . . . . 0.0 110.313 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 50.85 32.43 7.23 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.469 -0.769 . . . . 0.0 111.168 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.9 mp 55.44 -85.24 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.726 -0.609 . . . . 0.0 110.991 -177.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.3 m -116.63 159.67 39.46 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.176 -0.952 . . . . 0.0 110.174 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -64.42 159.63 69.46 Favored 'Cis proline' 0 N--CA 1.495 1.601 0 C-N-CA 123.194 -1.586 . . . . 0.0 110.461 -17.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.8 m -80.89 156.08 72.63 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.588 -0.695 . . . . 0.0 110.273 -177.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -59.25 148.21 87.21 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.328 1.173 . . . . 0.0 110.751 -177.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.32 150.05 38.57 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.761 -0.587 . . . . 0.0 110.187 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 49.5 mm -119.83 143.59 35.45 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.682 -0.636 . . . . 0.0 109.827 -178.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -63.25 153.05 76.66 Favored 'Trans proline' 0 N--CA 1.486 1.07 0 O-C-N 123.221 1.116 . . . . 0.0 110.513 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.0 t -111.86 144.29 41.41 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.616 -0.678 . . . . 0.0 110.169 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.5 p-10 -94.38 23.2 5.35 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.713 -0.617 . . . . 0.0 110.845 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 50.5 m -75.47 125.1 28.33 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.454 -0.779 . . . . 0.0 110.171 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -70.44 144.88 51.33 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.584 -0.697 . . . . 0.0 110.43 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.413 ' CE2' ' HA2' ' A' ' 134' ' ' GLY . 65.4 t80 -155.92 102.51 2.12 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.635 -0.666 . . . . 0.0 110.055 178.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -58.95 -39.87 76.84 Favored 'Trans proline' 0 N--CA 1.488 1.161 0 O-C-N 123.129 1.068 . . . . 0.0 110.792 -174.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.413 ' HA2' ' CE2' ' A' ' 132' ' ' TYR . . . 81.13 -155.14 36.05 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 178.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -73.04 -49.92 0.22 Allowed 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.361 1.19 . . . . 0.0 110.914 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -87.88 9.89 20.53 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.55 -0.719 . . . . 0.0 111.36 -173.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.71 61.51 3.06 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.922 -1.111 . . . . 0.0 110.705 -177.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.454 ' CE1' ' CG2' ' A' ' 174' ' ' ILE . 64.3 t80 -79.85 118.81 21.97 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.663 -0.648 . . . . 0.0 110.07 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -130.01 160.04 34.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.787 -0.571 . . . . 0.0 110.316 -175.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 72.3 t -123.99 147.09 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.751 -0.593 . . . . 0.0 109.764 177.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.9 p -155.17 163.65 39.93 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.251 0.548 . . . . 0.0 109.932 176.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.494 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 67.3 m-85 -126.69 125.13 41.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.723 -0.611 . . . . 0.0 109.844 -176.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -57.88 144.29 39.5 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.571 -0.706 . . . . 0.0 110.34 -176.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -120.13 156.38 31.16 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.61 -0.681 . . . . 0.0 110.656 -175.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.6 p -149.29 171.89 15.76 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.681 -0.637 . . . . 0.0 110.075 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 54.2 p -61.63 162.34 8.56 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.633 -0.667 . . . . 0.0 110.056 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 80.9 p -59.12 95.15 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.593 -0.692 . . . . 0.0 110.322 -177.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.07 150.66 21.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.767 -0.583 . . . . 0.0 110.211 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -81.23 145.92 30.71 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.569 -0.707 . . . . 0.0 110.056 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.8 p 50.14 37.43 14.54 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.592 -0.693 . . . . 0.0 111.253 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.3 134.76 57.31 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.637 -0.664 . . . . 0.0 110.182 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 61.6 p -60.09 -33.22 71.79 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.753 -0.592 . . . . 0.0 110.005 175.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.418 ' CZ2' ' HD2' ' A' ' 171' ' ' PRO . 68.5 p-90 -171.28 143.48 1.88 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.784 -0.572 . . . . 0.0 110.063 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.5 t -142.03 142.54 32.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.83 -0.544 . . . . 0.0 110.011 -177.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.494 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 64.9 t80 -125.62 140.03 53.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.534 -0.729 . . . . 0.0 110.646 -172.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 40.6 t -109.59 124.46 51.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.863 -0.523 . . . . 0.0 109.944 176.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 56.1 m -71.12 -37.1 72.35 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.794 -0.566 . . . . 0.0 110.513 -177.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -59.9 -34.29 72.99 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.604 -0.685 . . . . 0.0 110.364 -178.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 58.0 mt -104.82 -11.99 16.51 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.656 -0.653 . . . . 0.0 110.871 -175.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.6 tttp 59.81 51.31 6.21 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.112 -0.992 . . . . 0.0 109.734 177.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -145.71 153.06 40.57 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.562 -174.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.5 tp -126.65 137.8 53.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.772 -0.58 . . . . 0.0 110.416 -175.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -117.15 134.28 54.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.683 -0.635 . . . . 0.0 109.414 174.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.28 158.37 44.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.615 -0.678 . . . . 0.0 111.0 -174.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -104.56 144.9 31.06 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.568 0.699 . . . . 0.0 110.491 173.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 16.8 tt -52.1 146.25 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.551 -0.718 . . . . 0.0 111.894 -174.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 63.96 10.17 5.11 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.629 -0.67 . . . . 0.0 112.448 176.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -96.12 155.04 16.93 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.987 -1.071 . . . . 0.0 110.705 175.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 90.5 m -84.63 126.18 33.13 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.709 -0.619 . . . . 0.0 110.537 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 42.9 t -114.3 90.08 19.49 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.627 -0.671 . . . . 0.0 110.046 172.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.418 ' HD2' ' CZ2' ' A' ' 153' ' ' TRP . 22.6 Cg_exo -61.78 129.29 27.12 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 O-C-N 123.334 1.176 . . . . 0.0 110.548 172.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.421 HG12 ' CE2' ' A' ' 142' ' ' PHE . 95.2 mt -123.26 139.38 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 175.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -106.77 135.92 47.49 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.559 -0.713 . . . . 0.0 110.753 -175.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.454 ' CG2' ' CE1' ' A' ' 138' ' ' PHE . 49.8 mm -95.3 135.01 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.75 -0.594 . . . . 0.0 109.715 171.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 31.7 tptt -117.21 130.57 56.67 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.679 -0.638 . . . . 0.0 110.518 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.5 m -136.87 159.78 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.518 -0.739 . . . . 0.0 109.977 175.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 80.3 mmm -78.4 -40.29 36.47 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.716 -0.615 . . . . 0.0 110.008 177.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 76.7 p -135.09 143.21 44.95 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.805 -0.559 . . . . 0.0 109.686 177.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -55.51 139.79 82.6 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 O-C-N 123.177 1.093 . . . . 0.0 110.92 -172.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.428 ' HG2' ' CD1' ' A' ' 251' ' ' TYR . 34.2 Cg_endo -68.12 169.99 15.46 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.211 1.111 . . . . 0.0 110.616 177.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -60.28 157.92 33.25 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 O-C-N 123.317 1.167 . . . . 0.0 110.685 -178.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -80.21 139.2 36.84 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.663 -0.648 . . . . 0.0 110.034 175.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.04 -24.94 30.22 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 -174.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.07 152.64 1.61 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.365 -1.08 . . . . 0.0 111.429 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.73 155.95 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.686 -0.634 . . . . 0.0 109.841 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 86.7 mt -109.04 137.97 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.629 -0.669 . . . . 0.0 109.539 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -115.03 146.24 41.47 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -176.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -139.97 127.94 22.16 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.454 -0.779 . . . . 0.0 110.327 174.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 30.6 ttp -137.26 139.95 29.45 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.752 -0.593 . . . . 0.0 111.19 -176.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -92.46 138.14 1.73 Allowed 'Trans proline' 0 C--N 1.32 -0.961 0 C-N-CA 121.15 1.233 . . . . 0.0 110.702 177.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 35.0 m -148.05 154.9 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.507 -0.746 . . . . 0.0 110.133 174.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.422 ' CE2' HG23 ' A' ' 202' ' ' VAL . 71.2 m-85 -60.3 164.96 3.84 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.529 -0.732 . . . . 0.0 110.487 178.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 36.8 tttt -79.86 -60.03 2.5 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.607 -0.683 . . . . 0.0 110.805 -174.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -80.1 150.73 30.16 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.525 -0.734 . . . . 0.0 110.293 -174.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.5 -38.68 72.12 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.334 -0.854 . . . . 0.0 110.749 -174.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -56.31 -25.12 47.51 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.487 -0.758 . . . . 0.0 110.633 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -110.01 -20.52 12.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.605 -0.684 . . . . 0.0 111.218 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.1 p -66.78 -20.24 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.153 -0.967 . . . . 0.0 110.604 -176.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 71.0 p -79.43 -15.44 57.81 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.577 -0.702 . . . . 0.0 110.813 175.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.22 135.18 33.56 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.355 -0.84 . . . . 0.0 110.031 173.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.9 t -72.89 143.98 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.661 -0.65 . . . . 0.0 110.221 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.422 HG23 ' CE2' ' A' ' 192' ' ' TYR . 63.1 t -84.97 136.31 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.583 -0.698 . . . . 0.0 109.318 171.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 9.2 pttt -134.91 -170.14 2.5 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.464 -0.773 . . . . 0.0 111.067 -166.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -95.15 159.34 15.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.715 -0.616 . . . . 0.0 110.426 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 59.6 m -80.18 160.53 67.97 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.644 -0.66 . . . . 0.0 109.425 176.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -63.86 -47.36 6.98 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 O-C-N 123.176 1.093 . . . . 0.0 109.88 176.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.445 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.6 p-10 -65.51 -44.26 87.51 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.733 -0.604 . . . . 0.0 111.23 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . 0.445 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 55.3 m170 -81.34 -27.93 34.73 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.407 -0.808 . . . . 0.0 111.319 -174.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -69.1 -42.02 76.68 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.367 -0.833 . . . . 0.0 110.146 171.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 26.9 tp -60.24 -28.94 68.43 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.707 -0.621 . . . . 0.0 110.575 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.1 t -48.33 -38.22 18.55 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.564 -0.71 . . . . 0.0 111.721 -177.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 53.19 102.68 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.588 -0.695 . . . . 0.0 111.305 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -92.17 22.15 4.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.535 -0.728 . . . . 0.0 110.931 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 53.59 75.13 0.28 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.044 -1.035 . . . . 0.0 110.836 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -66.06 -10.35 39.4 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.55 -0.719 . . . . 0.0 111.33 -177.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -60.03 119.21 7.35 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.157 -0.964 . . . . 0.0 110.391 176.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 78.22 20.01 73.36 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -114.61 145.51 41.9 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.3 -1.118 . . . . 0.0 110.528 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.3 mt -84.8 -25.08 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.661 -0.649 . . . . 0.0 110.5 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -124.91 92.88 46.91 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.445 -0.784 . . . . 0.0 110.419 -176.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.418 ' HD2' ' CE1' ' A' ' 236' ' ' TYR . 21.1 Cg_exo -62.41 137.24 63.94 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.299 1.157 . . . . 0.0 110.461 -178.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -60.5 -17.98 51.37 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 O-C-N 123.024 1.012 . . . . 0.0 111.318 -178.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 24.0 t -53.47 -26.33 19.98 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.24 -0.912 . . . . 0.0 111.186 -177.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -103.1 130.7 50.34 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.538 -0.726 . . . . 0.0 110.375 -178.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 30.7 tp -61.27 -36.85 81.15 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.662 -0.649 . . . . 0.0 110.257 -178.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 80.8 mt -98.96 136.78 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.757 -0.59 . . . . 0.0 109.867 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -132.53 158.01 43.23 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.704 -0.622 . . . . 0.0 110.381 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 86.3 t -103.45 146.68 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.694 -0.629 . . . . 0.0 110.034 177.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -118.79 129.62 55.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.727 -0.608 . . . . 0.0 110.329 170.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.12 24.18 20.32 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 167.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -139.7 107.29 5.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.427 -1.043 . . . . 0.0 110.104 174.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 93.5 p -63.36 -15.12 56.51 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.641 -0.662 . . . . 0.0 111.197 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -97.02 9.99 40.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.266 -0.896 . . . . 0.0 111.265 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.87 126.2 26.52 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.185 -0.947 . . . . 0.0 110.112 176.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -139.69 155.2 47.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.794 -0.566 . . . . 0.0 109.759 176.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.418 ' CE1' ' HD2' ' A' ' 221' ' ' PRO . 77.2 m-85 -118.77 150.67 39.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.506 -0.746 . . . . 0.0 110.558 -176.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.19 159.88 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.817 -0.552 . . . . 0.0 110.3 178.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -120.1 129.78 54.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.667 -0.645 . . . . 0.0 110.063 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -65.01 130.01 94.71 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.626 -0.671 . . . . 0.0 109.886 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -66.36 -27.66 47.4 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.164 1.086 . . . . 0.0 111.111 -171.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.5 mt -100.35 -50.49 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.377 -0.827 . . . . 0.0 110.978 -168.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.7 p -105.38 12.16 31.91 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.37 -0.831 . . . . 0.0 111.846 -175.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.87 -5.16 13.4 Favored Glycine 0 N--CA 1.497 2.736 0 O-C-N 121.055 -1.028 . . . . 0.0 111.898 173.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 23.1 mmt85 -46.19 142.12 3.01 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-N 119.125 1.462 . . . . 0.0 112.265 -174.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -107.29 141.67 38.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.637 -0.664 . . . . 0.0 110.143 175.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 80.0 p -154.77 159.89 40.94 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.547 -0.721 . . . . 0.0 110.609 177.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.417 ' HB ' ' CD2' ' A' ' 236' ' ' TYR . 8.4 p -123.28 148.25 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.739 -0.601 . . . . 0.0 109.696 178.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 82.4 mt -129.57 154.58 46.92 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.878 -175.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 34.7 m -151.15 151.73 29.97 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.823 -0.548 . . . . 0.0 109.943 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -71.07 140.11 37.1 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.303 1.159 . . . . 0.0 110.084 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.428 ' CD1' ' HG2' ' A' ' 180' ' ' PRO . 58.9 t80 -76.6 125.0 28.47 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.435 -0.791 . . . . 0.0 110.168 174.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -100.0 160.16 27.94 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.795 -0.565 . . . . 0.0 109.907 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -58.68 159.8 19.47 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 O-C-N 123.305 1.161 . . . . 0.0 110.48 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.02 149.92 76.42 Favored 'Trans proline' 0 N--CA 1.487 1.126 0 O-C-N 123.218 1.115 . . . . 0.0 110.539 -177.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -61.98 148.1 44.92 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.689 -0.632 . . . . 0.0 110.21 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.5 t -69.9 127.24 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.496 -0.752 . . . . 0.0 110.124 -170.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.01 -10.1 55.27 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.406 ' OG1' ' CD2' ' A' ' 260' ' ' PHE . 9.9 t -144.59 173.12 12.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.177 -1.19 . . . . 0.0 110.604 174.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -106.88 13.05 28.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.657 -0.652 . . . . 0.0 111.728 -168.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . 0.406 ' CD2' ' OG1' ' A' ' 258' ' ' THR . 14.7 p90 -119.95 168.02 11.56 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.149 -0.969 . . . . 0.0 111.136 -175.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 92.4 m -117.8 146.89 43.52 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.768 -0.583 . . . . 0.0 109.861 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 47.5 m -117.73 134.9 54.42 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.599 -0.688 . . . . 0.0 110.942 -175.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 59.6 t -131.02 137.36 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 71.9 mt -104.7 121.88 44.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.422 -0.799 . . . . 0.0 109.958 -171.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -106.38 151.8 24.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.709 -0.619 . . . . 0.0 110.616 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -136.61 142.93 43.31 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -111.26 130.02 55.79 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.54 -0.725 . . . . 0.0 110.426 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -96.85 3.85 51.98 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.682 -0.636 . . . . 0.0 112.052 -175.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.79 165.02 29.27 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.053 -1.03 . . . . 0.0 109.961 174.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -119.43 159.82 23.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.643 -0.661 . . . . 0.0 110.187 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 29.5 m -59.31 -32.39 70.01 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.356 -0.84 . . . . 0.0 110.912 -163.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 47.1 p -97.58 11.47 36.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.405 -0.809 . . . . 0.0 111.978 -164.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 30.0 p -95.07 118.07 31.26 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.116 -0.99 . . . . 0.0 110.631 178.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.15 139.16 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.462 -0.774 . . . . 0.0 110.189 -172.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 100.87 -5.12 56.38 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -123.74 -113.98 2.1 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 170.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 26.6 ttt -64.16 -23.71 67.42 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.62 -0.93 . . . . 0.0 110.489 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 10.2 p30 44.52 54.46 6.39 Favored 'General case' 0 N--CA 1.504 2.273 0 CA-C-O 121.331 0.586 . . . . 0.0 112.58 172.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 22.8 mtp85 54.74 26.93 8.11 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.312 -0.867 . . . . 0.0 111.365 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 82.0 mtt-85 -115.02 114.6 43.62 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.388 -0.82 . . . . 0.0 109.956 173.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.45 145.39 98.09 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 O-C-N 122.969 0.984 . . . . 0.0 110.614 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 44.9 pt -131.92 174.72 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-O 121.758 0.79 . . . . 0.0 110.862 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 29.2 mt -124.44 149.88 46.28 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.43 HD12 ' CE1' ' A' ' 301' ' ' PHE . 81.3 mt -118.33 128.68 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.218 178.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 85.4 mt -109.72 127.38 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -174.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 61.8 t -119.0 126.79 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.6 p -125.26 154.07 42.23 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.664 -0.647 . . . . 0.0 110.624 -173.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.428 ' HB2' ' CE1' ' A' ' 138' ' ' PHE . 29.7 tp -105.19 126.16 51.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.697 -0.627 . . . . 0.0 109.503 169.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -130.96 149.62 52.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.916 -0.49 . . . . 0.0 109.681 -173.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 23.4 p -89.93 160.37 16.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.6 -0.688 . . . . 0.0 109.999 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -55.89 -26.15 45.94 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.568 -0.707 . . . . 0.0 111.082 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 45.4 p30 -90.14 9.52 27.99 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.467 -0.771 . . . . 0.0 111.931 -173.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.61 20.21 45.27 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 120.182 -1.008 . . . . 0.0 110.755 171.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -107.93 140.21 41.4 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.274 -1.133 . . . . 0.0 110.002 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 61.1 t -87.63 133.12 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.551 -0.718 . . . . 0.0 110.278 -172.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 96.1 mt -99.86 -40.19 7.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.697 -0.627 . . . . 0.0 110.522 178.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -167.54 154.97 25.57 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -133.86 136.9 44.68 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.616 -0.932 . . . . 0.0 110.791 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -135.01 155.84 50.07 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.661 -0.65 . . . . 0.0 109.874 172.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 98.1 m -142.52 153.18 43.38 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.399 -0.813 . . . . 0.0 110.781 -175.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.43 ' CE1' HD12 ' A' ' 284' ' ' ILE . 46.2 p90 -145.02 164.15 32.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.608 -0.683 . . . . 0.0 110.071 176.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -104.84 136.1 44.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.609 -0.682 . . . . 0.0 110.173 -177.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -124.48 143.84 50.42 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.715 -169.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 61.8 ttm-85 -138.13 141.88 40.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.712 -0.617 . . . . 0.0 109.744 173.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 77.2 mt -108.74 122.94 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.577 -0.702 . . . . 0.0 109.671 175.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.8 p -145.39 168.89 19.43 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.53 -0.731 . . . . 0.0 110.645 -172.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -71.28 -40.05 71.14 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.674 -0.642 . . . . 0.0 110.77 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.8 t -127.14 85.37 61.19 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.454 -0.779 . . . . 0.0 110.514 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -56.03 -27.79 66.15 Favored 'Trans proline' 0 N--CA 1.489 1.257 0 O-C-N 123.231 1.122 . . . . 0.0 110.674 174.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -68.14 -37.06 86.62 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.126 -1.589 . . . . 0.0 109.126 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -72.85 -39.92 66.14 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.647 -0.913 . . . . 0.0 109.749 -173.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -69.49 -40.51 77.0 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 120.067 -0.653 . . . . 0.0 109.934 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -62.06 -42.83 99.6 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.557 -0.715 . . . . 0.0 110.122 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -63.87 -40.27 96.15 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.599 -0.688 . . . . 0.0 110.563 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.19 -51.97 66.79 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.503 -0.748 . . . . 0.0 110.392 -174.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -61.66 -37.78 85.31 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.458 -0.776 . . . . 0.0 110.029 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -63.26 -39.88 95.84 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.651 -0.655 . . . . 0.0 110.278 178.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -62.15 -35.27 78.28 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.526 -0.733 . . . . 0.0 109.925 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 22.7 t -63.82 -33.42 75.64 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.782 -0.574 . . . . 0.0 110.237 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 83.7 mt -78.32 -47.62 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.641 -0.662 . . . . 0.0 110.056 -176.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -60.72 -37.7 82.62 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.712 -0.618 . . . . 0.0 110.392 -177.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 35.7 tttt -61.52 -47.58 84.93 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.567 -0.708 . . . . 0.0 110.199 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -70.21 -37.99 75.19 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.707 -0.62 . . . . 0.0 110.469 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -105.02 125.08 50.59 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.667 -0.646 . . . . 0.0 110.553 -174.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 61.8 t -101.37 130.07 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.637 -0.664 . . . . 0.0 109.843 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 50.9 m -63.45 140.15 58.84 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.71 -0.619 . . . . 0.0 110.31 -178.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 46.9 p-10 -78.94 150.01 32.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.626 -0.672 . . . . 0.0 110.295 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 44.8 m -62.5 153.78 30.62 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.607 -0.683 . . . . 0.0 110.209 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 72.0 p -93.71 -21.77 19.14 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.631 -0.668 . . . . 0.0 110.638 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 40.0 mttp -59.27 -31.51 69.18 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.413 -0.804 . . . . 0.0 110.426 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 54.4 46.04 25.87 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.542 -0.724 . . . . 0.0 110.732 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -141.06 -172.54 13.11 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -80.18 118.75 22.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.636 -0.92 . . . . 0.0 110.249 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -61.64 147.95 44.14 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.731 -0.606 . . . . 0.0 110.232 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -132.04 162.57 30.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.615 -0.678 . . . . 0.0 110.306 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 53.35 32.22 13.34 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.499 -0.751 . . . . 0.0 110.793 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -107.24 128.67 54.64 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.582 -0.699 . . . . 0.0 110.145 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -59.14 -36.79 75.85 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.598 -0.688 . . . . 0.0 110.475 -178.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 67.3 p -126.86 162.18 26.5 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.616 -0.677 . . . . 0.0 110.248 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -60.07 -39.51 86.3 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.602 -0.686 . . . . 0.0 110.263 178.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -163.29 -178.21 36.84 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 16.4 tt -147.87 151.94 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.609 -0.936 . . . . 0.0 110.229 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -83.99 -36.4 23.22 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.634 -0.666 . . . . 0.0 110.216 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 64.7 mtt -104.87 145.94 29.7 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.598 -0.688 . . . . 0.0 110.274 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 67.3 p . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.2 179.959 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.0 m -80.57 -30.16 36.97 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.683 -0.892 . . . . 0.0 110.155 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.7 m -120.31 147.37 45.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.622 -0.674 . . . . 0.0 110.248 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.4 t -167.21 46.05 0.06 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.596 -0.69 . . . . 0.0 110.312 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -60.2 -39.47 86.67 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.634 -0.666 . . . . 0.0 110.346 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -158.0 84.01 0.87 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.672 -0.643 . . . . 0.0 110.28 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 50.15 -159.4 0.07 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.494 -0.754 . . . . 0.0 111.242 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.8 mt 52.61 34.54 15.98 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.45 -0.781 . . . . 0.0 111.007 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 68.3 p -123.05 163.11 35.5 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.638 -0.664 . . . . 0.0 110.237 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -59.38 151.28 69.39 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 O-C-N 123.243 1.128 . . . . 0.0 110.59 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 96.0 p -81.63 146.51 56.99 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.63 -0.669 . . . . 0.0 110.179 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -60.3 152.22 68.32 Favored 'Trans proline' 0 N--CA 1.487 1.145 0 O-C-N 123.263 1.139 . . . . 0.0 110.507 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.69 142.65 44.42 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.622 -0.674 . . . . 0.0 110.12 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 51.5 mm -121.44 99.95 45.03 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.715 -0.615 . . . . 0.0 109.998 -177.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -60.77 152.09 72.22 Favored 'Trans proline' 0 N--CA 1.487 1.134 0 O-C-N 123.237 1.125 . . . . 0.0 110.583 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.6 t -113.42 150.6 32.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.637 -0.665 . . . . 0.0 110.342 -178.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.9 p-10 -94.97 24.95 4.43 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.644 -0.66 . . . . 0.0 110.797 -178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 52.1 m -72.09 125.21 26.71 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.593 -0.692 . . . . 0.0 110.248 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -71.09 144.9 50.16 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.754 -0.591 . . . . 0.0 110.538 -177.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -152.18 101.02 2.81 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.732 -0.605 . . . . 0.0 110.134 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -59.07 -39.96 75.11 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.042 1.022 . . . . 0.0 110.792 -174.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.42 -155.12 46.75 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -76.36 -44.0 0.27 Allowed 'Trans proline' 0 C--N 1.317 -1.08 0 O-C-N 123.38 1.2 . . . . 0.0 110.991 -174.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -86.91 8.84 21.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.503 -0.748 . . . . 0.0 111.425 -173.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 t 53.62 60.54 3.62 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.956 -1.09 . . . . 0.0 110.772 -176.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -77.84 118.41 20.14 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.585 -0.697 . . . . 0.0 109.871 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -130.03 159.99 35.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.862 -0.523 . . . . 0.0 110.124 -178.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.8 t -125.98 146.07 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.797 -0.564 . . . . 0.0 109.726 177.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.8 p -155.31 161.12 41.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.772 -0.58 . . . . 0.0 110.03 177.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.415 ' CE2' HG12 ' A' ' 172' ' ' ILE . 71.5 m-85 -126.71 125.24 41.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.769 -0.582 . . . . 0.0 109.772 -176.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -56.95 140.99 46.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.573 -0.704 . . . . 0.0 110.511 -174.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -101.21 131.46 47.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.686 -0.634 . . . . 0.0 110.392 -175.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 91.0 p -126.85 158.68 36.05 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.641 -0.662 . . . . 0.0 110.09 178.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 54.6 p -64.17 163.26 12.94 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.671 -0.643 . . . . 0.0 110.102 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.7 t -71.89 64.35 0.5 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.578 -0.701 . . . . 0.0 110.219 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.96 147.6 45.07 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.666 -0.646 . . . . 0.0 110.202 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 50.8 pttt -59.4 149.35 29.56 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.618 -0.677 . . . . 0.0 110.487 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.5 m 53.07 51.1 16.42 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.37 -0.831 . . . . 0.0 110.955 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.88 123.12 26.92 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.71 -0.619 . . . . 0.0 110.103 177.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.401 ' OG1' ' CD1' ' A' ' 153' ' ' TRP . 44.9 p -60.07 -34.12 73.01 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.7 -0.625 . . . . 0.0 110.243 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.416 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -170.87 144.35 2.2 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.435 0.636 . . . . 0.0 110.237 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.4 t -142.09 142.66 32.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.863 -0.523 . . . . 0.0 109.971 -176.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -125.44 140.12 53.06 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.499 -0.751 . . . . 0.0 110.553 -172.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.2 t -110.69 124.5 52.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.852 -0.53 . . . . 0.0 109.773 176.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 60.6 m -70.63 -36.99 73.73 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.808 -0.558 . . . . 0.0 110.417 -177.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -59.54 -33.59 71.59 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.587 -0.695 . . . . 0.0 110.43 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 57.0 mt -104.85 -12.06 16.45 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.711 -0.618 . . . . 0.0 110.826 -175.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 78.8 tttt 59.84 50.25 7.14 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.126 -0.984 . . . . 0.0 109.678 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -145.84 153.1 40.51 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.571 -174.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.5 tp -126.5 137.83 53.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.739 -0.601 . . . . 0.0 110.25 -176.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -115.81 134.51 54.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.668 -0.645 . . . . 0.0 109.33 175.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.47 158.57 44.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.646 -0.659 . . . . 0.0 110.808 -176.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -104.54 144.56 31.52 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.668 171.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 17.2 tt -51.46 147.43 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 CA-C-O 121.572 0.701 . . . . 0.0 112.107 -173.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 64.99 9.99 5.89 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.555 -0.715 . . . . 0.0 112.734 174.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -94.22 155.15 17.19 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.951 -1.093 . . . . 0.0 111.045 173.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 87.3 m -81.28 126.22 31.28 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.767 -0.583 . . . . 0.0 110.596 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 43.9 t -114.13 90.04 18.8 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.602 -0.686 . . . . 0.0 110.175 173.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.416 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 18.4 Cg_exo -63.38 128.83 23.55 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 O-C-N 123.281 1.148 . . . . 0.0 110.598 173.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.415 HG12 ' CE2' ' A' ' 142' ' ' PHE . 97.5 mt -123.34 143.43 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.597 -0.689 . . . . 0.0 109.36 175.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -110.47 134.82 51.99 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.453 -0.779 . . . . 0.0 110.857 -175.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.5 mm -95.26 135.03 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.644 -0.66 . . . . 0.0 109.7 169.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.9 tttt -115.21 128.29 56.06 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.466 175.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.9 m -136.64 159.71 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.69 -0.631 . . . . 0.0 109.832 174.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.7 mmm -75.22 -40.51 59.04 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.771 -0.581 . . . . 0.0 110.166 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 76.8 p -135.71 143.25 43.96 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.834 -0.541 . . . . 0.0 109.725 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -55.31 139.85 81.55 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 O-C-N 123.106 1.056 . . . . 0.0 110.921 -172.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.428 ' HG3' ' CE2' ' A' ' 251' ' ' TYR . 19.6 Cg_endo -63.05 167.85 11.67 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.226 1.119 . . . . 0.0 110.637 178.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -61.04 156.71 42.95 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 O-C-N 123.395 1.208 . . . . 0.0 110.509 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -74.5 139.01 43.55 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.672 -0.642 . . . . 0.0 109.858 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.69 -24.97 29.29 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 -175.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.2 150.36 2.49 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.317 -1.107 . . . . 0.0 111.323 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 33.6 m -129.79 155.92 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.765 -0.585 . . . . 0.0 109.664 176.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 83.3 mt -106.93 138.31 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.747 -0.595 . . . . 0.0 109.435 175.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 56.6 mtp85 -114.95 144.99 42.71 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -176.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -137.8 128.03 26.11 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.426 -0.796 . . . . 0.0 110.324 174.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 1.6 ttp -137.3 135.84 19.97 Favored Pre-proline 0 N--CA 1.495 1.816 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.957 -175.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -91.19 138.18 2.25 Favored 'Trans proline' 0 C--N 1.32 -0.951 0 O-C-N 123.196 1.103 . . . . 0.0 110.777 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 35.5 m -148.21 154.95 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.578 -0.702 . . . . 0.0 109.904 173.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.444 ' CE2' ' CG2' ' A' ' 202' ' ' VAL . 89.6 m-85 -60.91 163.24 5.98 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.379 -0.826 . . . . 0.0 110.385 -178.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 39.6 tttm -78.64 -60.02 2.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.622 -0.674 . . . . 0.0 110.71 -175.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -80.05 150.33 30.38 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.597 -0.69 . . . . 0.0 110.356 -175.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.42 -37.88 70.8 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.404 -0.81 . . . . 0.0 110.713 -175.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -56.37 -25.24 48.79 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.562 -0.711 . . . . 0.0 110.56 -175.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.441 ' CD2' ' NH1' ' A' ' 280' ' ' ARG . 62.9 m170 -109.94 -20.64 12.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.577 -0.702 . . . . 0.0 111.112 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.2 p -67.05 -20.2 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.244 -0.91 . . . . 0.0 110.62 -176.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 82.3 p -79.42 -16.96 55.3 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.55 -0.719 . . . . 0.0 110.705 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -88.3 138.52 31.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.359 -0.838 . . . . 0.0 110.058 173.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.9 t -72.87 139.85 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.606 -0.684 . . . . 0.0 110.428 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.444 ' CG2' ' CE2' ' A' ' 192' ' ' TYR . 63.9 t -84.93 138.92 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.561 -0.712 . . . . 0.0 109.421 170.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 10.6 pttt -134.9 -170.45 2.57 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.463 -0.773 . . . . 0.0 110.993 -171.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -95.47 156.82 16.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.77 -0.581 . . . . 0.0 110.321 174.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 60.7 m -68.46 163.99 48.35 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 121.554 -0.716 . . . . 0.0 109.07 171.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -63.54 -47.47 7.37 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 O-C-N 123.022 1.012 . . . . 0.0 109.964 177.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.433 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.3 p-10 -65.55 -43.88 88.52 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.579 -0.701 . . . . 0.0 111.118 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . 0.433 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 52.5 m170 -80.06 -27.93 39.29 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.482 -0.762 . . . . 0.0 111.186 -174.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -68.97 -37.87 79.05 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.504 -0.747 . . . . 0.0 110.345 175.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 27.6 tp -54.14 -31.02 51.26 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.464 -0.772 . . . . 0.0 110.948 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 26.1 t -48.24 -27.57 2.54 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.435 -0.791 . . . . 0.0 111.639 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 37.6 ptt85 -55.69 -28.05 53.56 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.53 -0.731 . . . . 0.0 110.886 -178.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -57.68 146.41 30.96 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.593 -0.692 . . . . 0.0 110.541 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 33.2 t80 54.09 64.01 1.98 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.512 -0.742 . . . . 0.0 110.643 -177.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -75.67 -10.16 59.21 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.561 -0.712 . . . . 0.0 111.114 178.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -58.63 125.06 21.82 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.103 -0.998 . . . . 0.0 110.424 175.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 95.01 -1.68 65.38 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -114.66 139.84 49.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.021 -1.281 . . . . 0.0 110.387 174.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.6 mt -84.94 -25.13 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.728 -0.608 . . . . 0.0 110.544 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -124.82 103.66 30.86 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.495 -0.753 . . . . 0.0 110.267 -173.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.421 ' HD2' ' CE2' ' A' ' 236' ' ' TYR . 29.4 Cg_exo -58.72 115.42 2.54 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 O-C-N 123.167 1.088 . . . . 0.0 110.762 -178.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.67 -19.86 39.72 Favored 'Trans proline' 0 N--CA 1.49 1.299 0 O-C-N 122.937 0.967 . . . . 0.0 111.425 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 25.2 t -51.65 -23.53 4.49 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.23 -0.919 . . . . 0.0 111.415 -177.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -106.86 132.82 52.38 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.426 -0.796 . . . . 0.0 110.21 177.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 58.6 tp -59.48 -39.63 84.37 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.588 -0.695 . . . . 0.0 110.352 -177.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 83.0 mt -102.85 136.76 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.85 -0.531 . . . . 0.0 109.642 177.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -136.95 162.96 31.84 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.746 -0.596 . . . . 0.0 110.341 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 94.5 t -109.09 146.79 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.826 -0.546 . . . . 0.0 110.129 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -120.81 121.54 38.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.809 -0.557 . . . . 0.0 110.348 174.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.98 24.09 10.88 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 169.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -137.23 106.74 6.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.413 -1.051 . . . . 0.0 109.988 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 46.0 m -63.16 -15.34 56.54 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.582 -0.699 . . . . 0.0 111.325 -176.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -99.94 5.59 45.25 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.275 -0.89 . . . . 0.0 111.608 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.94 131.4 49.58 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.039 -1.038 . . . . 0.0 110.16 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -139.72 158.07 44.71 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.797 -0.565 . . . . 0.0 109.811 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.421 ' CE2' ' HD2' ' A' ' 221' ' ' PRO . 72.6 m-85 -112.35 150.64 30.78 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.618 -0.677 . . . . 0.0 110.361 -178.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.26 159.91 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.737 -0.602 . . . . 0.0 110.174 176.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -122.62 129.96 52.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.787 -0.57 . . . . 0.0 110.094 175.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -64.96 130.07 94.72 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.654 -0.654 . . . . 0.0 109.87 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -66.42 -27.92 46.67 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 O-C-N 123.193 1.102 . . . . 0.0 111.049 -170.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.0 mt -100.51 -50.46 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.423 -0.798 . . . . 0.0 110.879 -168.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.1 p -105.32 12.06 32.14 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.396 -0.815 . . . . 0.0 111.875 -175.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.9 -6.23 10.29 Favored Glycine 0 N--CA 1.496 2.69 0 O-C-N 121.034 -1.041 . . . . 0.0 111.941 172.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -46.12 142.03 3.0 Favored 'General case' 0 N--CA 1.506 2.327 0 CA-C-N 119.081 1.441 . . . . 0.0 112.258 -173.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -104.7 141.57 36.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.559 -0.713 . . . . 0.0 110.218 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 72.4 p -154.76 159.93 40.97 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.61 -0.682 . . . . 0.0 110.476 176.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 8.2 p -125.31 148.21 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.788 -0.57 . . . . 0.0 109.643 177.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 71.4 mt -129.5 154.7 46.75 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.633 -174.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 35.8 m -150.86 151.7 30.52 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.769 -0.582 . . . . 0.0 110.042 176.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -71.09 137.99 32.7 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 O-C-N 123.298 1.157 . . . . 0.0 109.994 177.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.428 ' CE2' ' HG3' ' A' ' 180' ' ' PRO . 10.5 t80 -76.54 126.02 30.25 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.573 -0.704 . . . . 0.0 110.221 176.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -100.01 160.07 28.16 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.771 -0.581 . . . . 0.0 109.979 176.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.88 159.11 22.25 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.199 1.105 . . . . 0.0 110.419 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.01 150.04 75.59 Favored 'Trans proline' 0 N--CA 1.488 1.187 0 O-C-N 123.26 1.137 . . . . 0.0 110.525 -177.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -61.16 147.46 44.05 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.669 -0.645 . . . . 0.0 110.139 -178.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.7 t -69.9 127.14 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.485 -0.759 . . . . 0.0 110.168 -170.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.53 -10.11 56.05 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.402 ' OG1' ' CD2' ' A' ' 260' ' ' PHE . 9.8 t -144.36 174.34 11.0 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.147 -1.208 . . . . 0.0 110.6 176.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -109.21 13.09 24.59 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.527 -0.733 . . . . 0.0 111.918 -166.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . 0.402 ' CD2' ' OG1' ' A' ' 258' ' ' THR . 47.1 p90 -120.95 168.06 11.89 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.081 -1.012 . . . . 0.0 111.193 -176.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 76.2 m -117.68 144.3 45.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.797 -0.564 . . . . 0.0 109.865 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 35.7 m -115.71 135.59 53.89 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.612 -0.68 . . . . 0.0 110.867 -175.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 62.9 t -131.18 137.28 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 174.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 72.4 mt -104.63 120.34 41.08 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.42 -0.8 . . . . 0.0 109.908 -171.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -105.03 155.39 19.02 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.741 -0.599 . . . . 0.0 110.825 -176.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -136.32 142.9 43.89 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -114.89 128.97 56.6 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.616 -0.677 . . . . 0.0 110.266 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -98.57 9.27 43.61 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.712 -0.617 . . . . 0.0 111.982 -175.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -144.58 161.32 39.43 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.178 -0.951 . . . . 0.0 110.112 173.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -119.91 164.06 16.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.786 -0.571 . . . . 0.0 110.286 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 27.6 m -57.6 -33.93 68.73 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.449 -0.782 . . . . 0.0 110.983 -164.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 67.6 m -105.21 14.95 28.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.497 -0.752 . . . . 0.0 112.042 -164.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 30.1 p -95.17 118.06 31.31 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.103 -0.998 . . . . 0.0 110.677 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 51.9 t -63.19 138.86 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.482 -0.761 . . . . 0.0 110.203 -171.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.76 -5.13 59.78 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 178.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.12 -99.3 0.86 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 172.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 93.4 mmm -63.29 -32.59 74.04 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.796 -0.826 . . . . 0.0 110.328 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.4 p30 44.05 48.75 7.45 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 175.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 54.95 29.97 13.17 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.392 -0.818 . . . . 0.0 111.146 175.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . 0.441 ' NH1' ' CD2' ' A' ' 197' ' ' HIS . 74.0 mtt180 -119.96 105.0 43.36 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.475 -0.766 . . . . 0.0 110.208 175.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -60.53 145.78 98.15 Favored 'Trans proline' 0 N--CA 1.487 1.115 0 O-C-N 123.094 1.049 . . . . 0.0 110.402 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 46.2 pt -131.95 177.63 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.856 0.836 . . . . 0.0 111.249 -175.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 24.8 mt -124.5 149.91 46.36 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.426 HD11 ' CE1' ' A' ' 301' ' ' PHE . 81.2 mt -117.83 130.33 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.318 179.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 80.8 mt -109.79 127.38 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 57.5 t -118.94 126.83 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.4 p -125.33 153.1 43.83 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.745 . . . . 0.0 110.632 -173.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 21.7 tp -104.5 124.39 49.19 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.726 -0.609 . . . . 0.0 109.468 169.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -132.16 151.72 51.64 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.87 -0.519 . . . . 0.0 109.806 -173.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 77.8 p -89.88 159.58 16.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.558 -0.714 . . . . 0.0 109.768 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -55.94 -26.11 46.43 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.564 -0.71 . . . . 0.0 110.789 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -88.34 9.76 22.19 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.552 -0.717 . . . . 0.0 111.808 -174.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 87.25 20.22 53.07 Favored Glycine 0 N--CA 1.495 2.583 0 O-C-N 121.083 -1.011 . . . . 0.0 110.687 170.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -106.21 140.15 39.61 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.218 -1.166 . . . . 0.0 110.231 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 59.1 t -89.59 130.97 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.592 -0.692 . . . . 0.0 110.29 -173.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 95.6 mt -100.11 -40.08 7.77 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.781 -0.574 . . . . 0.0 110.528 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -166.25 154.67 25.38 Favored Glycine 0 N--CA 1.497 2.719 0 C-N-CA 119.898 -1.144 . . . . 0.0 110.391 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -135.09 137.46 42.87 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.692 -0.887 . . . . 0.0 110.667 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -137.67 157.82 45.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.684 -0.635 . . . . 0.0 109.963 170.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 78.7 m -141.33 156.81 45.8 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.43 -0.794 . . . . 0.0 110.684 -175.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.426 ' CE1' HD11 ' A' ' 284' ' ' ILE . 47.8 p90 -144.91 162.14 37.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.681 -0.637 . . . . 0.0 110.164 175.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -104.94 134.5 47.95 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.501 -0.749 . . . . 0.0 110.051 -177.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -118.78 143.99 46.57 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.728 -169.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 55.7 ttt85 -138.3 136.79 36.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.766 -0.584 . . . . 0.0 109.792 172.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 78.9 mt -108.27 123.0 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.608 -0.682 . . . . 0.0 109.542 177.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.4 p -145.07 172.82 12.53 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.571 -0.706 . . . . 0.0 110.769 -171.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -72.21 -40.09 68.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.676 -0.64 . . . . 0.0 110.566 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.8 t -131.26 89.08 42.45 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.627 -0.671 . . . . 0.0 110.53 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.3 -29.57 58.2 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 O-C-N 123.162 1.085 . . . . 0.0 110.996 173.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -65.95 -37.81 93.57 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -72.5 -41.04 66.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.758 -0.848 . . . . 0.0 109.829 -173.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -69.45 -39.61 77.68 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 120.056 -0.657 . . . . 0.0 110.076 -178.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -61.6 -43.23 99.25 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.284 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -64.27 -40.12 95.32 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.613 -0.679 . . . . 0.0 110.503 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.64 -50.95 70.49 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.502 -0.749 . . . . 0.0 110.512 -173.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -61.38 -37.77 84.62 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.507 -0.746 . . . . 0.0 110.142 -177.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -64.96 -40.7 95.4 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.593 -0.692 . . . . 0.0 110.247 178.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -62.78 -35.16 78.93 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.552 -0.718 . . . . 0.0 110.2 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 54.7 p -66.11 -29.31 69.61 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.64 -0.662 . . . . 0.0 110.294 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 83.9 mt -79.71 -45.74 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.638 -0.664 . . . . 0.0 109.919 -178.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -59.17 -41.71 89.09 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.588 -0.695 . . . . 0.0 110.516 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -61.42 -45.47 94.18 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.578 -0.701 . . . . 0.0 110.219 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -64.73 -33.79 76.79 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.682 -0.636 . . . . 0.0 110.304 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -94.89 125.06 39.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.63 -0.669 . . . . 0.0 110.529 -175.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 62.3 t -120.29 130.09 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.653 -0.654 . . . . 0.0 109.694 176.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 30.7 t -95.07 132.86 39.51 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.646 -0.658 . . . . 0.0 110.401 -177.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -92.29 123.12 35.38 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.699 -0.626 . . . . 0.0 110.167 177.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 30.4 t -86.16 133.0 33.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.576 -0.703 . . . . 0.0 110.2 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 40.9 m -96.03 -26.15 15.64 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.655 -0.653 . . . . 0.0 110.606 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -70.78 135.71 48.35 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.484 -0.76 . . . . 0.0 110.269 -178.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 54.38 44.89 28.24 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.511 -0.743 . . . . 0.0 110.826 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -171.81 179.25 43.62 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -86.08 123.93 31.93 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.662 -0.905 . . . . 0.0 110.256 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -60.18 143.7 51.79 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.582 -0.699 . . . . 0.0 110.261 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -65.25 -29.84 70.66 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.639 -0.663 . . . . 0.0 110.407 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 55.46 -85.02 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.704 -0.622 . . . . 0.0 110.884 -176.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -90.52 136.69 32.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.097 -1.002 . . . . 0.0 110.108 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -87.57 108.23 18.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.664 -0.647 . . . . 0.0 110.324 -177.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 76.8 p -114.93 25.48 10.89 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.716 -0.615 . . . . 0.0 110.374 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -114.5 143.79 44.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.543 -0.723 . . . . 0.0 110.375 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 151.9 45.43 0.02 OUTLIER Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 16.9 tt -145.37 137.22 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.633 -0.922 . . . . 0.0 110.152 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -89.37 -62.58 1.45 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.616 -0.677 . . . . 0.0 110.215 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 87.4 mtp -122.64 -39.87 2.5 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.665 -0.647 . . . . 0.0 110.234 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 12.3 p . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.264 -179.707 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 67.4 m -154.79 158.04 38.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.588 -0.948 . . . . 0.0 110.175 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.1 m -119.91 149.28 42.36 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.703 -0.623 . . . . 0.0 110.279 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 71.2 p -99.93 162.59 12.9 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.638 -0.664 . . . . 0.0 110.185 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 53.64 27.0 6.27 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.532 -0.73 . . . . 0.0 110.745 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -84.99 171.88 11.76 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.683 -0.636 . . . . 0.0 110.565 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 51.99 24.07 2.47 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.455 -0.778 . . . . 0.0 111.251 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.2 mt 55.18 -86.15 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.656 -0.653 . . . . 0.0 111.159 -178.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.1 p -69.84 164.25 53.04 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.115 -0.991 . . . . 0.0 110.164 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -63.77 151.21 71.14 Favored 'Cis proline' 0 N--CA 1.495 1.615 0 C-N-CA 123.161 -1.6 . . . . 0.0 110.41 -18.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.1 p -81.37 144.59 53.86 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.651 -0.656 . . . . 0.0 110.059 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -60.25 145.72 97.96 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 O-C-N 123.188 1.099 . . . . 0.0 110.61 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.58 144.69 41.7 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.617 -0.677 . . . . 0.0 110.082 177.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 49.0 mm -122.63 99.84 41.73 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.585 -0.697 . . . . 0.0 110.096 -177.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.45 154.36 64.79 Favored 'Trans proline' 0 C--N 1.316 -1.168 0 O-C-N 123.261 1.137 . . . . 0.0 110.586 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 30.4 t -112.29 145.32 40.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.681 -0.637 . . . . 0.0 110.31 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 p-10 -96.31 26.06 4.56 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.636 -0.665 . . . . 0.0 110.598 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 47.6 m -73.94 125.13 27.52 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.575 -0.703 . . . . 0.0 110.395 -178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -73.36 144.98 46.25 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.689 -0.632 . . . . 0.0 110.462 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.407 ' CE2' ' HA2' ' A' ' 134' ' ' GLY . 62.8 t80 -157.01 101.78 1.94 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.7 -0.625 . . . . 0.0 110.137 178.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -58.64 -39.9 78.42 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 O-C-N 123.094 1.049 . . . . 0.0 110.948 -175.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.407 ' HA2' ' CE2' ' A' ' 132' ' ' TYR . . . 78.76 -155.12 40.66 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 178.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -73.14 -49.1 0.24 Allowed 'Trans proline' 0 C--N 1.317 -1.116 0 O-C-N 123.337 1.177 . . . . 0.0 110.874 -174.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -85.18 6.67 24.88 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.626 -0.672 . . . . 0.0 111.432 -174.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 t 54.17 62.09 2.75 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.964 -1.085 . . . . 0.0 110.675 -176.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.433 ' CE2' ' CG2' ' A' ' 174' ' ' ILE . 59.3 t80 -77.87 120.86 23.34 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.655 -0.653 . . . . 0.0 109.993 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -130.06 159.95 35.19 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.309 0.576 . . . . 0.0 110.134 -177.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 64.8 t -124.97 145.23 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.76 -0.588 . . . . 0.0 109.897 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 80.0 p -155.41 160.94 41.05 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.345 0.593 . . . . 0.0 109.937 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.49 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 59.8 m-85 -126.64 125.21 41.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.728 -0.608 . . . . 0.0 109.848 -176.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -58.03 143.23 44.08 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.545 -0.722 . . . . 0.0 110.34 -175.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -120.12 158.04 27.72 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.573 -0.705 . . . . 0.0 110.566 -175.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.7 p -147.74 170.87 16.65 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.773 -0.58 . . . . 0.0 110.019 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 39.7 m -59.89 157.86 11.7 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.586 -0.696 . . . . 0.0 110.209 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 33.9 p -59.7 90.91 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.616 -0.678 . . . . 0.0 110.388 -177.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.02 152.49 21.15 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.725 -0.61 . . . . 0.0 110.241 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -79.9 149.37 30.93 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.734 -0.604 . . . . 0.0 110.009 177.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.2 p 50.6 35.59 11.89 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.534 -0.729 . . . . 0.0 111.247 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.9 132.23 52.33 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.6 -0.687 . . . . 0.0 110.068 177.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 82.1 p -60.06 -33.99 72.81 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.689 -0.632 . . . . 0.0 109.933 176.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.416 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.8 p-90 -170.74 143.5 2.14 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.366 0.603 . . . . 0.0 110.238 177.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.6 t -142.11 142.58 32.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.9 -0.5 . . . . 0.0 109.978 -176.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.49 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 60.9 t80 -125.58 140.01 53.11 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.496 -0.753 . . . . 0.0 110.771 -172.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 31.5 t -112.2 125.02 53.69 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.007 177.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 54.1 m -70.81 -37.12 73.22 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.724 -0.61 . . . . 0.0 110.534 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -59.25 -34.55 72.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.618 -0.676 . . . . 0.0 110.502 -177.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.1 mt -104.84 -12.0 16.49 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.933 -175.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 49.7 tttt 59.83 51.37 6.14 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.991 -1.068 . . . . 0.0 109.637 178.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -145.15 153.13 41.05 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.571 -173.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.9 tp -126.54 137.71 53.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.788 -0.57 . . . . 0.0 110.208 -176.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -115.59 134.42 55.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.64 -0.662 . . . . 0.0 109.292 173.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.43 158.62 43.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.736 -0.602 . . . . 0.0 110.85 -177.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -104.42 143.08 33.49 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.553 -0.717 . . . . 0.0 109.795 171.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 17.3 tt -52.44 148.45 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.538 -0.727 . . . . 0.0 111.851 -173.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 66.38 9.13 6.2 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.624 -0.672 . . . . 0.0 112.596 175.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -94.41 155.13 17.11 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.933 -1.105 . . . . 0.0 110.983 172.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 88.5 m -84.07 126.21 32.85 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.719 -0.613 . . . . 0.0 110.433 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 48.5 t -113.09 90.19 15.58 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.658 -0.652 . . . . 0.0 110.075 174.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.416 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 22.5 Cg_exo -61.33 130.52 32.4 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.276 1.145 . . . . 0.0 110.704 173.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.42 HG12 ' CE2' ' A' ' 142' ' ' PHE . 94.5 mt -124.61 141.91 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.639 -0.663 . . . . 0.0 109.28 175.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . 0.436 ' NE2' ' CE1' ' A' ' 260' ' ' PHE . 98.4 mt-30 -108.9 136.45 48.43 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.524 -0.735 . . . . 0.0 110.826 -175.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.433 ' CG2' ' CE2' ' A' ' 138' ' ' PHE . 48.5 mm -95.24 135.06 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.694 -0.629 . . . . 0.0 109.64 169.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -117.65 129.37 55.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.606 -0.684 . . . . 0.0 110.405 176.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 17.1 m -136.67 159.75 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.538 -0.726 . . . . 0.0 110.057 175.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 80.7 mmm -77.46 -40.3 43.64 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.703 -0.623 . . . . 0.0 110.122 177.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 75.6 p -135.48 143.24 44.37 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.744 -0.597 . . . . 0.0 109.693 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -55.49 139.89 82.56 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 O-C-N 123.114 1.06 . . . . 0.0 110.911 -172.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.43 ' HG2' ' CD1' ' A' ' 251' ' ' TYR . 32.1 Cg_endo -67.67 169.98 14.84 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 O-C-N 123.211 1.111 . . . . 0.0 110.565 177.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -60.49 155.32 47.98 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.35 1.184 . . . . 0.0 110.551 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -77.8 140.61 39.43 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.591 -0.693 . . . . 0.0 109.925 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.65 -24.93 29.47 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -174.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.16 152.78 1.61 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.337 -1.096 . . . . 0.0 111.404 178.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.8 155.89 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.713 -0.617 . . . . 0.0 109.765 176.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 81.1 mt -108.89 138.17 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.645 -0.659 . . . . 0.0 109.49 176.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -115.08 146.05 41.7 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -175.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -139.03 128.48 24.34 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.535 -0.728 . . . . 0.0 110.226 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 26.3 ttp -137.27 136.37 20.64 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.788 -0.57 . . . . 0.0 110.905 -176.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -91.86 138.08 1.96 Allowed 'Trans proline' 0 C--N 1.32 -0.953 0 O-C-N 123.164 1.086 . . . . 0.0 110.643 177.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 35.2 m -148.42 154.95 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.528 -0.733 . . . . 0.0 109.907 174.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.447 ' CE2' ' CG2' ' A' ' 202' ' ' VAL . 91.3 m-85 -60.6 163.92 5.01 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.447 -0.783 . . . . 0.0 110.413 -178.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -79.93 -59.99 2.51 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.661 -0.65 . . . . 0.0 110.785 -174.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 35.0 mttm -80.03 150.68 30.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.628 -0.67 . . . . 0.0 110.395 -175.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.43 -38.3 71.39 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.435 -0.791 . . . . 0.0 110.718 -175.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -56.49 -25.04 49.96 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.518 -0.739 . . . . 0.0 110.594 -175.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -110.01 -20.56 12.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.58 -0.7 . . . . 0.0 111.088 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.1 p -67.02 -20.27 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.137 -0.977 . . . . 0.0 110.592 -176.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 81.6 p -79.34 -17.06 55.29 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.545 -0.722 . . . . 0.0 110.753 175.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -88.39 138.79 31.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.38 -0.825 . . . . 0.0 110.041 173.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 57.6 t -73.24 142.73 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.585 -0.697 . . . . 0.0 110.156 176.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.447 ' CG2' ' CE2' ' A' ' 192' ' ' TYR . 77.8 t -84.9 140.15 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.552 -0.718 . . . . 0.0 109.443 171.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.2 pttp -134.84 -170.27 2.53 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.539 -0.726 . . . . 0.0 110.873 -169.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -95.28 156.38 16.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.735 -0.603 . . . . 0.0 110.52 178.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 60.1 m -72.86 163.59 67.12 Favored Pre-proline 0 N--CA 1.497 1.887 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 172.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -64.23 -47.58 5.99 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.031 1.016 . . . . 0.0 109.927 178.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.435 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.4 p-10 -65.42 -43.57 90.12 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.602 -0.686 . . . . 0.0 111.149 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . 0.435 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 54.2 m170 -80.32 -27.88 38.29 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.455 -0.778 . . . . 0.0 111.264 -175.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -67.76 -34.96 77.84 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.405 -0.809 . . . . 0.0 110.223 174.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 26.5 tp -53.81 -33.19 55.34 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.435 -0.791 . . . . 0.0 110.751 177.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 29.9 t -48.45 -27.04 2.41 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.503 -0.748 . . . . 0.0 111.373 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -53.47 -35.22 60.32 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.495 -0.753 . . . . 0.0 110.918 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . 0.418 ' HG3' ' CD2' ' A' ' 214' ' ' PHE . 25.0 tp10 -60.27 151.74 26.7 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.679 -0.638 . . . . 0.0 110.196 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.418 ' CD2' ' HG3' ' A' ' 213' ' ' GLU . 95.9 m-85 53.09 57.37 6.38 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.515 -0.741 . . . . 0.0 110.98 -177.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -66.09 -10.2 38.28 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.508 -0.745 . . . . 0.0 110.966 176.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -58.04 125.16 21.96 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.17 -0.956 . . . . 0.0 110.319 173.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 95.13 2.57 62.23 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 120.362 -0.923 . . . . 0.0 110.931 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -114.63 139.91 49.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.023 -1.281 . . . . 0.0 110.259 170.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.1 mt -89.73 -25.2 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.617 -0.677 . . . . 0.0 110.589 -176.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -124.88 130.05 24.36 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.417 -0.802 . . . . 0.0 110.29 -175.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.451 ' CG ' ' CE2' ' A' ' 236' ' ' TYR . 23.4 Cg_endo -65.76 109.88 1.55 Allowed 'Trans proline' 0 N--CA 1.487 1.128 0 O-C-N 123.061 1.032 . . . . 0.0 110.628 -173.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -60.14 -15.88 36.68 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 O-C-N 123.07 1.037 . . . . 0.0 111.438 -178.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 25.4 m -49.41 -28.56 5.28 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.143 -0.973 . . . . 0.0 111.681 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . 0.402 ' CD2' ' O ' ' A' ' 226' ' ' ILE . 5.6 t60 -107.76 139.78 41.81 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.454 -0.779 . . . . 0.0 110.482 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 40.7 tp -58.29 -38.61 77.36 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.648 -0.657 . . . . 0.0 110.566 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.402 ' O ' ' CD2' ' A' ' 224' ' ' HIS . 91.3 mt -107.67 136.77 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 121.159 0.504 . . . . 0.0 110.111 -176.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 71.9 mtm-85 -140.53 167.92 21.02 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.638 -0.664 . . . . 0.0 110.1 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 82.9 t -105.28 146.73 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.37 0.605 . . . . 0.0 110.211 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -116.39 130.0 56.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.729 -0.607 . . . . 0.0 110.356 169.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.36 25.26 16.65 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 167.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -140.9 107.45 5.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.443 -1.034 . . . . 0.0 110.061 175.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 27.2 t -62.89 -15.26 54.4 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.588 -0.695 . . . . 0.0 111.329 -177.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 63.1 m170 -99.77 6.38 45.47 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.21 -0.931 . . . . 0.0 111.612 -177.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.32 128.51 36.71 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.081 -1.012 . . . . 0.0 110.241 176.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -139.75 158.05 44.74 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.785 -0.572 . . . . 0.0 109.681 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.451 ' CE2' ' CG ' ' A' ' 221' ' ' PRO . 93.4 m-85 -116.86 150.6 38.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.574 -0.704 . . . . 0.0 110.686 -176.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.14 159.94 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.81 -0.556 . . . . 0.0 110.167 177.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -120.59 130.0 54.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.775 -0.578 . . . . 0.0 110.193 176.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -65.09 130.1 94.71 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.706 -0.621 . . . . 0.0 109.878 177.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -66.37 -27.62 47.35 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 O-C-N 123.128 1.068 . . . . 0.0 111.038 -171.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 82.9 mt -100.43 -50.41 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.292 -0.88 . . . . 0.0 111.013 -167.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.7 p -105.38 12.14 31.93 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.326 -0.859 . . . . 0.0 111.828 -175.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.86 -5.63 11.93 Favored Glycine 0 N--CA 1.496 2.678 0 O-C-N 121.131 -0.981 . . . . 0.0 111.832 174.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 22.9 mmt85 -46.09 142.0 2.99 Favored 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 119.194 1.497 . . . . 0.0 112.23 -173.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -105.59 145.43 30.99 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.607 -0.683 . . . . 0.0 110.091 175.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.0 p -154.74 159.92 40.99 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.623 -0.673 . . . . 0.0 110.534 176.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 8.2 p -123.82 148.1 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.731 -0.606 . . . . 0.0 109.695 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 81.7 mt -129.76 154.57 47.07 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.867 -176.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 35.7 m -150.69 151.67 30.89 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.813 -0.554 . . . . 0.0 109.986 174.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -71.1 140.03 36.85 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 O-C-N 123.329 1.173 . . . . 0.0 110.085 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.43 ' CD1' ' HG2' ' A' ' 180' ' ' PRO . 58.7 t80 -76.6 126.1 30.39 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.505 -0.747 . . . . 0.0 110.194 174.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -100.08 160.09 28.09 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.687 -0.633 . . . . 0.0 109.887 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.88 159.84 20.01 Favored 'Trans proline' 0 N--CA 1.488 1.188 0 O-C-N 123.204 1.107 . . . . 0.0 110.403 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.07 150.03 75.97 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 O-C-N 123.274 1.144 . . . . 0.0 110.501 -177.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -61.6 146.76 47.88 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.674 -0.641 . . . . 0.0 110.123 -178.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.84 127.2 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.517 -0.739 . . . . 0.0 110.145 -170.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.02 -10.2 55.32 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.4 ' OG1' ' CD2' ' A' ' 260' ' ' PHE . 9.8 t -144.23 174.39 10.93 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.105 -1.233 . . . . 0.0 110.641 176.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -108.84 13.13 25.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.595 -0.691 . . . . 0.0 111.948 -167.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . 0.436 ' CE1' ' NE2' ' A' ' 173' ' ' GLN . 46.6 p90 -121.76 168.11 12.2 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.155 -0.965 . . . . 0.0 111.122 -176.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 85.5 m -117.77 145.86 44.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.778 -0.576 . . . . 0.0 109.87 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 55.3 m -116.02 135.58 53.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.633 -0.667 . . . . 0.0 110.903 -174.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.9 t -131.77 137.27 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 173.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 77.2 mt -104.69 121.6 43.91 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.477 -0.764 . . . . 0.0 110.005 -170.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -107.94 149.24 28.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.705 -0.622 . . . . 0.0 110.556 -176.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -136.55 143.01 43.45 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.674 -0.642 . . . . 0.0 109.545 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -120.2 136.99 54.45 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.638 -0.664 . . . . 0.0 110.452 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.43 12.53 31.41 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 120.179 -0.608 . . . . 0.0 112.195 -176.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -144.6 159.16 43.26 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.075 -1.016 . . . . 0.0 109.838 176.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -120.31 163.42 17.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.651 -0.656 . . . . 0.0 110.401 -177.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 43.4 m -57.11 -34.18 68.1 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.46 -0.775 . . . . 0.0 111.1 -165.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 65.5 m -104.6 15.02 28.84 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.411 -0.806 . . . . 0.0 111.967 -164.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 30.3 p -93.61 118.03 30.85 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.088 -1.007 . . . . 0.0 110.581 178.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.2 t -63.58 139.45 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.442 -0.786 . . . . 0.0 110.419 -169.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.47 -5.09 60.35 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.97 -99.33 0.87 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 173.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 93.5 mmm -61.42 -31.87 71.81 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.614 -0.933 . . . . 0.0 110.109 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 23.6 p30 42.25 47.02 4.02 Favored 'General case' 0 N--CA 1.507 2.38 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 174.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 22.9 mtt180 54.87 31.58 16.04 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.274 -0.891 . . . . 0.0 111.207 176.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 -120.1 104.94 43.11 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.458 -0.776 . . . . 0.0 110.056 173.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -59.99 148.24 89.75 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 O-C-N 123.094 1.049 . . . . 0.0 110.468 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 46.7 pt -131.86 176.74 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.806 0.812 . . . . 0.0 111.118 -175.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 27.5 mt -124.37 149.83 46.23 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.425 HD12 ' CE1' ' A' ' 301' ' ' PHE . 81.4 mt -116.89 130.76 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.21 178.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 79.4 mt -109.8 126.37 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 58.7 t -118.92 126.75 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 46.1 p -125.21 153.54 42.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.554 -0.716 . . . . 0.0 110.721 -173.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.422 ' HB2' ' CE2' ' A' ' 138' ' ' PHE . 26.3 tp -104.08 126.42 51.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.785 -0.572 . . . . 0.0 109.5 169.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -130.44 150.25 51.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.91 -0.494 . . . . 0.0 109.861 -173.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.402 ' CG2' ' CD1' ' A' ' 296' ' ' LEU . 22.8 p -89.87 161.73 15.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.687 -0.633 . . . . 0.0 109.928 177.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -55.89 -26.15 45.96 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.641 -0.662 . . . . 0.0 111.042 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 45.6 p30 -89.87 9.19 28.53 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.408 -0.807 . . . . 0.0 112.004 -173.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.61 20.19 45.36 Favored Glycine 0 N--CA 1.494 2.522 0 O-C-N 121.09 -1.006 . . . . 0.0 110.725 171.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -107.03 140.21 40.2 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.295 -1.121 . . . . 0.0 110.163 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 72.1 t -85.24 132.79 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.588 -0.695 . . . . 0.0 110.228 -174.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.402 ' CD1' ' CG2' ' A' ' 290' ' ' THR . 95.2 mt -100.01 -40.15 7.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.621 -0.674 . . . . 0.0 110.399 176.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -163.64 153.44 23.88 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -133.87 136.19 44.18 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.609 -0.936 . . . . 0.0 110.648 -178.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -134.73 157.81 45.75 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.611 -0.681 . . . . 0.0 110.026 172.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 95.3 m -143.02 153.25 42.78 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.474 -0.766 . . . . 0.0 110.629 -176.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.425 ' CE1' HD12 ' A' ' 284' ' ' ILE . 47.8 p90 -145.01 162.38 37.06 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.631 -0.668 . . . . 0.0 110.174 176.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -104.86 135.11 46.82 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.543 -0.723 . . . . 0.0 110.238 -176.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -120.09 143.61 48.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.62 -0.675 . . . . 0.0 110.737 -170.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -138.28 138.29 38.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.786 -0.571 . . . . 0.0 109.74 173.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 73.9 mt -109.01 122.96 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.541 -0.724 . . . . 0.0 109.667 176.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.3 p -145.17 171.56 14.35 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.625 -0.672 . . . . 0.0 110.657 -172.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -70.89 -40.11 72.4 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.658 -0.651 . . . . 0.0 110.494 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.8 t -130.44 89.11 45.23 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.524 -0.735 . . . . 0.0 110.467 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.25 -29.27 56.34 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 O-C-N 123.146 1.077 . . . . 0.0 111.025 173.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -65.63 -37.81 93.96 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 177.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 37.6 ttp180 -72.82 -42.1 64.18 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.714 -0.874 . . . . 0.0 109.938 -173.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -69.53 -40.47 76.89 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.172 -178.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 73.2 ttt-85 -60.23 -43.38 96.1 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.449 -0.782 . . . . 0.0 110.351 178.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -64.42 -41.02 96.84 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.585 -0.697 . . . . 0.0 110.522 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -60.94 -50.14 74.62 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.506 -0.746 . . . . 0.0 110.462 -173.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -61.92 -37.77 85.88 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.433 -0.792 . . . . 0.0 110.06 -178.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -62.04 -41.27 97.95 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.631 -0.668 . . . . 0.0 110.141 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -62.8 -35.25 79.26 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.565 -0.71 . . . . 0.0 109.925 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 23.4 m -63.81 -33.0 74.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.719 -0.613 . . . . 0.0 110.221 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 84.2 mt -79.25 -45.09 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.689 -0.632 . . . . 0.0 109.927 -176.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -60.21 -41.49 93.16 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.622 -0.674 . . . . 0.0 110.38 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -64.52 -46.72 81.7 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.598 -0.688 . . . . 0.0 110.252 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -66.92 -35.1 79.23 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.668 -0.645 . . . . 0.0 110.383 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -97.85 124.98 42.49 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.591 -0.693 . . . . 0.0 110.547 -175.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 62.4 t -113.08 130.12 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.641 -0.662 . . . . 0.0 109.733 177.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 29.4 t -91.16 140.0 30.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.689 -0.632 . . . . 0.0 110.372 -176.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -85.16 122.01 28.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.718 -0.613 . . . . 0.0 110.298 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 29.7 t -67.91 152.88 44.86 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.674 -0.641 . . . . 0.0 110.146 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 70.6 p -92.19 -22.09 20.02 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.643 -0.66 . . . . 0.0 110.619 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -59.71 -34.11 72.49 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.419 -0.8 . . . . 0.0 110.282 177.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -100.9 108.73 20.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.704 -0.622 . . . . 0.0 110.263 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -61.42 -35.39 90.95 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 46.5 p30 -154.93 160.0 40.83 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.648 -0.913 . . . . 0.0 110.419 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -61.43 142.58 56.88 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.685 -0.634 . . . . 0.0 110.198 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -139.54 159.56 41.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.588 -0.695 . . . . 0.0 110.378 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 55.17 -86.03 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.724 -0.61 . . . . 0.0 111.18 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -76.29 133.86 39.93 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.214 -0.929 . . . . 0.0 110.337 -175.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -121.39 153.43 37.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.681 -0.637 . . . . 0.0 110.234 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 9.8 t -132.21 155.52 48.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.652 -0.655 . . . . 0.0 110.433 179.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -125.99 145.37 50.33 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.673 -0.642 . . . . 0.0 110.212 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -84.82 179.61 51.23 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 82.0 mt -95.29 133.73 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.683 -0.892 . . . . 0.0 110.101 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 54.9 47.34 22.49 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.469 -0.77 . . . . 0.0 110.952 178.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 64.6 mtt -123.39 156.08 36.13 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.582 -0.699 . . . . 0.0 110.202 176.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 7.4 t . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 118.103 -0.951 . . . . 0.0 110.212 -179.879 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.348 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 60.4 m -85.3 155.76 21.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.576 -0.955 . . . . 0.0 110.325 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 84.2 p -141.09 164.61 29.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.62 -0.675 . . . . 0.0 110.103 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 47.5 m -109.2 130.52 55.49 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.648 -0.657 . . . . 0.0 110.313 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -62.85 -39.24 93.8 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.663 -0.648 . . . . 0.0 110.299 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -83.21 138.98 33.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.631 -0.668 . . . . 0.0 110.386 -176.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 53.2 -156.07 0.19 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.373 -0.83 . . . . 0.0 110.856 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 28.0 tp 54.12 89.43 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.279 -0.888 . . . . 0.0 110.781 -177.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.4 t -60.8 162.41 12.21 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.689 -0.632 . . . . 0.0 110.113 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -67.97 153.86 87.65 Favored 'Cis proline' 0 N--CA 1.496 1.661 0 C-N-CA 123.228 -1.572 . . . . 0.0 110.499 -13.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.0 p -82.68 164.75 45.6 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.651 -0.656 . . . . 0.0 110.163 178.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -58.96 148.1 86.57 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 O-C-N 123.244 1.128 . . . . 0.0 110.668 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.81 143.08 42.08 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.686 -0.633 . . . . 0.0 110.251 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 49.7 mm -124.22 99.99 36.52 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.641 -0.662 . . . . 0.0 109.984 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -60.2 151.42 73.45 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 O-C-N 123.194 1.102 . . . . 0.0 110.513 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.6 t -111.25 151.29 28.46 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.589 -0.694 . . . . 0.0 110.313 -177.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -93.85 22.92 5.19 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.614 -0.679 . . . . 0.0 110.893 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 48.2 m -71.67 125.14 26.34 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.542 -0.724 . . . . 0.0 110.226 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -70.74 144.9 50.78 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.715 -0.615 . . . . 0.0 110.461 -177.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.416 ' CE1' ' HA2' ' A' ' 134' ' ' GLY . 64.9 t80 -154.93 101.37 2.32 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.72 -0.613 . . . . 0.0 110.061 178.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -58.79 -39.88 77.67 Favored 'Trans proline' 0 N--CA 1.488 1.153 0 O-C-N 123.115 1.061 . . . . 0.0 110.799 -174.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.416 ' HA2' ' CE1' ' A' ' 132' ' ' TYR . . . 81.64 -155.2 35.22 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 177.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -74.27 -48.89 0.2 Allowed 'Trans proline' 0 C--N 1.316 -1.156 0 O-C-N 123.385 1.203 . . . . 0.0 110.873 -174.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -86.98 9.03 20.76 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.635 -0.665 . . . . 0.0 111.403 -173.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.57 62.11 2.79 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.99 -1.069 . . . . 0.0 110.686 -177.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.444 ' CE1' ' CG2' ' A' ' 174' ' ' ILE . 65.2 t80 -79.27 119.3 22.15 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.559 -0.713 . . . . 0.0 110.048 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -130.05 159.94 35.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.785 -0.572 . . . . 0.0 110.37 -175.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 59.4 t -125.11 146.54 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.698 -0.626 . . . . 0.0 109.819 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.6 p -155.18 161.55 41.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.736 -0.602 . . . . 0.0 110.024 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.422 ' CE2' HG12 ' A' ' 172' ' ' ILE . 41.2 m-85 -126.7 125.16 41.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.789 -0.57 . . . . 0.0 109.923 -176.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -60.2 137.31 58.14 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.592 -0.692 . . . . 0.0 110.146 -176.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -109.19 140.14 43.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.602 -0.686 . . . . 0.0 110.495 -174.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 97.1 p -131.19 160.53 34.54 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.8 -0.562 . . . . 0.0 110.115 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 55.8 p -63.84 164.96 9.28 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.586 -0.697 . . . . 0.0 110.161 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.4 t -63.66 84.5 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.728 -0.608 . . . . 0.0 110.329 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -89.97 162.08 15.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.62 -0.675 . . . . 0.0 110.236 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 36.4 mttp -73.29 141.78 47.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.612 -0.68 . . . . 0.0 110.138 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 52.44 63.65 2.16 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.453 -0.78 . . . . 0.0 110.954 -178.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -84.11 121.33 27.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.596 -0.69 . . . . 0.0 110.076 178.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 44.1 p -60.12 -34.09 73.03 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.682 -0.636 . . . . 0.0 110.229 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.429 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.0 p-90 -171.26 144.29 2.0 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.62 -0.675 . . . . 0.0 110.117 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.4 t -142.13 142.7 32.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.882 -0.511 . . . . 0.0 109.992 -176.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.403 ' CG ' ' HB2' ' A' ' 142' ' ' PHE . 63.2 t80 -125.41 140.06 53.12 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.54 -0.725 . . . . 0.0 110.423 -173.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.8 t -110.56 123.96 50.94 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 120.379 -0.529 . . . . 0.0 109.811 176.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 56.1 m -70.71 -37.1 73.53 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.872 -0.518 . . . . 0.0 110.376 -177.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -59.75 -33.28 71.46 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.58 -0.7 . . . . 0.0 110.478 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 57.7 mt -104.81 -11.96 16.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.666 -0.646 . . . . 0.0 110.81 -175.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 79.9 tttt 59.79 49.65 7.81 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.978 -1.076 . . . . 0.0 109.704 177.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -146.58 153.03 39.88 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.8 -174.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.6 tp -126.58 137.84 53.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.841 -0.537 . . . . 0.0 110.413 -175.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -117.66 134.27 55.07 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.645 -0.659 . . . . 0.0 109.487 175.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.35 158.4 44.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.671 -0.643 . . . . 0.0 111.173 -174.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -104.63 141.3 36.67 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.585 -0.697 . . . . 0.0 110.525 172.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 18.8 tt -55.39 149.9 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.594 -0.691 . . . . 0.0 111.444 -175.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 64.79 10.08 5.78 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.559 -0.713 . . . . 0.0 112.481 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -96.18 155.07 16.91 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.959 -1.088 . . . . 0.0 110.611 172.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 77.4 m -81.16 126.07 31.03 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.631 -0.668 . . . . 0.0 110.325 177.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 43.5 t -115.13 89.64 21.04 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.652 -0.655 . . . . 0.0 110.273 175.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.429 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 15.5 Cg_exo -65.8 124.94 13.42 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 O-C-N 123.281 1.148 . . . . 0.0 110.675 173.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.422 HG12 ' CE2' ' A' ' 142' ' ' PHE . 97.3 mt -119.87 140.83 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.634 -0.667 . . . . 0.0 109.246 172.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -106.79 135.46 48.29 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.454 -0.779 . . . . 0.0 110.74 -174.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.444 ' CG2' ' CE1' ' A' ' 138' ' ' PHE . 49.6 mm -95.27 134.97 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.708 -0.62 . . . . 0.0 109.687 170.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -117.48 130.69 56.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.557 -0.714 . . . . 0.0 110.44 176.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.6 m -136.67 159.75 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.573 -0.704 . . . . 0.0 109.99 175.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 80.6 mmm -78.75 -40.56 33.03 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.67 -0.644 . . . . 0.0 110.068 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 76.8 p -135.02 143.24 45.22 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.735 -0.603 . . . . 0.0 109.722 177.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -55.84 139.89 84.57 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 O-C-N 123.161 1.085 . . . . 0.0 110.855 -172.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.426 ' HG2' ' CD1' ' A' ' 251' ' ' TYR . 32.5 Cg_endo -67.47 170.03 14.44 Favored 'Trans proline' 0 N--CA 1.487 1.113 0 O-C-N 123.131 1.069 . . . . 0.0 110.619 177.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -60.75 157.39 37.92 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 O-C-N 123.293 1.154 . . . . 0.0 110.53 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -79.8 140.87 36.7 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.574 -0.704 . . . . 0.0 109.949 175.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.7 -24.91 29.57 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -174.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.14 153.78 1.34 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.378 -1.072 . . . . 0.0 111.398 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.8 155.95 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.751 -0.593 . . . . 0.0 109.779 176.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 52.4 mt -108.06 135.59 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 -114.78 143.88 44.38 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -176.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -139.47 123.75 18.04 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.598 -0.689 . . . . 0.0 110.408 177.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 26.8 ttm -137.36 138.05 23.96 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.797 -0.564 . . . . 0.0 111.073 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -91.13 138.17 2.27 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 O-C-N 123.187 1.098 . . . . 0.0 110.643 176.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.8 m -146.79 154.85 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.471 -0.768 . . . . 0.0 110.212 173.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.425 ' CE2' HG21 ' A' ' 202' ' ' VAL . 87.1 m-85 -58.49 167.55 1.4 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.511 -0.743 . . . . 0.0 110.679 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -84.94 -60.08 2.15 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.639 -0.663 . . . . 0.0 110.863 -174.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -80.08 152.11 29.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.544 -0.722 . . . . 0.0 110.286 -175.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.67 -38.06 71.68 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.332 -0.855 . . . . 0.0 110.713 -176.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.4 mp0 -56.5 -24.81 48.8 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.483 -0.76 . . . . 0.0 110.616 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.415 ' HB3' ' CD1' ' A' ' 192' ' ' TYR . 99.5 m-70 -109.53 -20.51 12.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.586 -0.696 . . . . 0.0 111.14 -178.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.2 p -68.05 -20.24 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.119 -0.988 . . . . 0.0 110.628 -176.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 78.8 p -79.45 -17.08 55.02 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.577 -0.702 . . . . 0.0 110.649 175.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -88.35 136.34 33.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.386 -0.821 . . . . 0.0 110.017 173.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 60.5 t -73.07 143.76 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.584 -0.698 . . . . 0.0 110.13 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.425 HG21 ' CE2' ' A' ' 192' ' ' TYR . 84.0 t -84.82 139.13 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.538 -0.726 . . . . 0.0 109.217 171.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -134.76 -170.04 2.48 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.508 -0.745 . . . . 0.0 111.157 -165.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -95.2 152.99 17.88 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.795 -0.565 . . . . 0.0 110.206 -176.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 56.5 m -76.5 157.75 82.07 Favored Pre-proline 0 N--CA 1.497 1.897 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 172.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -63.52 -47.45 7.45 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 O-C-N 123.086 1.045 . . . . 0.0 109.998 177.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.402 ' ND2' ' NE2' ' A' ' 208' ' ' HIS . 28.7 p-10 -65.43 -44.39 87.49 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.578 -0.701 . . . . 0.0 111.261 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . 0.402 ' NE2' ' ND2' ' A' ' 207' ' ' ASN . 51.2 m170 -81.72 -27.77 33.72 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.432 -0.793 . . . . 0.0 111.234 -174.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -68.59 -39.71 80.81 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.395 -0.816 . . . . 0.0 110.075 172.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 25.4 tp -58.14 -30.95 66.74 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.605 -0.684 . . . . 0.0 110.66 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 29.8 t -48.37 142.94 5.14 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.553 -0.717 . . . . 0.0 111.554 -178.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.446 ' NH1' ' CE2' ' A' ' 214' ' ' PHE . 6.1 ptm85 -57.22 136.76 56.48 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.666 -0.646 . . . . 0.0 110.816 -175.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -102.21 -70.03 0.77 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.767 -0.583 . . . . 0.0 110.128 177.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.446 ' CE2' ' NH1' ' A' ' 212' ' ' ARG . 93.6 m-85 51.33 73.53 0.3 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.283 -0.886 . . . . 0.0 111.148 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -67.48 -10.18 49.1 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.632 -0.668 . . . . 0.0 111.032 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -60.03 121.19 11.23 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.195 -0.941 . . . . 0.0 110.236 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 80.6 17.88 72.16 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -143.65 139.92 29.83 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.196 -1.179 . . . . 0.0 109.927 175.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 82.9 mt -85.15 -25.2 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.662 -0.649 . . . . 0.0 110.52 -178.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -124.98 89.97 51.79 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.499 -0.751 . . . . 0.0 110.356 -177.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.417 ' HD2' ' CE1' ' A' ' 236' ' ' TYR . 22.6 Cg_endo -67.01 142.06 60.43 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.38 1.2 . . . . 0.0 110.513 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -57.47 -20.79 42.46 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 O-C-N 123.114 1.06 . . . . 0.0 111.46 -176.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 91.2 p -53.79 -22.27 9.14 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.21 -0.931 . . . . 0.0 111.377 -175.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -93.58 131.85 38.46 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.302 -0.874 . . . . 0.0 110.151 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 57.5 tp -59.69 -40.43 87.85 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.553 -0.717 . . . . 0.0 110.161 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 83.9 mt -106.31 136.65 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.905 -0.497 . . . . 0.0 109.707 176.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 40.6 mtm105 -133.52 157.78 44.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.693 -0.629 . . . . 0.0 110.129 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 79.2 t -102.41 146.58 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.649 -0.657 . . . . 0.0 110.098 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -120.76 130.01 53.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.857 -0.527 . . . . 0.0 110.332 171.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.39 20.69 19.29 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 169.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -140.99 107.06 5.18 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.276 -1.132 . . . . 0.0 110.08 174.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 42.8 m -63.3 -15.26 56.7 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.56 -0.712 . . . . 0.0 111.269 -175.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -100.05 8.1 44.21 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.219 -0.925 . . . . 0.0 111.59 -177.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.2 129.4 41.09 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.104 -0.998 . . . . 0.0 110.345 177.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -139.79 158.1 44.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.826 -0.546 . . . . 0.0 109.709 177.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.417 ' CE1' ' HD2' ' A' ' 221' ' ' PRO . 74.4 m-85 -112.16 150.57 30.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.522 -0.736 . . . . 0.0 110.539 -177.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.21 159.9 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.804 -0.56 . . . . 0.0 110.155 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -122.53 130.04 52.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.68 -0.638 . . . . 0.0 110.194 176.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -65.08 130.12 94.72 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.625 -0.672 . . . . 0.0 109.823 178.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -66.48 -27.79 46.34 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 O-C-N 123.155 1.082 . . . . 0.0 111.006 -171.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 82.8 mt -100.55 -50.39 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.471 -0.768 . . . . 0.0 110.99 -167.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.1 p -105.47 12.11 31.82 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.41 -0.806 . . . . 0.0 111.877 -174.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.82 -5.11 13.24 Favored Glycine 0 N--CA 1.496 2.638 0 O-C-N 121.128 -0.982 . . . . 0.0 111.9 173.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -46.11 142.02 3.0 Favored 'General case' 0 N--CA 1.504 2.234 0 CA-C-N 119.104 1.452 . . . . 0.0 112.3 -174.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.6 mp0 -106.09 141.62 37.15 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.577 -0.702 . . . . 0.0 110.156 176.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 80.0 p -154.84 159.96 40.9 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.585 -0.697 . . . . 0.0 110.45 177.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 8.4 p -123.72 148.22 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.735 -0.603 . . . . 0.0 109.793 178.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 82.9 mt -129.57 154.63 46.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.644 -0.66 . . . . 0.0 110.094 -175.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 35.9 m -151.51 151.83 29.53 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.781 -0.574 . . . . 0.0 109.934 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -71.14 139.33 35.3 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 O-C-N 123.254 1.133 . . . . 0.0 109.993 176.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.426 ' CD1' ' HG2' ' A' ' 180' ' ' PRO . 60.6 t80 -75.06 124.48 27.07 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.42 -0.8 . . . . 0.0 110.21 176.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -100.04 160.12 28.03 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.665 -0.647 . . . . 0.0 110.072 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -59.53 159.95 22.05 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 O-C-N 123.241 1.127 . . . . 0.0 110.448 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -59.45 149.92 78.63 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 O-C-N 123.243 1.128 . . . . 0.0 110.426 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -60.91 147.63 42.44 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.612 -0.68 . . . . 0.0 110.19 -178.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.9 t -69.87 127.24 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.557 -0.715 . . . . 0.0 110.212 -170.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.97 -10.05 55.35 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.407 ' OG1' ' CD2' ' A' ' 260' ' ' PHE . 10.1 t -144.42 173.81 11.46 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.078 -1.248 . . . . 0.0 110.664 175.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -107.05 13.21 27.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.662 -0.649 . . . . 0.0 111.764 -168.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . 0.407 ' CD2' ' OG1' ' A' ' 258' ' ' THR . 14.1 p90 -119.98 168.04 11.55 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.154 -0.966 . . . . 0.0 111.118 -175.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 93.3 m -117.79 146.73 43.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.761 -0.587 . . . . 0.0 109.887 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 45.3 m -116.46 136.41 53.01 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.524 -0.735 . . . . 0.0 110.857 -175.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.2 t -128.39 136.02 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 172.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 71.3 mt -104.94 120.75 42.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.565 -0.709 . . . . 0.0 110.015 -174.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . 0.421 ' CE2' HD13 ' A' ' 172' ' ' ILE . 2.9 m-30 -95.5 157.37 15.92 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.642 -0.661 . . . . 0.0 110.605 176.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -136.47 142.83 43.59 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 168.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -114.32 133.16 55.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.498 -0.751 . . . . 0.0 110.459 -177.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.25 3.31 35.38 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.685 -0.634 . . . . 0.0 111.975 -178.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -144.63 159.95 41.97 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.102 -0.999 . . . . 0.0 109.929 174.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -119.78 163.54 17.31 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.435 0.636 . . . . 0.0 110.484 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 32.4 m -58.22 -32.62 68.48 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.465 -0.772 . . . . 0.0 110.975 -164.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 49.1 p -101.51 13.05 36.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.47 -0.769 . . . . 0.0 111.941 -164.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 30.7 p -94.26 118.08 31.06 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.077 -1.014 . . . . 0.0 110.612 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 61.2 t -63.82 139.92 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.44 -0.788 . . . . 0.0 110.351 -170.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 100.13 -5.11 57.54 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 177.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.81 -99.05 0.87 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 171.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 93.3 mmm -62.91 -32.1 73.31 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.7 -0.882 . . . . 0.0 110.287 178.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.3 p30 44.31 49.88 7.89 Favored 'General case' 0 N--CA 1.504 2.243 0 CA-C-O 121.262 0.553 . . . . 0.0 112.449 174.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 21.3 mtt180 54.85 28.64 10.69 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.29 -0.881 . . . . 0.0 111.197 175.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -116.82 106.01 48.67 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.561 -0.712 . . . . 0.0 109.995 174.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.37 147.71 89.92 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 O-C-N 123.029 1.015 . . . . 0.0 110.609 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 45.2 pt -131.87 177.34 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.646 0.736 . . . . 0.0 110.876 -177.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 35.3 mt -124.3 149.85 46.08 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.417 ' HB ' ' CE2' ' A' ' 301' ' ' PHE . 81.2 mt -112.02 129.94 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 79.4 mt -109.81 125.26 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.423 HG22 ' CE1' ' A' ' 301' ' ' PHE . 63.1 t -118.99 126.78 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.9 p -125.24 152.16 44.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.631 -0.668 . . . . 0.0 110.594 -173.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.414 ' HB2' ' CE1' ' A' ' 138' ' ' PHE . 26.2 tp -101.03 127.14 47.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.715 -0.615 . . . . 0.0 109.5 167.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -130.27 150.32 51.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.856 -0.528 . . . . 0.0 109.926 -173.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 8.2 p -89.99 161.14 16.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.579 -0.701 . . . . 0.0 109.971 177.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -55.89 -26.14 45.96 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.502 -0.749 . . . . 0.0 111.043 -176.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 49.1 p30 -87.61 8.28 25.99 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.424 -0.797 . . . . 0.0 111.904 -174.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 88.19 20.19 50.17 Favored Glycine 0 N--CA 1.494 2.548 0 O-C-N 121.067 -1.021 . . . . 0.0 110.648 172.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -107.6 140.21 40.96 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.323 -1.104 . . . . 0.0 110.111 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 58.6 t -83.91 133.56 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.563 -0.711 . . . . 0.0 110.15 -174.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 95.7 mt -99.93 -40.15 7.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.711 -0.618 . . . . 0.0 110.283 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -167.26 150.41 17.02 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -133.47 137.29 45.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.612 -0.934 . . . . 0.0 110.718 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -130.61 155.21 46.93 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.619 -0.676 . . . . 0.0 110.229 172.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 79.5 m -139.15 146.73 40.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.469 -0.769 . . . . 0.0 110.831 -174.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.423 ' CE1' HG22 ' A' ' 286' ' ' VAL . 9.2 p90 -147.76 162.08 39.93 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.782 -0.574 . . . . 0.0 109.979 177.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -104.77 138.44 41.05 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.542 -0.724 . . . . 0.0 110.331 -175.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -125.14 143.63 50.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.651 -0.655 . . . . 0.0 110.596 -171.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -138.19 140.77 39.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.75 -0.594 . . . . 0.0 109.755 174.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 63.8 mt -108.88 122.87 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.501 -0.749 . . . . 0.0 109.645 176.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.9 p -145.24 168.66 19.88 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.636 -0.665 . . . . 0.0 110.657 -172.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -70.03 -40.18 75.33 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.64 -0.663 . . . . 0.0 110.638 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.8 t -127.99 86.55 57.87 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.522 -0.736 . . . . 0.0 110.457 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -56.23 -27.69 67.51 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 O-C-N 123.198 1.104 . . . . 0.0 110.573 174.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -68.47 -36.79 84.63 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -72.18 -39.95 68.29 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.708 -0.877 . . . . 0.0 109.873 -173.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -69.58 -39.26 77.43 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.062 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 -61.61 -44.01 97.8 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.301 178.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -65.12 -39.42 93.05 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.569 -0.707 . . . . 0.0 110.476 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.32 -49.95 74.94 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.599 -0.688 . . . . 0.0 110.44 -173.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -61.63 -37.67 84.85 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.487 -0.758 . . . . 0.0 110.02 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -62.0 -41.22 97.82 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.624 -0.673 . . . . 0.0 110.099 177.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -62.59 -35.16 78.63 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.695 -0.628 . . . . 0.0 109.988 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 24.2 m -63.21 -32.68 74.14 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.759 -0.588 . . . . 0.0 110.289 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 83.6 mt -77.3 -46.96 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.63 -0.669 . . . . 0.0 110.02 -177.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -60.7 -41.75 95.83 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.641 -0.662 . . . . 0.0 110.303 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -65.26 -42.56 93.12 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.587 -0.696 . . . . 0.0 110.081 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -60.86 -35.11 75.74 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.748 -0.595 . . . . 0.0 110.161 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -96.3 104.27 16.22 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.672 -0.643 . . . . 0.0 110.314 -178.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 61.8 t -125.07 130.04 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.645 -0.659 . . . . 0.0 109.854 176.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 29.3 t -95.04 131.66 40.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.646 -0.659 . . . . 0.0 110.248 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -91.5 114.66 27.25 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.666 -0.646 . . . . 0.0 110.259 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 27.5 t -94.07 137.68 32.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.622 -0.674 . . . . 0.0 110.227 178.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 30.8 m -137.57 135.03 36.29 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.746 -0.596 . . . . 0.0 110.094 178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 43.9 mttp -60.55 -37.6 81.77 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.576 -0.703 . . . . 0.0 110.322 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -111.46 147.09 36.04 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.658 -0.651 . . . . 0.0 110.243 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -59.86 -34.62 83.58 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 48.8 p30 -106.35 160.0 15.71 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.674 -0.898 . . . . 0.0 110.306 177.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -142.04 151.91 42.87 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.514 -0.741 . . . . 0.0 110.385 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -60.11 -39.01 84.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.649 -0.657 . . . . 0.0 110.329 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 54.27 101.62 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.456 -0.777 . . . . 0.0 110.872 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -90.55 134.03 34.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.612 -0.68 . . . . 0.0 110.258 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -100.86 139.03 37.12 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.67 -0.644 . . . . 0.0 110.303 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 71.1 p -122.73 166.01 15.62 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.711 -0.618 . . . . 0.0 110.208 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . 0.405 ' CD2' ' O ' ' A' ' 341' ' ' GLY . 57.0 p-80 -59.08 -33.53 70.92 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.575 -0.703 . . . . 0.0 110.462 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . 0.405 ' O ' ' CD2' ' A' ' 340' ' ' HIS . . . 81.74 -163.95 44.5 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 175.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 15.1 tt -147.67 154.21 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.703 -0.881 . . . . 0.0 110.145 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -91.26 124.72 35.67 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.62 -0.675 . . . . 0.0 110.361 -178.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 70.8 mtm 54.86 -86.55 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.687 -0.633 . . . . 0.0 111.053 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 22.4 p . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.237 -177.738 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 75.1 m -86.19 9.24 18.12 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.669 -0.9 . . . . 0.0 111.344 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 57.0 p -73.1 160.82 31.42 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.3 -0.875 . . . . 0.0 110.165 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 44.6 m -123.46 139.54 53.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.636 -0.665 . . . . 0.0 110.292 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -66.37 -25.96 67.04 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.603 -0.686 . . . . 0.0 110.416 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -84.65 120.6 26.57 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.592 -0.693 . . . . 0.0 110.187 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 52.13 179.63 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.516 -0.74 . . . . 0.0 111.027 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.4 mt 52.49 28.41 5.93 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.472 -0.767 . . . . 0.0 110.91 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.0 p -123.34 170.45 8.33 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.676 -0.64 . . . . 0.0 110.278 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.4 163.08 10.95 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 O-C-N 123.349 1.184 . . . . 0.0 110.67 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.42 160.66 67.06 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.679 -0.638 . . . . 0.0 110.22 -177.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -58.77 144.93 97.85 Favored 'Trans proline' 0 N--CA 1.488 1.174 0 O-C-N 123.282 1.148 . . . . 0.0 110.773 -176.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.98 148.66 36.15 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.657 -0.652 . . . . 0.0 110.289 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 50.1 mm -119.92 100.04 48.71 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.654 -0.654 . . . . 0.0 109.847 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -59.66 151.75 67.74 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 O-C-N 123.179 1.094 . . . . 0.0 110.783 -178.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.2 t -113.01 152.49 29.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.696 -0.628 . . . . 0.0 110.281 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -94.69 25.0 4.26 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.611 -0.681 . . . . 0.0 110.824 -178.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 51.0 m -70.06 125.21 26.09 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.613 -0.679 . . . . 0.0 110.249 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -70.06 144.94 52.02 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.616 -0.678 . . . . 0.0 110.432 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.421 ' CE1' ' HA2' ' A' ' 134' ' ' GLY . 43.2 t80 -155.47 101.4 2.22 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.587 -0.696 . . . . 0.0 110.018 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -59.29 -39.97 72.78 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 O-C-N 123.185 1.097 . . . . 0.0 110.762 -173.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.421 ' HA2' ' CE1' ' A' ' 132' ' ' TYR . . . 82.67 -155.1 33.28 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -73.8 -50.01 0.18 Allowed 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.382 1.201 . . . . 0.0 110.881 -174.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -87.75 9.68 20.85 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.576 -0.702 . . . . 0.0 111.337 -173.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 t 53.81 61.69 2.97 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.961 -1.087 . . . . 0.0 110.632 -176.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.447 ' CE1' ' CG2' ' A' ' 174' ' ' ILE . 64.4 t80 -80.27 118.69 22.15 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.651 -0.656 . . . . 0.0 109.932 -178.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -129.98 163.21 26.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.768 -0.582 . . . . 0.0 110.413 -174.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 62.9 t -125.16 147.73 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.729 -0.607 . . . . 0.0 109.773 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.7 p -155.16 163.32 40.38 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.942 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.438 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 73.1 m-85 -126.68 125.17 41.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.784 -0.573 . . . . 0.0 109.855 -176.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -56.47 143.62 34.38 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.624 -0.672 . . . . 0.0 110.488 -174.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -94.2 130.04 40.58 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.636 -0.665 . . . . 0.0 110.603 -172.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.2 t -125.18 146.62 49.42 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.697 -0.627 . . . . 0.0 110.058 177.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 56.8 p -64.21 165.35 9.49 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.678 -0.639 . . . . 0.0 110.1 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.0 t -71.63 64.74 0.46 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.611 -0.681 . . . . 0.0 110.348 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.32 157.83 35.06 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.598 -0.689 . . . . 0.0 110.144 179.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -73.51 150.55 41.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.605 -0.684 . . . . 0.0 110.01 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.7 m 52.84 48.09 23.23 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.525 -0.734 . . . . 0.0 110.945 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.32 126.58 30.99 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.685 -0.635 . . . . 0.0 110.218 178.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.403 ' OG1' ' CD1' ' A' ' 153' ' ' TRP . 44.6 p -60.07 -33.99 72.83 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.674 -0.641 . . . . 0.0 110.204 177.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.418 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -171.45 145.94 2.17 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.709 -0.62 . . . . 0.0 110.001 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.7 t -142.12 142.65 32.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.8 -0.563 . . . . 0.0 110.082 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.438 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 61.7 t80 -125.57 140.09 53.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.646 -0.659 . . . . 0.0 110.483 -172.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.4 t -109.78 124.07 50.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.842 -0.536 . . . . 0.0 109.785 175.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 48.7 m -71.35 -37.11 71.7 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.357 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -60.75 -31.64 70.97 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.605 -0.684 . . . . 0.0 110.25 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 58.2 mt -104.79 -12.19 16.43 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.612 -0.68 . . . . 0.0 110.786 -174.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 46.5 tttt 59.73 47.56 10.28 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.05 -1.031 . . . . 0.0 109.751 176.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -147.68 153.12 38.91 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.627 -0.671 . . . . 0.0 110.89 -173.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.6 tp -126.61 137.86 53.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.771 -0.581 . . . . 0.0 110.408 -176.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -115.51 132.94 56.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.646 -0.659 . . . . 0.0 109.231 174.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.37 158.41 44.32 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.659 -0.651 . . . . 0.0 111.134 -173.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -104.58 144.08 32.19 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.494 0.664 . . . . 0.0 110.316 173.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 17.2 tt -52.06 147.22 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.52 -0.737 . . . . 0.0 111.871 -174.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 64.42 10.0 5.39 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.614 -0.679 . . . . 0.0 112.544 175.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -95.36 155.08 16.89 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.001 -1.062 . . . . 0.0 110.894 175.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 84.9 m -83.23 126.1 32.29 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.708 -0.62 . . . . 0.0 110.522 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 43.3 t -115.14 90.29 23.34 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.615 -0.678 . . . . 0.0 110.12 174.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.418 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 18.9 Cg_endo -64.41 131.44 29.98 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.239 1.126 . . . . 0.0 110.45 176.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.408 HG12 ' CE2' ' A' ' 142' ' ' PHE . 93.6 mt -123.78 141.56 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . 0.4 ' OE1' ' CD1' ' A' ' 260' ' ' PHE . 67.1 mm-40 -109.17 133.72 52.65 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.566 -0.709 . . . . 0.0 110.408 -173.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.447 ' CG2' ' CE1' ' A' ' 138' ' ' PHE . 49.4 mm -95.38 135.01 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.574 -0.704 . . . . 0.0 109.725 171.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 32.2 tttt -119.52 131.13 55.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.594 -0.691 . . . . 0.0 110.453 177.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.7 m -136.83 159.72 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.59 -0.694 . . . . 0.0 110.05 175.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 78.8 mmm -78.32 -40.3 37.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.726 -0.609 . . . . 0.0 110.019 176.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 77.0 p -134.15 143.21 46.2 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.735 -0.603 . . . . 0.0 109.718 177.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -55.3 139.85 81.45 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 O-C-N 123.076 1.04 . . . . 0.0 110.892 -172.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.423 ' HG2' ' CD1' ' A' ' 251' ' ' TYR . 36.8 Cg_endo -68.56 170.06 15.91 Favored 'Trans proline' 0 N--CA 1.487 1.099 0 O-C-N 123.153 1.081 . . . . 0.0 110.629 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -60.4 155.41 47.04 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.404 1.213 . . . . 0.0 110.602 -178.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -78.69 138.47 38.29 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.58 -0.7 . . . . 0.0 109.981 175.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.28 -24.78 30.85 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -174.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.14 151.91 1.87 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.364 -1.08 . . . . 0.0 111.452 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.0 m -129.71 155.97 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.707 -0.62 . . . . 0.0 109.625 176.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 81.6 mt -108.43 139.3 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.685 -0.635 . . . . 0.0 109.537 176.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 38.9 mtm180 -114.87 146.81 40.69 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -176.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -140.55 127.61 20.83 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.372 174.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 33.3 ttm -137.34 139.04 26.55 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.805 -0.56 . . . . 0.0 110.938 -177.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -91.44 138.15 2.14 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 120.983 1.122 . . . . 0.0 110.702 176.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.9 m -147.22 154.94 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.599 -0.688 . . . . 0.0 110.14 174.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.442 ' CE2' ' CG2' ' A' ' 202' ' ' VAL . 90.4 m-85 -60.32 165.9 3.31 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.478 -0.764 . . . . 0.0 110.399 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -82.99 -60.1 2.27 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.621 -0.675 . . . . 0.0 110.832 -174.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -80.11 151.96 29.55 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.501 -0.749 . . . . 0.0 110.373 -175.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.67 -38.31 72.05 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.36 -0.838 . . . . 0.0 110.709 -175.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -56.5 -24.92 49.51 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.48 -0.763 . . . . 0.0 110.652 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.405 ' HB3' ' CG ' ' A' ' 192' ' ' TYR . 98.9 m-70 -109.69 -20.49 12.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.53 -0.732 . . . . 0.0 111.167 -178.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.1 p -67.74 -20.3 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.086 -1.008 . . . . 0.0 110.655 -176.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 67.0 p -79.35 -17.1 55.17 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.537 -0.727 . . . . 0.0 110.742 175.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -88.31 137.24 32.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.292 -0.88 . . . . 0.0 110.097 173.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 54.1 t -74.09 142.01 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.612 -0.68 . . . . 0.0 110.262 177.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.442 ' CG2' ' CE2' ' A' ' 192' ' ' TYR . 67.8 t -84.84 138.8 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.579 -0.701 . . . . 0.0 109.331 170.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.9 pttp -134.86 -170.16 2.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.482 -0.761 . . . . 0.0 111.185 -168.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -95.27 153.9 17.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.794 -0.567 . . . . 0.0 110.499 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 60.3 m -76.04 160.6 78.0 Favored Pre-proline 0 N--CA 1.497 1.887 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 174.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -64.2 -47.38 6.32 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 O-C-N 123.189 1.099 . . . . 0.0 109.842 176.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.445 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.6 p-10 -65.54 -44.35 87.12 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.626 -0.671 . . . . 0.0 111.223 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . 0.445 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 55.6 m170 -80.76 -27.73 36.69 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.479 -0.763 . . . . 0.0 111.358 -174.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -66.71 -42.06 87.01 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.442 -0.786 . . . . 0.0 109.919 172.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 23.3 tp -70.15 -34.27 72.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.611 -0.681 . . . . 0.0 110.298 174.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.9 t -48.41 -37.46 17.07 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.657 -0.652 . . . . 0.0 111.886 -175.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -128.04 137.51 52.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.55 -0.719 . . . . 0.0 110.291 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . 0.421 ' HG3' ' CD2' ' A' ' 214' ' ' PHE . 17.6 pt-20 -150.86 -160.46 1.17 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.692 -0.63 . . . . 0.0 110.242 -177.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.421 ' CD2' ' HG3' ' A' ' 213' ' ' GLU . 21.5 m-85 54.08 70.5 0.6 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.306 -0.872 . . . . 0.0 110.785 -179.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -69.02 -10.31 56.88 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.672 -0.642 . . . . 0.0 111.114 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -60.16 118.09 5.93 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.196 -0.94 . . . . 0.0 110.358 177.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 80.51 20.01 67.39 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 177.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -114.65 139.95 49.23 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.269 -1.136 . . . . 0.0 110.321 177.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.8 mt -84.95 -25.11 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.704 -0.622 . . . . 0.0 110.445 -178.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -125.01 90.01 51.72 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.492 -0.755 . . . . 0.0 110.263 -178.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.424 ' HD2' ' CE2' ' A' ' 236' ' ' TYR . 21.4 Cg_exo -62.34 136.01 57.2 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.317 1.167 . . . . 0.0 110.379 -177.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -57.46 -22.25 49.65 Favored 'Trans proline' 0 N--CA 1.49 1.278 0 O-C-N 123.054 1.028 . . . . 0.0 111.286 -176.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 25.2 m -52.89 -28.78 24.75 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.33 -0.856 . . . . 0.0 111.422 -174.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . 0.419 ' CE1' ' HB3' ' A' ' 236' ' ' TYR . 95.1 m-70 -100.12 129.39 46.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.436 -0.79 . . . . 0.0 110.601 -174.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 55.2 tp -60.97 -37.51 82.68 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.618 -0.676 . . . . 0.0 110.236 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 82.1 mt -101.01 136.75 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.786 -0.571 . . . . 0.0 109.85 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 -133.28 158.71 42.26 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.646 -0.659 . . . . 0.0 110.254 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 93.0 t -103.93 146.7 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.725 -0.61 . . . . 0.0 110.137 178.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -118.5 130.0 55.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.73 -0.606 . . . . 0.0 110.477 170.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 92.42 25.02 22.47 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 167.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -138.86 108.1 6.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.433 -1.04 . . . . 0.0 110.017 174.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 92.6 p -63.35 -15.14 56.51 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.675 -0.641 . . . . 0.0 111.287 -177.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -97.28 9.36 42.46 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.299 -0.876 . . . . 0.0 111.155 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -62.24 125.44 23.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.222 -0.924 . . . . 0.0 110.156 176.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -139.72 154.81 47.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.798 -0.564 . . . . 0.0 109.74 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.424 ' CE2' ' HD2' ' A' ' 221' ' ' PRO . 91.1 m-85 -117.36 150.73 38.36 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.605 -176.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.19 160.03 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.782 -0.574 . . . . 0.0 110.234 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -114.69 130.05 56.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.768 -0.583 . . . . 0.0 110.038 174.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -63.78 130.11 94.21 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.71 -0.619 . . . . 0.0 109.741 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -64.98 -28.69 57.76 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.232 1.122 . . . . 0.0 111.045 -170.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.9 mt -102.16 -50.53 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.387 -0.821 . . . . 0.0 111.041 -167.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 9.3 p -105.5 12.27 31.58 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.327 -0.858 . . . . 0.0 111.917 -176.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 72.14 -5.01 15.46 Favored Glycine 0 N--CA 1.497 2.737 0 O-C-N 121.057 -1.027 . . . . 0.0 112.001 171.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -45.82 142.14 2.68 Favored 'General case' 0 N--CA 1.505 2.324 0 CA-C-N 119.137 1.469 . . . . 0.0 112.509 -174.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -96.01 143.55 27.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.551 -0.718 . . . . 0.0 110.099 172.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 77.9 p -154.7 159.87 41.0 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.579 -0.7 . . . . 0.0 110.483 174.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.42 ' HB ' ' CD1' ' A' ' 236' ' ' TYR . 8.6 p -125.12 148.33 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.78 -0.575 . . . . 0.0 109.781 179.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 81.6 mt -129.64 154.55 47.0 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.651 -177.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 34.1 m -151.53 151.68 29.22 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.789 -0.569 . . . . 0.0 109.985 176.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -71.07 139.04 34.89 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 123.297 1.156 . . . . 0.0 110.018 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.423 ' CD1' ' HG2' ' A' ' 180' ' ' PRO . 59.9 t80 -75.96 125.61 29.44 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.491 -0.756 . . . . 0.0 110.123 174.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -100.06 160.01 28.3 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.725 -0.609 . . . . 0.0 109.996 177.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -58.94 159.93 19.9 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.268 1.141 . . . . 0.0 110.417 178.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.38 149.91 78.32 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 O-C-N 123.187 1.098 . . . . 0.0 110.493 -177.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -61.82 148.48 43.07 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.681 -0.637 . . . . 0.0 110.138 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.2 t -69.92 127.2 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.534 -0.729 . . . . 0.0 110.12 -170.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.98 -10.14 55.37 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.407 ' OG1' ' CD2' ' A' ' 260' ' ' PHE . 9.9 t -144.73 174.11 11.26 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.124 -1.221 . . . . 0.0 110.616 175.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -107.26 13.16 27.47 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.612 -0.68 . . . . 0.0 111.707 -168.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . 0.407 ' CD2' ' OG1' ' A' ' 258' ' ' THR . 13.5 p90 -119.86 168.08 11.46 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.152 -0.967 . . . . 0.0 111.135 -174.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 88.4 m -117.77 147.49 42.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.741 -0.599 . . . . 0.0 109.905 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 47.0 m -118.14 136.28 53.71 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.56 -0.712 . . . . 0.0 111.048 -174.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.8 t -131.92 137.26 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 172.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 67.8 mt -104.62 120.73 42.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.467 -0.77 . . . . 0.0 109.826 -172.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -106.29 151.2 25.13 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.678 -0.639 . . . . 0.0 110.604 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -136.58 142.86 43.39 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -112.0 130.08 55.98 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.595 -0.69 . . . . 0.0 110.453 -177.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -96.16 3.0 53.54 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.633 -0.667 . . . . 0.0 111.973 -176.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.81 165.04 29.24 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.076 -1.015 . . . . 0.0 110.123 175.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -121.7 163.4 19.1 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.646 -0.659 . . . . 0.0 110.417 -178.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 29.6 m -58.42 -35.14 71.62 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.427 -0.796 . . . . 0.0 110.986 -163.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 51.3 p -103.46 15.0 30.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.409 -0.807 . . . . 0.0 111.949 -163.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 29.7 p -93.96 118.05 30.95 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.063 -1.023 . . . . 0.0 110.712 178.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 60.0 t -62.75 138.82 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.519 -0.738 . . . . 0.0 110.352 -171.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.08 -5.21 61.2 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 178.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.13 -101.66 0.95 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 172.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 93.4 mmm -60.93 -29.95 69.91 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.657 -0.908 . . . . 0.0 110.124 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 22.6 p30 42.86 44.74 4.03 Favored 'General case' 0 N--CA 1.505 2.312 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 173.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 55.02 34.66 22.96 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.355 -0.841 . . . . 0.0 111.11 175.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -120.04 105.74 42.12 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.54 -0.725 . . . . 0.0 109.98 172.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -58.93 144.94 98.74 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 O-C-N 123.112 1.059 . . . . 0.0 110.573 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 46.2 pt -131.97 175.36 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 122.006 0.908 . . . . 0.0 111.244 -173.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 26.0 mt -124.44 149.84 46.34 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.426 HD12 ' CE1' ' A' ' 301' ' ' PHE . 82.4 mt -115.83 129.63 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.173 178.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 82.1 mt -109.74 125.52 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 -176.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 60.4 t -118.9 126.76 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.5 p -125.29 155.0 40.88 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.655 -0.653 . . . . 0.0 110.614 -172.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 30.5 tp -107.02 126.13 51.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.803 -0.561 . . . . 0.0 109.564 170.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -131.77 151.41 51.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.855 -0.528 . . . . 0.0 109.853 -174.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 71.4 p -89.9 157.8 17.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.605 -0.684 . . . . 0.0 109.779 178.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -56.12 -26.02 48.36 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.506 -0.746 . . . . 0.0 110.739 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -87.14 9.55 19.61 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.55 -0.719 . . . . 0.0 111.789 -174.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 87.63 20.09 52.26 Favored Glycine 0 N--CA 1.493 2.49 0 O-C-N 121.068 -1.02 . . . . 0.0 110.76 170.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -108.53 140.22 42.17 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.294 -1.121 . . . . 0.0 110.208 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 59.5 t -86.76 134.98 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.571 -0.706 . . . . 0.0 110.043 -173.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 96.4 mt -99.87 -40.14 7.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.658 -0.651 . . . . 0.0 110.457 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -175.35 162.42 31.92 Favored Glycine 0 N--CA 1.496 2.674 0 C-N-CA 119.922 -1.132 . . . . 0.0 110.384 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -130.73 139.83 50.3 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.672 -0.899 . . . . 0.0 110.567 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -136.59 155.07 50.42 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.479 -0.763 . . . . 0.0 109.869 170.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 89.1 m -143.56 154.76 43.92 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.327 -0.858 . . . . 0.0 110.874 -175.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.426 ' CE1' HD12 ' A' ' 284' ' ' ILE . 48.7 p90 -145.72 163.91 33.44 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.717 -0.614 . . . . 0.0 110.108 176.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -104.89 135.84 45.5 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.457 -0.777 . . . . 0.0 110.325 -177.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -123.84 144.42 49.74 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.633 -0.667 . . . . 0.0 110.729 -170.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -138.67 137.0 36.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.815 -0.553 . . . . 0.0 109.812 173.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 75.0 mt -105.8 123.56 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.58 -0.7 . . . . 0.0 109.584 176.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.2 p -145.15 164.9 29.87 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.569 -0.707 . . . . 0.0 110.948 -169.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -66.43 -39.92 89.2 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.671 -0.643 . . . . 0.0 110.615 -177.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.9 t -131.31 89.06 42.31 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.534 -0.729 . . . . 0.0 110.576 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -56.71 -29.3 79.67 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 123.136 1.072 . . . . 0.0 110.477 173.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.15 -37.93 93.46 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 176.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -70.23 -38.41 75.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.536 -0.979 . . . . 0.0 109.779 -175.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -69.4 -36.13 76.45 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.986 178.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 47.7 ttt-85 -57.04 -48.39 78.63 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.529 -0.732 . . . . 0.0 110.57 175.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -64.99 -38.54 91.28 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.72 -0.613 . . . . 0.0 110.448 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.85 -52.16 65.26 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.501 -0.749 . . . . 0.0 110.475 -173.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -61.39 -37.68 84.29 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.434 -0.791 . . . . 0.0 110.155 -177.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -66.29 -38.95 88.96 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.67 -0.644 . . . . 0.0 110.301 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -62.15 -35.11 77.78 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.597 -0.689 . . . . 0.0 110.038 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 24.5 m -61.72 -34.1 75.21 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.651 -0.656 . . . . 0.0 110.102 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 84.4 mt -79.74 -44.7 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.634 -0.666 . . . . 0.0 110.049 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -58.98 -38.13 78.42 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.667 -0.646 . . . . 0.0 110.602 -178.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -60.98 -48.3 82.47 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.538 -0.726 . . . . 0.0 110.181 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -73.54 -43.27 60.33 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.632 -0.667 . . . . 0.0 110.26 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -105.03 125.07 50.57 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.675 -0.641 . . . . 0.0 110.552 -175.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 61.9 t -108.32 129.97 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.682 -0.636 . . . . 0.0 109.806 178.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 49.3 m -95.05 140.07 30.51 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.681 -0.637 . . . . 0.0 110.456 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -91.84 125.14 36.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.648 -0.658 . . . . 0.0 110.143 176.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 53.7 p -61.54 157.08 18.02 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.635 -0.665 . . . . 0.0 110.082 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 49.1 m -103.65 133.58 48.42 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.652 -0.655 . . . . 0.0 110.471 -177.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 49.3 tttt -100.07 150.18 22.74 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.68 -0.637 . . . . 0.0 109.995 175.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -60.82 101.94 0.17 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.639 -0.663 . . . . 0.0 110.168 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 86.68 178.14 49.32 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -178.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . 0.402 ' O ' ' CE2' ' A' ' 335' ' ' PHE . 67.9 m-20 59.47 79.94 0.21 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.5 -1.0 . . . . 0.0 110.229 175.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -66.55 145.88 55.13 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.573 -0.704 . . . . 0.0 110.223 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . 0.402 ' CE2' ' O ' ' A' ' 333' ' ' ASP . 96.6 m-85 -118.8 155.91 30.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.643 -0.661 . . . . 0.0 110.338 179.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 55.71 -86.31 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.763 -0.585 . . . . 0.0 111.11 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 54.89 -86.31 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.318 -0.864 . . . . 0.0 110.88 -175.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -114.52 110.52 19.95 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.178 -0.951 . . . . 0.0 110.212 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 67.3 p -124.74 156.93 36.87 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.631 -0.668 . . . . 0.0 110.256 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -141.81 145.45 34.74 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.677 -0.639 . . . . 0.0 110.212 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 77.62 41.53 19.71 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 177.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 16.1 tt -142.63 136.24 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.609 -0.936 . . . . 0.0 110.095 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -93.95 145.74 24.42 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.663 -0.648 . . . . 0.0 110.283 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 87.8 mtp 51.79 91.61 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.503 -0.748 . . . . 0.0 111.014 178.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 9.0 m . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.255 179.865 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 30.0 t -87.12 144.28 26.93 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.649 -0.912 . . . . 0.0 110.273 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.5 t 51.64 89.97 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.463 -0.773 . . . . 0.0 111.078 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.404 ' OG1' ' CD2' ' A' ' 117' ' ' PHE . 70.5 p -69.59 -27.38 65.06 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.679 -0.638 . . . . 0.0 110.293 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.404 ' CD2' ' OG1' ' A' ' 116' ' ' THR . 97.4 m-85 -108.65 137.16 47.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.595 -0.691 . . . . 0.0 110.255 178.206 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -158.11 155.56 29.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.694 -0.629 . . . . 0.0 110.238 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 50.62 -169.58 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.411 -0.805 . . . . 0.0 111.189 178.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 25.1 tp 56.72 159.07 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.631 -0.668 . . . . 0.0 110.808 -175.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 9.6 t -87.09 160.14 49.73 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.553 -0.717 . . . . 0.0 110.171 179.084 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -65.26 152.16 77.26 Favored 'Cis proline' 0 N--CA 1.495 1.599 0 C-N-CA 123.166 -1.598 . . . . 0.0 110.391 -16.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 79.8 p -81.63 145.31 54.32 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.654 -0.654 . . . . 0.0 110.167 -179.029 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -59.92 150.31 78.8 Favored 'Trans proline' 0 N--CA 1.487 1.147 0 O-C-N 123.239 1.126 . . . . 0.0 110.553 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.83 150.02 39.42 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.624 -0.673 . . . . 0.0 110.004 178.492 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 50.3 mm -119.93 139.56 28.41 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.663 -0.648 . . . . 0.0 109.936 -177.55 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.91 151.91 83.11 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.153 1.081 . . . . 0.0 110.431 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 27.8 t -113.17 142.52 45.68 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.673 -0.642 . . . . 0.0 110.211 179.387 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.9 p-10 -96.33 24.62 5.61 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.722 -0.611 . . . . 0.0 110.681 -179.227 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 51.6 m -76.63 125.17 28.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.54 -0.725 . . . . 0.0 110.279 -179.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -70.14 144.91 51.89 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.672 -0.642 . . . . 0.0 110.41 -177.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -154.25 99.41 2.5 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.774 -0.579 . . . . 0.0 110.153 178.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -58.8 -39.91 77.37 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 O-C-N 123.202 1.106 . . . . 0.0 110.774 -176.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.69 -155.11 47.93 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 178.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -73.29 -46.19 0.38 Allowed 'Trans proline' 0 C--N 1.316 -1.176 0 O-C-N 123.363 1.191 . . . . 0.0 110.922 -174.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -85.9 6.7 27.22 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.531 -0.731 . . . . 0.0 111.382 -173.679 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.72 61.18 3.22 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.853 -1.154 . . . . 0.0 110.656 -175.519 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.417 ' CE1' HG22 ' A' ' 174' ' ' ILE . 54.6 t80 -77.82 119.29 21.1 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.64 -0.662 . . . . 0.0 109.852 -178.678 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -130.07 159.93 35.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.826 -0.546 . . . . 0.0 110.189 -178.419 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 68.5 t -124.57 147.65 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.694 -0.629 . . . . 0.0 109.902 176.131 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.9 p -155.04 164.23 39.17 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.075 177.132 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.486 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 88.0 m-85 -126.64 125.25 41.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.84 -0.537 . . . . 0.0 109.894 -176.532 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -56.58 147.76 21.45 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.705 -0.622 . . . . 0.0 110.684 -173.217 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -104.06 146.68 28.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.69 -0.631 . . . . 0.0 110.421 -175.096 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 84.0 p -145.09 160.61 41.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.704 -0.623 . . . . 0.0 110.114 177.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 45.4 m -61.82 155.77 22.27 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.651 -0.655 . . . . 0.0 110.083 179.212 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 77.0 p -60.82 91.76 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.692 -0.63 . . . . 0.0 110.158 -179.254 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.05 147.56 23.58 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.704 -0.623 . . . . 0.0 110.348 -178.588 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -71.88 139.3 48.75 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.698 -0.626 . . . . 0.0 110.152 178.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 34.5 m 52.78 43.23 31.69 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.404 -0.81 . . . . 0.0 110.976 -179.281 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.43 136.32 57.85 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.643 -0.66 . . . . 0.0 110.198 177.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 80.9 p -59.99 -32.49 70.9 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.641 -0.662 . . . . 0.0 109.868 174.197 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.422 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -171.34 142.8 1.75 Allowed 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.319 0.581 . . . . 0.0 110.253 176.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.7 t -142.12 142.72 32.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.935 -0.478 . . . . 0.0 109.997 -177.318 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.486 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 52.0 t80 -125.52 140.06 53.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.545 -0.722 . . . . 0.0 110.524 -172.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.5 t -111.84 124.31 52.08 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 120.401 -0.52 . . . . 0.0 109.789 176.118 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 62.3 m -70.58 -37.05 73.9 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.771 -0.581 . . . . 0.0 110.45 -177.658 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -59.1 -33.03 70.36 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.529 -0.732 . . . . 0.0 110.53 -178.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.1 mt -104.84 -11.99 16.5 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.688 -0.632 . . . . 0.0 110.787 -175.805 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 70.7 tttt 59.74 49.54 8.03 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.046 -1.034 . . . . 0.0 109.653 177.703 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 40.5 tttt -146.56 153.11 39.98 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.754 -0.591 . . . . 0.0 110.668 -174.054 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.5 tp -126.52 137.76 53.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.805 -0.559 . . . . 0.0 110.171 -177.333 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -115.16 134.78 54.85 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.8 p -138.42 158.61 43.95 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 120.114 -0.635 . . . . 0.0 111.114 -174.029 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -104.42 141.99 35.38 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.557 -0.714 . . . . 0.0 110.209 173.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 18.3 tt -54.85 146.23 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.562 -0.712 . . . . 0.0 111.561 -171.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 64.36 9.98 5.33 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.552 -0.718 . . . . 0.0 112.479 177.017 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -96.13 155.08 16.91 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.896 -1.128 . . . . 0.0 110.747 175.114 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 86.7 m -81.12 126.2 31.17 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.738 -0.601 . . . . 0.0 110.634 -177.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 46.9 t -115.53 90.23 25.07 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.702 -0.624 . . . . 0.0 110.11 172.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.422 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 22.0 Cg_exo -62.37 130.89 31.78 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 O-C-N 123.276 1.145 . . . . 0.0 110.624 174.079 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.415 HG12 ' CE2' ' A' ' 142' ' ' PHE . 94.5 mt -125.41 142.92 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.655 -0.653 . . . . 0.0 109.299 175.593 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -108.44 136.21 48.45 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.517 -0.739 . . . . 0.0 110.739 -176.209 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.417 HG22 ' CE1' ' A' ' 138' ' ' PHE . 48.5 mm -95.27 131.55 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.724 -0.61 . . . . 0.0 109.613 169.241 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -112.99 128.28 56.45 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.607 -0.683 . . . . 0.0 110.447 176.28 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.2 m -136.59 159.79 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.594 -0.691 . . . . 0.0 109.903 175.104 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.5 mmm -76.47 -40.81 49.35 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.632 -0.668 . . . . 0.0 110.104 178.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 77.5 p -135.44 143.15 44.05 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.782 -0.574 . . . . 0.0 109.65 178.356 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -55.22 139.8 81.02 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 O-C-N 123.142 1.075 . . . . 0.0 110.841 -171.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.431 ' HG2' ' CD1' ' A' ' 251' ' ' TYR . 29.8 Cg_endo -66.58 170.0 13.25 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 O-C-N 123.212 1.111 . . . . 0.0 110.618 178.411 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -60.85 156.25 44.68 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.358 1.189 . . . . 0.0 110.5 -178.293 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -79.1 139.32 38.1 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.651 -0.656 . . . . 0.0 109.954 176.118 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 98.53 -24.94 29.94 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -174.167 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.18 152.35 1.76 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.359 -1.083 . . . . 0.0 111.426 177.684 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 33.8 m -129.78 155.95 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.766 -0.584 . . . . 0.0 109.649 176.293 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 80.4 mt -109.17 138.78 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.676 -0.64 . . . . 0.0 109.51 176.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 30.8 mtm180 -114.9 147.27 40.18 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -175.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -140.13 127.18 20.89 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.501 -0.749 . . . . 0.0 110.259 173.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 3.2 ttp -137.24 138.33 24.93 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.777 -0.577 . . . . 0.0 110.926 -176.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -91.9 138.09 1.95 Allowed 'Trans proline' 0 C--N 1.32 -0.949 0 C-N-CA 121.023 1.149 . . . . 0.0 110.771 177.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.7 m -147.43 154.82 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.505 -0.747 . . . . 0.0 110.101 174.089 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.42 ' CE2' HG21 ' A' ' 202' ' ' VAL . 63.3 m-85 -60.05 162.06 6.12 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.409 -0.807 . . . . 0.0 110.55 -179.155 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 29.0 tttp -79.19 -60.02 2.54 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.665 -0.647 . . . . 0.0 110.878 -173.092 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -80.15 152.04 29.44 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.587 -0.695 . . . . 0.0 110.425 -175.373 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.52 -37.95 71.16 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.376 -0.827 . . . . 0.0 110.674 -177.084 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -56.86 -25.02 55.67 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.548 -0.72 . . . . 0.0 110.572 -177.438 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.407 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 65.0 m170 -108.81 -20.58 13.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.598 -0.689 . . . . 0.0 111.116 -178.816 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.2 p -68.45 -20.28 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.148 -0.97 . . . . 0.0 110.581 -175.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 67.3 p -79.42 -17.03 55.18 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.516 -0.74 . . . . 0.0 110.678 174.37 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.39 136.54 32.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.366 -0.834 . . . . 0.0 110.025 173.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.9 t -72.92 145.08 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.569 -0.707 . . . . 0.0 110.269 178.354 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.42 HG21 ' CE2' ' A' ' 192' ' ' TYR . 57.8 t -84.88 139.9 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 170.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 11.9 pttt -134.72 -170.46 2.56 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.509 -0.744 . . . . 0.0 111.195 -169.34 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 63.8 mmt-85 -95.37 150.92 19.75 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.827 -0.546 . . . . 0.0 110.423 -176.23 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 60.9 m -73.06 163.16 70.61 Favored Pre-proline 0 N--CA 1.497 1.894 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 169.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -63.96 -47.66 6.34 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 123.044 1.023 . . . . 0.0 109.903 177.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.41 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.4 p-10 -65.56 -44.06 87.93 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.627 -0.671 . . . . 0.0 111.124 178.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . 0.41 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 51.4 m170 -80.68 -27.79 36.97 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.414 -0.804 . . . . 0.0 111.394 -174.527 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -66.14 -36.73 83.91 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.385 -0.822 . . . . 0.0 110.172 174.028 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 23.3 tp -55.23 -35.19 64.67 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.482 -0.762 . . . . 0.0 110.772 177.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 24.5 t -48.39 -27.73 2.79 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.448 -0.783 . . . . 0.0 111.548 178.029 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -54.45 -26.16 29.31 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.545 -0.722 . . . . 0.0 111.175 -177.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -54.88 149.41 11.54 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.418 -0.801 . . . . 0.0 110.955 -176.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 40.2 t80 53.78 70.78 0.56 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.388 -0.82 . . . . 0.0 110.844 179.307 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -83.39 -10.13 58.62 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.607 -0.683 . . . . 0.0 111.155 176.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -59.88 125.1 22.33 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.174 -0.954 . . . . 0.0 110.337 176.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 95.14 -1.46 64.91 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 120.447 -0.882 . . . . 0.0 110.928 179.035 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -114.67 139.77 49.38 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.012 -1.287 . . . . 0.0 110.401 173.602 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.9 mt -88.07 -25.08 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.722 -0.611 . . . . 0.0 110.444 -179.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -124.91 95.14 42.78 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.527 -0.733 . . . . 0.0 110.173 -177.506 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -64.96 144.04 81.25 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.275 1.145 . . . . 0.0 110.612 -175.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.91 -19.59 40.42 Favored 'Trans proline' 0 N--CA 1.489 1.212 0 O-C-N 123.107 1.056 . . . . 0.0 111.321 -179.544 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 96.6 p -53.89 -22.12 9.27 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.178 -0.952 . . . . 0.0 111.211 -177.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . 0.467 ' CE1' ' CG ' ' A' ' 236' ' ' TYR . 41.0 m80 -104.33 128.71 52.17 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.471 -0.768 . . . . 0.0 110.203 177.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 57.2 tp -66.66 -38.37 86.71 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.577 -0.702 . . . . 0.0 110.113 -177.603 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 85.5 mt -104.7 136.72 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -134.57 159.52 40.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.701 -0.624 . . . . 0.0 110.189 -178.401 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 91.2 t -104.46 146.74 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.766 -0.584 . . . . 0.0 110.103 178.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -118.1 124.4 47.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.732 -0.605 . . . . 0.0 110.361 172.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.05 23.82 14.15 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 168.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -137.17 107.6 6.48 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.464 -1.021 . . . . 0.0 110.028 174.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 26.3 t -62.89 -15.18 53.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.67 -0.643 . . . . 0.0 111.322 -178.001 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -100.02 7.98 44.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.246 -0.909 . . . . 0.0 111.524 -177.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.06 130.76 47.99 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.191 -0.943 . . . . 0.0 110.213 176.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -139.76 157.95 44.9 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.75 -0.594 . . . . 0.0 109.807 177.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.467 ' CG ' ' CE1' ' A' ' 224' ' ' HIS . 78.6 m-85 -115.01 150.73 35.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.596 -0.69 . . . . 0.0 110.658 -176.394 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.16 159.93 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.827 -0.546 . . . . 0.0 110.081 176.38 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -121.46 130.11 53.38 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.69 -0.631 . . . . 0.0 110.344 178.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -64.74 110.34 3.97 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.636 -0.665 . . . . 0.0 109.697 176.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -59.76 -25.11 78.2 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.141 1.074 . . . . 0.0 111.078 -171.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.8 mt -100.72 -50.41 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.409 -0.807 . . . . 0.0 110.853 -171.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 17.4 p -105.43 12.16 31.83 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.41 -0.807 . . . . 0.0 111.96 -173.211 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 82.32 -25.07 4.48 Favored Glycine 0 N--CA 1.498 2.781 0 O-C-N 120.997 -1.064 . . . . 0.0 111.885 169.169 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -45.83 142.14 2.69 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-N 118.652 1.226 . . . . 0.0 112.678 -168.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -104.41 146.08 29.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.7 -0.625 . . . . 0.0 109.93 173.681 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 77.9 p -154.74 159.98 41.03 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.609 -0.682 . . . . 0.0 110.39 178.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 8.6 p -123.23 148.25 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.75 -0.593 . . . . 0.0 109.816 179.535 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 83.9 mt -129.57 154.62 46.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.653 -0.655 . . . . 0.0 109.662 -176.506 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 35.1 m -151.35 151.73 29.63 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.769 -0.582 . . . . 0.0 110.045 175.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -71.1 138.6 33.92 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 O-C-N 123.232 1.122 . . . . 0.0 109.991 177.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.431 ' CD1' ' HG2' ' A' ' 180' ' ' PRO . 57.1 t80 -74.07 127.16 32.2 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.53 -0.731 . . . . 0.0 110.194 175.376 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -99.95 160.09 28.13 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.697 -0.627 . . . . 0.0 109.974 175.111 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -58.55 157.86 25.61 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 O-C-N 123.291 1.153 . . . . 0.0 110.518 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.15 149.92 77.06 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 O-C-N 123.203 1.107 . . . . 0.0 110.514 -177.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -60.64 147.65 41.17 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.569 -0.707 . . . . 0.0 110.254 -178.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.87 127.2 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.508 -0.745 . . . . 0.0 110.219 -170.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.06 -10.27 55.18 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.405 ' OG1' ' CE2' ' A' ' 260' ' ' PHE . 10.1 t -144.12 174.12 11.15 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.115 -1.227 . . . . 0.0 110.676 176.027 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -107.39 13.17 27.27 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.647 -0.658 . . . . 0.0 111.812 -168.325 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . 0.405 ' CE2' ' OG1' ' A' ' 258' ' ' THR . 14.6 p90 -119.92 168.01 11.56 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.116 -0.99 . . . . 0.0 111.155 -175.184 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 82.2 m -117.77 145.75 44.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.791 -0.568 . . . . 0.0 109.854 179.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 42.2 m -116.62 135.93 53.39 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.582 -0.699 . . . . 0.0 110.78 -176.55 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.9 t -132.31 137.33 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 175.094 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 76.6 mt -104.59 120.92 42.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.493 -0.755 . . . . 0.0 109.991 -170.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -105.29 153.64 21.33 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.672 -0.643 . . . . 0.0 110.823 -176.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -136.54 142.92 43.46 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -114.99 133.82 55.71 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.463 -0.773 . . . . 0.0 110.47 -179.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -102.44 9.42 39.66 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.606 -0.684 . . . . 0.0 112.053 -175.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -144.61 159.05 43.44 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.083 -1.011 . . . . 0.0 110.108 173.06 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -119.27 163.11 17.62 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.752 -0.593 . . . . 0.0 110.423 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 25.1 m -57.95 -31.48 66.88 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.44 -0.788 . . . . 0.0 110.843 -166.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 51.1 p -105.72 14.95 27.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.352 -0.843 . . . . 0.0 111.965 -165.222 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 29.6 p -94.18 118.1 31.07 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.139 -0.975 . . . . 0.0 110.539 177.571 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.89 139.23 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.436 -0.79 . . . . 0.0 110.177 -170.5 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.6 -5.13 60.12 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 178.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.05 -97.69 0.81 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 173.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 93.0 mmm -64.03 -33.76 76.46 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.74 -0.859 . . . . 0.0 110.41 178.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.1 p30 43.72 50.77 6.69 Favored 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 175.486 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 54.86 31.86 16.6 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.294 -0.879 . . . . 0.0 111.188 176.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -120.02 104.94 43.3 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.498 -0.751 . . . . 0.0 110.148 174.247 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -60.37 148.16 91.42 Favored 'Trans proline' 0 N--CA 1.487 1.139 0 O-C-N 123.104 1.055 . . . . 0.0 110.528 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 45.5 pt -131.99 177.42 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 CA-C-O 121.79 0.805 . . . . 0.0 111.037 -176.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 28.1 mt -124.34 149.9 46.09 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.425 ' HB ' ' CZ ' ' A' ' 301' ' ' PHE . 81.4 mt -115.79 130.19 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.931 -0.707 . . . . 0.0 109.315 177.705 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 83.3 mt -109.88 126.19 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.483 -177.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 57.8 t -118.96 126.84 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.5 p -125.24 151.61 45.68 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.581 -0.7 . . . . 0.0 110.736 -173.467 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 21.8 tp -101.3 125.67 47.96 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 167.427 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -130.58 150.54 51.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.845 -0.534 . . . . 0.0 110.005 -172.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.4 ' CG2' ' CD1' ' A' ' 296' ' ' LEU . 17.1 p -89.96 161.13 16.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.678 -0.639 . . . . 0.0 109.967 177.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -55.95 -26.07 46.33 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.579 -0.701 . . . . 0.0 110.98 -176.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 47.0 p30 -90.36 9.36 29.23 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.373 -0.829 . . . . 0.0 111.908 -173.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.41 20.15 46.23 Favored Glycine 0 N--CA 1.494 2.546 0 C-N-CA 120.169 -1.015 . . . . 0.0 110.841 171.055 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -107.58 140.16 41.01 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.357 -1.084 . . . . 0.0 110.075 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 59.8 t -87.68 132.14 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.543 -0.723 . . . . 0.0 110.164 -173.35 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.4 ' CD1' ' CG2' ' A' ' 290' ' ' THR . 96.1 mt -99.97 -40.2 7.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.667 -0.646 . . . . 0.0 110.44 178.15 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -159.97 148.62 17.35 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -178.14 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -135.09 133.14 38.97 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.73 -0.864 . . . . 0.0 110.566 -178.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -135.03 156.17 49.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.705 -0.622 . . . . 0.0 109.976 172.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 83.0 m -141.77 154.21 45.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.431 -0.793 . . . . 0.0 110.541 -176.269 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.425 ' CZ ' ' HB ' ' A' ' 284' ' ' ILE . 49.3 p90 -144.96 164.62 30.57 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.694 -0.628 . . . . 0.0 110.247 177.14 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -104.87 134.58 47.76 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.548 -0.72 . . . . 0.0 110.048 -177.137 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -121.77 143.68 49.24 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.704 -169.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 64.5 ttt-85 -139.82 134.86 32.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.761 -0.587 . . . . 0.0 109.633 173.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 33.5 mt -106.79 122.86 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.585 -0.697 . . . . 0.0 109.67 178.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.2 p -145.12 170.92 15.29 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.594 -0.691 . . . . 0.0 110.975 -169.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -70.23 -40.05 74.72 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.752 -0.593 . . . . 0.0 110.604 -178.481 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 3.7 t -131.15 88.85 43.65 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.591 -0.693 . . . . 0.0 110.422 179.139 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -55.85 -29.04 70.72 Favored 'Trans proline' 0 N--CA 1.488 1.187 0 O-C-N 123.176 1.092 . . . . 0.0 110.82 174.48 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.6 -37.83 92.83 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 177.136 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 72.2 ttt-85 -72.4 -40.49 67.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.67 -0.9 . . . . 0.0 109.77 -173.327 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -69.43 -38.35 77.8 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.256 -178.347 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -61.23 -43.7 98.46 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.467 -0.77 . . . . 0.0 110.226 178.227 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 52.5 tttt -64.9 -39.41 93.48 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.509 -0.744 . . . . 0.0 110.469 177.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.44 -49.82 75.27 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.515 -0.74 . . . . 0.0 110.573 -173.342 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -61.61 -37.67 84.81 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.564 -0.71 . . . . 0.0 110.075 -178.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -61.79 -41.27 97.52 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.59 -0.694 . . . . 0.0 110.041 177.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -62.8 -35.04 78.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.665 -0.647 . . . . 0.0 109.995 178.353 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 22.8 t -63.3 -32.76 74.26 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.676 -0.64 . . . . 0.0 110.219 -179.698 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 83.2 mt -77.19 -45.67 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.605 -0.684 . . . . 0.0 110.037 -177.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -60.3 -40.04 89.07 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.61 -0.681 . . . . 0.0 110.374 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -61.8 -41.29 97.56 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.674 -0.641 . . . . 0.0 110.057 178.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -60.8 -33.98 73.82 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.677 -0.639 . . . . 0.0 110.111 177.561 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -97.38 125.02 41.75 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.7 -0.625 . . . . 0.0 110.387 -178.233 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 61.6 t -121.11 129.94 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.636 -0.665 . . . . 0.0 109.959 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 50.3 m -65.34 140.14 58.64 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.702 -0.623 . . . . 0.0 110.168 179.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -83.07 116.42 22.3 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.712 -0.617 . . . . 0.0 110.187 179.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 53.4 m -94.07 152.06 19.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.69 -0.631 . . . . 0.0 110.313 -179.184 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 73.3 p -94.26 -19.27 20.86 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.727 -0.608 . . . . 0.0 110.761 179.014 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 25.3 tttp -58.56 -33.36 69.84 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.332 -0.855 . . . . 0.0 110.464 179.2 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -57.52 -33.87 68.52 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.524 -0.735 . . . . 0.0 110.511 -178.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 66.09 -120.85 17.13 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.025 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . 0.401 ' O ' ' CE1' ' A' ' 335' ' ' PHE . 31.5 t0 -80.9 118.94 22.83 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.687 -0.89 . . . . 0.0 110.222 -179.142 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -64.22 147.72 51.73 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.661 -0.649 . . . . 0.0 110.205 -179.311 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . 0.401 ' CE1' ' O ' ' A' ' 333' ' ' ASP . 96.0 m-85 -117.67 156.16 28.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.629 -0.669 . . . . 0.0 110.166 179.131 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 55.65 -84.23 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.817 -0.552 . . . . 0.0 111.05 -177.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -136.22 161.87 34.55 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.245 -0.909 . . . . 0.0 110.386 -178.027 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 41.5 p-10 -88.63 13.34 12.43 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.63 -0.668 . . . . 0.0 111.371 -176.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 46.4 m -83.5 137.23 33.97 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.204 -0.935 . . . . 0.0 110.144 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -117.51 139.64 50.67 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.649 -0.657 . . . . 0.0 110.375 -179.17 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 171.24 -126.71 1.34 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 26.5 pt -95.69 149.63 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.651 -0.911 . . . . 0.0 110.397 179.406 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -91.49 126.26 36.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.598 -0.689 . . . . 0.0 110.221 -179.52 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 50.9 ttm -100.17 134.89 42.43 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.609 -0.682 . . . . 0.0 110.248 -179.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 118.045 -0.978 . . . . 0.0 110.348 -179.968 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.6 t . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.12 0.486 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.9 p-10 -96.15 25.86 4.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.652 -0.655 . . . . 0.0 110.601 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 51.0 m -71.04 125.19 26.2 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.573 -0.704 . . . . 0.0 110.27 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -71.42 144.98 49.59 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.661 -0.649 . . . . 0.0 110.443 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -153.87 99.05 2.59 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.742 -0.599 . . . . 0.0 110.073 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -59.39 -39.94 72.11 Favored 'Trans proline' 0 N--CA 1.487 1.147 0 O-C-N 123.175 1.092 . . . . 0.0 110.705 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.45 -155.16 48.36 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -75.75 -42.03 0.48 Allowed 'Trans proline' 0 C--N 1.316 -1.155 0 O-C-N 123.34 1.179 . . . . 0.0 110.993 -174.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -87.65 6.63 33.76 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.559 -0.713 . . . . 0.0 111.509 -173.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.69 60.97 3.33 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.98 -1.075 . . . . 0.0 110.672 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.687 ' HA ' HG12 ' A' ' 176' ' ' VAL . 50.4 t80 -77.89 118.87 20.62 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.63 -0.669 . . . . 0.0 109.955 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -130.04 161.42 31.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.81 -0.556 . . . . 0.0 110.068 -178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 62.9 t -126.48 145.74 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.696 -0.628 . . . . 0.0 109.893 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 78.4 p -155.43 160.29 40.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.802 -0.561 . . . . 0.0 110.043 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.498 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 71.7 m-85 . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.849 -0.532 . . . . 0.0 109.885 -175.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 121.154 0.502 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 43.5 p -60.1 -34.0 72.88 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.795 -0.565 . . . . 0.0 110.072 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.443 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -171.44 144.52 1.96 Allowed 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.397 0.617 . . . . 0.0 110.331 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.6 t -142.08 142.51 32.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.929 -0.482 . . . . 0.0 109.878 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.498 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 64.7 t80 -125.65 140.04 53.05 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.509 -0.744 . . . . 0.0 110.787 -171.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.2 t -111.7 124.88 53.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.8 -0.562 . . . . 0.0 109.958 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 59.2 m -70.95 -37.02 72.81 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.749 -0.595 . . . . 0.0 110.571 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -59.01 -34.75 72.24 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.573 -0.704 . . . . 0.0 110.444 -177.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.0 mt -104.83 -12.04 16.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.662 -0.649 . . . . 0.0 110.88 -176.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 82.3 tttt 59.73 51.62 6.1 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.074 -1.017 . . . . 0.0 109.673 178.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -145.09 153.07 41.04 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.594 -173.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.683 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.56 137.73 53.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.779 -0.576 . . . . 0.0 110.24 -175.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -116.0 135.4 54.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.674 -0.641 . . . . 0.0 109.288 173.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.9 p -138.36 158.42 44.31 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.705 -0.622 . . . . 0.0 110.899 -175.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.429 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 50.1 mt-30 -104.5 144.07 32.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.64 -0.662 . . . . 0.0 110.277 173.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.428 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.2 tt -52.81 146.05 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-O 121.592 0.711 . . . . 0.0 111.802 -173.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.5 10.0 5.46 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.554 -0.716 . . . . 0.0 112.484 176.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.429 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 73.5 mmtt -96.61 155.06 16.93 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.995 -1.066 . . . . 0.0 110.867 175.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 85.0 m -84.5 126.13 33.01 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.689 -0.632 . . . . 0.0 110.668 -177.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' CYS . . . . . 0.683 ' SG ' HD21 ' A' ' 162' ' ' LEU . 44.7 t -115.37 90.19 24.12 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.576 -0.702 . . . . 0.0 110.202 174.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.443 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 21.2 Cg_exo -62.59 131.1 32.17 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.216 1.114 . . . . 0.0 110.691 173.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.414 HG12 ' CE2' ' A' ' 142' ' ' PHE . 95.1 mt -125.08 143.82 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.659 -0.651 . . . . 0.0 109.279 175.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -109.47 135.36 50.61 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.496 -0.753 . . . . 0.0 110.813 -175.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.402 HG23 ' CE1' ' A' ' 138' ' ' PHE . 48.7 mm -95.29 135.01 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.604 -0.685 . . . . 0.0 109.584 168.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -116.11 128.0 55.3 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.608 -0.683 . . . . 0.0 110.406 175.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.687 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.1 m -136.57 159.72 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.674 -0.641 . . . . 0.0 109.892 175.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.7 mmm -74.46 -40.44 61.89 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.704 -0.622 . . . . 0.0 110.094 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 77.5 p -135.87 143.23 43.56 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.752 -0.593 . . . . 0.0 109.825 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -55.34 139.9 81.72 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 O-C-N 123.17 1.089 . . . . 0.0 110.861 -173.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.789 ' HB3' HD21 ' A' ' 288' ' ' LEU . 18.0 Cg_endo -61.97 166.9 11.46 Favored 'Trans proline' 0 N--CA 1.487 1.145 0 O-C-N 123.217 1.114 . . . . 0.0 110.72 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -61.06 155.68 49.09 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 O-C-N 123.382 1.201 . . . . 0.0 110.41 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -73.55 138.66 45.11 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.652 -0.655 . . . . 0.0 109.93 176.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.57 -24.94 29.36 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -174.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.14 150.94 2.18 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.367 -1.078 . . . . 0.0 111.426 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.78 155.94 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.735 -0.603 . . . . 0.0 109.906 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.683 HD11 ' CD2' ' A' ' 251' ' ' TYR . 53.4 mt -109.61 135.57 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.723 ' HG2' HD22 ' A' ' 248' ' ' LEU . 59.6 mtt180 -114.95 145.97 41.67 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.674 -0.641 . . . . 0.0 109.292 -174.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.651 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -140.54 127.74 21.01 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.546 -0.721 . . . . 0.0 110.312 173.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.4 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 41.3 ttp -137.25 139.91 29.35 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.766 -0.584 . . . . 0.0 111.061 -177.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.587 ' HD3' HD12 ' A' ' 226' ' ' ILE . 72.9 Cg_endo -91.12 138.2 2.28 Favored 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 121.051 1.167 . . . . 0.0 110.789 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.438 HG12 ' CZ ' ' A' ' 244' ' ' ARG . 34.8 m -147.38 154.85 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.539 -0.725 . . . . 0.0 110.06 174.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.569 ' HA ' HG22 ' A' ' 282' ' ' ILE . 78.3 m-85 -63.02 167.69 4.64 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.457 -0.777 . . . . 0.0 110.517 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.416 ' HA ' HD12 ' A' ' 283' ' ' LEU . 86.3 tttt -85.05 -60.12 2.14 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.657 -0.652 . . . . 0.0 110.834 -173.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -80.11 152.33 29.35 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.593 -0.692 . . . . 0.0 110.284 -175.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.454 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.67 -38.68 72.54 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.364 -0.835 . . . . 0.0 110.664 -175.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -56.58 -24.77 49.66 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.499 -0.751 . . . . 0.0 110.558 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.406 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 98.7 m-70 -109.71 -20.49 12.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.534 -0.729 . . . . 0.0 111.167 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.454 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -67.65 -20.22 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.12 -0.987 . . . . 0.0 110.581 -176.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 67.8 p -79.42 -16.85 55.48 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.544 -0.723 . . . . 0.0 110.856 174.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.35 136.41 33.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.303 -0.873 . . . . 0.0 110.086 175.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.1 t -73.0 143.26 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.661 -0.649 . . . . 0.0 110.267 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.685 HG23 HH12 ' A' ' 244' ' ' ARG . 60.8 t -84.94 136.39 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.625 -0.672 . . . . 0.0 109.224 171.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.8 pttt -134.89 -170.22 2.52 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.453 -0.779 . . . . 0.0 111.137 -168.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -95.3 158.96 15.23 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.776 -0.578 . . . . 0.0 110.34 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 56.9 m . . . . . 0 N--CA 1.497 1.91 0 O-C-N 121.551 -0.718 . . . . 0.0 109.304 175.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.407 ' HA ' ' CG ' ' A' ' 268' ' ' MET . 39.5 tp . . . . . 0 N--CA 1.497 1.887 0 CA-C-O 120.795 0.331 . . . . 0.0 110.285 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.587 HD12 ' HD3' ' A' ' 190' ' ' PRO . 83.2 mt -101.42 136.77 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.795 -0.566 . . . . 0.0 109.84 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -131.69 156.98 44.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.688 -0.633 . . . . 0.0 110.328 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.524 HG23 HG21 ' A' ' 247' ' ' VAL . 88.3 t -103.13 146.65 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.749 -0.595 . . . . 0.0 109.941 176.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -118.24 126.76 52.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.721 -0.612 . . . . 0.0 110.368 171.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 96.98 21.4 20.91 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 168.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -139.4 105.23 5.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.3 -1.118 . . . . 0.0 110.038 174.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 91.6 p -63.65 -15.1 57.42 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.604 -0.685 . . . . 0.0 111.232 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -97.02 9.97 40.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.245 -0.909 . . . . 0.0 111.235 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.75 130.49 46.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.127 -0.983 . . . . 0.0 110.09 175.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -139.74 157.96 44.89 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.668 -0.645 . . . . 0.0 109.862 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -118.58 150.81 39.03 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.576 -0.702 . . . . 0.0 110.646 -176.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.11 159.9 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.776 -0.578 . . . . 0.0 110.128 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -120.38 130.04 54.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.738 -0.601 . . . . 0.0 110.262 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.27 119.08 46.3 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.625 -0.672 . . . . 0.0 109.669 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.16 -27.7 78.93 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 O-C-N 123.059 1.031 . . . . 0.0 110.874 -172.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 84.0 mt -102.99 -50.32 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.434 -0.792 . . . . 0.0 110.952 -170.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 18.6 p -105.33 12.23 31.92 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.379 -0.826 . . . . 0.0 111.975 -171.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 82.95 -25.04 4.9 Favored Glycine 0 N--CA 1.497 2.737 0 O-C-N 121.009 -1.057 . . . . 0.0 111.825 168.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.685 HH12 HG23 ' A' ' 202' ' ' VAL . 26.7 mmt180 -45.89 142.13 2.75 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 118.598 1.199 . . . . 0.0 112.627 -168.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -105.22 146.9 28.65 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.659 -0.651 . . . . 0.0 110.036 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.2 p -154.74 159.92 40.99 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.576 -0.703 . . . . 0.0 110.35 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.524 HG21 HG23 ' A' ' 228' ' ' VAL . 8.4 p -122.92 148.1 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.729 -0.607 . . . . 0.0 109.814 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.723 HD22 ' HG2' ' A' ' 187' ' ' ARG . 81.9 mt -129.71 154.61 46.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.738 -0.601 . . . . 0.0 109.891 -175.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.441 HG13 ' C ' ' A' ' 248' ' ' LEU . 33.8 m -151.3 151.84 29.91 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.878 -0.514 . . . . 0.0 109.935 175.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -71.04 138.95 34.81 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 O-C-N 123.269 1.142 . . . . 0.0 109.95 177.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.683 ' CD2' HD11 ' A' ' 186' ' ' ILE . 10.0 t80 -78.69 126.51 30.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.496 -0.753 . . . . 0.0 110.21 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -99.97 160.05 28.22 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.695 -0.628 . . . . 0.0 110.059 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -59.17 159.53 22.01 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.234 1.123 . . . . 0.0 110.423 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.38 149.96 78.02 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 O-C-N 123.261 1.137 . . . . 0.0 110.536 -177.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -61.3 148.09 42.4 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.679 -0.638 . . . . 0.0 110.2 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.9 t -69.84 127.2 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.563 -0.711 . . . . 0.0 110.178 -170.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.03 -10.14 55.23 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 10.0 t -144.5 173.25 11.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.169 -1.195 . . . . 0.0 110.642 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -106.9 13.22 27.98 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.674 -0.641 . . . . 0.0 111.743 -168.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -119.99 168.06 11.54 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.159 -0.963 . . . . 0.0 111.092 -175.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 84.1 m -117.75 145.69 44.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.813 -0.554 . . . . 0.0 109.837 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 52.2 m -114.94 135.54 54.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.594 -0.691 . . . . 0.0 110.934 -174.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.6 t -130.12 137.24 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 72.1 mt -104.73 119.07 38.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.581 -0.7 . . . . 0.0 109.863 -172.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.651 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 6.0 m-30 -105.89 151.24 24.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.675 -0.64 . . . . 0.0 110.614 -177.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -136.6 142.91 43.35 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -112.23 131.06 55.7 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.518 -0.739 . . . . 0.0 110.437 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' MET . . . . . 0.407 ' CG ' ' HA ' ' A' ' 225' ' ' LEU . 5.0 ppp? -100.23 7.43 44.48 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.683 -0.636 . . . . 0.0 111.972 -175.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 269' ' ' CYS . . . . . 0.67 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.6 OUTLIER -144.76 164.95 29.48 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.075 -1.016 . . . . 0.0 109.834 171.558 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.61 ' HA ' HG21 ' A' ' 305' ' ' ILE . 28.0 p30 -120.7 161.94 20.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.651 -0.656 . . . . 0.0 110.456 -178.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 271' ' ' SER . . . . . 0.428 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 22.5 m -58.08 -33.42 69.05 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.48 -0.762 . . . . 0.0 111.082 -163.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 48.8 p -99.4 11.5 38.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.466 -0.771 . . . . 0.0 112.011 -163.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 30.2 p -94.48 118.01 31.0 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.124 -0.985 . . . . 0.0 110.672 178.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.7 t -64.12 140.04 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.504 -0.748 . . . . 0.0 110.412 -169.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.46 -5.21 58.63 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -125.46 -100.43 1.25 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 170.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' MET . . . . . 0.428 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.3 mmm -64.28 -31.44 72.65 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.687 -0.89 . . . . 0.0 110.319 176.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.7 p30 43.38 51.51 5.98 Favored 'General case' 0 N--CA 1.505 2.301 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 175.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 54.81 27.05 8.39 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.275 -0.891 . . . . 0.0 111.145 175.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -118.32 105.91 45.72 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.575 -0.703 . . . . 0.0 110.057 176.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.51 147.27 92.27 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 O-C-N 123.119 1.063 . . . . 0.0 110.6 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.569 HG22 ' HA ' ' A' ' 192' ' ' TYR . 45.7 pt -131.88 178.32 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 121.744 0.783 . . . . 0.0 110.832 -177.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 302' ' ' GLU . 31.3 mt -124.4 149.87 46.22 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.685 HD12 ' CE1' ' A' ' 301' ' ' PHE . 81.2 mt -115.27 130.34 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.621 HG23 ' SG ' ' A' ' 300' ' ' CYS . 82.0 mt -109.74 126.26 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -176.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 59.7 t -118.9 126.71 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.425 HG22 ' HG2' ' A' ' 298' ' ' ARG . 45.6 p -125.26 152.76 44.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.637 -0.665 . . . . 0.0 110.665 -174.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.789 HD21 ' HB3' ' A' ' 180' ' ' PRO . 19.8 tp -102.59 126.17 49.58 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 168.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.638 ' OE2' HG13 ' A' ' 295' ' ' VAL . 73.3 mm-40 -131.78 149.13 52.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.814 -0.554 . . . . 0.0 110.003 -172.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.82 ' CG2' HD11 ' A' ' 296' ' ' LEU . 19.0 p -89.98 161.11 16.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.706 -0.621 . . . . 0.0 110.115 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -55.95 -26.12 46.52 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.603 -0.686 . . . . 0.0 111.094 -176.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 46.0 p30 -90.18 9.66 27.57 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.399 -0.813 . . . . 0.0 111.889 -173.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 88.79 20.19 48.23 Favored Glycine 0 N--CA 1.494 2.542 0 O-C-N 121.12 -0.987 . . . . 0.0 110.655 171.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -107.98 140.15 41.56 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.267 -1.137 . . . . 0.0 110.025 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.638 HG13 ' OE2' ' A' ' 289' ' ' GLU . 60.8 t -88.74 132.23 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.65 -0.656 . . . . 0.0 110.234 -172.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.82 HD11 ' CG2' ' A' ' 290' ' ' THR . 96.2 mt -99.88 -40.08 7.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.707 -0.62 . . . . 0.0 110.532 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -162.61 150.83 20.33 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.425 ' HG2' HG22 ' A' ' 287' ' ' THR . 78.5 mtm180 -135.15 134.77 40.52 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.686 -0.89 . . . . 0.0 110.566 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -137.34 158.69 43.87 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.676 -0.64 . . . . 0.0 109.982 172.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' CYS . . . . . 0.621 ' SG ' HG23 ' A' ' 285' ' ' ILE . 97.7 m -142.56 155.69 45.03 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.424 -0.797 . . . . 0.0 110.713 -175.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.685 ' CE1' HD12 ' A' ' 284' ' ' ILE . 47.9 p90 -144.94 163.73 33.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.72 -0.612 . . . . 0.0 110.113 175.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.446 ' HA ' HD23 ' A' ' 283' ' ' LEU . 56.8 tt0 -104.91 135.37 46.39 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.496 -0.752 . . . . 0.0 110.151 -177.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -124.29 143.5 50.52 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.677 -170.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -138.67 139.01 38.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.843 -0.536 . . . . 0.0 109.806 173.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.67 HD13 ' O ' ' A' ' 269' ' ' CYS . 74.5 mt -105.82 122.93 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.549 -0.72 . . . . 0.0 109.59 175.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.9 p -145.18 168.24 20.85 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.558 -0.714 . . . . 0.0 110.968 -170.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -68.8 -39.97 79.81 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.686 -0.633 . . . . 0.0 110.636 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 4.1 t -131.25 88.54 44.2 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.534 -0.729 . . . . 0.0 110.496 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.33 -29.35 67.3 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 O-C-N 123.185 1.098 . . . . 0.0 110.914 174.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.36 -37.77 93.07 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -73.25 -40.63 64.48 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.689 -0.889 . . . . 0.0 109.875 -173.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -69.47 -39.96 77.4 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.164 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -61.01 -44.15 97.83 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.456 -0.777 . . . . 0.0 110.289 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -64.68 -40.14 94.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.557 -0.714 . . . . 0.0 110.495 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.57 -50.05 74.2 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.499 -0.751 . . . . 0.0 110.486 -173.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 N--CA 1.495 1.817 0 O-C-N 121.501 -0.749 . . . . 0.0 110.084 -178.283 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.5 t . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.05 0.453 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.5 p-10 -94.06 23.22 5.11 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.69 -0.631 . . . . 0.0 110.915 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 50.4 m -75.4 125.16 28.44 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.445 -0.785 . . . . 0.0 110.233 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -69.61 144.97 52.84 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.639 -0.663 . . . . 0.0 110.478 -177.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -153.18 100.59 2.65 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.647 -0.658 . . . . 0.0 110.118 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -59.14 -39.96 74.3 Favored 'Trans proline' 0 N--CA 1.489 1.206 0 O-C-N 123.129 1.068 . . . . 0.0 110.774 -175.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.3 -155.17 48.59 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -75.47 -43.57 0.35 Allowed 'Trans proline' 0 C--N 1.317 -1.095 0 O-C-N 123.303 1.159 . . . . 0.0 110.978 -174.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -86.77 8.1 24.12 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.529 -0.732 . . . . 0.0 111.412 -173.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.39 59.67 4.23 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.997 -1.064 . . . . 0.0 110.72 -176.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.68 ' HA ' HG12 ' A' ' 176' ' ' VAL . 64.8 t80 -77.82 117.25 19.01 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.572 -0.705 . . . . 0.0 109.933 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -130.05 160.01 35.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.855 -0.528 . . . . 0.0 110.141 -178.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 63.8 t -126.41 146.42 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.681 -0.637 . . . . 0.0 109.816 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 78.4 p -155.26 161.4 41.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.765 -0.584 . . . . 0.0 110.069 177.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.497 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 67.1 m-85 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.8 -0.562 . . . . 0.0 109.851 -176.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 121.142 0.496 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.5 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 82.1 p -60.03 -32.92 71.34 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.715 -0.616 . . . . 0.0 109.99 175.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.5 ' HD1' ' HG1' ' A' ' 152' ' ' THR . 68.8 p-90 -171.04 143.74 2.02 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.329 0.585 . . . . 0.0 110.059 177.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.0 t -142.15 142.63 32.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.88 -0.513 . . . . 0.0 110.072 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.497 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 44.7 t80 -125.49 140.06 53.09 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.551 -0.718 . . . . 0.0 110.514 -172.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.8 t -111.79 124.94 53.41 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 120.383 -0.527 . . . . 0.0 109.878 176.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 56.5 m -70.68 -37.07 73.61 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.789 -0.569 . . . . 0.0 110.483 -177.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -59.49 -33.86 71.86 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.645 -0.659 . . . . 0.0 110.441 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.505 HD11 ' OD1' ' A' ' 316' ' ' ASP . 57.1 mt -104.77 -12.04 16.52 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.678 -0.639 . . . . 0.0 110.88 -175.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 30.5 tttt 59.77 50.3 7.19 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.051 -1.031 . . . . 0.0 109.675 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -146.42 153.09 40.07 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.74 -0.6 . . . . 0.0 110.612 -174.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.618 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.55 137.85 53.4 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.833 -0.542 . . . . 0.0 110.209 -176.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -114.94 135.2 54.47 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.1 p -138.34 158.5 44.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.72 -0.612 . . . . 0.0 111.044 -175.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.421 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 65.5 mt-30 -104.45 140.94 37.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.628 -0.67 . . . . 0.0 110.021 172.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.432 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.1 tt -52.25 148.67 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.502 -0.749 . . . . 0.0 111.917 -172.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.79 10.05 5.77 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.539 -0.726 . . . . 0.0 112.509 176.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.421 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 26.7 mmtt -95.35 155.11 16.87 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.924 -1.11 . . . . 0.0 110.955 174.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 87.3 m -84.68 126.25 33.22 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.721 -0.612 . . . . 0.0 110.552 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' CYS . . . . . 0.618 ' SG ' HD21 ' A' ' 162' ' ' LEU . 29.9 t -115.15 90.36 23.62 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.572 -0.705 . . . . 0.0 110.178 176.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.42 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 22.6 Cg_endo -65.83 130.82 25.59 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 O-C-N 123.271 1.143 . . . . 0.0 110.597 176.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.411 HG12 ' CE2' ' A' ' 142' ' ' PHE . 96.9 mt -123.51 142.06 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.692 -0.63 . . . . 0.0 109.306 176.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -109.08 134.7 51.34 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.552 -0.718 . . . . 0.0 110.713 -176.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.1 mm -95.29 134.76 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.67 -0.644 . . . . 0.0 109.66 169.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -115.16 127.27 55.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.593 -0.692 . . . . 0.0 110.452 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.68 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.0 m -136.66 159.77 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.639 -0.663 . . . . 0.0 109.852 174.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.6 mmm -76.32 -40.69 50.73 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.658 -0.651 . . . . 0.0 110.092 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.5 p -134.45 143.28 46.09 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.763 -0.586 . . . . 0.0 109.9 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.8 Cg_exo -55.5 139.92 82.64 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 O-C-N 123.173 1.091 . . . . 0.0 110.947 -173.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.795 ' HB3' HD21 ' A' ' 288' ' ' LEU . 19.3 Cg_endo -59.95 165.2 10.67 Favored 'Trans proline' 0 C--N 1.316 -1.167 0 O-C-N 123.17 1.09 . . . . 0.0 110.656 177.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -62.04 154.86 59.25 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 O-C-N 123.312 1.164 . . . . 0.0 110.446 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -64.67 137.54 57.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.65 -0.656 . . . . 0.0 110.117 173.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 96.8 -24.96 28.67 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.861 -1.295 . . . . 0.0 109.861 -177.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.15 149.21 2.96 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.324 -1.104 . . . . 0.0 111.423 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.74 155.95 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.72 -0.612 . . . . 0.0 109.831 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.686 HD11 ' CD2' ' A' ' 251' ' ' TYR . 64.0 mt -108.79 135.21 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.732 ' HG2' HD22 ' A' ' 248' ' ' LEU . 69.5 mtt180 -114.95 145.85 41.8 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -174.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.646 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -140.54 126.53 19.51 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.534 -0.729 . . . . 0.0 110.212 173.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.409 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 32.9 ttp -137.22 139.0 26.76 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.804 -0.56 . . . . 0.0 110.98 -176.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.534 ' HD3' HD12 ' A' ' 226' ' ' ILE . 71.0 Cg_endo -91.11 138.25 2.29 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 O-C-N 123.204 1.107 . . . . 0.0 110.81 177.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.404 HG13 ' C ' ' A' ' 190' ' ' PRO . 35.9 m -146.22 154.87 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.554 -0.716 . . . . 0.0 110.118 173.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.66 ' HA ' HG22 ' A' ' 282' ' ' ILE . 83.4 m-85 -60.73 161.32 8.07 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.467 -0.771 . . . . 0.0 110.402 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.422 ' HA ' HD12 ' A' ' 283' ' ' LEU . 33.7 tttt -77.6 -60.07 2.52 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.632 -0.668 . . . . 0.0 110.827 -174.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -80.13 151.02 30.02 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.558 -0.713 . . . . 0.0 110.34 -175.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.456 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.54 -37.81 71.0 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.421 -0.8 . . . . 0.0 110.695 -176.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -56.61 -24.78 50.28 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.529 -0.732 . . . . 0.0 110.573 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.404 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 64.2 m170 -109.49 -20.51 12.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.531 -0.731 . . . . 0.0 111.165 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.456 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -67.72 -20.22 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.174 -0.954 . . . . 0.0 110.574 -176.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 67.7 p -79.36 -16.98 55.4 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.562 -0.711 . . . . 0.0 110.735 174.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -88.36 137.3 32.45 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.349 -0.845 . . . . 0.0 110.092 173.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.9 t -73.0 142.0 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.626 -0.671 . . . . 0.0 110.299 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.529 HG22 ' CE2' ' A' ' 192' ' ' TYR . 75.8 t -84.96 139.7 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.542 -0.724 . . . . 0.0 109.344 170.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 14.7 pttt -134.86 -170.08 2.49 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.553 -0.717 . . . . 0.0 110.883 -170.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -95.13 154.72 17.05 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.741 -0.599 . . . . 0.0 110.286 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.703 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 42.0 m . . . . . 0 N--CA 1.497 1.88 0 O-C-N 121.632 -0.668 . . . . 0.0 109.271 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 30.1 tp . . . . . 0 N--CA 1.496 1.84 0 CA-C-O 120.925 0.393 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.534 HD12 ' HD3' ' A' ' 190' ' ' PRO . 84.8 mt -103.94 136.76 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.746 -0.596 . . . . 0.0 109.917 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -131.6 156.7 45.34 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.667 -0.646 . . . . 0.0 110.318 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.575 HG23 HG21 ' A' ' 247' ' ' VAL . 89.4 t -102.28 146.62 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.772 -0.58 . . . . 0.0 109.974 176.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -117.96 130.03 55.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.722 -0.611 . . . . 0.0 110.431 171.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 93.15 21.55 29.81 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 167.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -136.73 107.24 6.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.319 -1.107 . . . . 0.0 110.048 173.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 94.5 p -63.43 -15.14 56.79 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.651 -0.656 . . . . 0.0 111.192 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -97.27 10.05 40.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.272 -0.892 . . . . 0.0 111.189 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.81 126.58 27.84 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.174 -0.954 . . . . 0.0 110.092 176.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -139.75 154.39 47.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.762 -0.586 . . . . 0.0 109.785 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.403 ' CD1' ' HB ' ' A' ' 247' ' ' VAL . 86.3 m-85 -116.95 150.7 38.11 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.596 -0.69 . . . . 0.0 110.538 -176.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.17 159.89 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.762 -0.587 . . . . 0.0 110.118 176.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -122.86 130.0 52.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.75 -0.594 . . . . 0.0 110.177 177.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -64.98 109.98 3.6 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.649 -0.657 . . . . 0.0 109.741 176.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -59.98 -24.46 76.51 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.083 1.044 . . . . 0.0 111.032 -172.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 84.3 mt -99.87 -50.39 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.488 -0.757 . . . . 0.0 110.766 -171.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 6.2 p -105.3 12.09 32.13 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.365 -0.834 . . . . 0.0 111.984 -173.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 81.97 -24.98 4.3 Favored Glycine 0 N--CA 1.496 2.7 0 O-C-N 120.982 -1.074 . . . . 0.0 111.888 169.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 -45.88 142.08 2.76 Favored 'General case' 0 N--CA 1.505 2.282 0 CA-C-N 118.59 1.195 . . . . 0.0 112.614 -168.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -108.8 144.58 36.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.629 -0.669 . . . . 0.0 110.063 174.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 78.8 p -154.83 159.96 40.91 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.62 -0.675 . . . . 0.0 110.48 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.575 HG21 HG23 ' A' ' 228' ' ' VAL . 8.3 p -123.07 148.12 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.77 -0.581 . . . . 0.0 109.695 177.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.732 HD22 ' HG2' ' A' ' 187' ' ' ARG . 81.3 mt -129.71 154.64 46.97 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.896 -176.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.442 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.9 m -150.57 151.84 31.48 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.807 -0.558 . . . . 0.0 109.944 175.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -71.11 138.81 34.31 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 O-C-N 123.188 1.099 . . . . 0.0 109.844 177.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.686 ' CD2' HD11 ' A' ' 186' ' ' ILE . 9.0 t80 -78.45 126.06 30.23 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.454 -0.779 . . . . 0.0 110.04 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -100.0 160.11 28.06 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.719 -0.613 . . . . 0.0 110.02 177.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -59.11 159.62 21.48 Favored 'Trans proline' 0 C--N 1.316 -1.157 0 O-C-N 123.276 1.145 . . . . 0.0 110.401 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.36 149.98 77.8 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.268 1.141 . . . . 0.0 110.521 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -60.53 148.42 37.95 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.681 -0.637 . . . . 0.0 110.241 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.82 127.17 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.516 -0.74 . . . . 0.0 110.154 -170.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.99 -10.17 55.39 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 10.0 t -144.66 173.31 11.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.177 -1.19 . . . . 0.0 110.586 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -107.19 13.14 27.6 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.63 -0.669 . . . . 0.0 111.783 -168.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -119.99 168.05 11.54 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.11 -0.994 . . . . 0.0 111.083 -175.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 83.6 m -117.72 145.83 44.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.729 -0.607 . . . . 0.0 109.876 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 42.8 m -115.59 135.72 53.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.622 -0.674 . . . . 0.0 110.885 -175.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.4 t -129.7 137.32 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 62.8 mt -104.63 118.57 36.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.511 -0.743 . . . . 0.0 109.73 -172.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.646 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 6.3 m-30 -105.56 151.31 24.48 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.694 -0.629 . . . . 0.0 110.578 -177.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -136.53 142.9 43.48 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -112.53 129.26 56.42 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.608 -0.682 . . . . 0.0 110.458 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -98.23 -1.84 41.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.741 -0.6 . . . . 0.0 111.95 -176.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.73 159.11 43.38 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.117 -0.989 . . . . 0.0 109.839 174.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.615 ' HA ' HD13 ' A' ' 305' ' ' ILE . 27.1 p30 -113.95 153.49 29.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.732 -0.605 . . . . 0.0 110.059 178.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' SER . . . . . 0.442 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 89.1 p -56.54 -26.51 55.09 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.43 -0.794 . . . . 0.0 111.189 -168.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 49.8 p -94.4 8.09 43.22 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.396 -0.815 . . . . 0.0 112.095 -166.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' CYS . . . . . 0.703 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 28.8 p -92.98 116.61 29.21 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.009 -1.057 . . . . 0.0 110.584 178.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.39 143.3 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.482 -0.761 . . . . 0.0 110.414 -166.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.55 -5.33 58.55 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.96 -93.13 0.66 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 170.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' MET . . . . . 0.442 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 94.3 mmm -66.31 -29.06 69.19 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.731 -0.864 . . . . 0.0 110.36 176.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.8 p30 45.1 52.46 8.41 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 172.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 54.91 33.14 19.33 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.255 -0.903 . . . . 0.0 111.227 174.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' ARG . . . . . 0.415 ' HA ' ' HD2' ' A' ' 281' ' ' PRO . 80.9 mtt180 -113.97 104.95 54.84 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.511 -0.743 . . . . 0.0 110.245 173.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 281' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 280' ' ' ARG . 13.6 Cg_endo -61.1 145.49 98.81 Favored 'Trans proline' 0 N--CA 1.488 1.171 0 O-C-N 123.107 1.056 . . . . 0.0 110.293 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.66 HG22 ' HA ' ' A' ' 192' ' ' TYR . 44.0 pt -131.97 176.82 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.943 0.878 . . . . 0.0 111.244 -174.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 302' ' ' GLU . 31.4 mt -124.29 149.86 46.05 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.708 HD12 ' CE1' ' A' ' 301' ' ' PHE . 81.6 mt -114.85 129.4 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.253 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.525 HG23 ' SG ' ' A' ' 300' ' ' CYS . 80.4 mt -109.8 126.26 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -176.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 58.3 t -118.96 126.77 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.3 p -125.27 152.24 44.9 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.621 -174.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.795 HD21 ' HB3' ' A' ' 180' ' ' PRO . 21.1 tp -101.44 125.29 48.06 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 167.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.572 ' OE2' HG13 ' A' ' 295' ' ' VAL . 73.6 mm-40 -131.17 150.84 51.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.85 -0.531 . . . . 0.0 109.979 -172.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.797 ' CG2' HD11 ' A' ' 296' ' ' LEU . 68.9 p -89.96 159.88 16.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.606 -0.684 . . . . 0.0 109.908 177.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -55.95 -26.1 46.48 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.523 -0.735 . . . . 0.0 110.809 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -87.5 9.69 20.12 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.477 -0.764 . . . . 0.0 111.862 -174.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 86.9 20.16 54.23 Favored Glycine 0 N--CA 1.495 2.567 0 C-N-CA 120.195 -1.002 . . . . 0.0 110.733 170.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -106.84 140.14 40.14 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.293 -1.122 . . . . 0.0 110.267 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.572 HG13 ' OE2' ' A' ' 289' ' ' GLU . 59.9 t -88.32 130.15 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.65 -0.656 . . . . 0.0 110.034 -175.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.797 HD11 ' CG2' ' A' ' 290' ' ' THR . 96.0 mt -99.94 -40.15 7.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.681 -0.637 . . . . 0.0 110.46 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -160.14 147.9 15.56 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.523 ' HD3' HG11 ' A' ' 295' ' ' VAL . 79.4 mtm180 -135.09 134.4 40.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.644 -0.915 . . . . 0.0 110.565 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -137.47 158.95 43.28 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.654 -0.654 . . . . 0.0 110.036 172.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' CYS . . . . . 0.525 ' SG ' HG23 ' A' ' 285' ' ' ILE . 92.8 m -142.26 155.73 45.25 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.467 -0.771 . . . . 0.0 110.745 -175.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.708 ' CE1' HD12 ' A' ' 284' ' ' ILE . 48.9 p90 -144.98 160.54 41.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.701 -0.625 . . . . 0.0 110.074 174.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.468 ' HA ' HD23 ' A' ' 283' ' ' LEU . 58.7 tt0 -104.88 135.92 45.33 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.539 -0.726 . . . . 0.0 110.178 -177.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -118.41 143.74 46.45 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.812 -169.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -138.57 138.07 37.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.819 -0.551 . . . . 0.0 109.759 173.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.615 HD13 ' HA ' ' A' ' 270' ' ' ASN . 34.8 mt -110.8 122.85 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.538 -0.726 . . . . 0.0 109.495 178.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.3 p -145.25 171.9 13.9 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.561 -0.712 . . . . 0.0 111.035 -169.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -70.32 -40.06 74.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.681 -0.637 . . . . 0.0 110.653 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 4.5 t -132.37 89.98 35.23 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.574 -0.704 . . . . 0.0 110.525 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.18 -30.08 69.5 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.15 1.079 . . . . 0.0 111.032 174.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.03 -37.48 93.19 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -73.66 -40.59 63.6 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.701 -0.882 . . . . 0.0 109.895 -173.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -69.56 -39.99 77.05 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 120.084 -0.647 . . . . 0.0 110.236 -177.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -61.26 -43.77 98.34 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.382 177.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -64.86 -38.36 90.71 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.524 -0.735 . . . . 0.0 110.461 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.84 -49.76 75.0 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.539 -0.726 . . . . 0.0 110.539 -173.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 316' ' ' ASP . . . . . 0.505 ' OD1' HD11 ' A' ' 159' ' ' LEU . 2.8 p30 . . . . . 0 N--CA 1.495 1.79 0 O-C-N 121.488 -0.758 . . . . 0.0 110.138 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.9 t . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.011 0.434 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -95.05 24.79 4.6 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.717 -0.614 . . . . 0.0 110.756 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 52.0 m -74.96 125.23 28.45 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.587 -0.696 . . . . 0.0 110.263 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -69.88 144.93 52.34 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.675 -0.64 . . . . 0.0 110.496 -177.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -156.96 102.33 1.93 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.675 -0.64 . . . . 0.0 110.048 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.97 -39.98 66.09 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 O-C-N 123.138 1.073 . . . . 0.0 110.699 -175.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.39 -155.15 43.35 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -72.65 -48.97 0.28 Allowed 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.318 1.168 . . . . 0.0 110.813 -175.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -83.77 4.64 28.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.537 -0.727 . . . . 0.0 111.369 -175.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 t 54.12 61.22 3.15 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.908 -1.12 . . . . 0.0 110.664 -176.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.725 ' HA ' HG12 ' A' ' 176' ' ' VAL . 63.0 t80 -77.96 119.92 22.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.522 -0.736 . . . . 0.0 110.04 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -129.98 160.01 34.93 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.778 -0.576 . . . . 0.0 110.072 -176.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.2 t -124.55 146.34 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.789 -0.57 . . . . 0.0 109.754 177.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.3 p -155.12 162.96 40.86 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.325 0.583 . . . . 0.0 109.941 177.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.492 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 71.2 m-85 . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.74 -0.6 . . . . 0.0 109.762 -176.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 121.169 0.509 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.429 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 65.2 p -60.13 -34.02 72.95 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.742 -0.599 . . . . 0.0 109.967 175.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.441 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -171.33 143.48 1.86 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.399 0.618 . . . . 0.0 110.406 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 13.4 t -142.16 142.68 32.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.899 -0.5 . . . . 0.0 109.892 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.492 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 62.3 t80 -125.56 140.03 53.09 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.399 -0.813 . . . . 0.0 110.646 -171.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.8 t -110.38 124.92 52.61 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.878 176.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 54.6 m -70.84 -37.0 73.12 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.838 -0.539 . . . . 0.0 110.414 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -59.36 -33.9 71.73 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.652 -0.655 . . . . 0.0 110.47 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.0 mt -104.79 -12.02 16.51 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.691 -0.631 . . . . 0.0 110.838 -175.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt 59.69 49.27 8.39 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.076 -1.015 . . . . 0.0 109.699 177.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.445 ' HE3' ' CZ ' ' A' ' 163' ' ' TYR . 34.2 ttpt -147.15 153.26 39.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.714 -0.616 . . . . 0.0 110.563 -173.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.656 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.5 tp -126.44 138.06 53.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.686 -0.633 . . . . 0.0 110.315 -173.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.445 ' CZ ' ' HE3' ' A' ' 161' ' ' LYS . 54.0 m-85 -114.72 133.75 55.64 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.36 158.46 44.24 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.65 -0.656 . . . . 0.0 110.824 -175.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.405 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 33.7 mt-30 -104.62 141.9 35.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.595 -0.691 . . . . 0.0 110.275 172.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.426 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 16.6 tt -51.42 147.38 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 CA-C-O 121.624 0.726 . . . . 0.0 111.989 -174.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.26 10.06 5.3 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.521 -0.737 . . . . 0.0 112.534 176.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.405 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 30.5 mmtm -96.28 155.04 16.93 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.899 -1.126 . . . . 0.0 110.838 175.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 86.5 m -84.37 126.22 33.02 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.707 -0.621 . . . . 0.0 110.525 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' CYS . . . . . 0.656 ' SG ' HD21 ' A' ' 162' ' ' LEU . 44.0 t -115.22 90.19 23.37 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.62 -0.675 . . . . 0.0 110.199 174.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.441 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 23.1 Cg_exo -61.85 130.75 32.27 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 O-C-N 123.278 1.146 . . . . 0.0 110.677 173.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.412 HG12 ' CE2' ' A' ' 142' ' ' PHE . 93.2 mt -124.97 142.16 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.626 -0.671 . . . . 0.0 109.219 175.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -107.93 136.3 47.87 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.475 -0.766 . . . . 0.0 110.826 -174.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.415 ' CG2' ' CE1' ' A' ' 138' ' ' PHE . 48.6 mm -95.22 135.07 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.757 -0.589 . . . . 0.0 109.691 169.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -118.09 128.99 55.27 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.415 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.725 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.3 m -136.24 159.82 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.63 -0.669 . . . . 0.0 109.979 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 81.2 mmm -77.75 -40.49 40.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.713 -0.617 . . . . 0.0 110.085 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.1 p -135.21 143.27 44.97 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.797 -0.564 . . . . 0.0 109.788 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 33.3 Cg_exo -55.57 139.8 82.96 Favored 'Trans proline' 0 N--CA 1.489 1.264 0 O-C-N 123.245 1.129 . . . . 0.0 110.871 -172.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.694 ' HB3' HD21 ' A' ' 288' ' ' LEU . 23.8 Cg_endo -64.47 169.38 11.23 Favored 'Trans proline' 0 N--CA 1.488 1.151 0 O-C-N 123.181 1.095 . . . . 0.0 110.704 178.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -61.19 158.26 35.87 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 O-C-N 123.321 1.169 . . . . 0.0 110.469 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -78.7 138.18 38.15 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.602 -0.686 . . . . 0.0 109.969 175.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.5 -24.84 30.6 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -174.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.2 151.09 2.17 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.35 -1.088 . . . . 0.0 111.322 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.7 155.95 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.727 -0.608 . . . . 0.0 109.762 176.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.65 HD11 ' CD2' ' A' ' 251' ' ' TYR . 66.5 mt -108.13 137.0 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.72 ' HG2' HD22 ' A' ' 248' ' ' LEU . 37.8 mtp180 -114.87 146.79 40.72 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -175.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.68 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -140.85 126.07 18.54 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.483 -0.761 . . . . 0.0 110.4 171.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 48.5 ttp -137.33 140.69 31.49 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.775 -0.578 . . . . 0.0 111.052 -176.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.651 ' HD3' HD12 ' A' ' 226' ' ' ILE . 74.0 Cg_endo -89.85 138.25 2.95 Favored 'Trans proline' 0 C--N 1.32 -0.96 0 O-C-N 123.24 1.126 . . . . 0.0 110.843 177.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.413 HG13 ' C ' ' A' ' 190' ' ' PRO . 34.7 m -146.39 154.82 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.547 -0.721 . . . . 0.0 110.085 173.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.653 ' HA ' HG22 ' A' ' 282' ' ' ILE . 88.3 m-85 -62.92 162.9 10.46 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.522 -0.736 . . . . 0.0 110.468 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.413 ' HA ' HD12 ' A' ' 283' ' ' LEU . 47.7 tttm -78.93 -60.04 2.54 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.659 -0.65 . . . . 0.0 110.815 -175.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 38.9 mttp -80.1 150.77 30.16 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.62 -0.675 . . . . 0.0 110.34 -175.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.456 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.52 -37.69 70.8 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.371 -0.831 . . . . 0.0 110.728 -176.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -56.44 -24.83 48.0 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.536 -0.727 . . . . 0.0 110.642 -176.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.42 ' HB3' ' CG ' ' A' ' 192' ' ' TYR . 92.0 m-70 -110.09 -20.51 12.67 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.174 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.456 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.1 p -67.07 -20.28 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.15 -0.969 . . . . 0.0 110.544 -176.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 71.9 p -79.29 -16.99 55.52 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.491 -0.756 . . . . 0.0 110.651 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -88.34 137.19 32.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.34 -0.85 . . . . 0.0 110.041 172.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.3 t -73.1 141.58 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.645 -0.659 . . . . 0.0 110.248 177.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.554 HG22 ' CE2' ' A' ' 192' ' ' TYR . 64.7 t -84.93 137.8 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.618 -0.676 . . . . 0.0 109.405 171.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 12.1 pttt -134.92 -170.29 2.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.543 -0.723 . . . . 0.0 111.035 -171.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 83.5 mtm-85 -95.26 158.7 15.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.781 -0.575 . . . . 0.0 110.34 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.697 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 56.5 m . . . . . 0 N--CA 1.497 1.878 0 O-C-N 121.679 -0.638 . . . . 0.0 109.513 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.41 ' HA ' ' CG ' ' A' ' 268' ' ' MET . 54.0 tp . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 120.941 0.4 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.651 HD12 ' HD3' ' A' ' 190' ' ' PRO . 82.6 mt -104.06 136.75 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.843 -0.536 . . . . 0.0 109.685 175.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -134.16 158.81 42.72 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.714 -0.616 . . . . 0.0 110.389 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.642 HG23 HG21 ' A' ' 247' ' ' VAL . 83.9 t -103.85 146.72 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.66 -0.65 . . . . 0.0 110.099 177.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -117.27 128.13 54.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.817 -0.552 . . . . 0.0 110.368 171.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.05 22.96 23.92 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 167.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -135.24 106.42 6.72 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.394 -1.062 . . . . 0.0 110.09 173.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 27.6 t -62.93 -15.12 54.3 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.649 -0.657 . . . . 0.0 111.24 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -100.13 5.02 44.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.198 -0.939 . . . . 0.0 111.61 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.4 131.16 49.33 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.039 -1.038 . . . . 0.0 110.276 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -139.76 157.74 45.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.782 -0.574 . . . . 0.0 109.62 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -115.72 150.63 36.52 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.592 -0.693 . . . . 0.0 110.497 -177.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.14 159.98 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.759 -0.588 . . . . 0.0 110.263 177.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -116.53 129.95 56.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.804 -0.56 . . . . 0.0 110.003 174.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -63.31 117.45 33.98 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.649 -0.657 . . . . 0.0 109.76 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.84 -27.18 80.09 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.096 1.051 . . . . 0.0 110.878 -172.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 84.2 mt -101.85 -50.34 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.439 -0.788 . . . . 0.0 110.907 -170.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 7.5 p -105.37 12.25 31.84 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.431 -0.793 . . . . 0.0 111.987 -172.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 81.25 -25.06 3.82 Favored Glycine 0 N--CA 1.498 2.787 0 O-C-N 121.006 -1.059 . . . . 0.0 111.868 170.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -45.71 142.09 2.61 Favored 'General case' 0 N--CA 1.505 2.285 0 CA-C-N 118.641 1.22 . . . . 0.0 112.726 -166.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -97.8 145.17 26.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.583 -0.698 . . . . 0.0 109.838 171.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 77.5 p -154.8 159.91 40.92 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.528 -0.732 . . . . 0.0 110.588 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.642 HG21 HG23 ' A' ' 228' ' ' VAL . 8.2 p -123.23 148.03 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.722 -0.611 . . . . 0.0 109.72 176.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.72 HD22 ' HG2' ' A' ' 187' ' ' ARG . 79.2 mt -129.78 154.76 46.9 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.833 -175.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.437 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.8 m -150.44 151.78 31.69 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.843 -0.536 . . . . 0.0 109.898 175.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -71.11 138.99 34.69 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 O-C-N 123.24 1.126 . . . . 0.0 109.923 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.65 ' CD2' HD11 ' A' ' 186' ' ' ILE . 9.9 t80 -80.05 123.43 27.84 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.543 -0.723 . . . . 0.0 110.188 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -99.99 160.1 28.1 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.717 -0.614 . . . . 0.0 110.07 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -58.83 160.1 19.03 Favored 'Trans proline' 0 N--CA 1.487 1.12 0 O-C-N 123.228 1.12 . . . . 0.0 110.414 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -58.67 149.91 73.55 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 O-C-N 123.171 1.09 . . . . 0.0 110.567 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -62.46 146.94 50.21 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.693 -0.629 . . . . 0.0 110.261 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.9 127.26 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.496 -0.752 . . . . 0.0 110.232 -171.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.65 -10.08 55.86 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 7.3 t -143.84 166.46 24.86 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.165 -1.197 . . . . 0.0 110.6 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -101.87 13.07 35.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.717 -0.615 . . . . 0.0 111.846 -168.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -127.57 168.13 15.4 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.098 -1.001 . . . . 0.0 111.126 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 83.2 m -117.67 147.31 43.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.701 -0.624 . . . . 0.0 109.912 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 31.1 m -116.32 135.9 53.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.592 -0.693 . . . . 0.0 110.922 -174.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.5 t -128.57 137.21 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 171.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 70.2 mt -104.74 119.84 39.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.457 -0.777 . . . . 0.0 109.849 -172.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.68 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 6.1 m-30 -105.97 151.3 24.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.683 -0.636 . . . . 0.0 110.639 -176.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -136.63 142.98 43.28 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -114.07 130.6 56.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.513 -0.742 . . . . 0.0 110.407 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' MET . . . . . 0.41 ' CG ' ' HA ' ' A' ' 225' ' ' LEU . 5.0 ppp? -99.12 1.4 45.04 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.708 -0.62 . . . . 0.0 111.963 -176.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -144.72 158.51 43.75 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.109 -0.994 . . . . 0.0 109.928 173.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.597 ' HA ' HD13 ' A' ' 305' ' ' ILE . 27.4 p30 -113.97 154.26 27.92 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.666 -0.646 . . . . 0.0 110.073 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' SER . . . . . 0.437 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 90.7 p -56.6 -26.97 57.0 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.373 -0.829 . . . . 0.0 111.096 -167.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 46.7 p -95.19 6.97 47.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.401 -0.812 . . . . 0.0 112.146 -165.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' CYS . . . . . 0.697 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 29.0 p -92.95 118.08 30.76 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.029 -1.044 . . . . 0.0 110.675 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.8 t -69.84 142.75 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.556 -0.715 . . . . 0.0 110.531 -168.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.4 -5.26 58.75 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.14 -95.45 0.74 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 169.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' MET . . . . . 0.437 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 95.3 mmm -64.7 -28.15 69.4 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.746 -0.855 . . . . 0.0 110.277 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 10.0 p30 44.73 50.92 8.51 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 172.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 54.76 34.12 21.08 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.375 -0.828 . . . . 0.0 111.316 174.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' ARG . . . . . 0.45 ' O ' HG23 ' A' ' 282' ' ' ILE . 88.7 mtt180 -115.94 104.93 52.03 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.548 -0.72 . . . . 0.0 110.141 172.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 280' ' ' ARG . 12.3 Cg_endo -60.26 145.03 99.43 Favored 'Trans proline' 0 N--CA 1.489 1.264 0 O-C-N 123.139 1.073 . . . . 0.0 110.374 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.653 HG22 ' HA ' ' A' ' 192' ' ' TYR . 42.8 pt -132.57 178.45 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 122.029 0.919 . . . . 0.0 111.373 -174.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 302' ' ' GLU . 34.5 mt -124.3 149.86 46.06 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.694 HD12 ' CE1' ' A' ' 301' ' ' PHE . 79.4 mt -112.24 128.71 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.646 HG23 ' SG ' ' A' ' 300' ' ' CYS . 77.8 mt -109.68 125.67 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -175.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 58.5 t -118.87 126.65 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.4 p -125.35 154.81 41.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.661 -0.649 . . . . 0.0 110.567 -174.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.694 HD21 ' HB3' ' A' ' 180' ' ' PRO . 24.4 tp -105.59 125.85 51.47 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 169.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.648 ' OE2' HG13 ' A' ' 295' ' ' VAL . 71.6 mm-40 -132.04 149.5 52.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.858 -0.526 . . . . 0.0 109.911 -173.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.823 ' CG2' HD11 ' A' ' 296' ' ' LEU . 25.4 p -89.98 161.28 15.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.703 -0.623 . . . . 0.0 110.031 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 69.7 ttp85 -55.94 -26.13 46.51 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.566 -0.708 . . . . 0.0 111.139 -175.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 44.7 p30 -90.87 9.82 28.82 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.444 -0.785 . . . . 0.0 111.963 -173.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.55 20.23 45.38 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.15 -1.024 . . . . 0.0 110.732 171.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -107.52 140.23 40.81 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.33 -1.1 . . . . 0.0 109.988 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.648 HG13 ' OE2' ' A' ' 289' ' ' GLU . 62.1 t -90.28 132.0 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.572 -0.705 . . . . 0.0 110.236 -172.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.823 HD11 ' CG2' ' A' ' 290' ' ' THR . 96.0 mt -99.84 -40.29 7.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.767 -0.583 . . . . 0.0 110.545 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -162.05 153.17 23.78 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -135.06 135.19 41.09 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.598 -0.942 . . . . 0.0 110.521 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -138.03 156.0 48.25 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.611 -0.681 . . . . 0.0 110.028 172.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' CYS . . . . . 0.646 ' SG ' HG23 ' A' ' 285' ' ' ILE . 98.3 m -143.23 155.7 44.57 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.379 -0.826 . . . . 0.0 110.844 -175.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.694 ' CE1' HD12 ' A' ' 284' ' ' ILE . 47.8 p90 -145.3 162.62 36.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.643 -0.661 . . . . 0.0 110.156 174.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.489 ' HA ' HD23 ' A' ' 283' ' ' LEU . 81.4 tt0 -104.77 137.34 42.71 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.591 -0.693 . . . . 0.0 110.219 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -118.94 144.66 46.32 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.766 -170.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -136.99 138.51 40.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.799 -0.563 . . . . 0.0 109.725 173.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.597 HD13 ' HA ' ' A' ' 270' ' ' ASN . 61.6 mt -112.02 122.86 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.572 -0.705 . . . . 0.0 109.63 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.1 p -145.42 173.73 11.75 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.589 -0.695 . . . . 0.0 110.683 -171.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -74.17 -40.12 62.77 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.573 -0.704 . . . . 0.0 110.639 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.8 t -127.25 86.86 57.75 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.494 -0.754 . . . . 0.0 110.475 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -55.81 -28.65 68.43 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.117 1.062 . . . . 0.0 110.768 174.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.88 -37.45 92.23 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -73.38 -41.05 63.86 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.643 -0.916 . . . . 0.0 109.889 -173.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -69.41 -40.33 77.38 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 120.076 -0.649 . . . . 0.0 110.153 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -61.28 -44.19 97.65 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.482 -0.762 . . . . 0.0 110.258 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 23.6 ttpt -63.73 -39.63 94.77 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.641 -0.662 . . . . 0.0 110.432 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.86 -51.9 66.34 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.517 -0.74 . . . . 0.0 110.396 -173.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.4 p30 . . . . . 0 N--CA 1.494 1.772 0 O-C-N 121.437 -0.789 . . . . 0.0 110.15 -177.551 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.6 t . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.035 0.445 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.6 p-10 -93.91 22.5 5.63 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.644 -0.66 . . . . 0.0 110.877 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 52.0 m -79.14 125.18 29.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.466 -0.771 . . . . 0.0 110.177 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -68.78 144.95 54.18 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.585 -0.697 . . . . 0.0 110.444 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.411 ' CE2' ' HA2' ' A' ' 134' ' ' GLY . 61.1 t80 -156.54 101.2 2.03 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.727 -0.608 . . . . 0.0 110.098 178.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.65 -39.89 78.48 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 O-C-N 123.126 1.066 . . . . 0.0 110.857 -175.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.411 ' HA2' ' CE2' ' A' ' 132' ' ' TYR . . . 79.3 -155.16 39.66 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -72.88 -48.33 0.29 Allowed 'Trans proline' 0 N--CA 1.486 1.079 0 O-C-N 123.402 1.212 . . . . 0.0 110.983 -174.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -86.47 8.36 22.19 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.614 -0.679 . . . . 0.0 111.351 -174.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.8 58.3 5.23 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.983 -1.073 . . . . 0.0 110.6 -176.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.729 ' HA ' HG12 ' A' ' 176' ' ' VAL . 71.7 t80 -79.38 115.81 19.25 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.604 -0.685 . . . . 0.0 109.877 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -130.05 160.04 34.9 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.28 0.562 . . . . 0.0 110.41 -174.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.451 HG22 ' CD1' ' A' ' 174' ' ' ILE . 78.8 t -122.01 150.32 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.831 -0.543 . . . . 0.0 109.807 174.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 78.2 p -154.91 169.21 24.58 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.012 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.494 ' CD2' ' CE2' ' A' ' 155' ' ' TYR . 97.3 m-85 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.884 -0.51 . . . . 0.0 109.938 -176.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 121.124 0.488 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.463 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 77.8 p -60.05 -32.21 70.71 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.653 -0.655 . . . . 0.0 109.922 174.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.463 ' HD1' ' HG1' ' A' ' 152' ' ' THR . 68.7 p-90 -171.46 143.78 1.84 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.403 0.621 . . . . 0.0 110.132 178.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.3 t -142.1 142.56 32.81 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.863 -0.523 . . . . 0.0 109.916 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.494 ' CE2' ' CD2' ' A' ' 142' ' ' PHE . 62.6 t80 -125.56 140.01 53.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.533 -0.729 . . . . 0.0 110.673 -172.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.5 t -111.3 124.01 51.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.829 -0.545 . . . . 0.0 109.775 175.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 62.0 m -70.88 -37.09 73.02 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.819 -0.55 . . . . 0.0 110.359 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -59.09 -33.05 70.37 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.555 -0.716 . . . . 0.0 110.447 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.523 HD11 ' OD1' ' A' ' 316' ' ' ASP . 55.1 mt -104.8 -12.03 16.5 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.77 -176.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt 59.76 47.76 9.96 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.039 -1.038 . . . . 0.0 109.728 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.423 ' HE3' ' CZ ' ' A' ' 163' ' ' TYR . 20.7 ttpt -148.21 153.23 38.48 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 120.161 -0.615 . . . . 0.0 110.803 -173.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.588 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.5 tp -126.49 137.93 53.44 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.731 -0.605 . . . . 0.0 110.437 -173.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.423 ' CZ ' ' HE3' ' A' ' 161' ' ' LYS . 98.7 m-85 -114.85 134.38 55.19 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.9 p -138.39 158.44 44.28 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.61 -0.681 . . . . 0.0 111.194 -176.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.424 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 59.0 mt-30 -104.47 142.18 35.06 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.663 -0.648 . . . . 0.0 110.336 173.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.431 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 18.0 tt -55.04 148.22 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.548 -0.72 . . . . 0.0 111.613 -173.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.37 10.01 5.36 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.544 -0.723 . . . . 0.0 112.511 177.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.424 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 73.5 mmtt -97.09 155.08 16.96 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.984 -1.073 . . . . 0.0 110.773 174.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 74.5 m -80.16 126.04 30.59 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.674 -0.641 . . . . 0.0 110.573 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' CYS . . . . . 0.588 ' SG ' HD21 ' A' ' 162' ' ' LEU . 31.4 t -117.1 90.37 33.21 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.625 -0.672 . . . . 0.0 110.182 174.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.426 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 26.1 Cg_endo -66.97 128.25 18.38 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 O-C-N 123.337 1.177 . . . . 0.0 110.756 176.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.65 HD12 ' CD2' ' A' ' 265' ' ' TYR . 83.7 mt -122.51 141.64 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.675 -0.641 . . . . 0.0 109.362 172.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -109.48 136.95 48.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.54 -0.725 . . . . 0.0 110.755 -173.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.671 HG21 ' CE1' ' A' ' 138' ' ' PHE . 50.4 mm -95.24 135.01 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.779 -0.576 . . . . 0.0 109.744 172.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 17.0 tptp -117.57 130.81 56.64 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.606 -0.684 . . . . 0.0 110.492 176.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.729 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.6 m -136.34 159.76 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.579 -0.701 . . . . 0.0 110.04 174.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 79.8 mmm -77.63 -39.79 44.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.724 -0.61 . . . . 0.0 110.029 176.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.3 p -135.66 143.24 44.0 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.831 -0.543 . . . . 0.0 109.709 177.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.9 Cg_exo -55.63 139.86 83.33 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 O-C-N 123.146 1.077 . . . . 0.0 110.821 -173.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.647 ' HB3' HD21 ' A' ' 288' ' ' LEU . 26.6 Cg_endo -65.19 169.61 11.94 Favored 'Trans proline' 0 N--CA 1.487 1.115 0 O-C-N 123.165 1.087 . . . . 0.0 110.684 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -61.27 156.7 44.17 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 O-C-N 123.37 1.195 . . . . 0.0 110.46 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -77.53 140.24 39.71 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.616 -0.677 . . . . 0.0 109.913 175.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.79 -24.91 29.62 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -175.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.16 151.64 1.97 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.363 -1.081 . . . . 0.0 111.319 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 33.8 m -129.77 155.89 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.766 -0.584 . . . . 0.0 109.597 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.634 HD11 ' CD2' ' A' ' 251' ' ' TYR . 79.3 mt -107.25 136.6 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.712 ' HG2' HD22 ' A' ' 248' ' ' LEU . 73.3 mtp180 -114.79 142.82 46.03 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -175.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -140.69 123.46 16.26 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.486 -0.759 . . . . 0.0 110.501 177.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 30.7 ttp -137.43 139.01 26.21 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.76 -0.587 . . . . 0.0 110.969 -175.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.746 ' HD3' HD12 ' A' ' 226' ' ' ILE . 72.7 Cg_endo -90.62 138.18 2.53 Favored 'Trans proline' 0 C--N 1.318 -1.03 0 O-C-N 123.246 1.13 . . . . 0.0 110.418 176.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.563 ' HB ' HG23 ' A' ' 198' ' ' VAL . 34.6 m -146.47 154.81 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.596 -0.69 . . . . 0.0 110.196 175.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.582 ' HA ' HG22 ' A' ' 282' ' ' ILE . 89.1 m-85 -59.82 160.35 7.73 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.495 -0.753 . . . . 0.0 110.495 178.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.442 ' HA ' HD12 ' A' ' 283' ' ' LEU . 34.1 tttt -74.04 -59.45 2.72 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.598 -0.688 . . . . 0.0 110.729 -175.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -80.01 148.78 30.98 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.57 -0.706 . . . . 0.0 110.398 -174.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.451 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.86 -38.11 72.26 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.355 -0.84 . . . . 0.0 110.695 -175.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -56.41 -24.94 48.34 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.441 -0.787 . . . . 0.0 110.629 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.404 ' O ' ' CD1' ' A' ' 192' ' ' TYR . 41.0 m80 -109.99 -20.51 12.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.597 -0.69 . . . . 0.0 111.188 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.563 HG23 ' HB ' ' A' ' 191' ' ' VAL . 3.2 p -67.25 -20.09 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.272 -0.892 . . . . 0.0 110.598 -176.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 69.2 p -79.27 -16.11 56.94 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.558 -0.714 . . . . 0.0 110.714 175.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -88.2 137.59 32.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.915 . . . . 0.0 110.049 172.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.7 t -73.01 142.36 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.606 -0.684 . . . . 0.0 110.25 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.477 HG22 ' CE1' ' A' ' 192' ' ' TYR . 77.0 t -84.81 139.11 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.514 -0.741 . . . . 0.0 109.339 170.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 14.1 pttt -134.81 -170.05 2.48 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.406 -0.809 . . . . 0.0 111.205 -165.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -95.13 154.4 17.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.783 -0.573 . . . . 0.0 110.62 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.614 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 61.0 m . . . . . 0 N--CA 1.496 1.867 0 O-C-N 121.668 -0.645 . . . . 0.0 109.303 172.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.495 HD12 ' HG3' ' A' ' 268' ' ' MET . 32.2 tp . . . . . 0 N--CA 1.496 1.871 0 CA-C-O 120.936 0.398 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.746 HD12 ' HD3' ' A' ' 190' ' ' PRO . 83.6 mt -98.17 136.78 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-O 121.232 0.539 . . . . 0.0 109.896 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 -131.14 159.38 37.85 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.735 -0.603 . . . . 0.0 110.084 175.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.574 HG23 HG21 ' A' ' 247' ' ' VAL . 73.7 t -105.62 146.68 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.425 0.631 . . . . 0.0 110.204 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -121.5 130.04 53.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.725 -0.609 . . . . 0.0 110.311 171.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 96.61 20.42 24.61 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 169.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -140.01 103.7 4.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.36 -1.082 . . . . 0.0 109.944 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 93.5 p -63.62 -15.21 57.59 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.657 -0.652 . . . . 0.0 111.15 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -97.43 9.86 41.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.29 -0.881 . . . . 0.0 111.17 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -62.07 132.71 53.77 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.235 -0.915 . . . . 0.0 110.102 176.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -139.65 157.96 44.9 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.691 -0.631 . . . . 0.0 109.826 177.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -114.2 150.68 33.91 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.516 -0.74 . . . . 0.0 110.576 -177.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.18 159.92 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.73 -0.606 . . . . 0.0 110.124 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -119.76 130.06 54.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.741 -0.6 . . . . 0.0 110.209 176.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -63.44 130.07 94.04 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.65 -0.656 . . . . 0.0 109.792 177.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -64.77 -27.66 59.81 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 O-C-N 123.118 1.062 . . . . 0.0 111.045 -170.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.2 mt -101.4 -50.5 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.411 -0.806 . . . . 0.0 111.108 -167.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 75.7 p -105.46 12.18 31.74 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.315 -0.865 . . . . 0.0 111.881 -174.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.93 -4.97 14.35 Favored Glycine 0 N--CA 1.496 2.645 0 O-C-N 121.1 -1.0 . . . . 0.0 111.837 174.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.476 ' CZ ' HG12 ' A' ' 191' ' ' VAL . 12.6 mmt180 -45.99 142.09 2.86 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 119.088 1.444 . . . . 0.0 112.334 -173.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -102.74 142.27 34.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.662 -0.649 . . . . 0.0 110.294 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 77.3 p -154.8 159.93 40.93 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.642 -0.661 . . . . 0.0 110.301 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.574 HG21 HG23 ' A' ' 228' ' ' VAL . 8.3 p -122.96 148.16 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.708 -0.62 . . . . 0.0 109.754 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.712 HD22 ' HG2' ' A' ' 187' ' ' ARG . 79.7 mt -129.69 154.63 46.96 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.763 -174.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.44 HG13 ' C ' ' A' ' 248' ' ' LEU . 33.8 m -150.9 151.74 30.5 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.873 -0.517 . . . . 0.0 109.901 174.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -70.96 137.67 32.44 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 O-C-N 123.273 1.144 . . . . 0.0 109.92 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.634 ' CD2' HD11 ' A' ' 186' ' ' ILE . 11.7 t80 -77.9 122.85 26.04 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.552 -0.717 . . . . 0.0 110.183 179.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -100.01 160.01 28.32 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.753 -0.592 . . . . 0.0 110.15 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.92 160.02 19.57 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 123.233 1.123 . . . . 0.0 110.403 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -58.56 150.06 71.67 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 123.29 1.153 . . . . 0.0 110.666 -177.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -61.13 147.31 44.44 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.672 -0.643 . . . . 0.0 110.184 -177.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.81 127.2 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.485 -0.759 . . . . 0.0 110.167 -170.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.87 -10.13 55.54 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 10.2 t -144.31 174.2 11.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.177 -1.19 . . . . 0.0 110.614 175.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -108.18 13.14 26.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.603 -0.686 . . . . 0.0 111.854 -167.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -124.59 168.13 13.55 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.178 -0.951 . . . . 0.0 111.189 -176.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 94.2 m -117.79 145.95 44.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.737 -0.602 . . . . 0.0 109.862 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 44.4 m -116.57 136.29 53.1 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.535 -0.728 . . . . 0.0 110.937 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 60.1 t -127.05 137.08 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 60.2 mt -104.82 121.21 43.19 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.603 -0.685 . . . . 0.0 109.747 -173.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.65 ' CD2' HD12 ' A' ' 172' ' ' ILE . 3.4 m-85 -99.95 156.71 17.0 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.578 -0.701 . . . . 0.0 110.88 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -136.41 142.94 43.72 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 171.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -110.4 128.97 55.84 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.551 -0.718 . . . . 0.0 110.27 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' MET . . . . . 0.495 ' HG3' HD12 ' A' ' 225' ' ' LEU . 5.2 ppp? -95.29 -0.11 53.22 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.712 -0.618 . . . . 0.0 112.019 -177.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' CYS . . . . . 0.722 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.6 OUTLIER -144.77 165.06 29.15 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.158 -0.964 . . . . 0.0 110.076 176.111 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.497 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.5 p30 -121.98 163.48 19.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.69 -0.631 . . . . 0.0 110.593 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 271' ' ' SER . . . . . 0.429 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 19.0 m -57.62 -34.15 69.0 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.414 -0.803 . . . . 0.0 111.136 -164.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 51.4 p -104.17 15.06 29.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.374 -0.829 . . . . 0.0 111.911 -163.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' CYS . . . . . 0.614 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 29.7 p -95.77 118.07 31.73 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.079 -1.013 . . . . 0.0 110.712 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 58.0 t -63.16 138.93 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.477 -0.764 . . . . 0.0 110.253 -171.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.04 -5.18 59.27 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.11 -98.33 0.83 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 171.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' MET . . . . . 0.429 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.2 mmm -63.17 -32.35 73.72 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.726 -0.867 . . . . 0.0 110.235 178.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.3 p30 44.21 48.84 7.79 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 174.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 54.76 30.27 13.27 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.377 -0.827 . . . . 0.0 111.306 174.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 15.4 mtt85 -119.45 107.04 41.58 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.59 -0.694 . . . . 0.0 110.08 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.58 148.0 89.29 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 O-C-N 123.127 1.067 . . . . 0.0 110.529 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.582 HG22 ' HA ' ' A' ' 192' ' ' TYR . 44.7 pt -131.9 177.52 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.709 0.766 . . . . 0.0 110.987 -176.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.478 HD23 ' HA ' ' A' ' 302' ' ' GLU . 34.3 mt -124.38 150.02 46.03 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 177.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.649 HD12 ' CE1' ' A' ' 301' ' ' PHE . 77.7 mt -112.65 128.29 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.562 -0.711 . . . . 0.0 109.089 176.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.505 HG23 ' SG ' ' A' ' 300' ' ' CYS . 81.3 mt -109.86 125.57 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -176.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 59.1 t -118.87 126.63 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.5 p -125.31 154.66 41.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.581 -0.699 . . . . 0.0 110.623 -175.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.647 HD21 ' HB3' ' A' ' 180' ' ' PRO . 22.8 tp -105.22 126.41 52.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.819 -0.551 . . . . 0.0 109.539 169.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.58 ' OE2' HG13 ' A' ' 295' ' ' VAL . 73.0 mm-40 -132.47 150.99 52.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.863 -0.523 . . . . 0.0 109.902 -174.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.749 HG22 HD11 ' A' ' 296' ' ' LEU . 68.6 p -89.89 159.47 16.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.619 -0.675 . . . . 0.0 109.648 177.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -55.86 -26.11 45.43 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.532 -0.73 . . . . 0.0 110.81 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -87.52 9.14 21.97 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.489 -0.757 . . . . 0.0 111.855 -174.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 87.22 20.26 53.05 Favored Glycine 0 N--CA 1.495 2.59 0 O-C-N 121.053 -1.03 . . . . 0.0 110.704 170.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -106.81 140.12 40.15 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.262 -1.14 . . . . 0.0 110.206 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.58 HG13 ' OE2' ' A' ' 289' ' ' GLU . 59.4 t -88.33 131.32 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.666 -0.646 . . . . 0.0 110.194 -173.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.749 HD11 HG22 ' A' ' 290' ' ' THR . 95.6 mt -99.91 -40.14 7.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.733 -0.604 . . . . 0.0 110.544 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -165.23 153.12 23.04 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -134.96 136.17 42.03 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.721 -0.87 . . . . 0.0 110.748 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -133.28 153.66 51.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.578 -0.701 . . . . 0.0 110.106 172.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' CYS . . . . . 0.505 ' SG ' HG23 ' A' ' 285' ' ' ILE . 99.8 m -142.76 151.63 41.46 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.486 -0.759 . . . . 0.0 110.659 -176.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.649 ' CE1' HD12 ' A' ' 284' ' ' ILE . 49.8 p90 -145.43 166.7 24.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.701 -0.625 . . . . 0.0 110.029 173.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.478 ' HA ' HD23 ' A' ' 283' ' ' LEU . 57.7 tt0 -104.78 136.1 44.93 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.449 -0.782 . . . . 0.0 110.277 -177.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -123.3 144.5 49.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.682 -0.636 . . . . 0.0 110.548 -170.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -137.66 137.87 38.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.844 -0.535 . . . . 0.0 109.796 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.722 HD13 ' O ' ' A' ' 269' ' ' CYS . 66.3 mt -106.34 123.0 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.581 -0.699 . . . . 0.0 109.556 175.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.0 p -145.17 167.28 23.15 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.56 -0.713 . . . . 0.0 110.89 -170.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -67.31 -40.1 85.96 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.675 -0.641 . . . . 0.0 110.616 -177.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 3.9 t -132.05 89.58 37.7 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.545 -0.722 . . . . 0.0 110.53 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -55.77 -29.04 69.95 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 O-C-N 123.23 1.121 . . . . 0.0 110.74 174.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.51 -37.94 93.02 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -72.56 -40.04 66.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.622 -0.928 . . . . 0.0 109.837 -173.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -69.51 -38.47 77.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.67 -0.644 . . . . 0.0 110.198 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -61.51 -43.21 99.28 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.228 178.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 14.5 ttpp -65.01 -38.73 91.88 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.586 -0.696 . . . . 0.0 110.419 176.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.22 -49.95 75.07 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.493 -0.755 . . . . 0.0 110.578 -173.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' ASP . . . . . 0.523 ' OD1' HD11 ' A' ' 159' ' ' LEU . 3.0 p30 . . . . . 0 N--CA 1.495 1.784 0 O-C-N 121.463 -0.773 . . . . 0.0 110.113 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.085 0.469 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -95.28 24.73 4.81 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.632 -0.667 . . . . 0.0 110.779 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 51.6 m -74.6 125.23 28.2 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.554 -0.716 . . . . 0.0 110.286 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -69.78 144.94 52.54 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.763 -0.586 . . . . 0.0 110.482 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -154.18 98.86 2.54 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.617 -0.677 . . . . 0.0 110.156 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -59.27 -39.95 73.1 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 O-C-N 123.261 1.137 . . . . 0.0 110.782 -176.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 73.76 -155.15 49.38 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -73.82 -45.65 0.37 Allowed 'Trans proline' 0 C--N 1.317 -1.096 0 O-C-N 123.38 1.2 . . . . 0.0 111.044 -174.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -86.24 8.07 22.69 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.474 -0.766 . . . . 0.0 111.383 -173.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.69 60.22 3.81 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.987 -1.071 . . . . 0.0 110.655 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.679 ' HA ' HG12 ' A' ' 176' ' ' VAL . 56.5 t80 -77.8 118.77 20.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.584 -0.697 . . . . 0.0 109.851 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.409 ' HA ' ' HG3' ' A' ' 299' ' ' ARG . 22.1 t70 -130.0 160.02 34.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.887 -0.508 . . . . 0.0 110.182 -178.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 80.6 t -125.16 146.92 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.729 -0.607 . . . . 0.0 109.785 176.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.4 p -157.73 171.03 21.04 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.88 176.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.414 ' CE1' HG12 ' A' ' 172' ' ' ILE . 57.7 m-85 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 121.118 0.485 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 69.0 p -60.03 -34.03 72.82 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.769 -0.582 . . . . 0.0 110.093 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.565 ' CE3' HD11 ' A' ' 162' ' ' LEU . 67.6 p-90 -170.75 148.08 2.89 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.834 -0.541 . . . . 0.0 109.964 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.4 t -141.7 142.44 33.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.749 -0.594 . . . . 0.0 109.884 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.403 ' HB2' HD12 ' A' ' 162' ' ' LEU . 62.0 t80 -125.54 140.07 53.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.52 -0.738 . . . . 0.0 110.589 -172.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 30.1 t -109.86 122.81 48.39 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.297 -0.561 . . . . 0.0 109.734 174.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 67.6 m -70.75 -36.98 73.38 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.353 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -59.38 -31.77 69.54 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.615 -0.678 . . . . 0.0 110.453 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.534 HD11 ' OD1' ' A' ' 316' ' ' ASP . 56.3 mt -104.78 -12.04 16.51 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.682 -0.636 . . . . 0.0 110.79 -175.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 32.5 tttt 59.68 48.52 9.27 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.007 -1.058 . . . . 0.0 109.682 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -146.93 153.06 39.65 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.736 -0.602 . . . . 0.0 110.638 -174.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.634 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.43 137.8 53.46 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.759 -0.588 . . . . 0.0 110.164 -175.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -115.85 132.67 56.57 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 175.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.1 p -138.36 158.43 44.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.663 -0.648 . . . . 0.0 111.046 -174.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.4 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 33.6 mt-30 -104.62 140.13 38.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.662 -0.649 . . . . 0.0 110.205 171.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.484 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.5 tt -52.61 149.14 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-O 121.619 0.723 . . . . 0.0 111.799 -174.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 66.06 8.35 5.41 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.489 -0.757 . . . . 0.0 112.483 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.4 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 63.4 mmtt -96.6 155.09 16.92 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.904 -1.123 . . . . 0.0 110.949 174.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 87.8 m -84.24 126.41 33.13 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.668 -0.645 . . . . 0.0 110.635 -177.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' CYS . . . . . 0.634 ' SG ' HD21 ' A' ' 162' ' ' LEU . 43.1 t -112.94 90.25 15.26 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.569 -0.707 . . . . 0.0 109.995 174.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -65.32 131.67 29.01 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.199 1.105 . . . . 0.0 110.484 176.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.414 HG12 ' CE1' ' A' ' 142' ' ' PHE . 92.5 mt -125.84 142.29 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.6 -0.688 . . . . 0.0 109.541 175.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -110.83 135.59 51.16 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.601 -0.687 . . . . 0.0 110.697 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.7 mm -95.33 134.91 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.556 -0.715 . . . . 0.0 109.579 169.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -116.21 128.47 55.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.602 -0.686 . . . . 0.0 110.445 176.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.679 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.5 m -136.29 159.77 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.548 -0.72 . . . . 0.0 109.886 174.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 81.9 mmm -75.45 -40.4 57.57 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.703 -0.623 . . . . 0.0 110.068 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 75.5 p -134.75 143.18 45.32 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.769 -0.582 . . . . 0.0 109.768 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 35.7 Cg_exo -54.95 139.79 79.34 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 O-C-N 123.138 1.073 . . . . 0.0 110.883 -172.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.579 ' HB3' HD21 ' A' ' 288' ' ' LEU . 20.5 Cg_endo -63.26 167.63 12.42 Favored 'Trans proline' 0 N--CA 1.487 1.099 0 O-C-N 123.191 1.1 . . . . 0.0 110.59 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -61.38 155.04 54.55 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.353 1.186 . . . . 0.0 110.321 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -72.99 139.0 46.38 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.591 -0.693 . . . . 0.0 109.853 175.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.71 -25.01 29.15 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -175.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.1 148.71 3.21 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.377 -1.072 . . . . 0.0 111.303 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.8 155.96 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.692 -0.63 . . . . 0.0 109.743 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.588 HD11 ' CD2' ' A' ' 251' ' ' TYR . 85.6 mt -106.57 137.91 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.698 -0.626 . . . . 0.0 109.457 176.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.729 ' HG2' HD22 ' A' ' 248' ' ' LEU . 70.8 mtp180 -114.85 141.96 47.2 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -176.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.618 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -137.39 125.83 23.45 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.471 -0.768 . . . . 0.0 110.353 175.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 39.4 ttm -137.27 139.11 26.95 Favored Pre-proline 0 N--CA 1.497 1.901 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.977 -176.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.508 ' HD3' HD12 ' A' ' 226' ' ' ILE . 72.8 Cg_endo -90.39 138.21 2.66 Favored 'Trans proline' 0 C--N 1.319 -0.982 0 C-N-CA 120.936 1.091 . . . . 0.0 110.858 177.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.494 HG12 ' CZ ' ' A' ' 244' ' ' ARG . 34.9 m -147.26 154.86 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.493 -0.755 . . . . 0.0 110.009 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.667 ' HA ' HG22 ' A' ' 282' ' ' ILE . 80.4 m-85 -61.49 165.0 5.17 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.431 -0.793 . . . . 0.0 110.448 -177.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -84.69 -60.06 2.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.605 -0.685 . . . . 0.0 110.841 -173.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 42.7 mttt -80.01 152.52 29.4 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.667 -0.646 . . . . 0.0 110.311 -174.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.454 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.68 -39.18 73.34 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.387 -0.821 . . . . 0.0 110.66 -174.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -56.62 -24.79 50.46 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.438 -0.789 . . . . 0.0 110.67 -177.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.473 ' CD2' ' HD3' ' A' ' 280' ' ' ARG . 51.1 m80 -109.23 -20.46 12.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.604 -0.685 . . . . 0.0 111.197 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.454 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -68.36 -20.28 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.144 -0.973 . . . . 0.0 110.639 -175.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 68.3 p -79.45 -17.15 54.85 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.551 -0.718 . . . . 0.0 110.858 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -88.36 137.7 32.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.302 -0.874 . . . . 0.0 110.186 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 57.7 t -72.95 146.49 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.587 -0.696 . . . . 0.0 110.146 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 60.0 t -84.82 140.06 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.575 -0.703 . . . . 0.0 109.203 172.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -134.83 -170.23 2.52 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.395 -0.815 . . . . 0.0 111.131 -167.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -95.21 154.14 17.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.771 -0.581 . . . . 0.0 110.461 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.863 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 63.3 m . . . . . 0 N--CA 1.496 1.847 0 O-C-N 121.649 -0.657 . . . . 0.0 109.274 173.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.492 HD12 ' HE3' ' A' ' 268' ' ' MET . 56.4 tp . . . . . 0 N--CA 1.498 1.972 0 CA-C-O 120.773 0.321 . . . . 0.0 110.576 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.508 HD12 ' HD3' ' A' ' 190' ' ' PRO . 84.7 mt -106.06 136.82 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 120.309 -0.557 . . . . 0.0 109.867 -177.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -132.84 158.23 43.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.785 -0.572 . . . . 0.0 110.171 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.493 HG23 HG21 ' A' ' 247' ' ' VAL . 94.0 t -105.22 146.68 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.693 -0.629 . . . . 0.0 110.122 177.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -119.45 127.97 53.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.768 -0.582 . . . . 0.0 110.352 170.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.17 21.1 21.34 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 168.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -140.2 105.54 5.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.381 -1.07 . . . . 0.0 110.048 174.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 95.2 p -63.58 -15.13 57.24 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.625 -0.672 . . . . 0.0 111.217 -178.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -96.74 9.93 40.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -0.834 . . . . 0.0 111.219 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -62.2 127.83 33.21 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.246 -0.908 . . . . 0.0 110.056 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -139.84 157.35 45.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.719 -0.613 . . . . 0.0 109.734 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.422 ' CD1' ' HB ' ' A' ' 247' ' ' VAL . 83.6 m-85 -117.98 150.61 38.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.599 -0.688 . . . . 0.0 110.627 -176.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.16 159.96 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.837 -0.54 . . . . 0.0 110.213 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -116.49 130.07 56.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.765 -0.584 . . . . 0.0 110.111 175.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -63.12 130.07 93.9 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.634 -0.667 . . . . 0.0 109.867 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -65.73 -29.31 51.23 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 123.197 1.104 . . . . 0.0 110.952 -171.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 82.5 mt -103.9 -50.45 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.484 -0.76 . . . . 0.0 111.071 -168.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 7.3 p -105.29 12.08 32.18 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.376 -0.827 . . . . 0.0 111.927 -173.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 73.66 -6.97 15.13 Favored Glycine 0 N--CA 1.497 2.701 0 O-C-N 121.077 -1.014 . . . . 0.0 112.125 171.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.494 ' CZ ' HG12 ' A' ' 191' ' ' VAL . 26.8 mmt180 -45.89 142.09 2.76 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-N 119.095 1.448 . . . . 0.0 112.312 -176.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -105.91 143.89 33.4 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.671 -0.643 . . . . 0.0 110.09 174.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 78.9 p -154.73 159.93 41.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.554 -0.716 . . . . 0.0 110.571 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.493 HG21 HG23 ' A' ' 228' ' ' VAL . 8.3 p -122.97 148.18 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.732 -0.605 . . . . 0.0 109.636 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.729 HD22 ' HG2' ' A' ' 187' ' ' ARG . 75.2 mt -129.68 154.6 46.98 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.71 -174.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.434 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.9 m -150.63 151.75 31.19 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.811 -0.555 . . . . 0.0 109.96 174.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -71.21 137.42 31.25 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.264 1.139 . . . . 0.0 109.913 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.588 ' CD2' HD11 ' A' ' 186' ' ' ILE . 8.9 t80 -76.95 125.5 29.41 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.509 -0.744 . . . . 0.0 109.984 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -99.98 160.12 28.05 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.658 -0.651 . . . . 0.0 110.145 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -58.81 159.64 20.37 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 O-C-N 123.284 1.15 . . . . 0.0 110.343 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.38 149.94 78.15 Favored 'Trans proline' 0 C--N 1.316 -1.132 0 O-C-N 123.177 1.093 . . . . 0.0 110.538 -176.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -61.14 149.75 36.34 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.695 -0.628 . . . . 0.0 110.146 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.0 t -69.83 127.09 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.552 -0.718 . . . . 0.0 110.198 -170.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.11 -10.06 56.68 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.409 HG21 ' CE1' ' A' ' 260' ' ' PHE . 9.6 t -145.39 175.39 10.35 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.182 -1.187 . . . . 0.0 110.604 175.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -110.52 13.23 22.71 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.531 -0.73 . . . . 0.0 111.93 -166.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.409 ' CE1' HG21 ' A' ' 258' ' ' THR . 49.4 p90 -120.04 168.01 11.61 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.074 -1.016 . . . . 0.0 111.16 -177.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 78.1 m -117.74 146.09 44.01 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.81 -0.556 . . . . 0.0 109.914 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 32.2 m -116.88 135.57 53.62 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.594 -0.691 . . . . 0.0 110.981 -175.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 65.1 t -131.42 137.27 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 74.0 mt -104.68 122.02 44.78 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.538 -0.726 . . . . 0.0 109.944 -171.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.618 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 6.1 m-30 -106.35 149.32 27.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.709 -0.62 . . . . 0.0 110.591 -177.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -136.63 142.99 43.28 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -113.57 130.7 56.32 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.47 -0.769 . . . . 0.0 110.395 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' MET . . . . . 0.492 ' HE3' HD12 ' A' ' 225' ' ' LEU . 0.0 OUTLIER -99.87 -0.62 39.27 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.782 -0.574 . . . . 0.0 111.844 -178.969 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 269' ' ' CYS . . . . . 0.548 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 7.0 t -144.78 158.05 43.94 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.147 -0.971 . . . . 0.0 109.009 176.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.558 ' HA ' HD13 ' A' ' 305' ' ' ILE . 26.1 p30 -119.0 152.32 36.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.678 -0.639 . . . . 0.0 110.262 -175.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' SER . . . . . 0.422 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 90.0 p -57.64 -25.39 60.09 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.481 -0.762 . . . . 0.0 111.148 -170.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 49.3 p -89.24 2.1 54.76 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.328 -0.858 . . . . 0.0 112.094 -167.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' CYS . . . . . 0.863 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 28.6 p -85.23 118.0 24.51 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.014 -1.053 . . . . 0.0 110.618 -178.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.63 140.17 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.457 -0.777 . . . . 0.0 110.445 -171.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 101.04 -5.18 56.07 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 177.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.11 -98.55 0.84 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 171.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' MET . . . . . 0.424 ' HE1' HD13 ' A' ' 282' ' ' ILE . 91.7 mmm -63.6 -30.96 72.0 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.73 -0.865 . . . . 0.0 110.332 178.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.1 p30 44.91 53.18 7.72 Favored 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 121.427 0.632 . . . . 0.0 112.338 173.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 17.1 mtt-85 54.89 34.97 23.31 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.336 -0.852 . . . . 0.0 111.328 175.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 280' ' ' ARG . . . . . 0.473 ' HD3' ' CD2' ' A' ' 197' ' ' HIS . 31.7 mtt-85 -112.43 104.94 56.22 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.575 -0.703 . . . . 0.0 110.085 169.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -60.13 148.95 87.54 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 O-C-N 123.12 1.063 . . . . 0.0 110.558 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.667 HG22 ' HA ' ' A' ' 192' ' ' TYR . 28.7 pt -131.97 179.16 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.811 0.815 . . . . 0.0 111.014 -177.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 302' ' ' GLU . 32.2 mt -124.37 149.96 46.07 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.706 HD12 ' CE1' ' A' ' 301' ' ' PHE . 80.6 mt -114.01 129.29 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.183 177.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.613 HG23 ' SG ' ' A' ' 300' ' ' CYS . 80.7 mt -109.73 125.92 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -175.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 60.0 t -118.89 126.72 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 44.8 p -125.3 153.09 43.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.652 -0.655 . . . . 0.0 110.642 -175.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.579 HD21 ' HB3' ' A' ' 180' ' ' PRO . 23.8 tp -102.85 126.03 49.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.799 -0.563 . . . . 0.0 109.509 170.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.674 ' OE2' HG13 ' A' ' 295' ' ' VAL . 73.5 mm-40 -132.78 150.59 52.14 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.79 -0.569 . . . . 0.0 109.967 -172.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.732 ' CG2' HD11 ' A' ' 296' ' ' LEU . 72.6 p -90.01 159.19 17.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.593 -0.692 . . . . 0.0 109.96 177.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -56.05 -26.12 47.85 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.533 -0.729 . . . . 0.0 110.935 -177.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -92.32 11.65 25.2 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.45 -0.781 . . . . 0.0 111.729 -173.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 90.05 20.12 44.02 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.11 -1.043 . . . . 0.0 110.932 167.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -105.49 140.14 39.04 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.28 -1.129 . . . . 0.0 110.154 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.675 HG11 ' NE ' ' A' ' 298' ' ' ARG . 59.4 t -90.66 130.9 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.63 -0.669 . . . . 0.0 110.159 -174.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.732 HD11 ' CG2' ' A' ' 290' ' ' THR . 95.8 mt -99.92 -40.21 7.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.768 -0.582 . . . . 0.0 110.781 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -161.64 154.71 25.76 Favored Glycine 0 N--CA 1.497 2.719 0 C-N-CA 119.987 -1.101 . . . . 0.0 110.359 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.675 ' NE ' HG11 ' A' ' 295' ' ' VAL . 41.1 mtt180 -135.15 135.92 41.48 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.642 -0.916 . . . . 0.0 110.383 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 299' ' ' ARG . . . . . 0.409 ' HG3' ' HA ' ' A' ' 139' ' ' ASP . 27.5 mmt180 -141.54 158.65 43.58 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.491 -0.755 . . . . 0.0 110.095 169.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 300' ' ' CYS . . . . . 0.613 ' SG ' HG23 ' A' ' 285' ' ' ILE . 94.8 m -143.59 157.91 44.06 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.407 -0.808 . . . . 0.0 110.701 -174.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.706 ' CE1' HD12 ' A' ' 284' ' ' ILE . 49.6 p90 -145.59 161.03 40.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.658 -0.651 . . . . 0.0 110.073 175.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.467 ' HA ' HD23 ' A' ' 283' ' ' LEU . 81.7 tt0 -104.9 136.71 43.88 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.548 -0.72 . . . . 0.0 110.178 -177.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -119.01 143.5 47.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.645 -0.659 . . . . 0.0 110.833 -169.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -138.5 138.25 37.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.772 -0.58 . . . . 0.0 109.601 172.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.558 HD13 ' HA ' ' A' ' 270' ' ' ASN . 65.7 mt -111.21 122.84 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.52 -0.738 . . . . 0.0 109.719 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.0 p -145.34 173.38 12.03 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.707 -0.621 . . . . 0.0 110.654 -172.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -74.13 -40.11 62.86 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.655 -0.653 . . . . 0.0 110.696 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.9 t -127.35 86.75 57.92 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.581 -0.699 . . . . 0.0 110.547 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -55.66 -28.62 66.81 Favored 'Trans proline' 0 N--CA 1.488 1.2 0 O-C-N 123.156 1.082 . . . . 0.0 110.813 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.97 -37.76 92.35 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -72.83 -40.48 65.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.692 -0.887 . . . . 0.0 109.881 -173.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -69.61 -38.25 77.18 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.283 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -62.08 -42.75 99.53 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.196 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -64.88 -37.43 87.62 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.5 -0.75 . . . . 0.0 110.342 175.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.63 -49.42 76.63 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.548 -0.72 . . . . 0.0 110.608 -173.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 316' ' ' ASP . . . . . 0.534 ' OD1' HD11 ' A' ' 159' ' ' LEU . 2.8 p30 . . . . . 0 N--CA 1.495 1.778 0 O-C-N 121.448 -0.782 . . . . 0.0 110.098 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 27.8 t . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.037 0.446 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.6 p-10 -99.93 24.85 7.96 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.718 -0.614 . . . . 0.0 110.731 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 53.1 m -78.14 125.19 29.0 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.53 -0.731 . . . . 0.0 110.25 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -71.04 144.95 50.22 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.739 -0.6 . . . . 0.0 110.403 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -158.57 101.83 1.66 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.675 -0.641 . . . . 0.0 110.07 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -59.21 -40.0 73.3 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.151 1.08 . . . . 0.0 110.729 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.08 -155.19 40.13 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -74.67 -43.29 0.47 Allowed 'Trans proline' 0 C--N 1.317 -1.116 0 O-C-N 123.315 1.166 . . . . 0.0 110.846 -175.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -88.65 4.41 47.24 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.577 -0.702 . . . . 0.0 111.437 -174.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 t 54.05 61.79 2.89 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.995 -1.066 . . . . 0.0 110.669 -176.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.732 ' HA ' HG12 ' A' ' 176' ' ' VAL . 59.5 t80 -78.0 120.77 23.31 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.606 -0.683 . . . . 0.0 110.111 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -130.01 160.01 34.96 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.8 -0.563 . . . . 0.0 110.129 -177.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 74.6 t -123.13 146.75 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.423 0.63 . . . . 0.0 110.046 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.0 p -157.3 171.08 21.04 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.126 0.489 . . . . 0.0 109.688 175.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.431 ' CE2' HG12 ' A' ' 172' ' ' ILE . 52.7 m-85 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.827 -0.545 . . . . 0.0 109.656 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 121.177 0.513 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.425 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 76.6 p -60.08 -34.04 72.9 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.71 -0.619 . . . . 0.0 109.928 177.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.518 ' HE3' HD11 ' A' ' 162' ' ' LEU . 67.2 p-90 -170.59 147.88 2.96 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.878 -0.514 . . . . 0.0 109.788 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 14.0 t -142.08 142.43 32.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.768 -0.583 . . . . 0.0 109.963 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -125.63 140.08 53.02 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.494 -0.754 . . . . 0.0 110.45 -172.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 30.7 t -109.72 122.5 47.62 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 120.324 -0.551 . . . . 0.0 109.748 175.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 63.6 m -70.77 -37.0 73.34 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.71 -0.619 . . . . 0.0 110.443 -177.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -60.46 -32.25 71.22 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.605 -0.684 . . . . 0.0 110.357 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 60.3 mt -104.79 -12.06 16.5 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.726 -0.609 . . . . 0.0 110.852 -176.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.5 tttm 59.84 50.75 6.63 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.081 -1.012 . . . . 0.0 109.702 177.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -146.34 153.0 40.03 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.598 -176.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.663 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.5 tp -126.63 137.87 53.36 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.791 -0.568 . . . . 0.0 110.24 -175.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -115.47 134.05 55.45 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.9 p -138.28 158.39 44.39 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.637 -0.664 . . . . 0.0 111.005 -175.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -104.55 143.04 33.59 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.499 0.666 . . . . 0.0 110.347 172.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.43 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.3 tt -52.53 147.68 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-O 121.583 0.706 . . . . 0.0 111.842 -173.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.36 9.98 5.33 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.638 -0.664 . . . . 0.0 112.461 177.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -96.82 155.1 16.92 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.975 -1.078 . . . . 0.0 110.811 175.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 87.3 m -82.78 126.17 32.11 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.709 -0.619 . . . . 0.0 110.607 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' CYS . . . . . 0.663 ' SG ' HD21 ' A' ' 162' ' ' LEU . 42.6 t -112.93 90.29 15.29 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.647 -0.658 . . . . 0.0 110.082 172.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.437 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 15.8 Cg_exo -65.1 128.65 21.07 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 O-C-N 123.264 1.139 . . . . 0.0 110.394 176.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.431 HG12 ' CE2' ' A' ' 142' ' ' PHE . 94.7 mt -122.38 139.42 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.621 -0.674 . . . . 0.0 109.393 177.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -108.69 137.0 47.33 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.645 -0.659 . . . . 0.0 110.488 -177.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.432 ' CG2' ' CE1' ' A' ' 138' ' ' PHE . 48.5 mm -95.23 132.77 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.66 -0.65 . . . . 0.0 109.562 171.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -115.93 128.95 56.17 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.699 -0.626 . . . . 0.0 110.352 176.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.732 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.0 m -136.74 159.71 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.575 -0.703 . . . . 0.0 110.012 176.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.5 mmm -75.45 -40.19 57.8 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.723 -0.611 . . . . 0.0 110.056 177.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 76.4 p -136.82 143.23 41.8 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.788 -0.57 . . . . 0.0 109.729 178.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 33.5 Cg_exo -55.4 139.91 82.06 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 O-C-N 123.21 1.11 . . . . 0.0 110.898 -171.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.765 ' HB3' HD21 ' A' ' 288' ' ' LEU . 33.4 Cg_endo -68.05 170.08 15.15 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 O-C-N 123.119 1.063 . . . . 0.0 110.558 178.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -60.5 155.04 49.66 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 O-C-N 123.289 1.152 . . . . 0.0 110.516 -178.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -77.55 140.2 39.68 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.598 -0.689 . . . . 0.0 109.931 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.67 -24.93 29.48 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -174.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.19 153.33 1.48 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.307 -1.114 . . . . 0.0 111.387 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.84 155.93 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.665 -0.647 . . . . 0.0 109.841 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.732 HD11 ' HD2' ' A' ' 251' ' ' TYR . 87.4 mt -109.25 137.92 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.662 -0.649 . . . . 0.0 109.652 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.726 ' HG2' HD22 ' A' ' 248' ' ' LEU . 40.4 mtm180 -114.97 146.95 40.67 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -176.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.656 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -140.59 127.72 20.91 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.503 -0.748 . . . . 0.0 110.343 173.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.411 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 21.1 ttm -137.31 139.71 28.61 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.811 -0.555 . . . . 0.0 110.978 -177.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.553 ' HD3' HD12 ' A' ' 226' ' ' ILE . 72.7 Cg_endo -91.98 138.17 1.93 Allowed 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 121.061 1.174 . . . . 0.0 110.778 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.478 HG12 ' CZ ' ' A' ' 244' ' ' ARG . 34.7 m -147.06 154.86 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.445 -0.784 . . . . 0.0 110.178 173.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.638 ' HA ' HG22 ' A' ' 282' ' ' ILE . 83.7 m-85 -60.7 164.56 4.56 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.425 -0.797 . . . . 0.0 110.441 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.413 ' HA ' HD12 ' A' ' 283' ' ' LEU . 75.2 tttt -80.74 -60.03 2.46 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.601 -0.687 . . . . 0.0 110.827 -174.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -80.12 151.25 29.91 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.587 -0.696 . . . . 0.0 110.385 -175.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.454 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.57 -37.94 71.27 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.392 -0.817 . . . . 0.0 110.684 -176.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -56.84 -24.91 54.67 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.488 -0.757 . . . . 0.0 110.542 -176.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.402 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 5.3 m-70 -109.27 -20.58 12.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.52 -0.738 . . . . 0.0 111.125 -178.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.454 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.1 p -68.0 -20.25 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.199 -0.938 . . . . 0.0 110.623 -176.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 72.3 p -79.43 -17.04 55.11 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.62 174.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -88.35 135.66 33.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.417 -0.802 . . . . 0.0 110.067 174.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.8 t -73.05 141.21 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.73 -0.606 . . . . 0.0 110.223 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.545 HG22 ' CE2' ' A' ' 192' ' ' TYR . 64.3 t -84.98 138.28 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.632 -0.667 . . . . 0.0 109.233 170.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -134.82 -170.25 2.52 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.536 -0.727 . . . . 0.0 111.229 -167.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 73.0 mtm-85 -95.25 154.68 17.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.853 -0.529 . . . . 0.0 110.389 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.565 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 57.0 m . . . . . 0 N--CA 1.496 1.827 0 O-C-N 121.62 -0.675 . . . . 0.0 109.247 174.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.677 HD12 ' HG3' ' A' ' 268' ' ' MET . 37.6 tp . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 120.884 0.373 . . . . 0.0 110.388 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.553 HD12 ' HD3' ' A' ' 190' ' ' PRO . 83.3 mt -102.44 136.88 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.814 -0.554 . . . . 0.0 109.883 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 50.0 mtt-85 -130.92 159.44 37.44 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.689 -0.632 . . . . 0.0 110.326 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.595 HG23 HG21 ' A' ' 247' ' ' VAL . 81.3 t -103.96 146.65 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.728 -0.607 . . . . 0.0 110.0 176.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -118.25 128.12 54.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.696 -0.627 . . . . 0.0 110.349 170.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 96.67 21.39 21.69 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 168.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -139.38 106.24 5.41 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.348 -1.089 . . . . 0.0 109.95 174.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 90.9 p -63.66 -15.09 57.4 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.64 -0.663 . . . . 0.0 111.201 -177.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -97.12 9.93 40.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.341 -0.849 . . . . 0.0 111.236 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.75 128.78 37.87 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.111 -0.993 . . . . 0.0 110.114 175.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -139.76 155.75 47.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.76 -0.587 . . . . 0.0 109.607 177.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.424 ' CD1' ' HB ' ' A' ' 247' ' ' VAL . 80.9 m-85 -119.12 150.74 39.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.568 -0.708 . . . . 0.0 110.61 -175.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.16 159.97 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.778 -0.576 . . . . 0.0 110.242 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -117.76 130.01 56.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.766 -0.584 . . . . 0.0 110.181 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -62.52 130.19 93.24 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.623 -0.673 . . . . 0.0 109.789 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -64.82 -28.04 59.3 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 O-C-N 123.135 1.071 . . . . 0.0 111.003 -170.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.0 mt -102.0 -50.43 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.344 -0.848 . . . . 0.0 111.014 -168.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 17.9 p -105.43 12.14 31.84 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.31 -0.869 . . . . 0.0 111.913 -174.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 72.17 -4.92 16.01 Favored Glycine 0 N--CA 1.497 2.723 0 O-C-N 121.074 -1.016 . . . . 0.0 112.022 172.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.478 ' CZ ' HG12 ' A' ' 191' ' ' VAL . 21.6 mmt180 -45.86 142.01 2.77 Favored 'General case' 0 N--CA 1.505 2.309 0 CA-C-N 119.119 1.46 . . . . 0.0 112.388 -175.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -103.54 143.36 32.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.618 -0.676 . . . . 0.0 110.119 175.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.2 p -154.81 159.94 40.92 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.595 -0.69 . . . . 0.0 110.348 176.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.595 HG21 HG23 ' A' ' 228' ' ' VAL . 8.6 p -123.17 148.23 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.836 -0.54 . . . . 0.0 109.814 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.726 HD22 ' HG2' ' A' ' 187' ' ' ARG . 81.8 mt -129.62 154.61 46.93 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.079 -0.649 . . . . 0.0 109.638 -177.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.443 HG13 ' C ' ' A' ' 248' ' ' LEU . 34.4 m -151.1 151.67 29.95 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.813 -0.554 . . . . 0.0 110.001 175.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -71.05 139.0 34.88 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 O-C-N 123.368 1.194 . . . . 0.0 110.08 177.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.732 ' HD2' HD11 ' A' ' 186' ' ' ILE . 58.9 t80 -75.9 124.47 27.39 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.099 175.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -99.99 160.11 28.07 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.694 -0.628 . . . . 0.0 109.953 176.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -58.37 158.49 22.59 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 O-C-N 123.294 1.155 . . . . 0.0 110.517 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -59.09 149.98 76.35 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 O-C-N 123.219 1.115 . . . . 0.0 110.511 -177.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -60.73 148.27 39.42 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.65 -0.656 . . . . 0.0 110.295 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.84 127.19 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.538 -0.726 . . . . 0.0 110.168 -171.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.96 -10.14 55.41 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 10.0 t -144.65 173.43 11.83 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.175 -1.191 . . . . 0.0 110.63 175.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -107.28 13.09 27.51 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.617 -0.677 . . . . 0.0 111.78 -168.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -119.92 168.01 11.56 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.181 -0.95 . . . . 0.0 111.168 -175.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 92.6 m -117.73 146.76 43.54 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.744 -0.597 . . . . 0.0 109.986 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 46.4 m -118.24 135.67 54.13 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.604 -0.685 . . . . 0.0 110.952 -174.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 60.2 t -132.56 137.23 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 172.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 75.1 mt -104.78 123.8 48.3 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.437 -0.789 . . . . 0.0 110.054 -171.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.656 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 6.1 m-30 -106.85 151.51 25.12 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.644 -0.66 . . . . 0.0 110.683 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -136.49 142.92 43.55 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -113.47 133.11 55.39 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.538 -0.726 . . . . 0.0 110.55 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' MET . . . . . 0.677 ' HG3' HD12 ' A' ' 225' ' ' LEU . 2.3 ppp? -97.68 2.66 49.97 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.709 -0.62 . . . . 0.0 112.164 -175.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 269' ' ' CYS . . . . . 0.683 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.7 OUTLIER -144.73 165.07 29.1 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.131 -0.981 . . . . 0.0 110.195 176.063 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.556 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.5 p30 -120.68 162.8 19.07 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.43 0.633 . . . . 0.0 110.407 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 271' ' ' SER . . . . . 0.43 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 25.2 m -58.8 -33.53 70.45 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.407 -0.808 . . . . 0.0 110.927 -163.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 49.9 p -100.75 12.17 38.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.466 -0.771 . . . . 0.0 112.018 -163.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' CYS . . . . . 0.565 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 30.4 p -94.54 118.1 31.15 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.03 -1.043 . . . . 0.0 110.742 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.2 t -63.2 139.78 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.431 -0.793 . . . . 0.0 110.393 -171.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.83 -5.28 58.08 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.08 -99.78 0.88 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 171.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' MET . . . . . 0.43 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.7 mmm -62.71 -31.53 72.46 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.773 -0.84 . . . . 0.0 110.308 178.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.3 p30 44.47 49.32 8.3 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 174.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 21.3 mtt180 54.79 31.71 16.1 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.331 -0.855 . . . . 0.0 111.179 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 280' ' ' ARG . . . . . 0.417 ' O ' HG23 ' A' ' 282' ' ' ILE . 75.5 mtt180 -119.31 104.96 45.04 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.508 -0.745 . . . . 0.0 110.07 174.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -59.98 145.26 98.79 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 O-C-N 123.162 1.085 . . . . 0.0 110.466 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.638 HG22 ' HA ' ' A' ' 192' ' ' TYR . 46.5 pt -131.98 176.38 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.874 0.845 . . . . 0.0 111.186 -174.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 302' ' ' GLU . 29.4 mt -124.37 149.86 46.18 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.704 HD12 ' CE1' ' A' ' 301' ' ' PHE . 79.0 mt -115.66 130.11 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.595 -0.69 . . . . 0.0 109.174 178.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.592 HG23 ' SG ' ' A' ' 300' ' ' CYS . 79.0 mt -109.86 126.06 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -176.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 57.8 t -118.86 126.93 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.426 HG22 ' HG2' ' A' ' 298' ' ' ARG . 45.2 p -125.27 152.91 44.01 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.592 -0.692 . . . . 0.0 110.614 -173.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.765 HD21 ' HB3' ' A' ' 180' ' ' PRO . 23.2 tp -103.54 126.68 50.83 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.754 -0.591 . . . . 0.0 109.434 168.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.54 ' OE2' HG13 ' A' ' 295' ' ' VAL . 72.6 mm-40 -130.52 152.03 50.34 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.892 -0.505 . . . . 0.0 109.876 -173.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.818 HG22 HD11 ' A' ' 296' ' ' LEU . 68.6 p -89.83 159.91 16.76 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.699 -0.625 . . . . 0.0 109.735 176.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -55.97 -26.1 46.76 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.515 -0.741 . . . . 0.0 110.772 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -86.96 9.18 20.27 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.521 -0.737 . . . . 0.0 111.845 -174.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 86.6 20.16 54.84 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 120.183 -1.008 . . . . 0.0 110.766 170.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -107.55 140.24 40.84 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.282 -1.128 . . . . 0.0 110.196 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.54 HG13 ' OE2' ' A' ' 289' ' ' GLU . 61.5 t -86.21 132.9 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.656 -0.653 . . . . 0.0 110.091 -174.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.818 HD11 HG22 ' A' ' 290' ' ' THR . 80.3 mt -99.89 -40.1 7.85 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.722 -0.611 . . . . 0.0 110.424 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -165.27 153.28 23.3 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.426 ' HG2' HG22 ' A' ' 287' ' ' THR . 79.3 mtm180 -133.49 136.46 45.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.686 -0.891 . . . . 0.0 110.751 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -135.59 158.29 44.74 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.634 -0.666 . . . . 0.0 109.862 172.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' CYS . . . . . 0.592 ' SG ' HG23 ' A' ' 285' ' ' ILE . 95.0 m -143.0 155.1 44.59 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.34 -0.85 . . . . 0.0 110.772 -175.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.704 ' CE1' HD12 ' A' ' 284' ' ' ILE . 49.4 p90 -144.97 162.76 36.11 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.734 -0.604 . . . . 0.0 110.052 175.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.436 ' HA ' HD23 ' A' ' 283' ' ' LEU . 82.0 tt0 -104.75 135.06 46.83 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.544 -0.723 . . . . 0.0 110.217 -177.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -122.84 143.18 50.03 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.701 -169.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -138.3 139.2 39.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.74 -0.6 . . . . 0.0 109.704 173.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.683 HD13 ' O ' ' A' ' 269' ' ' CYS . 70.5 mt -108.02 122.8 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.537 -0.727 . . . . 0.0 109.605 176.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.9 p -145.27 169.34 18.43 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.629 -0.67 . . . . 0.0 110.676 -171.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -71.32 -40.1 70.98 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.631 -0.668 . . . . 0.0 110.64 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.9 t -127.5 86.05 59.42 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.468 -0.77 . . . . 0.0 110.47 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -55.87 -28.36 67.41 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 O-C-N 123.122 1.064 . . . . 0.0 110.812 174.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -67.59 -36.73 88.62 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -73.35 -39.83 64.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.72 -0.871 . . . . 0.0 109.822 -173.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -69.56 -40.94 76.51 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.137 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -61.88 -43.46 98.81 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.477 -0.765 . . . . 0.0 110.24 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -64.79 -39.06 92.97 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.532 -0.73 . . . . 0.0 110.478 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.2 -50.5 72.88 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.439 -0.788 . . . . 0.0 110.427 -173.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.1 p30 . . . . . 0 N--CA 1.496 1.839 0 O-C-N 121.455 -0.778 . . . . 0.0 110.1 -178.996 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.973 0.416 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -92.8 21.2 5.78 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.675 -0.641 . . . . 0.0 111.004 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 54.9 m -72.07 125.11 26.44 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.371 -0.831 . . . . 0.0 110.223 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -69.99 144.89 52.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.679 -0.638 . . . . 0.0 110.558 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -153.64 102.41 2.53 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.744 -0.597 . . . . 0.0 110.182 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -58.53 -39.95 78.56 Favored 'Trans proline' 0 N--CA 1.487 1.142 0 O-C-N 123.096 1.051 . . . . 0.0 110.922 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.43 -155.13 45.04 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -74.69 -46.12 0.27 Allowed 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.366 1.193 . . . . 0.0 111.007 -173.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -89.66 12.12 17.78 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.557 -0.715 . . . . 0.0 111.285 -172.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.5 60.93 3.38 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.017 -1.052 . . . . 0.0 110.709 -176.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.666 ' HA ' HG12 ' A' ' 176' ' ' VAL . 43.8 t80 -77.82 118.32 20.05 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.643 -0.661 . . . . 0.0 109.73 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.403 ' HA ' ' HG3' ' A' ' 299' ' ' ARG . 22.6 t70 -129.98 159.94 35.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.784 -0.573 . . . . 0.0 110.196 -177.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 64.3 t -125.76 146.75 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.802 -0.561 . . . . 0.0 109.716 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.2 p -155.27 162.43 40.89 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.276 0.56 . . . . 0.0 110.108 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.501 ' CD2' ' CE2' ' A' ' 155' ' ' TYR . 72.7 m-85 . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.837 -0.54 . . . . 0.0 109.708 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 121.139 0.495 . . . . 0.0 110.036 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.405 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 75.5 p -60.11 -34.05 72.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.768 -0.583 . . . . 0.0 109.96 176.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.431 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -171.65 143.66 1.75 Allowed 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.497 0.665 . . . . 0.0 110.489 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 9.9 t -142.16 142.53 32.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.817 -0.552 . . . . 0.0 110.042 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.501 ' CE2' ' CD2' ' A' ' 142' ' ' PHE . 43.8 t80 -125.47 140.09 53.07 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.534 -0.729 . . . . 0.0 110.529 -173.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 30.6 t -111.47 125.66 54.13 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 120.431 -0.507 . . . . 0.0 109.871 176.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 59.4 m -70.78 -37.08 73.3 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.866 -0.521 . . . . 0.0 110.469 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -59.51 -32.99 70.8 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.601 -0.687 . . . . 0.0 110.36 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.543 HD11 ' OD1' ' A' ' 316' ' ' ASP . 55.9 mt -104.74 -12.15 16.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.771 -0.58 . . . . 0.0 110.806 -175.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.1 ttpt 59.81 47.23 10.46 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.025 -1.047 . . . . 0.0 109.693 176.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -148.31 153.26 38.41 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.786 -172.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.504 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.5 137.87 53.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.799 -0.563 . . . . 0.0 110.246 -173.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -114.83 132.84 56.36 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 174.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.32 158.38 44.39 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 120.109 -0.636 . . . . 0.0 111.024 -175.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.412 ' HG3' ' HD3' ' A' ' 309' ' ' PRO . 24.3 mt-30 -104.55 143.6 32.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.553 -0.717 . . . . 0.0 110.481 173.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.43 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.7 tt -53.69 146.58 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 CA-C-O 121.586 0.708 . . . . 0.0 111.687 -173.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.27 10.0 5.26 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.601 -0.687 . . . . 0.0 112.448 176.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.404 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 20.0 mmtp -95.19 154.99 16.92 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.964 -1.085 . . . . 0.0 110.666 175.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 87.4 m -83.1 126.17 32.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.728 -0.607 . . . . 0.0 110.523 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' CYS . . . . . 0.504 ' SG ' HD21 ' A' ' 162' ' ' LEU . 49.5 t -114.33 90.08 19.58 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.635 -0.666 . . . . 0.0 110.041 172.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.431 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 21.7 Cg_exo -62.2 129.48 27.19 Favored 'Trans proline' 0 C--N 1.316 -1.158 0 O-C-N 123.225 1.119 . . . . 0.0 110.562 173.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.416 HG12 ' CE1' ' A' ' 142' ' ' PHE . 97.3 mt -124.39 141.96 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 176.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -109.69 135.45 50.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.443 -0.785 . . . . 0.0 110.789 -175.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.3 mm -95.22 134.99 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.68 -0.638 . . . . 0.0 109.669 169.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -116.54 129.03 55.96 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.618 -0.676 . . . . 0.0 110.455 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.666 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.1 m -136.77 159.78 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.566 -0.709 . . . . 0.0 109.868 174.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 81.3 mmm -78.22 -42.45 31.27 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.738 -0.601 . . . . 0.0 110.148 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.2 p -131.7 143.2 48.14 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.799 -0.563 . . . . 0.0 109.702 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.8 Cg_exo -55.55 139.8 82.81 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 O-C-N 123.181 1.095 . . . . 0.0 110.876 -171.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.609 ' HB3' HD21 ' A' ' 288' ' ' LEU . 35.3 Cg_endo -67.6 170.03 14.63 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 O-C-N 123.168 1.088 . . . . 0.0 110.627 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -60.81 157.11 39.53 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 123.419 1.22 . . . . 0.0 110.514 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -78.73 139.13 38.5 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.647 -0.658 . . . . 0.0 110.024 175.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.06 -25.05 29.76 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -174.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -49.98 150.44 2.28 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.334 -1.098 . . . . 0.0 111.443 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.76 155.99 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.794 -0.566 . . . . 0.0 109.736 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.721 HD11 ' HD2' ' A' ' 251' ' ' TYR . 79.7 mt -108.27 137.1 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.667 -0.646 . . . . 0.0 109.437 176.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.743 ' HG2' HD22 ' A' ' 248' ' ' LEU . 61.6 mtt180 -114.99 143.09 45.72 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -176.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.652 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -137.35 127.25 25.7 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.46 -0.775 . . . . 0.0 110.28 176.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.407 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 23.9 ttm -137.22 139.91 29.41 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.787 -0.571 . . . . 0.0 111.086 -176.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.61 ' HD3' HD12 ' A' ' 226' ' ' ILE . 72.1 Cg_endo -91.97 138.22 1.94 Allowed 'Trans proline' 0 C--N 1.319 -0.992 0 C-N-CA 121.051 1.167 . . . . 0.0 110.643 177.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.416 HG13 ' C ' ' A' ' 190' ' ' PRO . 34.9 m -146.52 154.9 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.548 -0.72 . . . . 0.0 110.093 174.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.554 ' HA ' HG22 ' A' ' 282' ' ' ILE . 86.1 m-85 -63.56 159.39 18.86 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.483 -0.761 . . . . 0.0 110.578 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.454 ' HA ' HD12 ' A' ' 283' ' ' LEU . 40.7 ttpt -75.39 -56.6 4.55 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.709 -0.619 . . . . 0.0 110.697 -175.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -79.98 147.61 31.5 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.554 -0.716 . . . . 0.0 110.29 -174.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.448 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.54 -38.51 71.97 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.38 -0.825 . . . . 0.0 110.716 -175.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 20.2 mp0 -56.55 -25.16 51.33 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.441 -0.787 . . . . 0.0 110.55 -176.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.409 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 77.4 m80 -109.84 -20.54 12.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.528 -0.733 . . . . 0.0 111.19 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.448 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -67.29 -20.24 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.202 -0.936 . . . . 0.0 110.527 -175.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 71.3 p -79.43 -16.87 55.43 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.551 -0.718 . . . . 0.0 110.578 175.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -88.38 137.77 32.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.316 -0.865 . . . . 0.0 110.027 172.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.1 t -72.98 144.35 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.651 -0.656 . . . . 0.0 110.184 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.441 HG22 ' CE2' ' A' ' 192' ' ' TYR . 61.8 t -84.91 138.89 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.569 -0.707 . . . . 0.0 109.175 173.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -134.87 -170.37 2.55 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.401 -0.812 . . . . 0.0 111.326 -167.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -95.37 159.13 15.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.818 -0.551 . . . . 0.0 110.617 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.529 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 60.7 m . . . . . 0 N--CA 1.497 1.9 0 O-C-N 121.605 -0.684 . . . . 0.0 109.324 174.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.775 HD21 ' CE ' ' A' ' 277' ' ' MET . 43.3 tp . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 120.87 0.367 . . . . 0.0 110.306 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.61 HD12 ' HD3' ' A' ' 190' ' ' PRO . 83.7 mt -102.82 136.79 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.785 -0.572 . . . . 0.0 109.744 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -134.05 159.84 39.58 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.749 -0.594 . . . . 0.0 110.187 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.505 HG23 HG21 ' A' ' 247' ' ' VAL . 97.2 t -105.72 146.71 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.71 -0.618 . . . . 0.0 110.09 178.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -118.08 123.91 46.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.738 -0.601 . . . . 0.0 110.444 172.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 95.71 24.05 16.72 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 167.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 33.5 t-20 -135.34 107.61 7.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.323 -1.104 . . . . 0.0 110.057 174.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 32.5 t -62.94 -15.14 54.56 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.677 -0.639 . . . . 0.0 111.309 -177.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -99.98 7.06 45.05 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.196 -0.94 . . . . 0.0 111.591 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.35 128.33 35.84 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.036 -1.04 . . . . 0.0 110.236 177.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -139.73 156.71 46.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.794 -0.566 . . . . 0.0 109.656 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.425 ' CD1' ' HB ' ' A' ' 247' ' ' VAL . 82.1 m-85 -118.72 150.76 39.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.601 -0.687 . . . . 0.0 110.685 -176.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.13 159.92 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.717 -0.614 . . . . 0.0 110.334 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -120.82 130.09 53.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.761 -0.587 . . . . 0.0 110.133 176.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -62.48 122.96 76.87 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.678 -0.639 . . . . 0.0 109.71 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.89 -28.08 67.09 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 O-C-N 123.047 1.025 . . . . 0.0 110.812 -173.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.7 mt -103.9 -50.25 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.469 -0.769 . . . . 0.0 110.899 -170.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 5.6 p -105.34 12.23 31.89 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.364 -0.835 . . . . 0.0 112.014 -170.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 81.09 -21.32 5.89 Favored Glycine 0 N--CA 1.497 2.72 0 O-C-N 121.004 -1.06 . . . . 0.0 111.795 170.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 -45.95 142.05 2.83 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-N 118.673 1.236 . . . . 0.0 112.429 -169.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -108.66 145.45 34.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.575 -0.703 . . . . 0.0 110.151 174.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.9 p -154.85 159.88 40.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.655 -0.653 . . . . 0.0 110.598 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.505 HG21 HG23 ' A' ' 228' ' ' VAL . 8.6 p -122.95 148.28 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.791 -0.568 . . . . 0.0 109.657 177.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.743 HD22 ' HG2' ' A' ' 187' ' ' ARG . 81.2 mt -129.58 154.61 46.9 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.829 -175.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.434 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.8 m -150.85 151.69 30.53 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.851 -0.531 . . . . 0.0 110.02 175.081 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -71.19 138.74 33.95 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 O-C-N 123.385 1.203 . . . . 0.0 109.988 176.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.721 ' HD2' HD11 ' A' ' 186' ' ' ILE . 60.9 t80 -75.0 127.31 32.94 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.487 -0.758 . . . . 0.0 110.224 174.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -100.0 160.12 28.05 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.738 -0.601 . . . . 0.0 109.983 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.94 157.81 27.46 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.266 1.14 . . . . 0.0 110.432 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.02 149.96 76.16 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 O-C-N 123.218 1.115 . . . . 0.0 110.499 -177.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -61.62 148.63 41.8 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.718 -0.614 . . . . 0.0 110.108 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.84 127.23 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.502 -0.749 . . . . 0.0 110.208 -170.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.16 -10.16 56.65 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.404 HG21 ' CE2' ' A' ' 260' ' ' PHE . 10.0 t -144.86 174.23 11.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.185 -1.185 . . . . 0.0 110.527 175.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -109.34 13.18 24.36 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.489 -0.757 . . . . 0.0 111.923 -166.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.404 ' CE2' HG21 ' A' ' 258' ' ' THR . 46.2 p90 -120.0 168.06 11.54 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.113 -0.992 . . . . 0.0 111.219 -175.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 83.1 m -117.7 145.62 44.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.793 -0.567 . . . . 0.0 109.87 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 41.5 m -116.92 135.43 53.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.622 -0.674 . . . . 0.0 110.88 -175.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 60.3 t -131.54 137.31 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 173.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 171' ' ' PRO . 75.0 mt -104.6 121.07 42.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.533 -0.729 . . . . 0.0 109.953 -171.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.652 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 5.4 m-30 -105.39 153.02 22.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.661 -0.649 . . . . 0.0 110.789 -177.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -136.55 142.95 43.44 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 177.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -113.58 131.87 55.94 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.536 -0.728 . . . . 0.0 110.388 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' MET . . . . . 0.436 ' HG3' HD12 ' A' ' 225' ' ' LEU . 5.4 ppp? -101.01 9.06 42.65 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.624 -0.672 . . . . 0.0 112.011 -175.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 269' ' ' CYS . . . . . 0.636 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.7 OUTLIER -144.7 164.99 29.32 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.079 -1.013 . . . . 0.0 110.146 172.25 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.611 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.3 p30 -123.06 163.98 19.47 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.391 0.615 . . . . 0.0 110.547 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 271' ' ' SER . . . . . 0.428 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 23.9 m -57.82 -33.93 69.13 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.479 -0.763 . . . . 0.0 111.104 -164.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 50.0 p -102.18 13.05 35.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.395 -0.816 . . . . 0.0 112.029 -163.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' CYS . . . . . 0.529 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 29.9 p -96.03 118.04 31.86 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.066 -1.021 . . . . 0.0 110.735 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.75 139.82 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.519 -0.738 . . . . 0.0 110.319 -171.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.04 -5.2 59.28 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.07 -96.75 0.78 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 170.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' MET . . . . . 0.775 ' CE ' HD21 ' A' ' 225' ' ' LEU . 15.7 mmt -64.33 -35.23 80.18 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.673 -0.898 . . . . 0.0 110.475 177.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.3 p30 42.63 50.66 4.96 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 33.3 mtp180 54.8 29.5 11.97 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.402 -0.811 . . . . 0.0 111.193 176.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -120.0 104.93 43.35 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.599 -0.688 . . . . 0.0 110.177 175.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -60.39 148.82 89.14 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 O-C-N 123.131 1.069 . . . . 0.0 110.518 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.554 HG22 ' HA ' ' A' ' 192' ' ' TYR . 45.8 pt -131.88 177.42 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.788 0.804 . . . . 0.0 111.087 -176.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 193' ' ' LYS . 21.7 mt -124.44 149.89 46.28 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.699 HD12 ' CE1' ' A' ' 301' ' ' PHE . 82.0 mt -117.98 129.71 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.353 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.579 HG23 ' SG ' ' A' ' 300' ' ' CYS . 81.0 mt -109.81 126.91 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -176.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 57.3 t -118.91 126.81 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.63 HG22 ' HG2' ' A' ' 298' ' ' ARG . 45.6 p -125.28 152.79 44.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.596 -0.69 . . . . 0.0 110.659 -174.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.609 HD21 ' HB3' ' A' ' 180' ' ' PRO . 24.0 tp -102.22 126.16 49.12 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.748 -0.595 . . . . 0.0 109.473 169.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -130.43 150.1 51.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.875 -0.516 . . . . 0.0 109.855 -173.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.825 ' CG2' HD11 ' A' ' 296' ' ' LEU . 22.1 p -89.85 160.89 16.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.619 -0.676 . . . . 0.0 109.897 176.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -55.84 -26.21 45.62 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.574 -0.704 . . . . 0.0 111.03 -176.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 45.3 p30 -90.59 9.7 28.51 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.491 -0.756 . . . . 0.0 111.937 -173.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.87 20.18 44.44 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 120.163 -1.018 . . . . 0.0 110.799 170.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -106.98 140.22 40.14 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.238 -1.154 . . . . 0.0 110.106 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 64.1 t -86.55 131.61 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.641 -0.662 . . . . 0.0 110.226 -173.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.825 HD11 ' CG2' ' A' ' 290' ' ' THR . 96.3 mt -99.97 -40.08 7.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.724 -0.61 . . . . 0.0 110.694 177.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -164.14 153.5 23.87 Favored Glycine 0 N--CA 1.497 2.736 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.298 -177.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.63 ' HG2' HG22 ' A' ' 287' ' ' THR . 95.1 mtt180 -135.2 136.44 41.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.749 -0.853 . . . . 0.0 110.719 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 299' ' ' ARG . . . . . 0.403 ' HG3' ' HA ' ' A' ' 139' ' ' ASP . 28.2 mmt180 -139.38 156.91 46.69 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.622 -0.674 . . . . 0.0 110.001 169.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 300' ' ' CYS . . . . . 0.579 ' SG ' HG23 ' A' ' 285' ' ' ILE . 80.6 m -141.8 157.23 45.26 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.459 -0.776 . . . . 0.0 110.622 -174.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.699 ' CE1' HD12 ' A' ' 284' ' ' ILE . 49.6 p90 -144.94 162.31 37.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.637 -0.664 . . . . 0.0 110.144 176.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.421 ' HA ' HD23 ' A' ' 283' ' ' LEU . 34.9 tt0 -104.88 134.97 47.11 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.596 -0.69 . . . . 0.0 110.184 -177.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -121.05 142.79 49.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.578 -0.702 . . . . 0.0 110.867 -169.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -137.06 138.95 40.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.792 -0.567 . . . . 0.0 109.622 172.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.636 HD13 ' O ' ' A' ' 269' ' ' CYS . 77.0 mt -108.28 122.81 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.549 -0.719 . . . . 0.0 109.763 177.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.1 p -145.29 168.88 19.38 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.64 -0.662 . . . . 0.0 110.615 -171.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -71.53 -40.07 70.32 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.695 -0.628 . . . . 0.0 110.664 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.8 t -127.25 85.34 61.2 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.532 -0.73 . . . . 0.0 110.568 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 309' ' ' PRO . . . . . 0.412 ' HD3' ' HG3' ' A' ' 165' ' ' GLN . 47.9 Cg_exo -55.39 -27.23 57.2 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 O-C-N 123.224 1.118 . . . . 0.0 110.728 174.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -68.39 -37.72 86.26 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -71.14 -38.36 72.26 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.605 -0.938 . . . . 0.0 109.74 -174.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -69.36 -35.39 75.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.68 -0.637 . . . . 0.0 110.11 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -58.52 -46.25 87.14 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.55 -0.719 . . . . 0.0 110.43 174.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -64.53 -38.01 89.52 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.647 -0.658 . . . . 0.0 110.345 178.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -62.65 -51.79 65.89 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.484 -0.76 . . . . 0.0 110.578 -173.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 316' ' ' ASP . . . . . 0.543 ' OD1' HD11 ' A' ' 159' ' ' LEU . 3.8 p30 . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.457 -0.777 . . . . 0.0 110.031 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.8 t . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.075 0.465 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -101.42 25.8 7.95 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.617 -0.677 . . . . 0.0 110.634 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 54.4 m -78.85 125.22 29.08 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.554 -0.716 . . . . 0.0 110.231 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -70.33 144.86 51.55 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.632 -0.667 . . . . 0.0 110.396 -178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -158.37 101.21 1.71 Allowed Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.684 -0.635 . . . . 0.0 110.182 178.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -58.76 -39.96 77.12 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 O-C-N 123.086 1.045 . . . . 0.0 110.844 -175.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.82 -155.08 40.49 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -73.11 -49.05 0.24 Allowed 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.308 1.162 . . . . 0.0 110.911 -174.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -85.43 6.99 24.32 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.617 -0.677 . . . . 0.0 111.425 -175.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.97 61.92 2.84 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.949 -1.095 . . . . 0.0 110.608 -176.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.728 ' HA ' HG12 ' A' ' 176' ' ' VAL . 60.2 t80 -77.97 120.48 22.88 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.525 -0.735 . . . . 0.0 109.983 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -129.79 159.92 35.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.835 -0.541 . . . . 0.0 110.124 -176.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.2 t -124.96 145.8 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.792 -0.568 . . . . 0.0 109.889 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.9 p -155.01 162.25 41.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.81 -0.556 . . . . 0.0 109.92 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.472 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 75.3 m-85 . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.808 -0.558 . . . . 0.0 109.799 -175.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.781 0 CA-C-O 121.206 0.527 . . . . 0.0 110.026 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 82.3 p -60.02 -34.05 72.84 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.751 -0.593 . . . . 0.0 109.944 176.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.435 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -172.04 144.02 1.63 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.763 -0.585 . . . . 0.0 110.164 178.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 13.3 t -142.17 142.57 32.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.84 -0.538 . . . . 0.0 109.947 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.472 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 63.7 t80 -125.56 140.06 53.06 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.548 -0.72 . . . . 0.0 110.553 -172.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.9 t -110.23 124.26 51.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.837 -0.539 . . . . 0.0 109.827 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 58.5 m -70.66 -37.03 73.67 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.772 -0.58 . . . . 0.0 110.481 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -59.66 -34.7 73.16 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.553 -0.717 . . . . 0.0 110.43 -177.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 57.5 mt -104.86 -11.75 16.6 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.662 -0.649 . . . . 0.0 110.864 -175.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 26.2 tttp 59.83 52.03 5.69 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.02 -1.05 . . . . 0.0 109.715 178.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -144.96 152.77 40.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.74 -0.6 . . . . 0.0 110.587 -175.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.627 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.5 tp -126.61 137.81 53.36 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.758 -0.589 . . . . 0.0 110.338 -176.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -115.18 135.45 54.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.616 -0.677 . . . . 0.0 109.243 173.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.8 p -138.28 158.38 44.41 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.922 -175.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.416 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 52.9 mt-30 -104.53 143.02 33.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.593 -0.692 . . . . 0.0 110.131 173.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.432 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 16.8 tt -52.54 146.28 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.499 -0.751 . . . . 0.0 111.895 -173.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.81 10.04 5.78 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.579 -0.7 . . . . 0.0 112.471 176.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.416 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 53.4 mmtt -95.64 155.08 16.89 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.961 -1.087 . . . . 0.0 110.897 174.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 90.5 m -82.94 126.17 32.21 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.628 -0.67 . . . . 0.0 110.689 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' CYS . . . . . 0.627 ' SG ' HD21 ' A' ' 162' ' ' LEU . 43.6 t -114.23 90.09 19.29 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.657 -0.652 . . . . 0.0 110.108 172.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.435 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 17.4 Cg_exo -63.79 129.41 24.7 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 123.248 1.13 . . . . 0.0 110.581 173.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.404 HG12 ' CE2' ' A' ' 142' ' ' PHE . 97.5 mt -123.12 141.35 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 175.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLN . . . . . 0.534 ' NE2' ' CE1' ' A' ' 260' ' ' PHE . 75.2 mt-30 -108.13 136.39 47.89 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.476 -0.765 . . . . 0.0 110.737 -175.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.443 HG21 ' CE1' ' A' ' 138' ' ' PHE . 48.6 mm -95.37 135.02 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.719 -0.613 . . . . 0.0 109.633 170.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -117.18 129.31 55.86 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.662 -0.649 . . . . 0.0 110.426 176.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.728 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.0 m -136.63 159.77 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.478 -0.764 . . . . 0.0 110.047 175.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 80.8 mmm -77.59 -40.24 42.85 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.745 -0.597 . . . . 0.0 110.007 177.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.9 p -135.51 143.28 44.45 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.832 -0.542 . . . . 0.0 109.675 177.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.6 Cg_exo -55.57 139.89 83.04 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 O-C-N 123.14 1.074 . . . . 0.0 110.887 -172.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.77 ' HB3' HD21 ' A' ' 288' ' ' LEU . 31.3 Cg_endo -67.35 170.04 14.26 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 O-C-N 123.25 1.132 . . . . 0.0 110.633 177.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -60.45 154.98 49.75 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.431 1.227 . . . . 0.0 110.546 -178.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -77.43 140.08 39.8 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.581 -0.699 . . . . 0.0 109.95 175.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.73 -25.06 28.96 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -174.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.22 153.08 1.56 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.363 -1.08 . . . . 0.0 111.41 178.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 33.9 m -129.66 155.93 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.661 -0.649 . . . . 0.0 109.686 176.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.705 HD11 ' HD2' ' A' ' 251' ' ' TYR . 82.6 mt -107.85 137.21 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.688 -0.633 . . . . 0.0 109.462 175.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.748 ' HG2' HD22 ' A' ' 248' ' ' LEU . 32.1 mtm180 -115.06 143.37 45.29 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 -176.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.664 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -136.62 126.48 25.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.568 -0.707 . . . . 0.0 110.235 175.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 23.8 ttp -137.24 137.14 21.8 Favored Pre-proline 0 N--CA 1.497 1.884 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.934 -176.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.643 ' HD3' HD12 ' A' ' 226' ' ' ILE . 72.7 Cg_endo -90.74 138.21 2.47 Favored 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 123.169 1.089 . . . . 0.0 110.706 177.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.427 HG13 ' C ' ' A' ' 190' ' ' PRO . 34.9 m -147.48 154.84 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.467 -0.771 . . . . 0.0 110.191 174.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.658 ' HA ' HG22 ' A' ' 282' ' ' ILE . 79.4 m-85 -63.8 162.81 12.82 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.546 -0.721 . . . . 0.0 110.487 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -79.35 -60.04 2.52 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.669 -0.644 . . . . 0.0 110.905 -173.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -80.11 150.66 30.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.574 -0.704 . . . . 0.0 110.281 -174.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.457 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.58 -38.12 71.53 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.424 -0.797 . . . . 0.0 110.686 -175.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -56.77 -24.91 53.54 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.494 -0.754 . . . . 0.0 110.565 -176.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.4 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 81.0 m-70 -109.68 -20.55 12.79 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.954 -0.699 . . . . 0.0 111.102 -178.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -67.71 -20.25 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.223 -0.923 . . . . 0.0 110.447 -176.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 67.2 p -79.37 -17.12 55.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.496 -0.752 . . . . 0.0 110.7 175.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -88.25 134.17 33.86 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.336 -0.853 . . . . 0.0 109.945 172.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.0 t -72.84 141.84 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.63 -0.669 . . . . 0.0 110.211 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.626 HG22 ' CZ ' ' A' ' 192' ' ' TYR . 58.4 t -84.86 140.05 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.571 -0.706 . . . . 0.0 109.153 171.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -134.71 -170.57 2.58 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.471 -0.768 . . . . 0.0 111.054 -170.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 13.6 mmp_? -95.62 157.35 15.94 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.732 -0.605 . . . . 0.0 110.106 178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 49.8 m . . . . . 0 N--CA 1.496 1.854 0 O-C-N 121.539 -0.726 . . . . 0.0 109.263 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 48.8 tp . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 120.978 0.418 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.643 HD12 ' HD3' ' A' ' 190' ' ' PRO . 86.2 mt -101.39 136.75 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.803 -0.561 . . . . 0.0 109.889 -175.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -135.18 159.72 40.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.71 -0.619 . . . . 0.0 110.317 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.493 HG23 HG21 ' A' ' 247' ' ' VAL . 94.6 t -105.18 146.82 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.704 -0.622 . . . . 0.0 110.138 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -120.99 124.51 45.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.777 -0.577 . . . . 0.0 110.27 172.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.78 24.16 11.09 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 169.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 -140.6 106.42 5.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.397 -1.06 . . . . 0.0 109.976 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 43.2 m -63.19 -15.28 56.46 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.519 -0.738 . . . . 0.0 111.341 -175.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -99.98 7.53 44.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 111.675 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.74 130.64 46.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.192 -0.942 . . . . 0.0 110.172 177.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -139.79 158.0 44.81 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.784 -0.572 . . . . 0.0 109.715 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -116.03 150.66 36.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.569 -0.707 . . . . 0.0 110.435 -177.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.16 159.88 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.79 -0.569 . . . . 0.0 110.26 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -123.43 128.25 49.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.73 -0.607 . . . . 0.0 110.08 174.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -65.12 130.05 94.68 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.669 -0.644 . . . . 0.0 109.85 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -67.07 -27.4 42.22 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 O-C-N 123.128 1.067 . . . . 0.0 111.008 -173.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 84.2 mt -100.57 -50.35 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.369 -0.832 . . . . 0.0 110.923 -168.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.3 p -105.28 12.13 32.12 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.338 -0.852 . . . . 0.0 111.831 -174.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.92 -5.43 12.82 Favored Glycine 0 N--CA 1.497 2.709 0 O-C-N 121.137 -0.977 . . . . 0.0 111.909 173.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 68.3 mmt-85 -46.04 142.0 2.94 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-N 119.192 1.496 . . . . 0.0 112.296 -175.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -109.24 140.8 42.4 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.682 -0.636 . . . . 0.0 110.037 172.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 78.5 p -154.75 159.99 41.02 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.591 -0.693 . . . . 0.0 110.689 178.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.493 HG21 HG23 ' A' ' 228' ' ' VAL . 8.2 p -124.17 148.32 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.798 -0.564 . . . . 0.0 109.657 176.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.748 HD22 ' HG2' ' A' ' 187' ' ' ARG . 84.4 mt -129.57 154.58 46.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.638 -0.664 . . . . 0.0 109.963 -175.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.446 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.9 m -151.28 151.71 29.72 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.794 -0.566 . . . . 0.0 109.947 176.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -71.08 138.95 34.7 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 O-C-N 123.275 1.145 . . . . 0.0 110.15 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.705 ' HD2' HD11 ' A' ' 186' ' ' ILE . 58.3 t80 -74.88 126.06 30.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.525 -0.734 . . . . 0.0 110.233 175.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -99.99 160.07 28.17 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.683 -0.635 . . . . 0.0 109.993 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.83 159.02 22.34 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 O-C-N 123.211 1.111 . . . . 0.0 110.529 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.38 149.98 77.93 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 O-C-N 123.251 1.132 . . . . 0.0 110.471 -178.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -61.31 146.94 46.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.737 -0.602 . . . . 0.0 110.233 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.94 127.25 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.517 -0.74 . . . . 0.0 110.164 -171.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.03 -10.15 55.25 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 10.0 t -144.0 173.44 11.71 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.168 -1.195 . . . . 0.0 110.625 175.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -106.83 13.15 28.19 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.612 -0.68 . . . . 0.0 111.756 -168.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.534 ' CE1' ' NE2' ' A' ' 173' ' ' GLN . 14.8 p90 -119.93 167.96 11.61 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.227 -0.921 . . . . 0.0 111.192 -175.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 94.1 m -117.75 146.31 43.87 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.762 -0.586 . . . . 0.0 109.868 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 39.7 m -116.74 135.77 53.5 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.577 -0.702 . . . . 0.0 110.941 -175.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.0 t -130.78 137.19 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 172.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 69.8 mt -104.53 121.6 43.82 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.49 -0.756 . . . . 0.0 109.94 -172.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.664 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 4.7 m-30 -106.56 154.84 20.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.65 -0.656 . . . . 0.0 110.824 -177.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -136.19 142.94 44.17 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -112.86 127.2 56.12 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.737 -0.602 . . . . 0.0 110.057 176.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 4.5 ppp? -95.74 7.3 46.7 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.705 -0.622 . . . . 0.0 111.898 -176.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' CYS . . . . . 0.672 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.8 OUTLIER -144.87 164.98 29.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.12 -0.987 . . . . 0.0 109.883 174.888 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.575 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.3 p30 -120.37 160.82 22.29 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.722 -0.611 . . . . 0.0 110.236 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 271' ' ' SER . . . . . 0.419 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 24.0 m -58.99 -31.72 69.03 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.458 -0.776 . . . . 0.0 110.908 -163.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 72.9 m -94.99 8.93 41.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.602 -0.686 . . . . 0.0 112.098 -164.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 31.9 p -95.42 118.18 31.69 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.03 -1.044 . . . . 0.0 110.869 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.11 141.05 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.467 -0.771 . . . . 0.0 110.324 -172.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 100.78 -5.22 56.56 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.0 -105.39 1.13 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 169.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' MET . . . . . 0.465 ' O ' ' ND2' ' A' ' 278' ' ' ASN . 97.0 mmm -61.35 -36.93 81.57 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.691 -0.888 . . . . 0.0 110.15 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 278' ' ' ASN . . . . . 0.465 ' ND2' ' O ' ' A' ' 277' ' ' MET . 5.7 p30 40.45 55.04 2.9 Favored 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 121.42 0.629 . . . . 0.0 112.664 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 55.62 34.09 22.53 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.456 -0.777 . . . . 0.0 111.523 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 280' ' ' ARG . . . . . 0.444 ' NH2' ' CZ ' ' A' ' 192' ' ' TYR . 35.6 mtm180 -120.12 106.09 41.44 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.295 -0.878 . . . . 0.0 110.161 165.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -60.7 147.98 93.13 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 O-C-N 123.073 1.039 . . . . 0.0 110.416 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.658 HG22 ' HA ' ' A' ' 192' ' ' TYR . 43.9 pt -131.94 179.52 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-O 121.798 0.808 . . . . 0.0 111.001 -176.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.479 HD23 ' HA ' ' A' ' 302' ' ' GLU . 33.0 mt -124.4 149.93 46.16 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.686 HD12 ' CE1' ' A' ' 301' ' ' PHE . 82.6 mt -115.17 129.9 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.609 HG23 ' SG ' ' A' ' 300' ' ' CYS . 77.7 mt -109.76 126.9 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -176.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 57.6 t -118.93 126.66 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.461 HG22 ' HG2' ' A' ' 298' ' ' ARG . 45.0 p -125.21 152.95 43.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.618 -0.676 . . . . 0.0 110.692 -174.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.77 HD21 ' HB3' ' A' ' 180' ' ' PRO . 26.3 tp -101.52 126.94 48.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.66 -0.65 . . . . 0.0 109.483 168.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.623 ' OE2' HG13 ' A' ' 295' ' ' VAL . 72.1 mm-40 -131.61 150.88 52.0 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -173.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.731 HG22 HD11 ' A' ' 296' ' ' LEU . 80.0 p -89.92 159.4 16.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.623 -0.673 . . . . 0.0 109.726 177.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 68.4 ttp85 -55.96 -26.02 46.31 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.619 -0.676 . . . . 0.0 110.796 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -87.62 9.72 20.36 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.5 -0.75 . . . . 0.0 111.841 -174.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 87.31 20.13 53.15 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 120.159 -1.02 . . . . 0.0 110.779 170.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -107.22 140.19 40.48 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.364 -1.08 . . . . 0.0 110.238 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.623 HG13 ' OE2' ' A' ' 289' ' ' GLU . 60.7 t -88.1 132.33 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.619 -0.676 . . . . 0.0 110.194 -174.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.731 HD11 HG22 ' A' ' 290' ' ' THR . 95.8 mt -99.94 -40.18 7.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.635 -0.666 . . . . 0.0 110.5 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -165.25 153.45 23.58 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.461 ' HG2' HG22 ' A' ' 287' ' ' THR . 78.5 mtm180 -134.72 136.24 42.55 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.672 -0.899 . . . . 0.0 110.908 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -134.0 158.5 43.37 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.572 -0.705 . . . . 0.0 109.77 170.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' CYS . . . . . 0.609 ' SG ' HG23 ' A' ' 285' ' ' ILE . 93.6 m -142.91 154.2 43.86 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.444 -0.785 . . . . 0.0 110.772 -175.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.686 ' CE1' HD12 ' A' ' 284' ' ' ILE . 46.0 p90 -145.0 162.1 37.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.702 -0.624 . . . . 0.0 110.017 175.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.479 ' HA ' HD23 ' A' ' 283' ' ' LEU . 57.1 tt0 -104.93 136.15 44.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.537 -0.727 . . . . 0.0 110.116 -178.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -122.55 144.05 49.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.647 -0.658 . . . . 0.0 110.769 -169.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -138.52 137.14 36.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.832 -0.543 . . . . 0.0 109.757 173.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.672 HD13 ' O ' ' A' ' 269' ' ' CYS . 67.5 mt -105.88 122.84 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.582 -0.699 . . . . 0.0 109.423 175.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.1 p -145.14 169.45 18.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.559 -0.713 . . . . 0.0 111.038 -169.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -69.63 -40.02 76.82 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.673 -0.642 . . . . 0.0 110.626 -178.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 4.2 t -131.39 88.34 44.22 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.578 -0.702 . . . . 0.0 110.5 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -55.25 -29.45 67.07 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 O-C-N 123.207 1.109 . . . . 0.0 111.023 174.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.43 -37.91 93.1 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.4 ttm-85 -73.47 -40.28 64.26 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.684 -0.892 . . . . 0.0 109.795 -173.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -69.43 -40.45 77.24 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.077 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -61.27 -44.54 97.07 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.271 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 28.9 tttp -64.01 -40.45 96.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.552 -0.717 . . . . 0.0 110.498 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.55 -50.6 71.99 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.487 -0.758 . . . . 0.0 110.476 -173.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 N--CA 1.494 1.763 0 O-C-N 121.449 -0.782 . . . . 0.0 110.127 -177.979 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.0 t . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 121.062 0.458 . . . . 0.0 110.261 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.5 p-10 -95.15 24.63 4.8 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.655 -0.653 . . . . 0.0 110.794 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 50.4 m -73.33 125.17 27.22 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.573 -0.705 . . . . 0.0 110.263 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -72.67 145.05 47.5 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.614 -0.679 . . . . 0.0 110.346 -178.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -154.8 101.41 2.34 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.747 -0.596 . . . . 0.0 110.24 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -58.92 -39.97 76.14 Favored 'Trans proline' 0 N--CA 1.488 1.18 0 O-C-N 123.151 1.079 . . . . 0.0 110.803 -177.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.31 -155.12 48.52 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -72.78 -46.88 0.38 Allowed 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 123.399 1.21 . . . . 0.0 111.066 -173.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -87.59 9.83 19.93 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.523 -0.736 . . . . 0.0 111.396 -173.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.81 59.69 4.13 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.983 -1.073 . . . . 0.0 110.58 -175.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.679 ' HA ' HG12 ' A' ' 176' ' ' VAL . 67.8 t80 -77.83 118.36 20.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.714 -0.616 . . . . 0.0 109.861 -179.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.407 ' HA ' ' HG3' ' A' ' 299' ' ' ARG . 18.4 t70 -130.02 159.89 35.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.781 -0.575 . . . . 0.0 110.193 -177.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 70.9 t -124.22 147.34 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.704 -0.622 . . . . 0.0 109.857 174.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 76.5 p -154.91 162.76 40.99 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 120.378 -0.529 . . . . 0.0 109.956 177.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.49 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 74.9 m-85 . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.81 -0.556 . . . . 0.0 109.897 -175.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.114 0.483 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.468 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 73.1 p -60.13 -33.76 72.59 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.678 -0.639 . . . . 0.0 109.974 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.468 ' HD1' ' HG1' ' A' ' 152' ' ' THR . 68.6 p-90 -171.03 144.68 2.16 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.356 0.598 . . . . 0.0 110.289 178.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 9.5 t -142.2 142.65 32.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.846 -0.534 . . . . 0.0 110.064 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.49 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 62.7 t80 -125.42 140.02 53.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.522 -0.736 . . . . 0.0 110.483 -172.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.4 t -110.09 124.94 52.41 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 120.386 -0.526 . . . . 0.0 109.872 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 49.5 m -70.73 -37.05 73.46 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.391 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -60.28 -32.27 71.03 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.635 -0.666 . . . . 0.0 110.323 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.442 HD11 ' HB2' ' A' ' 316' ' ' ASP . 59.2 mt -104.76 -12.12 16.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.73 -0.606 . . . . 0.0 110.835 -174.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 71.4 tttt 59.78 47.47 10.27 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.019 -1.051 . . . . 0.0 109.58 177.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.7 tttp -146.68 153.15 39.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.706 -0.621 . . . . 0.0 110.666 -172.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.641 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.41 137.79 53.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.776 -0.577 . . . . 0.0 110.307 -176.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -114.92 131.62 56.82 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 175.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.3 158.48 44.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.69 -0.631 . . . . 0.0 110.941 -173.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.406 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 39.3 mt-30 -104.69 141.47 36.4 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.47 0.652 . . . . 0.0 110.351 172.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.435 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 16.7 tt -52.19 148.06 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 121.622 0.725 . . . . 0.0 111.857 -174.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.29 10.01 5.29 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.558 -0.714 . . . . 0.0 112.516 177.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.406 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 54.9 mmtt -96.65 155.08 16.92 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.892 -1.13 . . . . 0.0 110.889 174.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 86.8 m -83.5 126.2 32.54 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.73 -0.606 . . . . 0.0 110.602 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' CYS . . . . . 0.641 ' SG ' HD21 ' A' ' 162' ' ' LEU . 44.4 t -114.85 90.1 21.44 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.55 -0.719 . . . . 0.0 110.222 173.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.439 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 19.3 Cg_exo -63.27 130.09 27.54 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 O-C-N 123.228 1.12 . . . . 0.0 110.753 173.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.405 HG12 ' CE2' ' A' ' 142' ' ' PHE . 97.0 mt -123.52 143.35 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.664 -0.647 . . . . 0.0 109.317 173.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -109.35 135.48 50.35 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.491 -0.756 . . . . 0.0 110.824 -175.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 48.9 mm -95.29 135.03 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.685 -0.634 . . . . 0.0 109.65 169.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 44.5 tttm -116.43 129.53 56.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.62 -0.675 . . . . 0.0 110.482 176.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.679 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.5 m -136.69 159.76 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.552 -0.718 . . . . 0.0 109.873 174.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.4 mmm -78.44 -41.63 32.33 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.692 -0.63 . . . . 0.0 110.15 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.417 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 76.9 p -133.81 143.2 46.58 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.773 -0.579 . . . . 0.0 109.634 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 34.6 Cg_exo -55.21 139.79 80.94 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 O-C-N 123.191 1.101 . . . . 0.0 110.925 -171.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.729 ' HB3' HD21 ' A' ' 288' ' ' LEU . 30.7 Cg_endo -66.81 170.1 13.39 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.17 1.09 . . . . 0.0 110.588 177.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -60.65 155.06 50.45 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.363 1.191 . . . . 0.0 110.537 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -78.08 140.59 39.09 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.619 -0.676 . . . . 0.0 109.91 175.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.83 -24.92 29.6 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -174.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.2 152.06 1.86 Allowed 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.348 -1.09 . . . . 0.0 111.436 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.79 156.3 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.814 -0.554 . . . . 0.0 109.805 176.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.671 HD11 ' HD2' ' A' ' 251' ' ' TYR . 52.4 mt -109.75 135.56 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.745 ' HG2' HD22 ' A' ' 248' ' ' LEU . 71.1 mtt180 -114.97 145.48 42.2 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -174.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.68 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -139.74 126.58 20.75 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.509 -0.744 . . . . 0.0 110.332 173.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 37.5 ttp -137.39 138.55 25.17 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.78 -0.575 . . . . 0.0 111.093 -176.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.508 ' HD3' HD12 ' A' ' 226' ' ' ILE . 73.9 Cg_endo -90.75 138.15 2.45 Favored 'Trans proline' 0 C--N 1.32 -0.941 0 O-C-N 123.207 1.109 . . . . 0.0 110.808 176.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.456 HG12 ' CZ ' ' A' ' 244' ' ' ARG . 34.8 m -147.31 154.78 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.487 -0.758 . . . . 0.0 110.109 173.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.645 ' HA ' HG22 ' A' ' 282' ' ' ILE . 90.4 m-85 -62.18 166.43 4.85 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.41 -0.806 . . . . 0.0 110.477 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -83.09 -60.04 2.28 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.671 -0.643 . . . . 0.0 110.824 -175.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 39.6 mttp -80.06 151.14 30.06 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.609 -0.682 . . . . 0.0 110.328 -175.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.456 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.55 -38.07 71.41 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.404 -0.81 . . . . 0.0 110.802 -175.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -56.75 -24.92 53.37 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.556 -0.715 . . . . 0.0 110.599 -176.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -109.7 -20.53 12.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.519 -0.738 . . . . 0.0 111.144 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.456 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.1 p -67.73 -20.23 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.181 -0.95 . . . . 0.0 110.518 -176.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 78.5 p -79.43 -17.01 55.19 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.779 175.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -88.28 137.86 31.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.367 -0.833 . . . . 0.0 110.089 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.7 t -73.13 140.89 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.614 -0.679 . . . . 0.0 110.295 177.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.551 HG22 ' CE1' ' A' ' 192' ' ' TYR . 62.0 t -85.0 138.57 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.552 -0.718 . . . . 0.0 109.345 170.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 14.2 pttt -134.92 -170.26 2.53 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.575 -0.703 . . . . 0.0 111.01 -171.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 84.7 mtm-85 -95.27 157.49 15.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.747 -0.596 . . . . 0.0 110.212 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.735 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 53.4 m . . . . . 0 N--CA 1.496 1.862 0 O-C-N 121.677 -0.64 . . . . 0.0 109.558 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.41 ' HA ' ' CG ' ' A' ' 268' ' ' MET . 54.9 tp . . . . . 0 N--CA 1.497 1.875 0 CA-C-O 120.946 0.403 . . . . 0.0 110.324 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.508 HD12 ' HD3' ' A' ' 190' ' ' PRO . 83.0 mt -105.51 136.8 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.747 -0.596 . . . . 0.0 109.735 177.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -132.35 157.13 45.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.677 -0.639 . . . . 0.0 110.264 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.473 HG23 HG21 ' A' ' 247' ' ' VAL . 75.2 t -102.52 146.58 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.727 -0.608 . . . . 0.0 110.022 176.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -117.83 130.08 56.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.7 -0.625 . . . . 0.0 110.386 170.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 95.65 20.71 25.97 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.559 -1.017 . . . . 0.0 110.559 168.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -138.84 105.88 5.45 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -1.119 . . . . 0.0 110.005 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 43.2 m -63.21 -15.23 56.32 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.596 -0.69 . . . . 0.0 111.285 -177.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -100.0 8.9 43.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.19 -0.944 . . . . 0.0 111.53 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.37 131.42 50.21 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.072 -1.018 . . . . 0.0 110.196 176.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -139.76 158.06 44.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.752 -0.592 . . . . 0.0 109.805 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -111.69 150.63 29.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.614 -0.679 . . . . 0.0 110.484 -177.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.17 159.92 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.732 -0.605 . . . . 0.0 110.216 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -121.03 130.1 53.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.813 -0.555 . . . . 0.0 110.154 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -63.23 130.0 93.89 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.664 -0.648 . . . . 0.0 109.853 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -65.23 -28.63 55.74 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 O-C-N 123.186 1.098 . . . . 0.0 110.968 -170.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.6 mt -102.15 -50.47 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.467 -0.77 . . . . 0.0 111.07 -168.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 14.1 p -105.3 12.18 32.04 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.392 -0.818 . . . . 0.0 111.942 -174.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 72.56 -4.89 18.57 Favored Glycine 0 N--CA 1.496 2.669 0 O-C-N 120.988 -1.07 . . . . 0.0 111.955 172.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.456 ' CZ ' HG12 ' A' ' 191' ' ' VAL . 21.4 mmt180 -45.92 142.02 2.83 Favored 'General case' 0 N--CA 1.506 2.328 0 CA-C-N 119.101 1.451 . . . . 0.0 112.339 -175.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -103.94 141.72 35.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.616 -0.678 . . . . 0.0 110.219 176.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.4 p -154.73 159.95 41.02 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.623 -0.673 . . . . 0.0 110.299 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.473 HG21 HG23 ' A' ' 228' ' ' VAL . 8.3 p -122.95 148.08 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.674 -0.641 . . . . 0.0 109.796 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.745 HD22 ' HG2' ' A' ' 187' ' ' ARG . 80.1 mt -129.63 154.62 46.93 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.816 -175.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.437 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.8 m -150.98 151.76 30.34 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.808 -0.558 . . . . 0.0 109.907 175.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -71.01 140.5 38.11 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 O-C-N 123.251 1.132 . . . . 0.0 110.003 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.671 ' HD2' HD11 ' A' ' 186' ' ' ILE . 60.6 t80 -76.06 125.41 29.08 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.459 -0.775 . . . . 0.0 110.155 177.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -100.05 160.14 27.96 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.739 -0.6 . . . . 0.0 109.998 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -59.0 159.13 22.58 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 O-C-N 123.284 1.149 . . . . 0.0 110.445 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -59.11 149.93 76.79 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 O-C-N 123.248 1.131 . . . . 0.0 110.515 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -60.36 147.45 40.6 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.627 -0.671 . . . . 0.0 110.319 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.7 t -69.83 127.25 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.619 -0.675 . . . . 0.0 110.22 -170.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.99 -10.09 55.33 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 9.6 t -144.35 173.27 11.92 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.224 -1.162 . . . . 0.0 110.558 175.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -106.92 13.21 27.95 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.651 -0.656 . . . . 0.0 111.804 -168.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -120.03 168.05 11.57 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.115 -0.991 . . . . 0.0 111.152 -175.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 82.3 m -117.75 146.25 43.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.729 -0.607 . . . . 0.0 109.788 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 35.6 m -116.72 136.61 52.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.636 -0.665 . . . . 0.0 110.917 -175.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 59.3 t -128.56 137.13 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 66.4 mt -104.78 119.49 39.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.497 -0.752 . . . . 0.0 109.831 -173.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.68 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 6.5 m-30 -105.69 151.06 24.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.62 -0.675 . . . . 0.0 110.718 -177.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -136.53 143.01 43.49 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -115.0 131.97 56.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.527 -0.733 . . . . 0.0 110.501 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' MET . . . . . 0.41 ' CG ' ' HA ' ' A' ' 225' ' ' LEU . 5.2 ppp? -100.24 1.16 41.57 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.654 -0.654 . . . . 0.0 111.9 -177.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.65 159.6 42.55 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.085 -1.009 . . . . 0.0 109.982 173.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.586 ' HA ' HD13 ' A' ' 305' ' ' ILE . 27.2 p30 -115.13 153.89 29.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.74 -0.6 . . . . 0.0 110.161 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 271' ' ' SER . . . . . 0.444 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 92.7 p -56.64 -26.7 56.76 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.404 -0.81 . . . . 0.0 111.155 -167.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 46.0 p -95.04 8.19 43.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.387 -0.821 . . . . 0.0 112.086 -165.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' CYS . . . . . 0.735 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 28.9 p -93.96 117.96 30.82 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.98 -1.075 . . . . 0.0 110.727 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 274' ' ' VAL . . . . . 0.447 HG22 ' NH1' ' A' ' 279' ' ' ARG . 60.2 t -69.68 143.34 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.561 -0.712 . . . . 0.0 110.533 -167.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.53 -5.28 58.55 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.04 -95.35 0.74 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 169.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' MET . . . . . 0.444 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 95.2 mmm -64.78 -28.61 69.69 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.74 -0.859 . . . . 0.0 110.386 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.9 p30 44.95 51.56 8.6 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 121.325 0.583 . . . . 0.0 112.507 172.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.447 ' NH1' HG22 ' A' ' 274' ' ' VAL . 37.9 mtt180 54.7 33.4 19.35 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.321 -0.862 . . . . 0.0 111.289 174.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' ARG . . . . . 0.434 ' O ' HG23 ' A' ' 282' ' ' ILE . 89.6 mtt180 -114.89 105.01 53.74 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.499 -0.751 . . . . 0.0 110.092 173.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 281' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 280' ' ' ARG . 13.2 Cg_endo -60.8 144.97 99.65 Favored 'Trans proline' 0 N--CA 1.488 1.175 0 O-C-N 123.138 1.073 . . . . 0.0 110.371 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.645 HG22 ' HA ' ' A' ' 192' ' ' TYR . 43.6 pt -132.58 177.84 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 121.943 0.878 . . . . 0.0 111.253 -174.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 302' ' ' GLU . 35.0 mt -124.34 149.9 46.09 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 177.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.669 HD12 ' CE1' ' A' ' 301' ' ' PHE . 80.8 mt -114.21 130.51 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.63 -0.669 . . . . 0.0 109.312 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.504 HG23 ' SG ' ' A' ' 300' ' ' CYS . 81.0 mt -109.78 125.91 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -176.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 75.8 t -118.98 126.71 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.7 p -125.28 153.01 43.89 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.717 -0.614 . . . . 0.0 110.72 -174.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.729 HD21 ' HB3' ' A' ' 180' ' ' PRO . 19.1 tp -100.29 126.95 46.68 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 166.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.696 ' OE2' HG13 ' A' ' 295' ' ' VAL . 74.5 mm-40 -132.69 149.72 52.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.756 -0.59 . . . . 0.0 110.01 -172.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.778 ' CG2' HD11 ' A' ' 296' ' ' LEU . 77.2 p -89.93 158.28 17.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.667 -0.646 . . . . 0.0 110.013 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -55.98 -26.16 47.19 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.559 -0.713 . . . . 0.0 111.009 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -92.93 12.86 22.37 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.47 -0.769 . . . . 0.0 111.697 -173.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.94 20.18 44.17 Favored Glycine 0 N--CA 1.494 2.539 0 C-N-CA 120.118 -1.039 . . . . 0.0 110.962 167.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -107.43 140.14 40.83 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.216 -1.167 . . . . 0.0 110.18 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.696 HG13 ' OE2' ' A' ' 289' ' ' GLU . 58.7 t -90.1 130.9 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.626 -0.671 . . . . 0.0 110.054 -175.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.778 HD11 ' CG2' ' A' ' 290' ' ' THR . 96.3 mt -99.97 -40.07 7.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.716 -0.615 . . . . 0.0 110.569 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -160.35 149.36 18.66 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.504 ' HD2' HG11 ' A' ' 295' ' ' VAL . 48.7 mtp180 -135.19 136.24 41.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.678 -0.895 . . . . 0.0 110.575 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 299' ' ' ARG . . . . . 0.407 ' HG3' ' HA ' ' A' ' 139' ' ' ASP . 0.4 OUTLIER -138.13 157.82 45.55 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.608 -0.682 . . . . 0.0 110.301 170.021 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 300' ' ' CYS . . . . . 0.504 ' SG ' HG23 ' A' ' 285' ' ' ILE . 82.2 m -141.88 154.96 45.5 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.493 -0.754 . . . . 0.0 110.643 -175.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.669 ' CE1' HD12 ' A' ' 284' ' ' ILE . 47.3 p90 -144.95 160.97 40.49 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.703 -0.623 . . . . 0.0 110.194 175.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.474 ' HA ' HD23 ' A' ' 283' ' ' LEU . 82.3 tt0 -104.93 136.89 43.56 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.571 -0.706 . . . . 0.0 110.125 -178.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -117.94 143.73 46.1 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.821 -169.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -137.1 138.57 40.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.822 -0.549 . . . . 0.0 109.713 172.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.586 HD13 ' HA ' ' A' ' 270' ' ' ASN . 56.2 mt -112.7 122.86 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.512 -0.743 . . . . 0.0 109.757 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.2 p -145.32 170.56 16.08 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.642 -0.662 . . . . 0.0 110.664 -171.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -71.97 -40.11 68.86 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.694 -0.629 . . . . 0.0 110.641 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.8 t -127.12 86.51 58.66 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.59 -0.694 . . . . 0.0 110.506 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 309' ' ' PRO . . . . . 0.403 ' HD3' ' HG3' ' A' ' 165' ' ' GLN . 37.5 Cg_exo -56.24 -28.2 70.14 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.169 1.089 . . . . 0.0 110.533 173.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -67.53 -37.57 89.86 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -70.5 -38.33 74.3 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.643 -0.916 . . . . 0.0 109.749 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -69.45 -35.42 75.64 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.085 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 37.7 ttt85 -57.16 -47.3 81.55 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.533 -0.73 . . . . 0.0 110.593 174.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -64.56 -39.02 92.98 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.575 -0.703 . . . . 0.0 110.401 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -62.44 -51.41 67.62 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.529 -0.732 . . . . 0.0 110.56 -173.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 316' ' ' ASP . . . . . 0.442 ' HB2' HD11 ' A' ' 159' ' ' LEU . 3.5 p30 . . . . . 0 N--CA 1.495 1.777 0 O-C-N 121.472 -0.767 . . . . 0.0 110.096 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.5 t . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.057 0.456 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -94.65 24.25 4.77 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.691 -0.63 . . . . 0.0 110.878 -178.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 50.9 m -72.33 125.18 26.72 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.496 -0.753 . . . . 0.0 110.148 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -68.5 144.94 54.45 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.614 -0.679 . . . . 0.0 110.388 -176.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -155.55 101.65 2.2 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.802 -0.561 . . . . 0.0 110.058 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -59.54 -39.87 71.25 Favored 'Trans proline' 0 N--CA 1.489 1.222 0 O-C-N 123.152 1.08 . . . . 0.0 110.677 -175.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.04 -155.17 42.1 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -73.29 -43.86 0.64 Allowed 'Trans proline' 0 C--N 1.316 -1.142 0 O-C-N 123.422 1.222 . . . . 0.0 110.89 -175.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -89.28 5.64 44.01 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.543 -0.723 . . . . 0.0 111.497 -174.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 t 53.99 59.43 4.26 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.978 -1.076 . . . . 0.0 110.729 -176.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.725 ' HA ' HG12 ' A' ' 176' ' ' VAL . 64.6 t80 -78.15 118.78 20.72 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.571 -0.706 . . . . 0.0 110.019 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -130.06 160.02 34.98 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.34 0.591 . . . . 0.0 110.321 -176.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.0 t -124.83 148.42 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.692 -0.63 . . . . 0.0 109.87 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.6 p -155.87 166.9 32.09 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.313 0.578 . . . . 0.0 110.088 176.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.496 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 66.3 m-85 . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.782 -0.574 . . . . 0.0 109.84 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 121.173 0.511 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 42.5 p -60.09 -34.08 72.98 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.643 -0.661 . . . . 0.0 110.094 176.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.442 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.8 p-90 -171.22 144.27 2.02 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.331 0.586 . . . . 0.0 110.224 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.0 t -142.09 142.6 32.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.897 -0.502 . . . . 0.0 109.985 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.496 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 64.7 t80 -125.61 139.98 53.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.486 -0.759 . . . . 0.0 110.775 -171.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.0 t -111.96 123.85 51.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.851 -0.531 . . . . 0.0 109.92 177.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 59.0 m -70.93 -37.01 72.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.806 -0.559 . . . . 0.0 110.568 -176.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -59.21 -35.36 73.48 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.505 -0.747 . . . . 0.0 110.522 -177.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.2 mt -104.86 -11.05 16.94 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.683 -0.636 . . . . 0.0 110.981 -176.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt 59.76 52.64 5.34 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.14 -0.975 . . . . 0.0 109.743 177.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -145.25 153.07 40.92 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.779 -0.576 . . . . 0.0 110.625 -175.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.618 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.58 137.76 53.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.758 -0.588 . . . . 0.0 110.206 -175.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -116.04 135.89 53.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.63 -0.669 . . . . 0.0 109.381 173.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.1 p -138.49 158.49 44.17 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.68 -0.638 . . . . 0.0 110.767 -177.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.431 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 55.4 mt-30 -104.61 144.49 31.64 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.505 -0.747 . . . . 0.0 109.882 171.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.418 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 16.3 tt -51.71 147.48 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.502 -0.749 . . . . 0.0 111.95 -174.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 65.11 10.0 5.99 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.637 -0.665 . . . . 0.0 112.702 174.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.431 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 20.3 mmtp -96.12 155.11 16.9 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.955 -1.091 . . . . 0.0 111.074 172.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 91.3 m -80.33 126.18 30.83 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.719 -0.613 . . . . 0.0 110.569 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' CYS . . . . . 0.618 ' SG ' HD21 ' A' ' 162' ' ' LEU . 48.6 t -116.32 90.03 28.34 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.604 -0.685 . . . . 0.0 110.126 174.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.442 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 15.2 Cg_exo -65.78 131.08 26.39 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 O-C-N 123.264 1.139 . . . . 0.0 110.756 174.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.635 HD12 ' CD2' ' A' ' 265' ' ' TYR . 78.2 mt -123.91 144.69 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.596 -0.69 . . . . 0.0 109.496 172.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLN . . . . . 0.405 ' OE1' ' CD1' ' A' ' 260' ' ' PHE . 70.5 mm-40 -108.42 133.05 53.12 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.52 -0.738 . . . . 0.0 110.361 -173.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.59 HG21 ' CE1' ' A' ' 138' ' ' PHE . 49.0 mm -95.35 135.0 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.652 -0.655 . . . . 0.0 109.657 170.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.0 tttp -119.3 130.28 55.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.531 -0.73 . . . . 0.0 110.529 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.725 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.4 m -136.2 159.73 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.605 -0.684 . . . . 0.0 109.905 175.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 81.6 mmm -77.13 -40.3 46.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.695 -0.628 . . . . 0.0 110.045 177.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.3 p -135.87 143.27 43.72 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.764 -0.585 . . . . 0.0 109.795 177.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.7 Cg_exo -55.69 139.89 83.68 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 O-C-N 123.217 1.114 . . . . 0.0 110.886 -172.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.742 ' HB3' HD21 ' A' ' 288' ' ' LEU . 23.4 Cg_endo -64.28 169.71 10.45 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.238 1.125 . . . . 0.0 110.69 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -61.06 156.54 44.02 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.35 1.184 . . . . 0.0 110.497 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -77.06 139.61 40.07 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.629 -0.669 . . . . 0.0 109.908 175.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.9 -25.02 29.24 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -175.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.12 152.97 1.53 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.296 -1.12 . . . . 0.0 111.325 176.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.77 155.98 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.748 -0.595 . . . . 0.0 109.774 176.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.641 HD11 ' CD2' ' A' ' 251' ' ' TYR . 72.4 mt -106.13 133.7 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 177.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.758 ' HG2' HD22 ' A' ' 248' ' ' LEU . 65.0 mtt180 -115.01 140.94 48.64 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -174.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -138.52 124.47 20.02 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.49 -0.757 . . . . 0.0 110.53 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 20.3 ttm -137.35 139.31 27.32 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.808 -0.558 . . . . 0.0 111.145 -175.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.718 ' HD3' HD12 ' A' ' 226' ' ' ILE . 71.2 Cg_endo -90.29 138.13 2.69 Favored 'Trans proline' 0 C--N 1.32 -0.948 0 O-C-N 123.185 1.097 . . . . 0.0 110.519 175.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.428 HG13 ' C ' ' A' ' 190' ' ' PRO . 34.8 m -147.07 154.92 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.577 -0.702 . . . . 0.0 110.211 174.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.647 ' HA ' HG22 ' A' ' 282' ' ' ILE . 82.3 m-85 -60.97 161.1 8.76 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.477 -0.764 . . . . 0.0 110.348 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -78.46 -60.04 2.53 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.635 -0.666 . . . . 0.0 110.812 -173.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -80.02 151.88 29.73 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.605 -0.685 . . . . 0.0 110.447 -174.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.447 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.41 -38.94 72.23 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.353 -0.842 . . . . 0.0 110.74 -176.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -56.37 -24.57 45.25 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.533 -0.73 . . . . 0.0 110.624 -176.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.412 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 60.4 m170 -110.01 -20.56 12.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.509 -0.744 . . . . 0.0 111.101 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.447 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.1 p -66.88 -20.34 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.111 -0.993 . . . . 0.0 110.639 -176.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 73.7 p -79.3 -16.96 55.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.522 -0.736 . . . . 0.0 110.78 175.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -88.41 134.62 33.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.338 -0.851 . . . . 0.0 110.064 173.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.3 t -73.16 143.69 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.612 -0.68 . . . . 0.0 110.269 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 78.9 t -84.9 139.56 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.527 -0.733 . . . . 0.0 109.326 170.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 9.3 pttt -134.9 -170.06 2.49 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.477 -0.765 . . . . 0.0 111.035 -167.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -95.07 154.2 17.28 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.712 -0.617 . . . . 0.0 110.317 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.553 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 56.3 m . . . . . 0 N--CA 1.496 1.865 0 O-C-N 121.647 -0.658 . . . . 0.0 109.249 174.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.401 ' HA ' ' HG3' ' A' ' 268' ' ' MET . 45.8 tp . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 120.938 0.399 . . . . 0.0 110.089 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.718 HD12 ' HD3' ' A' ' 190' ' ' PRO . 79.3 mt -99.21 136.79 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.836 -0.54 . . . . 0.0 109.659 175.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -135.05 157.61 46.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.737 -0.602 . . . . 0.0 109.971 176.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.463 HG23 HG21 ' A' ' 247' ' ' VAL . 72.6 t -103.52 146.65 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.712 -0.618 . . . . 0.0 110.161 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -122.06 130.01 52.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.746 -0.596 . . . . 0.0 110.285 170.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 99.12 19.51 21.19 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 170.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -140.7 104.52 4.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.267 -1.137 . . . . 0.0 110.028 174.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 45.8 m -63.42 -15.31 57.27 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.666 -0.646 . . . . 0.0 111.276 -176.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -100.01 7.63 44.59 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.22 -0.925 . . . . 0.0 111.55 -177.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.61 133.37 55.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.088 -1.007 . . . . 0.0 110.21 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -139.83 157.98 44.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.735 -0.603 . . . . 0.0 109.809 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.426 ' CD1' ' HB ' ' A' ' 247' ' ' VAL . 84.3 m-85 -114.37 150.65 34.27 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.552 -0.717 . . . . 0.0 110.497 -178.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.22 159.92 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.76 -0.588 . . . . 0.0 110.266 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -119.22 130.04 55.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.769 -0.582 . . . . 0.0 110.163 175.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -65.09 130.11 94.72 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.676 -0.64 . . . . 0.0 109.838 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -66.36 -27.66 47.37 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 O-C-N 123.172 1.09 . . . . 0.0 111.021 -171.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 82.6 mt -100.49 -50.54 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.399 -0.813 . . . . 0.0 110.942 -167.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.3 p -105.3 12.04 32.21 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.322 -0.861 . . . . 0.0 111.887 -175.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.88 -5.11 13.57 Favored Glycine 0 N--CA 1.495 2.582 0 O-C-N 121.08 -1.012 . . . . 0.0 111.916 173.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 22.2 mmt85 -46.14 142.02 3.02 Favored 'General case' 0 N--CA 1.505 2.276 0 CA-C-N 119.108 1.454 . . . . 0.0 112.321 -174.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -106.27 139.91 40.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.628 -0.67 . . . . 0.0 110.123 175.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 78.7 p -154.74 159.98 41.03 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.635 -0.665 . . . . 0.0 110.518 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.463 HG21 HG23 ' A' ' 228' ' ' VAL . 8.3 p -122.96 148.17 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.78 -0.575 . . . . 0.0 109.666 177.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.758 HD22 ' HG2' ' A' ' 187' ' ' ARG . 83.0 mt -129.64 154.52 47.04 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.045 -175.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.443 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.4 m -151.12 151.76 30.09 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.812 -0.555 . . . . 0.0 109.84 175.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -70.57 137.16 32.5 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 O-C-N 123.237 1.125 . . . . 0.0 109.979 177.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.641 ' CD2' HD11 ' A' ' 186' ' ' ILE . 13.9 t80 -77.23 124.29 27.63 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.572 -0.705 . . . . 0.0 110.201 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -100.01 160.06 28.2 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.719 -0.613 . . . . 0.0 110.177 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -59.26 159.99 20.9 Favored 'Trans proline' 0 C--N 1.316 -1.163 0 O-C-N 123.244 1.129 . . . . 0.0 110.434 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.88 150.22 73.3 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 O-C-N 123.194 1.102 . . . . 0.0 110.567 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -60.02 148.11 36.72 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.575 -0.703 . . . . 0.0 110.323 -178.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.84 127.25 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.457 -0.777 . . . . 0.0 110.068 -170.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.92 -10.12 55.46 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 9.5 t -144.68 173.71 11.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.163 -1.198 . . . . 0.0 110.601 175.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -106.94 13.18 27.96 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.66 -0.65 . . . . 0.0 111.768 -168.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.405 ' CD1' ' OE1' ' A' ' 173' ' ' GLN . 13.8 p90 -119.94 168.02 11.56 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.212 -0.93 . . . . 0.0 111.233 -175.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 86.4 m -117.86 147.78 42.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.768 -0.583 . . . . 0.0 109.841 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 40.6 m -115.95 137.54 52.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.553 -0.717 . . . . 0.0 110.91 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 57.9 t -128.62 136.87 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 170.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 64.7 mt -104.87 120.12 40.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.494 -0.754 . . . . 0.0 109.815 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.635 ' CD2' HD12 ' A' ' 172' ' ' ILE . 3.3 m-85 -99.19 156.4 16.98 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.796 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -136.42 142.99 43.7 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 171.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -113.41 129.58 56.51 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.61 -0.681 . . . . 0.0 110.163 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' MET . . . . . 0.401 ' HG3' ' HA ' ' A' ' 225' ' ' LEU . 0.0 OUTLIER -98.98 5.85 46.98 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.636 -0.665 . . . . 0.0 111.724 -176.308 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 269' ' ' CYS . . . . . 0.528 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.8 OUTLIER -144.78 161.33 39.52 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.141 -0.975 . . . . 0.0 110.069 173.636 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.662 ' HA ' HG21 ' A' ' 305' ' ' ILE . 26.9 p30 -116.27 158.71 22.95 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.731 -0.605 . . . . 0.0 109.822 176.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 271' ' ' SER . . . . . 0.405 ' HA ' ' HB3' ' A' ' 277' ' ' MET . 19.2 m -58.6 -32.65 69.19 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.376 -0.827 . . . . 0.0 110.947 -163.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 73.1 m -93.93 10.7 32.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.601 -0.687 . . . . 0.0 111.986 -165.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' CYS . . . . . 0.553 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 31.7 p -93.8 118.19 31.1 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.069 -1.019 . . . . 0.0 110.593 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.3 t -61.34 139.9 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.389 -0.819 . . . . 0.0 110.218 -171.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 101.0 -5.11 56.16 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -124.89 -115.87 2.12 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 170.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' MET . . . . . 0.421 ' C ' ' ND2' ' A' ' 278' ' ' ASN . 26.9 ttt -60.27 -24.94 65.32 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.613 -0.934 . . . . 0.0 110.409 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' ASN . . . . . 0.421 ' ND2' ' C ' ' A' ' 277' ' ' MET . 7.2 p30 43.87 55.07 5.41 Favored 'General case' 0 N--CA 1.504 2.241 0 CA-C-O 121.434 0.635 . . . . 0.0 112.584 172.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 54.94 30.36 13.87 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.401 -0.812 . . . . 0.0 111.317 175.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -116.81 116.42 38.35 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.468 -0.77 . . . . 0.0 110.128 170.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' PRO . . . . . 0.404 ' HA ' ' CE ' ' A' ' 277' ' ' MET . 12.0 Cg_endo -59.68 145.66 97.54 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 O-C-N 123.042 1.022 . . . . 0.0 110.495 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.647 HG22 ' HA ' ' A' ' 192' ' ' TYR . 45.4 pt -131.97 175.73 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 121.762 0.791 . . . . 0.0 110.89 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.48 HD23 ' HA ' ' A' ' 302' ' ' GLU . 32.0 mt -124.42 149.92 46.21 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.512 HD12 ' CE1' ' A' ' 301' ' ' PHE . 79.1 mt -112.58 127.95 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.057 176.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.686 HG23 ' SG ' ' A' ' 300' ' ' CYS . 76.5 mt -109.85 126.34 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.436 -175.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 59.1 t -118.92 126.55 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.3 p -125.4 153.93 42.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.643 -0.661 . . . . 0.0 110.536 -174.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.742 HD21 ' HB3' ' A' ' 180' ' ' PRO . 24.3 tp -103.55 126.57 50.78 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 169.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.562 ' OE2' HG13 ' A' ' 295' ' ' VAL . 75.1 mm-40 -132.15 150.24 52.2 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.996 -173.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.759 ' CG2' HD11 ' A' ' 296' ' ' LEU . 76.5 p -89.96 159.21 17.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.732 -0.605 . . . . 0.0 109.907 178.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -55.95 -26.16 46.8 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.534 -0.729 . . . . 0.0 110.905 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -93.07 12.95 22.33 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.479 -0.763 . . . . 0.0 111.697 -174.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.41 20.16 46.22 Favored Glycine 0 N--CA 1.495 2.62 0 C-N-CA 120.132 -1.033 . . . . 0.0 110.972 167.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -105.64 140.16 39.13 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.203 -1.175 . . . . 0.0 110.231 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.562 HG13 ' OE2' ' A' ' 289' ' ' GLU . 59.4 t -87.52 131.32 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.678 -0.639 . . . . 0.0 110.008 -176.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.759 HD11 ' CG2' ' A' ' 290' ' ' THR . 96.9 mt -99.87 -40.11 7.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.718 -0.614 . . . . 0.0 110.484 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -162.7 151.6 21.48 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.434 ' HD2' HG11 ' A' ' 295' ' ' VAL . 46.3 mtp180 -135.01 134.35 40.36 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.719 -0.871 . . . . 0.0 110.469 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -136.3 152.81 51.09 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.558 -0.713 . . . . 0.0 110.236 172.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' CYS . . . . . 0.686 ' SG ' HG23 ' A' ' 285' ' ' ILE . 90.7 m -142.49 153.18 43.41 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.415 -0.803 . . . . 0.0 110.772 -175.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.512 ' CE1' HD12 ' A' ' 284' ' ' ILE . 51.1 p90 -145.82 166.77 24.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.671 -0.643 . . . . 0.0 109.97 174.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.48 ' HA ' HD23 ' A' ' 283' ' ' LEU . 58.0 tt0 -104.84 136.91 43.45 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.527 -0.733 . . . . 0.0 110.225 -177.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -119.4 145.47 46.19 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.626 -171.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 40.0 tpt85 -138.09 134.01 34.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.71 -0.619 . . . . 0.0 109.699 174.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.662 HG21 ' HA ' ' A' ' 270' ' ' ASN . 80.5 mt -105.75 122.87 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.504 -0.748 . . . . 0.0 109.583 176.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.4 p -145.21 173.23 12.12 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.535 -0.728 . . . . 0.0 110.648 -171.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -72.46 -40.13 67.23 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.704 -0.623 . . . . 0.0 110.582 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.7 t -131.04 89.37 42.52 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.544 -0.722 . . . . 0.0 110.467 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 309' ' ' PRO . . . . . 0.408 ' CG ' ' HG3' ' A' ' 165' ' ' GLN . 50.7 Cg_exo -54.13 -30.52 60.99 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 O-C-N 123.188 1.099 . . . . 0.0 111.03 172.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -65.4 -37.15 93.51 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -73.26 -40.44 64.63 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.669 -0.901 . . . . 0.0 109.802 -173.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -69.52 -41.33 76.15 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 120.084 -0.647 . . . . 0.0 110.092 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 72.4 ttt-85 -61.21 -41.8 97.48 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.564 -0.71 . . . . 0.0 110.346 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -64.17 -38.61 91.66 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.49 -0.757 . . . . 0.0 110.451 178.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -62.7 -52.85 61.68 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.486 -0.759 . . . . 0.0 110.541 -173.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.4 p30 . . . . . 0 N--CA 1.496 1.839 0 O-C-N 121.464 -0.773 . . . . 0.0 110.158 -176.992 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.3 t . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.108 0.48 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 p-10 -95.58 25.17 4.68 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.664 -0.647 . . . . 0.0 110.775 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 55.1 m -72.3 125.25 26.88 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.511 -0.743 . . . . 0.0 110.242 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -72.3 144.88 48.18 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.705 -0.622 . . . . 0.0 110.437 -178.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.429 ' CE1' ' HA2' ' A' ' 134' ' ' GLY . 65.0 t80 -159.64 100.62 1.5 Allowed Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.671 -0.643 . . . . 0.0 110.129 178.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -58.72 -39.93 77.61 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 O-C-N 123.182 1.096 . . . . 0.0 110.818 -176.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.429 ' HA2' ' CE1' ' A' ' 132' ' ' TYR . . . 79.95 -155.16 38.37 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -73.3 -48.31 0.27 Allowed 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.385 1.203 . . . . 0.0 110.901 -174.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -85.05 6.28 26.02 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.557 -0.714 . . . . 0.0 111.341 -174.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.92 59.79 4.04 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.983 -1.073 . . . . 0.0 110.669 -176.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.733 ' HA ' HG12 ' A' ' 176' ' ' VAL . 64.5 t80 -78.35 118.75 20.83 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.54 -0.725 . . . . 0.0 109.959 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -130.1 159.98 35.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.811 -0.556 . . . . 0.0 110.289 -175.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 66.7 t -124.01 146.29 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 121.272 0.558 . . . . 0.0 110.087 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.0 p -156.95 169.09 25.59 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.218 0.532 . . . . 0.0 109.757 174.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.43 ' CE2' HG12 ' A' ' 172' ' ' ILE . 36.4 m-85 . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.7 -0.625 . . . . 0.0 109.792 -177.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.883 0 CA-C-O 121.227 0.537 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 46.6 p -60.12 -34.05 72.98 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.698 -0.626 . . . . 0.0 110.117 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.585 ' CE3' HD11 ' A' ' 162' ' ' LEU . 64.3 p-90 -170.54 148.0 3.01 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.817 -0.552 . . . . 0.0 109.867 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 15.1 t -142.12 142.41 32.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.777 -0.577 . . . . 0.0 110.063 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.443 ' HB2' HD12 ' A' ' 162' ' ' LEU . 61.0 t80 -125.52 140.08 53.07 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.487 -0.758 . . . . 0.0 110.538 -172.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.2 t -110.01 123.09 49.04 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.863 176.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 61.6 m -70.58 -37.11 73.89 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.763 -0.586 . . . . 0.0 110.503 -176.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -59.28 -34.23 72.03 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.516 -0.74 . . . . 0.0 110.533 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.6 mt -104.75 -11.02 17.04 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.628 -0.67 . . . . 0.0 110.889 -175.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 62.8 tttt 59.86 52.52 5.32 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.063 -1.023 . . . . 0.0 109.735 177.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -145.72 152.99 40.48 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.632 -175.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.679 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.61 137.73 53.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.744 -0.598 . . . . 0.0 110.203 -176.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -117.27 132.81 56.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.54 -0.725 . . . . 0.0 109.283 175.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.1 p -138.31 158.47 44.22 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.983 -175.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -104.53 142.77 34.03 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.456 0.646 . . . . 0.0 110.11 172.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.433 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.2 tt -51.28 147.48 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 CA-C-O 121.655 0.74 . . . . 0.0 112.117 -173.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.47 9.89 5.36 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.543 -0.723 . . . . 0.0 112.481 177.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -96.51 155.12 16.9 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.996 -1.065 . . . . 0.0 110.93 175.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 84.1 m -84.03 126.19 32.81 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.646 -0.659 . . . . 0.0 110.841 -176.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' CYS . . . . . 0.679 ' SG ' HD21 ' A' ' 162' ' ' LEU . 42.8 t -113.38 90.23 16.68 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.603 -0.685 . . . . 0.0 110.137 174.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.432 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 15.3 Cg_exo -65.9 130.81 25.46 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.298 1.157 . . . . 0.0 110.449 177.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.43 HG12 ' CE2' ' A' ' 142' ' ' PHE . 93.8 mt -124.21 139.39 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.696 -0.628 . . . . 0.0 109.408 176.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -108.95 134.35 51.74 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.613 -0.68 . . . . 0.0 110.664 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.607 HG21 ' CE1' ' A' ' 138' ' ' PHE . 49.6 mm -95.3 135.14 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.637 -0.664 . . . . 0.0 109.612 172.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -118.62 130.36 55.83 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.461 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.733 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.5 m -136.36 159.72 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.523 -0.736 . . . . 0.0 109.971 175.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 80.7 mmm -77.23 -40.21 45.75 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.751 -0.593 . . . . 0.0 110.054 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.5 p -135.15 143.26 45.05 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.79 -0.569 . . . . 0.0 109.826 177.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.9 Cg_exo -55.58 139.92 83.08 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 O-C-N 123.145 1.076 . . . . 0.0 110.859 -172.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.614 ' HB3' HD21 ' A' ' 288' ' ' LEU . 25.5 Cg_endo -64.88 169.16 12.17 Favored 'Trans proline' 0 N--CA 1.487 1.095 0 O-C-N 123.127 1.067 . . . . 0.0 110.687 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -61.12 155.85 48.43 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 O-C-N 123.379 1.199 . . . . 0.0 110.496 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -75.3 139.4 42.46 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.656 -0.652 . . . . 0.0 109.931 175.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.76 -25.05 28.99 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 -175.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.14 150.81 2.24 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.355 -1.085 . . . . 0.0 111.391 178.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.79 155.92 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.665 -0.647 . . . . 0.0 109.897 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.652 HD11 ' CD2' ' A' ' 251' ' ' TYR . 74.0 mt -108.78 135.25 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.727 ' HG2' HD22 ' A' ' 248' ' ' LEU . 54.1 mtt180 -114.97 147.71 39.7 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -174.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.64 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -141.36 128.14 20.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.386 -0.821 . . . . 0.0 110.405 173.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.402 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 31.6 ttp -137.23 140.25 30.4 Favored Pre-proline 0 N--CA 1.496 1.864 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.062 -177.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.562 ' HD3' HD12 ' A' ' 226' ' ' ILE . 72.9 Cg_endo -91.5 138.2 2.13 Favored 'Trans proline' 0 C--N 1.32 -0.957 0 C-N-CA 121.08 1.187 . . . . 0.0 110.858 177.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.461 HG12 ' CZ ' ' A' ' 244' ' ' ARG . 35.0 m -147.91 154.9 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.546 -0.721 . . . . 0.0 109.924 174.117 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.626 ' HA ' HG22 ' A' ' 282' ' ' ILE . 82.5 m-85 -60.4 168.52 2.05 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.395 -0.816 . . . . 0.0 110.513 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.46 ' HA ' HD12 ' A' ' 283' ' ' LEU . 68.8 tttt -84.08 -60.11 2.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.588 -0.695 . . . . 0.0 110.76 -175.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 43.1 mttp -80.16 151.68 29.62 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.54 -0.725 . . . . 0.0 110.305 -175.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.451 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.76 -38.36 72.34 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.384 -0.823 . . . . 0.0 110.633 -176.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -56.39 -24.52 45.22 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.386 -0.821 . . . . 0.0 110.584 -177.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.419 ' HB3' ' CG ' ' A' ' 192' ' ' TYR . 96.6 m-70 -109.97 -20.52 12.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.466 -0.771 . . . . 0.0 111.21 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.451 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -67.41 -20.2 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.194 -0.941 . . . . 0.0 110.595 -176.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 74.4 p -79.38 -16.92 55.46 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.524 -0.735 . . . . 0.0 110.767 175.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.45 135.1 33.64 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.348 -0.845 . . . . 0.0 110.064 173.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.414 HG21 ' O ' ' A' ' 242' ' ' THR . 62.0 t -73.38 140.97 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.564 -0.71 . . . . 0.0 110.348 178.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.523 HG22 ' CE1' ' A' ' 192' ' ' TYR . 65.7 t -84.89 140.05 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.594 -0.691 . . . . 0.0 109.506 172.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -134.91 -170.28 2.53 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.53 -0.731 . . . . 0.0 110.99 -169.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 81.3 mtm-85 -95.36 157.06 16.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.842 -0.536 . . . . 0.0 110.424 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.599 ' HG ' ' HG ' ' A' ' 273' ' ' CYS . 58.8 m . . . . . 0 N--CA 1.497 1.909 0 O-C-N 121.651 -0.656 . . . . 0.0 109.475 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.816 HD21 ' CE ' ' A' ' 277' ' ' MET . 61.9 tp . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 120.875 0.369 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.562 HD12 ' HD3' ' A' ' 190' ' ' PRO . 82.2 mt -102.21 136.75 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 120.329 -0.548 . . . . 0.0 109.685 177.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 22.2 mtp-105 -131.75 157.23 44.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.758 -0.589 . . . . 0.0 110.157 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.486 HG23 HG21 ' A' ' 247' ' ' VAL . 99.3 t -104.8 146.5 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.737 -0.602 . . . . 0.0 110.042 176.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -118.9 123.65 45.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.768 -0.583 . . . . 0.0 110.473 172.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 96.31 23.32 17.1 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 168.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -135.0 108.82 8.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.369 -1.077 . . . . 0.0 110.142 174.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 27.3 t -62.88 -15.14 53.73 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.609 -0.682 . . . . 0.0 111.318 -177.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -99.35 9.91 42.42 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.29 -0.881 . . . . 0.0 111.552 -177.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.46 124.49 20.51 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.092 -1.005 . . . . 0.0 110.235 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -139.78 158.05 44.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.794 -0.566 . . . . 0.0 109.678 177.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -117.98 150.72 38.79 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.546 -0.721 . . . . 0.0 110.793 -175.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.07 159.95 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.819 -0.551 . . . . 0.0 110.108 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -120.0 130.03 54.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.792 -0.567 . . . . 0.0 110.299 177.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -63.77 130.07 94.18 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.653 -0.655 . . . . 0.0 109.784 178.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -65.97 -28.35 49.94 Favored 'Trans proline' 0 C--N 1.316 -1.168 0 O-C-N 123.042 1.022 . . . . 0.0 110.97 -170.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.8 mt -101.14 -50.5 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.465 -0.772 . . . . 0.0 111.019 -168.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.414 ' O ' HG21 ' A' ' 201' ' ' VAL . 13.0 p -105.34 12.15 32.0 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.338 -0.851 . . . . 0.0 111.872 -175.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 72.37 -4.92 17.22 Favored Glycine 0 N--CA 1.496 2.667 0 O-C-N 121.013 -1.055 . . . . 0.0 111.968 172.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.461 ' CZ ' HG12 ' A' ' 191' ' ' VAL . 22.1 mmt180 -46.0 142.07 2.87 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 119.163 1.482 . . . . 0.0 112.389 -175.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -104.25 143.35 33.08 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.674 -0.641 . . . . 0.0 110.204 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.1 p -154.71 160.04 41.1 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.608 -0.682 . . . . 0.0 110.213 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.486 HG21 HG23 ' A' ' 228' ' ' VAL . 8.5 p -123.01 148.19 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.707 -0.621 . . . . 0.0 109.779 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.727 HD22 ' HG2' ' A' ' 187' ' ' ARG . 83.0 mt -129.82 154.69 47.0 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 120.204 -0.599 . . . . 0.0 109.931 -174.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.43 HG13 ' C ' ' A' ' 248' ' ' LEU . 32.1 m -150.69 151.81 31.15 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.783 -0.573 . . . . 0.0 109.816 174.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -70.94 139.46 36.19 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 O-C-N 123.267 1.141 . . . . 0.0 110.029 177.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.652 ' CD2' HD11 ' A' ' 186' ' ' ILE . 10.2 t80 -79.59 122.16 26.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.519 -0.738 . . . . 0.0 110.07 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -100.08 160.09 28.08 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.706 -0.621 . . . . 0.0 110.184 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -58.95 160.08 19.46 Favored 'Trans proline' 0 N--CA 1.488 1.174 0 O-C-N 123.285 1.15 . . . . 0.0 110.457 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.17 150.05 76.32 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 O-C-N 123.276 1.145 . . . . 0.0 110.613 -177.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -60.95 149.56 36.15 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.609 -0.682 . . . . 0.0 110.189 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.84 127.21 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.496 -0.752 . . . . 0.0 110.148 -170.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.29 -10.18 56.46 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 9.4 t -145.41 175.39 10.35 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.25 -1.147 . . . . 0.0 110.619 175.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -110.03 13.09 23.42 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.617 -0.677 . . . . 0.0 111.883 -167.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -120.84 168.03 11.89 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.141 -0.974 . . . . 0.0 111.177 -177.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 93.4 m -117.87 147.56 42.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.793 -0.567 . . . . 0.0 109.837 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 32.7 m -117.78 136.14 53.59 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.567 -0.708 . . . . 0.0 110.945 -175.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 57.9 t -130.44 137.18 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 171.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 74.0 mt -104.88 120.94 42.63 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.512 -0.742 . . . . 0.0 110.004 -173.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.64 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 5.9 m-30 -105.55 150.62 25.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.688 -0.633 . . . . 0.0 110.662 -177.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -136.56 142.99 43.42 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -113.31 131.93 55.76 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.584 -0.697 . . . . 0.0 110.48 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 268' ' ' MET . . . . . 0.436 ' HG3' HD12 ' A' ' 225' ' ' LEU . 5.0 ppp? -101.28 9.43 41.75 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.657 -0.652 . . . . 0.0 111.963 -176.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 269' ' ' CYS . . . . . 0.549 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.8 OUTLIER -144.6 163.45 33.88 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.115 -0.991 . . . . 0.0 110.076 171.417 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.654 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.9 p30 -121.34 163.97 17.8 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.442 0.639 . . . . 0.0 110.434 -177.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 271' ' ' SER . . . . . 0.426 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 50.4 m -58.22 -34.07 70.0 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.44 -0.788 . . . . 0.0 111.058 -163.116 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 49.6 p -103.62 15.05 29.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.39 -0.819 . . . . 0.0 111.844 -163.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 273' ' ' CYS . . . . . 0.599 ' HG ' ' HG ' ' A' ' 205' ' ' CYS . 30.5 p -94.86 118.09 31.21 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.11 -0.994 . . . . 0.0 110.585 177.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 60.1 t -64.24 139.9 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.42 -0.8 . . . . 0.0 110.332 -169.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.22 -5.17 58.98 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.0 -95.6 0.75 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 172.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 277' ' ' MET . . . . . 0.816 ' CE ' HD21 ' A' ' 225' ' ' LEU . 15.9 mmt -63.04 -34.12 76.89 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.699 -0.883 . . . . 0.0 110.304 177.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.4 p30 43.38 48.1 5.92 Favored 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 176.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 36.2 mtt180 54.73 29.46 11.76 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.356 -0.84 . . . . 0.0 111.2 175.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -120.07 105.06 43.0 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.58 -0.7 . . . . 0.0 110.078 175.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.77 147.6 91.62 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 O-C-N 123.128 1.067 . . . . 0.0 110.481 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.626 HG22 ' HA ' ' A' ' 192' ' ' TYR . 45.4 pt -132.02 178.0 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.779 0.8 . . . . 0.0 111.011 -175.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 193' ' ' LYS . 30.4 mt -124.42 149.88 46.26 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.698 HD12 ' CE1' ' A' ' 301' ' ' PHE . 79.9 mt -115.33 130.1 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.245 177.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.519 HG23 ' SG ' ' A' ' 300' ' ' CYS . 80.9 mt -109.76 126.39 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -176.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 57.5 t -118.86 126.78 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.6 p -125.25 153.71 42.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.603 -0.686 . . . . 0.0 110.579 -173.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.614 HD21 ' HB3' ' A' ' 180' ' ' PRO . 25.0 tp -103.97 125.87 50.67 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 169.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.661 ' OE2' HG13 ' A' ' 295' ' ' VAL . 73.9 mm-40 -131.24 149.92 52.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.885 -0.509 . . . . 0.0 109.882 -173.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.728 ' CG2' HD11 ' A' ' 296' ' ' LEU . 74.4 p -89.86 159.36 17.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.629 -0.669 . . . . 0.0 109.774 177.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -55.96 -26.07 46.53 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.582 -0.699 . . . . 0.0 110.823 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -87.27 9.68 19.53 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.519 -0.738 . . . . 0.0 111.783 -174.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 87.51 20.19 52.32 Favored Glycine 0 N--CA 1.495 2.606 0 O-C-N 121.089 -1.007 . . . . 0.0 110.731 170.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -108.02 140.26 41.44 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.283 -1.127 . . . . 0.0 110.175 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.661 HG13 ' OE2' ' A' ' 289' ' ' GLU . 60.0 t -89.55 132.56 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.587 -0.696 . . . . 0.0 110.067 -174.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.728 HD11 ' CG2' ' A' ' 290' ' ' THR . 96.2 mt -99.97 -40.1 7.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.671 -0.643 . . . . 0.0 110.489 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -161.67 154.83 25.91 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -178.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 47.7 mtp180 -134.9 135.15 41.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.669 -0.9 . . . . 0.0 110.746 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 -135.18 158.03 45.4 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.609 -0.682 . . . . 0.0 109.958 172.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 300' ' ' CYS . . . . . 0.519 ' SG ' HG23 ' A' ' 285' ' ' ILE . 85.9 m -144.29 153.83 42.43 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.504 -0.747 . . . . 0.0 110.745 -176.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.698 ' CE1' HD12 ' A' ' 284' ' ' ILE . 49.3 p90 -144.96 162.17 37.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.705 -0.622 . . . . 0.0 110.05 174.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.45 ' HA ' HD23 ' A' ' 283' ' ' LEU . 82.1 tt0 -104.84 135.36 46.35 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.479 -0.763 . . . . 0.0 110.198 -176.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -120.06 142.93 48.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.626 -0.671 . . . . 0.0 110.687 -170.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -138.49 138.82 38.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.795 -0.565 . . . . 0.0 109.795 173.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.654 HG21 ' HA ' ' A' ' 270' ' ' ASN . 78.7 mt -108.75 122.89 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.544 -0.723 . . . . 0.0 109.619 177.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.9 p -145.36 170.56 16.1 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.66 -0.65 . . . . 0.0 110.69 -171.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -72.52 -40.12 67.05 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.613 -0.68 . . . . 0.0 110.708 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.8 t -127.95 86.43 58.17 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.591 -0.693 . . . . 0.0 110.484 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -55.91 -29.21 71.97 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 O-C-N 123.134 1.07 . . . . 0.0 110.899 174.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.48 -37.98 93.09 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.014 -1.635 . . . . 0.0 109.014 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -73.28 -40.02 64.9 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.748 -0.854 . . . . 0.0 109.751 -173.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -69.44 -39.78 77.6 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.163 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -61.86 -45.56 93.23 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.306 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 23.7 ttpt -64.11 -39.22 93.58 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.585 -0.697 . . . . 0.0 110.47 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.66 -50.71 71.4 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.495 -0.753 . . . . 0.0 110.426 -174.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 2.9 p30 . . . . . 0 N--CA 1.495 1.789 0 O-C-N 121.45 -0.781 . . . . 0.0 110.105 -178.254 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.4 t . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 121.099 0.476 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -95.42 24.39 5.17 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.68 -0.637 . . . . 0.0 110.64 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 54.6 m -72.71 125.18 26.88 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.567 -0.708 . . . . 0.0 110.337 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -70.97 144.98 50.33 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.723 -0.611 . . . . 0.0 110.291 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -158.28 102.07 1.71 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.603 -0.686 . . . . 0.0 110.164 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -58.77 -39.96 77.1 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 O-C-N 123.177 1.093 . . . . 0.0 110.691 -178.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.12 -155.15 45.6 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 177.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -72.75 -45.93 0.47 Allowed 'Trans proline' 0 N--CA 1.486 1.067 0 O-C-N 123.33 1.174 . . . . 0.0 111.004 -174.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -89.1 9.1 26.65 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.615 -0.678 . . . . 0.0 111.453 -172.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.71 61.63 3.01 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.975 -1.078 . . . . 0.0 110.732 -176.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.619 ' HA ' HG12 ' A' ' 176' ' ' VAL . 46.6 t80 -77.92 118.2 20.0 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.648 -0.657 . . . . 0.0 109.83 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -130.04 160.04 34.9 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.312 0.577 . . . . 0.0 110.178 -177.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 78.6 t -124.31 148.78 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.69 -0.631 . . . . 0.0 109.775 176.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.4 p -157.1 171.02 21.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.813 -0.554 . . . . 0.0 109.928 176.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.422 ' CE1' HG12 ' A' ' 172' ' ' ILE . 64.8 m-85 . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.821 -0.549 . . . . 0.0 109.64 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 121.145 0.497 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.4 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 76.1 p -60.06 -33.88 72.67 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.668 -0.645 . . . . 0.0 109.928 174.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.425 ' CE3' HD11 ' A' ' 162' ' ' LEU . 67.5 p-90 -170.06 148.02 3.33 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.964 -0.46 . . . . 0.0 109.784 178.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.9 t -142.04 142.37 32.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.789 -0.57 . . . . 0.0 109.974 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.414 ' HB2' HD12 ' A' ' 162' ' ' LEU . 62.9 t80 -125.76 140.12 52.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.513 -0.742 . . . . 0.0 110.559 -172.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 31.2 t -110.43 121.07 44.41 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.727 174.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 69.4 m -71.42 -36.45 71.31 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.702 -0.624 . . . . 0.0 110.489 -176.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -58.76 -33.83 70.72 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.586 -0.696 . . . . 0.0 110.526 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 53.9 mt -104.82 -11.33 16.84 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.734 -0.604 . . . . 0.0 110.851 -176.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt 59.87 51.84 5.76 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.045 -1.034 . . . . 0.0 109.825 176.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -147.14 152.86 39.13 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.696 -0.628 . . . . 0.0 110.714 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.425 HD11 ' CE3' ' A' ' 153' ' ' TRP . 14.6 tp -126.65 137.88 53.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.793 -0.567 . . . . 0.0 110.375 -173.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -117.54 133.32 56.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.537 -0.727 . . . . 0.0 109.462 175.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.1 p -138.3 158.31 44.54 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 120.111 -0.636 . . . . 0.0 111.104 -175.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -104.69 141.59 36.19 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.588 -0.695 . . . . 0.0 110.33 172.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.437 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 18.0 tt -54.6 149.43 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.529 -0.732 . . . . 0.0 111.552 -173.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.22 10.01 5.22 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.593 -0.692 . . . . 0.0 112.515 178.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -96.4 155.13 16.89 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.958 -1.089 . . . . 0.0 110.784 174.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 70.2 m -79.96 126.09 30.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.702 -0.624 . . . . 0.0 110.61 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 42.3 t -115.43 90.23 24.54 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.624 -0.673 . . . . 0.0 110.22 174.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -69.99 125.41 11.99 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.266 1.14 . . . . 0.0 110.521 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.643 HD12 ' CD2' ' A' ' 265' ' ' TYR . 86.4 mt -122.22 143.43 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.594 -0.692 . . . . 0.0 109.575 173.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLN . . . . . 0.422 ' NE2' ' CE1' ' A' ' 260' ' ' PHE . 95.4 mt-30 -109.14 136.64 48.3 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.611 -0.681 . . . . 0.0 110.707 -175.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.3 mm -95.23 135.02 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.674 -0.641 . . . . 0.0 109.744 169.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 35.2 tttm -117.05 130.27 56.55 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.509 -0.745 . . . . 0.0 110.581 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.619 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.0 m -136.01 159.8 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.63 -0.669 . . . . 0.0 109.797 174.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 79.0 mmm -81.3 -45.4 16.27 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.62 -0.675 . . . . 0.0 110.151 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.417 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.0 p -126.52 143.18 45.37 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.724 -0.61 . . . . 0.0 109.684 177.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.5 Cg_exo -55.5 139.74 82.54 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 O-C-N 123.205 1.108 . . . . 0.0 110.902 -171.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.745 ' HB3' HD21 ' A' ' 288' ' ' LEU . 36.0 Cg_endo -67.51 170.01 14.53 Favored 'Trans proline' 0 N--CA 1.487 1.128 0 O-C-N 123.226 1.119 . . . . 0.0 110.542 177.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -60.26 155.77 44.2 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 123.326 1.172 . . . . 0.0 110.622 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -78.16 138.26 38.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.599 -0.688 . . . . 0.0 109.931 175.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.24 -24.97 30.08 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -174.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.13 151.2 2.09 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.381 -1.07 . . . . 0.0 111.48 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 35.4 m -129.75 156.03 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.777 -0.577 . . . . 0.0 109.853 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.693 HD11 ' HD2' ' A' ' 251' ' ' TYR . 53.7 mt -107.34 134.9 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 178.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.736 ' HG2' HD22 ' A' ' 248' ' ' LEU . 70.8 mtt180 -114.94 141.34 48.09 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -174.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.42 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -138.51 123.72 19.21 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.456 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 44.5 ttp -137.34 140.61 31.22 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.773 -0.579 . . . . 0.0 111.222 -175.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.637 ' HD3' HD12 ' A' ' 226' ' ' ILE . 71.7 Cg_endo -90.98 138.22 2.34 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 O-C-N 123.243 1.128 . . . . 0.0 110.717 176.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.434 HG13 ' C ' ' A' ' 190' ' ' PRO . 34.7 m -147.48 154.84 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.51 -0.744 . . . . 0.0 110.134 173.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.636 ' HA ' HG22 ' A' ' 282' ' ' ILE . 88.3 m-85 -61.33 166.67 3.71 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.488 -0.758 . . . . 0.0 110.429 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -84.67 -59.96 2.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.678 -0.639 . . . . 0.0 110.849 -175.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -80.08 152.24 29.44 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.656 -0.653 . . . . 0.0 110.319 -175.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.455 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.81 -38.58 72.78 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.333 -0.854 . . . . 0.0 110.72 -175.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -56.58 -24.57 48.28 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.539 -0.726 . . . . 0.0 110.567 -177.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.433 ' HB3' ' CD1' ' A' ' 192' ' ' TYR . 47.8 m80 -109.89 -20.46 12.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.565 -0.71 . . . . 0.0 111.116 -178.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.1 p -67.56 -20.19 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.145 -0.972 . . . . 0.0 110.606 -176.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 69.2 p -79.35 -17.01 55.37 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.535 -0.728 . . . . 0.0 110.678 174.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.41 136.93 32.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.357 -0.84 . . . . 0.0 110.029 174.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.8 t -73.02 146.03 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.623 -0.673 . . . . 0.0 110.228 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.581 HG23 HH12 ' A' ' 244' ' ' ARG . 60.8 t -84.95 136.16 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.595 -0.69 . . . . 0.0 109.191 172.041 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.0 pttp -134.95 -170.18 2.51 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.508 -0.745 . . . . 0.0 111.073 -167.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -95.1 159.32 15.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.75 -0.594 . . . . 0.0 110.501 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.563 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 59.9 m . . . . . 0 N--CA 1.497 1.888 0 O-C-N 121.627 -0.67 . . . . 0.0 109.281 175.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.405 ' HA ' ' CG ' ' A' ' 268' ' ' MET . 55.9 tp . . . . . 0 N--CA 1.497 1.878 0 CA-C-O 120.831 0.348 . . . . 0.0 110.325 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.637 HD12 ' HD3' ' A' ' 190' ' ' PRO . 80.9 mt -104.17 136.75 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.821 -0.549 . . . . 0.0 109.818 178.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -132.56 159.17 40.23 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.716 -0.615 . . . . 0.0 110.111 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.589 HG23 HG21 ' A' ' 247' ' ' VAL . 70.5 t -105.59 146.74 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.663 -0.648 . . . . 0.0 110.144 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -121.78 130.05 53.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.715 -0.616 . . . . 0.0 110.303 171.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.8 20.58 21.19 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.526 -1.029 . . . . 0.0 110.526 170.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -141.27 105.16 4.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.307 -1.114 . . . . 0.0 109.988 174.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 93.1 p -63.6 -15.13 57.3 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.603 -0.686 . . . . 0.0 111.224 -177.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -97.24 9.96 40.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.303 -0.873 . . . . 0.0 111.187 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.97 130.35 45.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.205 -0.934 . . . . 0.0 110.081 176.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -139.77 156.25 46.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.774 -0.579 . . . . 0.0 109.719 177.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.423 ' CD1' ' HB ' ' A' ' 247' ' ' VAL . 90.4 m-85 -117.96 150.66 38.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.513 -0.742 . . . . 0.0 110.617 -176.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.08 159.89 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.902 -0.499 . . . . 0.0 110.224 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -119.65 130.08 54.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.771 -0.581 . . . . 0.0 110.113 176.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -61.72 126.04 86.09 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.657 -0.652 . . . . 0.0 109.754 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -65.01 -29.15 57.27 Favored 'Trans proline' 0 C--N 1.317 -1.123 0 O-C-N 123.201 1.106 . . . . 0.0 110.782 -172.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.9 mt -104.15 -50.25 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.553 -0.717 . . . . 0.0 110.943 -170.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 20.3 p -105.26 12.25 32.02 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.372 -0.83 . . . . 0.0 111.945 -170.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 82.31 -23.24 5.55 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 120.97 -1.081 . . . . 0.0 111.85 168.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.581 HH12 HG23 ' A' ' 202' ' ' VAL . 25.9 mmt180 -45.79 142.07 2.69 Favored 'General case' 0 N--CA 1.505 2.325 0 CA-C-N 118.572 1.186 . . . . 0.0 112.569 -168.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -105.12 146.17 29.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.637 -0.664 . . . . 0.0 110.093 174.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 78.8 p -154.79 159.92 40.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.584 -0.698 . . . . 0.0 110.404 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.589 HG21 HG23 ' A' ' 228' ' ' VAL . 8.3 p -122.95 148.1 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.746 -0.596 . . . . 0.0 109.69 178.054 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.736 HD22 ' HG2' ' A' ' 187' ' ' ARG . 81.6 mt -129.69 154.58 47.02 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.797 -175.338 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.443 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.4 m -151.07 151.75 30.14 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.822 -0.549 . . . . 0.0 110.008 175.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -71.09 139.08 34.9 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 O-C-N 123.237 1.125 . . . . 0.0 109.999 177.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.693 ' HD2' HD11 ' A' ' 186' ' ' ILE . 61.8 t80 -76.04 123.9 26.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.488 -0.758 . . . . 0.0 110.219 176.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -99.95 160.09 28.15 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.668 -0.645 . . . . 0.0 110.029 176.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -58.76 159.72 19.96 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 O-C-N 123.154 1.081 . . . . 0.0 110.42 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.03 149.98 76.06 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 O-C-N 123.26 1.137 . . . . 0.0 110.522 -176.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -61.71 148.2 43.56 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.648 -0.658 . . . . 0.0 110.138 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.9 t -69.81 127.18 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.586 -0.696 . . . . 0.0 110.233 -170.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.93 -10.13 55.45 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 10.2 t -144.63 174.42 10.98 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.148 -1.207 . . . . 0.0 110.648 175.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -108.27 13.14 25.97 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.613 -0.679 . . . . 0.0 111.83 -167.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.422 ' CE1' ' NE2' ' A' ' 173' ' ' GLN . 40.2 p90 -123.88 168.17 13.13 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.096 -1.003 . . . . 0.0 111.148 -175.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 71.9 m -117.73 145.23 44.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.799 -0.563 . . . . 0.0 109.75 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 28.4 m -115.28 137.41 52.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.615 -0.678 . . . . 0.0 110.882 -174.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 57.8 t -128.78 136.99 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 172.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 63.9 mt -104.73 120.47 41.43 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.534 -0.729 . . . . 0.0 109.873 -174.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.643 ' CD2' HD12 ' A' ' 172' ' ' ILE . 3.8 m-85 -98.41 156.19 16.87 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.627 -0.67 . . . . 0.0 110.842 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -136.49 142.89 43.56 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 171.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -111.89 132.02 54.99 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.61 -0.681 . . . . 0.0 110.397 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 268' ' ' MET . . . . . 0.405 ' CG ' ' HA ' ' A' ' 225' ' ' LEU . 5.2 ppp? -102.73 6.77 39.63 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.659 -0.651 . . . . 0.0 111.874 -177.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 269' ' ' CYS . . . . . 0.661 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.6 OUTLIER -144.73 160.45 41.2 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.985 -1.072 . . . . 0.0 109.908 171.822 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.522 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.3 p30 -119.77 163.49 17.38 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.459 0.647 . . . . 0.0 110.506 -178.153 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 271' ' ' SER . . . . . 0.426 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 50.1 m -58.63 -33.09 69.66 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.482 -0.761 . . . . 0.0 111.028 -163.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 50.0 p -100.77 12.68 37.03 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.431 -0.793 . . . . 0.0 111.954 -163.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 273' ' ' CYS . . . . . 0.563 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 29.6 p -94.69 117.99 31.02 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.091 -1.006 . . . . 0.0 110.625 177.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.4 t -64.42 139.78 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.561 -0.712 . . . . 0.0 110.356 -169.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.37 -5.02 60.5 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -125.06 -100.33 1.28 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 170.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 277' ' ' MET . . . . . 0.426 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.4 mmm -64.87 -31.44 72.67 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.693 -0.887 . . . . 0.0 110.355 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.8 p30 43.1 52.11 5.45 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 175.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 54.85 27.0 8.37 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.328 -0.858 . . . . 0.0 111.182 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 36.6 mtt180 -118.77 106.36 44.08 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.56 -0.712 . . . . 0.0 110.046 175.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.38 149.19 82.9 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 O-C-N 123.015 1.008 . . . . 0.0 110.691 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.636 HG22 ' HA ' ' A' ' 192' ' ' TYR . 44.6 pt -131.93 -179.7 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-O 121.752 0.786 . . . . 0.0 110.742 -177.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 302' ' ' GLU . 34.7 mt -124.33 149.93 46.03 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.56 HD12 ' CE1' ' A' ' 301' ' ' PHE . 77.7 mt -113.83 128.75 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.125 176.246 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.627 HG23 ' SG ' ' A' ' 300' ' ' CYS . 80.0 mt -109.84 126.46 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -175.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 59.2 t -118.88 126.69 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.2 p -125.36 154.7 41.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.683 -0.635 . . . . 0.0 110.516 -175.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.745 HD21 ' HB3' ' A' ' 180' ' ' PRO . 28.8 tp -102.61 126.42 49.68 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 168.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.746 ' OE2' HG13 ' A' ' 295' ' ' VAL . 74.1 mm-40 -131.61 150.3 52.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.845 -0.534 . . . . 0.0 109.937 -171.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.696 ' CG2' HD11 ' A' ' 296' ' ' LEU . 76.8 p -90.03 157.43 17.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.67 -0.644 . . . . 0.0 109.909 177.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -56.08 -26.1 48.12 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.587 -0.696 . . . . 0.0 110.932 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -91.03 11.86 21.65 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.451 -0.78 . . . . 0.0 111.745 -174.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 90.25 20.15 43.15 Favored Glycine 0 N--CA 1.494 2.541 0 C-N-CA 120.139 -1.029 . . . . 0.0 110.922 168.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -109.15 140.17 43.09 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.3 -1.118 . . . . 0.0 110.062 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.746 HG13 ' OE2' ' A' ' 289' ' ' GLU . 59.2 t -91.64 133.39 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.558 -0.714 . . . . 0.0 110.234 -174.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.696 HD11 ' CG2' ' A' ' 290' ' ' THR . 93.9 mt -99.97 -40.0 7.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.757 -0.589 . . . . 0.0 110.586 -179.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -159.29 155.41 26.5 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.698 ' CZ ' HG11 ' A' ' 295' ' ' VAL . 57.2 mtt85 -135.06 136.28 41.91 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.764 -0.845 . . . . 0.0 110.349 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -136.58 153.99 50.81 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.44 -0.787 . . . . 0.0 110.19 168.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 300' ' ' CYS . . . . . 0.627 ' SG ' HG23 ' A' ' 285' ' ' ILE . 95.8 m -143.29 154.01 43.35 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.545 -0.722 . . . . 0.0 110.626 -175.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.56 ' CE1' HD12 ' A' ' 284' ' ' ILE . 51.7 p90 -145.77 166.8 24.82 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.647 -0.658 . . . . 0.0 109.962 173.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.474 ' HA ' HD23 ' A' ' 283' ' ' LEU . 82.0 tt0 -104.92 135.62 45.93 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.421 -0.8 . . . . 0.0 110.193 -177.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -122.67 144.26 49.25 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.722 -169.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -138.08 138.94 39.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.747 -0.596 . . . . 0.0 109.694 173.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.661 HD13 ' O ' ' A' ' 269' ' ' CYS . 74.0 mt -107.42 122.83 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.548 -0.72 . . . . 0.0 109.735 176.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.8 p -145.27 169.71 17.7 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.7 -0.625 . . . . 0.0 110.647 -172.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -71.55 -40.11 70.24 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.626 -0.671 . . . . 0.0 110.648 -178.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.7 t -127.16 86.07 59.61 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.476 -0.765 . . . . 0.0 110.468 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -55.94 -28.16 67.15 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 O-C-N 123.251 1.132 . . . . 0.0 110.766 174.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -67.05 -37.8 92.11 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 177.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -72.76 -40.84 65.69 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.737 -0.86 . . . . 0.0 109.845 -173.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -69.5 -38.91 77.82 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.162 -178.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -61.81 -43.22 99.28 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.195 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 21.0 ttpp -64.18 -38.53 91.39 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.582 -0.699 . . . . 0.0 110.446 178.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -60.74 -50.52 73.13 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.507 -0.746 . . . . 0.0 110.46 -173.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 2.8 p30 . . . . . 0 N--CA 1.495 1.775 0 O-C-N 121.482 -0.761 . . . . 0.0 110.087 -179.12 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.7 t . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.097 0.475 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.7 p-10 -94.31 23.54 5.07 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.658 -0.651 . . . . 0.0 110.885 -178.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 54.0 m -72.35 125.15 26.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.471 -0.768 . . . . 0.0 110.212 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -70.53 144.92 51.17 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.602 -0.686 . . . . 0.0 110.401 -177.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.426 ' CE1' ' HA2' ' A' ' 134' ' ' GLY . 52.6 t80 -157.33 101.22 1.89 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.618 -0.676 . . . . 0.0 110.101 178.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.51 -39.94 78.76 Favored 'Trans proline' 0 N--CA 1.488 1.204 0 O-C-N 123.153 1.081 . . . . 0.0 110.952 -174.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.426 ' HA2' ' CE1' ' A' ' 132' ' ' TYR . . . 79.84 -155.11 38.52 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -74.18 -47.61 0.24 Allowed 'Trans proline' 0 C--N 1.317 -1.085 0 O-C-N 123.313 1.165 . . . . 0.0 110.846 -175.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -84.19 5.16 27.45 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.525 -0.734 . . . . 0.0 111.431 -175.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 54.01 59.97 3.92 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.898 -1.126 . . . . 0.0 110.681 -176.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.728 ' HA ' HG12 ' A' ' 176' ' ' VAL . 64.6 t80 -77.96 118.94 20.74 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.57 -0.706 . . . . 0.0 110.008 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -129.96 159.92 35.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.785 -0.572 . . . . 0.0 110.215 -175.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 71.9 t -123.65 146.66 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-O 121.443 0.639 . . . . 0.0 110.174 177.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 76.8 p -157.06 171.16 20.95 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 175.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.422 ' CE2' HG12 ' A' ' 172' ' ' ILE . 64.8 m-85 . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.706 -0.622 . . . . 0.0 109.916 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 121.117 0.484 . . . . 0.0 109.943 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 57.9 p -60.15 -34.09 73.07 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.773 -0.579 . . . . 0.0 110.118 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.547 ' CE3' HD11 ' A' ' 162' ' ' LEU . 66.9 p-90 -170.46 148.14 3.09 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.636 -0.665 . . . . 0.0 109.752 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 13.7 t -141.52 142.36 33.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.717 -0.614 . . . . 0.0 110.031 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -125.65 140.04 53.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.482 -0.761 . . . . 0.0 110.532 -172.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 32.8 t -109.82 122.31 47.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.783 -0.573 . . . . 0.0 109.785 175.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 65.1 m -70.66 -36.8 73.56 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.689 -0.632 . . . . 0.0 110.482 -177.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -58.79 -34.28 71.29 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.615 -0.678 . . . . 0.0 110.582 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 53.8 mt -104.8 -11.71 16.66 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.61 -0.681 . . . . 0.0 110.804 -176.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.0 tttm 59.82 52.18 5.59 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.14 -0.975 . . . . 0.0 109.732 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -145.86 152.88 40.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.714 -0.616 . . . . 0.0 110.562 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.669 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.5 tp -126.66 137.83 53.34 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.863 -0.523 . . . . 0.0 110.256 -175.137 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -116.96 133.86 55.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.557 -0.714 . . . . 0.0 109.319 174.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.9 p -138.29 158.46 44.25 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 120.036 -0.665 . . . . 0.0 110.979 -174.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -104.52 143.9 32.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.62 -0.675 . . . . 0.0 110.398 172.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 16.9 tt -52.47 147.77 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 CA-C-O 121.64 0.733 . . . . 0.0 111.841 -173.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.16 10.01 5.18 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.628 -0.67 . . . . 0.0 112.539 177.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 32.3 mmtt -96.52 155.13 16.9 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.04 -1.037 . . . . 0.0 110.788 175.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 85.6 m -84.31 126.21 32.98 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.666 -0.646 . . . . 0.0 110.676 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' CYS . . . . . 0.669 ' SG ' HD21 ' A' ' 162' ' ' LEU . 42.6 t -112.63 90.31 14.67 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.514 -0.741 . . . . 0.0 110.082 173.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -64.75 129.28 23.03 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 123.339 1.179 . . . . 0.0 110.445 176.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.422 HG12 ' CE2' ' A' ' 142' ' ' PHE . 95.4 mt -123.17 138.67 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.665 -0.647 . . . . 0.0 109.36 176.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -108.72 133.97 52.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.546 -0.722 . . . . 0.0 110.637 -176.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.59 HG21 ' CE1' ' A' ' 138' ' ' PHE . 49.5 mm -95.37 135.07 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.641 -0.662 . . . . 0.0 109.674 172.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -118.08 129.93 55.85 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.583 -0.698 . . . . 0.0 110.597 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.728 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.3 m -136.3 159.74 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.475 -0.766 . . . . 0.0 109.957 175.152 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 79.7 mmm -77.46 -40.37 43.43 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.745 -0.597 . . . . 0.0 110.018 177.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.0 p -134.1 143.21 46.22 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.78 -0.575 . . . . 0.0 109.793 177.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 33.2 Cg_exo -55.67 139.88 83.6 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 O-C-N 123.2 1.105 . . . . 0.0 110.86 -173.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.616 ' HB3' HD21 ' A' ' 288' ' ' LEU . 23.5 Cg_endo -64.5 168.18 13.54 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 O-C-N 123.23 1.121 . . . . 0.0 110.635 178.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -61.53 158.21 37.72 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 O-C-N 123.353 1.186 . . . . 0.0 110.413 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -77.76 137.9 38.71 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.667 -0.645 . . . . 0.0 109.889 175.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.53 -24.97 30.08 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -174.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.1 149.98 2.58 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.367 -1.078 . . . . 0.0 111.373 177.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.71 155.99 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.654 -0.654 . . . . 0.0 109.816 176.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.656 HD11 ' CD2' ' A' ' 251' ' ' TYR . 69.8 mt -108.46 136.21 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.745 ' HG2' HD22 ' A' ' 248' ' ' LEU . 36.5 mtp180 -114.89 146.11 41.46 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -175.015 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.629 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -140.6 127.56 20.68 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.439 -0.788 . . . . 0.0 110.337 172.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.405 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 25.0 ttm -137.2 139.36 27.87 Favored Pre-proline 0 N--CA 1.495 1.811 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.031 -177.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.503 ' HD3' HD12 ' A' ' 226' ' ' ILE . 72.6 Cg_endo -91.34 138.29 2.21 Favored 'Trans proline' 0 C--N 1.32 -0.972 0 O-C-N 123.288 1.152 . . . . 0.0 110.772 177.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.428 HG13 ' C ' ' A' ' 190' ' ' PRO . 34.7 m -147.24 154.89 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.518 -0.739 . . . . 0.0 110.059 174.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.631 ' HA ' HG22 ' A' ' 282' ' ' ILE . 77.3 m-85 -61.6 164.78 5.58 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.47 -0.769 . . . . 0.0 110.545 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.437 ' HA ' HD12 ' A' ' 283' ' ' LEU . 48.7 tttp -80.33 -60.02 2.48 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.625 -0.672 . . . . 0.0 110.843 -174.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -80.04 151.2 30.06 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.601 -0.687 . . . . 0.0 110.372 -175.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.453 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.44 -38.52 71.74 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.368 -0.832 . . . . 0.0 110.736 -175.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -56.49 -24.92 49.34 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.525 -0.735 . . . . 0.0 110.58 -176.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.42 ' HB3' ' CG ' ' A' ' 192' ' ' TYR . 63.2 m170 -110.05 -20.49 12.69 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.094 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.453 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -67.14 -20.22 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.157 -0.964 . . . . 0.0 110.564 -176.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 81.3 p -79.35 -17.08 55.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.502 -0.749 . . . . 0.0 110.777 175.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.25 135.65 33.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.342 -0.849 . . . . 0.0 110.09 173.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.99 142.97 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.682 -0.636 . . . . 0.0 110.22 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 60.2 t -84.93 138.82 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.529 -0.732 . . . . 0.0 109.257 172.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 14.0 pttt -134.77 -170.29 2.53 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.412 -0.805 . . . . 0.0 111.345 -168.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 74.4 mtm-85 -95.3 156.05 16.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.807 -0.558 . . . . 0.0 110.319 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.498 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 48.7 m . . . . . 0 N--CA 1.496 1.849 0 O-C-N 121.571 -0.706 . . . . 0.0 109.237 173.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.515 HD12 ' HG3' ' A' ' 268' ' ' MET . 41.3 tp . . . . . 0 N--CA 1.497 1.879 0 CA-C-O 120.824 0.345 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.503 HD12 ' HD3' ' A' ' 190' ' ' PRO . 84.3 mt -101.81 136.75 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.767 -0.583 . . . . 0.0 110.034 -176.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -125.65 158.11 35.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.692 -0.63 . . . . 0.0 110.135 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.462 HG23 HG21 ' A' ' 247' ' ' VAL . 90.3 t -104.44 146.6 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.701 -0.625 . . . . 0.0 109.844 172.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -118.74 128.13 54.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.629 -0.67 . . . . 0.0 110.4 170.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.11 20.93 21.99 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 168.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -139.37 105.05 5.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.313 -1.11 . . . . 0.0 110.034 174.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 44.2 m -63.49 -15.21 57.2 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.547 -0.721 . . . . 0.0 111.24 -176.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -100.01 8.02 44.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.223 -0.923 . . . . 0.0 111.621 -177.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.68 133.22 55.33 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.108 -0.995 . . . . 0.0 110.175 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -139.8 158.06 44.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.756 -0.59 . . . . 0.0 109.83 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -113.87 150.6 33.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.596 -0.69 . . . . 0.0 110.556 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.06 159.98 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.771 -0.58 . . . . 0.0 110.233 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -122.7 130.05 52.51 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.743 -0.598 . . . . 0.0 110.201 177.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -65.04 112.36 7.99 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.672 -0.643 . . . . 0.0 109.714 177.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -60.23 -25.55 80.37 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.107 1.056 . . . . 0.0 110.998 -172.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.8 mt -101.14 -50.32 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.368 -0.832 . . . . 0.0 110.824 -171.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 6.6 p -105.33 12.16 31.99 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.341 -0.85 . . . . 0.0 111.998 -172.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 82.29 -24.85 4.58 Favored Glycine 0 N--CA 1.497 2.742 0 O-C-N 121.007 -1.058 . . . . 0.0 111.813 170.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 23.8 mmt85 -45.81 142.13 2.67 Favored 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 118.54 1.17 . . . . 0.0 112.544 -168.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -108.51 145.08 35.28 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.626 -0.671 . . . . 0.0 110.047 174.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 77.3 p -154.84 159.91 40.87 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.572 -0.705 . . . . 0.0 110.487 178.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.462 HG21 HG23 ' A' ' 228' ' ' VAL . 8.5 p -123.01 148.07 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.77 -0.581 . . . . 0.0 109.655 178.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.745 HD22 ' HG2' ' A' ' 187' ' ' ARG . 78.8 mt -129.69 154.62 46.97 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.872 -173.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.438 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.9 m -150.69 151.82 31.16 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.819 -0.55 . . . . 0.0 109.858 174.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -71.02 139.49 35.99 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.173 1.091 . . . . 0.0 110.012 177.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.656 ' CD2' HD11 ' A' ' 186' ' ' ILE . 9.4 t80 -79.82 123.37 27.66 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.463 -0.773 . . . . 0.0 110.05 178.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -100.1 160.05 28.19 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.677 -0.64 . . . . 0.0 110.095 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -58.91 159.97 19.7 Favored 'Trans proline' 0 N--CA 1.487 1.118 0 O-C-N 123.298 1.157 . . . . 0.0 110.425 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -59.15 149.95 76.85 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.245 1.129 . . . . 0.0 110.614 -176.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -61.21 148.94 39.19 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.692 -0.63 . . . . 0.0 110.166 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.78 127.22 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.469 -0.769 . . . . 0.0 110.158 -170.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.92 -10.11 55.46 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 9.9 t -145.02 173.33 11.98 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.245 -1.15 . . . . 0.0 110.607 175.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -107.35 13.14 27.35 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.586 -0.696 . . . . 0.0 111.743 -168.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -120.01 168.0 11.61 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.167 -0.958 . . . . 0.0 111.164 -175.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 93.2 m -117.71 147.01 43.34 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.781 -0.574 . . . . 0.0 109.859 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 38.5 m -116.83 135.0 54.08 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.541 -0.724 . . . . 0.0 110.927 -175.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.4 t -129.66 137.12 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 171.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 70.1 mt -104.83 122.09 45.03 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.582 -0.699 . . . . 0.0 109.903 -173.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.629 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 6.6 m-30 -106.92 149.4 27.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.637 -0.664 . . . . 0.0 110.633 -178.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -136.63 142.95 43.27 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -111.04 131.55 54.97 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.575 -0.703 . . . . 0.0 110.499 -176.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 268' ' ' MET . . . . . 0.515 ' HG3' HD12 ' A' ' 225' ' ' LEU . 3.9 ppp? -96.79 2.87 52.38 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.708 -0.62 . . . . 0.0 112.119 -176.03 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 269' ' ' CYS . . . . . 0.656 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.8 OUTLIER -144.67 165.03 29.2 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.055 -1.028 . . . . 0.0 110.11 174.704 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.596 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.6 p30 -119.86 162.37 19.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.72 -0.612 . . . . 0.0 110.303 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 271' ' ' SER . . . . . 0.423 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 23.1 m -58.29 -33.47 69.49 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.468 -0.77 . . . . 0.0 110.983 -163.255 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 49.2 p -97.9 9.88 41.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.458 -0.776 . . . . 0.0 112.07 -163.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 273' ' ' CYS . . . . . 0.498 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 31.2 p -93.79 118.07 30.94 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.09 -1.006 . . . . 0.0 110.691 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 60.4 t -64.42 140.52 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.442 -0.786 . . . . 0.0 110.305 -170.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 100.74 -5.21 56.62 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 177.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.62 -99.16 0.88 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 170.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 277' ' ' MET . . . . . 0.423 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.2 mmm -63.85 -31.59 72.82 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.639 -0.918 . . . . 0.0 110.3 178.069 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.5 p30 43.84 50.56 6.92 Favored 'General case' 0 N--CA 1.504 2.234 0 CA-C-O 121.286 0.565 . . . . 0.0 112.521 175.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 22.0 mtt180 54.81 29.67 12.31 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.29 -0.881 . . . . 0.0 111.17 175.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -119.28 104.97 45.08 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.517 -0.739 . . . . 0.0 110.149 175.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.85 145.95 96.96 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 123.077 1.04 . . . . 0.0 110.522 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.631 HG22 ' HA ' ' A' ' 192' ' ' TYR . 45.6 pt -131.98 177.59 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 121.79 0.805 . . . . 0.0 111.132 -175.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 302' ' ' GLU . 30.1 mt -124.34 149.9 46.1 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.702 HD12 ' CE1' ' A' ' 301' ' ' PHE . 77.6 mt -115.03 129.91 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.213 177.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.526 HG23 ' SG ' ' A' ' 300' ' ' CYS . 82.3 mt -109.71 127.17 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -176.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 58.7 t -118.83 126.73 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.069 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.634 HG22 ' HG2' ' A' ' 298' ' ' ARG . 45.5 p -125.21 153.8 42.57 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.466 -174.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.616 HD21 ' HB3' ' A' ' 180' ' ' PRO . 27.1 tp -105.32 126.08 51.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.73 -0.606 . . . . 0.0 109.535 169.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.566 ' OE2' HG13 ' A' ' 295' ' ' VAL . 71.0 mm-40 -131.79 148.86 52.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.955 -0.466 . . . . 0.0 109.768 -174.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.81 ' CG2' HD11 ' A' ' 296' ' ' LEU . 54.4 p -89.88 161.68 15.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.641 -0.662 . . . . 0.0 109.98 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -55.99 -26.09 46.89 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.544 -0.723 . . . . 0.0 111.112 -174.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 40.8 p30 -91.6 10.25 28.85 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.379 -0.826 . . . . 0.0 111.923 -173.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.85 20.19 44.47 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 120.14 -1.028 . . . . 0.0 110.725 171.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -106.0 140.15 39.44 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.256 -1.144 . . . . 0.0 110.001 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.566 HG13 ' OE2' ' A' ' 289' ' ' GLU . 58.5 t -89.21 132.09 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.634 -0.666 . . . . 0.0 110.282 -172.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.81 HD11 ' CG2' ' A' ' 290' ' ' THR . 95.9 mt -99.92 -40.2 7.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.682 -0.636 . . . . 0.0 110.694 178.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -169.34 158.54 31.01 Favored Glycine 0 N--CA 1.496 2.686 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.612 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.634 ' HG2' HG22 ' A' ' 287' ' ' THR . 94.1 mtt180 -134.6 138.89 44.93 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.619 -0.93 . . . . 0.0 110.957 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -132.76 159.27 40.21 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.639 -0.663 . . . . 0.0 109.727 169.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 300' ' ' CYS . . . . . 0.526 ' SG ' HG23 ' A' ' 285' ' ' ILE . 87.6 m -144.06 154.38 43.16 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.409 -0.807 . . . . 0.0 110.76 -176.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.702 ' CE1' HD12 ' A' ' 284' ' ' ILE . 48.7 p90 -145.78 161.86 38.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.614 -0.679 . . . . 0.0 110.087 174.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.462 ' HA ' HD23 ' A' ' 283' ' ' LEU . 82.4 tt0 -104.83 136.81 43.64 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.619 -0.676 . . . . 0.0 110.224 -176.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -124.3 142.75 51.01 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.779 -170.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -138.11 140.91 40.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.793 -0.567 . . . . 0.0 109.684 172.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.656 HD13 ' O ' ' A' ' 269' ' ' CYS . 74.5 mt -108.29 122.78 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.462 -0.774 . . . . 0.0 109.688 176.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.0 p -145.31 170.28 16.61 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.605 -0.684 . . . . 0.0 110.676 -171.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -72.47 -40.18 67.17 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.662 -0.649 . . . . 0.0 110.648 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.7 t -126.83 85.75 60.18 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.471 -0.768 . . . . 0.0 110.485 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -55.69 -28.19 64.91 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 O-C-N 123.121 1.064 . . . . 0.0 110.856 174.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.95 -38.18 92.66 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 177.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 57.5 ttt85 -72.61 -40.37 66.54 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.621 -0.929 . . . . 0.0 109.875 -173.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -69.53 -38.91 77.71 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.137 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.401 ' HA ' ' OD2' ' A' ' 316' ' ' ASP . 70.3 ttt180 -61.25 -43.28 99.13 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.52 -0.738 . . . . 0.0 110.251 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -64.51 -40.82 96.34 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.567 -0.708 . . . . 0.0 110.604 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -60.73 -49.88 75.71 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.478 -0.764 . . . . 0.0 110.559 -173.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 316' ' ' ASP . . . . . 0.401 ' OD2' ' HA ' ' A' ' 313' ' ' ARG . 2.9 p30 . . . . . 0 N--CA 1.495 1.816 0 O-C-N 121.418 -0.802 . . . . 0.0 110.045 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 27.5 t . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.115 0.483 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.4 p-10 -101.89 25.22 8.91 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.586 -0.696 . . . . 0.0 110.699 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 49.1 m -79.17 125.23 29.17 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.617 -0.677 . . . . 0.0 110.262 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -68.86 144.93 54.1 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.696 -0.628 . . . . 0.0 110.418 -177.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -154.3 99.81 2.48 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.76 -0.587 . . . . 0.0 110.038 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.47 -39.99 78.58 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 O-C-N 123.181 1.095 . . . . 0.0 110.823 -175.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.94 -155.19 47.65 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -73.72 -46.31 0.34 Allowed 'Trans proline' 0 C--N 1.316 -1.155 0 O-C-N 123.354 1.186 . . . . 0.0 110.959 -173.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -87.38 9.08 21.76 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.509 -0.745 . . . . 0.0 111.376 -173.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.61 61.28 3.18 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.991 -1.068 . . . . 0.0 110.727 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.677 ' HA ' HG12 ' A' ' 176' ' ' VAL . 46.3 t80 -77.86 119.22 21.03 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.587 -0.696 . . . . 0.0 109.869 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -130.08 160.43 33.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.829 -0.545 . . . . 0.0 110.154 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 63.2 t -125.76 145.57 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.82 -0.55 . . . . 0.0 109.767 177.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 78.4 p -155.46 160.51 40.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.734 -0.603 . . . . 0.0 110.067 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.434 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 67.8 m-85 . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.854 -0.529 . . . . 0.0 109.788 -176.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.196 0.522 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.441 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 75.8 p -60.09 -33.09 71.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.716 -0.615 . . . . 0.0 109.932 176.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.441 ' HD1' ' HG1' ' A' ' 152' ' ' THR . 68.6 p-90 -170.95 142.6 1.88 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.309 0.576 . . . . 0.0 110.026 178.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 13.2 t -142.2 142.57 32.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.942 -0.474 . . . . 0.0 109.952 -176.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.434 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 64.1 t80 -125.51 140.03 53.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.523 -0.736 . . . . 0.0 110.544 -172.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 28.5 t -110.24 124.41 51.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.861 -0.525 . . . . 0.0 109.845 176.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 58.6 m -70.76 -36.94 73.33 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.789 -0.569 . . . . 0.0 110.556 -177.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -59.43 -34.66 72.77 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.561 -0.712 . . . . 0.0 110.464 -177.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 57.4 mt -104.88 -11.98 16.47 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.672 -0.642 . . . . 0.0 110.88 -175.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 59.8 tttt 59.79 52.01 5.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.065 -1.022 . . . . 0.0 109.746 178.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -145.35 152.99 40.74 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.707 -0.621 . . . . 0.0 110.556 -175.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.656 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.55 137.79 53.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.69 -0.631 . . . . 0.0 110.344 -176.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -116.19 134.2 55.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.675 -0.641 . . . . 0.0 109.382 174.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.3 158.39 44.39 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.939 -175.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -104.61 143.38 33.15 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.469 0.652 . . . . 0.0 110.396 173.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.439 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 16.7 tt -52.0 146.51 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.608 -0.682 . . . . 0.0 111.813 -175.043 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 65.2 10.01 6.06 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.665 -0.647 . . . . 0.0 112.415 177.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -96.63 155.13 16.9 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.068 -1.02 . . . . 0.0 110.832 174.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 62.3 m -88.53 126.22 35.15 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.662 -0.648 . . . . 0.0 110.669 -177.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' CYS . . . . . 0.656 ' SG ' HD21 ' A' ' 162' ' ' LEU . 44.2 t -113.71 90.08 17.45 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.59 -0.694 . . . . 0.0 110.19 175.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.439 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 23.7 Cg_exo -60.75 130.26 32.45 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 O-C-N 123.268 1.141 . . . . 0.0 110.678 172.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.402 HG12 ' CE2' ' A' ' 142' ' ' PHE . 97.5 mt -124.9 141.66 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 176.096 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -109.5 135.43 50.51 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.464 -0.772 . . . . 0.0 110.879 -175.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.408 HG23 ' CE1' ' A' ' 138' ' ' PHE . 50.5 mm -95.29 133.58 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.713 -0.617 . . . . 0.0 109.624 169.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 40.2 tttp -114.49 128.77 56.51 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.579 -0.701 . . . . 0.0 110.449 176.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.677 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.1 m -136.72 159.88 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.588 -0.695 . . . . 0.0 109.86 175.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.7 mmm -76.57 -41.4 46.53 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.666 -0.646 . . . . 0.0 110.1 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.0 p -134.78 143.27 45.65 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.763 -0.586 . . . . 0.0 109.695 178.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.9 Cg_exo -55.45 139.74 82.24 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 O-C-N 123.156 1.082 . . . . 0.0 110.889 -171.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.683 ' HB3' HD21 ' A' ' 288' ' ' LEU . 34.9 Cg_endo -67.63 169.99 14.76 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 O-C-N 123.157 1.082 . . . . 0.0 110.608 177.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -60.81 155.28 50.05 Favored 'Trans proline' 0 C--N 1.316 -1.152 0 O-C-N 123.327 1.172 . . . . 0.0 110.521 -178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -77.46 141.09 39.88 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.519 -0.738 . . . . 0.0 109.879 174.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.8 -24.88 29.76 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -174.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.19 150.74 2.31 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.412 -1.052 . . . . 0.0 111.4 177.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.7 156.04 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.762 -0.586 . . . . 0.0 109.688 176.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.742 HD11 ' HD2' ' A' ' 251' ' ' TYR . 84.2 mt -109.16 141.49 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.752 -0.592 . . . . 0.0 109.599 177.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.68 ' HG2' HD22 ' A' ' 248' ' ' LEU . 70.6 mtp180 -114.78 145.2 42.37 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -176.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.638 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -140.03 126.29 19.98 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.339 173.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.407 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 41.9 ttm -137.24 139.9 29.37 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.81 -0.557 . . . . 0.0 111.059 -176.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.494 ' HD3' HD12 ' A' ' 226' ' ' ILE . 73.9 Cg_endo -91.19 138.23 2.26 Favored 'Trans proline' 0 C--N 1.32 -0.964 0 O-C-N 123.3 1.158 . . . . 0.0 110.812 177.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.438 HG13 ' C ' ' A' ' 190' ' ' PRO . 34.8 m -147.7 154.9 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.574 -0.704 . . . . 0.0 109.988 173.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.6 ' HA ' HG22 ' A' ' 282' ' ' ILE . 87.2 m-85 -61.49 165.76 4.59 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.462 -0.774 . . . . 0.0 110.447 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.486 ' HA ' HD12 ' A' ' 283' ' ' LEU . 33.2 ttmt -83.99 -60.05 2.22 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.626 -0.671 . . . . 0.0 110.799 -173.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 48.3 mttt -80.04 152.49 29.37 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.639 -0.663 . . . . 0.0 110.332 -175.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.452 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.56 -38.75 72.36 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.462 -0.774 . . . . 0.0 110.698 -175.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -56.48 -24.91 49.25 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.519 -0.738 . . . . 0.0 110.621 -176.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.413 ' HB3' ' CG ' ' A' ' 192' ' ' TYR . 77.8 m80 -109.7 -20.5 12.8 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.137 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -67.6 -20.23 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.123 -0.986 . . . . 0.0 110.576 -175.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 71.7 p -79.48 -16.91 55.25 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.763 174.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -88.37 134.93 33.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.359 -0.838 . . . . 0.0 110.1 173.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 242' ' ' THR . 60.9 t -72.97 145.91 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.615 -0.678 . . . . 0.0 110.27 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 60.6 t -84.72 139.79 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.564 -0.71 . . . . 0.0 109.223 172.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.8 pttp -134.85 -170.16 2.51 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.422 -0.799 . . . . 0.0 111.295 -166.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -95.21 152.59 18.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.789 -0.57 . . . . 0.0 110.102 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 36.5 m . . . . . 0 N--CA 1.498 1.938 0 O-C-N 121.471 -0.768 . . . . 0.0 109.025 173.858 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 58.8 tp . . . . . 0 N--CA 1.497 1.902 0 CA-C-O 120.879 0.371 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.494 HD12 ' HD3' ' A' ' 190' ' ' PRO . 83.7 mt -104.94 136.81 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.834 -0.541 . . . . 0.0 109.801 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -132.47 157.82 43.65 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.797 -0.564 . . . . 0.0 110.292 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.461 HG23 HG21 ' A' ' 247' ' ' VAL . 94.1 t -102.67 146.56 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.722 -0.611 . . . . 0.0 109.909 175.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -117.26 124.14 48.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.722 -0.611 . . . . 0.0 110.428 172.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 95.79 24.33 15.77 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 167.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -137.27 107.07 6.23 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.5 -1.0 . . . . 0.0 110.015 174.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 28.0 t -63.03 -15.2 55.66 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.611 -0.68 . . . . 0.0 111.203 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -100.0 9.34 43.06 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.289 -0.882 . . . . 0.0 111.588 -177.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.37 127.91 33.77 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.129 -0.982 . . . . 0.0 110.179 176.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -139.75 158.01 44.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.707 -0.62 . . . . 0.0 109.868 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -114.67 150.66 34.85 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.604 -0.685 . . . . 0.0 110.576 -176.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.13 160.0 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.742 -0.599 . . . . 0.0 110.173 177.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -119.17 130.06 55.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.703 -0.623 . . . . 0.0 110.227 176.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -64.18 130.04 94.36 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.66 -0.65 . . . . 0.0 109.833 178.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -65.41 -28.34 54.39 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.187 1.098 . . . . 0.0 111.024 -170.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.8 mt -101.74 -50.5 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.425 -0.797 . . . . 0.0 111.051 -167.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.445 ' O ' HG21 ' A' ' 201' ' ' VAL . 11.1 p -105.4 12.18 31.86 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.446 -0.784 . . . . 0.0 111.843 -174.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 72.3 -5.01 16.43 Favored Glycine 0 N--CA 1.496 2.688 0 O-C-N 121.102 -0.999 . . . . 0.0 112.007 173.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.419 ' CZ ' HG12 ' A' ' 191' ' ' VAL . 23.4 mmt180 -45.91 142.05 2.8 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-N 119.134 1.467 . . . . 0.0 112.36 -174.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -103.61 143.43 32.77 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.715 -0.616 . . . . 0.0 110.117 175.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 76.5 p -154.74 159.95 41.0 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.637 -0.664 . . . . 0.0 110.332 177.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.461 HG21 HG23 ' A' ' 228' ' ' VAL . 8.2 p -123.0 148.2 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.789 -0.569 . . . . 0.0 109.699 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 187' ' ' ARG . 79.9 mt -129.51 154.56 46.9 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.615 -175.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.439 HG13 ' C ' ' A' ' 248' ' ' LEU . 32.5 m -151.13 151.78 30.09 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.776 -0.577 . . . . 0.0 109.955 175.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -71.14 139.59 35.81 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 O-C-N 123.333 1.175 . . . . 0.0 110.009 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.742 ' HD2' HD11 ' A' ' 186' ' ' ILE . 59.2 t80 -75.76 127.22 32.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.539 -0.726 . . . . 0.0 110.123 175.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -100.11 160.09 28.06 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.765 -0.584 . . . . 0.0 109.979 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -58.77 158.34 24.71 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.213 1.112 . . . . 0.0 110.496 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.25 149.95 77.43 Favored 'Trans proline' 0 N--CA 1.487 1.145 0 O-C-N 123.206 1.109 . . . . 0.0 110.549 -177.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -61.87 147.73 45.69 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.603 -0.686 . . . . 0.0 110.146 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.92 127.25 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.537 -0.727 . . . . 0.0 110.161 -170.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.95 -10.17 55.43 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.431 HG21 ' CE2' ' A' ' 260' ' ' PHE . 9.2 t -144.46 174.14 11.19 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.253 -1.145 . . . . 0.0 110.566 175.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -108.08 13.22 26.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.622 -0.674 . . . . 0.0 111.839 -167.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 258' ' ' THR . 38.6 p90 -120.0 168.09 11.51 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.15 -0.969 . . . . 0.0 111.101 -175.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 76.9 m -117.75 145.87 44.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.756 -0.59 . . . . 0.0 109.836 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 55.8 m -116.64 134.81 54.37 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.478 0.656 . . . . 0.0 110.91 -174.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 64.0 t -130.35 137.32 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 172.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 171' ' ' PRO . 76.1 mt -104.73 120.47 41.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.518 -0.739 . . . . 0.0 109.89 -171.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.638 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 6.0 m-30 -106.51 151.67 24.68 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.693 -0.63 . . . . 0.0 110.486 -177.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -136.54 142.89 43.46 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -113.48 131.73 55.93 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.6 -0.688 . . . . 0.0 110.259 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 268' ' ' MET . . . . . 0.466 ' HE2' ' HB2' ' A' ' 268' ' ' MET . 4.9 ppp? -104.17 9.68 36.11 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.582 -0.699 . . . . 0.0 111.897 -175.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 269' ' ' CYS . . . . . 0.574 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.7 OUTLIER -144.62 160.37 41.29 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.035 -1.041 . . . . 0.0 109.861 170.837 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.646 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.5 p30 -117.49 162.43 17.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.682 -0.636 . . . . 0.0 110.31 -177.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 271' ' ' SER . . . . . 0.427 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 20.1 m -58.78 -32.28 69.15 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.582 -0.699 . . . . 0.0 110.925 -163.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 48.0 p -99.79 12.89 35.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.507 -0.746 . . . . 0.0 111.962 -164.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 32.0 p -94.54 118.15 31.24 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.552 177.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 60.1 t -64.02 139.54 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.46 -0.775 . . . . 0.0 110.399 -167.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.56 -5.16 58.44 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 176.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -124.46 -100.05 1.33 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 170.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 277' ' ' MET . . . . . 0.427 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.2 mmm -63.96 -31.98 73.36 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.654 -0.909 . . . . 0.0 110.207 176.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.5 p30 43.53 51.15 6.31 Favored 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 175.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 54.78 27.42 8.85 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.394 -0.816 . . . . 0.0 111.163 175.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 77.2 mtt180 -117.67 106.42 46.23 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.476 -0.765 . . . . 0.0 110.09 175.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.56 146.71 94.43 Favored 'Trans proline' 0 N--CA 1.488 1.171 0 O-C-N 123.137 1.072 . . . . 0.0 110.577 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.6 HG22 ' HA ' ' A' ' 192' ' ' TYR . 45.4 pt -131.96 178.34 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.761 0.791 . . . . 0.0 110.773 -176.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' ' 193' ' ' LYS . 28.0 mt -124.41 149.84 46.28 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.69 HD12 ' CE1' ' A' ' 301' ' ' PHE . 80.3 mt -115.82 130.44 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.617 -0.677 . . . . 0.0 109.239 177.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.647 HG23 ' SG ' ' A' ' 300' ' ' CYS . 85.3 mt -109.79 126.22 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -176.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 58.5 t -118.91 126.7 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.4 p -125.25 154.69 41.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.673 -0.642 . . . . 0.0 110.795 -175.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.683 HD21 ' HB3' ' A' ' 180' ' ' PRO . 23.6 tp -104.82 126.83 52.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.816 -0.553 . . . . 0.0 109.575 170.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.743 ' OE2' HG13 ' A' ' 295' ' ' VAL . 72.0 mm-40 -132.44 149.83 52.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.897 -0.502 . . . . 0.0 109.912 -172.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.834 ' CG2' HD11 ' A' ' 296' ' ' LEU . 26.1 p -90.42 160.88 15.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.639 -0.663 . . . . 0.0 110.015 177.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -55.95 -26.14 46.7 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.506 -0.746 . . . . 0.0 111.002 -175.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 44.8 p30 -89.72 9.77 25.88 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.414 -0.804 . . . . 0.0 111.9 -172.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.7 20.17 45.08 Favored Glycine 0 N--CA 1.495 2.6 0 C-N-CA 120.143 -1.027 . . . . 0.0 110.677 171.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -108.98 140.13 42.91 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.32 -1.106 . . . . 0.0 109.921 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.743 HG13 ' OE2' ' A' ' 289' ' ' GLU . 60.3 t -91.83 133.3 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.527 -0.733 . . . . 0.0 110.217 -172.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.834 HD11 ' CG2' ' A' ' 290' ' ' THR . 71.6 mt -99.87 -40.24 7.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.792 -0.567 . . . . 0.0 110.59 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -158.36 154.87 25.93 Favored Glycine 0 N--CA 1.496 2.697 0 C-N-CA 119.917 -1.135 . . . . 0.0 110.516 -177.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.713 ' CZ ' HG11 ' A' ' 295' ' ' VAL . 55.5 mtt85 -135.03 136.32 42.0 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.722 -0.869 . . . . 0.0 110.211 178.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -140.69 157.26 45.69 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.487 -0.758 . . . . 0.0 110.152 169.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 300' ' ' CYS . . . . . 0.647 ' SG ' HG23 ' A' ' 285' ' ' ILE . 95.3 m -142.52 156.63 45.15 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.512 -0.743 . . . . 0.0 110.632 -175.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.69 ' CE1' HD12 ' A' ' 284' ' ' ILE . 48.5 p90 -145.0 162.88 35.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.681 -0.637 . . . . 0.0 110.199 176.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.417 ' HA ' HD23 ' A' ' 283' ' ' LEU . 81.8 tt0 -104.96 136.15 44.97 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.526 -0.734 . . . . 0.0 110.11 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -121.66 144.21 48.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.614 -0.679 . . . . 0.0 110.814 -169.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -139.23 139.51 37.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.857 -0.527 . . . . 0.0 109.744 172.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.646 HG21 ' HA ' ' A' ' 270' ' ' ASN . 82.6 mt -108.71 122.84 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.465 -0.772 . . . . 0.0 109.726 176.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.8 p -145.31 171.02 15.17 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.609 -0.682 . . . . 0.0 110.606 -172.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -73.2 -40.09 65.02 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.589 -0.694 . . . . 0.0 110.7 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.7 t -127.12 85.66 60.55 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.524 -0.735 . . . . 0.0 110.49 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -55.88 -27.85 64.95 Favored 'Trans proline' 0 C--N 1.314 -1.259 0 O-C-N 123.226 1.119 . . . . 0.0 110.772 174.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -67.6 -38.1 89.99 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -72.89 -40.46 65.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.674 -0.897 . . . . 0.0 109.803 -173.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -69.59 -39.35 77.35 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.061 -178.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -61.38 -44.66 96.78 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.219 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -64.04 -40.16 95.7 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.606 -0.684 . . . . 0.0 110.459 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.6 -50.73 71.43 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.548 -0.72 . . . . 0.0 110.419 -173.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.1 p30 . . . . . 0 N--CA 1.496 1.843 0 O-C-N 121.509 -0.744 . . . . 0.0 110.107 -178.214 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.2 t . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.035 0.445 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 p-10 -96.33 24.34 5.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.637 -0.664 . . . . 0.0 110.721 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 49.9 m -77.8 125.16 28.92 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.577 -0.702 . . . . 0.0 110.274 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -71.16 144.96 50.03 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.686 -0.634 . . . . 0.0 110.414 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -157.78 101.48 1.8 Allowed Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.746 -0.596 . . . . 0.0 110.077 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -59.73 -39.87 69.46 Favored 'Trans proline' 0 N--CA 1.488 1.167 0 O-C-N 123.179 1.094 . . . . 0.0 110.681 -175.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.08 -155.12 43.9 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -73.6 -44.85 0.46 Allowed 'Trans proline' 0 C--N 1.317 -1.09 0 O-C-N 123.344 1.181 . . . . 0.0 110.855 -175.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -86.92 4.34 41.93 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.585 -0.697 . . . . 0.0 111.498 -174.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.82 61.6 3.01 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.888 -1.133 . . . . 0.0 110.716 -176.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.727 ' HA ' HG12 ' A' ' 176' ' ' VAL . 63.1 t80 -78.04 120.46 22.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.643 -0.661 . . . . 0.0 110.106 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -129.98 159.97 35.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.763 -0.586 . . . . 0.0 110.261 -177.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 64.5 t -126.28 146.3 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.789 -0.57 . . . . 0.0 109.831 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.9 p -154.98 162.75 41.0 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.947 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.419 ' CE2' HG12 ' A' ' 172' ' ' ILE . 76.2 m-85 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.771 -0.581 . . . . 0.0 109.944 -175.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 121.163 0.506 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.425 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 65.4 p -60.1 -34.08 72.98 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.613 -0.68 . . . . 0.0 110.055 176.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.425 ' HD1' ' HG1' ' A' ' 152' ' ' THR . 68.7 p-90 -171.83 144.15 1.74 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.43 0.633 . . . . 0.0 110.158 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.3 t -142.11 142.59 32.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.788 -0.57 . . . . 0.0 109.943 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -125.52 140.07 53.07 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.532 -0.73 . . . . 0.0 110.579 -172.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.7 t -110.43 123.56 50.11 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 120.366 -0.533 . . . . 0.0 109.641 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 63.1 m -70.82 -37.11 73.21 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.755 -0.591 . . . . 0.0 110.42 -177.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -58.94 -32.76 69.88 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.582 -0.699 . . . . 0.0 110.275 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.507 HD11 ' OD1' ' A' ' 316' ' ' ASP . 37.7 mt -104.8 -12.11 16.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.71 -0.619 . . . . 0.0 110.712 -175.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 31.6 tttm 59.68 47.92 9.97 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.971 -1.08 . . . . 0.0 109.761 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.444 ' HE3' ' CZ ' ' A' ' 163' ' ' TYR . 33.9 ttpt -147.19 153.16 39.5 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 120.114 -0.635 . . . . 0.0 110.725 -174.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.58 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.6 138.18 53.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.763 -0.585 . . . . 0.0 110.374 -173.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.444 ' CZ ' ' HE3' ' A' ' 161' ' ' LYS . 52.3 m-85 -114.7 135.04 54.59 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 174.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.9 p -138.33 158.4 44.36 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.034 -176.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.416 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 57.0 mt-30 -104.55 142.86 33.89 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.611 -0.681 . . . . 0.0 110.211 173.15 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.428 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.2 tt -52.41 147.42 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.461 -0.774 . . . . 0.0 111.837 -174.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.89 9.97 5.78 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.539 -0.726 . . . . 0.0 112.487 176.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.416 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 72.2 mmtt -95.68 155.09 16.89 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.994 -1.067 . . . . 0.0 110.906 174.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 88.2 m -84.49 126.17 33.04 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.725 -0.609 . . . . 0.0 110.59 -178.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' CYS . . . . . 0.58 ' SG ' HD21 ' A' ' 162' ' ' LEU . 48.9 t -114.22 90.32 19.91 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.59 -0.694 . . . . 0.0 110.18 175.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.406 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 21.3 Cg_endo -65.94 129.65 22.52 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 O-C-N 123.261 1.137 . . . . 0.0 110.59 176.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.419 HG12 ' CE2' ' A' ' 142' ' ' PHE . 93.9 mt -123.15 141.69 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.62 -0.675 . . . . 0.0 109.329 176.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -109.06 135.35 50.37 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.519 -0.738 . . . . 0.0 110.761 -175.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.424 HG21 ' CE1' ' A' ' 138' ' ' PHE . 48.3 mm -95.24 135.03 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.652 -0.655 . . . . 0.0 109.642 170.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -117.84 128.84 55.24 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.42 175.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.727 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.1 m -136.47 159.75 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.532 -0.73 . . . . 0.0 109.949 175.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.0 mmm -77.07 -40.47 46.04 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.683 -0.635 . . . . 0.0 110.113 178.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.415 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.4 p -135.3 143.18 44.43 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.746 -0.596 . . . . 0.0 109.849 178.277 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.5 Cg_exo -55.94 139.87 85.09 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 O-C-N 123.181 1.095 . . . . 0.0 110.828 -173.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.771 ' HB3' HD21 ' A' ' 288' ' ' LEU . 20.8 Cg_endo -63.49 169.1 10.25 Favored 'Trans proline' 0 N--CA 1.488 1.18 0 O-C-N 123.204 1.107 . . . . 0.0 110.728 176.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -61.16 157.5 39.42 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.376 1.198 . . . . 0.0 110.482 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -76.61 137.45 39.49 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.635 -0.666 . . . . 0.0 109.898 175.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.51 -25.09 29.62 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -174.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.08 151.98 1.81 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.335 -1.097 . . . . 0.0 111.396 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.77 155.95 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.698 -0.627 . . . . 0.0 109.935 177.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.667 HD11 ' CD2' ' A' ' 251' ' ' TYR . 72.4 mt -108.47 135.51 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.728 ' HG2' HD22 ' A' ' 248' ' ' LEU . 61.8 mtt180 -115.05 147.13 40.54 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.702 -0.623 . . . . 0.0 109.376 -175.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.647 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -140.12 128.7 22.93 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.536 -0.728 . . . . 0.0 110.138 172.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.413 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 22.6 ttp -137.29 137.18 21.82 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.796 -0.565 . . . . 0.0 111.083 -176.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.493 ' HD3' HD12 ' A' ' 226' ' ' ILE . 71.8 Cg_endo -91.43 138.19 2.15 Favored 'Trans proline' 0 C--N 1.32 -0.959 0 C-N-CA 121.038 1.159 . . . . 0.0 110.773 177.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.423 HG13 ' C ' ' A' ' 190' ' ' PRO . 35.0 m -146.99 154.86 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.486 -0.759 . . . . 0.0 110.022 173.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.624 ' HA ' HG22 ' A' ' 282' ' ' ILE . 87.6 m-85 -61.48 160.02 11.85 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.464 -0.773 . . . . 0.0 110.397 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.444 ' HA ' HD12 ' A' ' 283' ' ' LEU . 85.7 tttt -76.21 -60.04 2.5 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.664 -0.647 . . . . 0.0 110.832 -173.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -80.01 150.7 30.32 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.58 -0.7 . . . . 0.0 110.356 -174.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.45 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.44 -38.86 72.2 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.385 -0.822 . . . . 0.0 110.728 -175.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -56.33 -25.04 47.58 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.555 -0.716 . . . . 0.0 110.668 -176.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.408 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 97.3 m-70 -110.03 -20.57 12.67 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.934 -0.706 . . . . 0.0 111.147 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.1 p -66.78 -20.25 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.154 -0.966 . . . . 0.0 110.573 -175.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 68.1 p -79.35 -17.05 55.29 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.713 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -88.27 136.39 33.0 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.353 -0.842 . . . . 0.0 109.951 172.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 56.9 t -73.02 146.48 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.61 -0.681 . . . . 0.0 110.133 178.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 79.5 t -84.92 139.65 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.598 -0.689 . . . . 0.0 109.261 172.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.7 pttp -134.82 -170.07 2.48 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.557 -0.715 . . . . 0.0 111.038 -166.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -95.12 154.04 17.37 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.744 -0.597 . . . . 0.0 110.442 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.614 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 58.7 m . . . . . 0 N--CA 1.496 1.857 0 O-C-N 121.641 -0.662 . . . . 0.0 109.272 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.519 HD12 ' HG3' ' A' ' 268' ' ' MET . 59.5 tp . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 120.968 0.413 . . . . 0.0 110.338 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.493 HD12 ' HD3' ' A' ' 190' ' ' PRO . 83.4 mt -103.97 136.79 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.729 -0.607 . . . . 0.0 109.949 -178.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -127.26 157.54 39.56 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.748 -0.595 . . . . 0.0 110.176 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.521 HG23 HG21 ' A' ' 247' ' ' VAL . 90.7 t -102.32 146.6 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.787 -0.571 . . . . 0.0 109.81 173.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -118.59 129.97 55.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.698 -0.626 . . . . 0.0 110.4 170.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.96 21.08 26.56 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 168.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 35.7 t-20 -138.45 105.65 5.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.305 -1.115 . . . . 0.0 110.054 174.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 43.7 m -63.28 -15.33 56.87 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.656 -0.653 . . . . 0.0 111.306 -176.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -99.92 7.58 44.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.214 -0.929 . . . . 0.0 111.597 -177.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.64 132.27 52.73 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.114 -0.991 . . . . 0.0 110.24 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -139.76 157.97 44.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.79 -0.569 . . . . 0.0 109.674 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -116.36 150.64 37.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.542 -0.724 . . . . 0.0 110.573 -177.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.19 159.89 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.824 -0.548 . . . . 0.0 110.24 177.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -123.71 128.21 49.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.76 -0.587 . . . . 0.0 110.05 174.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -65.09 130.05 94.69 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.678 -0.639 . . . . 0.0 109.893 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -66.8 -26.48 44.93 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 O-C-N 123.036 1.019 . . . . 0.0 111.029 -172.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.2 mt -99.06 -50.45 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.371 -0.831 . . . . 0.0 110.916 -168.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.0 p -105.33 12.07 32.11 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.406 -0.809 . . . . 0.0 111.835 -175.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.89 -5.08 13.77 Favored Glycine 0 N--CA 1.496 2.691 0 O-C-N 121.058 -1.027 . . . . 0.0 111.709 174.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 69.5 mmt-85 -46.18 141.98 3.07 Favored 'General case' 0 N--CA 1.505 2.278 0 CA-C-N 119.07 1.435 . . . . 0.0 112.363 -172.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -108.13 139.55 42.63 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.651 -0.655 . . . . 0.0 110.091 174.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 77.8 p -154.76 159.94 40.98 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.569 -0.707 . . . . 0.0 110.619 177.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.521 HG21 HG23 ' A' ' 228' ' ' VAL . 8.4 p -123.67 148.1 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.706 -0.621 . . . . 0.0 109.713 177.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.728 HD22 ' HG2' ' A' ' 187' ' ' ARG . 83.0 mt -129.67 154.71 46.86 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.032 -174.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.442 HG13 ' C ' ' A' ' 248' ' ' LEU . 36.0 m -150.77 151.76 30.87 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.855 -0.528 . . . . 0.0 109.878 175.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -70.6 139.4 37.22 Favored 'Trans proline' 0 C--N 1.315 -1.184 0 O-C-N 123.292 1.154 . . . . 0.0 110.055 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.667 ' CD2' HD11 ' A' ' 186' ' ' ILE . 10.0 t80 -79.66 123.29 27.5 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.539 -0.726 . . . . 0.0 110.16 178.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -100.04 160.1 28.07 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.693 -0.629 . . . . 0.0 110.19 178.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -59.08 160.05 20.05 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.362 1.191 . . . . 0.0 110.472 178.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.87 150.01 74.63 Favored 'Trans proline' 0 N--CA 1.489 1.244 0 O-C-N 123.293 1.154 . . . . 0.0 110.501 -177.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -60.91 147.94 41.41 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.626 -0.671 . . . . 0.0 110.184 -178.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.85 127.24 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.557 -0.715 . . . . 0.0 110.168 -170.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.88 -10.23 55.59 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 10.2 t -144.62 174.42 10.98 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.187 -1.184 . . . . 0.0 110.613 175.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -108.71 13.06 25.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.57 -0.706 . . . . 0.0 111.85 -167.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -122.41 168.07 12.54 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.125 -0.984 . . . . 0.0 111.149 -176.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 87.2 m -117.69 145.56 44.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.748 -0.595 . . . . 0.0 109.849 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 38.6 m -116.22 135.73 53.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.557 -0.715 . . . . 0.0 110.939 -175.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 57.6 t -129.03 137.29 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 172.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 62.7 mt -104.72 119.97 40.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.525 -0.734 . . . . 0.0 109.793 -172.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.647 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 6.7 m-30 -106.67 150.97 25.7 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.63 -0.669 . . . . 0.0 110.664 -178.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -136.47 142.91 43.59 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -113.15 132.67 55.37 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.56 -0.713 . . . . 0.0 110.48 -176.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 268' ' ' MET . . . . . 0.519 ' HG3' HD12 ' A' ' 225' ' ' LEU . 0.1 OUTLIER -103.21 8.52 38.46 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.711 -0.618 . . . . 0.0 112.172 -175.135 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 269' ' ' CYS . . . . . 0.681 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.6 OUTLIER -144.68 165.1 29.0 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.045 -1.034 . . . . 0.0 109.906 171.259 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.614 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.9 p30 -121.68 161.61 22.21 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.394 0.616 . . . . 0.0 110.38 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 271' ' ' SER . . . . . 0.426 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 26.7 m -58.36 -33.56 69.7 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.465 -0.772 . . . . 0.0 111.09 -163.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 70.6 m -97.56 10.54 39.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.494 -0.754 . . . . 0.0 112.089 -164.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 273' ' ' CYS . . . . . 0.614 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 30.5 p -93.9 118.1 31.0 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.027 -1.045 . . . . 0.0 110.644 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.81 139.87 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.505 -0.747 . . . . 0.0 110.349 -169.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.57 -5.13 60.16 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 178.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -125.18 -100.2 1.26 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 170.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 277' ' ' MET . . . . . 0.426 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.4 mmm -65.55 -32.77 74.54 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.614 -0.933 . . . . 0.0 110.419 176.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.6 p30 42.47 53.11 4.7 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 176.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 54.8 27.44 8.9 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.328 -0.858 . . . . 0.0 111.184 176.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -119.12 105.15 45.21 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.484 -0.76 . . . . 0.0 110.098 175.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -59.45 151.02 71.73 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 O-C-N 123.135 1.071 . . . . 0.0 110.686 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.624 HG22 ' HA ' ' A' ' 192' ' ' TYR . 46.3 pt -131.81 177.63 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.766 0.793 . . . . 0.0 110.922 -177.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 193' ' ' LYS . 24.4 mt -124.33 149.81 46.17 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.692 HD12 ' CE1' ' A' ' 301' ' ' PHE . 80.2 mt -118.1 129.12 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.232 178.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.642 HG23 ' SG ' ' A' ' 300' ' ' CYS . 84.7 mt -109.79 127.55 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 120.251 -0.579 . . . . 0.0 109.448 -175.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 59.5 t -118.87 126.79 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.4 p -125.23 153.66 42.81 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 120.136 -0.625 . . . . 0.0 110.55 -174.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.771 HD21 ' HB3' ' A' ' 180' ' ' PRO . 20.7 tp -104.09 125.59 50.55 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 168.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.652 ' OE2' HG13 ' A' ' 295' ' ' VAL . 73.5 mm-40 -131.8 150.43 52.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.855 -0.528 . . . . 0.0 109.851 -171.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.807 HG22 HD11 ' A' ' 296' ' ' LEU . 68.4 p -89.86 159.54 16.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.632 -0.668 . . . . 0.0 109.708 177.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 28.7 tpt180 -56.03 -25.98 46.96 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.521 -0.737 . . . . 0.0 110.761 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -86.65 8.96 20.18 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.482 -0.762 . . . . 0.0 111.706 -174.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 86.95 20.13 54.22 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 120.186 -1.007 . . . . 0.0 110.673 170.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -107.86 140.12 41.44 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.214 -1.168 . . . . 0.0 110.252 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.652 HG13 ' OE2' ' A' ' 289' ' ' GLU . 60.5 t -88.86 131.4 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.683 -0.635 . . . . 0.0 110.133 -174.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.807 HD11 HG22 ' A' ' 290' ' ' THR . 76.8 mt -99.78 -40.18 7.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.753 -0.592 . . . . 0.0 110.504 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -159.68 151.77 22.58 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.453 ' HD2' HG11 ' A' ' 295' ' ' VAL . 46.3 mtp180 -135.08 134.29 40.16 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.643 -0.916 . . . . 0.0 110.606 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -136.76 157.88 45.73 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.568 -0.707 . . . . 0.0 109.848 172.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 300' ' ' CYS . . . . . 0.642 ' SG ' HG23 ' A' ' 285' ' ' ILE . 94.7 m -143.18 156.69 44.83 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.358 -0.838 . . . . 0.0 110.846 -175.019 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.692 ' CE1' HD12 ' A' ' 284' ' ' ILE . 47.1 p90 -145.21 162.17 37.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.653 -0.654 . . . . 0.0 110.12 175.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.402 ' HA ' HD23 ' A' ' 283' ' ' LEU . 82.3 tt0 -104.85 135.36 46.36 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.515 -0.741 . . . . 0.0 110.16 -178.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -123.6 142.99 50.5 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.736 -170.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 53.4 ttt85 -139.04 140.33 38.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.853 -0.53 . . . . 0.0 109.769 173.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.681 HD13 ' O ' ' A' ' 269' ' ' CYS . 73.6 mt -107.78 123.0 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.611 -0.68 . . . . 0.0 109.602 176.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.9 p -145.13 167.56 22.45 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.592 -0.692 . . . . 0.0 110.929 -170.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -67.8 -40.07 83.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.633 -0.667 . . . . 0.0 110.628 -177.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 3.9 t -132.09 89.49 37.77 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.592 -0.693 . . . . 0.0 110.448 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.54 -29.86 71.57 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 O-C-N 123.089 1.047 . . . . 0.0 110.853 174.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.26 -37.28 92.76 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -73.25 -40.37 64.69 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.752 -0.852 . . . . 0.0 109.779 -173.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -69.53 -40.14 77.07 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.183 -178.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -61.72 -43.19 99.34 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.301 178.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -65.06 -39.74 93.7 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.494 -0.754 . . . . 0.0 110.445 177.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.37 -49.86 75.21 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.515 -0.74 . . . . 0.0 110.551 -173.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 316' ' ' ASP . . . . . 0.507 ' OD1' HD11 ' A' ' 159' ' ' LEU . 3.2 p30 . . . . . 0 N--CA 1.494 1.73 0 O-C-N 121.389 -0.82 . . . . 0.0 110.09 -178.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.0 t . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.029 0.442 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.5 p-10 -94.38 23.2 5.35 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.713 -0.617 . . . . 0.0 110.845 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 50.5 m -75.47 125.1 28.33 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.454 -0.779 . . . . 0.0 110.171 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -70.44 144.88 51.33 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.584 -0.697 . . . . 0.0 110.43 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.43 ' CE2' ' HA2' ' A' ' 134' ' ' GLY . 65.4 t80 -155.92 102.51 2.12 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.635 -0.666 . . . . 0.0 110.055 178.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -58.95 -39.87 76.84 Favored 'Trans proline' 0 N--CA 1.488 1.161 0 O-C-N 123.129 1.068 . . . . 0.0 110.792 -174.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.43 ' HA2' ' CE2' ' A' ' 132' ' ' TYR . . . 81.13 -155.14 36.05 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 178.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -73.04 -49.92 0.22 Allowed 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.361 1.19 . . . . 0.0 110.914 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -87.88 9.89 20.53 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.55 -0.719 . . . . 0.0 111.36 -173.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.71 61.51 3.06 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.922 -1.111 . . . . 0.0 110.705 -177.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.723 ' HA ' HG12 ' A' ' 176' ' ' VAL . 64.3 t80 -79.85 118.81 21.97 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.663 -0.648 . . . . 0.0 110.07 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -130.01 160.04 34.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.787 -0.571 . . . . 0.0 110.316 -175.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 72.3 t -123.99 147.09 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.751 -0.593 . . . . 0.0 109.764 177.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.9 p -155.17 163.65 39.93 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.251 0.548 . . . . 0.0 109.932 176.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.494 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 67.3 m-85 . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.723 -0.611 . . . . 0.0 109.844 -176.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 121.229 0.538 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.501 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 61.6 p -60.09 -33.22 71.79 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.753 -0.592 . . . . 0.0 110.005 175.011 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.501 ' HD1' ' HG1' ' A' ' 152' ' ' THR . 68.5 p-90 -171.28 143.48 1.88 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.784 -0.572 . . . . 0.0 110.063 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.5 t -142.03 142.54 32.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.83 -0.544 . . . . 0.0 110.011 -177.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.494 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 64.9 t80 -125.62 140.03 53.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.534 -0.729 . . . . 0.0 110.646 -172.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 40.6 t -109.59 124.46 51.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.863 -0.523 . . . . 0.0 109.944 176.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 56.1 m -71.12 -37.1 72.35 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.794 -0.566 . . . . 0.0 110.513 -177.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -59.9 -34.29 72.99 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.604 -0.685 . . . . 0.0 110.364 -178.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 58.0 mt -104.82 -11.99 16.51 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.656 -0.653 . . . . 0.0 110.871 -175.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.6 tttp 59.81 51.31 6.21 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.112 -0.992 . . . . 0.0 109.734 177.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -145.71 153.06 40.57 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.562 -174.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.67 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.5 tp -126.65 137.8 53.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.772 -0.58 . . . . 0.0 110.416 -175.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -117.15 134.28 54.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.683 -0.635 . . . . 0.0 109.414 174.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.28 158.37 44.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.615 -0.678 . . . . 0.0 111.0 -174.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.404 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 38.3 mt-30 -104.56 144.9 31.06 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.568 0.699 . . . . 0.0 110.491 173.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.417 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 16.8 tt -52.1 146.25 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.551 -0.718 . . . . 0.0 111.894 -174.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 63.96 10.17 5.11 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.629 -0.67 . . . . 0.0 112.448 176.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.404 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 74.5 mmtt -96.12 155.04 16.93 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.987 -1.071 . . . . 0.0 110.705 175.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 90.5 m -84.63 126.18 33.13 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.709 -0.619 . . . . 0.0 110.537 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' CYS . . . . . 0.67 ' SG ' HD21 ' A' ' 162' ' ' LEU . 42.9 t -114.3 90.08 19.49 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.627 -0.671 . . . . 0.0 110.046 172.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.436 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 22.6 Cg_exo -61.78 129.29 27.12 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 O-C-N 123.334 1.176 . . . . 0.0 110.548 172.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.416 HG12 ' CE2' ' A' ' 142' ' ' PHE . 95.2 mt -123.26 139.38 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 175.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -106.77 135.92 47.49 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.559 -0.713 . . . . 0.0 110.753 -175.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.629 HG21 ' CE1' ' A' ' 138' ' ' PHE . 49.8 mm -95.3 135.01 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.75 -0.594 . . . . 0.0 109.715 171.204 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 31.7 tptt -117.21 130.57 56.67 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.679 -0.638 . . . . 0.0 110.518 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.723 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.5 m -136.87 159.78 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.518 -0.739 . . . . 0.0 109.977 175.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 80.3 mmm -78.4 -40.29 36.47 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.716 -0.615 . . . . 0.0 110.008 177.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.416 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 76.7 p -135.09 143.21 44.95 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.805 -0.559 . . . . 0.0 109.686 177.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.4 Cg_exo -55.51 139.79 82.6 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 O-C-N 123.177 1.093 . . . . 0.0 110.92 -172.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.66 ' HB3' HD21 ' A' ' 288' ' ' LEU . 34.2 Cg_endo -68.12 169.99 15.46 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.211 1.111 . . . . 0.0 110.616 177.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -60.28 157.92 33.25 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 O-C-N 123.317 1.167 . . . . 0.0 110.685 -178.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -80.21 139.2 36.84 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.663 -0.648 . . . . 0.0 110.034 175.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.04 -24.94 30.22 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 -174.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.07 152.64 1.61 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.365 -1.08 . . . . 0.0 111.429 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.73 155.95 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.686 -0.634 . . . . 0.0 109.841 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.739 HD11 ' HD2' ' A' ' 251' ' ' TYR . 86.7 mt -109.04 137.97 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.629 -0.669 . . . . 0.0 109.539 176.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.733 ' HG2' HD22 ' A' ' 248' ' ' LEU . 58.3 mtt180 -115.03 146.24 41.47 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -176.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.678 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -139.97 127.94 22.16 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.454 -0.779 . . . . 0.0 110.327 174.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.405 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 30.6 ttp -137.26 139.95 29.45 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.752 -0.593 . . . . 0.0 111.19 -176.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.654 ' HD3' HD12 ' A' ' 226' ' ' ILE . 75.2 Cg_endo -92.46 138.14 1.73 Allowed 'Trans proline' 0 C--N 1.32 -0.961 0 C-N-CA 121.15 1.233 . . . . 0.0 110.702 177.021 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.44 HG13 ' C ' ' A' ' 190' ' ' PRO . 35.0 m -148.05 154.9 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.507 -0.746 . . . . 0.0 110.133 174.217 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.629 ' HA ' HG22 ' A' ' 282' ' ' ILE . 71.2 m-85 -60.3 164.96 3.84 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.529 -0.732 . . . . 0.0 110.487 178.161 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.422 ' HA ' HD12 ' A' ' 283' ' ' LEU . 36.8 tttt -79.86 -60.03 2.5 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.607 -0.683 . . . . 0.0 110.805 -174.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -80.1 150.73 30.16 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.525 -0.734 . . . . 0.0 110.293 -174.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.44 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.5 -38.68 72.12 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.334 -0.854 . . . . 0.0 110.749 -174.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -56.31 -25.12 47.51 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.487 -0.758 . . . . 0.0 110.633 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -110.01 -20.52 12.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.605 -0.684 . . . . 0.0 111.218 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.1 p -66.78 -20.24 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.153 -0.967 . . . . 0.0 110.604 -176.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 71.0 p -79.43 -15.44 57.81 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.577 -0.702 . . . . 0.0 110.813 175.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.22 135.18 33.56 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.355 -0.84 . . . . 0.0 110.031 173.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.9 t -72.89 143.98 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.661 -0.65 . . . . 0.0 110.221 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 63.1 t -84.97 136.31 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.583 -0.698 . . . . 0.0 109.318 171.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 9.2 pttt -134.91 -170.14 2.5 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.464 -0.773 . . . . 0.0 111.067 -166.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -95.15 159.34 15.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.715 -0.616 . . . . 0.0 110.426 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.68 ' HG ' ' HG ' ' A' ' 273' ' ' CYS . 59.6 m . . . . . 0 N--CA 1.495 1.812 0 O-C-N 121.644 -0.66 . . . . 0.0 109.425 176.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.449 HD12 ' HG3' ' A' ' 268' ' ' MET . 30.7 tp . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 120.824 0.345 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.654 HD12 ' HD3' ' A' ' 190' ' ' PRO . 80.8 mt -98.96 136.78 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.757 -0.59 . . . . 0.0 109.867 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -132.53 158.01 43.23 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.704 -0.622 . . . . 0.0 110.381 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.574 HG23 HG21 ' A' ' 247' ' ' VAL . 86.3 t -103.45 146.68 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.694 -0.629 . . . . 0.0 110.034 177.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -118.79 129.62 55.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.727 -0.608 . . . . 0.0 110.329 170.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.12 24.18 20.32 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 167.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -139.7 107.29 5.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.427 -1.043 . . . . 0.0 110.104 174.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 93.5 p -63.36 -15.12 56.51 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.641 -0.662 . . . . 0.0 111.197 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -97.02 9.99 40.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.266 -0.896 . . . . 0.0 111.265 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.87 126.2 26.52 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.185 -0.947 . . . . 0.0 110.112 176.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -139.69 155.2 47.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.794 -0.566 . . . . 0.0 109.759 176.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.42 ' CD2' ' HB ' ' A' ' 247' ' ' VAL . 77.2 m-85 -118.77 150.67 39.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.506 -0.746 . . . . 0.0 110.558 -176.021 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.19 159.88 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.817 -0.552 . . . . 0.0 110.3 178.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -120.1 129.78 54.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.667 -0.645 . . . . 0.0 110.063 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -65.01 130.01 94.71 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.626 -0.671 . . . . 0.0 109.886 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -66.36 -27.66 47.4 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.164 1.086 . . . . 0.0 111.111 -171.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.5 mt -100.35 -50.49 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.377 -0.827 . . . . 0.0 110.978 -168.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.7 p -105.38 12.16 31.91 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.37 -0.831 . . . . 0.0 111.846 -175.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.87 -5.16 13.4 Favored Glycine 0 N--CA 1.497 2.736 0 O-C-N 121.055 -1.028 . . . . 0.0 111.898 173.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 23.1 mmt85 -46.19 142.12 3.01 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-N 119.125 1.462 . . . . 0.0 112.265 -174.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -107.29 141.67 38.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.637 -0.664 . . . . 0.0 110.143 175.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 80.0 p -154.77 159.89 40.94 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.547 -0.721 . . . . 0.0 110.609 177.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.574 HG21 HG23 ' A' ' 228' ' ' VAL . 8.4 p -123.28 148.25 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.739 -0.601 . . . . 0.0 109.696 178.273 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.733 HD22 ' HG2' ' A' ' 187' ' ' ARG . 82.4 mt -129.57 154.58 46.92 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.878 -175.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.443 HG13 ' C ' ' A' ' 248' ' ' LEU . 34.7 m -151.15 151.73 29.97 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.823 -0.548 . . . . 0.0 109.943 175.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -71.07 140.11 37.1 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.303 1.159 . . . . 0.0 110.084 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.739 ' HD2' HD11 ' A' ' 186' ' ' ILE . 58.9 t80 -76.6 125.0 28.47 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.435 -0.791 . . . . 0.0 110.168 174.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -100.0 160.16 27.94 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.795 -0.565 . . . . 0.0 109.907 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -58.68 159.8 19.47 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 O-C-N 123.305 1.161 . . . . 0.0 110.48 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.02 149.92 76.42 Favored 'Trans proline' 0 N--CA 1.487 1.126 0 O-C-N 123.218 1.115 . . . . 0.0 110.539 -177.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -61.98 148.1 44.92 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.689 -0.632 . . . . 0.0 110.21 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.5 t -69.9 127.24 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.496 -0.752 . . . . 0.0 110.124 -170.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.01 -10.1 55.27 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 9.9 t -144.59 173.12 12.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.177 -1.19 . . . . 0.0 110.604 174.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -106.88 13.05 28.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.657 -0.652 . . . . 0.0 111.728 -168.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -119.95 168.02 11.56 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.149 -0.969 . . . . 0.0 111.136 -175.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 92.4 m -117.8 146.89 43.52 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.768 -0.583 . . . . 0.0 109.861 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 47.5 m -117.73 134.9 54.42 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.599 -0.688 . . . . 0.0 110.942 -175.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 59.6 t -131.02 137.36 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 71.9 mt -104.7 121.88 44.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.422 -0.799 . . . . 0.0 109.958 -171.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.678 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 5.8 m-30 -106.38 151.8 24.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.709 -0.619 . . . . 0.0 110.616 -177.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -136.61 142.93 43.31 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -111.26 130.02 55.79 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.54 -0.725 . . . . 0.0 110.426 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 268' ' ' MET . . . . . 0.449 ' HG3' HD12 ' A' ' 225' ' ' LEU . 5.2 ppp? -96.85 3.85 51.98 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.682 -0.636 . . . . 0.0 112.052 -175.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 269' ' ' CYS . . . . . 0.647 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.5 OUTLIER -144.79 165.02 29.27 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.053 -1.03 . . . . 0.0 109.961 174.067 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.617 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.7 p30 -119.43 159.82 23.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.643 -0.661 . . . . 0.0 110.187 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 271' ' ' SER . . . . . 0.401 ' HA ' ' HB3' ' A' ' 277' ' ' MET . 29.5 m -59.31 -32.39 70.01 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.356 -0.84 . . . . 0.0 110.912 -163.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 47.1 p -97.58 11.47 36.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.405 -0.809 . . . . 0.0 111.978 -164.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 273' ' ' CYS . . . . . 0.68 ' HG ' ' HG ' ' A' ' 205' ' ' CYS . 30.0 p -95.07 118.07 31.26 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.116 -0.99 . . . . 0.0 110.631 178.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.15 139.16 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.462 -0.774 . . . . 0.0 110.189 -172.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 100.87 -5.12 56.38 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -123.74 -113.98 2.1 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 170.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 277' ' ' MET . . . . . 0.403 ' CE ' ' HA ' ' A' ' 281' ' ' PRO . 26.6 ttt -64.16 -23.71 67.42 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.62 -0.93 . . . . 0.0 110.489 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 10.2 p30 44.52 54.46 6.39 Favored 'General case' 0 N--CA 1.504 2.273 0 CA-C-O 121.331 0.586 . . . . 0.0 112.58 172.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 22.8 mtp85 54.74 26.93 8.11 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.312 -0.867 . . . . 0.0 111.365 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 280' ' ' ARG . . . . . 0.401 ' HA ' ' HD2' ' A' ' 281' ' ' PRO . 82.0 mtt-85 -115.02 114.6 43.62 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.388 -0.82 . . . . 0.0 109.956 173.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 281' ' ' PRO . . . . . 0.403 ' HA ' ' CE ' ' A' ' 277' ' ' MET . 11.9 Cg_endo -59.45 145.39 98.09 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 O-C-N 122.969 0.984 . . . . 0.0 110.614 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.629 HG22 ' HA ' ' A' ' 192' ' ' TYR . 44.9 pt -131.92 174.72 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-O 121.758 0.79 . . . . 0.0 110.862 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 193' ' ' LYS . 29.2 mt -124.44 149.88 46.28 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 284' ' ' ILE . . . . . . . . . . . . . 81.3 mt -118.33 128.68 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.218 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.628 HG23 ' SG ' ' A' ' 300' ' ' CYS . 85.4 mt -109.72 127.38 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -174.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 61.8 t -119.0 126.79 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.6 p -125.26 154.07 42.23 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.664 -0.647 . . . . 0.0 110.624 -173.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.66 HD21 ' HB3' ' A' ' 180' ' ' PRO . 29.7 tp -105.19 126.16 51.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.697 -0.627 . . . . 0.0 109.503 169.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.634 ' OE2' HG13 ' A' ' 295' ' ' VAL . 72.5 mm-40 -130.96 149.62 52.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.916 -0.49 . . . . 0.0 109.681 -173.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.799 ' CG2' HD11 ' A' ' 296' ' ' LEU . 23.4 p -89.93 160.37 16.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.6 -0.688 . . . . 0.0 109.999 178.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -55.89 -26.15 45.94 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.568 -0.707 . . . . 0.0 111.082 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 45.4 p30 -90.14 9.52 27.99 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.467 -0.771 . . . . 0.0 111.931 -173.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.61 20.21 45.27 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 120.182 -1.008 . . . . 0.0 110.755 171.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -107.93 140.21 41.4 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.274 -1.133 . . . . 0.0 110.002 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.634 HG13 ' OE2' ' A' ' 289' ' ' GLU . 61.1 t -87.63 133.12 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.551 -0.718 . . . . 0.0 110.278 -172.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.799 HD11 ' CG2' ' A' ' 290' ' ' THR . 96.1 mt -99.86 -40.19 7.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.697 -0.627 . . . . 0.0 110.522 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -167.54 154.97 25.57 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -133.86 136.9 44.68 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.616 -0.932 . . . . 0.0 110.791 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -135.01 155.84 50.07 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.661 -0.65 . . . . 0.0 109.874 172.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 300' ' ' CYS . . . . . 0.628 ' SG ' HG23 ' A' ' 285' ' ' ILE . 98.1 m -142.52 153.18 43.38 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.399 -0.813 . . . . 0.0 110.781 -175.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -145.02 164.15 32.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.608 -0.683 . . . . 0.0 110.071 176.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.418 ' HA ' HD23 ' A' ' 283' ' ' LEU . 82.1 tt0 -104.84 136.1 44.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.609 -0.682 . . . . 0.0 110.173 -177.051 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -124.48 143.84 50.42 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.715 -169.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 61.8 ttm-85 -138.13 141.88 40.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.712 -0.617 . . . . 0.0 109.744 173.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.647 HD13 ' O ' ' A' ' 269' ' ' CYS . 77.2 mt -108.74 122.94 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.577 -0.702 . . . . 0.0 109.671 175.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.8 p -145.39 168.89 19.43 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.53 -0.731 . . . . 0.0 110.645 -172.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -71.28 -40.05 71.14 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.674 -0.642 . . . . 0.0 110.77 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.8 t -127.14 85.37 61.19 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.454 -0.779 . . . . 0.0 110.514 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 309' ' ' PRO . . . . . 0.4 ' HD3' ' HG3' ' A' ' 165' ' ' GLN . 43.7 Cg_exo -56.03 -27.79 66.15 Favored 'Trans proline' 0 N--CA 1.489 1.257 0 O-C-N 123.231 1.122 . . . . 0.0 110.674 174.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -68.14 -37.06 86.62 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.126 -1.589 . . . . 0.0 109.126 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -72.85 -39.92 66.14 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.647 -0.913 . . . . 0.0 109.749 -173.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -69.49 -40.51 77.0 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 120.067 -0.653 . . . . 0.0 109.934 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -62.06 -42.83 99.6 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.557 -0.715 . . . . 0.0 110.122 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -63.87 -40.27 96.15 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.599 -0.688 . . . . 0.0 110.563 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.19 -51.97 66.79 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.503 -0.748 . . . . 0.0 110.392 -174.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.6 p30 . . . . . 0 N--CA 1.494 1.77 0 O-C-N 121.458 -0.776 . . . . 0.0 110.029 -178.437 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.6 t . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.082 0.467 . . . . 0.0 110.342 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.9 p-10 -94.97 24.95 4.43 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.644 -0.66 . . . . 0.0 110.797 -178.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 52.1 m -72.09 125.21 26.71 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.593 -0.692 . . . . 0.0 110.248 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -71.09 144.9 50.16 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.754 -0.591 . . . . 0.0 110.538 -177.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -152.18 101.02 2.81 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.732 -0.605 . . . . 0.0 110.134 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -59.07 -39.96 75.11 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.042 1.022 . . . . 0.0 110.792 -174.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.42 -155.12 46.75 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -76.36 -44.0 0.27 Allowed 'Trans proline' 0 C--N 1.317 -1.08 0 O-C-N 123.38 1.2 . . . . 0.0 110.991 -174.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -86.91 8.84 21.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.503 -0.748 . . . . 0.0 111.425 -173.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 t 53.62 60.54 3.62 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.956 -1.09 . . . . 0.0 110.772 -176.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.67 ' HA ' HG12 ' A' ' 176' ' ' VAL . 37.3 t80 -77.84 118.41 20.14 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.585 -0.697 . . . . 0.0 109.871 -178.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -130.03 159.99 35.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.862 -0.523 . . . . 0.0 110.124 -178.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.8 t -125.98 146.07 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.797 -0.564 . . . . 0.0 109.726 177.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.8 p -155.31 161.12 41.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.772 -0.58 . . . . 0.0 110.03 177.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.406 ' CE2' HG12 ' A' ' 172' ' ' ILE . 71.5 m-85 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.769 -0.582 . . . . 0.0 109.772 -176.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 121.113 0.482 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.425 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 44.9 p -60.07 -34.12 73.01 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.7 -0.625 . . . . 0.0 110.243 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.438 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -170.87 144.35 2.2 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.435 0.636 . . . . 0.0 110.237 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.4 t -142.09 142.66 32.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.863 -0.523 . . . . 0.0 109.971 -176.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -125.44 140.12 53.06 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.499 -0.751 . . . . 0.0 110.553 -172.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.2 t -110.69 124.5 52.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.852 -0.53 . . . . 0.0 109.773 176.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 60.6 m -70.63 -36.99 73.73 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.808 -0.558 . . . . 0.0 110.417 -177.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -59.54 -33.59 71.59 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.587 -0.695 . . . . 0.0 110.43 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.429 HD11 ' OD1' ' A' ' 316' ' ' ASP . 57.0 mt -104.85 -12.06 16.45 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.711 -0.618 . . . . 0.0 110.826 -175.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 78.8 tttt 59.84 50.25 7.14 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.126 -0.984 . . . . 0.0 109.678 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -145.84 153.1 40.51 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.571 -174.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.607 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.5 tp -126.5 137.83 53.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.739 -0.601 . . . . 0.0 110.25 -176.293 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -115.81 134.51 54.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.668 -0.645 . . . . 0.0 109.33 175.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.47 158.57 44.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.646 -0.659 . . . . 0.0 110.808 -176.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.434 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 54.5 mt-30 -104.54 144.56 31.52 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.668 171.142 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.413 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.2 tt -51.46 147.43 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 CA-C-O 121.572 0.701 . . . . 0.0 112.107 -173.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.99 9.99 5.89 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.555 -0.715 . . . . 0.0 112.734 174.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.434 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 59.3 mmtt -94.22 155.15 17.19 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.951 -1.093 . . . . 0.0 111.045 173.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 87.3 m -81.28 126.22 31.28 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.767 -0.583 . . . . 0.0 110.596 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' CYS . . . . . 0.607 ' SG ' HD21 ' A' ' 162' ' ' LEU . 43.9 t -114.13 90.04 18.8 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.602 -0.686 . . . . 0.0 110.175 173.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.438 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 18.4 Cg_exo -63.38 128.83 23.55 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 O-C-N 123.281 1.148 . . . . 0.0 110.598 173.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.406 HG12 ' CE2' ' A' ' 142' ' ' PHE . 97.5 mt -123.34 143.43 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.597 -0.689 . . . . 0.0 109.36 175.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -110.47 134.82 51.99 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.453 -0.779 . . . . 0.0 110.857 -175.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.5 mm -95.26 135.03 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.644 -0.66 . . . . 0.0 109.7 169.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.9 tttt -115.21 128.29 56.06 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.466 175.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.67 HG12 ' HA ' ' A' ' 138' ' ' PHE . 15.9 m -136.64 159.71 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.69 -0.631 . . . . 0.0 109.832 174.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.7 mmm -75.22 -40.51 59.04 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.771 -0.581 . . . . 0.0 110.166 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 76.8 p -135.71 143.25 43.96 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.834 -0.541 . . . . 0.0 109.725 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 33.5 Cg_exo -55.31 139.85 81.55 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 O-C-N 123.106 1.056 . . . . 0.0 110.921 -172.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.691 ' HB3' HD21 ' A' ' 288' ' ' LEU . 19.6 Cg_endo -63.05 167.85 11.67 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.226 1.119 . . . . 0.0 110.637 178.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -61.04 156.71 42.95 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 O-C-N 123.395 1.208 . . . . 0.0 110.509 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -74.5 139.01 43.55 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.672 -0.642 . . . . 0.0 109.858 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.69 -24.97 29.29 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 -175.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.2 150.36 2.49 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.317 -1.107 . . . . 0.0 111.323 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 33.6 m -129.79 155.92 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.765 -0.585 . . . . 0.0 109.664 176.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.601 HD11 ' HD2' ' A' ' 251' ' ' TYR . 83.3 mt -106.93 138.31 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.747 -0.595 . . . . 0.0 109.435 175.171 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.758 ' HG2' HD22 ' A' ' 248' ' ' LEU . 56.6 mtp85 -114.95 144.99 42.71 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -176.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.68 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -137.8 128.03 26.11 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.426 -0.796 . . . . 0.0 110.324 174.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 1.6 ttp -137.3 135.84 19.97 Favored Pre-proline 0 N--CA 1.495 1.816 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.957 -175.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.633 ' HD3' HD12 ' A' ' 226' ' ' ILE . 73.3 Cg_endo -91.19 138.18 2.25 Favored 'Trans proline' 0 C--N 1.32 -0.951 0 O-C-N 123.196 1.103 . . . . 0.0 110.777 177.204 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.432 HG13 ' C ' ' A' ' 190' ' ' PRO . 35.5 m -148.21 154.95 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.578 -0.702 . . . . 0.0 109.904 173.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.677 ' HA ' HG22 ' A' ' 282' ' ' ILE . 89.6 m-85 -60.91 163.24 5.98 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.379 -0.826 . . . . 0.0 110.385 -178.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.469 ' HA ' HD12 ' A' ' 283' ' ' LEU . 39.6 tttm -78.64 -60.02 2.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.622 -0.674 . . . . 0.0 110.71 -175.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -80.05 150.33 30.38 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.597 -0.69 . . . . 0.0 110.356 -175.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.455 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.42 -37.88 70.8 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.404 -0.81 . . . . 0.0 110.713 -175.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -56.37 -25.24 48.79 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.562 -0.711 . . . . 0.0 110.56 -175.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.408 ' HB3' ' CG ' ' A' ' 192' ' ' TYR . 5.3 m-70 -109.94 -20.64 12.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.577 -0.702 . . . . 0.0 111.112 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -67.05 -20.2 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.244 -0.91 . . . . 0.0 110.62 -176.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 82.3 p -79.42 -16.96 55.3 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.55 -0.719 . . . . 0.0 110.705 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -88.3 138.52 31.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.359 -0.838 . . . . 0.0 110.058 173.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.9 t -72.87 139.85 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.606 -0.684 . . . . 0.0 110.428 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.561 HG22 ' CE2' ' A' ' 192' ' ' TYR . 63.9 t -84.93 138.92 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.561 -0.712 . . . . 0.0 109.421 170.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 10.6 pttt -134.9 -170.45 2.57 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.463 -0.773 . . . . 0.0 110.993 -171.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -95.47 156.82 16.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.77 -0.581 . . . . 0.0 110.321 174.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.495 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 60.7 m . . . . . 0 N--CA 1.498 1.935 0 O-C-N 121.554 -0.716 . . . . 0.0 109.07 171.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.475 HD12 ' HG3' ' A' ' 268' ' ' MET . 58.6 tp . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 120.836 0.35 . . . . 0.0 110.352 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.633 HD12 ' HD3' ' A' ' 190' ' ' PRO . 83.0 mt -102.85 136.76 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.85 -0.531 . . . . 0.0 109.642 177.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -136.95 162.96 31.84 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.746 -0.596 . . . . 0.0 110.341 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.478 HG23 HG21 ' A' ' 247' ' ' VAL . 94.5 t -109.09 146.79 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.826 -0.546 . . . . 0.0 110.129 -178.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -120.81 121.54 38.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.809 -0.557 . . . . 0.0 110.348 174.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.98 24.09 10.88 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 169.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -137.23 106.74 6.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.413 -1.051 . . . . 0.0 109.988 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 46.0 m -63.16 -15.34 56.54 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.582 -0.699 . . . . 0.0 111.325 -176.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -99.94 5.59 45.25 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.275 -0.89 . . . . 0.0 111.608 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.94 131.4 49.58 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.039 -1.038 . . . . 0.0 110.16 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -139.72 158.07 44.71 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.797 -0.565 . . . . 0.0 109.811 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -112.35 150.64 30.78 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.618 -0.677 . . . . 0.0 110.361 -178.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.26 159.91 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.737 -0.602 . . . . 0.0 110.174 176.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -122.62 129.96 52.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.787 -0.57 . . . . 0.0 110.094 175.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -64.96 130.07 94.72 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.654 -0.654 . . . . 0.0 109.87 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -66.42 -27.92 46.67 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 O-C-N 123.193 1.102 . . . . 0.0 111.049 -170.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.0 mt -100.51 -50.46 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.423 -0.798 . . . . 0.0 110.879 -168.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.1 p -105.32 12.06 32.14 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.396 -0.815 . . . . 0.0 111.875 -175.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.9 -6.23 10.29 Favored Glycine 0 N--CA 1.496 2.69 0 O-C-N 121.034 -1.041 . . . . 0.0 111.941 172.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -46.12 142.03 3.0 Favored 'General case' 0 N--CA 1.506 2.327 0 CA-C-N 119.081 1.441 . . . . 0.0 112.258 -173.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -104.7 141.57 36.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.559 -0.713 . . . . 0.0 110.218 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 72.4 p -154.76 159.93 40.97 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.61 -0.682 . . . . 0.0 110.476 176.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.478 HG21 HG23 ' A' ' 228' ' ' VAL . 8.2 p -125.31 148.21 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.788 -0.57 . . . . 0.0 109.643 177.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.758 HD22 ' HG2' ' A' ' 187' ' ' ARG . 71.4 mt -129.5 154.7 46.75 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.633 -174.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.446 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.8 m -150.86 151.7 30.52 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.769 -0.582 . . . . 0.0 110.042 176.087 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -71.09 137.99 32.7 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 O-C-N 123.298 1.157 . . . . 0.0 109.994 177.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.601 ' HD2' HD11 ' A' ' 186' ' ' ILE . 10.5 t80 -76.54 126.02 30.25 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.573 -0.704 . . . . 0.0 110.221 176.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -100.01 160.07 28.16 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.771 -0.581 . . . . 0.0 109.979 176.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.88 159.11 22.25 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.199 1.105 . . . . 0.0 110.419 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.01 150.04 75.59 Favored 'Trans proline' 0 N--CA 1.488 1.187 0 O-C-N 123.26 1.137 . . . . 0.0 110.525 -177.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -61.16 147.46 44.05 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.669 -0.645 . . . . 0.0 110.139 -178.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.7 t -69.9 127.14 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.485 -0.759 . . . . 0.0 110.168 -170.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.53 -10.11 56.05 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 9.8 t -144.36 174.34 11.0 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.147 -1.208 . . . . 0.0 110.6 176.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -109.21 13.09 24.59 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.527 -0.733 . . . . 0.0 111.918 -166.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -120.95 168.06 11.89 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.081 -1.012 . . . . 0.0 111.193 -176.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 76.2 m -117.68 144.3 45.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.797 -0.564 . . . . 0.0 109.865 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 35.7 m -115.71 135.59 53.89 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.612 -0.68 . . . . 0.0 110.867 -175.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 62.9 t -131.18 137.28 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 174.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 72.4 mt -104.63 120.34 41.08 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.42 -0.8 . . . . 0.0 109.908 -171.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.68 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 4.6 m-30 -105.03 155.39 19.02 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.741 -0.599 . . . . 0.0 110.825 -176.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -136.32 142.9 43.89 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -114.89 128.97 56.6 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.616 -0.677 . . . . 0.0 110.266 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 268' ' ' MET . . . . . 0.475 ' HG3' HD12 ' A' ' 225' ' ' LEU . 5.0 ppp? -98.57 9.27 43.61 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.712 -0.617 . . . . 0.0 111.982 -175.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 269' ' ' CYS . . . . . 0.569 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.8 OUTLIER -144.58 161.32 39.43 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.178 -0.951 . . . . 0.0 110.112 173.662 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.693 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.1 p30 -119.91 164.06 16.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.786 -0.571 . . . . 0.0 110.286 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 271' ' ' SER . . . . . 0.424 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 27.6 m -57.6 -33.93 68.73 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.449 -0.782 . . . . 0.0 110.983 -164.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 67.6 m -105.21 14.95 28.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.497 -0.752 . . . . 0.0 112.042 -164.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 273' ' ' CYS . . . . . 0.495 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 30.1 p -95.17 118.06 31.31 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.103 -0.998 . . . . 0.0 110.677 178.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 51.9 t -63.19 138.86 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.482 -0.761 . . . . 0.0 110.203 -171.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.76 -5.13 59.78 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 178.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.12 -99.3 0.86 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 172.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 277' ' ' MET . . . . . 0.424 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.4 mmm -63.29 -32.59 74.04 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.796 -0.826 . . . . 0.0 110.328 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.4 p30 44.05 48.75 7.45 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 175.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 54.95 29.97 13.17 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.392 -0.818 . . . . 0.0 111.146 175.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 74.0 mtt180 -119.96 105.0 43.36 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.475 -0.766 . . . . 0.0 110.208 175.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -60.53 145.78 98.15 Favored 'Trans proline' 0 N--CA 1.487 1.115 0 O-C-N 123.094 1.049 . . . . 0.0 110.402 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.677 HG22 ' HA ' ' A' ' 192' ' ' TYR . 46.2 pt -131.95 177.63 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.856 0.836 . . . . 0.0 111.249 -175.074 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' A' ' 193' ' ' LYS . 24.8 mt -124.5 149.91 46.36 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.678 HD12 ' CE1' ' A' ' 301' ' ' PHE . 81.2 mt -117.83 130.33 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.318 179.149 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.512 HG23 ' SG ' ' A' ' 300' ' ' CYS . 80.8 mt -109.79 127.38 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -176.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 57.5 t -118.94 126.83 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.634 HG22 ' HG2' ' A' ' 298' ' ' ARG . 45.4 p -125.33 153.1 43.83 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.745 . . . . 0.0 110.632 -173.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.691 HD21 ' HB3' ' A' ' 180' ' ' PRO . 21.7 tp -104.5 124.39 49.19 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.726 -0.609 . . . . 0.0 109.468 169.448 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.597 ' OE2' HG13 ' A' ' 295' ' ' VAL . 70.1 mm-40 -132.16 151.72 51.64 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.87 -0.519 . . . . 0.0 109.806 -173.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.715 ' CG2' HD11 ' A' ' 296' ' ' LEU . 77.8 p -89.88 159.58 16.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.558 -0.714 . . . . 0.0 109.768 177.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -55.94 -26.11 46.43 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.564 -0.71 . . . . 0.0 110.789 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -88.34 9.76 22.19 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.552 -0.717 . . . . 0.0 111.808 -174.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 87.25 20.22 53.07 Favored Glycine 0 N--CA 1.495 2.583 0 O-C-N 121.083 -1.011 . . . . 0.0 110.687 170.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -106.21 140.15 39.61 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.218 -1.166 . . . . 0.0 110.231 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.597 HG13 ' OE2' ' A' ' 289' ' ' GLU . 59.1 t -89.59 130.97 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.592 -0.692 . . . . 0.0 110.29 -173.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.715 HD11 ' CG2' ' A' ' 290' ' ' THR . 95.6 mt -100.11 -40.08 7.77 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.781 -0.574 . . . . 0.0 110.528 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -166.25 154.67 25.38 Favored Glycine 0 N--CA 1.497 2.719 0 C-N-CA 119.898 -1.144 . . . . 0.0 110.391 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.634 ' HG2' HG22 ' A' ' 287' ' ' THR . 91.1 mtt180 -135.09 137.46 42.87 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.692 -0.887 . . . . 0.0 110.667 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -137.67 157.82 45.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.684 -0.635 . . . . 0.0 109.963 170.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 300' ' ' CYS . . . . . 0.512 ' SG ' HG23 ' A' ' 285' ' ' ILE . 78.7 m -141.33 156.81 45.8 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.43 -0.794 . . . . 0.0 110.684 -175.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.678 ' CE1' HD12 ' A' ' 284' ' ' ILE . 47.8 p90 -144.91 162.14 37.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.681 -0.637 . . . . 0.0 110.164 175.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.408 ' HA ' HD23 ' A' ' 283' ' ' LEU . 56.7 tt0 -104.94 134.5 47.95 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.501 -0.749 . . . . 0.0 110.051 -177.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -118.78 143.99 46.57 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.728 -169.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 55.7 ttt85 -138.3 136.79 36.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.766 -0.584 . . . . 0.0 109.792 172.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.693 HG21 ' HA ' ' A' ' 270' ' ' ASN . 78.9 mt -108.27 123.0 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.608 -0.682 . . . . 0.0 109.542 177.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.4 p -145.07 172.82 12.53 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.571 -0.706 . . . . 0.0 110.769 -171.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -72.21 -40.09 68.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.676 -0.64 . . . . 0.0 110.566 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.8 t -131.26 89.08 42.45 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.627 -0.671 . . . . 0.0 110.53 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 309' ' ' PRO . . . . . 0.407 ' CG ' ' HG3' ' A' ' 165' ' ' GLN . 51.2 Cg_exo -54.3 -29.57 58.2 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 O-C-N 123.162 1.085 . . . . 0.0 110.996 173.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -65.95 -37.81 93.57 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -72.5 -41.04 66.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.758 -0.848 . . . . 0.0 109.829 -173.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -69.45 -39.61 77.68 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 120.056 -0.657 . . . . 0.0 110.076 -178.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -61.6 -43.23 99.25 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.284 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -64.27 -40.12 95.32 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.613 -0.679 . . . . 0.0 110.503 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.64 -50.95 70.49 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.502 -0.749 . . . . 0.0 110.512 -173.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 316' ' ' ASP . . . . . 0.429 ' OD1' HD11 ' A' ' 159' ' ' LEU . 3.4 p30 . . . . . 0 N--CA 1.495 1.792 0 O-C-N 121.507 -0.746 . . . . 0.0 110.142 -177.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 30.4 t . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 121.043 0.449 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 p-10 -96.31 26.06 4.56 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.636 -0.665 . . . . 0.0 110.598 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 47.6 m -73.94 125.13 27.52 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.575 -0.703 . . . . 0.0 110.395 -178.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -73.36 144.98 46.25 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.689 -0.632 . . . . 0.0 110.462 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.422 ' CE2' ' HA2' ' A' ' 134' ' ' GLY . 62.8 t80 -157.01 101.78 1.94 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.7 -0.625 . . . . 0.0 110.137 178.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -58.64 -39.9 78.42 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 O-C-N 123.094 1.049 . . . . 0.0 110.948 -175.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.422 ' HA2' ' CE2' ' A' ' 132' ' ' TYR . . . 78.76 -155.12 40.66 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 178.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -73.14 -49.1 0.24 Allowed 'Trans proline' 0 C--N 1.317 -1.116 0 O-C-N 123.337 1.177 . . . . 0.0 110.874 -174.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -85.18 6.67 24.88 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.626 -0.672 . . . . 0.0 111.432 -174.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 t 54.17 62.09 2.75 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.964 -1.085 . . . . 0.0 110.675 -176.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.724 ' HA ' HG12 ' A' ' 176' ' ' VAL . 59.3 t80 -77.87 120.86 23.34 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.655 -0.653 . . . . 0.0 109.993 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -130.06 159.95 35.19 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.309 0.576 . . . . 0.0 110.134 -177.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 64.8 t -124.97 145.23 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.76 -0.588 . . . . 0.0 109.897 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 80.0 p -155.41 160.94 41.05 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.345 0.593 . . . . 0.0 109.937 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.49 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 59.8 m-85 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.728 -0.608 . . . . 0.0 109.848 -176.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.871 0 CA-C-O 121.193 0.521 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.501 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 82.1 p -60.06 -33.99 72.81 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.689 -0.632 . . . . 0.0 109.933 176.135 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.501 ' HD1' ' HG1' ' A' ' 152' ' ' THR . 68.8 p-90 -170.74 143.5 2.14 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.366 0.603 . . . . 0.0 110.238 177.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.6 t -142.11 142.58 32.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.9 -0.5 . . . . 0.0 109.978 -176.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.49 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 60.9 t80 -125.58 140.01 53.11 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.496 -0.753 . . . . 0.0 110.771 -172.185 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 31.5 t -112.2 125.02 53.69 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.007 177.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 54.1 m -70.81 -37.12 73.22 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.724 -0.61 . . . . 0.0 110.534 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -59.25 -34.55 72.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.618 -0.676 . . . . 0.0 110.502 -177.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.1 mt -104.84 -12.0 16.49 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.933 -175.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 49.7 tttt 59.83 51.37 6.14 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.991 -1.068 . . . . 0.0 109.637 178.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -145.15 153.13 41.05 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.571 -173.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.57 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.9 tp -126.54 137.71 53.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.788 -0.57 . . . . 0.0 110.208 -176.19 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -115.59 134.42 55.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.64 -0.662 . . . . 0.0 109.292 173.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.43 158.62 43.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.736 -0.602 . . . . 0.0 110.85 -177.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.419 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 53.0 mt-30 -104.42 143.08 33.49 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.553 -0.717 . . . . 0.0 109.795 171.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.45 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.3 tt -52.44 148.45 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.538 -0.727 . . . . 0.0 111.851 -173.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 66.38 9.13 6.2 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.624 -0.672 . . . . 0.0 112.596 175.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.419 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 74.9 mmtt -94.41 155.13 17.11 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.933 -1.105 . . . . 0.0 110.983 172.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 88.5 m -84.07 126.21 32.85 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.719 -0.613 . . . . 0.0 110.433 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' CYS . . . . . 0.57 ' SG ' HD21 ' A' ' 162' ' ' LEU . 48.5 t -113.09 90.19 15.58 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.658 -0.652 . . . . 0.0 110.075 174.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.437 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 22.5 Cg_exo -61.33 130.52 32.4 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.276 1.145 . . . . 0.0 110.704 173.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.416 HG12 ' CE2' ' A' ' 142' ' ' PHE . 94.5 mt -124.61 141.91 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.639 -0.663 . . . . 0.0 109.28 175.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' GLN . . . . . 0.436 ' NE2' ' CE1' ' A' ' 260' ' ' PHE . 98.4 mt-30 -108.9 136.45 48.43 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.524 -0.735 . . . . 0.0 110.826 -175.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.433 ' CG2' ' CE2' ' A' ' 138' ' ' PHE . 48.5 mm -95.24 135.06 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.694 -0.629 . . . . 0.0 109.64 169.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -117.65 129.37 55.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.606 -0.684 . . . . 0.0 110.405 176.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.724 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.1 m -136.67 159.75 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.538 -0.726 . . . . 0.0 110.057 175.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 80.7 mmm -77.46 -40.3 43.64 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.703 -0.623 . . . . 0.0 110.122 177.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.417 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 75.6 p -135.48 143.24 44.37 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.744 -0.597 . . . . 0.0 109.693 177.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.7 Cg_exo -55.49 139.89 82.56 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 O-C-N 123.114 1.06 . . . . 0.0 110.911 -172.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.763 ' HB3' HD21 ' A' ' 288' ' ' LEU . 32.1 Cg_endo -67.67 169.98 14.84 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 O-C-N 123.211 1.111 . . . . 0.0 110.565 177.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -60.49 155.32 47.98 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.35 1.184 . . . . 0.0 110.551 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -77.8 140.61 39.43 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.591 -0.693 . . . . 0.0 109.925 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.65 -24.93 29.47 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -174.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.16 152.78 1.61 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.337 -1.096 . . . . 0.0 111.404 178.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.8 155.89 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.713 -0.617 . . . . 0.0 109.765 176.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.726 HD11 ' HD2' ' A' ' 251' ' ' TYR . 81.1 mt -108.89 138.17 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.645 -0.659 . . . . 0.0 109.49 176.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.729 ' HG2' HD22 ' A' ' 248' ' ' LEU . 61.9 mtt180 -115.08 146.05 41.7 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -175.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.684 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -139.03 128.48 24.34 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.535 -0.728 . . . . 0.0 110.226 174.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.412 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 26.3 ttp -137.27 136.37 20.64 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.788 -0.57 . . . . 0.0 110.905 -176.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.504 ' HB3' HD11 ' A' ' 226' ' ' ILE . 74.1 Cg_endo -91.86 138.08 1.96 Allowed 'Trans proline' 0 C--N 1.32 -0.953 0 O-C-N 123.164 1.086 . . . . 0.0 110.643 177.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.439 HG13 ' C ' ' A' ' 190' ' ' PRO . 35.2 m -148.42 154.95 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.528 -0.733 . . . . 0.0 109.907 174.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.695 ' HA ' HG22 ' A' ' 282' ' ' ILE . 91.3 m-85 -60.6 163.92 5.01 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.447 -0.783 . . . . 0.0 110.413 -178.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.465 ' HA ' HD12 ' A' ' 283' ' ' LEU . 78.8 tttt -79.93 -59.99 2.51 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.661 -0.65 . . . . 0.0 110.785 -174.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 35.0 mttm -80.03 150.68 30.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.628 -0.67 . . . . 0.0 110.395 -175.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.454 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.43 -38.3 71.39 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.435 -0.791 . . . . 0.0 110.718 -175.081 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -56.49 -25.04 49.96 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.518 -0.739 . . . . 0.0 110.594 -175.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -110.01 -20.56 12.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.58 -0.7 . . . . 0.0 111.088 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.454 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.1 p -67.02 -20.27 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.137 -0.977 . . . . 0.0 110.592 -176.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 81.6 p -79.34 -17.06 55.29 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.545 -0.722 . . . . 0.0 110.753 175.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -88.39 138.79 31.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.38 -0.825 . . . . 0.0 110.041 173.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 57.6 t -73.24 142.73 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.585 -0.697 . . . . 0.0 110.156 176.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.541 HG22 ' CE2' ' A' ' 192' ' ' TYR . 77.8 t -84.9 140.15 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.552 -0.718 . . . . 0.0 109.443 171.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.2 pttp -134.84 -170.27 2.53 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.539 -0.726 . . . . 0.0 110.873 -169.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -95.28 156.38 16.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.735 -0.603 . . . . 0.0 110.52 178.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.64 ' HG ' ' HG ' ' A' ' 273' ' ' CYS . 60.1 m . . . . . 0 N--CA 1.497 1.887 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 172.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.4 ' CD1' ' HB2' ' A' ' 269' ' ' CYS . 40.7 tp . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 120.887 0.375 . . . . 0.0 110.566 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.504 HD11 ' HB3' ' A' ' 190' ' ' PRO . 91.3 mt -107.67 136.77 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 121.159 0.504 . . . . 0.0 110.111 -176.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 71.9 mtm-85 -140.53 167.92 21.02 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.638 -0.664 . . . . 0.0 110.1 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.489 HG23 HG21 ' A' ' 247' ' ' VAL . 82.9 t -105.28 146.73 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.37 0.605 . . . . 0.0 110.211 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -116.39 130.0 56.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.729 -0.607 . . . . 0.0 110.356 169.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.36 25.26 16.65 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 167.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -140.9 107.45 5.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.443 -1.034 . . . . 0.0 110.061 175.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 27.2 t -62.89 -15.26 54.4 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.588 -0.695 . . . . 0.0 111.329 -177.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 63.1 m170 -99.77 6.38 45.47 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.21 -0.931 . . . . 0.0 111.612 -177.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.32 128.51 36.71 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.081 -1.012 . . . . 0.0 110.241 176.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -139.75 158.05 44.74 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.785 -0.572 . . . . 0.0 109.681 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -116.86 150.6 38.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.574 -0.704 . . . . 0.0 110.686 -176.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.14 159.94 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.81 -0.556 . . . . 0.0 110.167 177.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -120.59 130.0 54.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.775 -0.578 . . . . 0.0 110.193 176.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -65.09 130.1 94.71 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.706 -0.621 . . . . 0.0 109.878 177.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -66.37 -27.62 47.35 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 O-C-N 123.128 1.068 . . . . 0.0 111.038 -171.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 82.9 mt -100.43 -50.41 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.292 -0.88 . . . . 0.0 111.013 -167.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.7 p -105.38 12.14 31.93 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.326 -0.859 . . . . 0.0 111.828 -175.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.86 -5.63 11.93 Favored Glycine 0 N--CA 1.496 2.678 0 O-C-N 121.131 -0.981 . . . . 0.0 111.832 174.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 22.9 mmt85 -46.09 142.0 2.99 Favored 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 119.194 1.497 . . . . 0.0 112.23 -173.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -105.59 145.43 30.99 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.607 -0.683 . . . . 0.0 110.091 175.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.0 p -154.74 159.92 40.99 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.623 -0.673 . . . . 0.0 110.534 176.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.489 HG21 HG23 ' A' ' 228' ' ' VAL . 8.2 p -123.82 148.1 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.731 -0.606 . . . . 0.0 109.695 178.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.729 HD22 ' HG2' ' A' ' 187' ' ' ARG . 81.7 mt -129.76 154.57 47.07 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.867 -176.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.441 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.7 m -150.69 151.67 30.89 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.813 -0.554 . . . . 0.0 109.986 174.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -71.1 140.03 36.85 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 O-C-N 123.329 1.173 . . . . 0.0 110.085 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.726 ' HD2' HD11 ' A' ' 186' ' ' ILE . 58.7 t80 -76.6 126.1 30.39 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.505 -0.747 . . . . 0.0 110.194 174.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -100.08 160.09 28.09 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.687 -0.633 . . . . 0.0 109.887 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.88 159.84 20.01 Favored 'Trans proline' 0 N--CA 1.488 1.188 0 O-C-N 123.204 1.107 . . . . 0.0 110.403 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.07 150.03 75.97 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 O-C-N 123.274 1.144 . . . . 0.0 110.501 -177.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -61.6 146.76 47.88 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.674 -0.641 . . . . 0.0 110.123 -178.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.84 127.2 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.517 -0.739 . . . . 0.0 110.145 -170.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.02 -10.2 55.32 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 9.8 t -144.23 174.39 10.93 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.105 -1.233 . . . . 0.0 110.641 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -108.84 13.13 25.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.595 -0.691 . . . . 0.0 111.948 -167.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.436 ' CE1' ' NE2' ' A' ' 173' ' ' GLN . 46.6 p90 -121.76 168.11 12.2 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.155 -0.965 . . . . 0.0 111.122 -176.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 85.5 m -117.77 145.86 44.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.778 -0.576 . . . . 0.0 109.87 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 55.3 m -116.02 135.58 53.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.633 -0.667 . . . . 0.0 110.903 -174.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.9 t -131.77 137.27 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 173.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 77.2 mt -104.69 121.6 43.91 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.477 -0.764 . . . . 0.0 110.005 -170.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.684 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 4.1 m-30 -107.94 149.24 28.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.705 -0.622 . . . . 0.0 110.556 -176.165 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -136.55 143.01 43.45 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.674 -0.642 . . . . 0.0 109.545 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -120.2 136.99 54.45 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.638 -0.664 . . . . 0.0 110.452 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 268' ' ' MET . . . . . 0.457 ' HE3' ' HB2' ' A' ' 269' ' ' CYS . 0.0 OUTLIER -105.43 12.53 31.41 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 120.179 -0.608 . . . . 0.0 112.195 -176.147 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 269' ' ' CYS . . . . . 0.676 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.6 OUTLIER -144.6 159.16 43.26 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.075 -1.016 . . . . 0.0 109.838 176.091 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.611 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.2 p30 -120.31 163.42 17.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.651 -0.656 . . . . 0.0 110.401 -177.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 271' ' ' SER . . . . . 0.417 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 43.4 m -57.11 -34.18 68.1 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.46 -0.775 . . . . 0.0 111.1 -165.137 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 65.5 m -104.6 15.02 28.84 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.411 -0.806 . . . . 0.0 111.967 -164.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 273' ' ' CYS . . . . . 0.64 ' HG ' ' HG ' ' A' ' 205' ' ' CYS . 30.3 p -93.61 118.03 30.85 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.088 -1.007 . . . . 0.0 110.581 178.097 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.2 t -63.58 139.45 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.442 -0.786 . . . . 0.0 110.419 -169.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.47 -5.09 60.35 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.97 -99.33 0.87 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 173.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 277' ' ' MET . . . . . 0.417 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.5 mmm -61.42 -31.87 71.81 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.614 -0.933 . . . . 0.0 110.109 177.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 23.6 p30 42.25 47.02 4.02 Favored 'General case' 0 N--CA 1.507 2.38 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 174.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 22.9 mtt180 54.87 31.58 16.04 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.274 -0.891 . . . . 0.0 111.207 176.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 -120.1 104.94 43.11 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.458 -0.776 . . . . 0.0 110.056 173.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -59.99 148.24 89.75 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 O-C-N 123.094 1.049 . . . . 0.0 110.468 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.695 HG22 ' HA ' ' A' ' 192' ' ' TYR . 46.7 pt -131.86 176.74 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.806 0.812 . . . . 0.0 111.118 -175.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 193' ' ' LYS . 27.5 mt -124.37 149.83 46.23 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.686 HD12 ' CE1' ' A' ' 301' ' ' PHE . 81.4 mt -116.89 130.76 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.21 178.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.476 HG23 ' SG ' ' A' ' 300' ' ' CYS . 79.4 mt -109.8 126.37 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -177.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 58.7 t -118.92 126.75 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 46.1 p -125.21 153.54 42.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.554 -0.716 . . . . 0.0 110.721 -173.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.763 HD21 ' HB3' ' A' ' 180' ' ' PRO . 26.3 tp -104.08 126.42 51.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.785 -0.572 . . . . 0.0 109.5 169.034 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.502 ' OE2' HG22 ' A' ' 295' ' ' VAL . 72.9 mm-40 -130.44 150.25 51.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.91 -0.494 . . . . 0.0 109.861 -173.148 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.824 ' CG2' HD11 ' A' ' 296' ' ' LEU . 22.8 p -89.87 161.73 15.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.687 -0.633 . . . . 0.0 109.928 177.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -55.89 -26.15 45.96 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.641 -0.662 . . . . 0.0 111.042 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 45.6 p30 -89.87 9.19 28.53 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.408 -0.807 . . . . 0.0 112.004 -173.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.61 20.19 45.36 Favored Glycine 0 N--CA 1.494 2.522 0 O-C-N 121.09 -1.006 . . . . 0.0 110.725 171.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -107.03 140.21 40.2 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.295 -1.121 . . . . 0.0 110.163 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.502 HG22 ' OE2' ' A' ' 289' ' ' GLU . 72.1 t -85.24 132.79 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.588 -0.695 . . . . 0.0 110.228 -174.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.824 HD11 ' CG2' ' A' ' 290' ' ' THR . 95.2 mt -100.01 -40.15 7.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.621 -0.674 . . . . 0.0 110.399 176.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -163.64 153.44 23.88 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -133.87 136.19 44.18 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.609 -0.936 . . . . 0.0 110.648 -178.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -134.73 157.81 45.75 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.611 -0.681 . . . . 0.0 110.026 172.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 300' ' ' CYS . . . . . 0.476 ' SG ' HG23 ' A' ' 285' ' ' ILE . 95.3 m -143.02 153.25 42.78 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.474 -0.766 . . . . 0.0 110.629 -176.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.686 ' CE1' HD12 ' A' ' 284' ' ' ILE . 47.8 p90 -145.01 162.38 37.06 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.631 -0.668 . . . . 0.0 110.174 176.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.413 ' HA ' HD23 ' A' ' 283' ' ' LEU . 81.9 tt0 -104.86 135.11 46.82 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.543 -0.723 . . . . 0.0 110.238 -176.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -120.09 143.61 48.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.62 -0.675 . . . . 0.0 110.737 -170.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -138.28 138.29 38.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.786 -0.571 . . . . 0.0 109.74 173.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.676 HD13 ' O ' ' A' ' 269' ' ' CYS . 73.9 mt -109.01 122.96 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.541 -0.724 . . . . 0.0 109.667 176.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.3 p -145.17 171.56 14.35 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.625 -0.672 . . . . 0.0 110.657 -172.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -70.89 -40.11 72.4 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.658 -0.651 . . . . 0.0 110.494 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.8 t -130.44 89.11 45.23 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.524 -0.735 . . . . 0.0 110.467 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 309' ' ' PRO . . . . . 0.406 ' CG ' ' HG3' ' A' ' 165' ' ' GLN . 50.6 Cg_exo -54.25 -29.27 56.34 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 O-C-N 123.146 1.077 . . . . 0.0 111.025 173.037 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -65.63 -37.81 93.96 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 177.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 37.6 ttp180 -72.82 -42.1 64.18 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.714 -0.874 . . . . 0.0 109.938 -173.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -69.53 -40.47 76.89 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.172 -178.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 73.2 ttt-85 -60.23 -43.38 96.1 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.449 -0.782 . . . . 0.0 110.351 178.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -64.42 -41.02 96.84 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.585 -0.697 . . . . 0.0 110.522 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -60.94 -50.14 74.62 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.506 -0.746 . . . . 0.0 110.462 -173.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.2 p30 . . . . . 0 N--CA 1.494 1.772 0 O-C-N 121.433 -0.792 . . . . 0.0 110.06 -178.703 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.6 t . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.133 0.492 . . . . 0.0 110.313 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -93.85 22.92 5.19 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.614 -0.679 . . . . 0.0 110.893 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 48.2 m -71.67 125.14 26.34 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.542 -0.724 . . . . 0.0 110.226 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -70.74 144.9 50.78 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.715 -0.615 . . . . 0.0 110.461 -177.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.43 ' CE1' ' HA2' ' A' ' 134' ' ' GLY . 64.9 t80 -154.93 101.37 2.32 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.72 -0.613 . . . . 0.0 110.061 178.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -58.79 -39.88 77.67 Favored 'Trans proline' 0 N--CA 1.488 1.153 0 O-C-N 123.115 1.061 . . . . 0.0 110.799 -174.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.43 ' HA2' ' CE1' ' A' ' 132' ' ' TYR . . . 81.64 -155.2 35.22 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 177.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -74.27 -48.89 0.2 Allowed 'Trans proline' 0 C--N 1.316 -1.156 0 O-C-N 123.385 1.203 . . . . 0.0 110.873 -174.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -86.98 9.03 20.76 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.635 -0.665 . . . . 0.0 111.403 -173.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.57 62.11 2.79 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.99 -1.069 . . . . 0.0 110.686 -177.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.721 ' HA ' HG12 ' A' ' 176' ' ' VAL . 65.2 t80 -79.27 119.3 22.15 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.559 -0.713 . . . . 0.0 110.048 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -130.05 159.94 35.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.785 -0.572 . . . . 0.0 110.37 -175.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 59.4 t -125.11 146.54 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.698 -0.626 . . . . 0.0 109.819 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.6 p -155.18 161.55 41.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.736 -0.602 . . . . 0.0 110.024 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.417 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 41.2 m-85 . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.789 -0.57 . . . . 0.0 109.923 -176.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.111 0.481 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 44.1 p -60.12 -34.09 73.03 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.682 -0.636 . . . . 0.0 110.229 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.448 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.0 p-90 -171.26 144.29 2.0 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.62 -0.675 . . . . 0.0 110.117 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.4 t -142.13 142.7 32.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.882 -0.511 . . . . 0.0 109.992 -176.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.417 ' CG ' ' HB2' ' A' ' 142' ' ' PHE . 63.2 t80 -125.41 140.06 53.12 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.54 -0.725 . . . . 0.0 110.423 -173.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.8 t -110.56 123.96 50.94 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 120.379 -0.529 . . . . 0.0 109.811 176.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 56.1 m -70.71 -37.1 73.53 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.872 -0.518 . . . . 0.0 110.376 -177.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -59.75 -33.28 71.46 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.58 -0.7 . . . . 0.0 110.478 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.47 HD11 ' OD1' ' A' ' 316' ' ' ASP . 57.7 mt -104.81 -11.96 16.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.666 -0.646 . . . . 0.0 110.81 -175.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 79.9 tttt 59.79 49.65 7.81 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.978 -1.076 . . . . 0.0 109.704 177.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -146.58 153.03 39.88 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.8 -174.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.6 tp -126.58 137.84 53.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.841 -0.537 . . . . 0.0 110.413 -175.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -117.66 134.27 55.07 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.645 -0.659 . . . . 0.0 109.487 175.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.35 158.4 44.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.671 -0.643 . . . . 0.0 111.173 -174.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.4 ' HG3' ' HD3' ' A' ' 309' ' ' PRO . 42.1 mt-30 -104.63 141.3 36.67 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.585 -0.697 . . . . 0.0 110.525 172.462 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.465 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 18.8 tt -55.39 149.9 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.594 -0.691 . . . . 0.0 111.444 -175.01 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.79 10.08 5.78 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.559 -0.713 . . . . 0.0 112.481 178.312 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -96.18 155.07 16.91 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.959 -1.088 . . . . 0.0 110.611 172.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 77.4 m -81.16 126.07 31.03 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.631 -0.668 . . . . 0.0 110.325 177.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 43.5 t -115.13 89.64 21.04 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.652 -0.655 . . . . 0.0 110.273 175.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.489 ' HA ' HD23 ' A' ' 264' ' ' LEU . 15.5 Cg_exo -65.8 124.94 13.42 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 O-C-N 123.281 1.148 . . . . 0.0 110.675 173.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.569 HD12 ' CD2' ' A' ' 265' ' ' TYR . 97.3 mt -119.87 140.83 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.634 -0.667 . . . . 0.0 109.246 172.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' GLN . . . . . 0.546 ' NE2' ' CE1' ' A' ' 260' ' ' PHE . 73.3 mt-30 -106.79 135.46 48.29 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.454 -0.779 . . . . 0.0 110.74 -174.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.586 HG21 ' CE1' ' A' ' 138' ' ' PHE . 49.6 mm -95.27 134.97 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.708 -0.62 . . . . 0.0 109.687 170.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -117.48 130.69 56.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.557 -0.714 . . . . 0.0 110.44 176.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.721 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.6 m -136.67 159.75 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.573 -0.704 . . . . 0.0 109.99 175.052 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 80.6 mmm -78.75 -40.56 33.03 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.67 -0.644 . . . . 0.0 110.068 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 76.8 p -135.02 143.24 45.22 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.735 -0.603 . . . . 0.0 109.722 177.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.4 Cg_exo -55.84 139.89 84.57 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 O-C-N 123.161 1.085 . . . . 0.0 110.855 -172.27 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.778 ' HB3' HD21 ' A' ' 288' ' ' LEU . 32.5 Cg_endo -67.47 170.03 14.44 Favored 'Trans proline' 0 N--CA 1.487 1.113 0 O-C-N 123.131 1.069 . . . . 0.0 110.619 177.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -60.75 157.39 37.92 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 O-C-N 123.293 1.154 . . . . 0.0 110.53 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -79.8 140.87 36.7 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.574 -0.704 . . . . 0.0 109.949 175.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.7 -24.91 29.57 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -174.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.14 153.78 1.34 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.378 -1.072 . . . . 0.0 111.398 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.8 155.95 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.751 -0.593 . . . . 0.0 109.779 176.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.678 HD11 ' HD2' ' A' ' 251' ' ' TYR . 52.4 mt -108.06 135.59 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.739 ' HG2' HD22 ' A' ' 248' ' ' LEU . 27.6 mtm180 -114.78 143.88 44.38 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -176.128 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -139.47 123.75 18.04 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.598 -0.689 . . . . 0.0 110.408 177.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.41 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 26.8 ttm -137.36 138.05 23.96 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.797 -0.564 . . . . 0.0 111.073 -175.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.551 ' HD3' HD12 ' A' ' 226' ' ' ILE . 62.6 Cg_endo -91.13 138.17 2.27 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 O-C-N 123.187 1.098 . . . . 0.0 110.643 176.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.419 HG13 ' C ' ' A' ' 190' ' ' PRO . 34.8 m -146.79 154.85 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.471 -0.768 . . . . 0.0 110.212 173.081 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.677 ' HA ' HG22 ' A' ' 282' ' ' ILE . 87.1 m-85 -58.49 167.55 1.4 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.511 -0.743 . . . . 0.0 110.679 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -84.94 -60.08 2.15 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.639 -0.663 . . . . 0.0 110.863 -174.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -80.08 152.11 29.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.544 -0.722 . . . . 0.0 110.286 -175.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.459 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.67 -38.06 71.68 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.332 -0.855 . . . . 0.0 110.713 -176.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.4 mp0 -56.5 -24.81 48.8 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.483 -0.76 . . . . 0.0 110.616 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.426 ' HB3' ' CD1' ' A' ' 192' ' ' TYR . 99.5 m-70 -109.53 -20.51 12.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.586 -0.696 . . . . 0.0 111.14 -178.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -68.05 -20.24 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.119 -0.988 . . . . 0.0 110.628 -176.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 78.8 p -79.45 -17.08 55.02 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.577 -0.702 . . . . 0.0 110.649 175.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -88.35 136.34 33.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.386 -0.821 . . . . 0.0 110.017 173.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 60.5 t -73.07 143.76 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.584 -0.698 . . . . 0.0 110.13 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.509 HG22 ' CE2' ' A' ' 192' ' ' TYR . 84.0 t -84.82 139.13 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.538 -0.726 . . . . 0.0 109.217 171.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -134.76 -170.04 2.48 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.508 -0.745 . . . . 0.0 111.157 -165.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -95.2 152.99 17.88 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.795 -0.565 . . . . 0.0 110.206 -176.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.496 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 56.5 m . . . . . 0 N--CA 1.497 1.897 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 172.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.405 ' HA ' ' HG3' ' A' ' 268' ' ' MET . 57.5 tp . . . . . 0 N--CA 1.497 1.901 0 CA-C-O 120.922 0.392 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.551 HD12 ' HD3' ' A' ' 190' ' ' PRO . 83.9 mt -106.31 136.65 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.905 -0.497 . . . . 0.0 109.707 176.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 40.6 mtm105 -133.52 157.78 44.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.693 -0.629 . . . . 0.0 110.129 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.419 HG23 HG21 ' A' ' 247' ' ' VAL . 79.2 t -102.41 146.58 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.649 -0.657 . . . . 0.0 110.098 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -120.76 130.01 53.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.857 -0.527 . . . . 0.0 110.332 171.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.39 20.69 19.29 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 169.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -140.99 107.06 5.18 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.276 -1.132 . . . . 0.0 110.08 174.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 42.8 m -63.3 -15.26 56.7 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.56 -0.712 . . . . 0.0 111.269 -175.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -100.05 8.1 44.21 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.219 -0.925 . . . . 0.0 111.59 -177.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.2 129.4 41.09 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.104 -0.998 . . . . 0.0 110.345 177.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -139.79 158.1 44.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.826 -0.546 . . . . 0.0 109.709 177.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -112.16 150.57 30.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.522 -0.736 . . . . 0.0 110.539 -177.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.21 159.9 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.804 -0.56 . . . . 0.0 110.155 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -122.53 130.04 52.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.68 -0.638 . . . . 0.0 110.194 176.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -65.08 130.12 94.72 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.625 -0.672 . . . . 0.0 109.823 178.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -66.48 -27.79 46.34 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 O-C-N 123.155 1.082 . . . . 0.0 111.006 -171.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 82.8 mt -100.55 -50.39 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.471 -0.768 . . . . 0.0 110.99 -167.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.1 p -105.47 12.11 31.82 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.41 -0.806 . . . . 0.0 111.877 -174.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.82 -5.11 13.24 Favored Glycine 0 N--CA 1.496 2.638 0 O-C-N 121.128 -0.982 . . . . 0.0 111.9 173.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -46.11 142.02 3.0 Favored 'General case' 0 N--CA 1.504 2.234 0 CA-C-N 119.104 1.452 . . . . 0.0 112.3 -174.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.6 mp0 -106.09 141.62 37.15 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.577 -0.702 . . . . 0.0 110.156 176.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 80.0 p -154.84 159.96 40.9 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.585 -0.697 . . . . 0.0 110.45 177.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.419 HG21 HG23 ' A' ' 228' ' ' VAL . 8.4 p -123.72 148.22 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.735 -0.603 . . . . 0.0 109.793 178.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.739 HD22 ' HG2' ' A' ' 187' ' ' ARG . 82.9 mt -129.57 154.63 46.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.644 -0.66 . . . . 0.0 110.094 -175.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.442 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.9 m -151.51 151.83 29.53 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.781 -0.574 . . . . 0.0 109.934 177.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -71.14 139.33 35.3 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 O-C-N 123.254 1.133 . . . . 0.0 109.993 176.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.678 ' HD2' HD11 ' A' ' 186' ' ' ILE . 60.6 t80 -75.06 124.48 27.07 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.42 -0.8 . . . . 0.0 110.21 176.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -100.04 160.12 28.03 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.665 -0.647 . . . . 0.0 110.072 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -59.53 159.95 22.05 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 O-C-N 123.241 1.127 . . . . 0.0 110.448 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -59.45 149.92 78.63 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 O-C-N 123.243 1.128 . . . . 0.0 110.426 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -60.91 147.63 42.44 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.612 -0.68 . . . . 0.0 110.19 -178.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.9 t -69.87 127.24 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.557 -0.715 . . . . 0.0 110.212 -170.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.97 -10.05 55.35 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 10.1 t -144.42 173.81 11.46 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.078 -1.248 . . . . 0.0 110.664 175.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -107.05 13.21 27.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.662 -0.649 . . . . 0.0 111.764 -168.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.546 ' CE1' ' NE2' ' A' ' 173' ' ' GLN . 14.1 p90 -119.98 168.04 11.55 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.154 -0.966 . . . . 0.0 111.118 -175.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 93.3 m -117.79 146.73 43.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.761 -0.587 . . . . 0.0 109.887 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 45.3 m -116.46 136.41 53.01 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.524 -0.735 . . . . 0.0 110.857 -175.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.2 t -128.39 136.02 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 172.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 171' ' ' PRO . 71.3 mt -104.94 120.75 42.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.565 -0.709 . . . . 0.0 110.015 -174.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.569 ' CD2' HD12 ' A' ' 172' ' ' ILE . 2.9 m-30 -95.5 157.37 15.92 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.642 -0.661 . . . . 0.0 110.605 176.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -136.47 142.83 43.59 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 168.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -114.32 133.16 55.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.498 -0.751 . . . . 0.0 110.459 -177.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 268' ' ' MET . . . . . 0.405 ' HG3' ' HA ' ' A' ' 225' ' ' LEU . 0.0 OUTLIER -103.25 3.31 35.38 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.685 -0.634 . . . . 0.0 111.975 -178.104 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 269' ' ' CYS . . . . . 0.728 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.8 OUTLIER -144.63 159.95 41.97 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.102 -0.999 . . . . 0.0 109.929 174.569 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.442 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.1 p30 -119.78 163.54 17.31 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.435 0.636 . . . . 0.0 110.484 -178.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 271' ' ' SER . . . . . 0.429 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 32.4 m -58.22 -32.62 68.48 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.465 -0.772 . . . . 0.0 110.975 -164.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 49.1 p -101.51 13.05 36.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.47 -0.769 . . . . 0.0 111.941 -164.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 273' ' ' CYS . . . . . 0.496 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 30.7 p -94.26 118.08 31.06 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.077 -1.014 . . . . 0.0 110.612 178.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 61.2 t -63.82 139.92 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.44 -0.788 . . . . 0.0 110.351 -170.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 100.13 -5.11 57.54 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 177.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.81 -99.05 0.87 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 171.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 277' ' ' MET . . . . . 0.429 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.3 mmm -62.91 -32.1 73.31 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.7 -0.882 . . . . 0.0 110.287 178.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.3 p30 44.31 49.88 7.89 Favored 'General case' 0 N--CA 1.504 2.243 0 CA-C-O 121.262 0.553 . . . . 0.0 112.449 174.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 21.3 mtt180 54.85 28.64 10.69 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.29 -0.881 . . . . 0.0 111.197 175.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -116.82 106.01 48.67 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.561 -0.712 . . . . 0.0 109.995 174.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.37 147.71 89.92 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 O-C-N 123.029 1.015 . . . . 0.0 110.609 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.677 HG22 ' HA ' ' A' ' 192' ' ' TYR . 45.2 pt -131.87 177.34 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.646 0.736 . . . . 0.0 110.876 -177.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 302' ' ' GLU . 35.3 mt -124.3 149.85 46.08 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.459 HD12 ' HB2' ' A' ' 303' ' ' ALA . 81.2 mt -112.02 129.94 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 79.4 mt -109.81 125.26 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 63.1 t -118.99 126.78 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.201 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.436 HG22 ' HG2' ' A' ' 298' ' ' ARG . 45.9 p -125.24 152.16 44.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.631 -0.668 . . . . 0.0 110.594 -173.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.778 HD21 ' HB3' ' A' ' 180' ' ' PRO . 26.2 tp -101.03 127.14 47.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.715 -0.615 . . . . 0.0 109.5 167.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.403 ' OE2' HG22 ' A' ' 295' ' ' VAL . 73.1 mm-40 -130.27 150.32 51.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.856 -0.528 . . . . 0.0 109.926 -173.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.862 HG23 HD11 ' A' ' 296' ' ' LEU . 8.2 p -89.99 161.14 16.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.579 -0.701 . . . . 0.0 109.971 177.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -55.89 -26.14 45.96 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.502 -0.749 . . . . 0.0 111.043 -176.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 49.1 p30 -87.61 8.28 25.99 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.424 -0.797 . . . . 0.0 111.904 -174.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 88.19 20.19 50.17 Favored Glycine 0 N--CA 1.494 2.548 0 O-C-N 121.067 -1.021 . . . . 0.0 110.648 172.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -107.6 140.21 40.96 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.323 -1.104 . . . . 0.0 110.111 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.403 HG22 ' OE2' ' A' ' 289' ' ' GLU . 58.6 t -83.91 133.56 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.563 -0.711 . . . . 0.0 110.15 -174.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.862 HD11 HG23 ' A' ' 290' ' ' THR . 95.7 mt -99.93 -40.15 7.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.711 -0.618 . . . . 0.0 110.283 176.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -167.26 150.41 17.02 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.436 ' HG2' HG22 ' A' ' 287' ' ' THR . 77.5 mtm180 -133.47 137.29 45.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.612 -0.934 . . . . 0.0 110.718 -178.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -130.61 155.21 46.93 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.619 -0.676 . . . . 0.0 110.229 172.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 79.5 m -139.15 146.73 40.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.469 -0.769 . . . . 0.0 110.831 -174.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.424 ' CE2' ' HB ' ' A' ' 284' ' ' ILE . 9.2 p90 -147.76 162.08 39.93 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.782 -0.574 . . . . 0.0 109.979 177.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.444 ' HA ' HD23 ' A' ' 283' ' ' LEU . 81.9 tt0 -104.77 138.44 41.05 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.542 -0.724 . . . . 0.0 110.331 -175.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.459 ' HB2' HD12 ' A' ' 284' ' ' ILE . . . -125.14 143.63 50.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.651 -0.655 . . . . 0.0 110.596 -171.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -138.19 140.77 39.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.75 -0.594 . . . . 0.0 109.755 174.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.728 HD13 ' O ' ' A' ' 269' ' ' CYS . 63.8 mt -108.88 122.87 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.501 -0.749 . . . . 0.0 109.645 176.346 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.9 p -145.24 168.66 19.88 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.636 -0.665 . . . . 0.0 110.657 -172.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -70.03 -40.18 75.33 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.64 -0.663 . . . . 0.0 110.638 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.8 t -127.99 86.55 57.87 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.522 -0.736 . . . . 0.0 110.457 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 309' ' ' PRO . . . . . 0.4 ' HD3' ' HG3' ' A' ' 165' ' ' GLN . 43.7 Cg_exo -56.23 -27.69 67.51 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 O-C-N 123.198 1.104 . . . . 0.0 110.573 174.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -68.47 -36.79 84.63 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -72.18 -39.95 68.29 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.708 -0.877 . . . . 0.0 109.873 -173.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -69.58 -39.26 77.43 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.062 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 -61.61 -44.01 97.8 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.301 178.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -65.12 -39.42 93.05 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.569 -0.707 . . . . 0.0 110.476 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.32 -49.95 74.94 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.599 -0.688 . . . . 0.0 110.44 -173.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 316' ' ' ASP . . . . . 0.47 ' OD1' HD11 ' A' ' 159' ' ' LEU . 3.1 p30 . . . . . 0 N--CA 1.495 1.799 0 O-C-N 121.487 -0.758 . . . . 0.0 110.02 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.2 t . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.02 0.438 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -94.69 25.0 4.26 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.611 -0.681 . . . . 0.0 110.824 -178.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 51.0 m -70.06 125.21 26.09 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.613 -0.679 . . . . 0.0 110.249 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -70.06 144.94 52.02 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.616 -0.678 . . . . 0.0 110.432 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.434 ' CE1' ' HA2' ' A' ' 134' ' ' GLY . 43.2 t80 -155.47 101.4 2.22 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.587 -0.696 . . . . 0.0 110.018 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -59.29 -39.97 72.78 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 O-C-N 123.185 1.097 . . . . 0.0 110.762 -173.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.434 ' HA2' ' CE1' ' A' ' 132' ' ' TYR . . . 82.67 -155.1 33.28 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -73.8 -50.01 0.18 Allowed 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.382 1.201 . . . . 0.0 110.881 -174.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -87.75 9.68 20.85 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.576 -0.702 . . . . 0.0 111.337 -173.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 t 53.81 61.69 2.97 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.961 -1.087 . . . . 0.0 110.632 -176.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.718 ' HA ' HG12 ' A' ' 176' ' ' VAL . 64.4 t80 -80.27 118.69 22.15 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.651 -0.656 . . . . 0.0 109.932 -178.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -129.98 163.21 26.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.768 -0.582 . . . . 0.0 110.413 -174.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 62.9 t -125.16 147.73 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.729 -0.607 . . . . 0.0 109.773 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.7 p -155.16 163.32 40.38 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.942 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.438 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 73.1 m-85 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.784 -0.573 . . . . 0.0 109.855 -176.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 121.191 0.519 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.406 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 44.6 p -60.07 -33.99 72.83 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.674 -0.641 . . . . 0.0 110.204 177.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.42 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -171.45 145.94 2.17 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.709 -0.62 . . . . 0.0 110.001 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.7 t -142.12 142.65 32.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.8 -0.563 . . . . 0.0 110.082 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.438 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 61.7 t80 -125.57 140.09 53.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.646 -0.659 . . . . 0.0 110.483 -172.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.4 t -109.78 124.07 50.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.842 -0.536 . . . . 0.0 109.785 175.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 48.7 m -71.35 -37.11 71.7 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.357 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -60.75 -31.64 70.97 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.605 -0.684 . . . . 0.0 110.25 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 58.2 mt -104.79 -12.19 16.43 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.612 -0.68 . . . . 0.0 110.786 -174.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 46.5 tttt 59.73 47.56 10.28 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.05 -1.031 . . . . 0.0 109.751 176.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -147.68 153.12 38.91 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.627 -0.671 . . . . 0.0 110.89 -173.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.662 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.61 137.86 53.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.771 -0.581 . . . . 0.0 110.408 -176.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -115.51 132.94 56.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.646 -0.659 . . . . 0.0 109.231 174.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.37 158.41 44.32 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.659 -0.651 . . . . 0.0 111.134 -173.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.405 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 50.7 mt-30 -104.58 144.08 32.19 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.494 0.664 . . . . 0.0 110.316 173.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.41 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.2 tt -52.06 147.22 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.52 -0.737 . . . . 0.0 111.871 -174.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.42 10.0 5.39 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.614 -0.679 . . . . 0.0 112.544 175.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.405 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 68.8 mmtt -95.36 155.08 16.89 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.001 -1.062 . . . . 0.0 110.894 175.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 84.9 m -83.23 126.1 32.29 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.708 -0.62 . . . . 0.0 110.522 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' CYS . . . . . 0.662 ' SG ' HD21 ' A' ' 162' ' ' LEU . 43.3 t -115.14 90.29 23.34 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.615 -0.678 . . . . 0.0 110.12 174.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.42 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 18.9 Cg_endo -64.41 131.44 29.98 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.239 1.126 . . . . 0.0 110.45 176.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.405 HG12 ' CE2' ' A' ' 142' ' ' PHE . 93.6 mt -123.78 141.56 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' GLN . . . . . 0.4 ' OE1' ' CD1' ' A' ' 260' ' ' PHE . 67.1 mm-40 -109.17 133.72 52.65 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.566 -0.709 . . . . 0.0 110.408 -173.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.614 HG21 ' CE1' ' A' ' 138' ' ' PHE . 49.4 mm -95.38 135.01 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.574 -0.704 . . . . 0.0 109.725 171.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 32.2 tttt -119.52 131.13 55.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.594 -0.691 . . . . 0.0 110.453 177.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.718 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.7 m -136.83 159.72 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.59 -0.694 . . . . 0.0 110.05 175.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 78.8 mmm -78.32 -40.3 37.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.726 -0.609 . . . . 0.0 110.019 176.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.0 p -134.15 143.21 46.2 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.735 -0.603 . . . . 0.0 109.718 177.132 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 33.6 Cg_exo -55.3 139.85 81.45 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 O-C-N 123.076 1.04 . . . . 0.0 110.892 -172.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.556 ' HB3' HD21 ' A' ' 288' ' ' LEU . 36.8 Cg_endo -68.56 170.06 15.91 Favored 'Trans proline' 0 N--CA 1.487 1.099 0 O-C-N 123.153 1.081 . . . . 0.0 110.629 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -60.4 155.41 47.04 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.404 1.213 . . . . 0.0 110.602 -178.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -78.69 138.47 38.29 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.58 -0.7 . . . . 0.0 109.981 175.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.28 -24.78 30.85 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -174.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.14 151.91 1.87 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.364 -1.08 . . . . 0.0 111.452 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.0 m -129.71 155.97 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.707 -0.62 . . . . 0.0 109.625 176.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.728 HD11 ' HD2' ' A' ' 251' ' ' TYR . 81.6 mt -108.43 139.3 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.685 -0.635 . . . . 0.0 109.537 176.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.727 ' HG2' HD22 ' A' ' 248' ' ' LEU . 38.9 mtm180 -114.87 146.81 40.69 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -176.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.675 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -140.55 127.61 20.83 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.372 174.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 33.3 ttm -137.34 139.04 26.55 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.805 -0.56 . . . . 0.0 110.938 -177.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.69 ' HD3' HD12 ' A' ' 226' ' ' ILE . 72.1 Cg_endo -91.44 138.15 2.14 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 120.983 1.122 . . . . 0.0 110.702 176.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.449 HG12 ' CZ ' ' A' ' 244' ' ' ARG . 34.9 m -147.22 154.94 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.599 -0.688 . . . . 0.0 110.14 174.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.642 ' HA ' HG22 ' A' ' 282' ' ' ILE . 90.4 m-85 -60.32 165.9 3.31 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.478 -0.764 . . . . 0.0 110.399 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.426 ' HA ' HD12 ' A' ' 283' ' ' LEU . 63.3 tttm -82.99 -60.1 2.27 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.621 -0.675 . . . . 0.0 110.832 -174.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -80.11 151.96 29.55 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.501 -0.749 . . . . 0.0 110.373 -175.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.452 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.67 -38.31 72.05 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.36 -0.838 . . . . 0.0 110.709 -175.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -56.5 -24.92 49.51 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.48 -0.763 . . . . 0.0 110.652 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.418 ' HB3' ' CG ' ' A' ' 192' ' ' TYR . 98.9 m-70 -109.69 -20.49 12.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.53 -0.732 . . . . 0.0 111.167 -178.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.1 p -67.74 -20.3 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.086 -1.008 . . . . 0.0 110.655 -176.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 67.0 p -79.35 -17.1 55.17 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.537 -0.727 . . . . 0.0 110.742 175.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -88.31 137.24 32.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.292 -0.88 . . . . 0.0 110.097 173.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 54.1 t -74.09 142.01 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.612 -0.68 . . . . 0.0 110.262 177.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.511 HG22 ' CE2' ' A' ' 192' ' ' TYR . 67.8 t -84.84 138.8 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.579 -0.701 . . . . 0.0 109.331 170.114 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.9 pttp -134.86 -170.16 2.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.482 -0.761 . . . . 0.0 111.185 -168.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -95.27 153.9 17.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.794 -0.567 . . . . 0.0 110.499 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.628 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 60.3 m . . . . . 0 N--CA 1.497 1.887 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 174.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.568 HD12 ' HG3' ' A' ' 268' ' ' MET . 55.2 tp . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 120.939 0.399 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.69 HD12 ' HD3' ' A' ' 190' ' ' PRO . 82.1 mt -101.01 136.75 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.786 -0.571 . . . . 0.0 109.85 -179.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 -133.28 158.71 42.26 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.646 -0.659 . . . . 0.0 110.254 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.666 HG23 HG21 ' A' ' 247' ' ' VAL . 93.0 t -103.93 146.7 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.725 -0.61 . . . . 0.0 110.137 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -118.5 130.0 55.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.73 -0.606 . . . . 0.0 110.477 170.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 92.42 25.02 22.47 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 167.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -138.86 108.1 6.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.433 -1.04 . . . . 0.0 110.017 174.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 92.6 p -63.35 -15.14 56.51 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.675 -0.641 . . . . 0.0 111.287 -177.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -97.28 9.36 42.46 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.299 -0.876 . . . . 0.0 111.155 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -62.24 125.44 23.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.222 -0.924 . . . . 0.0 110.156 176.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -139.72 154.81 47.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.798 -0.564 . . . . 0.0 109.74 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.422 ' CD1' ' HB ' ' A' ' 247' ' ' VAL . 91.1 m-85 -117.36 150.73 38.36 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.605 -176.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.19 160.03 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.782 -0.574 . . . . 0.0 110.234 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -114.69 130.05 56.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.768 -0.583 . . . . 0.0 110.038 174.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -63.78 130.11 94.21 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.71 -0.619 . . . . 0.0 109.741 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -64.98 -28.69 57.76 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.232 1.122 . . . . 0.0 111.045 -170.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.9 mt -102.16 -50.53 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.387 -0.821 . . . . 0.0 111.041 -167.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 9.3 p -105.5 12.27 31.58 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.327 -0.858 . . . . 0.0 111.917 -176.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 72.14 -5.01 15.46 Favored Glycine 0 N--CA 1.497 2.737 0 O-C-N 121.057 -1.027 . . . . 0.0 112.001 171.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.449 ' CZ ' HG12 ' A' ' 191' ' ' VAL . 22.6 mmt180 -45.82 142.14 2.68 Favored 'General case' 0 N--CA 1.505 2.324 0 CA-C-N 119.137 1.469 . . . . 0.0 112.509 -174.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -96.01 143.55 27.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.551 -0.718 . . . . 0.0 110.099 172.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 77.9 p -154.7 159.87 41.0 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.579 -0.7 . . . . 0.0 110.483 174.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.666 HG21 HG23 ' A' ' 228' ' ' VAL . 8.6 p -125.12 148.33 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.78 -0.575 . . . . 0.0 109.781 179.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.727 HD22 ' HG2' ' A' ' 187' ' ' ARG . 81.6 mt -129.64 154.55 47.0 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.651 -177.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.452 HG13 ' C ' ' A' ' 248' ' ' LEU . 34.1 m -151.53 151.68 29.22 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.789 -0.569 . . . . 0.0 109.985 176.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -71.07 139.04 34.89 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 123.297 1.156 . . . . 0.0 110.018 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.728 ' HD2' HD11 ' A' ' 186' ' ' ILE . 59.9 t80 -75.96 125.61 29.44 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.491 -0.756 . . . . 0.0 110.123 174.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -100.06 160.01 28.3 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.725 -0.609 . . . . 0.0 109.996 177.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -58.94 159.93 19.9 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.268 1.141 . . . . 0.0 110.417 178.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.38 149.91 78.32 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 O-C-N 123.187 1.098 . . . . 0.0 110.493 -177.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -61.82 148.48 43.07 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.681 -0.637 . . . . 0.0 110.138 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.2 t -69.92 127.2 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.534 -0.729 . . . . 0.0 110.12 -170.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.98 -10.14 55.37 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 9.9 t -144.73 174.11 11.26 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.124 -1.221 . . . . 0.0 110.616 175.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -107.26 13.16 27.47 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.612 -0.68 . . . . 0.0 111.707 -168.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.4 ' CD1' ' OE1' ' A' ' 173' ' ' GLN . 13.5 p90 -119.86 168.08 11.46 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.152 -0.967 . . . . 0.0 111.135 -174.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 88.4 m -117.77 147.49 42.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.741 -0.599 . . . . 0.0 109.905 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 47.0 m -118.14 136.28 53.71 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.56 -0.712 . . . . 0.0 111.048 -174.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.8 t -131.92 137.26 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 172.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 67.8 mt -104.62 120.73 42.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.467 -0.77 . . . . 0.0 109.826 -172.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.675 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 5.0 m-30 -106.29 151.2 25.13 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.678 -0.639 . . . . 0.0 110.604 -177.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -136.58 142.86 43.39 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -112.0 130.08 55.98 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.595 -0.69 . . . . 0.0 110.453 -177.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 268' ' ' MET . . . . . 0.568 ' HG3' HD12 ' A' ' 225' ' ' LEU . 5.0 ppp? -96.16 3.0 53.54 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.633 -0.667 . . . . 0.0 111.973 -176.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 269' ' ' CYS . . . . . 0.626 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.5 OUTLIER -144.81 165.04 29.24 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.076 -1.015 . . . . 0.0 110.123 175.874 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.635 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.3 p30 -121.7 163.4 19.1 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.646 -0.659 . . . . 0.0 110.417 -178.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 271' ' ' SER . . . . . 0.423 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 29.6 m -58.42 -35.14 71.62 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.427 -0.796 . . . . 0.0 110.986 -163.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 51.3 p -103.46 15.0 30.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.409 -0.807 . . . . 0.0 111.949 -163.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 273' ' ' CYS . . . . . 0.628 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 29.7 p -93.96 118.05 30.95 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.063 -1.023 . . . . 0.0 110.712 178.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 60.0 t -62.75 138.82 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.519 -0.738 . . . . 0.0 110.352 -171.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.08 -5.21 61.2 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 178.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.13 -101.66 0.95 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 172.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 277' ' ' MET . . . . . 0.423 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.4 mmm -60.93 -29.95 69.91 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.657 -0.908 . . . . 0.0 110.124 178.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 22.6 p30 42.86 44.74 4.03 Favored 'General case' 0 N--CA 1.505 2.312 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 173.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 55.02 34.66 22.96 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.355 -0.841 . . . . 0.0 111.11 175.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 280' ' ' ARG . . . . . 0.468 ' O ' HG23 ' A' ' 282' ' ' ILE . 88.5 mtt180 -120.04 105.74 42.12 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.54 -0.725 . . . . 0.0 109.98 172.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 281' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 280' ' ' ARG . 11.3 Cg_endo -58.93 144.94 98.74 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 O-C-N 123.112 1.059 . . . . 0.0 110.573 -178.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.642 HG22 ' HA ' ' A' ' 192' ' ' TYR . 46.2 pt -131.97 175.36 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 122.006 0.908 . . . . 0.0 111.244 -173.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 302' ' ' GLU . 26.0 mt -124.44 149.84 46.34 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.699 HD12 ' CE1' ' A' ' 301' ' ' PHE . 82.4 mt -115.83 129.63 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.173 178.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.61 HG23 ' SG ' ' A' ' 300' ' ' CYS . 82.1 mt -109.74 125.52 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 -176.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 60.4 t -118.9 126.76 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.5 p -125.29 155.0 40.88 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.655 -0.653 . . . . 0.0 110.614 -172.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.575 HD22 ' CD1' ' A' ' 138' ' ' PHE . 30.5 tp -107.02 126.13 51.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.803 -0.561 . . . . 0.0 109.564 170.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.593 ' OE2' HG13 ' A' ' 295' ' ' VAL . 69.4 mm-40 -131.77 151.41 51.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.855 -0.528 . . . . 0.0 109.853 -174.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.645 HG22 HD11 ' A' ' 296' ' ' LEU . 71.4 p -89.9 157.8 17.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.605 -0.684 . . . . 0.0 109.779 178.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -56.12 -26.02 48.36 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.506 -0.746 . . . . 0.0 110.739 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -87.14 9.55 19.61 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.55 -0.719 . . . . 0.0 111.789 -174.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 87.63 20.09 52.26 Favored Glycine 0 N--CA 1.493 2.49 0 O-C-N 121.068 -1.02 . . . . 0.0 110.76 170.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -108.53 140.22 42.17 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.294 -1.121 . . . . 0.0 110.208 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.618 HG11 ' HE ' ' A' ' 298' ' ' ARG . 59.5 t -86.76 134.98 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.571 -0.706 . . . . 0.0 110.043 -173.294 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.645 HD11 HG22 ' A' ' 290' ' ' THR . 96.4 mt -99.87 -40.14 7.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.658 -0.651 . . . . 0.0 110.457 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -175.35 162.42 31.92 Favored Glycine 0 N--CA 1.496 2.674 0 C-N-CA 119.922 -1.132 . . . . 0.0 110.384 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.618 ' HE ' HG11 ' A' ' 295' ' ' VAL . 84.2 mtt180 -130.73 139.83 50.3 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.672 -0.899 . . . . 0.0 110.567 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -136.59 155.07 50.42 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.479 -0.763 . . . . 0.0 109.869 170.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 300' ' ' CYS . . . . . 0.61 ' SG ' HG23 ' A' ' 285' ' ' ILE . 89.1 m -143.56 154.76 43.92 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.327 -0.858 . . . . 0.0 110.874 -175.131 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.699 ' CE1' HD12 ' A' ' 284' ' ' ILE . 48.7 p90 -145.72 163.91 33.44 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.717 -0.614 . . . . 0.0 110.108 176.303 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.429 ' HA ' HD23 ' A' ' 283' ' ' LEU . 56.6 tt0 -104.89 135.84 45.5 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.457 -0.777 . . . . 0.0 110.325 -177.021 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -123.84 144.42 49.74 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.633 -0.667 . . . . 0.0 110.729 -170.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -138.67 137.0 36.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.815 -0.553 . . . . 0.0 109.812 173.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.635 HG21 ' HA ' ' A' ' 270' ' ' ASN . 75.0 mt -105.8 123.56 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.58 -0.7 . . . . 0.0 109.584 176.093 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.2 p -145.15 164.9 29.87 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.569 -0.707 . . . . 0.0 110.948 -169.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -66.43 -39.92 89.2 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.671 -0.643 . . . . 0.0 110.615 -177.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.9 t -131.31 89.06 42.31 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.534 -0.729 . . . . 0.0 110.576 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -56.71 -29.3 79.67 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 123.136 1.072 . . . . 0.0 110.477 173.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.15 -37.93 93.46 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 176.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -70.23 -38.41 75.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.536 -0.979 . . . . 0.0 109.779 -175.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -69.4 -36.13 76.45 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.986 178.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 47.7 ttt-85 -57.04 -48.39 78.63 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.529 -0.732 . . . . 0.0 110.57 175.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -64.99 -38.54 91.28 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.72 -0.613 . . . . 0.0 110.448 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.85 -52.16 65.26 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.501 -0.749 . . . . 0.0 110.475 -173.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.6 p30 . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.434 -0.791 . . . . 0.0 110.155 -177.123 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 27.8 t . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.031 0.443 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.9 p-10 -96.33 24.62 5.61 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.722 -0.611 . . . . 0.0 110.681 -179.227 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 51.6 m -76.63 125.17 28.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.54 -0.725 . . . . 0.0 110.279 -179.403 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -70.14 144.91 51.89 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.672 -0.642 . . . . 0.0 110.41 -177.862 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -154.25 99.41 2.5 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.774 -0.579 . . . . 0.0 110.153 178.6 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -58.8 -39.91 77.37 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 O-C-N 123.202 1.106 . . . . 0.0 110.774 -176.651 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.69 -155.11 47.93 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 178.609 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -73.29 -46.19 0.38 Allowed 'Trans proline' 0 C--N 1.316 -1.176 0 O-C-N 123.363 1.191 . . . . 0.0 110.922 -174.442 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -85.9 6.7 27.22 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.531 -0.731 . . . . 0.0 111.382 -173.679 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.72 61.18 3.22 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.853 -1.154 . . . . 0.0 110.656 -175.519 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.689 ' HA ' HG12 ' A' ' 176' ' ' VAL . 54.6 t80 -77.82 119.29 21.1 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.64 -0.662 . . . . 0.0 109.852 -178.678 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -130.07 159.93 35.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.826 -0.546 . . . . 0.0 110.189 -178.419 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 68.5 t -124.57 147.65 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.694 -0.629 . . . . 0.0 109.902 176.131 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.9 p -155.04 164.23 39.17 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.075 177.132 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.486 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 88.0 m-85 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.84 -0.537 . . . . 0.0 109.894 -176.532 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.803 0 CA-C-O 121.153 0.501 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.497 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 80.9 p -59.99 -32.49 70.9 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.641 -0.662 . . . . 0.0 109.868 174.197 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.497 ' HD1' ' HG1' ' A' ' 152' ' ' THR . 68.7 p-90 -171.34 142.8 1.75 Allowed 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.319 0.581 . . . . 0.0 110.253 176.872 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.7 t -142.12 142.72 32.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.935 -0.478 . . . . 0.0 109.997 -177.318 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.486 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 52.0 t80 -125.52 140.06 53.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.545 -0.722 . . . . 0.0 110.524 -172.62 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.5 t -111.84 124.31 52.08 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 120.401 -0.52 . . . . 0.0 109.789 176.118 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 62.3 m -70.58 -37.05 73.9 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.771 -0.581 . . . . 0.0 110.45 -177.658 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -59.1 -33.03 70.36 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.529 -0.732 . . . . 0.0 110.53 -178.522 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.469 HD11 ' OD1' ' A' ' 316' ' ' ASP . 56.1 mt -104.84 -11.99 16.5 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.688 -0.632 . . . . 0.0 110.787 -175.805 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 70.7 tttt 59.74 49.54 8.03 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.046 -1.034 . . . . 0.0 109.653 177.703 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 40.5 tttt -146.56 153.11 39.98 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.754 -0.591 . . . . 0.0 110.668 -174.054 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.604 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.5 tp -126.52 137.76 53.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.805 -0.559 . . . . 0.0 110.171 -177.333 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -115.16 134.78 54.85 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.671 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.8 p -138.42 158.61 43.95 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 120.114 -0.635 . . . . 0.0 111.114 -174.029 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.428 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 52.4 mt-30 -104.42 141.99 35.38 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.557 -0.714 . . . . 0.0 110.209 173.645 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.439 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 18.3 tt -54.85 146.23 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.562 -0.712 . . . . 0.0 111.561 -171.914 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.36 9.98 5.33 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.552 -0.718 . . . . 0.0 112.479 177.017 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.428 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 67.5 mmtt -96.13 155.08 16.91 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.896 -1.128 . . . . 0.0 110.747 175.114 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 86.7 m -81.12 126.2 31.17 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.738 -0.601 . . . . 0.0 110.634 -177.581 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 170' ' ' CYS . . . . . 0.604 ' SG ' HD21 ' A' ' 162' ' ' LEU . 46.9 t -115.53 90.23 25.07 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.702 -0.624 . . . . 0.0 110.11 172.722 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.441 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 22.0 Cg_exo -62.37 130.89 31.78 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 O-C-N 123.276 1.145 . . . . 0.0 110.624 174.079 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.413 HG12 ' CE2' ' A' ' 142' ' ' PHE . 94.5 mt -125.41 142.92 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.655 -0.653 . . . . 0.0 109.299 175.593 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 173' ' ' GLN . . . . . 0.529 ' NE2' ' CE1' ' A' ' 260' ' ' PHE . 69.0 mt-30 -108.44 136.21 48.45 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.517 -0.739 . . . . 0.0 110.739 -176.209 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.419 HG23 ' CE1' ' A' ' 138' ' ' PHE . 48.5 mm -95.27 131.55 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.724 -0.61 . . . . 0.0 109.613 169.241 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -112.99 128.28 56.45 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.607 -0.683 . . . . 0.0 110.447 176.28 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.689 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.2 m -136.59 159.79 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.594 -0.691 . . . . 0.0 109.903 175.104 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.5 mmm -76.47 -40.81 49.35 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.632 -0.668 . . . . 0.0 110.104 178.647 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.411 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.5 p -135.44 143.15 44.05 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.782 -0.574 . . . . 0.0 109.65 178.356 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 34.1 Cg_exo -55.22 139.8 81.02 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 O-C-N 123.142 1.075 . . . . 0.0 110.841 -171.648 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.804 ' HB3' HD21 ' A' ' 288' ' ' LEU . 29.8 Cg_endo -66.58 170.0 13.25 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 O-C-N 123.212 1.111 . . . . 0.0 110.618 178.411 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -60.85 156.25 44.68 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.358 1.189 . . . . 0.0 110.5 -178.293 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -79.1 139.32 38.1 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.651 -0.656 . . . . 0.0 109.954 176.118 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 98.53 -24.94 29.94 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -174.167 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.18 152.35 1.76 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.359 -1.083 . . . . 0.0 111.426 177.684 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 33.8 m -129.78 155.95 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.766 -0.584 . . . . 0.0 109.649 176.293 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.712 HD11 ' HD2' ' A' ' 251' ' ' TYR . 80.4 mt -109.17 138.78 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.676 -0.64 . . . . 0.0 109.51 176.626 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.721 ' HG2' HD22 ' A' ' 248' ' ' LEU . 30.8 mtm180 -114.9 147.27 40.18 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -175.763 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.718 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -140.13 127.18 20.89 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.501 -0.749 . . . . 0.0 110.259 173.456 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.413 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 3.2 ttp -137.24 138.33 24.93 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.777 -0.577 . . . . 0.0 110.926 -176.756 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.689 ' HD3' HD12 ' A' ' 226' ' ' ILE . 71.9 Cg_endo -91.9 138.09 1.95 Allowed 'Trans proline' 0 C--N 1.32 -0.949 0 C-N-CA 121.023 1.149 . . . . 0.0 110.771 177.77 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.431 HG13 ' C ' ' A' ' 190' ' ' PRO . 34.7 m -147.43 154.82 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.505 -0.747 . . . . 0.0 110.101 174.089 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.676 ' HA ' HG22 ' A' ' 282' ' ' ILE . 63.3 m-85 -60.05 162.06 6.12 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.409 -0.807 . . . . 0.0 110.55 -179.155 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.5 ' HA ' HD12 ' A' ' 283' ' ' LEU . 29.0 tttp -79.19 -60.02 2.54 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.665 -0.647 . . . . 0.0 110.878 -173.092 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -80.15 152.04 29.44 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.587 -0.695 . . . . 0.0 110.425 -175.373 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.457 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.52 -37.95 71.16 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.376 -0.827 . . . . 0.0 110.674 -177.084 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -56.86 -25.02 55.67 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.548 -0.72 . . . . 0.0 110.572 -177.438 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.411 ' HB3' ' CG ' ' A' ' 192' ' ' TYR . 65.0 m170 -108.81 -20.58 13.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.598 -0.689 . . . . 0.0 111.116 -178.816 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -68.45 -20.28 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.148 -0.97 . . . . 0.0 110.581 -175.861 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 67.3 p -79.42 -17.03 55.18 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.516 -0.74 . . . . 0.0 110.678 174.37 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.39 136.54 32.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.366 -0.834 . . . . 0.0 110.025 173.574 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 242' ' ' THR . 61.9 t -72.92 145.08 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.569 -0.707 . . . . 0.0 110.269 178.354 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.631 HG23 HH12 ' A' ' 244' ' ' ARG . 57.8 t -84.88 139.9 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 170.873 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 11.9 pttt -134.72 -170.46 2.56 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.509 -0.744 . . . . 0.0 111.195 -169.34 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 63.8 mmt-85 -95.37 150.92 19.75 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.827 -0.546 . . . . 0.0 110.423 -176.23 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.658 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 60.9 m . . . . . 0 N--CA 1.497 1.894 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 169.964 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.564 HD12 ' HG3' ' A' ' 268' ' ' MET . 57.2 tp . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 120.93 0.395 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.689 HD12 ' HD3' ' A' ' 190' ' ' PRO . 85.5 mt -104.7 136.72 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.589 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -134.57 159.52 40.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.701 -0.624 . . . . 0.0 110.189 -178.401 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.596 HG23 HG21 ' A' ' 247' ' ' VAL . 91.2 t -104.46 146.74 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.766 -0.584 . . . . 0.0 110.103 178.991 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -118.1 124.4 47.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.732 -0.605 . . . . 0.0 110.361 172.288 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.05 23.82 14.15 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 168.939 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -137.17 107.6 6.48 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.464 -1.021 . . . . 0.0 110.028 174.695 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 26.3 t -62.89 -15.18 53.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.67 -0.643 . . . . 0.0 111.322 -178.001 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -100.02 7.98 44.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.246 -0.909 . . . . 0.0 111.524 -177.621 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.06 130.76 47.99 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.191 -0.943 . . . . 0.0 110.213 176.978 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -139.76 157.95 44.9 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.75 -0.594 . . . . 0.0 109.807 177.701 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -115.01 150.73 35.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.596 -0.69 . . . . 0.0 110.658 -176.394 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.16 159.93 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.827 -0.546 . . . . 0.0 110.081 176.38 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -121.46 130.11 53.38 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.69 -0.631 . . . . 0.0 110.344 178.87 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -64.74 110.34 3.97 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.636 -0.665 . . . . 0.0 109.697 176.804 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -59.76 -25.11 78.2 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.141 1.074 . . . . 0.0 111.078 -171.956 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.8 mt -100.72 -50.41 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.409 -0.807 . . . . 0.0 110.853 -171.832 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.422 ' O ' HG22 ' A' ' 201' ' ' VAL . 17.4 p -105.43 12.16 31.83 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.41 -0.807 . . . . 0.0 111.96 -173.211 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 82.32 -25.07 4.48 Favored Glycine 0 N--CA 1.498 2.781 0 O-C-N 120.997 -1.064 . . . . 0.0 111.885 169.169 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.631 HH12 HG23 ' A' ' 202' ' ' VAL . 29.7 mmt180 -45.83 142.14 2.69 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-N 118.652 1.226 . . . . 0.0 112.678 -168.445 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -104.41 146.08 29.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.7 -0.625 . . . . 0.0 109.93 173.681 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 77.9 p -154.74 159.98 41.03 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.609 -0.682 . . . . 0.0 110.39 178.58 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.596 HG21 HG23 ' A' ' 228' ' ' VAL . 8.6 p -123.23 148.25 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.75 -0.593 . . . . 0.0 109.816 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.721 HD22 ' HG2' ' A' ' 187' ' ' ARG . 83.9 mt -129.57 154.62 46.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.653 -0.655 . . . . 0.0 109.662 -176.506 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.442 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.1 m -151.35 151.73 29.63 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.769 -0.582 . . . . 0.0 110.045 175.992 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -71.1 138.6 33.92 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 O-C-N 123.232 1.122 . . . . 0.0 109.991 177.12 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.712 ' HD2' HD11 ' A' ' 186' ' ' ILE . 57.1 t80 -74.07 127.16 32.2 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.53 -0.731 . . . . 0.0 110.194 175.376 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -99.95 160.09 28.13 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.697 -0.627 . . . . 0.0 109.974 175.111 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -58.55 157.86 25.61 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 O-C-N 123.291 1.153 . . . . 0.0 110.518 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.15 149.92 77.06 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 O-C-N 123.203 1.107 . . . . 0.0 110.514 -177.732 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -60.64 147.65 41.17 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.569 -0.707 . . . . 0.0 110.254 -178.721 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.87 127.2 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.508 -0.745 . . . . 0.0 110.219 -170.879 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.06 -10.27 55.18 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.49 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.405 ' OG1' ' CE2' ' A' ' 260' ' ' PHE . 10.1 t -144.12 174.12 11.15 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.115 -1.227 . . . . 0.0 110.676 176.027 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -107.39 13.17 27.27 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.647 -0.658 . . . . 0.0 111.812 -168.325 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.529 ' CE1' ' NE2' ' A' ' 173' ' ' GLN . 14.6 p90 -119.92 168.01 11.56 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.116 -0.99 . . . . 0.0 111.155 -175.184 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 82.2 m -117.77 145.75 44.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.791 -0.568 . . . . 0.0 109.854 179.553 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 42.2 m -116.62 135.93 53.39 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.582 -0.699 . . . . 0.0 110.78 -176.55 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.9 t -132.31 137.33 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 175.094 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 76.6 mt -104.59 120.92 42.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.493 -0.755 . . . . 0.0 109.991 -170.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.718 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 4.8 m-30 -105.29 153.64 21.33 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.672 -0.643 . . . . 0.0 110.823 -176.947 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -136.54 142.92 43.46 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.165 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -114.99 133.82 55.71 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.463 -0.773 . . . . 0.0 110.47 -179.414 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 268' ' ' MET . . . . . 0.564 ' HG3' HD12 ' A' ' 225' ' ' LEU . 5.0 ppp? -102.44 9.42 39.66 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.606 -0.684 . . . . 0.0 112.053 -175.683 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 269' ' ' CYS . . . . . 0.811 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.7 OUTLIER -144.61 159.05 43.44 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.083 -1.011 . . . . 0.0 110.108 173.06 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.455 ' HA ' HG21 ' A' ' 305' ' ' ILE . 26.9 p30 -119.27 163.11 17.62 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.752 -0.593 . . . . 0.0 110.423 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 271' ' ' SER . . . . . 0.419 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 25.1 m -57.95 -31.48 66.88 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.44 -0.788 . . . . 0.0 110.843 -166.671 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 51.1 p -105.72 14.95 27.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.352 -0.843 . . . . 0.0 111.965 -165.222 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 273' ' ' CYS . . . . . 0.658 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 29.6 p -94.18 118.1 31.07 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.139 -0.975 . . . . 0.0 110.539 177.571 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.89 139.23 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.436 -0.79 . . . . 0.0 110.177 -170.5 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.6 -5.13 60.12 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 178.794 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.05 -97.69 0.81 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 173.799 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 277' ' ' MET . . . . . 0.419 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.0 mmm -64.03 -33.76 76.46 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.74 -0.859 . . . . 0.0 110.41 178.589 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.1 p30 43.72 50.77 6.69 Favored 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 175.486 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 54.86 31.86 16.6 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.294 -0.879 . . . . 0.0 111.188 176.854 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -120.02 104.94 43.3 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.498 -0.751 . . . . 0.0 110.148 174.247 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -60.37 148.16 91.42 Favored 'Trans proline' 0 N--CA 1.487 1.139 0 O-C-N 123.104 1.055 . . . . 0.0 110.528 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.676 HG22 ' HA ' ' A' ' 192' ' ' TYR . 45.5 pt -131.99 177.42 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 CA-C-O 121.79 0.805 . . . . 0.0 111.037 -176.811 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.5 HD12 ' HA ' ' A' ' 193' ' ' LYS . 28.1 mt -124.34 149.9 46.09 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.613 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.677 HD12 ' CE1' ' A' ' 301' ' ' PHE . 81.4 mt -115.79 130.19 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.931 -0.707 . . . . 0.0 109.315 177.705 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.603 HG23 ' SG ' ' A' ' 300' ' ' CYS . 83.3 mt -109.88 126.19 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.483 -177.62 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 57.8 t -118.96 126.84 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.696 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.5 p -125.24 151.61 45.68 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.581 -0.7 . . . . 0.0 110.736 -173.467 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.804 HD21 ' HB3' ' A' ' 180' ' ' PRO . 21.8 tp -101.3 125.67 47.96 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 167.427 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.522 ' OE2' HG13 ' A' ' 295' ' ' VAL . 73.5 mm-40 -130.58 150.54 51.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.845 -0.534 . . . . 0.0 110.005 -172.566 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.837 ' CG2' HD11 ' A' ' 296' ' ' LEU . 17.1 p -89.96 161.13 16.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.678 -0.639 . . . . 0.0 109.967 177.789 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -55.95 -26.07 46.33 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.579 -0.701 . . . . 0.0 110.98 -176.635 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 47.0 p30 -90.36 9.36 29.23 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.373 -0.829 . . . . 0.0 111.908 -173.567 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.41 20.15 46.23 Favored Glycine 0 N--CA 1.494 2.546 0 C-N-CA 120.169 -1.015 . . . . 0.0 110.841 171.055 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -107.58 140.16 41.01 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.357 -1.084 . . . . 0.0 110.075 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.522 HG13 ' OE2' ' A' ' 289' ' ' GLU . 59.8 t -87.68 132.14 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.543 -0.723 . . . . 0.0 110.164 -173.35 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.837 HD11 ' CG2' ' A' ' 290' ' ' THR . 96.1 mt -99.97 -40.2 7.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.667 -0.646 . . . . 0.0 110.44 178.15 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -159.97 148.62 17.35 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -178.14 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.495 ' HD3' HG11 ' A' ' 295' ' ' VAL . 79.1 mtm180 -135.09 133.14 38.97 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.73 -0.864 . . . . 0.0 110.566 -178.61 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -135.03 156.17 49.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.705 -0.622 . . . . 0.0 109.976 172.32 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 300' ' ' CYS . . . . . 0.603 ' SG ' HG23 ' A' ' 285' ' ' ILE . 83.0 m -141.77 154.21 45.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.431 -0.793 . . . . 0.0 110.541 -176.269 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.677 ' CE1' HD12 ' A' ' 284' ' ' ILE . 49.3 p90 -144.96 164.62 30.57 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.694 -0.628 . . . . 0.0 110.247 177.14 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.428 ' HA ' HD23 ' A' ' 283' ' ' LEU . 83.7 tt0 -104.87 134.58 47.76 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.548 -0.72 . . . . 0.0 110.048 -177.137 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -121.77 143.68 49.24 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.704 -169.818 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 64.5 ttt-85 -139.82 134.86 32.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.761 -0.587 . . . . 0.0 109.633 173.585 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.811 HD13 ' O ' ' A' ' 269' ' ' CYS . 33.5 mt -106.79 122.86 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.585 -0.697 . . . . 0.0 109.67 178.627 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.2 p -145.12 170.92 15.29 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.594 -0.691 . . . . 0.0 110.975 -169.851 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -70.23 -40.05 74.72 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.752 -0.593 . . . . 0.0 110.604 -178.481 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 3.7 t -131.15 88.85 43.65 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.591 -0.693 . . . . 0.0 110.422 179.139 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -55.85 -29.04 70.72 Favored 'Trans proline' 0 N--CA 1.488 1.187 0 O-C-N 123.176 1.092 . . . . 0.0 110.82 174.48 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.6 -37.83 92.83 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 177.136 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 72.2 ttt-85 -72.4 -40.49 67.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.67 -0.9 . . . . 0.0 109.77 -173.327 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -69.43 -38.35 77.8 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.256 -178.347 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -61.23 -43.7 98.46 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.467 -0.77 . . . . 0.0 110.226 178.227 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 52.5 tttt -64.9 -39.41 93.48 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.509 -0.744 . . . . 0.0 110.469 177.931 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.44 -49.82 75.27 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.515 -0.74 . . . . 0.0 110.573 -173.342 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 316' ' ' ASP . . . . . 0.469 ' OD1' HD11 ' A' ' 159' ' ' LEU . 3.1 p30 . . . . . 0 N--CA 1.496 1.84 0 O-C-N 121.564 -0.71 . . . . 0.0 110.075 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.8 t -82.2 -25.82 33.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.67 -0.9 . . . . 0.0 110.468 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.486 ' C ' HG22 ' A' ' 116' ' ' THR . 22.9 m -58.36 -33.32 69.44 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.536 -0.727 . . . . 0.0 110.46 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.486 HG22 ' C ' ' A' ' 115' ' ' SER . 13.0 t 40.29 41.82 1.09 Allowed 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 176.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 52.01 -172.06 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.436 -0.79 . . . . 0.0 111.035 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 53.63 44.51 29.66 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.441 -0.787 . . . . 0.0 110.809 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -168.09 115.54 0.71 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.682 -0.637 . . . . 0.0 110.173 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 28.3 tp 55.8 -87.14 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.633 -0.667 . . . . 0.0 110.754 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.5 p -137.1 167.16 22.13 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.153 -0.967 . . . . 0.0 110.221 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -66.29 153.03 81.56 Favored 'Cis proline' 0 N--CA 1.495 1.573 0 C-N-CA 123.039 -1.65 . . . . 0.0 110.35 -17.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 71.1 m -82.21 145.58 52.75 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.648 -0.657 . . . . 0.0 110.146 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -59.55 146.11 96.12 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 O-C-N 123.179 1.094 . . . . 0.0 110.639 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.86 144.88 40.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.67 -0.644 . . . . 0.0 110.119 178.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.635 HD11 HG22 ' A' ' 199' ' ' THR . 51.1 mm -120.71 99.95 46.98 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.624 -0.672 . . . . 0.0 110.029 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -60.81 148.38 92.26 Favored 'Trans proline' 0 N--CA 1.488 1.169 0 O-C-N 123.208 1.11 . . . . 0.0 110.531 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.6 t -117.25 145.6 43.83 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.657 -0.652 . . . . 0.0 110.289 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.9 p-10 -96.15 25.86 4.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.652 -0.655 . . . . 0.0 110.601 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 51.0 m -71.04 125.19 26.2 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.573 -0.704 . . . . 0.0 110.27 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -71.42 144.98 49.59 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.661 -0.649 . . . . 0.0 110.443 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -153.87 99.05 2.59 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.742 -0.599 . . . . 0.0 110.073 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -59.39 -39.94 72.11 Favored 'Trans proline' 0 N--CA 1.487 1.147 0 O-C-N 123.175 1.092 . . . . 0.0 110.705 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.45 -155.16 48.36 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -75.75 -42.03 0.48 Allowed 'Trans proline' 0 C--N 1.316 -1.155 0 O-C-N 123.34 1.179 . . . . 0.0 110.993 -174.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -87.65 6.63 33.76 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.559 -0.713 . . . . 0.0 111.509 -173.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.69 60.97 3.33 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.98 -1.075 . . . . 0.0 110.672 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.687 ' HA ' HG12 ' A' ' 176' ' ' VAL . 50.4 t80 -77.89 118.87 20.62 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.63 -0.669 . . . . 0.0 109.955 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -130.04 161.42 31.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.81 -0.556 . . . . 0.0 110.068 -178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 62.9 t -126.48 145.74 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.696 -0.628 . . . . 0.0 109.893 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 78.4 p -155.43 160.29 40.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.802 -0.561 . . . . 0.0 110.043 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.498 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 71.7 m-85 -126.7 125.31 41.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.849 -0.532 . . . . 0.0 109.885 -175.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -56.79 147.91 21.94 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.551 -0.718 . . . . 0.0 110.587 -173.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -100.8 146.42 27.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.7 -0.625 . . . . 0.0 110.312 -177.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 83.9 p -143.4 163.21 33.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.669 -0.644 . . . . 0.0 110.163 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 43.9 m -61.37 157.75 16.02 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.684 -0.635 . . . . 0.0 110.186 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.4 p -72.37 63.85 0.56 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.6 -0.687 . . . . 0.0 110.083 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.95 152.68 43.38 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.536 -0.727 . . . . 0.0 110.189 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -76.21 155.49 34.43 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.66 -0.65 . . . . 0.0 110.026 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 34.9 t 53.24 29.15 8.02 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.454 -0.779 . . . . 0.0 110.903 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -60.38 132.13 52.95 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.66 -0.65 . . . . 0.0 110.241 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 43.5 p -60.1 -34.0 72.88 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.795 -0.565 . . . . 0.0 110.072 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.443 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -171.44 144.52 1.96 Allowed 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.397 0.617 . . . . 0.0 110.331 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.6 t -142.08 142.51 32.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.929 -0.482 . . . . 0.0 109.878 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.498 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 64.7 t80 -125.65 140.04 53.05 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.509 -0.744 . . . . 0.0 110.787 -171.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.2 t -111.7 124.88 53.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.8 -0.562 . . . . 0.0 109.958 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 59.2 m -70.95 -37.02 72.81 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.749 -0.595 . . . . 0.0 110.571 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -59.01 -34.75 72.24 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.573 -0.704 . . . . 0.0 110.444 -177.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.499 HD21 HD11 ' A' ' 320' ' ' ILE . 56.0 mt -104.83 -12.04 16.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.662 -0.649 . . . . 0.0 110.88 -176.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 82.3 tttt 59.73 51.62 6.1 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.074 -1.017 . . . . 0.0 109.673 178.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -145.09 153.07 41.04 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.594 -173.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.683 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.56 137.73 53.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.779 -0.576 . . . . 0.0 110.24 -175.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -116.0 135.4 54.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.674 -0.641 . . . . 0.0 109.288 173.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.9 p -138.36 158.42 44.31 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.705 -0.622 . . . . 0.0 110.899 -175.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.429 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 50.1 mt-30 -104.5 144.07 32.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.64 -0.662 . . . . 0.0 110.277 173.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.428 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.2 tt -52.81 146.05 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-O 121.592 0.711 . . . . 0.0 111.802 -173.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.5 10.0 5.46 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.554 -0.716 . . . . 0.0 112.484 176.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.429 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 73.5 mmtt -96.61 155.06 16.93 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.995 -1.066 . . . . 0.0 110.867 175.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 85.0 m -84.5 126.13 33.01 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.689 -0.632 . . . . 0.0 110.668 -177.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' CYS . . . . . 0.683 ' SG ' HD21 ' A' ' 162' ' ' LEU . 44.7 t -115.37 90.19 24.12 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.576 -0.702 . . . . 0.0 110.202 174.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.443 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 21.2 Cg_exo -62.59 131.1 32.17 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.216 1.114 . . . . 0.0 110.691 173.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.414 HG12 ' CE2' ' A' ' 142' ' ' PHE . 95.1 mt -125.08 143.82 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.659 -0.651 . . . . 0.0 109.279 175.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -109.47 135.36 50.61 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.496 -0.753 . . . . 0.0 110.813 -175.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.402 HG23 ' CE1' ' A' ' 138' ' ' PHE . 48.7 mm -95.29 135.01 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.604 -0.685 . . . . 0.0 109.584 168.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -116.11 128.0 55.3 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.608 -0.683 . . . . 0.0 110.406 175.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.687 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.1 m -136.57 159.72 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.674 -0.641 . . . . 0.0 109.892 175.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.7 mmm -74.46 -40.44 61.89 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.704 -0.622 . . . . 0.0 110.094 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 77.5 p -135.87 143.23 43.56 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.752 -0.593 . . . . 0.0 109.825 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -55.34 139.9 81.72 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 O-C-N 123.17 1.089 . . . . 0.0 110.861 -173.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.789 ' HB3' HD21 ' A' ' 288' ' ' LEU . 18.0 Cg_endo -61.97 166.9 11.46 Favored 'Trans proline' 0 N--CA 1.487 1.145 0 O-C-N 123.217 1.114 . . . . 0.0 110.72 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -61.06 155.68 49.09 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 O-C-N 123.382 1.201 . . . . 0.0 110.41 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -73.55 138.66 45.11 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.652 -0.655 . . . . 0.0 109.93 176.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.57 -24.94 29.36 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -174.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.14 150.94 2.18 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.367 -1.078 . . . . 0.0 111.426 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.78 155.94 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.735 -0.603 . . . . 0.0 109.906 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.683 HD11 ' CD2' ' A' ' 251' ' ' TYR . 53.4 mt -109.61 135.57 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.723 ' HG2' HD22 ' A' ' 248' ' ' LEU . 59.6 mtt180 -114.95 145.97 41.67 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.674 -0.641 . . . . 0.0 109.292 -174.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.651 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -140.54 127.74 21.01 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.546 -0.721 . . . . 0.0 110.312 173.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.4 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 41.3 ttp -137.25 139.91 29.35 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.766 -0.584 . . . . 0.0 111.061 -177.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.587 ' HD3' HD12 ' A' ' 226' ' ' ILE . 72.9 Cg_endo -91.12 138.2 2.28 Favored 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 121.051 1.167 . . . . 0.0 110.789 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.438 HG12 ' CZ ' ' A' ' 244' ' ' ARG . 34.8 m -147.38 154.85 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.539 -0.725 . . . . 0.0 110.06 174.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.569 ' HA ' HG22 ' A' ' 282' ' ' ILE . 78.3 m-85 -63.02 167.69 4.64 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.457 -0.777 . . . . 0.0 110.517 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.416 ' HA ' HD12 ' A' ' 283' ' ' LEU . 86.3 tttt -85.05 -60.12 2.14 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.657 -0.652 . . . . 0.0 110.834 -173.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -80.11 152.33 29.35 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.593 -0.692 . . . . 0.0 110.284 -175.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.454 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.67 -38.68 72.54 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.364 -0.835 . . . . 0.0 110.664 -175.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -56.58 -24.77 49.66 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.499 -0.751 . . . . 0.0 110.558 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.406 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 98.7 m-70 -109.71 -20.49 12.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.534 -0.729 . . . . 0.0 111.167 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.454 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -67.65 -20.22 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.12 -0.987 . . . . 0.0 110.581 -176.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.635 HG22 HD11 ' A' ' 126' ' ' ILE . 67.8 p -79.42 -16.85 55.48 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.544 -0.723 . . . . 0.0 110.856 174.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.35 136.41 33.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.303 -0.873 . . . . 0.0 110.086 175.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.1 t -73.0 143.26 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.661 -0.649 . . . . 0.0 110.267 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.685 HG23 HH12 ' A' ' 244' ' ' ARG . 60.8 t -84.94 136.39 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.625 -0.672 . . . . 0.0 109.224 171.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.8 pttt -134.89 -170.22 2.52 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.453 -0.779 . . . . 0.0 111.137 -168.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -95.3 158.96 15.23 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.776 -0.578 . . . . 0.0 110.34 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 56.9 m -77.26 157.42 80.79 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.551 -0.718 . . . . 0.0 109.304 175.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.405 ' HD3' ' HA3' ' A' ' 275' ' ' GLY . 17.2 Cg_exo -63.37 -47.31 7.96 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 123.122 1.064 . . . . 0.0 109.97 176.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.431 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.3 p-10 -65.44 -43.74 89.5 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.549 -0.719 . . . . 0.0 111.091 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' HIS . . . . . 0.431 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 53.6 m170 -81.75 -27.99 33.53 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.459 -0.775 . . . . 0.0 111.266 -175.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -69.15 -38.87 79.0 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.384 -0.822 . . . . 0.0 110.402 172.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 26.7 tp -56.43 -35.91 68.38 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.57 -0.706 . . . . 0.0 110.836 -176.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 30.2 t -48.42 140.4 7.86 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.472 -0.767 . . . . 0.0 111.313 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.434 ' HB2' ' CE2' ' A' ' 214' ' ' PHE . 92.3 mtt-85 -60.33 141.08 56.71 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.575 -0.703 . . . . 0.0 110.274 -176.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -65.51 -32.81 74.62 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.692 -0.63 . . . . 0.0 110.518 -176.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.434 ' CE2' ' HB2' ' A' ' 212' ' ' ARG . 52.2 m-85 51.2 47.54 24.66 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.534 -0.729 . . . . 0.0 110.975 -175.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -73.38 -10.15 59.44 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.737 -0.602 . . . . 0.0 111.346 -175.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -58.5 113.03 1.8 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.206 -0.934 . . . . 0.0 110.743 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 73.97 19.98 79.74 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 174.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -114.89 140.15 49.21 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.303 -1.116 . . . . 0.0 110.471 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.8 mt -84.91 -25.06 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.688 -0.632 . . . . 0.0 110.416 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -124.99 93.95 44.83 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.462 -0.774 . . . . 0.0 110.586 -176.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.429 ' HD2' ' CE2' ' A' ' 236' ' ' TYR . 24.7 Cg_endo -67.21 144.29 68.15 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 O-C-N 123.323 1.17 . . . . 0.0 110.445 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 221' ' ' PRO . 33.5 Cg_exo -57.49 -19.59 37.05 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 O-C-N 123.124 1.065 . . . . 0.0 111.528 -177.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 27.4 m -51.26 -26.95 8.07 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.187 -0.946 . . . . 0.0 111.444 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' HIS . . . . . 0.408 ' CD2' ' HB3' ' A' ' 236' ' ' TYR . 75.6 m80 -102.58 130.53 49.47 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.458 -0.776 . . . . 0.0 110.269 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.407 ' HA ' ' CG ' ' A' ' 268' ' ' MET . 39.5 tp -60.58 -38.14 83.63 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.641 -0.662 . . . . 0.0 110.285 -178.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.587 HD12 ' HD3' ' A' ' 190' ' ' PRO . 83.2 mt -101.42 136.77 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.795 -0.566 . . . . 0.0 109.84 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -131.69 156.98 44.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.688 -0.633 . . . . 0.0 110.328 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.524 HG23 HG21 ' A' ' 247' ' ' VAL . 88.3 t -103.13 146.65 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.749 -0.595 . . . . 0.0 109.941 176.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -118.24 126.76 52.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.721 -0.612 . . . . 0.0 110.368 171.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 96.98 21.4 20.91 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 168.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -139.4 105.23 5.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.3 -1.118 . . . . 0.0 110.038 174.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 91.6 p -63.65 -15.1 57.42 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.604 -0.685 . . . . 0.0 111.232 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -97.02 9.97 40.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.245 -0.909 . . . . 0.0 111.235 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.75 130.49 46.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.127 -0.983 . . . . 0.0 110.09 175.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -139.74 157.96 44.89 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.668 -0.645 . . . . 0.0 109.862 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.429 ' CE2' ' HD2' ' A' ' 221' ' ' PRO . 88.0 m-85 -118.58 150.81 39.03 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.576 -0.702 . . . . 0.0 110.646 -176.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.11 159.9 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.776 -0.578 . . . . 0.0 110.128 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -120.38 130.04 54.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.738 -0.601 . . . . 0.0 110.262 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.27 119.08 46.3 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.625 -0.672 . . . . 0.0 109.669 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.16 -27.7 78.93 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 O-C-N 123.059 1.031 . . . . 0.0 110.874 -172.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 84.0 mt -102.99 -50.32 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.434 -0.792 . . . . 0.0 110.952 -170.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 18.6 p -105.33 12.23 31.92 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.379 -0.826 . . . . 0.0 111.975 -171.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 82.95 -25.04 4.9 Favored Glycine 0 N--CA 1.497 2.737 0 O-C-N 121.009 -1.057 . . . . 0.0 111.825 168.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.685 HH12 HG23 ' A' ' 202' ' ' VAL . 26.7 mmt180 -45.89 142.13 2.75 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 118.598 1.199 . . . . 0.0 112.627 -168.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -105.22 146.9 28.65 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.659 -0.651 . . . . 0.0 110.036 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.2 p -154.74 159.92 40.99 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.576 -0.703 . . . . 0.0 110.35 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.524 HG21 HG23 ' A' ' 228' ' ' VAL . 8.4 p -122.92 148.1 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.729 -0.607 . . . . 0.0 109.814 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.723 HD22 ' HG2' ' A' ' 187' ' ' ARG . 81.9 mt -129.71 154.61 46.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.738 -0.601 . . . . 0.0 109.891 -175.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.441 HG13 ' C ' ' A' ' 248' ' ' LEU . 33.8 m -151.3 151.84 29.91 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.878 -0.514 . . . . 0.0 109.935 175.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -71.04 138.95 34.81 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 O-C-N 123.269 1.142 . . . . 0.0 109.95 177.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.683 ' CD2' HD11 ' A' ' 186' ' ' ILE . 10.0 t80 -78.69 126.51 30.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.496 -0.753 . . . . 0.0 110.21 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -99.97 160.05 28.22 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.695 -0.628 . . . . 0.0 110.059 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -59.17 159.53 22.01 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.234 1.123 . . . . 0.0 110.423 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.38 149.96 78.02 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 O-C-N 123.261 1.137 . . . . 0.0 110.536 -177.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -61.3 148.09 42.4 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.679 -0.638 . . . . 0.0 110.2 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.9 t -69.84 127.2 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.563 -0.711 . . . . 0.0 110.178 -170.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.03 -10.14 55.23 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 10.0 t -144.5 173.25 11.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.169 -1.195 . . . . 0.0 110.642 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -106.9 13.22 27.98 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.674 -0.641 . . . . 0.0 111.743 -168.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -119.99 168.06 11.54 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.159 -0.963 . . . . 0.0 111.092 -175.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 84.1 m -117.75 145.69 44.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.813 -0.554 . . . . 0.0 109.837 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 52.2 m -114.94 135.54 54.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.594 -0.691 . . . . 0.0 110.934 -174.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.6 t -130.12 137.24 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 72.1 mt -104.73 119.07 38.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.581 -0.7 . . . . 0.0 109.863 -172.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.651 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 6.0 m-30 -105.89 151.24 24.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.675 -0.64 . . . . 0.0 110.614 -177.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -136.6 142.91 43.35 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -112.23 131.06 55.7 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.518 -0.739 . . . . 0.0 110.437 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' MET . . . . . 0.407 ' CG ' ' HA ' ' A' ' 225' ' ' LEU . 5.0 ppp? -100.23 7.43 44.48 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.683 -0.636 . . . . 0.0 111.972 -175.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' CYS . . . . . 0.67 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.6 OUTLIER -144.76 164.95 29.48 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.075 -1.016 . . . . 0.0 109.834 171.558 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.61 ' HA ' HG21 ' A' ' 305' ' ' ILE . 28.0 p30 -120.7 161.94 20.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.651 -0.656 . . . . 0.0 110.456 -178.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' SER . . . . . 0.428 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 22.5 m -58.08 -33.42 69.05 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.48 -0.762 . . . . 0.0 111.082 -163.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 48.8 p -99.4 11.5 38.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.466 -0.771 . . . . 0.0 112.011 -163.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 30.2 p -94.48 118.01 31.0 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.124 -0.985 . . . . 0.0 110.672 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.7 t -64.12 140.04 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.504 -0.748 . . . . 0.0 110.412 -169.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' GLY . . . . . 0.405 ' HA3' ' HD3' ' A' ' 206' ' ' PRO . . . 99.46 -5.21 58.63 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 177.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -125.46 -100.43 1.25 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 170.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' MET . . . . . 0.428 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.3 mmm -64.28 -31.44 72.65 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.687 -0.89 . . . . 0.0 110.319 176.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.7 p30 43.38 51.51 5.98 Favored 'General case' 0 N--CA 1.505 2.301 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 175.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 54.81 27.05 8.39 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.275 -0.891 . . . . 0.0 111.145 175.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -118.32 105.91 45.72 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.575 -0.703 . . . . 0.0 110.057 176.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.51 147.27 92.27 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 O-C-N 123.119 1.063 . . . . 0.0 110.6 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.569 HG22 ' HA ' ' A' ' 192' ' ' TYR . 45.7 pt -131.88 178.32 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 121.744 0.783 . . . . 0.0 110.832 -177.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 302' ' ' GLU . 31.3 mt -124.4 149.87 46.22 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.685 HD12 ' CE1' ' A' ' 301' ' ' PHE . 81.2 mt -115.27 130.34 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.621 HG23 ' SG ' ' A' ' 300' ' ' CYS . 82.0 mt -109.74 126.26 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -176.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 59.7 t -118.9 126.71 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.425 HG22 ' HG2' ' A' ' 298' ' ' ARG . 45.6 p -125.26 152.76 44.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.637 -0.665 . . . . 0.0 110.665 -174.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.789 HD21 ' HB3' ' A' ' 180' ' ' PRO . 19.8 tp -102.59 126.17 49.58 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 168.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.638 ' OE2' HG13 ' A' ' 295' ' ' VAL . 73.3 mm-40 -131.78 149.13 52.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.814 -0.554 . . . . 0.0 110.003 -172.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.82 ' CG2' HD11 ' A' ' 296' ' ' LEU . 19.0 p -89.98 161.11 16.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.706 -0.621 . . . . 0.0 110.115 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -55.95 -26.12 46.52 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.603 -0.686 . . . . 0.0 111.094 -176.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 46.0 p30 -90.18 9.66 27.57 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.399 -0.813 . . . . 0.0 111.889 -173.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 88.79 20.19 48.23 Favored Glycine 0 N--CA 1.494 2.542 0 O-C-N 121.12 -0.987 . . . . 0.0 110.655 171.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -107.98 140.15 41.56 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.267 -1.137 . . . . 0.0 110.025 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.638 HG13 ' OE2' ' A' ' 289' ' ' GLU . 60.8 t -88.74 132.23 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.65 -0.656 . . . . 0.0 110.234 -172.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.82 HD11 ' CG2' ' A' ' 290' ' ' THR . 96.2 mt -99.88 -40.08 7.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.707 -0.62 . . . . 0.0 110.532 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -162.61 150.83 20.33 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.425 ' HG2' HG22 ' A' ' 287' ' ' THR . 78.5 mtm180 -135.15 134.77 40.52 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.686 -0.89 . . . . 0.0 110.566 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -137.34 158.69 43.87 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.676 -0.64 . . . . 0.0 109.982 172.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' CYS . . . . . 0.621 ' SG ' HG23 ' A' ' 285' ' ' ILE . 97.7 m -142.56 155.69 45.03 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.424 -0.797 . . . . 0.0 110.713 -175.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.685 ' CE1' HD12 ' A' ' 284' ' ' ILE . 47.9 p90 -144.94 163.73 33.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.72 -0.612 . . . . 0.0 110.113 175.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.446 ' HA ' HD23 ' A' ' 283' ' ' LEU . 56.8 tt0 -104.91 135.37 46.39 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.496 -0.752 . . . . 0.0 110.151 -177.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -124.29 143.5 50.52 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.677 -170.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -138.67 139.01 38.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.843 -0.536 . . . . 0.0 109.806 173.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.67 HD13 ' O ' ' A' ' 269' ' ' CYS . 74.5 mt -105.82 122.93 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.549 -0.72 . . . . 0.0 109.59 175.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.9 p -145.18 168.24 20.85 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.558 -0.714 . . . . 0.0 110.968 -170.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -68.8 -39.97 79.81 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.686 -0.633 . . . . 0.0 110.636 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 4.1 t -131.25 88.54 44.2 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.534 -0.729 . . . . 0.0 110.496 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.33 -29.35 67.3 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 O-C-N 123.185 1.098 . . . . 0.0 110.914 174.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.36 -37.77 93.07 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -73.25 -40.63 64.48 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.689 -0.889 . . . . 0.0 109.875 -173.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -69.47 -39.96 77.4 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.164 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -61.01 -44.15 97.83 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.456 -0.777 . . . . 0.0 110.289 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -64.68 -40.14 94.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.557 -0.714 . . . . 0.0 110.495 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.57 -50.05 74.2 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.499 -0.751 . . . . 0.0 110.486 -173.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -61.3 -37.82 84.58 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.501 -0.749 . . . . 0.0 110.084 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -63.49 -40.53 97.32 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.625 -0.672 . . . . 0.0 110.166 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -62.48 -35.2 78.58 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.603 -0.685 . . . . 0.0 109.977 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 23.8 m -62.8 -33.66 75.66 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.719 -0.613 . . . . 0.0 110.228 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.499 HD11 HD21 ' A' ' 159' ' ' LEU . 83.5 mt -78.34 -44.41 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.606 -0.684 . . . . 0.0 109.936 -177.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -58.95 -40.64 85.27 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.658 -0.651 . . . . 0.0 110.503 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -61.39 -44.33 97.33 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.613 -0.679 . . . . 0.0 110.185 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -63.9 -33.77 76.45 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.66 -0.65 . . . . 0.0 110.236 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -98.09 125.12 42.94 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.675 -0.64 . . . . 0.0 110.411 -176.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.53 130.05 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.65 -0.656 . . . . 0.0 109.783 178.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 29.4 t -95.06 139.98 30.65 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.595 -0.69 . . . . 0.0 110.39 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -84.65 124.41 31.44 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.668 -0.645 . . . . 0.0 110.207 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 11.0 t -61.17 148.27 41.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.566 -0.709 . . . . 0.0 110.175 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 76.9 p -99.83 22.01 11.71 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.62 -0.675 . . . . 0.0 110.901 -176.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -60.09 -36.53 77.6 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.464 -0.772 . . . . 0.0 110.226 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -111.66 138.59 48.03 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.67 -0.644 . . . . 0.0 110.145 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -60.26 -36.04 89.76 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -160.44 160.03 31.66 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.655 -0.909 . . . . 0.0 110.366 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -87.88 130.86 34.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.63 -0.669 . . . . 0.0 110.17 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -72.33 -44.92 61.96 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.685 -0.634 . . . . 0.0 110.397 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -85.85 -37.24 19.4 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.637 -0.664 . . . . 0.0 110.506 -176.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 53.72 46.73 25.29 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.395 -0.815 . . . . 0.0 110.744 -178.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -101.34 133.32 46.11 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.649 -0.657 . . . . 0.0 110.439 -177.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 76.4 p -97.0 26.27 4.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.626 -0.671 . . . . 0.0 110.398 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -68.71 154.07 42.63 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.568 -0.708 . . . . 0.0 110.239 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 97.7 168.81 32.48 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 50.9 mm -94.14 136.1 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.604 -0.939 . . . . 0.0 110.089 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -84.94 -38.04 19.82 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.602 -0.686 . . . . 0.0 110.382 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 23.0 ptt? -138.83 55.05 1.73 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.58 -0.7 . . . . 0.0 110.443 -177.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 345' ' ' THR . . . . . 0.554 HG22 ' O ' ' A' ' 345' ' ' THR . 51.0 m . . . . . 0 N--CA 1.5 2.047 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.823 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 75.2 m -86.28 9.31 18.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.587 -0.949 . . . . 0.0 111.361 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 86.8 p -61.64 -28.36 69.32 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.212 -0.93 . . . . 0.0 110.257 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.9 p -122.44 161.67 23.09 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.643 -0.66 . . . . 0.0 110.295 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -133.51 151.74 51.8 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.655 -0.653 . . . . 0.0 110.33 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -88.67 119.46 29.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.633 -0.667 . . . . 0.0 110.45 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 50.1 83.36 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.543 -0.723 . . . . 0.0 111.404 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 88.7 mt 51.38 -176.23 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.345 -0.847 . . . . 0.0 111.111 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.3 p -130.47 161.04 63.05 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.601 -0.687 . . . . 0.0 110.245 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -61.76 151.86 78.04 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 O-C-N 123.273 1.144 . . . . 0.0 110.333 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 79.1 p -81.47 141.56 49.14 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.632 -0.667 . . . . 0.0 110.078 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.613 ' HB3' HG22 ' A' ' 242' ' ' THR . 19.4 Cg_endo -64.73 144.97 85.63 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 O-C-N 123.244 1.128 . . . . 0.0 110.533 -177.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.43 141.4 41.4 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.665 -0.647 . . . . 0.0 110.03 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.565 HD12 HG13 ' A' ' 198' ' ' VAL . 50.4 mm -123.52 99.95 38.86 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.698 -0.626 . . . . 0.0 110.062 -178.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -61.13 152.99 67.82 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 O-C-N 123.236 1.124 . . . . 0.0 110.461 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.5 t -108.4 148.64 29.84 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.667 -0.645 . . . . 0.0 110.233 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.5 p-10 -94.06 23.22 5.11 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.69 -0.631 . . . . 0.0 110.915 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 50.4 m -75.4 125.16 28.44 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.445 -0.785 . . . . 0.0 110.233 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -69.61 144.97 52.84 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.639 -0.663 . . . . 0.0 110.478 -177.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -153.18 100.59 2.65 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.647 -0.658 . . . . 0.0 110.118 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -59.14 -39.96 74.3 Favored 'Trans proline' 0 N--CA 1.489 1.206 0 O-C-N 123.129 1.068 . . . . 0.0 110.774 -175.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.3 -155.17 48.59 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -75.47 -43.57 0.35 Allowed 'Trans proline' 0 C--N 1.317 -1.095 0 O-C-N 123.303 1.159 . . . . 0.0 110.978 -174.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -86.77 8.1 24.12 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.529 -0.732 . . . . 0.0 111.412 -173.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.39 59.67 4.23 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.997 -1.064 . . . . 0.0 110.72 -176.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.68 ' HA ' HG12 ' A' ' 176' ' ' VAL . 64.8 t80 -77.82 117.25 19.01 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.572 -0.705 . . . . 0.0 109.933 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -130.05 160.01 35.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.855 -0.528 . . . . 0.0 110.141 -178.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 63.8 t -126.41 146.42 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.681 -0.637 . . . . 0.0 109.816 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 78.4 p -155.26 161.4 41.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.765 -0.584 . . . . 0.0 110.069 177.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.497 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 67.1 m-85 -126.74 125.24 41.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.8 -0.562 . . . . 0.0 109.851 -176.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -57.47 144.05 38.17 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.594 -0.691 . . . . 0.0 110.267 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -120.05 156.18 31.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.608 -0.682 . . . . 0.0 110.747 -173.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 23.2 t -148.21 165.74 30.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.725 -0.609 . . . . 0.0 109.994 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 54.5 p -61.43 162.74 7.56 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.585 -0.697 . . . . 0.0 110.058 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.601 HG22 HH21 ' A' ' 313' ' ' ARG . 71.7 p -59.96 92.44 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.563 -0.71 . . . . 0.0 110.263 -177.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.06 148.86 22.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.734 -0.604 . . . . 0.0 110.256 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -72.81 137.22 45.62 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.686 -0.634 . . . . 0.0 110.132 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.3 m 53.41 51.43 15.37 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.492 -0.755 . . . . 0.0 110.96 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.98 132.96 46.73 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.623 -0.673 . . . . 0.0 110.172 177.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.5 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 82.1 p -60.03 -32.92 71.34 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.715 -0.616 . . . . 0.0 109.99 175.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.5 ' HD1' ' HG1' ' A' ' 152' ' ' THR . 68.8 p-90 -171.04 143.74 2.02 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.329 0.585 . . . . 0.0 110.059 177.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.0 t -142.15 142.63 32.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.88 -0.513 . . . . 0.0 110.072 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.497 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 44.7 t80 -125.49 140.06 53.09 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.551 -0.718 . . . . 0.0 110.514 -172.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.8 t -111.79 124.94 53.41 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 120.383 -0.527 . . . . 0.0 109.878 176.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 56.5 m -70.68 -37.07 73.61 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.789 -0.569 . . . . 0.0 110.483 -177.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -59.49 -33.86 71.86 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.645 -0.659 . . . . 0.0 110.441 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.505 HD11 ' OD1' ' A' ' 316' ' ' ASP . 57.1 mt -104.77 -12.04 16.52 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.678 -0.639 . . . . 0.0 110.88 -175.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 30.5 tttt 59.77 50.3 7.19 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.051 -1.031 . . . . 0.0 109.675 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -146.42 153.09 40.07 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.74 -0.6 . . . . 0.0 110.612 -174.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.618 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.55 137.85 53.4 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.833 -0.542 . . . . 0.0 110.209 -176.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -114.94 135.2 54.47 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.1 p -138.34 158.5 44.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.72 -0.612 . . . . 0.0 111.044 -175.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.421 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 65.5 mt-30 -104.45 140.94 37.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.628 -0.67 . . . . 0.0 110.021 172.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.432 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.1 tt -52.25 148.67 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.502 -0.749 . . . . 0.0 111.917 -172.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.79 10.05 5.77 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.539 -0.726 . . . . 0.0 112.509 176.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.421 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 26.7 mmtt -95.35 155.11 16.87 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.924 -1.11 . . . . 0.0 110.955 174.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 87.3 m -84.68 126.25 33.22 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.721 -0.612 . . . . 0.0 110.552 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' CYS . . . . . 0.618 ' SG ' HD21 ' A' ' 162' ' ' LEU . 29.9 t -115.15 90.36 23.62 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.572 -0.705 . . . . 0.0 110.178 176.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.42 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 22.6 Cg_endo -65.83 130.82 25.59 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 O-C-N 123.271 1.143 . . . . 0.0 110.597 176.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.411 HG12 ' CE2' ' A' ' 142' ' ' PHE . 96.9 mt -123.51 142.06 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.692 -0.63 . . . . 0.0 109.306 176.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -109.08 134.7 51.34 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.552 -0.718 . . . . 0.0 110.713 -176.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.1 mm -95.29 134.76 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.67 -0.644 . . . . 0.0 109.66 169.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -115.16 127.27 55.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.593 -0.692 . . . . 0.0 110.452 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.68 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.0 m -136.66 159.77 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.639 -0.663 . . . . 0.0 109.852 174.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.6 mmm -76.32 -40.69 50.73 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.658 -0.651 . . . . 0.0 110.092 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.5 p -134.45 143.28 46.09 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.763 -0.586 . . . . 0.0 109.9 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.8 Cg_exo -55.5 139.92 82.64 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 O-C-N 123.173 1.091 . . . . 0.0 110.947 -173.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.795 ' HB3' HD21 ' A' ' 288' ' ' LEU . 19.3 Cg_endo -59.95 165.2 10.67 Favored 'Trans proline' 0 C--N 1.316 -1.167 0 O-C-N 123.17 1.09 . . . . 0.0 110.656 177.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -62.04 154.86 59.25 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 O-C-N 123.312 1.164 . . . . 0.0 110.446 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -64.67 137.54 57.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.65 -0.656 . . . . 0.0 110.117 173.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 96.8 -24.96 28.67 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.861 -1.295 . . . . 0.0 109.861 -177.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.15 149.21 2.96 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.324 -1.104 . . . . 0.0 111.423 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.74 155.95 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.72 -0.612 . . . . 0.0 109.831 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.686 HD11 ' CD2' ' A' ' 251' ' ' TYR . 64.0 mt -108.79 135.21 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.732 ' HG2' HD22 ' A' ' 248' ' ' LEU . 69.5 mtt180 -114.95 145.85 41.8 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -174.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.646 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -140.54 126.53 19.51 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.534 -0.729 . . . . 0.0 110.212 173.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.409 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 32.9 ttp -137.22 139.0 26.76 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.804 -0.56 . . . . 0.0 110.98 -176.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.534 ' HD3' HD12 ' A' ' 226' ' ' ILE . 71.0 Cg_endo -91.11 138.25 2.29 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 O-C-N 123.204 1.107 . . . . 0.0 110.81 177.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.404 HG13 ' C ' ' A' ' 190' ' ' PRO . 35.9 m -146.22 154.87 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.554 -0.716 . . . . 0.0 110.118 173.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.66 ' HA ' HG22 ' A' ' 282' ' ' ILE . 83.4 m-85 -60.73 161.32 8.07 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.467 -0.771 . . . . 0.0 110.402 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.422 ' HA ' HD12 ' A' ' 283' ' ' LEU . 33.7 tttt -77.6 -60.07 2.52 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.632 -0.668 . . . . 0.0 110.827 -174.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -80.13 151.02 30.02 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.558 -0.713 . . . . 0.0 110.34 -175.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.456 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.54 -37.81 71.0 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.421 -0.8 . . . . 0.0 110.695 -176.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -56.61 -24.78 50.28 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.529 -0.732 . . . . 0.0 110.573 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.404 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 64.2 m170 -109.49 -20.51 12.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.531 -0.731 . . . . 0.0 111.165 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.565 HG13 HD12 ' A' ' 126' ' ' ILE . 3.2 p -67.72 -20.22 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.174 -0.954 . . . . 0.0 110.574 -176.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.504 HG22 HD11 ' A' ' 126' ' ' ILE . 67.7 p -79.36 -16.98 55.4 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.562 -0.711 . . . . 0.0 110.735 174.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -88.36 137.3 32.45 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.349 -0.845 . . . . 0.0 110.092 173.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.9 t -73.0 142.0 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.626 -0.671 . . . . 0.0 110.299 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.529 HG22 ' CE2' ' A' ' 192' ' ' TYR . 75.8 t -84.96 139.7 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.542 -0.724 . . . . 0.0 109.344 170.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 14.7 pttt -134.86 -170.08 2.49 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.553 -0.717 . . . . 0.0 110.883 -170.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.41 ' HD2' ' HA ' ' A' ' 223' ' ' SER . 81.3 mtp180 -95.13 154.72 17.05 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.741 -0.599 . . . . 0.0 110.286 178.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 42.0 m -72.75 154.75 91.19 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.632 -0.668 . . . . 0.0 109.271 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -62.52 -47.31 9.68 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 O-C-N 123.123 1.065 . . . . 0.0 110.048 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.414 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.6 p-10 -65.45 -44.16 88.11 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.599 -0.688 . . . . 0.0 111.223 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' HIS . . . . . 0.414 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 52.1 m170 -82.23 -28.0 32.19 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.453 -0.779 . . . . 0.0 111.171 -174.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -69.08 -37.24 78.36 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.395 -0.815 . . . . 0.0 110.297 172.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 26.4 tp -55.52 -33.61 63.92 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.558 -0.714 . . . . 0.0 110.898 -177.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 31.1 t -48.29 145.73 3.16 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.535 -0.728 . . . . 0.0 111.292 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -59.95 142.19 54.21 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.585 -0.697 . . . . 0.0 110.388 -175.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -61.12 -39.84 91.53 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.62 -0.675 . . . . 0.0 110.174 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.404 ' O ' ' CD2' ' A' ' 214' ' ' PHE . 55.2 t80 50.52 50.69 18.35 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.486 -0.759 . . . . 0.0 111.091 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -75.13 -10.18 59.23 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.633 -0.667 . . . . 0.0 111.334 -178.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -58.96 114.06 2.38 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.116 -0.99 . . . . 0.0 110.731 -177.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 74.63 20.06 79.67 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 173.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -114.85 139.93 49.36 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.334 -1.098 . . . . 0.0 110.469 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 83.8 mt -88.27 -25.21 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.6 -0.688 . . . . 0.0 110.364 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.413 ' HB1' ' CG ' ' A' ' 227' ' ' ARG . . . -126.7 97.55 33.01 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.497 -0.752 . . . . 0.0 110.472 -177.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.403 ' HA ' ' HD3' ' A' ' 222' ' ' PRO . 19.2 Cg_endo -64.21 144.28 86.16 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 O-C-N 123.368 1.193 . . . . 0.0 110.48 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 221' ' ' PRO . 33.6 Cg_exo -57.47 -20.02 38.89 Favored 'Trans proline' 0 N--CA 1.489 1.246 0 O-C-N 123.153 1.081 . . . . 0.0 111.449 -178.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.41 ' HA ' ' HD2' ' A' ' 204' ' ' ARG . 87.5 p -53.78 -22.49 9.54 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.192 -0.943 . . . . 0.0 111.283 -176.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' HIS . . . . . 0.421 ' CD2' ' HB3' ' A' ' 236' ' ' TYR . 77.4 m80 -103.74 130.4 51.25 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.493 -0.754 . . . . 0.0 110.352 178.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 30.1 tp -61.0 -37.69 83.41 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.673 -0.642 . . . . 0.0 110.289 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.534 HD12 ' HD3' ' A' ' 190' ' ' PRO . 84.8 mt -103.94 136.76 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.746 -0.596 . . . . 0.0 109.917 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.413 ' CG ' ' HB1' ' A' ' 220' ' ' ALA . 79.1 mtm180 -131.6 156.7 45.34 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.667 -0.646 . . . . 0.0 110.318 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.575 HG23 HG21 ' A' ' 247' ' ' VAL . 89.4 t -102.28 146.62 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.772 -0.58 . . . . 0.0 109.974 176.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -117.96 130.03 55.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.722 -0.611 . . . . 0.0 110.431 171.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 93.15 21.55 29.81 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 167.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -136.73 107.24 6.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.319 -1.107 . . . . 0.0 110.048 173.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 94.5 p -63.43 -15.14 56.79 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.651 -0.656 . . . . 0.0 111.192 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -97.27 10.05 40.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.272 -0.892 . . . . 0.0 111.189 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.81 126.58 27.84 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.174 -0.954 . . . . 0.0 110.092 176.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -139.75 154.39 47.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.762 -0.586 . . . . 0.0 109.785 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.421 ' HB3' ' CD2' ' A' ' 224' ' ' HIS . 86.3 m-85 -116.95 150.7 38.11 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.596 -0.69 . . . . 0.0 110.538 -176.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.17 159.89 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.762 -0.587 . . . . 0.0 110.118 176.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -122.86 130.0 52.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.75 -0.594 . . . . 0.0 110.177 177.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -64.98 109.98 3.6 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.649 -0.657 . . . . 0.0 109.741 176.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -59.98 -24.46 76.51 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.083 1.044 . . . . 0.0 111.032 -172.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 84.3 mt -99.87 -50.39 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.488 -0.757 . . . . 0.0 110.766 -171.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.613 HG22 ' HB3' ' A' ' 124' ' ' PRO . 6.2 p -105.3 12.09 32.13 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.365 -0.834 . . . . 0.0 111.984 -173.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 81.97 -24.98 4.3 Favored Glycine 0 N--CA 1.496 2.7 0 O-C-N 120.982 -1.074 . . . . 0.0 111.888 169.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 -45.88 142.08 2.76 Favored 'General case' 0 N--CA 1.505 2.282 0 CA-C-N 118.59 1.195 . . . . 0.0 112.614 -168.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -108.8 144.58 36.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.629 -0.669 . . . . 0.0 110.063 174.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 78.8 p -154.83 159.96 40.91 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.62 -0.675 . . . . 0.0 110.48 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.575 HG21 HG23 ' A' ' 228' ' ' VAL . 8.3 p -123.07 148.12 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.77 -0.581 . . . . 0.0 109.695 177.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.732 HD22 ' HG2' ' A' ' 187' ' ' ARG . 81.3 mt -129.71 154.64 46.97 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.896 -176.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.442 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.9 m -150.57 151.84 31.48 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.807 -0.558 . . . . 0.0 109.944 175.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -71.11 138.81 34.31 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 O-C-N 123.188 1.099 . . . . 0.0 109.844 177.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.686 ' CD2' HD11 ' A' ' 186' ' ' ILE . 9.0 t80 -78.45 126.06 30.23 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.454 -0.779 . . . . 0.0 110.04 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -100.0 160.11 28.06 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.719 -0.613 . . . . 0.0 110.02 177.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -59.11 159.62 21.48 Favored 'Trans proline' 0 C--N 1.316 -1.157 0 O-C-N 123.276 1.145 . . . . 0.0 110.401 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.36 149.98 77.8 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.268 1.141 . . . . 0.0 110.521 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -60.53 148.42 37.95 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.681 -0.637 . . . . 0.0 110.241 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.82 127.17 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.516 -0.74 . . . . 0.0 110.154 -170.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.99 -10.17 55.39 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 10.0 t -144.66 173.31 11.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.177 -1.19 . . . . 0.0 110.586 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -107.19 13.14 27.6 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.63 -0.669 . . . . 0.0 111.783 -168.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -119.99 168.05 11.54 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.11 -0.994 . . . . 0.0 111.083 -175.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 83.6 m -117.72 145.83 44.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.729 -0.607 . . . . 0.0 109.876 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 42.8 m -115.59 135.72 53.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.622 -0.674 . . . . 0.0 110.885 -175.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.4 t -129.7 137.32 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 62.8 mt -104.63 118.57 36.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.511 -0.743 . . . . 0.0 109.73 -172.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.646 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 6.3 m-30 -105.56 151.31 24.48 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.694 -0.629 . . . . 0.0 110.578 -177.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -136.53 142.9 43.48 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -112.53 129.26 56.42 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.608 -0.682 . . . . 0.0 110.458 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -98.23 -1.84 41.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.741 -0.6 . . . . 0.0 111.95 -176.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.73 159.11 43.38 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.117 -0.989 . . . . 0.0 109.839 174.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.615 ' HA ' HD13 ' A' ' 305' ' ' ILE . 27.1 p30 -113.95 153.49 29.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.732 -0.605 . . . . 0.0 110.059 178.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' SER . . . . . 0.442 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 89.1 p -56.54 -26.51 55.09 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.43 -0.794 . . . . 0.0 111.189 -168.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 49.8 p -94.4 8.09 43.22 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.396 -0.815 . . . . 0.0 112.095 -166.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 28.8 p -92.98 116.61 29.21 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.009 -1.057 . . . . 0.0 110.584 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.39 143.3 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.482 -0.761 . . . . 0.0 110.414 -166.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.55 -5.33 58.55 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.96 -93.13 0.66 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 170.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' MET . . . . . 0.442 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 94.3 mmm -66.31 -29.06 69.19 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.731 -0.864 . . . . 0.0 110.36 176.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.8 p30 45.1 52.46 8.41 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 172.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 54.91 33.14 19.33 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.255 -0.903 . . . . 0.0 111.227 174.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' ARG . . . . . 0.415 ' HA ' ' HD2' ' A' ' 281' ' ' PRO . 80.9 mtt180 -113.97 104.95 54.84 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.511 -0.743 . . . . 0.0 110.245 173.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 280' ' ' ARG . 13.6 Cg_endo -61.1 145.49 98.81 Favored 'Trans proline' 0 N--CA 1.488 1.171 0 O-C-N 123.107 1.056 . . . . 0.0 110.293 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.66 HG22 ' HA ' ' A' ' 192' ' ' TYR . 44.0 pt -131.97 176.82 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.943 0.878 . . . . 0.0 111.244 -174.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 302' ' ' GLU . 31.4 mt -124.29 149.86 46.05 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.708 HD12 ' CE1' ' A' ' 301' ' ' PHE . 81.6 mt -114.85 129.4 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.253 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.525 HG23 ' SG ' ' A' ' 300' ' ' CYS . 80.4 mt -109.8 126.26 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -176.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 58.3 t -118.96 126.77 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.3 p -125.27 152.24 44.9 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.621 -174.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.795 HD21 ' HB3' ' A' ' 180' ' ' PRO . 21.1 tp -101.44 125.29 48.06 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 167.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.572 ' OE2' HG13 ' A' ' 295' ' ' VAL . 73.6 mm-40 -131.17 150.84 51.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.85 -0.531 . . . . 0.0 109.979 -172.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.797 ' CG2' HD11 ' A' ' 296' ' ' LEU . 68.9 p -89.96 159.88 16.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.606 -0.684 . . . . 0.0 109.908 177.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -55.95 -26.1 46.48 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.523 -0.735 . . . . 0.0 110.809 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -87.5 9.69 20.12 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.477 -0.764 . . . . 0.0 111.862 -174.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 86.9 20.16 54.23 Favored Glycine 0 N--CA 1.495 2.567 0 C-N-CA 120.195 -1.002 . . . . 0.0 110.733 170.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -106.84 140.14 40.14 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.293 -1.122 . . . . 0.0 110.267 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.572 HG13 ' OE2' ' A' ' 289' ' ' GLU . 59.9 t -88.32 130.15 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.65 -0.656 . . . . 0.0 110.034 -175.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.797 HD11 ' CG2' ' A' ' 290' ' ' THR . 96.0 mt -99.94 -40.15 7.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.681 -0.637 . . . . 0.0 110.46 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -160.14 147.9 15.56 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.523 ' HD3' HG11 ' A' ' 295' ' ' VAL . 79.4 mtm180 -135.09 134.4 40.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.644 -0.915 . . . . 0.0 110.565 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -137.47 158.95 43.28 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.654 -0.654 . . . . 0.0 110.036 172.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' CYS . . . . . 0.525 ' SG ' HG23 ' A' ' 285' ' ' ILE . 92.8 m -142.26 155.73 45.25 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.467 -0.771 . . . . 0.0 110.745 -175.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.708 ' CE1' HD12 ' A' ' 284' ' ' ILE . 48.9 p90 -144.98 160.54 41.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.701 -0.625 . . . . 0.0 110.074 174.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.468 ' HA ' HD23 ' A' ' 283' ' ' LEU . 58.7 tt0 -104.88 135.92 45.33 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.539 -0.726 . . . . 0.0 110.178 -177.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -118.41 143.74 46.45 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.812 -169.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -138.57 138.07 37.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.819 -0.551 . . . . 0.0 109.759 173.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.615 HD13 ' HA ' ' A' ' 270' ' ' ASN . 34.8 mt -110.8 122.85 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.538 -0.726 . . . . 0.0 109.495 178.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.3 p -145.25 171.9 13.9 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.561 -0.712 . . . . 0.0 111.035 -169.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -70.32 -40.06 74.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.681 -0.637 . . . . 0.0 110.653 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 4.5 t -132.37 89.98 35.23 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.574 -0.704 . . . . 0.0 110.525 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.18 -30.08 69.5 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.15 1.079 . . . . 0.0 111.032 174.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.03 -37.48 93.19 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -73.66 -40.59 63.6 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.701 -0.882 . . . . 0.0 109.895 -173.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -69.56 -39.99 77.05 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 120.084 -0.647 . . . . 0.0 110.236 -177.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.601 HH21 HG22 ' A' ' 147' ' ' THR . 34.3 ttp180 -61.26 -43.77 98.34 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.382 177.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -64.86 -38.36 90.71 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.524 -0.735 . . . . 0.0 110.461 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.84 -49.76 75.0 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.539 -0.726 . . . . 0.0 110.539 -173.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' ASP . . . . . 0.505 ' OD1' HD11 ' A' ' 159' ' ' LEU . 2.8 p30 -60.84 -37.68 82.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.488 -0.758 . . . . 0.0 110.138 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -63.29 -40.69 98.07 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.622 -0.674 . . . . 0.0 110.11 177.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -62.62 -35.15 78.66 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.705 -0.622 . . . . 0.0 109.929 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 23.8 m -62.01 -33.44 74.34 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.74 -0.6 . . . . 0.0 110.183 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 83.5 mt -77.78 -45.62 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.607 -0.683 . . . . 0.0 110.014 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -60.52 -38.02 83.04 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.616 -0.678 . . . . 0.0 110.441 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 34.8 tttm -60.48 -39.94 89.48 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.589 -0.694 . . . . 0.0 110.189 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -60.52 -33.17 72.25 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.726 -0.609 . . . . 0.0 110.094 176.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -98.32 125.05 43.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.727 -0.608 . . . . 0.0 110.339 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 61.8 t -114.86 130.02 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.557 -0.715 . . . . 0.0 109.995 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 65.3 p -95.11 140.1 30.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.59 -0.694 . . . . 0.0 110.225 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -74.23 136.68 42.73 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.681 -0.637 . . . . 0.0 110.153 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 58.4 p -80.55 157.54 26.05 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.616 -0.678 . . . . 0.0 110.21 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 77.3 p -102.12 19.91 17.67 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.688 -0.632 . . . . 0.0 110.871 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 20.0 mtpp -60.42 -38.0 82.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.346 -0.846 . . . . 0.0 110.279 -178.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -60.42 -34.83 74.51 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.669 -0.644 . . . . 0.0 110.312 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 98.55 -27.43 19.63 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 59.46 79.89 0.21 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.437 -1.037 . . . . 0.0 110.257 175.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -92.57 119.67 32.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.622 -0.674 . . . . 0.0 110.193 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -61.09 -44.27 97.61 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.657 -0.652 . . . . 0.0 110.27 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 55.99 161.98 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.566 -0.709 . . . . 0.0 110.869 -175.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -61.12 -35.77 77.94 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.5 -0.75 . . . . 0.0 110.23 179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -105.43 129.9 53.64 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.615 -0.678 . . . . 0.0 110.297 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 9.2 t -130.99 157.38 43.13 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.711 -0.618 . . . . 0.0 110.403 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -122.68 145.4 48.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.659 -0.65 . . . . 0.0 110.264 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -73.05 64.47 1.59 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 82.6 mt -92.95 138.95 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.662 -0.905 . . . . 0.0 110.006 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -90.76 135.34 33.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.617 -0.677 . . . . 0.0 110.224 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 71.0 mtm -60.42 -35.34 75.56 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.665 -0.647 . . . . 0.0 110.33 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 30.0 p . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.239 -179.831 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 82.5 p -81.86 -24.33 35.85 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.657 -0.908 . . . . 0.0 110.508 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.8 m -119.18 148.71 42.8 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.493 -0.755 . . . . 0.0 110.287 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 46.3 m -120.74 142.39 49.58 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.71 -0.619 . . . . 0.0 110.222 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -114.13 149.57 35.43 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.656 -0.653 . . . . 0.0 110.212 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.421 ' O ' ' HB3' ' A' ' 119' ' ' ALA . 55.7 p30 -88.25 11.49 16.37 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.647 -0.658 . . . . 0.0 111.515 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 118' ' ' ASP . . . 58.16 -82.97 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.223 -0.923 . . . . 0.0 110.731 -175.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 34.4 tp 56.1 -85.78 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.444 -0.785 . . . . 0.0 110.801 -176.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 59.5 p -73.41 150.97 89.58 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.117 -0.99 . . . . 0.0 109.977 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.65 154.96 39.38 Favored 'Cis proline' 0 N--CA 1.494 1.543 0 C-N-CA 123.215 -1.577 . . . . 0.0 110.317 -22.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 2.4 m -80.39 147.28 63.71 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.672 -0.643 . . . . 0.0 110.341 -176.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.407 ' HB3' HG22 ' A' ' 242' ' ' THR . 14.7 Cg_endo -61.43 146.02 97.53 Favored 'Trans proline' 0 C--N 1.318 -1.069 0 O-C-N 123.264 1.139 . . . . 0.0 110.526 -178.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.9 141.97 42.21 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.666 -0.646 . . . . 0.0 110.097 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.517 HD11 HG22 ' A' ' 199' ' ' THR . 50.6 mm -123.01 99.94 40.53 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.623 -0.673 . . . . 0.0 110.026 -178.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 126' ' ' ILE . 13.5 Cg_endo -60.93 151.26 79.07 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 O-C-N 123.287 1.151 . . . . 0.0 110.538 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.9 t -110.08 147.69 33.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.655 -0.653 . . . . 0.0 110.338 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -95.05 24.79 4.6 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.717 -0.614 . . . . 0.0 110.756 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 52.0 m -74.96 125.23 28.45 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.587 -0.696 . . . . 0.0 110.263 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -69.88 144.93 52.34 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.675 -0.64 . . . . 0.0 110.496 -177.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -156.96 102.33 1.93 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.675 -0.64 . . . . 0.0 110.048 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.97 -39.98 66.09 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 O-C-N 123.138 1.073 . . . . 0.0 110.699 -175.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.39 -155.15 43.35 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -72.65 -48.97 0.28 Allowed 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.318 1.168 . . . . 0.0 110.813 -175.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -83.77 4.64 28.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.537 -0.727 . . . . 0.0 111.369 -175.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 t 54.12 61.22 3.15 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.908 -1.12 . . . . 0.0 110.664 -176.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.725 ' HA ' HG12 ' A' ' 176' ' ' VAL . 63.0 t80 -77.96 119.92 22.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.522 -0.736 . . . . 0.0 110.04 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -129.98 160.01 34.93 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.778 -0.576 . . . . 0.0 110.072 -176.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.2 t -124.55 146.34 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.789 -0.57 . . . . 0.0 109.754 177.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.3 p -155.12 162.96 40.86 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.325 0.583 . . . . 0.0 109.941 177.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.492 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 71.2 m-85 -126.74 125.2 41.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.74 -0.6 . . . . 0.0 109.762 -176.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -55.96 144.21 29.31 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.577 -0.702 . . . . 0.0 110.752 -173.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -97.01 134.08 40.84 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.703 -0.623 . . . . 0.0 110.38 -176.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 50.8 m -126.01 151.77 46.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.637 -0.665 . . . . 0.0 110.162 178.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 43.4 m -60.43 159.61 10.03 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.533 -0.729 . . . . 0.0 110.137 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.8 p -64.13 84.65 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.624 -0.673 . . . . 0.0 110.206 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.11 155.24 19.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.751 -0.593 . . . . 0.0 110.198 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -80.74 149.01 29.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.682 -0.636 . . . . 0.0 110.078 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 41.4 t 52.71 35.25 17.95 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.344 -0.847 . . . . 0.0 111.018 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.04 132.92 55.37 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.621 -0.674 . . . . 0.0 110.205 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.429 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 65.2 p -60.13 -34.02 72.95 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.742 -0.599 . . . . 0.0 109.967 175.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.441 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -171.33 143.48 1.86 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.399 0.618 . . . . 0.0 110.406 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 13.4 t -142.16 142.68 32.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.899 -0.5 . . . . 0.0 109.892 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.492 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 62.3 t80 -125.56 140.03 53.09 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.399 -0.813 . . . . 0.0 110.646 -171.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.8 t -110.38 124.92 52.61 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.878 176.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 54.6 m -70.84 -37.0 73.12 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.838 -0.539 . . . . 0.0 110.414 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -59.36 -33.9 71.73 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.652 -0.655 . . . . 0.0 110.47 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.0 mt -104.79 -12.02 16.51 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.691 -0.631 . . . . 0.0 110.838 -175.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt 59.69 49.27 8.39 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.076 -1.015 . . . . 0.0 109.699 177.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.445 ' HE3' ' CZ ' ' A' ' 163' ' ' TYR . 34.2 ttpt -147.15 153.26 39.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.714 -0.616 . . . . 0.0 110.563 -173.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.656 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.5 tp -126.44 138.06 53.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.686 -0.633 . . . . 0.0 110.315 -173.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.445 ' CZ ' ' HE3' ' A' ' 161' ' ' LYS . 54.0 m-85 -114.72 133.75 55.64 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.36 158.46 44.24 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.65 -0.656 . . . . 0.0 110.824 -175.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.405 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 33.7 mt-30 -104.62 141.9 35.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.595 -0.691 . . . . 0.0 110.275 172.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.426 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 16.6 tt -51.42 147.38 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 CA-C-O 121.624 0.726 . . . . 0.0 111.989 -174.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.26 10.06 5.3 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.521 -0.737 . . . . 0.0 112.534 176.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.405 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 30.5 mmtm -96.28 155.04 16.93 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.899 -1.126 . . . . 0.0 110.838 175.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 86.5 m -84.37 126.22 33.02 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.707 -0.621 . . . . 0.0 110.525 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' CYS . . . . . 0.656 ' SG ' HD21 ' A' ' 162' ' ' LEU . 44.0 t -115.22 90.19 23.37 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.62 -0.675 . . . . 0.0 110.199 174.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.441 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 23.1 Cg_exo -61.85 130.75 32.27 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 O-C-N 123.278 1.146 . . . . 0.0 110.677 173.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.412 HG12 ' CE2' ' A' ' 142' ' ' PHE . 93.2 mt -124.97 142.16 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.626 -0.671 . . . . 0.0 109.219 175.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -107.93 136.3 47.87 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.475 -0.766 . . . . 0.0 110.826 -174.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.415 ' CG2' ' CE1' ' A' ' 138' ' ' PHE . 48.6 mm -95.22 135.07 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.757 -0.589 . . . . 0.0 109.691 169.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -118.09 128.99 55.27 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.415 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.725 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.3 m -136.24 159.82 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.63 -0.669 . . . . 0.0 109.979 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 81.2 mmm -77.75 -40.49 40.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.713 -0.617 . . . . 0.0 110.085 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.1 p -135.21 143.27 44.97 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.797 -0.564 . . . . 0.0 109.788 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 33.3 Cg_exo -55.57 139.8 82.96 Favored 'Trans proline' 0 N--CA 1.489 1.264 0 O-C-N 123.245 1.129 . . . . 0.0 110.871 -172.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.694 ' HB3' HD21 ' A' ' 288' ' ' LEU . 23.8 Cg_endo -64.47 169.38 11.23 Favored 'Trans proline' 0 N--CA 1.488 1.151 0 O-C-N 123.181 1.095 . . . . 0.0 110.704 178.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -61.19 158.26 35.87 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 O-C-N 123.321 1.169 . . . . 0.0 110.469 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -78.7 138.18 38.15 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.602 -0.686 . . . . 0.0 109.969 175.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.5 -24.84 30.6 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -174.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.2 151.09 2.17 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.35 -1.088 . . . . 0.0 111.322 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.7 155.95 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.727 -0.608 . . . . 0.0 109.762 176.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.65 HD11 ' CD2' ' A' ' 251' ' ' TYR . 66.5 mt -108.13 137.0 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.72 ' HG2' HD22 ' A' ' 248' ' ' LEU . 37.8 mtp180 -114.87 146.79 40.72 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -175.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.68 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -140.85 126.07 18.54 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.483 -0.761 . . . . 0.0 110.4 171.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 48.5 ttp -137.33 140.69 31.49 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.775 -0.578 . . . . 0.0 111.052 -176.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.651 ' HD3' HD12 ' A' ' 226' ' ' ILE . 74.0 Cg_endo -89.85 138.25 2.95 Favored 'Trans proline' 0 C--N 1.32 -0.96 0 O-C-N 123.24 1.126 . . . . 0.0 110.843 177.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.413 HG13 ' C ' ' A' ' 190' ' ' PRO . 34.7 m -146.39 154.82 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.547 -0.721 . . . . 0.0 110.085 173.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.653 ' HA ' HG22 ' A' ' 282' ' ' ILE . 88.3 m-85 -62.92 162.9 10.46 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.522 -0.736 . . . . 0.0 110.468 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.413 ' HA ' HD12 ' A' ' 283' ' ' LEU . 47.7 tttm -78.93 -60.04 2.54 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.659 -0.65 . . . . 0.0 110.815 -175.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 38.9 mttp -80.1 150.77 30.16 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.62 -0.675 . . . . 0.0 110.34 -175.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.456 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.52 -37.69 70.8 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.371 -0.831 . . . . 0.0 110.728 -176.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -56.44 -24.83 48.0 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.536 -0.727 . . . . 0.0 110.642 -176.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.42 ' HB3' ' CG ' ' A' ' 192' ' ' TYR . 92.0 m-70 -110.09 -20.51 12.67 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.174 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.456 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.1 p -67.07 -20.28 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.15 -0.969 . . . . 0.0 110.544 -176.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.517 HG22 HD11 ' A' ' 126' ' ' ILE . 71.9 p -79.29 -16.99 55.52 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.491 -0.756 . . . . 0.0 110.651 175.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -88.34 137.19 32.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.34 -0.85 . . . . 0.0 110.041 172.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.3 t -73.1 141.58 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.645 -0.659 . . . . 0.0 110.248 177.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.554 HG22 ' CE2' ' A' ' 192' ' ' TYR . 64.7 t -84.93 137.8 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.618 -0.676 . . . . 0.0 109.405 171.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 12.1 pttt -134.92 -170.29 2.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.543 -0.723 . . . . 0.0 111.035 -171.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 83.5 mtm-85 -95.26 158.7 15.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.781 -0.575 . . . . 0.0 110.34 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 56.5 m -75.81 157.42 83.84 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.679 -0.638 . . . . 0.0 109.513 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -63.34 -47.33 7.97 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.247 1.13 . . . . 0.0 109.99 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.443 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.4 p-10 -65.41 -43.96 88.95 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.579 -0.701 . . . . 0.0 111.159 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' HIS . . . . . 0.443 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 54.9 m170 -81.12 -27.87 35.37 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.423 -0.798 . . . . 0.0 111.196 -175.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -69.16 -39.82 78.53 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.374 -0.829 . . . . 0.0 110.21 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 26.6 tp -58.12 -34.79 70.61 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.66 -0.65 . . . . 0.0 110.697 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 29.0 t -48.46 143.98 4.48 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.481 -0.762 . . . . 0.0 111.347 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.437 ' HD3' ' CE1' ' A' ' 214' ' ' PHE . 53.8 ttt85 -61.92 139.8 58.35 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.654 -0.654 . . . . 0.0 110.023 -176.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -63.04 -32.49 73.87 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.751 -0.593 . . . . 0.0 110.589 -176.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.437 ' CE1' ' HD3' ' A' ' 212' ' ' ARG . 60.6 m-85 52.05 47.9 23.82 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.553 -0.717 . . . . 0.0 110.836 -175.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -74.0 -10.13 59.33 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.796 -0.565 . . . . 0.0 111.313 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -58.53 113.86 2.19 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.17 -0.956 . . . . 0.0 110.766 -177.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 75.16 20.04 79.39 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 173.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -114.79 139.89 49.36 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.307 -1.114 . . . . 0.0 110.522 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.7 mt -85.66 -25.05 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.712 -0.618 . . . . 0.0 110.466 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.779 ' HB1' ' HB3' ' A' ' 227' ' ' ARG . . . -124.95 96.09 40.83 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.439 -0.788 . . . . 0.0 110.371 -173.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.429 ' HD2' ' CE2' ' A' ' 236' ' ' TYR . 15.3 Cg_exo -65.11 140.13 63.94 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.326 1.172 . . . . 0.0 110.621 -177.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -60.87 -17.33 50.2 Favored 'Trans proline' 0 N--CA 1.488 1.172 0 O-C-N 123.043 1.023 . . . . 0.0 111.325 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 30.2 m -51.81 -24.08 5.57 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.159 -0.963 . . . . 0.0 111.29 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' HIS . . . . . 0.493 ' CE1' ' HB2' ' A' ' 236' ' ' TYR . 48.1 m80 -103.02 132.65 49.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.448 -0.783 . . . . 0.0 110.286 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.41 ' HA ' ' CG ' ' A' ' 268' ' ' MET . 54.0 tp -59.83 -40.33 88.12 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.558 -0.714 . . . . 0.0 110.283 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.651 HD12 ' HD3' ' A' ' 190' ' ' PRO . 82.6 mt -104.06 136.75 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.843 -0.536 . . . . 0.0 109.685 175.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.779 ' HB3' ' HB1' ' A' ' 220' ' ' ALA . 79.3 mtm180 -134.16 158.81 42.72 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.714 -0.616 . . . . 0.0 110.389 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.642 HG23 HG21 ' A' ' 247' ' ' VAL . 83.9 t -103.85 146.72 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.66 -0.65 . . . . 0.0 110.099 177.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -117.27 128.13 54.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.817 -0.552 . . . . 0.0 110.368 171.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.05 22.96 23.92 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 167.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -135.24 106.42 6.72 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.394 -1.062 . . . . 0.0 110.09 173.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 27.6 t -62.93 -15.12 54.3 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.649 -0.657 . . . . 0.0 111.24 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -100.13 5.02 44.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.198 -0.939 . . . . 0.0 111.61 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.4 131.16 49.33 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.039 -1.038 . . . . 0.0 110.276 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -139.76 157.74 45.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.782 -0.574 . . . . 0.0 109.62 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.493 ' HB2' ' CE1' ' A' ' 224' ' ' HIS . 93.1 m-85 -115.72 150.63 36.52 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.592 -0.693 . . . . 0.0 110.497 -177.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.14 159.98 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.759 -0.588 . . . . 0.0 110.263 177.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -116.53 129.95 56.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.804 -0.56 . . . . 0.0 110.003 174.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -63.31 117.45 33.98 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.649 -0.657 . . . . 0.0 109.76 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.84 -27.18 80.09 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.096 1.051 . . . . 0.0 110.878 -172.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 84.2 mt -101.85 -50.34 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.439 -0.788 . . . . 0.0 110.907 -170.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.407 HG22 ' HB3' ' A' ' 124' ' ' PRO . 7.5 p -105.37 12.25 31.84 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.431 -0.793 . . . . 0.0 111.987 -172.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 81.25 -25.06 3.82 Favored Glycine 0 N--CA 1.498 2.787 0 O-C-N 121.006 -1.059 . . . . 0.0 111.868 170.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -45.71 142.09 2.61 Favored 'General case' 0 N--CA 1.505 2.285 0 CA-C-N 118.641 1.22 . . . . 0.0 112.726 -166.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -97.8 145.17 26.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.583 -0.698 . . . . 0.0 109.838 171.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 77.5 p -154.8 159.91 40.92 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.528 -0.732 . . . . 0.0 110.588 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.642 HG21 HG23 ' A' ' 228' ' ' VAL . 8.2 p -123.23 148.03 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.722 -0.611 . . . . 0.0 109.72 176.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.72 HD22 ' HG2' ' A' ' 187' ' ' ARG . 79.2 mt -129.78 154.76 46.9 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.833 -175.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.437 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.8 m -150.44 151.78 31.69 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.843 -0.536 . . . . 0.0 109.898 175.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -71.11 138.99 34.69 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 O-C-N 123.24 1.126 . . . . 0.0 109.923 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.65 ' CD2' HD11 ' A' ' 186' ' ' ILE . 9.9 t80 -80.05 123.43 27.84 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.543 -0.723 . . . . 0.0 110.188 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -99.99 160.1 28.1 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.717 -0.614 . . . . 0.0 110.07 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -58.83 160.1 19.03 Favored 'Trans proline' 0 N--CA 1.487 1.12 0 O-C-N 123.228 1.12 . . . . 0.0 110.414 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -58.67 149.91 73.55 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 O-C-N 123.171 1.09 . . . . 0.0 110.567 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -62.46 146.94 50.21 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.693 -0.629 . . . . 0.0 110.261 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.9 127.26 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.496 -0.752 . . . . 0.0 110.232 -171.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.65 -10.08 55.86 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 7.3 t -143.84 166.46 24.86 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.165 -1.197 . . . . 0.0 110.6 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -101.87 13.07 35.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.717 -0.615 . . . . 0.0 111.846 -168.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -127.57 168.13 15.4 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.098 -1.001 . . . . 0.0 111.126 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 83.2 m -117.67 147.31 43.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.701 -0.624 . . . . 0.0 109.912 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 31.1 m -116.32 135.9 53.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.592 -0.693 . . . . 0.0 110.922 -174.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.5 t -128.57 137.21 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 171.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 70.2 mt -104.74 119.84 39.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.457 -0.777 . . . . 0.0 109.849 -172.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.68 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 6.1 m-30 -105.97 151.3 24.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.683 -0.636 . . . . 0.0 110.639 -176.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -136.63 142.98 43.28 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -114.07 130.6 56.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.513 -0.742 . . . . 0.0 110.407 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' MET . . . . . 0.41 ' CG ' ' HA ' ' A' ' 225' ' ' LEU . 5.0 ppp? -99.12 1.4 45.04 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.708 -0.62 . . . . 0.0 111.963 -176.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -144.72 158.51 43.75 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.109 -0.994 . . . . 0.0 109.928 173.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.597 ' HA ' HD13 ' A' ' 305' ' ' ILE . 27.4 p30 -113.97 154.26 27.92 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.666 -0.646 . . . . 0.0 110.073 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' SER . . . . . 0.437 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 90.7 p -56.6 -26.97 57.0 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.373 -0.829 . . . . 0.0 111.096 -167.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 46.7 p -95.19 6.97 47.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.401 -0.812 . . . . 0.0 112.146 -165.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 29.0 p -92.95 118.08 30.76 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.029 -1.044 . . . . 0.0 110.675 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.8 t -69.84 142.75 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.556 -0.715 . . . . 0.0 110.531 -168.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.4 -5.26 58.75 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.14 -95.45 0.74 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 169.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' MET . . . . . 0.437 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 95.3 mmm -64.7 -28.15 69.4 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.746 -0.855 . . . . 0.0 110.277 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 10.0 p30 44.73 50.92 8.51 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 172.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 54.76 34.12 21.08 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.375 -0.828 . . . . 0.0 111.316 174.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' ARG . . . . . 0.45 ' O ' HG23 ' A' ' 282' ' ' ILE . 88.7 mtt180 -115.94 104.93 52.03 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.548 -0.72 . . . . 0.0 110.141 172.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 280' ' ' ARG . 12.3 Cg_endo -60.26 145.03 99.43 Favored 'Trans proline' 0 N--CA 1.489 1.264 0 O-C-N 123.139 1.073 . . . . 0.0 110.374 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.653 HG22 ' HA ' ' A' ' 192' ' ' TYR . 42.8 pt -132.57 178.45 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 122.029 0.919 . . . . 0.0 111.373 -174.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 302' ' ' GLU . 34.5 mt -124.3 149.86 46.06 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.694 HD12 ' CE1' ' A' ' 301' ' ' PHE . 79.4 mt -112.24 128.71 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.646 HG23 ' SG ' ' A' ' 300' ' ' CYS . 77.8 mt -109.68 125.67 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -175.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 58.5 t -118.87 126.65 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.4 p -125.35 154.81 41.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.661 -0.649 . . . . 0.0 110.567 -174.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.694 HD21 ' HB3' ' A' ' 180' ' ' PRO . 24.4 tp -105.59 125.85 51.47 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 169.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.648 ' OE2' HG13 ' A' ' 295' ' ' VAL . 71.6 mm-40 -132.04 149.5 52.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.858 -0.526 . . . . 0.0 109.911 -173.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.823 ' CG2' HD11 ' A' ' 296' ' ' LEU . 25.4 p -89.98 161.28 15.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.703 -0.623 . . . . 0.0 110.031 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 69.7 ttp85 -55.94 -26.13 46.51 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.566 -0.708 . . . . 0.0 111.139 -175.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 44.7 p30 -90.87 9.82 28.82 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.444 -0.785 . . . . 0.0 111.963 -173.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.55 20.23 45.38 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.15 -1.024 . . . . 0.0 110.732 171.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -107.52 140.23 40.81 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.33 -1.1 . . . . 0.0 109.988 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.648 HG13 ' OE2' ' A' ' 289' ' ' GLU . 62.1 t -90.28 132.0 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.572 -0.705 . . . . 0.0 110.236 -172.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.823 HD11 ' CG2' ' A' ' 290' ' ' THR . 96.0 mt -99.84 -40.29 7.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.767 -0.583 . . . . 0.0 110.545 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -162.05 153.17 23.78 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -135.06 135.19 41.09 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.598 -0.942 . . . . 0.0 110.521 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -138.03 156.0 48.25 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.611 -0.681 . . . . 0.0 110.028 172.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' CYS . . . . . 0.646 ' SG ' HG23 ' A' ' 285' ' ' ILE . 98.3 m -143.23 155.7 44.57 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.379 -0.826 . . . . 0.0 110.844 -175.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.694 ' CE1' HD12 ' A' ' 284' ' ' ILE . 47.8 p90 -145.3 162.62 36.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.643 -0.661 . . . . 0.0 110.156 174.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.489 ' HA ' HD23 ' A' ' 283' ' ' LEU . 81.4 tt0 -104.77 137.34 42.71 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.591 -0.693 . . . . 0.0 110.219 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -118.94 144.66 46.32 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.766 -170.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -136.99 138.51 40.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.799 -0.563 . . . . 0.0 109.725 173.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.597 HD13 ' HA ' ' A' ' 270' ' ' ASN . 61.6 mt -112.02 122.86 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.572 -0.705 . . . . 0.0 109.63 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.1 p -145.42 173.73 11.75 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.589 -0.695 . . . . 0.0 110.683 -171.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -74.17 -40.12 62.77 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.573 -0.704 . . . . 0.0 110.639 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.8 t -127.25 86.86 57.75 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.494 -0.754 . . . . 0.0 110.475 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -55.81 -28.65 68.43 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.117 1.062 . . . . 0.0 110.768 174.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.88 -37.45 92.23 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -73.38 -41.05 63.86 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.643 -0.916 . . . . 0.0 109.889 -173.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -69.41 -40.33 77.38 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 120.076 -0.649 . . . . 0.0 110.153 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -61.28 -44.19 97.65 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.482 -0.762 . . . . 0.0 110.258 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 23.6 ttpt -63.73 -39.63 94.77 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.641 -0.662 . . . . 0.0 110.432 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.86 -51.9 66.34 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.517 -0.74 . . . . 0.0 110.396 -173.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -61.53 -37.74 84.86 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.437 -0.789 . . . . 0.0 110.15 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -65.29 -39.9 93.14 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.272 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -62.46 -35.13 78.33 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.537 -0.727 . . . . 0.0 110.021 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 22.9 t -62.75 -34.32 76.98 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.632 -0.667 . . . . 0.0 110.171 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 79.9 mt -79.61 -42.66 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.696 -0.627 . . . . 0.0 109.95 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -58.56 -38.83 78.68 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.639 -0.663 . . . . 0.0 110.522 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 37.4 tttp -59.19 -41.44 88.5 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.555 -0.715 . . . . 0.0 110.286 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -62.73 -33.25 74.75 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.634 -0.666 . . . . 0.0 110.067 176.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -92.31 125.13 36.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.738 -0.601 . . . . 0.0 110.388 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 62.3 t -103.3 130.11 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.648 -0.657 . . . . 0.0 109.858 178.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 28.7 t -94.95 140.07 30.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.61 -0.681 . . . . 0.0 110.277 -177.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -82.77 120.61 25.84 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.687 -0.633 . . . . 0.0 110.301 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 29.6 t -94.03 152.62 18.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.619 -0.676 . . . . 0.0 110.158 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 71.7 p -90.27 -25.83 20.34 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.646 -0.659 . . . . 0.0 110.226 -178.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -61.27 -36.22 79.43 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.451 -0.781 . . . . 0.0 110.096 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -112.78 142.36 45.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.718 -0.614 . . . . 0.0 110.078 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -58.89 -37.91 91.65 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -178.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 59.41 79.98 0.21 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.564 -0.962 . . . . 0.0 110.224 175.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.76 ' HB3' ' CZ ' ' A' ' 336' ' ' ARG . . . -79.91 121.72 25.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.531 -0.73 . . . . 0.0 110.123 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -63.38 -35.66 81.14 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.654 -0.654 . . . . 0.0 110.215 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.76 ' CZ ' ' HB3' ' A' ' 334' ' ' ALA . 77.1 mtt85 51.97 178.15 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.478 -0.763 . . . . 0.0 111.019 -177.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -60.31 -36.42 77.87 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.573 -0.704 . . . . 0.0 110.328 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 54.5 t30 53.29 45.7 27.95 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.486 -0.759 . . . . 0.0 110.928 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 73.3 p -65.06 -33.54 76.29 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.63 -0.669 . . . . 0.0 110.119 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -131.15 127.64 38.45 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.677 -0.64 . . . . 0.0 110.222 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 341' ' ' GLY . . . . . 0.432 ' C ' HG23 ' A' ' 342' ' ' ILE . . . -87.17 176.91 47.35 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.433 HD12 ' SD ' ' A' ' 344' ' ' MET . 45.3 pt -147.36 158.92 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.624 -0.927 . . . . 0.0 110.209 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -90.57 5.39 48.07 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.729 -0.607 . . . . 0.0 111.322 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 344' ' ' MET . . . . . 0.433 ' SD ' HD12 ' A' ' 342' ' ' ILE . 64.7 mtt -61.05 -35.25 76.43 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.118 -0.989 . . . . 0.0 110.241 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 7.4 t . . . . . 0 N--CA 1.495 1.8 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.305 -179.823 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 60.3 p -84.3 160.28 20.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.631 -0.923 . . . . 0.0 110.282 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 46.8 m -63.96 153.65 36.46 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.678 -0.639 . . . . 0.0 110.218 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 44.9 m -60.32 -37.61 81.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.629 -0.669 . . . . 0.0 110.342 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.452 ' CD2' HD22 ' A' ' 120' ' ' LEU . 99.0 m-85 -117.62 154.45 31.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.649 -0.657 . . . . 0.0 110.283 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -85.38 123.33 30.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.757 -0.59 . . . . 0.0 110.412 -178.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 53.16 43.24 31.85 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.452 -0.78 . . . . 0.0 111.043 177.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.452 HD22 ' CD2' ' A' ' 117' ' ' PHE . 21.8 tp -85.36 134.48 34.09 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.594 -0.691 . . . . 0.0 110.191 177.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.64 178.69 0.25 Allowed Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.696 -0.628 . . . . 0.0 110.088 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -64.08 151.54 72.57 Favored 'Cis proline' 0 N--CA 1.496 1.654 0 C-N-CA 123.303 -1.54 . . . . 0.0 110.501 -12.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 57.5 p -81.46 153.0 70.9 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.655 -0.653 . . . . 0.0 110.298 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -59.57 153.84 52.4 Favored 'Trans proline' 0 N--CA 1.488 1.187 0 O-C-N 123.338 1.178 . . . . 0.0 110.5 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.31 150.03 40.37 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.696 -0.628 . . . . 0.0 110.097 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.477 HD11 HG22 ' A' ' 199' ' ' THR . 50.0 mm -119.9 140.39 29.62 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.643 -0.661 . . . . 0.0 109.955 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -62.2 153.62 68.56 Favored 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.164 1.086 . . . . 0.0 110.362 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.6 t -107.27 144.89 33.43 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.605 -0.684 . . . . 0.0 110.156 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.6 p-10 -93.91 22.5 5.63 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.644 -0.66 . . . . 0.0 110.877 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 52.0 m -79.14 125.18 29.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.466 -0.771 . . . . 0.0 110.177 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -68.78 144.95 54.18 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.585 -0.697 . . . . 0.0 110.444 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.411 ' CE2' ' HA2' ' A' ' 134' ' ' GLY . 61.1 t80 -156.54 101.2 2.03 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.727 -0.608 . . . . 0.0 110.098 178.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.65 -39.89 78.48 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 O-C-N 123.126 1.066 . . . . 0.0 110.857 -175.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.411 ' HA2' ' CE2' ' A' ' 132' ' ' TYR . . . 79.3 -155.16 39.66 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -72.88 -48.33 0.29 Allowed 'Trans proline' 0 N--CA 1.486 1.079 0 O-C-N 123.402 1.212 . . . . 0.0 110.983 -174.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -86.47 8.36 22.19 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.614 -0.679 . . . . 0.0 111.351 -174.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.8 58.3 5.23 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.983 -1.073 . . . . 0.0 110.6 -176.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.729 ' HA ' HG12 ' A' ' 176' ' ' VAL . 71.7 t80 -79.38 115.81 19.25 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.604 -0.685 . . . . 0.0 109.877 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -130.05 160.04 34.9 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.28 0.562 . . . . 0.0 110.41 -174.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.451 HG22 ' CD1' ' A' ' 174' ' ' ILE . 78.8 t -122.01 150.32 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.831 -0.543 . . . . 0.0 109.807 174.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 78.2 p -154.91 169.21 24.58 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.012 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.494 ' CD2' ' CE2' ' A' ' 155' ' ' TYR . 97.3 m-85 -126.63 125.26 41.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.884 -0.51 . . . . 0.0 109.938 -176.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -57.56 144.45 37.18 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.663 -0.648 . . . . 0.0 110.415 -177.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -94.69 140.99 29.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.658 -0.651 . . . . 0.0 110.579 -174.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 28.1 t -141.74 152.21 43.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.681 -0.637 . . . . 0.0 110.137 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 54.0 p -62.81 163.76 8.94 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.671 -0.643 . . . . 0.0 110.07 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.2 p -72.74 63.95 0.64 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.649 -0.657 . . . . 0.0 110.097 -178.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.58 150.07 49.03 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.617 -0.677 . . . . 0.0 110.186 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.8 tptm -65.1 140.31 58.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.725 -0.61 . . . . 0.0 110.164 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.4 p 51.2 48.09 23.66 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.579 -0.701 . . . . 0.0 111.216 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.44 137.18 57.29 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.689 -0.632 . . . . 0.0 110.182 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.463 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 77.8 p -60.05 -32.21 70.71 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.653 -0.655 . . . . 0.0 109.922 174.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.463 ' HD1' ' HG1' ' A' ' 152' ' ' THR . 68.7 p-90 -171.46 143.78 1.84 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.403 0.621 . . . . 0.0 110.132 178.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.3 t -142.1 142.56 32.81 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.863 -0.523 . . . . 0.0 109.916 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.494 ' CE2' ' CD2' ' A' ' 142' ' ' PHE . 62.6 t80 -125.56 140.01 53.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.533 -0.729 . . . . 0.0 110.673 -172.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.5 t -111.3 124.01 51.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.829 -0.545 . . . . 0.0 109.775 175.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 62.0 m -70.88 -37.09 73.02 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.819 -0.55 . . . . 0.0 110.359 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -59.09 -33.05 70.37 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.555 -0.716 . . . . 0.0 110.447 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.523 HD11 ' OD1' ' A' ' 316' ' ' ASP . 55.1 mt -104.8 -12.03 16.5 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.77 -176.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt 59.76 47.76 9.96 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.039 -1.038 . . . . 0.0 109.728 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.423 ' HE3' ' CZ ' ' A' ' 163' ' ' TYR . 20.7 ttpt -148.21 153.23 38.48 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 120.161 -0.615 . . . . 0.0 110.803 -173.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.588 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.5 tp -126.49 137.93 53.44 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.731 -0.605 . . . . 0.0 110.437 -173.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.423 ' CZ ' ' HE3' ' A' ' 161' ' ' LYS . 98.7 m-85 -114.85 134.38 55.19 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.9 p -138.39 158.44 44.28 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.61 -0.681 . . . . 0.0 111.194 -176.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.424 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 59.0 mt-30 -104.47 142.18 35.06 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.663 -0.648 . . . . 0.0 110.336 173.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.431 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 18.0 tt -55.04 148.22 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.548 -0.72 . . . . 0.0 111.613 -173.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.37 10.01 5.36 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.544 -0.723 . . . . 0.0 112.511 177.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.424 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 73.5 mmtt -97.09 155.08 16.96 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.984 -1.073 . . . . 0.0 110.773 174.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 74.5 m -80.16 126.04 30.59 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.674 -0.641 . . . . 0.0 110.573 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' CYS . . . . . 0.588 ' SG ' HD21 ' A' ' 162' ' ' LEU . 31.4 t -117.1 90.37 33.21 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.625 -0.672 . . . . 0.0 110.182 174.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.426 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 26.1 Cg_endo -66.97 128.25 18.38 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 O-C-N 123.337 1.177 . . . . 0.0 110.756 176.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.65 HD12 ' CD2' ' A' ' 265' ' ' TYR . 83.7 mt -122.51 141.64 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.675 -0.641 . . . . 0.0 109.362 172.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -109.48 136.95 48.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.54 -0.725 . . . . 0.0 110.755 -173.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.671 HG21 ' CE1' ' A' ' 138' ' ' PHE . 50.4 mm -95.24 135.01 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.779 -0.576 . . . . 0.0 109.744 172.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 17.0 tptp -117.57 130.81 56.64 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.606 -0.684 . . . . 0.0 110.492 176.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.729 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.6 m -136.34 159.76 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.579 -0.701 . . . . 0.0 110.04 174.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 79.8 mmm -77.63 -39.79 44.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.724 -0.61 . . . . 0.0 110.029 176.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.3 p -135.66 143.24 44.0 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.831 -0.543 . . . . 0.0 109.709 177.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.9 Cg_exo -55.63 139.86 83.33 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 O-C-N 123.146 1.077 . . . . 0.0 110.821 -173.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.647 ' HB3' HD21 ' A' ' 288' ' ' LEU . 26.6 Cg_endo -65.19 169.61 11.94 Favored 'Trans proline' 0 N--CA 1.487 1.115 0 O-C-N 123.165 1.087 . . . . 0.0 110.684 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -61.27 156.7 44.17 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 O-C-N 123.37 1.195 . . . . 0.0 110.46 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -77.53 140.24 39.71 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.616 -0.677 . . . . 0.0 109.913 175.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.79 -24.91 29.62 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -175.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.16 151.64 1.97 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.363 -1.081 . . . . 0.0 111.319 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 33.8 m -129.77 155.89 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.766 -0.584 . . . . 0.0 109.597 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.634 HD11 ' CD2' ' A' ' 251' ' ' TYR . 79.3 mt -107.25 136.6 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.712 ' HG2' HD22 ' A' ' 248' ' ' LEU . 73.3 mtp180 -114.79 142.82 46.03 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -175.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -140.69 123.46 16.26 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.486 -0.759 . . . . 0.0 110.501 177.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 30.7 ttp -137.43 139.01 26.21 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.76 -0.587 . . . . 0.0 110.969 -175.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.746 ' HD3' HD12 ' A' ' 226' ' ' ILE . 72.7 Cg_endo -90.62 138.18 2.53 Favored 'Trans proline' 0 C--N 1.318 -1.03 0 O-C-N 123.246 1.13 . . . . 0.0 110.418 176.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.563 ' HB ' HG23 ' A' ' 198' ' ' VAL . 34.6 m -146.47 154.81 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.596 -0.69 . . . . 0.0 110.196 175.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.582 ' HA ' HG22 ' A' ' 282' ' ' ILE . 89.1 m-85 -59.82 160.35 7.73 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.495 -0.753 . . . . 0.0 110.495 178.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.442 ' HA ' HD12 ' A' ' 283' ' ' LEU . 34.1 tttt -74.04 -59.45 2.72 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.598 -0.688 . . . . 0.0 110.729 -175.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -80.01 148.78 30.98 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.57 -0.706 . . . . 0.0 110.398 -174.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.451 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.86 -38.11 72.26 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.355 -0.84 . . . . 0.0 110.695 -175.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -56.41 -24.94 48.34 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.441 -0.787 . . . . 0.0 110.629 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.404 ' O ' ' CD1' ' A' ' 192' ' ' TYR . 41.0 m80 -109.99 -20.51 12.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.597 -0.69 . . . . 0.0 111.188 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.563 HG23 ' HB ' ' A' ' 191' ' ' VAL . 3.2 p -67.25 -20.09 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.272 -0.892 . . . . 0.0 110.598 -176.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.477 HG22 HD11 ' A' ' 126' ' ' ILE . 69.2 p -79.27 -16.11 56.94 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.558 -0.714 . . . . 0.0 110.714 175.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -88.2 137.59 32.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.915 . . . . 0.0 110.049 172.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.7 t -73.01 142.36 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.606 -0.684 . . . . 0.0 110.25 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.477 HG22 ' CE1' ' A' ' 192' ' ' TYR . 77.0 t -84.81 139.11 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.514 -0.741 . . . . 0.0 109.339 170.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 14.1 pttt -134.81 -170.05 2.48 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.406 -0.809 . . . . 0.0 111.205 -165.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -95.13 154.4 17.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.783 -0.573 . . . . 0.0 110.62 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 61.0 m -76.17 160.94 76.94 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.668 -0.645 . . . . 0.0 109.303 172.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -64.21 -47.33 6.36 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 O-C-N 123.217 1.114 . . . . 0.0 109.811 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.445 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.7 p-10 -65.47 -44.44 87.14 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.641 -0.662 . . . . 0.0 111.318 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' HIS . . . . . 0.445 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 55.4 m170 -80.71 -27.85 36.82 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.391 -0.818 . . . . 0.0 111.41 -174.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -69.02 -42.11 76.82 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.385 -0.822 . . . . 0.0 110.175 173.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 23.9 tp -69.7 -30.33 67.95 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.694 -0.629 . . . . 0.0 110.5 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.8 t -48.39 -36.46 14.69 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.682 -0.636 . . . . 0.0 111.843 -175.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -126.86 139.08 53.35 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.547 -0.721 . . . . 0.0 110.411 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -140.42 -177.18 4.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.673 -0.642 . . . . 0.0 110.114 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 54.07 75.13 0.29 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.422 -0.799 . . . . 0.0 110.848 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -64.76 -10.34 26.9 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.642 -0.661 . . . . 0.0 111.345 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -58.65 121.78 11.86 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.07 -1.019 . . . . 0.0 110.362 174.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 94.89 1.51 63.27 Favored Glycine 0 N--CA 1.492 2.413 0 C-N-CA 120.414 -0.898 . . . . 0.0 110.977 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -114.7 140.1 49.13 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.088 -1.242 . . . . 0.0 110.392 178.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.6 mt -85.0 -25.11 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.607 -0.683 . . . . 0.0 110.446 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.571 ' HB1' ' HD2' ' A' ' 227' ' ' ARG . . . -125.03 95.41 41.98 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.414 -0.804 . . . . 0.0 110.311 -177.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.452 ' HD2' ' CE1' ' A' ' 236' ' ' TYR . 17.1 Cg_exo -63.42 136.96 57.62 Favored 'Trans proline' 0 C--N 1.316 -1.152 0 O-C-N 123.27 1.142 . . . . 0.0 110.365 -177.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.6 -21.88 48.94 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 O-C-N 123.064 1.034 . . . . 0.0 111.244 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 86.8 p -53.77 -22.89 10.34 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.412 -0.805 . . . . 0.0 111.226 -175.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' HIS . . . . . 0.485 ' CD2' ' CD2' ' A' ' 236' ' ' TYR . 88.9 m-70 -103.45 126.0 50.36 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.459 -0.776 . . . . 0.0 110.155 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.495 HD12 ' HG3' ' A' ' 268' ' ' MET . 32.2 tp -60.98 -36.26 78.96 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.675 -0.641 . . . . 0.0 110.166 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.746 HD12 ' HD3' ' A' ' 190' ' ' PRO . 83.6 mt -98.17 136.78 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-O 121.232 0.539 . . . . 0.0 109.896 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.571 ' HD2' ' HB1' ' A' ' 220' ' ' ALA . 77.0 mtm180 -131.14 159.38 37.85 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.735 -0.603 . . . . 0.0 110.084 175.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.574 HG23 HG21 ' A' ' 247' ' ' VAL . 73.7 t -105.62 146.68 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.425 0.631 . . . . 0.0 110.204 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -121.5 130.04 53.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.725 -0.609 . . . . 0.0 110.311 171.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 96.61 20.42 24.61 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 169.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -140.01 103.7 4.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.36 -1.082 . . . . 0.0 109.944 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 93.5 p -63.62 -15.21 57.59 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.657 -0.652 . . . . 0.0 111.15 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -97.43 9.86 41.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.29 -0.881 . . . . 0.0 111.17 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -62.07 132.71 53.77 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.235 -0.915 . . . . 0.0 110.102 176.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -139.65 157.96 44.9 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.691 -0.631 . . . . 0.0 109.826 177.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.485 ' CD2' ' CD2' ' A' ' 224' ' ' HIS . 87.0 m-85 -114.2 150.68 33.91 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.516 -0.74 . . . . 0.0 110.576 -177.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.18 159.92 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.73 -0.606 . . . . 0.0 110.124 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -119.76 130.06 54.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.741 -0.6 . . . . 0.0 110.209 176.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -63.44 130.07 94.04 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.65 -0.656 . . . . 0.0 109.792 177.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -64.77 -27.66 59.81 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 O-C-N 123.118 1.062 . . . . 0.0 111.045 -170.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.2 mt -101.4 -50.5 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.411 -0.806 . . . . 0.0 111.108 -167.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 75.7 p -105.46 12.18 31.74 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.315 -0.865 . . . . 0.0 111.881 -174.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.93 -4.97 14.35 Favored Glycine 0 N--CA 1.496 2.645 0 O-C-N 121.1 -1.0 . . . . 0.0 111.837 174.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.476 ' CZ ' HG12 ' A' ' 191' ' ' VAL . 12.6 mmt180 -45.99 142.09 2.86 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 119.088 1.444 . . . . 0.0 112.334 -173.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -102.74 142.27 34.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.662 -0.649 . . . . 0.0 110.294 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 77.3 p -154.8 159.93 40.93 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.642 -0.661 . . . . 0.0 110.301 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.574 HG21 HG23 ' A' ' 228' ' ' VAL . 8.3 p -122.96 148.16 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.708 -0.62 . . . . 0.0 109.754 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.712 HD22 ' HG2' ' A' ' 187' ' ' ARG . 79.7 mt -129.69 154.63 46.96 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.763 -174.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.44 HG13 ' C ' ' A' ' 248' ' ' LEU . 33.8 m -150.9 151.74 30.5 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.873 -0.517 . . . . 0.0 109.901 174.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -70.96 137.67 32.44 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 O-C-N 123.273 1.144 . . . . 0.0 109.92 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.634 ' CD2' HD11 ' A' ' 186' ' ' ILE . 11.7 t80 -77.9 122.85 26.04 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.552 -0.717 . . . . 0.0 110.183 179.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -100.01 160.01 28.32 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.753 -0.592 . . . . 0.0 110.15 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.92 160.02 19.57 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 123.233 1.123 . . . . 0.0 110.403 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -58.56 150.06 71.67 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 123.29 1.153 . . . . 0.0 110.666 -177.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -61.13 147.31 44.44 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.672 -0.643 . . . . 0.0 110.184 -177.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.81 127.2 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.485 -0.759 . . . . 0.0 110.167 -170.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.87 -10.13 55.54 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 10.2 t -144.31 174.2 11.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.177 -1.19 . . . . 0.0 110.614 175.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -108.18 13.14 26.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.603 -0.686 . . . . 0.0 111.854 -167.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -124.59 168.13 13.55 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.178 -0.951 . . . . 0.0 111.189 -176.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 94.2 m -117.79 145.95 44.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.737 -0.602 . . . . 0.0 109.862 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 44.4 m -116.57 136.29 53.1 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.535 -0.728 . . . . 0.0 110.937 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 60.1 t -127.05 137.08 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 60.2 mt -104.82 121.21 43.19 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.603 -0.685 . . . . 0.0 109.747 -173.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.65 ' CD2' HD12 ' A' ' 172' ' ' ILE . 3.4 m-85 -99.95 156.71 17.0 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.578 -0.701 . . . . 0.0 110.88 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -136.41 142.94 43.72 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 171.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -110.4 128.97 55.84 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.551 -0.718 . . . . 0.0 110.27 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' MET . . . . . 0.495 ' HG3' HD12 ' A' ' 225' ' ' LEU . 5.2 ppp? -95.29 -0.11 53.22 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.712 -0.618 . . . . 0.0 112.019 -177.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' CYS . . . . . 0.722 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.6 OUTLIER -144.77 165.06 29.15 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.158 -0.964 . . . . 0.0 110.076 176.111 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.497 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.5 p30 -121.98 163.48 19.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.69 -0.631 . . . . 0.0 110.593 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' SER . . . . . 0.429 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 19.0 m -57.62 -34.15 69.0 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.414 -0.803 . . . . 0.0 111.136 -164.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 51.4 p -104.17 15.06 29.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.374 -0.829 . . . . 0.0 111.911 -163.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 29.7 p -95.77 118.07 31.73 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.079 -1.013 . . . . 0.0 110.712 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 58.0 t -63.16 138.93 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.477 -0.764 . . . . 0.0 110.253 -171.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.04 -5.18 59.27 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.11 -98.33 0.83 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 171.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' MET . . . . . 0.429 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.2 mmm -63.17 -32.35 73.72 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.726 -0.867 . . . . 0.0 110.235 178.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.3 p30 44.21 48.84 7.79 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 174.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 54.76 30.27 13.27 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.377 -0.827 . . . . 0.0 111.306 174.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 15.4 mtt85 -119.45 107.04 41.58 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.59 -0.694 . . . . 0.0 110.08 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.58 148.0 89.29 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 O-C-N 123.127 1.067 . . . . 0.0 110.529 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.582 HG22 ' HA ' ' A' ' 192' ' ' TYR . 44.7 pt -131.9 177.52 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.709 0.766 . . . . 0.0 110.987 -176.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.478 HD23 ' HA ' ' A' ' 302' ' ' GLU . 34.3 mt -124.38 150.02 46.03 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 177.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.649 HD12 ' CE1' ' A' ' 301' ' ' PHE . 77.7 mt -112.65 128.29 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.562 -0.711 . . . . 0.0 109.089 176.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.505 HG23 ' SG ' ' A' ' 300' ' ' CYS . 81.3 mt -109.86 125.57 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -176.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 59.1 t -118.87 126.63 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.5 p -125.31 154.66 41.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.581 -0.699 . . . . 0.0 110.623 -175.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.647 HD21 ' HB3' ' A' ' 180' ' ' PRO . 22.8 tp -105.22 126.41 52.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.819 -0.551 . . . . 0.0 109.539 169.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.58 ' OE2' HG13 ' A' ' 295' ' ' VAL . 73.0 mm-40 -132.47 150.99 52.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.863 -0.523 . . . . 0.0 109.902 -174.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.749 HG22 HD11 ' A' ' 296' ' ' LEU . 68.6 p -89.89 159.47 16.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.619 -0.675 . . . . 0.0 109.648 177.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -55.86 -26.11 45.43 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.532 -0.73 . . . . 0.0 110.81 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -87.52 9.14 21.97 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.489 -0.757 . . . . 0.0 111.855 -174.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 87.22 20.26 53.05 Favored Glycine 0 N--CA 1.495 2.59 0 O-C-N 121.053 -1.03 . . . . 0.0 110.704 170.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -106.81 140.12 40.15 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.262 -1.14 . . . . 0.0 110.206 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.58 HG13 ' OE2' ' A' ' 289' ' ' GLU . 59.4 t -88.33 131.32 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.666 -0.646 . . . . 0.0 110.194 -173.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.749 HD11 HG22 ' A' ' 290' ' ' THR . 95.6 mt -99.91 -40.14 7.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.733 -0.604 . . . . 0.0 110.544 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -165.23 153.12 23.04 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -134.96 136.17 42.03 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.721 -0.87 . . . . 0.0 110.748 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -133.28 153.66 51.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.578 -0.701 . . . . 0.0 110.106 172.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' CYS . . . . . 0.505 ' SG ' HG23 ' A' ' 285' ' ' ILE . 99.8 m -142.76 151.63 41.46 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.486 -0.759 . . . . 0.0 110.659 -176.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.649 ' CE1' HD12 ' A' ' 284' ' ' ILE . 49.8 p90 -145.43 166.7 24.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.701 -0.625 . . . . 0.0 110.029 173.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.478 ' HA ' HD23 ' A' ' 283' ' ' LEU . 57.7 tt0 -104.78 136.1 44.93 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.449 -0.782 . . . . 0.0 110.277 -177.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -123.3 144.5 49.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.682 -0.636 . . . . 0.0 110.548 -170.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -137.66 137.87 38.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.844 -0.535 . . . . 0.0 109.796 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.722 HD13 ' O ' ' A' ' 269' ' ' CYS . 66.3 mt -106.34 123.0 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.581 -0.699 . . . . 0.0 109.556 175.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.0 p -145.17 167.28 23.15 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.56 -0.713 . . . . 0.0 110.89 -170.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -67.31 -40.1 85.96 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.675 -0.641 . . . . 0.0 110.616 -177.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 3.9 t -132.05 89.58 37.7 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.545 -0.722 . . . . 0.0 110.53 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -55.77 -29.04 69.95 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 O-C-N 123.23 1.121 . . . . 0.0 110.74 174.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.51 -37.94 93.02 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -72.56 -40.04 66.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.622 -0.928 . . . . 0.0 109.837 -173.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -69.51 -38.47 77.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.67 -0.644 . . . . 0.0 110.198 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -61.51 -43.21 99.28 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.228 178.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 14.5 ttpp -65.01 -38.73 91.88 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.586 -0.696 . . . . 0.0 110.419 176.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.22 -49.95 75.07 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.493 -0.755 . . . . 0.0 110.578 -173.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' ASP . . . . . 0.523 ' OD1' HD11 ' A' ' 159' ' ' LEU . 3.0 p30 -61.29 -37.69 84.1 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.463 -0.773 . . . . 0.0 110.113 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -61.58 -40.88 96.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.606 -0.684 . . . . 0.0 110.146 177.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -62.5 -35.17 78.54 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.586 -0.696 . . . . 0.0 109.956 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 23.8 m -62.09 -33.34 74.26 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.758 -0.589 . . . . 0.0 110.173 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 83.6 mt -77.42 -44.21 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.619 -0.675 . . . . 0.0 109.965 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.402 ' HA ' ' HG2' ' A' ' 324' ' ' GLN . 60.4 ttt180 -58.84 -39.58 81.69 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.575 -0.703 . . . . 0.0 110.492 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -61.05 -40.26 92.97 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.655 -0.653 . . . . 0.0 110.163 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -60.91 -31.89 71.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.677 -0.639 . . . . 0.0 110.204 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' GLN . . . . . 0.402 ' HG2' ' HA ' ' A' ' 321' ' ' ARG . 20.1 pt20 -105.11 125.07 50.58 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.702 -0.624 . . . . 0.0 110.495 -177.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 61.7 t -120.5 130.04 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.54 -0.725 . . . . 0.0 109.923 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 29.9 t -95.15 139.96 30.75 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.683 -0.636 . . . . 0.0 110.204 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -100.97 142.68 32.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.609 -0.682 . . . . 0.0 110.356 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 78.6 p -94.05 155.05 17.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.675 -0.641 . . . . 0.0 110.276 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 75.0 p -96.35 -21.89 17.52 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.606 -0.684 . . . . 0.0 110.765 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -60.45 -33.94 73.27 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.448 -0.782 . . . . 0.0 110.443 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 42.2 p-10 -89.14 13.97 11.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.592 -0.692 . . . . 0.0 111.337 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -157.05 114.26 0.6 Allowed Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -85.52 117.35 24.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.589 -0.948 . . . . 0.0 110.313 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -145.48 152.38 39.69 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.656 -0.652 . . . . 0.0 110.252 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -119.99 151.9 38.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.571 -0.706 . . . . 0.0 110.241 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 51.63 94.82 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.497 -0.752 . . . . 0.0 111.142 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -60.74 -34.34 74.29 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.621 -0.675 . . . . 0.0 110.22 178.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -58.97 -30.91 68.28 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.675 -0.641 . . . . 0.0 110.47 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 74.4 p -96.17 26.3 4.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.594 -0.692 . . . . 0.0 110.476 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -104.63 160.7 14.74 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.581 -0.7 . . . . 0.0 110.185 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -79.49 -177.23 49.97 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -177.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 51.4 mm -92.62 141.19 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.7 -0.883 . . . . 0.0 110.129 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -82.19 -31.99 30.11 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.677 -0.639 . . . . 0.0 110.133 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 93.3 mmm -100.67 142.25 32.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.597 -0.689 . . . . 0.0 110.271 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 117.917 -1.039 . . . . 0.0 110.347 179.962 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 27.3 t -156.31 148.74 23.56 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.642 -0.917 . . . . 0.0 110.212 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.5 m -59.69 -34.45 72.9 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.645 -0.66 . . . . 0.0 110.359 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 44.9 m -59.81 -37.21 78.51 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.657 -0.652 . . . . 0.0 110.277 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -106.35 137.29 44.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.573 -0.704 . . . . 0.0 110.234 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -83.46 141.0 31.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.578 -0.701 . . . . 0.0 110.243 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -165.46 153.83 11.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.723 -0.61 . . . . 0.0 110.144 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.9 mt 52.11 -179.0 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.487 -0.758 . . . . 0.0 111.091 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.9 m -76.97 160.96 75.18 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.741 -0.599 . . . . 0.0 110.213 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -66.21 151.94 80.59 Favored 'Cis proline' 0 N--CA 1.496 1.65 0 C-N-CA 123.133 -1.611 . . . . 0.0 110.421 -16.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 7.6 m -81.5 149.42 64.81 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.68 -0.638 . . . . 0.0 110.27 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -59.51 158.46 27.41 Favored 'Trans proline' 0 N--CA 1.488 1.169 0 O-C-N 123.309 1.163 . . . . 0.0 110.502 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -73.98 135.5 43.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.656 -0.653 . . . . 0.0 110.119 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.615 HD11 HG22 ' A' ' 199' ' ' THR . 50.2 mm -124.94 106.13 29.01 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.69 -0.631 . . . . 0.0 109.991 -177.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 126' ' ' ILE . 12.0 Cg_endo -60.02 148.22 89.95 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 O-C-N 123.104 1.055 . . . . 0.0 110.467 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.3 t -110.56 147.09 34.9 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.707 -0.621 . . . . 0.0 110.378 -177.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -95.28 24.73 4.81 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.632 -0.667 . . . . 0.0 110.779 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 51.6 m -74.6 125.23 28.2 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.554 -0.716 . . . . 0.0 110.286 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -69.78 144.94 52.54 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.763 -0.586 . . . . 0.0 110.482 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -154.18 98.86 2.54 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.617 -0.677 . . . . 0.0 110.156 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -59.27 -39.95 73.1 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 O-C-N 123.261 1.137 . . . . 0.0 110.782 -176.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 73.76 -155.15 49.38 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -73.82 -45.65 0.37 Allowed 'Trans proline' 0 C--N 1.317 -1.096 0 O-C-N 123.38 1.2 . . . . 0.0 111.044 -174.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -86.24 8.07 22.69 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.474 -0.766 . . . . 0.0 111.383 -173.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.69 60.22 3.81 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.987 -1.071 . . . . 0.0 110.655 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.679 ' HA ' HG12 ' A' ' 176' ' ' VAL . 56.5 t80 -77.8 118.77 20.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.584 -0.697 . . . . 0.0 109.851 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.409 ' HA ' ' HG3' ' A' ' 299' ' ' ARG . 22.1 t70 -130.0 160.02 34.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.887 -0.508 . . . . 0.0 110.182 -178.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 80.6 t -125.16 146.92 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.729 -0.607 . . . . 0.0 109.785 176.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.4 p -157.73 171.03 21.04 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.88 176.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.414 ' CE1' HG12 ' A' ' 172' ' ' ILE . 57.7 m-85 -126.41 125.06 41.55 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.05 150.02 17.96 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.585 -0.697 . . . . 0.0 110.437 -176.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -69.99 136.22 50.22 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.584 -0.698 . . . . 0.0 110.391 -170.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 28.0 t -133.15 145.58 50.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.707 -0.62 . . . . 0.0 110.1 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 60.8 p -69.87 166.41 19.52 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.634 -0.666 . . . . 0.0 110.231 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 74.8 p -97.27 28.55 3.6 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.724 -0.61 . . . . 0.0 110.133 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.08 159.09 12.34 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.689 -0.632 . . . . 0.0 110.262 -176.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -58.94 157.63 9.61 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.699 -0.625 . . . . 0.0 110.394 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 75.5 m 53.6 33.64 16.88 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.496 -0.753 . . . . 0.0 111.008 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -70.44 126.68 30.32 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.702 -0.624 . . . . 0.0 109.854 173.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 69.0 p -60.03 -34.03 72.82 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.769 -0.582 . . . . 0.0 110.093 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.565 ' CE3' HD11 ' A' ' 162' ' ' LEU . 67.6 p-90 -170.75 148.08 2.89 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.834 -0.541 . . . . 0.0 109.964 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.4 t -141.7 142.44 33.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.749 -0.594 . . . . 0.0 109.884 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.403 ' HB2' HD12 ' A' ' 162' ' ' LEU . 62.0 t80 -125.54 140.07 53.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.52 -0.738 . . . . 0.0 110.589 -172.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 30.1 t -109.86 122.81 48.39 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.297 -0.561 . . . . 0.0 109.734 174.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 67.6 m -70.75 -36.98 73.38 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.353 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -59.38 -31.77 69.54 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.615 -0.678 . . . . 0.0 110.453 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.534 HD11 ' OD1' ' A' ' 316' ' ' ASP . 56.3 mt -104.78 -12.04 16.51 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.682 -0.636 . . . . 0.0 110.79 -175.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 32.5 tttt 59.68 48.52 9.27 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.007 -1.058 . . . . 0.0 109.682 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -146.93 153.06 39.65 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.736 -0.602 . . . . 0.0 110.638 -174.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.634 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.43 137.8 53.46 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.759 -0.588 . . . . 0.0 110.164 -175.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -115.85 132.67 56.57 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 175.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.1 p -138.36 158.43 44.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.663 -0.648 . . . . 0.0 111.046 -174.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.4 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 33.6 mt-30 -104.62 140.13 38.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.662 -0.649 . . . . 0.0 110.205 171.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.484 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.5 tt -52.61 149.14 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-O 121.619 0.723 . . . . 0.0 111.799 -174.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 66.06 8.35 5.41 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.489 -0.757 . . . . 0.0 112.483 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.4 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 63.4 mmtt -96.6 155.09 16.92 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.904 -1.123 . . . . 0.0 110.949 174.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 87.8 m -84.24 126.41 33.13 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.668 -0.645 . . . . 0.0 110.635 -177.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' CYS . . . . . 0.634 ' SG ' HD21 ' A' ' 162' ' ' LEU . 43.1 t -112.94 90.25 15.26 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.569 -0.707 . . . . 0.0 109.995 174.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -65.32 131.67 29.01 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.199 1.105 . . . . 0.0 110.484 176.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.414 HG12 ' CE1' ' A' ' 142' ' ' PHE . 92.5 mt -125.84 142.29 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.6 -0.688 . . . . 0.0 109.541 175.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -110.83 135.59 51.16 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.601 -0.687 . . . . 0.0 110.697 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.7 mm -95.33 134.91 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.556 -0.715 . . . . 0.0 109.579 169.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -116.21 128.47 55.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.602 -0.686 . . . . 0.0 110.445 176.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.679 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.5 m -136.29 159.77 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.548 -0.72 . . . . 0.0 109.886 174.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 81.9 mmm -75.45 -40.4 57.57 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.703 -0.623 . . . . 0.0 110.068 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 75.5 p -134.75 143.18 45.32 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.769 -0.582 . . . . 0.0 109.768 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 35.7 Cg_exo -54.95 139.79 79.34 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 O-C-N 123.138 1.073 . . . . 0.0 110.883 -172.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.579 ' HB3' HD21 ' A' ' 288' ' ' LEU . 20.5 Cg_endo -63.26 167.63 12.42 Favored 'Trans proline' 0 N--CA 1.487 1.099 0 O-C-N 123.191 1.1 . . . . 0.0 110.59 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -61.38 155.04 54.55 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.353 1.186 . . . . 0.0 110.321 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -72.99 139.0 46.38 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.591 -0.693 . . . . 0.0 109.853 175.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.71 -25.01 29.15 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -175.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.1 148.71 3.21 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.377 -1.072 . . . . 0.0 111.303 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.8 155.96 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.692 -0.63 . . . . 0.0 109.743 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.588 HD11 ' CD2' ' A' ' 251' ' ' TYR . 85.6 mt -106.57 137.91 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.698 -0.626 . . . . 0.0 109.457 176.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.729 ' HG2' HD22 ' A' ' 248' ' ' LEU . 70.8 mtp180 -114.85 141.96 47.2 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -176.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.618 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -137.39 125.83 23.45 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.471 -0.768 . . . . 0.0 110.353 175.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 39.4 ttm -137.27 139.11 26.95 Favored Pre-proline 0 N--CA 1.497 1.901 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.977 -176.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.508 ' HD3' HD12 ' A' ' 226' ' ' ILE . 72.8 Cg_endo -90.39 138.21 2.66 Favored 'Trans proline' 0 C--N 1.319 -0.982 0 C-N-CA 120.936 1.091 . . . . 0.0 110.858 177.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.494 HG12 ' CZ ' ' A' ' 244' ' ' ARG . 34.9 m -147.26 154.86 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.493 -0.755 . . . . 0.0 110.009 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.667 ' HA ' HG22 ' A' ' 282' ' ' ILE . 80.4 m-85 -61.49 165.0 5.17 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.431 -0.793 . . . . 0.0 110.448 -177.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -84.69 -60.06 2.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.605 -0.685 . . . . 0.0 110.841 -173.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 42.7 mttt -80.01 152.52 29.4 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.667 -0.646 . . . . 0.0 110.311 -174.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.454 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.68 -39.18 73.34 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.387 -0.821 . . . . 0.0 110.66 -174.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -56.62 -24.79 50.46 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.438 -0.789 . . . . 0.0 110.67 -177.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.473 ' CD2' ' HD3' ' A' ' 280' ' ' ARG . 51.1 m80 -109.23 -20.46 12.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.604 -0.685 . . . . 0.0 111.197 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.454 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -68.36 -20.28 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.144 -0.973 . . . . 0.0 110.639 -175.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.615 HG22 HD11 ' A' ' 126' ' ' ILE . 68.3 p -79.45 -17.15 54.85 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.551 -0.718 . . . . 0.0 110.858 174.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -88.36 137.7 32.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.302 -0.874 . . . . 0.0 110.186 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 57.7 t -72.95 146.49 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.587 -0.696 . . . . 0.0 110.146 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 60.0 t -84.82 140.06 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.575 -0.703 . . . . 0.0 109.203 172.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -134.83 -170.23 2.52 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.395 -0.815 . . . . 0.0 111.131 -167.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -95.21 154.14 17.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.771 -0.581 . . . . 0.0 110.461 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 63.3 m -77.52 162.75 67.45 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.649 -0.657 . . . . 0.0 109.274 173.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -63.9 -47.39 6.84 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 O-C-N 123.092 1.048 . . . . 0.0 109.849 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.449 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.8 p-10 -65.55 -44.55 86.47 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.62 -0.675 . . . . 0.0 111.257 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' HIS . . . . . 0.449 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 55.8 m170 -81.4 -27.94 34.56 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.349 -0.845 . . . . 0.0 111.526 -174.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -69.17 -39.37 78.78 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.31 -0.868 . . . . 0.0 110.359 173.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 23.1 tp -55.99 -34.84 66.13 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.533 -0.729 . . . . 0.0 110.866 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 28.0 t -48.34 132.77 16.39 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.447 -0.783 . . . . 0.0 111.404 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -61.19 143.63 55.19 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.728 -0.608 . . . . 0.0 110.248 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -60.84 -40.36 92.54 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.685 -0.634 . . . . 0.0 110.253 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 57.5 t80 50.6 50.7 18.38 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.425 -0.797 . . . . 0.0 111.145 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -75.3 -10.21 59.26 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.734 -0.604 . . . . 0.0 111.18 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -59.98 117.3 4.9 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.231 -0.918 . . . . 0.0 110.498 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 77.78 20.02 74.5 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.491 -1.043 . . . . 0.0 110.491 176.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -143.16 139.96 30.58 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.311 -1.111 . . . . 0.0 110.101 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.8 mt -88.21 -25.09 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.741 -0.6 . . . . 0.0 110.456 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.425 ' HB1' ' OH ' ' A' ' 236' ' ' TYR . . . -124.98 89.96 51.8 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.415 -0.803 . . . . 0.0 110.459 -175.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -62.58 145.24 95.31 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 O-C-N 123.24 1.126 . . . . 0.0 110.537 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -59.36 -18.52 46.14 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.201 1.106 . . . . 0.0 111.293 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 24.4 m -53.03 -28.38 24.14 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.157 -0.964 . . . . 0.0 111.168 -178.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -89.69 129.75 36.07 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.496 -0.752 . . . . 0.0 110.117 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.492 HD12 ' HE3' ' A' ' 268' ' ' MET . 56.4 tp -57.19 -42.53 81.41 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.573 -0.705 . . . . 0.0 110.576 -175.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.508 HD12 ' HD3' ' A' ' 190' ' ' PRO . 84.7 mt -106.06 136.82 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 120.309 -0.557 . . . . 0.0 109.867 -177.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -132.84 158.23 43.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.785 -0.572 . . . . 0.0 110.171 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.493 HG23 HG21 ' A' ' 247' ' ' VAL . 94.0 t -105.22 146.68 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.693 -0.629 . . . . 0.0 110.122 177.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -119.45 127.97 53.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.768 -0.582 . . . . 0.0 110.352 170.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.17 21.1 21.34 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 168.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -140.2 105.54 5.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.381 -1.07 . . . . 0.0 110.048 174.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 95.2 p -63.58 -15.13 57.24 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.625 -0.672 . . . . 0.0 111.217 -178.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -96.74 9.93 40.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -0.834 . . . . 0.0 111.219 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -62.2 127.83 33.21 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.246 -0.908 . . . . 0.0 110.056 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -139.84 157.35 45.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.719 -0.613 . . . . 0.0 109.734 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.425 ' OH ' ' HB1' ' A' ' 220' ' ' ALA . 83.6 m-85 -117.98 150.61 38.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.599 -0.688 . . . . 0.0 110.627 -176.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.16 159.96 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.837 -0.54 . . . . 0.0 110.213 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -116.49 130.07 56.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.765 -0.584 . . . . 0.0 110.111 175.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -63.12 130.07 93.9 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.634 -0.667 . . . . 0.0 109.867 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -65.73 -29.31 51.23 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 123.197 1.104 . . . . 0.0 110.952 -171.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 82.5 mt -103.9 -50.45 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.484 -0.76 . . . . 0.0 111.071 -168.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 7.3 p -105.29 12.08 32.18 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.376 -0.827 . . . . 0.0 111.927 -173.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 73.66 -6.97 15.13 Favored Glycine 0 N--CA 1.497 2.701 0 O-C-N 121.077 -1.014 . . . . 0.0 112.125 171.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.494 ' CZ ' HG12 ' A' ' 191' ' ' VAL . 26.8 mmt180 -45.89 142.09 2.76 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-N 119.095 1.448 . . . . 0.0 112.312 -176.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -105.91 143.89 33.4 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.671 -0.643 . . . . 0.0 110.09 174.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 78.9 p -154.73 159.93 41.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.554 -0.716 . . . . 0.0 110.571 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.493 HG21 HG23 ' A' ' 228' ' ' VAL . 8.3 p -122.97 148.18 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.732 -0.605 . . . . 0.0 109.636 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.729 HD22 ' HG2' ' A' ' 187' ' ' ARG . 75.2 mt -129.68 154.6 46.98 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.71 -174.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.434 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.9 m -150.63 151.75 31.19 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.811 -0.555 . . . . 0.0 109.96 174.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -71.21 137.42 31.25 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.264 1.139 . . . . 0.0 109.913 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.588 ' CD2' HD11 ' A' ' 186' ' ' ILE . 8.9 t80 -76.95 125.5 29.41 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.509 -0.744 . . . . 0.0 109.984 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -99.98 160.12 28.05 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.658 -0.651 . . . . 0.0 110.145 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -58.81 159.64 20.37 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 O-C-N 123.284 1.15 . . . . 0.0 110.343 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.38 149.94 78.15 Favored 'Trans proline' 0 C--N 1.316 -1.132 0 O-C-N 123.177 1.093 . . . . 0.0 110.538 -176.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -61.14 149.75 36.34 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.695 -0.628 . . . . 0.0 110.146 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.0 t -69.83 127.09 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.552 -0.718 . . . . 0.0 110.198 -170.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.11 -10.06 56.68 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.409 HG21 ' CE1' ' A' ' 260' ' ' PHE . 9.6 t -145.39 175.39 10.35 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.182 -1.187 . . . . 0.0 110.604 175.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -110.52 13.23 22.71 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.531 -0.73 . . . . 0.0 111.93 -166.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.409 ' CE1' HG21 ' A' ' 258' ' ' THR . 49.4 p90 -120.04 168.01 11.61 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.074 -1.016 . . . . 0.0 111.16 -177.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 78.1 m -117.74 146.09 44.01 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.81 -0.556 . . . . 0.0 109.914 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 32.2 m -116.88 135.57 53.62 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.594 -0.691 . . . . 0.0 110.981 -175.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 65.1 t -131.42 137.27 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 74.0 mt -104.68 122.02 44.78 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.538 -0.726 . . . . 0.0 109.944 -171.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.618 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 6.1 m-30 -106.35 149.32 27.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.709 -0.62 . . . . 0.0 110.591 -177.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -136.63 142.99 43.28 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -113.57 130.7 56.32 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.47 -0.769 . . . . 0.0 110.395 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' MET . . . . . 0.492 ' HE3' HD12 ' A' ' 225' ' ' LEU . 0.0 OUTLIER -99.87 -0.62 39.27 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.782 -0.574 . . . . 0.0 111.844 -178.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 269' ' ' CYS . . . . . 0.481 ' HB3' ' HE3' ' A' ' 268' ' ' MET . 7.0 t -144.78 158.05 43.94 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.147 -0.971 . . . . 0.0 109.009 176.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.558 ' HA ' HD13 ' A' ' 305' ' ' ILE . 26.1 p30 -119.0 152.32 36.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.678 -0.639 . . . . 0.0 110.262 -175.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' SER . . . . . 0.422 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 90.0 p -57.64 -25.39 60.09 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.481 -0.762 . . . . 0.0 111.148 -170.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 49.3 p -89.24 2.1 54.76 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.328 -0.858 . . . . 0.0 112.094 -167.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 28.6 p -85.23 118.0 24.51 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.014 -1.053 . . . . 0.0 110.618 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.63 140.17 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.457 -0.777 . . . . 0.0 110.445 -171.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 101.04 -5.18 56.07 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 177.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.11 -98.55 0.84 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 171.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' MET . . . . . 0.424 ' HE1' HD13 ' A' ' 282' ' ' ILE . 91.7 mmm -63.6 -30.96 72.0 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.73 -0.865 . . . . 0.0 110.332 178.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.1 p30 44.91 53.18 7.72 Favored 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 121.427 0.632 . . . . 0.0 112.338 173.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 17.1 mtt-85 54.89 34.97 23.31 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.336 -0.852 . . . . 0.0 111.328 175.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' ARG . . . . . 0.473 ' HD3' ' CD2' ' A' ' 197' ' ' HIS . 31.7 mtt-85 -112.43 104.94 56.22 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.575 -0.703 . . . . 0.0 110.085 169.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -60.13 148.95 87.54 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 O-C-N 123.12 1.063 . . . . 0.0 110.558 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.667 HG22 ' HA ' ' A' ' 192' ' ' TYR . 28.7 pt -131.97 179.16 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.811 0.815 . . . . 0.0 111.014 -177.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 302' ' ' GLU . 32.2 mt -124.37 149.96 46.07 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.706 HD12 ' CE1' ' A' ' 301' ' ' PHE . 80.6 mt -114.01 129.29 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.183 177.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.613 HG23 ' SG ' ' A' ' 300' ' ' CYS . 80.7 mt -109.73 125.92 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -175.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 60.0 t -118.89 126.72 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 44.8 p -125.3 153.09 43.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.652 -0.655 . . . . 0.0 110.642 -175.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.579 HD21 ' HB3' ' A' ' 180' ' ' PRO . 23.8 tp -102.85 126.03 49.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.799 -0.563 . . . . 0.0 109.509 170.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.674 ' OE2' HG13 ' A' ' 295' ' ' VAL . 73.5 mm-40 -132.78 150.59 52.14 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.79 -0.569 . . . . 0.0 109.967 -172.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.732 ' CG2' HD11 ' A' ' 296' ' ' LEU . 72.6 p -90.01 159.19 17.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.593 -0.692 . . . . 0.0 109.96 177.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -56.05 -26.12 47.85 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.533 -0.729 . . . . 0.0 110.935 -177.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -92.32 11.65 25.2 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.45 -0.781 . . . . 0.0 111.729 -173.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 90.05 20.12 44.02 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.11 -1.043 . . . . 0.0 110.932 167.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -105.49 140.14 39.04 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.28 -1.129 . . . . 0.0 110.154 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.675 HG11 ' NE ' ' A' ' 298' ' ' ARG . 59.4 t -90.66 130.9 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.63 -0.669 . . . . 0.0 110.159 -174.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.732 HD11 ' CG2' ' A' ' 290' ' ' THR . 95.8 mt -99.92 -40.21 7.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.768 -0.582 . . . . 0.0 110.781 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -161.64 154.71 25.76 Favored Glycine 0 N--CA 1.497 2.719 0 C-N-CA 119.987 -1.101 . . . . 0.0 110.359 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.675 ' NE ' HG11 ' A' ' 295' ' ' VAL . 41.1 mtt180 -135.15 135.92 41.48 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.642 -0.916 . . . . 0.0 110.383 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 299' ' ' ARG . . . . . 0.409 ' HG3' ' HA ' ' A' ' 139' ' ' ASP . 27.5 mmt180 -141.54 158.65 43.58 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.491 -0.755 . . . . 0.0 110.095 169.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 300' ' ' CYS . . . . . 0.613 ' SG ' HG23 ' A' ' 285' ' ' ILE . 94.8 m -143.59 157.91 44.06 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.407 -0.808 . . . . 0.0 110.701 -174.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.706 ' CE1' HD12 ' A' ' 284' ' ' ILE . 49.6 p90 -145.59 161.03 40.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.658 -0.651 . . . . 0.0 110.073 175.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.467 ' HA ' HD23 ' A' ' 283' ' ' LEU . 81.7 tt0 -104.9 136.71 43.88 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.548 -0.72 . . . . 0.0 110.178 -177.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -119.01 143.5 47.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.645 -0.659 . . . . 0.0 110.833 -169.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -138.5 138.25 37.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.772 -0.58 . . . . 0.0 109.601 172.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.558 HD13 ' HA ' ' A' ' 270' ' ' ASN . 65.7 mt -111.21 122.84 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.52 -0.738 . . . . 0.0 109.719 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.0 p -145.34 173.38 12.03 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.707 -0.621 . . . . 0.0 110.654 -172.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -74.13 -40.11 62.86 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.655 -0.653 . . . . 0.0 110.696 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.9 t -127.35 86.75 57.92 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.581 -0.699 . . . . 0.0 110.547 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -55.66 -28.62 66.81 Favored 'Trans proline' 0 N--CA 1.488 1.2 0 O-C-N 123.156 1.082 . . . . 0.0 110.813 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.97 -37.76 92.35 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -72.83 -40.48 65.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.692 -0.887 . . . . 0.0 109.881 -173.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -69.61 -38.25 77.18 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.283 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -62.08 -42.75 99.53 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.196 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -64.88 -37.43 87.62 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.5 -0.75 . . . . 0.0 110.342 175.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.63 -49.42 76.63 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.548 -0.72 . . . . 0.0 110.608 -173.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' ASP . . . . . 0.534 ' OD1' HD11 ' A' ' 159' ' ' LEU . 2.8 p30 -61.08 -37.69 83.6 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.448 -0.782 . . . . 0.0 110.098 -178.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -62.98 -41.2 99.49 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.035 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -62.84 -35.14 78.97 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.67 -0.644 . . . . 0.0 109.876 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 23.9 m -63.42 -32.36 73.78 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.792 -0.567 . . . . 0.0 110.173 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 83.4 mt -76.79 -48.15 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.61 -0.681 . . . . 0.0 109.986 -177.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -61.03 -39.74 90.92 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.635 -0.666 . . . . 0.0 110.437 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -60.66 -43.78 97.24 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.57 -0.706 . . . . 0.0 110.329 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -62.1 -33.15 73.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.607 -0.683 . . . . 0.0 110.082 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -93.55 124.96 37.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.643 -0.66 . . . . 0.0 110.385 -178.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.23 130.19 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.643 -0.66 . . . . 0.0 109.808 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 59.9 p -93.43 140.03 30.03 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.702 -0.624 . . . . 0.0 110.278 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -88.64 121.8 31.4 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.686 -0.634 . . . . 0.0 110.262 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 29.8 t -69.49 144.17 53.28 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.601 -0.687 . . . . 0.0 109.992 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 67.5 p -132.63 164.72 26.07 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.624 -0.672 . . . . 0.0 110.287 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 31.4 mmtm -88.09 155.04 20.0 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.642 -0.661 . . . . 0.0 110.133 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -58.66 -27.98 65.28 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.621 -0.675 . . . . 0.0 110.63 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -170.44 -178.9 41.54 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 59.51 79.85 0.22 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.502 -0.999 . . . . 0.0 110.236 176.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -165.83 103.8 0.68 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.669 -0.644 . . . . 0.0 110.266 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -117.25 148.18 41.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.65 -0.656 . . . . 0.0 110.308 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 51.61 95.85 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.484 -0.76 . . . . 0.0 111.156 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -115.47 143.49 45.23 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.56 -0.712 . . . . 0.0 110.264 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 53.71 42.63 31.77 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.429 -0.794 . . . . 0.0 110.903 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 74.6 p -67.69 -33.26 74.56 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.669 -0.645 . . . . 0.0 110.255 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' HIS . . . . . 0.491 ' HB3' HG22 ' A' ' 342' ' ' ILE . 77.1 m80 -59.56 -41.98 91.38 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.619 -0.676 . . . . 0.0 110.383 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 76.06 28.02 61.21 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.491 HG22 ' HB3' ' A' ' 340' ' ' HIS . 15.9 tt -148.17 146.55 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.631 -0.923 . . . . 0.0 110.253 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -92.69 124.28 36.58 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.689 -0.632 . . . . 0.0 110.222 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 65.1 mtt -60.4 -35.3 75.44 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.579 -0.701 . . . . 0.0 110.292 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 345' ' ' THR . . . . . 0.514 ' OXT' HG22 ' A' ' 345' ' ' THR . 16.3 m . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.19 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 60.3 p -84.4 160.71 20.56 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.701 -0.882 . . . . 0.0 110.262 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 96.6 p -122.72 153.99 38.71 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.609 -0.682 . . . . 0.0 110.15 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.7 t -131.82 25.1 4.67 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.631 -0.668 . . . . 0.0 110.757 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -60.61 -37.65 82.11 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.496 -0.753 . . . . 0.0 110.198 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -81.01 -29.02 35.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.642 -0.661 . . . . 0.0 110.203 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 50.55 -163.39 0.05 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.367 -0.833 . . . . 0.0 111.148 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.418 HD23 ' C ' ' A' ' 120' ' ' LEU . 6.7 tt 63.04 -70.21 0.06 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.6 -0.688 . . . . 0.0 111.035 -175.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.8 t -63.54 158.14 60.76 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.391 -0.818 . . . . 0.0 110.159 -176.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -62.25 150.59 62.1 Favored 'Cis proline' 0 N--CA 1.496 1.651 0 C-N-CA 123.086 -1.631 . . . . 0.0 110.33 -19.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 26.7 t -81.19 144.77 54.86 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.604 -0.685 . . . . 0.0 110.21 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -64.42 147.15 90.61 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 O-C-N 123.253 1.133 . . . . 0.0 110.297 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.77 139.5 41.86 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.621 -0.674 . . . . 0.0 110.032 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 50.2 mm -121.69 139.4 29.95 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.67 -0.644 . . . . 0.0 109.958 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.83 152.71 79.45 Favored 'Trans proline' 0 N--CA 1.487 1.12 0 O-C-N 123.148 1.078 . . . . 0.0 110.376 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 27.8 t -112.49 142.67 44.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.656 -0.653 . . . . 0.0 110.322 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.6 p-10 -99.93 24.85 7.96 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.718 -0.614 . . . . 0.0 110.731 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 53.1 m -78.14 125.19 29.0 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.53 -0.731 . . . . 0.0 110.25 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -71.04 144.95 50.22 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.739 -0.6 . . . . 0.0 110.403 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -158.57 101.83 1.66 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.675 -0.641 . . . . 0.0 110.07 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -59.21 -40.0 73.3 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.151 1.08 . . . . 0.0 110.729 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.08 -155.19 40.13 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -74.67 -43.29 0.47 Allowed 'Trans proline' 0 C--N 1.317 -1.116 0 O-C-N 123.315 1.166 . . . . 0.0 110.846 -175.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -88.65 4.41 47.24 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.577 -0.702 . . . . 0.0 111.437 -174.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 t 54.05 61.79 2.89 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.995 -1.066 . . . . 0.0 110.669 -176.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.732 ' HA ' HG12 ' A' ' 176' ' ' VAL . 59.5 t80 -78.0 120.77 23.31 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.606 -0.683 . . . . 0.0 110.111 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -130.01 160.01 34.96 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.8 -0.563 . . . . 0.0 110.129 -177.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 74.6 t -123.13 146.75 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.423 0.63 . . . . 0.0 110.046 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.0 p -157.3 171.08 21.04 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.126 0.489 . . . . 0.0 109.688 175.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.431 ' CE2' HG12 ' A' ' 172' ' ' ILE . 52.7 m-85 -126.48 125.16 41.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.827 -0.545 . . . . 0.0 109.656 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -57.38 139.47 52.97 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.591 -0.693 . . . . 0.0 110.378 -175.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -78.63 144.13 35.73 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.552 -0.718 . . . . 0.0 110.656 -169.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 83.2 p -142.84 161.82 37.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.721 -0.612 . . . . 0.0 110.067 177.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 47.5 m -62.72 161.78 11.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.61 -0.681 . . . . 0.0 110.228 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 77.8 p -92.61 44.44 1.16 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.618 -0.676 . . . . 0.0 110.178 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.11 156.12 36.95 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.735 -0.603 . . . . 0.0 110.243 -176.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -63.21 162.12 12.5 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.691 -0.631 . . . . 0.0 110.063 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 60.3 m 53.24 26.96 5.53 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.434 -0.791 . . . . 0.0 111.018 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.88 131.7 49.65 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.556 -0.715 . . . . 0.0 109.923 175.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.425 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 76.6 p -60.08 -34.04 72.9 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.71 -0.619 . . . . 0.0 109.928 177.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.518 ' HE3' HD11 ' A' ' 162' ' ' LEU . 67.2 p-90 -170.59 147.88 2.96 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.878 -0.514 . . . . 0.0 109.788 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 14.0 t -142.08 142.43 32.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.768 -0.583 . . . . 0.0 109.963 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -125.63 140.08 53.02 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.494 -0.754 . . . . 0.0 110.45 -172.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 30.7 t -109.72 122.5 47.62 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 120.324 -0.551 . . . . 0.0 109.748 175.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 63.6 m -70.77 -37.0 73.34 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.71 -0.619 . . . . 0.0 110.443 -177.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -60.46 -32.25 71.22 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.605 -0.684 . . . . 0.0 110.357 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 60.3 mt -104.79 -12.06 16.5 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.726 -0.609 . . . . 0.0 110.852 -176.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.5 tttm 59.84 50.75 6.63 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.081 -1.012 . . . . 0.0 109.702 177.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -146.34 153.0 40.03 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.598 -176.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.663 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.5 tp -126.63 137.87 53.36 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.791 -0.568 . . . . 0.0 110.24 -175.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -115.47 134.05 55.45 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.9 p -138.28 158.39 44.39 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.637 -0.664 . . . . 0.0 111.005 -175.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -104.55 143.04 33.59 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.499 0.666 . . . . 0.0 110.347 172.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.43 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.3 tt -52.53 147.68 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-O 121.583 0.706 . . . . 0.0 111.842 -173.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.36 9.98 5.33 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.638 -0.664 . . . . 0.0 112.461 177.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -96.82 155.1 16.92 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.975 -1.078 . . . . 0.0 110.811 175.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 87.3 m -82.78 126.17 32.11 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.709 -0.619 . . . . 0.0 110.607 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' CYS . . . . . 0.663 ' SG ' HD21 ' A' ' 162' ' ' LEU . 42.6 t -112.93 90.29 15.29 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.647 -0.658 . . . . 0.0 110.082 172.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.437 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 15.8 Cg_exo -65.1 128.65 21.07 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 O-C-N 123.264 1.139 . . . . 0.0 110.394 176.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.431 HG12 ' CE2' ' A' ' 142' ' ' PHE . 94.7 mt -122.38 139.42 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.621 -0.674 . . . . 0.0 109.393 177.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -108.69 137.0 47.33 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.645 -0.659 . . . . 0.0 110.488 -177.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.432 ' CG2' ' CE1' ' A' ' 138' ' ' PHE . 48.5 mm -95.23 132.77 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.66 -0.65 . . . . 0.0 109.562 171.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -115.93 128.95 56.17 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.699 -0.626 . . . . 0.0 110.352 176.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.732 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.0 m -136.74 159.71 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.575 -0.703 . . . . 0.0 110.012 176.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.5 mmm -75.45 -40.19 57.8 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.723 -0.611 . . . . 0.0 110.056 177.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 76.4 p -136.82 143.23 41.8 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.788 -0.57 . . . . 0.0 109.729 178.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 33.5 Cg_exo -55.4 139.91 82.06 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 O-C-N 123.21 1.11 . . . . 0.0 110.898 -171.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.765 ' HB3' HD21 ' A' ' 288' ' ' LEU . 33.4 Cg_endo -68.05 170.08 15.15 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 O-C-N 123.119 1.063 . . . . 0.0 110.558 178.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -60.5 155.04 49.66 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 O-C-N 123.289 1.152 . . . . 0.0 110.516 -178.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -77.55 140.2 39.68 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.598 -0.689 . . . . 0.0 109.931 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.67 -24.93 29.48 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -174.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.19 153.33 1.48 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.307 -1.114 . . . . 0.0 111.387 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.84 155.93 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.665 -0.647 . . . . 0.0 109.841 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.732 HD11 ' HD2' ' A' ' 251' ' ' TYR . 87.4 mt -109.25 137.92 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.662 -0.649 . . . . 0.0 109.652 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.726 ' HG2' HD22 ' A' ' 248' ' ' LEU . 40.4 mtm180 -114.97 146.95 40.67 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -176.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.656 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -140.59 127.72 20.91 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.503 -0.748 . . . . 0.0 110.343 173.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.411 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 21.1 ttm -137.31 139.71 28.61 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.811 -0.555 . . . . 0.0 110.978 -177.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.553 ' HD3' HD12 ' A' ' 226' ' ' ILE . 72.7 Cg_endo -91.98 138.17 1.93 Allowed 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 121.061 1.174 . . . . 0.0 110.778 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.478 HG12 ' CZ ' ' A' ' 244' ' ' ARG . 34.7 m -147.06 154.86 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.445 -0.784 . . . . 0.0 110.178 173.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.638 ' HA ' HG22 ' A' ' 282' ' ' ILE . 83.7 m-85 -60.7 164.56 4.56 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.425 -0.797 . . . . 0.0 110.441 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.413 ' HA ' HD12 ' A' ' 283' ' ' LEU . 75.2 tttt -80.74 -60.03 2.46 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.601 -0.687 . . . . 0.0 110.827 -174.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -80.12 151.25 29.91 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.587 -0.696 . . . . 0.0 110.385 -175.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.454 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.57 -37.94 71.27 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.392 -0.817 . . . . 0.0 110.684 -176.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -56.84 -24.91 54.67 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.488 -0.757 . . . . 0.0 110.542 -176.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.402 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 5.3 m-70 -109.27 -20.58 12.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.52 -0.738 . . . . 0.0 111.125 -178.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.454 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.1 p -68.0 -20.25 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.199 -0.938 . . . . 0.0 110.623 -176.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 72.3 p -79.43 -17.04 55.11 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.62 174.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -88.35 135.66 33.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.417 -0.802 . . . . 0.0 110.067 174.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.8 t -73.05 141.21 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.73 -0.606 . . . . 0.0 110.223 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.545 HG22 ' CE2' ' A' ' 192' ' ' TYR . 64.3 t -84.98 138.28 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.632 -0.667 . . . . 0.0 109.233 170.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -134.82 -170.25 2.52 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.536 -0.727 . . . . 0.0 111.229 -167.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 223' ' ' SER . 73.0 mtm-85 -95.25 154.68 17.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.853 -0.529 . . . . 0.0 110.389 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 57.0 m -76.0 156.82 84.03 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.62 -0.675 . . . . 0.0 109.247 174.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -63.48 -47.4 7.61 Favored 'Trans proline' 0 C--N 1.315 -1.234 0 O-C-N 123.192 1.101 . . . . 0.0 109.96 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.43 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.6 p-10 -65.44 -44.49 87.14 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.649 -0.657 . . . . 0.0 111.312 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' HIS . . . . . 0.43 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 52.6 m170 -81.34 -27.94 34.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.367 -0.833 . . . . 0.0 111.253 -174.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -68.99 -42.07 77.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.416 -0.802 . . . . 0.0 110.221 173.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 26.3 tp -63.61 -36.68 84.63 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.634 -0.666 . . . . 0.0 110.268 178.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.0 t -48.46 -41.44 29.6 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.551 -0.718 . . . . 0.0 111.608 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 49.93 -167.28 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.435 -0.791 . . . . 0.0 111.202 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -167.95 48.65 0.05 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.614 -0.679 . . . . 0.0 110.073 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 52.16 75.03 0.24 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.405 -0.809 . . . . 0.0 110.928 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -66.74 -10.27 45.31 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.633 -0.667 . . . . 0.0 111.238 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -60.09 118.27 6.12 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.192 -0.943 . . . . 0.0 110.333 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 79.08 20.16 70.76 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -114.75 146.69 40.69 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.251 -1.146 . . . . 0.0 110.4 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.9 mt -84.81 -25.03 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.674 -0.642 . . . . 0.0 110.564 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.554 ' HB2' ' OH ' ' A' ' 236' ' ' TYR . . . -124.9 97.45 38.38 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.414 -0.804 . . . . 0.0 110.544 -175.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -65.66 157.51 58.26 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.348 1.183 . . . . 0.0 110.415 177.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -56.44 -20.92 35.07 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 O-C-N 123.226 1.119 . . . . 0.0 111.492 -174.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.4 ' HA ' ' HD3' ' A' ' 204' ' ' ARG . 25.7 m -52.79 -28.35 22.14 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.268 -0.895 . . . . 0.0 111.432 -176.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' HIS . . . . . 0.434 ' CD2' ' HB3' ' A' ' 236' ' ' TYR . 47.0 m80 -96.0 124.03 39.85 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.357 -0.839 . . . . 0.0 110.653 -174.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.677 HD12 ' HG3' ' A' ' 268' ' ' MET . 37.6 tp -66.11 -36.04 82.1 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.609 -0.682 . . . . 0.0 110.388 178.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.553 HD12 ' HD3' ' A' ' 190' ' ' PRO . 83.3 mt -102.44 136.88 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.814 -0.554 . . . . 0.0 109.883 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 50.0 mtt-85 -130.92 159.44 37.44 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.689 -0.632 . . . . 0.0 110.326 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.595 HG23 HG21 ' A' ' 247' ' ' VAL . 81.3 t -103.96 146.65 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.728 -0.607 . . . . 0.0 110.0 176.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -118.25 128.12 54.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.696 -0.627 . . . . 0.0 110.349 170.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 96.67 21.39 21.69 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 168.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -139.38 106.24 5.41 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.348 -1.089 . . . . 0.0 109.95 174.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 90.9 p -63.66 -15.09 57.4 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.64 -0.663 . . . . 0.0 111.201 -177.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -97.12 9.93 40.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.341 -0.849 . . . . 0.0 111.236 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.75 128.78 37.87 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.111 -0.993 . . . . 0.0 110.114 175.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -139.76 155.75 47.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.76 -0.587 . . . . 0.0 109.607 177.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.554 ' OH ' ' HB2' ' A' ' 220' ' ' ALA . 80.9 m-85 -119.12 150.74 39.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.568 -0.708 . . . . 0.0 110.61 -175.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.16 159.97 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.778 -0.576 . . . . 0.0 110.242 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -117.76 130.01 56.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.766 -0.584 . . . . 0.0 110.181 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -62.52 130.19 93.24 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.623 -0.673 . . . . 0.0 109.789 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -64.82 -28.04 59.3 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 O-C-N 123.135 1.071 . . . . 0.0 111.003 -170.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.0 mt -102.0 -50.43 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.344 -0.848 . . . . 0.0 111.014 -168.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 17.9 p -105.43 12.14 31.84 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.31 -0.869 . . . . 0.0 111.913 -174.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 72.17 -4.92 16.01 Favored Glycine 0 N--CA 1.497 2.723 0 O-C-N 121.074 -1.016 . . . . 0.0 112.022 172.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.478 ' CZ ' HG12 ' A' ' 191' ' ' VAL . 21.6 mmt180 -45.86 142.01 2.77 Favored 'General case' 0 N--CA 1.505 2.309 0 CA-C-N 119.119 1.46 . . . . 0.0 112.388 -175.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -103.54 143.36 32.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.618 -0.676 . . . . 0.0 110.119 175.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.2 p -154.81 159.94 40.92 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.595 -0.69 . . . . 0.0 110.348 176.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.595 HG21 HG23 ' A' ' 228' ' ' VAL . 8.6 p -123.17 148.23 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.836 -0.54 . . . . 0.0 109.814 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.726 HD22 ' HG2' ' A' ' 187' ' ' ARG . 81.8 mt -129.62 154.61 46.93 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.079 -0.649 . . . . 0.0 109.638 -177.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.443 HG13 ' C ' ' A' ' 248' ' ' LEU . 34.4 m -151.1 151.67 29.95 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.813 -0.554 . . . . 0.0 110.001 175.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -71.05 139.0 34.88 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 O-C-N 123.368 1.194 . . . . 0.0 110.08 177.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.732 ' HD2' HD11 ' A' ' 186' ' ' ILE . 58.9 t80 -75.9 124.47 27.39 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.099 175.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -99.99 160.11 28.07 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.694 -0.628 . . . . 0.0 109.953 176.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -58.37 158.49 22.59 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 O-C-N 123.294 1.155 . . . . 0.0 110.517 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -59.09 149.98 76.35 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 O-C-N 123.219 1.115 . . . . 0.0 110.511 -177.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -60.73 148.27 39.42 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.65 -0.656 . . . . 0.0 110.295 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.84 127.19 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.538 -0.726 . . . . 0.0 110.168 -171.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.96 -10.14 55.41 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 10.0 t -144.65 173.43 11.83 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.175 -1.191 . . . . 0.0 110.63 175.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -107.28 13.09 27.51 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.617 -0.677 . . . . 0.0 111.78 -168.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -119.92 168.01 11.56 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.181 -0.95 . . . . 0.0 111.168 -175.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 92.6 m -117.73 146.76 43.54 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.744 -0.597 . . . . 0.0 109.986 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 46.4 m -118.24 135.67 54.13 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.604 -0.685 . . . . 0.0 110.952 -174.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 60.2 t -132.56 137.23 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 172.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 75.1 mt -104.78 123.8 48.3 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.437 -0.789 . . . . 0.0 110.054 -171.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.656 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 6.1 m-30 -106.85 151.51 25.12 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.644 -0.66 . . . . 0.0 110.683 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -136.49 142.92 43.55 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -113.47 133.11 55.39 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.538 -0.726 . . . . 0.0 110.55 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' MET . . . . . 0.677 ' HG3' HD12 ' A' ' 225' ' ' LEU . 2.3 ppp? -97.68 2.66 49.97 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.709 -0.62 . . . . 0.0 112.164 -175.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' CYS . . . . . 0.683 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.7 OUTLIER -144.73 165.07 29.1 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.131 -0.981 . . . . 0.0 110.195 176.063 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.556 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.5 p30 -120.68 162.8 19.07 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.43 0.633 . . . . 0.0 110.407 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' SER . . . . . 0.43 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 25.2 m -58.8 -33.53 70.45 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.407 -0.808 . . . . 0.0 110.927 -163.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 49.9 p -100.75 12.17 38.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.466 -0.771 . . . . 0.0 112.018 -163.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 30.4 p -94.54 118.1 31.15 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.03 -1.043 . . . . 0.0 110.742 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.2 t -63.2 139.78 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.431 -0.793 . . . . 0.0 110.393 -171.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.83 -5.28 58.08 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.08 -99.78 0.88 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 171.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' MET . . . . . 0.43 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.7 mmm -62.71 -31.53 72.46 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.773 -0.84 . . . . 0.0 110.308 178.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.3 p30 44.47 49.32 8.3 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 174.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 21.3 mtt180 54.79 31.71 16.1 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.331 -0.855 . . . . 0.0 111.179 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' ARG . . . . . 0.417 ' O ' HG23 ' A' ' 282' ' ' ILE . 75.5 mtt180 -119.31 104.96 45.04 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.508 -0.745 . . . . 0.0 110.07 174.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -59.98 145.26 98.79 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 O-C-N 123.162 1.085 . . . . 0.0 110.466 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.638 HG22 ' HA ' ' A' ' 192' ' ' TYR . 46.5 pt -131.98 176.38 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.874 0.845 . . . . 0.0 111.186 -174.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 302' ' ' GLU . 29.4 mt -124.37 149.86 46.18 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.704 HD12 ' CE1' ' A' ' 301' ' ' PHE . 79.0 mt -115.66 130.11 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.595 -0.69 . . . . 0.0 109.174 178.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.592 HG23 ' SG ' ' A' ' 300' ' ' CYS . 79.0 mt -109.86 126.06 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -176.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 57.8 t -118.86 126.93 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.426 HG22 ' HG2' ' A' ' 298' ' ' ARG . 45.2 p -125.27 152.91 44.01 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.592 -0.692 . . . . 0.0 110.614 -173.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.765 HD21 ' HB3' ' A' ' 180' ' ' PRO . 23.2 tp -103.54 126.68 50.83 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.754 -0.591 . . . . 0.0 109.434 168.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.54 ' OE2' HG13 ' A' ' 295' ' ' VAL . 72.6 mm-40 -130.52 152.03 50.34 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.892 -0.505 . . . . 0.0 109.876 -173.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.818 HG22 HD11 ' A' ' 296' ' ' LEU . 68.6 p -89.83 159.91 16.76 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.699 -0.625 . . . . 0.0 109.735 176.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -55.97 -26.1 46.76 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.515 -0.741 . . . . 0.0 110.772 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -86.96 9.18 20.27 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.521 -0.737 . . . . 0.0 111.845 -174.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 86.6 20.16 54.84 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 120.183 -1.008 . . . . 0.0 110.766 170.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -107.55 140.24 40.84 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.282 -1.128 . . . . 0.0 110.196 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.54 HG13 ' OE2' ' A' ' 289' ' ' GLU . 61.5 t -86.21 132.9 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.656 -0.653 . . . . 0.0 110.091 -174.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.818 HD11 HG22 ' A' ' 290' ' ' THR . 80.3 mt -99.89 -40.1 7.85 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.722 -0.611 . . . . 0.0 110.424 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -165.27 153.28 23.3 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.426 ' HG2' HG22 ' A' ' 287' ' ' THR . 79.3 mtm180 -133.49 136.46 45.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.686 -0.891 . . . . 0.0 110.751 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -135.59 158.29 44.74 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.634 -0.666 . . . . 0.0 109.862 172.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' CYS . . . . . 0.592 ' SG ' HG23 ' A' ' 285' ' ' ILE . 95.0 m -143.0 155.1 44.59 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.34 -0.85 . . . . 0.0 110.772 -175.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.704 ' CE1' HD12 ' A' ' 284' ' ' ILE . 49.4 p90 -144.97 162.76 36.11 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.734 -0.604 . . . . 0.0 110.052 175.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.436 ' HA ' HD23 ' A' ' 283' ' ' LEU . 82.0 tt0 -104.75 135.06 46.83 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.544 -0.723 . . . . 0.0 110.217 -177.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -122.84 143.18 50.03 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.701 -169.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -138.3 139.2 39.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.74 -0.6 . . . . 0.0 109.704 173.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.683 HD13 ' O ' ' A' ' 269' ' ' CYS . 70.5 mt -108.02 122.8 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.537 -0.727 . . . . 0.0 109.605 176.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.9 p -145.27 169.34 18.43 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.629 -0.67 . . . . 0.0 110.676 -171.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -71.32 -40.1 70.98 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.631 -0.668 . . . . 0.0 110.64 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.9 t -127.5 86.05 59.42 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.468 -0.77 . . . . 0.0 110.47 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -55.87 -28.36 67.41 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 O-C-N 123.122 1.064 . . . . 0.0 110.812 174.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -67.59 -36.73 88.62 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -73.35 -39.83 64.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.72 -0.871 . . . . 0.0 109.822 -173.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -69.56 -40.94 76.51 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.137 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -61.88 -43.46 98.81 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.477 -0.765 . . . . 0.0 110.24 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -64.79 -39.06 92.97 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.532 -0.73 . . . . 0.0 110.478 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.2 -50.5 72.88 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.439 -0.788 . . . . 0.0 110.427 -173.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -61.42 -37.72 84.52 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.455 -0.778 . . . . 0.0 110.1 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -61.56 -40.68 95.59 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.601 -0.687 . . . . 0.0 110.132 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -62.34 -35.18 78.3 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.646 -0.659 . . . . 0.0 109.938 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 23.1 m -62.27 -33.74 75.22 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.665 -0.647 . . . . 0.0 110.223 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 83.6 mt -78.12 -43.08 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.692 -0.63 . . . . 0.0 109.953 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -58.64 -39.82 81.64 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.576 -0.702 . . . . 0.0 110.544 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -60.99 -42.14 97.85 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.672 -0.643 . . . . 0.0 110.131 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -61.59 -34.55 75.81 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.643 -0.661 . . . . 0.0 110.15 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -97.66 125.13 42.26 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.716 -0.615 . . . . 0.0 110.355 -176.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 62.2 t -110.86 130.08 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.698 -0.626 . . . . 0.0 109.849 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 50.1 m -95.1 140.19 30.39 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.683 -0.636 . . . . 0.0 110.265 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -68.49 144.88 54.49 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.76 -0.587 . . . . 0.0 110.142 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 55.0 p -68.65 162.34 26.21 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.665 -0.647 . . . . 0.0 110.152 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 71.6 p -92.82 -24.1 18.62 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.648 -0.658 . . . . 0.0 110.465 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -60.14 -36.15 76.89 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.452 -0.78 . . . . 0.0 110.254 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -110.04 137.65 47.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.652 -0.655 . . . . 0.0 110.218 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -84.15 -177.55 51.42 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -75.46 128.14 34.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.609 -0.936 . . . . 0.0 110.254 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -146.42 155.03 42.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.64 -0.662 . . . . 0.0 110.325 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -139.77 166.16 25.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.577 -0.702 . . . . 0.0 110.35 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 56.84 -84.4 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.745 -0.597 . . . . 0.0 111.052 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -57.31 -37.35 72.34 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.151 -0.968 . . . . 0.0 110.681 -174.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -104.91 137.04 43.29 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.67 -0.644 . . . . 0.0 110.274 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 339' ' ' THR . . . . . 0.43 HG22 ' H ' ' A' ' 341' ' ' GLY . 52.4 m -121.31 144.78 48.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.65 -0.656 . . . . 0.0 110.292 -178.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -57.23 -34.81 68.96 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.632 -0.668 . . . . 0.0 110.587 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 341' ' ' GLY . . . . . 0.43 ' H ' HG22 ' A' ' 339' ' ' THR . . . 101.72 -24.35 31.77 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.416 HG22 ' H ' ' A' ' 342' ' ' ILE . 16.3 tt -92.37 150.18 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.452 -1.028 . . . . 0.0 110.324 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -92.2 127.3 37.62 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.653 -0.654 . . . . 0.0 110.241 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 93.4 mmm -59.93 -35.49 75.03 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.697 -0.627 . . . . 0.0 110.329 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 345' ' ' THR . . . . . 0.566 HG22 ' O ' ' A' ' 345' ' ' THR . 25.0 m . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.205 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 31.5 m -80.79 -30.97 35.88 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.656 -0.908 . . . . 0.0 110.249 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.6 m -59.95 -36.97 78.24 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.606 -0.684 . . . . 0.0 110.345 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 64.1 p -67.29 -29.65 69.3 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.649 -0.657 . . . . 0.0 110.157 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -59.71 -43.21 94.22 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.596 -0.69 . . . . 0.0 110.433 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -86.94 6.59 31.36 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.659 -0.65 . . . . 0.0 111.438 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 50.02 -161.04 0.06 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.084 -1.01 . . . . 0.0 111.267 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.463 ' O ' HD23 ' A' ' 120' ' ' LEU . 7.4 tt 51.69 91.13 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.491 -0.756 . . . . 0.0 111.153 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 27.0 m -127.87 164.24 38.13 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.666 -0.646 . . . . 0.0 110.269 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -61.04 153.67 62.49 Favored 'Trans proline' 0 N--CA 1.488 1.161 0 O-C-N 123.302 1.159 . . . . 0.0 110.289 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.9 m -81.53 136.35 48.88 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.645 -0.66 . . . . 0.0 110.138 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.604 ' HB3' HG22 ' A' ' 242' ' ' THR . 23.2 Cg_endo -65.97 148.11 85.45 Favored 'Trans proline' 0 N--CA 1.487 1.126 0 O-C-N 123.11 1.058 . . . . 0.0 110.426 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.91 139.49 41.65 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.653 -0.654 . . . . 0.0 110.026 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.524 HD11 HG22 ' A' ' 199' ' ' THR . 50.7 mm -126.05 99.96 30.88 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.648 -0.658 . . . . 0.0 110.128 -177.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -61.64 154.89 56.9 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 O-C-N 123.248 1.13 . . . . 0.0 110.437 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 32.4 t -108.89 150.6 27.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.64 -0.662 . . . . 0.0 110.274 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -92.8 21.2 5.78 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.675 -0.641 . . . . 0.0 111.004 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 54.9 m -72.07 125.11 26.44 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.371 -0.831 . . . . 0.0 110.223 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -69.99 144.89 52.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.679 -0.638 . . . . 0.0 110.558 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -153.64 102.41 2.53 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.744 -0.597 . . . . 0.0 110.182 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -58.53 -39.95 78.56 Favored 'Trans proline' 0 N--CA 1.487 1.142 0 O-C-N 123.096 1.051 . . . . 0.0 110.922 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.43 -155.13 45.04 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -74.69 -46.12 0.27 Allowed 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.366 1.193 . . . . 0.0 111.007 -173.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -89.66 12.12 17.78 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.557 -0.715 . . . . 0.0 111.285 -172.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.5 60.93 3.38 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.017 -1.052 . . . . 0.0 110.709 -176.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.666 ' HA ' HG12 ' A' ' 176' ' ' VAL . 43.8 t80 -77.82 118.32 20.05 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.643 -0.661 . . . . 0.0 109.73 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.403 ' HA ' ' HG3' ' A' ' 299' ' ' ARG . 22.6 t70 -129.98 159.94 35.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.784 -0.573 . . . . 0.0 110.196 -177.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 64.3 t -125.76 146.75 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.802 -0.561 . . . . 0.0 109.716 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.2 p -155.27 162.43 40.89 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.276 0.56 . . . . 0.0 110.108 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.501 ' CD2' ' CE2' ' A' ' 155' ' ' TYR . 72.7 m-85 -126.67 125.2 41.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.837 -0.54 . . . . 0.0 109.708 -177.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -57.08 145.31 31.29 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.59 -0.694 . . . . 0.0 110.527 -174.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -99.04 135.8 39.92 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.675 -0.641 . . . . 0.0 110.413 -175.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 49.5 m -125.68 154.72 41.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.675 -0.641 . . . . 0.0 110.029 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.0 m -59.23 157.36 10.79 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.504 -0.747 . . . . 0.0 110.264 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.462 HG22 ' HD3' ' A' ' 313' ' ' ARG . 64.6 p -68.22 75.83 0.24 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.729 -0.607 . . . . 0.0 110.148 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.07 156.72 18.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.537 -0.727 . . . . 0.0 110.264 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -76.59 156.92 32.39 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.619 -0.676 . . . . 0.0 110.087 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.9 p 50.99 31.1 5.89 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.571 -0.706 . . . . 0.0 111.277 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.02 131.37 49.39 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.608 -0.683 . . . . 0.0 110.036 176.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.405 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 75.5 p -60.11 -34.05 72.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.768 -0.583 . . . . 0.0 109.96 176.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.431 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -171.65 143.66 1.75 Allowed 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.497 0.665 . . . . 0.0 110.489 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 9.9 t -142.16 142.53 32.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.817 -0.552 . . . . 0.0 110.042 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.501 ' CE2' ' CD2' ' A' ' 142' ' ' PHE . 43.8 t80 -125.47 140.09 53.07 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.534 -0.729 . . . . 0.0 110.529 -173.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 30.6 t -111.47 125.66 54.13 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 120.431 -0.507 . . . . 0.0 109.871 176.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 59.4 m -70.78 -37.08 73.3 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.866 -0.521 . . . . 0.0 110.469 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -59.51 -32.99 70.8 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.601 -0.687 . . . . 0.0 110.36 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.543 HD11 ' OD1' ' A' ' 316' ' ' ASP . 55.9 mt -104.74 -12.15 16.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.771 -0.58 . . . . 0.0 110.806 -175.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.1 ttpt 59.81 47.23 10.46 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.025 -1.047 . . . . 0.0 109.693 176.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -148.31 153.26 38.41 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.786 -172.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.504 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.5 137.87 53.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.799 -0.563 . . . . 0.0 110.246 -173.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -114.83 132.84 56.36 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 174.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.32 158.38 44.39 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 120.109 -0.636 . . . . 0.0 111.024 -175.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.412 ' HG3' ' HD3' ' A' ' 309' ' ' PRO . 24.3 mt-30 -104.55 143.6 32.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.553 -0.717 . . . . 0.0 110.481 173.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.43 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.7 tt -53.69 146.58 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 CA-C-O 121.586 0.708 . . . . 0.0 111.687 -173.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.27 10.0 5.26 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.601 -0.687 . . . . 0.0 112.448 176.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.404 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 20.0 mmtp -95.19 154.99 16.92 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.964 -1.085 . . . . 0.0 110.666 175.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 87.4 m -83.1 126.17 32.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.728 -0.607 . . . . 0.0 110.523 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' CYS . . . . . 0.504 ' SG ' HD21 ' A' ' 162' ' ' LEU . 49.5 t -114.33 90.08 19.58 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.635 -0.666 . . . . 0.0 110.041 172.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.431 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 21.7 Cg_exo -62.2 129.48 27.19 Favored 'Trans proline' 0 C--N 1.316 -1.158 0 O-C-N 123.225 1.119 . . . . 0.0 110.562 173.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.416 HG12 ' CE1' ' A' ' 142' ' ' PHE . 97.3 mt -124.39 141.96 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 176.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -109.69 135.45 50.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.443 -0.785 . . . . 0.0 110.789 -175.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.3 mm -95.22 134.99 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.68 -0.638 . . . . 0.0 109.669 169.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -116.54 129.03 55.96 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.618 -0.676 . . . . 0.0 110.455 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.666 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.1 m -136.77 159.78 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.566 -0.709 . . . . 0.0 109.868 174.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 81.3 mmm -78.22 -42.45 31.27 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.738 -0.601 . . . . 0.0 110.148 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.2 p -131.7 143.2 48.14 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.799 -0.563 . . . . 0.0 109.702 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.8 Cg_exo -55.55 139.8 82.81 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 O-C-N 123.181 1.095 . . . . 0.0 110.876 -171.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.609 ' HB3' HD21 ' A' ' 288' ' ' LEU . 35.3 Cg_endo -67.6 170.03 14.63 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 O-C-N 123.168 1.088 . . . . 0.0 110.627 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -60.81 157.11 39.53 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 123.419 1.22 . . . . 0.0 110.514 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -78.73 139.13 38.5 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.647 -0.658 . . . . 0.0 110.024 175.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.06 -25.05 29.76 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -174.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -49.98 150.44 2.28 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.334 -1.098 . . . . 0.0 111.443 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.76 155.99 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.794 -0.566 . . . . 0.0 109.736 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.721 HD11 ' HD2' ' A' ' 251' ' ' TYR . 79.7 mt -108.27 137.1 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.667 -0.646 . . . . 0.0 109.437 176.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.743 ' HG2' HD22 ' A' ' 248' ' ' LEU . 61.6 mtt180 -114.99 143.09 45.72 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -176.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.652 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -137.35 127.25 25.7 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.46 -0.775 . . . . 0.0 110.28 176.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.407 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 23.9 ttm -137.22 139.91 29.41 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.787 -0.571 . . . . 0.0 111.086 -176.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.61 ' HD3' HD12 ' A' ' 226' ' ' ILE . 72.1 Cg_endo -91.97 138.22 1.94 Allowed 'Trans proline' 0 C--N 1.319 -0.992 0 C-N-CA 121.051 1.167 . . . . 0.0 110.643 177.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.416 HG13 ' C ' ' A' ' 190' ' ' PRO . 34.9 m -146.52 154.9 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.548 -0.72 . . . . 0.0 110.093 174.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.554 ' HA ' HG22 ' A' ' 282' ' ' ILE . 86.1 m-85 -63.56 159.39 18.86 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.483 -0.761 . . . . 0.0 110.578 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.454 ' HA ' HD12 ' A' ' 283' ' ' LEU . 40.7 ttpt -75.39 -56.6 4.55 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.709 -0.619 . . . . 0.0 110.697 -175.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -79.98 147.61 31.5 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.554 -0.716 . . . . 0.0 110.29 -174.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.448 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.54 -38.51 71.97 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.38 -0.825 . . . . 0.0 110.716 -175.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 20.2 mp0 -56.55 -25.16 51.33 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.441 -0.787 . . . . 0.0 110.55 -176.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.409 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 77.4 m80 -109.84 -20.54 12.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.528 -0.733 . . . . 0.0 111.19 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.448 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -67.29 -20.24 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.202 -0.936 . . . . 0.0 110.527 -175.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.524 HG22 HD11 ' A' ' 126' ' ' ILE . 71.3 p -79.43 -16.87 55.43 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.551 -0.718 . . . . 0.0 110.578 175.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -88.38 137.77 32.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.316 -0.865 . . . . 0.0 110.027 172.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.1 t -72.98 144.35 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.651 -0.656 . . . . 0.0 110.184 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.441 HG22 ' CE2' ' A' ' 192' ' ' TYR . 61.8 t -84.91 138.89 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.569 -0.707 . . . . 0.0 109.175 173.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -134.87 -170.37 2.55 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.401 -0.812 . . . . 0.0 111.326 -167.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -95.37 159.13 15.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.818 -0.551 . . . . 0.0 110.617 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 60.7 m -78.82 160.92 70.74 Favored Pre-proline 0 N--CA 1.497 1.9 0 O-C-N 121.605 -0.684 . . . . 0.0 109.324 174.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -64.09 -47.39 6.5 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 O-C-N 123.17 1.089 . . . . 0.0 109.929 177.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.441 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.3 p-10 -65.44 -43.86 89.11 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.577 -0.702 . . . . 0.0 111.106 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' HIS . . . . . 0.441 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 55.5 m170 -80.43 -27.71 37.91 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.54 -0.725 . . . . 0.0 111.363 -175.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -69.06 -42.08 76.73 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.447 -0.783 . . . . 0.0 110.177 174.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 22.7 tp -60.56 -39.98 89.95 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.627 -0.67 . . . . 0.0 110.289 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 28.6 t -48.45 138.44 10.25 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.512 -0.742 . . . . 0.0 111.225 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -121.7 130.23 53.3 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.661 -0.649 . . . . 0.0 110.298 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -100.68 24.33 9.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.624 -0.673 . . . . 0.0 110.343 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 52.48 75.05 0.24 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.445 -0.784 . . . . 0.0 110.747 -176.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -66.01 -10.3 38.5 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.685 -0.634 . . . . 0.0 111.365 -174.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -59.29 118.64 6.17 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.165 -0.959 . . . . 0.0 110.366 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 79.31 20.06 70.37 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -114.67 140.65 48.67 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.321 -1.105 . . . . 0.0 110.426 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.1 mt -84.92 -25.06 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.633 -0.667 . . . . 0.0 110.557 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.523 ' HB1' ' HB3' ' A' ' 227' ' ' ARG . . . -124.94 90.01 51.71 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.37 -0.831 . . . . 0.0 110.49 -174.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.437 ' HD2' ' CE2' ' A' ' 236' ' ' TYR . 17.7 Cg_endo -65.06 141.38 69.83 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.283 1.149 . . . . 0.0 110.642 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -61.14 -17.5 52.64 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 O-C-N 123.136 1.072 . . . . 0.0 111.392 -177.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 88.1 p -54.35 -22.25 11.67 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.152 -0.968 . . . . 0.0 111.251 -176.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' HIS . . . . . 0.422 ' CD2' ' HB3' ' A' ' 236' ' ' TYR . 76.3 m80 -103.58 131.73 50.45 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.441 -0.787 . . . . 0.0 110.252 178.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.775 HD21 ' CE ' ' A' ' 277' ' ' MET . 43.3 tp -60.43 -38.0 82.7 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.637 -0.665 . . . . 0.0 110.306 -178.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.61 HD12 ' HD3' ' A' ' 190' ' ' PRO . 83.7 mt -102.82 136.79 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.785 -0.572 . . . . 0.0 109.744 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.523 ' HB3' ' HB1' ' A' ' 220' ' ' ALA . 79.3 mtm180 -134.05 159.84 39.58 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.749 -0.594 . . . . 0.0 110.187 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.505 HG23 HG21 ' A' ' 247' ' ' VAL . 97.2 t -105.72 146.71 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.71 -0.618 . . . . 0.0 110.09 178.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -118.08 123.91 46.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.738 -0.601 . . . . 0.0 110.444 172.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 95.71 24.05 16.72 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 167.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 33.5 t-20 -135.34 107.61 7.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.323 -1.104 . . . . 0.0 110.057 174.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 32.5 t -62.94 -15.14 54.56 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.677 -0.639 . . . . 0.0 111.309 -177.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -99.98 7.06 45.05 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.196 -0.94 . . . . 0.0 111.591 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.35 128.33 35.84 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.036 -1.04 . . . . 0.0 110.236 177.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -139.73 156.71 46.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.794 -0.566 . . . . 0.0 109.656 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.437 ' CE2' ' HD2' ' A' ' 221' ' ' PRO . 82.1 m-85 -118.72 150.76 39.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.601 -0.687 . . . . 0.0 110.685 -176.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.13 159.92 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.717 -0.614 . . . . 0.0 110.334 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -120.82 130.09 53.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.761 -0.587 . . . . 0.0 110.133 176.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -62.48 122.96 76.87 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.678 -0.639 . . . . 0.0 109.71 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.89 -28.08 67.09 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 O-C-N 123.047 1.025 . . . . 0.0 110.812 -173.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.7 mt -103.9 -50.25 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.469 -0.769 . . . . 0.0 110.899 -170.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.604 HG22 ' HB3' ' A' ' 124' ' ' PRO . 5.6 p -105.34 12.23 31.89 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.364 -0.835 . . . . 0.0 112.014 -170.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 81.09 -21.32 5.89 Favored Glycine 0 N--CA 1.497 2.72 0 O-C-N 121.004 -1.06 . . . . 0.0 111.795 170.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 -45.95 142.05 2.83 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-N 118.673 1.236 . . . . 0.0 112.429 -169.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -108.66 145.45 34.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.575 -0.703 . . . . 0.0 110.151 174.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.9 p -154.85 159.88 40.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.655 -0.653 . . . . 0.0 110.598 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.505 HG21 HG23 ' A' ' 228' ' ' VAL . 8.6 p -122.95 148.28 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.791 -0.568 . . . . 0.0 109.657 177.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.743 HD22 ' HG2' ' A' ' 187' ' ' ARG . 81.2 mt -129.58 154.61 46.9 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.829 -175.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.434 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.8 m -150.85 151.69 30.53 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.851 -0.531 . . . . 0.0 110.02 175.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -71.19 138.74 33.95 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 O-C-N 123.385 1.203 . . . . 0.0 109.988 176.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.721 ' HD2' HD11 ' A' ' 186' ' ' ILE . 60.9 t80 -75.0 127.31 32.94 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.487 -0.758 . . . . 0.0 110.224 174.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -100.0 160.12 28.05 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.738 -0.601 . . . . 0.0 109.983 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.94 157.81 27.46 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.266 1.14 . . . . 0.0 110.432 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.02 149.96 76.16 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 O-C-N 123.218 1.115 . . . . 0.0 110.499 -177.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -61.62 148.63 41.8 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.718 -0.614 . . . . 0.0 110.108 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.84 127.23 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.502 -0.749 . . . . 0.0 110.208 -170.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.16 -10.16 56.65 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.404 HG21 ' CE2' ' A' ' 260' ' ' PHE . 10.0 t -144.86 174.23 11.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.185 -1.185 . . . . 0.0 110.527 175.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -109.34 13.18 24.36 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.489 -0.757 . . . . 0.0 111.923 -166.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.404 ' CE2' HG21 ' A' ' 258' ' ' THR . 46.2 p90 -120.0 168.06 11.54 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.113 -0.992 . . . . 0.0 111.219 -175.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 83.1 m -117.7 145.62 44.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.793 -0.567 . . . . 0.0 109.87 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 41.5 m -116.92 135.43 53.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.622 -0.674 . . . . 0.0 110.88 -175.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 60.3 t -131.54 137.31 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 173.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 171' ' ' PRO . 75.0 mt -104.6 121.07 42.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.533 -0.729 . . . . 0.0 109.953 -171.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.652 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 5.4 m-30 -105.39 153.02 22.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.661 -0.649 . . . . 0.0 110.789 -177.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -136.55 142.95 43.44 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 177.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -113.58 131.87 55.94 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.536 -0.728 . . . . 0.0 110.388 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' MET . . . . . 0.436 ' HG3' HD12 ' A' ' 225' ' ' LEU . 5.4 ppp? -101.01 9.06 42.65 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.624 -0.672 . . . . 0.0 112.011 -175.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 269' ' ' CYS . . . . . 0.636 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.7 OUTLIER -144.7 164.99 29.32 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.079 -1.013 . . . . 0.0 110.146 172.25 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.611 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.3 p30 -123.06 163.98 19.47 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.391 0.615 . . . . 0.0 110.547 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 271' ' ' SER . . . . . 0.428 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 23.9 m -57.82 -33.93 69.13 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.479 -0.763 . . . . 0.0 111.104 -164.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 50.0 p -102.18 13.05 35.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.395 -0.816 . . . . 0.0 112.029 -163.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 29.9 p -96.03 118.04 31.86 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.066 -1.021 . . . . 0.0 110.735 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.75 139.82 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.519 -0.738 . . . . 0.0 110.319 -171.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.04 -5.2 59.28 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.07 -96.75 0.78 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 170.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' MET . . . . . 0.775 ' CE ' HD21 ' A' ' 225' ' ' LEU . 15.7 mmt -64.33 -35.23 80.18 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.673 -0.898 . . . . 0.0 110.475 177.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.3 p30 42.63 50.66 4.96 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 33.3 mtp180 54.8 29.5 11.97 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.402 -0.811 . . . . 0.0 111.193 176.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -120.0 104.93 43.35 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.599 -0.688 . . . . 0.0 110.177 175.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -60.39 148.82 89.14 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 O-C-N 123.131 1.069 . . . . 0.0 110.518 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.554 HG22 ' HA ' ' A' ' 192' ' ' TYR . 45.8 pt -131.88 177.42 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.788 0.804 . . . . 0.0 111.087 -176.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 193' ' ' LYS . 21.7 mt -124.44 149.89 46.28 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.699 HD12 ' CE1' ' A' ' 301' ' ' PHE . 82.0 mt -117.98 129.71 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.353 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.579 HG23 ' SG ' ' A' ' 300' ' ' CYS . 81.0 mt -109.81 126.91 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -176.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 57.3 t -118.91 126.81 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.63 HG22 ' HG2' ' A' ' 298' ' ' ARG . 45.6 p -125.28 152.79 44.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.596 -0.69 . . . . 0.0 110.659 -174.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.609 HD21 ' HB3' ' A' ' 180' ' ' PRO . 24.0 tp -102.22 126.16 49.12 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.748 -0.595 . . . . 0.0 109.473 169.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -130.43 150.1 51.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.875 -0.516 . . . . 0.0 109.855 -173.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.825 ' CG2' HD11 ' A' ' 296' ' ' LEU . 22.1 p -89.85 160.89 16.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.619 -0.676 . . . . 0.0 109.897 176.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -55.84 -26.21 45.62 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.574 -0.704 . . . . 0.0 111.03 -176.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 45.3 p30 -90.59 9.7 28.51 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.491 -0.756 . . . . 0.0 111.937 -173.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.87 20.18 44.44 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 120.163 -1.018 . . . . 0.0 110.799 170.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -106.98 140.22 40.14 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.238 -1.154 . . . . 0.0 110.106 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 64.1 t -86.55 131.61 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.641 -0.662 . . . . 0.0 110.226 -173.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.825 HD11 ' CG2' ' A' ' 290' ' ' THR . 96.3 mt -99.97 -40.08 7.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.724 -0.61 . . . . 0.0 110.694 177.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -164.14 153.5 23.87 Favored Glycine 0 N--CA 1.497 2.736 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.298 -177.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.63 ' HG2' HG22 ' A' ' 287' ' ' THR . 95.1 mtt180 -135.2 136.44 41.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.749 -0.853 . . . . 0.0 110.719 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 299' ' ' ARG . . . . . 0.403 ' HG3' ' HA ' ' A' ' 139' ' ' ASP . 28.2 mmt180 -139.38 156.91 46.69 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.622 -0.674 . . . . 0.0 110.001 169.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 300' ' ' CYS . . . . . 0.579 ' SG ' HG23 ' A' ' 285' ' ' ILE . 80.6 m -141.8 157.23 45.26 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.459 -0.776 . . . . 0.0 110.622 -174.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.699 ' CE1' HD12 ' A' ' 284' ' ' ILE . 49.6 p90 -144.94 162.31 37.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.637 -0.664 . . . . 0.0 110.144 176.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.421 ' HA ' HD23 ' A' ' 283' ' ' LEU . 34.9 tt0 -104.88 134.97 47.11 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.596 -0.69 . . . . 0.0 110.184 -177.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -121.05 142.79 49.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.578 -0.702 . . . . 0.0 110.867 -169.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -137.06 138.95 40.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.792 -0.567 . . . . 0.0 109.622 172.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.636 HD13 ' O ' ' A' ' 269' ' ' CYS . 77.0 mt -108.28 122.81 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.549 -0.719 . . . . 0.0 109.763 177.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.1 p -145.29 168.88 19.38 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.64 -0.662 . . . . 0.0 110.615 -171.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -71.53 -40.07 70.32 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.695 -0.628 . . . . 0.0 110.664 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.8 t -127.25 85.34 61.2 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.532 -0.73 . . . . 0.0 110.568 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' PRO . . . . . 0.412 ' HD3' ' HG3' ' A' ' 165' ' ' GLN . 47.9 Cg_exo -55.39 -27.23 57.2 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 O-C-N 123.224 1.118 . . . . 0.0 110.728 174.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -68.39 -37.72 86.26 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -71.14 -38.36 72.26 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.605 -0.938 . . . . 0.0 109.74 -174.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -69.36 -35.39 75.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.68 -0.637 . . . . 0.0 110.11 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.462 ' HD3' HG22 ' A' ' 147' ' ' THR . 47.3 ttt180 -58.52 -46.25 87.14 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.55 -0.719 . . . . 0.0 110.43 174.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -64.53 -38.01 89.52 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.647 -0.658 . . . . 0.0 110.345 178.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -62.65 -51.79 65.89 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.484 -0.76 . . . . 0.0 110.578 -173.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' ASP . . . . . 0.543 ' OD1' HD11 ' A' ' 159' ' ' LEU . 3.8 p30 -61.44 -37.74 84.66 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.457 -0.777 . . . . 0.0 110.031 -176.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -64.67 -41.1 96.32 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.236 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -62.47 -35.08 78.2 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.693 -0.63 . . . . 0.0 110.058 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 24.3 m -62.76 -32.62 73.81 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.742 -0.599 . . . . 0.0 110.209 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 83.4 mt -78.46 -46.5 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.72 -0.612 . . . . 0.0 109.919 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -59.49 -42.41 92.08 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.621 -0.674 . . . . 0.0 110.459 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -66.3 -47.07 74.78 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.689 -0.632 . . . . 0.0 110.201 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -63.62 -36.65 84.53 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.727 -0.608 . . . . 0.0 110.295 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -104.95 124.99 50.46 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.64 -0.663 . . . . 0.0 110.492 -175.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 62.6 t -121.14 130.11 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.678 -0.639 . . . . 0.0 109.793 177.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 30.4 t -95.09 138.18 33.16 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.608 -0.682 . . . . 0.0 110.263 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -87.98 115.46 25.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.673 -0.642 . . . . 0.0 110.177 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 51.2 m -80.06 150.92 30.16 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.59 -0.694 . . . . 0.0 110.186 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 331' ' ' ASN . 9.7 t -143.29 152.31 41.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.663 -0.648 . . . . 0.0 110.386 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -60.83 -40.4 92.65 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.693 -0.629 . . . . 0.0 110.584 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' ASN . . . . . 0.562 ' O ' HG23 ' A' ' 329' ' ' THR . 88.3 m-20 -107.92 145.72 33.39 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.653 -0.654 . . . . 0.0 110.271 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -59.07 -36.8 90.12 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 333' ' ' ASP . . . . . 0.401 ' OD2' ' CZ ' ' A' ' 335' ' ' PHE . 18.4 t70 -87.07 114.51 23.75 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.61 -0.935 . . . . 0.0 110.123 177.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -109.4 146.6 34.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.536 -0.728 . . . . 0.0 110.364 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.401 ' CZ ' ' OD2' ' A' ' 333' ' ' ASP . 99.2 m-85 -115.49 146.64 41.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.726 -0.609 . . . . 0.0 110.146 177.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 51.78 -166.7 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.422 -0.799 . . . . 0.0 110.968 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -142.37 159.14 42.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.685 -0.635 . . . . 0.0 110.448 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -91.92 13.51 18.35 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.689 -0.632 . . . . 0.0 111.151 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 41.5 m -59.77 -37.03 77.9 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.319 -0.863 . . . . 0.0 110.342 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 83.5 t60 52.79 26.07 4.28 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.475 -0.766 . . . . 0.0 111.074 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 94.72 -44.2 2.25 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 178.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.437 HG22 ' O ' ' A' ' 344' ' ' MET . 82.2 mt -94.31 129.82 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.574 -0.956 . . . . 0.0 110.124 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -85.02 -30.06 24.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.682 -0.636 . . . . 0.0 110.196 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 344' ' ' MET . . . . . 0.437 ' O ' HG22 ' A' ' 342' ' ' ILE . 10.9 tpt -98.01 135.43 39.73 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.658 -0.651 . . . . 0.0 110.281 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.225 -179.973 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 76.7 p -156.17 164.51 38.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.595 -0.944 . . . . 0.0 110.247 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 29.5 t -119.74 141.5 49.37 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.648 -0.657 . . . . 0.0 110.225 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.8 p -124.25 163.32 21.86 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.655 -0.653 . . . . 0.0 110.139 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -131.97 156.55 45.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.662 -0.648 . . . . 0.0 110.294 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -85.81 143.83 28.07 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.655 -0.653 . . . . 0.0 110.362 -178.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 50.69 -158.73 0.09 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.473 -0.767 . . . . 0.0 111.167 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 26.3 tp 56.77 158.93 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.67 -0.644 . . . . 0.0 110.831 -175.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.3 m -82.9 171.86 10.76 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.534 -0.729 . . . . 0.0 110.27 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -66.68 152.22 82.49 Favored 'Cis proline' 0 N--CA 1.496 1.635 0 C-N-CA 123.128 -1.613 . . . . 0.0 110.501 -13.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.403 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . 49.3 m -81.59 146.82 57.81 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.651 -0.656 . . . . 0.0 110.127 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 123' ' ' SER . 24.3 Cg_exo -59.83 145.01 99.34 Favored 'Trans proline' 0 N--CA 1.487 1.128 0 O-C-N 123.194 1.102 . . . . 0.0 110.569 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.97 145.59 40.21 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.597 -0.689 . . . . 0.0 110.202 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 50.4 mm -120.0 139.99 29.12 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.632 -0.667 . . . . 0.0 109.909 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -61.72 149.83 88.31 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 O-C-N 123.134 1.071 . . . . 0.0 110.353 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.8 t -114.24 143.07 45.44 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.629 -0.669 . . . . 0.0 110.275 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -101.42 25.8 7.95 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.617 -0.677 . . . . 0.0 110.634 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 54.4 m -78.85 125.22 29.08 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.554 -0.716 . . . . 0.0 110.231 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -70.33 144.86 51.55 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.632 -0.667 . . . . 0.0 110.396 -178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -158.37 101.21 1.71 Allowed Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.684 -0.635 . . . . 0.0 110.182 178.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -58.76 -39.96 77.12 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 O-C-N 123.086 1.045 . . . . 0.0 110.844 -175.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.82 -155.08 40.49 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -73.11 -49.05 0.24 Allowed 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.308 1.162 . . . . 0.0 110.911 -174.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -85.43 6.99 24.32 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.617 -0.677 . . . . 0.0 111.425 -175.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.97 61.92 2.84 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.949 -1.095 . . . . 0.0 110.608 -176.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.728 ' HA ' HG12 ' A' ' 176' ' ' VAL . 60.2 t80 -77.97 120.48 22.88 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.525 -0.735 . . . . 0.0 109.983 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -129.79 159.92 35.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.835 -0.541 . . . . 0.0 110.124 -176.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.2 t -124.96 145.8 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.792 -0.568 . . . . 0.0 109.889 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.9 p -155.01 162.25 41.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.81 -0.556 . . . . 0.0 109.92 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.472 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 75.3 m-85 -126.66 125.23 41.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.808 -0.558 . . . . 0.0 109.799 -175.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -58.06 144.6 39.37 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.655 -0.653 . . . . 0.0 110.394 -174.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -93.61 138.96 31.32 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.617 -0.677 . . . . 0.0 110.35 -175.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 28.5 t -131.06 148.34 52.73 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.754 -0.591 . . . . 0.0 110.09 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 41.7 m -60.58 158.43 12.42 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.609 -0.682 . . . . 0.0 110.133 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 147' ' ' THR . 7.7 t -70.91 67.51 0.4 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.734 -0.604 . . . . 0.0 110.283 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -78.13 149.61 33.8 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.605 -0.684 . . . . 0.0 110.161 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -58.59 145.14 40.56 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.62 -0.675 . . . . 0.0 110.473 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.8 p 50.8 49.1 21.69 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.581 -0.699 . . . . 0.0 111.315 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.74 130.74 43.7 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.676 -0.64 . . . . 0.0 110.026 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 82.3 p -60.02 -34.05 72.84 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.751 -0.593 . . . . 0.0 109.944 176.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.435 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -172.04 144.02 1.63 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.763 -0.585 . . . . 0.0 110.164 178.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 13.3 t -142.17 142.57 32.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.84 -0.538 . . . . 0.0 109.947 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.472 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 63.7 t80 -125.56 140.06 53.06 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.548 -0.72 . . . . 0.0 110.553 -172.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.9 t -110.23 124.26 51.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.837 -0.539 . . . . 0.0 109.827 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 58.5 m -70.66 -37.03 73.67 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.772 -0.58 . . . . 0.0 110.481 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -59.66 -34.7 73.16 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.553 -0.717 . . . . 0.0 110.43 -177.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.705 HD21 HD11 ' A' ' 320' ' ' ILE . 57.5 mt -104.86 -11.75 16.6 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.662 -0.649 . . . . 0.0 110.864 -175.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 26.2 tttp 59.83 52.03 5.69 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.02 -1.05 . . . . 0.0 109.715 178.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -144.96 152.77 40.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.74 -0.6 . . . . 0.0 110.587 -175.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.627 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.5 tp -126.61 137.81 53.36 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.758 -0.589 . . . . 0.0 110.338 -176.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -115.18 135.45 54.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.616 -0.677 . . . . 0.0 109.243 173.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.8 p -138.28 158.38 44.41 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.922 -175.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.416 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 52.9 mt-30 -104.53 143.02 33.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.593 -0.692 . . . . 0.0 110.131 173.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.432 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 16.8 tt -52.54 146.28 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.499 -0.751 . . . . 0.0 111.895 -173.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.81 10.04 5.78 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.579 -0.7 . . . . 0.0 112.471 176.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.416 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 53.4 mmtt -95.64 155.08 16.89 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.961 -1.087 . . . . 0.0 110.897 174.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 90.5 m -82.94 126.17 32.21 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.628 -0.67 . . . . 0.0 110.689 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' CYS . . . . . 0.627 ' SG ' HD21 ' A' ' 162' ' ' LEU . 43.6 t -114.23 90.09 19.29 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.657 -0.652 . . . . 0.0 110.108 172.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.435 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 17.4 Cg_exo -63.79 129.41 24.7 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 123.248 1.13 . . . . 0.0 110.581 173.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.404 HG12 ' CE2' ' A' ' 142' ' ' PHE . 97.5 mt -123.12 141.35 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 175.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLN . . . . . 0.534 ' NE2' ' CE1' ' A' ' 260' ' ' PHE . 75.2 mt-30 -108.13 136.39 47.89 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.476 -0.765 . . . . 0.0 110.737 -175.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.443 HG21 ' CE1' ' A' ' 138' ' ' PHE . 48.6 mm -95.37 135.02 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.719 -0.613 . . . . 0.0 109.633 170.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -117.18 129.31 55.86 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.662 -0.649 . . . . 0.0 110.426 176.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.728 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.0 m -136.63 159.77 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.478 -0.764 . . . . 0.0 110.047 175.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 80.8 mmm -77.59 -40.24 42.85 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.745 -0.597 . . . . 0.0 110.007 177.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.9 p -135.51 143.28 44.45 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.832 -0.542 . . . . 0.0 109.675 177.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.6 Cg_exo -55.57 139.89 83.04 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 O-C-N 123.14 1.074 . . . . 0.0 110.887 -172.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.77 ' HB3' HD21 ' A' ' 288' ' ' LEU . 31.3 Cg_endo -67.35 170.04 14.26 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 O-C-N 123.25 1.132 . . . . 0.0 110.633 177.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -60.45 154.98 49.75 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.431 1.227 . . . . 0.0 110.546 -178.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -77.43 140.08 39.8 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.581 -0.699 . . . . 0.0 109.95 175.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.73 -25.06 28.96 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -174.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.22 153.08 1.56 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.363 -1.08 . . . . 0.0 111.41 178.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 33.9 m -129.66 155.93 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.661 -0.649 . . . . 0.0 109.686 176.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.705 HD11 ' HD2' ' A' ' 251' ' ' TYR . 82.6 mt -107.85 137.21 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.688 -0.633 . . . . 0.0 109.462 175.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.748 ' HG2' HD22 ' A' ' 248' ' ' LEU . 32.1 mtm180 -115.06 143.37 45.29 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 -176.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.664 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -136.62 126.48 25.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.568 -0.707 . . . . 0.0 110.235 175.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 23.8 ttp -137.24 137.14 21.8 Favored Pre-proline 0 N--CA 1.497 1.884 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.934 -176.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.643 ' HD3' HD12 ' A' ' 226' ' ' ILE . 72.7 Cg_endo -90.74 138.21 2.47 Favored 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 123.169 1.089 . . . . 0.0 110.706 177.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.427 HG13 ' C ' ' A' ' 190' ' ' PRO . 34.9 m -147.48 154.84 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.467 -0.771 . . . . 0.0 110.191 174.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.658 ' HA ' HG22 ' A' ' 282' ' ' ILE . 79.4 m-85 -63.8 162.81 12.82 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.546 -0.721 . . . . 0.0 110.487 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -79.35 -60.04 2.52 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.669 -0.644 . . . . 0.0 110.905 -173.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -80.11 150.66 30.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.574 -0.704 . . . . 0.0 110.281 -174.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.457 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.58 -38.12 71.53 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.424 -0.797 . . . . 0.0 110.686 -175.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -56.77 -24.91 53.54 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.494 -0.754 . . . . 0.0 110.565 -176.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.4 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 81.0 m-70 -109.68 -20.55 12.79 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.954 -0.699 . . . . 0.0 111.102 -178.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -67.71 -20.25 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.223 -0.923 . . . . 0.0 110.447 -176.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 67.2 p -79.37 -17.12 55.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.496 -0.752 . . . . 0.0 110.7 175.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -88.25 134.17 33.86 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.336 -0.853 . . . . 0.0 109.945 172.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.0 t -72.84 141.84 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.63 -0.669 . . . . 0.0 110.211 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.626 HG22 ' CZ ' ' A' ' 192' ' ' TYR . 58.4 t -84.86 140.05 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.571 -0.706 . . . . 0.0 109.153 171.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -134.71 -170.57 2.58 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.471 -0.768 . . . . 0.0 111.054 -170.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 13.6 mmp_? -95.62 157.35 15.94 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.732 -0.605 . . . . 0.0 110.106 178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 49.8 m -75.15 154.72 86.41 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.539 -0.726 . . . . 0.0 109.263 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.403 ' HD3' ' HA3' ' A' ' 275' ' ' GLY . 17.6 Cg_exo -62.74 -47.44 8.96 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 O-C-N 123.181 1.095 . . . . 0.0 110.067 177.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.442 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.7 p-10 -65.46 -44.45 87.17 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.573 -0.705 . . . . 0.0 111.232 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' HIS . . . . . 0.442 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 53.9 m170 -81.04 -27.83 35.6 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.413 -0.805 . . . . 0.0 111.346 -174.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -69.13 -42.07 76.51 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.429 -0.794 . . . . 0.0 110.027 171.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 27.3 tp -70.05 -32.79 71.08 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.666 -0.646 . . . . 0.0 110.373 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.4 t -48.46 -33.03 8.66 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.671 -0.643 . . . . 0.0 111.75 -176.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -116.35 125.46 52.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.575 -0.703 . . . . 0.0 110.209 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -127.38 164.07 22.63 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.727 -0.608 . . . . 0.0 110.394 -177.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 53.17 75.13 0.26 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.42 -0.8 . . . . 0.0 110.854 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -83.32 8.1 14.56 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.597 -0.689 . . . . 0.0 111.358 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -60.21 122.86 15.5 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.037 -1.039 . . . . 0.0 110.11 173.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 95.01 2.28 62.57 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -177.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -114.56 146.41 40.8 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.05 -1.265 . . . . 0.0 110.404 175.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.4 mt -84.87 -24.33 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.706 -0.621 . . . . 0.0 110.764 -174.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.627 ' HB1' ' HD2' ' A' ' 227' ' ' ARG . . . -124.8 94.47 44.2 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.335 -0.853 . . . . 0.0 110.622 -173.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.445 ' HD2' ' CE2' ' A' ' 236' ' ' TYR . 17.3 Cg_exo -63.52 139.17 68.92 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 O-C-N 123.335 1.176 . . . . 0.0 110.514 -178.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -60.79 -18.38 55.87 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 O-C-N 123.035 1.018 . . . . 0.0 111.23 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 86.5 p -56.19 -21.22 21.7 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.282 -0.886 . . . . 0.0 111.216 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' HIS . . . . . 0.432 ' CE1' ' HB3' ' A' ' 236' ' ' TYR . 98.5 m-70 -107.08 130.21 54.71 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.479 -0.763 . . . . 0.0 110.496 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 48.8 tp -61.6 -38.04 86.12 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.731 -0.606 . . . . 0.0 110.253 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.643 HD12 ' HD3' ' A' ' 190' ' ' PRO . 86.2 mt -101.39 136.75 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.803 -0.561 . . . . 0.0 109.889 -175.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.627 ' HD2' ' HB1' ' A' ' 220' ' ' ALA . 79.1 mtm180 -135.18 159.72 40.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.71 -0.619 . . . . 0.0 110.317 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.493 HG23 HG21 ' A' ' 247' ' ' VAL . 94.6 t -105.18 146.82 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.704 -0.622 . . . . 0.0 110.138 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -120.99 124.51 45.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.777 -0.577 . . . . 0.0 110.27 172.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.78 24.16 11.09 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 169.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 -140.6 106.42 5.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.397 -1.06 . . . . 0.0 109.976 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 43.2 m -63.19 -15.28 56.46 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.519 -0.738 . . . . 0.0 111.341 -175.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -99.98 7.53 44.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 111.675 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.74 130.64 46.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.192 -0.942 . . . . 0.0 110.172 177.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -139.79 158.0 44.81 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.784 -0.572 . . . . 0.0 109.715 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.445 ' CE2' ' HD2' ' A' ' 221' ' ' PRO . 80.4 m-85 -116.03 150.66 36.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.569 -0.707 . . . . 0.0 110.435 -177.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.16 159.88 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.79 -0.569 . . . . 0.0 110.26 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -123.43 128.25 49.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.73 -0.607 . . . . 0.0 110.08 174.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -65.12 130.05 94.68 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.669 -0.644 . . . . 0.0 109.85 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -67.07 -27.4 42.22 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 O-C-N 123.128 1.067 . . . . 0.0 111.008 -173.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 84.2 mt -100.57 -50.35 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.369 -0.832 . . . . 0.0 110.923 -168.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.3 p -105.28 12.13 32.12 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.338 -0.852 . . . . 0.0 111.831 -174.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.92 -5.43 12.82 Favored Glycine 0 N--CA 1.497 2.709 0 O-C-N 121.137 -0.977 . . . . 0.0 111.909 173.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 68.3 mmt-85 -46.04 142.0 2.94 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-N 119.192 1.496 . . . . 0.0 112.296 -175.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -109.24 140.8 42.4 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.682 -0.636 . . . . 0.0 110.037 172.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 78.5 p -154.75 159.99 41.02 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.591 -0.693 . . . . 0.0 110.689 178.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.493 HG21 HG23 ' A' ' 228' ' ' VAL . 8.2 p -124.17 148.32 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.798 -0.564 . . . . 0.0 109.657 176.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.748 HD22 ' HG2' ' A' ' 187' ' ' ARG . 84.4 mt -129.57 154.58 46.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.638 -0.664 . . . . 0.0 109.963 -175.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.446 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.9 m -151.28 151.71 29.72 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.794 -0.566 . . . . 0.0 109.947 176.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -71.08 138.95 34.7 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 O-C-N 123.275 1.145 . . . . 0.0 110.15 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.705 ' HD2' HD11 ' A' ' 186' ' ' ILE . 58.3 t80 -74.88 126.06 30.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.525 -0.734 . . . . 0.0 110.233 175.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -99.99 160.07 28.17 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.683 -0.635 . . . . 0.0 109.993 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.83 159.02 22.34 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 O-C-N 123.211 1.111 . . . . 0.0 110.529 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.38 149.98 77.93 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 O-C-N 123.251 1.132 . . . . 0.0 110.471 -178.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -61.31 146.94 46.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.737 -0.602 . . . . 0.0 110.233 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.94 127.25 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.517 -0.74 . . . . 0.0 110.164 -171.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.03 -10.15 55.25 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 10.0 t -144.0 173.44 11.71 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.168 -1.195 . . . . 0.0 110.625 175.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -106.83 13.15 28.19 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.612 -0.68 . . . . 0.0 111.756 -168.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.534 ' CE1' ' NE2' ' A' ' 173' ' ' GLN . 14.8 p90 -119.93 167.96 11.61 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.227 -0.921 . . . . 0.0 111.192 -175.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 94.1 m -117.75 146.31 43.87 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.762 -0.586 . . . . 0.0 109.868 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 39.7 m -116.74 135.77 53.5 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.577 -0.702 . . . . 0.0 110.941 -175.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.0 t -130.78 137.19 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 172.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 69.8 mt -104.53 121.6 43.82 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.49 -0.756 . . . . 0.0 109.94 -172.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.664 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 4.7 m-30 -106.56 154.84 20.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.65 -0.656 . . . . 0.0 110.824 -177.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -136.19 142.94 44.17 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -112.86 127.2 56.12 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.737 -0.602 . . . . 0.0 110.057 176.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 4.5 ppp? -95.74 7.3 46.7 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.705 -0.622 . . . . 0.0 111.898 -176.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' CYS . . . . . 0.672 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.8 OUTLIER -144.87 164.98 29.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.12 -0.987 . . . . 0.0 109.883 174.888 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.575 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.3 p30 -120.37 160.82 22.29 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.722 -0.611 . . . . 0.0 110.236 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' SER . . . . . 0.419 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 24.0 m -58.99 -31.72 69.03 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.458 -0.776 . . . . 0.0 110.908 -163.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 72.9 m -94.99 8.93 41.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.602 -0.686 . . . . 0.0 112.098 -164.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 31.9 p -95.42 118.18 31.69 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.03 -1.044 . . . . 0.0 110.869 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.11 141.05 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.467 -0.771 . . . . 0.0 110.324 -172.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' GLY . . . . . 0.403 ' HA3' ' HD3' ' A' ' 206' ' ' PRO . . . 100.78 -5.22 56.56 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.0 -105.39 1.13 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 169.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' MET . . . . . 0.465 ' O ' ' ND2' ' A' ' 278' ' ' ASN . 97.0 mmm -61.35 -36.93 81.57 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.691 -0.888 . . . . 0.0 110.15 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' ASN . . . . . 0.465 ' ND2' ' O ' ' A' ' 277' ' ' MET . 5.7 p30 40.45 55.04 2.9 Favored 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 121.42 0.629 . . . . 0.0 112.664 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 55.62 34.09 22.53 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.456 -0.777 . . . . 0.0 111.523 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' ARG . . . . . 0.444 ' NH2' ' CZ ' ' A' ' 192' ' ' TYR . 35.6 mtm180 -120.12 106.09 41.44 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.295 -0.878 . . . . 0.0 110.161 165.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -60.7 147.98 93.13 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 O-C-N 123.073 1.039 . . . . 0.0 110.416 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.658 HG22 ' HA ' ' A' ' 192' ' ' TYR . 43.9 pt -131.94 179.52 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-O 121.798 0.808 . . . . 0.0 111.001 -176.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.479 HD23 ' HA ' ' A' ' 302' ' ' GLU . 33.0 mt -124.4 149.93 46.16 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.686 HD12 ' CE1' ' A' ' 301' ' ' PHE . 82.6 mt -115.17 129.9 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.609 HG23 ' SG ' ' A' ' 300' ' ' CYS . 77.7 mt -109.76 126.9 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -176.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 57.6 t -118.93 126.66 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.461 HG22 ' HG2' ' A' ' 298' ' ' ARG . 45.0 p -125.21 152.95 43.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.618 -0.676 . . . . 0.0 110.692 -174.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.77 HD21 ' HB3' ' A' ' 180' ' ' PRO . 26.3 tp -101.52 126.94 48.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.66 -0.65 . . . . 0.0 109.483 168.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.623 ' OE2' HG13 ' A' ' 295' ' ' VAL . 72.1 mm-40 -131.61 150.88 52.0 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -173.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.731 HG22 HD11 ' A' ' 296' ' ' LEU . 80.0 p -89.92 159.4 16.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.623 -0.673 . . . . 0.0 109.726 177.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 68.4 ttp85 -55.96 -26.02 46.31 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.619 -0.676 . . . . 0.0 110.796 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -87.62 9.72 20.36 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.5 -0.75 . . . . 0.0 111.841 -174.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 87.31 20.13 53.15 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 120.159 -1.02 . . . . 0.0 110.779 170.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -107.22 140.19 40.48 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.364 -1.08 . . . . 0.0 110.238 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.623 HG13 ' OE2' ' A' ' 289' ' ' GLU . 60.7 t -88.1 132.33 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.619 -0.676 . . . . 0.0 110.194 -174.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.731 HD11 HG22 ' A' ' 290' ' ' THR . 95.8 mt -99.94 -40.18 7.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.635 -0.666 . . . . 0.0 110.5 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -165.25 153.45 23.58 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.461 ' HG2' HG22 ' A' ' 287' ' ' THR . 78.5 mtm180 -134.72 136.24 42.55 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.672 -0.899 . . . . 0.0 110.908 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -134.0 158.5 43.37 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.572 -0.705 . . . . 0.0 109.77 170.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' CYS . . . . . 0.609 ' SG ' HG23 ' A' ' 285' ' ' ILE . 93.6 m -142.91 154.2 43.86 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.444 -0.785 . . . . 0.0 110.772 -175.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.686 ' CE1' HD12 ' A' ' 284' ' ' ILE . 46.0 p90 -145.0 162.1 37.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.702 -0.624 . . . . 0.0 110.017 175.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.479 ' HA ' HD23 ' A' ' 283' ' ' LEU . 57.1 tt0 -104.93 136.15 44.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.537 -0.727 . . . . 0.0 110.116 -178.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -122.55 144.05 49.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.647 -0.658 . . . . 0.0 110.769 -169.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -138.52 137.14 36.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.832 -0.543 . . . . 0.0 109.757 173.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.672 HD13 ' O ' ' A' ' 269' ' ' CYS . 67.5 mt -105.88 122.84 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.582 -0.699 . . . . 0.0 109.423 175.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.1 p -145.14 169.45 18.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.559 -0.713 . . . . 0.0 111.038 -169.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -69.63 -40.02 76.82 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.673 -0.642 . . . . 0.0 110.626 -178.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 4.2 t -131.39 88.34 44.22 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.578 -0.702 . . . . 0.0 110.5 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -55.25 -29.45 67.07 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 O-C-N 123.207 1.109 . . . . 0.0 111.023 174.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.43 -37.91 93.1 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.4 ttm-85 -73.47 -40.28 64.26 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.684 -0.892 . . . . 0.0 109.795 -173.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -69.43 -40.45 77.24 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.077 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -61.27 -44.54 97.07 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.271 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 28.9 tttp -64.01 -40.45 96.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.552 -0.717 . . . . 0.0 110.498 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.55 -50.6 71.99 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.487 -0.758 . . . . 0.0 110.476 -173.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -61.57 -37.83 85.27 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.449 -0.782 . . . . 0.0 110.127 -177.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -63.72 -40.56 97.07 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.646 -0.659 . . . . 0.0 110.178 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -62.61 -35.25 78.97 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.678 -0.639 . . . . 0.0 109.967 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 22.8 t -63.1 -32.51 73.9 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.647 -0.658 . . . . 0.0 110.206 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.705 HD11 HD21 ' A' ' 159' ' ' LEU . 83.8 mt -79.51 -44.07 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.647 -0.658 . . . . 0.0 109.894 -177.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.406 ' HA ' ' HG2' ' A' ' 324' ' ' GLN . 69.7 ttt180 -58.4 -41.3 84.61 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.657 -0.652 . . . . 0.0 110.537 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -63.05 -41.91 99.58 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.631 -0.668 . . . . 0.0 110.257 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -63.77 -32.6 74.15 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.645 -0.659 . . . . 0.0 110.273 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' GLN . . . . . 0.406 ' HG2' ' HA ' ' A' ' 321' ' ' ARG . 14.7 pt20 -105.15 125.14 50.65 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.665 -0.647 . . . . 0.0 110.637 -175.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 61.6 t -109.02 130.09 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.6 -0.688 . . . . 0.0 109.766 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 53.1 p -80.91 140.01 35.56 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.67 -0.644 . . . . 0.0 110.417 -177.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -117.6 141.8 47.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.632 -0.667 . . . . 0.0 110.216 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 54.3 p -65.1 160.45 21.07 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.669 -0.644 . . . . 0.0 110.214 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 77.1 p -138.72 28.2 2.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.696 -0.627 . . . . 0.0 110.297 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -83.08 146.56 28.63 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.672 -0.642 . . . . 0.0 110.173 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -87.47 10.67 16.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.664 -0.647 . . . . 0.0 111.278 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -84.23 -178.71 51.58 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -84.47 119.21 24.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.698 -0.884 . . . . 0.0 110.217 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -92.69 138.6 31.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.634 -0.666 . . . . 0.0 110.207 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -60.54 -38.69 85.29 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.676 -0.64 . . . . 0.0 110.303 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 51.37 90.54 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.362 -0.836 . . . . 0.0 111.128 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -60.66 -34.85 74.92 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.617 -0.677 . . . . 0.0 110.239 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -105.45 142.71 34.74 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.672 -0.643 . . . . 0.0 110.22 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 75.4 p -101.2 24.02 10.06 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.599 -0.688 . . . . 0.0 110.672 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -119.79 131.72 55.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.486 -0.759 . . . . 0.0 110.254 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -85.33 -176.69 50.6 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 26.9 pt -96.7 151.78 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.657 -0.908 . . . . 0.0 110.364 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -91.35 143.81 26.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.627 -0.671 . . . . 0.0 110.267 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 88.3 mtp -60.1 -35.21 74.71 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.592 -0.693 . . . . 0.0 110.344 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 10.3 m . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.288 -179.889 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 29.1 t -156.43 150.02 24.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.643 -0.916 . . . . 0.0 110.215 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 45.1 m -62.11 157.12 19.8 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.673 -0.642 . . . . 0.0 110.106 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.551 HG23 ' H ' ' A' ' 119' ' ' ALA . 6.2 t -64.93 146.79 54.48 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.687 -0.633 . . . . 0.0 110.343 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -63.5 -43.06 98.35 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.716 -0.615 . . . . 0.0 110.553 -177.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -78.93 -36.05 42.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.631 -0.668 . . . . 0.0 110.284 -174.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.551 ' H ' HG23 ' A' ' 116' ' ' THR . . . 57.01 -84.59 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.664 -0.648 . . . . 0.0 110.761 -176.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.721 HD13 ' N ' ' A' ' 121' ' ' SER . 0.5 OUTLIER -85.36 134.23 34.1 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.255 -0.903 . . . . 0.0 110.051 -178.405 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.721 ' N ' HD13 ' A' ' 120' ' ' LEU . 3.9 m -76.15 110.56 11.49 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.678 -0.639 . . . . 0.0 110.17 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 121' ' ' SER . 14.3 Cg_endo -61.02 151.99 74.42 Favored 'Trans proline' 0 N--CA 1.488 1.149 0 O-C-N 123.072 1.038 . . . . 0.0 110.432 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.0 m -81.71 150.95 67.24 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.62 -0.675 . . . . 0.0 110.163 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.494 ' HB3' HG22 ' A' ' 242' ' ' THR . 15.2 Cg_endo -61.65 147.79 94.53 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.334 1.176 . . . . 0.0 110.385 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.6 142.54 42.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.672 -0.642 . . . . 0.0 110.152 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.54 HD11 HG22 ' A' ' 199' ' ' THR . 50.8 mm -122.76 100.03 41.16 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.667 -0.645 . . . . 0.0 109.953 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -60.79 151.0 80.06 Favored 'Trans proline' 0 C--N 1.317 -1.122 0 O-C-N 123.213 1.112 . . . . 0.0 110.53 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.0 t -114.57 148.03 38.6 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.631 -0.668 . . . . 0.0 110.261 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.5 p-10 -95.15 24.63 4.8 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.655 -0.653 . . . . 0.0 110.794 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 50.4 m -73.33 125.17 27.22 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.573 -0.705 . . . . 0.0 110.263 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -72.67 145.05 47.5 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.614 -0.679 . . . . 0.0 110.346 -178.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -154.8 101.41 2.34 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.747 -0.596 . . . . 0.0 110.24 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -58.92 -39.97 76.14 Favored 'Trans proline' 0 N--CA 1.488 1.18 0 O-C-N 123.151 1.079 . . . . 0.0 110.803 -177.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.31 -155.12 48.52 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -72.78 -46.88 0.38 Allowed 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 123.399 1.21 . . . . 0.0 111.066 -173.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -87.59 9.83 19.93 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.523 -0.736 . . . . 0.0 111.396 -173.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.81 59.69 4.13 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.983 -1.073 . . . . 0.0 110.58 -175.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.679 ' HA ' HG12 ' A' ' 176' ' ' VAL . 67.8 t80 -77.83 118.36 20.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.714 -0.616 . . . . 0.0 109.861 -179.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.407 ' HA ' ' HG3' ' A' ' 299' ' ' ARG . 18.4 t70 -130.02 159.89 35.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.781 -0.575 . . . . 0.0 110.193 -177.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 70.9 t -124.22 147.34 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.704 -0.622 . . . . 0.0 109.857 174.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 76.5 p -154.91 162.76 40.99 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 120.378 -0.529 . . . . 0.0 109.956 177.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.49 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 74.9 m-85 -126.66 125.27 41.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.81 -0.556 . . . . 0.0 109.897 -175.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -56.83 140.81 46.86 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.618 -0.676 . . . . 0.0 110.554 -174.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -101.83 130.0 48.18 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.727 -0.608 . . . . 0.0 110.45 -175.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 51.1 m -122.03 150.68 41.76 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.677 -0.64 . . . . 0.0 110.153 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.9 m -60.55 160.76 8.52 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.604 -0.685 . . . . 0.0 110.164 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.667 HG22 ' HD3' ' A' ' 313' ' ' ARG . 68.8 p -62.35 86.49 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.716 -0.615 . . . . 0.0 110.231 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.02 158.38 17.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.687 -0.633 . . . . 0.0 110.266 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -78.51 142.37 37.47 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.647 -0.658 . . . . 0.0 110.042 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.76 55.29 9.22 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.332 -0.855 . . . . 0.0 110.942 -178.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.7 129.88 35.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.6 -0.688 . . . . 0.0 110.137 177.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.468 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 73.1 p -60.13 -33.76 72.59 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.678 -0.639 . . . . 0.0 109.974 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.468 ' HD1' ' HG1' ' A' ' 152' ' ' THR . 68.6 p-90 -171.03 144.68 2.16 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.356 0.598 . . . . 0.0 110.289 178.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 9.5 t -142.2 142.65 32.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.846 -0.534 . . . . 0.0 110.064 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.49 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 62.7 t80 -125.42 140.02 53.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.522 -0.736 . . . . 0.0 110.483 -172.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.4 t -110.09 124.94 52.41 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 120.386 -0.526 . . . . 0.0 109.872 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 49.5 m -70.73 -37.05 73.46 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.391 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -60.28 -32.27 71.03 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.635 -0.666 . . . . 0.0 110.323 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.442 HD11 ' HB2' ' A' ' 316' ' ' ASP . 59.2 mt -104.76 -12.12 16.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.73 -0.606 . . . . 0.0 110.835 -174.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 71.4 tttt 59.78 47.47 10.27 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.019 -1.051 . . . . 0.0 109.58 177.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.7 tttp -146.68 153.15 39.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.706 -0.621 . . . . 0.0 110.666 -172.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.641 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.41 137.79 53.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.776 -0.577 . . . . 0.0 110.307 -176.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -114.92 131.62 56.82 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 175.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.3 158.48 44.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.69 -0.631 . . . . 0.0 110.941 -173.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.406 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 39.3 mt-30 -104.69 141.47 36.4 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.47 0.652 . . . . 0.0 110.351 172.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.435 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 16.7 tt -52.19 148.06 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 121.622 0.725 . . . . 0.0 111.857 -174.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.29 10.01 5.29 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.558 -0.714 . . . . 0.0 112.516 177.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.406 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 54.9 mmtt -96.65 155.08 16.92 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.892 -1.13 . . . . 0.0 110.889 174.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 86.8 m -83.5 126.2 32.54 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.73 -0.606 . . . . 0.0 110.602 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' CYS . . . . . 0.641 ' SG ' HD21 ' A' ' 162' ' ' LEU . 44.4 t -114.85 90.1 21.44 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.55 -0.719 . . . . 0.0 110.222 173.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.439 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 19.3 Cg_exo -63.27 130.09 27.54 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 O-C-N 123.228 1.12 . . . . 0.0 110.753 173.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.405 HG12 ' CE2' ' A' ' 142' ' ' PHE . 97.0 mt -123.52 143.35 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.664 -0.647 . . . . 0.0 109.317 173.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -109.35 135.48 50.35 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.491 -0.756 . . . . 0.0 110.824 -175.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 48.9 mm -95.29 135.03 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.685 -0.634 . . . . 0.0 109.65 169.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 44.5 tttm -116.43 129.53 56.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.62 -0.675 . . . . 0.0 110.482 176.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.679 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.5 m -136.69 159.76 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.552 -0.718 . . . . 0.0 109.873 174.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.4 mmm -78.44 -41.63 32.33 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.692 -0.63 . . . . 0.0 110.15 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.417 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 76.9 p -133.81 143.2 46.58 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.773 -0.579 . . . . 0.0 109.634 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 34.6 Cg_exo -55.21 139.79 80.94 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 O-C-N 123.191 1.101 . . . . 0.0 110.925 -171.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.729 ' HB3' HD21 ' A' ' 288' ' ' LEU . 30.7 Cg_endo -66.81 170.1 13.39 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.17 1.09 . . . . 0.0 110.588 177.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -60.65 155.06 50.45 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.363 1.191 . . . . 0.0 110.537 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -78.08 140.59 39.09 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.619 -0.676 . . . . 0.0 109.91 175.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.83 -24.92 29.6 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -174.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.2 152.06 1.86 Allowed 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.348 -1.09 . . . . 0.0 111.436 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.79 156.3 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.814 -0.554 . . . . 0.0 109.805 176.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.671 HD11 ' HD2' ' A' ' 251' ' ' TYR . 52.4 mt -109.75 135.56 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.745 ' HG2' HD22 ' A' ' 248' ' ' LEU . 71.1 mtt180 -114.97 145.48 42.2 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -174.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.68 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -139.74 126.58 20.75 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.509 -0.744 . . . . 0.0 110.332 173.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 37.5 ttp -137.39 138.55 25.17 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.78 -0.575 . . . . 0.0 111.093 -176.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.508 ' HD3' HD12 ' A' ' 226' ' ' ILE . 73.9 Cg_endo -90.75 138.15 2.45 Favored 'Trans proline' 0 C--N 1.32 -0.941 0 O-C-N 123.207 1.109 . . . . 0.0 110.808 176.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.456 HG12 ' CZ ' ' A' ' 244' ' ' ARG . 34.8 m -147.31 154.78 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.487 -0.758 . . . . 0.0 110.109 173.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.645 ' HA ' HG22 ' A' ' 282' ' ' ILE . 90.4 m-85 -62.18 166.43 4.85 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.41 -0.806 . . . . 0.0 110.477 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -83.09 -60.04 2.28 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.671 -0.643 . . . . 0.0 110.824 -175.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 39.6 mttp -80.06 151.14 30.06 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.609 -0.682 . . . . 0.0 110.328 -175.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.456 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.55 -38.07 71.41 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.404 -0.81 . . . . 0.0 110.802 -175.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -56.75 -24.92 53.37 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.556 -0.715 . . . . 0.0 110.599 -176.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -109.7 -20.53 12.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.519 -0.738 . . . . 0.0 111.144 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.456 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.1 p -67.73 -20.23 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.181 -0.95 . . . . 0.0 110.518 -176.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.54 HG22 HD11 ' A' ' 126' ' ' ILE . 78.5 p -79.43 -17.01 55.19 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.779 175.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -88.28 137.86 31.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.367 -0.833 . . . . 0.0 110.089 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.7 t -73.13 140.89 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.614 -0.679 . . . . 0.0 110.295 177.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.551 HG22 ' CE1' ' A' ' 192' ' ' TYR . 62.0 t -85.0 138.57 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.552 -0.718 . . . . 0.0 109.345 170.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 14.2 pttt -134.92 -170.26 2.53 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.575 -0.703 . . . . 0.0 111.01 -171.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 84.7 mtm-85 -95.27 157.49 15.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.747 -0.596 . . . . 0.0 110.212 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 53.4 m -73.74 156.37 88.4 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.677 -0.64 . . . . 0.0 109.558 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -62.95 -47.34 8.7 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.201 1.106 . . . . 0.0 110.074 176.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.443 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.4 p-10 -65.45 -44.05 88.49 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.541 -0.724 . . . . 0.0 111.149 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' HIS . . . . . 0.443 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 55.0 m170 -81.24 -27.93 35.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.342 -0.849 . . . . 0.0 111.18 -175.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -69.01 -41.96 77.08 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.441 -0.787 . . . . 0.0 110.263 172.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 27.3 tp -59.15 -34.65 72.33 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.547 -0.721 . . . . 0.0 110.518 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 29.4 t -48.3 145.29 3.4 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.526 -0.734 . . . . 0.0 111.424 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 62.9 mtm180 -59.79 143.72 50.32 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.612 -0.68 . . . . 0.0 110.385 -177.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -61.24 -37.26 82.42 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.72 -0.613 . . . . 0.0 110.403 -176.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 52.28 50.15 18.99 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.431 -0.793 . . . . 0.0 110.916 -176.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -74.27 -10.18 59.34 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.64 -0.662 . . . . 0.0 111.174 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -59.49 118.89 6.56 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.167 -0.958 . . . . 0.0 110.48 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 75.01 19.96 79.67 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 176.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -114.74 139.93 49.3 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.276 -1.132 . . . . 0.0 110.396 178.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 85.3 mt -84.92 -25.22 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.619 -0.675 . . . . 0.0 110.338 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.582 ' HB1' ' OH ' ' A' ' 236' ' ' TYR . . . -130.94 129.96 22.71 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.515 -0.741 . . . . 0.0 110.199 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.425 ' HD2' ' CE2' ' A' ' 236' ' ' TYR . 44.1 Cg_endo -74.55 138.36 24.11 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 O-C-N 123.101 1.053 . . . . 0.0 110.748 -177.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 221' ' ' PRO . 26.0 Cg_exo -58.96 -18.33 42.21 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 O-C-N 123.036 1.019 . . . . 0.0 111.413 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 30.7 m -50.73 -24.27 3.29 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.248 -0.907 . . . . 0.0 111.587 -177.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -104.06 133.75 48.48 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.454 -0.779 . . . . 0.0 110.4 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.41 ' HA ' ' CG ' ' A' ' 268' ' ' MET . 54.9 tp -59.7 -39.7 85.47 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.626 -0.671 . . . . 0.0 110.324 -178.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.508 HD12 ' HD3' ' A' ' 190' ' ' PRO . 83.0 mt -105.51 136.8 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.747 -0.596 . . . . 0.0 109.735 177.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -132.35 157.13 45.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.677 -0.639 . . . . 0.0 110.264 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.473 HG23 HG21 ' A' ' 247' ' ' VAL . 75.2 t -102.52 146.58 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.727 -0.608 . . . . 0.0 110.022 176.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -117.83 130.08 56.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.7 -0.625 . . . . 0.0 110.386 170.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 95.65 20.71 25.97 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.559 -1.017 . . . . 0.0 110.559 168.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -138.84 105.88 5.45 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -1.119 . . . . 0.0 110.005 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 43.2 m -63.21 -15.23 56.32 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.596 -0.69 . . . . 0.0 111.285 -177.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -100.0 8.9 43.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.19 -0.944 . . . . 0.0 111.53 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.37 131.42 50.21 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.072 -1.018 . . . . 0.0 110.196 176.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -139.76 158.06 44.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.752 -0.592 . . . . 0.0 109.805 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.582 ' OH ' ' HB1' ' A' ' 220' ' ' ALA . 72.7 m-85 -111.69 150.63 29.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.614 -0.679 . . . . 0.0 110.484 -177.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.17 159.92 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.732 -0.605 . . . . 0.0 110.216 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -121.03 130.1 53.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.813 -0.555 . . . . 0.0 110.154 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -63.23 130.0 93.89 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.664 -0.648 . . . . 0.0 109.853 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -65.23 -28.63 55.74 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 O-C-N 123.186 1.098 . . . . 0.0 110.968 -170.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.6 mt -102.15 -50.47 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.467 -0.77 . . . . 0.0 111.07 -168.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.494 HG22 ' HB3' ' A' ' 124' ' ' PRO . 14.1 p -105.3 12.18 32.04 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.392 -0.818 . . . . 0.0 111.942 -174.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 72.56 -4.89 18.57 Favored Glycine 0 N--CA 1.496 2.669 0 O-C-N 120.988 -1.07 . . . . 0.0 111.955 172.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.456 ' CZ ' HG12 ' A' ' 191' ' ' VAL . 21.4 mmt180 -45.92 142.02 2.83 Favored 'General case' 0 N--CA 1.506 2.328 0 CA-C-N 119.101 1.451 . . . . 0.0 112.339 -175.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -103.94 141.72 35.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.616 -0.678 . . . . 0.0 110.219 176.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.4 p -154.73 159.95 41.02 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.623 -0.673 . . . . 0.0 110.299 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.473 HG21 HG23 ' A' ' 228' ' ' VAL . 8.3 p -122.95 148.08 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.674 -0.641 . . . . 0.0 109.796 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.745 HD22 ' HG2' ' A' ' 187' ' ' ARG . 80.1 mt -129.63 154.62 46.93 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.816 -175.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.437 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.8 m -150.98 151.76 30.34 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.808 -0.558 . . . . 0.0 109.907 175.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -71.01 140.5 38.11 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 O-C-N 123.251 1.132 . . . . 0.0 110.003 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.671 ' HD2' HD11 ' A' ' 186' ' ' ILE . 60.6 t80 -76.06 125.41 29.08 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.459 -0.775 . . . . 0.0 110.155 177.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -100.05 160.14 27.96 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.739 -0.6 . . . . 0.0 109.998 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -59.0 159.13 22.58 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 O-C-N 123.284 1.149 . . . . 0.0 110.445 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -59.11 149.93 76.79 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 O-C-N 123.248 1.131 . . . . 0.0 110.515 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -60.36 147.45 40.6 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.627 -0.671 . . . . 0.0 110.319 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.7 t -69.83 127.25 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.619 -0.675 . . . . 0.0 110.22 -170.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.99 -10.09 55.33 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 9.6 t -144.35 173.27 11.92 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.224 -1.162 . . . . 0.0 110.558 175.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -106.92 13.21 27.95 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.651 -0.656 . . . . 0.0 111.804 -168.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -120.03 168.05 11.57 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.115 -0.991 . . . . 0.0 111.152 -175.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 82.3 m -117.75 146.25 43.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.729 -0.607 . . . . 0.0 109.788 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 35.6 m -116.72 136.61 52.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.636 -0.665 . . . . 0.0 110.917 -175.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 59.3 t -128.56 137.13 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 66.4 mt -104.78 119.49 39.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.497 -0.752 . . . . 0.0 109.831 -173.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.68 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 6.5 m-30 -105.69 151.06 24.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.62 -0.675 . . . . 0.0 110.718 -177.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -136.53 143.01 43.49 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -115.0 131.97 56.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.527 -0.733 . . . . 0.0 110.501 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' MET . . . . . 0.41 ' CG ' ' HA ' ' A' ' 225' ' ' LEU . 5.2 ppp? -100.24 1.16 41.57 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.654 -0.654 . . . . 0.0 111.9 -177.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.65 159.6 42.55 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.085 -1.009 . . . . 0.0 109.982 173.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.586 ' HA ' HD13 ' A' ' 305' ' ' ILE . 27.2 p30 -115.13 153.89 29.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.74 -0.6 . . . . 0.0 110.161 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' SER . . . . . 0.444 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 92.7 p -56.64 -26.7 56.76 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.404 -0.81 . . . . 0.0 111.155 -167.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 46.0 p -95.04 8.19 43.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.387 -0.821 . . . . 0.0 112.086 -165.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 28.9 p -93.96 117.96 30.82 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.98 -1.075 . . . . 0.0 110.727 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' VAL . . . . . 0.447 HG22 ' NH1' ' A' ' 279' ' ' ARG . 60.2 t -69.68 143.34 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.561 -0.712 . . . . 0.0 110.533 -167.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.53 -5.28 58.55 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.04 -95.35 0.74 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 169.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' MET . . . . . 0.444 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 95.2 mmm -64.78 -28.61 69.69 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.74 -0.859 . . . . 0.0 110.386 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.9 p30 44.95 51.56 8.6 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 121.325 0.583 . . . . 0.0 112.507 172.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.447 ' NH1' HG22 ' A' ' 274' ' ' VAL . 37.9 mtt180 54.7 33.4 19.35 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.321 -0.862 . . . . 0.0 111.289 174.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' ARG . . . . . 0.434 ' O ' HG23 ' A' ' 282' ' ' ILE . 89.6 mtt180 -114.89 105.01 53.74 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.499 -0.751 . . . . 0.0 110.092 173.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 281' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 280' ' ' ARG . 13.2 Cg_endo -60.8 144.97 99.65 Favored 'Trans proline' 0 N--CA 1.488 1.175 0 O-C-N 123.138 1.073 . . . . 0.0 110.371 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.645 HG22 ' HA ' ' A' ' 192' ' ' TYR . 43.6 pt -132.58 177.84 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 121.943 0.878 . . . . 0.0 111.253 -174.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 302' ' ' GLU . 35.0 mt -124.34 149.9 46.09 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 177.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.669 HD12 ' CE1' ' A' ' 301' ' ' PHE . 80.8 mt -114.21 130.51 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.63 -0.669 . . . . 0.0 109.312 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.504 HG23 ' SG ' ' A' ' 300' ' ' CYS . 81.0 mt -109.78 125.91 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -176.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 75.8 t -118.98 126.71 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.7 p -125.28 153.01 43.89 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.717 -0.614 . . . . 0.0 110.72 -174.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.729 HD21 ' HB3' ' A' ' 180' ' ' PRO . 19.1 tp -100.29 126.95 46.68 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 166.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.696 ' OE2' HG13 ' A' ' 295' ' ' VAL . 74.5 mm-40 -132.69 149.72 52.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.756 -0.59 . . . . 0.0 110.01 -172.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.778 ' CG2' HD11 ' A' ' 296' ' ' LEU . 77.2 p -89.93 158.28 17.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.667 -0.646 . . . . 0.0 110.013 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -55.98 -26.16 47.19 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.559 -0.713 . . . . 0.0 111.009 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -92.93 12.86 22.37 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.47 -0.769 . . . . 0.0 111.697 -173.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.94 20.18 44.17 Favored Glycine 0 N--CA 1.494 2.539 0 C-N-CA 120.118 -1.039 . . . . 0.0 110.962 167.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -107.43 140.14 40.83 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.216 -1.167 . . . . 0.0 110.18 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.696 HG13 ' OE2' ' A' ' 289' ' ' GLU . 58.7 t -90.1 130.9 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.626 -0.671 . . . . 0.0 110.054 -175.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.778 HD11 ' CG2' ' A' ' 290' ' ' THR . 96.3 mt -99.97 -40.07 7.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.716 -0.615 . . . . 0.0 110.569 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -160.35 149.36 18.66 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.504 ' HD2' HG11 ' A' ' 295' ' ' VAL . 48.7 mtp180 -135.19 136.24 41.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.678 -0.895 . . . . 0.0 110.575 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 299' ' ' ARG . . . . . 0.407 ' HG3' ' HA ' ' A' ' 139' ' ' ASP . 0.4 OUTLIER -138.13 157.82 45.55 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.608 -0.682 . . . . 0.0 110.301 170.021 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 300' ' ' CYS . . . . . 0.504 ' SG ' HG23 ' A' ' 285' ' ' ILE . 82.2 m -141.88 154.96 45.5 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.493 -0.754 . . . . 0.0 110.643 -175.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.669 ' CE1' HD12 ' A' ' 284' ' ' ILE . 47.3 p90 -144.95 160.97 40.49 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.703 -0.623 . . . . 0.0 110.194 175.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.474 ' HA ' HD23 ' A' ' 283' ' ' LEU . 82.3 tt0 -104.93 136.89 43.56 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.571 -0.706 . . . . 0.0 110.125 -178.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -117.94 143.73 46.1 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.821 -169.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -137.1 138.57 40.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.822 -0.549 . . . . 0.0 109.713 172.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.586 HD13 ' HA ' ' A' ' 270' ' ' ASN . 56.2 mt -112.7 122.86 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.512 -0.743 . . . . 0.0 109.757 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.2 p -145.32 170.56 16.08 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.642 -0.662 . . . . 0.0 110.664 -171.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -71.97 -40.11 68.86 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.694 -0.629 . . . . 0.0 110.641 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.8 t -127.12 86.51 58.66 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.59 -0.694 . . . . 0.0 110.506 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' PRO . . . . . 0.403 ' HD3' ' HG3' ' A' ' 165' ' ' GLN . 37.5 Cg_exo -56.24 -28.2 70.14 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.169 1.089 . . . . 0.0 110.533 173.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -67.53 -37.57 89.86 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -70.5 -38.33 74.3 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.643 -0.916 . . . . 0.0 109.749 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -69.45 -35.42 75.64 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.085 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.667 ' HD3' HG22 ' A' ' 147' ' ' THR . 37.7 ttt85 -57.16 -47.3 81.55 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.533 -0.73 . . . . 0.0 110.593 174.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -64.56 -39.02 92.98 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.575 -0.703 . . . . 0.0 110.401 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -62.44 -51.41 67.62 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.529 -0.732 . . . . 0.0 110.56 -173.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' ASP . . . . . 0.442 ' HB2' HD11 ' A' ' 159' ' ' LEU . 3.5 p30 -61.16 -37.77 84.08 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.472 -0.767 . . . . 0.0 110.096 -176.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -66.06 -40.58 91.03 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.257 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -62.86 -35.22 79.28 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.568 -0.707 . . . . 0.0 110.136 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 59.8 p -64.59 -29.66 70.68 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.679 -0.638 . . . . 0.0 110.097 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 83.9 mt -81.26 -45.82 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.641 -0.662 . . . . 0.0 110.047 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -59.47 -39.56 84.09 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.686 -0.633 . . . . 0.0 110.546 -177.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -63.57 -43.13 97.89 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.574 -0.704 . . . . 0.0 110.224 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -66.15 -35.8 81.43 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.669 -0.644 . . . . 0.0 110.339 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -105.07 125.06 50.57 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.647 -0.658 . . . . 0.0 110.952 -174.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 61.8 t -105.5 130.08 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.487 -0.758 . . . . 0.0 109.706 176.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 49.6 m -95.16 140.11 30.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.63 -0.669 . . . . 0.0 110.476 -176.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -80.0 150.05 30.55 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.678 -0.638 . . . . 0.0 110.192 176.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 30.9 t -75.81 137.97 40.86 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.693 -0.629 . . . . 0.0 110.266 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 40.1 m -94.92 -25.53 16.51 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.657 -0.652 . . . . 0.0 110.543 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -58.58 -34.52 71.18 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.503 -0.748 . . . . 0.0 110.567 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -89.07 107.57 19.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.615 -0.678 . . . . 0.0 110.238 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -61.29 -33.69 85.38 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -147.97 160.04 43.24 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.571 -0.959 . . . . 0.0 110.358 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -139.95 159.69 41.61 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.598 -0.689 . . . . 0.0 110.294 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -104.73 139.82 38.98 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.669 -0.644 . . . . 0.0 110.216 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 52.58 -166.59 0.06 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.424 -0.797 . . . . 0.0 110.787 -178.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -97.75 129.07 44.8 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.668 -0.645 . . . . 0.0 110.306 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -116.75 130.47 56.74 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.737 -0.602 . . . . 0.0 110.177 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 66.5 p -119.31 158.22 26.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.696 -0.627 . . . . 0.0 110.262 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -131.72 154.51 48.94 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.699 -0.626 . . . . 0.0 110.318 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 78.67 30.07 49.9 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 27.2 pt -96.37 147.5 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.628 -0.925 . . . . 0.0 110.389 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -143.95 160.67 40.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.586 -0.696 . . . . 0.0 110.055 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 64.6 mtt 52.67 26.55 4.49 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.414 -0.804 . . . . 0.0 110.967 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 117.957 -1.021 . . . . 0.0 110.279 -179.885 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 29.7 t -86.96 144.17 27.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.621 -0.929 . . . . 0.0 110.28 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 86.3 p -61.65 -28.77 69.62 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.659 -0.651 . . . . 0.0 110.247 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 49.6 m -122.49 139.04 54.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.65 -0.656 . . . . 0.0 110.284 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -103.56 134.13 47.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.668 -0.645 . . . . 0.0 110.21 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -155.97 94.34 1.53 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.737 -0.602 . . . . 0.0 110.269 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.12 -28.73 62.43 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.682 -0.636 . . . . 0.0 110.317 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 29.7 tp 56.77 -85.81 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.72 -0.613 . . . . 0.0 110.739 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 21.0 p -70.52 159.5 84.75 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.169 -0.957 . . . . 0.0 110.198 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -66.47 153.04 82.26 Favored 'Cis proline' 0 N--CA 1.496 1.626 0 C-N-CA 123.147 -1.606 . . . . 0.0 110.509 -15.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.7 m -82.13 161.72 59.23 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.691 -0.631 . . . . 0.0 110.219 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -60.69 147.31 95.29 Favored 'Trans proline' 0 C--N 1.316 -1.147 0 O-C-N 123.316 1.166 . . . . 0.0 110.494 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.82 142.32 42.26 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.641 -0.662 . . . . 0.0 110.25 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.574 HD11 HG22 ' A' ' 199' ' ' THR . 49.4 mm -119.96 107.8 39.51 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.676 -0.64 . . . . 0.0 109.885 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 126' ' ' ILE . 11.8 Cg_endo -59.7 150.54 76.17 Favored 'Trans proline' 0 N--CA 1.487 1.136 0 O-C-N 123.117 1.062 . . . . 0.0 110.597 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.5 t -114.43 148.3 37.95 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.632 -0.668 . . . . 0.0 110.252 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -94.65 24.25 4.77 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.691 -0.63 . . . . 0.0 110.878 -178.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 50.9 m -72.33 125.18 26.72 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.496 -0.753 . . . . 0.0 110.148 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -68.5 144.94 54.45 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.614 -0.679 . . . . 0.0 110.388 -176.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -155.55 101.65 2.2 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.802 -0.561 . . . . 0.0 110.058 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -59.54 -39.87 71.25 Favored 'Trans proline' 0 N--CA 1.489 1.222 0 O-C-N 123.152 1.08 . . . . 0.0 110.677 -175.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.04 -155.17 42.1 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -73.29 -43.86 0.64 Allowed 'Trans proline' 0 C--N 1.316 -1.142 0 O-C-N 123.422 1.222 . . . . 0.0 110.89 -175.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -89.28 5.64 44.01 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.543 -0.723 . . . . 0.0 111.497 -174.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 t 53.99 59.43 4.26 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.978 -1.076 . . . . 0.0 110.729 -176.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.725 ' HA ' HG12 ' A' ' 176' ' ' VAL . 64.6 t80 -78.15 118.78 20.72 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.571 -0.706 . . . . 0.0 110.019 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -130.06 160.02 34.98 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.34 0.591 . . . . 0.0 110.321 -176.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.0 t -124.83 148.42 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.692 -0.63 . . . . 0.0 109.87 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.6 p -155.87 166.9 32.09 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.313 0.578 . . . . 0.0 110.088 176.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.496 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 66.3 m-85 -126.58 125.16 41.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.782 -0.574 . . . . 0.0 109.84 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -56.77 141.88 42.65 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.603 -0.686 . . . . 0.0 110.44 -175.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -95.81 125.77 40.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.646 -0.658 . . . . 0.0 110.542 -173.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 49.7 m -122.97 149.22 44.56 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.703 -0.623 . . . . 0.0 110.101 177.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 42.4 m -61.18 160.24 10.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.622 -0.674 . . . . 0.0 110.197 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 147' ' ' THR . 6.7 t -67.77 75.42 0.19 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.66 -0.65 . . . . 0.0 110.237 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.7 162.01 25.45 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.632 -0.668 . . . . 0.0 110.205 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -75.48 143.58 42.51 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.6 -0.687 . . . . 0.0 110.031 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.81 56.05 8.14 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.409 -0.807 . . . . 0.0 110.914 -177.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -79.88 129.25 34.34 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.634 -0.666 . . . . 0.0 110.194 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 42.5 p -60.09 -34.08 72.98 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.643 -0.661 . . . . 0.0 110.094 176.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.442 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.8 p-90 -171.22 144.27 2.02 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.331 0.586 . . . . 0.0 110.224 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.0 t -142.09 142.6 32.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.897 -0.502 . . . . 0.0 109.985 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.496 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 64.7 t80 -125.61 139.98 53.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.486 -0.759 . . . . 0.0 110.775 -171.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.0 t -111.96 123.85 51.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.851 -0.531 . . . . 0.0 109.92 177.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 59.0 m -70.93 -37.01 72.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.806 -0.559 . . . . 0.0 110.568 -176.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -59.21 -35.36 73.48 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.505 -0.747 . . . . 0.0 110.522 -177.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.2 mt -104.86 -11.05 16.94 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.683 -0.636 . . . . 0.0 110.981 -176.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt 59.76 52.64 5.34 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.14 -0.975 . . . . 0.0 109.743 177.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -145.25 153.07 40.92 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.779 -0.576 . . . . 0.0 110.625 -175.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.618 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.58 137.76 53.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.758 -0.588 . . . . 0.0 110.206 -175.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -116.04 135.89 53.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.63 -0.669 . . . . 0.0 109.381 173.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.1 p -138.49 158.49 44.17 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.68 -0.638 . . . . 0.0 110.767 -177.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.431 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 55.4 mt-30 -104.61 144.49 31.64 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.505 -0.747 . . . . 0.0 109.882 171.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.418 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 16.3 tt -51.71 147.48 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.502 -0.749 . . . . 0.0 111.95 -174.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 65.11 10.0 5.99 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.637 -0.665 . . . . 0.0 112.702 174.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.431 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 20.3 mmtp -96.12 155.11 16.9 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.955 -1.091 . . . . 0.0 111.074 172.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 91.3 m -80.33 126.18 30.83 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.719 -0.613 . . . . 0.0 110.569 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' CYS . . . . . 0.618 ' SG ' HD21 ' A' ' 162' ' ' LEU . 48.6 t -116.32 90.03 28.34 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.604 -0.685 . . . . 0.0 110.126 174.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.442 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 15.2 Cg_exo -65.78 131.08 26.39 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 O-C-N 123.264 1.139 . . . . 0.0 110.756 174.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.635 HD12 ' CD2' ' A' ' 265' ' ' TYR . 78.2 mt -123.91 144.69 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.596 -0.69 . . . . 0.0 109.496 172.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLN . . . . . 0.405 ' OE1' ' CD1' ' A' ' 260' ' ' PHE . 70.5 mm-40 -108.42 133.05 53.12 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.52 -0.738 . . . . 0.0 110.361 -173.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.59 HG21 ' CE1' ' A' ' 138' ' ' PHE . 49.0 mm -95.35 135.0 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.652 -0.655 . . . . 0.0 109.657 170.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.0 tttp -119.3 130.28 55.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.531 -0.73 . . . . 0.0 110.529 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.725 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.4 m -136.2 159.73 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.605 -0.684 . . . . 0.0 109.905 175.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 81.6 mmm -77.13 -40.3 46.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.695 -0.628 . . . . 0.0 110.045 177.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.3 p -135.87 143.27 43.72 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.764 -0.585 . . . . 0.0 109.795 177.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.7 Cg_exo -55.69 139.89 83.68 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 O-C-N 123.217 1.114 . . . . 0.0 110.886 -172.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.742 ' HB3' HD21 ' A' ' 288' ' ' LEU . 23.4 Cg_endo -64.28 169.71 10.45 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.238 1.125 . . . . 0.0 110.69 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -61.06 156.54 44.02 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.35 1.184 . . . . 0.0 110.497 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -77.06 139.61 40.07 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.629 -0.669 . . . . 0.0 109.908 175.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.9 -25.02 29.24 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -175.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.12 152.97 1.53 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.296 -1.12 . . . . 0.0 111.325 176.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.77 155.98 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.748 -0.595 . . . . 0.0 109.774 176.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.641 HD11 ' CD2' ' A' ' 251' ' ' TYR . 72.4 mt -106.13 133.7 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 177.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.758 ' HG2' HD22 ' A' ' 248' ' ' LEU . 65.0 mtt180 -115.01 140.94 48.64 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -174.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -138.52 124.47 20.02 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.49 -0.757 . . . . 0.0 110.53 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 20.3 ttm -137.35 139.31 27.32 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.808 -0.558 . . . . 0.0 111.145 -175.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.718 ' HD3' HD12 ' A' ' 226' ' ' ILE . 71.2 Cg_endo -90.29 138.13 2.69 Favored 'Trans proline' 0 C--N 1.32 -0.948 0 O-C-N 123.185 1.097 . . . . 0.0 110.519 175.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.428 HG13 ' C ' ' A' ' 190' ' ' PRO . 34.8 m -147.07 154.92 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.577 -0.702 . . . . 0.0 110.211 174.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.647 ' HA ' HG22 ' A' ' 282' ' ' ILE . 82.3 m-85 -60.97 161.1 8.76 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.477 -0.764 . . . . 0.0 110.348 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -78.46 -60.04 2.53 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.635 -0.666 . . . . 0.0 110.812 -173.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -80.02 151.88 29.73 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.605 -0.685 . . . . 0.0 110.447 -174.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.447 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.41 -38.94 72.23 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.353 -0.842 . . . . 0.0 110.74 -176.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -56.37 -24.57 45.25 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.533 -0.73 . . . . 0.0 110.624 -176.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.412 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 60.4 m170 -110.01 -20.56 12.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.509 -0.744 . . . . 0.0 111.101 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.447 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.1 p -66.88 -20.34 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.111 -0.993 . . . . 0.0 110.639 -176.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.574 HG22 HD11 ' A' ' 126' ' ' ILE . 73.7 p -79.3 -16.96 55.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.522 -0.736 . . . . 0.0 110.78 175.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -88.41 134.62 33.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.338 -0.851 . . . . 0.0 110.064 173.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.3 t -73.16 143.69 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.612 -0.68 . . . . 0.0 110.269 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 78.9 t -84.9 139.56 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.527 -0.733 . . . . 0.0 109.326 170.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 9.3 pttt -134.9 -170.06 2.49 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.477 -0.765 . . . . 0.0 111.035 -167.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -95.07 154.2 17.28 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.712 -0.617 . . . . 0.0 110.317 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 56.3 m -76.04 157.29 83.55 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.647 -0.658 . . . . 0.0 109.249 174.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -63.11 -47.31 8.44 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 O-C-N 123.088 1.046 . . . . 0.0 110.023 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.415 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.6 p-10 -65.48 -44.36 87.36 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.639 -0.663 . . . . 0.0 111.169 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' HIS . . . . . 0.415 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 51.9 m170 -81.93 -28.04 33.01 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.461 -0.775 . . . . 0.0 111.279 -174.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -69.05 -38.78 79.3 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.323 -0.861 . . . . 0.0 110.314 172.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 25.3 tp -57.38 -31.97 66.33 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.62 -0.675 . . . . 0.0 110.786 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 31.3 t -48.41 138.23 10.4 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.532 -0.73 . . . . 0.0 111.442 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 34.8 ptt-85 -58.82 126.16 26.53 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.668 -0.645 . . . . 0.0 110.572 -175.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -75.51 -54.67 6.64 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.557 -0.715 . . . . 0.0 110.599 -175.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 51.46 54.55 10.87 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.442 -0.786 . . . . 0.0 111.208 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -69.23 -10.36 57.39 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.619 -0.675 . . . . 0.0 111.001 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -61.29 121.12 11.78 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.264 -0.897 . . . . 0.0 110.162 175.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 78.17 20.02 73.46 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -138.36 139.85 39.2 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.251 -1.146 . . . . 0.0 110.004 177.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.582 HD13 ' HA ' ' A' ' 232' ' ' SER . 81.8 mt -85.59 -25.18 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.705 -0.622 . . . . 0.0 110.522 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.802 ' HB1' ' HB3' ' A' ' 227' ' ' ARG . . . -124.94 89.9 51.87 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.483 -0.761 . . . . 0.0 110.592 -173.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.438 ' HD2' ' CE2' ' A' ' 236' ' ' TYR . 35.5 Cg_endo -70.67 145.72 52.64 Favored 'Trans proline' 0 N--CA 1.487 1.124 0 O-C-N 123.278 1.146 . . . . 0.0 110.673 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -59.4 -17.94 43.22 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 O-C-N 123.222 1.117 . . . . 0.0 111.454 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 27.3 t -51.81 -23.95 5.4 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.163 -0.96 . . . . 0.0 111.393 -178.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' HIS . . . . . 0.43 ' CE1' ' HB3' ' A' ' 236' ' ' TYR . 99.2 m-70 -104.32 132.4 50.61 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.441 -0.787 . . . . 0.0 110.245 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.401 ' HA ' ' HG3' ' A' ' 268' ' ' MET . 45.8 tp -60.27 -40.31 89.94 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.55 -0.719 . . . . 0.0 110.089 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.718 HD12 ' HD3' ' A' ' 190' ' ' PRO . 79.3 mt -99.21 136.79 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.836 -0.54 . . . . 0.0 109.659 175.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.802 ' HB3' ' HB1' ' A' ' 220' ' ' ALA . 79.1 mtm180 -135.05 157.61 46.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.737 -0.602 . . . . 0.0 109.971 176.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.463 HG23 HG21 ' A' ' 247' ' ' VAL . 72.6 t -103.52 146.65 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.712 -0.618 . . . . 0.0 110.161 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -122.06 130.01 52.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.746 -0.596 . . . . 0.0 110.285 170.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 99.12 19.51 21.19 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 170.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -140.7 104.52 4.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.267 -1.137 . . . . 0.0 110.028 174.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' SER . . . . . 0.582 ' HA ' HD13 ' A' ' 219' ' ' ILE . 45.8 m -63.42 -15.31 57.27 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.666 -0.646 . . . . 0.0 111.276 -176.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -100.01 7.63 44.59 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.22 -0.925 . . . . 0.0 111.55 -177.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.61 133.37 55.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.088 -1.007 . . . . 0.0 110.21 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -139.83 157.98 44.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.735 -0.603 . . . . 0.0 109.809 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.438 ' CE2' ' HD2' ' A' ' 221' ' ' PRO . 84.3 m-85 -114.37 150.65 34.27 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.552 -0.717 . . . . 0.0 110.497 -178.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.22 159.92 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.76 -0.588 . . . . 0.0 110.266 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -119.22 130.04 55.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.769 -0.582 . . . . 0.0 110.163 175.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -65.09 130.11 94.72 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.676 -0.64 . . . . 0.0 109.838 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -66.36 -27.66 47.37 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 O-C-N 123.172 1.09 . . . . 0.0 111.021 -171.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 82.6 mt -100.49 -50.54 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.399 -0.813 . . . . 0.0 110.942 -167.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.3 p -105.3 12.04 32.21 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.322 -0.861 . . . . 0.0 111.887 -175.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.88 -5.11 13.57 Favored Glycine 0 N--CA 1.495 2.582 0 O-C-N 121.08 -1.012 . . . . 0.0 111.916 173.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 22.2 mmt85 -46.14 142.02 3.02 Favored 'General case' 0 N--CA 1.505 2.276 0 CA-C-N 119.108 1.454 . . . . 0.0 112.321 -174.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -106.27 139.91 40.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.628 -0.67 . . . . 0.0 110.123 175.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 78.7 p -154.74 159.98 41.03 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.635 -0.665 . . . . 0.0 110.518 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.463 HG21 HG23 ' A' ' 228' ' ' VAL . 8.3 p -122.96 148.17 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.78 -0.575 . . . . 0.0 109.666 177.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.758 HD22 ' HG2' ' A' ' 187' ' ' ARG . 83.0 mt -129.64 154.52 47.04 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.045 -175.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.443 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.4 m -151.12 151.76 30.09 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.812 -0.555 . . . . 0.0 109.84 175.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -70.57 137.16 32.5 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 O-C-N 123.237 1.125 . . . . 0.0 109.979 177.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.641 ' CD2' HD11 ' A' ' 186' ' ' ILE . 13.9 t80 -77.23 124.29 27.63 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.572 -0.705 . . . . 0.0 110.201 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -100.01 160.06 28.2 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.719 -0.613 . . . . 0.0 110.177 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -59.26 159.99 20.9 Favored 'Trans proline' 0 C--N 1.316 -1.163 0 O-C-N 123.244 1.129 . . . . 0.0 110.434 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.88 150.22 73.3 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 O-C-N 123.194 1.102 . . . . 0.0 110.567 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -60.02 148.11 36.72 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.575 -0.703 . . . . 0.0 110.323 -178.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.84 127.25 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.457 -0.777 . . . . 0.0 110.068 -170.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.92 -10.12 55.46 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 9.5 t -144.68 173.71 11.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.163 -1.198 . . . . 0.0 110.601 175.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -106.94 13.18 27.96 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.66 -0.65 . . . . 0.0 111.768 -168.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.405 ' CD1' ' OE1' ' A' ' 173' ' ' GLN . 13.8 p90 -119.94 168.02 11.56 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.212 -0.93 . . . . 0.0 111.233 -175.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 86.4 m -117.86 147.78 42.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.768 -0.583 . . . . 0.0 109.841 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 40.6 m -115.95 137.54 52.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.553 -0.717 . . . . 0.0 110.91 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 57.9 t -128.62 136.87 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 170.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 64.7 mt -104.87 120.12 40.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.494 -0.754 . . . . 0.0 109.815 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.635 ' CD2' HD12 ' A' ' 172' ' ' ILE . 3.3 m-85 -99.19 156.4 16.98 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.796 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -136.42 142.99 43.7 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 171.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -113.41 129.58 56.51 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.61 -0.681 . . . . 0.0 110.163 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' MET . . . . . 0.401 ' HG3' ' HA ' ' A' ' 225' ' ' LEU . 0.0 OUTLIER -98.98 5.85 46.98 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.636 -0.665 . . . . 0.0 111.724 -176.308 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 269' ' ' CYS . . . . . 0.528 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.8 OUTLIER -144.78 161.33 39.52 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.141 -0.975 . . . . 0.0 110.069 173.636 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.662 ' HA ' HG21 ' A' ' 305' ' ' ILE . 26.9 p30 -116.27 158.71 22.95 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.731 -0.605 . . . . 0.0 109.822 176.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' SER . . . . . 0.405 ' HA ' ' HB3' ' A' ' 277' ' ' MET . 19.2 m -58.6 -32.65 69.19 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.376 -0.827 . . . . 0.0 110.947 -163.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 73.1 m -93.93 10.7 32.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.601 -0.687 . . . . 0.0 111.986 -165.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 31.7 p -93.8 118.19 31.1 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.069 -1.019 . . . . 0.0 110.593 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.3 t -61.34 139.9 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.389 -0.819 . . . . 0.0 110.218 -171.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 101.0 -5.11 56.16 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -124.89 -115.87 2.12 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 170.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' MET . . . . . 0.421 ' C ' ' ND2' ' A' ' 278' ' ' ASN . 26.9 ttt -60.27 -24.94 65.32 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.613 -0.934 . . . . 0.0 110.409 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' ASN . . . . . 0.421 ' ND2' ' C ' ' A' ' 277' ' ' MET . 7.2 p30 43.87 55.07 5.41 Favored 'General case' 0 N--CA 1.504 2.241 0 CA-C-O 121.434 0.635 . . . . 0.0 112.584 172.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 54.94 30.36 13.87 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.401 -0.812 . . . . 0.0 111.317 175.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -116.81 116.42 38.35 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.468 -0.77 . . . . 0.0 110.128 170.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' PRO . . . . . 0.404 ' HA ' ' CE ' ' A' ' 277' ' ' MET . 12.0 Cg_endo -59.68 145.66 97.54 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 O-C-N 123.042 1.022 . . . . 0.0 110.495 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.647 HG22 ' HA ' ' A' ' 192' ' ' TYR . 45.4 pt -131.97 175.73 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 121.762 0.791 . . . . 0.0 110.89 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.48 HD23 ' HA ' ' A' ' 302' ' ' GLU . 32.0 mt -124.42 149.92 46.21 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.512 HD12 ' CE1' ' A' ' 301' ' ' PHE . 79.1 mt -112.58 127.95 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.057 176.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.686 HG23 ' SG ' ' A' ' 300' ' ' CYS . 76.5 mt -109.85 126.34 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.436 -175.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 59.1 t -118.92 126.55 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.3 p -125.4 153.93 42.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.643 -0.661 . . . . 0.0 110.536 -174.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.742 HD21 ' HB3' ' A' ' 180' ' ' PRO . 24.3 tp -103.55 126.57 50.78 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 169.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.562 ' OE2' HG13 ' A' ' 295' ' ' VAL . 75.1 mm-40 -132.15 150.24 52.2 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.996 -173.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.759 ' CG2' HD11 ' A' ' 296' ' ' LEU . 76.5 p -89.96 159.21 17.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.732 -0.605 . . . . 0.0 109.907 178.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -55.95 -26.16 46.8 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.534 -0.729 . . . . 0.0 110.905 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -93.07 12.95 22.33 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.479 -0.763 . . . . 0.0 111.697 -174.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.41 20.16 46.22 Favored Glycine 0 N--CA 1.495 2.62 0 C-N-CA 120.132 -1.033 . . . . 0.0 110.972 167.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -105.64 140.16 39.13 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.203 -1.175 . . . . 0.0 110.231 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.562 HG13 ' OE2' ' A' ' 289' ' ' GLU . 59.4 t -87.52 131.32 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.678 -0.639 . . . . 0.0 110.008 -176.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.759 HD11 ' CG2' ' A' ' 290' ' ' THR . 96.9 mt -99.87 -40.11 7.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.718 -0.614 . . . . 0.0 110.484 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -162.7 151.6 21.48 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.434 ' HD2' HG11 ' A' ' 295' ' ' VAL . 46.3 mtp180 -135.01 134.35 40.36 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.719 -0.871 . . . . 0.0 110.469 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -136.3 152.81 51.09 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.558 -0.713 . . . . 0.0 110.236 172.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' CYS . . . . . 0.686 ' SG ' HG23 ' A' ' 285' ' ' ILE . 90.7 m -142.49 153.18 43.41 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.415 -0.803 . . . . 0.0 110.772 -175.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.512 ' CE1' HD12 ' A' ' 284' ' ' ILE . 51.1 p90 -145.82 166.77 24.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.671 -0.643 . . . . 0.0 109.97 174.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.48 ' HA ' HD23 ' A' ' 283' ' ' LEU . 58.0 tt0 -104.84 136.91 43.45 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.527 -0.733 . . . . 0.0 110.225 -177.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -119.4 145.47 46.19 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.626 -171.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 40.0 tpt85 -138.09 134.01 34.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.71 -0.619 . . . . 0.0 109.699 174.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.662 HG21 ' HA ' ' A' ' 270' ' ' ASN . 80.5 mt -105.75 122.87 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.504 -0.748 . . . . 0.0 109.583 176.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.4 p -145.21 173.23 12.12 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.535 -0.728 . . . . 0.0 110.648 -171.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -72.46 -40.13 67.23 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.704 -0.623 . . . . 0.0 110.582 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.7 t -131.04 89.37 42.52 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.544 -0.722 . . . . 0.0 110.467 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 309' ' ' PRO . . . . . 0.408 ' CG ' ' HG3' ' A' ' 165' ' ' GLN . 50.7 Cg_exo -54.13 -30.52 60.99 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 O-C-N 123.188 1.099 . . . . 0.0 111.03 172.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -65.4 -37.15 93.51 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -73.26 -40.44 64.63 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.669 -0.901 . . . . 0.0 109.802 -173.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -69.52 -41.33 76.15 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 120.084 -0.647 . . . . 0.0 110.092 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 72.4 ttt-85 -61.21 -41.8 97.48 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.564 -0.71 . . . . 0.0 110.346 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -64.17 -38.61 91.66 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.49 -0.757 . . . . 0.0 110.451 178.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -62.7 -52.85 61.68 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.486 -0.759 . . . . 0.0 110.541 -173.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -61.39 -37.79 84.71 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.464 -0.773 . . . . 0.0 110.158 -176.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -65.94 -39.6 90.64 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.687 -0.633 . . . . 0.0 110.227 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -62.49 -35.3 78.91 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.583 -0.698 . . . . 0.0 109.969 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 23.4 m -62.16 -33.35 74.33 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.615 -0.678 . . . . 0.0 110.198 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 83.7 mt -79.19 -44.57 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.578 -0.701 . . . . 0.0 109.993 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 55.4 ttt85 -58.85 -39.94 82.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.596 -0.69 . . . . 0.0 110.546 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 49.9 mttt -66.16 -46.86 75.95 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.633 -0.667 . . . . 0.0 110.178 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -69.04 -42.04 76.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.669 -0.644 . . . . 0.0 110.238 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -105.12 125.03 50.53 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.722 -0.611 . . . . 0.0 110.479 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.12 128.51 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.581 -0.699 . . . . 0.0 109.916 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 65.9 p -95.12 140.14 30.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.608 -0.683 . . . . 0.0 110.186 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -89.24 112.89 24.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.598 -0.689 . . . . 0.0 110.199 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 50.4 m -71.88 149.66 44.96 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.575 -0.703 . . . . 0.0 110.096 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 331' ' ' ASN . 74.2 m -104.0 117.2 33.72 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.668 -0.645 . . . . 0.0 110.304 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 64.3 mttt -68.58 -40.4 80.56 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.66 -0.65 . . . . 0.0 110.31 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' ASN . . . . . 0.425 ' O ' HG22 ' A' ' 329' ' ' THR . 42.8 p-10 -152.72 -164.66 2.0 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.626 -0.671 . . . . 0.0 110.386 -177.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -60.17 145.62 46.31 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -82.8 117.38 22.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.645 -0.915 . . . . 0.0 110.31 -176.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -147.14 149.7 33.52 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.775 -0.578 . . . . 0.0 110.066 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 52.91 26.53 4.73 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.438 -0.789 . . . . 0.0 110.872 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 52.88 26.56 4.72 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.469 -0.769 . . . . 0.0 110.938 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 53.73 40.54 31.61 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.532 -0.73 . . . . 0.0 110.836 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 53.22 42.11 32.13 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.44 -0.787 . . . . 0.0 110.887 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 48.3 m -124.1 137.09 54.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.577 -0.702 . . . . 0.0 110.365 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -60.76 -40.84 94.01 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.697 -0.627 . . . . 0.0 110.255 178.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 99.63 123.91 5.11 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 15.8 tt -147.45 147.32 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.652 -0.911 . . . . 0.0 110.202 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -92.39 127.77 38.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.631 -0.668 . . . . 0.0 110.266 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 88.4 mtp -59.86 -35.43 74.77 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.62 -0.675 . . . . 0.0 110.384 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.352 179.803 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 60.3 p -84.38 161.23 20.45 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.687 -0.89 . . . . 0.0 110.233 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 29.4 t -118.03 143.37 46.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.611 -0.68 . . . . 0.0 110.251 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 67.4 p -122.6 161.96 22.75 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.689 -0.632 . . . . 0.0 110.272 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -102.03 133.52 46.72 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.654 -0.653 . . . . 0.0 110.26 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -157.73 163.44 38.13 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.61 -0.681 . . . . 0.0 110.308 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 51.43 -169.87 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.474 -0.767 . . . . 0.0 111.104 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.597 ' N ' HD12 ' A' ' 120' ' ' LEU . 8.1 mp 52.64 -171.08 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.512 -0.742 . . . . 0.0 111.0 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.1 t -108.21 165.34 12.9 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.658 -0.651 . . . . 0.0 110.162 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -63.37 151.7 70.01 Favored 'Cis proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.138 -1.609 . . . . 0.0 110.505 -18.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 2.2 m -81.66 149.58 64.56 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.621 -0.675 . . . . 0.0 110.241 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -61.73 150.46 85.69 Favored 'Trans proline' 0 C--N 1.316 -1.155 0 O-C-N 123.393 1.207 . . . . 0.0 110.384 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.07 143.41 43.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.614 -0.678 . . . . 0.0 110.102 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.515 HD11 HG22 ' A' ' 199' ' ' THR . 51.5 mm -121.93 100.09 43.5 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.668 -0.645 . . . . 0.0 109.96 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -60.22 149.39 85.57 Favored 'Trans proline' 0 N--CA 1.487 1.118 0 O-C-N 123.232 1.122 . . . . 0.0 110.66 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.3 t -114.58 147.31 39.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.691 -0.631 . . . . 0.0 110.306 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 p-10 -95.58 25.17 4.68 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.664 -0.647 . . . . 0.0 110.775 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 55.1 m -72.3 125.25 26.88 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.511 -0.743 . . . . 0.0 110.242 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -72.3 144.88 48.18 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.705 -0.622 . . . . 0.0 110.437 -178.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.429 ' CE1' ' HA2' ' A' ' 134' ' ' GLY . 65.0 t80 -159.64 100.62 1.5 Allowed Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.671 -0.643 . . . . 0.0 110.129 178.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -58.72 -39.93 77.61 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 O-C-N 123.182 1.096 . . . . 0.0 110.818 -176.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.429 ' HA2' ' CE1' ' A' ' 132' ' ' TYR . . . 79.95 -155.16 38.37 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -73.3 -48.31 0.27 Allowed 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.385 1.203 . . . . 0.0 110.901 -174.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -85.05 6.28 26.02 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.557 -0.714 . . . . 0.0 111.341 -174.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.92 59.79 4.04 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.983 -1.073 . . . . 0.0 110.669 -176.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.733 ' HA ' HG12 ' A' ' 176' ' ' VAL . 64.5 t80 -78.35 118.75 20.83 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.54 -0.725 . . . . 0.0 109.959 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -130.1 159.98 35.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.811 -0.556 . . . . 0.0 110.289 -175.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 66.7 t -124.01 146.29 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 121.272 0.558 . . . . 0.0 110.087 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.0 p -156.95 169.09 25.59 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.218 0.532 . . . . 0.0 109.757 174.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.43 ' CE2' HG12 ' A' ' 172' ' ' ILE . 36.4 m-85 -126.6 125.09 41.38 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.7 -0.625 . . . . 0.0 109.792 -177.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -59.18 140.13 56.22 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.541 -0.724 . . . . 0.0 110.178 -178.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -105.8 152.14 23.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.55 -0.719 . . . . 0.0 110.853 -166.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 82.9 p -146.05 166.86 24.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.742 -0.599 . . . . 0.0 109.901 176.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 56.3 p -63.77 164.18 10.43 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.578 -0.701 . . . . 0.0 110.108 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 147' ' ' THR . 6.8 t -71.2 65.02 0.38 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.56 -0.713 . . . . 0.0 110.297 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.13 152.04 46.48 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.596 -0.69 . . . . 0.0 110.132 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -73.31 155.7 39.18 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.667 -0.646 . . . . 0.0 110.046 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.6 t 53.23 29.62 8.72 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.432 -0.793 . . . . 0.0 110.91 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -60.16 129.98 44.43 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.568 -0.707 . . . . 0.0 110.245 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 46.6 p -60.12 -34.05 72.98 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.698 -0.626 . . . . 0.0 110.117 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.585 ' CE3' HD11 ' A' ' 162' ' ' LEU . 64.3 p-90 -170.54 148.0 3.01 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.817 -0.552 . . . . 0.0 109.867 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 15.1 t -142.12 142.41 32.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.777 -0.577 . . . . 0.0 110.063 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.443 ' HB2' HD12 ' A' ' 162' ' ' LEU . 61.0 t80 -125.52 140.08 53.07 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.487 -0.758 . . . . 0.0 110.538 -172.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.2 t -110.01 123.09 49.04 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.863 176.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 61.6 m -70.58 -37.11 73.89 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.763 -0.586 . . . . 0.0 110.503 -176.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -59.28 -34.23 72.03 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.516 -0.74 . . . . 0.0 110.533 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.6 mt -104.75 -11.02 17.04 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.628 -0.67 . . . . 0.0 110.889 -175.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 62.8 tttt 59.86 52.52 5.32 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.063 -1.023 . . . . 0.0 109.735 177.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -145.72 152.99 40.48 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.632 -175.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.679 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.61 137.73 53.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.744 -0.598 . . . . 0.0 110.203 -176.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -117.27 132.81 56.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.54 -0.725 . . . . 0.0 109.283 175.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.1 p -138.31 158.47 44.22 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.983 -175.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -104.53 142.77 34.03 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.456 0.646 . . . . 0.0 110.11 172.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.433 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.2 tt -51.28 147.48 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 CA-C-O 121.655 0.74 . . . . 0.0 112.117 -173.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.47 9.89 5.36 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.543 -0.723 . . . . 0.0 112.481 177.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -96.51 155.12 16.9 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.996 -1.065 . . . . 0.0 110.93 175.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 84.1 m -84.03 126.19 32.81 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.646 -0.659 . . . . 0.0 110.841 -176.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' CYS . . . . . 0.679 ' SG ' HD21 ' A' ' 162' ' ' LEU . 42.8 t -113.38 90.23 16.68 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.603 -0.685 . . . . 0.0 110.137 174.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.432 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 15.3 Cg_exo -65.9 130.81 25.46 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.298 1.157 . . . . 0.0 110.449 177.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.43 HG12 ' CE2' ' A' ' 142' ' ' PHE . 93.8 mt -124.21 139.39 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.696 -0.628 . . . . 0.0 109.408 176.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 10.3 mp0 -108.95 134.35 51.74 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.613 -0.68 . . . . 0.0 110.664 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.607 HG21 ' CE1' ' A' ' 138' ' ' PHE . 49.6 mm -95.3 135.14 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.637 -0.664 . . . . 0.0 109.612 172.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -118.62 130.36 55.83 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.461 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.733 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.5 m -136.36 159.72 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.523 -0.736 . . . . 0.0 109.971 175.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 80.7 mmm -77.23 -40.21 45.75 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.751 -0.593 . . . . 0.0 110.054 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.5 p -135.15 143.26 45.05 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.79 -0.569 . . . . 0.0 109.826 177.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.9 Cg_exo -55.58 139.92 83.08 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 O-C-N 123.145 1.076 . . . . 0.0 110.859 -172.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.614 ' HB3' HD21 ' A' ' 288' ' ' LEU . 25.5 Cg_endo -64.88 169.16 12.17 Favored 'Trans proline' 0 N--CA 1.487 1.095 0 O-C-N 123.127 1.067 . . . . 0.0 110.687 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -61.12 155.85 48.43 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 O-C-N 123.379 1.199 . . . . 0.0 110.496 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -75.3 139.4 42.46 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.656 -0.652 . . . . 0.0 109.931 175.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.76 -25.05 28.99 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 -175.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.14 150.81 2.24 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.355 -1.085 . . . . 0.0 111.391 178.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.79 155.92 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.665 -0.647 . . . . 0.0 109.897 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.652 HD11 ' CD2' ' A' ' 251' ' ' TYR . 74.0 mt -108.78 135.25 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.727 ' HG2' HD22 ' A' ' 248' ' ' LEU . 54.1 mtt180 -114.97 147.71 39.7 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -174.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.64 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -141.36 128.14 20.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.386 -0.821 . . . . 0.0 110.405 173.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.402 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 31.6 ttp -137.23 140.25 30.4 Favored Pre-proline 0 N--CA 1.496 1.864 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.062 -177.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.562 ' HD3' HD12 ' A' ' 226' ' ' ILE . 72.9 Cg_endo -91.5 138.2 2.13 Favored 'Trans proline' 0 C--N 1.32 -0.957 0 C-N-CA 121.08 1.187 . . . . 0.0 110.858 177.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.461 HG12 ' CZ ' ' A' ' 244' ' ' ARG . 35.0 m -147.91 154.9 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.546 -0.721 . . . . 0.0 109.924 174.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.626 ' HA ' HG22 ' A' ' 282' ' ' ILE . 82.5 m-85 -60.4 168.52 2.05 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.395 -0.816 . . . . 0.0 110.513 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.46 ' HA ' HD12 ' A' ' 283' ' ' LEU . 68.8 tttt -84.08 -60.11 2.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.588 -0.695 . . . . 0.0 110.76 -175.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 43.1 mttp -80.16 151.68 29.62 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.54 -0.725 . . . . 0.0 110.305 -175.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.451 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.76 -38.36 72.34 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.384 -0.823 . . . . 0.0 110.633 -176.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -56.39 -24.52 45.22 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.386 -0.821 . . . . 0.0 110.584 -177.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.419 ' HB3' ' CG ' ' A' ' 192' ' ' TYR . 96.6 m-70 -109.97 -20.52 12.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.466 -0.771 . . . . 0.0 111.21 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.451 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -67.41 -20.2 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.194 -0.941 . . . . 0.0 110.595 -176.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.515 HG22 HD11 ' A' ' 126' ' ' ILE . 74.4 p -79.38 -16.92 55.46 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.524 -0.735 . . . . 0.0 110.767 175.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.45 135.1 33.64 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.348 -0.845 . . . . 0.0 110.064 173.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.414 HG21 ' O ' ' A' ' 242' ' ' THR . 62.0 t -73.38 140.97 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.564 -0.71 . . . . 0.0 110.348 178.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.523 HG22 ' CE1' ' A' ' 192' ' ' TYR . 65.7 t -84.89 140.05 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.594 -0.691 . . . . 0.0 109.506 172.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -134.91 -170.28 2.53 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.53 -0.731 . . . . 0.0 110.99 -169.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 81.3 mtm-85 -95.36 157.06 16.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.842 -0.536 . . . . 0.0 110.424 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 58.8 m -75.39 159.4 82.09 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.651 -0.656 . . . . 0.0 109.475 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.4 ' HD3' ' HA3' ' A' ' 275' ' ' GLY . 16.7 Cg_exo -64.0 -47.36 6.7 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 O-C-N 123.146 1.077 . . . . 0.0 109.985 176.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.438 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.1 p-10 -65.39 -43.4 90.79 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.575 -0.703 . . . . 0.0 111.045 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' HIS . . . . . 0.438 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 55.1 m170 -81.12 -27.85 35.39 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.49 -0.757 . . . . 0.0 111.245 -175.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -69.07 -38.76 79.23 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.387 -0.82 . . . . 0.0 110.321 172.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 23.5 tp -56.5 -36.13 68.8 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.504 -0.747 . . . . 0.0 110.785 -176.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 29.6 t -48.35 138.9 9.42 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.558 -0.714 . . . . 0.0 111.306 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 214' ' ' PHE . 27.1 mmt85 -61.04 145.84 49.35 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.61 -0.682 . . . . 0.0 110.18 -177.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -64.42 -32.69 74.42 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.691 -0.631 . . . . 0.0 110.454 -177.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 212' ' ' ARG . 63.0 m-85 51.78 46.73 26.09 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.461 -0.774 . . . . 0.0 110.883 -176.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -75.7 -10.21 59.25 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.14 -177.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -61.14 117.9 6.13 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.132 -0.98 . . . . 0.0 110.255 177.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 77.18 20.1 75.96 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -139.64 140.03 36.84 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.316 -1.108 . . . . 0.0 110.057 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 86.5 mt -84.95 -25.06 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.728 -0.607 . . . . 0.0 110.587 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.61 ' HB3' ' NH2' ' A' ' 227' ' ' ARG . . . -124.85 98.16 37.22 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.362 -0.836 . . . . 0.0 110.644 -172.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -70.58 153.26 65.28 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.346 1.182 . . . . 0.0 110.591 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -60.69 -16.29 42.53 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 O-C-N 123.236 1.124 . . . . 0.0 111.419 -177.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 32.0 m -50.42 -23.96 2.76 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.127 -0.983 . . . . 0.0 111.333 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -100.71 128.37 46.79 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.545 -0.722 . . . . 0.0 110.141 176.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.816 HD21 ' CE ' ' A' ' 277' ' ' MET . 61.9 tp -60.25 -39.15 85.73 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.606 -0.684 . . . . 0.0 110.235 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.562 HD12 ' HD3' ' A' ' 190' ' ' PRO . 82.2 mt -102.21 136.75 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 120.329 -0.548 . . . . 0.0 109.685 177.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.61 ' NH2' ' HB3' ' A' ' 220' ' ' ALA . 22.2 mtp-105 -131.75 157.23 44.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.758 -0.589 . . . . 0.0 110.157 -178.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.486 HG23 HG21 ' A' ' 247' ' ' VAL . 99.3 t -104.8 146.5 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.737 -0.602 . . . . 0.0 110.042 176.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -118.9 123.65 45.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.768 -0.583 . . . . 0.0 110.473 172.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 96.31 23.32 17.1 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 168.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -135.0 108.82 8.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.369 -1.077 . . . . 0.0 110.142 174.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 27.3 t -62.88 -15.14 53.73 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.609 -0.682 . . . . 0.0 111.318 -177.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -99.35 9.91 42.42 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.29 -0.881 . . . . 0.0 111.552 -177.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.46 124.49 20.51 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.092 -1.005 . . . . 0.0 110.235 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -139.78 158.05 44.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.794 -0.566 . . . . 0.0 109.678 177.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.474 ' OH ' ' HB1' ' A' ' 220' ' ' ALA . 97.4 m-85 -117.98 150.72 38.79 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.546 -0.721 . . . . 0.0 110.793 -175.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.07 159.95 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.819 -0.551 . . . . 0.0 110.108 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -120.0 130.03 54.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.792 -0.567 . . . . 0.0 110.299 177.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -63.77 130.07 94.18 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.653 -0.655 . . . . 0.0 109.784 178.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -65.97 -28.35 49.94 Favored 'Trans proline' 0 C--N 1.316 -1.168 0 O-C-N 123.042 1.022 . . . . 0.0 110.97 -170.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.8 mt -101.14 -50.5 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.465 -0.772 . . . . 0.0 111.019 -168.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.414 ' O ' HG21 ' A' ' 201' ' ' VAL . 13.0 p -105.34 12.15 32.0 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.338 -0.851 . . . . 0.0 111.872 -175.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 72.37 -4.92 17.22 Favored Glycine 0 N--CA 1.496 2.667 0 O-C-N 121.013 -1.055 . . . . 0.0 111.968 172.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.461 ' CZ ' HG12 ' A' ' 191' ' ' VAL . 22.1 mmt180 -46.0 142.07 2.87 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 119.163 1.482 . . . . 0.0 112.389 -175.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -104.25 143.35 33.08 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.674 -0.641 . . . . 0.0 110.204 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.1 p -154.71 160.04 41.1 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.608 -0.682 . . . . 0.0 110.213 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.486 HG21 HG23 ' A' ' 228' ' ' VAL . 8.5 p -123.01 148.19 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.707 -0.621 . . . . 0.0 109.779 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.727 HD22 ' HG2' ' A' ' 187' ' ' ARG . 83.0 mt -129.82 154.69 47.0 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 120.204 -0.599 . . . . 0.0 109.931 -174.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.43 HG13 ' C ' ' A' ' 248' ' ' LEU . 32.1 m -150.69 151.81 31.15 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.783 -0.573 . . . . 0.0 109.816 174.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -70.94 139.46 36.19 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 O-C-N 123.267 1.141 . . . . 0.0 110.029 177.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.652 ' CD2' HD11 ' A' ' 186' ' ' ILE . 10.2 t80 -79.59 122.16 26.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.519 -0.738 . . . . 0.0 110.07 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -100.08 160.09 28.08 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.706 -0.621 . . . . 0.0 110.184 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -58.95 160.08 19.46 Favored 'Trans proline' 0 N--CA 1.488 1.174 0 O-C-N 123.285 1.15 . . . . 0.0 110.457 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.17 150.05 76.32 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 O-C-N 123.276 1.145 . . . . 0.0 110.613 -177.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -60.95 149.56 36.15 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.609 -0.682 . . . . 0.0 110.189 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.84 127.21 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.496 -0.752 . . . . 0.0 110.148 -170.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.29 -10.18 56.46 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 9.4 t -145.41 175.39 10.35 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.25 -1.147 . . . . 0.0 110.619 175.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -110.03 13.09 23.42 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.617 -0.677 . . . . 0.0 111.883 -167.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -120.84 168.03 11.89 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.141 -0.974 . . . . 0.0 111.177 -177.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 93.4 m -117.87 147.56 42.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.793 -0.567 . . . . 0.0 109.837 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 32.7 m -117.78 136.14 53.59 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.567 -0.708 . . . . 0.0 110.945 -175.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 57.9 t -130.44 137.18 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 171.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 74.0 mt -104.88 120.94 42.63 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.512 -0.742 . . . . 0.0 110.004 -173.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.64 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 5.9 m-30 -105.55 150.62 25.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.688 -0.633 . . . . 0.0 110.662 -177.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -136.56 142.99 43.42 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -113.31 131.93 55.76 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.584 -0.697 . . . . 0.0 110.48 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' MET . . . . . 0.436 ' HG3' HD12 ' A' ' 225' ' ' LEU . 5.0 ppp? -101.28 9.43 41.75 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.657 -0.652 . . . . 0.0 111.963 -176.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 269' ' ' CYS . . . . . 0.549 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.8 OUTLIER -144.6 163.45 33.88 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.115 -0.991 . . . . 0.0 110.076 171.417 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.654 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.9 p30 -121.34 163.97 17.8 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.442 0.639 . . . . 0.0 110.434 -177.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 271' ' ' SER . . . . . 0.426 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 50.4 m -58.22 -34.07 70.0 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.44 -0.788 . . . . 0.0 111.058 -163.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 49.6 p -103.62 15.05 29.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.39 -0.819 . . . . 0.0 111.844 -163.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 30.5 p -94.86 118.09 31.21 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.11 -0.994 . . . . 0.0 110.585 177.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 60.1 t -64.24 139.9 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.42 -0.8 . . . . 0.0 110.332 -169.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 275' ' ' GLY . . . . . 0.4 ' HA3' ' HD3' ' A' ' 206' ' ' PRO . . . 99.22 -5.17 58.98 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 177.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.0 -95.6 0.75 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 172.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 277' ' ' MET . . . . . 0.816 ' CE ' HD21 ' A' ' 225' ' ' LEU . 15.9 mmt -63.04 -34.12 76.89 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.699 -0.883 . . . . 0.0 110.304 177.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.4 p30 43.38 48.1 5.92 Favored 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 176.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 36.2 mtt180 54.73 29.46 11.76 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.356 -0.84 . . . . 0.0 111.2 175.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -120.07 105.06 43.0 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.58 -0.7 . . . . 0.0 110.078 175.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.77 147.6 91.62 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 O-C-N 123.128 1.067 . . . . 0.0 110.481 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.626 HG22 ' HA ' ' A' ' 192' ' ' TYR . 45.4 pt -132.02 178.0 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.779 0.8 . . . . 0.0 111.011 -175.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 193' ' ' LYS . 30.4 mt -124.42 149.88 46.26 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.698 HD12 ' CE1' ' A' ' 301' ' ' PHE . 79.9 mt -115.33 130.1 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.245 177.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.519 HG23 ' SG ' ' A' ' 300' ' ' CYS . 80.9 mt -109.76 126.39 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -176.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 57.5 t -118.86 126.78 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.6 p -125.25 153.71 42.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.603 -0.686 . . . . 0.0 110.579 -173.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.614 HD21 ' HB3' ' A' ' 180' ' ' PRO . 25.0 tp -103.97 125.87 50.67 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 169.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.661 ' OE2' HG13 ' A' ' 295' ' ' VAL . 73.9 mm-40 -131.24 149.92 52.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.885 -0.509 . . . . 0.0 109.882 -173.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.728 ' CG2' HD11 ' A' ' 296' ' ' LEU . 74.4 p -89.86 159.36 17.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.629 -0.669 . . . . 0.0 109.774 177.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -55.96 -26.07 46.53 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.582 -0.699 . . . . 0.0 110.823 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -87.27 9.68 19.53 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.519 -0.738 . . . . 0.0 111.783 -174.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 87.51 20.19 52.32 Favored Glycine 0 N--CA 1.495 2.606 0 O-C-N 121.089 -1.007 . . . . 0.0 110.731 170.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -108.02 140.26 41.44 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.283 -1.127 . . . . 0.0 110.175 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.661 HG13 ' OE2' ' A' ' 289' ' ' GLU . 60.0 t -89.55 132.56 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.587 -0.696 . . . . 0.0 110.067 -174.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.728 HD11 ' CG2' ' A' ' 290' ' ' THR . 96.2 mt -99.97 -40.1 7.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.671 -0.643 . . . . 0.0 110.489 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -161.67 154.83 25.91 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -178.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 47.7 mtp180 -134.9 135.15 41.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.669 -0.9 . . . . 0.0 110.746 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 -135.18 158.03 45.4 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.609 -0.682 . . . . 0.0 109.958 172.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 300' ' ' CYS . . . . . 0.519 ' SG ' HG23 ' A' ' 285' ' ' ILE . 85.9 m -144.29 153.83 42.43 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.504 -0.747 . . . . 0.0 110.745 -176.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.698 ' CE1' HD12 ' A' ' 284' ' ' ILE . 49.3 p90 -144.96 162.17 37.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.705 -0.622 . . . . 0.0 110.05 174.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.45 ' HA ' HD23 ' A' ' 283' ' ' LEU . 82.1 tt0 -104.84 135.36 46.35 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.479 -0.763 . . . . 0.0 110.198 -176.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -120.06 142.93 48.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.626 -0.671 . . . . 0.0 110.687 -170.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -138.49 138.82 38.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.795 -0.565 . . . . 0.0 109.795 173.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.654 HG21 ' HA ' ' A' ' 270' ' ' ASN . 78.7 mt -108.75 122.89 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.544 -0.723 . . . . 0.0 109.619 177.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.9 p -145.36 170.56 16.1 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.66 -0.65 . . . . 0.0 110.69 -171.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -72.52 -40.12 67.05 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.613 -0.68 . . . . 0.0 110.708 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.8 t -127.95 86.43 58.17 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.591 -0.693 . . . . 0.0 110.484 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -55.91 -29.21 71.97 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 O-C-N 123.134 1.07 . . . . 0.0 110.899 174.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.48 -37.98 93.09 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.014 -1.635 . . . . 0.0 109.014 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -73.28 -40.02 64.9 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.748 -0.854 . . . . 0.0 109.751 -173.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -69.44 -39.78 77.6 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.163 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -61.86 -45.56 93.23 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.306 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 23.7 ttpt -64.11 -39.22 93.58 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.585 -0.697 . . . . 0.0 110.47 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.66 -50.71 71.4 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.495 -0.753 . . . . 0.0 110.426 -174.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -61.56 -37.77 85.05 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.45 -0.781 . . . . 0.0 110.105 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -62.3 -40.13 95.27 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.635 -0.665 . . . . 0.0 110.016 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -62.39 -35.18 78.39 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.619 -0.676 . . . . 0.0 109.957 178.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 22.6 t -62.76 -32.06 73.14 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.658 -0.651 . . . . 0.0 110.32 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 51.3 mm -78.38 -45.98 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.593 -0.692 . . . . 0.0 109.964 -177.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -59.09 -42.08 89.6 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.629 -0.669 . . . . 0.0 110.536 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -65.63 -46.29 79.78 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.628 -0.67 . . . . 0.0 110.339 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -66.11 -36.28 82.74 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.68 -0.638 . . . . 0.0 110.349 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -105.03 125.08 50.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.629 -0.669 . . . . 0.0 110.474 -175.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 62.5 t -122.1 130.04 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.586 -0.696 . . . . 0.0 109.789 176.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 48.9 m -95.18 140.05 30.65 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.575 -0.703 . . . . 0.0 110.342 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -106.37 144.25 33.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.693 -0.629 . . . . 0.0 110.15 177.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 50.4 m -65.99 148.51 51.69 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.638 -0.664 . . . . 0.0 110.147 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 74.1 p -96.21 -26.74 15.32 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.687 -0.633 . . . . 0.0 110.497 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -60.35 -41.04 92.8 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.501 -0.75 . . . . 0.0 110.395 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -60.31 -36.08 77.08 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.635 -0.666 . . . . 0.0 110.362 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -92.97 134.27 12.1 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -147.57 82.35 1.53 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.67 -0.9 . . . . 0.0 110.155 178.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.604 ' HB1' ' CD ' ' A' ' 337' ' ' GLN . . . -152.53 149.35 28.42 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.693 -0.629 . . . . 0.0 110.201 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -125.59 153.86 43.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.553 -0.717 . . . . 0.0 110.469 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 53.23 46.0 27.4 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.473 -0.767 . . . . 0.0 111.282 175.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 337' ' ' GLN . . . . . 0.604 ' CD ' ' HB1' ' A' ' 334' ' ' ALA . 95.0 mt-30 -117.77 139.09 51.55 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.55 -0.719 . . . . 0.0 110.288 173.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -119.44 136.85 54.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.666 -0.646 . . . . 0.0 110.245 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 9.8 t -134.33 152.74 51.98 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.69 -0.631 . . . . 0.0 110.44 178.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -60.99 -41.94 97.46 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.704 -0.622 . . . . 0.0 110.212 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 84.58 -170.52 46.37 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 82.4 mt -94.0 133.81 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.634 -0.921 . . . . 0.0 109.97 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -154.12 -50.21 0.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.704 -0.622 . . . . 0.0 110.27 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 65.0 mtt -59.86 -35.44 74.79 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.679 -0.638 . . . . 0.0 110.365 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 7.4 t . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 118.035 -0.984 . . . . 0.0 110.364 179.954 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 75.2 m -86.77 10.37 16.11 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.703 -0.881 . . . . 0.0 111.363 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 86.6 p -61.52 -29.88 70.27 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.135 -0.978 . . . . 0.0 110.263 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 43.4 m -61.13 -38.69 87.26 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.611 -0.681 . . . . 0.0 110.566 -177.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -59.19 -40.95 87.35 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.595 -0.69 . . . . 0.0 110.585 -175.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -85.7 -162.56 0.74 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.644 -0.66 . . . . 0.0 110.336 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 54.61 28.0 9.31 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.325 -0.859 . . . . 0.0 110.798 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 88.4 mt 51.76 32.07 9.01 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.374 -0.829 . . . . 0.0 111.194 176.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.2 m -117.79 154.82 51.21 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.625 -0.672 . . . . 0.0 110.079 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -58.36 150.45 36.99 Favored 'Cis proline' 0 N--CA 1.496 1.623 0 C-N-CA 123.066 -1.639 . . . . 0.0 110.258 -23.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 66.3 m -81.69 141.14 47.88 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.583 -0.698 . . . . 0.0 110.296 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.639 ' HB3' HG22 ' A' ' 242' ' ' THR . 29.7 Cg_endo -68.04 152.61 76.46 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 O-C-N 123.207 1.109 . . . . 0.0 110.552 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.94 144.49 43.2 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.652 -0.655 . . . . 0.0 109.996 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.715 HD11 HG22 ' A' ' 199' ' ' THR . 50.1 mm -121.19 100.85 45.01 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.663 -0.648 . . . . 0.0 110.186 -176.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -61.25 154.01 61.11 Favored 'Trans proline' 0 N--CA 1.487 1.118 0 O-C-N 123.189 1.099 . . . . 0.0 110.364 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.4 t -109.97 146.88 34.49 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.67 -0.644 . . . . 0.0 110.43 -177.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -95.42 24.39 5.17 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.68 -0.637 . . . . 0.0 110.64 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 54.6 m -72.71 125.18 26.88 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.567 -0.708 . . . . 0.0 110.337 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -70.97 144.98 50.33 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.723 -0.611 . . . . 0.0 110.291 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -158.28 102.07 1.71 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.603 -0.686 . . . . 0.0 110.164 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -58.77 -39.96 77.1 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 O-C-N 123.177 1.093 . . . . 0.0 110.691 -178.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.12 -155.15 45.6 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 177.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -72.75 -45.93 0.47 Allowed 'Trans proline' 0 N--CA 1.486 1.067 0 O-C-N 123.33 1.174 . . . . 0.0 111.004 -174.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -89.1 9.1 26.65 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.615 -0.678 . . . . 0.0 111.453 -172.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.71 61.63 3.01 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.975 -1.078 . . . . 0.0 110.732 -176.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.619 ' HA ' HG12 ' A' ' 176' ' ' VAL . 46.6 t80 -77.92 118.2 20.0 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.648 -0.657 . . . . 0.0 109.83 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -130.04 160.04 34.9 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.312 0.577 . . . . 0.0 110.178 -177.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 78.6 t -124.31 148.78 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.69 -0.631 . . . . 0.0 109.775 176.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.4 p -157.1 171.02 21.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.813 -0.554 . . . . 0.0 109.928 176.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.422 ' CE1' HG12 ' A' ' 172' ' ' ILE . 64.8 m-85 -126.36 125.14 41.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.821 -0.549 . . . . 0.0 109.64 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.28 142.04 44.65 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.574 -0.704 . . . . 0.0 110.497 -175.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -76.33 144.97 39.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.589 -0.695 . . . . 0.0 110.687 -169.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 83.1 p -145.44 162.63 36.86 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.74 -0.6 . . . . 0.0 110.027 176.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 24.1 t -77.2 157.03 31.11 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.53 -0.731 . . . . 0.0 110.123 179.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 66.6 p -79.12 59.49 2.75 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.682 -0.636 . . . . 0.0 110.145 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.92 158.88 32.58 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.663 -0.648 . . . . 0.0 110.242 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 68.3 mttt -75.22 162.25 28.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.62 -0.675 . . . . 0.0 110.162 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 27.7 t 53.18 25.97 4.69 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.494 -0.754 . . . . 0.0 111.054 -177.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.68 134.32 56.14 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.602 -0.686 . . . . 0.0 110.158 177.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.4 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 76.1 p -60.06 -33.88 72.67 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.668 -0.645 . . . . 0.0 109.928 174.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.425 ' CE3' HD11 ' A' ' 162' ' ' LEU . 67.5 p-90 -170.06 148.02 3.33 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.964 -0.46 . . . . 0.0 109.784 178.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.9 t -142.04 142.37 32.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.789 -0.57 . . . . 0.0 109.974 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.414 ' HB2' HD12 ' A' ' 162' ' ' LEU . 62.9 t80 -125.76 140.12 52.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.513 -0.742 . . . . 0.0 110.559 -172.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 31.2 t -110.43 121.07 44.41 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.727 174.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 69.4 m -71.42 -36.45 71.31 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.702 -0.624 . . . . 0.0 110.489 -176.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -58.76 -33.83 70.72 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.586 -0.696 . . . . 0.0 110.526 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 53.9 mt -104.82 -11.33 16.84 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.734 -0.604 . . . . 0.0 110.851 -176.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt 59.87 51.84 5.76 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.045 -1.034 . . . . 0.0 109.825 176.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -147.14 152.86 39.13 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.696 -0.628 . . . . 0.0 110.714 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.425 HD11 ' CE3' ' A' ' 153' ' ' TRP . 14.6 tp -126.65 137.88 53.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.793 -0.567 . . . . 0.0 110.375 -173.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -117.54 133.32 56.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.537 -0.727 . . . . 0.0 109.462 175.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.1 p -138.3 158.31 44.54 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 120.111 -0.636 . . . . 0.0 111.104 -175.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -104.69 141.59 36.19 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.588 -0.695 . . . . 0.0 110.33 172.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.437 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 18.0 tt -54.6 149.43 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.529 -0.732 . . . . 0.0 111.552 -173.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.22 10.01 5.22 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.593 -0.692 . . . . 0.0 112.515 178.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -96.4 155.13 16.89 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.958 -1.089 . . . . 0.0 110.784 174.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 70.2 m -79.96 126.09 30.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.702 -0.624 . . . . 0.0 110.61 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 42.3 t -115.43 90.23 24.54 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.624 -0.673 . . . . 0.0 110.22 174.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -69.99 125.41 11.99 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.266 1.14 . . . . 0.0 110.521 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.643 HD12 ' CD2' ' A' ' 265' ' ' TYR . 86.4 mt -122.22 143.43 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.594 -0.692 . . . . 0.0 109.575 173.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLN . . . . . 0.422 ' NE2' ' CE1' ' A' ' 260' ' ' PHE . 95.4 mt-30 -109.14 136.64 48.3 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.611 -0.681 . . . . 0.0 110.707 -175.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.3 mm -95.23 135.02 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.674 -0.641 . . . . 0.0 109.744 169.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 35.2 tttm -117.05 130.27 56.55 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.509 -0.745 . . . . 0.0 110.581 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.619 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.0 m -136.01 159.8 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.63 -0.669 . . . . 0.0 109.797 174.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 79.0 mmm -81.3 -45.4 16.27 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.62 -0.675 . . . . 0.0 110.151 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.417 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.0 p -126.52 143.18 45.37 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.724 -0.61 . . . . 0.0 109.684 177.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.5 Cg_exo -55.5 139.74 82.54 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 O-C-N 123.205 1.108 . . . . 0.0 110.902 -171.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.745 ' HB3' HD21 ' A' ' 288' ' ' LEU . 36.0 Cg_endo -67.51 170.01 14.53 Favored 'Trans proline' 0 N--CA 1.487 1.128 0 O-C-N 123.226 1.119 . . . . 0.0 110.542 177.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -60.26 155.77 44.2 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 123.326 1.172 . . . . 0.0 110.622 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -78.16 138.26 38.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.599 -0.688 . . . . 0.0 109.931 175.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.24 -24.97 30.08 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -174.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.13 151.2 2.09 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.381 -1.07 . . . . 0.0 111.48 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 35.4 m -129.75 156.03 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.777 -0.577 . . . . 0.0 109.853 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.693 HD11 ' HD2' ' A' ' 251' ' ' TYR . 53.7 mt -107.34 134.9 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 178.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.736 ' HG2' HD22 ' A' ' 248' ' ' LEU . 70.8 mtt180 -114.94 141.34 48.09 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -174.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.42 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -138.51 123.72 19.21 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.456 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 44.5 ttp -137.34 140.61 31.22 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.773 -0.579 . . . . 0.0 111.222 -175.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.637 ' HD3' HD12 ' A' ' 226' ' ' ILE . 71.7 Cg_endo -90.98 138.22 2.34 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 O-C-N 123.243 1.128 . . . . 0.0 110.717 176.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.434 HG13 ' C ' ' A' ' 190' ' ' PRO . 34.7 m -147.48 154.84 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.51 -0.744 . . . . 0.0 110.134 173.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.636 ' HA ' HG22 ' A' ' 282' ' ' ILE . 88.3 m-85 -61.33 166.67 3.71 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.488 -0.758 . . . . 0.0 110.429 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -84.67 -59.96 2.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.678 -0.639 . . . . 0.0 110.849 -175.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -80.08 152.24 29.44 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.656 -0.653 . . . . 0.0 110.319 -175.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.455 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.81 -38.58 72.78 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.333 -0.854 . . . . 0.0 110.72 -175.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -56.58 -24.57 48.28 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.539 -0.726 . . . . 0.0 110.567 -177.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.433 ' HB3' ' CD1' ' A' ' 192' ' ' TYR . 47.8 m80 -109.89 -20.46 12.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.565 -0.71 . . . . 0.0 111.116 -178.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.1 p -67.56 -20.19 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.145 -0.972 . . . . 0.0 110.606 -176.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.715 HG22 HD11 ' A' ' 126' ' ' ILE . 69.2 p -79.35 -17.01 55.37 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.535 -0.728 . . . . 0.0 110.678 174.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.41 136.93 32.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.357 -0.84 . . . . 0.0 110.029 174.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.8 t -73.02 146.03 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.623 -0.673 . . . . 0.0 110.228 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.581 HG23 HH12 ' A' ' 244' ' ' ARG . 60.8 t -84.95 136.16 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.595 -0.69 . . . . 0.0 109.191 172.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.0 pttp -134.95 -170.18 2.51 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.508 -0.745 . . . . 0.0 111.073 -167.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -95.1 159.32 15.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.75 -0.594 . . . . 0.0 110.501 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 59.9 m -80.05 160.48 68.44 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.627 -0.67 . . . . 0.0 109.281 175.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -64.14 -47.33 6.5 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.171 1.09 . . . . 0.0 109.841 176.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.442 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.5 p-10 -65.42 -44.38 87.57 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.556 -0.715 . . . . 0.0 111.162 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' HIS . . . . . 0.442 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 55.0 m170 -81.42 -27.96 34.48 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.438 -0.789 . . . . 0.0 111.391 -174.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -69.13 -41.35 77.45 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.387 -0.821 . . . . 0.0 110.243 172.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 26.4 tp -58.48 -34.1 70.52 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.58 -0.7 . . . . 0.0 110.695 -178.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 29.1 t -48.37 142.81 5.28 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.549 -0.719 . . . . 0.0 111.404 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -62.83 130.62 45.64 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.634 -0.666 . . . . 0.0 110.163 -176.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -63.68 -34.89 78.86 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.718 -0.614 . . . . 0.0 110.206 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.406 ' CD2' ' O ' ' A' ' 214' ' ' PHE . 56.6 t80 52.64 50.48 18.06 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.381 -0.824 . . . . 0.0 110.772 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -72.49 -10.09 59.36 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.691 -0.63 . . . . 0.0 111.264 -177.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -59.81 119.63 8.05 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.136 -0.978 . . . . 0.0 110.434 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 75.73 20.0 78.53 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 177.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -114.85 140.45 48.94 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.284 -1.127 . . . . 0.0 110.362 178.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.2 mt -84.86 -25.16 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.602 -0.686 . . . . 0.0 110.401 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.544 ' HB1' ' OH ' ' A' ' 236' ' ' TYR . . . -127.56 127.57 24.07 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.476 -0.765 . . . . 0.0 110.33 -178.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.439 ' HG2' ' CE1' ' A' ' 224' ' ' HIS . 21.0 Cg_endo -66.6 123.32 10.94 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 O-C-N 123.082 1.043 . . . . 0.0 110.479 178.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -59.18 -19.35 49.18 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 O-C-N 122.977 0.988 . . . . 0.0 111.424 -176.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 86.9 p -54.35 -22.32 11.86 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.257 -0.902 . . . . 0.0 111.35 -175.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' HIS . . . . . 0.439 ' CE1' ' HG2' ' A' ' 221' ' ' PRO . 80.2 m80 -84.08 133.42 34.64 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.414 -0.803 . . . . 0.0 110.226 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.405 ' HA ' ' CG ' ' A' ' 268' ' ' MET . 55.9 tp -59.52 -39.21 83.16 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.563 -0.711 . . . . 0.0 110.325 -177.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.637 HD12 ' HD3' ' A' ' 190' ' ' PRO . 80.9 mt -104.17 136.75 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.821 -0.549 . . . . 0.0 109.818 178.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -132.56 159.17 40.23 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.716 -0.615 . . . . 0.0 110.111 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.589 HG23 HG21 ' A' ' 247' ' ' VAL . 70.5 t -105.59 146.74 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.663 -0.648 . . . . 0.0 110.144 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -121.78 130.05 53.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.715 -0.616 . . . . 0.0 110.303 171.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.8 20.58 21.19 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.526 -1.029 . . . . 0.0 110.526 170.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -141.27 105.16 4.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.307 -1.114 . . . . 0.0 109.988 174.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 93.1 p -63.6 -15.13 57.3 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.603 -0.686 . . . . 0.0 111.224 -177.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -97.24 9.96 40.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.303 -0.873 . . . . 0.0 111.187 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.97 130.35 45.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.205 -0.934 . . . . 0.0 110.081 176.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -139.77 156.25 46.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.774 -0.579 . . . . 0.0 109.719 177.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.544 ' OH ' ' HB1' ' A' ' 220' ' ' ALA . 90.4 m-85 -117.96 150.66 38.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.513 -0.742 . . . . 0.0 110.617 -176.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.08 159.89 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.902 -0.499 . . . . 0.0 110.224 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -119.65 130.08 54.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.771 -0.581 . . . . 0.0 110.113 176.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -61.72 126.04 86.09 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.657 -0.652 . . . . 0.0 109.754 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -65.01 -29.15 57.27 Favored 'Trans proline' 0 C--N 1.317 -1.123 0 O-C-N 123.201 1.106 . . . . 0.0 110.782 -172.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.9 mt -104.15 -50.25 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.553 -0.717 . . . . 0.0 110.943 -170.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.639 HG22 ' HB3' ' A' ' 124' ' ' PRO . 20.3 p -105.26 12.25 32.02 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.372 -0.83 . . . . 0.0 111.945 -170.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 82.31 -23.24 5.55 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 120.97 -1.081 . . . . 0.0 111.85 168.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.581 HH12 HG23 ' A' ' 202' ' ' VAL . 25.9 mmt180 -45.79 142.07 2.69 Favored 'General case' 0 N--CA 1.505 2.325 0 CA-C-N 118.572 1.186 . . . . 0.0 112.569 -168.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -105.12 146.17 29.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.637 -0.664 . . . . 0.0 110.093 174.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 78.8 p -154.79 159.92 40.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.584 -0.698 . . . . 0.0 110.404 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.589 HG21 HG23 ' A' ' 228' ' ' VAL . 8.3 p -122.95 148.1 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.746 -0.596 . . . . 0.0 109.69 178.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.736 HD22 ' HG2' ' A' ' 187' ' ' ARG . 81.6 mt -129.69 154.58 47.02 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.797 -175.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.443 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.4 m -151.07 151.75 30.14 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.822 -0.549 . . . . 0.0 110.008 175.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -71.09 139.08 34.9 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 O-C-N 123.237 1.125 . . . . 0.0 109.999 177.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.693 ' HD2' HD11 ' A' ' 186' ' ' ILE . 61.8 t80 -76.04 123.9 26.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.488 -0.758 . . . . 0.0 110.219 176.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -99.95 160.09 28.15 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.668 -0.645 . . . . 0.0 110.029 176.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -58.76 159.72 19.96 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 O-C-N 123.154 1.081 . . . . 0.0 110.42 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.03 149.98 76.06 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 O-C-N 123.26 1.137 . . . . 0.0 110.522 -176.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -61.71 148.2 43.56 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.648 -0.658 . . . . 0.0 110.138 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.9 t -69.81 127.18 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.586 -0.696 . . . . 0.0 110.233 -170.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.93 -10.13 55.45 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 10.2 t -144.63 174.42 10.98 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.148 -1.207 . . . . 0.0 110.648 175.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -108.27 13.14 25.97 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.613 -0.679 . . . . 0.0 111.83 -167.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.422 ' CE1' ' NE2' ' A' ' 173' ' ' GLN . 40.2 p90 -123.88 168.17 13.13 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.096 -1.003 . . . . 0.0 111.148 -175.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 71.9 m -117.73 145.23 44.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.799 -0.563 . . . . 0.0 109.75 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 28.4 m -115.28 137.41 52.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.615 -0.678 . . . . 0.0 110.882 -174.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 57.8 t -128.78 136.99 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 172.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 63.9 mt -104.73 120.47 41.43 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.534 -0.729 . . . . 0.0 109.873 -174.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.643 ' CD2' HD12 ' A' ' 172' ' ' ILE . 3.8 m-85 -98.41 156.19 16.87 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.627 -0.67 . . . . 0.0 110.842 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -136.49 142.89 43.56 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 171.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -111.89 132.02 54.99 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.61 -0.681 . . . . 0.0 110.397 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 268' ' ' MET . . . . . 0.405 ' CG ' ' HA ' ' A' ' 225' ' ' LEU . 5.2 ppp? -102.73 6.77 39.63 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.659 -0.651 . . . . 0.0 111.874 -177.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 269' ' ' CYS . . . . . 0.661 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.6 OUTLIER -144.73 160.45 41.2 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.985 -1.072 . . . . 0.0 109.908 171.822 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.522 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.3 p30 -119.77 163.49 17.38 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.459 0.647 . . . . 0.0 110.506 -178.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 271' ' ' SER . . . . . 0.426 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 50.1 m -58.63 -33.09 69.66 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.482 -0.761 . . . . 0.0 111.028 -163.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 50.0 p -100.77 12.68 37.03 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.431 -0.793 . . . . 0.0 111.954 -163.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 29.6 p -94.69 117.99 31.02 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.091 -1.006 . . . . 0.0 110.625 177.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.4 t -64.42 139.78 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.561 -0.712 . . . . 0.0 110.356 -169.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.37 -5.02 60.5 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -125.06 -100.33 1.28 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 170.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' MET . . . . . 0.426 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.4 mmm -64.87 -31.44 72.67 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.693 -0.887 . . . . 0.0 110.355 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.8 p30 43.1 52.11 5.45 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 175.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 54.85 27.0 8.37 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.328 -0.858 . . . . 0.0 111.182 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 36.6 mtt180 -118.77 106.36 44.08 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.56 -0.712 . . . . 0.0 110.046 175.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.38 149.19 82.9 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 O-C-N 123.015 1.008 . . . . 0.0 110.691 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.636 HG22 ' HA ' ' A' ' 192' ' ' TYR . 44.6 pt -131.93 -179.7 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-O 121.752 0.786 . . . . 0.0 110.742 -177.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 302' ' ' GLU . 34.7 mt -124.33 149.93 46.03 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.56 HD12 ' CE1' ' A' ' 301' ' ' PHE . 77.7 mt -113.83 128.75 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.125 176.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.627 HG23 ' SG ' ' A' ' 300' ' ' CYS . 80.0 mt -109.84 126.46 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -175.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 59.2 t -118.88 126.69 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.2 p -125.36 154.7 41.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.683 -0.635 . . . . 0.0 110.516 -175.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.745 HD21 ' HB3' ' A' ' 180' ' ' PRO . 28.8 tp -102.61 126.42 49.68 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 168.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.746 ' OE2' HG13 ' A' ' 295' ' ' VAL . 74.1 mm-40 -131.61 150.3 52.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.845 -0.534 . . . . 0.0 109.937 -171.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.696 ' CG2' HD11 ' A' ' 296' ' ' LEU . 76.8 p -90.03 157.43 17.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.67 -0.644 . . . . 0.0 109.909 177.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -56.08 -26.1 48.12 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.587 -0.696 . . . . 0.0 110.932 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -91.03 11.86 21.65 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.451 -0.78 . . . . 0.0 111.745 -174.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 90.25 20.15 43.15 Favored Glycine 0 N--CA 1.494 2.541 0 C-N-CA 120.139 -1.029 . . . . 0.0 110.922 168.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -109.15 140.17 43.09 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.3 -1.118 . . . . 0.0 110.062 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.746 HG13 ' OE2' ' A' ' 289' ' ' GLU . 59.2 t -91.64 133.39 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.558 -0.714 . . . . 0.0 110.234 -174.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.696 HD11 ' CG2' ' A' ' 290' ' ' THR . 93.9 mt -99.97 -40.0 7.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.757 -0.589 . . . . 0.0 110.586 -179.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -159.29 155.41 26.5 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.698 ' CZ ' HG11 ' A' ' 295' ' ' VAL . 57.2 mtt85 -135.06 136.28 41.91 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.764 -0.845 . . . . 0.0 110.349 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -136.58 153.99 50.81 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.44 -0.787 . . . . 0.0 110.19 168.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' CYS . . . . . 0.627 ' SG ' HG23 ' A' ' 285' ' ' ILE . 95.8 m -143.29 154.01 43.35 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.545 -0.722 . . . . 0.0 110.626 -175.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.56 ' CE1' HD12 ' A' ' 284' ' ' ILE . 51.7 p90 -145.77 166.8 24.82 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.647 -0.658 . . . . 0.0 109.962 173.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.474 ' HA ' HD23 ' A' ' 283' ' ' LEU . 82.0 tt0 -104.92 135.62 45.93 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.421 -0.8 . . . . 0.0 110.193 -177.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -122.67 144.26 49.25 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.722 -169.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -138.08 138.94 39.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.747 -0.596 . . . . 0.0 109.694 173.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.661 HD13 ' O ' ' A' ' 269' ' ' CYS . 74.0 mt -107.42 122.83 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.548 -0.72 . . . . 0.0 109.735 176.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.8 p -145.27 169.71 17.7 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.7 -0.625 . . . . 0.0 110.647 -172.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -71.55 -40.11 70.24 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.626 -0.671 . . . . 0.0 110.648 -178.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.7 t -127.16 86.07 59.61 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.476 -0.765 . . . . 0.0 110.468 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -55.94 -28.16 67.15 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 O-C-N 123.251 1.132 . . . . 0.0 110.766 174.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -67.05 -37.8 92.11 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 177.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -72.76 -40.84 65.69 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.737 -0.86 . . . . 0.0 109.845 -173.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -69.5 -38.91 77.82 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.162 -178.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -61.81 -43.22 99.28 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.195 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 21.0 ttpp -64.18 -38.53 91.39 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.582 -0.699 . . . . 0.0 110.446 178.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -60.74 -50.52 73.13 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.507 -0.746 . . . . 0.0 110.46 -173.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -61.55 -37.81 85.15 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.482 -0.761 . . . . 0.0 110.087 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -62.07 -39.56 92.84 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.634 -0.666 . . . . 0.0 110.137 177.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -62.38 -35.17 78.34 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.601 -0.687 . . . . 0.0 109.926 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 24.5 m -62.57 -32.49 73.48 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.728 -0.608 . . . . 0.0 110.176 178.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 51.4 mm -77.56 -45.32 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.686 -0.634 . . . . 0.0 109.943 -178.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -59.11 -40.33 85.03 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.637 -0.664 . . . . 0.0 110.541 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -65.17 -43.3 92.19 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.645 -0.659 . . . . 0.0 110.07 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -65.65 -38.34 89.05 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.708 -0.62 . . . . 0.0 110.377 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -105.15 125.04 50.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.619 -0.675 . . . . 0.0 110.484 -175.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 62.9 t -116.41 130.07 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.6 -0.687 . . . . 0.0 109.834 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 29.3 t -95.11 137.13 34.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.624 -0.673 . . . . 0.0 110.332 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -114.43 116.74 29.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.649 -0.657 . . . . 0.0 110.228 177.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 49.4 m -94.09 142.63 27.17 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.595 -0.691 . . . . 0.0 110.301 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 67.9 p -135.68 157.33 47.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.624 -0.673 . . . . 0.0 109.994 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -61.29 -46.86 88.57 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.58 -0.7 . . . . 0.0 110.285 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -67.42 -46.85 71.97 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.555 -0.716 . . . . 0.0 110.291 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 96.1 -26.77 19.43 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 333' ' ' ASP . . . . . 0.407 ' O ' ' HB3' ' A' ' 334' ' ' ALA . 79.0 m-20 -101.48 160.06 14.76 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.521 -0.988 . . . . 0.0 110.44 -177.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 333' ' ' ASP . . . 57.59 109.69 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.585 -0.697 . . . . 0.0 110.711 -177.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -58.45 -45.95 87.53 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.608 -0.682 . . . . 0.0 110.379 -178.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 55.2 mmm-85 51.41 58.91 5.0 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.43 -0.794 . . . . 0.0 111.048 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -58.72 -41.51 86.56 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.561 -0.712 . . . . 0.0 110.384 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 27.7 t30 52.43 42.77 31.3 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.428 -0.795 . . . . 0.0 111.064 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 28.2 m -125.57 138.16 53.94 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.576 -0.702 . . . . 0.0 110.261 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -58.78 -38.97 79.7 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.574 -0.704 . . . . 0.0 110.489 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -148.01 -173.71 19.21 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 51.6 mm -91.96 132.43 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.601 -0.94 . . . . 0.0 110.075 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -93.09 148.66 21.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.625 -0.672 . . . . 0.0 110.348 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 93.3 mmm -59.96 -34.86 73.84 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.59 -0.694 . . . . 0.0 110.333 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 59.1 m . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.25 179.9 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 35.9 m -80.77 -29.28 36.2 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.676 -0.896 . . . . 0.0 110.18 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 57.6 p -71.77 163.26 28.12 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.649 -0.657 . . . . 0.0 110.181 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.813 HG23 ' H ' ' A' ' 119' ' ' ALA . 8.7 t -130.86 153.93 48.6 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.598 -0.689 . . . . 0.0 110.513 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -62.94 -37.68 88.02 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.671 -0.643 . . . . 0.0 110.696 -175.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -78.94 -31.91 45.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.504 -0.748 . . . . 0.0 110.226 -175.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.813 ' H ' HG23 ' A' ' 116' ' ' THR . . . 49.72 70.48 0.49 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.456 -0.777 . . . . 0.0 111.272 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.3 mt 55.75 -85.43 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.757 -0.589 . . . . 0.0 111.063 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 74.3 p -105.16 164.93 14.1 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.204 -0.935 . . . . 0.0 110.174 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -63.26 152.35 70.14 Favored 'Cis proline' 0 N--CA 1.495 1.563 0 C-N-CA 123.194 -1.586 . . . . 0.0 110.44 -18.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.9 m -82.01 158.97 66.62 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.638 -0.664 . . . . 0.0 110.274 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.517 ' HB3' HG22 ' A' ' 242' ' ' THR . 26.0 Cg_exo -59.04 147.11 91.79 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.333 1.175 . . . . 0.0 110.643 -178.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.59 144.02 42.03 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.666 -0.646 . . . . 0.0 110.136 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.619 HD11 HG22 ' A' ' 199' ' ' THR . 50.7 mm -121.88 100.02 43.7 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.711 -0.618 . . . . 0.0 109.998 -178.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 126' ' ' ILE . 12.6 Cg_endo -60.34 151.21 75.8 Favored 'Trans proline' 0 N--CA 1.487 1.147 0 O-C-N 123.185 1.097 . . . . 0.0 110.623 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.7 t -112.3 149.77 31.93 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.641 -0.662 . . . . 0.0 110.219 -178.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.7 p-10 -94.31 23.54 5.07 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.658 -0.651 . . . . 0.0 110.885 -178.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 54.0 m -72.35 125.15 26.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.471 -0.768 . . . . 0.0 110.212 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -70.53 144.92 51.17 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.602 -0.686 . . . . 0.0 110.401 -177.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.426 ' CE1' ' HA2' ' A' ' 134' ' ' GLY . 52.6 t80 -157.33 101.22 1.89 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.618 -0.676 . . . . 0.0 110.101 178.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.51 -39.94 78.76 Favored 'Trans proline' 0 N--CA 1.488 1.204 0 O-C-N 123.153 1.081 . . . . 0.0 110.952 -174.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.426 ' HA2' ' CE1' ' A' ' 132' ' ' TYR . . . 79.84 -155.11 38.52 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -74.18 -47.61 0.24 Allowed 'Trans proline' 0 C--N 1.317 -1.085 0 O-C-N 123.313 1.165 . . . . 0.0 110.846 -175.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -84.19 5.16 27.45 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.525 -0.734 . . . . 0.0 111.431 -175.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 54.01 59.97 3.92 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.898 -1.126 . . . . 0.0 110.681 -176.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.728 ' HA ' HG12 ' A' ' 176' ' ' VAL . 64.6 t80 -77.96 118.94 20.74 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.57 -0.706 . . . . 0.0 110.008 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -129.96 159.92 35.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.785 -0.572 . . . . 0.0 110.215 -175.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 71.9 t -123.65 146.66 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-O 121.443 0.639 . . . . 0.0 110.174 177.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 76.8 p -157.06 171.16 20.95 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 175.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.422 ' CE2' HG12 ' A' ' 172' ' ' ILE . 64.8 m-85 -126.57 125.08 41.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.706 -0.622 . . . . 0.0 109.916 -177.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -57.15 150.1 18.19 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.614 -0.679 . . . . 0.0 110.537 -177.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -69.99 133.56 47.39 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.652 -0.655 . . . . 0.0 110.542 -170.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.8 t -128.83 147.44 50.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.761 -0.587 . . . . 0.0 110.043 178.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 56.3 p -67.06 162.92 21.13 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.631 -0.668 . . . . 0.0 110.307 -178.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 73.3 p -101.84 26.31 7.63 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.682 -0.636 . . . . 0.0 110.178 178.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . -75.02 162.06 28.9 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.601 -0.687 . . . . 0.0 110.208 -177.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -55.51 170.55 0.24 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.577 -0.702 . . . . 0.0 110.724 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 68.0 m 52.83 26.38 4.54 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.548 -0.72 . . . . 0.0 111.091 -178.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 148' ' ' ALA . . . -77.26 120.63 22.56 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.594 -0.691 . . . . 0.0 109.943 176.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 57.9 p -60.15 -34.09 73.07 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.773 -0.579 . . . . 0.0 110.118 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.547 ' CE3' HD11 ' A' ' 162' ' ' LEU . 66.9 p-90 -170.46 148.14 3.09 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.636 -0.665 . . . . 0.0 109.752 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 13.7 t -141.52 142.36 33.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.717 -0.614 . . . . 0.0 110.031 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -125.65 140.04 53.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.482 -0.761 . . . . 0.0 110.532 -172.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 32.8 t -109.82 122.31 47.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.783 -0.573 . . . . 0.0 109.785 175.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 65.1 m -70.66 -36.8 73.56 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.689 -0.632 . . . . 0.0 110.482 -177.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -58.79 -34.28 71.29 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.615 -0.678 . . . . 0.0 110.582 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 53.8 mt -104.8 -11.71 16.66 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.61 -0.681 . . . . 0.0 110.804 -176.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.0 tttm 59.82 52.18 5.59 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.14 -0.975 . . . . 0.0 109.732 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -145.86 152.88 40.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.714 -0.616 . . . . 0.0 110.562 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.669 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.5 tp -126.66 137.83 53.34 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.863 -0.523 . . . . 0.0 110.256 -175.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -116.96 133.86 55.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.557 -0.714 . . . . 0.0 109.319 174.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.9 p -138.29 158.46 44.25 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 120.036 -0.665 . . . . 0.0 110.979 -174.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -104.52 143.9 32.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.62 -0.675 . . . . 0.0 110.398 172.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 16.9 tt -52.47 147.77 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 CA-C-O 121.64 0.733 . . . . 0.0 111.841 -173.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.16 10.01 5.18 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.628 -0.67 . . . . 0.0 112.539 177.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 32.3 mmtt -96.52 155.13 16.9 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.04 -1.037 . . . . 0.0 110.788 175.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 85.6 m -84.31 126.21 32.98 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.666 -0.646 . . . . 0.0 110.676 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' CYS . . . . . 0.669 ' SG ' HD21 ' A' ' 162' ' ' LEU . 42.6 t -112.63 90.31 14.67 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.514 -0.741 . . . . 0.0 110.082 173.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -64.75 129.28 23.03 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 123.339 1.179 . . . . 0.0 110.445 176.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.422 HG12 ' CE2' ' A' ' 142' ' ' PHE . 95.4 mt -123.17 138.67 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.665 -0.647 . . . . 0.0 109.36 176.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -108.72 133.97 52.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.546 -0.722 . . . . 0.0 110.637 -176.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.59 HG21 ' CE1' ' A' ' 138' ' ' PHE . 49.5 mm -95.37 135.07 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.641 -0.662 . . . . 0.0 109.674 172.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -118.08 129.93 55.85 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.583 -0.698 . . . . 0.0 110.597 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.728 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.3 m -136.3 159.74 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.475 -0.766 . . . . 0.0 109.957 175.152 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 79.7 mmm -77.46 -40.37 43.43 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.745 -0.597 . . . . 0.0 110.018 177.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.0 p -134.1 143.21 46.22 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.78 -0.575 . . . . 0.0 109.793 177.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 33.2 Cg_exo -55.67 139.88 83.6 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 O-C-N 123.2 1.105 . . . . 0.0 110.86 -173.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.616 ' HB3' HD21 ' A' ' 288' ' ' LEU . 23.5 Cg_endo -64.5 168.18 13.54 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 O-C-N 123.23 1.121 . . . . 0.0 110.635 178.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -61.53 158.21 37.72 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 O-C-N 123.353 1.186 . . . . 0.0 110.413 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -77.76 137.9 38.71 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.667 -0.645 . . . . 0.0 109.889 175.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.53 -24.97 30.08 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -174.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.1 149.98 2.58 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.367 -1.078 . . . . 0.0 111.373 177.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.71 155.99 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.654 -0.654 . . . . 0.0 109.816 176.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.656 HD11 ' CD2' ' A' ' 251' ' ' TYR . 69.8 mt -108.46 136.21 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.745 ' HG2' HD22 ' A' ' 248' ' ' LEU . 36.5 mtp180 -114.89 146.11 41.46 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -175.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.629 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -140.6 127.56 20.68 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.439 -0.788 . . . . 0.0 110.337 172.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.405 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 25.0 ttm -137.2 139.36 27.87 Favored Pre-proline 0 N--CA 1.495 1.811 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.031 -177.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.503 ' HD3' HD12 ' A' ' 226' ' ' ILE . 72.6 Cg_endo -91.34 138.29 2.21 Favored 'Trans proline' 0 C--N 1.32 -0.972 0 O-C-N 123.288 1.152 . . . . 0.0 110.772 177.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.428 HG13 ' C ' ' A' ' 190' ' ' PRO . 34.7 m -147.24 154.89 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.518 -0.739 . . . . 0.0 110.059 174.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.631 ' HA ' HG22 ' A' ' 282' ' ' ILE . 77.3 m-85 -61.6 164.78 5.58 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.47 -0.769 . . . . 0.0 110.545 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.437 ' HA ' HD12 ' A' ' 283' ' ' LEU . 48.7 tttp -80.33 -60.02 2.48 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.625 -0.672 . . . . 0.0 110.843 -174.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -80.04 151.2 30.06 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.601 -0.687 . . . . 0.0 110.372 -175.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.453 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.44 -38.52 71.74 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.368 -0.832 . . . . 0.0 110.736 -175.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -56.49 -24.92 49.34 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.525 -0.735 . . . . 0.0 110.58 -176.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.42 ' HB3' ' CG ' ' A' ' 192' ' ' TYR . 63.2 m170 -110.05 -20.49 12.69 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.094 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.453 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -67.14 -20.22 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.157 -0.964 . . . . 0.0 110.564 -176.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.619 HG22 HD11 ' A' ' 126' ' ' ILE . 81.3 p -79.35 -17.08 55.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.502 -0.749 . . . . 0.0 110.777 175.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.25 135.65 33.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.342 -0.849 . . . . 0.0 110.09 173.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.99 142.97 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.682 -0.636 . . . . 0.0 110.22 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 60.2 t -84.93 138.82 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.529 -0.732 . . . . 0.0 109.257 172.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 14.0 pttt -134.77 -170.29 2.53 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.412 -0.805 . . . . 0.0 111.345 -168.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 74.4 mtm-85 -95.3 156.05 16.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.807 -0.558 . . . . 0.0 110.319 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 48.7 m -75.64 154.75 85.48 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.571 -0.706 . . . . 0.0 109.237 173.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.4 ' HD3' ' HA3' ' A' ' 275' ' ' GLY . 17.4 Cg_exo -62.83 -47.35 8.95 Favored 'Trans proline' 0 C--N 1.315 -1.231 0 O-C-N 123.147 1.077 . . . . 0.0 110.056 176.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.412 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.7 p-10 -65.44 -44.1 88.37 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.566 -0.709 . . . . 0.0 111.245 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' HIS . . . . . 0.412 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 51.2 m170 -82.06 -28.27 32.52 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.411 -0.805 . . . . 0.0 111.171 -174.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 59.4 tt0 -69.2 -37.8 78.3 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.424 -0.798 . . . . 0.0 110.313 172.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 27.1 tp -55.62 -34.56 64.99 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.509 -0.745 . . . . 0.0 110.946 -175.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 28.6 t -48.4 137.51 11.25 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.477 -0.764 . . . . 0.0 111.392 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.442 ' HB2' ' CE2' ' A' ' 214' ' ' PHE . 88.7 mtt180 -60.52 144.26 51.81 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.667 -0.646 . . . . 0.0 110.336 -176.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -63.69 -37.34 86.99 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.727 -0.608 . . . . 0.0 110.328 -178.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.442 ' CE2' ' HB2' ' A' ' 212' ' ' ARG . 8.1 m-85 51.36 50.74 18.29 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.394 -0.816 . . . . 0.0 110.967 -177.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -67.67 -10.39 51.89 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.605 -0.684 . . . . 0.0 111.161 -176.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.63 119.73 9.24 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.202 -0.936 . . . . 0.0 110.208 177.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 74.15 20.12 79.71 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -140.56 153.48 46.15 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.314 -1.11 . . . . 0.0 110.024 -177.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.2 mt -114.97 -8.65 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.678 -0.639 . . . . 0.0 111.143 -177.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -124.94 93.15 46.4 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.18 -0.95 . . . . 0.0 110.474 -173.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.426 ' HD2' ' CE2' ' A' ' 236' ' ' TYR . 28.7 Cg_endo -67.96 150.92 78.27 Favored 'Trans proline' 0 C--N 1.316 -1.168 0 O-C-N 123.355 1.187 . . . . 0.0 110.608 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -60.37 -16.77 43.42 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 O-C-N 123.183 1.097 . . . . 0.0 111.432 -176.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 26.3 m -51.77 -27.1 11.11 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.173 -0.954 . . . . 0.0 111.303 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' HIS . . . . . 0.407 ' CD2' ' HB3' ' A' ' 245' ' ' GLN . 12.9 t-80 -109.64 129.28 55.61 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.497 -0.752 . . . . 0.0 110.46 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.515 HD12 ' HG3' ' A' ' 268' ' ' MET . 41.3 tp -60.53 -36.43 78.39 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.617 -0.677 . . . . 0.0 110.341 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.503 HD12 ' HD3' ' A' ' 190' ' ' PRO . 84.3 mt -101.81 136.75 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.767 -0.583 . . . . 0.0 110.034 -176.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -125.65 158.11 35.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.692 -0.63 . . . . 0.0 110.135 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.462 HG23 HG21 ' A' ' 247' ' ' VAL . 90.3 t -104.44 146.6 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.701 -0.625 . . . . 0.0 109.844 172.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -118.74 128.13 54.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.629 -0.67 . . . . 0.0 110.4 170.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.11 20.93 21.99 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 168.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -139.37 105.05 5.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.313 -1.11 . . . . 0.0 110.034 174.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 44.2 m -63.49 -15.21 57.2 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.547 -0.721 . . . . 0.0 111.24 -176.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -100.01 8.02 44.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.223 -0.923 . . . . 0.0 111.621 -177.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.68 133.22 55.33 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.108 -0.995 . . . . 0.0 110.175 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -139.8 158.06 44.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.756 -0.59 . . . . 0.0 109.83 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.426 ' CE2' ' HD2' ' A' ' 221' ' ' PRO . 90.4 m-85 -113.87 150.6 33.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.596 -0.69 . . . . 0.0 110.556 -177.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.06 159.98 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.771 -0.58 . . . . 0.0 110.233 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -122.7 130.05 52.51 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.743 -0.598 . . . . 0.0 110.201 177.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -65.04 112.36 7.99 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.672 -0.643 . . . . 0.0 109.714 177.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -60.23 -25.55 80.37 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.107 1.056 . . . . 0.0 110.998 -172.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.8 mt -101.14 -50.32 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.368 -0.832 . . . . 0.0 110.824 -171.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.517 HG22 ' HB3' ' A' ' 124' ' ' PRO . 6.6 p -105.33 12.16 31.99 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.341 -0.85 . . . . 0.0 111.998 -172.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 82.29 -24.85 4.58 Favored Glycine 0 N--CA 1.497 2.742 0 O-C-N 121.007 -1.058 . . . . 0.0 111.813 170.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 23.8 mmt85 -45.81 142.13 2.67 Favored 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 118.54 1.17 . . . . 0.0 112.544 -168.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.407 ' HB3' ' CD2' ' A' ' 224' ' ' HIS . 18.2 mp0 -108.51 145.08 35.28 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.626 -0.671 . . . . 0.0 110.047 174.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 77.3 p -154.84 159.91 40.87 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.572 -0.705 . . . . 0.0 110.487 178.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.462 HG21 HG23 ' A' ' 228' ' ' VAL . 8.5 p -123.01 148.07 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.77 -0.581 . . . . 0.0 109.655 178.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.745 HD22 ' HG2' ' A' ' 187' ' ' ARG . 78.8 mt -129.69 154.62 46.97 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.872 -173.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.438 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.9 m -150.69 151.82 31.16 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.819 -0.55 . . . . 0.0 109.858 174.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -71.02 139.49 35.99 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.173 1.091 . . . . 0.0 110.012 177.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.656 ' CD2' HD11 ' A' ' 186' ' ' ILE . 9.4 t80 -79.82 123.37 27.66 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.463 -0.773 . . . . 0.0 110.05 178.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -100.1 160.05 28.19 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.677 -0.64 . . . . 0.0 110.095 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -58.91 159.97 19.7 Favored 'Trans proline' 0 N--CA 1.487 1.118 0 O-C-N 123.298 1.157 . . . . 0.0 110.425 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -59.15 149.95 76.85 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.245 1.129 . . . . 0.0 110.614 -176.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -61.21 148.94 39.19 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.692 -0.63 . . . . 0.0 110.166 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.78 127.22 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.469 -0.769 . . . . 0.0 110.158 -170.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.92 -10.11 55.46 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 9.9 t -145.02 173.33 11.98 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.245 -1.15 . . . . 0.0 110.607 175.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -107.35 13.14 27.35 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.586 -0.696 . . . . 0.0 111.743 -168.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -120.01 168.0 11.61 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.167 -0.958 . . . . 0.0 111.164 -175.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 93.2 m -117.71 147.01 43.34 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.781 -0.574 . . . . 0.0 109.859 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 38.5 m -116.83 135.0 54.08 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.541 -0.724 . . . . 0.0 110.927 -175.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.4 t -129.66 137.12 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 171.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 70.1 mt -104.83 122.09 45.03 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.582 -0.699 . . . . 0.0 109.903 -173.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.629 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 6.6 m-30 -106.92 149.4 27.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.637 -0.664 . . . . 0.0 110.633 -178.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -136.63 142.95 43.27 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -111.04 131.55 54.97 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.575 -0.703 . . . . 0.0 110.499 -176.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' MET . . . . . 0.515 ' HG3' HD12 ' A' ' 225' ' ' LEU . 3.9 ppp? -96.79 2.87 52.38 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.708 -0.62 . . . . 0.0 112.119 -176.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 269' ' ' CYS . . . . . 0.656 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.8 OUTLIER -144.67 165.03 29.2 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.055 -1.028 . . . . 0.0 110.11 174.704 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.596 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.6 p30 -119.86 162.37 19.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.72 -0.612 . . . . 0.0 110.303 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 271' ' ' SER . . . . . 0.423 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 23.1 m -58.29 -33.47 69.49 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.468 -0.77 . . . . 0.0 110.983 -163.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 49.2 p -97.9 9.88 41.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.458 -0.776 . . . . 0.0 112.07 -163.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 31.2 p -93.79 118.07 30.94 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.09 -1.006 . . . . 0.0 110.691 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 60.4 t -64.42 140.52 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.442 -0.786 . . . . 0.0 110.305 -170.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 275' ' ' GLY . . . . . 0.4 ' HA3' ' HD3' ' A' ' 206' ' ' PRO . . . 100.74 -5.21 56.62 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 177.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.62 -99.16 0.88 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 170.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 277' ' ' MET . . . . . 0.423 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.2 mmm -63.85 -31.59 72.82 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.639 -0.918 . . . . 0.0 110.3 178.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.5 p30 43.84 50.56 6.92 Favored 'General case' 0 N--CA 1.504 2.234 0 CA-C-O 121.286 0.565 . . . . 0.0 112.521 175.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 22.0 mtt180 54.81 29.67 12.31 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.29 -0.881 . . . . 0.0 111.17 175.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -119.28 104.97 45.08 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.517 -0.739 . . . . 0.0 110.149 175.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.85 145.95 96.96 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 123.077 1.04 . . . . 0.0 110.522 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.631 HG22 ' HA ' ' A' ' 192' ' ' TYR . 45.6 pt -131.98 177.59 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 121.79 0.805 . . . . 0.0 111.132 -175.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 302' ' ' GLU . 30.1 mt -124.34 149.9 46.1 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.702 HD12 ' CE1' ' A' ' 301' ' ' PHE . 77.6 mt -115.03 129.91 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.213 177.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.526 HG23 ' SG ' ' A' ' 300' ' ' CYS . 82.3 mt -109.71 127.17 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -176.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 58.7 t -118.83 126.73 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.634 HG22 ' HG2' ' A' ' 298' ' ' ARG . 45.5 p -125.21 153.8 42.57 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.466 -174.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.616 HD21 ' HB3' ' A' ' 180' ' ' PRO . 27.1 tp -105.32 126.08 51.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.73 -0.606 . . . . 0.0 109.535 169.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.566 ' OE2' HG13 ' A' ' 295' ' ' VAL . 71.0 mm-40 -131.79 148.86 52.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.955 -0.466 . . . . 0.0 109.768 -174.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.81 ' CG2' HD11 ' A' ' 296' ' ' LEU . 54.4 p -89.88 161.68 15.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.641 -0.662 . . . . 0.0 109.98 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -55.99 -26.09 46.89 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.544 -0.723 . . . . 0.0 111.112 -174.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 40.8 p30 -91.6 10.25 28.85 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.379 -0.826 . . . . 0.0 111.923 -173.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.85 20.19 44.47 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 120.14 -1.028 . . . . 0.0 110.725 171.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -106.0 140.15 39.44 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.256 -1.144 . . . . 0.0 110.001 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.566 HG13 ' OE2' ' A' ' 289' ' ' GLU . 58.5 t -89.21 132.09 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.634 -0.666 . . . . 0.0 110.282 -172.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.81 HD11 ' CG2' ' A' ' 290' ' ' THR . 95.9 mt -99.92 -40.2 7.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.682 -0.636 . . . . 0.0 110.694 178.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -169.34 158.54 31.01 Favored Glycine 0 N--CA 1.496 2.686 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.612 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.634 ' HG2' HG22 ' A' ' 287' ' ' THR . 94.1 mtt180 -134.6 138.89 44.93 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.619 -0.93 . . . . 0.0 110.957 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -132.76 159.27 40.21 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.639 -0.663 . . . . 0.0 109.727 169.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 300' ' ' CYS . . . . . 0.526 ' SG ' HG23 ' A' ' 285' ' ' ILE . 87.6 m -144.06 154.38 43.16 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.409 -0.807 . . . . 0.0 110.76 -176.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.702 ' CE1' HD12 ' A' ' 284' ' ' ILE . 48.7 p90 -145.78 161.86 38.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.614 -0.679 . . . . 0.0 110.087 174.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.462 ' HA ' HD23 ' A' ' 283' ' ' LEU . 82.4 tt0 -104.83 136.81 43.64 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.619 -0.676 . . . . 0.0 110.224 -176.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -124.3 142.75 51.01 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.779 -170.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -138.11 140.91 40.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.793 -0.567 . . . . 0.0 109.684 172.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.656 HD13 ' O ' ' A' ' 269' ' ' CYS . 74.5 mt -108.29 122.78 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.462 -0.774 . . . . 0.0 109.688 176.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.0 p -145.31 170.28 16.61 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.605 -0.684 . . . . 0.0 110.676 -171.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -72.47 -40.18 67.17 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.662 -0.649 . . . . 0.0 110.648 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.7 t -126.83 85.75 60.18 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.471 -0.768 . . . . 0.0 110.485 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -55.69 -28.19 64.91 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 O-C-N 123.121 1.064 . . . . 0.0 110.856 174.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.95 -38.18 92.66 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 177.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 57.5 ttt85 -72.61 -40.37 66.54 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.621 -0.929 . . . . 0.0 109.875 -173.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -69.53 -38.91 77.71 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.137 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.401 ' HA ' ' OD2' ' A' ' 316' ' ' ASP . 70.3 ttt180 -61.25 -43.28 99.13 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.52 -0.738 . . . . 0.0 110.251 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -64.51 -40.82 96.34 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.567 -0.708 . . . . 0.0 110.604 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -60.73 -49.88 75.71 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.478 -0.764 . . . . 0.0 110.559 -173.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 316' ' ' ASP . . . . . 0.401 ' OD2' ' HA ' ' A' ' 313' ' ' ARG . 2.9 p30 -61.27 -37.72 84.16 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.418 -0.802 . . . . 0.0 110.045 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -61.31 -40.57 94.69 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.557 -0.714 . . . . 0.0 110.171 177.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -63.05 -35.28 79.73 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.671 -0.643 . . . . 0.0 110.249 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 37.0 p -66.65 -28.58 68.59 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.661 -0.65 . . . . 0.0 110.318 -178.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 50.9 mm -78.85 -44.37 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.61 -0.681 . . . . 0.0 109.956 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -59.14 -39.76 83.4 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.626 -0.671 . . . . 0.0 110.452 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 20.0 mtpp -61.79 -42.43 98.99 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.186 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -64.49 -32.95 74.8 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.63 -0.669 . . . . 0.0 110.276 178.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -84.55 125.02 32.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.669 -0.644 . . . . 0.0 110.396 -176.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 61.8 t -117.26 130.15 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.587 -0.696 . . . . 0.0 109.787 178.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 28.9 t -60.19 140.05 57.19 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.63 -0.669 . . . . 0.0 110.277 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -72.38 143.46 48.57 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.701 -0.625 . . . . 0.0 110.244 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 63.7 m -94.05 159.22 15.26 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.674 -0.641 . . . . 0.0 110.173 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 4.6 m -139.85 27.45 2.21 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.591 -0.693 . . . . 0.0 110.401 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -96.22 21.68 8.63 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.54 -0.725 . . . . 0.0 110.624 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 41.5 p-10 -84.83 -165.65 1.25 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.456 -0.777 . . . . 0.0 110.453 -178.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 92.63 -161.68 26.19 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -80.18 121.21 25.3 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.672 -0.899 . . . . 0.0 110.269 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -140.01 157.37 45.77 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.689 -0.632 . . . . 0.0 110.18 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -120.94 160.71 22.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.681 -0.637 . . . . 0.0 110.46 -177.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 56.45 -85.39 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.766 -0.584 . . . . 0.0 111.146 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 53.16 48.07 23.03 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.122 -0.986 . . . . 0.0 110.878 -176.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -58.1 -36.76 73.35 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.58 -0.7 . . . . 0.0 110.535 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 68.5 p -123.59 158.54 31.2 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.664 -0.647 . . . . 0.0 110.19 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -128.98 145.86 51.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.609 -0.682 . . . . 0.0 110.286 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -97.67 27.24 19.74 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.632 HG22 ' H ' ' A' ' 344' ' ' MET . 82.3 mt -93.77 135.27 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.556 -0.967 . . . . 0.0 109.866 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -90.72 16.5 9.1 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.648 -0.658 . . . . 0.0 111.148 -177.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 344' ' ' MET . . . . . 0.632 ' H ' HG22 ' A' ' 342' ' ' ILE . 70.1 mtm -125.8 157.03 38.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.276 -0.89 . . . . 0.0 110.236 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.236 -179.992 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 74.9 m -86.09 9.22 17.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.689 -0.889 . . . . 0.0 111.332 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.6 m -120.02 147.05 45.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.183 -0.948 . . . . 0.0 110.294 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 49.1 m -123.66 140.9 52.53 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.733 -0.605 . . . . 0.0 110.238 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -115.62 148.57 39.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.618 -0.677 . . . . 0.0 110.242 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -80.36 -31.97 37.79 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.659 -0.651 . . . . 0.0 110.215 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 56.45 -84.69 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.646 -0.659 . . . . 0.0 110.843 -176.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 30.3 tp 55.85 -86.66 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.23 -0.919 . . . . 0.0 110.857 -177.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.9 p -131.55 162.58 55.26 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.132 -0.98 . . . . 0.0 110.305 -177.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -64.84 151.48 75.4 Favored 'Cis proline' 0 N--CA 1.496 1.618 0 C-N-CA 123.101 -1.625 . . . . 0.0 110.31 -17.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.8 t -81.27 144.06 53.29 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.631 -0.668 . . . . 0.0 110.153 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -64.23 146.78 90.85 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.297 1.156 . . . . 0.0 110.362 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.5 149.01 38.53 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.663 -0.648 . . . . 0.0 109.991 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.681 HD11 HG22 ' A' ' 199' ' ' THR . 49.9 mm -119.99 138.34 26.86 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.573 -0.705 . . . . 0.0 109.982 -178.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -65.61 154.47 73.64 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 123.141 1.074 . . . . 0.0 110.418 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 27.5 t -114.22 142.88 45.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.612 -0.68 . . . . 0.0 110.238 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.4 p-10 -101.89 25.22 8.91 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.586 -0.696 . . . . 0.0 110.699 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 49.1 m -79.17 125.23 29.17 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.617 -0.677 . . . . 0.0 110.262 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -68.86 144.93 54.1 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.696 -0.628 . . . . 0.0 110.418 -177.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -154.3 99.81 2.48 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.76 -0.587 . . . . 0.0 110.038 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.47 -39.99 78.58 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 O-C-N 123.181 1.095 . . . . 0.0 110.823 -175.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.94 -155.19 47.65 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -73.72 -46.31 0.34 Allowed 'Trans proline' 0 C--N 1.316 -1.155 0 O-C-N 123.354 1.186 . . . . 0.0 110.959 -173.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -87.38 9.08 21.76 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.509 -0.745 . . . . 0.0 111.376 -173.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.61 61.28 3.18 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.991 -1.068 . . . . 0.0 110.727 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.677 ' HA ' HG12 ' A' ' 176' ' ' VAL . 46.3 t80 -77.86 119.22 21.03 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.587 -0.696 . . . . 0.0 109.869 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -130.08 160.43 33.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.829 -0.545 . . . . 0.0 110.154 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 63.2 t -125.76 145.57 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.82 -0.55 . . . . 0.0 109.767 177.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 78.4 p -155.46 160.51 40.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.734 -0.603 . . . . 0.0 110.067 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.434 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 67.8 m-85 -126.75 125.23 41.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.854 -0.529 . . . . 0.0 109.788 -176.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -58.1 137.48 56.9 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.623 -0.673 . . . . 0.0 110.287 -175.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -120.14 155.54 32.86 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.683 -0.635 . . . . 0.0 110.517 -176.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 23.2 t -149.29 171.74 16.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.697 -0.627 . . . . 0.0 110.05 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 43.9 m -59.62 156.33 13.81 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.58 -0.7 . . . . 0.0 110.179 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.1 p -59.11 98.93 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.619 -0.676 . . . . 0.0 110.351 -176.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.12 149.08 22.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.735 -0.603 . . . . 0.0 110.224 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -69.4 133.58 47.95 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.583 -0.698 . . . . 0.0 109.961 178.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.0 t 52.49 74.93 0.25 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.411 -0.806 . . . . 0.0 110.87 -177.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -93.31 132.52 37.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.589 -0.694 . . . . 0.0 110.149 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.441 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 75.8 p -60.09 -33.09 71.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.716 -0.615 . . . . 0.0 109.932 176.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.441 ' HD1' ' HG1' ' A' ' 152' ' ' THR . 68.6 p-90 -170.95 142.6 1.88 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.309 0.576 . . . . 0.0 110.026 178.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 13.2 t -142.2 142.57 32.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.942 -0.474 . . . . 0.0 109.952 -176.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.434 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 64.1 t80 -125.51 140.03 53.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.523 -0.736 . . . . 0.0 110.544 -172.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 28.5 t -110.24 124.41 51.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.861 -0.525 . . . . 0.0 109.845 176.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 58.6 m -70.76 -36.94 73.33 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.789 -0.569 . . . . 0.0 110.556 -177.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -59.43 -34.66 72.77 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.561 -0.712 . . . . 0.0 110.464 -177.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 57.4 mt -104.88 -11.98 16.47 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.672 -0.642 . . . . 0.0 110.88 -175.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 59.8 tttt 59.79 52.01 5.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.065 -1.022 . . . . 0.0 109.746 178.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -145.35 152.99 40.74 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.707 -0.621 . . . . 0.0 110.556 -175.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.656 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.55 137.79 53.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.69 -0.631 . . . . 0.0 110.344 -176.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -116.19 134.2 55.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.675 -0.641 . . . . 0.0 109.382 174.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.3 158.39 44.39 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.939 -175.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -104.61 143.38 33.15 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.469 0.652 . . . . 0.0 110.396 173.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.439 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 16.7 tt -52.0 146.51 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.608 -0.682 . . . . 0.0 111.813 -175.043 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 65.2 10.01 6.06 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.665 -0.647 . . . . 0.0 112.415 177.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -96.63 155.13 16.9 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.068 -1.02 . . . . 0.0 110.832 174.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 62.3 m -88.53 126.22 35.15 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.662 -0.648 . . . . 0.0 110.669 -177.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' CYS . . . . . 0.656 ' SG ' HD21 ' A' ' 162' ' ' LEU . 44.2 t -113.71 90.08 17.45 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.59 -0.694 . . . . 0.0 110.19 175.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.439 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 23.7 Cg_exo -60.75 130.26 32.45 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 O-C-N 123.268 1.141 . . . . 0.0 110.678 172.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.402 HG12 ' CE2' ' A' ' 142' ' ' PHE . 97.5 mt -124.9 141.66 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 176.096 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -109.5 135.43 50.51 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.464 -0.772 . . . . 0.0 110.879 -175.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.408 HG23 ' CE1' ' A' ' 138' ' ' PHE . 50.5 mm -95.29 133.58 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.713 -0.617 . . . . 0.0 109.624 169.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 40.2 tttp -114.49 128.77 56.51 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.579 -0.701 . . . . 0.0 110.449 176.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.677 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.1 m -136.72 159.88 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.588 -0.695 . . . . 0.0 109.86 175.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.7 mmm -76.57 -41.4 46.53 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.666 -0.646 . . . . 0.0 110.1 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.0 p -134.78 143.27 45.65 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.763 -0.586 . . . . 0.0 109.695 178.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.9 Cg_exo -55.45 139.74 82.24 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 O-C-N 123.156 1.082 . . . . 0.0 110.889 -171.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.683 ' HB3' HD21 ' A' ' 288' ' ' LEU . 34.9 Cg_endo -67.63 169.99 14.76 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 O-C-N 123.157 1.082 . . . . 0.0 110.608 177.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -60.81 155.28 50.05 Favored 'Trans proline' 0 C--N 1.316 -1.152 0 O-C-N 123.327 1.172 . . . . 0.0 110.521 -178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -77.46 141.09 39.88 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.519 -0.738 . . . . 0.0 109.879 174.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.8 -24.88 29.76 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -174.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.19 150.74 2.31 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.412 -1.052 . . . . 0.0 111.4 177.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.7 156.04 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.762 -0.586 . . . . 0.0 109.688 176.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.742 HD11 ' HD2' ' A' ' 251' ' ' TYR . 84.2 mt -109.16 141.49 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.752 -0.592 . . . . 0.0 109.599 177.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.68 ' HG2' HD22 ' A' ' 248' ' ' LEU . 70.6 mtp180 -114.78 145.2 42.37 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -176.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.638 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -140.03 126.29 19.98 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.339 173.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.407 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 41.9 ttm -137.24 139.9 29.37 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.81 -0.557 . . . . 0.0 111.059 -176.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.494 ' HD3' HD12 ' A' ' 226' ' ' ILE . 73.9 Cg_endo -91.19 138.23 2.26 Favored 'Trans proline' 0 C--N 1.32 -0.964 0 O-C-N 123.3 1.158 . . . . 0.0 110.812 177.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.438 HG13 ' C ' ' A' ' 190' ' ' PRO . 34.8 m -147.7 154.9 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.574 -0.704 . . . . 0.0 109.988 173.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.6 ' HA ' HG22 ' A' ' 282' ' ' ILE . 87.2 m-85 -61.49 165.76 4.59 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.462 -0.774 . . . . 0.0 110.447 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.486 ' HA ' HD12 ' A' ' 283' ' ' LEU . 33.2 ttmt -83.99 -60.05 2.22 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.626 -0.671 . . . . 0.0 110.799 -173.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 48.3 mttt -80.04 152.49 29.37 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.639 -0.663 . . . . 0.0 110.332 -175.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.452 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.56 -38.75 72.36 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.462 -0.774 . . . . 0.0 110.698 -175.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -56.48 -24.91 49.25 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.519 -0.738 . . . . 0.0 110.621 -176.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.413 ' HB3' ' CG ' ' A' ' 192' ' ' TYR . 77.8 m80 -109.7 -20.5 12.8 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.137 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -67.6 -20.23 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.123 -0.986 . . . . 0.0 110.576 -175.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.681 HG22 HD11 ' A' ' 126' ' ' ILE . 71.7 p -79.48 -16.91 55.25 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.763 174.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -88.37 134.93 33.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.359 -0.838 . . . . 0.0 110.1 173.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 242' ' ' THR . 60.9 t -72.97 145.91 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.615 -0.678 . . . . 0.0 110.27 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 60.6 t -84.72 139.79 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.564 -0.71 . . . . 0.0 109.223 172.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.8 pttp -134.85 -170.16 2.51 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.422 -0.799 . . . . 0.0 111.295 -166.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -95.21 152.59 18.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.789 -0.57 . . . . 0.0 110.102 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 36.5 m -73.5 152.16 89.67 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.471 -0.768 . . . . 0.0 109.025 173.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.408 ' HD3' ' HA3' ' A' ' 275' ' ' GLY . 19.6 Cg_exo -61.8 -47.31 11.25 Favored 'Trans proline' 0 C--N 1.315 -1.231 0 O-C-N 123.071 1.037 . . . . 0.0 110.243 177.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.408 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.6 p-10 -65.38 -44.1 88.64 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.615 -0.678 . . . . 0.0 111.236 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' HIS . . . . . 0.408 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 52.0 m170 -82.82 -27.93 30.56 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.442 -0.786 . . . . 0.0 111.191 -174.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -69.05 -39.24 79.26 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.341 -0.849 . . . . 0.0 110.302 174.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 25.9 tp -57.11 -35.93 70.02 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.493 -0.755 . . . . 0.0 110.75 -177.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 30.6 t -48.28 141.03 6.87 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.504 -0.748 . . . . 0.0 111.376 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -60.76 141.54 56.84 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.595 -0.691 . . . . 0.0 110.248 -177.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -64.04 -37.06 86.06 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.736 -0.603 . . . . 0.0 110.143 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.406 ' CD2' ' O ' ' A' ' 214' ' ' PHE . 59.1 t80 51.21 51.32 17.2 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.521 -0.737 . . . . 0.0 111.038 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -73.34 -10.22 59.52 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.711 -0.618 . . . . 0.0 111.16 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -60.41 118.55 6.6 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.254 -0.904 . . . . 0.0 110.326 177.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 78.0 20.04 73.86 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 177.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -139.52 140.02 37.06 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.292 -1.122 . . . . 0.0 110.139 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.1 mt -84.91 -24.89 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.689 -0.632 . . . . 0.0 110.529 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -124.83 99.35 35.32 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.429 -0.794 . . . . 0.0 110.482 -173.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 222' ' ' PRO . 22.2 Cg_endo -66.08 149.49 85.78 Favored 'Trans proline' 0 C--N 1.316 -1.132 0 O-C-N 123.211 1.111 . . . . 0.0 110.645 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 221' ' ' PRO . 33.0 Cg_exo -57.5 -19.57 37.07 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 O-C-N 123.285 1.15 . . . . 0.0 111.484 -178.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 25.9 m -51.14 -27.06 7.62 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.153 -0.967 . . . . 0.0 111.467 -177.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -101.92 129.93 48.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.517 -0.739 . . . . 0.0 110.433 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.72 -39.42 88.54 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.69 -0.631 . . . . 0.0 110.202 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.494 HD12 ' HD3' ' A' ' 190' ' ' PRO . 83.7 mt -104.94 136.81 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.834 -0.541 . . . . 0.0 109.801 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -132.47 157.82 43.65 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.797 -0.564 . . . . 0.0 110.292 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.461 HG23 HG21 ' A' ' 247' ' ' VAL . 94.1 t -102.67 146.56 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.722 -0.611 . . . . 0.0 109.909 175.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -117.26 124.14 48.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.722 -0.611 . . . . 0.0 110.428 172.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 95.79 24.33 15.77 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 167.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -137.27 107.07 6.23 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.5 -1.0 . . . . 0.0 110.015 174.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 28.0 t -63.03 -15.2 55.66 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.611 -0.68 . . . . 0.0 111.203 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -100.0 9.34 43.06 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.289 -0.882 . . . . 0.0 111.588 -177.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.37 127.91 33.77 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.129 -0.982 . . . . 0.0 110.179 176.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -139.75 158.01 44.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.707 -0.62 . . . . 0.0 109.868 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -114.67 150.66 34.85 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.604 -0.685 . . . . 0.0 110.576 -176.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.13 160.0 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.742 -0.599 . . . . 0.0 110.173 177.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -119.17 130.06 55.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.703 -0.623 . . . . 0.0 110.227 176.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -64.18 130.04 94.36 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.66 -0.65 . . . . 0.0 109.833 178.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -65.41 -28.34 54.39 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.187 1.098 . . . . 0.0 111.024 -170.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.8 mt -101.74 -50.5 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.425 -0.797 . . . . 0.0 111.051 -167.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.445 ' O ' HG21 ' A' ' 201' ' ' VAL . 11.1 p -105.4 12.18 31.86 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.446 -0.784 . . . . 0.0 111.843 -174.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 72.3 -5.01 16.43 Favored Glycine 0 N--CA 1.496 2.688 0 O-C-N 121.102 -0.999 . . . . 0.0 112.007 173.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.419 ' CZ ' HG12 ' A' ' 191' ' ' VAL . 23.4 mmt180 -45.91 142.05 2.8 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-N 119.134 1.467 . . . . 0.0 112.36 -174.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -103.61 143.43 32.77 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.715 -0.616 . . . . 0.0 110.117 175.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 76.5 p -154.74 159.95 41.0 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.637 -0.664 . . . . 0.0 110.332 177.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.461 HG21 HG23 ' A' ' 228' ' ' VAL . 8.2 p -123.0 148.2 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.789 -0.569 . . . . 0.0 109.699 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 187' ' ' ARG . 79.9 mt -129.51 154.56 46.9 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.615 -175.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.439 HG13 ' C ' ' A' ' 248' ' ' LEU . 32.5 m -151.13 151.78 30.09 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.776 -0.577 . . . . 0.0 109.955 175.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -71.14 139.59 35.81 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 O-C-N 123.333 1.175 . . . . 0.0 110.009 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.742 ' HD2' HD11 ' A' ' 186' ' ' ILE . 59.2 t80 -75.76 127.22 32.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.539 -0.726 . . . . 0.0 110.123 175.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -100.11 160.09 28.06 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.765 -0.584 . . . . 0.0 109.979 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -58.77 158.34 24.71 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.213 1.112 . . . . 0.0 110.496 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.25 149.95 77.43 Favored 'Trans proline' 0 N--CA 1.487 1.145 0 O-C-N 123.206 1.109 . . . . 0.0 110.549 -177.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -61.87 147.73 45.69 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.603 -0.686 . . . . 0.0 110.146 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.92 127.25 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.537 -0.727 . . . . 0.0 110.161 -170.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.95 -10.17 55.43 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.431 HG21 ' CE2' ' A' ' 260' ' ' PHE . 9.2 t -144.46 174.14 11.19 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.253 -1.145 . . . . 0.0 110.566 175.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -108.08 13.22 26.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.622 -0.674 . . . . 0.0 111.839 -167.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 258' ' ' THR . 38.6 p90 -120.0 168.09 11.51 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.15 -0.969 . . . . 0.0 111.101 -175.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 76.9 m -117.75 145.87 44.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.756 -0.59 . . . . 0.0 109.836 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 55.8 m -116.64 134.81 54.37 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.478 0.656 . . . . 0.0 110.91 -174.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 64.0 t -130.35 137.32 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 172.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 171' ' ' PRO . 76.1 mt -104.73 120.47 41.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.518 -0.739 . . . . 0.0 109.89 -171.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.638 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 6.0 m-30 -106.51 151.67 24.68 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.693 -0.63 . . . . 0.0 110.486 -177.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -136.54 142.89 43.46 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -113.48 131.73 55.93 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.6 -0.688 . . . . 0.0 110.259 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -104.17 9.68 36.11 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.582 -0.699 . . . . 0.0 111.897 -175.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' CYS . . . . . 0.574 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.7 OUTLIER -144.62 160.37 41.29 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.035 -1.041 . . . . 0.0 109.861 170.837 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.646 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.5 p30 -117.49 162.43 17.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.682 -0.636 . . . . 0.0 110.31 -177.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 271' ' ' SER . . . . . 0.427 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 20.1 m -58.78 -32.28 69.15 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.582 -0.699 . . . . 0.0 110.925 -163.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 48.0 p -99.79 12.89 35.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.507 -0.746 . . . . 0.0 111.962 -164.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 32.0 p -94.54 118.15 31.24 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.552 177.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 60.1 t -64.02 139.54 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.46 -0.775 . . . . 0.0 110.399 -167.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 275' ' ' GLY . . . . . 0.408 ' HA3' ' HD3' ' A' ' 206' ' ' PRO . . . 99.56 -5.16 58.44 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 176.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -124.46 -100.05 1.33 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 170.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' MET . . . . . 0.427 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.2 mmm -63.96 -31.98 73.36 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.654 -0.909 . . . . 0.0 110.207 176.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.5 p30 43.53 51.15 6.31 Favored 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 175.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 54.78 27.42 8.85 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.394 -0.816 . . . . 0.0 111.163 175.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 77.2 mtt180 -117.67 106.42 46.23 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.476 -0.765 . . . . 0.0 110.09 175.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.56 146.71 94.43 Favored 'Trans proline' 0 N--CA 1.488 1.171 0 O-C-N 123.137 1.072 . . . . 0.0 110.577 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.6 HG22 ' HA ' ' A' ' 192' ' ' TYR . 45.4 pt -131.96 178.34 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.761 0.791 . . . . 0.0 110.773 -176.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' ' 193' ' ' LYS . 28.0 mt -124.41 149.84 46.28 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.69 HD12 ' CE1' ' A' ' 301' ' ' PHE . 80.3 mt -115.82 130.44 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.617 -0.677 . . . . 0.0 109.239 177.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.647 HG23 ' SG ' ' A' ' 300' ' ' CYS . 85.3 mt -109.79 126.22 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -176.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 58.5 t -118.91 126.7 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.4 p -125.25 154.69 41.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.673 -0.642 . . . . 0.0 110.795 -175.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.683 HD21 ' HB3' ' A' ' 180' ' ' PRO . 23.6 tp -104.82 126.83 52.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.816 -0.553 . . . . 0.0 109.575 170.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.743 ' OE2' HG13 ' A' ' 295' ' ' VAL . 72.0 mm-40 -132.44 149.83 52.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.897 -0.502 . . . . 0.0 109.912 -172.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.834 ' CG2' HD11 ' A' ' 296' ' ' LEU . 26.1 p -90.42 160.88 15.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.639 -0.663 . . . . 0.0 110.015 177.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -55.95 -26.14 46.7 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.506 -0.746 . . . . 0.0 111.002 -175.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 44.8 p30 -89.72 9.77 25.88 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.414 -0.804 . . . . 0.0 111.9 -172.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.7 20.17 45.08 Favored Glycine 0 N--CA 1.495 2.6 0 C-N-CA 120.143 -1.027 . . . . 0.0 110.677 171.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -108.98 140.13 42.91 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.32 -1.106 . . . . 0.0 109.921 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.743 HG13 ' OE2' ' A' ' 289' ' ' GLU . 60.3 t -91.83 133.3 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.527 -0.733 . . . . 0.0 110.217 -172.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.834 HD11 ' CG2' ' A' ' 290' ' ' THR . 71.6 mt -99.87 -40.24 7.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.792 -0.567 . . . . 0.0 110.59 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -158.36 154.87 25.93 Favored Glycine 0 N--CA 1.496 2.697 0 C-N-CA 119.917 -1.135 . . . . 0.0 110.516 -177.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.713 ' CZ ' HG11 ' A' ' 295' ' ' VAL . 55.5 mtt85 -135.03 136.32 42.0 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.722 -0.869 . . . . 0.0 110.211 178.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -140.69 157.26 45.69 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.487 -0.758 . . . . 0.0 110.152 169.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 300' ' ' CYS . . . . . 0.647 ' SG ' HG23 ' A' ' 285' ' ' ILE . 95.3 m -142.52 156.63 45.15 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.512 -0.743 . . . . 0.0 110.632 -175.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.69 ' CE1' HD12 ' A' ' 284' ' ' ILE . 48.5 p90 -145.0 162.88 35.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.681 -0.637 . . . . 0.0 110.199 176.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.417 ' HA ' HD23 ' A' ' 283' ' ' LEU . 81.8 tt0 -104.96 136.15 44.97 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.526 -0.734 . . . . 0.0 110.11 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -121.66 144.21 48.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.614 -0.679 . . . . 0.0 110.814 -169.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -139.23 139.51 37.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.857 -0.527 . . . . 0.0 109.744 172.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.646 HG21 ' HA ' ' A' ' 270' ' ' ASN . 82.6 mt -108.71 122.84 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.465 -0.772 . . . . 0.0 109.726 176.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.8 p -145.31 171.02 15.17 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.609 -0.682 . . . . 0.0 110.606 -172.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -73.2 -40.09 65.02 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.589 -0.694 . . . . 0.0 110.7 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.7 t -127.12 85.66 60.55 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.524 -0.735 . . . . 0.0 110.49 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -55.88 -27.85 64.95 Favored 'Trans proline' 0 C--N 1.314 -1.259 0 O-C-N 123.226 1.119 . . . . 0.0 110.772 174.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -67.6 -38.1 89.99 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -72.89 -40.46 65.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.674 -0.897 . . . . 0.0 109.803 -173.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -69.59 -39.35 77.35 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.061 -178.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -61.38 -44.66 96.78 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.219 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -64.04 -40.16 95.7 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.606 -0.684 . . . . 0.0 110.459 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.6 -50.73 71.43 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.548 -0.72 . . . . 0.0 110.419 -173.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -61.62 -37.76 85.12 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.509 -0.744 . . . . 0.0 110.107 -178.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -62.93 -39.61 95.11 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.646 -0.659 . . . . 0.0 110.138 178.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -62.25 -35.22 78.28 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.647 -0.658 . . . . 0.0 109.949 178.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 23.9 m -63.13 -33.38 75.34 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.686 -0.634 . . . . 0.0 110.322 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 51.0 mm -77.82 -43.51 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.61 -0.681 . . . . 0.0 110.012 -177.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -58.73 -41.17 85.79 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.639 -0.663 . . . . 0.0 110.444 178.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 32.4 tttp -61.76 -41.75 98.09 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.652 -0.655 . . . . 0.0 110.088 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -61.38 -33.8 74.27 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.63 -0.669 . . . . 0.0 110.136 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -85.97 125.03 33.08 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.699 -0.626 . . . . 0.0 110.397 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 62.3 t -118.6 130.17 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.699 -0.626 . . . . 0.0 109.803 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 29.4 t -95.09 139.98 30.67 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.669 -0.645 . . . . 0.0 110.239 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -106.55 150.09 26.5 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.682 -0.636 . . . . 0.0 110.442 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 29.7 t -94.05 146.05 24.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.646 -0.659 . . . . 0.0 110.238 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 48.6 m -97.89 134.39 41.09 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.689 -0.632 . . . . 0.0 110.267 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -100.02 146.29 26.91 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.687 -0.633 . . . . 0.0 110.245 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -59.26 -33.2 70.76 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.625 -0.672 . . . . 0.0 110.298 178.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -142.3 179.96 19.7 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 46.8 p30 -146.19 160.02 42.52 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.698 -0.883 . . . . 0.0 110.475 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -147.17 155.88 42.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.674 -0.641 . . . . 0.0 110.278 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -59.32 -38.51 80.48 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.671 -0.643 . . . . 0.0 110.365 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 53.3 99.35 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.51 -0.744 . . . . 0.0 110.994 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -60.2 -33.24 71.97 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.598 -0.689 . . . . 0.0 110.3 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 338' ' ' ASN . . . . . 0.402 ' OD1' ' CE1' ' A' ' 340' ' ' HIS . 22.7 t-20 -89.13 128.02 35.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.603 -0.686 . . . . 0.0 110.264 -178.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 51.2 m -118.32 141.99 47.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.626 -0.671 . . . . 0.0 110.286 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 340' ' ' HIS . . . . . 0.402 ' CE1' ' OD1' ' A' ' 338' ' ' ASN . 99.4 m-70 -116.6 144.41 44.41 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.558 -0.714 . . . . 0.0 110.282 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -59.46 -30.43 68.23 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.608 HD12 ' O ' ' A' ' 344' ' ' MET . 26.4 pt -94.33 147.67 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.637 -0.919 . . . . 0.0 110.322 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -83.54 -34.74 25.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.673 -0.642 . . . . 0.0 110.186 -179.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 344' ' ' MET . . . . . 0.608 ' O ' HD12 ' A' ' 342' ' ' ILE . 70.3 mtm -120.37 152.44 37.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.622 -0.674 . . . . 0.0 110.256 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 7.4 t . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.315 -179.92 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 29.4 t -156.24 148.19 23.11 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.644 -0.915 . . . . 0.0 110.289 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 29.0 t -119.86 142.9 48.24 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.619 -0.676 . . . . 0.0 110.243 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 49.6 m -121.69 140.11 52.72 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.562 -0.711 . . . . 0.0 110.295 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -118.76 153.04 35.06 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.714 -0.617 . . . . 0.0 110.207 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -80.15 -30.44 38.95 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.667 -0.646 . . . . 0.0 110.119 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 50.78 -165.57 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.368 -0.832 . . . . 0.0 111.159 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.4 mt 52.75 -165.56 0.07 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.434 -0.791 . . . . 0.0 110.922 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.82 174.45 2.39 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.638 -0.664 . . . . 0.0 110.081 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -64.27 152.55 73.91 Favored 'Cis proline' 0 N--CA 1.496 1.623 0 C-N-CA 123.304 -1.54 . . . . 0.0 110.493 -14.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.0 156.48 69.64 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.682 -0.636 . . . . 0.0 110.213 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -59.08 145.04 98.99 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 O-C-N 123.28 1.147 . . . . 0.0 110.666 -178.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.86 150.09 37.69 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.776 -0.578 . . . . 0.0 110.121 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 50.0 mm -119.94 139.52 28.35 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.579 -0.701 . . . . 0.0 109.845 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -61.56 150.04 87.12 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 O-C-N 123.134 1.071 . . . . 0.0 110.383 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.2 t -114.8 143.42 45.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.731 -0.606 . . . . 0.0 110.219 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 p-10 -96.33 24.34 5.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.637 -0.664 . . . . 0.0 110.721 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 49.9 m -77.8 125.16 28.92 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.577 -0.702 . . . . 0.0 110.274 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -71.16 144.96 50.03 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.686 -0.634 . . . . 0.0 110.414 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -157.78 101.48 1.8 Allowed Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.746 -0.596 . . . . 0.0 110.077 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -59.73 -39.87 69.46 Favored 'Trans proline' 0 N--CA 1.488 1.167 0 O-C-N 123.179 1.094 . . . . 0.0 110.681 -175.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.08 -155.12 43.9 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -73.6 -44.85 0.46 Allowed 'Trans proline' 0 C--N 1.317 -1.09 0 O-C-N 123.344 1.181 . . . . 0.0 110.855 -175.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -86.92 4.34 41.93 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.585 -0.697 . . . . 0.0 111.498 -174.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.82 61.6 3.01 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.888 -1.133 . . . . 0.0 110.716 -176.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.727 ' HA ' HG12 ' A' ' 176' ' ' VAL . 63.1 t80 -78.04 120.46 22.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.643 -0.661 . . . . 0.0 110.106 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -129.98 159.97 35.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.763 -0.586 . . . . 0.0 110.261 -177.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 64.5 t -126.28 146.3 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.789 -0.57 . . . . 0.0 109.831 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.9 p -154.98 162.75 41.0 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.947 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.419 ' CE2' HG12 ' A' ' 172' ' ' ILE . 76.2 m-85 -126.66 125.26 41.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.771 -0.581 . . . . 0.0 109.944 -175.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -57.11 145.97 29.27 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.568 -0.708 . . . . 0.0 110.516 -174.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -106.61 148.28 28.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.598 -0.688 . . . . 0.0 110.466 -175.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 83.8 p -143.37 163.44 33.04 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.702 -0.624 . . . . 0.0 110.049 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 44.8 m -61.24 154.85 22.45 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.569 -0.707 . . . . 0.0 110.121 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 73.9 p -67.78 78.4 0.2 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.616 -0.677 . . . . 0.0 110.033 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.11 142.23 27.91 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.692 -0.63 . . . . 0.0 110.25 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -60.02 157.85 12.08 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.629 -0.67 . . . . 0.0 110.464 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 66.1 m 52.31 31.77 9.93 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.426 -0.796 . . . . 0.0 111.093 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.2 129.62 41.61 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.628 -0.67 . . . . 0.0 110.049 177.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.425 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 65.4 p -60.1 -34.08 72.98 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.613 -0.68 . . . . 0.0 110.055 176.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.425 ' HD1' ' HG1' ' A' ' 152' ' ' THR . 68.7 p-90 -171.83 144.15 1.74 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.43 0.633 . . . . 0.0 110.158 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.3 t -142.11 142.59 32.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.788 -0.57 . . . . 0.0 109.943 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -125.52 140.07 53.07 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.532 -0.73 . . . . 0.0 110.579 -172.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.7 t -110.43 123.56 50.11 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 120.366 -0.533 . . . . 0.0 109.641 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 63.1 m -70.82 -37.11 73.21 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.755 -0.591 . . . . 0.0 110.42 -177.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -58.94 -32.76 69.88 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.582 -0.699 . . . . 0.0 110.275 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.507 HD11 ' OD1' ' A' ' 316' ' ' ASP . 37.7 mt -104.8 -12.11 16.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.71 -0.619 . . . . 0.0 110.712 -175.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 31.6 tttm 59.68 47.92 9.97 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.971 -1.08 . . . . 0.0 109.761 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.444 ' HE3' ' CZ ' ' A' ' 163' ' ' TYR . 33.9 ttpt -147.19 153.16 39.5 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 120.114 -0.635 . . . . 0.0 110.725 -174.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.58 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.6 138.18 53.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.763 -0.585 . . . . 0.0 110.374 -173.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.444 ' CZ ' ' HE3' ' A' ' 161' ' ' LYS . 52.3 m-85 -114.7 135.04 54.59 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 174.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.9 p -138.33 158.4 44.36 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.034 -176.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.416 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 57.0 mt-30 -104.55 142.86 33.89 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.611 -0.681 . . . . 0.0 110.211 173.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.428 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.2 tt -52.41 147.42 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.461 -0.774 . . . . 0.0 111.837 -174.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.89 9.97 5.78 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.539 -0.726 . . . . 0.0 112.487 176.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.416 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 72.2 mmtt -95.68 155.09 16.89 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.994 -1.067 . . . . 0.0 110.906 174.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 88.2 m -84.49 126.17 33.04 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.725 -0.609 . . . . 0.0 110.59 -178.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' CYS . . . . . 0.58 ' SG ' HD21 ' A' ' 162' ' ' LEU . 48.9 t -114.22 90.32 19.91 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.59 -0.694 . . . . 0.0 110.18 175.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.406 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 21.3 Cg_endo -65.94 129.65 22.52 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 O-C-N 123.261 1.137 . . . . 0.0 110.59 176.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.419 HG12 ' CE2' ' A' ' 142' ' ' PHE . 93.9 mt -123.15 141.69 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.62 -0.675 . . . . 0.0 109.329 176.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -109.06 135.35 50.37 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.519 -0.738 . . . . 0.0 110.761 -175.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.424 HG21 ' CE1' ' A' ' 138' ' ' PHE . 48.3 mm -95.24 135.03 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.652 -0.655 . . . . 0.0 109.642 170.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -117.84 128.84 55.24 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.42 175.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.727 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.1 m -136.47 159.75 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.532 -0.73 . . . . 0.0 109.949 175.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.0 mmm -77.07 -40.47 46.04 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.683 -0.635 . . . . 0.0 110.113 178.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.415 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.4 p -135.3 143.18 44.43 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.746 -0.596 . . . . 0.0 109.849 178.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.5 Cg_exo -55.94 139.87 85.09 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 O-C-N 123.181 1.095 . . . . 0.0 110.828 -173.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.771 ' HB3' HD21 ' A' ' 288' ' ' LEU . 20.8 Cg_endo -63.49 169.1 10.25 Favored 'Trans proline' 0 N--CA 1.488 1.18 0 O-C-N 123.204 1.107 . . . . 0.0 110.728 176.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -61.16 157.5 39.42 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.376 1.198 . . . . 0.0 110.482 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -76.61 137.45 39.49 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.635 -0.666 . . . . 0.0 109.898 175.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.51 -25.09 29.62 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -174.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.08 151.98 1.81 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.335 -1.097 . . . . 0.0 111.396 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.77 155.95 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.698 -0.627 . . . . 0.0 109.935 177.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.667 HD11 ' CD2' ' A' ' 251' ' ' TYR . 72.4 mt -108.47 135.51 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.728 ' HG2' HD22 ' A' ' 248' ' ' LEU . 61.8 mtt180 -115.05 147.13 40.54 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.702 -0.623 . . . . 0.0 109.376 -175.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.647 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -140.12 128.7 22.93 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.536 -0.728 . . . . 0.0 110.138 172.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.413 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 22.6 ttp -137.29 137.18 21.82 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.796 -0.565 . . . . 0.0 111.083 -176.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.493 ' HD3' HD12 ' A' ' 226' ' ' ILE . 71.8 Cg_endo -91.43 138.19 2.15 Favored 'Trans proline' 0 C--N 1.32 -0.959 0 C-N-CA 121.038 1.159 . . . . 0.0 110.773 177.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.423 HG13 ' C ' ' A' ' 190' ' ' PRO . 35.0 m -146.99 154.86 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.486 -0.759 . . . . 0.0 110.022 173.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.624 ' HA ' HG22 ' A' ' 282' ' ' ILE . 87.6 m-85 -61.48 160.02 11.85 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.464 -0.773 . . . . 0.0 110.397 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.444 ' HA ' HD12 ' A' ' 283' ' ' LEU . 85.7 tttt -76.21 -60.04 2.5 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.664 -0.647 . . . . 0.0 110.832 -173.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -80.01 150.7 30.32 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.58 -0.7 . . . . 0.0 110.356 -174.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.45 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.44 -38.86 72.2 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.385 -0.822 . . . . 0.0 110.728 -175.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -56.33 -25.04 47.58 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.555 -0.716 . . . . 0.0 110.668 -176.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.408 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 97.3 m-70 -110.03 -20.57 12.67 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.934 -0.706 . . . . 0.0 111.147 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.1 p -66.78 -20.25 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.154 -0.966 . . . . 0.0 110.573 -175.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 68.1 p -79.35 -17.05 55.29 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.713 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -88.27 136.39 33.0 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.353 -0.842 . . . . 0.0 109.951 172.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 56.9 t -73.02 146.48 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.61 -0.681 . . . . 0.0 110.133 178.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 79.5 t -84.92 139.65 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.598 -0.689 . . . . 0.0 109.261 172.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.7 pttp -134.82 -170.07 2.48 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.557 -0.715 . . . . 0.0 111.038 -166.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.46 ' HG2' ' HE3' ' A' ' 268' ' ' MET . 79.9 mtp180 -95.12 154.04 17.37 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.744 -0.597 . . . . 0.0 110.442 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 58.7 m -74.86 159.42 83.07 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.641 -0.662 . . . . 0.0 109.272 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -63.74 -47.41 7.12 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.179 1.094 . . . . 0.0 109.851 176.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.423 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.4 p-10 -65.46 -44.09 88.26 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.549 -0.719 . . . . 0.0 111.165 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' HIS . . . . . 0.423 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 52.8 m170 -81.84 -29.41 32.59 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.431 -0.793 . . . . 0.0 111.437 -174.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -69.19 -36.15 77.0 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.309 -0.869 . . . . 0.0 110.392 172.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 26.3 tp -54.32 -34.41 60.94 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.591 -0.693 . . . . 0.0 111.087 -175.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 29.1 t -48.38 142.96 5.15 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.437 -0.789 . . . . 0.0 111.252 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -59.24 143.9 47.79 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.655 -0.653 . . . . 0.0 110.445 -175.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -60.57 -41.95 95.64 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.716 -0.615 . . . . 0.0 110.128 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 20.1 t80 50.56 50.52 18.7 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.467 -0.77 . . . . 0.0 111.017 177.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -80.2 -10.1 59.75 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.586 -0.696 . . . . 0.0 111.31 -177.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -59.33 115.25 3.11 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.114 -0.991 . . . . 0.0 110.698 -177.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 73.13 20.16 79.86 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 173.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -114.89 140.04 49.29 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.284 -1.127 . . . . 0.0 110.47 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.2 mt -84.98 -25.09 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.686 -0.633 . . . . 0.0 110.411 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -124.96 92.87 46.87 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.499 -0.75 . . . . 0.0 110.485 -175.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -64.49 145.46 87.65 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 O-C-N 123.362 1.19 . . . . 0.0 110.543 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -59.75 -18.4 48.36 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 O-C-N 123.238 1.125 . . . . 0.0 111.586 -174.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 85.9 p -55.28 -22.94 20.54 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.161 -0.962 . . . . 0.0 111.276 -176.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' HIS . . . . . 0.423 ' CE1' ' CB ' ' A' ' 236' ' ' TYR . 55.2 m80 -102.05 130.9 48.74 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.339 -0.851 . . . . 0.0 110.614 -177.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.519 HD12 ' HG3' ' A' ' 268' ' ' MET . 59.5 tp -62.18 -36.76 82.87 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.695 -0.628 . . . . 0.0 110.338 177.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.493 HD12 ' HD3' ' A' ' 190' ' ' PRO . 83.4 mt -103.97 136.79 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.729 -0.607 . . . . 0.0 109.949 -178.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -127.26 157.54 39.56 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.748 -0.595 . . . . 0.0 110.176 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.521 HG23 HG21 ' A' ' 247' ' ' VAL . 90.7 t -102.32 146.6 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.787 -0.571 . . . . 0.0 109.81 173.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -118.59 129.97 55.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.698 -0.626 . . . . 0.0 110.4 170.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.96 21.08 26.56 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 168.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 35.7 t-20 -138.45 105.65 5.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.305 -1.115 . . . . 0.0 110.054 174.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 43.7 m -63.28 -15.33 56.87 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.656 -0.653 . . . . 0.0 111.306 -176.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -99.92 7.58 44.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.214 -0.929 . . . . 0.0 111.597 -177.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.64 132.27 52.73 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.114 -0.991 . . . . 0.0 110.24 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -139.76 157.97 44.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.79 -0.569 . . . . 0.0 109.674 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.423 ' CB ' ' CE1' ' A' ' 224' ' ' HIS . 75.3 m-85 -116.36 150.64 37.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.542 -0.724 . . . . 0.0 110.573 -177.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.19 159.89 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.824 -0.548 . . . . 0.0 110.24 177.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -123.71 128.21 49.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.76 -0.587 . . . . 0.0 110.05 174.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -65.09 130.05 94.69 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.678 -0.639 . . . . 0.0 109.893 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -66.8 -26.48 44.93 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 O-C-N 123.036 1.019 . . . . 0.0 111.029 -172.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.2 mt -99.06 -50.45 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.371 -0.831 . . . . 0.0 110.916 -168.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.0 p -105.33 12.07 32.11 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.406 -0.809 . . . . 0.0 111.835 -175.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.89 -5.08 13.77 Favored Glycine 0 N--CA 1.496 2.691 0 O-C-N 121.058 -1.027 . . . . 0.0 111.709 174.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 69.5 mmt-85 -46.18 141.98 3.07 Favored 'General case' 0 N--CA 1.505 2.278 0 CA-C-N 119.07 1.435 . . . . 0.0 112.363 -172.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -108.13 139.55 42.63 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.651 -0.655 . . . . 0.0 110.091 174.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 77.8 p -154.76 159.94 40.98 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.569 -0.707 . . . . 0.0 110.619 177.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.521 HG21 HG23 ' A' ' 228' ' ' VAL . 8.4 p -123.67 148.1 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.706 -0.621 . . . . 0.0 109.713 177.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.728 HD22 ' HG2' ' A' ' 187' ' ' ARG . 83.0 mt -129.67 154.71 46.86 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.032 -174.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.442 HG13 ' C ' ' A' ' 248' ' ' LEU . 36.0 m -150.77 151.76 30.87 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.855 -0.528 . . . . 0.0 109.878 175.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -70.6 139.4 37.22 Favored 'Trans proline' 0 C--N 1.315 -1.184 0 O-C-N 123.292 1.154 . . . . 0.0 110.055 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.667 ' CD2' HD11 ' A' ' 186' ' ' ILE . 10.0 t80 -79.66 123.29 27.5 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.539 -0.726 . . . . 0.0 110.16 178.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -100.04 160.1 28.07 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.693 -0.629 . . . . 0.0 110.19 178.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -59.08 160.05 20.05 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.362 1.191 . . . . 0.0 110.472 178.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.87 150.01 74.63 Favored 'Trans proline' 0 N--CA 1.489 1.244 0 O-C-N 123.293 1.154 . . . . 0.0 110.501 -177.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -60.91 147.94 41.41 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.626 -0.671 . . . . 0.0 110.184 -178.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.85 127.24 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.557 -0.715 . . . . 0.0 110.168 -170.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.88 -10.23 55.59 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 10.2 t -144.62 174.42 10.98 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.187 -1.184 . . . . 0.0 110.613 175.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -108.71 13.06 25.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.57 -0.706 . . . . 0.0 111.85 -167.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -122.41 168.07 12.54 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.125 -0.984 . . . . 0.0 111.149 -176.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 87.2 m -117.69 145.56 44.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.748 -0.595 . . . . 0.0 109.849 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 38.6 m -116.22 135.73 53.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.557 -0.715 . . . . 0.0 110.939 -175.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 57.6 t -129.03 137.29 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 172.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 62.7 mt -104.72 119.97 40.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.525 -0.734 . . . . 0.0 109.793 -172.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.647 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 6.7 m-30 -106.67 150.97 25.7 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.63 -0.669 . . . . 0.0 110.664 -178.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -136.47 142.91 43.59 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -113.15 132.67 55.37 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.56 -0.713 . . . . 0.0 110.48 -176.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 268' ' ' MET . . . . . 0.519 ' HG3' HD12 ' A' ' 225' ' ' LEU . 0.1 OUTLIER -103.21 8.52 38.46 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.711 -0.618 . . . . 0.0 112.172 -175.135 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 269' ' ' CYS . . . . . 0.681 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.6 OUTLIER -144.68 165.1 29.0 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.045 -1.034 . . . . 0.0 109.906 171.259 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.614 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.9 p30 -121.68 161.61 22.21 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.394 0.616 . . . . 0.0 110.38 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 271' ' ' SER . . . . . 0.426 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 26.7 m -58.36 -33.56 69.7 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.465 -0.772 . . . . 0.0 111.09 -163.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 70.6 m -97.56 10.54 39.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.494 -0.754 . . . . 0.0 112.089 -164.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 30.5 p -93.9 118.1 31.0 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.027 -1.045 . . . . 0.0 110.644 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.81 139.87 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.505 -0.747 . . . . 0.0 110.349 -169.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.57 -5.13 60.16 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 178.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -125.18 -100.2 1.26 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 170.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 277' ' ' MET . . . . . 0.426 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.4 mmm -65.55 -32.77 74.54 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.614 -0.933 . . . . 0.0 110.419 176.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.6 p30 42.47 53.11 4.7 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 176.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 54.8 27.44 8.9 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.328 -0.858 . . . . 0.0 111.184 176.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -119.12 105.15 45.21 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.484 -0.76 . . . . 0.0 110.098 175.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -59.45 151.02 71.73 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 O-C-N 123.135 1.071 . . . . 0.0 110.686 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.624 HG22 ' HA ' ' A' ' 192' ' ' TYR . 46.3 pt -131.81 177.63 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.766 0.793 . . . . 0.0 110.922 -177.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 193' ' ' LYS . 24.4 mt -124.33 149.81 46.17 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.692 HD12 ' CE1' ' A' ' 301' ' ' PHE . 80.2 mt -118.1 129.12 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.232 178.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.642 HG23 ' SG ' ' A' ' 300' ' ' CYS . 84.7 mt -109.79 127.55 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 120.251 -0.579 . . . . 0.0 109.448 -175.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 59.5 t -118.87 126.79 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.4 p -125.23 153.66 42.81 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 120.136 -0.625 . . . . 0.0 110.55 -174.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.771 HD21 ' HB3' ' A' ' 180' ' ' PRO . 20.7 tp -104.09 125.59 50.55 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 168.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.652 ' OE2' HG13 ' A' ' 295' ' ' VAL . 73.5 mm-40 -131.8 150.43 52.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.855 -0.528 . . . . 0.0 109.851 -171.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.807 HG22 HD11 ' A' ' 296' ' ' LEU . 68.4 p -89.86 159.54 16.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.632 -0.668 . . . . 0.0 109.708 177.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 28.7 tpt180 -56.03 -25.98 46.96 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.521 -0.737 . . . . 0.0 110.761 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -86.65 8.96 20.18 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.482 -0.762 . . . . 0.0 111.706 -174.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 86.95 20.13 54.22 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 120.186 -1.007 . . . . 0.0 110.673 170.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -107.86 140.12 41.44 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.214 -1.168 . . . . 0.0 110.252 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.652 HG13 ' OE2' ' A' ' 289' ' ' GLU . 60.5 t -88.86 131.4 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.683 -0.635 . . . . 0.0 110.133 -174.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.807 HD11 HG22 ' A' ' 290' ' ' THR . 76.8 mt -99.78 -40.18 7.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.753 -0.592 . . . . 0.0 110.504 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -159.68 151.77 22.58 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.453 ' HD2' HG11 ' A' ' 295' ' ' VAL . 46.3 mtp180 -135.08 134.29 40.16 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.643 -0.916 . . . . 0.0 110.606 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -136.76 157.88 45.73 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.568 -0.707 . . . . 0.0 109.848 172.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 300' ' ' CYS . . . . . 0.642 ' SG ' HG23 ' A' ' 285' ' ' ILE . 94.7 m -143.18 156.69 44.83 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.358 -0.838 . . . . 0.0 110.846 -175.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.692 ' CE1' HD12 ' A' ' 284' ' ' ILE . 47.1 p90 -145.21 162.17 37.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.653 -0.654 . . . . 0.0 110.12 175.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.402 ' HA ' HD23 ' A' ' 283' ' ' LEU . 82.3 tt0 -104.85 135.36 46.36 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.515 -0.741 . . . . 0.0 110.16 -178.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -123.6 142.99 50.5 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.736 -170.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 53.4 ttt85 -139.04 140.33 38.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.853 -0.53 . . . . 0.0 109.769 173.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.681 HD13 ' O ' ' A' ' 269' ' ' CYS . 73.6 mt -107.78 123.0 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.611 -0.68 . . . . 0.0 109.602 176.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.9 p -145.13 167.56 22.45 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.592 -0.692 . . . . 0.0 110.929 -170.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -67.8 -40.07 83.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.633 -0.667 . . . . 0.0 110.628 -177.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 3.9 t -132.09 89.49 37.77 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.592 -0.693 . . . . 0.0 110.448 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.54 -29.86 71.57 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 O-C-N 123.089 1.047 . . . . 0.0 110.853 174.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.26 -37.28 92.76 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -73.25 -40.37 64.69 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.752 -0.852 . . . . 0.0 109.779 -173.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -69.53 -40.14 77.07 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.183 -178.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -61.72 -43.19 99.34 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.301 178.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -65.06 -39.74 93.7 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.494 -0.754 . . . . 0.0 110.445 177.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.37 -49.86 75.21 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.515 -0.74 . . . . 0.0 110.551 -173.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 316' ' ' ASP . . . . . 0.507 ' OD1' HD11 ' A' ' 159' ' ' LEU . 3.2 p30 -61.39 -37.66 84.22 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.389 -0.82 . . . . 0.0 110.09 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -62.3 -41.27 98.38 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.59 -0.694 . . . . 0.0 110.026 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -62.48 -35.2 78.61 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.7 -0.625 . . . . 0.0 109.917 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 24.6 m -62.14 -32.62 73.24 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.726 -0.609 . . . . 0.0 110.113 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 84.0 mt -78.95 -42.8 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.714 -0.616 . . . . 0.0 109.925 -177.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -58.48 -41.62 85.69 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.683 -0.636 . . . . 0.0 110.53 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -62.58 -42.69 99.71 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.687 -0.633 . . . . 0.0 110.249 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -63.85 -33.64 76.15 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.646 -0.659 . . . . 0.0 110.275 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -96.9 125.04 41.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.714 -0.616 . . . . 0.0 110.367 -177.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 61.5 t -121.45 130.08 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.643 -0.66 . . . . 0.0 109.849 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 49.5 m -95.11 140.01 30.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.696 -0.627 . . . . 0.0 110.329 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -82.04 136.85 35.18 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.694 -0.629 . . . . 0.0 110.29 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 52.1 m -94.08 151.3 19.61 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.642 -0.661 . . . . 0.0 110.403 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 329' ' ' THR . . . . . 0.695 HG22 ' HG3' ' A' ' 330' ' ' LYS . 99.5 m 55.57 -87.02 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.695 -0.628 . . . . 0.0 110.957 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 330' ' ' LYS . . . . . 0.695 ' HG3' HG22 ' A' ' 329' ' ' THR . 34.9 mttm -91.94 147.35 23.03 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.058 -1.026 . . . . 0.0 110.271 -176.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -58.69 -38.39 78.13 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.64 -0.663 . . . . 0.0 110.421 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -149.87 166.69 29.87 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -101.95 147.63 26.31 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.698 -0.884 . . . . 0.0 110.188 178.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -144.91 150.7 37.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.653 -0.655 . . . . 0.0 110.323 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.402 ' O ' ' CD2' ' A' ' 335' ' ' PHE . 64.2 t80 -168.3 32.99 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.629 -0.67 . . . . 0.0 110.089 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 55.55 -85.83 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.689 -0.632 . . . . 0.0 111.086 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -58.85 -37.48 76.59 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.146 -0.971 . . . . 0.0 110.481 -176.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -105.03 140.38 38.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.581 -0.699 . . . . 0.0 110.235 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 66.7 p -121.86 162.08 21.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.679 -0.638 . . . . 0.0 110.316 -179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -60.08 -35.38 75.05 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.613 -0.68 . . . . 0.0 110.364 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -58.66 -33.32 71.94 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -177.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 82.1 mt -92.95 128.57 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.675 -0.897 . . . . 0.0 109.96 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -84.98 -36.39 21.37 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.615 -0.678 . . . . 0.0 110.138 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 59.9 ttp -122.43 147.38 46.38 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.631 -0.668 . . . . 0.0 110.294 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.319 179.886 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.9 t -156.31 148.51 23.32 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.627 -0.925 . . . . 0.0 110.24 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 90.7 p -123.41 155.99 36.34 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.714 -0.616 . . . . 0.0 110.215 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 45.0 m -59.51 -40.37 86.85 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.576 -0.703 . . . . 0.0 110.358 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -119.26 125.1 48.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.65 -0.656 . . . . 0.0 110.285 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -88.32 113.57 24.06 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.591 -0.693 . . . . 0.0 110.313 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 50.85 32.43 7.23 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.469 -0.769 . . . . 0.0 111.168 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.59 ' N ' HD12 ' A' ' 120' ' ' LEU . 7.9 mp 55.44 -85.24 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.726 -0.609 . . . . 0.0 110.991 -177.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.3 m -116.63 159.67 39.46 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.176 -0.952 . . . . 0.0 110.174 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -64.42 159.63 69.46 Favored 'Cis proline' 0 N--CA 1.495 1.601 0 C-N-CA 123.194 -1.586 . . . . 0.0 110.461 -17.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.8 m -80.89 156.08 72.63 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.588 -0.695 . . . . 0.0 110.273 -177.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -59.25 148.21 87.21 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.328 1.173 . . . . 0.0 110.751 -177.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.32 150.05 38.57 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.761 -0.587 . . . . 0.0 110.187 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.438 HG23 ' HD2' ' A' ' 127' ' ' PRO . 49.5 mm -119.83 143.59 35.45 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.682 -0.636 . . . . 0.0 109.827 -178.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.438 ' HD2' HG23 ' A' ' 126' ' ' ILE . 19.1 Cg_endo -63.25 153.05 76.66 Favored 'Trans proline' 0 N--CA 1.486 1.07 0 O-C-N 123.221 1.116 . . . . 0.0 110.513 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.0 t -111.86 144.29 41.41 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.616 -0.678 . . . . 0.0 110.169 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.5 p-10 -94.38 23.2 5.35 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.713 -0.617 . . . . 0.0 110.845 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 50.5 m -75.47 125.1 28.33 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.454 -0.779 . . . . 0.0 110.171 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -70.44 144.88 51.33 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.584 -0.697 . . . . 0.0 110.43 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.43 ' CE2' ' HA2' ' A' ' 134' ' ' GLY . 65.4 t80 -155.92 102.51 2.12 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.635 -0.666 . . . . 0.0 110.055 178.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -58.95 -39.87 76.84 Favored 'Trans proline' 0 N--CA 1.488 1.161 0 O-C-N 123.129 1.068 . . . . 0.0 110.792 -174.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.43 ' HA2' ' CE2' ' A' ' 132' ' ' TYR . . . 81.13 -155.14 36.05 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 178.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -73.04 -49.92 0.22 Allowed 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.361 1.19 . . . . 0.0 110.914 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -87.88 9.89 20.53 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.55 -0.719 . . . . 0.0 111.36 -173.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.71 61.51 3.06 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.922 -1.111 . . . . 0.0 110.705 -177.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.723 ' HA ' HG12 ' A' ' 176' ' ' VAL . 64.3 t80 -79.85 118.81 21.97 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.663 -0.648 . . . . 0.0 110.07 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -130.01 160.04 34.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.787 -0.571 . . . . 0.0 110.316 -175.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 72.3 t -123.99 147.09 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.751 -0.593 . . . . 0.0 109.764 177.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.9 p -155.17 163.65 39.93 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.251 0.548 . . . . 0.0 109.932 176.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.494 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 67.3 m-85 -126.69 125.13 41.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.723 -0.611 . . . . 0.0 109.844 -176.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -57.88 144.29 39.5 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.571 -0.706 . . . . 0.0 110.34 -176.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -120.13 156.38 31.16 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.61 -0.681 . . . . 0.0 110.656 -175.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.6 p -149.29 171.89 15.76 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.681 -0.637 . . . . 0.0 110.075 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 54.2 p -61.63 162.34 8.56 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.633 -0.667 . . . . 0.0 110.056 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 80.9 p -59.12 95.15 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.593 -0.692 . . . . 0.0 110.322 -177.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.07 150.66 21.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.767 -0.583 . . . . 0.0 110.211 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -81.23 145.92 30.71 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.569 -0.707 . . . . 0.0 110.056 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.8 p 50.14 37.43 14.54 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.592 -0.693 . . . . 0.0 111.253 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.3 134.76 57.31 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.637 -0.664 . . . . 0.0 110.182 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.501 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 61.6 p -60.09 -33.22 71.79 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.753 -0.592 . . . . 0.0 110.005 175.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.501 ' HD1' ' HG1' ' A' ' 152' ' ' THR . 68.5 p-90 -171.28 143.48 1.88 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.784 -0.572 . . . . 0.0 110.063 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.5 t -142.03 142.54 32.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.83 -0.544 . . . . 0.0 110.011 -177.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.494 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 64.9 t80 -125.62 140.03 53.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.534 -0.729 . . . . 0.0 110.646 -172.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 40.6 t -109.59 124.46 51.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.863 -0.523 . . . . 0.0 109.944 176.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 56.1 m -71.12 -37.1 72.35 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.794 -0.566 . . . . 0.0 110.513 -177.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -59.9 -34.29 72.99 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.604 -0.685 . . . . 0.0 110.364 -178.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 58.0 mt -104.82 -11.99 16.51 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.656 -0.653 . . . . 0.0 110.871 -175.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.6 tttp 59.81 51.31 6.21 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.112 -0.992 . . . . 0.0 109.734 177.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -145.71 153.06 40.57 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.562 -174.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.67 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.5 tp -126.65 137.8 53.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.772 -0.58 . . . . 0.0 110.416 -175.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -117.15 134.28 54.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.683 -0.635 . . . . 0.0 109.414 174.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.28 158.37 44.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.615 -0.678 . . . . 0.0 111.0 -174.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.404 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 38.3 mt-30 -104.56 144.9 31.06 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.568 0.699 . . . . 0.0 110.491 173.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.417 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 16.8 tt -52.1 146.25 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.551 -0.718 . . . . 0.0 111.894 -174.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 63.96 10.17 5.11 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.629 -0.67 . . . . 0.0 112.448 176.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.404 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 74.5 mmtt -96.12 155.04 16.93 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.987 -1.071 . . . . 0.0 110.705 175.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 90.5 m -84.63 126.18 33.13 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.709 -0.619 . . . . 0.0 110.537 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' CYS . . . . . 0.67 ' SG ' HD21 ' A' ' 162' ' ' LEU . 42.9 t -114.3 90.08 19.49 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.627 -0.671 . . . . 0.0 110.046 172.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.436 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 22.6 Cg_exo -61.78 129.29 27.12 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 O-C-N 123.334 1.176 . . . . 0.0 110.548 172.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.416 HG12 ' CE2' ' A' ' 142' ' ' PHE . 95.2 mt -123.26 139.38 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 175.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -106.77 135.92 47.49 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.559 -0.713 . . . . 0.0 110.753 -175.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.629 HG21 ' CE1' ' A' ' 138' ' ' PHE . 49.8 mm -95.3 135.01 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.75 -0.594 . . . . 0.0 109.715 171.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 31.7 tptt -117.21 130.57 56.67 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.679 -0.638 . . . . 0.0 110.518 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.723 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.5 m -136.87 159.78 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.518 -0.739 . . . . 0.0 109.977 175.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 80.3 mmm -78.4 -40.29 36.47 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.716 -0.615 . . . . 0.0 110.008 177.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.416 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 76.7 p -135.09 143.21 44.95 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.805 -0.559 . . . . 0.0 109.686 177.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.4 Cg_exo -55.51 139.79 82.6 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 O-C-N 123.177 1.093 . . . . 0.0 110.92 -172.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.66 ' HB3' HD21 ' A' ' 288' ' ' LEU . 34.2 Cg_endo -68.12 169.99 15.46 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.211 1.111 . . . . 0.0 110.616 177.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -60.28 157.92 33.25 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 O-C-N 123.317 1.167 . . . . 0.0 110.685 -178.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -80.21 139.2 36.84 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.663 -0.648 . . . . 0.0 110.034 175.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.04 -24.94 30.22 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 -174.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.07 152.64 1.61 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.365 -1.08 . . . . 0.0 111.429 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.73 155.95 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.686 -0.634 . . . . 0.0 109.841 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.739 HD11 ' HD2' ' A' ' 251' ' ' TYR . 86.7 mt -109.04 137.97 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.629 -0.669 . . . . 0.0 109.539 176.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.733 ' HG2' HD22 ' A' ' 248' ' ' LEU . 58.3 mtt180 -115.03 146.24 41.47 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -176.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.678 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -139.97 127.94 22.16 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.454 -0.779 . . . . 0.0 110.327 174.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.405 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 30.6 ttp -137.26 139.95 29.45 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.752 -0.593 . . . . 0.0 111.19 -176.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.654 ' HD3' HD12 ' A' ' 226' ' ' ILE . 75.2 Cg_endo -92.46 138.14 1.73 Allowed 'Trans proline' 0 C--N 1.32 -0.961 0 C-N-CA 121.15 1.233 . . . . 0.0 110.702 177.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.44 HG13 ' C ' ' A' ' 190' ' ' PRO . 35.0 m -148.05 154.9 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.507 -0.746 . . . . 0.0 110.133 174.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.629 ' HA ' HG22 ' A' ' 282' ' ' ILE . 71.2 m-85 -60.3 164.96 3.84 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.529 -0.732 . . . . 0.0 110.487 178.161 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.422 ' HA ' HD12 ' A' ' 283' ' ' LEU . 36.8 tttt -79.86 -60.03 2.5 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.607 -0.683 . . . . 0.0 110.805 -174.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -80.1 150.73 30.16 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.525 -0.734 . . . . 0.0 110.293 -174.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.44 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.5 -38.68 72.12 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.334 -0.854 . . . . 0.0 110.749 -174.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -56.31 -25.12 47.51 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.487 -0.758 . . . . 0.0 110.633 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -110.01 -20.52 12.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.605 -0.684 . . . . 0.0 111.218 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.1 p -66.78 -20.24 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.153 -0.967 . . . . 0.0 110.604 -176.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 71.0 p -79.43 -15.44 57.81 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.577 -0.702 . . . . 0.0 110.813 175.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.22 135.18 33.56 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.355 -0.84 . . . . 0.0 110.031 173.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.9 t -72.89 143.98 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.661 -0.65 . . . . 0.0 110.221 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 63.1 t -84.97 136.31 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.583 -0.698 . . . . 0.0 109.318 171.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 9.2 pttt -134.91 -170.14 2.5 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.464 -0.773 . . . . 0.0 111.067 -166.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.448 ' NE ' ' HE3' ' A' ' 268' ' ' MET . 78.6 mtp180 -95.15 159.34 15.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.715 -0.616 . . . . 0.0 110.426 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 59.6 m -80.18 160.53 67.97 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.644 -0.66 . . . . 0.0 109.425 176.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -63.86 -47.36 6.98 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 O-C-N 123.176 1.093 . . . . 0.0 109.88 176.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.445 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.6 p-10 -65.51 -44.26 87.51 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.733 -0.604 . . . . 0.0 111.23 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' HIS . . . . . 0.445 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 55.3 m170 -81.34 -27.93 34.73 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.407 -0.808 . . . . 0.0 111.319 -174.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -69.1 -42.02 76.68 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.367 -0.833 . . . . 0.0 110.146 171.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 26.9 tp -60.24 -28.94 68.43 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.707 -0.621 . . . . 0.0 110.575 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.1 t -48.33 -38.22 18.55 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.564 -0.71 . . . . 0.0 111.721 -177.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 53.19 102.68 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.588 -0.695 . . . . 0.0 111.305 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -92.17 22.15 4.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.535 -0.728 . . . . 0.0 110.931 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 53.59 75.13 0.28 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.044 -1.035 . . . . 0.0 110.836 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -66.06 -10.35 39.4 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.55 -0.719 . . . . 0.0 111.33 -177.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -60.03 119.21 7.35 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.157 -0.964 . . . . 0.0 110.391 176.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 78.22 20.01 73.36 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -114.61 145.51 41.9 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.3 -1.118 . . . . 0.0 110.528 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.3 mt -84.8 -25.08 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.661 -0.649 . . . . 0.0 110.5 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -124.91 92.88 46.91 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.445 -0.784 . . . . 0.0 110.419 -176.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.45 ' HD2' ' CE1' ' A' ' 236' ' ' TYR . 21.1 Cg_exo -62.41 137.24 63.94 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.299 1.157 . . . . 0.0 110.461 -178.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -60.5 -17.98 51.37 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 O-C-N 123.024 1.012 . . . . 0.0 111.318 -178.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.422 ' HA ' ' HD2' ' A' ' 204' ' ' ARG . 24.0 t -53.47 -26.33 19.98 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.24 -0.912 . . . . 0.0 111.186 -177.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -103.1 130.7 50.34 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.538 -0.726 . . . . 0.0 110.375 -178.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.449 HD12 ' HG3' ' A' ' 268' ' ' MET . 30.7 tp -61.27 -36.85 81.15 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.662 -0.649 . . . . 0.0 110.257 -178.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.654 HD12 ' HD3' ' A' ' 190' ' ' PRO . 80.8 mt -98.96 136.78 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.757 -0.59 . . . . 0.0 109.867 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -132.53 158.01 43.23 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.704 -0.622 . . . . 0.0 110.381 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.574 HG23 HG21 ' A' ' 247' ' ' VAL . 86.3 t -103.45 146.68 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.694 -0.629 . . . . 0.0 110.034 177.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -118.79 129.62 55.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.727 -0.608 . . . . 0.0 110.329 170.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.12 24.18 20.32 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 167.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -139.7 107.29 5.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.427 -1.043 . . . . 0.0 110.104 174.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 93.5 p -63.36 -15.12 56.51 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.641 -0.662 . . . . 0.0 111.197 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -97.02 9.99 40.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.266 -0.896 . . . . 0.0 111.265 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.87 126.2 26.52 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.185 -0.947 . . . . 0.0 110.112 176.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -139.69 155.2 47.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.794 -0.566 . . . . 0.0 109.759 176.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.45 ' CE1' ' HD2' ' A' ' 221' ' ' PRO . 77.2 m-85 -118.77 150.67 39.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.506 -0.746 . . . . 0.0 110.558 -176.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.19 159.88 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.817 -0.552 . . . . 0.0 110.3 178.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -120.1 129.78 54.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.667 -0.645 . . . . 0.0 110.063 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -65.01 130.01 94.71 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.626 -0.671 . . . . 0.0 109.886 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -66.36 -27.66 47.4 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.164 1.086 . . . . 0.0 111.111 -171.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.5 mt -100.35 -50.49 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.377 -0.827 . . . . 0.0 110.978 -168.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.7 p -105.38 12.16 31.91 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.37 -0.831 . . . . 0.0 111.846 -175.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.87 -5.16 13.4 Favored Glycine 0 N--CA 1.497 2.736 0 O-C-N 121.055 -1.028 . . . . 0.0 111.898 173.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 23.1 mmt85 -46.19 142.12 3.01 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-N 119.125 1.462 . . . . 0.0 112.265 -174.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -107.29 141.67 38.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.637 -0.664 . . . . 0.0 110.143 175.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 80.0 p -154.77 159.89 40.94 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.547 -0.721 . . . . 0.0 110.609 177.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.574 HG21 HG23 ' A' ' 228' ' ' VAL . 8.4 p -123.28 148.25 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.739 -0.601 . . . . 0.0 109.696 178.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.733 HD22 ' HG2' ' A' ' 187' ' ' ARG . 82.4 mt -129.57 154.58 46.92 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.878 -175.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.443 HG13 ' C ' ' A' ' 248' ' ' LEU . 34.7 m -151.15 151.73 29.97 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.823 -0.548 . . . . 0.0 109.943 175.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -71.07 140.11 37.1 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.303 1.159 . . . . 0.0 110.084 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.739 ' HD2' HD11 ' A' ' 186' ' ' ILE . 58.9 t80 -76.6 125.0 28.47 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.435 -0.791 . . . . 0.0 110.168 174.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -100.0 160.16 27.94 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.795 -0.565 . . . . 0.0 109.907 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -58.68 159.8 19.47 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 O-C-N 123.305 1.161 . . . . 0.0 110.48 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.02 149.92 76.42 Favored 'Trans proline' 0 N--CA 1.487 1.126 0 O-C-N 123.218 1.115 . . . . 0.0 110.539 -177.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -61.98 148.1 44.92 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.689 -0.632 . . . . 0.0 110.21 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.5 t -69.9 127.24 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.496 -0.752 . . . . 0.0 110.124 -170.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.01 -10.1 55.27 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 9.9 t -144.59 173.12 12.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.177 -1.19 . . . . 0.0 110.604 174.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -106.88 13.05 28.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.657 -0.652 . . . . 0.0 111.728 -168.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -119.95 168.02 11.56 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.149 -0.969 . . . . 0.0 111.136 -175.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 92.4 m -117.8 146.89 43.52 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.768 -0.583 . . . . 0.0 109.861 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 47.5 m -117.73 134.9 54.42 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.599 -0.688 . . . . 0.0 110.942 -175.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 59.6 t -131.02 137.36 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 71.9 mt -104.7 121.88 44.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.422 -0.799 . . . . 0.0 109.958 -171.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.678 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 5.8 m-30 -106.38 151.8 24.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.709 -0.619 . . . . 0.0 110.616 -177.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -136.61 142.93 43.31 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -111.26 130.02 55.79 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.54 -0.725 . . . . 0.0 110.426 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 268' ' ' MET . . . . . 0.449 ' HG3' HD12 ' A' ' 225' ' ' LEU . 5.2 ppp? -96.85 3.85 51.98 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.682 -0.636 . . . . 0.0 112.052 -175.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 269' ' ' CYS . . . . . 0.647 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.5 OUTLIER -144.79 165.02 29.27 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.053 -1.03 . . . . 0.0 109.961 174.067 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.617 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.7 p30 -119.43 159.82 23.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.643 -0.661 . . . . 0.0 110.187 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 271' ' ' SER . . . . . 0.401 ' HA ' ' HB3' ' A' ' 277' ' ' MET . 29.5 m -59.31 -32.39 70.01 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.356 -0.84 . . . . 0.0 110.912 -163.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 47.1 p -97.58 11.47 36.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.405 -0.809 . . . . 0.0 111.978 -164.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 30.0 p -95.07 118.07 31.26 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.116 -0.99 . . . . 0.0 110.631 178.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.15 139.16 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.462 -0.774 . . . . 0.0 110.189 -172.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 100.87 -5.12 56.38 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -123.74 -113.98 2.1 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 170.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 277' ' ' MET . . . . . 0.403 ' CE ' ' HA ' ' A' ' 281' ' ' PRO . 26.6 ttt -64.16 -23.71 67.42 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.62 -0.93 . . . . 0.0 110.489 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 10.2 p30 44.52 54.46 6.39 Favored 'General case' 0 N--CA 1.504 2.273 0 CA-C-O 121.331 0.586 . . . . 0.0 112.58 172.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 22.8 mtp85 54.74 26.93 8.11 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.312 -0.867 . . . . 0.0 111.365 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 280' ' ' ARG . . . . . 0.401 ' HA ' ' HD2' ' A' ' 281' ' ' PRO . 82.0 mtt-85 -115.02 114.6 43.62 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.388 -0.82 . . . . 0.0 109.956 173.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 281' ' ' PRO . . . . . 0.403 ' HA ' ' CE ' ' A' ' 277' ' ' MET . 11.9 Cg_endo -59.45 145.39 98.09 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 O-C-N 122.969 0.984 . . . . 0.0 110.614 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.629 HG22 ' HA ' ' A' ' 192' ' ' TYR . 44.9 pt -131.92 174.72 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-O 121.758 0.79 . . . . 0.0 110.862 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 193' ' ' LYS . 29.2 mt -124.44 149.88 46.28 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 284' ' ' ILE . . . . . . . . . . . . . 81.3 mt -118.33 128.68 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.218 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.628 HG23 ' SG ' ' A' ' 300' ' ' CYS . 85.4 mt -109.72 127.38 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -174.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 61.8 t -119.0 126.79 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.6 p -125.26 154.07 42.23 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.664 -0.647 . . . . 0.0 110.624 -173.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.66 HD21 ' HB3' ' A' ' 180' ' ' PRO . 29.7 tp -105.19 126.16 51.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.697 -0.627 . . . . 0.0 109.503 169.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.634 ' OE2' HG13 ' A' ' 295' ' ' VAL . 72.5 mm-40 -130.96 149.62 52.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.916 -0.49 . . . . 0.0 109.681 -173.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.799 ' CG2' HD11 ' A' ' 296' ' ' LEU . 23.4 p -89.93 160.37 16.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.6 -0.688 . . . . 0.0 109.999 178.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -55.89 -26.15 45.94 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.568 -0.707 . . . . 0.0 111.082 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 45.4 p30 -90.14 9.52 27.99 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.467 -0.771 . . . . 0.0 111.931 -173.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.61 20.21 45.27 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 120.182 -1.008 . . . . 0.0 110.755 171.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -107.93 140.21 41.4 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.274 -1.133 . . . . 0.0 110.002 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.634 HG13 ' OE2' ' A' ' 289' ' ' GLU . 61.1 t -87.63 133.12 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.551 -0.718 . . . . 0.0 110.278 -172.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.799 HD11 ' CG2' ' A' ' 290' ' ' THR . 96.1 mt -99.86 -40.19 7.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.697 -0.627 . . . . 0.0 110.522 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -167.54 154.97 25.57 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -133.86 136.9 44.68 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.616 -0.932 . . . . 0.0 110.791 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -135.01 155.84 50.07 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.661 -0.65 . . . . 0.0 109.874 172.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 300' ' ' CYS . . . . . 0.628 ' SG ' HG23 ' A' ' 285' ' ' ILE . 98.1 m -142.52 153.18 43.38 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.399 -0.813 . . . . 0.0 110.781 -175.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -145.02 164.15 32.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.608 -0.683 . . . . 0.0 110.071 176.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.418 ' HA ' HD23 ' A' ' 283' ' ' LEU . 82.1 tt0 -104.84 136.1 44.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.609 -0.682 . . . . 0.0 110.173 -177.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -124.48 143.84 50.42 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.715 -169.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 61.8 ttm-85 -138.13 141.88 40.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.712 -0.617 . . . . 0.0 109.744 173.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.647 HD13 ' O ' ' A' ' 269' ' ' CYS . 77.2 mt -108.74 122.94 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.577 -0.702 . . . . 0.0 109.671 175.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.8 p -145.39 168.89 19.43 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.53 -0.731 . . . . 0.0 110.645 -172.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -71.28 -40.05 71.14 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.674 -0.642 . . . . 0.0 110.77 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.8 t -127.14 85.37 61.19 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.454 -0.779 . . . . 0.0 110.514 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 309' ' ' PRO . . . . . 0.4 ' HD3' ' HG3' ' A' ' 165' ' ' GLN . 43.7 Cg_exo -56.03 -27.79 66.15 Favored 'Trans proline' 0 N--CA 1.489 1.257 0 O-C-N 123.231 1.122 . . . . 0.0 110.674 174.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -68.14 -37.06 86.62 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.126 -1.589 . . . . 0.0 109.126 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -72.85 -39.92 66.14 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.647 -0.913 . . . . 0.0 109.749 -173.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -69.49 -40.51 77.0 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 120.067 -0.653 . . . . 0.0 109.934 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -62.06 -42.83 99.6 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.557 -0.715 . . . . 0.0 110.122 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -63.87 -40.27 96.15 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.599 -0.688 . . . . 0.0 110.563 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.19 -51.97 66.79 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.503 -0.748 . . . . 0.0 110.392 -174.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -61.66 -37.78 85.31 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.458 -0.776 . . . . 0.0 110.029 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -63.26 -39.88 95.84 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.651 -0.655 . . . . 0.0 110.278 178.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -62.15 -35.27 78.28 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.526 -0.733 . . . . 0.0 109.925 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 22.7 t -63.82 -33.42 75.64 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.782 -0.574 . . . . 0.0 110.237 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 83.7 mt -78.32 -47.62 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.641 -0.662 . . . . 0.0 110.056 -176.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -60.72 -37.7 82.62 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.712 -0.618 . . . . 0.0 110.392 -177.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 35.7 tttt -61.52 -47.58 84.93 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.567 -0.708 . . . . 0.0 110.199 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -70.21 -37.99 75.19 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.707 -0.62 . . . . 0.0 110.469 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -105.02 125.08 50.59 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.667 -0.646 . . . . 0.0 110.553 -174.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.483 HG13 HG21 ' A' ' 345' ' ' THR . 61.8 t -101.37 130.07 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.637 -0.664 . . . . 0.0 109.843 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 50.9 m -63.45 140.15 58.84 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.71 -0.619 . . . . 0.0 110.31 -178.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 46.9 p-10 -78.94 150.01 32.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.626 -0.672 . . . . 0.0 110.295 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 44.8 m -62.5 153.78 30.62 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.607 -0.683 . . . . 0.0 110.209 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 72.0 p -93.71 -21.77 19.14 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.631 -0.668 . . . . 0.0 110.638 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 40.0 mttp -59.27 -31.51 69.18 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.413 -0.804 . . . . 0.0 110.426 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 54.4 46.04 25.87 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.542 -0.724 . . . . 0.0 110.732 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -141.06 -172.54 13.11 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -80.18 118.75 22.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.636 -0.92 . . . . 0.0 110.249 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -61.64 147.95 44.14 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.731 -0.606 . . . . 0.0 110.232 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -132.04 162.57 30.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.615 -0.678 . . . . 0.0 110.306 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 53.35 32.22 13.34 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.499 -0.751 . . . . 0.0 110.793 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -107.24 128.67 54.64 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.582 -0.699 . . . . 0.0 110.145 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -59.14 -36.79 75.85 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.598 -0.688 . . . . 0.0 110.475 -178.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 67.3 p -126.86 162.18 26.5 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.616 -0.677 . . . . 0.0 110.248 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -60.07 -39.51 86.3 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.602 -0.686 . . . . 0.0 110.263 178.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -163.29 -178.21 36.84 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 16.4 tt -147.87 151.94 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.609 -0.936 . . . . 0.0 110.229 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -83.99 -36.4 23.22 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.634 -0.666 . . . . 0.0 110.216 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 64.7 mtt -104.87 145.94 29.7 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.598 -0.688 . . . . 0.0 110.274 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 345' ' ' THR . . . . . 0.483 HG21 HG13 ' A' ' 325' ' ' VAL . 67.3 p . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.2 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.455 ' O ' HG23 ' A' ' 241' ' ' ILE . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.0 m -80.57 -30.16 36.97 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.683 -0.892 . . . . 0.0 110.155 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.7 m -120.31 147.37 45.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.622 -0.674 . . . . 0.0 110.248 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.4 t -167.21 46.05 0.06 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.596 -0.69 . . . . 0.0 110.312 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -60.2 -39.47 86.67 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.634 -0.666 . . . . 0.0 110.346 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -158.0 84.01 0.87 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.672 -0.643 . . . . 0.0 110.28 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 50.15 -159.4 0.07 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.494 -0.754 . . . . 0.0 111.242 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.8 mt 52.61 34.54 15.98 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.45 -0.781 . . . . 0.0 111.007 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 68.3 p -123.05 163.11 35.5 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.638 -0.664 . . . . 0.0 110.237 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -59.38 151.28 69.39 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 O-C-N 123.243 1.128 . . . . 0.0 110.59 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.409 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . 96.0 p -81.63 146.51 56.99 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.63 -0.669 . . . . 0.0 110.179 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 123' ' ' SER . 23.6 Cg_exo -60.3 152.22 68.32 Favored 'Trans proline' 0 N--CA 1.487 1.145 0 O-C-N 123.263 1.139 . . . . 0.0 110.507 178.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.69 142.65 44.42 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.622 -0.674 . . . . 0.0 110.12 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.811 HD11 HG22 ' A' ' 199' ' ' THR . 51.5 mm -121.44 99.95 45.03 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.715 -0.615 . . . . 0.0 109.998 -177.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 126' ' ' ILE . 13.3 Cg_endo -60.77 152.09 72.22 Favored 'Trans proline' 0 N--CA 1.487 1.134 0 O-C-N 123.237 1.125 . . . . 0.0 110.583 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.6 t -113.42 150.6 32.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.637 -0.665 . . . . 0.0 110.342 -178.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.9 p-10 -94.97 24.95 4.43 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.644 -0.66 . . . . 0.0 110.797 -178.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 52.1 m -72.09 125.21 26.71 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.593 -0.692 . . . . 0.0 110.248 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -71.09 144.9 50.16 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.754 -0.591 . . . . 0.0 110.538 -177.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -152.18 101.02 2.81 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.732 -0.605 . . . . 0.0 110.134 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -59.07 -39.96 75.11 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.042 1.022 . . . . 0.0 110.792 -174.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.42 -155.12 46.75 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -76.36 -44.0 0.27 Allowed 'Trans proline' 0 C--N 1.317 -1.08 0 O-C-N 123.38 1.2 . . . . 0.0 110.991 -174.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -86.91 8.84 21.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.503 -0.748 . . . . 0.0 111.425 -173.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 t 53.62 60.54 3.62 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.956 -1.09 . . . . 0.0 110.772 -176.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.67 ' HA ' HG12 ' A' ' 176' ' ' VAL . 37.3 t80 -77.84 118.41 20.14 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.585 -0.697 . . . . 0.0 109.871 -178.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -130.03 159.99 35.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.862 -0.523 . . . . 0.0 110.124 -178.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.8 t -125.98 146.07 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.797 -0.564 . . . . 0.0 109.726 177.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.8 p -155.31 161.12 41.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.772 -0.58 . . . . 0.0 110.03 177.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.406 ' CE2' HG12 ' A' ' 172' ' ' ILE . 71.5 m-85 -126.71 125.24 41.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.769 -0.582 . . . . 0.0 109.772 -176.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -56.95 140.99 46.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.573 -0.704 . . . . 0.0 110.511 -174.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -101.21 131.46 47.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.686 -0.634 . . . . 0.0 110.392 -175.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 91.0 p -126.85 158.68 36.05 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.641 -0.662 . . . . 0.0 110.09 178.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 54.6 p -64.17 163.26 12.94 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.671 -0.643 . . . . 0.0 110.102 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 147' ' ' THR . 7.7 t -71.89 64.35 0.5 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.578 -0.701 . . . . 0.0 110.219 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.96 147.6 45.07 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.666 -0.646 . . . . 0.0 110.202 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 50.8 pttt -59.4 149.35 29.56 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.618 -0.677 . . . . 0.0 110.487 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.5 m 53.07 51.1 16.42 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.37 -0.831 . . . . 0.0 110.955 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.88 123.12 26.92 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.71 -0.619 . . . . 0.0 110.103 177.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.425 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 44.9 p -60.07 -34.12 73.01 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.7 -0.625 . . . . 0.0 110.243 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.438 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -170.87 144.35 2.2 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.435 0.636 . . . . 0.0 110.237 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.4 t -142.09 142.66 32.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.863 -0.523 . . . . 0.0 109.971 -176.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -125.44 140.12 53.06 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.499 -0.751 . . . . 0.0 110.553 -172.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.2 t -110.69 124.5 52.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.852 -0.53 . . . . 0.0 109.773 176.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 60.6 m -70.63 -36.99 73.73 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.808 -0.558 . . . . 0.0 110.417 -177.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -59.54 -33.59 71.59 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.587 -0.695 . . . . 0.0 110.43 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.429 HD11 ' OD1' ' A' ' 316' ' ' ASP . 57.0 mt -104.85 -12.06 16.45 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.711 -0.618 . . . . 0.0 110.826 -175.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 78.8 tttt 59.84 50.25 7.14 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.126 -0.984 . . . . 0.0 109.678 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -145.84 153.1 40.51 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.571 -174.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.607 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.5 tp -126.5 137.83 53.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.739 -0.601 . . . . 0.0 110.25 -176.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -115.81 134.51 54.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.668 -0.645 . . . . 0.0 109.33 175.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.47 158.57 44.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.646 -0.659 . . . . 0.0 110.808 -176.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.434 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 54.5 mt-30 -104.54 144.56 31.52 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.668 171.142 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.413 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.2 tt -51.46 147.43 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 CA-C-O 121.572 0.701 . . . . 0.0 112.107 -173.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.99 9.99 5.89 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.555 -0.715 . . . . 0.0 112.734 174.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.434 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 59.3 mmtt -94.22 155.15 17.19 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.951 -1.093 . . . . 0.0 111.045 173.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 87.3 m -81.28 126.22 31.28 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.767 -0.583 . . . . 0.0 110.596 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' CYS . . . . . 0.607 ' SG ' HD21 ' A' ' 162' ' ' LEU . 43.9 t -114.13 90.04 18.8 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.602 -0.686 . . . . 0.0 110.175 173.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.438 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 18.4 Cg_exo -63.38 128.83 23.55 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 O-C-N 123.281 1.148 . . . . 0.0 110.598 173.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.406 HG12 ' CE2' ' A' ' 142' ' ' PHE . 97.5 mt -123.34 143.43 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.597 -0.689 . . . . 0.0 109.36 175.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -110.47 134.82 51.99 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.453 -0.779 . . . . 0.0 110.857 -175.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.5 mm -95.26 135.03 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.644 -0.66 . . . . 0.0 109.7 169.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.9 tttt -115.21 128.29 56.06 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.466 175.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.67 HG12 ' HA ' ' A' ' 138' ' ' PHE . 15.9 m -136.64 159.71 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.69 -0.631 . . . . 0.0 109.832 174.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.7 mmm -75.22 -40.51 59.04 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.771 -0.581 . . . . 0.0 110.166 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 76.8 p -135.71 143.25 43.96 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.834 -0.541 . . . . 0.0 109.725 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 33.5 Cg_exo -55.31 139.85 81.55 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 O-C-N 123.106 1.056 . . . . 0.0 110.921 -172.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.691 ' HB3' HD21 ' A' ' 288' ' ' LEU . 19.6 Cg_endo -63.05 167.85 11.67 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.226 1.119 . . . . 0.0 110.637 178.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -61.04 156.71 42.95 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 O-C-N 123.395 1.208 . . . . 0.0 110.509 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -74.5 139.01 43.55 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.672 -0.642 . . . . 0.0 109.858 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.69 -24.97 29.29 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 -175.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.2 150.36 2.49 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.317 -1.107 . . . . 0.0 111.323 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 33.6 m -129.79 155.92 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.765 -0.585 . . . . 0.0 109.664 176.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.601 HD11 ' HD2' ' A' ' 251' ' ' TYR . 83.3 mt -106.93 138.31 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.747 -0.595 . . . . 0.0 109.435 175.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.758 ' HG2' HD22 ' A' ' 248' ' ' LEU . 56.6 mtp85 -114.95 144.99 42.71 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -176.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.68 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -137.8 128.03 26.11 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.426 -0.796 . . . . 0.0 110.324 174.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 1.6 ttp -137.3 135.84 19.97 Favored Pre-proline 0 N--CA 1.495 1.816 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.957 -175.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.633 ' HD3' HD12 ' A' ' 226' ' ' ILE . 73.3 Cg_endo -91.19 138.18 2.25 Favored 'Trans proline' 0 C--N 1.32 -0.951 0 O-C-N 123.196 1.103 . . . . 0.0 110.777 177.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.432 HG13 ' C ' ' A' ' 190' ' ' PRO . 35.5 m -148.21 154.95 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.578 -0.702 . . . . 0.0 109.904 173.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.677 ' HA ' HG22 ' A' ' 282' ' ' ILE . 89.6 m-85 -60.91 163.24 5.98 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.379 -0.826 . . . . 0.0 110.385 -178.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.469 ' HA ' HD12 ' A' ' 283' ' ' LEU . 39.6 tttm -78.64 -60.02 2.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.622 -0.674 . . . . 0.0 110.71 -175.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -80.05 150.33 30.38 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.597 -0.69 . . . . 0.0 110.356 -175.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.455 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.42 -37.88 70.8 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.404 -0.81 . . . . 0.0 110.713 -175.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -56.37 -25.24 48.79 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.562 -0.711 . . . . 0.0 110.56 -175.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.408 ' HB3' ' CG ' ' A' ' 192' ' ' TYR . 5.3 m-70 -109.94 -20.64 12.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.577 -0.702 . . . . 0.0 111.112 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -67.05 -20.2 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.244 -0.91 . . . . 0.0 110.62 -176.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.811 HG22 HD11 ' A' ' 126' ' ' ILE . 82.3 p -79.42 -16.96 55.3 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.55 -0.719 . . . . 0.0 110.705 175.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -88.3 138.52 31.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.359 -0.838 . . . . 0.0 110.058 173.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.9 t -72.87 139.85 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.606 -0.684 . . . . 0.0 110.428 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.561 HG22 ' CE2' ' A' ' 192' ' ' TYR . 63.9 t -84.93 138.92 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.561 -0.712 . . . . 0.0 109.421 170.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 10.6 pttt -134.9 -170.45 2.57 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.463 -0.773 . . . . 0.0 110.993 -171.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -95.47 156.82 16.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.77 -0.581 . . . . 0.0 110.321 174.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 60.7 m -68.46 163.99 48.35 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 121.554 -0.716 . . . . 0.0 109.07 171.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -63.54 -47.47 7.37 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 O-C-N 123.022 1.012 . . . . 0.0 109.964 177.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.433 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.3 p-10 -65.55 -43.88 88.52 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.579 -0.701 . . . . 0.0 111.118 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' HIS . . . . . 0.433 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 52.5 m170 -80.06 -27.93 39.29 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.482 -0.762 . . . . 0.0 111.186 -174.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -68.97 -37.87 79.05 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.504 -0.747 . . . . 0.0 110.345 175.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 27.6 tp -54.14 -31.02 51.26 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.464 -0.772 . . . . 0.0 110.948 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 26.1 t -48.24 -27.57 2.54 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.435 -0.791 . . . . 0.0 111.639 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 37.6 ptt85 -55.69 -28.05 53.56 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.53 -0.731 . . . . 0.0 110.886 -178.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -57.68 146.41 30.96 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.593 -0.692 . . . . 0.0 110.541 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 33.2 t80 54.09 64.01 1.98 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.512 -0.742 . . . . 0.0 110.643 -177.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -75.67 -10.16 59.21 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.561 -0.712 . . . . 0.0 111.114 178.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -58.63 125.06 21.82 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.103 -0.998 . . . . 0.0 110.424 175.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 95.01 -1.68 65.38 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -114.66 139.84 49.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.021 -1.281 . . . . 0.0 110.387 174.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.6 mt -84.94 -25.13 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.728 -0.608 . . . . 0.0 110.544 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.543 ' HB1' ' HD2' ' A' ' 227' ' ' ARG . . . -124.82 103.66 30.86 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.495 -0.753 . . . . 0.0 110.267 -173.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.426 ' HD2' ' CE2' ' A' ' 236' ' ' TYR . 29.4 Cg_exo -58.72 115.42 2.54 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 O-C-N 123.167 1.088 . . . . 0.0 110.762 -178.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.67 -19.86 39.72 Favored 'Trans proline' 0 N--CA 1.49 1.299 0 O-C-N 122.937 0.967 . . . . 0.0 111.425 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 25.2 t -51.65 -23.53 4.49 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.23 -0.919 . . . . 0.0 111.415 -177.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -106.86 132.82 52.38 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.426 -0.796 . . . . 0.0 110.21 177.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.475 HD12 ' HG3' ' A' ' 268' ' ' MET . 58.6 tp -59.48 -39.63 84.37 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.588 -0.695 . . . . 0.0 110.352 -177.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.633 HD12 ' HD3' ' A' ' 190' ' ' PRO . 83.0 mt -102.85 136.76 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.85 -0.531 . . . . 0.0 109.642 177.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.543 ' HD2' ' HB1' ' A' ' 220' ' ' ALA . 84.0 mtm180 -136.95 162.96 31.84 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.746 -0.596 . . . . 0.0 110.341 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.478 HG23 HG21 ' A' ' 247' ' ' VAL . 94.5 t -109.09 146.79 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.826 -0.546 . . . . 0.0 110.129 -178.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -120.81 121.54 38.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.809 -0.557 . . . . 0.0 110.348 174.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.98 24.09 10.88 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 169.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -137.23 106.74 6.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.413 -1.051 . . . . 0.0 109.988 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 46.0 m -63.16 -15.34 56.54 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.582 -0.699 . . . . 0.0 111.325 -176.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -99.94 5.59 45.25 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.275 -0.89 . . . . 0.0 111.608 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.94 131.4 49.58 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.039 -1.038 . . . . 0.0 110.16 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -139.72 158.07 44.71 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.797 -0.565 . . . . 0.0 109.811 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.426 ' CE2' ' HD2' ' A' ' 221' ' ' PRO . 72.6 m-85 -112.35 150.64 30.78 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.618 -0.677 . . . . 0.0 110.361 -178.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.26 159.91 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.737 -0.602 . . . . 0.0 110.174 176.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -122.62 129.96 52.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.787 -0.57 . . . . 0.0 110.094 175.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -64.96 130.07 94.72 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.654 -0.654 . . . . 0.0 109.87 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -66.42 -27.92 46.67 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 O-C-N 123.193 1.102 . . . . 0.0 111.049 -170.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.455 HG23 ' O ' ' A' ' 113' ' ' GLY . 83.0 mt -100.51 -50.46 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.423 -0.798 . . . . 0.0 110.879 -168.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.1 p -105.32 12.06 32.14 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.396 -0.815 . . . . 0.0 111.875 -175.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.9 -6.23 10.29 Favored Glycine 0 N--CA 1.496 2.69 0 O-C-N 121.034 -1.041 . . . . 0.0 111.941 172.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -46.12 142.03 3.0 Favored 'General case' 0 N--CA 1.506 2.327 0 CA-C-N 119.081 1.441 . . . . 0.0 112.258 -173.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -104.7 141.57 36.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.559 -0.713 . . . . 0.0 110.218 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 72.4 p -154.76 159.93 40.97 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.61 -0.682 . . . . 0.0 110.476 176.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.478 HG21 HG23 ' A' ' 228' ' ' VAL . 8.2 p -125.31 148.21 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.788 -0.57 . . . . 0.0 109.643 177.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.758 HD22 ' HG2' ' A' ' 187' ' ' ARG . 71.4 mt -129.5 154.7 46.75 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.633 -174.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.446 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.8 m -150.86 151.7 30.52 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.769 -0.582 . . . . 0.0 110.042 176.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -71.09 137.99 32.7 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 O-C-N 123.298 1.157 . . . . 0.0 109.994 177.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.601 ' HD2' HD11 ' A' ' 186' ' ' ILE . 10.5 t80 -76.54 126.02 30.25 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.573 -0.704 . . . . 0.0 110.221 176.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -100.01 160.07 28.16 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.771 -0.581 . . . . 0.0 109.979 176.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.88 159.11 22.25 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.199 1.105 . . . . 0.0 110.419 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.01 150.04 75.59 Favored 'Trans proline' 0 N--CA 1.488 1.187 0 O-C-N 123.26 1.137 . . . . 0.0 110.525 -177.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -61.16 147.46 44.05 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.669 -0.645 . . . . 0.0 110.139 -178.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.7 t -69.9 127.14 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.485 -0.759 . . . . 0.0 110.168 -170.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.53 -10.11 56.05 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 9.8 t -144.36 174.34 11.0 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.147 -1.208 . . . . 0.0 110.6 176.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -109.21 13.09 24.59 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.527 -0.733 . . . . 0.0 111.918 -166.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -120.95 168.06 11.89 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.081 -1.012 . . . . 0.0 111.193 -176.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 76.2 m -117.68 144.3 45.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.797 -0.564 . . . . 0.0 109.865 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 35.7 m -115.71 135.59 53.89 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.612 -0.68 . . . . 0.0 110.867 -175.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 62.9 t -131.18 137.28 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 174.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 72.4 mt -104.63 120.34 41.08 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.42 -0.8 . . . . 0.0 109.908 -171.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.68 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 4.6 m-30 -105.03 155.39 19.02 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.741 -0.599 . . . . 0.0 110.825 -176.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -136.32 142.9 43.89 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -114.89 128.97 56.6 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.616 -0.677 . . . . 0.0 110.266 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 268' ' ' MET . . . . . 0.475 ' HG3' HD12 ' A' ' 225' ' ' LEU . 5.0 ppp? -98.57 9.27 43.61 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.712 -0.617 . . . . 0.0 111.982 -175.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 269' ' ' CYS . . . . . 0.569 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.8 OUTLIER -144.58 161.32 39.43 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.178 -0.951 . . . . 0.0 110.112 173.662 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.693 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.1 p30 -119.91 164.06 16.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.786 -0.571 . . . . 0.0 110.286 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 271' ' ' SER . . . . . 0.424 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 27.6 m -57.6 -33.93 68.73 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.449 -0.782 . . . . 0.0 110.983 -164.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 67.6 m -105.21 14.95 28.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.497 -0.752 . . . . 0.0 112.042 -164.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 30.1 p -95.17 118.06 31.31 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.103 -0.998 . . . . 0.0 110.677 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 51.9 t -63.19 138.86 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.482 -0.761 . . . . 0.0 110.203 -171.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.76 -5.13 59.78 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 178.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.12 -99.3 0.86 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 172.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 277' ' ' MET . . . . . 0.424 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.4 mmm -63.29 -32.59 74.04 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.796 -0.826 . . . . 0.0 110.328 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.4 p30 44.05 48.75 7.45 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 175.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 54.95 29.97 13.17 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.392 -0.818 . . . . 0.0 111.146 175.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 74.0 mtt180 -119.96 105.0 43.36 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.475 -0.766 . . . . 0.0 110.208 175.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -60.53 145.78 98.15 Favored 'Trans proline' 0 N--CA 1.487 1.115 0 O-C-N 123.094 1.049 . . . . 0.0 110.402 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.677 HG22 ' HA ' ' A' ' 192' ' ' TYR . 46.2 pt -131.95 177.63 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.856 0.836 . . . . 0.0 111.249 -175.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' A' ' 193' ' ' LYS . 24.8 mt -124.5 149.91 46.36 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.678 HD12 ' CE1' ' A' ' 301' ' ' PHE . 81.2 mt -117.83 130.33 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.318 179.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.512 HG23 ' SG ' ' A' ' 300' ' ' CYS . 80.8 mt -109.79 127.38 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -176.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 57.5 t -118.94 126.83 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.634 HG22 ' HG2' ' A' ' 298' ' ' ARG . 45.4 p -125.33 153.1 43.83 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.745 . . . . 0.0 110.632 -173.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.691 HD21 ' HB3' ' A' ' 180' ' ' PRO . 21.7 tp -104.5 124.39 49.19 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.726 -0.609 . . . . 0.0 109.468 169.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.597 ' OE2' HG13 ' A' ' 295' ' ' VAL . 70.1 mm-40 -132.16 151.72 51.64 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.87 -0.519 . . . . 0.0 109.806 -173.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.715 ' CG2' HD11 ' A' ' 296' ' ' LEU . 77.8 p -89.88 159.58 16.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.558 -0.714 . . . . 0.0 109.768 177.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -55.94 -26.11 46.43 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.564 -0.71 . . . . 0.0 110.789 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -88.34 9.76 22.19 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.552 -0.717 . . . . 0.0 111.808 -174.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 87.25 20.22 53.07 Favored Glycine 0 N--CA 1.495 2.583 0 O-C-N 121.083 -1.011 . . . . 0.0 110.687 170.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -106.21 140.15 39.61 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.218 -1.166 . . . . 0.0 110.231 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.597 HG13 ' OE2' ' A' ' 289' ' ' GLU . 59.1 t -89.59 130.97 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.592 -0.692 . . . . 0.0 110.29 -173.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.715 HD11 ' CG2' ' A' ' 290' ' ' THR . 95.6 mt -100.11 -40.08 7.77 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.781 -0.574 . . . . 0.0 110.528 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -166.25 154.67 25.38 Favored Glycine 0 N--CA 1.497 2.719 0 C-N-CA 119.898 -1.144 . . . . 0.0 110.391 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.634 ' HG2' HG22 ' A' ' 287' ' ' THR . 91.1 mtt180 -135.09 137.46 42.87 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.692 -0.887 . . . . 0.0 110.667 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -137.67 157.82 45.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.684 -0.635 . . . . 0.0 109.963 170.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 300' ' ' CYS . . . . . 0.512 ' SG ' HG23 ' A' ' 285' ' ' ILE . 78.7 m -141.33 156.81 45.8 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.43 -0.794 . . . . 0.0 110.684 -175.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.678 ' CE1' HD12 ' A' ' 284' ' ' ILE . 47.8 p90 -144.91 162.14 37.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.681 -0.637 . . . . 0.0 110.164 175.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.408 ' HA ' HD23 ' A' ' 283' ' ' LEU . 56.7 tt0 -104.94 134.5 47.95 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.501 -0.749 . . . . 0.0 110.051 -177.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -118.78 143.99 46.57 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.728 -169.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 55.7 ttt85 -138.3 136.79 36.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.766 -0.584 . . . . 0.0 109.792 172.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.693 HG21 ' HA ' ' A' ' 270' ' ' ASN . 78.9 mt -108.27 123.0 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.608 -0.682 . . . . 0.0 109.542 177.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.4 p -145.07 172.82 12.53 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.571 -0.706 . . . . 0.0 110.769 -171.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -72.21 -40.09 68.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.676 -0.64 . . . . 0.0 110.566 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.8 t -131.26 89.08 42.45 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.627 -0.671 . . . . 0.0 110.53 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 309' ' ' PRO . . . . . 0.407 ' CG ' ' HG3' ' A' ' 165' ' ' GLN . 51.2 Cg_exo -54.3 -29.57 58.2 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 O-C-N 123.162 1.085 . . . . 0.0 110.996 173.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -65.95 -37.81 93.57 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -72.5 -41.04 66.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.758 -0.848 . . . . 0.0 109.829 -173.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -69.45 -39.61 77.68 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 120.056 -0.657 . . . . 0.0 110.076 -178.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -61.6 -43.23 99.25 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.284 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -64.27 -40.12 95.32 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.613 -0.679 . . . . 0.0 110.503 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.64 -50.95 70.49 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.502 -0.749 . . . . 0.0 110.512 -173.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 316' ' ' ASP . . . . . 0.429 ' OD1' HD11 ' A' ' 159' ' ' LEU . 3.4 p30 -61.38 -37.77 84.62 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.507 -0.746 . . . . 0.0 110.142 -177.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -64.96 -40.7 95.4 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.593 -0.692 . . . . 0.0 110.247 178.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -62.78 -35.16 78.93 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.552 -0.718 . . . . 0.0 110.2 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 54.7 p -66.11 -29.31 69.61 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.64 -0.662 . . . . 0.0 110.294 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 83.9 mt -79.71 -45.74 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.638 -0.664 . . . . 0.0 109.919 -178.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -59.17 -41.71 89.09 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.588 -0.695 . . . . 0.0 110.516 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -61.42 -45.47 94.18 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.578 -0.701 . . . . 0.0 110.219 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -64.73 -33.79 76.79 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.682 -0.636 . . . . 0.0 110.304 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -94.89 125.06 39.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.63 -0.669 . . . . 0.0 110.529 -175.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 62.3 t -120.29 130.09 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.653 -0.654 . . . . 0.0 109.694 176.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 30.7 t -95.07 132.86 39.51 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.646 -0.658 . . . . 0.0 110.401 -177.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -92.29 123.12 35.38 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.699 -0.626 . . . . 0.0 110.167 177.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 30.4 t -86.16 133.0 33.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.576 -0.703 . . . . 0.0 110.2 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 40.9 m -96.03 -26.15 15.64 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.655 -0.653 . . . . 0.0 110.606 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -70.78 135.71 48.35 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.484 -0.76 . . . . 0.0 110.269 -178.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 54.38 44.89 28.24 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.511 -0.743 . . . . 0.0 110.826 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -171.81 179.25 43.62 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -86.08 123.93 31.93 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.662 -0.905 . . . . 0.0 110.256 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -60.18 143.7 51.79 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.582 -0.699 . . . . 0.0 110.261 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -65.25 -29.84 70.66 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.639 -0.663 . . . . 0.0 110.407 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 55.46 -85.02 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.704 -0.622 . . . . 0.0 110.884 -176.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -90.52 136.69 32.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.097 -1.002 . . . . 0.0 110.108 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -87.57 108.23 18.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.664 -0.647 . . . . 0.0 110.324 -177.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 76.8 p -114.93 25.48 10.89 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.716 -0.615 . . . . 0.0 110.374 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -114.5 143.79 44.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.543 -0.723 . . . . 0.0 110.375 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 151.9 45.43 0.02 OUTLIER Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.528 HD11 ' OXT' ' A' ' 345' ' ' THR . 16.9 tt -145.37 137.22 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.633 -0.922 . . . . 0.0 110.152 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -89.37 -62.58 1.45 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.616 -0.677 . . . . 0.0 110.215 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 87.4 mtp -122.64 -39.87 2.5 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.665 -0.647 . . . . 0.0 110.234 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 345' ' ' THR . . . . . 0.528 ' OXT' HD11 ' A' ' 342' ' ' ILE . 12.3 p . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.264 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 67.4 m -154.79 158.04 38.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.588 -0.948 . . . . 0.0 110.175 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.1 m -119.91 149.28 42.36 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.703 -0.623 . . . . 0.0 110.279 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 71.2 p -99.93 162.59 12.9 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.638 -0.664 . . . . 0.0 110.185 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 53.64 27.0 6.27 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.532 -0.73 . . . . 0.0 110.745 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -84.99 171.88 11.76 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.683 -0.636 . . . . 0.0 110.565 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 51.99 24.07 2.47 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.455 -0.778 . . . . 0.0 111.251 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.2 mt 55.18 -86.15 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.656 -0.653 . . . . 0.0 111.159 -178.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.1 p -69.84 164.25 53.04 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.115 -0.991 . . . . 0.0 110.164 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -63.77 151.21 71.14 Favored 'Cis proline' 0 N--CA 1.495 1.615 0 C-N-CA 123.161 -1.6 . . . . 0.0 110.41 -18.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.1 p -81.37 144.59 53.86 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.651 -0.656 . . . . 0.0 110.059 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.409 ' HB3' HG22 ' A' ' 242' ' ' THR . 23.3 Cg_exo -60.25 145.72 97.96 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 O-C-N 123.188 1.099 . . . . 0.0 110.61 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.58 144.69 41.7 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.617 -0.677 . . . . 0.0 110.082 177.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.923 HD11 HG22 ' A' ' 199' ' ' THR . 49.0 mm -122.63 99.84 41.73 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.585 -0.697 . . . . 0.0 110.096 -177.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.45 154.36 64.79 Favored 'Trans proline' 0 C--N 1.316 -1.168 0 O-C-N 123.261 1.137 . . . . 0.0 110.586 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 30.4 t -112.29 145.32 40.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.681 -0.637 . . . . 0.0 110.31 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 p-10 -96.31 26.06 4.56 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.636 -0.665 . . . . 0.0 110.598 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 47.6 m -73.94 125.13 27.52 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.575 -0.703 . . . . 0.0 110.395 -178.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -73.36 144.98 46.25 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.689 -0.632 . . . . 0.0 110.462 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.422 ' CE2' ' HA2' ' A' ' 134' ' ' GLY . 62.8 t80 -157.01 101.78 1.94 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.7 -0.625 . . . . 0.0 110.137 178.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -58.64 -39.9 78.42 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 O-C-N 123.094 1.049 . . . . 0.0 110.948 -175.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.422 ' HA2' ' CE2' ' A' ' 132' ' ' TYR . . . 78.76 -155.12 40.66 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 178.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -73.14 -49.1 0.24 Allowed 'Trans proline' 0 C--N 1.317 -1.116 0 O-C-N 123.337 1.177 . . . . 0.0 110.874 -174.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -85.18 6.67 24.88 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.626 -0.672 . . . . 0.0 111.432 -174.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 t 54.17 62.09 2.75 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.964 -1.085 . . . . 0.0 110.675 -176.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.724 ' HA ' HG12 ' A' ' 176' ' ' VAL . 59.3 t80 -77.87 120.86 23.34 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.655 -0.653 . . . . 0.0 109.993 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -130.06 159.95 35.19 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.309 0.576 . . . . 0.0 110.134 -177.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 64.8 t -124.97 145.23 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.76 -0.588 . . . . 0.0 109.897 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 80.0 p -155.41 160.94 41.05 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.345 0.593 . . . . 0.0 109.937 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.49 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 59.8 m-85 -126.64 125.21 41.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.728 -0.608 . . . . 0.0 109.848 -176.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -58.03 143.23 44.08 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.545 -0.722 . . . . 0.0 110.34 -175.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -120.12 158.04 27.72 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.573 -0.705 . . . . 0.0 110.566 -175.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.7 p -147.74 170.87 16.65 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.773 -0.58 . . . . 0.0 110.019 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 39.7 m -59.89 157.86 11.7 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.586 -0.696 . . . . 0.0 110.209 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 33.9 p -59.7 90.91 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.616 -0.678 . . . . 0.0 110.388 -177.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.02 152.49 21.15 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.725 -0.61 . . . . 0.0 110.241 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -79.9 149.37 30.93 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.734 -0.604 . . . . 0.0 110.009 177.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.2 p 50.6 35.59 11.89 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.534 -0.729 . . . . 0.0 111.247 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.9 132.23 52.33 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.6 -0.687 . . . . 0.0 110.068 177.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.501 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 82.1 p -60.06 -33.99 72.81 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.689 -0.632 . . . . 0.0 109.933 176.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.501 ' HD1' ' HG1' ' A' ' 152' ' ' THR . 68.8 p-90 -170.74 143.5 2.14 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.366 0.603 . . . . 0.0 110.238 177.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.6 t -142.11 142.58 32.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.9 -0.5 . . . . 0.0 109.978 -176.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.49 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 60.9 t80 -125.58 140.01 53.11 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.496 -0.753 . . . . 0.0 110.771 -172.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 31.5 t -112.2 125.02 53.69 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.007 177.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 54.1 m -70.81 -37.12 73.22 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.724 -0.61 . . . . 0.0 110.534 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -59.25 -34.55 72.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.618 -0.676 . . . . 0.0 110.502 -177.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.668 HD21 HD11 ' A' ' 320' ' ' ILE . 56.1 mt -104.84 -12.0 16.49 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.933 -175.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 49.7 tttt 59.83 51.37 6.14 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.991 -1.068 . . . . 0.0 109.637 178.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -145.15 153.13 41.05 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.571 -173.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.57 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.9 tp -126.54 137.71 53.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.788 -0.57 . . . . 0.0 110.208 -176.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -115.59 134.42 55.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.64 -0.662 . . . . 0.0 109.292 173.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.43 158.62 43.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.736 -0.602 . . . . 0.0 110.85 -177.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.419 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 53.0 mt-30 -104.42 143.08 33.49 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.553 -0.717 . . . . 0.0 109.795 171.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.45 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.3 tt -52.44 148.45 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.538 -0.727 . . . . 0.0 111.851 -173.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 66.38 9.13 6.2 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.624 -0.672 . . . . 0.0 112.596 175.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.419 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 74.9 mmtt -94.41 155.13 17.11 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.933 -1.105 . . . . 0.0 110.983 172.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 88.5 m -84.07 126.21 32.85 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.719 -0.613 . . . . 0.0 110.433 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' CYS . . . . . 0.57 ' SG ' HD21 ' A' ' 162' ' ' LEU . 48.5 t -113.09 90.19 15.58 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.658 -0.652 . . . . 0.0 110.075 174.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.437 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 22.5 Cg_exo -61.33 130.52 32.4 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.276 1.145 . . . . 0.0 110.704 173.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.416 HG12 ' CE2' ' A' ' 142' ' ' PHE . 94.5 mt -124.61 141.91 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.639 -0.663 . . . . 0.0 109.28 175.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -108.9 136.45 48.43 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.524 -0.735 . . . . 0.0 110.826 -175.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.433 ' CG2' ' CE2' ' A' ' 138' ' ' PHE . 48.5 mm -95.24 135.06 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.694 -0.629 . . . . 0.0 109.64 169.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -117.65 129.37 55.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.606 -0.684 . . . . 0.0 110.405 176.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.724 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.1 m -136.67 159.75 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.538 -0.726 . . . . 0.0 110.057 175.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 80.7 mmm -77.46 -40.3 43.64 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.703 -0.623 . . . . 0.0 110.122 177.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.417 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 75.6 p -135.48 143.24 44.37 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.744 -0.597 . . . . 0.0 109.693 177.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.7 Cg_exo -55.49 139.89 82.56 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 O-C-N 123.114 1.06 . . . . 0.0 110.911 -172.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.763 ' HB3' HD21 ' A' ' 288' ' ' LEU . 32.1 Cg_endo -67.67 169.98 14.84 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 O-C-N 123.211 1.111 . . . . 0.0 110.565 177.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -60.49 155.32 47.98 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.35 1.184 . . . . 0.0 110.551 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -77.8 140.61 39.43 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.591 -0.693 . . . . 0.0 109.925 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.65 -24.93 29.47 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -174.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.16 152.78 1.61 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.337 -1.096 . . . . 0.0 111.404 178.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.8 155.89 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.713 -0.617 . . . . 0.0 109.765 176.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.726 HD11 ' HD2' ' A' ' 251' ' ' TYR . 81.1 mt -108.89 138.17 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.645 -0.659 . . . . 0.0 109.49 176.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.729 ' HG2' HD22 ' A' ' 248' ' ' LEU . 61.9 mtt180 -115.08 146.05 41.7 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -175.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.684 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -139.03 128.48 24.34 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.535 -0.728 . . . . 0.0 110.226 174.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.412 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 26.3 ttp -137.27 136.37 20.64 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.788 -0.57 . . . . 0.0 110.905 -176.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.504 ' HB3' HD11 ' A' ' 226' ' ' ILE . 74.1 Cg_endo -91.86 138.08 1.96 Allowed 'Trans proline' 0 C--N 1.32 -0.953 0 O-C-N 123.164 1.086 . . . . 0.0 110.643 177.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.439 HG13 ' C ' ' A' ' 190' ' ' PRO . 35.2 m -148.42 154.95 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.528 -0.733 . . . . 0.0 109.907 174.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.695 ' HA ' HG22 ' A' ' 282' ' ' ILE . 91.3 m-85 -60.6 163.92 5.01 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.447 -0.783 . . . . 0.0 110.413 -178.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.465 ' HA ' HD12 ' A' ' 283' ' ' LEU . 78.8 tttt -79.93 -59.99 2.51 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.661 -0.65 . . . . 0.0 110.785 -174.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 35.0 mttm -80.03 150.68 30.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.628 -0.67 . . . . 0.0 110.395 -175.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.454 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.43 -38.3 71.39 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.435 -0.791 . . . . 0.0 110.718 -175.081 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -56.49 -25.04 49.96 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.518 -0.739 . . . . 0.0 110.594 -175.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -110.01 -20.56 12.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.58 -0.7 . . . . 0.0 111.088 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.454 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.1 p -67.02 -20.27 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.137 -0.977 . . . . 0.0 110.592 -176.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.923 HG22 HD11 ' A' ' 126' ' ' ILE . 81.6 p -79.34 -17.06 55.29 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.545 -0.722 . . . . 0.0 110.753 175.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -88.39 138.79 31.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.38 -0.825 . . . . 0.0 110.041 173.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 57.6 t -73.24 142.73 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.585 -0.697 . . . . 0.0 110.156 176.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.541 HG22 ' CE2' ' A' ' 192' ' ' TYR . 77.8 t -84.9 140.15 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.552 -0.718 . . . . 0.0 109.443 171.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.2 pttp -134.84 -170.27 2.53 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.539 -0.726 . . . . 0.0 110.873 -169.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.439 ' HD2' ' HA ' ' A' ' 223' ' ' SER . 73.9 mtp180 -95.28 156.38 16.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.735 -0.603 . . . . 0.0 110.52 178.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 60.1 m -72.86 163.59 67.12 Favored Pre-proline 0 N--CA 1.497 1.887 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 172.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -64.23 -47.58 5.99 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.031 1.016 . . . . 0.0 109.927 178.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.435 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.4 p-10 -65.42 -43.57 90.12 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.602 -0.686 . . . . 0.0 111.149 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' HIS . . . . . 0.435 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 54.2 m170 -80.32 -27.88 38.29 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.455 -0.778 . . . . 0.0 111.264 -175.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -67.76 -34.96 77.84 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.405 -0.809 . . . . 0.0 110.223 174.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 26.5 tp -53.81 -33.19 55.34 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.435 -0.791 . . . . 0.0 110.751 177.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 29.9 t -48.45 -27.04 2.41 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.503 -0.748 . . . . 0.0 111.373 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -53.47 -35.22 60.32 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.495 -0.753 . . . . 0.0 110.918 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' GLU . . . . . 0.441 ' HG3' ' CD2' ' A' ' 214' ' ' PHE . 25.0 tp10 -60.27 151.74 26.7 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.679 -0.638 . . . . 0.0 110.196 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.441 ' CD2' ' HG3' ' A' ' 213' ' ' GLU . 95.9 m-85 53.09 57.37 6.38 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.515 -0.741 . . . . 0.0 110.98 -177.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -66.09 -10.2 38.28 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.508 -0.745 . . . . 0.0 110.966 176.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -58.04 125.16 21.96 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.17 -0.956 . . . . 0.0 110.319 173.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 95.13 2.57 62.23 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 120.362 -0.923 . . . . 0.0 110.931 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -114.63 139.91 49.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.023 -1.281 . . . . 0.0 110.259 170.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.1 mt -89.73 -25.2 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.617 -0.677 . . . . 0.0 110.589 -176.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.522 ' HB1' ' HD2' ' A' ' 227' ' ' ARG . . . -124.88 130.05 24.36 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.417 -0.802 . . . . 0.0 110.29 -175.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.451 ' CG ' ' CE2' ' A' ' 236' ' ' TYR . 23.4 Cg_endo -65.76 109.88 1.55 Allowed 'Trans proline' 0 N--CA 1.487 1.128 0 O-C-N 123.061 1.032 . . . . 0.0 110.628 -173.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -60.14 -15.88 36.68 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 O-C-N 123.07 1.037 . . . . 0.0 111.438 -178.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' A' ' 204' ' ' ARG . 25.4 m -49.41 -28.56 5.28 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.143 -0.973 . . . . 0.0 111.681 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' HIS . . . . . 0.402 ' CD2' ' O ' ' A' ' 226' ' ' ILE . 5.6 t60 -107.76 139.78 41.81 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.454 -0.779 . . . . 0.0 110.482 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.4 ' CD1' ' HB2' ' A' ' 269' ' ' CYS . 40.7 tp -58.29 -38.61 77.36 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.648 -0.657 . . . . 0.0 110.566 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.504 HD11 ' HB3' ' A' ' 190' ' ' PRO . 91.3 mt -107.67 136.77 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 121.159 0.504 . . . . 0.0 110.111 -176.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.522 ' HD2' ' HB1' ' A' ' 220' ' ' ALA . 71.9 mtm-85 -140.53 167.92 21.02 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.638 -0.664 . . . . 0.0 110.1 177.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.489 HG23 HG21 ' A' ' 247' ' ' VAL . 82.9 t -105.28 146.73 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.37 0.605 . . . . 0.0 110.211 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -116.39 130.0 56.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.729 -0.607 . . . . 0.0 110.356 169.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.36 25.26 16.65 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 167.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -140.9 107.45 5.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.443 -1.034 . . . . 0.0 110.061 175.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 27.2 t -62.89 -15.26 54.4 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.588 -0.695 . . . . 0.0 111.329 -177.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 63.1 m170 -99.77 6.38 45.47 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.21 -0.931 . . . . 0.0 111.612 -177.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.32 128.51 36.71 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.081 -1.012 . . . . 0.0 110.241 176.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -139.75 158.05 44.74 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.785 -0.572 . . . . 0.0 109.681 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.451 ' CE2' ' CG ' ' A' ' 221' ' ' PRO . 93.4 m-85 -116.86 150.6 38.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.574 -0.704 . . . . 0.0 110.686 -176.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.14 159.94 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.81 -0.556 . . . . 0.0 110.167 177.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -120.59 130.0 54.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.775 -0.578 . . . . 0.0 110.193 176.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -65.09 130.1 94.71 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.706 -0.621 . . . . 0.0 109.878 177.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -66.37 -27.62 47.35 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 O-C-N 123.128 1.068 . . . . 0.0 111.038 -171.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 82.9 mt -100.43 -50.41 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.292 -0.88 . . . . 0.0 111.013 -167.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.409 HG22 ' HB3' ' A' ' 124' ' ' PRO . 3.7 p -105.38 12.14 31.93 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.326 -0.859 . . . . 0.0 111.828 -175.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.86 -5.63 11.93 Favored Glycine 0 N--CA 1.496 2.678 0 O-C-N 121.131 -0.981 . . . . 0.0 111.832 174.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 22.9 mmt85 -46.09 142.0 2.99 Favored 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 119.194 1.497 . . . . 0.0 112.23 -173.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -105.59 145.43 30.99 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.607 -0.683 . . . . 0.0 110.091 175.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.0 p -154.74 159.92 40.99 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.623 -0.673 . . . . 0.0 110.534 176.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.489 HG21 HG23 ' A' ' 228' ' ' VAL . 8.2 p -123.82 148.1 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.731 -0.606 . . . . 0.0 109.695 178.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.729 HD22 ' HG2' ' A' ' 187' ' ' ARG . 81.7 mt -129.76 154.57 47.07 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.867 -176.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.441 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.7 m -150.69 151.67 30.89 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.813 -0.554 . . . . 0.0 109.986 174.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -71.1 140.03 36.85 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 O-C-N 123.329 1.173 . . . . 0.0 110.085 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.726 ' HD2' HD11 ' A' ' 186' ' ' ILE . 58.7 t80 -76.6 126.1 30.39 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.505 -0.747 . . . . 0.0 110.194 174.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -100.08 160.09 28.09 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.687 -0.633 . . . . 0.0 109.887 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.88 159.84 20.01 Favored 'Trans proline' 0 N--CA 1.488 1.188 0 O-C-N 123.204 1.107 . . . . 0.0 110.403 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.07 150.03 75.97 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 O-C-N 123.274 1.144 . . . . 0.0 110.501 -177.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -61.6 146.76 47.88 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.674 -0.641 . . . . 0.0 110.123 -178.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.84 127.2 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.517 -0.739 . . . . 0.0 110.145 -170.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.02 -10.2 55.32 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 9.8 t -144.23 174.39 10.93 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.105 -1.233 . . . . 0.0 110.641 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -108.84 13.13 25.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.595 -0.691 . . . . 0.0 111.948 -167.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -121.76 168.11 12.2 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.155 -0.965 . . . . 0.0 111.122 -176.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 85.5 m -117.77 145.86 44.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.778 -0.576 . . . . 0.0 109.87 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 55.3 m -116.02 135.58 53.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.633 -0.667 . . . . 0.0 110.903 -174.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.9 t -131.77 137.27 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 173.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 77.2 mt -104.69 121.6 43.91 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.477 -0.764 . . . . 0.0 110.005 -170.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.684 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 4.1 m-30 -107.94 149.24 28.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.705 -0.622 . . . . 0.0 110.556 -176.165 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -136.55 143.01 43.45 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.674 -0.642 . . . . 0.0 109.545 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -120.2 136.99 54.45 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.638 -0.664 . . . . 0.0 110.452 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' MET . . . . . 0.457 ' HE3' ' HB2' ' A' ' 269' ' ' CYS . 0.0 OUTLIER -105.43 12.53 31.41 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 120.179 -0.608 . . . . 0.0 112.195 -176.147 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 269' ' ' CYS . . . . . 0.676 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.6 OUTLIER -144.6 159.16 43.26 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.075 -1.016 . . . . 0.0 109.838 176.091 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.611 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.2 p30 -120.31 163.42 17.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.651 -0.656 . . . . 0.0 110.401 -177.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 271' ' ' SER . . . . . 0.417 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 43.4 m -57.11 -34.18 68.1 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.46 -0.775 . . . . 0.0 111.1 -165.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 65.5 m -104.6 15.02 28.84 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.411 -0.806 . . . . 0.0 111.967 -164.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 30.3 p -93.61 118.03 30.85 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.088 -1.007 . . . . 0.0 110.581 178.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.2 t -63.58 139.45 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.442 -0.786 . . . . 0.0 110.419 -169.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.47 -5.09 60.35 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.97 -99.33 0.87 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 173.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 277' ' ' MET . . . . . 0.417 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.5 mmm -61.42 -31.87 71.81 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.614 -0.933 . . . . 0.0 110.109 177.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 23.6 p30 42.25 47.02 4.02 Favored 'General case' 0 N--CA 1.507 2.38 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 174.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 22.9 mtt180 54.87 31.58 16.04 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.274 -0.891 . . . . 0.0 111.207 176.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 -120.1 104.94 43.11 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.458 -0.776 . . . . 0.0 110.056 173.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -59.99 148.24 89.75 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 O-C-N 123.094 1.049 . . . . 0.0 110.468 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.695 HG22 ' HA ' ' A' ' 192' ' ' TYR . 46.7 pt -131.86 176.74 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.806 0.812 . . . . 0.0 111.118 -175.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 193' ' ' LYS . 27.5 mt -124.37 149.83 46.23 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.686 HD12 ' CE1' ' A' ' 301' ' ' PHE . 81.4 mt -116.89 130.76 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.21 178.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.476 HG23 ' SG ' ' A' ' 300' ' ' CYS . 79.4 mt -109.8 126.37 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -177.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 58.7 t -118.92 126.75 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 46.1 p -125.21 153.54 42.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.554 -0.716 . . . . 0.0 110.721 -173.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.763 HD21 ' HB3' ' A' ' 180' ' ' PRO . 26.3 tp -104.08 126.42 51.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.785 -0.572 . . . . 0.0 109.5 169.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.502 ' OE2' HG22 ' A' ' 295' ' ' VAL . 72.9 mm-40 -130.44 150.25 51.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.91 -0.494 . . . . 0.0 109.861 -173.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.824 ' CG2' HD11 ' A' ' 296' ' ' LEU . 22.8 p -89.87 161.73 15.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.687 -0.633 . . . . 0.0 109.928 177.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -55.89 -26.15 45.96 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.641 -0.662 . . . . 0.0 111.042 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 45.6 p30 -89.87 9.19 28.53 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.408 -0.807 . . . . 0.0 112.004 -173.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.61 20.19 45.36 Favored Glycine 0 N--CA 1.494 2.522 0 O-C-N 121.09 -1.006 . . . . 0.0 110.725 171.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -107.03 140.21 40.2 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.295 -1.121 . . . . 0.0 110.163 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.502 HG22 ' OE2' ' A' ' 289' ' ' GLU . 72.1 t -85.24 132.79 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.588 -0.695 . . . . 0.0 110.228 -174.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.824 HD11 ' CG2' ' A' ' 290' ' ' THR . 95.2 mt -100.01 -40.15 7.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.621 -0.674 . . . . 0.0 110.399 176.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -163.64 153.44 23.88 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -133.87 136.19 44.18 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.609 -0.936 . . . . 0.0 110.648 -178.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -134.73 157.81 45.75 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.611 -0.681 . . . . 0.0 110.026 172.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 300' ' ' CYS . . . . . 0.476 ' SG ' HG23 ' A' ' 285' ' ' ILE . 95.3 m -143.02 153.25 42.78 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.474 -0.766 . . . . 0.0 110.629 -176.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.686 ' CE1' HD12 ' A' ' 284' ' ' ILE . 47.8 p90 -145.01 162.38 37.06 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.631 -0.668 . . . . 0.0 110.174 176.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.413 ' HA ' HD23 ' A' ' 283' ' ' LEU . 81.9 tt0 -104.86 135.11 46.82 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.543 -0.723 . . . . 0.0 110.238 -176.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -120.09 143.61 48.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.62 -0.675 . . . . 0.0 110.737 -170.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -138.28 138.29 38.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.786 -0.571 . . . . 0.0 109.74 173.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.676 HD13 ' O ' ' A' ' 269' ' ' CYS . 73.9 mt -109.01 122.96 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.541 -0.724 . . . . 0.0 109.667 176.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.3 p -145.17 171.56 14.35 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.625 -0.672 . . . . 0.0 110.657 -172.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -70.89 -40.11 72.4 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.658 -0.651 . . . . 0.0 110.494 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.8 t -130.44 89.11 45.23 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.524 -0.735 . . . . 0.0 110.467 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 309' ' ' PRO . . . . . 0.406 ' CG ' ' HG3' ' A' ' 165' ' ' GLN . 50.6 Cg_exo -54.25 -29.27 56.34 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 O-C-N 123.146 1.077 . . . . 0.0 111.025 173.037 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -65.63 -37.81 93.96 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 177.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 37.6 ttp180 -72.82 -42.1 64.18 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.714 -0.874 . . . . 0.0 109.938 -173.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -69.53 -40.47 76.89 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.172 -178.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 73.2 ttt-85 -60.23 -43.38 96.1 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.449 -0.782 . . . . 0.0 110.351 178.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -64.42 -41.02 96.84 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.585 -0.697 . . . . 0.0 110.522 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -60.94 -50.14 74.62 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.506 -0.746 . . . . 0.0 110.462 -173.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -61.92 -37.77 85.88 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.433 -0.792 . . . . 0.0 110.06 -178.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -62.04 -41.27 97.95 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.631 -0.668 . . . . 0.0 110.141 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -62.8 -35.25 79.26 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.565 -0.71 . . . . 0.0 109.925 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 23.4 m -63.81 -33.0 74.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.719 -0.613 . . . . 0.0 110.221 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.668 HD11 HD21 ' A' ' 159' ' ' LEU . 84.2 mt -79.25 -45.09 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.689 -0.632 . . . . 0.0 109.927 -176.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -60.21 -41.49 93.16 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.622 -0.674 . . . . 0.0 110.38 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -64.52 -46.72 81.7 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.598 -0.688 . . . . 0.0 110.252 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -66.92 -35.1 79.23 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.668 -0.645 . . . . 0.0 110.383 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 324' ' ' GLN . . . . . 0.508 ' OE1' HG22 ' A' ' 320' ' ' ILE . 96.4 mt-30 -97.85 124.98 42.49 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.591 -0.693 . . . . 0.0 110.547 -175.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 62.4 t -113.08 130.12 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.641 -0.662 . . . . 0.0 109.733 177.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 29.4 t -91.16 140.0 30.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.689 -0.632 . . . . 0.0 110.372 -176.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -85.16 122.01 28.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.718 -0.613 . . . . 0.0 110.298 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 29.7 t -67.91 152.88 44.86 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.674 -0.641 . . . . 0.0 110.146 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 70.6 p -92.19 -22.09 20.02 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.643 -0.66 . . . . 0.0 110.619 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -59.71 -34.11 72.49 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.419 -0.8 . . . . 0.0 110.282 177.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -100.9 108.73 20.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.704 -0.622 . . . . 0.0 110.263 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -61.42 -35.39 90.95 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 46.5 p30 -154.93 160.0 40.83 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.648 -0.913 . . . . 0.0 110.419 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -61.43 142.58 56.88 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.685 -0.634 . . . . 0.0 110.198 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -139.54 159.56 41.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.588 -0.695 . . . . 0.0 110.378 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 55.17 -86.03 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.724 -0.61 . . . . 0.0 111.18 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -76.29 133.86 39.93 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.214 -0.929 . . . . 0.0 110.337 -175.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -121.39 153.43 37.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.681 -0.637 . . . . 0.0 110.234 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 9.8 t -132.21 155.52 48.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.652 -0.655 . . . . 0.0 110.433 179.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -125.99 145.37 50.33 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.673 -0.642 . . . . 0.0 110.212 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -84.82 179.61 51.23 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.589 HG22 ' HG3' ' A' ' 343' ' ' GLN . 82.0 mt -95.29 133.73 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.683 -0.892 . . . . 0.0 110.101 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 343' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 342' ' ' ILE . 94.9 mt-30 54.9 47.34 22.49 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.469 -0.77 . . . . 0.0 110.952 178.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 64.6 mtt -123.39 156.08 36.13 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.582 -0.699 . . . . 0.0 110.202 176.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 7.4 t . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 118.103 -0.951 . . . . 0.0 110.212 -179.879 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.348 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 60.4 m -85.3 155.76 21.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.576 -0.955 . . . . 0.0 110.325 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 84.2 p -141.09 164.61 29.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.62 -0.675 . . . . 0.0 110.103 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 47.5 m -109.2 130.52 55.49 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.648 -0.657 . . . . 0.0 110.313 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -62.85 -39.24 93.8 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.663 -0.648 . . . . 0.0 110.299 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -83.21 138.98 33.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.631 -0.668 . . . . 0.0 110.386 -176.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 53.2 -156.07 0.19 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.373 -0.83 . . . . 0.0 110.856 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 28.0 tp 54.12 89.43 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.279 -0.888 . . . . 0.0 110.781 -177.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.4 t -60.8 162.41 12.21 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.689 -0.632 . . . . 0.0 110.113 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -67.97 153.86 87.65 Favored 'Cis proline' 0 N--CA 1.496 1.661 0 C-N-CA 123.228 -1.572 . . . . 0.0 110.499 -13.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.0 p -82.68 164.75 45.6 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.651 -0.656 . . . . 0.0 110.163 178.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -58.96 148.1 86.57 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 O-C-N 123.244 1.128 . . . . 0.0 110.668 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.81 143.08 42.08 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.686 -0.633 . . . . 0.0 110.251 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.415 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 49.7 mm -124.22 99.99 36.52 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.641 -0.662 . . . . 0.0 109.984 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 126' ' ' ILE . 12.2 Cg_endo -60.2 151.42 73.45 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 O-C-N 123.194 1.102 . . . . 0.0 110.513 -179.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.6 t -111.25 151.29 28.46 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.589 -0.694 . . . . 0.0 110.313 -177.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -93.85 22.92 5.19 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.614 -0.679 . . . . 0.0 110.893 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 48.2 m -71.67 125.14 26.34 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.542 -0.724 . . . . 0.0 110.226 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -70.74 144.9 50.78 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.715 -0.615 . . . . 0.0 110.461 -177.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.43 ' CE1' ' HA2' ' A' ' 134' ' ' GLY . 64.9 t80 -154.93 101.37 2.32 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.72 -0.613 . . . . 0.0 110.061 178.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -58.79 -39.88 77.67 Favored 'Trans proline' 0 N--CA 1.488 1.153 0 O-C-N 123.115 1.061 . . . . 0.0 110.799 -174.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.43 ' HA2' ' CE1' ' A' ' 132' ' ' TYR . . . 81.64 -155.2 35.22 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 177.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -74.27 -48.89 0.2 Allowed 'Trans proline' 0 C--N 1.316 -1.156 0 O-C-N 123.385 1.203 . . . . 0.0 110.873 -174.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -86.98 9.03 20.76 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.635 -0.665 . . . . 0.0 111.403 -173.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.57 62.11 2.79 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.99 -1.069 . . . . 0.0 110.686 -177.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.721 ' HA ' HG12 ' A' ' 176' ' ' VAL . 65.2 t80 -79.27 119.3 22.15 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.559 -0.713 . . . . 0.0 110.048 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -130.05 159.94 35.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.785 -0.572 . . . . 0.0 110.37 -175.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 59.4 t -125.11 146.54 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.698 -0.626 . . . . 0.0 109.819 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.6 p -155.18 161.55 41.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.736 -0.602 . . . . 0.0 110.024 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.417 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 41.2 m-85 -126.7 125.16 41.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.789 -0.57 . . . . 0.0 109.923 -176.076 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -60.2 137.31 58.14 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.592 -0.692 . . . . 0.0 110.146 -176.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -109.19 140.14 43.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.602 -0.686 . . . . 0.0 110.495 -174.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 97.1 p -131.19 160.53 34.54 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.8 -0.562 . . . . 0.0 110.115 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 55.8 p -63.84 164.96 9.28 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.586 -0.697 . . . . 0.0 110.161 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 147' ' ' THR . 5.4 t -63.66 84.5 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.728 -0.608 . . . . 0.0 110.329 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -89.97 162.08 15.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.62 -0.675 . . . . 0.0 110.236 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 36.4 mttp -73.29 141.78 47.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.612 -0.68 . . . . 0.0 110.138 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 52.44 63.65 2.16 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.453 -0.78 . . . . 0.0 110.954 -178.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -84.11 121.33 27.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.596 -0.69 . . . . 0.0 110.076 178.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 44.1 p -60.12 -34.09 73.03 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.682 -0.636 . . . . 0.0 110.229 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.448 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.0 p-90 -171.26 144.29 2.0 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.62 -0.675 . . . . 0.0 110.117 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.4 t -142.13 142.7 32.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.882 -0.511 . . . . 0.0 109.992 -176.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.417 ' CG ' ' HB2' ' A' ' 142' ' ' PHE . 63.2 t80 -125.41 140.06 53.12 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.54 -0.725 . . . . 0.0 110.423 -173.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.8 t -110.56 123.96 50.94 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 120.379 -0.529 . . . . 0.0 109.811 176.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 56.1 m -70.71 -37.1 73.53 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.872 -0.518 . . . . 0.0 110.376 -177.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -59.75 -33.28 71.46 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.58 -0.7 . . . . 0.0 110.478 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.47 HD11 ' OD1' ' A' ' 316' ' ' ASP . 57.7 mt -104.81 -11.96 16.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.666 -0.646 . . . . 0.0 110.81 -175.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 79.9 tttt 59.79 49.65 7.81 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.978 -1.076 . . . . 0.0 109.704 177.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -146.58 153.03 39.88 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.8 -174.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.6 tp -126.58 137.84 53.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.841 -0.537 . . . . 0.0 110.413 -175.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -117.66 134.27 55.07 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.645 -0.659 . . . . 0.0 109.487 175.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.35 158.4 44.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.671 -0.643 . . . . 0.0 111.173 -174.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.4 ' HG3' ' HD3' ' A' ' 309' ' ' PRO . 42.1 mt-30 -104.63 141.3 36.67 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.585 -0.697 . . . . 0.0 110.525 172.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.465 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 18.8 tt -55.39 149.9 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.594 -0.691 . . . . 0.0 111.444 -175.01 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.79 10.08 5.78 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.559 -0.713 . . . . 0.0 112.481 178.312 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -96.18 155.07 16.91 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.959 -1.088 . . . . 0.0 110.611 172.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 77.4 m -81.16 126.07 31.03 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.631 -0.668 . . . . 0.0 110.325 177.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 43.5 t -115.13 89.64 21.04 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.652 -0.655 . . . . 0.0 110.273 175.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.489 ' HA ' HD23 ' A' ' 264' ' ' LEU . 15.5 Cg_exo -65.8 124.94 13.42 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 O-C-N 123.281 1.148 . . . . 0.0 110.675 173.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.569 HD12 ' CD2' ' A' ' 265' ' ' TYR . 97.3 mt -119.87 140.83 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.634 -0.667 . . . . 0.0 109.246 172.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLN . . . . . 0.546 ' NE2' ' CE1' ' A' ' 260' ' ' PHE . 73.3 mt-30 -106.79 135.46 48.29 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.454 -0.779 . . . . 0.0 110.74 -174.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.586 HG21 ' CE1' ' A' ' 138' ' ' PHE . 49.6 mm -95.27 134.97 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.708 -0.62 . . . . 0.0 109.687 170.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -117.48 130.69 56.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.557 -0.714 . . . . 0.0 110.44 176.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.721 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.6 m -136.67 159.75 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.573 -0.704 . . . . 0.0 109.99 175.052 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 80.6 mmm -78.75 -40.56 33.03 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.67 -0.644 . . . . 0.0 110.068 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 76.8 p -135.02 143.24 45.22 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.735 -0.603 . . . . 0.0 109.722 177.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.4 Cg_exo -55.84 139.89 84.57 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 O-C-N 123.161 1.085 . . . . 0.0 110.855 -172.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.778 ' HB3' HD21 ' A' ' 288' ' ' LEU . 32.5 Cg_endo -67.47 170.03 14.44 Favored 'Trans proline' 0 N--CA 1.487 1.113 0 O-C-N 123.131 1.069 . . . . 0.0 110.619 177.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -60.75 157.39 37.92 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 O-C-N 123.293 1.154 . . . . 0.0 110.53 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -79.8 140.87 36.7 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.574 -0.704 . . . . 0.0 109.949 175.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.7 -24.91 29.57 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -174.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.14 153.78 1.34 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.378 -1.072 . . . . 0.0 111.398 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.8 155.95 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.751 -0.593 . . . . 0.0 109.779 176.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.678 HD11 ' HD2' ' A' ' 251' ' ' TYR . 52.4 mt -108.06 135.59 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.739 ' HG2' HD22 ' A' ' 248' ' ' LEU . 27.6 mtm180 -114.78 143.88 44.38 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -176.128 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -139.47 123.75 18.04 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.598 -0.689 . . . . 0.0 110.408 177.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.41 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 26.8 ttm -137.36 138.05 23.96 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.797 -0.564 . . . . 0.0 111.073 -175.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.551 ' HD3' HD12 ' A' ' 226' ' ' ILE . 62.6 Cg_endo -91.13 138.17 2.27 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 O-C-N 123.187 1.098 . . . . 0.0 110.643 176.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.419 HG13 ' C ' ' A' ' 190' ' ' PRO . 34.8 m -146.79 154.85 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.471 -0.768 . . . . 0.0 110.212 173.081 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.677 ' HA ' HG22 ' A' ' 282' ' ' ILE . 87.1 m-85 -58.49 167.55 1.4 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.511 -0.743 . . . . 0.0 110.679 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -84.94 -60.08 2.15 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.639 -0.663 . . . . 0.0 110.863 -174.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -80.08 152.11 29.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.544 -0.722 . . . . 0.0 110.286 -175.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.459 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.67 -38.06 71.68 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.332 -0.855 . . . . 0.0 110.713 -176.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.4 mp0 -56.5 -24.81 48.8 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.483 -0.76 . . . . 0.0 110.616 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.426 ' HB3' ' CD1' ' A' ' 192' ' ' TYR . 99.5 m-70 -109.53 -20.51 12.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.586 -0.696 . . . . 0.0 111.14 -178.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -68.05 -20.24 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.119 -0.988 . . . . 0.0 110.628 -176.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 78.8 p -79.45 -17.08 55.02 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.577 -0.702 . . . . 0.0 110.649 175.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -88.35 136.34 33.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.386 -0.821 . . . . 0.0 110.017 173.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 60.5 t -73.07 143.76 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.584 -0.698 . . . . 0.0 110.13 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.509 HG22 ' CE2' ' A' ' 192' ' ' TYR . 84.0 t -84.82 139.13 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.538 -0.726 . . . . 0.0 109.217 171.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -134.76 -170.04 2.48 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.508 -0.745 . . . . 0.0 111.157 -165.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -95.2 152.99 17.88 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.795 -0.565 . . . . 0.0 110.206 -176.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 56.5 m -76.5 157.75 82.07 Favored Pre-proline 0 N--CA 1.497 1.897 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 172.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -63.52 -47.45 7.45 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 O-C-N 123.086 1.045 . . . . 0.0 109.998 177.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.402 ' ND2' ' NE2' ' A' ' 208' ' ' HIS . 28.7 p-10 -65.43 -44.39 87.49 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.578 -0.701 . . . . 0.0 111.261 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' HIS . . . . . 0.402 ' NE2' ' ND2' ' A' ' 207' ' ' ASN . 51.2 m170 -81.72 -27.77 33.72 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.432 -0.793 . . . . 0.0 111.234 -174.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -68.59 -39.71 80.81 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.395 -0.816 . . . . 0.0 110.075 172.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 25.4 tp -58.14 -30.95 66.74 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.605 -0.684 . . . . 0.0 110.66 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 29.8 t -48.37 142.94 5.14 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.553 -0.717 . . . . 0.0 111.554 -178.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.446 ' NH1' ' CE2' ' A' ' 214' ' ' PHE . 6.1 ptm85 -57.22 136.76 56.48 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.666 -0.646 . . . . 0.0 110.816 -175.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -102.21 -70.03 0.77 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.767 -0.583 . . . . 0.0 110.128 177.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.446 ' CE2' ' NH1' ' A' ' 212' ' ' ARG . 93.6 m-85 51.33 73.53 0.3 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.283 -0.886 . . . . 0.0 111.148 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -67.48 -10.18 49.1 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.632 -0.668 . . . . 0.0 111.032 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -60.03 121.19 11.23 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.195 -0.941 . . . . 0.0 110.236 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 80.6 17.88 72.16 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -143.65 139.92 29.83 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.196 -1.179 . . . . 0.0 109.927 175.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 232' ' ' SER . 82.9 mt -85.15 -25.2 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.662 -0.649 . . . . 0.0 110.52 -178.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.508 ' HB1' ' HB3' ' A' ' 227' ' ' ARG . . . -124.98 89.97 51.79 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.499 -0.751 . . . . 0.0 110.356 -177.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.433 ' HD2' ' CE1' ' A' ' 236' ' ' TYR . 22.6 Cg_endo -67.01 142.06 60.43 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.38 1.2 . . . . 0.0 110.513 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -57.47 -20.79 42.46 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 O-C-N 123.114 1.06 . . . . 0.0 111.46 -176.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 91.2 p -53.79 -22.27 9.14 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.21 -0.931 . . . . 0.0 111.377 -175.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -93.58 131.85 38.46 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.302 -0.874 . . . . 0.0 110.151 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.405 ' HA ' ' HG3' ' A' ' 268' ' ' MET . 57.5 tp -59.69 -40.43 87.85 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.553 -0.717 . . . . 0.0 110.161 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.551 HD12 ' HD3' ' A' ' 190' ' ' PRO . 83.9 mt -106.31 136.65 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.905 -0.497 . . . . 0.0 109.707 176.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.508 ' HB3' ' HB1' ' A' ' 220' ' ' ALA . 40.6 mtm105 -133.52 157.78 44.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.693 -0.629 . . . . 0.0 110.129 176.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.419 HG23 HG21 ' A' ' 247' ' ' VAL . 79.2 t -102.41 146.58 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.649 -0.657 . . . . 0.0 110.098 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -120.76 130.01 53.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.857 -0.527 . . . . 0.0 110.332 171.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.39 20.69 19.29 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 169.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -140.99 107.06 5.18 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.276 -1.132 . . . . 0.0 110.08 174.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' SER . . . . . 0.411 ' HA ' HD13 ' A' ' 219' ' ' ILE . 42.8 m -63.3 -15.26 56.7 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.56 -0.712 . . . . 0.0 111.269 -175.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -100.05 8.1 44.21 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.219 -0.925 . . . . 0.0 111.59 -177.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.2 129.4 41.09 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.104 -0.998 . . . . 0.0 110.345 177.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -139.79 158.1 44.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.826 -0.546 . . . . 0.0 109.709 177.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.433 ' CE1' ' HD2' ' A' ' 221' ' ' PRO . 74.4 m-85 -112.16 150.57 30.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.522 -0.736 . . . . 0.0 110.539 -177.043 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.21 159.9 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.804 -0.56 . . . . 0.0 110.155 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -122.53 130.04 52.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.68 -0.638 . . . . 0.0 110.194 176.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -65.08 130.12 94.72 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.625 -0.672 . . . . 0.0 109.823 178.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -66.48 -27.79 46.34 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 O-C-N 123.155 1.082 . . . . 0.0 111.006 -171.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 82.8 mt -100.55 -50.39 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.471 -0.768 . . . . 0.0 110.99 -167.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.1 p -105.47 12.11 31.82 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.41 -0.806 . . . . 0.0 111.877 -174.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.82 -5.11 13.24 Favored Glycine 0 N--CA 1.496 2.638 0 O-C-N 121.128 -0.982 . . . . 0.0 111.9 173.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -46.11 142.02 3.0 Favored 'General case' 0 N--CA 1.504 2.234 0 CA-C-N 119.104 1.452 . . . . 0.0 112.3 -174.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.6 mp0 -106.09 141.62 37.15 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.577 -0.702 . . . . 0.0 110.156 176.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 80.0 p -154.84 159.96 40.9 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.585 -0.697 . . . . 0.0 110.45 177.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.419 HG21 HG23 ' A' ' 228' ' ' VAL . 8.4 p -123.72 148.22 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.735 -0.603 . . . . 0.0 109.793 178.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.739 HD22 ' HG2' ' A' ' 187' ' ' ARG . 82.9 mt -129.57 154.63 46.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.644 -0.66 . . . . 0.0 110.094 -175.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.442 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.9 m -151.51 151.83 29.53 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.781 -0.574 . . . . 0.0 109.934 177.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -71.14 139.33 35.3 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 O-C-N 123.254 1.133 . . . . 0.0 109.993 176.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.678 ' HD2' HD11 ' A' ' 186' ' ' ILE . 60.6 t80 -75.06 124.48 27.07 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.42 -0.8 . . . . 0.0 110.21 176.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -100.04 160.12 28.03 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.665 -0.647 . . . . 0.0 110.072 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -59.53 159.95 22.05 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 O-C-N 123.241 1.127 . . . . 0.0 110.448 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -59.45 149.92 78.63 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 O-C-N 123.243 1.128 . . . . 0.0 110.426 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -60.91 147.63 42.44 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.612 -0.68 . . . . 0.0 110.19 -178.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.9 t -69.87 127.24 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.557 -0.715 . . . . 0.0 110.212 -170.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.97 -10.05 55.35 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 10.1 t -144.42 173.81 11.46 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.078 -1.248 . . . . 0.0 110.664 175.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -107.05 13.21 27.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.662 -0.649 . . . . 0.0 111.764 -168.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.546 ' CE1' ' NE2' ' A' ' 173' ' ' GLN . 14.1 p90 -119.98 168.04 11.55 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.154 -0.966 . . . . 0.0 111.118 -175.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 93.3 m -117.79 146.73 43.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.761 -0.587 . . . . 0.0 109.887 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 45.3 m -116.46 136.41 53.01 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.524 -0.735 . . . . 0.0 110.857 -175.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.2 t -128.39 136.02 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 172.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 171' ' ' PRO . 71.3 mt -104.94 120.75 42.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.565 -0.709 . . . . 0.0 110.015 -174.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.569 ' CD2' HD12 ' A' ' 172' ' ' ILE . 2.9 m-30 -95.5 157.37 15.92 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.642 -0.661 . . . . 0.0 110.605 176.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -136.47 142.83 43.59 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 168.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -114.32 133.16 55.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.498 -0.751 . . . . 0.0 110.459 -177.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' MET . . . . . 0.405 ' HG3' ' HA ' ' A' ' 225' ' ' LEU . 0.0 OUTLIER -103.25 3.31 35.38 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.685 -0.634 . . . . 0.0 111.975 -178.104 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 269' ' ' CYS . . . . . 0.728 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.8 OUTLIER -144.63 159.95 41.97 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.102 -0.999 . . . . 0.0 109.929 174.569 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.442 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.1 p30 -119.78 163.54 17.31 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.435 0.636 . . . . 0.0 110.484 -178.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 271' ' ' SER . . . . . 0.429 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 32.4 m -58.22 -32.62 68.48 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.465 -0.772 . . . . 0.0 110.975 -164.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 49.1 p -101.51 13.05 36.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.47 -0.769 . . . . 0.0 111.941 -164.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 30.7 p -94.26 118.08 31.06 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.077 -1.014 . . . . 0.0 110.612 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 61.2 t -63.82 139.92 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.44 -0.788 . . . . 0.0 110.351 -170.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 100.13 -5.11 57.54 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 177.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.81 -99.05 0.87 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 171.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 277' ' ' MET . . . . . 0.429 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.3 mmm -62.91 -32.1 73.31 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.7 -0.882 . . . . 0.0 110.287 178.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.3 p30 44.31 49.88 7.89 Favored 'General case' 0 N--CA 1.504 2.243 0 CA-C-O 121.262 0.553 . . . . 0.0 112.449 174.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 21.3 mtt180 54.85 28.64 10.69 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.29 -0.881 . . . . 0.0 111.197 175.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -116.82 106.01 48.67 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.561 -0.712 . . . . 0.0 109.995 174.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.37 147.71 89.92 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 O-C-N 123.029 1.015 . . . . 0.0 110.609 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.677 HG22 ' HA ' ' A' ' 192' ' ' TYR . 45.2 pt -131.87 177.34 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.646 0.736 . . . . 0.0 110.876 -177.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 302' ' ' GLU . 35.3 mt -124.3 149.85 46.08 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.459 HD12 ' HB2' ' A' ' 303' ' ' ALA . 81.2 mt -112.02 129.94 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 79.4 mt -109.81 125.26 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 63.1 t -118.99 126.78 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.436 HG22 ' HG2' ' A' ' 298' ' ' ARG . 45.9 p -125.24 152.16 44.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.631 -0.668 . . . . 0.0 110.594 -173.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.778 HD21 ' HB3' ' A' ' 180' ' ' PRO . 26.2 tp -101.03 127.14 47.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.715 -0.615 . . . . 0.0 109.5 167.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.403 ' OE2' HG22 ' A' ' 295' ' ' VAL . 73.1 mm-40 -130.27 150.32 51.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.856 -0.528 . . . . 0.0 109.926 -173.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.862 HG23 HD11 ' A' ' 296' ' ' LEU . 8.2 p -89.99 161.14 16.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.579 -0.701 . . . . 0.0 109.971 177.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -55.89 -26.14 45.96 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.502 -0.749 . . . . 0.0 111.043 -176.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 49.1 p30 -87.61 8.28 25.99 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.424 -0.797 . . . . 0.0 111.904 -174.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 88.19 20.19 50.17 Favored Glycine 0 N--CA 1.494 2.548 0 O-C-N 121.067 -1.021 . . . . 0.0 110.648 172.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -107.6 140.21 40.96 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.323 -1.104 . . . . 0.0 110.111 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.403 HG22 ' OE2' ' A' ' 289' ' ' GLU . 58.6 t -83.91 133.56 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.563 -0.711 . . . . 0.0 110.15 -174.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.862 HD11 HG23 ' A' ' 290' ' ' THR . 95.7 mt -99.93 -40.15 7.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.711 -0.618 . . . . 0.0 110.283 176.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -167.26 150.41 17.02 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.436 ' HG2' HG22 ' A' ' 287' ' ' THR . 77.5 mtm180 -133.47 137.29 45.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.612 -0.934 . . . . 0.0 110.718 -178.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -130.61 155.21 46.93 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.619 -0.676 . . . . 0.0 110.229 172.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 79.5 m -139.15 146.73 40.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.469 -0.769 . . . . 0.0 110.831 -174.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.424 ' CE2' ' HB ' ' A' ' 284' ' ' ILE . 9.2 p90 -147.76 162.08 39.93 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.782 -0.574 . . . . 0.0 109.979 177.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.444 ' HA ' HD23 ' A' ' 283' ' ' LEU . 81.9 tt0 -104.77 138.44 41.05 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.542 -0.724 . . . . 0.0 110.331 -175.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.459 ' HB2' HD12 ' A' ' 284' ' ' ILE . . . -125.14 143.63 50.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.651 -0.655 . . . . 0.0 110.596 -171.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -138.19 140.77 39.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.75 -0.594 . . . . 0.0 109.755 174.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.728 HD13 ' O ' ' A' ' 269' ' ' CYS . 63.8 mt -108.88 122.87 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.501 -0.749 . . . . 0.0 109.645 176.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.9 p -145.24 168.66 19.88 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.636 -0.665 . . . . 0.0 110.657 -172.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -70.03 -40.18 75.33 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.64 -0.663 . . . . 0.0 110.638 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.8 t -127.99 86.55 57.87 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.522 -0.736 . . . . 0.0 110.457 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 309' ' ' PRO . . . . . 0.4 ' HD3' ' HG3' ' A' ' 165' ' ' GLN . 43.7 Cg_exo -56.23 -27.69 67.51 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 O-C-N 123.198 1.104 . . . . 0.0 110.573 174.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -68.47 -36.79 84.63 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -72.18 -39.95 68.29 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.708 -0.877 . . . . 0.0 109.873 -173.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -69.58 -39.26 77.43 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.062 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 -61.61 -44.01 97.8 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.301 178.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -65.12 -39.42 93.05 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.569 -0.707 . . . . 0.0 110.476 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.32 -49.95 74.94 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.599 -0.688 . . . . 0.0 110.44 -173.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 316' ' ' ASP . . . . . 0.47 ' OD1' HD11 ' A' ' 159' ' ' LEU . 3.1 p30 -61.63 -37.67 84.85 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.487 -0.758 . . . . 0.0 110.02 -178.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -62.0 -41.22 97.82 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.624 -0.673 . . . . 0.0 110.099 177.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -62.59 -35.16 78.63 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.695 -0.628 . . . . 0.0 109.988 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 24.2 m -63.21 -32.68 74.14 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.759 -0.588 . . . . 0.0 110.289 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 83.6 mt -77.3 -46.96 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.63 -0.669 . . . . 0.0 110.02 -177.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -60.7 -41.75 95.83 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.641 -0.662 . . . . 0.0 110.303 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -65.26 -42.56 93.12 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.587 -0.696 . . . . 0.0 110.081 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -60.86 -35.11 75.74 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.748 -0.595 . . . . 0.0 110.161 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -96.3 104.27 16.22 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.672 -0.643 . . . . 0.0 110.314 -178.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 61.8 t -125.07 130.04 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.645 -0.659 . . . . 0.0 109.854 176.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 29.3 t -95.04 131.66 40.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.646 -0.659 . . . . 0.0 110.248 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -91.5 114.66 27.25 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.666 -0.646 . . . . 0.0 110.259 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 27.5 t -94.07 137.68 32.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.622 -0.674 . . . . 0.0 110.227 178.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 30.8 m -137.57 135.03 36.29 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.746 -0.596 . . . . 0.0 110.094 178.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 43.9 mttp -60.55 -37.6 81.77 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.576 -0.703 . . . . 0.0 110.322 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -111.46 147.09 36.04 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.658 -0.651 . . . . 0.0 110.243 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -59.86 -34.62 83.58 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 48.8 p30 -106.35 160.0 15.71 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.674 -0.898 . . . . 0.0 110.306 177.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -142.04 151.91 42.87 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.514 -0.741 . . . . 0.0 110.385 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -60.11 -39.01 84.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.649 -0.657 . . . . 0.0 110.329 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 54.27 101.62 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.456 -0.777 . . . . 0.0 110.872 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -90.55 134.03 34.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.612 -0.68 . . . . 0.0 110.258 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -100.86 139.03 37.12 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.67 -0.644 . . . . 0.0 110.303 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 71.1 p -122.73 166.01 15.62 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.711 -0.618 . . . . 0.0 110.208 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 340' ' ' HIS . . . . . 0.405 ' CD2' ' O ' ' A' ' 341' ' ' GLY . 57.0 p-80 -59.08 -33.53 70.92 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.575 -0.703 . . . . 0.0 110.462 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 341' ' ' GLY . . . . . 0.405 ' O ' ' CD2' ' A' ' 340' ' ' HIS . . . 81.74 -163.95 44.5 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 175.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 15.1 tt -147.67 154.21 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.703 -0.881 . . . . 0.0 110.145 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -91.26 124.72 35.67 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.62 -0.675 . . . . 0.0 110.361 -178.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 70.8 mtm 54.86 -86.55 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.687 -0.633 . . . . 0.0 111.053 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 22.4 p . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.237 -177.738 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 75.1 m -86.19 9.24 18.12 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.669 -0.9 . . . . 0.0 111.344 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 57.0 p -73.1 160.82 31.42 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.3 -0.875 . . . . 0.0 110.165 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.569 HG22 ' H ' ' A' ' 118' ' ' ASP . 44.6 m -123.46 139.54 53.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.636 -0.665 . . . . 0.0 110.292 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -66.37 -25.96 67.04 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.603 -0.686 . . . . 0.0 110.416 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.569 ' H ' HG22 ' A' ' 116' ' ' THR . 23.1 t70 -84.65 120.6 26.57 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.592 -0.693 . . . . 0.0 110.187 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 52.13 179.63 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.516 -0.74 . . . . 0.0 111.027 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.4 mt 52.49 28.41 5.93 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.472 -0.767 . . . . 0.0 110.91 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.0 p -123.34 170.45 8.33 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.676 -0.64 . . . . 0.0 110.278 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.4 163.08 10.95 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 O-C-N 123.349 1.184 . . . . 0.0 110.67 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.42 160.66 67.06 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.679 -0.638 . . . . 0.0 110.22 -177.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -58.77 144.93 97.85 Favored 'Trans proline' 0 N--CA 1.488 1.174 0 O-C-N 123.282 1.148 . . . . 0.0 110.773 -176.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.98 148.66 36.15 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.657 -0.652 . . . . 0.0 110.289 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.466 HD11 HG22 ' A' ' 199' ' ' THR . 50.1 mm -119.92 100.04 48.71 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.654 -0.654 . . . . 0.0 109.847 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 126' ' ' ILE . 12.0 Cg_endo -59.66 151.75 67.74 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 O-C-N 123.179 1.094 . . . . 0.0 110.783 -178.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.2 t -113.01 152.49 29.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.696 -0.628 . . . . 0.0 110.281 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -94.69 25.0 4.26 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.611 -0.681 . . . . 0.0 110.824 -178.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 51.0 m -70.06 125.21 26.09 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.613 -0.679 . . . . 0.0 110.249 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -70.06 144.94 52.02 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.616 -0.678 . . . . 0.0 110.432 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.434 ' CE1' ' HA2' ' A' ' 134' ' ' GLY . 43.2 t80 -155.47 101.4 2.22 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.587 -0.696 . . . . 0.0 110.018 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -59.29 -39.97 72.78 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 O-C-N 123.185 1.097 . . . . 0.0 110.762 -173.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.434 ' HA2' ' CE1' ' A' ' 132' ' ' TYR . . . 82.67 -155.1 33.28 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -73.8 -50.01 0.18 Allowed 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.382 1.201 . . . . 0.0 110.881 -174.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -87.75 9.68 20.85 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.576 -0.702 . . . . 0.0 111.337 -173.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 t 53.81 61.69 2.97 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.961 -1.087 . . . . 0.0 110.632 -176.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.718 ' HA ' HG12 ' A' ' 176' ' ' VAL . 64.4 t80 -80.27 118.69 22.15 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.651 -0.656 . . . . 0.0 109.932 -178.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -129.98 163.21 26.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.768 -0.582 . . . . 0.0 110.413 -174.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 62.9 t -125.16 147.73 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.729 -0.607 . . . . 0.0 109.773 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.7 p -155.16 163.32 40.38 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.942 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.438 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 73.1 m-85 -126.68 125.17 41.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.784 -0.573 . . . . 0.0 109.855 -176.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -56.47 143.62 34.38 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.624 -0.672 . . . . 0.0 110.488 -174.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -94.2 130.04 40.58 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.636 -0.665 . . . . 0.0 110.603 -172.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.2 t -125.18 146.62 49.42 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.697 -0.627 . . . . 0.0 110.058 177.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 56.8 p -64.21 165.35 9.49 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.678 -0.639 . . . . 0.0 110.1 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 147' ' ' THR . 7.0 t -71.63 64.74 0.46 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.611 -0.681 . . . . 0.0 110.348 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.32 157.83 35.06 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.598 -0.689 . . . . 0.0 110.144 179.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -73.51 150.55 41.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.605 -0.684 . . . . 0.0 110.01 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.7 m 52.84 48.09 23.23 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.525 -0.734 . . . . 0.0 110.945 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.32 126.58 30.99 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.685 -0.635 . . . . 0.0 110.218 178.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.406 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 44.6 p -60.07 -33.99 72.83 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.674 -0.641 . . . . 0.0 110.204 177.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.42 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -171.45 145.94 2.17 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.709 -0.62 . . . . 0.0 110.001 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.7 t -142.12 142.65 32.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.8 -0.563 . . . . 0.0 110.082 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.438 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 61.7 t80 -125.57 140.09 53.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.646 -0.659 . . . . 0.0 110.483 -172.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.4 t -109.78 124.07 50.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.842 -0.536 . . . . 0.0 109.785 175.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 48.7 m -71.35 -37.11 71.7 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.357 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -60.75 -31.64 70.97 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.605 -0.684 . . . . 0.0 110.25 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 58.2 mt -104.79 -12.19 16.43 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.612 -0.68 . . . . 0.0 110.786 -174.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 46.5 tttt 59.73 47.56 10.28 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.05 -1.031 . . . . 0.0 109.751 176.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -147.68 153.12 38.91 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.627 -0.671 . . . . 0.0 110.89 -173.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.662 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.61 137.86 53.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.771 -0.581 . . . . 0.0 110.408 -176.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -115.51 132.94 56.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.646 -0.659 . . . . 0.0 109.231 174.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.37 158.41 44.32 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.659 -0.651 . . . . 0.0 111.134 -173.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.405 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 50.7 mt-30 -104.58 144.08 32.19 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.494 0.664 . . . . 0.0 110.316 173.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.41 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.2 tt -52.06 147.22 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.52 -0.737 . . . . 0.0 111.871 -174.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.42 10.0 5.39 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.614 -0.679 . . . . 0.0 112.544 175.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.405 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 68.8 mmtt -95.36 155.08 16.89 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.001 -1.062 . . . . 0.0 110.894 175.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 84.9 m -83.23 126.1 32.29 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.708 -0.62 . . . . 0.0 110.522 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' CYS . . . . . 0.662 ' SG ' HD21 ' A' ' 162' ' ' LEU . 43.3 t -115.14 90.29 23.34 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.615 -0.678 . . . . 0.0 110.12 174.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.42 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 18.9 Cg_endo -64.41 131.44 29.98 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.239 1.126 . . . . 0.0 110.45 176.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.405 HG12 ' CE2' ' A' ' 142' ' ' PHE . 93.6 mt -123.78 141.56 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLN . . . . . 0.4 ' OE1' ' CD1' ' A' ' 260' ' ' PHE . 67.1 mm-40 -109.17 133.72 52.65 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.566 -0.709 . . . . 0.0 110.408 -173.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.614 HG21 ' CE1' ' A' ' 138' ' ' PHE . 49.4 mm -95.38 135.01 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.574 -0.704 . . . . 0.0 109.725 171.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 32.2 tttt -119.52 131.13 55.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.594 -0.691 . . . . 0.0 110.453 177.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.718 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.7 m -136.83 159.72 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.59 -0.694 . . . . 0.0 110.05 175.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 78.8 mmm -78.32 -40.3 37.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.726 -0.609 . . . . 0.0 110.019 176.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.0 p -134.15 143.21 46.2 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.735 -0.603 . . . . 0.0 109.718 177.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 33.6 Cg_exo -55.3 139.85 81.45 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 O-C-N 123.076 1.04 . . . . 0.0 110.892 -172.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.556 ' HB3' HD21 ' A' ' 288' ' ' LEU . 36.8 Cg_endo -68.56 170.06 15.91 Favored 'Trans proline' 0 N--CA 1.487 1.099 0 O-C-N 123.153 1.081 . . . . 0.0 110.629 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -60.4 155.41 47.04 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.404 1.213 . . . . 0.0 110.602 -178.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -78.69 138.47 38.29 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.58 -0.7 . . . . 0.0 109.981 175.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.28 -24.78 30.85 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -174.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.14 151.91 1.87 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.364 -1.08 . . . . 0.0 111.452 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.0 m -129.71 155.97 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.707 -0.62 . . . . 0.0 109.625 176.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.728 HD11 ' HD2' ' A' ' 251' ' ' TYR . 81.6 mt -108.43 139.3 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.685 -0.635 . . . . 0.0 109.537 176.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.727 ' HG2' HD22 ' A' ' 248' ' ' LEU . 38.9 mtm180 -114.87 146.81 40.69 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -176.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.675 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -140.55 127.61 20.83 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.372 174.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 33.3 ttm -137.34 139.04 26.55 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.805 -0.56 . . . . 0.0 110.938 -177.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.69 ' HD3' HD12 ' A' ' 226' ' ' ILE . 72.1 Cg_endo -91.44 138.15 2.14 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 120.983 1.122 . . . . 0.0 110.702 176.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.449 HG12 ' CZ ' ' A' ' 244' ' ' ARG . 34.9 m -147.22 154.94 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.599 -0.688 . . . . 0.0 110.14 174.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.642 ' HA ' HG22 ' A' ' 282' ' ' ILE . 90.4 m-85 -60.32 165.9 3.31 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.478 -0.764 . . . . 0.0 110.399 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.426 ' HA ' HD12 ' A' ' 283' ' ' LEU . 63.3 tttm -82.99 -60.1 2.27 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.621 -0.675 . . . . 0.0 110.832 -174.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -80.11 151.96 29.55 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.501 -0.749 . . . . 0.0 110.373 -175.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.452 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.67 -38.31 72.05 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.36 -0.838 . . . . 0.0 110.709 -175.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -56.5 -24.92 49.51 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.48 -0.763 . . . . 0.0 110.652 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.418 ' HB3' ' CG ' ' A' ' 192' ' ' TYR . 98.9 m-70 -109.69 -20.49 12.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.53 -0.732 . . . . 0.0 111.167 -178.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.1 p -67.74 -20.3 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.086 -1.008 . . . . 0.0 110.655 -176.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.466 HG22 HD11 ' A' ' 126' ' ' ILE . 67.0 p -79.35 -17.1 55.17 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.537 -0.727 . . . . 0.0 110.742 175.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -88.31 137.24 32.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.292 -0.88 . . . . 0.0 110.097 173.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 54.1 t -74.09 142.01 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.612 -0.68 . . . . 0.0 110.262 177.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.511 HG22 ' CE2' ' A' ' 192' ' ' TYR . 67.8 t -84.84 138.8 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.579 -0.701 . . . . 0.0 109.331 170.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.9 pttp -134.86 -170.16 2.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.482 -0.761 . . . . 0.0 111.185 -168.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -95.27 153.9 17.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.794 -0.567 . . . . 0.0 110.499 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 60.3 m -76.04 160.6 78.0 Favored Pre-proline 0 N--CA 1.497 1.887 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 174.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -64.2 -47.38 6.32 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 O-C-N 123.189 1.099 . . . . 0.0 109.842 176.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.445 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.6 p-10 -65.54 -44.35 87.12 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.626 -0.671 . . . . 0.0 111.223 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' HIS . . . . . 0.445 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 55.6 m170 -80.76 -27.73 36.69 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.479 -0.763 . . . . 0.0 111.358 -174.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -66.71 -42.06 87.01 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.442 -0.786 . . . . 0.0 109.919 172.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 23.3 tp -70.15 -34.27 72.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.611 -0.681 . . . . 0.0 110.298 174.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.9 t -48.41 -37.46 17.07 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.657 -0.652 . . . . 0.0 111.886 -175.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -128.04 137.51 52.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.55 -0.719 . . . . 0.0 110.291 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' GLU . . . . . 0.437 ' HG3' ' CD2' ' A' ' 214' ' ' PHE . 17.6 pt-20 -150.86 -160.46 1.17 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.692 -0.63 . . . . 0.0 110.242 -177.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.437 ' CD2' ' HG3' ' A' ' 213' ' ' GLU . 21.5 m-85 54.08 70.5 0.6 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.306 -0.872 . . . . 0.0 110.785 -179.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -69.02 -10.31 56.88 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.672 -0.642 . . . . 0.0 111.114 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -60.16 118.09 5.93 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.196 -0.94 . . . . 0.0 110.358 177.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 80.51 20.01 67.39 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 177.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -114.65 139.95 49.23 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.269 -1.136 . . . . 0.0 110.321 177.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.8 mt -84.95 -25.11 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.704 -0.622 . . . . 0.0 110.445 -178.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.655 ' HB1' ' HD2' ' A' ' 227' ' ' ARG . . . -125.01 90.01 51.72 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.492 -0.755 . . . . 0.0 110.263 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.454 ' HD2' ' CE2' ' A' ' 236' ' ' TYR . 21.4 Cg_exo -62.34 136.01 57.2 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.317 1.167 . . . . 0.0 110.379 -177.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.417 ' O ' ' HE3' ' A' ' 268' ' ' MET . 27.9 Cg_exo -57.46 -22.25 49.65 Favored 'Trans proline' 0 N--CA 1.49 1.278 0 O-C-N 123.054 1.028 . . . . 0.0 111.286 -176.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 25.2 m -52.89 -28.78 24.75 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.33 -0.856 . . . . 0.0 111.422 -174.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' HIS . . . . . 0.436 ' CE1' ' HB3' ' A' ' 236' ' ' TYR . 95.1 m-70 -100.12 129.39 46.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.436 -0.79 . . . . 0.0 110.601 -174.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.568 HD12 ' HG3' ' A' ' 268' ' ' MET . 55.2 tp -60.97 -37.51 82.68 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.618 -0.676 . . . . 0.0 110.236 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.69 HD12 ' HD3' ' A' ' 190' ' ' PRO . 82.1 mt -101.01 136.75 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.786 -0.571 . . . . 0.0 109.85 -179.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.655 ' HD2' ' HB1' ' A' ' 220' ' ' ALA . 65.1 mtm180 -133.28 158.71 42.26 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.646 -0.659 . . . . 0.0 110.254 178.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.666 HG23 HG21 ' A' ' 247' ' ' VAL . 93.0 t -103.93 146.7 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.725 -0.61 . . . . 0.0 110.137 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -118.5 130.0 55.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.73 -0.606 . . . . 0.0 110.477 170.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 92.42 25.02 22.47 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 167.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -138.86 108.1 6.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.433 -1.04 . . . . 0.0 110.017 174.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 92.6 p -63.35 -15.14 56.51 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.675 -0.641 . . . . 0.0 111.287 -177.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -97.28 9.36 42.46 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.299 -0.876 . . . . 0.0 111.155 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -62.24 125.44 23.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.222 -0.924 . . . . 0.0 110.156 176.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -139.72 154.81 47.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.798 -0.564 . . . . 0.0 109.74 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.454 ' CE2' ' HD2' ' A' ' 221' ' ' PRO . 91.1 m-85 -117.36 150.73 38.36 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.605 -176.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.19 160.03 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.782 -0.574 . . . . 0.0 110.234 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -114.69 130.05 56.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.768 -0.583 . . . . 0.0 110.038 174.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -63.78 130.11 94.21 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.71 -0.619 . . . . 0.0 109.741 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -64.98 -28.69 57.76 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.232 1.122 . . . . 0.0 111.045 -170.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.9 mt -102.16 -50.53 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.387 -0.821 . . . . 0.0 111.041 -167.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 9.3 p -105.5 12.27 31.58 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.327 -0.858 . . . . 0.0 111.917 -176.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 72.14 -5.01 15.46 Favored Glycine 0 N--CA 1.497 2.737 0 O-C-N 121.057 -1.027 . . . . 0.0 112.001 171.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.449 ' CZ ' HG12 ' A' ' 191' ' ' VAL . 22.6 mmt180 -45.82 142.14 2.68 Favored 'General case' 0 N--CA 1.505 2.324 0 CA-C-N 119.137 1.469 . . . . 0.0 112.509 -174.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -96.01 143.55 27.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.551 -0.718 . . . . 0.0 110.099 172.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 77.9 p -154.7 159.87 41.0 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.579 -0.7 . . . . 0.0 110.483 174.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.666 HG21 HG23 ' A' ' 228' ' ' VAL . 8.6 p -125.12 148.33 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.78 -0.575 . . . . 0.0 109.781 179.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.727 HD22 ' HG2' ' A' ' 187' ' ' ARG . 81.6 mt -129.64 154.55 47.0 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.651 -177.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.452 HG13 ' C ' ' A' ' 248' ' ' LEU . 34.1 m -151.53 151.68 29.22 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.789 -0.569 . . . . 0.0 109.985 176.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -71.07 139.04 34.89 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 123.297 1.156 . . . . 0.0 110.018 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.728 ' HD2' HD11 ' A' ' 186' ' ' ILE . 59.9 t80 -75.96 125.61 29.44 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.491 -0.756 . . . . 0.0 110.123 174.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -100.06 160.01 28.3 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.725 -0.609 . . . . 0.0 109.996 177.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -58.94 159.93 19.9 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.268 1.141 . . . . 0.0 110.417 178.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.38 149.91 78.32 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 O-C-N 123.187 1.098 . . . . 0.0 110.493 -177.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -61.82 148.48 43.07 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.681 -0.637 . . . . 0.0 110.138 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.2 t -69.92 127.2 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.534 -0.729 . . . . 0.0 110.12 -170.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.98 -10.14 55.37 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 9.9 t -144.73 174.11 11.26 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.124 -1.221 . . . . 0.0 110.616 175.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -107.26 13.16 27.47 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.612 -0.68 . . . . 0.0 111.707 -168.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.4 ' CD1' ' OE1' ' A' ' 173' ' ' GLN . 13.5 p90 -119.86 168.08 11.46 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.152 -0.967 . . . . 0.0 111.135 -174.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 88.4 m -117.77 147.49 42.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.741 -0.599 . . . . 0.0 109.905 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 47.0 m -118.14 136.28 53.71 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.56 -0.712 . . . . 0.0 111.048 -174.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.8 t -131.92 137.26 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 172.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 67.8 mt -104.62 120.73 42.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.467 -0.77 . . . . 0.0 109.826 -172.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.675 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 5.0 m-30 -106.29 151.2 25.13 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.678 -0.639 . . . . 0.0 110.604 -177.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -136.58 142.86 43.39 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -112.0 130.08 55.98 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.595 -0.69 . . . . 0.0 110.453 -177.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 268' ' ' MET . . . . . 0.568 ' HG3' HD12 ' A' ' 225' ' ' LEU . 5.0 ppp? -96.16 3.0 53.54 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.633 -0.667 . . . . 0.0 111.973 -176.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 269' ' ' CYS . . . . . 0.626 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.5 OUTLIER -144.81 165.04 29.24 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.076 -1.015 . . . . 0.0 110.123 175.874 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.635 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.3 p30 -121.7 163.4 19.1 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.646 -0.659 . . . . 0.0 110.417 -178.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 271' ' ' SER . . . . . 0.423 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 29.6 m -58.42 -35.14 71.62 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.427 -0.796 . . . . 0.0 110.986 -163.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 51.3 p -103.46 15.0 30.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.409 -0.807 . . . . 0.0 111.949 -163.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 29.7 p -93.96 118.05 30.95 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.063 -1.023 . . . . 0.0 110.712 178.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 60.0 t -62.75 138.82 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.519 -0.738 . . . . 0.0 110.352 -171.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.08 -5.21 61.2 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 178.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.13 -101.66 0.95 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 172.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 277' ' ' MET . . . . . 0.423 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.4 mmm -60.93 -29.95 69.91 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.657 -0.908 . . . . 0.0 110.124 178.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 22.6 p30 42.86 44.74 4.03 Favored 'General case' 0 N--CA 1.505 2.312 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 173.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 55.02 34.66 22.96 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.355 -0.841 . . . . 0.0 111.11 175.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 280' ' ' ARG . . . . . 0.468 ' O ' HG23 ' A' ' 282' ' ' ILE . 88.5 mtt180 -120.04 105.74 42.12 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.54 -0.725 . . . . 0.0 109.98 172.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 281' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 280' ' ' ARG . 11.3 Cg_endo -58.93 144.94 98.74 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 O-C-N 123.112 1.059 . . . . 0.0 110.573 -178.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.642 HG22 ' HA ' ' A' ' 192' ' ' TYR . 46.2 pt -131.97 175.36 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 122.006 0.908 . . . . 0.0 111.244 -173.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 302' ' ' GLU . 26.0 mt -124.44 149.84 46.34 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.699 HD12 ' CE1' ' A' ' 301' ' ' PHE . 82.4 mt -115.83 129.63 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.173 178.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.61 HG23 ' SG ' ' A' ' 300' ' ' CYS . 82.1 mt -109.74 125.52 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 -176.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 60.4 t -118.9 126.76 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.5 p -125.29 155.0 40.88 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.655 -0.653 . . . . 0.0 110.614 -172.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.575 HD22 ' CD1' ' A' ' 138' ' ' PHE . 30.5 tp -107.02 126.13 51.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.803 -0.561 . . . . 0.0 109.564 170.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.593 ' OE2' HG13 ' A' ' 295' ' ' VAL . 69.4 mm-40 -131.77 151.41 51.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.855 -0.528 . . . . 0.0 109.853 -174.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.645 HG22 HD11 ' A' ' 296' ' ' LEU . 71.4 p -89.9 157.8 17.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.605 -0.684 . . . . 0.0 109.779 178.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -56.12 -26.02 48.36 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.506 -0.746 . . . . 0.0 110.739 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -87.14 9.55 19.61 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.55 -0.719 . . . . 0.0 111.789 -174.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 87.63 20.09 52.26 Favored Glycine 0 N--CA 1.493 2.49 0 O-C-N 121.068 -1.02 . . . . 0.0 110.76 170.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -108.53 140.22 42.17 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.294 -1.121 . . . . 0.0 110.208 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.618 HG11 ' HE ' ' A' ' 298' ' ' ARG . 59.5 t -86.76 134.98 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.571 -0.706 . . . . 0.0 110.043 -173.294 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.645 HD11 HG22 ' A' ' 290' ' ' THR . 96.4 mt -99.87 -40.14 7.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.658 -0.651 . . . . 0.0 110.457 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -175.35 162.42 31.92 Favored Glycine 0 N--CA 1.496 2.674 0 C-N-CA 119.922 -1.132 . . . . 0.0 110.384 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.618 ' HE ' HG11 ' A' ' 295' ' ' VAL . 84.2 mtt180 -130.73 139.83 50.3 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.672 -0.899 . . . . 0.0 110.567 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -136.59 155.07 50.42 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.479 -0.763 . . . . 0.0 109.869 170.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 300' ' ' CYS . . . . . 0.61 ' SG ' HG23 ' A' ' 285' ' ' ILE . 89.1 m -143.56 154.76 43.92 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.327 -0.858 . . . . 0.0 110.874 -175.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.699 ' CE1' HD12 ' A' ' 284' ' ' ILE . 48.7 p90 -145.72 163.91 33.44 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.717 -0.614 . . . . 0.0 110.108 176.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.429 ' HA ' HD23 ' A' ' 283' ' ' LEU . 56.6 tt0 -104.89 135.84 45.5 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.457 -0.777 . . . . 0.0 110.325 -177.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -123.84 144.42 49.74 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.633 -0.667 . . . . 0.0 110.729 -170.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -138.67 137.0 36.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.815 -0.553 . . . . 0.0 109.812 173.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.635 HG21 ' HA ' ' A' ' 270' ' ' ASN . 75.0 mt -105.8 123.56 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.58 -0.7 . . . . 0.0 109.584 176.093 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.2 p -145.15 164.9 29.87 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.569 -0.707 . . . . 0.0 110.948 -169.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -66.43 -39.92 89.2 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.671 -0.643 . . . . 0.0 110.615 -177.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.9 t -131.31 89.06 42.31 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.534 -0.729 . . . . 0.0 110.576 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -56.71 -29.3 79.67 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 123.136 1.072 . . . . 0.0 110.477 173.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.15 -37.93 93.46 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 176.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -70.23 -38.41 75.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.536 -0.979 . . . . 0.0 109.779 -175.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -69.4 -36.13 76.45 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.986 178.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 47.7 ttt-85 -57.04 -48.39 78.63 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.529 -0.732 . . . . 0.0 110.57 175.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -64.99 -38.54 91.28 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.72 -0.613 . . . . 0.0 110.448 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.85 -52.16 65.26 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.501 -0.749 . . . . 0.0 110.475 -173.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -61.39 -37.68 84.29 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.434 -0.791 . . . . 0.0 110.155 -177.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -66.29 -38.95 88.96 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.67 -0.644 . . . . 0.0 110.301 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -62.15 -35.11 77.78 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.597 -0.689 . . . . 0.0 110.038 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 24.5 m -61.72 -34.1 75.21 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.651 -0.656 . . . . 0.0 110.102 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 84.4 mt -79.74 -44.7 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.634 -0.666 . . . . 0.0 110.049 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -58.98 -38.13 78.42 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.667 -0.646 . . . . 0.0 110.602 -178.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -60.98 -48.3 82.47 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.538 -0.726 . . . . 0.0 110.181 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -73.54 -43.27 60.33 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.632 -0.667 . . . . 0.0 110.26 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -105.03 125.07 50.57 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.675 -0.641 . . . . 0.0 110.552 -175.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 61.9 t -108.32 129.97 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.682 -0.636 . . . . 0.0 109.806 178.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 49.3 m -95.05 140.07 30.51 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.681 -0.637 . . . . 0.0 110.456 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -91.84 125.14 36.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.648 -0.658 . . . . 0.0 110.143 176.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 53.7 p -61.54 157.08 18.02 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.635 -0.665 . . . . 0.0 110.082 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 49.1 m -103.65 133.58 48.42 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.652 -0.655 . . . . 0.0 110.471 -177.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 49.3 tttt -100.07 150.18 22.74 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.68 -0.637 . . . . 0.0 109.995 175.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -60.82 101.94 0.17 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.639 -0.663 . . . . 0.0 110.168 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 86.68 178.14 49.32 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -178.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 333' ' ' ASP . . . . . 0.402 ' O ' ' CE2' ' A' ' 335' ' ' PHE . 67.9 m-20 59.47 79.94 0.21 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.5 -1.0 . . . . 0.0 110.229 175.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -66.55 145.88 55.13 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.573 -0.704 . . . . 0.0 110.223 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.402 ' CE2' ' O ' ' A' ' 333' ' ' ASP . 96.6 m-85 -118.8 155.91 30.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.643 -0.661 . . . . 0.0 110.338 179.059 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 55.71 -86.31 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.763 -0.585 . . . . 0.0 111.11 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 54.89 -86.31 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.318 -0.864 . . . . 0.0 110.88 -175.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -114.52 110.52 19.95 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.178 -0.951 . . . . 0.0 110.212 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 67.3 p -124.74 156.93 36.87 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.631 -0.668 . . . . 0.0 110.256 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -141.81 145.45 34.74 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.677 -0.639 . . . . 0.0 110.212 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 77.62 41.53 19.71 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 177.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 16.1 tt -142.63 136.24 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.609 -0.936 . . . . 0.0 110.095 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -93.95 145.74 24.42 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.663 -0.648 . . . . 0.0 110.283 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 87.8 mtp 51.79 91.61 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.503 -0.748 . . . . 0.0 111.014 178.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 9.0 m . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.255 179.865 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 30.0 t -87.12 144.28 26.93 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.649 -0.912 . . . . 0.0 110.273 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.5 t 51.64 89.97 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.463 -0.773 . . . . 0.0 111.078 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 70.5 p -69.59 -27.38 65.06 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.679 -0.638 . . . . 0.0 110.293 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -108.65 137.16 47.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.595 -0.691 . . . . 0.0 110.255 178.206 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -158.11 155.56 29.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.694 -0.629 . . . . 0.0 110.238 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 50.62 -169.58 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.411 -0.805 . . . . 0.0 111.189 178.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 25.1 tp 56.72 159.07 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.631 -0.668 . . . . 0.0 110.808 -175.542 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 9.6 t -87.09 160.14 49.73 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.553 -0.717 . . . . 0.0 110.171 179.084 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -65.26 152.16 77.26 Favored 'Cis proline' 0 N--CA 1.495 1.599 0 C-N-CA 123.166 -1.598 . . . . 0.0 110.391 -16.825 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 79.8 p -81.63 145.31 54.32 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.654 -0.654 . . . . 0.0 110.167 -179.029 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.4 ' HB3' ' CG2' ' A' ' 242' ' ' THR . 24.0 Cg_exo -59.92 150.31 78.8 Favored 'Trans proline' 0 N--CA 1.487 1.147 0 O-C-N 123.239 1.126 . . . . 0.0 110.553 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.83 150.02 39.42 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.624 -0.673 . . . . 0.0 110.004 178.492 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.408 HD11 HG22 ' A' ' 199' ' ' THR . 50.3 mm -119.93 139.56 28.41 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.663 -0.648 . . . . 0.0 109.936 -177.55 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.91 151.91 83.11 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.153 1.081 . . . . 0.0 110.431 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 27.8 t -113.17 142.52 45.68 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.673 -0.642 . . . . 0.0 110.211 179.387 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.9 p-10 -96.33 24.62 5.61 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.722 -0.611 . . . . 0.0 110.681 -179.227 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 51.6 m -76.63 125.17 28.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.54 -0.725 . . . . 0.0 110.279 -179.403 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -70.14 144.91 51.89 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.672 -0.642 . . . . 0.0 110.41 -177.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -154.25 99.41 2.5 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.774 -0.579 . . . . 0.0 110.153 178.6 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -58.8 -39.91 77.37 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 O-C-N 123.202 1.106 . . . . 0.0 110.774 -176.651 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.69 -155.11 47.93 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 178.609 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -73.29 -46.19 0.38 Allowed 'Trans proline' 0 C--N 1.316 -1.176 0 O-C-N 123.363 1.191 . . . . 0.0 110.922 -174.442 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -85.9 6.7 27.22 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.531 -0.731 . . . . 0.0 111.382 -173.679 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.72 61.18 3.22 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.853 -1.154 . . . . 0.0 110.656 -175.519 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.689 ' HA ' HG12 ' A' ' 176' ' ' VAL . 54.6 t80 -77.82 119.29 21.1 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.64 -0.662 . . . . 0.0 109.852 -178.678 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -130.07 159.93 35.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.826 -0.546 . . . . 0.0 110.189 -178.419 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 68.5 t -124.57 147.65 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.694 -0.629 . . . . 0.0 109.902 176.131 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.9 p -155.04 164.23 39.17 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.075 177.132 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.486 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 88.0 m-85 -126.64 125.25 41.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.84 -0.537 . . . . 0.0 109.894 -176.532 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -56.58 147.76 21.45 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.705 -0.622 . . . . 0.0 110.684 -173.217 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -104.06 146.68 28.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.69 -0.631 . . . . 0.0 110.421 -175.096 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 84.0 p -145.09 160.61 41.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.704 -0.623 . . . . 0.0 110.114 177.32 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 45.4 m -61.82 155.77 22.27 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.651 -0.655 . . . . 0.0 110.083 179.212 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 77.0 p -60.82 91.76 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.692 -0.63 . . . . 0.0 110.158 -179.254 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.05 147.56 23.58 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.704 -0.623 . . . . 0.0 110.348 -178.588 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -71.88 139.3 48.75 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.698 -0.626 . . . . 0.0 110.152 178.838 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 34.5 m 52.78 43.23 31.69 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.404 -0.81 . . . . 0.0 110.976 -179.281 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.43 136.32 57.85 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.643 -0.66 . . . . 0.0 110.198 177.931 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.497 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 80.9 p -59.99 -32.49 70.9 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.641 -0.662 . . . . 0.0 109.868 174.197 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.497 ' HD1' ' HG1' ' A' ' 152' ' ' THR . 68.7 p-90 -171.34 142.8 1.75 Allowed 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.319 0.581 . . . . 0.0 110.253 176.872 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.7 t -142.12 142.72 32.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.935 -0.478 . . . . 0.0 109.997 -177.318 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.486 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 52.0 t80 -125.52 140.06 53.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.545 -0.722 . . . . 0.0 110.524 -172.62 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.5 t -111.84 124.31 52.08 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 120.401 -0.52 . . . . 0.0 109.789 176.118 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 62.3 m -70.58 -37.05 73.9 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.771 -0.581 . . . . 0.0 110.45 -177.658 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -59.1 -33.03 70.36 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.529 -0.732 . . . . 0.0 110.53 -178.522 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.469 HD11 ' OD1' ' A' ' 316' ' ' ASP . 56.1 mt -104.84 -11.99 16.5 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.688 -0.632 . . . . 0.0 110.787 -175.805 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 70.7 tttt 59.74 49.54 8.03 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.046 -1.034 . . . . 0.0 109.653 177.703 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 40.5 tttt -146.56 153.11 39.98 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.754 -0.591 . . . . 0.0 110.668 -174.054 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.604 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.5 tp -126.52 137.76 53.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.805 -0.559 . . . . 0.0 110.171 -177.333 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -115.16 134.78 54.85 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.671 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.8 p -138.42 158.61 43.95 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 120.114 -0.635 . . . . 0.0 111.114 -174.029 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.428 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 52.4 mt-30 -104.42 141.99 35.38 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.557 -0.714 . . . . 0.0 110.209 173.645 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.439 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 18.3 tt -54.85 146.23 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.562 -0.712 . . . . 0.0 111.561 -171.914 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.36 9.98 5.33 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.552 -0.718 . . . . 0.0 112.479 177.017 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.428 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 67.5 mmtt -96.13 155.08 16.91 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.896 -1.128 . . . . 0.0 110.747 175.114 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 86.7 m -81.12 126.2 31.17 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.738 -0.601 . . . . 0.0 110.634 -177.581 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 170' ' ' CYS . . . . . 0.604 ' SG ' HD21 ' A' ' 162' ' ' LEU . 46.9 t -115.53 90.23 25.07 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.702 -0.624 . . . . 0.0 110.11 172.722 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.441 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 22.0 Cg_exo -62.37 130.89 31.78 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 O-C-N 123.276 1.145 . . . . 0.0 110.624 174.079 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.413 HG12 ' CE2' ' A' ' 142' ' ' PHE . 94.5 mt -125.41 142.92 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.655 -0.653 . . . . 0.0 109.299 175.593 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 173' ' ' GLN . . . . . 0.529 ' NE2' ' CE1' ' A' ' 260' ' ' PHE . 69.0 mt-30 -108.44 136.21 48.45 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.517 -0.739 . . . . 0.0 110.739 -176.209 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.419 HG23 ' CE1' ' A' ' 138' ' ' PHE . 48.5 mm -95.27 131.55 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.724 -0.61 . . . . 0.0 109.613 169.241 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -112.99 128.28 56.45 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.607 -0.683 . . . . 0.0 110.447 176.28 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.689 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.2 m -136.59 159.79 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.594 -0.691 . . . . 0.0 109.903 175.104 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.5 mmm -76.47 -40.81 49.35 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.632 -0.668 . . . . 0.0 110.104 178.647 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.411 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.5 p -135.44 143.15 44.05 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.782 -0.574 . . . . 0.0 109.65 178.356 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 34.1 Cg_exo -55.22 139.8 81.02 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 O-C-N 123.142 1.075 . . . . 0.0 110.841 -171.648 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.804 ' HB3' HD21 ' A' ' 288' ' ' LEU . 29.8 Cg_endo -66.58 170.0 13.25 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 O-C-N 123.212 1.111 . . . . 0.0 110.618 178.411 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -60.85 156.25 44.68 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.358 1.189 . . . . 0.0 110.5 -178.293 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -79.1 139.32 38.1 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.651 -0.656 . . . . 0.0 109.954 176.118 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 98.53 -24.94 29.94 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -174.167 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.18 152.35 1.76 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.359 -1.083 . . . . 0.0 111.426 177.684 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 33.8 m -129.78 155.95 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.766 -0.584 . . . . 0.0 109.649 176.293 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.712 HD11 ' HD2' ' A' ' 251' ' ' TYR . 80.4 mt -109.17 138.78 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.676 -0.64 . . . . 0.0 109.51 176.626 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.721 ' HG2' HD22 ' A' ' 248' ' ' LEU . 30.8 mtm180 -114.9 147.27 40.18 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -175.763 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.718 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -140.13 127.18 20.89 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.501 -0.749 . . . . 0.0 110.259 173.456 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.413 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 3.2 ttp -137.24 138.33 24.93 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.777 -0.577 . . . . 0.0 110.926 -176.756 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.689 ' HD3' HD12 ' A' ' 226' ' ' ILE . 71.9 Cg_endo -91.9 138.09 1.95 Allowed 'Trans proline' 0 C--N 1.32 -0.949 0 C-N-CA 121.023 1.149 . . . . 0.0 110.771 177.77 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.431 HG13 ' C ' ' A' ' 190' ' ' PRO . 34.7 m -147.43 154.82 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.505 -0.747 . . . . 0.0 110.101 174.089 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.676 ' HA ' HG22 ' A' ' 282' ' ' ILE . 63.3 m-85 -60.05 162.06 6.12 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.409 -0.807 . . . . 0.0 110.55 -179.155 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.5 ' HA ' HD12 ' A' ' 283' ' ' LEU . 29.0 tttp -79.19 -60.02 2.54 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.665 -0.647 . . . . 0.0 110.878 -173.092 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -80.15 152.04 29.44 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.587 -0.695 . . . . 0.0 110.425 -175.373 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.457 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.52 -37.95 71.16 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.376 -0.827 . . . . 0.0 110.674 -177.084 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -56.86 -25.02 55.67 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.548 -0.72 . . . . 0.0 110.572 -177.438 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.411 ' HB3' ' CG ' ' A' ' 192' ' ' TYR . 65.0 m170 -108.81 -20.58 13.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.598 -0.689 . . . . 0.0 111.116 -178.816 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -68.45 -20.28 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.148 -0.97 . . . . 0.0 110.581 -175.861 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.408 HG22 HD11 ' A' ' 126' ' ' ILE . 67.3 p -79.42 -17.03 55.18 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.516 -0.74 . . . . 0.0 110.678 174.37 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.39 136.54 32.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.366 -0.834 . . . . 0.0 110.025 173.574 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 242' ' ' THR . 61.9 t -72.92 145.08 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.569 -0.707 . . . . 0.0 110.269 178.354 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.631 HG23 HH12 ' A' ' 244' ' ' ARG . 57.8 t -84.88 139.9 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 170.873 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 11.9 pttt -134.72 -170.46 2.56 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.509 -0.744 . . . . 0.0 111.195 -169.34 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 63.8 mmt-85 -95.37 150.92 19.75 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.827 -0.546 . . . . 0.0 110.423 -176.23 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 60.9 m -73.06 163.16 70.61 Favored Pre-proline 0 N--CA 1.497 1.894 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 169.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -63.96 -47.66 6.34 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 123.044 1.023 . . . . 0.0 109.903 177.899 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.41 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.4 p-10 -65.56 -44.06 87.93 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.627 -0.671 . . . . 0.0 111.124 178.928 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 208' ' ' HIS . . . . . 0.41 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 51.4 m170 -80.68 -27.79 36.97 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.414 -0.804 . . . . 0.0 111.394 -174.527 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -66.14 -36.73 83.91 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.385 -0.822 . . . . 0.0 110.172 174.028 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 23.3 tp -55.23 -35.19 64.67 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.482 -0.762 . . . . 0.0 110.772 177.458 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 24.5 t -48.39 -27.73 2.79 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.448 -0.783 . . . . 0.0 111.548 178.029 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -54.45 -26.16 29.31 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.545 -0.722 . . . . 0.0 111.175 -177.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -54.88 149.41 11.54 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.418 -0.801 . . . . 0.0 110.955 -176.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 40.2 t80 53.78 70.78 0.56 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.388 -0.82 . . . . 0.0 110.844 179.307 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -83.39 -10.13 58.62 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.607 -0.683 . . . . 0.0 111.155 176.147 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -59.88 125.1 22.33 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.174 -0.954 . . . . 0.0 110.337 176.714 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 95.14 -1.46 64.91 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 120.447 -0.882 . . . . 0.0 110.928 179.035 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -114.67 139.77 49.38 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.012 -1.287 . . . . 0.0 110.401 173.602 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.9 mt -88.07 -25.08 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.722 -0.611 . . . . 0.0 110.444 -179.835 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.538 ' HB1' ' HD2' ' A' ' 227' ' ' ARG . . . -124.91 95.14 42.78 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.527 -0.733 . . . . 0.0 110.173 -177.506 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -64.96 144.04 81.25 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.275 1.145 . . . . 0.0 110.612 -175.574 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.91 -19.59 40.42 Favored 'Trans proline' 0 N--CA 1.489 1.212 0 O-C-N 123.107 1.056 . . . . 0.0 111.321 -179.544 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 96.6 p -53.89 -22.12 9.27 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.178 -0.952 . . . . 0.0 111.211 -177.759 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 224' ' ' HIS . . . . . 0.467 ' CE1' ' CG ' ' A' ' 236' ' ' TYR . 41.0 m80 -104.33 128.71 52.17 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.471 -0.768 . . . . 0.0 110.203 177.875 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.564 HD12 ' HG3' ' A' ' 268' ' ' MET . 57.2 tp -66.66 -38.37 86.71 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.577 -0.702 . . . . 0.0 110.113 -177.603 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.689 HD12 ' HD3' ' A' ' 190' ' ' PRO . 85.5 mt -104.7 136.72 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.589 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.538 ' HD2' ' HB1' ' A' ' 220' ' ' ALA . 78.7 mtm180 -134.57 159.52 40.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.701 -0.624 . . . . 0.0 110.189 -178.401 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.596 HG23 HG21 ' A' ' 247' ' ' VAL . 91.2 t -104.46 146.74 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.766 -0.584 . . . . 0.0 110.103 178.991 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -118.1 124.4 47.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.732 -0.605 . . . . 0.0 110.361 172.288 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.05 23.82 14.15 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 168.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -137.17 107.6 6.48 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.464 -1.021 . . . . 0.0 110.028 174.695 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 26.3 t -62.89 -15.18 53.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.67 -0.643 . . . . 0.0 111.322 -178.001 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -100.02 7.98 44.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.246 -0.909 . . . . 0.0 111.524 -177.621 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.06 130.76 47.99 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.191 -0.943 . . . . 0.0 110.213 176.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -139.76 157.95 44.9 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.75 -0.594 . . . . 0.0 109.807 177.701 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.467 ' CG ' ' CE1' ' A' ' 224' ' ' HIS . 78.6 m-85 -115.01 150.73 35.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.596 -0.69 . . . . 0.0 110.658 -176.394 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.16 159.93 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.827 -0.546 . . . . 0.0 110.081 176.38 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -121.46 130.11 53.38 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.69 -0.631 . . . . 0.0 110.344 178.87 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -64.74 110.34 3.97 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.636 -0.665 . . . . 0.0 109.697 176.804 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -59.76 -25.11 78.2 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.141 1.074 . . . . 0.0 111.078 -171.956 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.8 mt -100.72 -50.41 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.409 -0.807 . . . . 0.0 110.853 -171.832 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.422 ' O ' HG22 ' A' ' 201' ' ' VAL . 17.4 p -105.43 12.16 31.83 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.41 -0.807 . . . . 0.0 111.96 -173.211 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 82.32 -25.07 4.48 Favored Glycine 0 N--CA 1.498 2.781 0 O-C-N 120.997 -1.064 . . . . 0.0 111.885 169.169 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.631 HH12 HG23 ' A' ' 202' ' ' VAL . 29.7 mmt180 -45.83 142.14 2.69 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-N 118.652 1.226 . . . . 0.0 112.678 -168.445 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -104.41 146.08 29.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.7 -0.625 . . . . 0.0 109.93 173.681 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 77.9 p -154.74 159.98 41.03 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.609 -0.682 . . . . 0.0 110.39 178.58 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.596 HG21 HG23 ' A' ' 228' ' ' VAL . 8.6 p -123.23 148.25 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.75 -0.593 . . . . 0.0 109.816 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.721 HD22 ' HG2' ' A' ' 187' ' ' ARG . 83.9 mt -129.57 154.62 46.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.653 -0.655 . . . . 0.0 109.662 -176.506 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.442 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.1 m -151.35 151.73 29.63 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.769 -0.582 . . . . 0.0 110.045 175.992 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -71.1 138.6 33.92 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 O-C-N 123.232 1.122 . . . . 0.0 109.991 177.12 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.712 ' HD2' HD11 ' A' ' 186' ' ' ILE . 57.1 t80 -74.07 127.16 32.2 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.53 -0.731 . . . . 0.0 110.194 175.376 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -99.95 160.09 28.13 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.697 -0.627 . . . . 0.0 109.974 175.111 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -58.55 157.86 25.61 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 O-C-N 123.291 1.153 . . . . 0.0 110.518 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.15 149.92 77.06 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 O-C-N 123.203 1.107 . . . . 0.0 110.514 -177.732 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -60.64 147.65 41.17 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.569 -0.707 . . . . 0.0 110.254 -178.721 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.87 127.2 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.508 -0.745 . . . . 0.0 110.219 -170.879 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.06 -10.27 55.18 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.49 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.405 ' OG1' ' CE2' ' A' ' 260' ' ' PHE . 10.1 t -144.12 174.12 11.15 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.115 -1.227 . . . . 0.0 110.676 176.027 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -107.39 13.17 27.27 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.647 -0.658 . . . . 0.0 111.812 -168.325 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.529 ' CE1' ' NE2' ' A' ' 173' ' ' GLN . 14.6 p90 -119.92 168.01 11.56 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.116 -0.99 . . . . 0.0 111.155 -175.184 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 82.2 m -117.77 145.75 44.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.791 -0.568 . . . . 0.0 109.854 179.553 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 42.2 m -116.62 135.93 53.39 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.582 -0.699 . . . . 0.0 110.78 -176.55 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.9 t -132.31 137.33 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 175.094 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 76.6 mt -104.59 120.92 42.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.493 -0.755 . . . . 0.0 109.991 -170.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.718 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 4.8 m-30 -105.29 153.64 21.33 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.672 -0.643 . . . . 0.0 110.823 -176.947 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -136.54 142.92 43.46 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.165 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -114.99 133.82 55.71 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.463 -0.773 . . . . 0.0 110.47 -179.414 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 268' ' ' MET . . . . . 0.564 ' HG3' HD12 ' A' ' 225' ' ' LEU . 5.0 ppp? -102.44 9.42 39.66 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.606 -0.684 . . . . 0.0 112.053 -175.683 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 269' ' ' CYS . . . . . 0.811 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.7 OUTLIER -144.61 159.05 43.44 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.083 -1.011 . . . . 0.0 110.108 173.06 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.455 ' HA ' HG21 ' A' ' 305' ' ' ILE . 26.9 p30 -119.27 163.11 17.62 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.752 -0.593 . . . . 0.0 110.423 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 271' ' ' SER . . . . . 0.419 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 25.1 m -57.95 -31.48 66.88 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.44 -0.788 . . . . 0.0 110.843 -166.671 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 51.1 p -105.72 14.95 27.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.352 -0.843 . . . . 0.0 111.965 -165.222 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 29.6 p -94.18 118.1 31.07 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.139 -0.975 . . . . 0.0 110.539 177.571 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.89 139.23 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.436 -0.79 . . . . 0.0 110.177 -170.5 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.6 -5.13 60.12 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 178.794 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.05 -97.69 0.81 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 173.799 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 277' ' ' MET . . . . . 0.419 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.0 mmm -64.03 -33.76 76.46 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.74 -0.859 . . . . 0.0 110.41 178.589 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.1 p30 43.72 50.77 6.69 Favored 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 175.486 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 54.86 31.86 16.6 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.294 -0.879 . . . . 0.0 111.188 176.854 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -120.02 104.94 43.3 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.498 -0.751 . . . . 0.0 110.148 174.247 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -60.37 148.16 91.42 Favored 'Trans proline' 0 N--CA 1.487 1.139 0 O-C-N 123.104 1.055 . . . . 0.0 110.528 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.676 HG22 ' HA ' ' A' ' 192' ' ' TYR . 45.5 pt -131.99 177.42 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 CA-C-O 121.79 0.805 . . . . 0.0 111.037 -176.811 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.5 HD12 ' HA ' ' A' ' 193' ' ' LYS . 28.1 mt -124.34 149.9 46.09 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.613 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.677 HD12 ' CE1' ' A' ' 301' ' ' PHE . 81.4 mt -115.79 130.19 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.931 -0.707 . . . . 0.0 109.315 177.705 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.603 HG23 ' SG ' ' A' ' 300' ' ' CYS . 83.3 mt -109.88 126.19 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.483 -177.62 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 57.8 t -118.96 126.84 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.696 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.5 p -125.24 151.61 45.68 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.581 -0.7 . . . . 0.0 110.736 -173.467 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.804 HD21 ' HB3' ' A' ' 180' ' ' PRO . 21.8 tp -101.3 125.67 47.96 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 167.427 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.522 ' OE2' HG13 ' A' ' 295' ' ' VAL . 73.5 mm-40 -130.58 150.54 51.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.845 -0.534 . . . . 0.0 110.005 -172.566 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.837 ' CG2' HD11 ' A' ' 296' ' ' LEU . 17.1 p -89.96 161.13 16.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.678 -0.639 . . . . 0.0 109.967 177.789 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -55.95 -26.07 46.33 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.579 -0.701 . . . . 0.0 110.98 -176.635 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 47.0 p30 -90.36 9.36 29.23 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.373 -0.829 . . . . 0.0 111.908 -173.567 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.41 20.15 46.23 Favored Glycine 0 N--CA 1.494 2.546 0 C-N-CA 120.169 -1.015 . . . . 0.0 110.841 171.055 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -107.58 140.16 41.01 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.357 -1.084 . . . . 0.0 110.075 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.522 HG13 ' OE2' ' A' ' 289' ' ' GLU . 59.8 t -87.68 132.14 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.543 -0.723 . . . . 0.0 110.164 -173.35 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.837 HD11 ' CG2' ' A' ' 290' ' ' THR . 96.1 mt -99.97 -40.2 7.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.667 -0.646 . . . . 0.0 110.44 178.15 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -159.97 148.62 17.35 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -178.14 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.495 ' HD3' HG11 ' A' ' 295' ' ' VAL . 79.1 mtm180 -135.09 133.14 38.97 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.73 -0.864 . . . . 0.0 110.566 -178.61 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -135.03 156.17 49.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.705 -0.622 . . . . 0.0 109.976 172.32 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 300' ' ' CYS . . . . . 0.603 ' SG ' HG23 ' A' ' 285' ' ' ILE . 83.0 m -141.77 154.21 45.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.431 -0.793 . . . . 0.0 110.541 -176.269 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.677 ' CE1' HD12 ' A' ' 284' ' ' ILE . 49.3 p90 -144.96 164.62 30.57 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.694 -0.628 . . . . 0.0 110.247 177.14 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.428 ' HA ' HD23 ' A' ' 283' ' ' LEU . 83.7 tt0 -104.87 134.58 47.76 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.548 -0.72 . . . . 0.0 110.048 -177.137 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -121.77 143.68 49.24 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.704 -169.818 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 64.5 ttt-85 -139.82 134.86 32.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.761 -0.587 . . . . 0.0 109.633 173.585 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.811 HD13 ' O ' ' A' ' 269' ' ' CYS . 33.5 mt -106.79 122.86 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.585 -0.697 . . . . 0.0 109.67 178.627 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.2 p -145.12 170.92 15.29 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.594 -0.691 . . . . 0.0 110.975 -169.851 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -70.23 -40.05 74.72 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.752 -0.593 . . . . 0.0 110.604 -178.481 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 3.7 t -131.15 88.85 43.65 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.591 -0.693 . . . . 0.0 110.422 179.139 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -55.85 -29.04 70.72 Favored 'Trans proline' 0 N--CA 1.488 1.187 0 O-C-N 123.176 1.092 . . . . 0.0 110.82 174.48 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.6 -37.83 92.83 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 177.136 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 72.2 ttt-85 -72.4 -40.49 67.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.67 -0.9 . . . . 0.0 109.77 -173.327 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -69.43 -38.35 77.8 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.256 -178.347 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -61.23 -43.7 98.46 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.467 -0.77 . . . . 0.0 110.226 178.227 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 52.5 tttt -64.9 -39.41 93.48 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.509 -0.744 . . . . 0.0 110.469 177.931 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.44 -49.82 75.27 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.515 -0.74 . . . . 0.0 110.573 -173.342 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 316' ' ' ASP . . . . . 0.469 ' OD1' HD11 ' A' ' 159' ' ' LEU . 3.1 p30 -61.61 -37.67 84.81 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.564 -0.71 . . . . 0.0 110.075 -178.691 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -61.79 -41.27 97.52 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.59 -0.694 . . . . 0.0 110.041 177.869 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -62.8 -35.04 78.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.665 -0.647 . . . . 0.0 109.995 178.353 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 22.8 t -63.3 -32.76 74.26 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.676 -0.64 . . . . 0.0 110.219 -179.698 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 83.2 mt -77.19 -45.67 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.605 -0.684 . . . . 0.0 110.037 -177.699 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -60.3 -40.04 89.07 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.61 -0.681 . . . . 0.0 110.374 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -61.8 -41.29 97.56 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.674 -0.641 . . . . 0.0 110.057 178.914 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -60.8 -33.98 73.82 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.677 -0.639 . . . . 0.0 110.111 177.561 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -97.38 125.02 41.75 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.7 -0.625 . . . . 0.0 110.387 -178.233 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 61.6 t -121.11 129.94 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.636 -0.665 . . . . 0.0 109.959 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 50.3 m -65.34 140.14 58.64 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.702 -0.623 . . . . 0.0 110.168 179.287 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -83.07 116.42 22.3 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.712 -0.617 . . . . 0.0 110.187 179.647 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 53.4 m -94.07 152.06 19.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.69 -0.631 . . . . 0.0 110.313 -179.184 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 73.3 p -94.26 -19.27 20.86 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.727 -0.608 . . . . 0.0 110.761 179.014 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 25.3 tttp -58.56 -33.36 69.84 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.332 -0.855 . . . . 0.0 110.464 179.2 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -57.52 -33.87 68.52 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.524 -0.735 . . . . 0.0 110.511 -178.846 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 66.09 -120.85 17.13 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.025 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 333' ' ' ASP . . . . . 0.401 ' O ' ' CE1' ' A' ' 335' ' ' PHE . 31.5 t0 -80.9 118.94 22.83 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.687 -0.89 . . . . 0.0 110.222 -179.142 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -64.22 147.72 51.73 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.661 -0.649 . . . . 0.0 110.205 -179.311 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.401 ' CE1' ' O ' ' A' ' 333' ' ' ASP . 96.0 m-85 -117.67 156.16 28.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.629 -0.669 . . . . 0.0 110.166 179.131 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 55.65 -84.23 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.817 -0.552 . . . . 0.0 111.05 -177.368 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -136.22 161.87 34.55 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.245 -0.909 . . . . 0.0 110.386 -178.027 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 41.5 p-10 -88.63 13.34 12.43 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.63 -0.668 . . . . 0.0 111.371 -176.619 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 46.4 m -83.5 137.23 33.97 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.204 -0.935 . . . . 0.0 110.144 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -117.51 139.64 50.67 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.649 -0.657 . . . . 0.0 110.375 -179.17 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 171.24 -126.71 1.34 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 26.5 pt -95.69 149.63 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.651 -0.911 . . . . 0.0 110.397 179.406 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -91.49 126.26 36.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.598 -0.689 . . . . 0.0 110.221 -179.52 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 50.9 ttm -100.17 134.89 42.43 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.609 -0.682 . . . . 0.0 110.248 -179.73 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 118.045 -0.978 . . . . 0.0 110.348 -179.968 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.6 t . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.12 0.486 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.9 p-10 -96.15 25.86 4.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.652 -0.655 . . . . 0.0 110.601 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 51.0 m -71.04 125.19 26.2 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.573 -0.704 . . . . 0.0 110.27 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -71.42 144.98 49.59 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.661 -0.649 . . . . 0.0 110.443 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -153.87 99.05 2.59 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.742 -0.599 . . . . 0.0 110.073 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -59.39 -39.94 72.11 Favored 'Trans proline' 0 N--CA 1.487 1.147 0 O-C-N 123.175 1.092 . . . . 0.0 110.705 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.45 -155.16 48.36 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -75.75 -42.03 0.48 Allowed 'Trans proline' 0 C--N 1.316 -1.155 0 O-C-N 123.34 1.179 . . . . 0.0 110.993 -174.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -87.65 6.63 33.76 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.559 -0.713 . . . . 0.0 111.509 -173.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.69 60.97 3.33 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.98 -1.075 . . . . 0.0 110.672 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.687 ' HA ' HG12 ' A' ' 176' ' ' VAL . 50.4 t80 -77.89 118.87 20.62 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.63 -0.669 . . . . 0.0 109.955 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -130.04 161.42 31.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.81 -0.556 . . . . 0.0 110.068 -178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 62.9 t -126.48 145.74 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.696 -0.628 . . . . 0.0 109.893 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 78.4 p -155.43 160.29 40.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.802 -0.561 . . . . 0.0 110.043 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.498 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 71.7 m-85 . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.849 -0.532 . . . . 0.0 109.885 -175.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 121.154 0.502 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 43.5 p -60.1 -34.0 72.88 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.795 -0.565 . . . . 0.0 110.072 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.443 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -171.44 144.52 1.96 Allowed 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.397 0.617 . . . . 0.0 110.331 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.6 t -142.08 142.51 32.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.929 -0.482 . . . . 0.0 109.878 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.498 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 64.7 t80 -125.65 140.04 53.05 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.509 -0.744 . . . . 0.0 110.787 -171.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.2 t -111.7 124.88 53.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.8 -0.562 . . . . 0.0 109.958 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 59.2 m -70.95 -37.02 72.81 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.749 -0.595 . . . . 0.0 110.571 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -59.01 -34.75 72.24 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.573 -0.704 . . . . 0.0 110.444 -177.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.0 mt -104.83 -12.04 16.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.662 -0.649 . . . . 0.0 110.88 -176.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 82.3 tttt 59.73 51.62 6.1 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.074 -1.017 . . . . 0.0 109.673 178.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -145.09 153.07 41.04 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.594 -173.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.683 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.56 137.73 53.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.779 -0.576 . . . . 0.0 110.24 -175.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -116.0 135.4 54.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.674 -0.641 . . . . 0.0 109.288 173.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.9 p -138.36 158.42 44.31 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.705 -0.622 . . . . 0.0 110.899 -175.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.429 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 50.1 mt-30 -104.5 144.07 32.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.64 -0.662 . . . . 0.0 110.277 173.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.428 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.2 tt -52.81 146.05 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-O 121.592 0.711 . . . . 0.0 111.802 -173.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.5 10.0 5.46 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.554 -0.716 . . . . 0.0 112.484 176.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.429 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 73.5 mmtt -96.61 155.06 16.93 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.995 -1.066 . . . . 0.0 110.867 175.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 85.0 m -84.5 126.13 33.01 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.689 -0.632 . . . . 0.0 110.668 -177.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' CYS . . . . . 0.683 ' SG ' HD21 ' A' ' 162' ' ' LEU . 44.7 t -115.37 90.19 24.12 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.576 -0.702 . . . . 0.0 110.202 174.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.443 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 21.2 Cg_exo -62.59 131.1 32.17 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.216 1.114 . . . . 0.0 110.691 173.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.414 HG12 ' CE2' ' A' ' 142' ' ' PHE . 95.1 mt -125.08 143.82 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.659 -0.651 . . . . 0.0 109.279 175.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -109.47 135.36 50.61 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.496 -0.753 . . . . 0.0 110.813 -175.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.402 HG23 ' CE1' ' A' ' 138' ' ' PHE . 48.7 mm -95.29 135.01 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.604 -0.685 . . . . 0.0 109.584 168.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -116.11 128.0 55.3 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.608 -0.683 . . . . 0.0 110.406 175.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.687 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.1 m -136.57 159.72 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.674 -0.641 . . . . 0.0 109.892 175.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.7 mmm -74.46 -40.44 61.89 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.704 -0.622 . . . . 0.0 110.094 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 77.5 p -135.87 143.23 43.56 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.752 -0.593 . . . . 0.0 109.825 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -55.34 139.9 81.72 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 O-C-N 123.17 1.089 . . . . 0.0 110.861 -173.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.789 ' HB3' HD21 ' A' ' 288' ' ' LEU . 18.0 Cg_endo -61.97 166.9 11.46 Favored 'Trans proline' 0 N--CA 1.487 1.145 0 O-C-N 123.217 1.114 . . . . 0.0 110.72 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -61.06 155.68 49.09 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 O-C-N 123.382 1.201 . . . . 0.0 110.41 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -73.55 138.66 45.11 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.652 -0.655 . . . . 0.0 109.93 176.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.57 -24.94 29.36 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -174.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.14 150.94 2.18 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.367 -1.078 . . . . 0.0 111.426 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.78 155.94 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.735 -0.603 . . . . 0.0 109.906 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.683 HD11 ' CD2' ' A' ' 251' ' ' TYR . 53.4 mt -109.61 135.57 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.723 ' HG2' HD22 ' A' ' 248' ' ' LEU . 59.6 mtt180 -114.95 145.97 41.67 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.674 -0.641 . . . . 0.0 109.292 -174.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.651 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -140.54 127.74 21.01 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.546 -0.721 . . . . 0.0 110.312 173.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.4 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 41.3 ttp -137.25 139.91 29.35 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.766 -0.584 . . . . 0.0 111.061 -177.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.587 ' HD3' HD12 ' A' ' 226' ' ' ILE . 72.9 Cg_endo -91.12 138.2 2.28 Favored 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 121.051 1.167 . . . . 0.0 110.789 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.438 HG12 ' CZ ' ' A' ' 244' ' ' ARG . 34.8 m -147.38 154.85 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.539 -0.725 . . . . 0.0 110.06 174.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.569 ' HA ' HG22 ' A' ' 282' ' ' ILE . 78.3 m-85 -63.02 167.69 4.64 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.457 -0.777 . . . . 0.0 110.517 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.416 ' HA ' HD12 ' A' ' 283' ' ' LEU . 86.3 tttt -85.05 -60.12 2.14 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.657 -0.652 . . . . 0.0 110.834 -173.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -80.11 152.33 29.35 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.593 -0.692 . . . . 0.0 110.284 -175.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.454 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.67 -38.68 72.54 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.364 -0.835 . . . . 0.0 110.664 -175.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -56.58 -24.77 49.66 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.499 -0.751 . . . . 0.0 110.558 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.406 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 98.7 m-70 -109.71 -20.49 12.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.534 -0.729 . . . . 0.0 111.167 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.454 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -67.65 -20.22 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.12 -0.987 . . . . 0.0 110.581 -176.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 67.8 p -79.42 -16.85 55.48 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.544 -0.723 . . . . 0.0 110.856 174.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.35 136.41 33.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.303 -0.873 . . . . 0.0 110.086 175.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.1 t -73.0 143.26 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.661 -0.649 . . . . 0.0 110.267 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.685 HG23 HH12 ' A' ' 244' ' ' ARG . 60.8 t -84.94 136.39 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.625 -0.672 . . . . 0.0 109.224 171.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.8 pttt -134.89 -170.22 2.52 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.453 -0.779 . . . . 0.0 111.137 -168.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -95.3 158.96 15.23 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.776 -0.578 . . . . 0.0 110.34 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 56.9 m . . . . . 0 N--CA 1.497 1.91 0 O-C-N 121.551 -0.718 . . . . 0.0 109.304 175.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.407 ' HA ' ' CG ' ' A' ' 268' ' ' MET . 39.5 tp . . . . . 0 N--CA 1.497 1.887 0 CA-C-O 120.795 0.331 . . . . 0.0 110.285 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.587 HD12 ' HD3' ' A' ' 190' ' ' PRO . 83.2 mt -101.42 136.77 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.795 -0.566 . . . . 0.0 109.84 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -131.69 156.98 44.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.688 -0.633 . . . . 0.0 110.328 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.524 HG23 HG21 ' A' ' 247' ' ' VAL . 88.3 t -103.13 146.65 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.749 -0.595 . . . . 0.0 109.941 176.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -118.24 126.76 52.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.721 -0.612 . . . . 0.0 110.368 171.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 96.98 21.4 20.91 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 168.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -139.4 105.23 5.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.3 -1.118 . . . . 0.0 110.038 174.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 91.6 p -63.65 -15.1 57.42 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.604 -0.685 . . . . 0.0 111.232 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -97.02 9.97 40.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.245 -0.909 . . . . 0.0 111.235 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.75 130.49 46.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.127 -0.983 . . . . 0.0 110.09 175.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -139.74 157.96 44.89 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.668 -0.645 . . . . 0.0 109.862 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -118.58 150.81 39.03 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.576 -0.702 . . . . 0.0 110.646 -176.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.11 159.9 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.776 -0.578 . . . . 0.0 110.128 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -120.38 130.04 54.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.738 -0.601 . . . . 0.0 110.262 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.27 119.08 46.3 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.625 -0.672 . . . . 0.0 109.669 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.16 -27.7 78.93 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 O-C-N 123.059 1.031 . . . . 0.0 110.874 -172.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 84.0 mt -102.99 -50.32 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.434 -0.792 . . . . 0.0 110.952 -170.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 18.6 p -105.33 12.23 31.92 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.379 -0.826 . . . . 0.0 111.975 -171.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 82.95 -25.04 4.9 Favored Glycine 0 N--CA 1.497 2.737 0 O-C-N 121.009 -1.057 . . . . 0.0 111.825 168.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.685 HH12 HG23 ' A' ' 202' ' ' VAL . 26.7 mmt180 -45.89 142.13 2.75 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 118.598 1.199 . . . . 0.0 112.627 -168.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -105.22 146.9 28.65 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.659 -0.651 . . . . 0.0 110.036 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.2 p -154.74 159.92 40.99 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.576 -0.703 . . . . 0.0 110.35 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.524 HG21 HG23 ' A' ' 228' ' ' VAL . 8.4 p -122.92 148.1 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.729 -0.607 . . . . 0.0 109.814 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.723 HD22 ' HG2' ' A' ' 187' ' ' ARG . 81.9 mt -129.71 154.61 46.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.738 -0.601 . . . . 0.0 109.891 -175.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.441 HG13 ' C ' ' A' ' 248' ' ' LEU . 33.8 m -151.3 151.84 29.91 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.878 -0.514 . . . . 0.0 109.935 175.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -71.04 138.95 34.81 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 O-C-N 123.269 1.142 . . . . 0.0 109.95 177.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.683 ' CD2' HD11 ' A' ' 186' ' ' ILE . 10.0 t80 -78.69 126.51 30.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.496 -0.753 . . . . 0.0 110.21 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -99.97 160.05 28.22 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.695 -0.628 . . . . 0.0 110.059 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -59.17 159.53 22.01 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.234 1.123 . . . . 0.0 110.423 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.38 149.96 78.02 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 O-C-N 123.261 1.137 . . . . 0.0 110.536 -177.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -61.3 148.09 42.4 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.679 -0.638 . . . . 0.0 110.2 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.9 t -69.84 127.2 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.563 -0.711 . . . . 0.0 110.178 -170.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.03 -10.14 55.23 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 10.0 t -144.5 173.25 11.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.169 -1.195 . . . . 0.0 110.642 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -106.9 13.22 27.98 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.674 -0.641 . . . . 0.0 111.743 -168.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -119.99 168.06 11.54 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.159 -0.963 . . . . 0.0 111.092 -175.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 84.1 m -117.75 145.69 44.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.813 -0.554 . . . . 0.0 109.837 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 52.2 m -114.94 135.54 54.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.594 -0.691 . . . . 0.0 110.934 -174.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.6 t -130.12 137.24 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 72.1 mt -104.73 119.07 38.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.581 -0.7 . . . . 0.0 109.863 -172.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.651 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 6.0 m-30 -105.89 151.24 24.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.675 -0.64 . . . . 0.0 110.614 -177.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -136.6 142.91 43.35 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -112.23 131.06 55.7 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.518 -0.739 . . . . 0.0 110.437 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' MET . . . . . 0.407 ' CG ' ' HA ' ' A' ' 225' ' ' LEU . 5.0 ppp? -100.23 7.43 44.48 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.683 -0.636 . . . . 0.0 111.972 -175.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . 0.67 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.6 OUTLIER -144.76 164.95 29.48 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.075 -1.016 . . . . 0.0 109.834 171.558 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.61 ' HA ' HG21 ' A' ' 305' ' ' ILE . 28.0 p30 -120.7 161.94 20.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.651 -0.656 . . . . 0.0 110.456 -178.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . 0.428 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 22.5 m -58.08 -33.42 69.05 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.48 -0.762 . . . . 0.0 111.082 -163.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 48.8 p -99.4 11.5 38.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.466 -0.771 . . . . 0.0 112.011 -163.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 30.2 p -94.48 118.01 31.0 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.124 -0.985 . . . . 0.0 110.672 178.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.7 t -64.12 140.04 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.504 -0.748 . . . . 0.0 110.412 -169.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.46 -5.21 58.63 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -125.46 -100.43 1.25 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 170.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . 0.428 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.3 mmm -64.28 -31.44 72.65 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.687 -0.89 . . . . 0.0 110.319 176.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.7 p30 43.38 51.51 5.98 Favored 'General case' 0 N--CA 1.505 2.301 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 175.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 54.81 27.05 8.39 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.275 -0.891 . . . . 0.0 111.145 175.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -118.32 105.91 45.72 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.575 -0.703 . . . . 0.0 110.057 176.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.51 147.27 92.27 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 O-C-N 123.119 1.063 . . . . 0.0 110.6 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.569 HG22 ' HA ' ' A' ' 192' ' ' TYR . 45.7 pt -131.88 178.32 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 121.744 0.783 . . . . 0.0 110.832 -177.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 302' ' ' GLU . 31.3 mt -124.4 149.87 46.22 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.685 HD12 ' CE1' ' A' ' 301' ' ' PHE . 81.2 mt -115.27 130.34 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.621 HG23 ' SG ' ' A' ' 300' ' ' CYS . 82.0 mt -109.74 126.26 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -176.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 59.7 t -118.9 126.71 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.425 HG22 ' HG2' ' A' ' 298' ' ' ARG . 45.6 p -125.26 152.76 44.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.637 -0.665 . . . . 0.0 110.665 -174.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.789 HD21 ' HB3' ' A' ' 180' ' ' PRO . 19.8 tp -102.59 126.17 49.58 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 168.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.638 ' OE2' HG13 ' A' ' 295' ' ' VAL . 73.3 mm-40 -131.78 149.13 52.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.814 -0.554 . . . . 0.0 110.003 -172.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.82 ' CG2' HD11 ' A' ' 296' ' ' LEU . 19.0 p -89.98 161.11 16.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.706 -0.621 . . . . 0.0 110.115 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -55.95 -26.12 46.52 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.603 -0.686 . . . . 0.0 111.094 -176.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 46.0 p30 -90.18 9.66 27.57 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.399 -0.813 . . . . 0.0 111.889 -173.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 88.79 20.19 48.23 Favored Glycine 0 N--CA 1.494 2.542 0 O-C-N 121.12 -0.987 . . . . 0.0 110.655 171.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -107.98 140.15 41.56 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.267 -1.137 . . . . 0.0 110.025 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.638 HG13 ' OE2' ' A' ' 289' ' ' GLU . 60.8 t -88.74 132.23 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.65 -0.656 . . . . 0.0 110.234 -172.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.82 HD11 ' CG2' ' A' ' 290' ' ' THR . 96.2 mt -99.88 -40.08 7.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.707 -0.62 . . . . 0.0 110.532 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -162.61 150.83 20.33 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.425 ' HG2' HG22 ' A' ' 287' ' ' THR . 78.5 mtm180 -135.15 134.77 40.52 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.686 -0.89 . . . . 0.0 110.566 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -137.34 158.69 43.87 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.676 -0.64 . . . . 0.0 109.982 172.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . 0.621 ' SG ' HG23 ' A' ' 285' ' ' ILE . 97.7 m -142.56 155.69 45.03 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.424 -0.797 . . . . 0.0 110.713 -175.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.685 ' CE1' HD12 ' A' ' 284' ' ' ILE . 47.9 p90 -144.94 163.73 33.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.72 -0.612 . . . . 0.0 110.113 175.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.446 ' HA ' HD23 ' A' ' 283' ' ' LEU . 56.8 tt0 -104.91 135.37 46.39 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.496 -0.752 . . . . 0.0 110.151 -177.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -124.29 143.5 50.52 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.677 -170.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -138.67 139.01 38.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.843 -0.536 . . . . 0.0 109.806 173.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.67 HD13 ' O ' ' A' ' 269' ' ' CYS . 74.5 mt -105.82 122.93 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.549 -0.72 . . . . 0.0 109.59 175.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.9 p -145.18 168.24 20.85 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.558 -0.714 . . . . 0.0 110.968 -170.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -68.8 -39.97 79.81 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.686 -0.633 . . . . 0.0 110.636 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 4.1 t -131.25 88.54 44.2 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.534 -0.729 . . . . 0.0 110.496 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.33 -29.35 67.3 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 O-C-N 123.185 1.098 . . . . 0.0 110.914 174.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.36 -37.77 93.07 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -73.25 -40.63 64.48 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.689 -0.889 . . . . 0.0 109.875 -173.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -69.47 -39.96 77.4 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.164 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -61.01 -44.15 97.83 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.456 -0.777 . . . . 0.0 110.289 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -64.68 -40.14 94.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.557 -0.714 . . . . 0.0 110.495 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.57 -50.05 74.2 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.499 -0.751 . . . . 0.0 110.486 -173.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 N--CA 1.495 1.817 0 O-C-N 121.501 -0.749 . . . . 0.0 110.084 -178.283 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.5 t . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.05 0.453 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.5 p-10 -94.06 23.22 5.11 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.69 -0.631 . . . . 0.0 110.915 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 50.4 m -75.4 125.16 28.44 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.445 -0.785 . . . . 0.0 110.233 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -69.61 144.97 52.84 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.639 -0.663 . . . . 0.0 110.478 -177.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -153.18 100.59 2.65 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.647 -0.658 . . . . 0.0 110.118 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -59.14 -39.96 74.3 Favored 'Trans proline' 0 N--CA 1.489 1.206 0 O-C-N 123.129 1.068 . . . . 0.0 110.774 -175.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.3 -155.17 48.59 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -75.47 -43.57 0.35 Allowed 'Trans proline' 0 C--N 1.317 -1.095 0 O-C-N 123.303 1.159 . . . . 0.0 110.978 -174.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -86.77 8.1 24.12 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.529 -0.732 . . . . 0.0 111.412 -173.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.39 59.67 4.23 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.997 -1.064 . . . . 0.0 110.72 -176.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.68 ' HA ' HG12 ' A' ' 176' ' ' VAL . 64.8 t80 -77.82 117.25 19.01 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.572 -0.705 . . . . 0.0 109.933 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -130.05 160.01 35.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.855 -0.528 . . . . 0.0 110.141 -178.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 63.8 t -126.41 146.42 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.681 -0.637 . . . . 0.0 109.816 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 78.4 p -155.26 161.4 41.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.765 -0.584 . . . . 0.0 110.069 177.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.497 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 67.1 m-85 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.8 -0.562 . . . . 0.0 109.851 -176.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 121.142 0.496 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.5 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 82.1 p -60.03 -32.92 71.34 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.715 -0.616 . . . . 0.0 109.99 175.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.5 ' HD1' ' HG1' ' A' ' 152' ' ' THR . 68.8 p-90 -171.04 143.74 2.02 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.329 0.585 . . . . 0.0 110.059 177.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.0 t -142.15 142.63 32.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.88 -0.513 . . . . 0.0 110.072 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.497 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 44.7 t80 -125.49 140.06 53.09 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.551 -0.718 . . . . 0.0 110.514 -172.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.8 t -111.79 124.94 53.41 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 120.383 -0.527 . . . . 0.0 109.878 176.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 56.5 m -70.68 -37.07 73.61 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.789 -0.569 . . . . 0.0 110.483 -177.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -59.49 -33.86 71.86 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.645 -0.659 . . . . 0.0 110.441 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.505 HD11 ' OD1' ' A' ' 316' ' ' ASP . 57.1 mt -104.77 -12.04 16.52 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.678 -0.639 . . . . 0.0 110.88 -175.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 30.5 tttt 59.77 50.3 7.19 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.051 -1.031 . . . . 0.0 109.675 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -146.42 153.09 40.07 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.74 -0.6 . . . . 0.0 110.612 -174.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.618 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.55 137.85 53.4 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.833 -0.542 . . . . 0.0 110.209 -176.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -114.94 135.2 54.47 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.1 p -138.34 158.5 44.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.72 -0.612 . . . . 0.0 111.044 -175.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.421 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 65.5 mt-30 -104.45 140.94 37.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.628 -0.67 . . . . 0.0 110.021 172.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.432 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.1 tt -52.25 148.67 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.502 -0.749 . . . . 0.0 111.917 -172.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.79 10.05 5.77 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.539 -0.726 . . . . 0.0 112.509 176.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.421 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 26.7 mmtt -95.35 155.11 16.87 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.924 -1.11 . . . . 0.0 110.955 174.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 87.3 m -84.68 126.25 33.22 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.721 -0.612 . . . . 0.0 110.552 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' CYS . . . . . 0.618 ' SG ' HD21 ' A' ' 162' ' ' LEU . 29.9 t -115.15 90.36 23.62 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.572 -0.705 . . . . 0.0 110.178 176.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.42 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 22.6 Cg_endo -65.83 130.82 25.59 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 O-C-N 123.271 1.143 . . . . 0.0 110.597 176.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.411 HG12 ' CE2' ' A' ' 142' ' ' PHE . 96.9 mt -123.51 142.06 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.692 -0.63 . . . . 0.0 109.306 176.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -109.08 134.7 51.34 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.552 -0.718 . . . . 0.0 110.713 -176.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.1 mm -95.29 134.76 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.67 -0.644 . . . . 0.0 109.66 169.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -115.16 127.27 55.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.593 -0.692 . . . . 0.0 110.452 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.68 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.0 m -136.66 159.77 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.639 -0.663 . . . . 0.0 109.852 174.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.6 mmm -76.32 -40.69 50.73 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.658 -0.651 . . . . 0.0 110.092 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.5 p -134.45 143.28 46.09 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.763 -0.586 . . . . 0.0 109.9 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.8 Cg_exo -55.5 139.92 82.64 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 O-C-N 123.173 1.091 . . . . 0.0 110.947 -173.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.795 ' HB3' HD21 ' A' ' 288' ' ' LEU . 19.3 Cg_endo -59.95 165.2 10.67 Favored 'Trans proline' 0 C--N 1.316 -1.167 0 O-C-N 123.17 1.09 . . . . 0.0 110.656 177.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -62.04 154.86 59.25 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 O-C-N 123.312 1.164 . . . . 0.0 110.446 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -64.67 137.54 57.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.65 -0.656 . . . . 0.0 110.117 173.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 96.8 -24.96 28.67 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.861 -1.295 . . . . 0.0 109.861 -177.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.15 149.21 2.96 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.324 -1.104 . . . . 0.0 111.423 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.74 155.95 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.72 -0.612 . . . . 0.0 109.831 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.686 HD11 ' CD2' ' A' ' 251' ' ' TYR . 64.0 mt -108.79 135.21 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.732 ' HG2' HD22 ' A' ' 248' ' ' LEU . 69.5 mtt180 -114.95 145.85 41.8 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -174.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.646 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -140.54 126.53 19.51 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.534 -0.729 . . . . 0.0 110.212 173.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.409 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 32.9 ttp -137.22 139.0 26.76 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.804 -0.56 . . . . 0.0 110.98 -176.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.534 ' HD3' HD12 ' A' ' 226' ' ' ILE . 71.0 Cg_endo -91.11 138.25 2.29 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 O-C-N 123.204 1.107 . . . . 0.0 110.81 177.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.404 HG13 ' C ' ' A' ' 190' ' ' PRO . 35.9 m -146.22 154.87 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.554 -0.716 . . . . 0.0 110.118 173.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.66 ' HA ' HG22 ' A' ' 282' ' ' ILE . 83.4 m-85 -60.73 161.32 8.07 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.467 -0.771 . . . . 0.0 110.402 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.422 ' HA ' HD12 ' A' ' 283' ' ' LEU . 33.7 tttt -77.6 -60.07 2.52 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.632 -0.668 . . . . 0.0 110.827 -174.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -80.13 151.02 30.02 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.558 -0.713 . . . . 0.0 110.34 -175.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.456 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.54 -37.81 71.0 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.421 -0.8 . . . . 0.0 110.695 -176.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -56.61 -24.78 50.28 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.529 -0.732 . . . . 0.0 110.573 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.404 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 64.2 m170 -109.49 -20.51 12.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.531 -0.731 . . . . 0.0 111.165 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.456 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -67.72 -20.22 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.174 -0.954 . . . . 0.0 110.574 -176.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 67.7 p -79.36 -16.98 55.4 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.562 -0.711 . . . . 0.0 110.735 174.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -88.36 137.3 32.45 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.349 -0.845 . . . . 0.0 110.092 173.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.9 t -73.0 142.0 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.626 -0.671 . . . . 0.0 110.299 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.529 HG22 ' CE2' ' A' ' 192' ' ' TYR . 75.8 t -84.96 139.7 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.542 -0.724 . . . . 0.0 109.344 170.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 14.7 pttt -134.86 -170.08 2.49 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.553 -0.717 . . . . 0.0 110.883 -170.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -95.13 154.72 17.05 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.741 -0.599 . . . . 0.0 110.286 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.703 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 42.0 m . . . . . 0 N--CA 1.497 1.88 0 O-C-N 121.632 -0.668 . . . . 0.0 109.271 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 30.1 tp . . . . . 0 N--CA 1.496 1.84 0 CA-C-O 120.925 0.393 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.534 HD12 ' HD3' ' A' ' 190' ' ' PRO . 84.8 mt -103.94 136.76 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.746 -0.596 . . . . 0.0 109.917 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -131.6 156.7 45.34 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.667 -0.646 . . . . 0.0 110.318 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.575 HG23 HG21 ' A' ' 247' ' ' VAL . 89.4 t -102.28 146.62 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.772 -0.58 . . . . 0.0 109.974 176.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -117.96 130.03 55.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.722 -0.611 . . . . 0.0 110.431 171.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 93.15 21.55 29.81 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 167.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -136.73 107.24 6.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.319 -1.107 . . . . 0.0 110.048 173.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 94.5 p -63.43 -15.14 56.79 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.651 -0.656 . . . . 0.0 111.192 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -97.27 10.05 40.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.272 -0.892 . . . . 0.0 111.189 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.81 126.58 27.84 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.174 -0.954 . . . . 0.0 110.092 176.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -139.75 154.39 47.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.762 -0.586 . . . . 0.0 109.785 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.403 ' CD1' ' HB ' ' A' ' 247' ' ' VAL . 86.3 m-85 -116.95 150.7 38.11 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.596 -0.69 . . . . 0.0 110.538 -176.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.17 159.89 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.762 -0.587 . . . . 0.0 110.118 176.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -122.86 130.0 52.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.75 -0.594 . . . . 0.0 110.177 177.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -64.98 109.98 3.6 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.649 -0.657 . . . . 0.0 109.741 176.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -59.98 -24.46 76.51 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.083 1.044 . . . . 0.0 111.032 -172.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 84.3 mt -99.87 -50.39 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.488 -0.757 . . . . 0.0 110.766 -171.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 6.2 p -105.3 12.09 32.13 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.365 -0.834 . . . . 0.0 111.984 -173.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 81.97 -24.98 4.3 Favored Glycine 0 N--CA 1.496 2.7 0 O-C-N 120.982 -1.074 . . . . 0.0 111.888 169.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 -45.88 142.08 2.76 Favored 'General case' 0 N--CA 1.505 2.282 0 CA-C-N 118.59 1.195 . . . . 0.0 112.614 -168.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -108.8 144.58 36.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.629 -0.669 . . . . 0.0 110.063 174.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 78.8 p -154.83 159.96 40.91 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.62 -0.675 . . . . 0.0 110.48 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.575 HG21 HG23 ' A' ' 228' ' ' VAL . 8.3 p -123.07 148.12 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.77 -0.581 . . . . 0.0 109.695 177.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.732 HD22 ' HG2' ' A' ' 187' ' ' ARG . 81.3 mt -129.71 154.64 46.97 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.896 -176.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.442 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.9 m -150.57 151.84 31.48 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.807 -0.558 . . . . 0.0 109.944 175.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -71.11 138.81 34.31 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 O-C-N 123.188 1.099 . . . . 0.0 109.844 177.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.686 ' CD2' HD11 ' A' ' 186' ' ' ILE . 9.0 t80 -78.45 126.06 30.23 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.454 -0.779 . . . . 0.0 110.04 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -100.0 160.11 28.06 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.719 -0.613 . . . . 0.0 110.02 177.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -59.11 159.62 21.48 Favored 'Trans proline' 0 C--N 1.316 -1.157 0 O-C-N 123.276 1.145 . . . . 0.0 110.401 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.36 149.98 77.8 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.268 1.141 . . . . 0.0 110.521 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -60.53 148.42 37.95 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.681 -0.637 . . . . 0.0 110.241 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.82 127.17 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.516 -0.74 . . . . 0.0 110.154 -170.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.99 -10.17 55.39 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 10.0 t -144.66 173.31 11.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.177 -1.19 . . . . 0.0 110.586 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -107.19 13.14 27.6 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.63 -0.669 . . . . 0.0 111.783 -168.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -119.99 168.05 11.54 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.11 -0.994 . . . . 0.0 111.083 -175.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 83.6 m -117.72 145.83 44.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.729 -0.607 . . . . 0.0 109.876 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 42.8 m -115.59 135.72 53.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.622 -0.674 . . . . 0.0 110.885 -175.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.4 t -129.7 137.32 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 62.8 mt -104.63 118.57 36.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.511 -0.743 . . . . 0.0 109.73 -172.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.646 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 6.3 m-30 -105.56 151.31 24.48 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.694 -0.629 . . . . 0.0 110.578 -177.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -136.53 142.9 43.48 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -112.53 129.26 56.42 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.608 -0.682 . . . . 0.0 110.458 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -98.23 -1.84 41.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.741 -0.6 . . . . 0.0 111.95 -176.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.73 159.11 43.38 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.117 -0.989 . . . . 0.0 109.839 174.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.615 ' HA ' HD13 ' A' ' 305' ' ' ILE . 27.1 p30 -113.95 153.49 29.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.732 -0.605 . . . . 0.0 110.059 178.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . 0.442 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 89.1 p -56.54 -26.51 55.09 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.43 -0.794 . . . . 0.0 111.189 -168.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 49.8 p -94.4 8.09 43.22 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.396 -0.815 . . . . 0.0 112.095 -166.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . 0.703 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 28.8 p -92.98 116.61 29.21 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.009 -1.057 . . . . 0.0 110.584 178.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.39 143.3 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.482 -0.761 . . . . 0.0 110.414 -166.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.55 -5.33 58.55 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.96 -93.13 0.66 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 170.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . 0.442 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 94.3 mmm -66.31 -29.06 69.19 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.731 -0.864 . . . . 0.0 110.36 176.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.8 p30 45.1 52.46 8.41 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 172.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 54.91 33.14 19.33 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.255 -0.903 . . . . 0.0 111.227 174.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' ARG . . . . . 0.415 ' HA ' ' HD2' ' A' ' 281' ' ' PRO . 80.9 mtt180 -113.97 104.95 54.84 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.511 -0.743 . . . . 0.0 110.245 173.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 280' ' ' ARG . 13.6 Cg_endo -61.1 145.49 98.81 Favored 'Trans proline' 0 N--CA 1.488 1.171 0 O-C-N 123.107 1.056 . . . . 0.0 110.293 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.66 HG22 ' HA ' ' A' ' 192' ' ' TYR . 44.0 pt -131.97 176.82 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.943 0.878 . . . . 0.0 111.244 -174.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 302' ' ' GLU . 31.4 mt -124.29 149.86 46.05 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.708 HD12 ' CE1' ' A' ' 301' ' ' PHE . 81.6 mt -114.85 129.4 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.253 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.525 HG23 ' SG ' ' A' ' 300' ' ' CYS . 80.4 mt -109.8 126.26 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -176.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 58.3 t -118.96 126.77 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.3 p -125.27 152.24 44.9 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.621 -174.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.795 HD21 ' HB3' ' A' ' 180' ' ' PRO . 21.1 tp -101.44 125.29 48.06 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 167.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.572 ' OE2' HG13 ' A' ' 295' ' ' VAL . 73.6 mm-40 -131.17 150.84 51.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.85 -0.531 . . . . 0.0 109.979 -172.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.797 ' CG2' HD11 ' A' ' 296' ' ' LEU . 68.9 p -89.96 159.88 16.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.606 -0.684 . . . . 0.0 109.908 177.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -55.95 -26.1 46.48 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.523 -0.735 . . . . 0.0 110.809 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -87.5 9.69 20.12 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.477 -0.764 . . . . 0.0 111.862 -174.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 86.9 20.16 54.23 Favored Glycine 0 N--CA 1.495 2.567 0 C-N-CA 120.195 -1.002 . . . . 0.0 110.733 170.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -106.84 140.14 40.14 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.293 -1.122 . . . . 0.0 110.267 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.572 HG13 ' OE2' ' A' ' 289' ' ' GLU . 59.9 t -88.32 130.15 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.65 -0.656 . . . . 0.0 110.034 -175.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.797 HD11 ' CG2' ' A' ' 290' ' ' THR . 96.0 mt -99.94 -40.15 7.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.681 -0.637 . . . . 0.0 110.46 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -160.14 147.9 15.56 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.523 ' HD3' HG11 ' A' ' 295' ' ' VAL . 79.4 mtm180 -135.09 134.4 40.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.644 -0.915 . . . . 0.0 110.565 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -137.47 158.95 43.28 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.654 -0.654 . . . . 0.0 110.036 172.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . 0.525 ' SG ' HG23 ' A' ' 285' ' ' ILE . 92.8 m -142.26 155.73 45.25 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.467 -0.771 . . . . 0.0 110.745 -175.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.708 ' CE1' HD12 ' A' ' 284' ' ' ILE . 48.9 p90 -144.98 160.54 41.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.701 -0.625 . . . . 0.0 110.074 174.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.468 ' HA ' HD23 ' A' ' 283' ' ' LEU . 58.7 tt0 -104.88 135.92 45.33 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.539 -0.726 . . . . 0.0 110.178 -177.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -118.41 143.74 46.45 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.812 -169.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -138.57 138.07 37.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.819 -0.551 . . . . 0.0 109.759 173.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.615 HD13 ' HA ' ' A' ' 270' ' ' ASN . 34.8 mt -110.8 122.85 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.538 -0.726 . . . . 0.0 109.495 178.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.3 p -145.25 171.9 13.9 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.561 -0.712 . . . . 0.0 111.035 -169.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -70.32 -40.06 74.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.681 -0.637 . . . . 0.0 110.653 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 4.5 t -132.37 89.98 35.23 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.574 -0.704 . . . . 0.0 110.525 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.18 -30.08 69.5 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.15 1.079 . . . . 0.0 111.032 174.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.03 -37.48 93.19 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -73.66 -40.59 63.6 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.701 -0.882 . . . . 0.0 109.895 -173.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -69.56 -39.99 77.05 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 120.084 -0.647 . . . . 0.0 110.236 -177.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -61.26 -43.77 98.34 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.382 177.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -64.86 -38.36 90.71 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.524 -0.735 . . . . 0.0 110.461 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.84 -49.76 75.0 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.539 -0.726 . . . . 0.0 110.539 -173.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . 0.505 ' OD1' HD11 ' A' ' 159' ' ' LEU . 2.8 p30 . . . . . 0 N--CA 1.495 1.79 0 O-C-N 121.488 -0.758 . . . . 0.0 110.138 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.9 t . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.011 0.434 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -95.05 24.79 4.6 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.717 -0.614 . . . . 0.0 110.756 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 52.0 m -74.96 125.23 28.45 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.587 -0.696 . . . . 0.0 110.263 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -69.88 144.93 52.34 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.675 -0.64 . . . . 0.0 110.496 -177.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -156.96 102.33 1.93 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.675 -0.64 . . . . 0.0 110.048 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.97 -39.98 66.09 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 O-C-N 123.138 1.073 . . . . 0.0 110.699 -175.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.39 -155.15 43.35 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -72.65 -48.97 0.28 Allowed 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.318 1.168 . . . . 0.0 110.813 -175.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -83.77 4.64 28.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.537 -0.727 . . . . 0.0 111.369 -175.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 t 54.12 61.22 3.15 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.908 -1.12 . . . . 0.0 110.664 -176.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.725 ' HA ' HG12 ' A' ' 176' ' ' VAL . 63.0 t80 -77.96 119.92 22.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.522 -0.736 . . . . 0.0 110.04 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -129.98 160.01 34.93 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.778 -0.576 . . . . 0.0 110.072 -176.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.2 t -124.55 146.34 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.789 -0.57 . . . . 0.0 109.754 177.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.3 p -155.12 162.96 40.86 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.325 0.583 . . . . 0.0 109.941 177.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.492 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 71.2 m-85 . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.74 -0.6 . . . . 0.0 109.762 -176.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 121.169 0.509 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.429 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 65.2 p -60.13 -34.02 72.95 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.742 -0.599 . . . . 0.0 109.967 175.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.441 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -171.33 143.48 1.86 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.399 0.618 . . . . 0.0 110.406 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 13.4 t -142.16 142.68 32.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.899 -0.5 . . . . 0.0 109.892 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.492 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 62.3 t80 -125.56 140.03 53.09 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.399 -0.813 . . . . 0.0 110.646 -171.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.8 t -110.38 124.92 52.61 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.878 176.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 54.6 m -70.84 -37.0 73.12 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.838 -0.539 . . . . 0.0 110.414 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -59.36 -33.9 71.73 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.652 -0.655 . . . . 0.0 110.47 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.0 mt -104.79 -12.02 16.51 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.691 -0.631 . . . . 0.0 110.838 -175.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt 59.69 49.27 8.39 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.076 -1.015 . . . . 0.0 109.699 177.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.445 ' HE3' ' CZ ' ' A' ' 163' ' ' TYR . 34.2 ttpt -147.15 153.26 39.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.714 -0.616 . . . . 0.0 110.563 -173.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.656 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.5 tp -126.44 138.06 53.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.686 -0.633 . . . . 0.0 110.315 -173.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.445 ' CZ ' ' HE3' ' A' ' 161' ' ' LYS . 54.0 m-85 -114.72 133.75 55.64 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.36 158.46 44.24 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.65 -0.656 . . . . 0.0 110.824 -175.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.405 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 33.7 mt-30 -104.62 141.9 35.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.595 -0.691 . . . . 0.0 110.275 172.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.426 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 16.6 tt -51.42 147.38 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 CA-C-O 121.624 0.726 . . . . 0.0 111.989 -174.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.26 10.06 5.3 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.521 -0.737 . . . . 0.0 112.534 176.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.405 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 30.5 mmtm -96.28 155.04 16.93 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.899 -1.126 . . . . 0.0 110.838 175.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 86.5 m -84.37 126.22 33.02 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.707 -0.621 . . . . 0.0 110.525 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' CYS . . . . . 0.656 ' SG ' HD21 ' A' ' 162' ' ' LEU . 44.0 t -115.22 90.19 23.37 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.62 -0.675 . . . . 0.0 110.199 174.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.441 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 23.1 Cg_exo -61.85 130.75 32.27 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 O-C-N 123.278 1.146 . . . . 0.0 110.677 173.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.412 HG12 ' CE2' ' A' ' 142' ' ' PHE . 93.2 mt -124.97 142.16 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.626 -0.671 . . . . 0.0 109.219 175.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -107.93 136.3 47.87 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.475 -0.766 . . . . 0.0 110.826 -174.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.415 ' CG2' ' CE1' ' A' ' 138' ' ' PHE . 48.6 mm -95.22 135.07 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.757 -0.589 . . . . 0.0 109.691 169.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -118.09 128.99 55.27 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.415 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.725 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.3 m -136.24 159.82 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.63 -0.669 . . . . 0.0 109.979 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 81.2 mmm -77.75 -40.49 40.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.713 -0.617 . . . . 0.0 110.085 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.1 p -135.21 143.27 44.97 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.797 -0.564 . . . . 0.0 109.788 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 33.3 Cg_exo -55.57 139.8 82.96 Favored 'Trans proline' 0 N--CA 1.489 1.264 0 O-C-N 123.245 1.129 . . . . 0.0 110.871 -172.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.694 ' HB3' HD21 ' A' ' 288' ' ' LEU . 23.8 Cg_endo -64.47 169.38 11.23 Favored 'Trans proline' 0 N--CA 1.488 1.151 0 O-C-N 123.181 1.095 . . . . 0.0 110.704 178.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -61.19 158.26 35.87 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 O-C-N 123.321 1.169 . . . . 0.0 110.469 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -78.7 138.18 38.15 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.602 -0.686 . . . . 0.0 109.969 175.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.5 -24.84 30.6 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -174.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.2 151.09 2.17 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.35 -1.088 . . . . 0.0 111.322 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.7 155.95 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.727 -0.608 . . . . 0.0 109.762 176.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.65 HD11 ' CD2' ' A' ' 251' ' ' TYR . 66.5 mt -108.13 137.0 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.72 ' HG2' HD22 ' A' ' 248' ' ' LEU . 37.8 mtp180 -114.87 146.79 40.72 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -175.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.68 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -140.85 126.07 18.54 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.483 -0.761 . . . . 0.0 110.4 171.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 48.5 ttp -137.33 140.69 31.49 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.775 -0.578 . . . . 0.0 111.052 -176.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.651 ' HD3' HD12 ' A' ' 226' ' ' ILE . 74.0 Cg_endo -89.85 138.25 2.95 Favored 'Trans proline' 0 C--N 1.32 -0.96 0 O-C-N 123.24 1.126 . . . . 0.0 110.843 177.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.413 HG13 ' C ' ' A' ' 190' ' ' PRO . 34.7 m -146.39 154.82 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.547 -0.721 . . . . 0.0 110.085 173.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.653 ' HA ' HG22 ' A' ' 282' ' ' ILE . 88.3 m-85 -62.92 162.9 10.46 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.522 -0.736 . . . . 0.0 110.468 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.413 ' HA ' HD12 ' A' ' 283' ' ' LEU . 47.7 tttm -78.93 -60.04 2.54 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.659 -0.65 . . . . 0.0 110.815 -175.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 38.9 mttp -80.1 150.77 30.16 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.62 -0.675 . . . . 0.0 110.34 -175.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.456 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.52 -37.69 70.8 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.371 -0.831 . . . . 0.0 110.728 -176.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -56.44 -24.83 48.0 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.536 -0.727 . . . . 0.0 110.642 -176.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.42 ' HB3' ' CG ' ' A' ' 192' ' ' TYR . 77.7 m80 -110.09 -20.51 12.67 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.174 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.456 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.1 p -67.07 -20.28 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.15 -0.969 . . . . 0.0 110.544 -176.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 71.9 p -79.29 -16.99 55.52 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.491 -0.756 . . . . 0.0 110.651 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -88.34 137.19 32.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.34 -0.85 . . . . 0.0 110.041 172.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.3 t -73.1 141.58 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.645 -0.659 . . . . 0.0 110.248 177.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.554 HG22 ' CE2' ' A' ' 192' ' ' TYR . 64.7 t -84.93 137.8 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.618 -0.676 . . . . 0.0 109.405 171.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 12.1 pttt -134.92 -170.29 2.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.543 -0.723 . . . . 0.0 111.035 -171.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 83.5 mtm-85 -95.26 158.7 15.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.781 -0.575 . . . . 0.0 110.34 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.697 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 56.5 m . . . . . 0 N--CA 1.497 1.878 0 O-C-N 121.679 -0.638 . . . . 0.0 109.513 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.41 ' HA ' ' CG ' ' A' ' 268' ' ' MET . 54.0 tp . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 120.941 0.4 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.651 HD12 ' HD3' ' A' ' 190' ' ' PRO . 82.6 mt -104.06 136.75 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.843 -0.536 . . . . 0.0 109.685 175.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -134.16 158.81 42.72 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.714 -0.616 . . . . 0.0 110.389 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.642 HG23 HG21 ' A' ' 247' ' ' VAL . 83.9 t -103.85 146.72 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.66 -0.65 . . . . 0.0 110.099 177.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -117.27 128.13 54.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.817 -0.552 . . . . 0.0 110.368 171.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.05 22.96 23.92 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 167.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -135.24 106.42 6.72 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.394 -1.062 . . . . 0.0 110.09 173.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 27.6 t -62.93 -15.12 54.3 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.649 -0.657 . . . . 0.0 111.24 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -100.13 5.02 44.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.198 -0.939 . . . . 0.0 111.61 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.4 131.16 49.33 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.039 -1.038 . . . . 0.0 110.276 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -139.76 157.74 45.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.782 -0.574 . . . . 0.0 109.62 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -115.72 150.63 36.52 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.592 -0.693 . . . . 0.0 110.497 -177.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.14 159.98 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.759 -0.588 . . . . 0.0 110.263 177.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -116.53 129.95 56.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.804 -0.56 . . . . 0.0 110.003 174.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -63.31 117.45 33.98 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.649 -0.657 . . . . 0.0 109.76 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.84 -27.18 80.09 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.096 1.051 . . . . 0.0 110.878 -172.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 84.2 mt -101.85 -50.34 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.439 -0.788 . . . . 0.0 110.907 -170.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 7.5 p -105.37 12.25 31.84 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.431 -0.793 . . . . 0.0 111.987 -172.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 81.25 -25.06 3.82 Favored Glycine 0 N--CA 1.498 2.787 0 O-C-N 121.006 -1.059 . . . . 0.0 111.868 170.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -45.71 142.09 2.61 Favored 'General case' 0 N--CA 1.505 2.285 0 CA-C-N 118.641 1.22 . . . . 0.0 112.726 -166.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -97.8 145.17 26.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.583 -0.698 . . . . 0.0 109.838 171.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 77.5 p -154.8 159.91 40.92 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.528 -0.732 . . . . 0.0 110.588 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.642 HG21 HG23 ' A' ' 228' ' ' VAL . 8.2 p -123.23 148.03 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.722 -0.611 . . . . 0.0 109.72 176.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.72 HD22 ' HG2' ' A' ' 187' ' ' ARG . 79.2 mt -129.78 154.76 46.9 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.833 -175.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.437 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.8 m -150.44 151.78 31.69 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.843 -0.536 . . . . 0.0 109.898 175.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -71.11 138.99 34.69 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 O-C-N 123.24 1.126 . . . . 0.0 109.923 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.65 ' CD2' HD11 ' A' ' 186' ' ' ILE . 9.9 t80 -80.05 123.43 27.84 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.543 -0.723 . . . . 0.0 110.188 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -99.99 160.1 28.1 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.717 -0.614 . . . . 0.0 110.07 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -58.83 160.1 19.03 Favored 'Trans proline' 0 N--CA 1.487 1.12 0 O-C-N 123.228 1.12 . . . . 0.0 110.414 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -58.67 149.91 73.55 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 O-C-N 123.171 1.09 . . . . 0.0 110.567 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -62.46 146.94 50.21 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.693 -0.629 . . . . 0.0 110.261 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.9 127.26 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.496 -0.752 . . . . 0.0 110.232 -171.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.65 -10.08 55.86 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 7.3 t -143.84 166.46 24.86 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.165 -1.197 . . . . 0.0 110.6 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -101.87 13.07 35.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.717 -0.615 . . . . 0.0 111.846 -168.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -127.57 168.13 15.4 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.098 -1.001 . . . . 0.0 111.126 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 83.2 m -117.67 147.31 43.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.701 -0.624 . . . . 0.0 109.912 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 31.1 m -116.32 135.9 53.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.592 -0.693 . . . . 0.0 110.922 -174.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.5 t -128.57 137.21 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 171.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 70.2 mt -104.74 119.84 39.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.457 -0.777 . . . . 0.0 109.849 -172.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.68 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 6.1 m-30 -105.97 151.3 24.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.683 -0.636 . . . . 0.0 110.639 -176.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -136.63 142.98 43.28 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -114.07 130.6 56.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.513 -0.742 . . . . 0.0 110.407 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' MET . . . . . 0.41 ' CG ' ' HA ' ' A' ' 225' ' ' LEU . 5.0 ppp? -99.12 1.4 45.04 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.708 -0.62 . . . . 0.0 111.963 -176.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -144.72 158.51 43.75 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.109 -0.994 . . . . 0.0 109.928 173.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.597 ' HA ' HD13 ' A' ' 305' ' ' ILE . 27.4 p30 -113.97 154.26 27.92 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.666 -0.646 . . . . 0.0 110.073 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . 0.437 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 90.7 p -56.6 -26.97 57.0 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.373 -0.829 . . . . 0.0 111.096 -167.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 46.7 p -95.19 6.97 47.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.401 -0.812 . . . . 0.0 112.146 -165.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . 0.697 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 29.0 p -92.95 118.08 30.76 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.029 -1.044 . . . . 0.0 110.675 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.8 t -69.84 142.75 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.556 -0.715 . . . . 0.0 110.531 -168.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.4 -5.26 58.75 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.14 -95.45 0.74 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 169.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . 0.437 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 95.3 mmm -64.7 -28.15 69.4 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.746 -0.855 . . . . 0.0 110.277 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 10.0 p30 44.73 50.92 8.51 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 172.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 54.76 34.12 21.08 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.375 -0.828 . . . . 0.0 111.316 174.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' ARG . . . . . 0.45 ' O ' HG23 ' A' ' 282' ' ' ILE . 88.7 mtt180 -115.94 104.93 52.03 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.548 -0.72 . . . . 0.0 110.141 172.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 280' ' ' ARG . 12.3 Cg_endo -60.26 145.03 99.43 Favored 'Trans proline' 0 N--CA 1.489 1.264 0 O-C-N 123.139 1.073 . . . . 0.0 110.374 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.653 HG22 ' HA ' ' A' ' 192' ' ' TYR . 42.8 pt -132.57 178.45 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 122.029 0.919 . . . . 0.0 111.373 -174.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 302' ' ' GLU . 34.5 mt -124.3 149.86 46.06 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.694 HD12 ' CE1' ' A' ' 301' ' ' PHE . 79.4 mt -112.24 128.71 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.646 HG23 ' SG ' ' A' ' 300' ' ' CYS . 77.8 mt -109.68 125.67 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -175.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 58.5 t -118.87 126.65 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.4 p -125.35 154.81 41.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.661 -0.649 . . . . 0.0 110.567 -174.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.694 HD21 ' HB3' ' A' ' 180' ' ' PRO . 24.4 tp -105.59 125.85 51.47 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 169.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.648 ' OE2' HG13 ' A' ' 295' ' ' VAL . 71.6 mm-40 -132.04 149.5 52.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.858 -0.526 . . . . 0.0 109.911 -173.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.823 ' CG2' HD11 ' A' ' 296' ' ' LEU . 25.4 p -89.98 161.28 15.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.703 -0.623 . . . . 0.0 110.031 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 69.7 ttp85 -55.94 -26.13 46.51 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.566 -0.708 . . . . 0.0 111.139 -175.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 44.7 p30 -90.87 9.82 28.82 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.444 -0.785 . . . . 0.0 111.963 -173.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.55 20.23 45.38 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.15 -1.024 . . . . 0.0 110.732 171.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -107.52 140.23 40.81 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.33 -1.1 . . . . 0.0 109.988 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.648 HG13 ' OE2' ' A' ' 289' ' ' GLU . 62.1 t -90.28 132.0 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.572 -0.705 . . . . 0.0 110.236 -172.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.823 HD11 ' CG2' ' A' ' 290' ' ' THR . 96.0 mt -99.84 -40.29 7.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.767 -0.583 . . . . 0.0 110.545 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -162.05 153.17 23.78 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -135.06 135.19 41.09 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.598 -0.942 . . . . 0.0 110.521 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -138.03 156.0 48.25 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.611 -0.681 . . . . 0.0 110.028 172.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . 0.646 ' SG ' HG23 ' A' ' 285' ' ' ILE . 98.3 m -143.23 155.7 44.57 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.379 -0.826 . . . . 0.0 110.844 -175.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.694 ' CE1' HD12 ' A' ' 284' ' ' ILE . 47.8 p90 -145.3 162.62 36.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.643 -0.661 . . . . 0.0 110.156 174.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.489 ' HA ' HD23 ' A' ' 283' ' ' LEU . 81.4 tt0 -104.77 137.34 42.71 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.591 -0.693 . . . . 0.0 110.219 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -118.94 144.66 46.32 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.766 -170.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -136.99 138.51 40.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.799 -0.563 . . . . 0.0 109.725 173.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.597 HD13 ' HA ' ' A' ' 270' ' ' ASN . 61.6 mt -112.02 122.86 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.572 -0.705 . . . . 0.0 109.63 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.1 p -145.42 173.73 11.75 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.589 -0.695 . . . . 0.0 110.683 -171.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -74.17 -40.12 62.77 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.573 -0.704 . . . . 0.0 110.639 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.8 t -127.25 86.86 57.75 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.494 -0.754 . . . . 0.0 110.475 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -55.81 -28.65 68.43 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.117 1.062 . . . . 0.0 110.768 174.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.88 -37.45 92.23 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -73.38 -41.05 63.86 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.643 -0.916 . . . . 0.0 109.889 -173.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -69.41 -40.33 77.38 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 120.076 -0.649 . . . . 0.0 110.153 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -61.28 -44.19 97.65 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.482 -0.762 . . . . 0.0 110.258 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 23.6 ttpt -63.73 -39.63 94.77 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.641 -0.662 . . . . 0.0 110.432 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.86 -51.9 66.34 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.517 -0.74 . . . . 0.0 110.396 -173.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.4 p30 . . . . . 0 N--CA 1.494 1.772 0 O-C-N 121.437 -0.789 . . . . 0.0 110.15 -177.551 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.6 t . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.035 0.445 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.6 p-10 -93.91 22.5 5.63 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.644 -0.66 . . . . 0.0 110.877 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 52.0 m -79.14 125.18 29.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.466 -0.771 . . . . 0.0 110.177 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -68.78 144.95 54.18 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.585 -0.697 . . . . 0.0 110.444 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.411 ' CE2' ' HA2' ' A' ' 134' ' ' GLY . 61.1 t80 -156.54 101.2 2.03 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.727 -0.608 . . . . 0.0 110.098 178.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.65 -39.89 78.48 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 O-C-N 123.126 1.066 . . . . 0.0 110.857 -175.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.411 ' HA2' ' CE2' ' A' ' 132' ' ' TYR . . . 79.3 -155.16 39.66 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -72.88 -48.33 0.29 Allowed 'Trans proline' 0 N--CA 1.486 1.079 0 O-C-N 123.402 1.212 . . . . 0.0 110.983 -174.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -86.47 8.36 22.19 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.614 -0.679 . . . . 0.0 111.351 -174.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.8 58.3 5.23 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.983 -1.073 . . . . 0.0 110.6 -176.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.729 ' HA ' HG12 ' A' ' 176' ' ' VAL . 71.7 t80 -79.38 115.81 19.25 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.604 -0.685 . . . . 0.0 109.877 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -130.05 160.04 34.9 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.28 0.562 . . . . 0.0 110.41 -174.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.451 HG22 ' CD1' ' A' ' 174' ' ' ILE . 78.8 t -122.01 150.32 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.831 -0.543 . . . . 0.0 109.807 174.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 78.2 p -154.91 169.21 24.58 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.012 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.494 ' CD2' ' CE2' ' A' ' 155' ' ' TYR . 97.3 m-85 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.884 -0.51 . . . . 0.0 109.938 -176.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 121.124 0.488 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.463 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 77.8 p -60.05 -32.21 70.71 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.653 -0.655 . . . . 0.0 109.922 174.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.463 ' HD1' ' HG1' ' A' ' 152' ' ' THR . 68.7 p-90 -171.46 143.78 1.84 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.403 0.621 . . . . 0.0 110.132 178.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.3 t -142.1 142.56 32.81 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.863 -0.523 . . . . 0.0 109.916 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.494 ' CE2' ' CD2' ' A' ' 142' ' ' PHE . 62.6 t80 -125.56 140.01 53.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.533 -0.729 . . . . 0.0 110.673 -172.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.5 t -111.3 124.01 51.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.829 -0.545 . . . . 0.0 109.775 175.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 62.0 m -70.88 -37.09 73.02 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.819 -0.55 . . . . 0.0 110.359 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -59.09 -33.05 70.37 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.555 -0.716 . . . . 0.0 110.447 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.523 HD11 ' OD1' ' A' ' 316' ' ' ASP . 55.1 mt -104.8 -12.03 16.5 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.77 -176.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt 59.76 47.76 9.96 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.039 -1.038 . . . . 0.0 109.728 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.423 ' HE3' ' CZ ' ' A' ' 163' ' ' TYR . 20.7 ttpt -148.21 153.23 38.48 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 120.161 -0.615 . . . . 0.0 110.803 -173.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.588 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.5 tp -126.49 137.93 53.44 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.731 -0.605 . . . . 0.0 110.437 -173.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.423 ' CZ ' ' HE3' ' A' ' 161' ' ' LYS . 98.7 m-85 -114.85 134.38 55.19 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.9 p -138.39 158.44 44.28 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.61 -0.681 . . . . 0.0 111.194 -176.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.424 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 59.0 mt-30 -104.47 142.18 35.06 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.663 -0.648 . . . . 0.0 110.336 173.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.431 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 18.0 tt -55.04 148.22 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.548 -0.72 . . . . 0.0 111.613 -173.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.37 10.01 5.36 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.544 -0.723 . . . . 0.0 112.511 177.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.424 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 73.5 mmtt -97.09 155.08 16.96 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.984 -1.073 . . . . 0.0 110.773 174.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 74.5 m -80.16 126.04 30.59 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.674 -0.641 . . . . 0.0 110.573 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' CYS . . . . . 0.588 ' SG ' HD21 ' A' ' 162' ' ' LEU . 31.4 t -117.1 90.37 33.21 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.625 -0.672 . . . . 0.0 110.182 174.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.426 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 26.1 Cg_endo -66.97 128.25 18.38 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 O-C-N 123.337 1.177 . . . . 0.0 110.756 176.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.65 HD12 ' CD2' ' A' ' 265' ' ' TYR . 83.7 mt -122.51 141.64 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.675 -0.641 . . . . 0.0 109.362 172.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -109.48 136.95 48.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.54 -0.725 . . . . 0.0 110.755 -173.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.671 HG21 ' CE1' ' A' ' 138' ' ' PHE . 50.4 mm -95.24 135.01 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.779 -0.576 . . . . 0.0 109.744 172.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 17.0 tptp -117.57 130.81 56.64 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.606 -0.684 . . . . 0.0 110.492 176.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.729 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.6 m -136.34 159.76 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.579 -0.701 . . . . 0.0 110.04 174.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 79.8 mmm -77.63 -39.79 44.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.724 -0.61 . . . . 0.0 110.029 176.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.3 p -135.66 143.24 44.0 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.831 -0.543 . . . . 0.0 109.709 177.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.9 Cg_exo -55.63 139.86 83.33 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 O-C-N 123.146 1.077 . . . . 0.0 110.821 -173.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.647 ' HB3' HD21 ' A' ' 288' ' ' LEU . 26.6 Cg_endo -65.19 169.61 11.94 Favored 'Trans proline' 0 N--CA 1.487 1.115 0 O-C-N 123.165 1.087 . . . . 0.0 110.684 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -61.27 156.7 44.17 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 O-C-N 123.37 1.195 . . . . 0.0 110.46 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -77.53 140.24 39.71 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.616 -0.677 . . . . 0.0 109.913 175.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.79 -24.91 29.62 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -175.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.16 151.64 1.97 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.363 -1.081 . . . . 0.0 111.319 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 33.8 m -129.77 155.89 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.766 -0.584 . . . . 0.0 109.597 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.634 HD11 ' CD2' ' A' ' 251' ' ' TYR . 79.3 mt -107.25 136.6 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.712 ' HG2' HD22 ' A' ' 248' ' ' LEU . 73.3 mtp180 -114.79 142.82 46.03 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -175.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -140.69 123.46 16.26 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.486 -0.759 . . . . 0.0 110.501 177.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 30.7 ttp -137.43 139.01 26.21 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.76 -0.587 . . . . 0.0 110.969 -175.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.746 ' HD3' HD12 ' A' ' 226' ' ' ILE . 72.7 Cg_endo -90.62 138.18 2.53 Favored 'Trans proline' 0 C--N 1.318 -1.03 0 O-C-N 123.246 1.13 . . . . 0.0 110.418 176.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.563 ' HB ' HG23 ' A' ' 198' ' ' VAL . 34.6 m -146.47 154.81 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.596 -0.69 . . . . 0.0 110.196 175.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.582 ' HA ' HG22 ' A' ' 282' ' ' ILE . 89.1 m-85 -59.82 160.35 7.73 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.495 -0.753 . . . . 0.0 110.495 178.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.442 ' HA ' HD12 ' A' ' 283' ' ' LEU . 34.1 tttt -74.04 -59.45 2.72 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.598 -0.688 . . . . 0.0 110.729 -175.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -80.01 148.78 30.98 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.57 -0.706 . . . . 0.0 110.398 -174.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.451 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.86 -38.11 72.26 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.355 -0.84 . . . . 0.0 110.695 -175.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -56.41 -24.94 48.34 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.441 -0.787 . . . . 0.0 110.629 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.404 ' O ' ' CD1' ' A' ' 192' ' ' TYR . 94.3 m-70 -109.99 -20.51 12.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.597 -0.69 . . . . 0.0 111.188 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.563 HG23 ' HB ' ' A' ' 191' ' ' VAL . 3.2 p -67.25 -20.09 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.272 -0.892 . . . . 0.0 110.598 -176.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 69.2 p -79.27 -16.11 56.94 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.558 -0.714 . . . . 0.0 110.714 175.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -88.2 137.59 32.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.915 . . . . 0.0 110.049 172.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.7 t -73.01 142.36 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.606 -0.684 . . . . 0.0 110.25 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.477 HG22 ' CE1' ' A' ' 192' ' ' TYR . 77.0 t -84.81 139.11 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.514 -0.741 . . . . 0.0 109.339 170.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 14.1 pttt -134.81 -170.05 2.48 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.406 -0.809 . . . . 0.0 111.205 -165.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -95.13 154.4 17.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.783 -0.573 . . . . 0.0 110.62 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.614 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 61.0 m . . . . . 0 N--CA 1.496 1.867 0 O-C-N 121.668 -0.645 . . . . 0.0 109.303 172.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.495 HD12 ' HG3' ' A' ' 268' ' ' MET . 32.2 tp . . . . . 0 N--CA 1.496 1.871 0 CA-C-O 120.936 0.398 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.746 HD12 ' HD3' ' A' ' 190' ' ' PRO . 83.6 mt -98.17 136.78 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-O 121.232 0.539 . . . . 0.0 109.896 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 -131.14 159.38 37.85 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.735 -0.603 . . . . 0.0 110.084 175.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.574 HG23 HG21 ' A' ' 247' ' ' VAL . 73.7 t -105.62 146.68 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.425 0.631 . . . . 0.0 110.204 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -121.5 130.04 53.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.725 -0.609 . . . . 0.0 110.311 171.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 96.61 20.42 24.61 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 169.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -140.01 103.7 4.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.36 -1.082 . . . . 0.0 109.944 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 93.5 p -63.62 -15.21 57.59 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.657 -0.652 . . . . 0.0 111.15 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -97.43 9.86 41.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.29 -0.881 . . . . 0.0 111.17 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -62.07 132.71 53.77 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.235 -0.915 . . . . 0.0 110.102 176.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -139.65 157.96 44.9 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.691 -0.631 . . . . 0.0 109.826 177.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -114.2 150.68 33.91 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.516 -0.74 . . . . 0.0 110.576 -177.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.18 159.92 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.73 -0.606 . . . . 0.0 110.124 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -119.76 130.06 54.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.741 -0.6 . . . . 0.0 110.209 176.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -63.44 130.07 94.04 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.65 -0.656 . . . . 0.0 109.792 177.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -64.77 -27.66 59.81 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 O-C-N 123.118 1.062 . . . . 0.0 111.045 -170.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.2 mt -101.4 -50.5 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.411 -0.806 . . . . 0.0 111.108 -167.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 75.7 p -105.46 12.18 31.74 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.315 -0.865 . . . . 0.0 111.881 -174.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.93 -4.97 14.35 Favored Glycine 0 N--CA 1.496 2.645 0 O-C-N 121.1 -1.0 . . . . 0.0 111.837 174.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.476 ' CZ ' HG12 ' A' ' 191' ' ' VAL . 12.6 mmt180 -45.99 142.09 2.86 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 119.088 1.444 . . . . 0.0 112.334 -173.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -102.74 142.27 34.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.662 -0.649 . . . . 0.0 110.294 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 77.3 p -154.8 159.93 40.93 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.642 -0.661 . . . . 0.0 110.301 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.574 HG21 HG23 ' A' ' 228' ' ' VAL . 8.3 p -122.96 148.16 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.708 -0.62 . . . . 0.0 109.754 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.712 HD22 ' HG2' ' A' ' 187' ' ' ARG . 79.7 mt -129.69 154.63 46.96 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.763 -174.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.44 HG13 ' C ' ' A' ' 248' ' ' LEU . 33.8 m -150.9 151.74 30.5 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.873 -0.517 . . . . 0.0 109.901 174.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -70.96 137.67 32.44 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 O-C-N 123.273 1.144 . . . . 0.0 109.92 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.634 ' CD2' HD11 ' A' ' 186' ' ' ILE . 11.7 t80 -77.9 122.85 26.04 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.552 -0.717 . . . . 0.0 110.183 179.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -100.01 160.01 28.32 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.753 -0.592 . . . . 0.0 110.15 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.92 160.02 19.57 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 123.233 1.123 . . . . 0.0 110.403 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -58.56 150.06 71.67 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 123.29 1.153 . . . . 0.0 110.666 -177.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -61.13 147.31 44.44 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.672 -0.643 . . . . 0.0 110.184 -177.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.81 127.2 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.485 -0.759 . . . . 0.0 110.167 -170.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.87 -10.13 55.54 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 10.2 t -144.31 174.2 11.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.177 -1.19 . . . . 0.0 110.614 175.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -108.18 13.14 26.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.603 -0.686 . . . . 0.0 111.854 -167.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -124.59 168.13 13.55 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.178 -0.951 . . . . 0.0 111.189 -176.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 94.2 m -117.79 145.95 44.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.737 -0.602 . . . . 0.0 109.862 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 44.4 m -116.57 136.29 53.1 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.535 -0.728 . . . . 0.0 110.937 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 60.1 t -127.05 137.08 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 60.2 mt -104.82 121.21 43.19 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.603 -0.685 . . . . 0.0 109.747 -173.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.65 ' CD2' HD12 ' A' ' 172' ' ' ILE . 3.4 m-85 -99.95 156.71 17.0 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.578 -0.701 . . . . 0.0 110.88 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -136.41 142.94 43.72 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 171.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -110.4 128.97 55.84 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.551 -0.718 . . . . 0.0 110.27 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' MET . . . . . 0.495 ' HG3' HD12 ' A' ' 225' ' ' LEU . 5.2 ppp? -95.29 -0.11 53.22 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.712 -0.618 . . . . 0.0 112.019 -177.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . 0.722 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.6 OUTLIER -144.77 165.06 29.15 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.158 -0.964 . . . . 0.0 110.076 176.111 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.497 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.5 p30 -121.98 163.48 19.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.69 -0.631 . . . . 0.0 110.593 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . 0.429 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 19.0 m -57.62 -34.15 69.0 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.414 -0.803 . . . . 0.0 111.136 -164.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 51.4 p -104.17 15.06 29.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.374 -0.829 . . . . 0.0 111.911 -163.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . 0.614 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 29.7 p -95.77 118.07 31.73 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.079 -1.013 . . . . 0.0 110.712 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 58.0 t -63.16 138.93 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.477 -0.764 . . . . 0.0 110.253 -171.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.04 -5.18 59.27 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.11 -98.33 0.83 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 171.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . 0.429 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.2 mmm -63.17 -32.35 73.72 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.726 -0.867 . . . . 0.0 110.235 178.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.3 p30 44.21 48.84 7.79 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 174.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 54.76 30.27 13.27 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.377 -0.827 . . . . 0.0 111.306 174.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 15.4 mtt85 -119.45 107.04 41.58 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.59 -0.694 . . . . 0.0 110.08 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.58 148.0 89.29 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 O-C-N 123.127 1.067 . . . . 0.0 110.529 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.582 HG22 ' HA ' ' A' ' 192' ' ' TYR . 44.7 pt -131.9 177.52 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.709 0.766 . . . . 0.0 110.987 -176.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.478 HD23 ' HA ' ' A' ' 302' ' ' GLU . 34.3 mt -124.38 150.02 46.03 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 177.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.649 HD12 ' CE1' ' A' ' 301' ' ' PHE . 77.7 mt -112.65 128.29 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.562 -0.711 . . . . 0.0 109.089 176.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.505 HG23 ' SG ' ' A' ' 300' ' ' CYS . 81.3 mt -109.86 125.57 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -176.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 59.1 t -118.87 126.63 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.5 p -125.31 154.66 41.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.581 -0.699 . . . . 0.0 110.623 -175.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.647 HD21 ' HB3' ' A' ' 180' ' ' PRO . 22.8 tp -105.22 126.41 52.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.819 -0.551 . . . . 0.0 109.539 169.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.58 ' OE2' HG13 ' A' ' 295' ' ' VAL . 73.0 mm-40 -132.47 150.99 52.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.863 -0.523 . . . . 0.0 109.902 -174.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.749 HG22 HD11 ' A' ' 296' ' ' LEU . 68.6 p -89.89 159.47 16.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.619 -0.675 . . . . 0.0 109.648 177.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -55.86 -26.11 45.43 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.532 -0.73 . . . . 0.0 110.81 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -87.52 9.14 21.97 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.489 -0.757 . . . . 0.0 111.855 -174.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 87.22 20.26 53.05 Favored Glycine 0 N--CA 1.495 2.59 0 O-C-N 121.053 -1.03 . . . . 0.0 110.704 170.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -106.81 140.12 40.15 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.262 -1.14 . . . . 0.0 110.206 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.58 HG13 ' OE2' ' A' ' 289' ' ' GLU . 59.4 t -88.33 131.32 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.666 -0.646 . . . . 0.0 110.194 -173.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.749 HD11 HG22 ' A' ' 290' ' ' THR . 95.6 mt -99.91 -40.14 7.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.733 -0.604 . . . . 0.0 110.544 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -165.23 153.12 23.04 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -134.96 136.17 42.03 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.721 -0.87 . . . . 0.0 110.748 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -133.28 153.66 51.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.578 -0.701 . . . . 0.0 110.106 172.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . 0.505 ' SG ' HG23 ' A' ' 285' ' ' ILE . 99.8 m -142.76 151.63 41.46 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.486 -0.759 . . . . 0.0 110.659 -176.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.649 ' CE1' HD12 ' A' ' 284' ' ' ILE . 49.8 p90 -145.43 166.7 24.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.701 -0.625 . . . . 0.0 110.029 173.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.478 ' HA ' HD23 ' A' ' 283' ' ' LEU . 57.7 tt0 -104.78 136.1 44.93 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.449 -0.782 . . . . 0.0 110.277 -177.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -123.3 144.5 49.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.682 -0.636 . . . . 0.0 110.548 -170.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -137.66 137.87 38.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.844 -0.535 . . . . 0.0 109.796 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.722 HD13 ' O ' ' A' ' 269' ' ' CYS . 66.3 mt -106.34 123.0 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.581 -0.699 . . . . 0.0 109.556 175.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.0 p -145.17 167.28 23.15 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.56 -0.713 . . . . 0.0 110.89 -170.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -67.31 -40.1 85.96 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.675 -0.641 . . . . 0.0 110.616 -177.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 3.9 t -132.05 89.58 37.7 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.545 -0.722 . . . . 0.0 110.53 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -55.77 -29.04 69.95 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 O-C-N 123.23 1.121 . . . . 0.0 110.74 174.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.51 -37.94 93.02 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -72.56 -40.04 66.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.622 -0.928 . . . . 0.0 109.837 -173.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -69.51 -38.47 77.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.67 -0.644 . . . . 0.0 110.198 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -61.51 -43.21 99.28 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.228 178.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 14.5 ttpp -65.01 -38.73 91.88 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.586 -0.696 . . . . 0.0 110.419 176.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.22 -49.95 75.07 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.493 -0.755 . . . . 0.0 110.578 -173.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . 0.523 ' OD1' HD11 ' A' ' 159' ' ' LEU . 3.0 p30 . . . . . 0 N--CA 1.495 1.784 0 O-C-N 121.463 -0.773 . . . . 0.0 110.113 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.085 0.469 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -95.28 24.73 4.81 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.632 -0.667 . . . . 0.0 110.779 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 51.6 m -74.6 125.23 28.2 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.554 -0.716 . . . . 0.0 110.286 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -69.78 144.94 52.54 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.763 -0.586 . . . . 0.0 110.482 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -154.18 98.86 2.54 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.617 -0.677 . . . . 0.0 110.156 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -59.27 -39.95 73.1 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 O-C-N 123.261 1.137 . . . . 0.0 110.782 -176.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 73.76 -155.15 49.38 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -73.82 -45.65 0.37 Allowed 'Trans proline' 0 C--N 1.317 -1.096 0 O-C-N 123.38 1.2 . . . . 0.0 111.044 -174.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -86.24 8.07 22.69 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.474 -0.766 . . . . 0.0 111.383 -173.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.69 60.22 3.81 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.987 -1.071 . . . . 0.0 110.655 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.679 ' HA ' HG12 ' A' ' 176' ' ' VAL . 56.5 t80 -77.8 118.77 20.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.584 -0.697 . . . . 0.0 109.851 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.409 ' HA ' ' HG3' ' A' ' 299' ' ' ARG . 22.1 t70 -130.0 160.02 34.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.887 -0.508 . . . . 0.0 110.182 -178.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 80.6 t -125.16 146.92 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.729 -0.607 . . . . 0.0 109.785 176.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.4 p -157.73 171.03 21.04 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.88 176.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.414 ' CE1' HG12 ' A' ' 172' ' ' ILE . 57.7 m-85 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 121.118 0.485 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 69.0 p -60.03 -34.03 72.82 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.769 -0.582 . . . . 0.0 110.093 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.565 ' CE3' HD11 ' A' ' 162' ' ' LEU . 67.6 p-90 -170.75 148.08 2.89 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.834 -0.541 . . . . 0.0 109.964 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.4 t -141.7 142.44 33.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.749 -0.594 . . . . 0.0 109.884 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.403 ' HB2' HD12 ' A' ' 162' ' ' LEU . 62.0 t80 -125.54 140.07 53.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.52 -0.738 . . . . 0.0 110.589 -172.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 30.1 t -109.86 122.81 48.39 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.297 -0.561 . . . . 0.0 109.734 174.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 67.6 m -70.75 -36.98 73.38 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.353 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -59.38 -31.77 69.54 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.615 -0.678 . . . . 0.0 110.453 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.534 HD11 ' OD1' ' A' ' 316' ' ' ASP . 56.3 mt -104.78 -12.04 16.51 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.682 -0.636 . . . . 0.0 110.79 -175.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 32.5 tttt 59.68 48.52 9.27 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.007 -1.058 . . . . 0.0 109.682 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -146.93 153.06 39.65 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.736 -0.602 . . . . 0.0 110.638 -174.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.634 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.43 137.8 53.46 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.759 -0.588 . . . . 0.0 110.164 -175.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -115.85 132.67 56.57 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 175.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.1 p -138.36 158.43 44.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.663 -0.648 . . . . 0.0 111.046 -174.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.4 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 44.6 mt-30 -104.62 140.13 38.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.662 -0.649 . . . . 0.0 110.205 171.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.484 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.5 tt -52.61 149.14 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-O 121.619 0.723 . . . . 0.0 111.799 -174.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 66.06 8.35 5.41 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.489 -0.757 . . . . 0.0 112.483 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.4 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 63.4 mmtt -96.6 155.09 16.92 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.904 -1.123 . . . . 0.0 110.949 174.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 87.8 m -84.24 126.41 33.13 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.668 -0.645 . . . . 0.0 110.635 -177.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' CYS . . . . . 0.634 ' SG ' HD21 ' A' ' 162' ' ' LEU . 43.1 t -112.94 90.25 15.26 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.569 -0.707 . . . . 0.0 109.995 174.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -65.32 131.67 29.01 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.199 1.105 . . . . 0.0 110.484 176.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.414 HG12 ' CE1' ' A' ' 142' ' ' PHE . 92.5 mt -125.84 142.29 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.6 -0.688 . . . . 0.0 109.541 175.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -110.83 135.59 51.16 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.601 -0.687 . . . . 0.0 110.697 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.7 mm -95.33 134.91 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.556 -0.715 . . . . 0.0 109.579 169.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -116.21 128.47 55.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.602 -0.686 . . . . 0.0 110.445 176.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.679 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.5 m -136.29 159.77 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.548 -0.72 . . . . 0.0 109.886 174.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 81.9 mmm -75.45 -40.4 57.57 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.703 -0.623 . . . . 0.0 110.068 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 75.5 p -134.75 143.18 45.32 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.769 -0.582 . . . . 0.0 109.768 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 35.7 Cg_exo -54.95 139.79 79.34 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 O-C-N 123.138 1.073 . . . . 0.0 110.883 -172.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.579 ' HB3' HD21 ' A' ' 288' ' ' LEU . 20.5 Cg_endo -63.26 167.63 12.42 Favored 'Trans proline' 0 N--CA 1.487 1.099 0 O-C-N 123.191 1.1 . . . . 0.0 110.59 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -61.38 155.04 54.55 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.353 1.186 . . . . 0.0 110.321 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -72.99 139.0 46.38 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.591 -0.693 . . . . 0.0 109.853 175.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.71 -25.01 29.15 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -175.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.1 148.71 3.21 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.377 -1.072 . . . . 0.0 111.303 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.8 155.96 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.692 -0.63 . . . . 0.0 109.743 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.588 HD11 ' CD2' ' A' ' 251' ' ' TYR . 85.6 mt -106.57 137.91 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.698 -0.626 . . . . 0.0 109.457 176.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.729 ' HG2' HD22 ' A' ' 248' ' ' LEU . 70.8 mtp180 -114.85 141.96 47.2 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -176.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.618 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -137.39 125.83 23.45 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.471 -0.768 . . . . 0.0 110.353 175.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 39.4 ttm -137.27 139.11 26.95 Favored Pre-proline 0 N--CA 1.497 1.901 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.977 -176.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.508 ' HD3' HD12 ' A' ' 226' ' ' ILE . 72.8 Cg_endo -90.39 138.21 2.66 Favored 'Trans proline' 0 C--N 1.319 -0.982 0 C-N-CA 120.936 1.091 . . . . 0.0 110.858 177.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.494 HG12 ' CZ ' ' A' ' 244' ' ' ARG . 34.9 m -147.26 154.86 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.493 -0.755 . . . . 0.0 110.009 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.667 ' HA ' HG22 ' A' ' 282' ' ' ILE . 80.4 m-85 -61.49 165.0 5.17 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.431 -0.793 . . . . 0.0 110.448 -177.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -84.69 -60.06 2.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.605 -0.685 . . . . 0.0 110.841 -173.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 42.7 mttt -80.01 152.52 29.4 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.667 -0.646 . . . . 0.0 110.311 -174.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.454 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.68 -39.18 73.34 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.387 -0.821 . . . . 0.0 110.66 -174.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -56.62 -24.79 50.46 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.438 -0.789 . . . . 0.0 110.67 -177.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.419 ' CE1' ' NH1' ' A' ' 280' ' ' ARG . 99.3 m-70 -109.23 -20.46 12.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.604 -0.685 . . . . 0.0 111.197 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.454 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -68.36 -20.28 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.144 -0.973 . . . . 0.0 110.639 -175.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 68.3 p -79.45 -17.15 54.85 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.551 -0.718 . . . . 0.0 110.858 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -88.36 137.7 32.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.302 -0.874 . . . . 0.0 110.186 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 57.7 t -72.95 146.49 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.587 -0.696 . . . . 0.0 110.146 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 60.0 t -84.82 140.06 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.575 -0.703 . . . . 0.0 109.203 172.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -134.83 -170.23 2.52 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.395 -0.815 . . . . 0.0 111.131 -167.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -95.21 154.14 17.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.771 -0.581 . . . . 0.0 110.461 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.863 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 63.3 m . . . . . 0 N--CA 1.496 1.847 0 O-C-N 121.649 -0.657 . . . . 0.0 109.274 173.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.492 HD12 ' HE3' ' A' ' 268' ' ' MET . 56.4 tp . . . . . 0 N--CA 1.498 1.972 0 CA-C-O 120.773 0.321 . . . . 0.0 110.576 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.508 HD12 ' HD3' ' A' ' 190' ' ' PRO . 84.7 mt -106.06 136.82 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 120.309 -0.557 . . . . 0.0 109.867 -177.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -132.84 158.23 43.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.785 -0.572 . . . . 0.0 110.171 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.493 HG23 HG21 ' A' ' 247' ' ' VAL . 94.0 t -105.22 146.68 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.693 -0.629 . . . . 0.0 110.122 177.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -119.45 127.97 53.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.768 -0.582 . . . . 0.0 110.352 170.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.17 21.1 21.34 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 168.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -140.2 105.54 5.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.381 -1.07 . . . . 0.0 110.048 174.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 95.2 p -63.58 -15.13 57.24 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.625 -0.672 . . . . 0.0 111.217 -178.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -96.74 9.93 40.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -0.834 . . . . 0.0 111.219 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -62.2 127.83 33.21 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.246 -0.908 . . . . 0.0 110.056 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -139.84 157.35 45.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.719 -0.613 . . . . 0.0 109.734 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.422 ' CD1' ' HB ' ' A' ' 247' ' ' VAL . 83.6 m-85 -117.98 150.61 38.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.599 -0.688 . . . . 0.0 110.627 -176.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.16 159.96 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.837 -0.54 . . . . 0.0 110.213 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -116.49 130.07 56.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.765 -0.584 . . . . 0.0 110.111 175.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -63.12 130.07 93.9 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.634 -0.667 . . . . 0.0 109.867 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -65.73 -29.31 51.23 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 123.197 1.104 . . . . 0.0 110.952 -171.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 82.5 mt -103.9 -50.45 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.484 -0.76 . . . . 0.0 111.071 -168.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 7.3 p -105.29 12.08 32.18 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.376 -0.827 . . . . 0.0 111.927 -173.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 73.66 -6.97 15.13 Favored Glycine 0 N--CA 1.497 2.701 0 O-C-N 121.077 -1.014 . . . . 0.0 112.125 171.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.494 ' CZ ' HG12 ' A' ' 191' ' ' VAL . 26.8 mmt180 -45.89 142.09 2.76 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-N 119.095 1.448 . . . . 0.0 112.312 -176.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -105.91 143.89 33.4 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.671 -0.643 . . . . 0.0 110.09 174.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 78.9 p -154.73 159.93 41.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.554 -0.716 . . . . 0.0 110.571 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.493 HG21 HG23 ' A' ' 228' ' ' VAL . 8.3 p -122.97 148.18 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.732 -0.605 . . . . 0.0 109.636 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.729 HD22 ' HG2' ' A' ' 187' ' ' ARG . 75.2 mt -129.68 154.6 46.98 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.71 -174.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.434 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.9 m -150.63 151.75 31.19 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.811 -0.555 . . . . 0.0 109.96 174.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -71.21 137.42 31.25 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.264 1.139 . . . . 0.0 109.913 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.588 ' CD2' HD11 ' A' ' 186' ' ' ILE . 8.9 t80 -76.95 125.5 29.41 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.509 -0.744 . . . . 0.0 109.984 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -99.98 160.12 28.05 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.658 -0.651 . . . . 0.0 110.145 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -58.81 159.64 20.37 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 O-C-N 123.284 1.15 . . . . 0.0 110.343 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.38 149.94 78.15 Favored 'Trans proline' 0 C--N 1.316 -1.132 0 O-C-N 123.177 1.093 . . . . 0.0 110.538 -176.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -61.14 149.75 36.34 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.695 -0.628 . . . . 0.0 110.146 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.0 t -69.83 127.09 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.552 -0.718 . . . . 0.0 110.198 -170.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.11 -10.06 56.68 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.409 HG21 ' CE1' ' A' ' 260' ' ' PHE . 9.6 t -145.39 175.39 10.35 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.182 -1.187 . . . . 0.0 110.604 175.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -110.52 13.23 22.71 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.531 -0.73 . . . . 0.0 111.93 -166.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.409 ' CE1' HG21 ' A' ' 258' ' ' THR . 49.4 p90 -120.04 168.01 11.61 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.074 -1.016 . . . . 0.0 111.16 -177.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 78.1 m -117.74 146.09 44.01 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.81 -0.556 . . . . 0.0 109.914 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 32.2 m -116.88 135.57 53.62 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.594 -0.691 . . . . 0.0 110.981 -175.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 65.1 t -131.42 137.27 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 74.0 mt -104.68 122.02 44.78 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.538 -0.726 . . . . 0.0 109.944 -171.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.618 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 6.1 m-30 -106.35 149.32 27.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.709 -0.62 . . . . 0.0 110.591 -177.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -136.63 142.99 43.28 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -113.57 130.7 56.32 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.47 -0.769 . . . . 0.0 110.395 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' MET . . . . . 0.492 ' HE3' HD12 ' A' ' 225' ' ' LEU . 0.0 OUTLIER -99.87 -0.62 39.27 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.782 -0.574 . . . . 0.0 111.844 -178.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . 0.548 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 7.0 t -144.78 158.05 43.94 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.147 -0.971 . . . . 0.0 109.009 176.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.558 ' HA ' HD13 ' A' ' 305' ' ' ILE . 26.1 p30 -119.0 152.32 36.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.678 -0.639 . . . . 0.0 110.262 -175.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . 0.422 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 90.0 p -57.64 -25.39 60.09 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.481 -0.762 . . . . 0.0 111.148 -170.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 49.3 p -89.24 2.1 54.76 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.328 -0.858 . . . . 0.0 112.094 -167.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . 0.863 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 28.6 p -85.23 118.0 24.51 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.014 -1.053 . . . . 0.0 110.618 -178.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.63 140.17 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.457 -0.777 . . . . 0.0 110.445 -171.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 101.04 -5.18 56.07 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 177.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.11 -98.55 0.84 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 171.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . 0.424 ' HE1' HD13 ' A' ' 282' ' ' ILE . 91.7 mmm -63.6 -30.96 72.0 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.73 -0.865 . . . . 0.0 110.332 178.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.1 p30 44.91 53.18 7.72 Favored 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 121.427 0.632 . . . . 0.0 112.338 173.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 17.1 mtt-85 54.89 34.97 23.31 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.336 -0.852 . . . . 0.0 111.328 175.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' ARG . . . . . 0.419 ' NH1' ' CE1' ' A' ' 197' ' ' HIS . 31.7 mtt-85 -112.43 104.94 56.22 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.575 -0.703 . . . . 0.0 110.085 169.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -60.13 148.95 87.54 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 O-C-N 123.12 1.063 . . . . 0.0 110.558 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.667 HG22 ' HA ' ' A' ' 192' ' ' TYR . 28.7 pt -131.97 179.16 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.811 0.815 . . . . 0.0 111.014 -177.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 302' ' ' GLU . 32.2 mt -124.37 149.96 46.07 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.706 HD12 ' CE1' ' A' ' 301' ' ' PHE . 80.6 mt -114.01 129.29 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.183 177.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.613 HG23 ' SG ' ' A' ' 300' ' ' CYS . 80.7 mt -109.73 125.92 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -175.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 60.0 t -118.89 126.72 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 44.8 p -125.3 153.09 43.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.652 -0.655 . . . . 0.0 110.642 -175.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.579 HD21 ' HB3' ' A' ' 180' ' ' PRO . 23.8 tp -102.85 126.03 49.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.799 -0.563 . . . . 0.0 109.509 170.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.674 ' OE2' HG13 ' A' ' 295' ' ' VAL . 73.5 mm-40 -132.78 150.59 52.14 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.79 -0.569 . . . . 0.0 109.967 -172.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.732 ' CG2' HD11 ' A' ' 296' ' ' LEU . 72.6 p -90.01 159.19 17.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.593 -0.692 . . . . 0.0 109.96 177.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -56.05 -26.12 47.85 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.533 -0.729 . . . . 0.0 110.935 -177.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -92.32 11.65 25.2 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.45 -0.781 . . . . 0.0 111.729 -173.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 90.05 20.12 44.02 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.11 -1.043 . . . . 0.0 110.932 167.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -105.49 140.14 39.04 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.28 -1.129 . . . . 0.0 110.154 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.675 HG11 ' NE ' ' A' ' 298' ' ' ARG . 59.4 t -90.66 130.9 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.63 -0.669 . . . . 0.0 110.159 -174.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.732 HD11 ' CG2' ' A' ' 290' ' ' THR . 95.8 mt -99.92 -40.21 7.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.768 -0.582 . . . . 0.0 110.781 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -161.64 154.71 25.76 Favored Glycine 0 N--CA 1.497 2.719 0 C-N-CA 119.987 -1.101 . . . . 0.0 110.359 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.675 ' NE ' HG11 ' A' ' 295' ' ' VAL . 41.1 mtt180 -135.15 135.92 41.48 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.642 -0.916 . . . . 0.0 110.383 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . 0.409 ' HG3' ' HA ' ' A' ' 139' ' ' ASP . 27.5 mmt180 -141.54 158.65 43.58 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.491 -0.755 . . . . 0.0 110.095 169.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . 0.613 ' SG ' HG23 ' A' ' 285' ' ' ILE . 94.8 m -143.59 157.91 44.06 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.407 -0.808 . . . . 0.0 110.701 -174.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.706 ' CE1' HD12 ' A' ' 284' ' ' ILE . 49.6 p90 -145.59 161.03 40.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.658 -0.651 . . . . 0.0 110.073 175.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.467 ' HA ' HD23 ' A' ' 283' ' ' LEU . 81.7 tt0 -104.9 136.71 43.88 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.548 -0.72 . . . . 0.0 110.178 -177.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -119.01 143.5 47.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.645 -0.659 . . . . 0.0 110.833 -169.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -138.5 138.25 37.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.772 -0.58 . . . . 0.0 109.601 172.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.558 HD13 ' HA ' ' A' ' 270' ' ' ASN . 65.7 mt -111.21 122.84 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.52 -0.738 . . . . 0.0 109.719 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.0 p -145.34 173.38 12.03 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.707 -0.621 . . . . 0.0 110.654 -172.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -74.13 -40.11 62.86 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.655 -0.653 . . . . 0.0 110.696 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.9 t -127.35 86.75 57.92 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.581 -0.699 . . . . 0.0 110.547 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -55.66 -28.62 66.81 Favored 'Trans proline' 0 N--CA 1.488 1.2 0 O-C-N 123.156 1.082 . . . . 0.0 110.813 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.97 -37.76 92.35 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -72.83 -40.48 65.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.692 -0.887 . . . . 0.0 109.881 -173.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -69.61 -38.25 77.18 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.283 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -62.08 -42.75 99.53 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.196 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -64.88 -37.43 87.62 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.5 -0.75 . . . . 0.0 110.342 175.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.63 -49.42 76.63 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.548 -0.72 . . . . 0.0 110.608 -173.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . 0.534 ' OD1' HD11 ' A' ' 159' ' ' LEU . 2.8 p30 . . . . . 0 N--CA 1.495 1.778 0 O-C-N 121.448 -0.782 . . . . 0.0 110.098 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 27.8 t . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.037 0.446 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.6 p-10 -99.93 24.85 7.96 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.718 -0.614 . . . . 0.0 110.731 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 53.1 m -78.14 125.19 29.0 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.53 -0.731 . . . . 0.0 110.25 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -71.04 144.95 50.22 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.739 -0.6 . . . . 0.0 110.403 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -158.57 101.83 1.66 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.675 -0.641 . . . . 0.0 110.07 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -59.21 -40.0 73.3 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.151 1.08 . . . . 0.0 110.729 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.08 -155.19 40.13 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -74.67 -43.29 0.47 Allowed 'Trans proline' 0 C--N 1.317 -1.116 0 O-C-N 123.315 1.166 . . . . 0.0 110.846 -175.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -88.65 4.41 47.24 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.577 -0.702 . . . . 0.0 111.437 -174.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 t 54.05 61.79 2.89 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.995 -1.066 . . . . 0.0 110.669 -176.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.732 ' HA ' HG12 ' A' ' 176' ' ' VAL . 59.5 t80 -78.0 120.77 23.31 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.606 -0.683 . . . . 0.0 110.111 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -130.01 160.01 34.96 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.8 -0.563 . . . . 0.0 110.129 -177.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 74.6 t -123.13 146.75 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.423 0.63 . . . . 0.0 110.046 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.0 p -157.3 171.08 21.04 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.126 0.489 . . . . 0.0 109.688 175.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.431 ' CE2' HG12 ' A' ' 172' ' ' ILE . 52.7 m-85 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.827 -0.545 . . . . 0.0 109.656 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 121.177 0.513 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.425 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 76.6 p -60.08 -34.04 72.9 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.71 -0.619 . . . . 0.0 109.928 177.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.518 ' HE3' HD11 ' A' ' 162' ' ' LEU . 67.2 p-90 -170.59 147.88 2.96 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.878 -0.514 . . . . 0.0 109.788 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 14.0 t -142.08 142.43 32.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.768 -0.583 . . . . 0.0 109.963 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -125.63 140.08 53.02 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.494 -0.754 . . . . 0.0 110.45 -172.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 30.7 t -109.72 122.5 47.62 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 120.324 -0.551 . . . . 0.0 109.748 175.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 63.6 m -70.77 -37.0 73.34 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.71 -0.619 . . . . 0.0 110.443 -177.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -60.46 -32.25 71.22 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.605 -0.684 . . . . 0.0 110.357 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 60.3 mt -104.79 -12.06 16.5 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.726 -0.609 . . . . 0.0 110.852 -176.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.5 tttm 59.84 50.75 6.63 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.081 -1.012 . . . . 0.0 109.702 177.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -146.34 153.0 40.03 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.598 -176.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.663 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.5 tp -126.63 137.87 53.36 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.791 -0.568 . . . . 0.0 110.24 -175.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -115.47 134.05 55.45 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.9 p -138.28 158.39 44.39 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.637 -0.664 . . . . 0.0 111.005 -175.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -104.55 143.04 33.59 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.499 0.666 . . . . 0.0 110.347 172.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.43 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.3 tt -52.53 147.68 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-O 121.583 0.706 . . . . 0.0 111.842 -173.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.36 9.98 5.33 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.638 -0.664 . . . . 0.0 112.461 177.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -96.82 155.1 16.92 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.975 -1.078 . . . . 0.0 110.811 175.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 87.3 m -82.78 126.17 32.11 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.709 -0.619 . . . . 0.0 110.607 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' CYS . . . . . 0.663 ' SG ' HD21 ' A' ' 162' ' ' LEU . 42.6 t -112.93 90.29 15.29 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.647 -0.658 . . . . 0.0 110.082 172.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.437 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 15.8 Cg_exo -65.1 128.65 21.07 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 O-C-N 123.264 1.139 . . . . 0.0 110.394 176.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.431 HG12 ' CE2' ' A' ' 142' ' ' PHE . 94.7 mt -122.38 139.42 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.621 -0.674 . . . . 0.0 109.393 177.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -108.69 137.0 47.33 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.645 -0.659 . . . . 0.0 110.488 -177.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.432 ' CG2' ' CE1' ' A' ' 138' ' ' PHE . 48.5 mm -95.23 132.77 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.66 -0.65 . . . . 0.0 109.562 171.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -115.93 128.95 56.17 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.699 -0.626 . . . . 0.0 110.352 176.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.732 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.0 m -136.74 159.71 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.575 -0.703 . . . . 0.0 110.012 176.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.5 mmm -75.45 -40.19 57.8 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.723 -0.611 . . . . 0.0 110.056 177.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 76.4 p -136.82 143.23 41.8 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.788 -0.57 . . . . 0.0 109.729 178.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 33.5 Cg_exo -55.4 139.91 82.06 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 O-C-N 123.21 1.11 . . . . 0.0 110.898 -171.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.765 ' HB3' HD21 ' A' ' 288' ' ' LEU . 33.4 Cg_endo -68.05 170.08 15.15 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 O-C-N 123.119 1.063 . . . . 0.0 110.558 178.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -60.5 155.04 49.66 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 O-C-N 123.289 1.152 . . . . 0.0 110.516 -178.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -77.55 140.2 39.68 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.598 -0.689 . . . . 0.0 109.931 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.67 -24.93 29.48 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -174.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.19 153.33 1.48 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.307 -1.114 . . . . 0.0 111.387 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.84 155.93 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.665 -0.647 . . . . 0.0 109.841 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.732 HD11 ' HD2' ' A' ' 251' ' ' TYR . 87.4 mt -109.25 137.92 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.662 -0.649 . . . . 0.0 109.652 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.726 ' HG2' HD22 ' A' ' 248' ' ' LEU . 40.4 mtm180 -114.97 146.95 40.67 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -176.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.656 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -140.59 127.72 20.91 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.503 -0.748 . . . . 0.0 110.343 173.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.411 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 21.1 ttm -137.31 139.71 28.61 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.811 -0.555 . . . . 0.0 110.978 -177.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.553 ' HD3' HD12 ' A' ' 226' ' ' ILE . 72.7 Cg_endo -91.98 138.17 1.93 Allowed 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 121.061 1.174 . . . . 0.0 110.778 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.478 HG12 ' CZ ' ' A' ' 244' ' ' ARG . 34.7 m -147.06 154.86 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.445 -0.784 . . . . 0.0 110.178 173.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.638 ' HA ' HG22 ' A' ' 282' ' ' ILE . 83.7 m-85 -60.7 164.56 4.56 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.425 -0.797 . . . . 0.0 110.441 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.413 ' HA ' HD12 ' A' ' 283' ' ' LEU . 75.2 tttt -80.74 -60.03 2.46 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.601 -0.687 . . . . 0.0 110.827 -174.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -80.12 151.25 29.91 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.587 -0.696 . . . . 0.0 110.385 -175.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.454 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.57 -37.94 71.27 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.392 -0.817 . . . . 0.0 110.684 -176.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -56.84 -24.91 54.67 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.488 -0.757 . . . . 0.0 110.542 -176.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.402 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 63.3 m170 -109.27 -20.58 12.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.52 -0.738 . . . . 0.0 111.125 -178.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.454 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.1 p -68.0 -20.25 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.199 -0.938 . . . . 0.0 110.623 -176.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 72.3 p -79.43 -17.04 55.11 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.62 174.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -88.35 135.66 33.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.417 -0.802 . . . . 0.0 110.067 174.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.8 t -73.05 141.21 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.73 -0.606 . . . . 0.0 110.223 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.545 HG22 ' CE2' ' A' ' 192' ' ' TYR . 64.3 t -84.98 138.28 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.632 -0.667 . . . . 0.0 109.233 170.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -134.82 -170.25 2.52 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.536 -0.727 . . . . 0.0 111.229 -167.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 73.0 mtm-85 -95.25 154.68 17.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.853 -0.529 . . . . 0.0 110.389 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.565 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 57.0 m . . . . . 0 N--CA 1.496 1.827 0 O-C-N 121.62 -0.675 . . . . 0.0 109.247 174.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.677 HD12 ' HG3' ' A' ' 268' ' ' MET . 37.6 tp . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 120.884 0.373 . . . . 0.0 110.388 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.553 HD12 ' HD3' ' A' ' 190' ' ' PRO . 83.3 mt -102.44 136.88 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.814 -0.554 . . . . 0.0 109.883 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 50.0 mtt-85 -130.92 159.44 37.44 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.689 -0.632 . . . . 0.0 110.326 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.595 HG23 HG21 ' A' ' 247' ' ' VAL . 81.3 t -103.96 146.65 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.728 -0.607 . . . . 0.0 110.0 176.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -118.25 128.12 54.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.696 -0.627 . . . . 0.0 110.349 170.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 96.67 21.39 21.69 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 168.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -139.38 106.24 5.41 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.348 -1.089 . . . . 0.0 109.95 174.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 90.9 p -63.66 -15.09 57.4 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.64 -0.663 . . . . 0.0 111.201 -177.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -97.12 9.93 40.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.341 -0.849 . . . . 0.0 111.236 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.75 128.78 37.87 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.111 -0.993 . . . . 0.0 110.114 175.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -139.76 155.75 47.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.76 -0.587 . . . . 0.0 109.607 177.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.424 ' CD1' ' HB ' ' A' ' 247' ' ' VAL . 80.9 m-85 -119.12 150.74 39.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.568 -0.708 . . . . 0.0 110.61 -175.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.16 159.97 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.778 -0.576 . . . . 0.0 110.242 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -117.76 130.01 56.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.766 -0.584 . . . . 0.0 110.181 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -62.52 130.19 93.24 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.623 -0.673 . . . . 0.0 109.789 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -64.82 -28.04 59.3 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 O-C-N 123.135 1.071 . . . . 0.0 111.003 -170.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.0 mt -102.0 -50.43 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.344 -0.848 . . . . 0.0 111.014 -168.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 17.9 p -105.43 12.14 31.84 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.31 -0.869 . . . . 0.0 111.913 -174.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 72.17 -4.92 16.01 Favored Glycine 0 N--CA 1.497 2.723 0 O-C-N 121.074 -1.016 . . . . 0.0 112.022 172.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.478 ' CZ ' HG12 ' A' ' 191' ' ' VAL . 21.6 mmt180 -45.86 142.01 2.77 Favored 'General case' 0 N--CA 1.505 2.309 0 CA-C-N 119.119 1.46 . . . . 0.0 112.388 -175.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -103.54 143.36 32.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.618 -0.676 . . . . 0.0 110.119 175.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.2 p -154.81 159.94 40.92 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.595 -0.69 . . . . 0.0 110.348 176.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.595 HG21 HG23 ' A' ' 228' ' ' VAL . 8.6 p -123.17 148.23 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.836 -0.54 . . . . 0.0 109.814 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.726 HD22 ' HG2' ' A' ' 187' ' ' ARG . 81.8 mt -129.62 154.61 46.93 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.079 -0.649 . . . . 0.0 109.638 -177.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.443 HG13 ' C ' ' A' ' 248' ' ' LEU . 34.4 m -151.1 151.67 29.95 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.813 -0.554 . . . . 0.0 110.001 175.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -71.05 139.0 34.88 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 O-C-N 123.368 1.194 . . . . 0.0 110.08 177.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.732 ' HD2' HD11 ' A' ' 186' ' ' ILE . 58.9 t80 -75.9 124.47 27.39 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.099 175.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -99.99 160.11 28.07 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.694 -0.628 . . . . 0.0 109.953 176.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -58.37 158.49 22.59 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 O-C-N 123.294 1.155 . . . . 0.0 110.517 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -59.09 149.98 76.35 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 O-C-N 123.219 1.115 . . . . 0.0 110.511 -177.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -60.73 148.27 39.42 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.65 -0.656 . . . . 0.0 110.295 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.84 127.19 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.538 -0.726 . . . . 0.0 110.168 -171.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.96 -10.14 55.41 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 10.0 t -144.65 173.43 11.83 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.175 -1.191 . . . . 0.0 110.63 175.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -107.28 13.09 27.51 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.617 -0.677 . . . . 0.0 111.78 -168.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -119.92 168.01 11.56 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.181 -0.95 . . . . 0.0 111.168 -175.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 92.6 m -117.73 146.76 43.54 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.744 -0.597 . . . . 0.0 109.986 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 46.4 m -118.24 135.67 54.13 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.604 -0.685 . . . . 0.0 110.952 -174.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 60.2 t -132.56 137.23 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 172.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 75.1 mt -104.78 123.8 48.3 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.437 -0.789 . . . . 0.0 110.054 -171.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.656 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 6.1 m-30 -106.85 151.51 25.12 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.644 -0.66 . . . . 0.0 110.683 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -136.49 142.92 43.55 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -113.47 133.11 55.39 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.538 -0.726 . . . . 0.0 110.55 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' MET . . . . . 0.677 ' HG3' HD12 ' A' ' 225' ' ' LEU . 2.3 ppp? -97.68 2.66 49.97 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.709 -0.62 . . . . 0.0 112.164 -175.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . 0.683 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.7 OUTLIER -144.73 165.07 29.1 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.131 -0.981 . . . . 0.0 110.195 176.063 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.556 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.5 p30 -120.68 162.8 19.07 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.43 0.633 . . . . 0.0 110.407 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . 0.43 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 25.2 m -58.8 -33.53 70.45 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.407 -0.808 . . . . 0.0 110.927 -163.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 49.9 p -100.75 12.17 38.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.466 -0.771 . . . . 0.0 112.018 -163.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . 0.565 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 30.4 p -94.54 118.1 31.15 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.03 -1.043 . . . . 0.0 110.742 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.2 t -63.2 139.78 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.431 -0.793 . . . . 0.0 110.393 -171.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.83 -5.28 58.08 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.08 -99.78 0.88 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 171.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . 0.43 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.7 mmm -62.71 -31.53 72.46 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.773 -0.84 . . . . 0.0 110.308 178.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.3 p30 44.47 49.32 8.3 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 174.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 21.3 mtt180 54.79 31.71 16.1 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.331 -0.855 . . . . 0.0 111.179 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' ARG . . . . . 0.417 ' O ' HG23 ' A' ' 282' ' ' ILE . 75.5 mtt180 -119.31 104.96 45.04 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.508 -0.745 . . . . 0.0 110.07 174.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -59.98 145.26 98.79 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 O-C-N 123.162 1.085 . . . . 0.0 110.466 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.638 HG22 ' HA ' ' A' ' 192' ' ' TYR . 46.5 pt -131.98 176.38 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.874 0.845 . . . . 0.0 111.186 -174.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 302' ' ' GLU . 29.4 mt -124.37 149.86 46.18 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.704 HD12 ' CE1' ' A' ' 301' ' ' PHE . 79.0 mt -115.66 130.11 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.595 -0.69 . . . . 0.0 109.174 178.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.592 HG23 ' SG ' ' A' ' 300' ' ' CYS . 79.0 mt -109.86 126.06 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -176.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 57.8 t -118.86 126.93 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.426 HG22 ' HG2' ' A' ' 298' ' ' ARG . 45.2 p -125.27 152.91 44.01 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.592 -0.692 . . . . 0.0 110.614 -173.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.765 HD21 ' HB3' ' A' ' 180' ' ' PRO . 23.2 tp -103.54 126.68 50.83 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.754 -0.591 . . . . 0.0 109.434 168.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.54 ' OE2' HG13 ' A' ' 295' ' ' VAL . 72.6 mm-40 -130.52 152.03 50.34 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.892 -0.505 . . . . 0.0 109.876 -173.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.818 HG22 HD11 ' A' ' 296' ' ' LEU . 68.6 p -89.83 159.91 16.76 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.699 -0.625 . . . . 0.0 109.735 176.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -55.97 -26.1 46.76 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.515 -0.741 . . . . 0.0 110.772 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -86.96 9.18 20.27 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.521 -0.737 . . . . 0.0 111.845 -174.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 86.6 20.16 54.84 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 120.183 -1.008 . . . . 0.0 110.766 170.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -107.55 140.24 40.84 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.282 -1.128 . . . . 0.0 110.196 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.54 HG13 ' OE2' ' A' ' 289' ' ' GLU . 61.5 t -86.21 132.9 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.656 -0.653 . . . . 0.0 110.091 -174.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.818 HD11 HG22 ' A' ' 290' ' ' THR . 80.3 mt -99.89 -40.1 7.85 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.722 -0.611 . . . . 0.0 110.424 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -165.27 153.28 23.3 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.426 ' HG2' HG22 ' A' ' 287' ' ' THR . 79.3 mtm180 -133.49 136.46 45.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.686 -0.891 . . . . 0.0 110.751 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -135.59 158.29 44.74 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.634 -0.666 . . . . 0.0 109.862 172.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . 0.592 ' SG ' HG23 ' A' ' 285' ' ' ILE . 95.0 m -143.0 155.1 44.59 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.34 -0.85 . . . . 0.0 110.772 -175.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.704 ' CE1' HD12 ' A' ' 284' ' ' ILE . 49.4 p90 -144.97 162.76 36.11 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.734 -0.604 . . . . 0.0 110.052 175.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.436 ' HA ' HD23 ' A' ' 283' ' ' LEU . 82.0 tt0 -104.75 135.06 46.83 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.544 -0.723 . . . . 0.0 110.217 -177.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -122.84 143.18 50.03 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.701 -169.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -138.3 139.2 39.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.74 -0.6 . . . . 0.0 109.704 173.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.683 HD13 ' O ' ' A' ' 269' ' ' CYS . 70.5 mt -108.02 122.8 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.537 -0.727 . . . . 0.0 109.605 176.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.9 p -145.27 169.34 18.43 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.629 -0.67 . . . . 0.0 110.676 -171.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -71.32 -40.1 70.98 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.631 -0.668 . . . . 0.0 110.64 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.9 t -127.5 86.05 59.42 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.468 -0.77 . . . . 0.0 110.47 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -55.87 -28.36 67.41 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 O-C-N 123.122 1.064 . . . . 0.0 110.812 174.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -67.59 -36.73 88.62 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -73.35 -39.83 64.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.72 -0.871 . . . . 0.0 109.822 -173.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -69.56 -40.94 76.51 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.137 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -61.88 -43.46 98.81 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.477 -0.765 . . . . 0.0 110.24 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -64.79 -39.06 92.97 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.532 -0.73 . . . . 0.0 110.478 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.2 -50.5 72.88 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.439 -0.788 . . . . 0.0 110.427 -173.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.1 p30 . . . . . 0 N--CA 1.496 1.839 0 O-C-N 121.455 -0.778 . . . . 0.0 110.1 -178.996 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.973 0.416 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -92.8 21.2 5.78 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.675 -0.641 . . . . 0.0 111.004 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 54.9 m -72.07 125.11 26.44 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.371 -0.831 . . . . 0.0 110.223 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -69.99 144.89 52.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.679 -0.638 . . . . 0.0 110.558 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -153.64 102.41 2.53 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.744 -0.597 . . . . 0.0 110.182 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -58.53 -39.95 78.56 Favored 'Trans proline' 0 N--CA 1.487 1.142 0 O-C-N 123.096 1.051 . . . . 0.0 110.922 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.43 -155.13 45.04 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -74.69 -46.12 0.27 Allowed 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.366 1.193 . . . . 0.0 111.007 -173.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -89.66 12.12 17.78 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.557 -0.715 . . . . 0.0 111.285 -172.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.5 60.93 3.38 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.017 -1.052 . . . . 0.0 110.709 -176.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.666 ' HA ' HG12 ' A' ' 176' ' ' VAL . 43.8 t80 -77.82 118.32 20.05 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.643 -0.661 . . . . 0.0 109.73 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.403 ' HA ' ' HG3' ' A' ' 299' ' ' ARG . 22.6 t70 -129.98 159.94 35.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.784 -0.573 . . . . 0.0 110.196 -177.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 64.3 t -125.76 146.75 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.802 -0.561 . . . . 0.0 109.716 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.2 p -155.27 162.43 40.89 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.276 0.56 . . . . 0.0 110.108 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.501 ' CD2' ' CE2' ' A' ' 155' ' ' TYR . 72.7 m-85 . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.837 -0.54 . . . . 0.0 109.708 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 121.139 0.495 . . . . 0.0 110.036 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.405 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 75.5 p -60.11 -34.05 72.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.768 -0.583 . . . . 0.0 109.96 176.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.431 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -171.65 143.66 1.75 Allowed 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.497 0.665 . . . . 0.0 110.489 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 9.9 t -142.16 142.53 32.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.817 -0.552 . . . . 0.0 110.042 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.501 ' CE2' ' CD2' ' A' ' 142' ' ' PHE . 43.8 t80 -125.47 140.09 53.07 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.534 -0.729 . . . . 0.0 110.529 -173.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 30.6 t -111.47 125.66 54.13 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 120.431 -0.507 . . . . 0.0 109.871 176.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 59.4 m -70.78 -37.08 73.3 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.866 -0.521 . . . . 0.0 110.469 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -59.51 -32.99 70.8 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.601 -0.687 . . . . 0.0 110.36 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.543 HD11 ' OD1' ' A' ' 316' ' ' ASP . 55.9 mt -104.74 -12.15 16.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.771 -0.58 . . . . 0.0 110.806 -175.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.1 ttpt 59.81 47.23 10.46 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.025 -1.047 . . . . 0.0 109.693 176.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -148.31 153.26 38.41 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.786 -172.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.504 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.5 137.87 53.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.799 -0.563 . . . . 0.0 110.246 -173.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -114.83 132.84 56.36 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 174.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.32 158.38 44.39 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 120.109 -0.636 . . . . 0.0 111.024 -175.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.412 ' HG3' ' HD3' ' A' ' 309' ' ' PRO . 37.2 mt-30 -104.55 143.6 32.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.553 -0.717 . . . . 0.0 110.481 173.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.43 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.7 tt -53.69 146.58 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 CA-C-O 121.586 0.708 . . . . 0.0 111.687 -173.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.27 10.0 5.26 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.601 -0.687 . . . . 0.0 112.448 176.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.404 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 20.0 mmtp -95.19 154.99 16.92 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.964 -1.085 . . . . 0.0 110.666 175.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 87.4 m -83.1 126.17 32.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.728 -0.607 . . . . 0.0 110.523 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' CYS . . . . . 0.504 ' SG ' HD21 ' A' ' 162' ' ' LEU . 49.5 t -114.33 90.08 19.58 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.635 -0.666 . . . . 0.0 110.041 172.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.431 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 21.7 Cg_exo -62.2 129.48 27.19 Favored 'Trans proline' 0 C--N 1.316 -1.158 0 O-C-N 123.225 1.119 . . . . 0.0 110.562 173.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.416 HG12 ' CE1' ' A' ' 142' ' ' PHE . 97.3 mt -124.39 141.96 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 176.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -109.69 135.45 50.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.443 -0.785 . . . . 0.0 110.789 -175.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.3 mm -95.22 134.99 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.68 -0.638 . . . . 0.0 109.669 169.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -116.54 129.03 55.96 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.618 -0.676 . . . . 0.0 110.455 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.666 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.1 m -136.77 159.78 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.566 -0.709 . . . . 0.0 109.868 174.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 81.3 mmm -78.22 -42.45 31.27 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.738 -0.601 . . . . 0.0 110.148 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.2 p -131.7 143.2 48.14 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.799 -0.563 . . . . 0.0 109.702 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.8 Cg_exo -55.55 139.8 82.81 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 O-C-N 123.181 1.095 . . . . 0.0 110.876 -171.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.609 ' HB3' HD21 ' A' ' 288' ' ' LEU . 35.3 Cg_endo -67.6 170.03 14.63 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 O-C-N 123.168 1.088 . . . . 0.0 110.627 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -60.81 157.11 39.53 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 123.419 1.22 . . . . 0.0 110.514 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -78.73 139.13 38.5 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.647 -0.658 . . . . 0.0 110.024 175.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.06 -25.05 29.76 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -174.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -49.98 150.44 2.28 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.334 -1.098 . . . . 0.0 111.443 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.76 155.99 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.794 -0.566 . . . . 0.0 109.736 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.721 HD11 ' HD2' ' A' ' 251' ' ' TYR . 79.7 mt -108.27 137.1 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.667 -0.646 . . . . 0.0 109.437 176.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.743 ' HG2' HD22 ' A' ' 248' ' ' LEU . 61.6 mtt180 -114.99 143.09 45.72 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -176.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.652 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -137.35 127.25 25.7 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.46 -0.775 . . . . 0.0 110.28 176.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.407 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 23.9 ttm -137.22 139.91 29.41 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.787 -0.571 . . . . 0.0 111.086 -176.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.61 ' HD3' HD12 ' A' ' 226' ' ' ILE . 72.1 Cg_endo -91.97 138.22 1.94 Allowed 'Trans proline' 0 C--N 1.319 -0.992 0 C-N-CA 121.051 1.167 . . . . 0.0 110.643 177.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.416 HG13 ' C ' ' A' ' 190' ' ' PRO . 34.9 m -146.52 154.9 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.548 -0.72 . . . . 0.0 110.093 174.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.554 ' HA ' HG22 ' A' ' 282' ' ' ILE . 86.1 m-85 -63.56 159.39 18.86 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.483 -0.761 . . . . 0.0 110.578 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.454 ' HA ' HD12 ' A' ' 283' ' ' LEU . 40.7 ttpt -75.39 -56.6 4.55 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.709 -0.619 . . . . 0.0 110.697 -175.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -79.98 147.61 31.5 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.554 -0.716 . . . . 0.0 110.29 -174.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.448 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.54 -38.51 71.97 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.38 -0.825 . . . . 0.0 110.716 -175.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 20.2 mp0 -56.55 -25.16 51.33 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.441 -0.787 . . . . 0.0 110.55 -176.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.409 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 77.4 m80 -109.84 -20.54 12.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.528 -0.733 . . . . 0.0 111.19 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.448 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -67.29 -20.24 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.202 -0.936 . . . . 0.0 110.527 -175.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 71.3 p -79.43 -16.87 55.43 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.551 -0.718 . . . . 0.0 110.578 175.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -88.38 137.77 32.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.316 -0.865 . . . . 0.0 110.027 172.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.1 t -72.98 144.35 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.651 -0.656 . . . . 0.0 110.184 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.441 HG22 ' CE2' ' A' ' 192' ' ' TYR . 61.8 t -84.91 138.89 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.569 -0.707 . . . . 0.0 109.175 173.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -134.87 -170.37 2.55 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.401 -0.812 . . . . 0.0 111.326 -167.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -95.37 159.13 15.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.818 -0.551 . . . . 0.0 110.617 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.529 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 60.7 m . . . . . 0 N--CA 1.497 1.9 0 O-C-N 121.605 -0.684 . . . . 0.0 109.324 174.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.775 HD21 ' CE ' ' A' ' 277' ' ' MET . 43.3 tp . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 120.87 0.367 . . . . 0.0 110.306 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.61 HD12 ' HD3' ' A' ' 190' ' ' PRO . 83.7 mt -102.82 136.79 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.785 -0.572 . . . . 0.0 109.744 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -134.05 159.84 39.58 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.749 -0.594 . . . . 0.0 110.187 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.505 HG23 HG21 ' A' ' 247' ' ' VAL . 97.2 t -105.72 146.71 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.71 -0.618 . . . . 0.0 110.09 178.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -118.08 123.91 46.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.738 -0.601 . . . . 0.0 110.444 172.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 95.71 24.05 16.72 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 167.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 33.5 t-20 -135.34 107.61 7.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.323 -1.104 . . . . 0.0 110.057 174.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 32.5 t -62.94 -15.14 54.56 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.677 -0.639 . . . . 0.0 111.309 -177.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -99.98 7.06 45.05 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.196 -0.94 . . . . 0.0 111.591 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.35 128.33 35.84 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.036 -1.04 . . . . 0.0 110.236 177.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -139.73 156.71 46.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.794 -0.566 . . . . 0.0 109.656 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.425 ' CD1' ' HB ' ' A' ' 247' ' ' VAL . 82.1 m-85 -118.72 150.76 39.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.601 -0.687 . . . . 0.0 110.685 -176.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.13 159.92 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.717 -0.614 . . . . 0.0 110.334 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -120.82 130.09 53.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.761 -0.587 . . . . 0.0 110.133 176.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -62.48 122.96 76.87 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.678 -0.639 . . . . 0.0 109.71 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.89 -28.08 67.09 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 O-C-N 123.047 1.025 . . . . 0.0 110.812 -173.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.7 mt -103.9 -50.25 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.469 -0.769 . . . . 0.0 110.899 -170.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 5.6 p -105.34 12.23 31.89 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.364 -0.835 . . . . 0.0 112.014 -170.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 81.09 -21.32 5.89 Favored Glycine 0 N--CA 1.497 2.72 0 O-C-N 121.004 -1.06 . . . . 0.0 111.795 170.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 -45.95 142.05 2.83 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-N 118.673 1.236 . . . . 0.0 112.429 -169.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -108.66 145.45 34.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.575 -0.703 . . . . 0.0 110.151 174.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.9 p -154.85 159.88 40.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.655 -0.653 . . . . 0.0 110.598 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.505 HG21 HG23 ' A' ' 228' ' ' VAL . 8.6 p -122.95 148.28 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.791 -0.568 . . . . 0.0 109.657 177.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.743 HD22 ' HG2' ' A' ' 187' ' ' ARG . 81.2 mt -129.58 154.61 46.9 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.829 -175.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.434 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.8 m -150.85 151.69 30.53 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.851 -0.531 . . . . 0.0 110.02 175.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -71.19 138.74 33.95 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 O-C-N 123.385 1.203 . . . . 0.0 109.988 176.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.721 ' HD2' HD11 ' A' ' 186' ' ' ILE . 60.9 t80 -75.0 127.31 32.94 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.487 -0.758 . . . . 0.0 110.224 174.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -100.0 160.12 28.05 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.738 -0.601 . . . . 0.0 109.983 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.94 157.81 27.46 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.266 1.14 . . . . 0.0 110.432 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.02 149.96 76.16 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 O-C-N 123.218 1.115 . . . . 0.0 110.499 -177.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -61.62 148.63 41.8 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.718 -0.614 . . . . 0.0 110.108 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.84 127.23 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.502 -0.749 . . . . 0.0 110.208 -170.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.16 -10.16 56.65 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.404 HG21 ' CE2' ' A' ' 260' ' ' PHE . 10.0 t -144.86 174.23 11.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.185 -1.185 . . . . 0.0 110.527 175.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -109.34 13.18 24.36 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.489 -0.757 . . . . 0.0 111.923 -166.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.404 ' CE2' HG21 ' A' ' 258' ' ' THR . 46.2 p90 -120.0 168.06 11.54 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.113 -0.992 . . . . 0.0 111.219 -175.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 83.1 m -117.7 145.62 44.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.793 -0.567 . . . . 0.0 109.87 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 41.5 m -116.92 135.43 53.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.622 -0.674 . . . . 0.0 110.88 -175.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 60.3 t -131.54 137.31 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 173.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 171' ' ' PRO . 75.0 mt -104.6 121.07 42.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.533 -0.729 . . . . 0.0 109.953 -171.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.652 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 5.4 m-30 -105.39 153.02 22.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.661 -0.649 . . . . 0.0 110.789 -177.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -136.55 142.95 43.44 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 177.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -113.58 131.87 55.94 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.536 -0.728 . . . . 0.0 110.388 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' MET . . . . . 0.436 ' HG3' HD12 ' A' ' 225' ' ' LEU . 5.4 ppp? -101.01 9.06 42.65 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.624 -0.672 . . . . 0.0 112.011 -175.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . 0.636 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.7 OUTLIER -144.7 164.99 29.32 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.079 -1.013 . . . . 0.0 110.146 172.25 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.611 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.3 p30 -123.06 163.98 19.47 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.391 0.615 . . . . 0.0 110.547 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . 0.428 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 23.9 m -57.82 -33.93 69.13 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.479 -0.763 . . . . 0.0 111.104 -164.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 50.0 p -102.18 13.05 35.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.395 -0.816 . . . . 0.0 112.029 -163.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . 0.529 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 29.9 p -96.03 118.04 31.86 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.066 -1.021 . . . . 0.0 110.735 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.75 139.82 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.519 -0.738 . . . . 0.0 110.319 -171.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.04 -5.2 59.28 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.07 -96.75 0.78 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 170.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . 0.775 ' CE ' HD21 ' A' ' 225' ' ' LEU . 15.7 mmt -64.33 -35.23 80.18 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.673 -0.898 . . . . 0.0 110.475 177.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.3 p30 42.63 50.66 4.96 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 33.3 mtp180 54.8 29.5 11.97 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.402 -0.811 . . . . 0.0 111.193 176.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -120.0 104.93 43.35 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.599 -0.688 . . . . 0.0 110.177 175.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -60.39 148.82 89.14 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 O-C-N 123.131 1.069 . . . . 0.0 110.518 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.554 HG22 ' HA ' ' A' ' 192' ' ' TYR . 45.8 pt -131.88 177.42 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.788 0.804 . . . . 0.0 111.087 -176.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 193' ' ' LYS . 21.7 mt -124.44 149.89 46.28 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.699 HD12 ' CE1' ' A' ' 301' ' ' PHE . 82.0 mt -117.98 129.71 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.353 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.579 HG23 ' SG ' ' A' ' 300' ' ' CYS . 81.0 mt -109.81 126.91 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -176.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 57.3 t -118.91 126.81 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.63 HG22 ' HG2' ' A' ' 298' ' ' ARG . 45.6 p -125.28 152.79 44.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.596 -0.69 . . . . 0.0 110.659 -174.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.609 HD21 ' HB3' ' A' ' 180' ' ' PRO . 24.0 tp -102.22 126.16 49.12 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.748 -0.595 . . . . 0.0 109.473 169.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -130.43 150.1 51.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.875 -0.516 . . . . 0.0 109.855 -173.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.825 ' CG2' HD11 ' A' ' 296' ' ' LEU . 22.1 p -89.85 160.89 16.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.619 -0.676 . . . . 0.0 109.897 176.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -55.84 -26.21 45.62 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.574 -0.704 . . . . 0.0 111.03 -176.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 45.3 p30 -90.59 9.7 28.51 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.491 -0.756 . . . . 0.0 111.937 -173.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.87 20.18 44.44 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 120.163 -1.018 . . . . 0.0 110.799 170.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -106.98 140.22 40.14 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.238 -1.154 . . . . 0.0 110.106 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 64.1 t -86.55 131.61 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.641 -0.662 . . . . 0.0 110.226 -173.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.825 HD11 ' CG2' ' A' ' 290' ' ' THR . 96.3 mt -99.97 -40.08 7.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.724 -0.61 . . . . 0.0 110.694 177.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -164.14 153.5 23.87 Favored Glycine 0 N--CA 1.497 2.736 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.298 -177.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.63 ' HG2' HG22 ' A' ' 287' ' ' THR . 95.1 mtt180 -135.2 136.44 41.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.749 -0.853 . . . . 0.0 110.719 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . 0.403 ' HG3' ' HA ' ' A' ' 139' ' ' ASP . 28.2 mmt180 -139.38 156.91 46.69 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.622 -0.674 . . . . 0.0 110.001 169.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . 0.579 ' SG ' HG23 ' A' ' 285' ' ' ILE . 80.6 m -141.8 157.23 45.26 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.459 -0.776 . . . . 0.0 110.622 -174.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.699 ' CE1' HD12 ' A' ' 284' ' ' ILE . 49.6 p90 -144.94 162.31 37.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.637 -0.664 . . . . 0.0 110.144 176.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.421 ' HA ' HD23 ' A' ' 283' ' ' LEU . 34.9 tt0 -104.88 134.97 47.11 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.596 -0.69 . . . . 0.0 110.184 -177.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -121.05 142.79 49.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.578 -0.702 . . . . 0.0 110.867 -169.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -137.06 138.95 40.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.792 -0.567 . . . . 0.0 109.622 172.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.636 HD13 ' O ' ' A' ' 269' ' ' CYS . 77.0 mt -108.28 122.81 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.549 -0.719 . . . . 0.0 109.763 177.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.1 p -145.29 168.88 19.38 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.64 -0.662 . . . . 0.0 110.615 -171.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -71.53 -40.07 70.32 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.695 -0.628 . . . . 0.0 110.664 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.8 t -127.25 85.34 61.2 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.532 -0.73 . . . . 0.0 110.568 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . 0.412 ' HD3' ' HG3' ' A' ' 165' ' ' GLN . 47.9 Cg_exo -55.39 -27.23 57.2 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 O-C-N 123.224 1.118 . . . . 0.0 110.728 174.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -68.39 -37.72 86.26 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -71.14 -38.36 72.26 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.605 -0.938 . . . . 0.0 109.74 -174.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -69.36 -35.39 75.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.68 -0.637 . . . . 0.0 110.11 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -58.52 -46.25 87.14 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.55 -0.719 . . . . 0.0 110.43 174.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -64.53 -38.01 89.52 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.647 -0.658 . . . . 0.0 110.345 178.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -62.65 -51.79 65.89 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.484 -0.76 . . . . 0.0 110.578 -173.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . 0.543 ' OD1' HD11 ' A' ' 159' ' ' LEU . 3.8 p30 . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.457 -0.777 . . . . 0.0 110.031 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.8 t . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.075 0.465 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -101.42 25.8 7.95 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.617 -0.677 . . . . 0.0 110.634 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 54.4 m -78.85 125.22 29.08 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.554 -0.716 . . . . 0.0 110.231 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -70.33 144.86 51.55 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.632 -0.667 . . . . 0.0 110.396 -178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -158.37 101.21 1.71 Allowed Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.684 -0.635 . . . . 0.0 110.182 178.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -58.76 -39.96 77.12 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 O-C-N 123.086 1.045 . . . . 0.0 110.844 -175.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.82 -155.08 40.49 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -73.11 -49.05 0.24 Allowed 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.308 1.162 . . . . 0.0 110.911 -174.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -85.43 6.99 24.32 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.617 -0.677 . . . . 0.0 111.425 -175.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.97 61.92 2.84 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.949 -1.095 . . . . 0.0 110.608 -176.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.728 ' HA ' HG12 ' A' ' 176' ' ' VAL . 60.2 t80 -77.97 120.48 22.88 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.525 -0.735 . . . . 0.0 109.983 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -129.79 159.92 35.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.835 -0.541 . . . . 0.0 110.124 -176.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.2 t -124.96 145.8 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.792 -0.568 . . . . 0.0 109.889 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.9 p -155.01 162.25 41.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.81 -0.556 . . . . 0.0 109.92 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.472 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 75.3 m-85 . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.808 -0.558 . . . . 0.0 109.799 -175.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.781 0 CA-C-O 121.206 0.527 . . . . 0.0 110.026 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 82.3 p -60.02 -34.05 72.84 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.751 -0.593 . . . . 0.0 109.944 176.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.435 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -172.04 144.02 1.63 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.763 -0.585 . . . . 0.0 110.164 178.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 13.3 t -142.17 142.57 32.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.84 -0.538 . . . . 0.0 109.947 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.472 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 63.7 t80 -125.56 140.06 53.06 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.548 -0.72 . . . . 0.0 110.553 -172.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.9 t -110.23 124.26 51.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.837 -0.539 . . . . 0.0 109.827 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 58.5 m -70.66 -37.03 73.67 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.772 -0.58 . . . . 0.0 110.481 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -59.66 -34.7 73.16 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.553 -0.717 . . . . 0.0 110.43 -177.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 57.5 mt -104.86 -11.75 16.6 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.662 -0.649 . . . . 0.0 110.864 -175.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 26.2 tttp 59.83 52.03 5.69 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.02 -1.05 . . . . 0.0 109.715 178.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -144.96 152.77 40.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.74 -0.6 . . . . 0.0 110.587 -175.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.627 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.5 tp -126.61 137.81 53.36 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.758 -0.589 . . . . 0.0 110.338 -176.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -115.18 135.45 54.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.616 -0.677 . . . . 0.0 109.243 173.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.8 p -138.28 158.38 44.41 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.922 -175.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.416 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 52.9 mt-30 -104.53 143.02 33.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.593 -0.692 . . . . 0.0 110.131 173.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.432 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 16.8 tt -52.54 146.28 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.499 -0.751 . . . . 0.0 111.895 -173.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.81 10.04 5.78 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.579 -0.7 . . . . 0.0 112.471 176.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.416 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 53.4 mmtt -95.64 155.08 16.89 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.961 -1.087 . . . . 0.0 110.897 174.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 90.5 m -82.94 126.17 32.21 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.628 -0.67 . . . . 0.0 110.689 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' CYS . . . . . 0.627 ' SG ' HD21 ' A' ' 162' ' ' LEU . 43.6 t -114.23 90.09 19.29 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.657 -0.652 . . . . 0.0 110.108 172.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.435 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 17.4 Cg_exo -63.79 129.41 24.7 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 123.248 1.13 . . . . 0.0 110.581 173.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.404 HG12 ' CE2' ' A' ' 142' ' ' PHE . 97.5 mt -123.12 141.35 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 175.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -108.13 136.39 47.89 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.476 -0.765 . . . . 0.0 110.737 -175.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.443 HG21 ' CE1' ' A' ' 138' ' ' PHE . 48.6 mm -95.37 135.02 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.719 -0.613 . . . . 0.0 109.633 170.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -117.18 129.31 55.86 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.662 -0.649 . . . . 0.0 110.426 176.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.728 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.0 m -136.63 159.77 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.478 -0.764 . . . . 0.0 110.047 175.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 80.8 mmm -77.59 -40.24 42.85 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.745 -0.597 . . . . 0.0 110.007 177.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.9 p -135.51 143.28 44.45 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.832 -0.542 . . . . 0.0 109.675 177.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.6 Cg_exo -55.57 139.89 83.04 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 O-C-N 123.14 1.074 . . . . 0.0 110.887 -172.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.77 ' HB3' HD21 ' A' ' 288' ' ' LEU . 31.3 Cg_endo -67.35 170.04 14.26 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 O-C-N 123.25 1.132 . . . . 0.0 110.633 177.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -60.45 154.98 49.75 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.431 1.227 . . . . 0.0 110.546 -178.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -77.43 140.08 39.8 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.581 -0.699 . . . . 0.0 109.95 175.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.73 -25.06 28.96 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -174.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.22 153.08 1.56 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.363 -1.08 . . . . 0.0 111.41 178.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 33.9 m -129.66 155.93 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.661 -0.649 . . . . 0.0 109.686 176.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.705 HD11 ' HD2' ' A' ' 251' ' ' TYR . 82.6 mt -107.85 137.21 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.688 -0.633 . . . . 0.0 109.462 175.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.748 ' HG2' HD22 ' A' ' 248' ' ' LEU . 32.1 mtm180 -115.06 143.37 45.29 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 -176.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.664 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -136.62 126.48 25.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.568 -0.707 . . . . 0.0 110.235 175.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 23.8 ttp -137.24 137.14 21.8 Favored Pre-proline 0 N--CA 1.497 1.884 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.934 -176.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.643 ' HD3' HD12 ' A' ' 226' ' ' ILE . 72.7 Cg_endo -90.74 138.21 2.47 Favored 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 123.169 1.089 . . . . 0.0 110.706 177.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.427 HG13 ' C ' ' A' ' 190' ' ' PRO . 34.9 m -147.48 154.84 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.467 -0.771 . . . . 0.0 110.191 174.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.658 ' HA ' HG22 ' A' ' 282' ' ' ILE . 79.4 m-85 -63.8 162.81 12.82 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.546 -0.721 . . . . 0.0 110.487 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -79.35 -60.04 2.52 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.669 -0.644 . . . . 0.0 110.905 -173.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -80.11 150.66 30.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.574 -0.704 . . . . 0.0 110.281 -174.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.457 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.58 -38.12 71.53 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.424 -0.797 . . . . 0.0 110.686 -175.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -56.77 -24.91 53.54 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.494 -0.754 . . . . 0.0 110.565 -176.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.4 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 81.0 m-70 -109.68 -20.55 12.79 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.954 -0.699 . . . . 0.0 111.102 -178.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -67.71 -20.25 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.223 -0.923 . . . . 0.0 110.447 -176.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 67.2 p -79.37 -17.12 55.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.496 -0.752 . . . . 0.0 110.7 175.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -88.25 134.17 33.86 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.336 -0.853 . . . . 0.0 109.945 172.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.0 t -72.84 141.84 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.63 -0.669 . . . . 0.0 110.211 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.626 HG22 ' CZ ' ' A' ' 192' ' ' TYR . 58.4 t -84.86 140.05 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.571 -0.706 . . . . 0.0 109.153 171.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -134.71 -170.57 2.58 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.471 -0.768 . . . . 0.0 111.054 -170.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 13.6 mmp_? -95.62 157.35 15.94 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.732 -0.605 . . . . 0.0 110.106 178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 49.8 m . . . . . 0 N--CA 1.496 1.854 0 O-C-N 121.539 -0.726 . . . . 0.0 109.263 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 48.8 tp . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 120.978 0.418 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.643 HD12 ' HD3' ' A' ' 190' ' ' PRO . 86.2 mt -101.39 136.75 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.803 -0.561 . . . . 0.0 109.889 -175.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -135.18 159.72 40.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.71 -0.619 . . . . 0.0 110.317 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.493 HG23 HG21 ' A' ' 247' ' ' VAL . 94.6 t -105.18 146.82 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.704 -0.622 . . . . 0.0 110.138 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -120.99 124.51 45.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.777 -0.577 . . . . 0.0 110.27 172.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.78 24.16 11.09 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 169.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 -140.6 106.42 5.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.397 -1.06 . . . . 0.0 109.976 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 43.2 m -63.19 -15.28 56.46 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.519 -0.738 . . . . 0.0 111.341 -175.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -99.98 7.53 44.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 111.675 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.74 130.64 46.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.192 -0.942 . . . . 0.0 110.172 177.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -139.79 158.0 44.81 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.784 -0.572 . . . . 0.0 109.715 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -116.03 150.66 36.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.569 -0.707 . . . . 0.0 110.435 -177.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.16 159.88 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.79 -0.569 . . . . 0.0 110.26 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -123.43 128.25 49.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.73 -0.607 . . . . 0.0 110.08 174.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -65.12 130.05 94.68 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.669 -0.644 . . . . 0.0 109.85 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -67.07 -27.4 42.22 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 O-C-N 123.128 1.067 . . . . 0.0 111.008 -173.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 84.2 mt -100.57 -50.35 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.369 -0.832 . . . . 0.0 110.923 -168.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.3 p -105.28 12.13 32.12 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.338 -0.852 . . . . 0.0 111.831 -174.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.92 -5.43 12.82 Favored Glycine 0 N--CA 1.497 2.709 0 O-C-N 121.137 -0.977 . . . . 0.0 111.909 173.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 68.3 mmt-85 -46.04 142.0 2.94 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-N 119.192 1.496 . . . . 0.0 112.296 -175.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -109.24 140.8 42.4 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.682 -0.636 . . . . 0.0 110.037 172.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 78.5 p -154.75 159.99 41.02 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.591 -0.693 . . . . 0.0 110.689 178.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.493 HG21 HG23 ' A' ' 228' ' ' VAL . 8.2 p -124.17 148.32 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.798 -0.564 . . . . 0.0 109.657 176.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.748 HD22 ' HG2' ' A' ' 187' ' ' ARG . 84.4 mt -129.57 154.58 46.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.638 -0.664 . . . . 0.0 109.963 -175.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.446 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.9 m -151.28 151.71 29.72 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.794 -0.566 . . . . 0.0 109.947 176.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -71.08 138.95 34.7 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 O-C-N 123.275 1.145 . . . . 0.0 110.15 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.705 ' HD2' HD11 ' A' ' 186' ' ' ILE . 58.3 t80 -74.88 126.06 30.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.525 -0.734 . . . . 0.0 110.233 175.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -99.99 160.07 28.17 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.683 -0.635 . . . . 0.0 109.993 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.83 159.02 22.34 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 O-C-N 123.211 1.111 . . . . 0.0 110.529 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.38 149.98 77.93 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 O-C-N 123.251 1.132 . . . . 0.0 110.471 -178.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -61.31 146.94 46.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.737 -0.602 . . . . 0.0 110.233 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.94 127.25 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.517 -0.74 . . . . 0.0 110.164 -171.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.03 -10.15 55.25 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 10.0 t -144.0 173.44 11.71 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.168 -1.195 . . . . 0.0 110.625 175.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -106.83 13.15 28.19 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.612 -0.68 . . . . 0.0 111.756 -168.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -119.93 167.96 11.61 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.227 -0.921 . . . . 0.0 111.192 -175.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 94.1 m -117.75 146.31 43.87 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.762 -0.586 . . . . 0.0 109.868 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 39.7 m -116.74 135.77 53.5 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.577 -0.702 . . . . 0.0 110.941 -175.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.0 t -130.78 137.19 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 172.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 69.8 mt -104.53 121.6 43.82 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.49 -0.756 . . . . 0.0 109.94 -172.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.664 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 4.7 m-30 -106.56 154.84 20.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.65 -0.656 . . . . 0.0 110.824 -177.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -136.19 142.94 44.17 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -112.86 127.2 56.12 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.737 -0.602 . . . . 0.0 110.057 176.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 4.5 ppp? -95.74 7.3 46.7 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.705 -0.622 . . . . 0.0 111.898 -176.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . 0.672 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.8 OUTLIER -144.87 164.98 29.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.12 -0.987 . . . . 0.0 109.883 174.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.575 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.3 p30 -120.37 160.82 22.29 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.722 -0.611 . . . . 0.0 110.236 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . 0.419 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 24.0 m -58.99 -31.72 69.03 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.458 -0.776 . . . . 0.0 110.908 -163.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 72.9 m -94.99 8.93 41.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.602 -0.686 . . . . 0.0 112.098 -164.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 31.9 p -95.42 118.18 31.69 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.03 -1.044 . . . . 0.0 110.869 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.11 141.05 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.467 -0.771 . . . . 0.0 110.324 -172.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 100.78 -5.22 56.56 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.0 -105.39 1.13 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 169.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . 0.431 ' SD ' HD13 ' A' ' 282' ' ' ILE . 97.0 mmm -61.35 -36.93 81.57 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.691 -0.888 . . . . 0.0 110.15 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 40.45 55.04 2.9 Favored 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 121.42 0.629 . . . . 0.0 112.664 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 55.62 34.09 22.53 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.456 -0.777 . . . . 0.0 111.523 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' ARG . . . . . 0.444 ' NH2' ' CZ ' ' A' ' 192' ' ' TYR . 35.6 mtm180 -120.12 106.09 41.44 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.295 -0.878 . . . . 0.0 110.161 165.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -60.7 147.98 93.13 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 O-C-N 123.073 1.039 . . . . 0.0 110.416 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.658 HG22 ' HA ' ' A' ' 192' ' ' TYR . 43.9 pt -131.94 179.52 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-O 121.798 0.808 . . . . 0.0 111.001 -176.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.479 HD23 ' HA ' ' A' ' 302' ' ' GLU . 33.0 mt -124.4 149.93 46.16 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.686 HD12 ' CE1' ' A' ' 301' ' ' PHE . 82.6 mt -115.17 129.9 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.609 HG23 ' SG ' ' A' ' 300' ' ' CYS . 77.7 mt -109.76 126.9 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -176.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 57.6 t -118.93 126.66 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.461 HG22 ' HG2' ' A' ' 298' ' ' ARG . 45.0 p -125.21 152.95 43.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.618 -0.676 . . . . 0.0 110.692 -174.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.77 HD21 ' HB3' ' A' ' 180' ' ' PRO . 26.3 tp -101.52 126.94 48.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.66 -0.65 . . . . 0.0 109.483 168.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.623 ' OE2' HG13 ' A' ' 295' ' ' VAL . 72.1 mm-40 -131.61 150.88 52.0 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -173.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.731 HG22 HD11 ' A' ' 296' ' ' LEU . 80.0 p -89.92 159.4 16.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.623 -0.673 . . . . 0.0 109.726 177.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 68.4 ttp85 -55.96 -26.02 46.31 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.619 -0.676 . . . . 0.0 110.796 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -87.62 9.72 20.36 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.5 -0.75 . . . . 0.0 111.841 -174.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 87.31 20.13 53.15 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 120.159 -1.02 . . . . 0.0 110.779 170.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -107.22 140.19 40.48 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.364 -1.08 . . . . 0.0 110.238 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.623 HG13 ' OE2' ' A' ' 289' ' ' GLU . 60.7 t -88.1 132.33 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.619 -0.676 . . . . 0.0 110.194 -174.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.731 HD11 HG22 ' A' ' 290' ' ' THR . 95.8 mt -99.94 -40.18 7.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.635 -0.666 . . . . 0.0 110.5 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -165.25 153.45 23.58 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.461 ' HG2' HG22 ' A' ' 287' ' ' THR . 78.5 mtm180 -134.72 136.24 42.55 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.672 -0.899 . . . . 0.0 110.908 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -134.0 158.5 43.37 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.572 -0.705 . . . . 0.0 109.77 170.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . 0.609 ' SG ' HG23 ' A' ' 285' ' ' ILE . 93.6 m -142.91 154.2 43.86 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.444 -0.785 . . . . 0.0 110.772 -175.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.686 ' CE1' HD12 ' A' ' 284' ' ' ILE . 46.0 p90 -145.0 162.1 37.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.702 -0.624 . . . . 0.0 110.017 175.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.479 ' HA ' HD23 ' A' ' 283' ' ' LEU . 57.1 tt0 -104.93 136.15 44.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.537 -0.727 . . . . 0.0 110.116 -178.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -122.55 144.05 49.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.647 -0.658 . . . . 0.0 110.769 -169.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -138.52 137.14 36.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.832 -0.543 . . . . 0.0 109.757 173.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.672 HD13 ' O ' ' A' ' 269' ' ' CYS . 67.5 mt -105.88 122.84 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.582 -0.699 . . . . 0.0 109.423 175.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.1 p -145.14 169.45 18.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.559 -0.713 . . . . 0.0 111.038 -169.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -69.63 -40.02 76.82 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.673 -0.642 . . . . 0.0 110.626 -178.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 4.2 t -131.39 88.34 44.22 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.578 -0.702 . . . . 0.0 110.5 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -55.25 -29.45 67.07 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 O-C-N 123.207 1.109 . . . . 0.0 111.023 174.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.43 -37.91 93.1 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.4 ttm-85 -73.47 -40.28 64.26 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.684 -0.892 . . . . 0.0 109.795 -173.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -69.43 -40.45 77.24 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.077 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -61.27 -44.54 97.07 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.271 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 28.9 tttp -64.01 -40.45 96.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.552 -0.717 . . . . 0.0 110.498 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.55 -50.6 71.99 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.487 -0.758 . . . . 0.0 110.476 -173.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 N--CA 1.494 1.763 0 O-C-N 121.449 -0.782 . . . . 0.0 110.127 -177.979 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.0 t . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 121.062 0.458 . . . . 0.0 110.261 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.5 p-10 -95.15 24.63 4.8 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.655 -0.653 . . . . 0.0 110.794 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 50.4 m -73.33 125.17 27.22 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.573 -0.705 . . . . 0.0 110.263 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -72.67 145.05 47.5 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.614 -0.679 . . . . 0.0 110.346 -178.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -154.8 101.41 2.34 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.747 -0.596 . . . . 0.0 110.24 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -58.92 -39.97 76.14 Favored 'Trans proline' 0 N--CA 1.488 1.18 0 O-C-N 123.151 1.079 . . . . 0.0 110.803 -177.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.31 -155.12 48.52 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -72.78 -46.88 0.38 Allowed 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 123.399 1.21 . . . . 0.0 111.066 -173.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -87.59 9.83 19.93 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.523 -0.736 . . . . 0.0 111.396 -173.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.81 59.69 4.13 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.983 -1.073 . . . . 0.0 110.58 -175.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.679 ' HA ' HG12 ' A' ' 176' ' ' VAL . 67.8 t80 -77.83 118.36 20.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.714 -0.616 . . . . 0.0 109.861 -179.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.407 ' HA ' ' HG3' ' A' ' 299' ' ' ARG . 18.4 t70 -130.02 159.89 35.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.781 -0.575 . . . . 0.0 110.193 -177.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 70.9 t -124.22 147.34 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.704 -0.622 . . . . 0.0 109.857 174.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 76.5 p -154.91 162.76 40.99 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 120.378 -0.529 . . . . 0.0 109.956 177.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.49 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 74.9 m-85 . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.81 -0.556 . . . . 0.0 109.897 -175.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.114 0.483 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.468 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 73.1 p -60.13 -33.76 72.59 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.678 -0.639 . . . . 0.0 109.974 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.468 ' HD1' ' HG1' ' A' ' 152' ' ' THR . 68.6 p-90 -171.03 144.68 2.16 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.356 0.598 . . . . 0.0 110.289 178.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 9.5 t -142.2 142.65 32.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.846 -0.534 . . . . 0.0 110.064 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.49 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 62.7 t80 -125.42 140.02 53.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.522 -0.736 . . . . 0.0 110.483 -172.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.4 t -110.09 124.94 52.41 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 120.386 -0.526 . . . . 0.0 109.872 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 49.5 m -70.73 -37.05 73.46 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.391 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -60.28 -32.27 71.03 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.635 -0.666 . . . . 0.0 110.323 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.442 HD11 ' HB2' ' A' ' 316' ' ' ASP . 59.2 mt -104.76 -12.12 16.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.73 -0.606 . . . . 0.0 110.835 -174.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 71.4 tttt 59.78 47.47 10.27 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.019 -1.051 . . . . 0.0 109.58 177.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.7 tttp -146.68 153.15 39.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.706 -0.621 . . . . 0.0 110.666 -172.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.641 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.41 137.79 53.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.776 -0.577 . . . . 0.0 110.307 -176.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -114.92 131.62 56.82 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 175.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.3 158.48 44.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.69 -0.631 . . . . 0.0 110.941 -173.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.406 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 39.3 mt-30 -104.69 141.47 36.4 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.47 0.652 . . . . 0.0 110.351 172.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.435 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 16.7 tt -52.19 148.06 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 121.622 0.725 . . . . 0.0 111.857 -174.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.29 10.01 5.29 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.558 -0.714 . . . . 0.0 112.516 177.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.406 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 54.9 mmtt -96.65 155.08 16.92 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.892 -1.13 . . . . 0.0 110.889 174.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 86.8 m -83.5 126.2 32.54 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.73 -0.606 . . . . 0.0 110.602 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' CYS . . . . . 0.641 ' SG ' HD21 ' A' ' 162' ' ' LEU . 44.4 t -114.85 90.1 21.44 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.55 -0.719 . . . . 0.0 110.222 173.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.439 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 19.3 Cg_exo -63.27 130.09 27.54 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 O-C-N 123.228 1.12 . . . . 0.0 110.753 173.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.405 HG12 ' CE2' ' A' ' 142' ' ' PHE . 97.0 mt -123.52 143.35 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.664 -0.647 . . . . 0.0 109.317 173.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -109.35 135.48 50.35 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.491 -0.756 . . . . 0.0 110.824 -175.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 48.9 mm -95.29 135.03 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.685 -0.634 . . . . 0.0 109.65 169.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 44.5 tttm -116.43 129.53 56.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.62 -0.675 . . . . 0.0 110.482 176.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.679 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.5 m -136.69 159.76 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.552 -0.718 . . . . 0.0 109.873 174.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.4 mmm -78.44 -41.63 32.33 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.692 -0.63 . . . . 0.0 110.15 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.417 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 76.9 p -133.81 143.2 46.58 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.773 -0.579 . . . . 0.0 109.634 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 34.6 Cg_exo -55.21 139.79 80.94 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 O-C-N 123.191 1.101 . . . . 0.0 110.925 -171.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.729 ' HB3' HD21 ' A' ' 288' ' ' LEU . 30.7 Cg_endo -66.81 170.1 13.39 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.17 1.09 . . . . 0.0 110.588 177.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -60.65 155.06 50.45 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.363 1.191 . . . . 0.0 110.537 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -78.08 140.59 39.09 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.619 -0.676 . . . . 0.0 109.91 175.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.83 -24.92 29.6 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -174.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.2 152.06 1.86 Allowed 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.348 -1.09 . . . . 0.0 111.436 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.79 156.3 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.814 -0.554 . . . . 0.0 109.805 176.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.671 HD11 ' HD2' ' A' ' 251' ' ' TYR . 52.4 mt -109.75 135.56 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.745 ' HG2' HD22 ' A' ' 248' ' ' LEU . 71.1 mtt180 -114.97 145.48 42.2 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -174.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.68 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -139.74 126.58 20.75 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.509 -0.744 . . . . 0.0 110.332 173.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 37.5 ttp -137.39 138.55 25.17 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.78 -0.575 . . . . 0.0 111.093 -176.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.508 ' HD3' HD12 ' A' ' 226' ' ' ILE . 73.9 Cg_endo -90.75 138.15 2.45 Favored 'Trans proline' 0 C--N 1.32 -0.941 0 O-C-N 123.207 1.109 . . . . 0.0 110.808 176.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.456 HG12 ' CZ ' ' A' ' 244' ' ' ARG . 34.8 m -147.31 154.78 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.487 -0.758 . . . . 0.0 110.109 173.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.645 ' HA ' HG22 ' A' ' 282' ' ' ILE . 90.4 m-85 -62.18 166.43 4.85 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.41 -0.806 . . . . 0.0 110.477 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -83.09 -60.04 2.28 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.671 -0.643 . . . . 0.0 110.824 -175.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 39.6 mttp -80.06 151.14 30.06 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.609 -0.682 . . . . 0.0 110.328 -175.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.456 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.55 -38.07 71.41 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.404 -0.81 . . . . 0.0 110.802 -175.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -56.75 -24.92 53.37 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.556 -0.715 . . . . 0.0 110.599 -176.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -109.7 -20.53 12.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.519 -0.738 . . . . 0.0 111.144 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.456 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.1 p -67.73 -20.23 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.181 -0.95 . . . . 0.0 110.518 -176.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 78.5 p -79.43 -17.01 55.19 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.779 175.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -88.28 137.86 31.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.367 -0.833 . . . . 0.0 110.089 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.7 t -73.13 140.89 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.614 -0.679 . . . . 0.0 110.295 177.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.551 HG22 ' CE1' ' A' ' 192' ' ' TYR . 62.0 t -85.0 138.57 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.552 -0.718 . . . . 0.0 109.345 170.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 14.2 pttt -134.92 -170.26 2.53 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.575 -0.703 . . . . 0.0 111.01 -171.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 84.7 mtm-85 -95.27 157.49 15.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.747 -0.596 . . . . 0.0 110.212 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.735 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 53.4 m . . . . . 0 N--CA 1.496 1.862 0 O-C-N 121.677 -0.64 . . . . 0.0 109.558 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.41 ' HA ' ' CG ' ' A' ' 268' ' ' MET . 54.9 tp . . . . . 0 N--CA 1.497 1.875 0 CA-C-O 120.946 0.403 . . . . 0.0 110.324 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.508 HD12 ' HD3' ' A' ' 190' ' ' PRO . 83.0 mt -105.51 136.8 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.747 -0.596 . . . . 0.0 109.735 177.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -132.35 157.13 45.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.677 -0.639 . . . . 0.0 110.264 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.473 HG23 HG21 ' A' ' 247' ' ' VAL . 75.2 t -102.52 146.58 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.727 -0.608 . . . . 0.0 110.022 176.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -117.83 130.08 56.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.7 -0.625 . . . . 0.0 110.386 170.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 95.65 20.71 25.97 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.559 -1.017 . . . . 0.0 110.559 168.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -138.84 105.88 5.45 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -1.119 . . . . 0.0 110.005 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 43.2 m -63.21 -15.23 56.32 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.596 -0.69 . . . . 0.0 111.285 -177.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -100.0 8.9 43.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.19 -0.944 . . . . 0.0 111.53 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.37 131.42 50.21 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.072 -1.018 . . . . 0.0 110.196 176.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -139.76 158.06 44.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.752 -0.592 . . . . 0.0 109.805 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -111.69 150.63 29.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.614 -0.679 . . . . 0.0 110.484 -177.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.17 159.92 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.732 -0.605 . . . . 0.0 110.216 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -121.03 130.1 53.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.813 -0.555 . . . . 0.0 110.154 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -63.23 130.0 93.89 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.664 -0.648 . . . . 0.0 109.853 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -65.23 -28.63 55.74 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 O-C-N 123.186 1.098 . . . . 0.0 110.968 -170.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.6 mt -102.15 -50.47 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.467 -0.77 . . . . 0.0 111.07 -168.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 14.1 p -105.3 12.18 32.04 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.392 -0.818 . . . . 0.0 111.942 -174.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 72.56 -4.89 18.57 Favored Glycine 0 N--CA 1.496 2.669 0 O-C-N 120.988 -1.07 . . . . 0.0 111.955 172.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.456 ' CZ ' HG12 ' A' ' 191' ' ' VAL . 21.4 mmt180 -45.92 142.02 2.83 Favored 'General case' 0 N--CA 1.506 2.328 0 CA-C-N 119.101 1.451 . . . . 0.0 112.339 -175.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -103.94 141.72 35.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.616 -0.678 . . . . 0.0 110.219 176.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.4 p -154.73 159.95 41.02 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.623 -0.673 . . . . 0.0 110.299 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.473 HG21 HG23 ' A' ' 228' ' ' VAL . 8.3 p -122.95 148.08 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.674 -0.641 . . . . 0.0 109.796 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.745 HD22 ' HG2' ' A' ' 187' ' ' ARG . 80.1 mt -129.63 154.62 46.93 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.816 -175.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.437 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.8 m -150.98 151.76 30.34 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.808 -0.558 . . . . 0.0 109.907 175.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -71.01 140.5 38.11 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 O-C-N 123.251 1.132 . . . . 0.0 110.003 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.671 ' HD2' HD11 ' A' ' 186' ' ' ILE . 60.6 t80 -76.06 125.41 29.08 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.459 -0.775 . . . . 0.0 110.155 177.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -100.05 160.14 27.96 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.739 -0.6 . . . . 0.0 109.998 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -59.0 159.13 22.58 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 O-C-N 123.284 1.149 . . . . 0.0 110.445 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -59.11 149.93 76.79 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 O-C-N 123.248 1.131 . . . . 0.0 110.515 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -60.36 147.45 40.6 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.627 -0.671 . . . . 0.0 110.319 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.7 t -69.83 127.25 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.619 -0.675 . . . . 0.0 110.22 -170.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.99 -10.09 55.33 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 9.6 t -144.35 173.27 11.92 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.224 -1.162 . . . . 0.0 110.558 175.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -106.92 13.21 27.95 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.651 -0.656 . . . . 0.0 111.804 -168.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -120.03 168.05 11.57 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.115 -0.991 . . . . 0.0 111.152 -175.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 82.3 m -117.75 146.25 43.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.729 -0.607 . . . . 0.0 109.788 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 35.6 m -116.72 136.61 52.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.636 -0.665 . . . . 0.0 110.917 -175.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 59.3 t -128.56 137.13 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 66.4 mt -104.78 119.49 39.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.497 -0.752 . . . . 0.0 109.831 -173.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.68 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 6.5 m-30 -105.69 151.06 24.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.62 -0.675 . . . . 0.0 110.718 -177.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -136.53 143.01 43.49 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -115.0 131.97 56.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.527 -0.733 . . . . 0.0 110.501 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' MET . . . . . 0.41 ' CG ' ' HA ' ' A' ' 225' ' ' LEU . 5.2 ppp? -100.24 1.16 41.57 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.654 -0.654 . . . . 0.0 111.9 -177.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.65 159.6 42.55 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.085 -1.009 . . . . 0.0 109.982 173.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.586 ' HA ' HD13 ' A' ' 305' ' ' ILE . 27.2 p30 -115.13 153.89 29.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.74 -0.6 . . . . 0.0 110.161 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . 0.444 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 92.7 p -56.64 -26.7 56.76 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.404 -0.81 . . . . 0.0 111.155 -167.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 46.0 p -95.04 8.19 43.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.387 -0.821 . . . . 0.0 112.086 -165.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . 0.735 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 28.9 p -93.96 117.96 30.82 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.98 -1.075 . . . . 0.0 110.727 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . 0.447 HG22 ' NH1' ' A' ' 279' ' ' ARG . 60.2 t -69.68 143.34 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.561 -0.712 . . . . 0.0 110.533 -167.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.53 -5.28 58.55 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.04 -95.35 0.74 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 169.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . 0.444 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 95.2 mmm -64.78 -28.61 69.69 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.74 -0.859 . . . . 0.0 110.386 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.9 p30 44.95 51.56 8.6 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 121.325 0.583 . . . . 0.0 112.507 172.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.447 ' NH1' HG22 ' A' ' 274' ' ' VAL . 37.9 mtt180 54.7 33.4 19.35 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.321 -0.862 . . . . 0.0 111.289 174.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' ARG . . . . . 0.434 ' O ' HG23 ' A' ' 282' ' ' ILE . 89.6 mtt180 -114.89 105.01 53.74 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.499 -0.751 . . . . 0.0 110.092 173.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 280' ' ' ARG . 13.2 Cg_endo -60.8 144.97 99.65 Favored 'Trans proline' 0 N--CA 1.488 1.175 0 O-C-N 123.138 1.073 . . . . 0.0 110.371 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.645 HG22 ' HA ' ' A' ' 192' ' ' TYR . 43.6 pt -132.58 177.84 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 121.943 0.878 . . . . 0.0 111.253 -174.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 302' ' ' GLU . 35.0 mt -124.34 149.9 46.09 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 177.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.669 HD12 ' CE1' ' A' ' 301' ' ' PHE . 80.8 mt -114.21 130.51 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.63 -0.669 . . . . 0.0 109.312 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.504 HG23 ' SG ' ' A' ' 300' ' ' CYS . 81.0 mt -109.78 125.91 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -176.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 75.8 t -118.98 126.71 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.7 p -125.28 153.01 43.89 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.717 -0.614 . . . . 0.0 110.72 -174.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.729 HD21 ' HB3' ' A' ' 180' ' ' PRO . 19.1 tp -100.29 126.95 46.68 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 166.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.696 ' OE2' HG13 ' A' ' 295' ' ' VAL . 74.5 mm-40 -132.69 149.72 52.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.756 -0.59 . . . . 0.0 110.01 -172.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.778 ' CG2' HD11 ' A' ' 296' ' ' LEU . 77.2 p -89.93 158.28 17.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.667 -0.646 . . . . 0.0 110.013 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -55.98 -26.16 47.19 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.559 -0.713 . . . . 0.0 111.009 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -92.93 12.86 22.37 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.47 -0.769 . . . . 0.0 111.697 -173.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.94 20.18 44.17 Favored Glycine 0 N--CA 1.494 2.539 0 C-N-CA 120.118 -1.039 . . . . 0.0 110.962 167.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -107.43 140.14 40.83 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.216 -1.167 . . . . 0.0 110.18 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.696 HG13 ' OE2' ' A' ' 289' ' ' GLU . 58.7 t -90.1 130.9 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.626 -0.671 . . . . 0.0 110.054 -175.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.778 HD11 ' CG2' ' A' ' 290' ' ' THR . 96.3 mt -99.97 -40.07 7.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.716 -0.615 . . . . 0.0 110.569 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -160.35 149.36 18.66 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.504 ' HD2' HG11 ' A' ' 295' ' ' VAL . 48.7 mtp180 -135.19 136.24 41.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.678 -0.895 . . . . 0.0 110.575 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . 0.407 ' HG3' ' HA ' ' A' ' 139' ' ' ASP . 0.4 OUTLIER -138.13 157.82 45.55 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.608 -0.682 . . . . 0.0 110.301 170.021 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . 0.504 ' SG ' HG23 ' A' ' 285' ' ' ILE . 82.2 m -141.88 154.96 45.5 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.493 -0.754 . . . . 0.0 110.643 -175.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.669 ' CE1' HD12 ' A' ' 284' ' ' ILE . 47.3 p90 -144.95 160.97 40.49 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.703 -0.623 . . . . 0.0 110.194 175.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.474 ' HA ' HD23 ' A' ' 283' ' ' LEU . 82.3 tt0 -104.93 136.89 43.56 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.571 -0.706 . . . . 0.0 110.125 -178.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -117.94 143.73 46.1 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.821 -169.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -137.1 138.57 40.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.822 -0.549 . . . . 0.0 109.713 172.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.586 HD13 ' HA ' ' A' ' 270' ' ' ASN . 56.2 mt -112.7 122.86 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.512 -0.743 . . . . 0.0 109.757 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.2 p -145.32 170.56 16.08 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.642 -0.662 . . . . 0.0 110.664 -171.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -71.97 -40.11 68.86 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.694 -0.629 . . . . 0.0 110.641 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.8 t -127.12 86.51 58.66 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.59 -0.694 . . . . 0.0 110.506 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . 0.403 ' HD3' ' HG3' ' A' ' 165' ' ' GLN . 37.5 Cg_exo -56.24 -28.2 70.14 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.169 1.089 . . . . 0.0 110.533 173.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -67.53 -37.57 89.86 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -70.5 -38.33 74.3 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.643 -0.916 . . . . 0.0 109.749 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -69.45 -35.42 75.64 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.085 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 37.7 ttt85 -57.16 -47.3 81.55 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.533 -0.73 . . . . 0.0 110.593 174.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -64.56 -39.02 92.98 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.575 -0.703 . . . . 0.0 110.401 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -62.44 -51.41 67.62 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.529 -0.732 . . . . 0.0 110.56 -173.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . 0.442 ' HB2' HD11 ' A' ' 159' ' ' LEU . 3.5 p30 . . . . . 0 N--CA 1.495 1.777 0 O-C-N 121.472 -0.767 . . . . 0.0 110.096 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.5 t . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.057 0.456 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -94.65 24.25 4.77 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.691 -0.63 . . . . 0.0 110.878 -178.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 50.9 m -72.33 125.18 26.72 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.496 -0.753 . . . . 0.0 110.148 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -68.5 144.94 54.45 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.614 -0.679 . . . . 0.0 110.388 -176.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -155.55 101.65 2.2 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.802 -0.561 . . . . 0.0 110.058 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -59.54 -39.87 71.25 Favored 'Trans proline' 0 N--CA 1.489 1.222 0 O-C-N 123.152 1.08 . . . . 0.0 110.677 -175.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.04 -155.17 42.1 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -73.29 -43.86 0.64 Allowed 'Trans proline' 0 C--N 1.316 -1.142 0 O-C-N 123.422 1.222 . . . . 0.0 110.89 -175.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -89.28 5.64 44.01 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.543 -0.723 . . . . 0.0 111.497 -174.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 t 53.99 59.43 4.26 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.978 -1.076 . . . . 0.0 110.729 -176.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.725 ' HA ' HG12 ' A' ' 176' ' ' VAL . 64.6 t80 -78.15 118.78 20.72 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.571 -0.706 . . . . 0.0 110.019 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -130.06 160.02 34.98 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.34 0.591 . . . . 0.0 110.321 -176.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.0 t -124.83 148.42 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.692 -0.63 . . . . 0.0 109.87 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.6 p -155.87 166.9 32.09 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.313 0.578 . . . . 0.0 110.088 176.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.496 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 66.3 m-85 . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.782 -0.574 . . . . 0.0 109.84 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 121.173 0.511 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 42.5 p -60.09 -34.08 72.98 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.643 -0.661 . . . . 0.0 110.094 176.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.442 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.8 p-90 -171.22 144.27 2.02 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.331 0.586 . . . . 0.0 110.224 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.0 t -142.09 142.6 32.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.897 -0.502 . . . . 0.0 109.985 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.496 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 64.7 t80 -125.61 139.98 53.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.486 -0.759 . . . . 0.0 110.775 -171.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.0 t -111.96 123.85 51.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.851 -0.531 . . . . 0.0 109.92 177.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 59.0 m -70.93 -37.01 72.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.806 -0.559 . . . . 0.0 110.568 -176.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -59.21 -35.36 73.48 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.505 -0.747 . . . . 0.0 110.522 -177.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.2 mt -104.86 -11.05 16.94 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.683 -0.636 . . . . 0.0 110.981 -176.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt 59.76 52.64 5.34 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.14 -0.975 . . . . 0.0 109.743 177.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -145.25 153.07 40.92 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.779 -0.576 . . . . 0.0 110.625 -175.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.618 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.58 137.76 53.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.758 -0.588 . . . . 0.0 110.206 -175.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -116.04 135.89 53.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.63 -0.669 . . . . 0.0 109.381 173.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.1 p -138.49 158.49 44.17 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.68 -0.638 . . . . 0.0 110.767 -177.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.431 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 55.4 mt-30 -104.61 144.49 31.64 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.505 -0.747 . . . . 0.0 109.882 171.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.418 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 16.3 tt -51.71 147.48 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.502 -0.749 . . . . 0.0 111.95 -174.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 65.11 10.0 5.99 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.637 -0.665 . . . . 0.0 112.702 174.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.431 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 20.3 mmtp -96.12 155.11 16.9 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.955 -1.091 . . . . 0.0 111.074 172.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 91.3 m -80.33 126.18 30.83 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.719 -0.613 . . . . 0.0 110.569 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' CYS . . . . . 0.618 ' SG ' HD21 ' A' ' 162' ' ' LEU . 48.6 t -116.32 90.03 28.34 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.604 -0.685 . . . . 0.0 110.126 174.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.442 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 15.2 Cg_exo -65.78 131.08 26.39 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 O-C-N 123.264 1.139 . . . . 0.0 110.756 174.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.635 HD12 ' CD2' ' A' ' 265' ' ' TYR . 78.2 mt -123.91 144.69 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.596 -0.69 . . . . 0.0 109.496 172.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.405 ' OE1' ' CD1' ' A' ' 260' ' ' PHE . 70.5 mm-40 -108.42 133.05 53.12 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.52 -0.738 . . . . 0.0 110.361 -173.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.59 HG21 ' CE1' ' A' ' 138' ' ' PHE . 49.0 mm -95.35 135.0 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.652 -0.655 . . . . 0.0 109.657 170.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.0 tttp -119.3 130.28 55.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.531 -0.73 . . . . 0.0 110.529 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.725 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.4 m -136.2 159.73 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.605 -0.684 . . . . 0.0 109.905 175.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 81.6 mmm -77.13 -40.3 46.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.695 -0.628 . . . . 0.0 110.045 177.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.3 p -135.87 143.27 43.72 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.764 -0.585 . . . . 0.0 109.795 177.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.7 Cg_exo -55.69 139.89 83.68 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 O-C-N 123.217 1.114 . . . . 0.0 110.886 -172.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.742 ' HB3' HD21 ' A' ' 288' ' ' LEU . 23.4 Cg_endo -64.28 169.71 10.45 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.238 1.125 . . . . 0.0 110.69 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -61.06 156.54 44.02 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.35 1.184 . . . . 0.0 110.497 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -77.06 139.61 40.07 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.629 -0.669 . . . . 0.0 109.908 175.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.9 -25.02 29.24 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -175.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.12 152.97 1.53 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.296 -1.12 . . . . 0.0 111.325 176.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.77 155.98 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.748 -0.595 . . . . 0.0 109.774 176.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.641 HD11 ' CD2' ' A' ' 251' ' ' TYR . 72.4 mt -106.13 133.7 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 177.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.758 ' HG2' HD22 ' A' ' 248' ' ' LEU . 65.0 mtt180 -115.01 140.94 48.64 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -174.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -138.52 124.47 20.02 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.49 -0.757 . . . . 0.0 110.53 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 20.3 ttm -137.35 139.31 27.32 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.808 -0.558 . . . . 0.0 111.145 -175.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.718 ' HD3' HD12 ' A' ' 226' ' ' ILE . 71.2 Cg_endo -90.29 138.13 2.69 Favored 'Trans proline' 0 C--N 1.32 -0.948 0 O-C-N 123.185 1.097 . . . . 0.0 110.519 175.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.428 HG13 ' C ' ' A' ' 190' ' ' PRO . 34.8 m -147.07 154.92 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.577 -0.702 . . . . 0.0 110.211 174.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.647 ' HA ' HG22 ' A' ' 282' ' ' ILE . 82.3 m-85 -60.97 161.1 8.76 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.477 -0.764 . . . . 0.0 110.348 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -78.46 -60.04 2.53 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.635 -0.666 . . . . 0.0 110.812 -173.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -80.02 151.88 29.73 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.605 -0.685 . . . . 0.0 110.447 -174.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.447 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.41 -38.94 72.23 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.353 -0.842 . . . . 0.0 110.74 -176.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -56.37 -24.57 45.25 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.533 -0.73 . . . . 0.0 110.624 -176.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.412 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 60.4 m170 -110.01 -20.56 12.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.509 -0.744 . . . . 0.0 111.101 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.447 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.1 p -66.88 -20.34 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.111 -0.993 . . . . 0.0 110.639 -176.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 73.7 p -79.3 -16.96 55.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.522 -0.736 . . . . 0.0 110.78 175.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -88.41 134.62 33.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.338 -0.851 . . . . 0.0 110.064 173.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.3 t -73.16 143.69 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.612 -0.68 . . . . 0.0 110.269 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 78.9 t -84.9 139.56 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.527 -0.733 . . . . 0.0 109.326 170.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 9.3 pttt -134.9 -170.06 2.49 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.477 -0.765 . . . . 0.0 111.035 -167.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -95.07 154.2 17.28 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.712 -0.617 . . . . 0.0 110.317 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.553 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 56.3 m . . . . . 0 N--CA 1.496 1.865 0 O-C-N 121.647 -0.658 . . . . 0.0 109.249 174.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.401 ' HA ' ' HG3' ' A' ' 268' ' ' MET . 45.8 tp . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 120.938 0.399 . . . . 0.0 110.089 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.718 HD12 ' HD3' ' A' ' 190' ' ' PRO . 79.3 mt -99.21 136.79 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.836 -0.54 . . . . 0.0 109.659 175.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -135.05 157.61 46.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.737 -0.602 . . . . 0.0 109.971 176.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.463 HG23 HG21 ' A' ' 247' ' ' VAL . 72.6 t -103.52 146.65 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.712 -0.618 . . . . 0.0 110.161 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -122.06 130.01 52.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.746 -0.596 . . . . 0.0 110.285 170.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 99.12 19.51 21.19 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 170.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -140.7 104.52 4.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.267 -1.137 . . . . 0.0 110.028 174.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 45.8 m -63.42 -15.31 57.27 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.666 -0.646 . . . . 0.0 111.276 -176.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -100.01 7.63 44.59 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.22 -0.925 . . . . 0.0 111.55 -177.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.61 133.37 55.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.088 -1.007 . . . . 0.0 110.21 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -139.83 157.98 44.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.735 -0.603 . . . . 0.0 109.809 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.426 ' CD1' ' HB ' ' A' ' 247' ' ' VAL . 84.3 m-85 -114.37 150.65 34.27 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.552 -0.717 . . . . 0.0 110.497 -178.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.22 159.92 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.76 -0.588 . . . . 0.0 110.266 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -119.22 130.04 55.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.769 -0.582 . . . . 0.0 110.163 175.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -65.09 130.11 94.72 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.676 -0.64 . . . . 0.0 109.838 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -66.36 -27.66 47.37 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 O-C-N 123.172 1.09 . . . . 0.0 111.021 -171.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 82.6 mt -100.49 -50.54 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.399 -0.813 . . . . 0.0 110.942 -167.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.3 p -105.3 12.04 32.21 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.322 -0.861 . . . . 0.0 111.887 -175.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.88 -5.11 13.57 Favored Glycine 0 N--CA 1.495 2.582 0 O-C-N 121.08 -1.012 . . . . 0.0 111.916 173.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 22.2 mmt85 -46.14 142.02 3.02 Favored 'General case' 0 N--CA 1.505 2.276 0 CA-C-N 119.108 1.454 . . . . 0.0 112.321 -174.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -106.27 139.91 40.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.628 -0.67 . . . . 0.0 110.123 175.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 78.7 p -154.74 159.98 41.03 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.635 -0.665 . . . . 0.0 110.518 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.463 HG21 HG23 ' A' ' 228' ' ' VAL . 8.3 p -122.96 148.17 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.78 -0.575 . . . . 0.0 109.666 177.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.758 HD22 ' HG2' ' A' ' 187' ' ' ARG . 83.0 mt -129.64 154.52 47.04 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.045 -175.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.443 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.4 m -151.12 151.76 30.09 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.812 -0.555 . . . . 0.0 109.84 175.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -70.57 137.16 32.5 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 O-C-N 123.237 1.125 . . . . 0.0 109.979 177.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.641 ' CD2' HD11 ' A' ' 186' ' ' ILE . 13.9 t80 -77.23 124.29 27.63 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.572 -0.705 . . . . 0.0 110.201 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -100.01 160.06 28.2 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.719 -0.613 . . . . 0.0 110.177 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -59.26 159.99 20.9 Favored 'Trans proline' 0 C--N 1.316 -1.163 0 O-C-N 123.244 1.129 . . . . 0.0 110.434 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.88 150.22 73.3 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 O-C-N 123.194 1.102 . . . . 0.0 110.567 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -60.02 148.11 36.72 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.575 -0.703 . . . . 0.0 110.323 -178.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.84 127.25 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.457 -0.777 . . . . 0.0 110.068 -170.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.92 -10.12 55.46 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 9.5 t -144.68 173.71 11.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.163 -1.198 . . . . 0.0 110.601 175.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -106.94 13.18 27.96 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.66 -0.65 . . . . 0.0 111.768 -168.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.405 ' CD1' ' OE1' ' A' ' 173' ' ' GLN . 13.8 p90 -119.94 168.02 11.56 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.212 -0.93 . . . . 0.0 111.233 -175.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 86.4 m -117.86 147.78 42.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.768 -0.583 . . . . 0.0 109.841 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 40.6 m -115.95 137.54 52.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.553 -0.717 . . . . 0.0 110.91 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 57.9 t -128.62 136.87 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 170.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 64.7 mt -104.87 120.12 40.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.494 -0.754 . . . . 0.0 109.815 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.635 ' CD2' HD12 ' A' ' 172' ' ' ILE . 3.3 m-85 -99.19 156.4 16.98 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.796 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -136.42 142.99 43.7 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 171.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -113.41 129.58 56.51 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.61 -0.681 . . . . 0.0 110.163 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' MET . . . . . 0.401 ' HG3' ' HA ' ' A' ' 225' ' ' LEU . 0.0 OUTLIER -98.98 5.85 46.98 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.636 -0.665 . . . . 0.0 111.724 -176.308 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . 0.528 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.8 OUTLIER -144.78 161.33 39.52 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.141 -0.975 . . . . 0.0 110.069 173.636 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.662 ' HA ' HG21 ' A' ' 305' ' ' ILE . 26.9 p30 -116.27 158.71 22.95 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.731 -0.605 . . . . 0.0 109.822 176.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . 0.405 ' HA ' ' HB3' ' A' ' 277' ' ' MET . 19.2 m -58.6 -32.65 69.19 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.376 -0.827 . . . . 0.0 110.947 -163.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 73.1 m -93.93 10.7 32.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.601 -0.687 . . . . 0.0 111.986 -165.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . 0.553 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 31.7 p -93.8 118.19 31.1 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.069 -1.019 . . . . 0.0 110.593 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.3 t -61.34 139.9 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.389 -0.819 . . . . 0.0 110.218 -171.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 101.0 -5.11 56.16 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -124.89 -115.87 2.12 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 170.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . 0.405 ' HB3' ' HA ' ' A' ' 271' ' ' SER . 26.9 ttt -60.27 -24.94 65.32 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.613 -0.934 . . . . 0.0 110.409 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 43.87 55.07 5.41 Favored 'General case' 0 N--CA 1.504 2.241 0 CA-C-O 121.434 0.635 . . . . 0.0 112.584 172.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 54.94 30.36 13.87 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.401 -0.812 . . . . 0.0 111.317 175.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -116.81 116.42 38.35 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.468 -0.77 . . . . 0.0 110.128 170.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . 0.404 ' HA ' ' CE ' ' A' ' 277' ' ' MET . 12.0 Cg_endo -59.68 145.66 97.54 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 O-C-N 123.042 1.022 . . . . 0.0 110.495 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.647 HG22 ' HA ' ' A' ' 192' ' ' TYR . 45.4 pt -131.97 175.73 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 121.762 0.791 . . . . 0.0 110.89 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.48 HD23 ' HA ' ' A' ' 302' ' ' GLU . 32.0 mt -124.42 149.92 46.21 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.512 HD12 ' CE1' ' A' ' 301' ' ' PHE . 79.1 mt -112.58 127.95 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.057 176.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.686 HG23 ' SG ' ' A' ' 300' ' ' CYS . 76.5 mt -109.85 126.34 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.436 -175.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 59.1 t -118.92 126.55 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.3 p -125.4 153.93 42.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.643 -0.661 . . . . 0.0 110.536 -174.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.742 HD21 ' HB3' ' A' ' 180' ' ' PRO . 24.3 tp -103.55 126.57 50.78 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 169.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.562 ' OE2' HG13 ' A' ' 295' ' ' VAL . 75.1 mm-40 -132.15 150.24 52.2 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.996 -173.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.759 ' CG2' HD11 ' A' ' 296' ' ' LEU . 76.5 p -89.96 159.21 17.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.732 -0.605 . . . . 0.0 109.907 178.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -55.95 -26.16 46.8 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.534 -0.729 . . . . 0.0 110.905 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -93.07 12.95 22.33 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.479 -0.763 . . . . 0.0 111.697 -174.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.41 20.16 46.22 Favored Glycine 0 N--CA 1.495 2.62 0 C-N-CA 120.132 -1.033 . . . . 0.0 110.972 167.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -105.64 140.16 39.13 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.203 -1.175 . . . . 0.0 110.231 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.562 HG13 ' OE2' ' A' ' 289' ' ' GLU . 59.4 t -87.52 131.32 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.678 -0.639 . . . . 0.0 110.008 -176.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.759 HD11 ' CG2' ' A' ' 290' ' ' THR . 96.9 mt -99.87 -40.11 7.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.718 -0.614 . . . . 0.0 110.484 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -162.7 151.6 21.48 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.434 ' HD2' HG11 ' A' ' 295' ' ' VAL . 46.3 mtp180 -135.01 134.35 40.36 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.719 -0.871 . . . . 0.0 110.469 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -136.3 152.81 51.09 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.558 -0.713 . . . . 0.0 110.236 172.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . 0.686 ' SG ' HG23 ' A' ' 285' ' ' ILE . 90.7 m -142.49 153.18 43.41 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.415 -0.803 . . . . 0.0 110.772 -175.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.512 ' CE1' HD12 ' A' ' 284' ' ' ILE . 51.1 p90 -145.82 166.77 24.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.671 -0.643 . . . . 0.0 109.97 174.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.48 ' HA ' HD23 ' A' ' 283' ' ' LEU . 58.0 tt0 -104.84 136.91 43.45 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.527 -0.733 . . . . 0.0 110.225 -177.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -119.4 145.47 46.19 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.626 -171.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 40.0 tpt85 -138.09 134.01 34.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.71 -0.619 . . . . 0.0 109.699 174.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.662 HG21 ' HA ' ' A' ' 270' ' ' ASN . 80.5 mt -105.75 122.87 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.504 -0.748 . . . . 0.0 109.583 176.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.4 p -145.21 173.23 12.12 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.535 -0.728 . . . . 0.0 110.648 -171.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -72.46 -40.13 67.23 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.704 -0.623 . . . . 0.0 110.582 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.7 t -131.04 89.37 42.52 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.544 -0.722 . . . . 0.0 110.467 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . 0.408 ' CG ' ' HG3' ' A' ' 165' ' ' GLN . 50.7 Cg_exo -54.13 -30.52 60.99 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 O-C-N 123.188 1.099 . . . . 0.0 111.03 172.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -65.4 -37.15 93.51 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -73.26 -40.44 64.63 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.669 -0.901 . . . . 0.0 109.802 -173.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -69.52 -41.33 76.15 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 120.084 -0.647 . . . . 0.0 110.092 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 72.4 ttt-85 -61.21 -41.8 97.48 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.564 -0.71 . . . . 0.0 110.346 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -64.17 -38.61 91.66 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.49 -0.757 . . . . 0.0 110.451 178.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -62.7 -52.85 61.68 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.486 -0.759 . . . . 0.0 110.541 -173.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.4 p30 . . . . . 0 N--CA 1.496 1.839 0 O-C-N 121.464 -0.773 . . . . 0.0 110.158 -176.992 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.3 t . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.108 0.48 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 p-10 -95.58 25.17 4.68 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.664 -0.647 . . . . 0.0 110.775 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 55.1 m -72.3 125.25 26.88 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.511 -0.743 . . . . 0.0 110.242 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -72.3 144.88 48.18 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.705 -0.622 . . . . 0.0 110.437 -178.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.429 ' CE1' ' HA2' ' A' ' 134' ' ' GLY . 65.0 t80 -159.64 100.62 1.5 Allowed Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.671 -0.643 . . . . 0.0 110.129 178.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -58.72 -39.93 77.61 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 O-C-N 123.182 1.096 . . . . 0.0 110.818 -176.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.429 ' HA2' ' CE1' ' A' ' 132' ' ' TYR . . . 79.95 -155.16 38.37 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -73.3 -48.31 0.27 Allowed 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.385 1.203 . . . . 0.0 110.901 -174.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -85.05 6.28 26.02 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.557 -0.714 . . . . 0.0 111.341 -174.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.92 59.79 4.04 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.983 -1.073 . . . . 0.0 110.669 -176.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.733 ' HA ' HG12 ' A' ' 176' ' ' VAL . 64.5 t80 -78.35 118.75 20.83 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.54 -0.725 . . . . 0.0 109.959 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -130.1 159.98 35.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.811 -0.556 . . . . 0.0 110.289 -175.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 66.7 t -124.01 146.29 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 121.272 0.558 . . . . 0.0 110.087 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.0 p -156.95 169.09 25.59 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.218 0.532 . . . . 0.0 109.757 174.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.43 ' CE2' HG12 ' A' ' 172' ' ' ILE . 36.4 m-85 . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.7 -0.625 . . . . 0.0 109.792 -177.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.883 0 CA-C-O 121.227 0.537 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 46.6 p -60.12 -34.05 72.98 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.698 -0.626 . . . . 0.0 110.117 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.585 ' CE3' HD11 ' A' ' 162' ' ' LEU . 64.3 p-90 -170.54 148.0 3.01 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.817 -0.552 . . . . 0.0 109.867 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 15.1 t -142.12 142.41 32.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.777 -0.577 . . . . 0.0 110.063 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.443 ' HB2' HD12 ' A' ' 162' ' ' LEU . 61.0 t80 -125.52 140.08 53.07 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.487 -0.758 . . . . 0.0 110.538 -172.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.2 t -110.01 123.09 49.04 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.863 176.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 61.6 m -70.58 -37.11 73.89 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.763 -0.586 . . . . 0.0 110.503 -176.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -59.28 -34.23 72.03 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.516 -0.74 . . . . 0.0 110.533 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.6 mt -104.75 -11.02 17.04 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.628 -0.67 . . . . 0.0 110.889 -175.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 62.8 tttt 59.86 52.52 5.32 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.063 -1.023 . . . . 0.0 109.735 177.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -145.72 152.99 40.48 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.632 -175.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.679 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.61 137.73 53.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.744 -0.598 . . . . 0.0 110.203 -176.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -117.27 132.81 56.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.54 -0.725 . . . . 0.0 109.283 175.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.1 p -138.31 158.47 44.22 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.983 -175.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -104.53 142.77 34.03 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.456 0.646 . . . . 0.0 110.11 172.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.433 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.2 tt -51.28 147.48 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 CA-C-O 121.655 0.74 . . . . 0.0 112.117 -173.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.47 9.89 5.36 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.543 -0.723 . . . . 0.0 112.481 177.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -96.51 155.12 16.9 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.996 -1.065 . . . . 0.0 110.93 175.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 84.1 m -84.03 126.19 32.81 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.646 -0.659 . . . . 0.0 110.841 -176.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' CYS . . . . . 0.679 ' SG ' HD21 ' A' ' 162' ' ' LEU . 42.8 t -113.38 90.23 16.68 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.603 -0.685 . . . . 0.0 110.137 174.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.432 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 15.3 Cg_exo -65.9 130.81 25.46 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.298 1.157 . . . . 0.0 110.449 177.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.43 HG12 ' CE2' ' A' ' 142' ' ' PHE . 93.8 mt -124.21 139.39 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.696 -0.628 . . . . 0.0 109.408 176.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 10.3 mp0 -108.95 134.35 51.74 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.613 -0.68 . . . . 0.0 110.664 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.607 HG21 ' CE1' ' A' ' 138' ' ' PHE . 49.6 mm -95.3 135.14 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.637 -0.664 . . . . 0.0 109.612 172.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -118.62 130.36 55.83 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.461 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.733 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.5 m -136.36 159.72 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.523 -0.736 . . . . 0.0 109.971 175.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 80.7 mmm -77.23 -40.21 45.75 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.751 -0.593 . . . . 0.0 110.054 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.5 p -135.15 143.26 45.05 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.79 -0.569 . . . . 0.0 109.826 177.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.9 Cg_exo -55.58 139.92 83.08 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 O-C-N 123.145 1.076 . . . . 0.0 110.859 -172.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.614 ' HB3' HD21 ' A' ' 288' ' ' LEU . 25.5 Cg_endo -64.88 169.16 12.17 Favored 'Trans proline' 0 N--CA 1.487 1.095 0 O-C-N 123.127 1.067 . . . . 0.0 110.687 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -61.12 155.85 48.43 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 O-C-N 123.379 1.199 . . . . 0.0 110.496 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -75.3 139.4 42.46 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.656 -0.652 . . . . 0.0 109.931 175.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.76 -25.05 28.99 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 -175.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.14 150.81 2.24 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.355 -1.085 . . . . 0.0 111.391 178.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.79 155.92 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.665 -0.647 . . . . 0.0 109.897 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.652 HD11 ' CD2' ' A' ' 251' ' ' TYR . 74.0 mt -108.78 135.25 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.727 ' HG2' HD22 ' A' ' 248' ' ' LEU . 54.1 mtt180 -114.97 147.71 39.7 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -174.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.64 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -141.36 128.14 20.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.386 -0.821 . . . . 0.0 110.405 173.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.402 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 31.6 ttp -137.23 140.25 30.4 Favored Pre-proline 0 N--CA 1.496 1.864 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.062 -177.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.562 ' HD3' HD12 ' A' ' 226' ' ' ILE . 72.9 Cg_endo -91.5 138.2 2.13 Favored 'Trans proline' 0 C--N 1.32 -0.957 0 C-N-CA 121.08 1.187 . . . . 0.0 110.858 177.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.461 HG12 ' CZ ' ' A' ' 244' ' ' ARG . 35.0 m -147.91 154.9 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.546 -0.721 . . . . 0.0 109.924 174.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.626 ' HA ' HG22 ' A' ' 282' ' ' ILE . 82.5 m-85 -60.4 168.52 2.05 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.395 -0.816 . . . . 0.0 110.513 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.46 ' HA ' HD12 ' A' ' 283' ' ' LEU . 68.8 tttt -84.08 -60.11 2.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.588 -0.695 . . . . 0.0 110.76 -175.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 43.1 mttp -80.16 151.68 29.62 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.54 -0.725 . . . . 0.0 110.305 -175.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.451 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.76 -38.36 72.34 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.384 -0.823 . . . . 0.0 110.633 -176.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -56.39 -24.52 45.22 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.386 -0.821 . . . . 0.0 110.584 -177.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.419 ' HB3' ' CG ' ' A' ' 192' ' ' TYR . 96.6 m-70 -109.97 -20.52 12.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.466 -0.771 . . . . 0.0 111.21 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.451 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -67.41 -20.2 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.194 -0.941 . . . . 0.0 110.595 -176.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 74.4 p -79.38 -16.92 55.46 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.524 -0.735 . . . . 0.0 110.767 175.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.45 135.1 33.64 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.348 -0.845 . . . . 0.0 110.064 173.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.414 HG21 ' O ' ' A' ' 242' ' ' THR . 62.0 t -73.38 140.97 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.564 -0.71 . . . . 0.0 110.348 178.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.523 HG22 ' CE1' ' A' ' 192' ' ' TYR . 65.7 t -84.89 140.05 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.594 -0.691 . . . . 0.0 109.506 172.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -134.91 -170.28 2.53 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.53 -0.731 . . . . 0.0 110.99 -169.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 81.3 mtm-85 -95.36 157.06 16.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.842 -0.536 . . . . 0.0 110.424 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.599 ' HG ' ' HG ' ' A' ' 273' ' ' CYS . 58.8 m . . . . . 0 N--CA 1.497 1.909 0 O-C-N 121.651 -0.656 . . . . 0.0 109.475 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.816 HD21 ' CE ' ' A' ' 277' ' ' MET . 61.9 tp . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 120.875 0.369 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.562 HD12 ' HD3' ' A' ' 190' ' ' PRO . 82.2 mt -102.21 136.75 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 120.329 -0.548 . . . . 0.0 109.685 177.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 22.2 mtp-105 -131.75 157.23 44.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.758 -0.589 . . . . 0.0 110.157 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.486 HG23 HG21 ' A' ' 247' ' ' VAL . 99.3 t -104.8 146.5 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.737 -0.602 . . . . 0.0 110.042 176.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -118.9 123.65 45.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.768 -0.583 . . . . 0.0 110.473 172.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 96.31 23.32 17.1 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 168.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -135.0 108.82 8.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.369 -1.077 . . . . 0.0 110.142 174.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 27.3 t -62.88 -15.14 53.73 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.609 -0.682 . . . . 0.0 111.318 -177.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -99.35 9.91 42.42 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.29 -0.881 . . . . 0.0 111.552 -177.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.46 124.49 20.51 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.092 -1.005 . . . . 0.0 110.235 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -139.78 158.05 44.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.794 -0.566 . . . . 0.0 109.678 177.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -117.98 150.72 38.79 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.546 -0.721 . . . . 0.0 110.793 -175.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.07 159.95 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.819 -0.551 . . . . 0.0 110.108 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -120.0 130.03 54.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.792 -0.567 . . . . 0.0 110.299 177.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -63.77 130.07 94.18 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.653 -0.655 . . . . 0.0 109.784 178.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -65.97 -28.35 49.94 Favored 'Trans proline' 0 C--N 1.316 -1.168 0 O-C-N 123.042 1.022 . . . . 0.0 110.97 -170.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.8 mt -101.14 -50.5 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.465 -0.772 . . . . 0.0 111.019 -168.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.414 ' O ' HG21 ' A' ' 201' ' ' VAL . 13.0 p -105.34 12.15 32.0 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.338 -0.851 . . . . 0.0 111.872 -175.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 72.37 -4.92 17.22 Favored Glycine 0 N--CA 1.496 2.667 0 O-C-N 121.013 -1.055 . . . . 0.0 111.968 172.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.461 ' CZ ' HG12 ' A' ' 191' ' ' VAL . 22.1 mmt180 -46.0 142.07 2.87 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 119.163 1.482 . . . . 0.0 112.389 -175.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -104.25 143.35 33.08 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.674 -0.641 . . . . 0.0 110.204 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.1 p -154.71 160.04 41.1 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.608 -0.682 . . . . 0.0 110.213 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.486 HG21 HG23 ' A' ' 228' ' ' VAL . 8.5 p -123.01 148.19 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.707 -0.621 . . . . 0.0 109.779 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.727 HD22 ' HG2' ' A' ' 187' ' ' ARG . 83.0 mt -129.82 154.69 47.0 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 120.204 -0.599 . . . . 0.0 109.931 -174.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.43 HG13 ' C ' ' A' ' 248' ' ' LEU . 32.1 m -150.69 151.81 31.15 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.783 -0.573 . . . . 0.0 109.816 174.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -70.94 139.46 36.19 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 O-C-N 123.267 1.141 . . . . 0.0 110.029 177.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.652 ' CD2' HD11 ' A' ' 186' ' ' ILE . 10.2 t80 -79.59 122.16 26.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.519 -0.738 . . . . 0.0 110.07 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -100.08 160.09 28.08 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.706 -0.621 . . . . 0.0 110.184 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -58.95 160.08 19.46 Favored 'Trans proline' 0 N--CA 1.488 1.174 0 O-C-N 123.285 1.15 . . . . 0.0 110.457 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.17 150.05 76.32 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 O-C-N 123.276 1.145 . . . . 0.0 110.613 -177.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -60.95 149.56 36.15 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.609 -0.682 . . . . 0.0 110.189 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.84 127.21 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.496 -0.752 . . . . 0.0 110.148 -170.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.29 -10.18 56.46 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 9.4 t -145.41 175.39 10.35 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.25 -1.147 . . . . 0.0 110.619 175.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -110.03 13.09 23.42 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.617 -0.677 . . . . 0.0 111.883 -167.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -120.84 168.03 11.89 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.141 -0.974 . . . . 0.0 111.177 -177.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 93.4 m -117.87 147.56 42.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.793 -0.567 . . . . 0.0 109.837 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 32.7 m -117.78 136.14 53.59 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.567 -0.708 . . . . 0.0 110.945 -175.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 57.9 t -130.44 137.18 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 171.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 74.0 mt -104.88 120.94 42.63 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.512 -0.742 . . . . 0.0 110.004 -173.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.64 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 5.9 m-30 -105.55 150.62 25.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.688 -0.633 . . . . 0.0 110.662 -177.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -136.56 142.99 43.42 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -113.31 131.93 55.76 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.584 -0.697 . . . . 0.0 110.48 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' MET . . . . . 0.436 ' HG3' HD12 ' A' ' 225' ' ' LEU . 5.0 ppp? -101.28 9.43 41.75 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.657 -0.652 . . . . 0.0 111.963 -176.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . 0.549 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.8 OUTLIER -144.6 163.45 33.88 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.115 -0.991 . . . . 0.0 110.076 171.417 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.654 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.9 p30 -121.34 163.97 17.8 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.442 0.639 . . . . 0.0 110.434 -177.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . 0.426 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 50.4 m -58.22 -34.07 70.0 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.44 -0.788 . . . . 0.0 111.058 -163.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 49.6 p -103.62 15.05 29.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.39 -0.819 . . . . 0.0 111.844 -163.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . 0.599 ' HG ' ' HG ' ' A' ' 205' ' ' CYS . 30.5 p -94.86 118.09 31.21 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.11 -0.994 . . . . 0.0 110.585 177.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 60.1 t -64.24 139.9 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.42 -0.8 . . . . 0.0 110.332 -169.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.22 -5.17 58.98 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.0 -95.6 0.75 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 172.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . 0.816 ' CE ' HD21 ' A' ' 225' ' ' LEU . 15.9 mmt -63.04 -34.12 76.89 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.699 -0.883 . . . . 0.0 110.304 177.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.4 p30 43.38 48.1 5.92 Favored 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 176.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 36.2 mtt180 54.73 29.46 11.76 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.356 -0.84 . . . . 0.0 111.2 175.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -120.07 105.06 43.0 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.58 -0.7 . . . . 0.0 110.078 175.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.77 147.6 91.62 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 O-C-N 123.128 1.067 . . . . 0.0 110.481 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.626 HG22 ' HA ' ' A' ' 192' ' ' TYR . 45.4 pt -132.02 178.0 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.779 0.8 . . . . 0.0 111.011 -175.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 193' ' ' LYS . 30.4 mt -124.42 149.88 46.26 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.698 HD12 ' CE1' ' A' ' 301' ' ' PHE . 79.9 mt -115.33 130.1 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.245 177.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.519 HG23 ' SG ' ' A' ' 300' ' ' CYS . 80.9 mt -109.76 126.39 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -176.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 57.5 t -118.86 126.78 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.6 p -125.25 153.71 42.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.603 -0.686 . . . . 0.0 110.579 -173.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.614 HD21 ' HB3' ' A' ' 180' ' ' PRO . 25.0 tp -103.97 125.87 50.67 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 169.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.661 ' OE2' HG13 ' A' ' 295' ' ' VAL . 73.9 mm-40 -131.24 149.92 52.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.885 -0.509 . . . . 0.0 109.882 -173.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.728 ' CG2' HD11 ' A' ' 296' ' ' LEU . 74.4 p -89.86 159.36 17.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.629 -0.669 . . . . 0.0 109.774 177.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -55.96 -26.07 46.53 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.582 -0.699 . . . . 0.0 110.823 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -87.27 9.68 19.53 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.519 -0.738 . . . . 0.0 111.783 -174.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 87.51 20.19 52.32 Favored Glycine 0 N--CA 1.495 2.606 0 O-C-N 121.089 -1.007 . . . . 0.0 110.731 170.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -108.02 140.26 41.44 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.283 -1.127 . . . . 0.0 110.175 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.661 HG13 ' OE2' ' A' ' 289' ' ' GLU . 60.0 t -89.55 132.56 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.587 -0.696 . . . . 0.0 110.067 -174.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.728 HD11 ' CG2' ' A' ' 290' ' ' THR . 96.2 mt -99.97 -40.1 7.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.671 -0.643 . . . . 0.0 110.489 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -161.67 154.83 25.91 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -178.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 47.7 mtp180 -134.9 135.15 41.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.669 -0.9 . . . . 0.0 110.746 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 -135.18 158.03 45.4 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.609 -0.682 . . . . 0.0 109.958 172.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . 0.519 ' SG ' HG23 ' A' ' 285' ' ' ILE . 85.9 m -144.29 153.83 42.43 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.504 -0.747 . . . . 0.0 110.745 -176.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.698 ' CE1' HD12 ' A' ' 284' ' ' ILE . 49.3 p90 -144.96 162.17 37.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.705 -0.622 . . . . 0.0 110.05 174.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.45 ' HA ' HD23 ' A' ' 283' ' ' LEU . 82.1 tt0 -104.84 135.36 46.35 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.479 -0.763 . . . . 0.0 110.198 -176.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -120.06 142.93 48.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.626 -0.671 . . . . 0.0 110.687 -170.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -138.49 138.82 38.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.795 -0.565 . . . . 0.0 109.795 173.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.654 HG21 ' HA ' ' A' ' 270' ' ' ASN . 78.7 mt -108.75 122.89 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.544 -0.723 . . . . 0.0 109.619 177.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.9 p -145.36 170.56 16.1 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.66 -0.65 . . . . 0.0 110.69 -171.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -72.52 -40.12 67.05 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.613 -0.68 . . . . 0.0 110.708 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.8 t -127.95 86.43 58.17 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.591 -0.693 . . . . 0.0 110.484 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -55.91 -29.21 71.97 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 O-C-N 123.134 1.07 . . . . 0.0 110.899 174.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.48 -37.98 93.09 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.014 -1.635 . . . . 0.0 109.014 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -73.28 -40.02 64.9 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.748 -0.854 . . . . 0.0 109.751 -173.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -69.44 -39.78 77.6 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.163 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -61.86 -45.56 93.23 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.306 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 23.7 ttpt -64.11 -39.22 93.58 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.585 -0.697 . . . . 0.0 110.47 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.66 -50.71 71.4 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.495 -0.753 . . . . 0.0 110.426 -174.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 2.9 p30 . . . . . 0 N--CA 1.495 1.789 0 O-C-N 121.45 -0.781 . . . . 0.0 110.105 -178.254 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.4 t . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 121.099 0.476 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -95.42 24.39 5.17 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.68 -0.637 . . . . 0.0 110.64 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 54.6 m -72.71 125.18 26.88 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.567 -0.708 . . . . 0.0 110.337 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -70.97 144.98 50.33 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.723 -0.611 . . . . 0.0 110.291 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -158.28 102.07 1.71 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.603 -0.686 . . . . 0.0 110.164 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -58.77 -39.96 77.1 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 O-C-N 123.177 1.093 . . . . 0.0 110.691 -178.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.12 -155.15 45.6 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 177.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -72.75 -45.93 0.47 Allowed 'Trans proline' 0 N--CA 1.486 1.067 0 O-C-N 123.33 1.174 . . . . 0.0 111.004 -174.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -89.1 9.1 26.65 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.615 -0.678 . . . . 0.0 111.453 -172.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.71 61.63 3.01 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.975 -1.078 . . . . 0.0 110.732 -176.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.619 ' HA ' HG12 ' A' ' 176' ' ' VAL . 46.6 t80 -77.92 118.2 20.0 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.648 -0.657 . . . . 0.0 109.83 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -130.04 160.04 34.9 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.312 0.577 . . . . 0.0 110.178 -177.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 78.6 t -124.31 148.78 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.69 -0.631 . . . . 0.0 109.775 176.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.4 p -157.1 171.02 21.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.813 -0.554 . . . . 0.0 109.928 176.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.422 ' CE1' HG12 ' A' ' 172' ' ' ILE . 64.8 m-85 . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.821 -0.549 . . . . 0.0 109.64 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 121.145 0.497 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.4 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 76.1 p -60.06 -33.88 72.67 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.668 -0.645 . . . . 0.0 109.928 174.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.425 ' CE3' HD11 ' A' ' 162' ' ' LEU . 67.5 p-90 -170.06 148.02 3.33 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.964 -0.46 . . . . 0.0 109.784 178.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.9 t -142.04 142.37 32.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.789 -0.57 . . . . 0.0 109.974 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.414 ' HB2' HD12 ' A' ' 162' ' ' LEU . 62.9 t80 -125.76 140.12 52.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.513 -0.742 . . . . 0.0 110.559 -172.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 31.2 t -110.43 121.07 44.41 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.727 174.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 69.4 m -71.42 -36.45 71.31 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.702 -0.624 . . . . 0.0 110.489 -176.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -58.76 -33.83 70.72 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.586 -0.696 . . . . 0.0 110.526 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 53.9 mt -104.82 -11.33 16.84 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.734 -0.604 . . . . 0.0 110.851 -176.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt 59.87 51.84 5.76 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.045 -1.034 . . . . 0.0 109.825 176.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -147.14 152.86 39.13 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.696 -0.628 . . . . 0.0 110.714 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.425 HD11 ' CE3' ' A' ' 153' ' ' TRP . 14.6 tp -126.65 137.88 53.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.793 -0.567 . . . . 0.0 110.375 -173.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -117.54 133.32 56.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.537 -0.727 . . . . 0.0 109.462 175.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.1 p -138.3 158.31 44.54 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 120.111 -0.636 . . . . 0.0 111.104 -175.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -104.69 141.59 36.19 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.588 -0.695 . . . . 0.0 110.33 172.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.437 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 18.0 tt -54.6 149.43 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.529 -0.732 . . . . 0.0 111.552 -173.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.22 10.01 5.22 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.593 -0.692 . . . . 0.0 112.515 178.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -96.4 155.13 16.89 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.958 -1.089 . . . . 0.0 110.784 174.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 70.2 m -79.96 126.09 30.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.702 -0.624 . . . . 0.0 110.61 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 42.3 t -115.43 90.23 24.54 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.624 -0.673 . . . . 0.0 110.22 174.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -69.99 125.41 11.99 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.266 1.14 . . . . 0.0 110.521 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.643 HD12 ' CD2' ' A' ' 265' ' ' TYR . 86.4 mt -122.22 143.43 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.594 -0.692 . . . . 0.0 109.575 173.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.422 ' NE2' ' CE1' ' A' ' 260' ' ' PHE . 95.4 mt-30 -109.14 136.64 48.3 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.611 -0.681 . . . . 0.0 110.707 -175.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.3 mm -95.23 135.02 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.674 -0.641 . . . . 0.0 109.744 169.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 35.2 tttm -117.05 130.27 56.55 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.509 -0.745 . . . . 0.0 110.581 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.619 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.0 m -136.01 159.8 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.63 -0.669 . . . . 0.0 109.797 174.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 79.0 mmm -81.3 -45.4 16.27 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.62 -0.675 . . . . 0.0 110.151 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.417 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.0 p -126.52 143.18 45.37 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.724 -0.61 . . . . 0.0 109.684 177.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.5 Cg_exo -55.5 139.74 82.54 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 O-C-N 123.205 1.108 . . . . 0.0 110.902 -171.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.745 ' HB3' HD21 ' A' ' 288' ' ' LEU . 36.0 Cg_endo -67.51 170.01 14.53 Favored 'Trans proline' 0 N--CA 1.487 1.128 0 O-C-N 123.226 1.119 . . . . 0.0 110.542 177.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -60.26 155.77 44.2 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 123.326 1.172 . . . . 0.0 110.622 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -78.16 138.26 38.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.599 -0.688 . . . . 0.0 109.931 175.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.24 -24.97 30.08 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -174.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.13 151.2 2.09 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.381 -1.07 . . . . 0.0 111.48 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 35.4 m -129.75 156.03 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.777 -0.577 . . . . 0.0 109.853 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.693 HD11 ' HD2' ' A' ' 251' ' ' TYR . 53.7 mt -107.34 134.9 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 178.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.736 ' HG2' HD22 ' A' ' 248' ' ' LEU . 70.8 mtt180 -114.94 141.34 48.09 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -174.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.42 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -138.51 123.72 19.21 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.456 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 44.5 ttp -137.34 140.61 31.22 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.773 -0.579 . . . . 0.0 111.222 -175.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.637 ' HD3' HD12 ' A' ' 226' ' ' ILE . 71.7 Cg_endo -90.98 138.22 2.34 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 O-C-N 123.243 1.128 . . . . 0.0 110.717 176.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.434 HG13 ' C ' ' A' ' 190' ' ' PRO . 34.7 m -147.48 154.84 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.51 -0.744 . . . . 0.0 110.134 173.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.636 ' HA ' HG22 ' A' ' 282' ' ' ILE . 88.3 m-85 -61.33 166.67 3.71 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.488 -0.758 . . . . 0.0 110.429 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -84.67 -59.96 2.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.678 -0.639 . . . . 0.0 110.849 -175.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -80.08 152.24 29.44 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.656 -0.653 . . . . 0.0 110.319 -175.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.455 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.81 -38.58 72.78 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.333 -0.854 . . . . 0.0 110.72 -175.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -56.58 -24.57 48.28 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.539 -0.726 . . . . 0.0 110.567 -177.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.433 ' HB3' ' CD1' ' A' ' 192' ' ' TYR . 47.8 m80 -109.89 -20.46 12.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.565 -0.71 . . . . 0.0 111.116 -178.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.1 p -67.56 -20.19 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.145 -0.972 . . . . 0.0 110.606 -176.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 69.2 p -79.35 -17.01 55.37 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.535 -0.728 . . . . 0.0 110.678 174.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.41 136.93 32.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.357 -0.84 . . . . 0.0 110.029 174.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.8 t -73.02 146.03 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.623 -0.673 . . . . 0.0 110.228 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.581 HG23 HH12 ' A' ' 244' ' ' ARG . 60.8 t -84.95 136.16 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.595 -0.69 . . . . 0.0 109.191 172.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.0 pttp -134.95 -170.18 2.51 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.508 -0.745 . . . . 0.0 111.073 -167.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -95.1 159.32 15.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.75 -0.594 . . . . 0.0 110.501 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.563 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 59.9 m . . . . . 0 N--CA 1.497 1.888 0 O-C-N 121.627 -0.67 . . . . 0.0 109.281 175.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.405 ' HA ' ' CG ' ' A' ' 268' ' ' MET . 55.9 tp . . . . . 0 N--CA 1.497 1.878 0 CA-C-O 120.831 0.348 . . . . 0.0 110.325 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.637 HD12 ' HD3' ' A' ' 190' ' ' PRO . 80.9 mt -104.17 136.75 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.821 -0.549 . . . . 0.0 109.818 178.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -132.56 159.17 40.23 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.716 -0.615 . . . . 0.0 110.111 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.589 HG23 HG21 ' A' ' 247' ' ' VAL . 70.5 t -105.59 146.74 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.663 -0.648 . . . . 0.0 110.144 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -121.78 130.05 53.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.715 -0.616 . . . . 0.0 110.303 171.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.8 20.58 21.19 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.526 -1.029 . . . . 0.0 110.526 170.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -141.27 105.16 4.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.307 -1.114 . . . . 0.0 109.988 174.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 93.1 p -63.6 -15.13 57.3 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.603 -0.686 . . . . 0.0 111.224 -177.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -97.24 9.96 40.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.303 -0.873 . . . . 0.0 111.187 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.97 130.35 45.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.205 -0.934 . . . . 0.0 110.081 176.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -139.77 156.25 46.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.774 -0.579 . . . . 0.0 109.719 177.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.423 ' CD1' ' HB ' ' A' ' 247' ' ' VAL . 90.4 m-85 -117.96 150.66 38.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.513 -0.742 . . . . 0.0 110.617 -176.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.08 159.89 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.902 -0.499 . . . . 0.0 110.224 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -119.65 130.08 54.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.771 -0.581 . . . . 0.0 110.113 176.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -61.72 126.04 86.09 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.657 -0.652 . . . . 0.0 109.754 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -65.01 -29.15 57.27 Favored 'Trans proline' 0 C--N 1.317 -1.123 0 O-C-N 123.201 1.106 . . . . 0.0 110.782 -172.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.9 mt -104.15 -50.25 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.553 -0.717 . . . . 0.0 110.943 -170.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 20.3 p -105.26 12.25 32.02 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.372 -0.83 . . . . 0.0 111.945 -170.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 82.31 -23.24 5.55 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 120.97 -1.081 . . . . 0.0 111.85 168.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.581 HH12 HG23 ' A' ' 202' ' ' VAL . 25.9 mmt180 -45.79 142.07 2.69 Favored 'General case' 0 N--CA 1.505 2.325 0 CA-C-N 118.572 1.186 . . . . 0.0 112.569 -168.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -105.12 146.17 29.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.637 -0.664 . . . . 0.0 110.093 174.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 78.8 p -154.79 159.92 40.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.584 -0.698 . . . . 0.0 110.404 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.589 HG21 HG23 ' A' ' 228' ' ' VAL . 8.3 p -122.95 148.1 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.746 -0.596 . . . . 0.0 109.69 178.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.736 HD22 ' HG2' ' A' ' 187' ' ' ARG . 81.6 mt -129.69 154.58 47.02 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.797 -175.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.443 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.4 m -151.07 151.75 30.14 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.822 -0.549 . . . . 0.0 110.008 175.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -71.09 139.08 34.9 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 O-C-N 123.237 1.125 . . . . 0.0 109.999 177.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.693 ' HD2' HD11 ' A' ' 186' ' ' ILE . 61.8 t80 -76.04 123.9 26.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.488 -0.758 . . . . 0.0 110.219 176.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -99.95 160.09 28.15 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.668 -0.645 . . . . 0.0 110.029 176.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -58.76 159.72 19.96 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 O-C-N 123.154 1.081 . . . . 0.0 110.42 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.03 149.98 76.06 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 O-C-N 123.26 1.137 . . . . 0.0 110.522 -176.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -61.71 148.2 43.56 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.648 -0.658 . . . . 0.0 110.138 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.9 t -69.81 127.18 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.586 -0.696 . . . . 0.0 110.233 -170.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.93 -10.13 55.45 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 10.2 t -144.63 174.42 10.98 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.148 -1.207 . . . . 0.0 110.648 175.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -108.27 13.14 25.97 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.613 -0.679 . . . . 0.0 111.83 -167.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.422 ' CE1' ' NE2' ' A' ' 173' ' ' GLN . 40.2 p90 -123.88 168.17 13.13 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.096 -1.003 . . . . 0.0 111.148 -175.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 71.9 m -117.73 145.23 44.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.799 -0.563 . . . . 0.0 109.75 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 28.4 m -115.28 137.41 52.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.615 -0.678 . . . . 0.0 110.882 -174.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 57.8 t -128.78 136.99 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 172.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 63.9 mt -104.73 120.47 41.43 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.534 -0.729 . . . . 0.0 109.873 -174.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.643 ' CD2' HD12 ' A' ' 172' ' ' ILE . 3.8 m-85 -98.41 156.19 16.87 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.627 -0.67 . . . . 0.0 110.842 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -136.49 142.89 43.56 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 171.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -111.89 132.02 54.99 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.61 -0.681 . . . . 0.0 110.397 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' MET . . . . . 0.405 ' CG ' ' HA ' ' A' ' 225' ' ' LEU . 5.2 ppp? -102.73 6.77 39.63 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.659 -0.651 . . . . 0.0 111.874 -177.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . 0.661 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.6 OUTLIER -144.73 160.45 41.2 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.985 -1.072 . . . . 0.0 109.908 171.822 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.522 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.3 p30 -119.77 163.49 17.38 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.459 0.647 . . . . 0.0 110.506 -178.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . 0.426 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 50.1 m -58.63 -33.09 69.66 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.482 -0.761 . . . . 0.0 111.028 -163.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 50.0 p -100.77 12.68 37.03 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.431 -0.793 . . . . 0.0 111.954 -163.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . 0.563 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 29.6 p -94.69 117.99 31.02 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.091 -1.006 . . . . 0.0 110.625 177.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.4 t -64.42 139.78 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.561 -0.712 . . . . 0.0 110.356 -169.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.37 -5.02 60.5 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -125.06 -100.33 1.28 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 170.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . 0.426 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.4 mmm -64.87 -31.44 72.67 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.693 -0.887 . . . . 0.0 110.355 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.8 p30 43.1 52.11 5.45 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 175.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 54.85 27.0 8.37 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.328 -0.858 . . . . 0.0 111.182 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 36.6 mtt180 -118.77 106.36 44.08 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.56 -0.712 . . . . 0.0 110.046 175.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.38 149.19 82.9 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 O-C-N 123.015 1.008 . . . . 0.0 110.691 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.636 HG22 ' HA ' ' A' ' 192' ' ' TYR . 44.6 pt -131.93 -179.7 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-O 121.752 0.786 . . . . 0.0 110.742 -177.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 302' ' ' GLU . 34.7 mt -124.33 149.93 46.03 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.56 HD12 ' CE1' ' A' ' 301' ' ' PHE . 77.7 mt -113.83 128.75 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.125 176.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.627 HG23 ' SG ' ' A' ' 300' ' ' CYS . 80.0 mt -109.84 126.46 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -175.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 59.2 t -118.88 126.69 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.2 p -125.36 154.7 41.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.683 -0.635 . . . . 0.0 110.516 -175.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.745 HD21 ' HB3' ' A' ' 180' ' ' PRO . 28.8 tp -102.61 126.42 49.68 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 168.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.746 ' OE2' HG13 ' A' ' 295' ' ' VAL . 74.1 mm-40 -131.61 150.3 52.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.845 -0.534 . . . . 0.0 109.937 -171.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.696 ' CG2' HD11 ' A' ' 296' ' ' LEU . 76.8 p -90.03 157.43 17.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.67 -0.644 . . . . 0.0 109.909 177.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -56.08 -26.1 48.12 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.587 -0.696 . . . . 0.0 110.932 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -91.03 11.86 21.65 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.451 -0.78 . . . . 0.0 111.745 -174.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 90.25 20.15 43.15 Favored Glycine 0 N--CA 1.494 2.541 0 C-N-CA 120.139 -1.029 . . . . 0.0 110.922 168.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -109.15 140.17 43.09 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.3 -1.118 . . . . 0.0 110.062 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.746 HG13 ' OE2' ' A' ' 289' ' ' GLU . 59.2 t -91.64 133.39 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.558 -0.714 . . . . 0.0 110.234 -174.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.696 HD11 ' CG2' ' A' ' 290' ' ' THR . 93.9 mt -99.97 -40.0 7.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.757 -0.589 . . . . 0.0 110.586 -179.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -159.29 155.41 26.5 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.698 ' CZ ' HG11 ' A' ' 295' ' ' VAL . 57.2 mtt85 -135.06 136.28 41.91 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.764 -0.845 . . . . 0.0 110.349 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -136.58 153.99 50.81 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.44 -0.787 . . . . 0.0 110.19 168.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . 0.627 ' SG ' HG23 ' A' ' 285' ' ' ILE . 95.8 m -143.29 154.01 43.35 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.545 -0.722 . . . . 0.0 110.626 -175.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.56 ' CE1' HD12 ' A' ' 284' ' ' ILE . 51.7 p90 -145.77 166.8 24.82 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.647 -0.658 . . . . 0.0 109.962 173.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.474 ' HA ' HD23 ' A' ' 283' ' ' LEU . 82.0 tt0 -104.92 135.62 45.93 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.421 -0.8 . . . . 0.0 110.193 -177.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -122.67 144.26 49.25 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.722 -169.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -138.08 138.94 39.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.747 -0.596 . . . . 0.0 109.694 173.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.661 HD13 ' O ' ' A' ' 269' ' ' CYS . 74.0 mt -107.42 122.83 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.548 -0.72 . . . . 0.0 109.735 176.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.8 p -145.27 169.71 17.7 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.7 -0.625 . . . . 0.0 110.647 -172.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -71.55 -40.11 70.24 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.626 -0.671 . . . . 0.0 110.648 -178.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.7 t -127.16 86.07 59.61 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.476 -0.765 . . . . 0.0 110.468 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -55.94 -28.16 67.15 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 O-C-N 123.251 1.132 . . . . 0.0 110.766 174.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -67.05 -37.8 92.11 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 177.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -72.76 -40.84 65.69 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.737 -0.86 . . . . 0.0 109.845 -173.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -69.5 -38.91 77.82 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.162 -178.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -61.81 -43.22 99.28 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.195 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 21.0 ttpp -64.18 -38.53 91.39 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.582 -0.699 . . . . 0.0 110.446 178.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -60.74 -50.52 73.13 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.507 -0.746 . . . . 0.0 110.46 -173.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 2.8 p30 . . . . . 0 N--CA 1.495 1.775 0 O-C-N 121.482 -0.761 . . . . 0.0 110.087 -179.12 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.7 t . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.097 0.475 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.7 p-10 -94.31 23.54 5.07 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.658 -0.651 . . . . 0.0 110.885 -178.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 54.0 m -72.35 125.15 26.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.471 -0.768 . . . . 0.0 110.212 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -70.53 144.92 51.17 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.602 -0.686 . . . . 0.0 110.401 -177.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.426 ' CE1' ' HA2' ' A' ' 134' ' ' GLY . 52.6 t80 -157.33 101.22 1.89 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.618 -0.676 . . . . 0.0 110.101 178.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.51 -39.94 78.76 Favored 'Trans proline' 0 N--CA 1.488 1.204 0 O-C-N 123.153 1.081 . . . . 0.0 110.952 -174.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.426 ' HA2' ' CE1' ' A' ' 132' ' ' TYR . . . 79.84 -155.11 38.52 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -74.18 -47.61 0.24 Allowed 'Trans proline' 0 C--N 1.317 -1.085 0 O-C-N 123.313 1.165 . . . . 0.0 110.846 -175.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -84.19 5.16 27.45 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.525 -0.734 . . . . 0.0 111.431 -175.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 54.01 59.97 3.92 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.898 -1.126 . . . . 0.0 110.681 -176.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.728 ' HA ' HG12 ' A' ' 176' ' ' VAL . 64.6 t80 -77.96 118.94 20.74 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.57 -0.706 . . . . 0.0 110.008 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -129.96 159.92 35.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.785 -0.572 . . . . 0.0 110.215 -175.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 71.9 t -123.65 146.66 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-O 121.443 0.639 . . . . 0.0 110.174 177.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 76.8 p -157.06 171.16 20.95 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 175.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.422 ' CE2' HG12 ' A' ' 172' ' ' ILE . 64.8 m-85 . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.706 -0.622 . . . . 0.0 109.916 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 121.117 0.484 . . . . 0.0 109.943 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 57.9 p -60.15 -34.09 73.07 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.773 -0.579 . . . . 0.0 110.118 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.547 ' CE3' HD11 ' A' ' 162' ' ' LEU . 66.9 p-90 -170.46 148.14 3.09 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.636 -0.665 . . . . 0.0 109.752 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 13.7 t -141.52 142.36 33.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.717 -0.614 . . . . 0.0 110.031 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -125.65 140.04 53.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.482 -0.761 . . . . 0.0 110.532 -172.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 32.8 t -109.82 122.31 47.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.783 -0.573 . . . . 0.0 109.785 175.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 65.1 m -70.66 -36.8 73.56 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.689 -0.632 . . . . 0.0 110.482 -177.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -58.79 -34.28 71.29 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.615 -0.678 . . . . 0.0 110.582 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 53.8 mt -104.8 -11.71 16.66 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.61 -0.681 . . . . 0.0 110.804 -176.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.0 tttm 59.82 52.18 5.59 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.14 -0.975 . . . . 0.0 109.732 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -145.86 152.88 40.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.714 -0.616 . . . . 0.0 110.562 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.669 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.5 tp -126.66 137.83 53.34 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.863 -0.523 . . . . 0.0 110.256 -175.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -116.96 133.86 55.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.557 -0.714 . . . . 0.0 109.319 174.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.9 p -138.29 158.46 44.25 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 120.036 -0.665 . . . . 0.0 110.979 -174.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -104.52 143.9 32.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.62 -0.675 . . . . 0.0 110.398 172.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 16.9 tt -52.47 147.77 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 CA-C-O 121.64 0.733 . . . . 0.0 111.841 -173.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.16 10.01 5.18 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.628 -0.67 . . . . 0.0 112.539 177.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 32.3 mmtt -96.52 155.13 16.9 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.04 -1.037 . . . . 0.0 110.788 175.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 85.6 m -84.31 126.21 32.98 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.666 -0.646 . . . . 0.0 110.676 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' CYS . . . . . 0.669 ' SG ' HD21 ' A' ' 162' ' ' LEU . 42.6 t -112.63 90.31 14.67 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.514 -0.741 . . . . 0.0 110.082 173.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -64.75 129.28 23.03 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 123.339 1.179 . . . . 0.0 110.445 176.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.422 HG12 ' CE2' ' A' ' 142' ' ' PHE . 95.4 mt -123.17 138.67 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.665 -0.647 . . . . 0.0 109.36 176.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -108.72 133.97 52.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.546 -0.722 . . . . 0.0 110.637 -176.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.59 HG21 ' CE1' ' A' ' 138' ' ' PHE . 49.5 mm -95.37 135.07 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.641 -0.662 . . . . 0.0 109.674 172.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -118.08 129.93 55.85 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.583 -0.698 . . . . 0.0 110.597 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.728 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.3 m -136.3 159.74 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.475 -0.766 . . . . 0.0 109.957 175.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 79.7 mmm -77.46 -40.37 43.43 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.745 -0.597 . . . . 0.0 110.018 177.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.0 p -134.1 143.21 46.22 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.78 -0.575 . . . . 0.0 109.793 177.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 33.2 Cg_exo -55.67 139.88 83.6 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 O-C-N 123.2 1.105 . . . . 0.0 110.86 -173.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.616 ' HB3' HD21 ' A' ' 288' ' ' LEU . 23.5 Cg_endo -64.5 168.18 13.54 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 O-C-N 123.23 1.121 . . . . 0.0 110.635 178.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -61.53 158.21 37.72 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 O-C-N 123.353 1.186 . . . . 0.0 110.413 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -77.76 137.9 38.71 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.667 -0.645 . . . . 0.0 109.889 175.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.53 -24.97 30.08 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -174.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.1 149.98 2.58 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.367 -1.078 . . . . 0.0 111.373 177.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.71 155.99 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.654 -0.654 . . . . 0.0 109.816 176.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.656 HD11 ' CD2' ' A' ' 251' ' ' TYR . 69.8 mt -108.46 136.21 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.745 ' HG2' HD22 ' A' ' 248' ' ' LEU . 36.5 mtp180 -114.89 146.11 41.46 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -175.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.629 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -140.6 127.56 20.68 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.439 -0.788 . . . . 0.0 110.337 172.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.405 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 25.0 ttm -137.2 139.36 27.87 Favored Pre-proline 0 N--CA 1.495 1.811 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.031 -177.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.503 ' HD3' HD12 ' A' ' 226' ' ' ILE . 72.6 Cg_endo -91.34 138.29 2.21 Favored 'Trans proline' 0 C--N 1.32 -0.972 0 O-C-N 123.288 1.152 . . . . 0.0 110.772 177.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.428 HG13 ' C ' ' A' ' 190' ' ' PRO . 34.7 m -147.24 154.89 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.518 -0.739 . . . . 0.0 110.059 174.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.631 ' HA ' HG22 ' A' ' 282' ' ' ILE . 77.3 m-85 -61.6 164.78 5.58 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.47 -0.769 . . . . 0.0 110.545 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.437 ' HA ' HD12 ' A' ' 283' ' ' LEU . 48.7 tttp -80.33 -60.02 2.48 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.625 -0.672 . . . . 0.0 110.843 -174.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -80.04 151.2 30.06 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.601 -0.687 . . . . 0.0 110.372 -175.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.453 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.44 -38.52 71.74 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.368 -0.832 . . . . 0.0 110.736 -175.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -56.49 -24.92 49.34 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.525 -0.735 . . . . 0.0 110.58 -176.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.42 ' HB3' ' CG ' ' A' ' 192' ' ' TYR . 63.2 m170 -110.05 -20.49 12.69 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.094 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.453 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -67.14 -20.22 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.157 -0.964 . . . . 0.0 110.564 -176.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 81.3 p -79.35 -17.08 55.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.502 -0.749 . . . . 0.0 110.777 175.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.25 135.65 33.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.342 -0.849 . . . . 0.0 110.09 173.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.99 142.97 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.682 -0.636 . . . . 0.0 110.22 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 60.2 t -84.93 138.82 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.529 -0.732 . . . . 0.0 109.257 172.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 14.0 pttt -134.77 -170.29 2.53 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.412 -0.805 . . . . 0.0 111.345 -168.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 74.4 mtm-85 -95.3 156.05 16.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.807 -0.558 . . . . 0.0 110.319 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.498 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 48.7 m . . . . . 0 N--CA 1.496 1.849 0 O-C-N 121.571 -0.706 . . . . 0.0 109.237 173.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.515 HD12 ' HG3' ' A' ' 268' ' ' MET . 41.3 tp . . . . . 0 N--CA 1.497 1.879 0 CA-C-O 120.824 0.345 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.503 HD12 ' HD3' ' A' ' 190' ' ' PRO . 84.3 mt -101.81 136.75 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.767 -0.583 . . . . 0.0 110.034 -176.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -125.65 158.11 35.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.692 -0.63 . . . . 0.0 110.135 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.462 HG23 HG21 ' A' ' 247' ' ' VAL . 90.3 t -104.44 146.6 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.701 -0.625 . . . . 0.0 109.844 172.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -118.74 128.13 54.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.629 -0.67 . . . . 0.0 110.4 170.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.11 20.93 21.99 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 168.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -139.37 105.05 5.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.313 -1.11 . . . . 0.0 110.034 174.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 44.2 m -63.49 -15.21 57.2 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.547 -0.721 . . . . 0.0 111.24 -176.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -100.01 8.02 44.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.223 -0.923 . . . . 0.0 111.621 -177.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.68 133.22 55.33 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.108 -0.995 . . . . 0.0 110.175 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -139.8 158.06 44.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.756 -0.59 . . . . 0.0 109.83 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -113.87 150.6 33.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.596 -0.69 . . . . 0.0 110.556 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.06 159.98 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.771 -0.58 . . . . 0.0 110.233 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -122.7 130.05 52.51 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.743 -0.598 . . . . 0.0 110.201 177.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -65.04 112.36 7.99 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.672 -0.643 . . . . 0.0 109.714 177.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -60.23 -25.55 80.37 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.107 1.056 . . . . 0.0 110.998 -172.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.8 mt -101.14 -50.32 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.368 -0.832 . . . . 0.0 110.824 -171.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 6.6 p -105.33 12.16 31.99 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.341 -0.85 . . . . 0.0 111.998 -172.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 82.29 -24.85 4.58 Favored Glycine 0 N--CA 1.497 2.742 0 O-C-N 121.007 -1.058 . . . . 0.0 111.813 170.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 23.8 mmt85 -45.81 142.13 2.67 Favored 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 118.54 1.17 . . . . 0.0 112.544 -168.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -108.51 145.08 35.28 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.626 -0.671 . . . . 0.0 110.047 174.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 77.3 p -154.84 159.91 40.87 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.572 -0.705 . . . . 0.0 110.487 178.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.462 HG21 HG23 ' A' ' 228' ' ' VAL . 8.5 p -123.01 148.07 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.77 -0.581 . . . . 0.0 109.655 178.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.745 HD22 ' HG2' ' A' ' 187' ' ' ARG . 78.8 mt -129.69 154.62 46.97 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.872 -173.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.438 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.9 m -150.69 151.82 31.16 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.819 -0.55 . . . . 0.0 109.858 174.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -71.02 139.49 35.99 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.173 1.091 . . . . 0.0 110.012 177.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.656 ' CD2' HD11 ' A' ' 186' ' ' ILE . 9.4 t80 -79.82 123.37 27.66 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.463 -0.773 . . . . 0.0 110.05 178.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -100.1 160.05 28.19 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.677 -0.64 . . . . 0.0 110.095 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -58.91 159.97 19.7 Favored 'Trans proline' 0 N--CA 1.487 1.118 0 O-C-N 123.298 1.157 . . . . 0.0 110.425 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -59.15 149.95 76.85 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.245 1.129 . . . . 0.0 110.614 -176.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -61.21 148.94 39.19 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.692 -0.63 . . . . 0.0 110.166 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.78 127.22 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.469 -0.769 . . . . 0.0 110.158 -170.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.92 -10.11 55.46 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 9.9 t -145.02 173.33 11.98 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.245 -1.15 . . . . 0.0 110.607 175.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -107.35 13.14 27.35 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.586 -0.696 . . . . 0.0 111.743 -168.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -120.01 168.0 11.61 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.167 -0.958 . . . . 0.0 111.164 -175.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 93.2 m -117.71 147.01 43.34 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.781 -0.574 . . . . 0.0 109.859 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 38.5 m -116.83 135.0 54.08 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.541 -0.724 . . . . 0.0 110.927 -175.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.4 t -129.66 137.12 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 171.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 70.1 mt -104.83 122.09 45.03 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.582 -0.699 . . . . 0.0 109.903 -173.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.629 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 6.6 m-30 -106.92 149.4 27.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.637 -0.664 . . . . 0.0 110.633 -178.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -136.63 142.95 43.27 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -111.04 131.55 54.97 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.575 -0.703 . . . . 0.0 110.499 -176.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' MET . . . . . 0.515 ' HG3' HD12 ' A' ' 225' ' ' LEU . 3.9 ppp? -96.79 2.87 52.38 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.708 -0.62 . . . . 0.0 112.119 -176.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . 0.656 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.8 OUTLIER -144.67 165.03 29.2 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.055 -1.028 . . . . 0.0 110.11 174.704 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.596 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.6 p30 -119.86 162.37 19.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.72 -0.612 . . . . 0.0 110.303 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . 0.423 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 23.1 m -58.29 -33.47 69.49 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.468 -0.77 . . . . 0.0 110.983 -163.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 49.2 p -97.9 9.88 41.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.458 -0.776 . . . . 0.0 112.07 -163.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . 0.498 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 31.2 p -93.79 118.07 30.94 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.09 -1.006 . . . . 0.0 110.691 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 60.4 t -64.42 140.52 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.442 -0.786 . . . . 0.0 110.305 -170.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 100.74 -5.21 56.62 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 177.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.62 -99.16 0.88 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 170.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . 0.423 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.2 mmm -63.85 -31.59 72.82 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.639 -0.918 . . . . 0.0 110.3 178.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.5 p30 43.84 50.56 6.92 Favored 'General case' 0 N--CA 1.504 2.234 0 CA-C-O 121.286 0.565 . . . . 0.0 112.521 175.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 22.0 mtt180 54.81 29.67 12.31 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.29 -0.881 . . . . 0.0 111.17 175.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -119.28 104.97 45.08 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.517 -0.739 . . . . 0.0 110.149 175.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.85 145.95 96.96 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 123.077 1.04 . . . . 0.0 110.522 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.631 HG22 ' HA ' ' A' ' 192' ' ' TYR . 45.6 pt -131.98 177.59 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 121.79 0.805 . . . . 0.0 111.132 -175.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 302' ' ' GLU . 30.1 mt -124.34 149.9 46.1 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.702 HD12 ' CE1' ' A' ' 301' ' ' PHE . 77.6 mt -115.03 129.91 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.213 177.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.526 HG23 ' SG ' ' A' ' 300' ' ' CYS . 82.3 mt -109.71 127.17 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -176.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 58.7 t -118.83 126.73 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.634 HG22 ' HG2' ' A' ' 298' ' ' ARG . 45.5 p -125.21 153.8 42.57 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.466 -174.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.616 HD21 ' HB3' ' A' ' 180' ' ' PRO . 27.1 tp -105.32 126.08 51.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.73 -0.606 . . . . 0.0 109.535 169.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.566 ' OE2' HG13 ' A' ' 295' ' ' VAL . 71.0 mm-40 -131.79 148.86 52.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.955 -0.466 . . . . 0.0 109.768 -174.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.81 ' CG2' HD11 ' A' ' 296' ' ' LEU . 54.4 p -89.88 161.68 15.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.641 -0.662 . . . . 0.0 109.98 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -55.99 -26.09 46.89 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.544 -0.723 . . . . 0.0 111.112 -174.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 40.8 p30 -91.6 10.25 28.85 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.379 -0.826 . . . . 0.0 111.923 -173.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.85 20.19 44.47 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 120.14 -1.028 . . . . 0.0 110.725 171.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -106.0 140.15 39.44 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.256 -1.144 . . . . 0.0 110.001 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.566 HG13 ' OE2' ' A' ' 289' ' ' GLU . 58.5 t -89.21 132.09 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.634 -0.666 . . . . 0.0 110.282 -172.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.81 HD11 ' CG2' ' A' ' 290' ' ' THR . 95.9 mt -99.92 -40.2 7.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.682 -0.636 . . . . 0.0 110.694 178.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -169.34 158.54 31.01 Favored Glycine 0 N--CA 1.496 2.686 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.612 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.634 ' HG2' HG22 ' A' ' 287' ' ' THR . 94.1 mtt180 -134.6 138.89 44.93 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.619 -0.93 . . . . 0.0 110.957 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -132.76 159.27 40.21 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.639 -0.663 . . . . 0.0 109.727 169.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . 0.526 ' SG ' HG23 ' A' ' 285' ' ' ILE . 87.6 m -144.06 154.38 43.16 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.409 -0.807 . . . . 0.0 110.76 -176.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.702 ' CE1' HD12 ' A' ' 284' ' ' ILE . 48.7 p90 -145.78 161.86 38.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.614 -0.679 . . . . 0.0 110.087 174.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.462 ' HA ' HD23 ' A' ' 283' ' ' LEU . 82.4 tt0 -104.83 136.81 43.64 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.619 -0.676 . . . . 0.0 110.224 -176.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -124.3 142.75 51.01 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.779 -170.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -138.11 140.91 40.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.793 -0.567 . . . . 0.0 109.684 172.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.656 HD13 ' O ' ' A' ' 269' ' ' CYS . 74.5 mt -108.29 122.78 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.462 -0.774 . . . . 0.0 109.688 176.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.0 p -145.31 170.28 16.61 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.605 -0.684 . . . . 0.0 110.676 -171.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -72.47 -40.18 67.17 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.662 -0.649 . . . . 0.0 110.648 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.7 t -126.83 85.75 60.18 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.471 -0.768 . . . . 0.0 110.485 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -55.69 -28.19 64.91 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 O-C-N 123.121 1.064 . . . . 0.0 110.856 174.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.95 -38.18 92.66 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 177.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 57.5 ttt85 -72.61 -40.37 66.54 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.621 -0.929 . . . . 0.0 109.875 -173.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -69.53 -38.91 77.71 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.137 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.401 ' HA ' ' OD2' ' A' ' 316' ' ' ASP . 70.3 ttt180 -61.25 -43.28 99.13 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.52 -0.738 . . . . 0.0 110.251 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -64.51 -40.82 96.34 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.567 -0.708 . . . . 0.0 110.604 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -60.73 -49.88 75.71 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.478 -0.764 . . . . 0.0 110.559 -173.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . 0.401 ' OD2' ' HA ' ' A' ' 313' ' ' ARG . 2.9 p30 . . . . . 0 N--CA 1.495 1.816 0 O-C-N 121.418 -0.802 . . . . 0.0 110.045 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 27.5 t . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.115 0.483 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.4 p-10 -101.89 25.22 8.91 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.586 -0.696 . . . . 0.0 110.699 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 49.1 m -79.17 125.23 29.17 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.617 -0.677 . . . . 0.0 110.262 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -68.86 144.93 54.1 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.696 -0.628 . . . . 0.0 110.418 -177.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -154.3 99.81 2.48 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.76 -0.587 . . . . 0.0 110.038 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.47 -39.99 78.58 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 O-C-N 123.181 1.095 . . . . 0.0 110.823 -175.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.94 -155.19 47.65 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -73.72 -46.31 0.34 Allowed 'Trans proline' 0 C--N 1.316 -1.155 0 O-C-N 123.354 1.186 . . . . 0.0 110.959 -173.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -87.38 9.08 21.76 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.509 -0.745 . . . . 0.0 111.376 -173.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.61 61.28 3.18 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.991 -1.068 . . . . 0.0 110.727 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.677 ' HA ' HG12 ' A' ' 176' ' ' VAL . 46.3 t80 -77.86 119.22 21.03 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.587 -0.696 . . . . 0.0 109.869 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -130.08 160.43 33.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.829 -0.545 . . . . 0.0 110.154 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 63.2 t -125.76 145.57 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.82 -0.55 . . . . 0.0 109.767 177.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 78.4 p -155.46 160.51 40.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.734 -0.603 . . . . 0.0 110.067 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.434 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 67.8 m-85 . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.854 -0.529 . . . . 0.0 109.788 -176.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.196 0.522 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.441 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 75.8 p -60.09 -33.09 71.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.716 -0.615 . . . . 0.0 109.932 176.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.441 ' HD1' ' HG1' ' A' ' 152' ' ' THR . 68.6 p-90 -170.95 142.6 1.88 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.309 0.576 . . . . 0.0 110.026 178.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 13.2 t -142.2 142.57 32.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.942 -0.474 . . . . 0.0 109.952 -176.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.434 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 64.1 t80 -125.51 140.03 53.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.523 -0.736 . . . . 0.0 110.544 -172.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 28.5 t -110.24 124.41 51.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.861 -0.525 . . . . 0.0 109.845 176.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 58.6 m -70.76 -36.94 73.33 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.789 -0.569 . . . . 0.0 110.556 -177.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -59.43 -34.66 72.77 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.561 -0.712 . . . . 0.0 110.464 -177.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 57.4 mt -104.88 -11.98 16.47 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.672 -0.642 . . . . 0.0 110.88 -175.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 59.8 tttt 59.79 52.01 5.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.065 -1.022 . . . . 0.0 109.746 178.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -145.35 152.99 40.74 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.707 -0.621 . . . . 0.0 110.556 -175.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.656 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.55 137.79 53.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.69 -0.631 . . . . 0.0 110.344 -176.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -116.19 134.2 55.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.675 -0.641 . . . . 0.0 109.382 174.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.3 158.39 44.39 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.939 -175.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -104.61 143.38 33.15 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.469 0.652 . . . . 0.0 110.396 173.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.439 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 16.7 tt -52.0 146.51 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.608 -0.682 . . . . 0.0 111.813 -175.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 65.2 10.01 6.06 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.665 -0.647 . . . . 0.0 112.415 177.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -96.63 155.13 16.9 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.068 -1.02 . . . . 0.0 110.832 174.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 62.3 m -88.53 126.22 35.15 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.662 -0.648 . . . . 0.0 110.669 -177.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' CYS . . . . . 0.656 ' SG ' HD21 ' A' ' 162' ' ' LEU . 44.2 t -113.71 90.08 17.45 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.59 -0.694 . . . . 0.0 110.19 175.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.439 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 23.7 Cg_exo -60.75 130.26 32.45 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 O-C-N 123.268 1.141 . . . . 0.0 110.678 172.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.402 HG12 ' CE2' ' A' ' 142' ' ' PHE . 97.5 mt -124.9 141.66 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 176.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -109.5 135.43 50.51 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.464 -0.772 . . . . 0.0 110.879 -175.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.408 HG23 ' CE1' ' A' ' 138' ' ' PHE . 50.5 mm -95.29 133.58 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.713 -0.617 . . . . 0.0 109.624 169.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 40.2 tttp -114.49 128.77 56.51 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.579 -0.701 . . . . 0.0 110.449 176.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.677 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.1 m -136.72 159.88 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.588 -0.695 . . . . 0.0 109.86 175.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.7 mmm -76.57 -41.4 46.53 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.666 -0.646 . . . . 0.0 110.1 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.0 p -134.78 143.27 45.65 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.763 -0.586 . . . . 0.0 109.695 178.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.9 Cg_exo -55.45 139.74 82.24 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 O-C-N 123.156 1.082 . . . . 0.0 110.889 -171.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.683 ' HB3' HD21 ' A' ' 288' ' ' LEU . 34.9 Cg_endo -67.63 169.99 14.76 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 O-C-N 123.157 1.082 . . . . 0.0 110.608 177.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -60.81 155.28 50.05 Favored 'Trans proline' 0 C--N 1.316 -1.152 0 O-C-N 123.327 1.172 . . . . 0.0 110.521 -178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -77.46 141.09 39.88 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.519 -0.738 . . . . 0.0 109.879 174.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.8 -24.88 29.76 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -174.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.19 150.74 2.31 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.412 -1.052 . . . . 0.0 111.4 177.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.7 156.04 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.762 -0.586 . . . . 0.0 109.688 176.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.742 HD11 ' HD2' ' A' ' 251' ' ' TYR . 84.2 mt -109.16 141.49 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.752 -0.592 . . . . 0.0 109.599 177.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.68 ' HG2' HD22 ' A' ' 248' ' ' LEU . 70.6 mtp180 -114.78 145.2 42.37 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -176.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.638 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -140.03 126.29 19.98 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.339 173.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.407 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 41.9 ttm -137.24 139.9 29.37 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.81 -0.557 . . . . 0.0 111.059 -176.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.494 ' HD3' HD12 ' A' ' 226' ' ' ILE . 73.9 Cg_endo -91.19 138.23 2.26 Favored 'Trans proline' 0 C--N 1.32 -0.964 0 O-C-N 123.3 1.158 . . . . 0.0 110.812 177.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.438 HG13 ' C ' ' A' ' 190' ' ' PRO . 34.8 m -147.7 154.9 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.574 -0.704 . . . . 0.0 109.988 173.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.6 ' HA ' HG22 ' A' ' 282' ' ' ILE . 87.2 m-85 -61.49 165.76 4.59 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.462 -0.774 . . . . 0.0 110.447 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.486 ' HA ' HD12 ' A' ' 283' ' ' LEU . 33.2 ttmt -83.99 -60.05 2.22 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.626 -0.671 . . . . 0.0 110.799 -173.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 48.3 mttt -80.04 152.49 29.37 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.639 -0.663 . . . . 0.0 110.332 -175.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.452 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.56 -38.75 72.36 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.462 -0.774 . . . . 0.0 110.698 -175.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -56.48 -24.91 49.25 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.519 -0.738 . . . . 0.0 110.621 -176.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.413 ' HB3' ' CG ' ' A' ' 192' ' ' TYR . 77.8 m80 -109.7 -20.5 12.8 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.137 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -67.6 -20.23 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.123 -0.986 . . . . 0.0 110.576 -175.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 71.7 p -79.48 -16.91 55.25 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.763 174.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -88.37 134.93 33.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.359 -0.838 . . . . 0.0 110.1 173.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 242' ' ' THR . 60.9 t -72.97 145.91 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.615 -0.678 . . . . 0.0 110.27 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 60.6 t -84.72 139.79 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.564 -0.71 . . . . 0.0 109.223 172.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.8 pttp -134.85 -170.16 2.51 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.422 -0.799 . . . . 0.0 111.295 -166.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -95.21 152.59 18.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.789 -0.57 . . . . 0.0 110.102 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 36.5 m . . . . . 0 N--CA 1.498 1.938 0 O-C-N 121.471 -0.768 . . . . 0.0 109.025 173.858 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 58.8 tp . . . . . 0 N--CA 1.497 1.902 0 CA-C-O 120.879 0.371 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.494 HD12 ' HD3' ' A' ' 190' ' ' PRO . 83.7 mt -104.94 136.81 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.834 -0.541 . . . . 0.0 109.801 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -132.47 157.82 43.65 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.797 -0.564 . . . . 0.0 110.292 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.461 HG23 HG21 ' A' ' 247' ' ' VAL . 94.1 t -102.67 146.56 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.722 -0.611 . . . . 0.0 109.909 175.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -117.26 124.14 48.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.722 -0.611 . . . . 0.0 110.428 172.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 95.79 24.33 15.77 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 167.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -137.27 107.07 6.23 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.5 -1.0 . . . . 0.0 110.015 174.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 28.0 t -63.03 -15.2 55.66 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.611 -0.68 . . . . 0.0 111.203 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -100.0 9.34 43.06 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.289 -0.882 . . . . 0.0 111.588 -177.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.37 127.91 33.77 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.129 -0.982 . . . . 0.0 110.179 176.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -139.75 158.01 44.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.707 -0.62 . . . . 0.0 109.868 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -114.67 150.66 34.85 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.604 -0.685 . . . . 0.0 110.576 -176.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.13 160.0 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.742 -0.599 . . . . 0.0 110.173 177.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -119.17 130.06 55.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.703 -0.623 . . . . 0.0 110.227 176.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -64.18 130.04 94.36 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.66 -0.65 . . . . 0.0 109.833 178.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -65.41 -28.34 54.39 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.187 1.098 . . . . 0.0 111.024 -170.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.8 mt -101.74 -50.5 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.425 -0.797 . . . . 0.0 111.051 -167.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.445 ' O ' HG21 ' A' ' 201' ' ' VAL . 11.1 p -105.4 12.18 31.86 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.446 -0.784 . . . . 0.0 111.843 -174.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 72.3 -5.01 16.43 Favored Glycine 0 N--CA 1.496 2.688 0 O-C-N 121.102 -0.999 . . . . 0.0 112.007 173.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.419 ' CZ ' HG12 ' A' ' 191' ' ' VAL . 23.4 mmt180 -45.91 142.05 2.8 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-N 119.134 1.467 . . . . 0.0 112.36 -174.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -103.61 143.43 32.77 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.715 -0.616 . . . . 0.0 110.117 175.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 76.5 p -154.74 159.95 41.0 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.637 -0.664 . . . . 0.0 110.332 177.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.461 HG21 HG23 ' A' ' 228' ' ' VAL . 8.2 p -123.0 148.2 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.789 -0.569 . . . . 0.0 109.699 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 187' ' ' ARG . 79.9 mt -129.51 154.56 46.9 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.615 -175.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.439 HG13 ' C ' ' A' ' 248' ' ' LEU . 32.5 m -151.13 151.78 30.09 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.776 -0.577 . . . . 0.0 109.955 175.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -71.14 139.59 35.81 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 O-C-N 123.333 1.175 . . . . 0.0 110.009 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.742 ' HD2' HD11 ' A' ' 186' ' ' ILE . 59.2 t80 -75.76 127.22 32.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.539 -0.726 . . . . 0.0 110.123 175.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -100.11 160.09 28.06 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.765 -0.584 . . . . 0.0 109.979 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -58.77 158.34 24.71 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.213 1.112 . . . . 0.0 110.496 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.25 149.95 77.43 Favored 'Trans proline' 0 N--CA 1.487 1.145 0 O-C-N 123.206 1.109 . . . . 0.0 110.549 -177.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -61.87 147.73 45.69 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.603 -0.686 . . . . 0.0 110.146 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.92 127.25 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.537 -0.727 . . . . 0.0 110.161 -170.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.95 -10.17 55.43 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.431 HG21 ' CE2' ' A' ' 260' ' ' PHE . 9.2 t -144.46 174.14 11.19 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.253 -1.145 . . . . 0.0 110.566 175.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -108.08 13.22 26.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.622 -0.674 . . . . 0.0 111.839 -167.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 258' ' ' THR . 38.6 p90 -120.0 168.09 11.51 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.15 -0.969 . . . . 0.0 111.101 -175.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 76.9 m -117.75 145.87 44.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.756 -0.59 . . . . 0.0 109.836 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 55.8 m -116.64 134.81 54.37 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.478 0.656 . . . . 0.0 110.91 -174.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 64.0 t -130.35 137.32 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 172.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 171' ' ' PRO . 76.1 mt -104.73 120.47 41.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.518 -0.739 . . . . 0.0 109.89 -171.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.638 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 6.0 m-30 -106.51 151.67 24.68 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.693 -0.63 . . . . 0.0 110.486 -177.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -136.54 142.89 43.46 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -113.48 131.73 55.93 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.6 -0.688 . . . . 0.0 110.259 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' MET . . . . . 0.466 ' HE2' ' HB2' ' A' ' 268' ' ' MET . 4.9 ppp? -104.17 9.68 36.11 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.582 -0.699 . . . . 0.0 111.897 -175.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . 0.574 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.7 OUTLIER -144.62 160.37 41.29 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.035 -1.041 . . . . 0.0 109.861 170.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.646 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.5 p30 -117.49 162.43 17.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.682 -0.636 . . . . 0.0 110.31 -177.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . 0.427 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 20.1 m -58.78 -32.28 69.15 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.582 -0.699 . . . . 0.0 110.925 -163.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 48.0 p -99.79 12.89 35.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.507 -0.746 . . . . 0.0 111.962 -164.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 32.0 p -94.54 118.15 31.24 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.552 177.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 60.1 t -64.02 139.54 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.46 -0.775 . . . . 0.0 110.399 -167.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.56 -5.16 58.44 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 176.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -124.46 -100.05 1.33 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 170.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . 0.427 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.2 mmm -63.96 -31.98 73.36 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.654 -0.909 . . . . 0.0 110.207 176.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.5 p30 43.53 51.15 6.31 Favored 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 175.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 54.78 27.42 8.85 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.394 -0.816 . . . . 0.0 111.163 175.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 77.2 mtt180 -117.67 106.42 46.23 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.476 -0.765 . . . . 0.0 110.09 175.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.56 146.71 94.43 Favored 'Trans proline' 0 N--CA 1.488 1.171 0 O-C-N 123.137 1.072 . . . . 0.0 110.577 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.6 HG22 ' HA ' ' A' ' 192' ' ' TYR . 45.4 pt -131.96 178.34 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.761 0.791 . . . . 0.0 110.773 -176.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' ' 193' ' ' LYS . 28.0 mt -124.41 149.84 46.28 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.69 HD12 ' CE1' ' A' ' 301' ' ' PHE . 80.3 mt -115.82 130.44 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.617 -0.677 . . . . 0.0 109.239 177.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.647 HG23 ' SG ' ' A' ' 300' ' ' CYS . 85.3 mt -109.79 126.22 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -176.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 58.5 t -118.91 126.7 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.4 p -125.25 154.69 41.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.673 -0.642 . . . . 0.0 110.795 -175.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.683 HD21 ' HB3' ' A' ' 180' ' ' PRO . 23.6 tp -104.82 126.83 52.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.816 -0.553 . . . . 0.0 109.575 170.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.743 ' OE2' HG13 ' A' ' 295' ' ' VAL . 72.0 mm-40 -132.44 149.83 52.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.897 -0.502 . . . . 0.0 109.912 -172.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.834 ' CG2' HD11 ' A' ' 296' ' ' LEU . 26.1 p -90.42 160.88 15.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.639 -0.663 . . . . 0.0 110.015 177.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -55.95 -26.14 46.7 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.506 -0.746 . . . . 0.0 111.002 -175.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 44.8 p30 -89.72 9.77 25.88 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.414 -0.804 . . . . 0.0 111.9 -172.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.7 20.17 45.08 Favored Glycine 0 N--CA 1.495 2.6 0 C-N-CA 120.143 -1.027 . . . . 0.0 110.677 171.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -108.98 140.13 42.91 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.32 -1.106 . . . . 0.0 109.921 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.743 HG13 ' OE2' ' A' ' 289' ' ' GLU . 60.3 t -91.83 133.3 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.527 -0.733 . . . . 0.0 110.217 -172.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.834 HD11 ' CG2' ' A' ' 290' ' ' THR . 71.6 mt -99.87 -40.24 7.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.792 -0.567 . . . . 0.0 110.59 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -158.36 154.87 25.93 Favored Glycine 0 N--CA 1.496 2.697 0 C-N-CA 119.917 -1.135 . . . . 0.0 110.516 -177.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.713 ' CZ ' HG11 ' A' ' 295' ' ' VAL . 55.5 mtt85 -135.03 136.32 42.0 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.722 -0.869 . . . . 0.0 110.211 178.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -140.69 157.26 45.69 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.487 -0.758 . . . . 0.0 110.152 169.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . 0.647 ' SG ' HG23 ' A' ' 285' ' ' ILE . 95.3 m -142.52 156.63 45.15 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.512 -0.743 . . . . 0.0 110.632 -175.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.69 ' CE1' HD12 ' A' ' 284' ' ' ILE . 48.5 p90 -145.0 162.88 35.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.681 -0.637 . . . . 0.0 110.199 176.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.417 ' HA ' HD23 ' A' ' 283' ' ' LEU . 81.8 tt0 -104.96 136.15 44.97 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.526 -0.734 . . . . 0.0 110.11 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -121.66 144.21 48.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.614 -0.679 . . . . 0.0 110.814 -169.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -139.23 139.51 37.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.857 -0.527 . . . . 0.0 109.744 172.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.646 HG21 ' HA ' ' A' ' 270' ' ' ASN . 82.6 mt -108.71 122.84 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.465 -0.772 . . . . 0.0 109.726 176.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.8 p -145.31 171.02 15.17 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.609 -0.682 . . . . 0.0 110.606 -172.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -73.2 -40.09 65.02 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.589 -0.694 . . . . 0.0 110.7 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.7 t -127.12 85.66 60.55 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.524 -0.735 . . . . 0.0 110.49 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -55.88 -27.85 64.95 Favored 'Trans proline' 0 C--N 1.314 -1.259 0 O-C-N 123.226 1.119 . . . . 0.0 110.772 174.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -67.6 -38.1 89.99 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -72.89 -40.46 65.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.674 -0.897 . . . . 0.0 109.803 -173.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -69.59 -39.35 77.35 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.061 -178.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -61.38 -44.66 96.78 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.219 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -64.04 -40.16 95.7 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.606 -0.684 . . . . 0.0 110.459 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.6 -50.73 71.43 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.548 -0.72 . . . . 0.0 110.419 -173.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.1 p30 . . . . . 0 N--CA 1.496 1.843 0 O-C-N 121.509 -0.744 . . . . 0.0 110.107 -178.214 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.2 t . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.035 0.445 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 p-10 -96.33 24.34 5.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.637 -0.664 . . . . 0.0 110.721 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 49.9 m -77.8 125.16 28.92 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.577 -0.702 . . . . 0.0 110.274 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -71.16 144.96 50.03 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.686 -0.634 . . . . 0.0 110.414 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -157.78 101.48 1.8 Allowed Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.746 -0.596 . . . . 0.0 110.077 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -59.73 -39.87 69.46 Favored 'Trans proline' 0 N--CA 1.488 1.167 0 O-C-N 123.179 1.094 . . . . 0.0 110.681 -175.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.08 -155.12 43.9 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -73.6 -44.85 0.46 Allowed 'Trans proline' 0 C--N 1.317 -1.09 0 O-C-N 123.344 1.181 . . . . 0.0 110.855 -175.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -86.92 4.34 41.93 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.585 -0.697 . . . . 0.0 111.498 -174.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.82 61.6 3.01 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.888 -1.133 . . . . 0.0 110.716 -176.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.727 ' HA ' HG12 ' A' ' 176' ' ' VAL . 63.1 t80 -78.04 120.46 22.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.643 -0.661 . . . . 0.0 110.106 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -129.98 159.97 35.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.763 -0.586 . . . . 0.0 110.261 -177.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 64.5 t -126.28 146.3 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.789 -0.57 . . . . 0.0 109.831 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.9 p -154.98 162.75 41.0 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.947 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.419 ' CE2' HG12 ' A' ' 172' ' ' ILE . 76.2 m-85 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.771 -0.581 . . . . 0.0 109.944 -175.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 121.163 0.506 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.425 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 65.4 p -60.1 -34.08 72.98 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.613 -0.68 . . . . 0.0 110.055 176.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.425 ' HD1' ' HG1' ' A' ' 152' ' ' THR . 68.7 p-90 -171.83 144.15 1.74 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.43 0.633 . . . . 0.0 110.158 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.3 t -142.11 142.59 32.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.788 -0.57 . . . . 0.0 109.943 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -125.52 140.07 53.07 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.532 -0.73 . . . . 0.0 110.579 -172.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.7 t -110.43 123.56 50.11 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 120.366 -0.533 . . . . 0.0 109.641 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 63.1 m -70.82 -37.11 73.21 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.755 -0.591 . . . . 0.0 110.42 -177.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -58.94 -32.76 69.88 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.582 -0.699 . . . . 0.0 110.275 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.507 HD11 ' OD1' ' A' ' 316' ' ' ASP . 37.7 mt -104.8 -12.11 16.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.71 -0.619 . . . . 0.0 110.712 -175.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 31.6 tttm 59.68 47.92 9.97 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.971 -1.08 . . . . 0.0 109.761 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.444 ' HE3' ' CZ ' ' A' ' 163' ' ' TYR . 33.9 ttpt -147.19 153.16 39.5 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 120.114 -0.635 . . . . 0.0 110.725 -174.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.58 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.6 138.18 53.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.763 -0.585 . . . . 0.0 110.374 -173.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.444 ' CZ ' ' HE3' ' A' ' 161' ' ' LYS . 52.3 m-85 -114.7 135.04 54.59 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 174.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.9 p -138.33 158.4 44.36 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.034 -176.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.416 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 57.0 mt-30 -104.55 142.86 33.89 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.611 -0.681 . . . . 0.0 110.211 173.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.428 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.2 tt -52.41 147.42 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.461 -0.774 . . . . 0.0 111.837 -174.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.89 9.97 5.78 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.539 -0.726 . . . . 0.0 112.487 176.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.416 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 72.2 mmtt -95.68 155.09 16.89 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.994 -1.067 . . . . 0.0 110.906 174.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 88.2 m -84.49 126.17 33.04 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.725 -0.609 . . . . 0.0 110.59 -178.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' CYS . . . . . 0.58 ' SG ' HD21 ' A' ' 162' ' ' LEU . 48.9 t -114.22 90.32 19.91 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.59 -0.694 . . . . 0.0 110.18 175.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.406 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 21.3 Cg_endo -65.94 129.65 22.52 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 O-C-N 123.261 1.137 . . . . 0.0 110.59 176.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.419 HG12 ' CE2' ' A' ' 142' ' ' PHE . 93.9 mt -123.15 141.69 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.62 -0.675 . . . . 0.0 109.329 176.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -109.06 135.35 50.37 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.519 -0.738 . . . . 0.0 110.761 -175.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.424 HG21 ' CE1' ' A' ' 138' ' ' PHE . 48.3 mm -95.24 135.03 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.652 -0.655 . . . . 0.0 109.642 170.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -117.84 128.84 55.24 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.42 175.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.727 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.1 m -136.47 159.75 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.532 -0.73 . . . . 0.0 109.949 175.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.0 mmm -77.07 -40.47 46.04 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.683 -0.635 . . . . 0.0 110.113 178.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.415 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.4 p -135.3 143.18 44.43 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.746 -0.596 . . . . 0.0 109.849 178.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.5 Cg_exo -55.94 139.87 85.09 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 O-C-N 123.181 1.095 . . . . 0.0 110.828 -173.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.771 ' HB3' HD21 ' A' ' 288' ' ' LEU . 20.8 Cg_endo -63.49 169.1 10.25 Favored 'Trans proline' 0 N--CA 1.488 1.18 0 O-C-N 123.204 1.107 . . . . 0.0 110.728 176.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -61.16 157.5 39.42 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.376 1.198 . . . . 0.0 110.482 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -76.61 137.45 39.49 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.635 -0.666 . . . . 0.0 109.898 175.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.51 -25.09 29.62 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -174.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.08 151.98 1.81 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.335 -1.097 . . . . 0.0 111.396 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.77 155.95 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.698 -0.627 . . . . 0.0 109.935 177.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.667 HD11 ' CD2' ' A' ' 251' ' ' TYR . 72.4 mt -108.47 135.51 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.728 ' HG2' HD22 ' A' ' 248' ' ' LEU . 61.8 mtt180 -115.05 147.13 40.54 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.702 -0.623 . . . . 0.0 109.376 -175.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.647 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -140.12 128.7 22.93 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.536 -0.728 . . . . 0.0 110.138 172.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.413 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 22.6 ttp -137.29 137.18 21.82 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.796 -0.565 . . . . 0.0 111.083 -176.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.493 ' HD3' HD12 ' A' ' 226' ' ' ILE . 71.8 Cg_endo -91.43 138.19 2.15 Favored 'Trans proline' 0 C--N 1.32 -0.959 0 C-N-CA 121.038 1.159 . . . . 0.0 110.773 177.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.423 HG13 ' C ' ' A' ' 190' ' ' PRO . 35.0 m -146.99 154.86 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.486 -0.759 . . . . 0.0 110.022 173.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.624 ' HA ' HG22 ' A' ' 282' ' ' ILE . 87.6 m-85 -61.48 160.02 11.85 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.464 -0.773 . . . . 0.0 110.397 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.444 ' HA ' HD12 ' A' ' 283' ' ' LEU . 85.7 tttt -76.21 -60.04 2.5 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.664 -0.647 . . . . 0.0 110.832 -173.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -80.01 150.7 30.32 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.58 -0.7 . . . . 0.0 110.356 -174.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.45 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.44 -38.86 72.2 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.385 -0.822 . . . . 0.0 110.728 -175.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -56.33 -25.04 47.58 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.555 -0.716 . . . . 0.0 110.668 -176.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.408 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 97.3 m-70 -110.03 -20.57 12.67 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.934 -0.706 . . . . 0.0 111.147 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.1 p -66.78 -20.25 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.154 -0.966 . . . . 0.0 110.573 -175.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 68.1 p -79.35 -17.05 55.29 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.713 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -88.27 136.39 33.0 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.353 -0.842 . . . . 0.0 109.951 172.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 56.9 t -73.02 146.48 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.61 -0.681 . . . . 0.0 110.133 178.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 79.5 t -84.92 139.65 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.598 -0.689 . . . . 0.0 109.261 172.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.7 pttp -134.82 -170.07 2.48 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.557 -0.715 . . . . 0.0 111.038 -166.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -95.12 154.04 17.37 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.744 -0.597 . . . . 0.0 110.442 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.614 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 58.7 m . . . . . 0 N--CA 1.496 1.857 0 O-C-N 121.641 -0.662 . . . . 0.0 109.272 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.519 HD12 ' HG3' ' A' ' 268' ' ' MET . 59.5 tp . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 120.968 0.413 . . . . 0.0 110.338 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.493 HD12 ' HD3' ' A' ' 190' ' ' PRO . 83.4 mt -103.97 136.79 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.729 -0.607 . . . . 0.0 109.949 -178.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -127.26 157.54 39.56 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.748 -0.595 . . . . 0.0 110.176 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.521 HG23 HG21 ' A' ' 247' ' ' VAL . 90.7 t -102.32 146.6 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.787 -0.571 . . . . 0.0 109.81 173.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -118.59 129.97 55.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.698 -0.626 . . . . 0.0 110.4 170.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.96 21.08 26.56 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 168.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 35.7 t-20 -138.45 105.65 5.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.305 -1.115 . . . . 0.0 110.054 174.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 43.7 m -63.28 -15.33 56.87 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.656 -0.653 . . . . 0.0 111.306 -176.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -99.92 7.58 44.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.214 -0.929 . . . . 0.0 111.597 -177.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.64 132.27 52.73 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.114 -0.991 . . . . 0.0 110.24 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -139.76 157.97 44.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.79 -0.569 . . . . 0.0 109.674 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -116.36 150.64 37.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.542 -0.724 . . . . 0.0 110.573 -177.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.19 159.89 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.824 -0.548 . . . . 0.0 110.24 177.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -123.71 128.21 49.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.76 -0.587 . . . . 0.0 110.05 174.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -65.09 130.05 94.69 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.678 -0.639 . . . . 0.0 109.893 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -66.8 -26.48 44.93 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 O-C-N 123.036 1.019 . . . . 0.0 111.029 -172.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.2 mt -99.06 -50.45 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.371 -0.831 . . . . 0.0 110.916 -168.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.0 p -105.33 12.07 32.11 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.406 -0.809 . . . . 0.0 111.835 -175.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.89 -5.08 13.77 Favored Glycine 0 N--CA 1.496 2.691 0 O-C-N 121.058 -1.027 . . . . 0.0 111.709 174.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 69.5 mmt-85 -46.18 141.98 3.07 Favored 'General case' 0 N--CA 1.505 2.278 0 CA-C-N 119.07 1.435 . . . . 0.0 112.363 -172.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -108.13 139.55 42.63 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.651 -0.655 . . . . 0.0 110.091 174.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 77.8 p -154.76 159.94 40.98 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.569 -0.707 . . . . 0.0 110.619 177.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.521 HG21 HG23 ' A' ' 228' ' ' VAL . 8.4 p -123.67 148.1 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.706 -0.621 . . . . 0.0 109.713 177.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.728 HD22 ' HG2' ' A' ' 187' ' ' ARG . 83.0 mt -129.67 154.71 46.86 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.032 -174.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.442 HG13 ' C ' ' A' ' 248' ' ' LEU . 36.0 m -150.77 151.76 30.87 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.855 -0.528 . . . . 0.0 109.878 175.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -70.6 139.4 37.22 Favored 'Trans proline' 0 C--N 1.315 -1.184 0 O-C-N 123.292 1.154 . . . . 0.0 110.055 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.667 ' CD2' HD11 ' A' ' 186' ' ' ILE . 10.0 t80 -79.66 123.29 27.5 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.539 -0.726 . . . . 0.0 110.16 178.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -100.04 160.1 28.07 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.693 -0.629 . . . . 0.0 110.19 178.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -59.08 160.05 20.05 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.362 1.191 . . . . 0.0 110.472 178.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.87 150.01 74.63 Favored 'Trans proline' 0 N--CA 1.489 1.244 0 O-C-N 123.293 1.154 . . . . 0.0 110.501 -177.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -60.91 147.94 41.41 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.626 -0.671 . . . . 0.0 110.184 -178.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.85 127.24 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.557 -0.715 . . . . 0.0 110.168 -170.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.88 -10.23 55.59 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 10.2 t -144.62 174.42 10.98 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.187 -1.184 . . . . 0.0 110.613 175.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -108.71 13.06 25.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.57 -0.706 . . . . 0.0 111.85 -167.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -122.41 168.07 12.54 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.125 -0.984 . . . . 0.0 111.149 -176.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 87.2 m -117.69 145.56 44.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.748 -0.595 . . . . 0.0 109.849 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 38.6 m -116.22 135.73 53.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.557 -0.715 . . . . 0.0 110.939 -175.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 57.6 t -129.03 137.29 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 172.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 62.7 mt -104.72 119.97 40.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.525 -0.734 . . . . 0.0 109.793 -172.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.647 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 6.7 m-30 -106.67 150.97 25.7 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.63 -0.669 . . . . 0.0 110.664 -178.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -136.47 142.91 43.59 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -113.15 132.67 55.37 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.56 -0.713 . . . . 0.0 110.48 -176.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' MET . . . . . 0.519 ' HG3' HD12 ' A' ' 225' ' ' LEU . 0.1 OUTLIER -103.21 8.52 38.46 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.711 -0.618 . . . . 0.0 112.172 -175.135 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . 0.681 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.6 OUTLIER -144.68 165.1 29.0 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.045 -1.034 . . . . 0.0 109.906 171.259 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.614 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.9 p30 -121.68 161.61 22.21 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.394 0.616 . . . . 0.0 110.38 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . 0.426 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 26.7 m -58.36 -33.56 69.7 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.465 -0.772 . . . . 0.0 111.09 -163.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 70.6 m -97.56 10.54 39.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.494 -0.754 . . . . 0.0 112.089 -164.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . 0.614 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 30.5 p -93.9 118.1 31.0 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.027 -1.045 . . . . 0.0 110.644 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.81 139.87 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.505 -0.747 . . . . 0.0 110.349 -169.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.57 -5.13 60.16 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 178.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -125.18 -100.2 1.26 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 170.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . 0.426 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.4 mmm -65.55 -32.77 74.54 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.614 -0.933 . . . . 0.0 110.419 176.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.6 p30 42.47 53.11 4.7 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 176.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 54.8 27.44 8.9 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.328 -0.858 . . . . 0.0 111.184 176.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -119.12 105.15 45.21 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.484 -0.76 . . . . 0.0 110.098 175.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -59.45 151.02 71.73 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 O-C-N 123.135 1.071 . . . . 0.0 110.686 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.624 HG22 ' HA ' ' A' ' 192' ' ' TYR . 46.3 pt -131.81 177.63 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.766 0.793 . . . . 0.0 110.922 -177.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 193' ' ' LYS . 24.4 mt -124.33 149.81 46.17 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.692 HD12 ' CE1' ' A' ' 301' ' ' PHE . 80.2 mt -118.1 129.12 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.232 178.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.642 HG23 ' SG ' ' A' ' 300' ' ' CYS . 84.7 mt -109.79 127.55 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 120.251 -0.579 . . . . 0.0 109.448 -175.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 59.5 t -118.87 126.79 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.4 p -125.23 153.66 42.81 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 120.136 -0.625 . . . . 0.0 110.55 -174.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.771 HD21 ' HB3' ' A' ' 180' ' ' PRO . 20.7 tp -104.09 125.59 50.55 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 168.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.652 ' OE2' HG13 ' A' ' 295' ' ' VAL . 73.5 mm-40 -131.8 150.43 52.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.855 -0.528 . . . . 0.0 109.851 -171.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.807 HG22 HD11 ' A' ' 296' ' ' LEU . 68.4 p -89.86 159.54 16.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.632 -0.668 . . . . 0.0 109.708 177.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 28.7 tpt180 -56.03 -25.98 46.96 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.521 -0.737 . . . . 0.0 110.761 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -86.65 8.96 20.18 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.482 -0.762 . . . . 0.0 111.706 -174.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 86.95 20.13 54.22 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 120.186 -1.007 . . . . 0.0 110.673 170.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -107.86 140.12 41.44 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.214 -1.168 . . . . 0.0 110.252 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.652 HG13 ' OE2' ' A' ' 289' ' ' GLU . 60.5 t -88.86 131.4 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.683 -0.635 . . . . 0.0 110.133 -174.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.807 HD11 HG22 ' A' ' 290' ' ' THR . 76.8 mt -99.78 -40.18 7.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.753 -0.592 . . . . 0.0 110.504 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -159.68 151.77 22.58 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.453 ' HD2' HG11 ' A' ' 295' ' ' VAL . 46.3 mtp180 -135.08 134.29 40.16 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.643 -0.916 . . . . 0.0 110.606 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -136.76 157.88 45.73 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.568 -0.707 . . . . 0.0 109.848 172.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . 0.642 ' SG ' HG23 ' A' ' 285' ' ' ILE . 94.7 m -143.18 156.69 44.83 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.358 -0.838 . . . . 0.0 110.846 -175.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.692 ' CE1' HD12 ' A' ' 284' ' ' ILE . 47.1 p90 -145.21 162.17 37.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.653 -0.654 . . . . 0.0 110.12 175.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.402 ' HA ' HD23 ' A' ' 283' ' ' LEU . 82.3 tt0 -104.85 135.36 46.36 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.515 -0.741 . . . . 0.0 110.16 -178.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -123.6 142.99 50.5 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.736 -170.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 53.4 ttt85 -139.04 140.33 38.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.853 -0.53 . . . . 0.0 109.769 173.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.681 HD13 ' O ' ' A' ' 269' ' ' CYS . 73.6 mt -107.78 123.0 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.611 -0.68 . . . . 0.0 109.602 176.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.9 p -145.13 167.56 22.45 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.592 -0.692 . . . . 0.0 110.929 -170.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -67.8 -40.07 83.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.633 -0.667 . . . . 0.0 110.628 -177.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 3.9 t -132.09 89.49 37.77 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.592 -0.693 . . . . 0.0 110.448 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.54 -29.86 71.57 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 O-C-N 123.089 1.047 . . . . 0.0 110.853 174.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.26 -37.28 92.76 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -73.25 -40.37 64.69 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.752 -0.852 . . . . 0.0 109.779 -173.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -69.53 -40.14 77.07 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.183 -178.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -61.72 -43.19 99.34 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.301 178.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -65.06 -39.74 93.7 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.494 -0.754 . . . . 0.0 110.445 177.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.37 -49.86 75.21 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.515 -0.74 . . . . 0.0 110.551 -173.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . 0.507 ' OD1' HD11 ' A' ' 159' ' ' LEU . 3.2 p30 . . . . . 0 N--CA 1.494 1.73 0 O-C-N 121.389 -0.82 . . . . 0.0 110.09 -178.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.0 t . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.029 0.442 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.5 p-10 -94.38 23.2 5.35 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.713 -0.617 . . . . 0.0 110.845 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 50.5 m -75.47 125.1 28.33 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.454 -0.779 . . . . 0.0 110.171 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -70.44 144.88 51.33 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.584 -0.697 . . . . 0.0 110.43 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.43 ' CE2' ' HA2' ' A' ' 134' ' ' GLY . 65.4 t80 -155.92 102.51 2.12 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.635 -0.666 . . . . 0.0 110.055 178.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -58.95 -39.87 76.84 Favored 'Trans proline' 0 N--CA 1.488 1.161 0 O-C-N 123.129 1.068 . . . . 0.0 110.792 -174.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.43 ' HA2' ' CE2' ' A' ' 132' ' ' TYR . . . 81.13 -155.14 36.05 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 178.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -73.04 -49.92 0.22 Allowed 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.361 1.19 . . . . 0.0 110.914 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -87.88 9.89 20.53 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.55 -0.719 . . . . 0.0 111.36 -173.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.71 61.51 3.06 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.922 -1.111 . . . . 0.0 110.705 -177.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.723 ' HA ' HG12 ' A' ' 176' ' ' VAL . 64.3 t80 -79.85 118.81 21.97 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.663 -0.648 . . . . 0.0 110.07 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -130.01 160.04 34.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.787 -0.571 . . . . 0.0 110.316 -175.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 72.3 t -123.99 147.09 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.751 -0.593 . . . . 0.0 109.764 177.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.9 p -155.17 163.65 39.93 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.251 0.548 . . . . 0.0 109.932 176.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.494 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 67.3 m-85 . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.723 -0.611 . . . . 0.0 109.844 -176.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 121.229 0.538 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.501 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 61.6 p -60.09 -33.22 71.79 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.753 -0.592 . . . . 0.0 110.005 175.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.501 ' HD1' ' HG1' ' A' ' 152' ' ' THR . 68.5 p-90 -171.28 143.48 1.88 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.784 -0.572 . . . . 0.0 110.063 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.5 t -142.03 142.54 32.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.83 -0.544 . . . . 0.0 110.011 -177.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.494 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 64.9 t80 -125.62 140.03 53.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.534 -0.729 . . . . 0.0 110.646 -172.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 40.6 t -109.59 124.46 51.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.863 -0.523 . . . . 0.0 109.944 176.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 56.1 m -71.12 -37.1 72.35 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.794 -0.566 . . . . 0.0 110.513 -177.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -59.9 -34.29 72.99 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.604 -0.685 . . . . 0.0 110.364 -178.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 58.0 mt -104.82 -11.99 16.51 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.656 -0.653 . . . . 0.0 110.871 -175.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.6 tttp 59.81 51.31 6.21 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.112 -0.992 . . . . 0.0 109.734 177.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -145.71 153.06 40.57 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.562 -174.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.67 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.5 tp -126.65 137.8 53.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.772 -0.58 . . . . 0.0 110.416 -175.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -117.15 134.28 54.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.683 -0.635 . . . . 0.0 109.414 174.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.28 158.37 44.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.615 -0.678 . . . . 0.0 111.0 -174.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.404 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 38.3 mt-30 -104.56 144.9 31.06 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.568 0.699 . . . . 0.0 110.491 173.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.417 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 16.8 tt -52.1 146.25 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.551 -0.718 . . . . 0.0 111.894 -174.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 63.96 10.17 5.11 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.629 -0.67 . . . . 0.0 112.448 176.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.404 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 74.5 mmtt -96.12 155.04 16.93 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.987 -1.071 . . . . 0.0 110.705 175.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 90.5 m -84.63 126.18 33.13 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.709 -0.619 . . . . 0.0 110.537 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' CYS . . . . . 0.67 ' SG ' HD21 ' A' ' 162' ' ' LEU . 42.9 t -114.3 90.08 19.49 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.627 -0.671 . . . . 0.0 110.046 172.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.436 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 22.6 Cg_exo -61.78 129.29 27.12 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 O-C-N 123.334 1.176 . . . . 0.0 110.548 172.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.416 HG12 ' CE2' ' A' ' 142' ' ' PHE . 95.2 mt -123.26 139.38 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 175.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -106.77 135.92 47.49 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.559 -0.713 . . . . 0.0 110.753 -175.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.629 HG21 ' CE1' ' A' ' 138' ' ' PHE . 49.8 mm -95.3 135.01 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.75 -0.594 . . . . 0.0 109.715 171.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 31.7 tptt -117.21 130.57 56.67 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.679 -0.638 . . . . 0.0 110.518 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.723 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.5 m -136.87 159.78 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.518 -0.739 . . . . 0.0 109.977 175.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 80.3 mmm -78.4 -40.29 36.47 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.716 -0.615 . . . . 0.0 110.008 177.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.416 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 76.7 p -135.09 143.21 44.95 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.805 -0.559 . . . . 0.0 109.686 177.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.4 Cg_exo -55.51 139.79 82.6 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 O-C-N 123.177 1.093 . . . . 0.0 110.92 -172.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.66 ' HB3' HD21 ' A' ' 288' ' ' LEU . 34.2 Cg_endo -68.12 169.99 15.46 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.211 1.111 . . . . 0.0 110.616 177.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -60.28 157.92 33.25 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 O-C-N 123.317 1.167 . . . . 0.0 110.685 -178.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -80.21 139.2 36.84 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.663 -0.648 . . . . 0.0 110.034 175.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.04 -24.94 30.22 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 -174.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.07 152.64 1.61 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.365 -1.08 . . . . 0.0 111.429 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.73 155.95 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.686 -0.634 . . . . 0.0 109.841 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.739 HD11 ' HD2' ' A' ' 251' ' ' TYR . 86.7 mt -109.04 137.97 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.629 -0.669 . . . . 0.0 109.539 176.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.733 ' HG2' HD22 ' A' ' 248' ' ' LEU . 58.3 mtt180 -115.03 146.24 41.47 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -176.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.678 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -139.97 127.94 22.16 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.454 -0.779 . . . . 0.0 110.327 174.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.405 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 30.6 ttp -137.26 139.95 29.45 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.752 -0.593 . . . . 0.0 111.19 -176.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.654 ' HD3' HD12 ' A' ' 226' ' ' ILE . 75.2 Cg_endo -92.46 138.14 1.73 Allowed 'Trans proline' 0 C--N 1.32 -0.961 0 C-N-CA 121.15 1.233 . . . . 0.0 110.702 177.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.44 HG13 ' C ' ' A' ' 190' ' ' PRO . 35.0 m -148.05 154.9 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.507 -0.746 . . . . 0.0 110.133 174.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.629 ' HA ' HG22 ' A' ' 282' ' ' ILE . 71.2 m-85 -60.3 164.96 3.84 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.529 -0.732 . . . . 0.0 110.487 178.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.422 ' HA ' HD12 ' A' ' 283' ' ' LEU . 36.8 tttt -79.86 -60.03 2.5 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.607 -0.683 . . . . 0.0 110.805 -174.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -80.1 150.73 30.16 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.525 -0.734 . . . . 0.0 110.293 -174.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.44 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.5 -38.68 72.12 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.334 -0.854 . . . . 0.0 110.749 -174.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -56.31 -25.12 47.51 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.487 -0.758 . . . . 0.0 110.633 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -110.01 -20.52 12.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.605 -0.684 . . . . 0.0 111.218 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.1 p -66.78 -20.24 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.153 -0.967 . . . . 0.0 110.604 -176.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 71.0 p -79.43 -15.44 57.81 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.577 -0.702 . . . . 0.0 110.813 175.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.22 135.18 33.56 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.355 -0.84 . . . . 0.0 110.031 173.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.9 t -72.89 143.98 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.661 -0.65 . . . . 0.0 110.221 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 63.1 t -84.97 136.31 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.583 -0.698 . . . . 0.0 109.318 171.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 9.2 pttt -134.91 -170.14 2.5 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.464 -0.773 . . . . 0.0 111.067 -166.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -95.15 159.34 15.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.715 -0.616 . . . . 0.0 110.426 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.68 ' HG ' ' HG ' ' A' ' 273' ' ' CYS . 59.6 m . . . . . 0 N--CA 1.495 1.812 0 O-C-N 121.644 -0.66 . . . . 0.0 109.425 176.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.449 HD12 ' HG3' ' A' ' 268' ' ' MET . 30.7 tp . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 120.824 0.345 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.654 HD12 ' HD3' ' A' ' 190' ' ' PRO . 80.8 mt -98.96 136.78 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.757 -0.59 . . . . 0.0 109.867 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -132.53 158.01 43.23 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.704 -0.622 . . . . 0.0 110.381 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.574 HG23 HG21 ' A' ' 247' ' ' VAL . 86.3 t -103.45 146.68 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.694 -0.629 . . . . 0.0 110.034 177.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -118.79 129.62 55.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.727 -0.608 . . . . 0.0 110.329 170.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.12 24.18 20.32 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 167.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -139.7 107.29 5.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.427 -1.043 . . . . 0.0 110.104 174.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 93.5 p -63.36 -15.12 56.51 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.641 -0.662 . . . . 0.0 111.197 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -97.02 9.99 40.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.266 -0.896 . . . . 0.0 111.265 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.87 126.2 26.52 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.185 -0.947 . . . . 0.0 110.112 176.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -139.69 155.2 47.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.794 -0.566 . . . . 0.0 109.759 176.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.42 ' CD2' ' HB ' ' A' ' 247' ' ' VAL . 77.2 m-85 -118.77 150.67 39.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.506 -0.746 . . . . 0.0 110.558 -176.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.19 159.88 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.817 -0.552 . . . . 0.0 110.3 178.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -120.1 129.78 54.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.667 -0.645 . . . . 0.0 110.063 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -65.01 130.01 94.71 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.626 -0.671 . . . . 0.0 109.886 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -66.36 -27.66 47.4 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.164 1.086 . . . . 0.0 111.111 -171.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.5 mt -100.35 -50.49 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.377 -0.827 . . . . 0.0 110.978 -168.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.7 p -105.38 12.16 31.91 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.37 -0.831 . . . . 0.0 111.846 -175.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.87 -5.16 13.4 Favored Glycine 0 N--CA 1.497 2.736 0 O-C-N 121.055 -1.028 . . . . 0.0 111.898 173.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 23.1 mmt85 -46.19 142.12 3.01 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-N 119.125 1.462 . . . . 0.0 112.265 -174.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -107.29 141.67 38.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.637 -0.664 . . . . 0.0 110.143 175.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 80.0 p -154.77 159.89 40.94 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.547 -0.721 . . . . 0.0 110.609 177.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.574 HG21 HG23 ' A' ' 228' ' ' VAL . 8.4 p -123.28 148.25 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.739 -0.601 . . . . 0.0 109.696 178.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.733 HD22 ' HG2' ' A' ' 187' ' ' ARG . 82.4 mt -129.57 154.58 46.92 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.878 -175.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.443 HG13 ' C ' ' A' ' 248' ' ' LEU . 34.7 m -151.15 151.73 29.97 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.823 -0.548 . . . . 0.0 109.943 175.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -71.07 140.11 37.1 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.303 1.159 . . . . 0.0 110.084 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.739 ' HD2' HD11 ' A' ' 186' ' ' ILE . 58.9 t80 -76.6 125.0 28.47 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.435 -0.791 . . . . 0.0 110.168 174.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -100.0 160.16 27.94 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.795 -0.565 . . . . 0.0 109.907 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -58.68 159.8 19.47 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 O-C-N 123.305 1.161 . . . . 0.0 110.48 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.02 149.92 76.42 Favored 'Trans proline' 0 N--CA 1.487 1.126 0 O-C-N 123.218 1.115 . . . . 0.0 110.539 -177.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -61.98 148.1 44.92 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.689 -0.632 . . . . 0.0 110.21 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.5 t -69.9 127.24 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.496 -0.752 . . . . 0.0 110.124 -170.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.01 -10.1 55.27 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 9.9 t -144.59 173.12 12.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.177 -1.19 . . . . 0.0 110.604 174.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -106.88 13.05 28.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.657 -0.652 . . . . 0.0 111.728 -168.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -119.95 168.02 11.56 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.149 -0.969 . . . . 0.0 111.136 -175.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 92.4 m -117.8 146.89 43.52 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.768 -0.583 . . . . 0.0 109.861 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 47.5 m -117.73 134.9 54.42 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.599 -0.688 . . . . 0.0 110.942 -175.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 59.6 t -131.02 137.36 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 71.9 mt -104.7 121.88 44.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.422 -0.799 . . . . 0.0 109.958 -171.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.678 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 5.8 m-30 -106.38 151.8 24.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.709 -0.619 . . . . 0.0 110.616 -177.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -136.61 142.93 43.31 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -111.26 130.02 55.79 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.54 -0.725 . . . . 0.0 110.426 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' MET . . . . . 0.449 ' HG3' HD12 ' A' ' 225' ' ' LEU . 5.2 ppp? -96.85 3.85 51.98 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.682 -0.636 . . . . 0.0 112.052 -175.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . 0.647 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.5 OUTLIER -144.79 165.02 29.27 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.053 -1.03 . . . . 0.0 109.961 174.067 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.617 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.7 p30 -119.43 159.82 23.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.643 -0.661 . . . . 0.0 110.187 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . 0.401 ' HA ' ' HB3' ' A' ' 277' ' ' MET . 29.5 m -59.31 -32.39 70.01 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.356 -0.84 . . . . 0.0 110.912 -163.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 47.1 p -97.58 11.47 36.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.405 -0.809 . . . . 0.0 111.978 -164.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . 0.68 ' HG ' ' HG ' ' A' ' 205' ' ' CYS . 30.0 p -95.07 118.07 31.26 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.116 -0.99 . . . . 0.0 110.631 178.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.15 139.16 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.462 -0.774 . . . . 0.0 110.189 -172.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 100.87 -5.12 56.38 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -123.74 -113.98 2.1 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 170.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . 0.403 ' CE ' ' HA ' ' A' ' 281' ' ' PRO . 26.6 ttt -64.16 -23.71 67.42 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.62 -0.93 . . . . 0.0 110.489 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 10.2 p30 44.52 54.46 6.39 Favored 'General case' 0 N--CA 1.504 2.273 0 CA-C-O 121.331 0.586 . . . . 0.0 112.58 172.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 22.8 mtp85 54.74 26.93 8.11 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.312 -0.867 . . . . 0.0 111.365 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' ARG . . . . . 0.401 ' HA ' ' HD2' ' A' ' 281' ' ' PRO . 82.0 mtt-85 -115.02 114.6 43.62 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.388 -0.82 . . . . 0.0 109.956 173.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . 0.403 ' HA ' ' CE ' ' A' ' 277' ' ' MET . 11.9 Cg_endo -59.45 145.39 98.09 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 O-C-N 122.969 0.984 . . . . 0.0 110.614 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.629 HG22 ' HA ' ' A' ' 192' ' ' TYR . 44.9 pt -131.92 174.72 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-O 121.758 0.79 . . . . 0.0 110.862 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 193' ' ' LYS . 29.2 mt -124.44 149.88 46.28 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . . . . . . . . . 81.3 mt -118.33 128.68 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.218 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.628 HG23 ' SG ' ' A' ' 300' ' ' CYS . 85.4 mt -109.72 127.38 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -174.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 61.8 t -119.0 126.79 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.6 p -125.26 154.07 42.23 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.664 -0.647 . . . . 0.0 110.624 -173.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.66 HD21 ' HB3' ' A' ' 180' ' ' PRO . 29.7 tp -105.19 126.16 51.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.697 -0.627 . . . . 0.0 109.503 169.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.634 ' OE2' HG13 ' A' ' 295' ' ' VAL . 72.5 mm-40 -130.96 149.62 52.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.916 -0.49 . . . . 0.0 109.681 -173.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.799 ' CG2' HD11 ' A' ' 296' ' ' LEU . 23.4 p -89.93 160.37 16.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.6 -0.688 . . . . 0.0 109.999 178.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -55.89 -26.15 45.94 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.568 -0.707 . . . . 0.0 111.082 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 45.4 p30 -90.14 9.52 27.99 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.467 -0.771 . . . . 0.0 111.931 -173.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.61 20.21 45.27 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 120.182 -1.008 . . . . 0.0 110.755 171.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -107.93 140.21 41.4 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.274 -1.133 . . . . 0.0 110.002 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.634 HG13 ' OE2' ' A' ' 289' ' ' GLU . 61.1 t -87.63 133.12 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.551 -0.718 . . . . 0.0 110.278 -172.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.799 HD11 ' CG2' ' A' ' 290' ' ' THR . 96.1 mt -99.86 -40.19 7.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.697 -0.627 . . . . 0.0 110.522 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -167.54 154.97 25.57 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -133.86 136.9 44.68 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.616 -0.932 . . . . 0.0 110.791 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -135.01 155.84 50.07 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.661 -0.65 . . . . 0.0 109.874 172.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . 0.628 ' SG ' HG23 ' A' ' 285' ' ' ILE . 98.1 m -142.52 153.18 43.38 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.399 -0.813 . . . . 0.0 110.781 -175.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -145.02 164.15 32.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.608 -0.683 . . . . 0.0 110.071 176.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.418 ' HA ' HD23 ' A' ' 283' ' ' LEU . 82.1 tt0 -104.84 136.1 44.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.609 -0.682 . . . . 0.0 110.173 -177.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -124.48 143.84 50.42 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.715 -169.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 61.8 ttm-85 -138.13 141.88 40.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.712 -0.617 . . . . 0.0 109.744 173.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.647 HD13 ' O ' ' A' ' 269' ' ' CYS . 77.2 mt -108.74 122.94 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.577 -0.702 . . . . 0.0 109.671 175.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.8 p -145.39 168.89 19.43 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.53 -0.731 . . . . 0.0 110.645 -172.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -71.28 -40.05 71.14 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.674 -0.642 . . . . 0.0 110.77 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.8 t -127.14 85.37 61.19 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.454 -0.779 . . . . 0.0 110.514 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . 0.4 ' HD3' ' HG3' ' A' ' 165' ' ' GLN . 43.7 Cg_exo -56.03 -27.79 66.15 Favored 'Trans proline' 0 N--CA 1.489 1.257 0 O-C-N 123.231 1.122 . . . . 0.0 110.674 174.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -68.14 -37.06 86.62 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.126 -1.589 . . . . 0.0 109.126 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -72.85 -39.92 66.14 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.647 -0.913 . . . . 0.0 109.749 -173.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -69.49 -40.51 77.0 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 120.067 -0.653 . . . . 0.0 109.934 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -62.06 -42.83 99.6 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.557 -0.715 . . . . 0.0 110.122 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -63.87 -40.27 96.15 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.599 -0.688 . . . . 0.0 110.563 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.19 -51.97 66.79 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.503 -0.748 . . . . 0.0 110.392 -174.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.6 p30 . . . . . 0 N--CA 1.494 1.77 0 O-C-N 121.458 -0.776 . . . . 0.0 110.029 -178.437 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.6 t . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.082 0.467 . . . . 0.0 110.342 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.9 p-10 -94.97 24.95 4.43 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.644 -0.66 . . . . 0.0 110.797 -178.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 52.1 m -72.09 125.21 26.71 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.593 -0.692 . . . . 0.0 110.248 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -71.09 144.9 50.16 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.754 -0.591 . . . . 0.0 110.538 -177.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -152.18 101.02 2.81 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.732 -0.605 . . . . 0.0 110.134 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -59.07 -39.96 75.11 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.042 1.022 . . . . 0.0 110.792 -174.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.42 -155.12 46.75 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -76.36 -44.0 0.27 Allowed 'Trans proline' 0 C--N 1.317 -1.08 0 O-C-N 123.38 1.2 . . . . 0.0 110.991 -174.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -86.91 8.84 21.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.503 -0.748 . . . . 0.0 111.425 -173.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 t 53.62 60.54 3.62 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.956 -1.09 . . . . 0.0 110.772 -176.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.67 ' HA ' HG12 ' A' ' 176' ' ' VAL . 37.3 t80 -77.84 118.41 20.14 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.585 -0.697 . . . . 0.0 109.871 -178.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -130.03 159.99 35.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.862 -0.523 . . . . 0.0 110.124 -178.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.8 t -125.98 146.07 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.797 -0.564 . . . . 0.0 109.726 177.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.8 p -155.31 161.12 41.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.772 -0.58 . . . . 0.0 110.03 177.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.406 ' CE2' HG12 ' A' ' 172' ' ' ILE . 71.5 m-85 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.769 -0.582 . . . . 0.0 109.772 -176.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 121.113 0.482 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.425 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 44.9 p -60.07 -34.12 73.01 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.7 -0.625 . . . . 0.0 110.243 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.438 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -170.87 144.35 2.2 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.435 0.636 . . . . 0.0 110.237 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.4 t -142.09 142.66 32.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.863 -0.523 . . . . 0.0 109.971 -176.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -125.44 140.12 53.06 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.499 -0.751 . . . . 0.0 110.553 -172.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.2 t -110.69 124.5 52.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.852 -0.53 . . . . 0.0 109.773 176.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 60.6 m -70.63 -36.99 73.73 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.808 -0.558 . . . . 0.0 110.417 -177.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -59.54 -33.59 71.59 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.587 -0.695 . . . . 0.0 110.43 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.429 HD11 ' OD1' ' A' ' 316' ' ' ASP . 57.0 mt -104.85 -12.06 16.45 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.711 -0.618 . . . . 0.0 110.826 -175.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 78.8 tttt 59.84 50.25 7.14 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.126 -0.984 . . . . 0.0 109.678 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -145.84 153.1 40.51 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.571 -174.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.607 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.5 tp -126.5 137.83 53.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.739 -0.601 . . . . 0.0 110.25 -176.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -115.81 134.51 54.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.668 -0.645 . . . . 0.0 109.33 175.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.47 158.57 44.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.646 -0.659 . . . . 0.0 110.808 -176.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.434 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 54.5 mt-30 -104.54 144.56 31.52 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.668 171.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.413 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.2 tt -51.46 147.43 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 CA-C-O 121.572 0.701 . . . . 0.0 112.107 -173.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.99 9.99 5.89 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.555 -0.715 . . . . 0.0 112.734 174.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.434 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 59.3 mmtt -94.22 155.15 17.19 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.951 -1.093 . . . . 0.0 111.045 173.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 87.3 m -81.28 126.22 31.28 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.767 -0.583 . . . . 0.0 110.596 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' CYS . . . . . 0.607 ' SG ' HD21 ' A' ' 162' ' ' LEU . 43.9 t -114.13 90.04 18.8 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.602 -0.686 . . . . 0.0 110.175 173.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.438 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 18.4 Cg_exo -63.38 128.83 23.55 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 O-C-N 123.281 1.148 . . . . 0.0 110.598 173.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.406 HG12 ' CE2' ' A' ' 142' ' ' PHE . 97.5 mt -123.34 143.43 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.597 -0.689 . . . . 0.0 109.36 175.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -110.47 134.82 51.99 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.453 -0.779 . . . . 0.0 110.857 -175.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.5 mm -95.26 135.03 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.644 -0.66 . . . . 0.0 109.7 169.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.9 tttt -115.21 128.29 56.06 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.466 175.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.67 HG12 ' HA ' ' A' ' 138' ' ' PHE . 15.9 m -136.64 159.71 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.69 -0.631 . . . . 0.0 109.832 174.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.7 mmm -75.22 -40.51 59.04 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.771 -0.581 . . . . 0.0 110.166 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 76.8 p -135.71 143.25 43.96 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.834 -0.541 . . . . 0.0 109.725 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 33.5 Cg_exo -55.31 139.85 81.55 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 O-C-N 123.106 1.056 . . . . 0.0 110.921 -172.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.691 ' HB3' HD21 ' A' ' 288' ' ' LEU . 19.6 Cg_endo -63.05 167.85 11.67 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.226 1.119 . . . . 0.0 110.637 178.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -61.04 156.71 42.95 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 O-C-N 123.395 1.208 . . . . 0.0 110.509 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -74.5 139.01 43.55 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.672 -0.642 . . . . 0.0 109.858 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.69 -24.97 29.29 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 -175.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.2 150.36 2.49 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.317 -1.107 . . . . 0.0 111.323 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 33.6 m -129.79 155.92 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.765 -0.585 . . . . 0.0 109.664 176.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.601 HD11 ' HD2' ' A' ' 251' ' ' TYR . 83.3 mt -106.93 138.31 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.747 -0.595 . . . . 0.0 109.435 175.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.758 ' HG2' HD22 ' A' ' 248' ' ' LEU . 56.6 mtp85 -114.95 144.99 42.71 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -176.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.68 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -137.8 128.03 26.11 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.426 -0.796 . . . . 0.0 110.324 174.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 1.6 ttp -137.3 135.84 19.97 Favored Pre-proline 0 N--CA 1.495 1.816 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.957 -175.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.633 ' HD3' HD12 ' A' ' 226' ' ' ILE . 73.3 Cg_endo -91.19 138.18 2.25 Favored 'Trans proline' 0 C--N 1.32 -0.951 0 O-C-N 123.196 1.103 . . . . 0.0 110.777 177.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.432 HG13 ' C ' ' A' ' 190' ' ' PRO . 35.5 m -148.21 154.95 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.578 -0.702 . . . . 0.0 109.904 173.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.677 ' HA ' HG22 ' A' ' 282' ' ' ILE . 89.6 m-85 -60.91 163.24 5.98 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.379 -0.826 . . . . 0.0 110.385 -178.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.469 ' HA ' HD12 ' A' ' 283' ' ' LEU . 39.6 tttm -78.64 -60.02 2.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.622 -0.674 . . . . 0.0 110.71 -175.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -80.05 150.33 30.38 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.597 -0.69 . . . . 0.0 110.356 -175.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.455 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.42 -37.88 70.8 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.404 -0.81 . . . . 0.0 110.713 -175.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -56.37 -25.24 48.79 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.562 -0.711 . . . . 0.0 110.56 -175.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.441 ' CD2' ' NH1' ' A' ' 280' ' ' ARG . 62.9 m170 -109.94 -20.64 12.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.577 -0.702 . . . . 0.0 111.112 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -67.05 -20.2 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.244 -0.91 . . . . 0.0 110.62 -176.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 82.3 p -79.42 -16.96 55.3 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.55 -0.719 . . . . 0.0 110.705 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -88.3 138.52 31.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.359 -0.838 . . . . 0.0 110.058 173.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.9 t -72.87 139.85 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.606 -0.684 . . . . 0.0 110.428 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.561 HG22 ' CE2' ' A' ' 192' ' ' TYR . 63.9 t -84.93 138.92 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.561 -0.712 . . . . 0.0 109.421 170.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 10.6 pttt -134.9 -170.45 2.57 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.463 -0.773 . . . . 0.0 110.993 -171.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -95.47 156.82 16.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.77 -0.581 . . . . 0.0 110.321 174.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.495 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 60.7 m . . . . . 0 N--CA 1.498 1.935 0 O-C-N 121.554 -0.716 . . . . 0.0 109.07 171.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.475 HD12 ' HG3' ' A' ' 268' ' ' MET . 58.6 tp . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 120.836 0.35 . . . . 0.0 110.352 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.633 HD12 ' HD3' ' A' ' 190' ' ' PRO . 83.0 mt -102.85 136.76 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.85 -0.531 . . . . 0.0 109.642 177.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -136.95 162.96 31.84 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.746 -0.596 . . . . 0.0 110.341 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.478 HG23 HG21 ' A' ' 247' ' ' VAL . 94.5 t -109.09 146.79 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.826 -0.546 . . . . 0.0 110.129 -178.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -120.81 121.54 38.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.809 -0.557 . . . . 0.0 110.348 174.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.98 24.09 10.88 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 169.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -137.23 106.74 6.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.413 -1.051 . . . . 0.0 109.988 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 46.0 m -63.16 -15.34 56.54 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.582 -0.699 . . . . 0.0 111.325 -176.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -99.94 5.59 45.25 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.275 -0.89 . . . . 0.0 111.608 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.94 131.4 49.58 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.039 -1.038 . . . . 0.0 110.16 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -139.72 158.07 44.71 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.797 -0.565 . . . . 0.0 109.811 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -112.35 150.64 30.78 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.618 -0.677 . . . . 0.0 110.361 -178.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.26 159.91 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.737 -0.602 . . . . 0.0 110.174 176.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -122.62 129.96 52.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.787 -0.57 . . . . 0.0 110.094 175.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -64.96 130.07 94.72 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.654 -0.654 . . . . 0.0 109.87 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -66.42 -27.92 46.67 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 O-C-N 123.193 1.102 . . . . 0.0 111.049 -170.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.0 mt -100.51 -50.46 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.423 -0.798 . . . . 0.0 110.879 -168.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.1 p -105.32 12.06 32.14 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.396 -0.815 . . . . 0.0 111.875 -175.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.9 -6.23 10.29 Favored Glycine 0 N--CA 1.496 2.69 0 O-C-N 121.034 -1.041 . . . . 0.0 111.941 172.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -46.12 142.03 3.0 Favored 'General case' 0 N--CA 1.506 2.327 0 CA-C-N 119.081 1.441 . . . . 0.0 112.258 -173.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -104.7 141.57 36.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.559 -0.713 . . . . 0.0 110.218 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 72.4 p -154.76 159.93 40.97 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.61 -0.682 . . . . 0.0 110.476 176.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.478 HG21 HG23 ' A' ' 228' ' ' VAL . 8.2 p -125.31 148.21 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.788 -0.57 . . . . 0.0 109.643 177.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.758 HD22 ' HG2' ' A' ' 187' ' ' ARG . 71.4 mt -129.5 154.7 46.75 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.633 -174.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.446 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.8 m -150.86 151.7 30.52 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.769 -0.582 . . . . 0.0 110.042 176.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -71.09 137.99 32.7 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 O-C-N 123.298 1.157 . . . . 0.0 109.994 177.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.601 ' HD2' HD11 ' A' ' 186' ' ' ILE . 10.5 t80 -76.54 126.02 30.25 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.573 -0.704 . . . . 0.0 110.221 176.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -100.01 160.07 28.16 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.771 -0.581 . . . . 0.0 109.979 176.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.88 159.11 22.25 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.199 1.105 . . . . 0.0 110.419 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.01 150.04 75.59 Favored 'Trans proline' 0 N--CA 1.488 1.187 0 O-C-N 123.26 1.137 . . . . 0.0 110.525 -177.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -61.16 147.46 44.05 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.669 -0.645 . . . . 0.0 110.139 -178.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.7 t -69.9 127.14 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.485 -0.759 . . . . 0.0 110.168 -170.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.53 -10.11 56.05 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 9.8 t -144.36 174.34 11.0 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.147 -1.208 . . . . 0.0 110.6 176.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -109.21 13.09 24.59 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.527 -0.733 . . . . 0.0 111.918 -166.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -120.95 168.06 11.89 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.081 -1.012 . . . . 0.0 111.193 -176.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 76.2 m -117.68 144.3 45.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.797 -0.564 . . . . 0.0 109.865 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 35.7 m -115.71 135.59 53.89 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.612 -0.68 . . . . 0.0 110.867 -175.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 62.9 t -131.18 137.28 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 174.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 72.4 mt -104.63 120.34 41.08 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.42 -0.8 . . . . 0.0 109.908 -171.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.68 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 4.6 m-30 -105.03 155.39 19.02 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.741 -0.599 . . . . 0.0 110.825 -176.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -136.32 142.9 43.89 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -114.89 128.97 56.6 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.616 -0.677 . . . . 0.0 110.266 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' MET . . . . . 0.475 ' HG3' HD12 ' A' ' 225' ' ' LEU . 5.0 ppp? -98.57 9.27 43.61 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.712 -0.617 . . . . 0.0 111.982 -175.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . 0.569 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.8 OUTLIER -144.58 161.32 39.43 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.178 -0.951 . . . . 0.0 110.112 173.662 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.693 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.1 p30 -119.91 164.06 16.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.786 -0.571 . . . . 0.0 110.286 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . 0.424 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 27.6 m -57.6 -33.93 68.73 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.449 -0.782 . . . . 0.0 110.983 -164.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 67.6 m -105.21 14.95 28.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.497 -0.752 . . . . 0.0 112.042 -164.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . 0.495 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 30.1 p -95.17 118.06 31.31 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.103 -0.998 . . . . 0.0 110.677 178.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 51.9 t -63.19 138.86 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.482 -0.761 . . . . 0.0 110.203 -171.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.76 -5.13 59.78 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 178.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.12 -99.3 0.86 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 172.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . 0.424 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.4 mmm -63.29 -32.59 74.04 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.796 -0.826 . . . . 0.0 110.328 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.4 p30 44.05 48.75 7.45 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 175.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 54.95 29.97 13.17 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.392 -0.818 . . . . 0.0 111.146 175.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' ARG . . . . . 0.441 ' NH1' ' CD2' ' A' ' 197' ' ' HIS . 74.0 mtt180 -119.96 105.0 43.36 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.475 -0.766 . . . . 0.0 110.208 175.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -60.53 145.78 98.15 Favored 'Trans proline' 0 N--CA 1.487 1.115 0 O-C-N 123.094 1.049 . . . . 0.0 110.402 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.677 HG22 ' HA ' ' A' ' 192' ' ' TYR . 46.2 pt -131.95 177.63 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.856 0.836 . . . . 0.0 111.249 -175.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' A' ' 193' ' ' LYS . 24.8 mt -124.5 149.91 46.36 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.678 HD12 ' CE1' ' A' ' 301' ' ' PHE . 81.2 mt -117.83 130.33 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.318 179.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.512 HG23 ' SG ' ' A' ' 300' ' ' CYS . 80.8 mt -109.79 127.38 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -176.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 57.5 t -118.94 126.83 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.634 HG22 ' HG2' ' A' ' 298' ' ' ARG . 45.4 p -125.33 153.1 43.83 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.745 . . . . 0.0 110.632 -173.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.691 HD21 ' HB3' ' A' ' 180' ' ' PRO . 21.7 tp -104.5 124.39 49.19 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.726 -0.609 . . . . 0.0 109.468 169.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.597 ' OE2' HG13 ' A' ' 295' ' ' VAL . 70.1 mm-40 -132.16 151.72 51.64 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.87 -0.519 . . . . 0.0 109.806 -173.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.715 ' CG2' HD11 ' A' ' 296' ' ' LEU . 77.8 p -89.88 159.58 16.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.558 -0.714 . . . . 0.0 109.768 177.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -55.94 -26.11 46.43 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.564 -0.71 . . . . 0.0 110.789 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -88.34 9.76 22.19 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.552 -0.717 . . . . 0.0 111.808 -174.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 87.25 20.22 53.07 Favored Glycine 0 N--CA 1.495 2.583 0 O-C-N 121.083 -1.011 . . . . 0.0 110.687 170.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -106.21 140.15 39.61 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.218 -1.166 . . . . 0.0 110.231 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.597 HG13 ' OE2' ' A' ' 289' ' ' GLU . 59.1 t -89.59 130.97 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.592 -0.692 . . . . 0.0 110.29 -173.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.715 HD11 ' CG2' ' A' ' 290' ' ' THR . 95.6 mt -100.11 -40.08 7.77 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.781 -0.574 . . . . 0.0 110.528 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -166.25 154.67 25.38 Favored Glycine 0 N--CA 1.497 2.719 0 C-N-CA 119.898 -1.144 . . . . 0.0 110.391 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.634 ' HG2' HG22 ' A' ' 287' ' ' THR . 91.1 mtt180 -135.09 137.46 42.87 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.692 -0.887 . . . . 0.0 110.667 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -137.67 157.82 45.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.684 -0.635 . . . . 0.0 109.963 170.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . 0.512 ' SG ' HG23 ' A' ' 285' ' ' ILE . 78.7 m -141.33 156.81 45.8 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.43 -0.794 . . . . 0.0 110.684 -175.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.678 ' CE1' HD12 ' A' ' 284' ' ' ILE . 47.8 p90 -144.91 162.14 37.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.681 -0.637 . . . . 0.0 110.164 175.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.408 ' HA ' HD23 ' A' ' 283' ' ' LEU . 56.7 tt0 -104.94 134.5 47.95 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.501 -0.749 . . . . 0.0 110.051 -177.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -118.78 143.99 46.57 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.728 -169.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 55.7 ttt85 -138.3 136.79 36.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.766 -0.584 . . . . 0.0 109.792 172.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.693 HG21 ' HA ' ' A' ' 270' ' ' ASN . 78.9 mt -108.27 123.0 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.608 -0.682 . . . . 0.0 109.542 177.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.4 p -145.07 172.82 12.53 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.571 -0.706 . . . . 0.0 110.769 -171.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -72.21 -40.09 68.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.676 -0.64 . . . . 0.0 110.566 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.8 t -131.26 89.08 42.45 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.627 -0.671 . . . . 0.0 110.53 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . 0.407 ' CG ' ' HG3' ' A' ' 165' ' ' GLN . 51.2 Cg_exo -54.3 -29.57 58.2 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 O-C-N 123.162 1.085 . . . . 0.0 110.996 173.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -65.95 -37.81 93.57 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -72.5 -41.04 66.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.758 -0.848 . . . . 0.0 109.829 -173.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -69.45 -39.61 77.68 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 120.056 -0.657 . . . . 0.0 110.076 -178.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -61.6 -43.23 99.25 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.284 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -64.27 -40.12 95.32 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.613 -0.679 . . . . 0.0 110.503 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.64 -50.95 70.49 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.502 -0.749 . . . . 0.0 110.512 -173.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . 0.429 ' OD1' HD11 ' A' ' 159' ' ' LEU . 3.4 p30 . . . . . 0 N--CA 1.495 1.792 0 O-C-N 121.507 -0.746 . . . . 0.0 110.142 -177.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 30.4 t . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 121.043 0.449 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 p-10 -96.31 26.06 4.56 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.636 -0.665 . . . . 0.0 110.598 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 47.6 m -73.94 125.13 27.52 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.575 -0.703 . . . . 0.0 110.395 -178.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -73.36 144.98 46.25 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.689 -0.632 . . . . 0.0 110.462 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.422 ' CE2' ' HA2' ' A' ' 134' ' ' GLY . 62.8 t80 -157.01 101.78 1.94 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.7 -0.625 . . . . 0.0 110.137 178.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -58.64 -39.9 78.42 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 O-C-N 123.094 1.049 . . . . 0.0 110.948 -175.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.422 ' HA2' ' CE2' ' A' ' 132' ' ' TYR . . . 78.76 -155.12 40.66 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 178.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -73.14 -49.1 0.24 Allowed 'Trans proline' 0 C--N 1.317 -1.116 0 O-C-N 123.337 1.177 . . . . 0.0 110.874 -174.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -85.18 6.67 24.88 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.626 -0.672 . . . . 0.0 111.432 -174.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 t 54.17 62.09 2.75 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.964 -1.085 . . . . 0.0 110.675 -176.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.724 ' HA ' HG12 ' A' ' 176' ' ' VAL . 59.3 t80 -77.87 120.86 23.34 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.655 -0.653 . . . . 0.0 109.993 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -130.06 159.95 35.19 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.309 0.576 . . . . 0.0 110.134 -177.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 64.8 t -124.97 145.23 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.76 -0.588 . . . . 0.0 109.897 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 80.0 p -155.41 160.94 41.05 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.345 0.593 . . . . 0.0 109.937 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.49 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 59.8 m-85 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.728 -0.608 . . . . 0.0 109.848 -176.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.871 0 CA-C-O 121.193 0.521 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.501 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 82.1 p -60.06 -33.99 72.81 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.689 -0.632 . . . . 0.0 109.933 176.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.501 ' HD1' ' HG1' ' A' ' 152' ' ' THR . 68.8 p-90 -170.74 143.5 2.14 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.366 0.603 . . . . 0.0 110.238 177.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.6 t -142.11 142.58 32.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.9 -0.5 . . . . 0.0 109.978 -176.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.49 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 60.9 t80 -125.58 140.01 53.11 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.496 -0.753 . . . . 0.0 110.771 -172.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 31.5 t -112.2 125.02 53.69 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.007 177.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 54.1 m -70.81 -37.12 73.22 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.724 -0.61 . . . . 0.0 110.534 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -59.25 -34.55 72.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.618 -0.676 . . . . 0.0 110.502 -177.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.1 mt -104.84 -12.0 16.49 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.933 -175.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 49.7 tttt 59.83 51.37 6.14 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.991 -1.068 . . . . 0.0 109.637 178.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -145.15 153.13 41.05 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.571 -173.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.57 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.9 tp -126.54 137.71 53.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.788 -0.57 . . . . 0.0 110.208 -176.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -115.59 134.42 55.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.64 -0.662 . . . . 0.0 109.292 173.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.43 158.62 43.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.736 -0.602 . . . . 0.0 110.85 -177.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.419 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 53.0 mt-30 -104.42 143.08 33.49 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.553 -0.717 . . . . 0.0 109.795 171.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.45 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.3 tt -52.44 148.45 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.538 -0.727 . . . . 0.0 111.851 -173.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 66.38 9.13 6.2 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.624 -0.672 . . . . 0.0 112.596 175.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.419 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 74.9 mmtt -94.41 155.13 17.11 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.933 -1.105 . . . . 0.0 110.983 172.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 88.5 m -84.07 126.21 32.85 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.719 -0.613 . . . . 0.0 110.433 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' CYS . . . . . 0.57 ' SG ' HD21 ' A' ' 162' ' ' LEU . 48.5 t -113.09 90.19 15.58 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.658 -0.652 . . . . 0.0 110.075 174.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.437 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 22.5 Cg_exo -61.33 130.52 32.4 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.276 1.145 . . . . 0.0 110.704 173.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.416 HG12 ' CE2' ' A' ' 142' ' ' PHE . 94.5 mt -124.61 141.91 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.639 -0.663 . . . . 0.0 109.28 175.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.436 ' NE2' ' CE1' ' A' ' 260' ' ' PHE . 98.4 mt-30 -108.9 136.45 48.43 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.524 -0.735 . . . . 0.0 110.826 -175.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.433 ' CG2' ' CE2' ' A' ' 138' ' ' PHE . 48.5 mm -95.24 135.06 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.694 -0.629 . . . . 0.0 109.64 169.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -117.65 129.37 55.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.606 -0.684 . . . . 0.0 110.405 176.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.724 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.1 m -136.67 159.75 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.538 -0.726 . . . . 0.0 110.057 175.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 80.7 mmm -77.46 -40.3 43.64 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.703 -0.623 . . . . 0.0 110.122 177.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.417 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 75.6 p -135.48 143.24 44.37 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.744 -0.597 . . . . 0.0 109.693 177.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.7 Cg_exo -55.49 139.89 82.56 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 O-C-N 123.114 1.06 . . . . 0.0 110.911 -172.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.763 ' HB3' HD21 ' A' ' 288' ' ' LEU . 32.1 Cg_endo -67.67 169.98 14.84 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 O-C-N 123.211 1.111 . . . . 0.0 110.565 177.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -60.49 155.32 47.98 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.35 1.184 . . . . 0.0 110.551 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -77.8 140.61 39.43 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.591 -0.693 . . . . 0.0 109.925 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.65 -24.93 29.47 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -174.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.16 152.78 1.61 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.337 -1.096 . . . . 0.0 111.404 178.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.8 155.89 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.713 -0.617 . . . . 0.0 109.765 176.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.726 HD11 ' HD2' ' A' ' 251' ' ' TYR . 81.1 mt -108.89 138.17 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.645 -0.659 . . . . 0.0 109.49 176.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.729 ' HG2' HD22 ' A' ' 248' ' ' LEU . 61.9 mtt180 -115.08 146.05 41.7 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -175.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.684 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -139.03 128.48 24.34 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.535 -0.728 . . . . 0.0 110.226 174.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.412 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 26.3 ttp -137.27 136.37 20.64 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.788 -0.57 . . . . 0.0 110.905 -176.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.504 ' HB3' HD11 ' A' ' 226' ' ' ILE . 74.1 Cg_endo -91.86 138.08 1.96 Allowed 'Trans proline' 0 C--N 1.32 -0.953 0 O-C-N 123.164 1.086 . . . . 0.0 110.643 177.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.439 HG13 ' C ' ' A' ' 190' ' ' PRO . 35.2 m -148.42 154.95 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.528 -0.733 . . . . 0.0 109.907 174.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.695 ' HA ' HG22 ' A' ' 282' ' ' ILE . 91.3 m-85 -60.6 163.92 5.01 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.447 -0.783 . . . . 0.0 110.413 -178.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.465 ' HA ' HD12 ' A' ' 283' ' ' LEU . 78.8 tttt -79.93 -59.99 2.51 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.661 -0.65 . . . . 0.0 110.785 -174.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 35.0 mttm -80.03 150.68 30.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.628 -0.67 . . . . 0.0 110.395 -175.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.454 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.43 -38.3 71.39 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.435 -0.791 . . . . 0.0 110.718 -175.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -56.49 -25.04 49.96 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.518 -0.739 . . . . 0.0 110.594 -175.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -110.01 -20.56 12.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.58 -0.7 . . . . 0.0 111.088 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.454 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.1 p -67.02 -20.27 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.137 -0.977 . . . . 0.0 110.592 -176.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 81.6 p -79.34 -17.06 55.29 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.545 -0.722 . . . . 0.0 110.753 175.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -88.39 138.79 31.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.38 -0.825 . . . . 0.0 110.041 173.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 57.6 t -73.24 142.73 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.585 -0.697 . . . . 0.0 110.156 176.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.541 HG22 ' CE2' ' A' ' 192' ' ' TYR . 77.8 t -84.9 140.15 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.552 -0.718 . . . . 0.0 109.443 171.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.2 pttp -134.84 -170.27 2.53 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.539 -0.726 . . . . 0.0 110.873 -169.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -95.28 156.38 16.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.735 -0.603 . . . . 0.0 110.52 178.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.64 ' HG ' ' HG ' ' A' ' 273' ' ' CYS . 60.1 m . . . . . 0 N--CA 1.497 1.887 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 172.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.4 ' CD1' ' HB2' ' A' ' 269' ' ' CYS . 40.7 tp . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 120.887 0.375 . . . . 0.0 110.566 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.504 HD11 ' HB3' ' A' ' 190' ' ' PRO . 91.3 mt -107.67 136.77 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 121.159 0.504 . . . . 0.0 110.111 -176.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 71.9 mtm-85 -140.53 167.92 21.02 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.638 -0.664 . . . . 0.0 110.1 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.489 HG23 HG21 ' A' ' 247' ' ' VAL . 82.9 t -105.28 146.73 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.37 0.605 . . . . 0.0 110.211 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -116.39 130.0 56.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.729 -0.607 . . . . 0.0 110.356 169.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.36 25.26 16.65 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 167.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -140.9 107.45 5.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.443 -1.034 . . . . 0.0 110.061 175.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 27.2 t -62.89 -15.26 54.4 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.588 -0.695 . . . . 0.0 111.329 -177.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 63.1 m170 -99.77 6.38 45.47 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.21 -0.931 . . . . 0.0 111.612 -177.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.32 128.51 36.71 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.081 -1.012 . . . . 0.0 110.241 176.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -139.75 158.05 44.74 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.785 -0.572 . . . . 0.0 109.681 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -116.86 150.6 38.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.574 -0.704 . . . . 0.0 110.686 -176.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.14 159.94 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.81 -0.556 . . . . 0.0 110.167 177.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -120.59 130.0 54.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.775 -0.578 . . . . 0.0 110.193 176.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -65.09 130.1 94.71 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.706 -0.621 . . . . 0.0 109.878 177.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -66.37 -27.62 47.35 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 O-C-N 123.128 1.068 . . . . 0.0 111.038 -171.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 82.9 mt -100.43 -50.41 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.292 -0.88 . . . . 0.0 111.013 -167.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.7 p -105.38 12.14 31.93 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.326 -0.859 . . . . 0.0 111.828 -175.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.86 -5.63 11.93 Favored Glycine 0 N--CA 1.496 2.678 0 O-C-N 121.131 -0.981 . . . . 0.0 111.832 174.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 22.9 mmt85 -46.09 142.0 2.99 Favored 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 119.194 1.497 . . . . 0.0 112.23 -173.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -105.59 145.43 30.99 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.607 -0.683 . . . . 0.0 110.091 175.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.0 p -154.74 159.92 40.99 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.623 -0.673 . . . . 0.0 110.534 176.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.489 HG21 HG23 ' A' ' 228' ' ' VAL . 8.2 p -123.82 148.1 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.731 -0.606 . . . . 0.0 109.695 178.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.729 HD22 ' HG2' ' A' ' 187' ' ' ARG . 81.7 mt -129.76 154.57 47.07 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.867 -176.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.441 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.7 m -150.69 151.67 30.89 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.813 -0.554 . . . . 0.0 109.986 174.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -71.1 140.03 36.85 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 O-C-N 123.329 1.173 . . . . 0.0 110.085 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.726 ' HD2' HD11 ' A' ' 186' ' ' ILE . 58.7 t80 -76.6 126.1 30.39 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.505 -0.747 . . . . 0.0 110.194 174.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -100.08 160.09 28.09 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.687 -0.633 . . . . 0.0 109.887 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.88 159.84 20.01 Favored 'Trans proline' 0 N--CA 1.488 1.188 0 O-C-N 123.204 1.107 . . . . 0.0 110.403 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.07 150.03 75.97 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 O-C-N 123.274 1.144 . . . . 0.0 110.501 -177.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -61.6 146.76 47.88 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.674 -0.641 . . . . 0.0 110.123 -178.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.84 127.2 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.517 -0.739 . . . . 0.0 110.145 -170.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.02 -10.2 55.32 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 9.8 t -144.23 174.39 10.93 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.105 -1.233 . . . . 0.0 110.641 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -108.84 13.13 25.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.595 -0.691 . . . . 0.0 111.948 -167.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.436 ' CE1' ' NE2' ' A' ' 173' ' ' GLN . 46.6 p90 -121.76 168.11 12.2 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.155 -0.965 . . . . 0.0 111.122 -176.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 85.5 m -117.77 145.86 44.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.778 -0.576 . . . . 0.0 109.87 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 55.3 m -116.02 135.58 53.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.633 -0.667 . . . . 0.0 110.903 -174.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.9 t -131.77 137.27 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 173.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 77.2 mt -104.69 121.6 43.91 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.477 -0.764 . . . . 0.0 110.005 -170.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.684 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 4.1 m-30 -107.94 149.24 28.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.705 -0.622 . . . . 0.0 110.556 -176.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -136.55 143.01 43.45 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.674 -0.642 . . . . 0.0 109.545 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -120.2 136.99 54.45 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.638 -0.664 . . . . 0.0 110.452 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' MET . . . . . 0.457 ' HE3' ' HB2' ' A' ' 269' ' ' CYS . 0.0 OUTLIER -105.43 12.53 31.41 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 120.179 -0.608 . . . . 0.0 112.195 -176.147 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . 0.676 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.6 OUTLIER -144.6 159.16 43.26 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.075 -1.016 . . . . 0.0 109.838 176.091 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.611 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.2 p30 -120.31 163.42 17.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.651 -0.656 . . . . 0.0 110.401 -177.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . 0.417 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 43.4 m -57.11 -34.18 68.1 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.46 -0.775 . . . . 0.0 111.1 -165.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 65.5 m -104.6 15.02 28.84 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.411 -0.806 . . . . 0.0 111.967 -164.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . 0.64 ' HG ' ' HG ' ' A' ' 205' ' ' CYS . 30.3 p -93.61 118.03 30.85 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.088 -1.007 . . . . 0.0 110.581 178.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.2 t -63.58 139.45 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.442 -0.786 . . . . 0.0 110.419 -169.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.47 -5.09 60.35 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.97 -99.33 0.87 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 173.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . 0.417 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.5 mmm -61.42 -31.87 71.81 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.614 -0.933 . . . . 0.0 110.109 177.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 23.6 p30 42.25 47.02 4.02 Favored 'General case' 0 N--CA 1.507 2.38 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 174.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 22.9 mtt180 54.87 31.58 16.04 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.274 -0.891 . . . . 0.0 111.207 176.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 -120.1 104.94 43.11 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.458 -0.776 . . . . 0.0 110.056 173.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -59.99 148.24 89.75 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 O-C-N 123.094 1.049 . . . . 0.0 110.468 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.695 HG22 ' HA ' ' A' ' 192' ' ' TYR . 46.7 pt -131.86 176.74 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.806 0.812 . . . . 0.0 111.118 -175.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 193' ' ' LYS . 27.5 mt -124.37 149.83 46.23 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.686 HD12 ' CE1' ' A' ' 301' ' ' PHE . 81.4 mt -116.89 130.76 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.21 178.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.476 HG23 ' SG ' ' A' ' 300' ' ' CYS . 79.4 mt -109.8 126.37 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -177.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 58.7 t -118.92 126.75 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 46.1 p -125.21 153.54 42.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.554 -0.716 . . . . 0.0 110.721 -173.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.763 HD21 ' HB3' ' A' ' 180' ' ' PRO . 26.3 tp -104.08 126.42 51.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.785 -0.572 . . . . 0.0 109.5 169.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.502 ' OE2' HG22 ' A' ' 295' ' ' VAL . 72.9 mm-40 -130.44 150.25 51.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.91 -0.494 . . . . 0.0 109.861 -173.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.824 ' CG2' HD11 ' A' ' 296' ' ' LEU . 22.8 p -89.87 161.73 15.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.687 -0.633 . . . . 0.0 109.928 177.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -55.89 -26.15 45.96 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.641 -0.662 . . . . 0.0 111.042 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 45.6 p30 -89.87 9.19 28.53 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.408 -0.807 . . . . 0.0 112.004 -173.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.61 20.19 45.36 Favored Glycine 0 N--CA 1.494 2.522 0 O-C-N 121.09 -1.006 . . . . 0.0 110.725 171.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -107.03 140.21 40.2 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.295 -1.121 . . . . 0.0 110.163 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.502 HG22 ' OE2' ' A' ' 289' ' ' GLU . 72.1 t -85.24 132.79 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.588 -0.695 . . . . 0.0 110.228 -174.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.824 HD11 ' CG2' ' A' ' 290' ' ' THR . 95.2 mt -100.01 -40.15 7.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.621 -0.674 . . . . 0.0 110.399 176.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -163.64 153.44 23.88 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -133.87 136.19 44.18 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.609 -0.936 . . . . 0.0 110.648 -178.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -134.73 157.81 45.75 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.611 -0.681 . . . . 0.0 110.026 172.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . 0.476 ' SG ' HG23 ' A' ' 285' ' ' ILE . 95.3 m -143.02 153.25 42.78 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.474 -0.766 . . . . 0.0 110.629 -176.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.686 ' CE1' HD12 ' A' ' 284' ' ' ILE . 47.8 p90 -145.01 162.38 37.06 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.631 -0.668 . . . . 0.0 110.174 176.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.413 ' HA ' HD23 ' A' ' 283' ' ' LEU . 81.9 tt0 -104.86 135.11 46.82 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.543 -0.723 . . . . 0.0 110.238 -176.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -120.09 143.61 48.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.62 -0.675 . . . . 0.0 110.737 -170.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -138.28 138.29 38.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.786 -0.571 . . . . 0.0 109.74 173.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.676 HD13 ' O ' ' A' ' 269' ' ' CYS . 73.9 mt -109.01 122.96 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.541 -0.724 . . . . 0.0 109.667 176.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.3 p -145.17 171.56 14.35 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.625 -0.672 . . . . 0.0 110.657 -172.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -70.89 -40.11 72.4 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.658 -0.651 . . . . 0.0 110.494 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.8 t -130.44 89.11 45.23 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.524 -0.735 . . . . 0.0 110.467 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . 0.406 ' CG ' ' HG3' ' A' ' 165' ' ' GLN . 50.6 Cg_exo -54.25 -29.27 56.34 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 O-C-N 123.146 1.077 . . . . 0.0 111.025 173.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -65.63 -37.81 93.96 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 177.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 37.6 ttp180 -72.82 -42.1 64.18 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.714 -0.874 . . . . 0.0 109.938 -173.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -69.53 -40.47 76.89 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.172 -178.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 73.2 ttt-85 -60.23 -43.38 96.1 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.449 -0.782 . . . . 0.0 110.351 178.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -64.42 -41.02 96.84 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.585 -0.697 . . . . 0.0 110.522 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -60.94 -50.14 74.62 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.506 -0.746 . . . . 0.0 110.462 -173.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.2 p30 . . . . . 0 N--CA 1.494 1.772 0 O-C-N 121.433 -0.792 . . . . 0.0 110.06 -178.703 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.6 t . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.133 0.492 . . . . 0.0 110.313 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -93.85 22.92 5.19 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.614 -0.679 . . . . 0.0 110.893 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 48.2 m -71.67 125.14 26.34 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.542 -0.724 . . . . 0.0 110.226 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -70.74 144.9 50.78 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.715 -0.615 . . . . 0.0 110.461 -177.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.43 ' CE1' ' HA2' ' A' ' 134' ' ' GLY . 64.9 t80 -154.93 101.37 2.32 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.72 -0.613 . . . . 0.0 110.061 178.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -58.79 -39.88 77.67 Favored 'Trans proline' 0 N--CA 1.488 1.153 0 O-C-N 123.115 1.061 . . . . 0.0 110.799 -174.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.43 ' HA2' ' CE1' ' A' ' 132' ' ' TYR . . . 81.64 -155.2 35.22 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 177.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -74.27 -48.89 0.2 Allowed 'Trans proline' 0 C--N 1.316 -1.156 0 O-C-N 123.385 1.203 . . . . 0.0 110.873 -174.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -86.98 9.03 20.76 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.635 -0.665 . . . . 0.0 111.403 -173.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.57 62.11 2.79 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.99 -1.069 . . . . 0.0 110.686 -177.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.721 ' HA ' HG12 ' A' ' 176' ' ' VAL . 65.2 t80 -79.27 119.3 22.15 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.559 -0.713 . . . . 0.0 110.048 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -130.05 159.94 35.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.785 -0.572 . . . . 0.0 110.37 -175.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 59.4 t -125.11 146.54 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.698 -0.626 . . . . 0.0 109.819 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.6 p -155.18 161.55 41.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.736 -0.602 . . . . 0.0 110.024 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.417 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 41.2 m-85 . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.789 -0.57 . . . . 0.0 109.923 -176.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.111 0.481 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 44.1 p -60.12 -34.09 73.03 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.682 -0.636 . . . . 0.0 110.229 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.448 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.0 p-90 -171.26 144.29 2.0 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.62 -0.675 . . . . 0.0 110.117 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.4 t -142.13 142.7 32.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.882 -0.511 . . . . 0.0 109.992 -176.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.417 ' CG ' ' HB2' ' A' ' 142' ' ' PHE . 63.2 t80 -125.41 140.06 53.12 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.54 -0.725 . . . . 0.0 110.423 -173.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.8 t -110.56 123.96 50.94 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 120.379 -0.529 . . . . 0.0 109.811 176.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 56.1 m -70.71 -37.1 73.53 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.872 -0.518 . . . . 0.0 110.376 -177.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -59.75 -33.28 71.46 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.58 -0.7 . . . . 0.0 110.478 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.47 HD11 ' OD1' ' A' ' 316' ' ' ASP . 57.7 mt -104.81 -11.96 16.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.666 -0.646 . . . . 0.0 110.81 -175.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 79.9 tttt 59.79 49.65 7.81 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.978 -1.076 . . . . 0.0 109.704 177.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -146.58 153.03 39.88 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.8 -174.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.6 tp -126.58 137.84 53.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.841 -0.537 . . . . 0.0 110.413 -175.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -117.66 134.27 55.07 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.645 -0.659 . . . . 0.0 109.487 175.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.35 158.4 44.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.671 -0.643 . . . . 0.0 111.173 -174.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.4 ' HG3' ' HD3' ' A' ' 309' ' ' PRO . 42.1 mt-30 -104.63 141.3 36.67 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.585 -0.697 . . . . 0.0 110.525 172.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.465 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 18.8 tt -55.39 149.9 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.594 -0.691 . . . . 0.0 111.444 -175.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.79 10.08 5.78 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.559 -0.713 . . . . 0.0 112.481 178.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -96.18 155.07 16.91 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.959 -1.088 . . . . 0.0 110.611 172.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 77.4 m -81.16 126.07 31.03 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.631 -0.668 . . . . 0.0 110.325 177.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 43.5 t -115.13 89.64 21.04 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.652 -0.655 . . . . 0.0 110.273 175.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.489 ' HA ' HD23 ' A' ' 264' ' ' LEU . 15.5 Cg_exo -65.8 124.94 13.42 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 O-C-N 123.281 1.148 . . . . 0.0 110.675 173.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.569 HD12 ' CD2' ' A' ' 265' ' ' TYR . 97.3 mt -119.87 140.83 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.634 -0.667 . . . . 0.0 109.246 172.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -106.79 135.46 48.29 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.454 -0.779 . . . . 0.0 110.74 -174.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.586 HG21 ' CE1' ' A' ' 138' ' ' PHE . 49.6 mm -95.27 134.97 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.708 -0.62 . . . . 0.0 109.687 170.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -117.48 130.69 56.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.557 -0.714 . . . . 0.0 110.44 176.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.721 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.6 m -136.67 159.75 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.573 -0.704 . . . . 0.0 109.99 175.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 80.6 mmm -78.75 -40.56 33.03 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.67 -0.644 . . . . 0.0 110.068 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 76.8 p -135.02 143.24 45.22 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.735 -0.603 . . . . 0.0 109.722 177.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.4 Cg_exo -55.84 139.89 84.57 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 O-C-N 123.161 1.085 . . . . 0.0 110.855 -172.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.778 ' HB3' HD21 ' A' ' 288' ' ' LEU . 32.5 Cg_endo -67.47 170.03 14.44 Favored 'Trans proline' 0 N--CA 1.487 1.113 0 O-C-N 123.131 1.069 . . . . 0.0 110.619 177.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -60.75 157.39 37.92 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 O-C-N 123.293 1.154 . . . . 0.0 110.53 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -79.8 140.87 36.7 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.574 -0.704 . . . . 0.0 109.949 175.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.7 -24.91 29.57 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -174.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.14 153.78 1.34 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.378 -1.072 . . . . 0.0 111.398 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.8 155.95 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.751 -0.593 . . . . 0.0 109.779 176.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.678 HD11 ' HD2' ' A' ' 251' ' ' TYR . 52.4 mt -108.06 135.59 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.739 ' HG2' HD22 ' A' ' 248' ' ' LEU . 27.6 mtm180 -114.78 143.88 44.38 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -176.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -139.47 123.75 18.04 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.598 -0.689 . . . . 0.0 110.408 177.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.41 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 26.8 ttm -137.36 138.05 23.96 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.797 -0.564 . . . . 0.0 111.073 -175.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.551 ' HD3' HD12 ' A' ' 226' ' ' ILE . 62.6 Cg_endo -91.13 138.17 2.27 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 O-C-N 123.187 1.098 . . . . 0.0 110.643 176.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.419 HG13 ' C ' ' A' ' 190' ' ' PRO . 34.8 m -146.79 154.85 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.471 -0.768 . . . . 0.0 110.212 173.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.677 ' HA ' HG22 ' A' ' 282' ' ' ILE . 87.1 m-85 -58.49 167.55 1.4 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.511 -0.743 . . . . 0.0 110.679 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -84.94 -60.08 2.15 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.639 -0.663 . . . . 0.0 110.863 -174.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -80.08 152.11 29.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.544 -0.722 . . . . 0.0 110.286 -175.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.459 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.67 -38.06 71.68 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.332 -0.855 . . . . 0.0 110.713 -176.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.4 mp0 -56.5 -24.81 48.8 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.483 -0.76 . . . . 0.0 110.616 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.426 ' HB3' ' CD1' ' A' ' 192' ' ' TYR . 99.5 m-70 -109.53 -20.51 12.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.586 -0.696 . . . . 0.0 111.14 -178.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -68.05 -20.24 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.119 -0.988 . . . . 0.0 110.628 -176.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 78.8 p -79.45 -17.08 55.02 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.577 -0.702 . . . . 0.0 110.649 175.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -88.35 136.34 33.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.386 -0.821 . . . . 0.0 110.017 173.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 60.5 t -73.07 143.76 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.584 -0.698 . . . . 0.0 110.13 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.509 HG22 ' CE2' ' A' ' 192' ' ' TYR . 84.0 t -84.82 139.13 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.538 -0.726 . . . . 0.0 109.217 171.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -134.76 -170.04 2.48 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.508 -0.745 . . . . 0.0 111.157 -165.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -95.2 152.99 17.88 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.795 -0.565 . . . . 0.0 110.206 -176.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.496 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 56.5 m . . . . . 0 N--CA 1.497 1.897 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 172.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.405 ' HA ' ' HG3' ' A' ' 268' ' ' MET . 57.5 tp . . . . . 0 N--CA 1.497 1.901 0 CA-C-O 120.922 0.392 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.551 HD12 ' HD3' ' A' ' 190' ' ' PRO . 83.9 mt -106.31 136.65 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.905 -0.497 . . . . 0.0 109.707 176.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 40.6 mtm105 -133.52 157.78 44.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.693 -0.629 . . . . 0.0 110.129 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.419 HG23 HG21 ' A' ' 247' ' ' VAL . 79.2 t -102.41 146.58 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.649 -0.657 . . . . 0.0 110.098 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -120.76 130.01 53.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.857 -0.527 . . . . 0.0 110.332 171.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.39 20.69 19.29 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 169.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -140.99 107.06 5.18 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.276 -1.132 . . . . 0.0 110.08 174.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 42.8 m -63.3 -15.26 56.7 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.56 -0.712 . . . . 0.0 111.269 -175.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -100.05 8.1 44.21 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.219 -0.925 . . . . 0.0 111.59 -177.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.2 129.4 41.09 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.104 -0.998 . . . . 0.0 110.345 177.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -139.79 158.1 44.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.826 -0.546 . . . . 0.0 109.709 177.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -112.16 150.57 30.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.522 -0.736 . . . . 0.0 110.539 -177.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.21 159.9 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.804 -0.56 . . . . 0.0 110.155 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -122.53 130.04 52.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.68 -0.638 . . . . 0.0 110.194 176.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -65.08 130.12 94.72 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.625 -0.672 . . . . 0.0 109.823 178.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -66.48 -27.79 46.34 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 O-C-N 123.155 1.082 . . . . 0.0 111.006 -171.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 82.8 mt -100.55 -50.39 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.471 -0.768 . . . . 0.0 110.99 -167.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.1 p -105.47 12.11 31.82 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.41 -0.806 . . . . 0.0 111.877 -174.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.82 -5.11 13.24 Favored Glycine 0 N--CA 1.496 2.638 0 O-C-N 121.128 -0.982 . . . . 0.0 111.9 173.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -46.11 142.02 3.0 Favored 'General case' 0 N--CA 1.504 2.234 0 CA-C-N 119.104 1.452 . . . . 0.0 112.3 -174.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.6 mp0 -106.09 141.62 37.15 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.577 -0.702 . . . . 0.0 110.156 176.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 80.0 p -154.84 159.96 40.9 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.585 -0.697 . . . . 0.0 110.45 177.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.419 HG21 HG23 ' A' ' 228' ' ' VAL . 8.4 p -123.72 148.22 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.735 -0.603 . . . . 0.0 109.793 178.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.739 HD22 ' HG2' ' A' ' 187' ' ' ARG . 82.9 mt -129.57 154.63 46.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.644 -0.66 . . . . 0.0 110.094 -175.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.442 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.9 m -151.51 151.83 29.53 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.781 -0.574 . . . . 0.0 109.934 177.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -71.14 139.33 35.3 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 O-C-N 123.254 1.133 . . . . 0.0 109.993 176.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.678 ' HD2' HD11 ' A' ' 186' ' ' ILE . 60.6 t80 -75.06 124.48 27.07 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.42 -0.8 . . . . 0.0 110.21 176.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -100.04 160.12 28.03 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.665 -0.647 . . . . 0.0 110.072 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -59.53 159.95 22.05 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 O-C-N 123.241 1.127 . . . . 0.0 110.448 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -59.45 149.92 78.63 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 O-C-N 123.243 1.128 . . . . 0.0 110.426 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -60.91 147.63 42.44 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.612 -0.68 . . . . 0.0 110.19 -178.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.9 t -69.87 127.24 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.557 -0.715 . . . . 0.0 110.212 -170.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.97 -10.05 55.35 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 10.1 t -144.42 173.81 11.46 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.078 -1.248 . . . . 0.0 110.664 175.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -107.05 13.21 27.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.662 -0.649 . . . . 0.0 111.764 -168.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -119.98 168.04 11.55 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.154 -0.966 . . . . 0.0 111.118 -175.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 93.3 m -117.79 146.73 43.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.761 -0.587 . . . . 0.0 109.887 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 45.3 m -116.46 136.41 53.01 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.524 -0.735 . . . . 0.0 110.857 -175.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.2 t -128.39 136.02 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 172.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 171' ' ' PRO . 71.3 mt -104.94 120.75 42.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.565 -0.709 . . . . 0.0 110.015 -174.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.569 ' CD2' HD12 ' A' ' 172' ' ' ILE . 2.9 m-30 -95.5 157.37 15.92 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.642 -0.661 . . . . 0.0 110.605 176.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -136.47 142.83 43.59 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 168.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -114.32 133.16 55.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.498 -0.751 . . . . 0.0 110.459 -177.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' MET . . . . . 0.405 ' HG3' ' HA ' ' A' ' 225' ' ' LEU . 0.0 OUTLIER -103.25 3.31 35.38 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.685 -0.634 . . . . 0.0 111.975 -178.104 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . 0.728 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.8 OUTLIER -144.63 159.95 41.97 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.102 -0.999 . . . . 0.0 109.929 174.569 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.442 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.1 p30 -119.78 163.54 17.31 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.435 0.636 . . . . 0.0 110.484 -178.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . 0.429 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 32.4 m -58.22 -32.62 68.48 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.465 -0.772 . . . . 0.0 110.975 -164.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 49.1 p -101.51 13.05 36.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.47 -0.769 . . . . 0.0 111.941 -164.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . 0.496 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 30.7 p -94.26 118.08 31.06 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.077 -1.014 . . . . 0.0 110.612 178.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 61.2 t -63.82 139.92 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.44 -0.788 . . . . 0.0 110.351 -170.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 100.13 -5.11 57.54 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 177.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.81 -99.05 0.87 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 171.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . 0.429 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.3 mmm -62.91 -32.1 73.31 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.7 -0.882 . . . . 0.0 110.287 178.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.3 p30 44.31 49.88 7.89 Favored 'General case' 0 N--CA 1.504 2.243 0 CA-C-O 121.262 0.553 . . . . 0.0 112.449 174.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 21.3 mtt180 54.85 28.64 10.69 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.29 -0.881 . . . . 0.0 111.197 175.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -116.82 106.01 48.67 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.561 -0.712 . . . . 0.0 109.995 174.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.37 147.71 89.92 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 O-C-N 123.029 1.015 . . . . 0.0 110.609 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.677 HG22 ' HA ' ' A' ' 192' ' ' TYR . 45.2 pt -131.87 177.34 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.646 0.736 . . . . 0.0 110.876 -177.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 302' ' ' GLU . 35.3 mt -124.3 149.85 46.08 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.459 HD12 ' HB2' ' A' ' 303' ' ' ALA . 81.2 mt -112.02 129.94 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 79.4 mt -109.81 125.26 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 63.1 t -118.99 126.78 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.436 HG22 ' HG2' ' A' ' 298' ' ' ARG . 45.9 p -125.24 152.16 44.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.631 -0.668 . . . . 0.0 110.594 -173.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.778 HD21 ' HB3' ' A' ' 180' ' ' PRO . 26.2 tp -101.03 127.14 47.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.715 -0.615 . . . . 0.0 109.5 167.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.403 ' OE2' HG22 ' A' ' 295' ' ' VAL . 73.1 mm-40 -130.27 150.32 51.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.856 -0.528 . . . . 0.0 109.926 -173.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.862 HG23 HD11 ' A' ' 296' ' ' LEU . 8.2 p -89.99 161.14 16.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.579 -0.701 . . . . 0.0 109.971 177.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -55.89 -26.14 45.96 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.502 -0.749 . . . . 0.0 111.043 -176.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 49.1 p30 -87.61 8.28 25.99 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.424 -0.797 . . . . 0.0 111.904 -174.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 88.19 20.19 50.17 Favored Glycine 0 N--CA 1.494 2.548 0 O-C-N 121.067 -1.021 . . . . 0.0 110.648 172.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -107.6 140.21 40.96 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.323 -1.104 . . . . 0.0 110.111 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.403 HG22 ' OE2' ' A' ' 289' ' ' GLU . 58.6 t -83.91 133.56 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.563 -0.711 . . . . 0.0 110.15 -174.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.862 HD11 HG23 ' A' ' 290' ' ' THR . 95.7 mt -99.93 -40.15 7.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.711 -0.618 . . . . 0.0 110.283 176.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -167.26 150.41 17.02 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.436 ' HG2' HG22 ' A' ' 287' ' ' THR . 77.5 mtm180 -133.47 137.29 45.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.612 -0.934 . . . . 0.0 110.718 -178.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -130.61 155.21 46.93 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.619 -0.676 . . . . 0.0 110.229 172.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 79.5 m -139.15 146.73 40.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.469 -0.769 . . . . 0.0 110.831 -174.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.424 ' CE2' ' HB ' ' A' ' 284' ' ' ILE . 9.2 p90 -147.76 162.08 39.93 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.782 -0.574 . . . . 0.0 109.979 177.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.444 ' HA ' HD23 ' A' ' 283' ' ' LEU . 81.9 tt0 -104.77 138.44 41.05 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.542 -0.724 . . . . 0.0 110.331 -175.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.459 ' HB2' HD12 ' A' ' 284' ' ' ILE . . . -125.14 143.63 50.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.651 -0.655 . . . . 0.0 110.596 -171.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -138.19 140.77 39.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.75 -0.594 . . . . 0.0 109.755 174.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.728 HD13 ' O ' ' A' ' 269' ' ' CYS . 63.8 mt -108.88 122.87 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.501 -0.749 . . . . 0.0 109.645 176.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.9 p -145.24 168.66 19.88 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.636 -0.665 . . . . 0.0 110.657 -172.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -70.03 -40.18 75.33 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.64 -0.663 . . . . 0.0 110.638 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.8 t -127.99 86.55 57.87 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.522 -0.736 . . . . 0.0 110.457 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . 0.4 ' HD3' ' HG3' ' A' ' 165' ' ' GLN . 43.7 Cg_exo -56.23 -27.69 67.51 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 O-C-N 123.198 1.104 . . . . 0.0 110.573 174.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -68.47 -36.79 84.63 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -72.18 -39.95 68.29 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.708 -0.877 . . . . 0.0 109.873 -173.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -69.58 -39.26 77.43 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.062 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 -61.61 -44.01 97.8 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.301 178.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -65.12 -39.42 93.05 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.569 -0.707 . . . . 0.0 110.476 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.32 -49.95 74.94 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.599 -0.688 . . . . 0.0 110.44 -173.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . 0.47 ' OD1' HD11 ' A' ' 159' ' ' LEU . 3.1 p30 . . . . . 0 N--CA 1.495 1.799 0 O-C-N 121.487 -0.758 . . . . 0.0 110.02 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.2 t . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.02 0.438 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -94.69 25.0 4.26 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.611 -0.681 . . . . 0.0 110.824 -178.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 51.0 m -70.06 125.21 26.09 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.613 -0.679 . . . . 0.0 110.249 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -70.06 144.94 52.02 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.616 -0.678 . . . . 0.0 110.432 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.434 ' CE1' ' HA2' ' A' ' 134' ' ' GLY . 43.2 t80 -155.47 101.4 2.22 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.587 -0.696 . . . . 0.0 110.018 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -59.29 -39.97 72.78 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 O-C-N 123.185 1.097 . . . . 0.0 110.762 -173.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.434 ' HA2' ' CE1' ' A' ' 132' ' ' TYR . . . 82.67 -155.1 33.28 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -73.8 -50.01 0.18 Allowed 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.382 1.201 . . . . 0.0 110.881 -174.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -87.75 9.68 20.85 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.576 -0.702 . . . . 0.0 111.337 -173.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 t 53.81 61.69 2.97 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.961 -1.087 . . . . 0.0 110.632 -176.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.718 ' HA ' HG12 ' A' ' 176' ' ' VAL . 64.4 t80 -80.27 118.69 22.15 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.651 -0.656 . . . . 0.0 109.932 -178.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -129.98 163.21 26.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.768 -0.582 . . . . 0.0 110.413 -174.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 62.9 t -125.16 147.73 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.729 -0.607 . . . . 0.0 109.773 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.7 p -155.16 163.32 40.38 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.942 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.438 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 73.1 m-85 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.784 -0.573 . . . . 0.0 109.855 -176.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 121.191 0.519 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.406 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 44.6 p -60.07 -33.99 72.83 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.674 -0.641 . . . . 0.0 110.204 177.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.42 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -171.45 145.94 2.17 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.709 -0.62 . . . . 0.0 110.001 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.7 t -142.12 142.65 32.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.8 -0.563 . . . . 0.0 110.082 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.438 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 61.7 t80 -125.57 140.09 53.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.646 -0.659 . . . . 0.0 110.483 -172.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.4 t -109.78 124.07 50.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.842 -0.536 . . . . 0.0 109.785 175.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 48.7 m -71.35 -37.11 71.7 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.357 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -60.75 -31.64 70.97 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.605 -0.684 . . . . 0.0 110.25 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 58.2 mt -104.79 -12.19 16.43 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.612 -0.68 . . . . 0.0 110.786 -174.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 46.5 tttt 59.73 47.56 10.28 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.05 -1.031 . . . . 0.0 109.751 176.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -147.68 153.12 38.91 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.627 -0.671 . . . . 0.0 110.89 -173.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.662 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.61 137.86 53.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.771 -0.581 . . . . 0.0 110.408 -176.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -115.51 132.94 56.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.646 -0.659 . . . . 0.0 109.231 174.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.37 158.41 44.32 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.659 -0.651 . . . . 0.0 111.134 -173.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.405 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 50.7 mt-30 -104.58 144.08 32.19 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.494 0.664 . . . . 0.0 110.316 173.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.41 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.2 tt -52.06 147.22 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.52 -0.737 . . . . 0.0 111.871 -174.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.42 10.0 5.39 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.614 -0.679 . . . . 0.0 112.544 175.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.405 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 68.8 mmtt -95.36 155.08 16.89 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.001 -1.062 . . . . 0.0 110.894 175.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 84.9 m -83.23 126.1 32.29 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.708 -0.62 . . . . 0.0 110.522 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' CYS . . . . . 0.662 ' SG ' HD21 ' A' ' 162' ' ' LEU . 43.3 t -115.14 90.29 23.34 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.615 -0.678 . . . . 0.0 110.12 174.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.42 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 18.9 Cg_endo -64.41 131.44 29.98 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.239 1.126 . . . . 0.0 110.45 176.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.405 HG12 ' CE2' ' A' ' 142' ' ' PHE . 93.6 mt -123.78 141.56 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.4 ' OE1' ' CD1' ' A' ' 260' ' ' PHE . 67.1 mm-40 -109.17 133.72 52.65 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.566 -0.709 . . . . 0.0 110.408 -173.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.614 HG21 ' CE1' ' A' ' 138' ' ' PHE . 49.4 mm -95.38 135.01 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.574 -0.704 . . . . 0.0 109.725 171.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 32.2 tttt -119.52 131.13 55.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.594 -0.691 . . . . 0.0 110.453 177.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.718 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.7 m -136.83 159.72 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.59 -0.694 . . . . 0.0 110.05 175.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 78.8 mmm -78.32 -40.3 37.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.726 -0.609 . . . . 0.0 110.019 176.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.0 p -134.15 143.21 46.2 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.735 -0.603 . . . . 0.0 109.718 177.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 33.6 Cg_exo -55.3 139.85 81.45 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 O-C-N 123.076 1.04 . . . . 0.0 110.892 -172.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.556 ' HB3' HD21 ' A' ' 288' ' ' LEU . 36.8 Cg_endo -68.56 170.06 15.91 Favored 'Trans proline' 0 N--CA 1.487 1.099 0 O-C-N 123.153 1.081 . . . . 0.0 110.629 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -60.4 155.41 47.04 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.404 1.213 . . . . 0.0 110.602 -178.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -78.69 138.47 38.29 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.58 -0.7 . . . . 0.0 109.981 175.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.28 -24.78 30.85 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -174.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.14 151.91 1.87 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.364 -1.08 . . . . 0.0 111.452 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.0 m -129.71 155.97 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.707 -0.62 . . . . 0.0 109.625 176.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.728 HD11 ' HD2' ' A' ' 251' ' ' TYR . 81.6 mt -108.43 139.3 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.685 -0.635 . . . . 0.0 109.537 176.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.727 ' HG2' HD22 ' A' ' 248' ' ' LEU . 38.9 mtm180 -114.87 146.81 40.69 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -176.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.675 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -140.55 127.61 20.83 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.372 174.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 33.3 ttm -137.34 139.04 26.55 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.805 -0.56 . . . . 0.0 110.938 -177.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.69 ' HD3' HD12 ' A' ' 226' ' ' ILE . 72.1 Cg_endo -91.44 138.15 2.14 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 120.983 1.122 . . . . 0.0 110.702 176.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.449 HG12 ' CZ ' ' A' ' 244' ' ' ARG . 34.9 m -147.22 154.94 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.599 -0.688 . . . . 0.0 110.14 174.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.642 ' HA ' HG22 ' A' ' 282' ' ' ILE . 90.4 m-85 -60.32 165.9 3.31 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.478 -0.764 . . . . 0.0 110.399 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.426 ' HA ' HD12 ' A' ' 283' ' ' LEU . 63.3 tttm -82.99 -60.1 2.27 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.621 -0.675 . . . . 0.0 110.832 -174.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -80.11 151.96 29.55 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.501 -0.749 . . . . 0.0 110.373 -175.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.452 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.67 -38.31 72.05 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.36 -0.838 . . . . 0.0 110.709 -175.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -56.5 -24.92 49.51 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.48 -0.763 . . . . 0.0 110.652 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.418 ' HB3' ' CG ' ' A' ' 192' ' ' TYR . 98.9 m-70 -109.69 -20.49 12.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.53 -0.732 . . . . 0.0 111.167 -178.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.1 p -67.74 -20.3 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.086 -1.008 . . . . 0.0 110.655 -176.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 67.0 p -79.35 -17.1 55.17 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.537 -0.727 . . . . 0.0 110.742 175.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -88.31 137.24 32.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.292 -0.88 . . . . 0.0 110.097 173.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 54.1 t -74.09 142.01 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.612 -0.68 . . . . 0.0 110.262 177.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.511 HG22 ' CE2' ' A' ' 192' ' ' TYR . 67.8 t -84.84 138.8 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.579 -0.701 . . . . 0.0 109.331 170.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.9 pttp -134.86 -170.16 2.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.482 -0.761 . . . . 0.0 111.185 -168.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -95.27 153.9 17.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.794 -0.567 . . . . 0.0 110.499 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.628 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 60.3 m . . . . . 0 N--CA 1.497 1.887 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 174.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.568 HD12 ' HG3' ' A' ' 268' ' ' MET . 55.2 tp . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 120.939 0.399 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.69 HD12 ' HD3' ' A' ' 190' ' ' PRO . 82.1 mt -101.01 136.75 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.786 -0.571 . . . . 0.0 109.85 -179.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 -133.28 158.71 42.26 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.646 -0.659 . . . . 0.0 110.254 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.666 HG23 HG21 ' A' ' 247' ' ' VAL . 93.0 t -103.93 146.7 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.725 -0.61 . . . . 0.0 110.137 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -118.5 130.0 55.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.73 -0.606 . . . . 0.0 110.477 170.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 92.42 25.02 22.47 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 167.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -138.86 108.1 6.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.433 -1.04 . . . . 0.0 110.017 174.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 92.6 p -63.35 -15.14 56.51 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.675 -0.641 . . . . 0.0 111.287 -177.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -97.28 9.36 42.46 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.299 -0.876 . . . . 0.0 111.155 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -62.24 125.44 23.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.222 -0.924 . . . . 0.0 110.156 176.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -139.72 154.81 47.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.798 -0.564 . . . . 0.0 109.74 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.422 ' CD1' ' HB ' ' A' ' 247' ' ' VAL . 91.1 m-85 -117.36 150.73 38.36 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.605 -176.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.19 160.03 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.782 -0.574 . . . . 0.0 110.234 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -114.69 130.05 56.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.768 -0.583 . . . . 0.0 110.038 174.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -63.78 130.11 94.21 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.71 -0.619 . . . . 0.0 109.741 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -64.98 -28.69 57.76 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.232 1.122 . . . . 0.0 111.045 -170.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.9 mt -102.16 -50.53 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.387 -0.821 . . . . 0.0 111.041 -167.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 9.3 p -105.5 12.27 31.58 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.327 -0.858 . . . . 0.0 111.917 -176.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 72.14 -5.01 15.46 Favored Glycine 0 N--CA 1.497 2.737 0 O-C-N 121.057 -1.027 . . . . 0.0 112.001 171.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.449 ' CZ ' HG12 ' A' ' 191' ' ' VAL . 22.6 mmt180 -45.82 142.14 2.68 Favored 'General case' 0 N--CA 1.505 2.324 0 CA-C-N 119.137 1.469 . . . . 0.0 112.509 -174.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -96.01 143.55 27.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.551 -0.718 . . . . 0.0 110.099 172.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 77.9 p -154.7 159.87 41.0 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.579 -0.7 . . . . 0.0 110.483 174.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.666 HG21 HG23 ' A' ' 228' ' ' VAL . 8.6 p -125.12 148.33 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.78 -0.575 . . . . 0.0 109.781 179.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.727 HD22 ' HG2' ' A' ' 187' ' ' ARG . 81.6 mt -129.64 154.55 47.0 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.651 -177.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.452 HG13 ' C ' ' A' ' 248' ' ' LEU . 34.1 m -151.53 151.68 29.22 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.789 -0.569 . . . . 0.0 109.985 176.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -71.07 139.04 34.89 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 123.297 1.156 . . . . 0.0 110.018 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.728 ' HD2' HD11 ' A' ' 186' ' ' ILE . 59.9 t80 -75.96 125.61 29.44 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.491 -0.756 . . . . 0.0 110.123 174.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -100.06 160.01 28.3 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.725 -0.609 . . . . 0.0 109.996 177.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -58.94 159.93 19.9 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.268 1.141 . . . . 0.0 110.417 178.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.38 149.91 78.32 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 O-C-N 123.187 1.098 . . . . 0.0 110.493 -177.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -61.82 148.48 43.07 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.681 -0.637 . . . . 0.0 110.138 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.2 t -69.92 127.2 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.534 -0.729 . . . . 0.0 110.12 -170.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.98 -10.14 55.37 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 9.9 t -144.73 174.11 11.26 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.124 -1.221 . . . . 0.0 110.616 175.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -107.26 13.16 27.47 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.612 -0.68 . . . . 0.0 111.707 -168.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.4 ' CD1' ' OE1' ' A' ' 173' ' ' GLN . 13.5 p90 -119.86 168.08 11.46 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.152 -0.967 . . . . 0.0 111.135 -174.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 88.4 m -117.77 147.49 42.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.741 -0.599 . . . . 0.0 109.905 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 47.0 m -118.14 136.28 53.71 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.56 -0.712 . . . . 0.0 111.048 -174.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.8 t -131.92 137.26 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 172.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 67.8 mt -104.62 120.73 42.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.467 -0.77 . . . . 0.0 109.826 -172.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.675 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 5.0 m-30 -106.29 151.2 25.13 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.678 -0.639 . . . . 0.0 110.604 -177.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -136.58 142.86 43.39 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -112.0 130.08 55.98 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.595 -0.69 . . . . 0.0 110.453 -177.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' MET . . . . . 0.568 ' HG3' HD12 ' A' ' 225' ' ' LEU . 5.0 ppp? -96.16 3.0 53.54 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.633 -0.667 . . . . 0.0 111.973 -176.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . 0.626 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.5 OUTLIER -144.81 165.04 29.24 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.076 -1.015 . . . . 0.0 110.123 175.874 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.635 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.3 p30 -121.7 163.4 19.1 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.646 -0.659 . . . . 0.0 110.417 -178.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . 0.423 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 29.6 m -58.42 -35.14 71.62 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.427 -0.796 . . . . 0.0 110.986 -163.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 51.3 p -103.46 15.0 30.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.409 -0.807 . . . . 0.0 111.949 -163.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . 0.628 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 29.7 p -93.96 118.05 30.95 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.063 -1.023 . . . . 0.0 110.712 178.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 60.0 t -62.75 138.82 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.519 -0.738 . . . . 0.0 110.352 -171.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.08 -5.21 61.2 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 178.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.13 -101.66 0.95 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 172.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . 0.423 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.4 mmm -60.93 -29.95 69.91 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.657 -0.908 . . . . 0.0 110.124 178.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 22.6 p30 42.86 44.74 4.03 Favored 'General case' 0 N--CA 1.505 2.312 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 173.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 55.02 34.66 22.96 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.355 -0.841 . . . . 0.0 111.11 175.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' ARG . . . . . 0.468 ' O ' HG23 ' A' ' 282' ' ' ILE . 88.5 mtt180 -120.04 105.74 42.12 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.54 -0.725 . . . . 0.0 109.98 172.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 280' ' ' ARG . 11.3 Cg_endo -58.93 144.94 98.74 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 O-C-N 123.112 1.059 . . . . 0.0 110.573 -178.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.642 HG22 ' HA ' ' A' ' 192' ' ' TYR . 46.2 pt -131.97 175.36 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 122.006 0.908 . . . . 0.0 111.244 -173.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 302' ' ' GLU . 26.0 mt -124.44 149.84 46.34 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.699 HD12 ' CE1' ' A' ' 301' ' ' PHE . 82.4 mt -115.83 129.63 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.173 178.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.61 HG23 ' SG ' ' A' ' 300' ' ' CYS . 82.1 mt -109.74 125.52 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 -176.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 60.4 t -118.9 126.76 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.5 p -125.29 155.0 40.88 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.655 -0.653 . . . . 0.0 110.614 -172.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.575 HD22 ' CD1' ' A' ' 138' ' ' PHE . 30.5 tp -107.02 126.13 51.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.803 -0.561 . . . . 0.0 109.564 170.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.593 ' OE2' HG13 ' A' ' 295' ' ' VAL . 69.4 mm-40 -131.77 151.41 51.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.855 -0.528 . . . . 0.0 109.853 -174.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.645 HG22 HD11 ' A' ' 296' ' ' LEU . 71.4 p -89.9 157.8 17.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.605 -0.684 . . . . 0.0 109.779 178.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -56.12 -26.02 48.36 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.506 -0.746 . . . . 0.0 110.739 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -87.14 9.55 19.61 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.55 -0.719 . . . . 0.0 111.789 -174.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 87.63 20.09 52.26 Favored Glycine 0 N--CA 1.493 2.49 0 O-C-N 121.068 -1.02 . . . . 0.0 110.76 170.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -108.53 140.22 42.17 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.294 -1.121 . . . . 0.0 110.208 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.618 HG11 ' HE ' ' A' ' 298' ' ' ARG . 59.5 t -86.76 134.98 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.571 -0.706 . . . . 0.0 110.043 -173.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.645 HD11 HG22 ' A' ' 290' ' ' THR . 96.4 mt -99.87 -40.14 7.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.658 -0.651 . . . . 0.0 110.457 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -175.35 162.42 31.92 Favored Glycine 0 N--CA 1.496 2.674 0 C-N-CA 119.922 -1.132 . . . . 0.0 110.384 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.618 ' HE ' HG11 ' A' ' 295' ' ' VAL . 84.2 mtt180 -130.73 139.83 50.3 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.672 -0.899 . . . . 0.0 110.567 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -136.59 155.07 50.42 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.479 -0.763 . . . . 0.0 109.869 170.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . 0.61 ' SG ' HG23 ' A' ' 285' ' ' ILE . 89.1 m -143.56 154.76 43.92 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.327 -0.858 . . . . 0.0 110.874 -175.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.699 ' CE1' HD12 ' A' ' 284' ' ' ILE . 48.7 p90 -145.72 163.91 33.44 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.717 -0.614 . . . . 0.0 110.108 176.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.429 ' HA ' HD23 ' A' ' 283' ' ' LEU . 56.6 tt0 -104.89 135.84 45.5 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.457 -0.777 . . . . 0.0 110.325 -177.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -123.84 144.42 49.74 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.633 -0.667 . . . . 0.0 110.729 -170.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -138.67 137.0 36.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.815 -0.553 . . . . 0.0 109.812 173.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.635 HG21 ' HA ' ' A' ' 270' ' ' ASN . 75.0 mt -105.8 123.56 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.58 -0.7 . . . . 0.0 109.584 176.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.2 p -145.15 164.9 29.87 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.569 -0.707 . . . . 0.0 110.948 -169.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -66.43 -39.92 89.2 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.671 -0.643 . . . . 0.0 110.615 -177.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.9 t -131.31 89.06 42.31 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.534 -0.729 . . . . 0.0 110.576 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -56.71 -29.3 79.67 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 123.136 1.072 . . . . 0.0 110.477 173.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.15 -37.93 93.46 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 176.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -70.23 -38.41 75.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.536 -0.979 . . . . 0.0 109.779 -175.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -69.4 -36.13 76.45 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.986 178.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 47.7 ttt-85 -57.04 -48.39 78.63 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.529 -0.732 . . . . 0.0 110.57 175.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -64.99 -38.54 91.28 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.72 -0.613 . . . . 0.0 110.448 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.85 -52.16 65.26 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.501 -0.749 . . . . 0.0 110.475 -173.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.6 p30 . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.434 -0.791 . . . . 0.0 110.155 -177.123 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 27.8 t . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.031 0.443 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.9 p-10 -96.33 24.62 5.61 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.722 -0.611 . . . . 0.0 110.681 -179.227 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 51.6 m -76.63 125.17 28.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.54 -0.725 . . . . 0.0 110.279 -179.403 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -70.14 144.91 51.89 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.672 -0.642 . . . . 0.0 110.41 -177.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -154.25 99.41 2.5 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.774 -0.579 . . . . 0.0 110.153 178.6 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -58.8 -39.91 77.37 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 O-C-N 123.202 1.106 . . . . 0.0 110.774 -176.651 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.69 -155.11 47.93 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 178.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -73.29 -46.19 0.38 Allowed 'Trans proline' 0 C--N 1.316 -1.176 0 O-C-N 123.363 1.191 . . . . 0.0 110.922 -174.442 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -85.9 6.7 27.22 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.531 -0.731 . . . . 0.0 111.382 -173.679 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.72 61.18 3.22 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.853 -1.154 . . . . 0.0 110.656 -175.519 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.689 ' HA ' HG12 ' A' ' 176' ' ' VAL . 54.6 t80 -77.82 119.29 21.1 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.64 -0.662 . . . . 0.0 109.852 -178.678 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -130.07 159.93 35.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.826 -0.546 . . . . 0.0 110.189 -178.419 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 68.5 t -124.57 147.65 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.694 -0.629 . . . . 0.0 109.902 176.131 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.9 p -155.04 164.23 39.17 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.075 177.132 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.486 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 88.0 m-85 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.84 -0.537 . . . . 0.0 109.894 -176.532 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.803 0 CA-C-O 121.153 0.501 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.497 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 80.9 p -59.99 -32.49 70.9 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.641 -0.662 . . . . 0.0 109.868 174.197 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.497 ' HD1' ' HG1' ' A' ' 152' ' ' THR . 68.7 p-90 -171.34 142.8 1.75 Allowed 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.319 0.581 . . . . 0.0 110.253 176.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.7 t -142.12 142.72 32.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.935 -0.478 . . . . 0.0 109.997 -177.318 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.486 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 52.0 t80 -125.52 140.06 53.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.545 -0.722 . . . . 0.0 110.524 -172.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.5 t -111.84 124.31 52.08 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 120.401 -0.52 . . . . 0.0 109.789 176.118 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 62.3 m -70.58 -37.05 73.9 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.771 -0.581 . . . . 0.0 110.45 -177.658 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -59.1 -33.03 70.36 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.529 -0.732 . . . . 0.0 110.53 -178.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.469 HD11 ' OD1' ' A' ' 316' ' ' ASP . 56.1 mt -104.84 -11.99 16.5 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.688 -0.632 . . . . 0.0 110.787 -175.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 70.7 tttt 59.74 49.54 8.03 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.046 -1.034 . . . . 0.0 109.653 177.703 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 40.5 tttt -146.56 153.11 39.98 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.754 -0.591 . . . . 0.0 110.668 -174.054 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.604 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.5 tp -126.52 137.76 53.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.805 -0.559 . . . . 0.0 110.171 -177.333 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -115.16 134.78 54.85 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.8 p -138.42 158.61 43.95 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 120.114 -0.635 . . . . 0.0 111.114 -174.029 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.428 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 52.4 mt-30 -104.42 141.99 35.38 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.557 -0.714 . . . . 0.0 110.209 173.645 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.439 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 18.3 tt -54.85 146.23 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.562 -0.712 . . . . 0.0 111.561 -171.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.36 9.98 5.33 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.552 -0.718 . . . . 0.0 112.479 177.017 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.428 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 67.5 mmtt -96.13 155.08 16.91 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.896 -1.128 . . . . 0.0 110.747 175.114 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 86.7 m -81.12 126.2 31.17 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.738 -0.601 . . . . 0.0 110.634 -177.581 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 170' ' ' CYS . . . . . 0.604 ' SG ' HD21 ' A' ' 162' ' ' LEU . 46.9 t -115.53 90.23 25.07 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.702 -0.624 . . . . 0.0 110.11 172.722 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.441 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 22.0 Cg_exo -62.37 130.89 31.78 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 O-C-N 123.276 1.145 . . . . 0.0 110.624 174.079 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.413 HG12 ' CE2' ' A' ' 142' ' ' PHE . 94.5 mt -125.41 142.92 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.655 -0.653 . . . . 0.0 109.299 175.593 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -108.44 136.21 48.45 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.517 -0.739 . . . . 0.0 110.739 -176.209 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.419 HG23 ' CE1' ' A' ' 138' ' ' PHE . 48.5 mm -95.27 131.55 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.724 -0.61 . . . . 0.0 109.613 169.241 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -112.99 128.28 56.45 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.607 -0.683 . . . . 0.0 110.447 176.28 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.689 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.2 m -136.59 159.79 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.594 -0.691 . . . . 0.0 109.903 175.104 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.5 mmm -76.47 -40.81 49.35 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.632 -0.668 . . . . 0.0 110.104 178.647 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.411 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.5 p -135.44 143.15 44.05 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.782 -0.574 . . . . 0.0 109.65 178.356 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 34.1 Cg_exo -55.22 139.8 81.02 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 O-C-N 123.142 1.075 . . . . 0.0 110.841 -171.648 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.804 ' HB3' HD21 ' A' ' 288' ' ' LEU . 29.8 Cg_endo -66.58 170.0 13.25 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 O-C-N 123.212 1.111 . . . . 0.0 110.618 178.411 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -60.85 156.25 44.68 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.358 1.189 . . . . 0.0 110.5 -178.293 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -79.1 139.32 38.1 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.651 -0.656 . . . . 0.0 109.954 176.118 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 98.53 -24.94 29.94 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -174.167 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.18 152.35 1.76 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.359 -1.083 . . . . 0.0 111.426 177.684 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 33.8 m -129.78 155.95 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.766 -0.584 . . . . 0.0 109.649 176.293 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.712 HD11 ' HD2' ' A' ' 251' ' ' TYR . 80.4 mt -109.17 138.78 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.676 -0.64 . . . . 0.0 109.51 176.626 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.721 ' HG2' HD22 ' A' ' 248' ' ' LEU . 30.8 mtm180 -114.9 147.27 40.18 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -175.763 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.718 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -140.13 127.18 20.89 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.501 -0.749 . . . . 0.0 110.259 173.456 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.413 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 3.2 ttp -137.24 138.33 24.93 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.777 -0.577 . . . . 0.0 110.926 -176.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.689 ' HD3' HD12 ' A' ' 226' ' ' ILE . 71.9 Cg_endo -91.9 138.09 1.95 Allowed 'Trans proline' 0 C--N 1.32 -0.949 0 C-N-CA 121.023 1.149 . . . . 0.0 110.771 177.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.431 HG13 ' C ' ' A' ' 190' ' ' PRO . 34.7 m -147.43 154.82 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.505 -0.747 . . . . 0.0 110.101 174.089 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.676 ' HA ' HG22 ' A' ' 282' ' ' ILE . 63.3 m-85 -60.05 162.06 6.12 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.409 -0.807 . . . . 0.0 110.55 -179.155 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.5 ' HA ' HD12 ' A' ' 283' ' ' LEU . 29.0 tttp -79.19 -60.02 2.54 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.665 -0.647 . . . . 0.0 110.878 -173.092 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -80.15 152.04 29.44 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.587 -0.695 . . . . 0.0 110.425 -175.373 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.457 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.52 -37.95 71.16 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.376 -0.827 . . . . 0.0 110.674 -177.084 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -56.86 -25.02 55.67 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.548 -0.72 . . . . 0.0 110.572 -177.438 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.411 ' HB3' ' CG ' ' A' ' 192' ' ' TYR . 65.0 m170 -108.81 -20.58 13.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.598 -0.689 . . . . 0.0 111.116 -178.816 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -68.45 -20.28 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.148 -0.97 . . . . 0.0 110.581 -175.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 67.3 p -79.42 -17.03 55.18 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.516 -0.74 . . . . 0.0 110.678 174.37 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.39 136.54 32.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.366 -0.834 . . . . 0.0 110.025 173.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 242' ' ' THR . 61.9 t -72.92 145.08 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.569 -0.707 . . . . 0.0 110.269 178.354 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.631 HG23 HH12 ' A' ' 244' ' ' ARG . 57.8 t -84.88 139.9 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 170.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 11.9 pttt -134.72 -170.46 2.56 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.509 -0.744 . . . . 0.0 111.195 -169.34 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 63.8 mmt-85 -95.37 150.92 19.75 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.827 -0.546 . . . . 0.0 110.423 -176.23 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.658 ' SG ' ' SG ' ' A' ' 273' ' ' CYS . 60.9 m . . . . . 0 N--CA 1.497 1.894 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 169.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.564 HD12 ' HG3' ' A' ' 268' ' ' MET . 57.2 tp . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 120.93 0.395 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.689 HD12 ' HD3' ' A' ' 190' ' ' PRO . 85.5 mt -104.7 136.72 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.589 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -134.57 159.52 40.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.701 -0.624 . . . . 0.0 110.189 -178.401 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.596 HG23 HG21 ' A' ' 247' ' ' VAL . 91.2 t -104.46 146.74 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.766 -0.584 . . . . 0.0 110.103 178.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -118.1 124.4 47.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.732 -0.605 . . . . 0.0 110.361 172.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.05 23.82 14.15 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 168.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -137.17 107.6 6.48 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.464 -1.021 . . . . 0.0 110.028 174.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 26.3 t -62.89 -15.18 53.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.67 -0.643 . . . . 0.0 111.322 -178.001 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -100.02 7.98 44.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.246 -0.909 . . . . 0.0 111.524 -177.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.06 130.76 47.99 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.191 -0.943 . . . . 0.0 110.213 176.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -139.76 157.95 44.9 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.75 -0.594 . . . . 0.0 109.807 177.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -115.01 150.73 35.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.596 -0.69 . . . . 0.0 110.658 -176.394 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.16 159.93 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.827 -0.546 . . . . 0.0 110.081 176.38 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -121.46 130.11 53.38 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.69 -0.631 . . . . 0.0 110.344 178.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -64.74 110.34 3.97 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.636 -0.665 . . . . 0.0 109.697 176.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -59.76 -25.11 78.2 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.141 1.074 . . . . 0.0 111.078 -171.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.8 mt -100.72 -50.41 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.409 -0.807 . . . . 0.0 110.853 -171.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.422 ' O ' HG22 ' A' ' 201' ' ' VAL . 17.4 p -105.43 12.16 31.83 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.41 -0.807 . . . . 0.0 111.96 -173.211 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 82.32 -25.07 4.48 Favored Glycine 0 N--CA 1.498 2.781 0 O-C-N 120.997 -1.064 . . . . 0.0 111.885 169.169 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.631 HH12 HG23 ' A' ' 202' ' ' VAL . 29.7 mmt180 -45.83 142.14 2.69 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-N 118.652 1.226 . . . . 0.0 112.678 -168.445 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -104.41 146.08 29.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.7 -0.625 . . . . 0.0 109.93 173.681 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 77.9 p -154.74 159.98 41.03 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.609 -0.682 . . . . 0.0 110.39 178.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.596 HG21 HG23 ' A' ' 228' ' ' VAL . 8.6 p -123.23 148.25 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.75 -0.593 . . . . 0.0 109.816 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.721 HD22 ' HG2' ' A' ' 187' ' ' ARG . 83.9 mt -129.57 154.62 46.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.653 -0.655 . . . . 0.0 109.662 -176.506 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.442 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.1 m -151.35 151.73 29.63 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.769 -0.582 . . . . 0.0 110.045 175.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -71.1 138.6 33.92 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 O-C-N 123.232 1.122 . . . . 0.0 109.991 177.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.712 ' HD2' HD11 ' A' ' 186' ' ' ILE . 57.1 t80 -74.07 127.16 32.2 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.53 -0.731 . . . . 0.0 110.194 175.376 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -99.95 160.09 28.13 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.697 -0.627 . . . . 0.0 109.974 175.111 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -58.55 157.86 25.61 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 O-C-N 123.291 1.153 . . . . 0.0 110.518 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.15 149.92 77.06 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 O-C-N 123.203 1.107 . . . . 0.0 110.514 -177.732 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -60.64 147.65 41.17 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.569 -0.707 . . . . 0.0 110.254 -178.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.87 127.2 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.508 -0.745 . . . . 0.0 110.219 -170.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.06 -10.27 55.18 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.405 ' OG1' ' CE2' ' A' ' 260' ' ' PHE . 10.1 t -144.12 174.12 11.15 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.115 -1.227 . . . . 0.0 110.676 176.027 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -107.39 13.17 27.27 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.647 -0.658 . . . . 0.0 111.812 -168.325 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.405 ' CE2' ' OG1' ' A' ' 258' ' ' THR . 14.6 p90 -119.92 168.01 11.56 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.116 -0.99 . . . . 0.0 111.155 -175.184 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 82.2 m -117.77 145.75 44.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.791 -0.568 . . . . 0.0 109.854 179.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 42.2 m -116.62 135.93 53.39 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.582 -0.699 . . . . 0.0 110.78 -176.55 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.9 t -132.31 137.33 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 175.094 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 76.6 mt -104.59 120.92 42.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.493 -0.755 . . . . 0.0 109.991 -170.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.718 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 4.8 m-30 -105.29 153.64 21.33 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.672 -0.643 . . . . 0.0 110.823 -176.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -136.54 142.92 43.46 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -114.99 133.82 55.71 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.463 -0.773 . . . . 0.0 110.47 -179.414 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 268' ' ' MET . . . . . 0.564 ' HG3' HD12 ' A' ' 225' ' ' LEU . 5.0 ppp? -102.44 9.42 39.66 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.606 -0.684 . . . . 0.0 112.053 -175.683 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . 0.811 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.7 OUTLIER -144.61 159.05 43.44 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.083 -1.011 . . . . 0.0 110.108 173.06 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.455 ' HA ' HG21 ' A' ' 305' ' ' ILE . 26.9 p30 -119.27 163.11 17.62 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.752 -0.593 . . . . 0.0 110.423 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . 0.419 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 25.1 m -57.95 -31.48 66.88 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.44 -0.788 . . . . 0.0 110.843 -166.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 51.1 p -105.72 14.95 27.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.352 -0.843 . . . . 0.0 111.965 -165.222 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . 0.658 ' SG ' ' SG ' ' A' ' 205' ' ' CYS . 29.6 p -94.18 118.1 31.07 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.139 -0.975 . . . . 0.0 110.539 177.571 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.89 139.23 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.436 -0.79 . . . . 0.0 110.177 -170.5 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.6 -5.13 60.12 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 178.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.05 -97.69 0.81 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 173.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . 0.419 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.0 mmm -64.03 -33.76 76.46 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.74 -0.859 . . . . 0.0 110.41 178.589 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.1 p30 43.72 50.77 6.69 Favored 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 175.486 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 54.86 31.86 16.6 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.294 -0.879 . . . . 0.0 111.188 176.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -120.02 104.94 43.3 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.498 -0.751 . . . . 0.0 110.148 174.247 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -60.37 148.16 91.42 Favored 'Trans proline' 0 N--CA 1.487 1.139 0 O-C-N 123.104 1.055 . . . . 0.0 110.528 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.676 HG22 ' HA ' ' A' ' 192' ' ' TYR . 45.5 pt -131.99 177.42 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 CA-C-O 121.79 0.805 . . . . 0.0 111.037 -176.811 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.5 HD12 ' HA ' ' A' ' 193' ' ' LYS . 28.1 mt -124.34 149.9 46.09 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.613 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.677 HD12 ' CE1' ' A' ' 301' ' ' PHE . 81.4 mt -115.79 130.19 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.931 -0.707 . . . . 0.0 109.315 177.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.603 HG23 ' SG ' ' A' ' 300' ' ' CYS . 83.3 mt -109.88 126.19 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.483 -177.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 57.8 t -118.96 126.84 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.696 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.5 p -125.24 151.61 45.68 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.581 -0.7 . . . . 0.0 110.736 -173.467 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.804 HD21 ' HB3' ' A' ' 180' ' ' PRO . 21.8 tp -101.3 125.67 47.96 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 167.427 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.522 ' OE2' HG13 ' A' ' 295' ' ' VAL . 73.5 mm-40 -130.58 150.54 51.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.845 -0.534 . . . . 0.0 110.005 -172.566 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.837 ' CG2' HD11 ' A' ' 296' ' ' LEU . 17.1 p -89.96 161.13 16.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.678 -0.639 . . . . 0.0 109.967 177.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -55.95 -26.07 46.33 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.579 -0.701 . . . . 0.0 110.98 -176.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 47.0 p30 -90.36 9.36 29.23 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.373 -0.829 . . . . 0.0 111.908 -173.567 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.41 20.15 46.23 Favored Glycine 0 N--CA 1.494 2.546 0 C-N-CA 120.169 -1.015 . . . . 0.0 110.841 171.055 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -107.58 140.16 41.01 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.357 -1.084 . . . . 0.0 110.075 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.522 HG13 ' OE2' ' A' ' 289' ' ' GLU . 59.8 t -87.68 132.14 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.543 -0.723 . . . . 0.0 110.164 -173.35 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.837 HD11 ' CG2' ' A' ' 290' ' ' THR . 96.1 mt -99.97 -40.2 7.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.667 -0.646 . . . . 0.0 110.44 178.15 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -159.97 148.62 17.35 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -178.14 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.495 ' HD3' HG11 ' A' ' 295' ' ' VAL . 79.1 mtm180 -135.09 133.14 38.97 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.73 -0.864 . . . . 0.0 110.566 -178.61 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -135.03 156.17 49.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.705 -0.622 . . . . 0.0 109.976 172.32 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . 0.603 ' SG ' HG23 ' A' ' 285' ' ' ILE . 83.0 m -141.77 154.21 45.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.431 -0.793 . . . . 0.0 110.541 -176.269 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.677 ' CE1' HD12 ' A' ' 284' ' ' ILE . 49.3 p90 -144.96 164.62 30.57 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.694 -0.628 . . . . 0.0 110.247 177.14 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.428 ' HA ' HD23 ' A' ' 283' ' ' LEU . 83.7 tt0 -104.87 134.58 47.76 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.548 -0.72 . . . . 0.0 110.048 -177.137 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -121.77 143.68 49.24 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.704 -169.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 64.5 ttt-85 -139.82 134.86 32.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.761 -0.587 . . . . 0.0 109.633 173.585 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.811 HD13 ' O ' ' A' ' 269' ' ' CYS . 33.5 mt -106.79 122.86 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.585 -0.697 . . . . 0.0 109.67 178.627 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.2 p -145.12 170.92 15.29 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.594 -0.691 . . . . 0.0 110.975 -169.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -70.23 -40.05 74.72 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.752 -0.593 . . . . 0.0 110.604 -178.481 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 3.7 t -131.15 88.85 43.65 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.591 -0.693 . . . . 0.0 110.422 179.139 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -55.85 -29.04 70.72 Favored 'Trans proline' 0 N--CA 1.488 1.187 0 O-C-N 123.176 1.092 . . . . 0.0 110.82 174.48 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.6 -37.83 92.83 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 177.136 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 72.2 ttt-85 -72.4 -40.49 67.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.67 -0.9 . . . . 0.0 109.77 -173.327 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -69.43 -38.35 77.8 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.256 -178.347 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -61.23 -43.7 98.46 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.467 -0.77 . . . . 0.0 110.226 178.227 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 52.5 tttt -64.9 -39.41 93.48 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.509 -0.744 . . . . 0.0 110.469 177.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.44 -49.82 75.27 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.515 -0.74 . . . . 0.0 110.573 -173.342 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . 0.469 ' OD1' HD11 ' A' ' 159' ' ' LEU . 3.1 p30 . . . . . 0 N--CA 1.496 1.84 0 O-C-N 121.564 -0.71 . . . . 0.0 110.075 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.8 t -82.2 -25.82 33.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.67 -0.9 . . . . 0.0 110.468 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.486 ' C ' HG22 ' A' ' 116' ' ' THR . 22.9 m -58.36 -33.32 69.44 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.536 -0.727 . . . . 0.0 110.46 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.486 HG22 ' C ' ' A' ' 115' ' ' SER . 13.0 t 40.29 41.82 1.09 Allowed 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 176.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 52.01 -172.06 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.436 -0.79 . . . . 0.0 111.035 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 53.63 44.51 29.66 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.441 -0.787 . . . . 0.0 110.809 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -168.09 115.54 0.71 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.682 -0.637 . . . . 0.0 110.173 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 28.3 tp 55.8 -87.14 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.633 -0.667 . . . . 0.0 110.754 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.5 p -137.1 167.16 22.13 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.153 -0.967 . . . . 0.0 110.221 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -66.29 153.03 81.56 Favored 'Cis proline' 0 N--CA 1.495 1.573 0 C-N-CA 123.039 -1.65 . . . . 0.0 110.35 -17.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 71.1 m -82.21 145.58 52.75 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.648 -0.657 . . . . 0.0 110.146 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -59.55 146.11 96.12 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 O-C-N 123.179 1.094 . . . . 0.0 110.639 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.86 144.88 40.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.67 -0.644 . . . . 0.0 110.119 178.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.635 HD11 HG22 ' A' ' 199' ' ' THR . 51.1 mm -120.71 99.95 46.98 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.624 -0.672 . . . . 0.0 110.029 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -60.81 148.38 92.26 Favored 'Trans proline' 0 N--CA 1.488 1.169 0 O-C-N 123.208 1.11 . . . . 0.0 110.531 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.6 t -117.25 145.6 43.83 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.657 -0.652 . . . . 0.0 110.289 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.9 p-10 -96.15 25.86 4.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.652 -0.655 . . . . 0.0 110.601 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 51.0 m -71.04 125.19 26.2 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.573 -0.704 . . . . 0.0 110.27 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -71.42 144.98 49.59 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.661 -0.649 . . . . 0.0 110.443 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -153.87 99.05 2.59 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.742 -0.599 . . . . 0.0 110.073 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -59.39 -39.94 72.11 Favored 'Trans proline' 0 N--CA 1.487 1.147 0 O-C-N 123.175 1.092 . . . . 0.0 110.705 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.45 -155.16 48.36 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -75.75 -42.03 0.48 Allowed 'Trans proline' 0 C--N 1.316 -1.155 0 O-C-N 123.34 1.179 . . . . 0.0 110.993 -174.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -87.65 6.63 33.76 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.559 -0.713 . . . . 0.0 111.509 -173.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.69 60.97 3.33 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.98 -1.075 . . . . 0.0 110.672 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.687 ' HA ' HG12 ' A' ' 176' ' ' VAL . 50.4 t80 -77.89 118.87 20.62 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.63 -0.669 . . . . 0.0 109.955 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -130.04 161.42 31.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.81 -0.556 . . . . 0.0 110.068 -178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 62.9 t -126.48 145.74 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.696 -0.628 . . . . 0.0 109.893 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 78.4 p -155.43 160.29 40.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.802 -0.561 . . . . 0.0 110.043 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.498 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 71.7 m-85 -126.7 125.31 41.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.849 -0.532 . . . . 0.0 109.885 -175.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -56.79 147.91 21.94 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.551 -0.718 . . . . 0.0 110.587 -173.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -100.8 146.42 27.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.7 -0.625 . . . . 0.0 110.312 -177.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 83.9 p -143.4 163.21 33.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.669 -0.644 . . . . 0.0 110.163 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 43.9 m -61.37 157.75 16.02 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.684 -0.635 . . . . 0.0 110.186 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.4 p -72.37 63.85 0.56 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.6 -0.687 . . . . 0.0 110.083 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.95 152.68 43.38 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.536 -0.727 . . . . 0.0 110.189 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -76.21 155.49 34.43 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.66 -0.65 . . . . 0.0 110.026 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 34.9 t 53.24 29.15 8.02 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.454 -0.779 . . . . 0.0 110.903 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -60.38 132.13 52.95 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.66 -0.65 . . . . 0.0 110.241 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 43.5 p -60.1 -34.0 72.88 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.795 -0.565 . . . . 0.0 110.072 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.443 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -171.44 144.52 1.96 Allowed 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.397 0.617 . . . . 0.0 110.331 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.6 t -142.08 142.51 32.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.929 -0.482 . . . . 0.0 109.878 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.498 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 64.7 t80 -125.65 140.04 53.05 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.509 -0.744 . . . . 0.0 110.787 -171.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.2 t -111.7 124.88 53.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.8 -0.562 . . . . 0.0 109.958 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 59.2 m -70.95 -37.02 72.81 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.749 -0.595 . . . . 0.0 110.571 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -59.01 -34.75 72.24 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.573 -0.704 . . . . 0.0 110.444 -177.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.499 HD21 HD11 ' A' ' 320' ' ' ILE . 56.0 mt -104.83 -12.04 16.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.662 -0.649 . . . . 0.0 110.88 -176.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 82.3 tttt 59.73 51.62 6.1 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.074 -1.017 . . . . 0.0 109.673 178.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -145.09 153.07 41.04 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.594 -173.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.683 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.56 137.73 53.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.779 -0.576 . . . . 0.0 110.24 -175.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -116.0 135.4 54.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.674 -0.641 . . . . 0.0 109.288 173.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.9 p -138.36 158.42 44.31 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.705 -0.622 . . . . 0.0 110.899 -175.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.429 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 50.1 mt-30 -104.5 144.07 32.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.64 -0.662 . . . . 0.0 110.277 173.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.428 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.2 tt -52.81 146.05 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-O 121.592 0.711 . . . . 0.0 111.802 -173.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.5 10.0 5.46 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.554 -0.716 . . . . 0.0 112.484 176.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.429 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 73.5 mmtt -96.61 155.06 16.93 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.995 -1.066 . . . . 0.0 110.867 175.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 85.0 m -84.5 126.13 33.01 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.689 -0.632 . . . . 0.0 110.668 -177.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . 0.683 ' SG ' HD21 ' A' ' 162' ' ' LEU . 44.7 t -115.37 90.19 24.12 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.576 -0.702 . . . . 0.0 110.202 174.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.443 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 21.2 Cg_exo -62.59 131.1 32.17 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.216 1.114 . . . . 0.0 110.691 173.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.414 HG12 ' CE2' ' A' ' 142' ' ' PHE . 95.1 mt -125.08 143.82 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.659 -0.651 . . . . 0.0 109.279 175.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -109.47 135.36 50.61 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.496 -0.753 . . . . 0.0 110.813 -175.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.402 HG23 ' CE1' ' A' ' 138' ' ' PHE . 48.7 mm -95.29 135.01 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.604 -0.685 . . . . 0.0 109.584 168.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -116.11 128.0 55.3 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.608 -0.683 . . . . 0.0 110.406 175.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.687 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.1 m -136.57 159.72 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.674 -0.641 . . . . 0.0 109.892 175.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.7 mmm -74.46 -40.44 61.89 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.704 -0.622 . . . . 0.0 110.094 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 77.5 p -135.87 143.23 43.56 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.752 -0.593 . . . . 0.0 109.825 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -55.34 139.9 81.72 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 O-C-N 123.17 1.089 . . . . 0.0 110.861 -173.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.789 ' HB3' HD21 ' A' ' 288' ' ' LEU . 18.0 Cg_endo -61.97 166.9 11.46 Favored 'Trans proline' 0 N--CA 1.487 1.145 0 O-C-N 123.217 1.114 . . . . 0.0 110.72 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -61.06 155.68 49.09 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 O-C-N 123.382 1.201 . . . . 0.0 110.41 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -73.55 138.66 45.11 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.652 -0.655 . . . . 0.0 109.93 176.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.57 -24.94 29.36 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -174.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.14 150.94 2.18 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.367 -1.078 . . . . 0.0 111.426 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.78 155.94 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.735 -0.603 . . . . 0.0 109.906 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.683 HD11 ' CD2' ' A' ' 251' ' ' TYR . 53.4 mt -109.61 135.57 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.723 ' HG2' HD22 ' A' ' 248' ' ' LEU . 59.6 mtt180 -114.95 145.97 41.67 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.674 -0.641 . . . . 0.0 109.292 -174.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.651 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -140.54 127.74 21.01 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.546 -0.721 . . . . 0.0 110.312 173.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.4 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 41.3 ttp -137.25 139.91 29.35 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.766 -0.584 . . . . 0.0 111.061 -177.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.587 ' HD3' HD12 ' A' ' 226' ' ' ILE . 72.9 Cg_endo -91.12 138.2 2.28 Favored 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 121.051 1.167 . . . . 0.0 110.789 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.438 HG12 ' CZ ' ' A' ' 244' ' ' ARG . 34.8 m -147.38 154.85 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.539 -0.725 . . . . 0.0 110.06 174.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.569 ' HA ' HG22 ' A' ' 282' ' ' ILE . 78.3 m-85 -63.02 167.69 4.64 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.457 -0.777 . . . . 0.0 110.517 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.416 ' HA ' HD12 ' A' ' 283' ' ' LEU . 86.3 tttt -85.05 -60.12 2.14 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.657 -0.652 . . . . 0.0 110.834 -173.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -80.11 152.33 29.35 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.593 -0.692 . . . . 0.0 110.284 -175.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.454 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.67 -38.68 72.54 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.364 -0.835 . . . . 0.0 110.664 -175.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -56.58 -24.77 49.66 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.499 -0.751 . . . . 0.0 110.558 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.406 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 98.7 m-70 -109.71 -20.49 12.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.534 -0.729 . . . . 0.0 111.167 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.454 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -67.65 -20.22 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.12 -0.987 . . . . 0.0 110.581 -176.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.635 HG22 HD11 ' A' ' 126' ' ' ILE . 67.8 p -79.42 -16.85 55.48 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.544 -0.723 . . . . 0.0 110.856 174.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.35 136.41 33.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.303 -0.873 . . . . 0.0 110.086 175.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.1 t -73.0 143.26 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.661 -0.649 . . . . 0.0 110.267 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.685 HG23 HH12 ' A' ' 244' ' ' ARG . 60.8 t -84.94 136.39 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.625 -0.672 . . . . 0.0 109.224 171.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.8 pttt -134.89 -170.22 2.52 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.453 -0.779 . . . . 0.0 111.137 -168.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -95.3 158.96 15.23 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.776 -0.578 . . . . 0.0 110.34 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 56.9 m -77.26 157.42 80.79 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.551 -0.718 . . . . 0.0 109.304 175.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.405 ' HD3' ' HA3' ' A' ' 275' ' ' GLY . 17.2 Cg_exo -63.37 -47.31 7.96 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 123.122 1.064 . . . . 0.0 109.97 176.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.431 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.3 p-10 -65.44 -43.74 89.5 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.549 -0.719 . . . . 0.0 111.091 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . 0.431 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 53.6 m170 -81.75 -27.99 33.53 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.459 -0.775 . . . . 0.0 111.266 -175.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -69.15 -38.87 79.0 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.384 -0.822 . . . . 0.0 110.402 172.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 26.7 tp -56.43 -35.91 68.38 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.57 -0.706 . . . . 0.0 110.836 -176.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 30.2 t -48.42 140.4 7.86 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.472 -0.767 . . . . 0.0 111.313 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.434 ' HB2' ' CE2' ' A' ' 214' ' ' PHE . 92.3 mtt-85 -60.33 141.08 56.71 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.575 -0.703 . . . . 0.0 110.274 -176.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -65.51 -32.81 74.62 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.692 -0.63 . . . . 0.0 110.518 -176.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.434 ' CE2' ' HB2' ' A' ' 212' ' ' ARG . 52.2 m-85 51.2 47.54 24.66 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.534 -0.729 . . . . 0.0 110.975 -175.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -73.38 -10.15 59.44 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.737 -0.602 . . . . 0.0 111.346 -175.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -58.5 113.03 1.8 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.206 -0.934 . . . . 0.0 110.743 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 73.97 19.98 79.74 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 174.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -114.89 140.15 49.21 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.303 -1.116 . . . . 0.0 110.471 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.8 mt -84.91 -25.06 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.688 -0.632 . . . . 0.0 110.416 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -124.99 93.95 44.83 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.462 -0.774 . . . . 0.0 110.586 -176.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.429 ' HD2' ' CE2' ' A' ' 236' ' ' TYR . 24.7 Cg_endo -67.21 144.29 68.15 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 O-C-N 123.323 1.17 . . . . 0.0 110.445 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 221' ' ' PRO . 33.5 Cg_exo -57.49 -19.59 37.05 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 O-C-N 123.124 1.065 . . . . 0.0 111.528 -177.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 27.4 m -51.26 -26.95 8.07 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.187 -0.946 . . . . 0.0 111.444 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . 0.408 ' CD2' ' HB3' ' A' ' 236' ' ' TYR . 75.6 m80 -102.58 130.53 49.47 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.458 -0.776 . . . . 0.0 110.269 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.407 ' HA ' ' CG ' ' A' ' 268' ' ' MET . 39.5 tp -60.58 -38.14 83.63 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.641 -0.662 . . . . 0.0 110.285 -178.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.587 HD12 ' HD3' ' A' ' 190' ' ' PRO . 83.2 mt -101.42 136.77 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.795 -0.566 . . . . 0.0 109.84 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -131.69 156.98 44.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.688 -0.633 . . . . 0.0 110.328 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.524 HG23 HG21 ' A' ' 247' ' ' VAL . 88.3 t -103.13 146.65 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.749 -0.595 . . . . 0.0 109.941 176.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -118.24 126.76 52.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.721 -0.612 . . . . 0.0 110.368 171.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 96.98 21.4 20.91 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 168.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -139.4 105.23 5.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.3 -1.118 . . . . 0.0 110.038 174.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 91.6 p -63.65 -15.1 57.42 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.604 -0.685 . . . . 0.0 111.232 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -97.02 9.97 40.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.245 -0.909 . . . . 0.0 111.235 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.75 130.49 46.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.127 -0.983 . . . . 0.0 110.09 175.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -139.74 157.96 44.89 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.668 -0.645 . . . . 0.0 109.862 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.429 ' CE2' ' HD2' ' A' ' 221' ' ' PRO . 88.0 m-85 -118.58 150.81 39.03 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.576 -0.702 . . . . 0.0 110.646 -176.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.11 159.9 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.776 -0.578 . . . . 0.0 110.128 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -120.38 130.04 54.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.738 -0.601 . . . . 0.0 110.262 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.27 119.08 46.3 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.625 -0.672 . . . . 0.0 109.669 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.16 -27.7 78.93 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 O-C-N 123.059 1.031 . . . . 0.0 110.874 -172.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 84.0 mt -102.99 -50.32 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.434 -0.792 . . . . 0.0 110.952 -170.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 18.6 p -105.33 12.23 31.92 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.379 -0.826 . . . . 0.0 111.975 -171.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 82.95 -25.04 4.9 Favored Glycine 0 N--CA 1.497 2.737 0 O-C-N 121.009 -1.057 . . . . 0.0 111.825 168.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.685 HH12 HG23 ' A' ' 202' ' ' VAL . 26.7 mmt180 -45.89 142.13 2.75 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 118.598 1.199 . . . . 0.0 112.627 -168.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -105.22 146.9 28.65 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.659 -0.651 . . . . 0.0 110.036 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.2 p -154.74 159.92 40.99 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.576 -0.703 . . . . 0.0 110.35 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.524 HG21 HG23 ' A' ' 228' ' ' VAL . 8.4 p -122.92 148.1 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.729 -0.607 . . . . 0.0 109.814 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.723 HD22 ' HG2' ' A' ' 187' ' ' ARG . 81.9 mt -129.71 154.61 46.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.738 -0.601 . . . . 0.0 109.891 -175.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.441 HG13 ' C ' ' A' ' 248' ' ' LEU . 33.8 m -151.3 151.84 29.91 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.878 -0.514 . . . . 0.0 109.935 175.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -71.04 138.95 34.81 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 O-C-N 123.269 1.142 . . . . 0.0 109.95 177.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.683 ' CD2' HD11 ' A' ' 186' ' ' ILE . 10.0 t80 -78.69 126.51 30.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.496 -0.753 . . . . 0.0 110.21 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -99.97 160.05 28.22 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.695 -0.628 . . . . 0.0 110.059 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -59.17 159.53 22.01 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.234 1.123 . . . . 0.0 110.423 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.38 149.96 78.02 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 O-C-N 123.261 1.137 . . . . 0.0 110.536 -177.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -61.3 148.09 42.4 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.679 -0.638 . . . . 0.0 110.2 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.9 t -69.84 127.2 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.563 -0.711 . . . . 0.0 110.178 -170.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.03 -10.14 55.23 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 10.0 t -144.5 173.25 11.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.169 -1.195 . . . . 0.0 110.642 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -106.9 13.22 27.98 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.674 -0.641 . . . . 0.0 111.743 -168.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -119.99 168.06 11.54 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.159 -0.963 . . . . 0.0 111.092 -175.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 84.1 m -117.75 145.69 44.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.813 -0.554 . . . . 0.0 109.837 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 52.2 m -114.94 135.54 54.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.594 -0.691 . . . . 0.0 110.934 -174.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.6 t -130.12 137.24 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 72.1 mt -104.73 119.07 38.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.581 -0.7 . . . . 0.0 109.863 -172.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.651 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 6.0 m-30 -105.89 151.24 24.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.675 -0.64 . . . . 0.0 110.614 -177.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -136.6 142.91 43.35 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -112.23 131.06 55.7 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.518 -0.739 . . . . 0.0 110.437 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' MET . . . . . 0.407 ' CG ' ' HA ' ' A' ' 225' ' ' LEU . 5.0 ppp? -100.23 7.43 44.48 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.683 -0.636 . . . . 0.0 111.972 -175.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . 0.67 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.6 OUTLIER -144.76 164.95 29.48 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.075 -1.016 . . . . 0.0 109.834 171.558 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.61 ' HA ' HG21 ' A' ' 305' ' ' ILE . 28.0 p30 -120.7 161.94 20.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.651 -0.656 . . . . 0.0 110.456 -178.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . 0.428 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 22.5 m -58.08 -33.42 69.05 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.48 -0.762 . . . . 0.0 111.082 -163.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 48.8 p -99.4 11.5 38.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.466 -0.771 . . . . 0.0 112.011 -163.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 30.2 p -94.48 118.01 31.0 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.124 -0.985 . . . . 0.0 110.672 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.7 t -64.12 140.04 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.504 -0.748 . . . . 0.0 110.412 -169.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . 0.405 ' HA3' ' HD3' ' A' ' 206' ' ' PRO . . . 99.46 -5.21 58.63 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 177.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -125.46 -100.43 1.25 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 170.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . 0.428 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.3 mmm -64.28 -31.44 72.65 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.687 -0.89 . . . . 0.0 110.319 176.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.7 p30 43.38 51.51 5.98 Favored 'General case' 0 N--CA 1.505 2.301 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 175.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 54.81 27.05 8.39 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.275 -0.891 . . . . 0.0 111.145 175.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -118.32 105.91 45.72 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.575 -0.703 . . . . 0.0 110.057 176.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.51 147.27 92.27 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 O-C-N 123.119 1.063 . . . . 0.0 110.6 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.569 HG22 ' HA ' ' A' ' 192' ' ' TYR . 45.7 pt -131.88 178.32 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 121.744 0.783 . . . . 0.0 110.832 -177.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 302' ' ' GLU . 31.3 mt -124.4 149.87 46.22 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.685 HD12 ' CE1' ' A' ' 301' ' ' PHE . 81.2 mt -115.27 130.34 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.621 HG23 ' SG ' ' A' ' 300' ' ' CYS . 82.0 mt -109.74 126.26 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -176.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 59.7 t -118.9 126.71 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.425 HG22 ' HG2' ' A' ' 298' ' ' ARG . 45.6 p -125.26 152.76 44.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.637 -0.665 . . . . 0.0 110.665 -174.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.789 HD21 ' HB3' ' A' ' 180' ' ' PRO . 19.8 tp -102.59 126.17 49.58 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 168.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.638 ' OE2' HG13 ' A' ' 295' ' ' VAL . 73.3 mm-40 -131.78 149.13 52.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.814 -0.554 . . . . 0.0 110.003 -172.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.82 ' CG2' HD11 ' A' ' 296' ' ' LEU . 19.0 p -89.98 161.11 16.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.706 -0.621 . . . . 0.0 110.115 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -55.95 -26.12 46.52 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.603 -0.686 . . . . 0.0 111.094 -176.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 46.0 p30 -90.18 9.66 27.57 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.399 -0.813 . . . . 0.0 111.889 -173.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 88.79 20.19 48.23 Favored Glycine 0 N--CA 1.494 2.542 0 O-C-N 121.12 -0.987 . . . . 0.0 110.655 171.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -107.98 140.15 41.56 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.267 -1.137 . . . . 0.0 110.025 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.638 HG13 ' OE2' ' A' ' 289' ' ' GLU . 60.8 t -88.74 132.23 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.65 -0.656 . . . . 0.0 110.234 -172.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.82 HD11 ' CG2' ' A' ' 290' ' ' THR . 96.2 mt -99.88 -40.08 7.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.707 -0.62 . . . . 0.0 110.532 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -162.61 150.83 20.33 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.425 ' HG2' HG22 ' A' ' 287' ' ' THR . 78.5 mtm180 -135.15 134.77 40.52 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.686 -0.89 . . . . 0.0 110.566 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -137.34 158.69 43.87 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.676 -0.64 . . . . 0.0 109.982 172.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . 0.621 ' SG ' HG23 ' A' ' 285' ' ' ILE . 97.7 m -142.56 155.69 45.03 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.424 -0.797 . . . . 0.0 110.713 -175.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.685 ' CE1' HD12 ' A' ' 284' ' ' ILE . 47.9 p90 -144.94 163.73 33.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.72 -0.612 . . . . 0.0 110.113 175.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.446 ' HA ' HD23 ' A' ' 283' ' ' LEU . 56.8 tt0 -104.91 135.37 46.39 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.496 -0.752 . . . . 0.0 110.151 -177.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -124.29 143.5 50.52 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.677 -170.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -138.67 139.01 38.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.843 -0.536 . . . . 0.0 109.806 173.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.67 HD13 ' O ' ' A' ' 269' ' ' CYS . 74.5 mt -105.82 122.93 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.549 -0.72 . . . . 0.0 109.59 175.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.9 p -145.18 168.24 20.85 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.558 -0.714 . . . . 0.0 110.968 -170.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -68.8 -39.97 79.81 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.686 -0.633 . . . . 0.0 110.636 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 4.1 t -131.25 88.54 44.2 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.534 -0.729 . . . . 0.0 110.496 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.33 -29.35 67.3 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 O-C-N 123.185 1.098 . . . . 0.0 110.914 174.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.36 -37.77 93.07 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -73.25 -40.63 64.48 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.689 -0.889 . . . . 0.0 109.875 -173.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -69.47 -39.96 77.4 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.164 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -61.01 -44.15 97.83 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.456 -0.777 . . . . 0.0 110.289 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -64.68 -40.14 94.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.557 -0.714 . . . . 0.0 110.495 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.57 -50.05 74.2 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.499 -0.751 . . . . 0.0 110.486 -173.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -61.3 -37.82 84.58 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.501 -0.749 . . . . 0.0 110.084 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -63.49 -40.53 97.32 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.625 -0.672 . . . . 0.0 110.166 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -62.48 -35.2 78.58 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.603 -0.685 . . . . 0.0 109.977 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 23.8 m -62.8 -33.66 75.66 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.719 -0.613 . . . . 0.0 110.228 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.499 HD11 HD21 ' A' ' 159' ' ' LEU . 83.5 mt -78.34 -44.41 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.606 -0.684 . . . . 0.0 109.936 -177.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -58.95 -40.64 85.27 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.658 -0.651 . . . . 0.0 110.503 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -61.39 -44.33 97.33 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.613 -0.679 . . . . 0.0 110.185 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -63.9 -33.77 76.45 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.66 -0.65 . . . . 0.0 110.236 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -98.09 125.12 42.94 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.675 -0.64 . . . . 0.0 110.411 -176.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.53 130.05 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.65 -0.656 . . . . 0.0 109.783 178.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 29.4 t -95.06 139.98 30.65 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.595 -0.69 . . . . 0.0 110.39 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -84.65 124.41 31.44 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.668 -0.645 . . . . 0.0 110.207 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 11.0 t -61.17 148.27 41.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.566 -0.709 . . . . 0.0 110.175 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 76.9 p -99.83 22.01 11.71 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.62 -0.675 . . . . 0.0 110.901 -176.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -60.09 -36.53 77.6 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.464 -0.772 . . . . 0.0 110.226 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -111.66 138.59 48.03 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.67 -0.644 . . . . 0.0 110.145 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -60.26 -36.04 89.76 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -160.44 160.03 31.66 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.655 -0.909 . . . . 0.0 110.366 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -87.88 130.86 34.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.63 -0.669 . . . . 0.0 110.17 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -72.33 -44.92 61.96 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.685 -0.634 . . . . 0.0 110.397 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -85.85 -37.24 19.4 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.637 -0.664 . . . . 0.0 110.506 -176.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 53.72 46.73 25.29 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.395 -0.815 . . . . 0.0 110.744 -178.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -101.34 133.32 46.11 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.649 -0.657 . . . . 0.0 110.439 -177.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 76.4 p -97.0 26.27 4.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.626 -0.671 . . . . 0.0 110.398 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -68.71 154.07 42.63 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.568 -0.708 . . . . 0.0 110.239 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 97.7 168.81 32.48 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 50.9 mm -94.14 136.1 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.604 -0.939 . . . . 0.0 110.089 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -84.94 -38.04 19.82 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.602 -0.686 . . . . 0.0 110.382 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 23.0 ptt? -138.83 55.05 1.73 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.58 -0.7 . . . . 0.0 110.443 -177.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . 0.554 HG22 ' O ' ' A' ' 345' ' ' THR . 51.0 m . . . . . 0 N--CA 1.5 2.047 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.823 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 75.2 m -86.28 9.31 18.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.587 -0.949 . . . . 0.0 111.361 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 86.8 p -61.64 -28.36 69.32 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.212 -0.93 . . . . 0.0 110.257 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.9 p -122.44 161.67 23.09 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.643 -0.66 . . . . 0.0 110.295 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -133.51 151.74 51.8 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.655 -0.653 . . . . 0.0 110.33 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -88.67 119.46 29.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.633 -0.667 . . . . 0.0 110.45 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 50.1 83.36 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.543 -0.723 . . . . 0.0 111.404 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 88.7 mt 51.38 -176.23 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.345 -0.847 . . . . 0.0 111.111 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.3 p -130.47 161.04 63.05 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.601 -0.687 . . . . 0.0 110.245 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -61.76 151.86 78.04 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 O-C-N 123.273 1.144 . . . . 0.0 110.333 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 79.1 p -81.47 141.56 49.14 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.632 -0.667 . . . . 0.0 110.078 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.613 ' HB3' HG22 ' A' ' 242' ' ' THR . 19.4 Cg_endo -64.73 144.97 85.63 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 O-C-N 123.244 1.128 . . . . 0.0 110.533 -177.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.43 141.4 41.4 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.665 -0.647 . . . . 0.0 110.03 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.565 HD12 HG13 ' A' ' 198' ' ' VAL . 50.4 mm -123.52 99.95 38.86 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.698 -0.626 . . . . 0.0 110.062 -178.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -61.13 152.99 67.82 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 O-C-N 123.236 1.124 . . . . 0.0 110.461 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.5 t -108.4 148.64 29.84 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.667 -0.645 . . . . 0.0 110.233 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.5 p-10 -94.06 23.22 5.11 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.69 -0.631 . . . . 0.0 110.915 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 50.4 m -75.4 125.16 28.44 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.445 -0.785 . . . . 0.0 110.233 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -69.61 144.97 52.84 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.639 -0.663 . . . . 0.0 110.478 -177.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -153.18 100.59 2.65 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.647 -0.658 . . . . 0.0 110.118 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -59.14 -39.96 74.3 Favored 'Trans proline' 0 N--CA 1.489 1.206 0 O-C-N 123.129 1.068 . . . . 0.0 110.774 -175.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.3 -155.17 48.59 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -75.47 -43.57 0.35 Allowed 'Trans proline' 0 C--N 1.317 -1.095 0 O-C-N 123.303 1.159 . . . . 0.0 110.978 -174.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -86.77 8.1 24.12 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.529 -0.732 . . . . 0.0 111.412 -173.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.39 59.67 4.23 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.997 -1.064 . . . . 0.0 110.72 -176.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.68 ' HA ' HG12 ' A' ' 176' ' ' VAL . 64.8 t80 -77.82 117.25 19.01 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.572 -0.705 . . . . 0.0 109.933 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -130.05 160.01 35.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.855 -0.528 . . . . 0.0 110.141 -178.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 63.8 t -126.41 146.42 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.681 -0.637 . . . . 0.0 109.816 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 78.4 p -155.26 161.4 41.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.765 -0.584 . . . . 0.0 110.069 177.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.497 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 67.1 m-85 -126.74 125.24 41.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.8 -0.562 . . . . 0.0 109.851 -176.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -57.47 144.05 38.17 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.594 -0.691 . . . . 0.0 110.267 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -120.05 156.18 31.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.608 -0.682 . . . . 0.0 110.747 -173.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 23.2 t -148.21 165.74 30.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.725 -0.609 . . . . 0.0 109.994 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 54.5 p -61.43 162.74 7.56 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.585 -0.697 . . . . 0.0 110.058 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.601 HG22 HH21 ' A' ' 313' ' ' ARG . 71.7 p -59.96 92.44 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.563 -0.71 . . . . 0.0 110.263 -177.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.06 148.86 22.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.734 -0.604 . . . . 0.0 110.256 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -72.81 137.22 45.62 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.686 -0.634 . . . . 0.0 110.132 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.3 m 53.41 51.43 15.37 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.492 -0.755 . . . . 0.0 110.96 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.98 132.96 46.73 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.623 -0.673 . . . . 0.0 110.172 177.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.5 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 82.1 p -60.03 -32.92 71.34 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.715 -0.616 . . . . 0.0 109.99 175.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.5 ' HD1' ' HG1' ' A' ' 152' ' ' THR . 68.8 p-90 -171.04 143.74 2.02 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.329 0.585 . . . . 0.0 110.059 177.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.0 t -142.15 142.63 32.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.88 -0.513 . . . . 0.0 110.072 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.497 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 44.7 t80 -125.49 140.06 53.09 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.551 -0.718 . . . . 0.0 110.514 -172.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.8 t -111.79 124.94 53.41 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 120.383 -0.527 . . . . 0.0 109.878 176.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 56.5 m -70.68 -37.07 73.61 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.789 -0.569 . . . . 0.0 110.483 -177.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -59.49 -33.86 71.86 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.645 -0.659 . . . . 0.0 110.441 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.505 HD11 ' OD1' ' A' ' 316' ' ' ASP . 57.1 mt -104.77 -12.04 16.52 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.678 -0.639 . . . . 0.0 110.88 -175.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 30.5 tttt 59.77 50.3 7.19 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.051 -1.031 . . . . 0.0 109.675 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -146.42 153.09 40.07 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.74 -0.6 . . . . 0.0 110.612 -174.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.618 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.55 137.85 53.4 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.833 -0.542 . . . . 0.0 110.209 -176.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -114.94 135.2 54.47 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.1 p -138.34 158.5 44.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.72 -0.612 . . . . 0.0 111.044 -175.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.421 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 65.5 mt-30 -104.45 140.94 37.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.628 -0.67 . . . . 0.0 110.021 172.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.432 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.1 tt -52.25 148.67 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.502 -0.749 . . . . 0.0 111.917 -172.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.79 10.05 5.77 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.539 -0.726 . . . . 0.0 112.509 176.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.421 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 26.7 mmtt -95.35 155.11 16.87 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.924 -1.11 . . . . 0.0 110.955 174.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 87.3 m -84.68 126.25 33.22 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.721 -0.612 . . . . 0.0 110.552 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . 0.618 ' SG ' HD21 ' A' ' 162' ' ' LEU . 29.9 t -115.15 90.36 23.62 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.572 -0.705 . . . . 0.0 110.178 176.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.42 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 22.6 Cg_endo -65.83 130.82 25.59 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 O-C-N 123.271 1.143 . . . . 0.0 110.597 176.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.411 HG12 ' CE2' ' A' ' 142' ' ' PHE . 96.9 mt -123.51 142.06 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.692 -0.63 . . . . 0.0 109.306 176.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -109.08 134.7 51.34 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.552 -0.718 . . . . 0.0 110.713 -176.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.1 mm -95.29 134.76 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.67 -0.644 . . . . 0.0 109.66 169.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -115.16 127.27 55.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.593 -0.692 . . . . 0.0 110.452 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.68 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.0 m -136.66 159.77 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.639 -0.663 . . . . 0.0 109.852 174.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.6 mmm -76.32 -40.69 50.73 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.658 -0.651 . . . . 0.0 110.092 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.5 p -134.45 143.28 46.09 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.763 -0.586 . . . . 0.0 109.9 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.8 Cg_exo -55.5 139.92 82.64 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 O-C-N 123.173 1.091 . . . . 0.0 110.947 -173.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.795 ' HB3' HD21 ' A' ' 288' ' ' LEU . 19.3 Cg_endo -59.95 165.2 10.67 Favored 'Trans proline' 0 C--N 1.316 -1.167 0 O-C-N 123.17 1.09 . . . . 0.0 110.656 177.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -62.04 154.86 59.25 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 O-C-N 123.312 1.164 . . . . 0.0 110.446 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -64.67 137.54 57.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.65 -0.656 . . . . 0.0 110.117 173.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 96.8 -24.96 28.67 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.861 -1.295 . . . . 0.0 109.861 -177.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.15 149.21 2.96 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.324 -1.104 . . . . 0.0 111.423 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.74 155.95 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.72 -0.612 . . . . 0.0 109.831 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.686 HD11 ' CD2' ' A' ' 251' ' ' TYR . 64.0 mt -108.79 135.21 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.732 ' HG2' HD22 ' A' ' 248' ' ' LEU . 69.5 mtt180 -114.95 145.85 41.8 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -174.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.646 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -140.54 126.53 19.51 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.534 -0.729 . . . . 0.0 110.212 173.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.409 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 32.9 ttp -137.22 139.0 26.76 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.804 -0.56 . . . . 0.0 110.98 -176.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.534 ' HD3' HD12 ' A' ' 226' ' ' ILE . 71.0 Cg_endo -91.11 138.25 2.29 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 O-C-N 123.204 1.107 . . . . 0.0 110.81 177.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.404 HG13 ' C ' ' A' ' 190' ' ' PRO . 35.9 m -146.22 154.87 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.554 -0.716 . . . . 0.0 110.118 173.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.66 ' HA ' HG22 ' A' ' 282' ' ' ILE . 83.4 m-85 -60.73 161.32 8.07 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.467 -0.771 . . . . 0.0 110.402 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.422 ' HA ' HD12 ' A' ' 283' ' ' LEU . 33.7 tttt -77.6 -60.07 2.52 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.632 -0.668 . . . . 0.0 110.827 -174.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -80.13 151.02 30.02 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.558 -0.713 . . . . 0.0 110.34 -175.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.456 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.54 -37.81 71.0 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.421 -0.8 . . . . 0.0 110.695 -176.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -56.61 -24.78 50.28 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.529 -0.732 . . . . 0.0 110.573 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.404 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 64.2 m170 -109.49 -20.51 12.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.531 -0.731 . . . . 0.0 111.165 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.565 HG13 HD12 ' A' ' 126' ' ' ILE . 3.2 p -67.72 -20.22 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.174 -0.954 . . . . 0.0 110.574 -176.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.504 HG22 HD11 ' A' ' 126' ' ' ILE . 67.7 p -79.36 -16.98 55.4 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.562 -0.711 . . . . 0.0 110.735 174.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -88.36 137.3 32.45 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.349 -0.845 . . . . 0.0 110.092 173.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.9 t -73.0 142.0 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.626 -0.671 . . . . 0.0 110.299 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.529 HG22 ' CE2' ' A' ' 192' ' ' TYR . 75.8 t -84.96 139.7 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.542 -0.724 . . . . 0.0 109.344 170.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 14.7 pttt -134.86 -170.08 2.49 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.553 -0.717 . . . . 0.0 110.883 -170.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.41 ' HD2' ' HA ' ' A' ' 223' ' ' SER . 81.3 mtp180 -95.13 154.72 17.05 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.741 -0.599 . . . . 0.0 110.286 178.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 42.0 m -72.75 154.75 91.19 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.632 -0.668 . . . . 0.0 109.271 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -62.52 -47.31 9.68 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 O-C-N 123.123 1.065 . . . . 0.0 110.048 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.414 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.6 p-10 -65.45 -44.16 88.11 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.599 -0.688 . . . . 0.0 111.223 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . 0.414 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 52.1 m170 -82.23 -28.0 32.19 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.453 -0.779 . . . . 0.0 111.171 -174.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -69.08 -37.24 78.36 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.395 -0.815 . . . . 0.0 110.297 172.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 26.4 tp -55.52 -33.61 63.92 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.558 -0.714 . . . . 0.0 110.898 -177.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 31.1 t -48.29 145.73 3.16 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.535 -0.728 . . . . 0.0 111.292 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -59.95 142.19 54.21 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.585 -0.697 . . . . 0.0 110.388 -175.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -61.12 -39.84 91.53 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.62 -0.675 . . . . 0.0 110.174 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.404 ' O ' ' CD2' ' A' ' 214' ' ' PHE . 55.2 t80 50.52 50.69 18.35 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.486 -0.759 . . . . 0.0 111.091 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -75.13 -10.18 59.23 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.633 -0.667 . . . . 0.0 111.334 -178.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -58.96 114.06 2.38 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.116 -0.99 . . . . 0.0 110.731 -177.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 74.63 20.06 79.67 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 173.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -114.85 139.93 49.36 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.334 -1.098 . . . . 0.0 110.469 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 83.8 mt -88.27 -25.21 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.6 -0.688 . . . . 0.0 110.364 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.413 ' HB1' ' CG ' ' A' ' 227' ' ' ARG . . . -126.7 97.55 33.01 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.497 -0.752 . . . . 0.0 110.472 -177.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.403 ' HA ' ' HD3' ' A' ' 222' ' ' PRO . 19.2 Cg_endo -64.21 144.28 86.16 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 O-C-N 123.368 1.193 . . . . 0.0 110.48 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 221' ' ' PRO . 33.6 Cg_exo -57.47 -20.02 38.89 Favored 'Trans proline' 0 N--CA 1.489 1.246 0 O-C-N 123.153 1.081 . . . . 0.0 111.449 -178.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.41 ' HA ' ' HD2' ' A' ' 204' ' ' ARG . 87.5 p -53.78 -22.49 9.54 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.192 -0.943 . . . . 0.0 111.283 -176.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . 0.421 ' CD2' ' HB3' ' A' ' 236' ' ' TYR . 77.4 m80 -103.74 130.4 51.25 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.493 -0.754 . . . . 0.0 110.352 178.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 30.1 tp -61.0 -37.69 83.41 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.673 -0.642 . . . . 0.0 110.289 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.534 HD12 ' HD3' ' A' ' 190' ' ' PRO . 84.8 mt -103.94 136.76 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.746 -0.596 . . . . 0.0 109.917 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.413 ' CG ' ' HB1' ' A' ' 220' ' ' ALA . 79.1 mtm180 -131.6 156.7 45.34 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.667 -0.646 . . . . 0.0 110.318 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.575 HG23 HG21 ' A' ' 247' ' ' VAL . 89.4 t -102.28 146.62 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.772 -0.58 . . . . 0.0 109.974 176.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -117.96 130.03 55.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.722 -0.611 . . . . 0.0 110.431 171.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 93.15 21.55 29.81 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 167.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -136.73 107.24 6.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.319 -1.107 . . . . 0.0 110.048 173.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 94.5 p -63.43 -15.14 56.79 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.651 -0.656 . . . . 0.0 111.192 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -97.27 10.05 40.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.272 -0.892 . . . . 0.0 111.189 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.81 126.58 27.84 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.174 -0.954 . . . . 0.0 110.092 176.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -139.75 154.39 47.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.762 -0.586 . . . . 0.0 109.785 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.421 ' HB3' ' CD2' ' A' ' 224' ' ' HIS . 86.3 m-85 -116.95 150.7 38.11 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.596 -0.69 . . . . 0.0 110.538 -176.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.17 159.89 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.762 -0.587 . . . . 0.0 110.118 176.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -122.86 130.0 52.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.75 -0.594 . . . . 0.0 110.177 177.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -64.98 109.98 3.6 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.649 -0.657 . . . . 0.0 109.741 176.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -59.98 -24.46 76.51 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.083 1.044 . . . . 0.0 111.032 -172.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 84.3 mt -99.87 -50.39 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.488 -0.757 . . . . 0.0 110.766 -171.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.613 HG22 ' HB3' ' A' ' 124' ' ' PRO . 6.2 p -105.3 12.09 32.13 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.365 -0.834 . . . . 0.0 111.984 -173.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 81.97 -24.98 4.3 Favored Glycine 0 N--CA 1.496 2.7 0 O-C-N 120.982 -1.074 . . . . 0.0 111.888 169.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 -45.88 142.08 2.76 Favored 'General case' 0 N--CA 1.505 2.282 0 CA-C-N 118.59 1.195 . . . . 0.0 112.614 -168.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -108.8 144.58 36.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.629 -0.669 . . . . 0.0 110.063 174.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 78.8 p -154.83 159.96 40.91 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.62 -0.675 . . . . 0.0 110.48 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.575 HG21 HG23 ' A' ' 228' ' ' VAL . 8.3 p -123.07 148.12 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.77 -0.581 . . . . 0.0 109.695 177.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.732 HD22 ' HG2' ' A' ' 187' ' ' ARG . 81.3 mt -129.71 154.64 46.97 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.896 -176.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.442 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.9 m -150.57 151.84 31.48 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.807 -0.558 . . . . 0.0 109.944 175.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -71.11 138.81 34.31 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 O-C-N 123.188 1.099 . . . . 0.0 109.844 177.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.686 ' CD2' HD11 ' A' ' 186' ' ' ILE . 9.0 t80 -78.45 126.06 30.23 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.454 -0.779 . . . . 0.0 110.04 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -100.0 160.11 28.06 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.719 -0.613 . . . . 0.0 110.02 177.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -59.11 159.62 21.48 Favored 'Trans proline' 0 C--N 1.316 -1.157 0 O-C-N 123.276 1.145 . . . . 0.0 110.401 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.36 149.98 77.8 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.268 1.141 . . . . 0.0 110.521 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -60.53 148.42 37.95 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.681 -0.637 . . . . 0.0 110.241 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.82 127.17 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.516 -0.74 . . . . 0.0 110.154 -170.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.99 -10.17 55.39 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 10.0 t -144.66 173.31 11.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.177 -1.19 . . . . 0.0 110.586 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -107.19 13.14 27.6 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.63 -0.669 . . . . 0.0 111.783 -168.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -119.99 168.05 11.54 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.11 -0.994 . . . . 0.0 111.083 -175.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 83.6 m -117.72 145.83 44.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.729 -0.607 . . . . 0.0 109.876 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 42.8 m -115.59 135.72 53.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.622 -0.674 . . . . 0.0 110.885 -175.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.4 t -129.7 137.32 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 62.8 mt -104.63 118.57 36.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.511 -0.743 . . . . 0.0 109.73 -172.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.646 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 6.3 m-30 -105.56 151.31 24.48 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.694 -0.629 . . . . 0.0 110.578 -177.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -136.53 142.9 43.48 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -112.53 129.26 56.42 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.608 -0.682 . . . . 0.0 110.458 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -98.23 -1.84 41.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.741 -0.6 . . . . 0.0 111.95 -176.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.73 159.11 43.38 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.117 -0.989 . . . . 0.0 109.839 174.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.615 ' HA ' HD13 ' A' ' 305' ' ' ILE . 27.1 p30 -113.95 153.49 29.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.732 -0.605 . . . . 0.0 110.059 178.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . 0.442 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 89.1 p -56.54 -26.51 55.09 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.43 -0.794 . . . . 0.0 111.189 -168.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 49.8 p -94.4 8.09 43.22 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.396 -0.815 . . . . 0.0 112.095 -166.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 28.8 p -92.98 116.61 29.21 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.009 -1.057 . . . . 0.0 110.584 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.39 143.3 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.482 -0.761 . . . . 0.0 110.414 -166.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.55 -5.33 58.55 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.96 -93.13 0.66 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 170.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . 0.442 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 94.3 mmm -66.31 -29.06 69.19 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.731 -0.864 . . . . 0.0 110.36 176.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.8 p30 45.1 52.46 8.41 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 172.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 54.91 33.14 19.33 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.255 -0.903 . . . . 0.0 111.227 174.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . 0.415 ' HA ' ' HD2' ' A' ' 281' ' ' PRO . 80.9 mtt180 -113.97 104.95 54.84 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.511 -0.743 . . . . 0.0 110.245 173.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 280' ' ' ARG . 13.6 Cg_endo -61.1 145.49 98.81 Favored 'Trans proline' 0 N--CA 1.488 1.171 0 O-C-N 123.107 1.056 . . . . 0.0 110.293 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.66 HG22 ' HA ' ' A' ' 192' ' ' TYR . 44.0 pt -131.97 176.82 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.943 0.878 . . . . 0.0 111.244 -174.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 302' ' ' GLU . 31.4 mt -124.29 149.86 46.05 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.708 HD12 ' CE1' ' A' ' 301' ' ' PHE . 81.6 mt -114.85 129.4 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.253 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.525 HG23 ' SG ' ' A' ' 300' ' ' CYS . 80.4 mt -109.8 126.26 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -176.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 58.3 t -118.96 126.77 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.3 p -125.27 152.24 44.9 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.621 -174.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.795 HD21 ' HB3' ' A' ' 180' ' ' PRO . 21.1 tp -101.44 125.29 48.06 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 167.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.572 ' OE2' HG13 ' A' ' 295' ' ' VAL . 73.6 mm-40 -131.17 150.84 51.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.85 -0.531 . . . . 0.0 109.979 -172.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.797 ' CG2' HD11 ' A' ' 296' ' ' LEU . 68.9 p -89.96 159.88 16.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.606 -0.684 . . . . 0.0 109.908 177.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -55.95 -26.1 46.48 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.523 -0.735 . . . . 0.0 110.809 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -87.5 9.69 20.12 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.477 -0.764 . . . . 0.0 111.862 -174.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 86.9 20.16 54.23 Favored Glycine 0 N--CA 1.495 2.567 0 C-N-CA 120.195 -1.002 . . . . 0.0 110.733 170.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -106.84 140.14 40.14 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.293 -1.122 . . . . 0.0 110.267 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.572 HG13 ' OE2' ' A' ' 289' ' ' GLU . 59.9 t -88.32 130.15 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.65 -0.656 . . . . 0.0 110.034 -175.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.797 HD11 ' CG2' ' A' ' 290' ' ' THR . 96.0 mt -99.94 -40.15 7.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.681 -0.637 . . . . 0.0 110.46 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -160.14 147.9 15.56 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.523 ' HD3' HG11 ' A' ' 295' ' ' VAL . 79.4 mtm180 -135.09 134.4 40.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.644 -0.915 . . . . 0.0 110.565 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -137.47 158.95 43.28 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.654 -0.654 . . . . 0.0 110.036 172.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . 0.525 ' SG ' HG23 ' A' ' 285' ' ' ILE . 92.8 m -142.26 155.73 45.25 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.467 -0.771 . . . . 0.0 110.745 -175.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.708 ' CE1' HD12 ' A' ' 284' ' ' ILE . 48.9 p90 -144.98 160.54 41.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.701 -0.625 . . . . 0.0 110.074 174.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.468 ' HA ' HD23 ' A' ' 283' ' ' LEU . 58.7 tt0 -104.88 135.92 45.33 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.539 -0.726 . . . . 0.0 110.178 -177.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -118.41 143.74 46.45 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.812 -169.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -138.57 138.07 37.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.819 -0.551 . . . . 0.0 109.759 173.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.615 HD13 ' HA ' ' A' ' 270' ' ' ASN . 34.8 mt -110.8 122.85 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.538 -0.726 . . . . 0.0 109.495 178.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.3 p -145.25 171.9 13.9 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.561 -0.712 . . . . 0.0 111.035 -169.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -70.32 -40.06 74.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.681 -0.637 . . . . 0.0 110.653 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 4.5 t -132.37 89.98 35.23 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.574 -0.704 . . . . 0.0 110.525 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.18 -30.08 69.5 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.15 1.079 . . . . 0.0 111.032 174.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.03 -37.48 93.19 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -73.66 -40.59 63.6 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.701 -0.882 . . . . 0.0 109.895 -173.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -69.56 -39.99 77.05 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 120.084 -0.647 . . . . 0.0 110.236 -177.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.601 HH21 HG22 ' A' ' 147' ' ' THR . 34.3 ttp180 -61.26 -43.77 98.34 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.382 177.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -64.86 -38.36 90.71 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.524 -0.735 . . . . 0.0 110.461 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.84 -49.76 75.0 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.539 -0.726 . . . . 0.0 110.539 -173.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . 0.505 ' OD1' HD11 ' A' ' 159' ' ' LEU . 2.8 p30 -60.84 -37.68 82.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.488 -0.758 . . . . 0.0 110.138 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -63.29 -40.69 98.07 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.622 -0.674 . . . . 0.0 110.11 177.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -62.62 -35.15 78.66 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.705 -0.622 . . . . 0.0 109.929 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 23.8 m -62.01 -33.44 74.34 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.74 -0.6 . . . . 0.0 110.183 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 83.5 mt -77.78 -45.62 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.607 -0.683 . . . . 0.0 110.014 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -60.52 -38.02 83.04 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.616 -0.678 . . . . 0.0 110.441 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 34.8 tttm -60.48 -39.94 89.48 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.589 -0.694 . . . . 0.0 110.189 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -60.52 -33.17 72.25 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.726 -0.609 . . . . 0.0 110.094 176.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -98.32 125.05 43.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.727 -0.608 . . . . 0.0 110.339 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 61.8 t -114.86 130.02 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.557 -0.715 . . . . 0.0 109.995 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 65.3 p -95.11 140.1 30.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.59 -0.694 . . . . 0.0 110.225 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -74.23 136.68 42.73 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.681 -0.637 . . . . 0.0 110.153 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 58.4 p -80.55 157.54 26.05 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.616 -0.678 . . . . 0.0 110.21 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 77.3 p -102.12 19.91 17.67 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.688 -0.632 . . . . 0.0 110.871 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 20.0 mtpp -60.42 -38.0 82.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.346 -0.846 . . . . 0.0 110.279 -178.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -60.42 -34.83 74.51 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.669 -0.644 . . . . 0.0 110.312 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 98.55 -27.43 19.63 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 59.46 79.89 0.21 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.437 -1.037 . . . . 0.0 110.257 175.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -92.57 119.67 32.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.622 -0.674 . . . . 0.0 110.193 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -61.09 -44.27 97.61 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.657 -0.652 . . . . 0.0 110.27 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 55.99 161.98 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.566 -0.709 . . . . 0.0 110.869 -175.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -61.12 -35.77 77.94 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.5 -0.75 . . . . 0.0 110.23 179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -105.43 129.9 53.64 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.615 -0.678 . . . . 0.0 110.297 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 9.2 t -130.99 157.38 43.13 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.711 -0.618 . . . . 0.0 110.403 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -122.68 145.4 48.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.659 -0.65 . . . . 0.0 110.264 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -73.05 64.47 1.59 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 82.6 mt -92.95 138.95 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.662 -0.905 . . . . 0.0 110.006 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -90.76 135.34 33.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.617 -0.677 . . . . 0.0 110.224 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 71.0 mtm -60.42 -35.34 75.56 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.665 -0.647 . . . . 0.0 110.33 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 30.0 p . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.239 -179.831 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 82.5 p -81.86 -24.33 35.85 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.657 -0.908 . . . . 0.0 110.508 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.8 m -119.18 148.71 42.8 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.493 -0.755 . . . . 0.0 110.287 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 46.3 m -120.74 142.39 49.58 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.71 -0.619 . . . . 0.0 110.222 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -114.13 149.57 35.43 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.656 -0.653 . . . . 0.0 110.212 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.421 ' O ' ' HB3' ' A' ' 119' ' ' ALA . 55.7 p30 -88.25 11.49 16.37 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.647 -0.658 . . . . 0.0 111.515 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 118' ' ' ASP . . . 58.16 -82.97 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.223 -0.923 . . . . 0.0 110.731 -175.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 34.4 tp 56.1 -85.78 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.444 -0.785 . . . . 0.0 110.801 -176.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 59.5 p -73.41 150.97 89.58 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.117 -0.99 . . . . 0.0 109.977 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.65 154.96 39.38 Favored 'Cis proline' 0 N--CA 1.494 1.543 0 C-N-CA 123.215 -1.577 . . . . 0.0 110.317 -22.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 2.4 m -80.39 147.28 63.71 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.672 -0.643 . . . . 0.0 110.341 -176.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.407 ' HB3' HG22 ' A' ' 242' ' ' THR . 14.7 Cg_endo -61.43 146.02 97.53 Favored 'Trans proline' 0 C--N 1.318 -1.069 0 O-C-N 123.264 1.139 . . . . 0.0 110.526 -178.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.9 141.97 42.21 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.666 -0.646 . . . . 0.0 110.097 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.517 HD11 HG22 ' A' ' 199' ' ' THR . 50.6 mm -123.01 99.94 40.53 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.623 -0.673 . . . . 0.0 110.026 -178.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 126' ' ' ILE . 13.5 Cg_endo -60.93 151.26 79.07 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 O-C-N 123.287 1.151 . . . . 0.0 110.538 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.9 t -110.08 147.69 33.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.655 -0.653 . . . . 0.0 110.338 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -95.05 24.79 4.6 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.717 -0.614 . . . . 0.0 110.756 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 52.0 m -74.96 125.23 28.45 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.587 -0.696 . . . . 0.0 110.263 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -69.88 144.93 52.34 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.675 -0.64 . . . . 0.0 110.496 -177.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -156.96 102.33 1.93 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.675 -0.64 . . . . 0.0 110.048 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.97 -39.98 66.09 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 O-C-N 123.138 1.073 . . . . 0.0 110.699 -175.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.39 -155.15 43.35 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -72.65 -48.97 0.28 Allowed 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.318 1.168 . . . . 0.0 110.813 -175.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -83.77 4.64 28.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.537 -0.727 . . . . 0.0 111.369 -175.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 t 54.12 61.22 3.15 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.908 -1.12 . . . . 0.0 110.664 -176.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.725 ' HA ' HG12 ' A' ' 176' ' ' VAL . 63.0 t80 -77.96 119.92 22.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.522 -0.736 . . . . 0.0 110.04 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -129.98 160.01 34.93 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.778 -0.576 . . . . 0.0 110.072 -176.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.2 t -124.55 146.34 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.789 -0.57 . . . . 0.0 109.754 177.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.3 p -155.12 162.96 40.86 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.325 0.583 . . . . 0.0 109.941 177.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.492 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 71.2 m-85 -126.74 125.2 41.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.74 -0.6 . . . . 0.0 109.762 -176.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -55.96 144.21 29.31 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.577 -0.702 . . . . 0.0 110.752 -173.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -97.01 134.08 40.84 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.703 -0.623 . . . . 0.0 110.38 -176.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 50.8 m -126.01 151.77 46.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.637 -0.665 . . . . 0.0 110.162 178.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 43.4 m -60.43 159.61 10.03 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.533 -0.729 . . . . 0.0 110.137 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.8 p -64.13 84.65 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.624 -0.673 . . . . 0.0 110.206 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.11 155.24 19.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.751 -0.593 . . . . 0.0 110.198 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -80.74 149.01 29.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.682 -0.636 . . . . 0.0 110.078 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 41.4 t 52.71 35.25 17.95 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.344 -0.847 . . . . 0.0 111.018 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.04 132.92 55.37 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.621 -0.674 . . . . 0.0 110.205 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.429 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 65.2 p -60.13 -34.02 72.95 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.742 -0.599 . . . . 0.0 109.967 175.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.441 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -171.33 143.48 1.86 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.399 0.618 . . . . 0.0 110.406 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 13.4 t -142.16 142.68 32.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.899 -0.5 . . . . 0.0 109.892 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.492 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 62.3 t80 -125.56 140.03 53.09 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.399 -0.813 . . . . 0.0 110.646 -171.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.8 t -110.38 124.92 52.61 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.878 176.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 54.6 m -70.84 -37.0 73.12 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.838 -0.539 . . . . 0.0 110.414 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -59.36 -33.9 71.73 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.652 -0.655 . . . . 0.0 110.47 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.0 mt -104.79 -12.02 16.51 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.691 -0.631 . . . . 0.0 110.838 -175.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt 59.69 49.27 8.39 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.076 -1.015 . . . . 0.0 109.699 177.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.445 ' HE3' ' CZ ' ' A' ' 163' ' ' TYR . 34.2 ttpt -147.15 153.26 39.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.714 -0.616 . . . . 0.0 110.563 -173.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.656 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.5 tp -126.44 138.06 53.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.686 -0.633 . . . . 0.0 110.315 -173.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.445 ' CZ ' ' HE3' ' A' ' 161' ' ' LYS . 54.0 m-85 -114.72 133.75 55.64 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.36 158.46 44.24 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.65 -0.656 . . . . 0.0 110.824 -175.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.405 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 33.7 mt-30 -104.62 141.9 35.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.595 -0.691 . . . . 0.0 110.275 172.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.426 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 16.6 tt -51.42 147.38 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 CA-C-O 121.624 0.726 . . . . 0.0 111.989 -174.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.26 10.06 5.3 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.521 -0.737 . . . . 0.0 112.534 176.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.405 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 30.5 mmtm -96.28 155.04 16.93 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.899 -1.126 . . . . 0.0 110.838 175.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 86.5 m -84.37 126.22 33.02 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.707 -0.621 . . . . 0.0 110.525 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . 0.656 ' SG ' HD21 ' A' ' 162' ' ' LEU . 44.0 t -115.22 90.19 23.37 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.62 -0.675 . . . . 0.0 110.199 174.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.441 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 23.1 Cg_exo -61.85 130.75 32.27 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 O-C-N 123.278 1.146 . . . . 0.0 110.677 173.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.412 HG12 ' CE2' ' A' ' 142' ' ' PHE . 93.2 mt -124.97 142.16 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.626 -0.671 . . . . 0.0 109.219 175.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -107.93 136.3 47.87 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.475 -0.766 . . . . 0.0 110.826 -174.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.415 ' CG2' ' CE1' ' A' ' 138' ' ' PHE . 48.6 mm -95.22 135.07 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.757 -0.589 . . . . 0.0 109.691 169.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -118.09 128.99 55.27 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.415 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.725 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.3 m -136.24 159.82 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.63 -0.669 . . . . 0.0 109.979 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 81.2 mmm -77.75 -40.49 40.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.713 -0.617 . . . . 0.0 110.085 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.1 p -135.21 143.27 44.97 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.797 -0.564 . . . . 0.0 109.788 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 33.3 Cg_exo -55.57 139.8 82.96 Favored 'Trans proline' 0 N--CA 1.489 1.264 0 O-C-N 123.245 1.129 . . . . 0.0 110.871 -172.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.694 ' HB3' HD21 ' A' ' 288' ' ' LEU . 23.8 Cg_endo -64.47 169.38 11.23 Favored 'Trans proline' 0 N--CA 1.488 1.151 0 O-C-N 123.181 1.095 . . . . 0.0 110.704 178.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -61.19 158.26 35.87 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 O-C-N 123.321 1.169 . . . . 0.0 110.469 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -78.7 138.18 38.15 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.602 -0.686 . . . . 0.0 109.969 175.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.5 -24.84 30.6 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -174.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.2 151.09 2.17 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.35 -1.088 . . . . 0.0 111.322 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.7 155.95 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.727 -0.608 . . . . 0.0 109.762 176.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.65 HD11 ' CD2' ' A' ' 251' ' ' TYR . 66.5 mt -108.13 137.0 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.72 ' HG2' HD22 ' A' ' 248' ' ' LEU . 37.8 mtp180 -114.87 146.79 40.72 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -175.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.68 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -140.85 126.07 18.54 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.483 -0.761 . . . . 0.0 110.4 171.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 48.5 ttp -137.33 140.69 31.49 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.775 -0.578 . . . . 0.0 111.052 -176.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.651 ' HD3' HD12 ' A' ' 226' ' ' ILE . 74.0 Cg_endo -89.85 138.25 2.95 Favored 'Trans proline' 0 C--N 1.32 -0.96 0 O-C-N 123.24 1.126 . . . . 0.0 110.843 177.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.413 HG13 ' C ' ' A' ' 190' ' ' PRO . 34.7 m -146.39 154.82 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.547 -0.721 . . . . 0.0 110.085 173.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.653 ' HA ' HG22 ' A' ' 282' ' ' ILE . 88.3 m-85 -62.92 162.9 10.46 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.522 -0.736 . . . . 0.0 110.468 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.413 ' HA ' HD12 ' A' ' 283' ' ' LEU . 47.7 tttm -78.93 -60.04 2.54 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.659 -0.65 . . . . 0.0 110.815 -175.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 38.9 mttp -80.1 150.77 30.16 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.62 -0.675 . . . . 0.0 110.34 -175.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.456 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.52 -37.69 70.8 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.371 -0.831 . . . . 0.0 110.728 -176.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -56.44 -24.83 48.0 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.536 -0.727 . . . . 0.0 110.642 -176.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.42 ' HB3' ' CG ' ' A' ' 192' ' ' TYR . 77.7 m80 -110.09 -20.51 12.67 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.174 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.456 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.1 p -67.07 -20.28 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.15 -0.969 . . . . 0.0 110.544 -176.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.517 HG22 HD11 ' A' ' 126' ' ' ILE . 71.9 p -79.29 -16.99 55.52 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.491 -0.756 . . . . 0.0 110.651 175.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -88.34 137.19 32.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.34 -0.85 . . . . 0.0 110.041 172.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.3 t -73.1 141.58 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.645 -0.659 . . . . 0.0 110.248 177.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.554 HG22 ' CE2' ' A' ' 192' ' ' TYR . 64.7 t -84.93 137.8 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.618 -0.676 . . . . 0.0 109.405 171.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 12.1 pttt -134.92 -170.29 2.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.543 -0.723 . . . . 0.0 111.035 -171.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 83.5 mtm-85 -95.26 158.7 15.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.781 -0.575 . . . . 0.0 110.34 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 56.5 m -75.81 157.42 83.84 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.679 -0.638 . . . . 0.0 109.513 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -63.34 -47.33 7.97 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.247 1.13 . . . . 0.0 109.99 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.443 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.4 p-10 -65.41 -43.96 88.95 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.579 -0.701 . . . . 0.0 111.159 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . 0.443 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 54.9 m170 -81.12 -27.87 35.37 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.423 -0.798 . . . . 0.0 111.196 -175.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -69.16 -39.82 78.53 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.374 -0.829 . . . . 0.0 110.21 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 26.6 tp -58.12 -34.79 70.61 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.66 -0.65 . . . . 0.0 110.697 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 29.0 t -48.46 143.98 4.48 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.481 -0.762 . . . . 0.0 111.347 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.437 ' HD3' ' CE1' ' A' ' 214' ' ' PHE . 53.8 ttt85 -61.92 139.8 58.35 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.654 -0.654 . . . . 0.0 110.023 -176.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -63.04 -32.49 73.87 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.751 -0.593 . . . . 0.0 110.589 -176.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.437 ' CE1' ' HD3' ' A' ' 212' ' ' ARG . 60.6 m-85 52.05 47.9 23.82 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.553 -0.717 . . . . 0.0 110.836 -175.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -74.0 -10.13 59.33 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.796 -0.565 . . . . 0.0 111.313 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -58.53 113.86 2.19 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.17 -0.956 . . . . 0.0 110.766 -177.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 75.16 20.04 79.39 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 173.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -114.79 139.89 49.36 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.307 -1.114 . . . . 0.0 110.522 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.7 mt -85.66 -25.05 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.712 -0.618 . . . . 0.0 110.466 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.779 ' HB1' ' HB3' ' A' ' 227' ' ' ARG . . . -124.95 96.09 40.83 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.439 -0.788 . . . . 0.0 110.371 -173.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.429 ' HD2' ' CE2' ' A' ' 236' ' ' TYR . 15.3 Cg_exo -65.11 140.13 63.94 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.326 1.172 . . . . 0.0 110.621 -177.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -60.87 -17.33 50.2 Favored 'Trans proline' 0 N--CA 1.488 1.172 0 O-C-N 123.043 1.023 . . . . 0.0 111.325 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 30.2 m -51.81 -24.08 5.57 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.159 -0.963 . . . . 0.0 111.29 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . 0.491 ' CD2' ' CG ' ' A' ' 236' ' ' TYR . 97.6 m-70 -103.02 132.65 49.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.448 -0.783 . . . . 0.0 110.286 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.41 ' HA ' ' CG ' ' A' ' 268' ' ' MET . 54.0 tp -59.83 -40.33 88.12 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.558 -0.714 . . . . 0.0 110.283 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.651 HD12 ' HD3' ' A' ' 190' ' ' PRO . 82.6 mt -104.06 136.75 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.843 -0.536 . . . . 0.0 109.685 175.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.779 ' HB3' ' HB1' ' A' ' 220' ' ' ALA . 79.3 mtm180 -134.16 158.81 42.72 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.714 -0.616 . . . . 0.0 110.389 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.642 HG23 HG21 ' A' ' 247' ' ' VAL . 83.9 t -103.85 146.72 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.66 -0.65 . . . . 0.0 110.099 177.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -117.27 128.13 54.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.817 -0.552 . . . . 0.0 110.368 171.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.05 22.96 23.92 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 167.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -135.24 106.42 6.72 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.394 -1.062 . . . . 0.0 110.09 173.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 27.6 t -62.93 -15.12 54.3 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.649 -0.657 . . . . 0.0 111.24 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -100.13 5.02 44.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.198 -0.939 . . . . 0.0 111.61 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.4 131.16 49.33 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.039 -1.038 . . . . 0.0 110.276 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -139.76 157.74 45.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.782 -0.574 . . . . 0.0 109.62 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.491 ' CG ' ' CD2' ' A' ' 224' ' ' HIS . 93.1 m-85 -115.72 150.63 36.52 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.592 -0.693 . . . . 0.0 110.497 -177.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.14 159.98 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.759 -0.588 . . . . 0.0 110.263 177.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -116.53 129.95 56.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.804 -0.56 . . . . 0.0 110.003 174.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -63.31 117.45 33.98 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.649 -0.657 . . . . 0.0 109.76 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.84 -27.18 80.09 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.096 1.051 . . . . 0.0 110.878 -172.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 84.2 mt -101.85 -50.34 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.439 -0.788 . . . . 0.0 110.907 -170.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.407 HG22 ' HB3' ' A' ' 124' ' ' PRO . 7.5 p -105.37 12.25 31.84 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.431 -0.793 . . . . 0.0 111.987 -172.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 81.25 -25.06 3.82 Favored Glycine 0 N--CA 1.498 2.787 0 O-C-N 121.006 -1.059 . . . . 0.0 111.868 170.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -45.71 142.09 2.61 Favored 'General case' 0 N--CA 1.505 2.285 0 CA-C-N 118.641 1.22 . . . . 0.0 112.726 -166.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -97.8 145.17 26.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.583 -0.698 . . . . 0.0 109.838 171.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 77.5 p -154.8 159.91 40.92 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.528 -0.732 . . . . 0.0 110.588 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.642 HG21 HG23 ' A' ' 228' ' ' VAL . 8.2 p -123.23 148.03 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.722 -0.611 . . . . 0.0 109.72 176.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.72 HD22 ' HG2' ' A' ' 187' ' ' ARG . 79.2 mt -129.78 154.76 46.9 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.833 -175.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.437 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.8 m -150.44 151.78 31.69 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.843 -0.536 . . . . 0.0 109.898 175.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -71.11 138.99 34.69 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 O-C-N 123.24 1.126 . . . . 0.0 109.923 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.65 ' CD2' HD11 ' A' ' 186' ' ' ILE . 9.9 t80 -80.05 123.43 27.84 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.543 -0.723 . . . . 0.0 110.188 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -99.99 160.1 28.1 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.717 -0.614 . . . . 0.0 110.07 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -58.83 160.1 19.03 Favored 'Trans proline' 0 N--CA 1.487 1.12 0 O-C-N 123.228 1.12 . . . . 0.0 110.414 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -58.67 149.91 73.55 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 O-C-N 123.171 1.09 . . . . 0.0 110.567 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -62.46 146.94 50.21 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.693 -0.629 . . . . 0.0 110.261 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.9 127.26 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.496 -0.752 . . . . 0.0 110.232 -171.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.65 -10.08 55.86 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 7.3 t -143.84 166.46 24.86 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.165 -1.197 . . . . 0.0 110.6 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -101.87 13.07 35.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.717 -0.615 . . . . 0.0 111.846 -168.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -127.57 168.13 15.4 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.098 -1.001 . . . . 0.0 111.126 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 83.2 m -117.67 147.31 43.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.701 -0.624 . . . . 0.0 109.912 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 31.1 m -116.32 135.9 53.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.592 -0.693 . . . . 0.0 110.922 -174.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.5 t -128.57 137.21 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 171.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 70.2 mt -104.74 119.84 39.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.457 -0.777 . . . . 0.0 109.849 -172.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.68 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 6.1 m-30 -105.97 151.3 24.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.683 -0.636 . . . . 0.0 110.639 -176.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -136.63 142.98 43.28 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -114.07 130.6 56.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.513 -0.742 . . . . 0.0 110.407 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' MET . . . . . 0.41 ' CG ' ' HA ' ' A' ' 225' ' ' LEU . 5.0 ppp? -99.12 1.4 45.04 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.708 -0.62 . . . . 0.0 111.963 -176.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -144.72 158.51 43.75 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.109 -0.994 . . . . 0.0 109.928 173.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.597 ' HA ' HD13 ' A' ' 305' ' ' ILE . 27.4 p30 -113.97 154.26 27.92 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.666 -0.646 . . . . 0.0 110.073 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . 0.437 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 90.7 p -56.6 -26.97 57.0 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.373 -0.829 . . . . 0.0 111.096 -167.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 46.7 p -95.19 6.97 47.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.401 -0.812 . . . . 0.0 112.146 -165.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 29.0 p -92.95 118.08 30.76 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.029 -1.044 . . . . 0.0 110.675 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.8 t -69.84 142.75 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.556 -0.715 . . . . 0.0 110.531 -168.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.4 -5.26 58.75 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.14 -95.45 0.74 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 169.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . 0.437 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 95.3 mmm -64.7 -28.15 69.4 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.746 -0.855 . . . . 0.0 110.277 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 10.0 p30 44.73 50.92 8.51 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 172.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 54.76 34.12 21.08 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.375 -0.828 . . . . 0.0 111.316 174.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . 0.45 ' O ' HG23 ' A' ' 282' ' ' ILE . 88.7 mtt180 -115.94 104.93 52.03 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.548 -0.72 . . . . 0.0 110.141 172.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 280' ' ' ARG . 12.3 Cg_endo -60.26 145.03 99.43 Favored 'Trans proline' 0 N--CA 1.489 1.264 0 O-C-N 123.139 1.073 . . . . 0.0 110.374 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.653 HG22 ' HA ' ' A' ' 192' ' ' TYR . 42.8 pt -132.57 178.45 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 122.029 0.919 . . . . 0.0 111.373 -174.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 302' ' ' GLU . 34.5 mt -124.3 149.86 46.06 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.694 HD12 ' CE1' ' A' ' 301' ' ' PHE . 79.4 mt -112.24 128.71 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.646 HG23 ' SG ' ' A' ' 300' ' ' CYS . 77.8 mt -109.68 125.67 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -175.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 58.5 t -118.87 126.65 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.4 p -125.35 154.81 41.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.661 -0.649 . . . . 0.0 110.567 -174.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.694 HD21 ' HB3' ' A' ' 180' ' ' PRO . 24.4 tp -105.59 125.85 51.47 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 169.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.648 ' OE2' HG13 ' A' ' 295' ' ' VAL . 71.6 mm-40 -132.04 149.5 52.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.858 -0.526 . . . . 0.0 109.911 -173.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.823 ' CG2' HD11 ' A' ' 296' ' ' LEU . 25.4 p -89.98 161.28 15.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.703 -0.623 . . . . 0.0 110.031 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 69.7 ttp85 -55.94 -26.13 46.51 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.566 -0.708 . . . . 0.0 111.139 -175.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 44.7 p30 -90.87 9.82 28.82 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.444 -0.785 . . . . 0.0 111.963 -173.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.55 20.23 45.38 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.15 -1.024 . . . . 0.0 110.732 171.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -107.52 140.23 40.81 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.33 -1.1 . . . . 0.0 109.988 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.648 HG13 ' OE2' ' A' ' 289' ' ' GLU . 62.1 t -90.28 132.0 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.572 -0.705 . . . . 0.0 110.236 -172.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.823 HD11 ' CG2' ' A' ' 290' ' ' THR . 96.0 mt -99.84 -40.29 7.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.767 -0.583 . . . . 0.0 110.545 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -162.05 153.17 23.78 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -135.06 135.19 41.09 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.598 -0.942 . . . . 0.0 110.521 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -138.03 156.0 48.25 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.611 -0.681 . . . . 0.0 110.028 172.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . 0.646 ' SG ' HG23 ' A' ' 285' ' ' ILE . 98.3 m -143.23 155.7 44.57 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.379 -0.826 . . . . 0.0 110.844 -175.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.694 ' CE1' HD12 ' A' ' 284' ' ' ILE . 47.8 p90 -145.3 162.62 36.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.643 -0.661 . . . . 0.0 110.156 174.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.489 ' HA ' HD23 ' A' ' 283' ' ' LEU . 81.4 tt0 -104.77 137.34 42.71 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.591 -0.693 . . . . 0.0 110.219 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -118.94 144.66 46.32 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.766 -170.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -136.99 138.51 40.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.799 -0.563 . . . . 0.0 109.725 173.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.597 HD13 ' HA ' ' A' ' 270' ' ' ASN . 61.6 mt -112.02 122.86 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.572 -0.705 . . . . 0.0 109.63 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.1 p -145.42 173.73 11.75 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.589 -0.695 . . . . 0.0 110.683 -171.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -74.17 -40.12 62.77 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.573 -0.704 . . . . 0.0 110.639 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.8 t -127.25 86.86 57.75 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.494 -0.754 . . . . 0.0 110.475 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -55.81 -28.65 68.43 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.117 1.062 . . . . 0.0 110.768 174.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.88 -37.45 92.23 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -73.38 -41.05 63.86 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.643 -0.916 . . . . 0.0 109.889 -173.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -69.41 -40.33 77.38 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 120.076 -0.649 . . . . 0.0 110.153 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -61.28 -44.19 97.65 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.482 -0.762 . . . . 0.0 110.258 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 23.6 ttpt -63.73 -39.63 94.77 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.641 -0.662 . . . . 0.0 110.432 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.86 -51.9 66.34 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.517 -0.74 . . . . 0.0 110.396 -173.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -61.53 -37.74 84.86 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.437 -0.789 . . . . 0.0 110.15 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -65.29 -39.9 93.14 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.272 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -62.46 -35.13 78.33 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.537 -0.727 . . . . 0.0 110.021 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 22.9 t -62.75 -34.32 76.98 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.632 -0.667 . . . . 0.0 110.171 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.487 HG22 HE21 ' A' ' 324' ' ' GLN . 79.9 mt -79.61 -42.66 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.696 -0.627 . . . . 0.0 109.95 -178.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -58.56 -38.83 78.68 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.639 -0.663 . . . . 0.0 110.522 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 37.4 tttp -59.19 -41.44 88.5 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.555 -0.715 . . . . 0.0 110.286 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -62.73 -33.25 74.75 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.634 -0.666 . . . . 0.0 110.067 176.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.487 HE21 HG22 ' A' ' 320' ' ' ILE . 47.5 mt-30 -92.31 125.13 36.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.738 -0.601 . . . . 0.0 110.388 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 62.3 t -103.3 130.11 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.648 -0.657 . . . . 0.0 109.858 178.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 28.7 t -94.95 140.07 30.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.61 -0.681 . . . . 0.0 110.277 -177.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -82.77 120.61 25.84 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.687 -0.633 . . . . 0.0 110.301 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 29.6 t -94.03 152.62 18.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.619 -0.676 . . . . 0.0 110.158 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 71.7 p -90.27 -25.83 20.34 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.646 -0.659 . . . . 0.0 110.226 -178.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -61.27 -36.22 79.43 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.451 -0.781 . . . . 0.0 110.096 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -112.78 142.36 45.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.718 -0.614 . . . . 0.0 110.078 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -58.89 -37.91 91.65 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -178.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 59.41 79.98 0.21 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.564 -0.962 . . . . 0.0 110.224 175.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.76 ' HB3' ' CZ ' ' A' ' 336' ' ' ARG . . . -79.91 121.72 25.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.531 -0.73 . . . . 0.0 110.123 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -63.38 -35.66 81.14 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.654 -0.654 . . . . 0.0 110.215 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.76 ' CZ ' ' HB3' ' A' ' 334' ' ' ALA . 77.1 mtt85 51.97 178.15 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.478 -0.763 . . . . 0.0 111.019 -177.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -60.31 -36.42 77.87 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.573 -0.704 . . . . 0.0 110.328 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 54.5 t30 53.29 45.7 27.95 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.486 -0.759 . . . . 0.0 110.928 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 73.3 p -65.06 -33.54 76.29 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.63 -0.669 . . . . 0.0 110.119 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -131.15 127.64 38.45 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.677 -0.64 . . . . 0.0 110.222 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . 0.432 ' C ' HG23 ' A' ' 342' ' ' ILE . . . -87.17 176.91 47.35 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.433 HD12 ' SD ' ' A' ' 344' ' ' MET . 45.3 pt -147.36 158.92 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.624 -0.927 . . . . 0.0 110.209 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -90.57 5.39 48.07 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.729 -0.607 . . . . 0.0 111.322 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . 0.433 ' SD ' HD12 ' A' ' 342' ' ' ILE . 64.7 mtt -61.05 -35.25 76.43 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.118 -0.989 . . . . 0.0 110.241 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 7.4 t . . . . . 0 N--CA 1.495 1.8 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.305 -179.823 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 60.3 p -84.3 160.28 20.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.631 -0.923 . . . . 0.0 110.282 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 46.8 m -63.96 153.65 36.46 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.678 -0.639 . . . . 0.0 110.218 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 44.9 m -60.32 -37.61 81.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.629 -0.669 . . . . 0.0 110.342 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.452 ' CD2' HD22 ' A' ' 120' ' ' LEU . 99.0 m-85 -117.62 154.45 31.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.649 -0.657 . . . . 0.0 110.283 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -85.38 123.33 30.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.757 -0.59 . . . . 0.0 110.412 -178.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 53.16 43.24 31.85 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.452 -0.78 . . . . 0.0 111.043 177.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.452 HD22 ' CD2' ' A' ' 117' ' ' PHE . 21.8 tp -85.36 134.48 34.09 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.594 -0.691 . . . . 0.0 110.191 177.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.64 178.69 0.25 Allowed Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.696 -0.628 . . . . 0.0 110.088 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -64.08 151.54 72.57 Favored 'Cis proline' 0 N--CA 1.496 1.654 0 C-N-CA 123.303 -1.54 . . . . 0.0 110.501 -12.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 57.5 p -81.46 153.0 70.9 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.655 -0.653 . . . . 0.0 110.298 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -59.57 153.84 52.4 Favored 'Trans proline' 0 N--CA 1.488 1.187 0 O-C-N 123.338 1.178 . . . . 0.0 110.5 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.31 150.03 40.37 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.696 -0.628 . . . . 0.0 110.097 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.477 HD11 HG22 ' A' ' 199' ' ' THR . 50.0 mm -119.9 140.39 29.62 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.643 -0.661 . . . . 0.0 109.955 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -62.2 153.62 68.56 Favored 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.164 1.086 . . . . 0.0 110.362 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.6 t -107.27 144.89 33.43 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.605 -0.684 . . . . 0.0 110.156 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.6 p-10 -93.91 22.5 5.63 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.644 -0.66 . . . . 0.0 110.877 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 52.0 m -79.14 125.18 29.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.466 -0.771 . . . . 0.0 110.177 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -68.78 144.95 54.18 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.585 -0.697 . . . . 0.0 110.444 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.411 ' CE2' ' HA2' ' A' ' 134' ' ' GLY . 61.1 t80 -156.54 101.2 2.03 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.727 -0.608 . . . . 0.0 110.098 178.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.65 -39.89 78.48 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 O-C-N 123.126 1.066 . . . . 0.0 110.857 -175.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.411 ' HA2' ' CE2' ' A' ' 132' ' ' TYR . . . 79.3 -155.16 39.66 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -72.88 -48.33 0.29 Allowed 'Trans proline' 0 N--CA 1.486 1.079 0 O-C-N 123.402 1.212 . . . . 0.0 110.983 -174.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -86.47 8.36 22.19 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.614 -0.679 . . . . 0.0 111.351 -174.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.8 58.3 5.23 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.983 -1.073 . . . . 0.0 110.6 -176.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.729 ' HA ' HG12 ' A' ' 176' ' ' VAL . 71.7 t80 -79.38 115.81 19.25 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.604 -0.685 . . . . 0.0 109.877 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -130.05 160.04 34.9 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.28 0.562 . . . . 0.0 110.41 -174.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.451 HG22 ' CD1' ' A' ' 174' ' ' ILE . 78.8 t -122.01 150.32 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.831 -0.543 . . . . 0.0 109.807 174.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 78.2 p -154.91 169.21 24.58 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.012 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.494 ' CD2' ' CE2' ' A' ' 155' ' ' TYR . 97.3 m-85 -126.63 125.26 41.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.884 -0.51 . . . . 0.0 109.938 -176.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -57.56 144.45 37.18 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.663 -0.648 . . . . 0.0 110.415 -177.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -94.69 140.99 29.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.658 -0.651 . . . . 0.0 110.579 -174.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 28.1 t -141.74 152.21 43.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.681 -0.637 . . . . 0.0 110.137 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 54.0 p -62.81 163.76 8.94 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.671 -0.643 . . . . 0.0 110.07 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.2 p -72.74 63.95 0.64 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.649 -0.657 . . . . 0.0 110.097 -178.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.58 150.07 49.03 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.617 -0.677 . . . . 0.0 110.186 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.8 tptm -65.1 140.31 58.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.725 -0.61 . . . . 0.0 110.164 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.4 p 51.2 48.09 23.66 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.579 -0.701 . . . . 0.0 111.216 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.44 137.18 57.29 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.689 -0.632 . . . . 0.0 110.182 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.463 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 77.8 p -60.05 -32.21 70.71 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.653 -0.655 . . . . 0.0 109.922 174.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.463 ' HD1' ' HG1' ' A' ' 152' ' ' THR . 68.7 p-90 -171.46 143.78 1.84 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.403 0.621 . . . . 0.0 110.132 178.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.3 t -142.1 142.56 32.81 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.863 -0.523 . . . . 0.0 109.916 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.494 ' CE2' ' CD2' ' A' ' 142' ' ' PHE . 62.6 t80 -125.56 140.01 53.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.533 -0.729 . . . . 0.0 110.673 -172.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.5 t -111.3 124.01 51.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.829 -0.545 . . . . 0.0 109.775 175.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 62.0 m -70.88 -37.09 73.02 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.819 -0.55 . . . . 0.0 110.359 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -59.09 -33.05 70.37 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.555 -0.716 . . . . 0.0 110.447 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.523 HD11 ' OD1' ' A' ' 316' ' ' ASP . 55.1 mt -104.8 -12.03 16.5 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.77 -176.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt 59.76 47.76 9.96 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.039 -1.038 . . . . 0.0 109.728 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.423 ' HE3' ' CZ ' ' A' ' 163' ' ' TYR . 20.7 ttpt -148.21 153.23 38.48 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 120.161 -0.615 . . . . 0.0 110.803 -173.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.588 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.5 tp -126.49 137.93 53.44 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.731 -0.605 . . . . 0.0 110.437 -173.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.423 ' CZ ' ' HE3' ' A' ' 161' ' ' LYS . 98.7 m-85 -114.85 134.38 55.19 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.9 p -138.39 158.44 44.28 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.61 -0.681 . . . . 0.0 111.194 -176.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.424 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 59.0 mt-30 -104.47 142.18 35.06 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.663 -0.648 . . . . 0.0 110.336 173.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.431 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 18.0 tt -55.04 148.22 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.548 -0.72 . . . . 0.0 111.613 -173.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.37 10.01 5.36 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.544 -0.723 . . . . 0.0 112.511 177.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.424 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 73.5 mmtt -97.09 155.08 16.96 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.984 -1.073 . . . . 0.0 110.773 174.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 74.5 m -80.16 126.04 30.59 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.674 -0.641 . . . . 0.0 110.573 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . 0.588 ' SG ' HD21 ' A' ' 162' ' ' LEU . 31.4 t -117.1 90.37 33.21 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.625 -0.672 . . . . 0.0 110.182 174.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.426 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 26.1 Cg_endo -66.97 128.25 18.38 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 O-C-N 123.337 1.177 . . . . 0.0 110.756 176.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.65 HD12 ' CD2' ' A' ' 265' ' ' TYR . 83.7 mt -122.51 141.64 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.675 -0.641 . . . . 0.0 109.362 172.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -109.48 136.95 48.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.54 -0.725 . . . . 0.0 110.755 -173.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.671 HG21 ' CE1' ' A' ' 138' ' ' PHE . 50.4 mm -95.24 135.01 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.779 -0.576 . . . . 0.0 109.744 172.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 17.0 tptp -117.57 130.81 56.64 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.606 -0.684 . . . . 0.0 110.492 176.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.729 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.6 m -136.34 159.76 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.579 -0.701 . . . . 0.0 110.04 174.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 79.8 mmm -77.63 -39.79 44.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.724 -0.61 . . . . 0.0 110.029 176.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.3 p -135.66 143.24 44.0 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.831 -0.543 . . . . 0.0 109.709 177.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.9 Cg_exo -55.63 139.86 83.33 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 O-C-N 123.146 1.077 . . . . 0.0 110.821 -173.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.647 ' HB3' HD21 ' A' ' 288' ' ' LEU . 26.6 Cg_endo -65.19 169.61 11.94 Favored 'Trans proline' 0 N--CA 1.487 1.115 0 O-C-N 123.165 1.087 . . . . 0.0 110.684 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -61.27 156.7 44.17 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 O-C-N 123.37 1.195 . . . . 0.0 110.46 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -77.53 140.24 39.71 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.616 -0.677 . . . . 0.0 109.913 175.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.79 -24.91 29.62 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -175.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.16 151.64 1.97 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.363 -1.081 . . . . 0.0 111.319 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 33.8 m -129.77 155.89 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.766 -0.584 . . . . 0.0 109.597 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.634 HD11 ' CD2' ' A' ' 251' ' ' TYR . 79.3 mt -107.25 136.6 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.712 ' HG2' HD22 ' A' ' 248' ' ' LEU . 73.3 mtp180 -114.79 142.82 46.03 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -175.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -140.69 123.46 16.26 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.486 -0.759 . . . . 0.0 110.501 177.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 30.7 ttp -137.43 139.01 26.21 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.76 -0.587 . . . . 0.0 110.969 -175.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.746 ' HD3' HD12 ' A' ' 226' ' ' ILE . 72.7 Cg_endo -90.62 138.18 2.53 Favored 'Trans proline' 0 C--N 1.318 -1.03 0 O-C-N 123.246 1.13 . . . . 0.0 110.418 176.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.563 ' HB ' HG23 ' A' ' 198' ' ' VAL . 34.6 m -146.47 154.81 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.596 -0.69 . . . . 0.0 110.196 175.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.582 ' HA ' HG22 ' A' ' 282' ' ' ILE . 89.1 m-85 -59.82 160.35 7.73 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.495 -0.753 . . . . 0.0 110.495 178.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.442 ' HA ' HD12 ' A' ' 283' ' ' LEU . 34.1 tttt -74.04 -59.45 2.72 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.598 -0.688 . . . . 0.0 110.729 -175.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -80.01 148.78 30.98 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.57 -0.706 . . . . 0.0 110.398 -174.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.451 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.86 -38.11 72.26 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.355 -0.84 . . . . 0.0 110.695 -175.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -56.41 -24.94 48.34 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.441 -0.787 . . . . 0.0 110.629 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.404 ' O ' ' CD1' ' A' ' 192' ' ' TYR . 94.3 m-70 -109.99 -20.51 12.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.597 -0.69 . . . . 0.0 111.188 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.563 HG23 ' HB ' ' A' ' 191' ' ' VAL . 3.2 p -67.25 -20.09 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.272 -0.892 . . . . 0.0 110.598 -176.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.477 HG22 HD11 ' A' ' 126' ' ' ILE . 69.2 p -79.27 -16.11 56.94 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.558 -0.714 . . . . 0.0 110.714 175.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -88.2 137.59 32.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.915 . . . . 0.0 110.049 172.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.7 t -73.01 142.36 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.606 -0.684 . . . . 0.0 110.25 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.477 HG22 ' CE1' ' A' ' 192' ' ' TYR . 77.0 t -84.81 139.11 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.514 -0.741 . . . . 0.0 109.339 170.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 14.1 pttt -134.81 -170.05 2.48 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.406 -0.809 . . . . 0.0 111.205 -165.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -95.13 154.4 17.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.783 -0.573 . . . . 0.0 110.62 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 61.0 m -76.17 160.94 76.94 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.668 -0.645 . . . . 0.0 109.303 172.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -64.21 -47.33 6.36 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 O-C-N 123.217 1.114 . . . . 0.0 109.811 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.445 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.7 p-10 -65.47 -44.44 87.14 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.641 -0.662 . . . . 0.0 111.318 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . 0.445 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 55.4 m170 -80.71 -27.85 36.82 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.391 -0.818 . . . . 0.0 111.41 -174.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -69.02 -42.11 76.82 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.385 -0.822 . . . . 0.0 110.175 173.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 23.9 tp -69.7 -30.33 67.95 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.694 -0.629 . . . . 0.0 110.5 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.8 t -48.39 -36.46 14.69 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.682 -0.636 . . . . 0.0 111.843 -175.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -126.86 139.08 53.35 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.547 -0.721 . . . . 0.0 110.411 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -140.42 -177.18 4.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.673 -0.642 . . . . 0.0 110.114 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 54.07 75.13 0.29 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.422 -0.799 . . . . 0.0 110.848 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -64.76 -10.34 26.9 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.642 -0.661 . . . . 0.0 111.345 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -58.65 121.78 11.86 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.07 -1.019 . . . . 0.0 110.362 174.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 94.89 1.51 63.27 Favored Glycine 0 N--CA 1.492 2.413 0 C-N-CA 120.414 -0.898 . . . . 0.0 110.977 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -114.7 140.1 49.13 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.088 -1.242 . . . . 0.0 110.392 178.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.6 mt -85.0 -25.11 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.607 -0.683 . . . . 0.0 110.446 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.571 ' HB1' ' HD2' ' A' ' 227' ' ' ARG . . . -125.03 95.41 41.98 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.414 -0.804 . . . . 0.0 110.311 -177.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.452 ' HD2' ' CE1' ' A' ' 236' ' ' TYR . 17.1 Cg_exo -63.42 136.96 57.62 Favored 'Trans proline' 0 C--N 1.316 -1.152 0 O-C-N 123.27 1.142 . . . . 0.0 110.365 -177.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.6 -21.88 48.94 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 O-C-N 123.064 1.034 . . . . 0.0 111.244 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 86.8 p -53.77 -22.89 10.34 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.412 -0.805 . . . . 0.0 111.226 -175.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . 0.485 ' CD2' ' CD2' ' A' ' 236' ' ' TYR . 88.9 m-70 -103.45 126.0 50.36 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.459 -0.776 . . . . 0.0 110.155 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.495 HD12 ' HG3' ' A' ' 268' ' ' MET . 32.2 tp -60.98 -36.26 78.96 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.675 -0.641 . . . . 0.0 110.166 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.746 HD12 ' HD3' ' A' ' 190' ' ' PRO . 83.6 mt -98.17 136.78 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-O 121.232 0.539 . . . . 0.0 109.896 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.571 ' HD2' ' HB1' ' A' ' 220' ' ' ALA . 77.0 mtm180 -131.14 159.38 37.85 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.735 -0.603 . . . . 0.0 110.084 175.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.574 HG23 HG21 ' A' ' 247' ' ' VAL . 73.7 t -105.62 146.68 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.425 0.631 . . . . 0.0 110.204 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -121.5 130.04 53.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.725 -0.609 . . . . 0.0 110.311 171.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 96.61 20.42 24.61 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 169.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -140.01 103.7 4.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.36 -1.082 . . . . 0.0 109.944 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 93.5 p -63.62 -15.21 57.59 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.657 -0.652 . . . . 0.0 111.15 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -97.43 9.86 41.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.29 -0.881 . . . . 0.0 111.17 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -62.07 132.71 53.77 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.235 -0.915 . . . . 0.0 110.102 176.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -139.65 157.96 44.9 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.691 -0.631 . . . . 0.0 109.826 177.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.485 ' CD2' ' CD2' ' A' ' 224' ' ' HIS . 87.0 m-85 -114.2 150.68 33.91 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.516 -0.74 . . . . 0.0 110.576 -177.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.18 159.92 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.73 -0.606 . . . . 0.0 110.124 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -119.76 130.06 54.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.741 -0.6 . . . . 0.0 110.209 176.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -63.44 130.07 94.04 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.65 -0.656 . . . . 0.0 109.792 177.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -64.77 -27.66 59.81 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 O-C-N 123.118 1.062 . . . . 0.0 111.045 -170.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.2 mt -101.4 -50.5 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.411 -0.806 . . . . 0.0 111.108 -167.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 75.7 p -105.46 12.18 31.74 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.315 -0.865 . . . . 0.0 111.881 -174.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.93 -4.97 14.35 Favored Glycine 0 N--CA 1.496 2.645 0 O-C-N 121.1 -1.0 . . . . 0.0 111.837 174.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.476 ' CZ ' HG12 ' A' ' 191' ' ' VAL . 12.6 mmt180 -45.99 142.09 2.86 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 119.088 1.444 . . . . 0.0 112.334 -173.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -102.74 142.27 34.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.662 -0.649 . . . . 0.0 110.294 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 77.3 p -154.8 159.93 40.93 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.642 -0.661 . . . . 0.0 110.301 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.574 HG21 HG23 ' A' ' 228' ' ' VAL . 8.3 p -122.96 148.16 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.708 -0.62 . . . . 0.0 109.754 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.712 HD22 ' HG2' ' A' ' 187' ' ' ARG . 79.7 mt -129.69 154.63 46.96 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.763 -174.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.44 HG13 ' C ' ' A' ' 248' ' ' LEU . 33.8 m -150.9 151.74 30.5 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.873 -0.517 . . . . 0.0 109.901 174.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -70.96 137.67 32.44 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 O-C-N 123.273 1.144 . . . . 0.0 109.92 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.634 ' CD2' HD11 ' A' ' 186' ' ' ILE . 11.7 t80 -77.9 122.85 26.04 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.552 -0.717 . . . . 0.0 110.183 179.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -100.01 160.01 28.32 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.753 -0.592 . . . . 0.0 110.15 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.92 160.02 19.57 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 123.233 1.123 . . . . 0.0 110.403 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -58.56 150.06 71.67 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 123.29 1.153 . . . . 0.0 110.666 -177.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -61.13 147.31 44.44 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.672 -0.643 . . . . 0.0 110.184 -177.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.81 127.2 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.485 -0.759 . . . . 0.0 110.167 -170.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.87 -10.13 55.54 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 10.2 t -144.31 174.2 11.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.177 -1.19 . . . . 0.0 110.614 175.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -108.18 13.14 26.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.603 -0.686 . . . . 0.0 111.854 -167.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -124.59 168.13 13.55 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.178 -0.951 . . . . 0.0 111.189 -176.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 94.2 m -117.79 145.95 44.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.737 -0.602 . . . . 0.0 109.862 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 44.4 m -116.57 136.29 53.1 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.535 -0.728 . . . . 0.0 110.937 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 60.1 t -127.05 137.08 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 60.2 mt -104.82 121.21 43.19 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.603 -0.685 . . . . 0.0 109.747 -173.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.65 ' CD2' HD12 ' A' ' 172' ' ' ILE . 3.4 m-85 -99.95 156.71 17.0 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.578 -0.701 . . . . 0.0 110.88 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -136.41 142.94 43.72 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 171.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -110.4 128.97 55.84 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.551 -0.718 . . . . 0.0 110.27 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' MET . . . . . 0.495 ' HG3' HD12 ' A' ' 225' ' ' LEU . 5.2 ppp? -95.29 -0.11 53.22 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.712 -0.618 . . . . 0.0 112.019 -177.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . 0.722 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.6 OUTLIER -144.77 165.06 29.15 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.158 -0.964 . . . . 0.0 110.076 176.111 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.497 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.5 p30 -121.98 163.48 19.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.69 -0.631 . . . . 0.0 110.593 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . 0.429 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 19.0 m -57.62 -34.15 69.0 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.414 -0.803 . . . . 0.0 111.136 -164.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 51.4 p -104.17 15.06 29.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.374 -0.829 . . . . 0.0 111.911 -163.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 29.7 p -95.77 118.07 31.73 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.079 -1.013 . . . . 0.0 110.712 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 58.0 t -63.16 138.93 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.477 -0.764 . . . . 0.0 110.253 -171.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.04 -5.18 59.27 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.11 -98.33 0.83 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 171.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . 0.429 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.2 mmm -63.17 -32.35 73.72 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.726 -0.867 . . . . 0.0 110.235 178.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.3 p30 44.21 48.84 7.79 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 174.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 54.76 30.27 13.27 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.377 -0.827 . . . . 0.0 111.306 174.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 15.4 mtt85 -119.45 107.04 41.58 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.59 -0.694 . . . . 0.0 110.08 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.58 148.0 89.29 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 O-C-N 123.127 1.067 . . . . 0.0 110.529 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.582 HG22 ' HA ' ' A' ' 192' ' ' TYR . 44.7 pt -131.9 177.52 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.709 0.766 . . . . 0.0 110.987 -176.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.478 HD23 ' HA ' ' A' ' 302' ' ' GLU . 34.3 mt -124.38 150.02 46.03 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 177.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.649 HD12 ' CE1' ' A' ' 301' ' ' PHE . 77.7 mt -112.65 128.29 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.562 -0.711 . . . . 0.0 109.089 176.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.505 HG23 ' SG ' ' A' ' 300' ' ' CYS . 81.3 mt -109.86 125.57 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -176.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 59.1 t -118.87 126.63 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.5 p -125.31 154.66 41.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.581 -0.699 . . . . 0.0 110.623 -175.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.647 HD21 ' HB3' ' A' ' 180' ' ' PRO . 22.8 tp -105.22 126.41 52.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.819 -0.551 . . . . 0.0 109.539 169.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.58 ' OE2' HG13 ' A' ' 295' ' ' VAL . 73.0 mm-40 -132.47 150.99 52.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.863 -0.523 . . . . 0.0 109.902 -174.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.749 HG22 HD11 ' A' ' 296' ' ' LEU . 68.6 p -89.89 159.47 16.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.619 -0.675 . . . . 0.0 109.648 177.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -55.86 -26.11 45.43 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.532 -0.73 . . . . 0.0 110.81 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -87.52 9.14 21.97 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.489 -0.757 . . . . 0.0 111.855 -174.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 87.22 20.26 53.05 Favored Glycine 0 N--CA 1.495 2.59 0 O-C-N 121.053 -1.03 . . . . 0.0 110.704 170.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -106.81 140.12 40.15 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.262 -1.14 . . . . 0.0 110.206 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.58 HG13 ' OE2' ' A' ' 289' ' ' GLU . 59.4 t -88.33 131.32 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.666 -0.646 . . . . 0.0 110.194 -173.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.749 HD11 HG22 ' A' ' 290' ' ' THR . 95.6 mt -99.91 -40.14 7.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.733 -0.604 . . . . 0.0 110.544 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -165.23 153.12 23.04 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -134.96 136.17 42.03 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.721 -0.87 . . . . 0.0 110.748 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -133.28 153.66 51.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.578 -0.701 . . . . 0.0 110.106 172.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . 0.505 ' SG ' HG23 ' A' ' 285' ' ' ILE . 99.8 m -142.76 151.63 41.46 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.486 -0.759 . . . . 0.0 110.659 -176.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.649 ' CE1' HD12 ' A' ' 284' ' ' ILE . 49.8 p90 -145.43 166.7 24.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.701 -0.625 . . . . 0.0 110.029 173.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.478 ' HA ' HD23 ' A' ' 283' ' ' LEU . 57.7 tt0 -104.78 136.1 44.93 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.449 -0.782 . . . . 0.0 110.277 -177.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -123.3 144.5 49.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.682 -0.636 . . . . 0.0 110.548 -170.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -137.66 137.87 38.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.844 -0.535 . . . . 0.0 109.796 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.722 HD13 ' O ' ' A' ' 269' ' ' CYS . 66.3 mt -106.34 123.0 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.581 -0.699 . . . . 0.0 109.556 175.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.0 p -145.17 167.28 23.15 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.56 -0.713 . . . . 0.0 110.89 -170.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -67.31 -40.1 85.96 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.675 -0.641 . . . . 0.0 110.616 -177.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 3.9 t -132.05 89.58 37.7 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.545 -0.722 . . . . 0.0 110.53 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -55.77 -29.04 69.95 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 O-C-N 123.23 1.121 . . . . 0.0 110.74 174.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.51 -37.94 93.02 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -72.56 -40.04 66.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.622 -0.928 . . . . 0.0 109.837 -173.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -69.51 -38.47 77.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.67 -0.644 . . . . 0.0 110.198 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -61.51 -43.21 99.28 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.228 178.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 14.5 ttpp -65.01 -38.73 91.88 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.586 -0.696 . . . . 0.0 110.419 176.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.22 -49.95 75.07 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.493 -0.755 . . . . 0.0 110.578 -173.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . 0.523 ' OD1' HD11 ' A' ' 159' ' ' LEU . 3.0 p30 -61.29 -37.69 84.1 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.463 -0.773 . . . . 0.0 110.113 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -61.58 -40.88 96.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.606 -0.684 . . . . 0.0 110.146 177.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -62.5 -35.17 78.54 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.586 -0.696 . . . . 0.0 109.956 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 23.8 m -62.09 -33.34 74.26 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.758 -0.589 . . . . 0.0 110.173 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 83.6 mt -77.42 -44.21 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.619 -0.675 . . . . 0.0 109.965 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.402 ' HA ' ' HG2' ' A' ' 324' ' ' GLN . 60.4 ttt180 -58.84 -39.58 81.69 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.575 -0.703 . . . . 0.0 110.492 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -61.05 -40.26 92.97 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.655 -0.653 . . . . 0.0 110.163 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -60.91 -31.89 71.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.677 -0.639 . . . . 0.0 110.204 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.402 ' HG2' ' HA ' ' A' ' 321' ' ' ARG . 13.2 pt20 -105.11 125.07 50.58 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.702 -0.624 . . . . 0.0 110.495 -177.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 61.7 t -120.5 130.04 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.54 -0.725 . . . . 0.0 109.923 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 29.9 t -95.15 139.96 30.75 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.683 -0.636 . . . . 0.0 110.204 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -100.97 142.68 32.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.609 -0.682 . . . . 0.0 110.356 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 78.6 p -94.05 155.05 17.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.675 -0.641 . . . . 0.0 110.276 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 75.0 p -96.35 -21.89 17.52 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.606 -0.684 . . . . 0.0 110.765 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -60.45 -33.94 73.27 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.448 -0.782 . . . . 0.0 110.443 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 42.2 p-10 -89.14 13.97 11.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.592 -0.692 . . . . 0.0 111.337 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -157.05 114.26 0.6 Allowed Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -85.52 117.35 24.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.589 -0.948 . . . . 0.0 110.313 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -145.48 152.38 39.69 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.656 -0.652 . . . . 0.0 110.252 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -119.99 151.9 38.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.571 -0.706 . . . . 0.0 110.241 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 51.63 94.82 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.497 -0.752 . . . . 0.0 111.142 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -60.74 -34.34 74.29 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.621 -0.675 . . . . 0.0 110.22 178.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -58.97 -30.91 68.28 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.675 -0.641 . . . . 0.0 110.47 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 74.4 p -96.17 26.3 4.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.594 -0.692 . . . . 0.0 110.476 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -104.63 160.7 14.74 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.581 -0.7 . . . . 0.0 110.185 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -79.49 -177.23 49.97 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -177.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 51.4 mm -92.62 141.19 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.7 -0.883 . . . . 0.0 110.129 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -82.19 -31.99 30.11 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.677 -0.639 . . . . 0.0 110.133 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 93.3 mmm -100.67 142.25 32.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.597 -0.689 . . . . 0.0 110.271 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 117.917 -1.039 . . . . 0.0 110.347 179.962 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 27.3 t -156.31 148.74 23.56 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.642 -0.917 . . . . 0.0 110.212 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.5 m -59.69 -34.45 72.9 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.645 -0.66 . . . . 0.0 110.359 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 44.9 m -59.81 -37.21 78.51 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.657 -0.652 . . . . 0.0 110.277 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -106.35 137.29 44.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.573 -0.704 . . . . 0.0 110.234 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -83.46 141.0 31.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.578 -0.701 . . . . 0.0 110.243 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -165.46 153.83 11.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.723 -0.61 . . . . 0.0 110.144 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.9 mt 52.11 -179.0 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.487 -0.758 . . . . 0.0 111.091 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.9 m -76.97 160.96 75.18 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.741 -0.599 . . . . 0.0 110.213 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -66.21 151.94 80.59 Favored 'Cis proline' 0 N--CA 1.496 1.65 0 C-N-CA 123.133 -1.611 . . . . 0.0 110.421 -16.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 7.6 m -81.5 149.42 64.81 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.68 -0.638 . . . . 0.0 110.27 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -59.51 158.46 27.41 Favored 'Trans proline' 0 N--CA 1.488 1.169 0 O-C-N 123.309 1.163 . . . . 0.0 110.502 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -73.98 135.5 43.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.656 -0.653 . . . . 0.0 110.119 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.615 HD11 HG22 ' A' ' 199' ' ' THR . 50.2 mm -124.94 106.13 29.01 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.69 -0.631 . . . . 0.0 109.991 -177.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 126' ' ' ILE . 12.0 Cg_endo -60.02 148.22 89.95 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 O-C-N 123.104 1.055 . . . . 0.0 110.467 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.3 t -110.56 147.09 34.9 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.707 -0.621 . . . . 0.0 110.378 -177.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -95.28 24.73 4.81 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.632 -0.667 . . . . 0.0 110.779 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 51.6 m -74.6 125.23 28.2 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.554 -0.716 . . . . 0.0 110.286 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -69.78 144.94 52.54 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.763 -0.586 . . . . 0.0 110.482 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -154.18 98.86 2.54 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.617 -0.677 . . . . 0.0 110.156 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -59.27 -39.95 73.1 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 O-C-N 123.261 1.137 . . . . 0.0 110.782 -176.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 73.76 -155.15 49.38 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -73.82 -45.65 0.37 Allowed 'Trans proline' 0 C--N 1.317 -1.096 0 O-C-N 123.38 1.2 . . . . 0.0 111.044 -174.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -86.24 8.07 22.69 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.474 -0.766 . . . . 0.0 111.383 -173.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.69 60.22 3.81 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.987 -1.071 . . . . 0.0 110.655 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.679 ' HA ' HG12 ' A' ' 176' ' ' VAL . 56.5 t80 -77.8 118.77 20.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.584 -0.697 . . . . 0.0 109.851 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.409 ' HA ' ' HG3' ' A' ' 299' ' ' ARG . 22.1 t70 -130.0 160.02 34.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.887 -0.508 . . . . 0.0 110.182 -178.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 80.6 t -125.16 146.92 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.729 -0.607 . . . . 0.0 109.785 176.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.4 p -157.73 171.03 21.04 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.88 176.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.414 ' CE1' HG12 ' A' ' 172' ' ' ILE . 57.7 m-85 -126.41 125.06 41.55 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.05 150.02 17.96 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.585 -0.697 . . . . 0.0 110.437 -176.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -69.99 136.22 50.22 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.584 -0.698 . . . . 0.0 110.391 -170.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 28.0 t -133.15 145.58 50.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.707 -0.62 . . . . 0.0 110.1 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 60.8 p -69.87 166.41 19.52 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.634 -0.666 . . . . 0.0 110.231 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 74.8 p -97.27 28.55 3.6 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.724 -0.61 . . . . 0.0 110.133 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.08 159.09 12.34 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.689 -0.632 . . . . 0.0 110.262 -176.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -58.94 157.63 9.61 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.699 -0.625 . . . . 0.0 110.394 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 75.5 m 53.6 33.64 16.88 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.496 -0.753 . . . . 0.0 111.008 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -70.44 126.68 30.32 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.702 -0.624 . . . . 0.0 109.854 173.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 69.0 p -60.03 -34.03 72.82 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.769 -0.582 . . . . 0.0 110.093 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.565 ' CE3' HD11 ' A' ' 162' ' ' LEU . 67.6 p-90 -170.75 148.08 2.89 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.834 -0.541 . . . . 0.0 109.964 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.4 t -141.7 142.44 33.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.749 -0.594 . . . . 0.0 109.884 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.403 ' HB2' HD12 ' A' ' 162' ' ' LEU . 62.0 t80 -125.54 140.07 53.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.52 -0.738 . . . . 0.0 110.589 -172.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 30.1 t -109.86 122.81 48.39 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.297 -0.561 . . . . 0.0 109.734 174.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 67.6 m -70.75 -36.98 73.38 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.353 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -59.38 -31.77 69.54 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.615 -0.678 . . . . 0.0 110.453 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.534 HD11 ' OD1' ' A' ' 316' ' ' ASP . 56.3 mt -104.78 -12.04 16.51 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.682 -0.636 . . . . 0.0 110.79 -175.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 32.5 tttt 59.68 48.52 9.27 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.007 -1.058 . . . . 0.0 109.682 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -146.93 153.06 39.65 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.736 -0.602 . . . . 0.0 110.638 -174.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.634 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.43 137.8 53.46 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.759 -0.588 . . . . 0.0 110.164 -175.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -115.85 132.67 56.57 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 175.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.1 p -138.36 158.43 44.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.663 -0.648 . . . . 0.0 111.046 -174.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.4 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 44.6 mt-30 -104.62 140.13 38.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.662 -0.649 . . . . 0.0 110.205 171.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.484 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.5 tt -52.61 149.14 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-O 121.619 0.723 . . . . 0.0 111.799 -174.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 66.06 8.35 5.41 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.489 -0.757 . . . . 0.0 112.483 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.4 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 63.4 mmtt -96.6 155.09 16.92 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.904 -1.123 . . . . 0.0 110.949 174.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 87.8 m -84.24 126.41 33.13 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.668 -0.645 . . . . 0.0 110.635 -177.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . 0.634 ' SG ' HD21 ' A' ' 162' ' ' LEU . 43.1 t -112.94 90.25 15.26 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.569 -0.707 . . . . 0.0 109.995 174.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -65.32 131.67 29.01 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.199 1.105 . . . . 0.0 110.484 176.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.414 HG12 ' CE1' ' A' ' 142' ' ' PHE . 92.5 mt -125.84 142.29 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.6 -0.688 . . . . 0.0 109.541 175.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -110.83 135.59 51.16 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.601 -0.687 . . . . 0.0 110.697 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.7 mm -95.33 134.91 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.556 -0.715 . . . . 0.0 109.579 169.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -116.21 128.47 55.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.602 -0.686 . . . . 0.0 110.445 176.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.679 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.5 m -136.29 159.77 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.548 -0.72 . . . . 0.0 109.886 174.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 81.9 mmm -75.45 -40.4 57.57 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.703 -0.623 . . . . 0.0 110.068 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 75.5 p -134.75 143.18 45.32 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.769 -0.582 . . . . 0.0 109.768 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 35.7 Cg_exo -54.95 139.79 79.34 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 O-C-N 123.138 1.073 . . . . 0.0 110.883 -172.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.579 ' HB3' HD21 ' A' ' 288' ' ' LEU . 20.5 Cg_endo -63.26 167.63 12.42 Favored 'Trans proline' 0 N--CA 1.487 1.099 0 O-C-N 123.191 1.1 . . . . 0.0 110.59 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -61.38 155.04 54.55 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.353 1.186 . . . . 0.0 110.321 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -72.99 139.0 46.38 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.591 -0.693 . . . . 0.0 109.853 175.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.71 -25.01 29.15 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -175.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.1 148.71 3.21 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.377 -1.072 . . . . 0.0 111.303 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.8 155.96 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.692 -0.63 . . . . 0.0 109.743 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.588 HD11 ' CD2' ' A' ' 251' ' ' TYR . 85.6 mt -106.57 137.91 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.698 -0.626 . . . . 0.0 109.457 176.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.729 ' HG2' HD22 ' A' ' 248' ' ' LEU . 70.8 mtp180 -114.85 141.96 47.2 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -176.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.618 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -137.39 125.83 23.45 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.471 -0.768 . . . . 0.0 110.353 175.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 39.4 ttm -137.27 139.11 26.95 Favored Pre-proline 0 N--CA 1.497 1.901 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.977 -176.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.508 ' HD3' HD12 ' A' ' 226' ' ' ILE . 72.8 Cg_endo -90.39 138.21 2.66 Favored 'Trans proline' 0 C--N 1.319 -0.982 0 C-N-CA 120.936 1.091 . . . . 0.0 110.858 177.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.494 HG12 ' CZ ' ' A' ' 244' ' ' ARG . 34.9 m -147.26 154.86 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.493 -0.755 . . . . 0.0 110.009 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.667 ' HA ' HG22 ' A' ' 282' ' ' ILE . 80.4 m-85 -61.49 165.0 5.17 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.431 -0.793 . . . . 0.0 110.448 -177.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -84.69 -60.06 2.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.605 -0.685 . . . . 0.0 110.841 -173.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 42.7 mttt -80.01 152.52 29.4 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.667 -0.646 . . . . 0.0 110.311 -174.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.454 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.68 -39.18 73.34 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.387 -0.821 . . . . 0.0 110.66 -174.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -56.62 -24.79 50.46 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.438 -0.789 . . . . 0.0 110.67 -177.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.419 ' CE1' ' NH1' ' A' ' 280' ' ' ARG . 99.3 m-70 -109.23 -20.46 12.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.604 -0.685 . . . . 0.0 111.197 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.454 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -68.36 -20.28 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.144 -0.973 . . . . 0.0 110.639 -175.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.615 HG22 HD11 ' A' ' 126' ' ' ILE . 68.3 p -79.45 -17.15 54.85 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.551 -0.718 . . . . 0.0 110.858 174.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -88.36 137.7 32.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.302 -0.874 . . . . 0.0 110.186 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 57.7 t -72.95 146.49 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.587 -0.696 . . . . 0.0 110.146 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 60.0 t -84.82 140.06 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.575 -0.703 . . . . 0.0 109.203 172.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -134.83 -170.23 2.52 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.395 -0.815 . . . . 0.0 111.131 -167.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -95.21 154.14 17.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.771 -0.581 . . . . 0.0 110.461 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 63.3 m -77.52 162.75 67.45 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.649 -0.657 . . . . 0.0 109.274 173.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -63.9 -47.39 6.84 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 O-C-N 123.092 1.048 . . . . 0.0 109.849 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.449 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.8 p-10 -65.55 -44.55 86.47 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.62 -0.675 . . . . 0.0 111.257 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . 0.449 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 55.8 m170 -81.4 -27.94 34.56 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.349 -0.845 . . . . 0.0 111.526 -174.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -69.17 -39.37 78.78 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.31 -0.868 . . . . 0.0 110.359 173.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 23.1 tp -55.99 -34.84 66.13 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.533 -0.729 . . . . 0.0 110.866 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 28.0 t -48.34 132.77 16.39 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.447 -0.783 . . . . 0.0 111.404 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -61.19 143.63 55.19 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.728 -0.608 . . . . 0.0 110.248 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -60.84 -40.36 92.54 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.685 -0.634 . . . . 0.0 110.253 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 57.5 t80 50.6 50.7 18.38 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.425 -0.797 . . . . 0.0 111.145 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -75.3 -10.21 59.26 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.734 -0.604 . . . . 0.0 111.18 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -59.98 117.3 4.9 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.231 -0.918 . . . . 0.0 110.498 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 77.78 20.02 74.5 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.491 -1.043 . . . . 0.0 110.491 176.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -143.16 139.96 30.58 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.311 -1.111 . . . . 0.0 110.101 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.8 mt -88.21 -25.09 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.741 -0.6 . . . . 0.0 110.456 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.425 ' HB1' ' OH ' ' A' ' 236' ' ' TYR . . . -124.98 89.96 51.8 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.415 -0.803 . . . . 0.0 110.459 -175.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -62.58 145.24 95.31 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 O-C-N 123.24 1.126 . . . . 0.0 110.537 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -59.36 -18.52 46.14 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.201 1.106 . . . . 0.0 111.293 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 24.4 m -53.03 -28.38 24.14 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.157 -0.964 . . . . 0.0 111.168 -178.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -89.69 129.75 36.07 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.496 -0.752 . . . . 0.0 110.117 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.492 HD12 ' HE3' ' A' ' 268' ' ' MET . 56.4 tp -57.19 -42.53 81.41 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.573 -0.705 . . . . 0.0 110.576 -175.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.508 HD12 ' HD3' ' A' ' 190' ' ' PRO . 84.7 mt -106.06 136.82 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 120.309 -0.557 . . . . 0.0 109.867 -177.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -132.84 158.23 43.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.785 -0.572 . . . . 0.0 110.171 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.493 HG23 HG21 ' A' ' 247' ' ' VAL . 94.0 t -105.22 146.68 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.693 -0.629 . . . . 0.0 110.122 177.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -119.45 127.97 53.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.768 -0.582 . . . . 0.0 110.352 170.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.17 21.1 21.34 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 168.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -140.2 105.54 5.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.381 -1.07 . . . . 0.0 110.048 174.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 95.2 p -63.58 -15.13 57.24 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.625 -0.672 . . . . 0.0 111.217 -178.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -96.74 9.93 40.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -0.834 . . . . 0.0 111.219 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -62.2 127.83 33.21 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.246 -0.908 . . . . 0.0 110.056 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -139.84 157.35 45.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.719 -0.613 . . . . 0.0 109.734 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.425 ' OH ' ' HB1' ' A' ' 220' ' ' ALA . 83.6 m-85 -117.98 150.61 38.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.599 -0.688 . . . . 0.0 110.627 -176.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.16 159.96 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.837 -0.54 . . . . 0.0 110.213 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -116.49 130.07 56.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.765 -0.584 . . . . 0.0 110.111 175.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -63.12 130.07 93.9 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.634 -0.667 . . . . 0.0 109.867 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -65.73 -29.31 51.23 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 123.197 1.104 . . . . 0.0 110.952 -171.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 82.5 mt -103.9 -50.45 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.484 -0.76 . . . . 0.0 111.071 -168.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 7.3 p -105.29 12.08 32.18 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.376 -0.827 . . . . 0.0 111.927 -173.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 73.66 -6.97 15.13 Favored Glycine 0 N--CA 1.497 2.701 0 O-C-N 121.077 -1.014 . . . . 0.0 112.125 171.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.494 ' CZ ' HG12 ' A' ' 191' ' ' VAL . 26.8 mmt180 -45.89 142.09 2.76 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-N 119.095 1.448 . . . . 0.0 112.312 -176.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -105.91 143.89 33.4 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.671 -0.643 . . . . 0.0 110.09 174.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 78.9 p -154.73 159.93 41.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.554 -0.716 . . . . 0.0 110.571 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.493 HG21 HG23 ' A' ' 228' ' ' VAL . 8.3 p -122.97 148.18 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.732 -0.605 . . . . 0.0 109.636 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.729 HD22 ' HG2' ' A' ' 187' ' ' ARG . 75.2 mt -129.68 154.6 46.98 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.71 -174.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.434 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.9 m -150.63 151.75 31.19 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.811 -0.555 . . . . 0.0 109.96 174.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -71.21 137.42 31.25 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.264 1.139 . . . . 0.0 109.913 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.588 ' CD2' HD11 ' A' ' 186' ' ' ILE . 8.9 t80 -76.95 125.5 29.41 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.509 -0.744 . . . . 0.0 109.984 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -99.98 160.12 28.05 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.658 -0.651 . . . . 0.0 110.145 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -58.81 159.64 20.37 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 O-C-N 123.284 1.15 . . . . 0.0 110.343 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.38 149.94 78.15 Favored 'Trans proline' 0 C--N 1.316 -1.132 0 O-C-N 123.177 1.093 . . . . 0.0 110.538 -176.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -61.14 149.75 36.34 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.695 -0.628 . . . . 0.0 110.146 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.0 t -69.83 127.09 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.552 -0.718 . . . . 0.0 110.198 -170.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.11 -10.06 56.68 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.409 HG21 ' CE1' ' A' ' 260' ' ' PHE . 9.6 t -145.39 175.39 10.35 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.182 -1.187 . . . . 0.0 110.604 175.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -110.52 13.23 22.71 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.531 -0.73 . . . . 0.0 111.93 -166.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.409 ' CE1' HG21 ' A' ' 258' ' ' THR . 49.4 p90 -120.04 168.01 11.61 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.074 -1.016 . . . . 0.0 111.16 -177.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 78.1 m -117.74 146.09 44.01 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.81 -0.556 . . . . 0.0 109.914 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 32.2 m -116.88 135.57 53.62 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.594 -0.691 . . . . 0.0 110.981 -175.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 65.1 t -131.42 137.27 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 74.0 mt -104.68 122.02 44.78 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.538 -0.726 . . . . 0.0 109.944 -171.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.618 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 6.1 m-30 -106.35 149.32 27.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.709 -0.62 . . . . 0.0 110.591 -177.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -136.63 142.99 43.28 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -113.57 130.7 56.32 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.47 -0.769 . . . . 0.0 110.395 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' MET . . . . . 0.492 ' HE3' HD12 ' A' ' 225' ' ' LEU . 0.0 OUTLIER -99.87 -0.62 39.27 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.782 -0.574 . . . . 0.0 111.844 -178.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . 0.481 ' HB3' ' HE3' ' A' ' 268' ' ' MET . 7.0 t -144.78 158.05 43.94 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.147 -0.971 . . . . 0.0 109.009 176.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.558 ' HA ' HD13 ' A' ' 305' ' ' ILE . 26.1 p30 -119.0 152.32 36.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.678 -0.639 . . . . 0.0 110.262 -175.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . 0.422 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 90.0 p -57.64 -25.39 60.09 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.481 -0.762 . . . . 0.0 111.148 -170.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 49.3 p -89.24 2.1 54.76 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.328 -0.858 . . . . 0.0 112.094 -167.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 28.6 p -85.23 118.0 24.51 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.014 -1.053 . . . . 0.0 110.618 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.63 140.17 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.457 -0.777 . . . . 0.0 110.445 -171.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 101.04 -5.18 56.07 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 177.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.11 -98.55 0.84 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 171.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . 0.424 ' HE1' HD13 ' A' ' 282' ' ' ILE . 91.7 mmm -63.6 -30.96 72.0 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.73 -0.865 . . . . 0.0 110.332 178.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.1 p30 44.91 53.18 7.72 Favored 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 121.427 0.632 . . . . 0.0 112.338 173.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 17.1 mtt-85 54.89 34.97 23.31 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.336 -0.852 . . . . 0.0 111.328 175.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . 0.419 ' NH1' ' CE1' ' A' ' 197' ' ' HIS . 31.7 mtt-85 -112.43 104.94 56.22 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.575 -0.703 . . . . 0.0 110.085 169.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -60.13 148.95 87.54 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 O-C-N 123.12 1.063 . . . . 0.0 110.558 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.667 HG22 ' HA ' ' A' ' 192' ' ' TYR . 28.7 pt -131.97 179.16 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.811 0.815 . . . . 0.0 111.014 -177.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 302' ' ' GLU . 32.2 mt -124.37 149.96 46.07 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.706 HD12 ' CE1' ' A' ' 301' ' ' PHE . 80.6 mt -114.01 129.29 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.183 177.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.613 HG23 ' SG ' ' A' ' 300' ' ' CYS . 80.7 mt -109.73 125.92 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -175.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 60.0 t -118.89 126.72 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 44.8 p -125.3 153.09 43.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.652 -0.655 . . . . 0.0 110.642 -175.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.579 HD21 ' HB3' ' A' ' 180' ' ' PRO . 23.8 tp -102.85 126.03 49.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.799 -0.563 . . . . 0.0 109.509 170.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.674 ' OE2' HG13 ' A' ' 295' ' ' VAL . 73.5 mm-40 -132.78 150.59 52.14 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.79 -0.569 . . . . 0.0 109.967 -172.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.732 ' CG2' HD11 ' A' ' 296' ' ' LEU . 72.6 p -90.01 159.19 17.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.593 -0.692 . . . . 0.0 109.96 177.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -56.05 -26.12 47.85 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.533 -0.729 . . . . 0.0 110.935 -177.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -92.32 11.65 25.2 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.45 -0.781 . . . . 0.0 111.729 -173.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 90.05 20.12 44.02 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.11 -1.043 . . . . 0.0 110.932 167.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -105.49 140.14 39.04 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.28 -1.129 . . . . 0.0 110.154 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.675 HG11 ' NE ' ' A' ' 298' ' ' ARG . 59.4 t -90.66 130.9 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.63 -0.669 . . . . 0.0 110.159 -174.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.732 HD11 ' CG2' ' A' ' 290' ' ' THR . 95.8 mt -99.92 -40.21 7.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.768 -0.582 . . . . 0.0 110.781 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -161.64 154.71 25.76 Favored Glycine 0 N--CA 1.497 2.719 0 C-N-CA 119.987 -1.101 . . . . 0.0 110.359 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.675 ' NE ' HG11 ' A' ' 295' ' ' VAL . 41.1 mtt180 -135.15 135.92 41.48 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.642 -0.916 . . . . 0.0 110.383 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . 0.409 ' HG3' ' HA ' ' A' ' 139' ' ' ASP . 27.5 mmt180 -141.54 158.65 43.58 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.491 -0.755 . . . . 0.0 110.095 169.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . 0.613 ' SG ' HG23 ' A' ' 285' ' ' ILE . 94.8 m -143.59 157.91 44.06 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.407 -0.808 . . . . 0.0 110.701 -174.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.706 ' CE1' HD12 ' A' ' 284' ' ' ILE . 49.6 p90 -145.59 161.03 40.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.658 -0.651 . . . . 0.0 110.073 175.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.467 ' HA ' HD23 ' A' ' 283' ' ' LEU . 81.7 tt0 -104.9 136.71 43.88 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.548 -0.72 . . . . 0.0 110.178 -177.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -119.01 143.5 47.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.645 -0.659 . . . . 0.0 110.833 -169.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -138.5 138.25 37.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.772 -0.58 . . . . 0.0 109.601 172.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.558 HD13 ' HA ' ' A' ' 270' ' ' ASN . 65.7 mt -111.21 122.84 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.52 -0.738 . . . . 0.0 109.719 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.0 p -145.34 173.38 12.03 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.707 -0.621 . . . . 0.0 110.654 -172.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -74.13 -40.11 62.86 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.655 -0.653 . . . . 0.0 110.696 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.9 t -127.35 86.75 57.92 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.581 -0.699 . . . . 0.0 110.547 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -55.66 -28.62 66.81 Favored 'Trans proline' 0 N--CA 1.488 1.2 0 O-C-N 123.156 1.082 . . . . 0.0 110.813 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.97 -37.76 92.35 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -72.83 -40.48 65.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.692 -0.887 . . . . 0.0 109.881 -173.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -69.61 -38.25 77.18 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.283 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -62.08 -42.75 99.53 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.196 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -64.88 -37.43 87.62 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.5 -0.75 . . . . 0.0 110.342 175.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.63 -49.42 76.63 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.548 -0.72 . . . . 0.0 110.608 -173.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . 0.534 ' OD1' HD11 ' A' ' 159' ' ' LEU . 2.8 p30 -61.08 -37.69 83.6 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.448 -0.782 . . . . 0.0 110.098 -178.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -62.98 -41.2 99.49 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.035 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -62.84 -35.14 78.97 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.67 -0.644 . . . . 0.0 109.876 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 23.9 m -63.42 -32.36 73.78 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.792 -0.567 . . . . 0.0 110.173 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 83.4 mt -76.79 -48.15 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.61 -0.681 . . . . 0.0 109.986 -177.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -61.03 -39.74 90.92 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.635 -0.666 . . . . 0.0 110.437 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -60.66 -43.78 97.24 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.57 -0.706 . . . . 0.0 110.329 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -62.1 -33.15 73.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.607 -0.683 . . . . 0.0 110.082 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -93.55 124.96 37.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.643 -0.66 . . . . 0.0 110.385 -178.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.23 130.19 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.643 -0.66 . . . . 0.0 109.808 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 59.9 p -93.43 140.03 30.03 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.702 -0.624 . . . . 0.0 110.278 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -88.64 121.8 31.4 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.686 -0.634 . . . . 0.0 110.262 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 29.8 t -69.49 144.17 53.28 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.601 -0.687 . . . . 0.0 109.992 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 67.5 p -132.63 164.72 26.07 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.624 -0.672 . . . . 0.0 110.287 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 31.4 mmtm -88.09 155.04 20.0 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.642 -0.661 . . . . 0.0 110.133 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -58.66 -27.98 65.28 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.621 -0.675 . . . . 0.0 110.63 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -170.44 -178.9 41.54 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 59.51 79.85 0.22 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.502 -0.999 . . . . 0.0 110.236 176.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -165.83 103.8 0.68 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.669 -0.644 . . . . 0.0 110.266 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -117.25 148.18 41.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.65 -0.656 . . . . 0.0 110.308 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 51.61 95.85 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.484 -0.76 . . . . 0.0 111.156 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -115.47 143.49 45.23 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.56 -0.712 . . . . 0.0 110.264 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 53.71 42.63 31.77 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.429 -0.794 . . . . 0.0 110.903 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 74.6 p -67.69 -33.26 74.56 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.669 -0.645 . . . . 0.0 110.255 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . 0.491 ' HB3' HG22 ' A' ' 342' ' ' ILE . 77.1 m80 -59.56 -41.98 91.38 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.619 -0.676 . . . . 0.0 110.383 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 76.06 28.02 61.21 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.491 HG22 ' HB3' ' A' ' 340' ' ' HIS . 15.9 tt -148.17 146.55 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.631 -0.923 . . . . 0.0 110.253 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -92.69 124.28 36.58 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.689 -0.632 . . . . 0.0 110.222 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 65.1 mtt -60.4 -35.3 75.44 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.579 -0.701 . . . . 0.0 110.292 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . 0.514 ' OXT' HG22 ' A' ' 345' ' ' THR . 16.3 m . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.19 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 60.3 p -84.4 160.71 20.56 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.701 -0.882 . . . . 0.0 110.262 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 96.6 p -122.72 153.99 38.71 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.609 -0.682 . . . . 0.0 110.15 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.7 t -131.82 25.1 4.67 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.631 -0.668 . . . . 0.0 110.757 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -60.61 -37.65 82.11 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.496 -0.753 . . . . 0.0 110.198 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -81.01 -29.02 35.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.642 -0.661 . . . . 0.0 110.203 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 50.55 -163.39 0.05 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.367 -0.833 . . . . 0.0 111.148 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.418 HD23 ' C ' ' A' ' 120' ' ' LEU . 6.7 tt 63.04 -70.21 0.06 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.6 -0.688 . . . . 0.0 111.035 -175.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.8 t -63.54 158.14 60.76 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.391 -0.818 . . . . 0.0 110.159 -176.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -62.25 150.59 62.1 Favored 'Cis proline' 0 N--CA 1.496 1.651 0 C-N-CA 123.086 -1.631 . . . . 0.0 110.33 -19.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 26.7 t -81.19 144.77 54.86 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.604 -0.685 . . . . 0.0 110.21 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -64.42 147.15 90.61 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 O-C-N 123.253 1.133 . . . . 0.0 110.297 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.77 139.5 41.86 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.621 -0.674 . . . . 0.0 110.032 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 50.2 mm -121.69 139.4 29.95 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.67 -0.644 . . . . 0.0 109.958 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.83 152.71 79.45 Favored 'Trans proline' 0 N--CA 1.487 1.12 0 O-C-N 123.148 1.078 . . . . 0.0 110.376 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 27.8 t -112.49 142.67 44.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.656 -0.653 . . . . 0.0 110.322 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.6 p-10 -99.93 24.85 7.96 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.718 -0.614 . . . . 0.0 110.731 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 53.1 m -78.14 125.19 29.0 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.53 -0.731 . . . . 0.0 110.25 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -71.04 144.95 50.22 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.739 -0.6 . . . . 0.0 110.403 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -158.57 101.83 1.66 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.675 -0.641 . . . . 0.0 110.07 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -59.21 -40.0 73.3 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.151 1.08 . . . . 0.0 110.729 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.08 -155.19 40.13 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -74.67 -43.29 0.47 Allowed 'Trans proline' 0 C--N 1.317 -1.116 0 O-C-N 123.315 1.166 . . . . 0.0 110.846 -175.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -88.65 4.41 47.24 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.577 -0.702 . . . . 0.0 111.437 -174.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 t 54.05 61.79 2.89 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.995 -1.066 . . . . 0.0 110.669 -176.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.732 ' HA ' HG12 ' A' ' 176' ' ' VAL . 59.5 t80 -78.0 120.77 23.31 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.606 -0.683 . . . . 0.0 110.111 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -130.01 160.01 34.96 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.8 -0.563 . . . . 0.0 110.129 -177.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 74.6 t -123.13 146.75 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.423 0.63 . . . . 0.0 110.046 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.0 p -157.3 171.08 21.04 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.126 0.489 . . . . 0.0 109.688 175.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.431 ' CE2' HG12 ' A' ' 172' ' ' ILE . 52.7 m-85 -126.48 125.16 41.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.827 -0.545 . . . . 0.0 109.656 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -57.38 139.47 52.97 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.591 -0.693 . . . . 0.0 110.378 -175.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -78.63 144.13 35.73 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.552 -0.718 . . . . 0.0 110.656 -169.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 83.2 p -142.84 161.82 37.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.721 -0.612 . . . . 0.0 110.067 177.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 47.5 m -62.72 161.78 11.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.61 -0.681 . . . . 0.0 110.228 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 77.8 p -92.61 44.44 1.16 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.618 -0.676 . . . . 0.0 110.178 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.11 156.12 36.95 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.735 -0.603 . . . . 0.0 110.243 -176.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -63.21 162.12 12.5 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.691 -0.631 . . . . 0.0 110.063 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 60.3 m 53.24 26.96 5.53 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.434 -0.791 . . . . 0.0 111.018 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.88 131.7 49.65 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.556 -0.715 . . . . 0.0 109.923 175.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.425 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 76.6 p -60.08 -34.04 72.9 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.71 -0.619 . . . . 0.0 109.928 177.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.518 ' HE3' HD11 ' A' ' 162' ' ' LEU . 67.2 p-90 -170.59 147.88 2.96 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.878 -0.514 . . . . 0.0 109.788 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 14.0 t -142.08 142.43 32.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.768 -0.583 . . . . 0.0 109.963 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -125.63 140.08 53.02 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.494 -0.754 . . . . 0.0 110.45 -172.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 30.7 t -109.72 122.5 47.62 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 120.324 -0.551 . . . . 0.0 109.748 175.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 63.6 m -70.77 -37.0 73.34 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.71 -0.619 . . . . 0.0 110.443 -177.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -60.46 -32.25 71.22 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.605 -0.684 . . . . 0.0 110.357 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 60.3 mt -104.79 -12.06 16.5 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.726 -0.609 . . . . 0.0 110.852 -176.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.5 tttm 59.84 50.75 6.63 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.081 -1.012 . . . . 0.0 109.702 177.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -146.34 153.0 40.03 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.598 -176.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.663 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.5 tp -126.63 137.87 53.36 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.791 -0.568 . . . . 0.0 110.24 -175.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -115.47 134.05 55.45 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.9 p -138.28 158.39 44.39 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.637 -0.664 . . . . 0.0 111.005 -175.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -104.55 143.04 33.59 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.499 0.666 . . . . 0.0 110.347 172.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.43 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.3 tt -52.53 147.68 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-O 121.583 0.706 . . . . 0.0 111.842 -173.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.36 9.98 5.33 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.638 -0.664 . . . . 0.0 112.461 177.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -96.82 155.1 16.92 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.975 -1.078 . . . . 0.0 110.811 175.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 87.3 m -82.78 126.17 32.11 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.709 -0.619 . . . . 0.0 110.607 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . 0.663 ' SG ' HD21 ' A' ' 162' ' ' LEU . 42.6 t -112.93 90.29 15.29 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.647 -0.658 . . . . 0.0 110.082 172.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.437 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 15.8 Cg_exo -65.1 128.65 21.07 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 O-C-N 123.264 1.139 . . . . 0.0 110.394 176.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.431 HG12 ' CE2' ' A' ' 142' ' ' PHE . 94.7 mt -122.38 139.42 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.621 -0.674 . . . . 0.0 109.393 177.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -108.69 137.0 47.33 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.645 -0.659 . . . . 0.0 110.488 -177.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.432 ' CG2' ' CE1' ' A' ' 138' ' ' PHE . 48.5 mm -95.23 132.77 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.66 -0.65 . . . . 0.0 109.562 171.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -115.93 128.95 56.17 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.699 -0.626 . . . . 0.0 110.352 176.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.732 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.0 m -136.74 159.71 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.575 -0.703 . . . . 0.0 110.012 176.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.5 mmm -75.45 -40.19 57.8 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.723 -0.611 . . . . 0.0 110.056 177.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 76.4 p -136.82 143.23 41.8 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.788 -0.57 . . . . 0.0 109.729 178.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 33.5 Cg_exo -55.4 139.91 82.06 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 O-C-N 123.21 1.11 . . . . 0.0 110.898 -171.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.765 ' HB3' HD21 ' A' ' 288' ' ' LEU . 33.4 Cg_endo -68.05 170.08 15.15 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 O-C-N 123.119 1.063 . . . . 0.0 110.558 178.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -60.5 155.04 49.66 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 O-C-N 123.289 1.152 . . . . 0.0 110.516 -178.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -77.55 140.2 39.68 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.598 -0.689 . . . . 0.0 109.931 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.67 -24.93 29.48 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -174.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.19 153.33 1.48 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.307 -1.114 . . . . 0.0 111.387 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.84 155.93 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.665 -0.647 . . . . 0.0 109.841 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.732 HD11 ' HD2' ' A' ' 251' ' ' TYR . 87.4 mt -109.25 137.92 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.662 -0.649 . . . . 0.0 109.652 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.726 ' HG2' HD22 ' A' ' 248' ' ' LEU . 40.4 mtm180 -114.97 146.95 40.67 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -176.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.656 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -140.59 127.72 20.91 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.503 -0.748 . . . . 0.0 110.343 173.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.411 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 21.1 ttm -137.31 139.71 28.61 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.811 -0.555 . . . . 0.0 110.978 -177.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.553 ' HD3' HD12 ' A' ' 226' ' ' ILE . 72.7 Cg_endo -91.98 138.17 1.93 Allowed 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 121.061 1.174 . . . . 0.0 110.778 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.478 HG12 ' CZ ' ' A' ' 244' ' ' ARG . 34.7 m -147.06 154.86 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.445 -0.784 . . . . 0.0 110.178 173.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.638 ' HA ' HG22 ' A' ' 282' ' ' ILE . 83.7 m-85 -60.7 164.56 4.56 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.425 -0.797 . . . . 0.0 110.441 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.413 ' HA ' HD12 ' A' ' 283' ' ' LEU . 75.2 tttt -80.74 -60.03 2.46 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.601 -0.687 . . . . 0.0 110.827 -174.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -80.12 151.25 29.91 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.587 -0.696 . . . . 0.0 110.385 -175.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.454 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.57 -37.94 71.27 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.392 -0.817 . . . . 0.0 110.684 -176.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -56.84 -24.91 54.67 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.488 -0.757 . . . . 0.0 110.542 -176.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.402 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 63.3 m170 -109.27 -20.58 12.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.52 -0.738 . . . . 0.0 111.125 -178.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.454 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.1 p -68.0 -20.25 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.199 -0.938 . . . . 0.0 110.623 -176.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 72.3 p -79.43 -17.04 55.11 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.62 174.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -88.35 135.66 33.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.417 -0.802 . . . . 0.0 110.067 174.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.8 t -73.05 141.21 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.73 -0.606 . . . . 0.0 110.223 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.545 HG22 ' CE2' ' A' ' 192' ' ' TYR . 64.3 t -84.98 138.28 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.632 -0.667 . . . . 0.0 109.233 170.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -134.82 -170.25 2.52 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.536 -0.727 . . . . 0.0 111.229 -167.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 223' ' ' SER . 73.0 mtm-85 -95.25 154.68 17.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.853 -0.529 . . . . 0.0 110.389 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 57.0 m -76.0 156.82 84.03 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.62 -0.675 . . . . 0.0 109.247 174.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -63.48 -47.4 7.61 Favored 'Trans proline' 0 C--N 1.315 -1.234 0 O-C-N 123.192 1.101 . . . . 0.0 109.96 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.43 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.6 p-10 -65.44 -44.49 87.14 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.649 -0.657 . . . . 0.0 111.312 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . 0.43 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 52.6 m170 -81.34 -27.94 34.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.367 -0.833 . . . . 0.0 111.253 -174.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -68.99 -42.07 77.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.416 -0.802 . . . . 0.0 110.221 173.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 26.3 tp -63.61 -36.68 84.63 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.634 -0.666 . . . . 0.0 110.268 178.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.0 t -48.46 -41.44 29.6 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.551 -0.718 . . . . 0.0 111.608 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 49.93 -167.28 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.435 -0.791 . . . . 0.0 111.202 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -167.95 48.65 0.05 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.614 -0.679 . . . . 0.0 110.073 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 52.16 75.03 0.24 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.405 -0.809 . . . . 0.0 110.928 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -66.74 -10.27 45.31 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.633 -0.667 . . . . 0.0 111.238 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -60.09 118.27 6.12 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.192 -0.943 . . . . 0.0 110.333 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 79.08 20.16 70.76 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -114.75 146.69 40.69 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.251 -1.146 . . . . 0.0 110.4 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.9 mt -84.81 -25.03 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.674 -0.642 . . . . 0.0 110.564 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.554 ' HB2' ' OH ' ' A' ' 236' ' ' TYR . . . -124.9 97.45 38.38 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.414 -0.804 . . . . 0.0 110.544 -175.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -65.66 157.51 58.26 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.348 1.183 . . . . 0.0 110.415 177.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -56.44 -20.92 35.07 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 O-C-N 123.226 1.119 . . . . 0.0 111.492 -174.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.4 ' HA ' ' HD3' ' A' ' 204' ' ' ARG . 25.7 m -52.79 -28.35 22.14 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.268 -0.895 . . . . 0.0 111.432 -176.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . 0.434 ' CD2' ' HB3' ' A' ' 236' ' ' TYR . 47.0 m80 -96.0 124.03 39.85 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.357 -0.839 . . . . 0.0 110.653 -174.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.677 HD12 ' HG3' ' A' ' 268' ' ' MET . 37.6 tp -66.11 -36.04 82.1 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.609 -0.682 . . . . 0.0 110.388 178.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.553 HD12 ' HD3' ' A' ' 190' ' ' PRO . 83.3 mt -102.44 136.88 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.814 -0.554 . . . . 0.0 109.883 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 50.0 mtt-85 -130.92 159.44 37.44 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.689 -0.632 . . . . 0.0 110.326 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.595 HG23 HG21 ' A' ' 247' ' ' VAL . 81.3 t -103.96 146.65 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.728 -0.607 . . . . 0.0 110.0 176.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -118.25 128.12 54.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.696 -0.627 . . . . 0.0 110.349 170.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 96.67 21.39 21.69 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 168.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -139.38 106.24 5.41 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.348 -1.089 . . . . 0.0 109.95 174.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 90.9 p -63.66 -15.09 57.4 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.64 -0.663 . . . . 0.0 111.201 -177.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -97.12 9.93 40.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.341 -0.849 . . . . 0.0 111.236 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.75 128.78 37.87 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.111 -0.993 . . . . 0.0 110.114 175.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -139.76 155.75 47.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.76 -0.587 . . . . 0.0 109.607 177.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.554 ' OH ' ' HB2' ' A' ' 220' ' ' ALA . 80.9 m-85 -119.12 150.74 39.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.568 -0.708 . . . . 0.0 110.61 -175.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.16 159.97 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.778 -0.576 . . . . 0.0 110.242 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -117.76 130.01 56.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.766 -0.584 . . . . 0.0 110.181 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -62.52 130.19 93.24 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.623 -0.673 . . . . 0.0 109.789 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -64.82 -28.04 59.3 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 O-C-N 123.135 1.071 . . . . 0.0 111.003 -170.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.0 mt -102.0 -50.43 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.344 -0.848 . . . . 0.0 111.014 -168.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 17.9 p -105.43 12.14 31.84 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.31 -0.869 . . . . 0.0 111.913 -174.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 72.17 -4.92 16.01 Favored Glycine 0 N--CA 1.497 2.723 0 O-C-N 121.074 -1.016 . . . . 0.0 112.022 172.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.478 ' CZ ' HG12 ' A' ' 191' ' ' VAL . 21.6 mmt180 -45.86 142.01 2.77 Favored 'General case' 0 N--CA 1.505 2.309 0 CA-C-N 119.119 1.46 . . . . 0.0 112.388 -175.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -103.54 143.36 32.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.618 -0.676 . . . . 0.0 110.119 175.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.2 p -154.81 159.94 40.92 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.595 -0.69 . . . . 0.0 110.348 176.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.595 HG21 HG23 ' A' ' 228' ' ' VAL . 8.6 p -123.17 148.23 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.836 -0.54 . . . . 0.0 109.814 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.726 HD22 ' HG2' ' A' ' 187' ' ' ARG . 81.8 mt -129.62 154.61 46.93 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.079 -0.649 . . . . 0.0 109.638 -177.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.443 HG13 ' C ' ' A' ' 248' ' ' LEU . 34.4 m -151.1 151.67 29.95 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.813 -0.554 . . . . 0.0 110.001 175.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -71.05 139.0 34.88 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 O-C-N 123.368 1.194 . . . . 0.0 110.08 177.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.732 ' HD2' HD11 ' A' ' 186' ' ' ILE . 58.9 t80 -75.9 124.47 27.39 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.099 175.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -99.99 160.11 28.07 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.694 -0.628 . . . . 0.0 109.953 176.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -58.37 158.49 22.59 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 O-C-N 123.294 1.155 . . . . 0.0 110.517 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -59.09 149.98 76.35 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 O-C-N 123.219 1.115 . . . . 0.0 110.511 -177.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -60.73 148.27 39.42 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.65 -0.656 . . . . 0.0 110.295 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.84 127.19 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.538 -0.726 . . . . 0.0 110.168 -171.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.96 -10.14 55.41 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 10.0 t -144.65 173.43 11.83 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.175 -1.191 . . . . 0.0 110.63 175.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -107.28 13.09 27.51 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.617 -0.677 . . . . 0.0 111.78 -168.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -119.92 168.01 11.56 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.181 -0.95 . . . . 0.0 111.168 -175.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 92.6 m -117.73 146.76 43.54 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.744 -0.597 . . . . 0.0 109.986 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 46.4 m -118.24 135.67 54.13 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.604 -0.685 . . . . 0.0 110.952 -174.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 60.2 t -132.56 137.23 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 172.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 75.1 mt -104.78 123.8 48.3 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.437 -0.789 . . . . 0.0 110.054 -171.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.656 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 6.1 m-30 -106.85 151.51 25.12 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.644 -0.66 . . . . 0.0 110.683 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -136.49 142.92 43.55 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -113.47 133.11 55.39 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.538 -0.726 . . . . 0.0 110.55 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' MET . . . . . 0.677 ' HG3' HD12 ' A' ' 225' ' ' LEU . 2.3 ppp? -97.68 2.66 49.97 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.709 -0.62 . . . . 0.0 112.164 -175.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . 0.683 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.7 OUTLIER -144.73 165.07 29.1 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.131 -0.981 . . . . 0.0 110.195 176.063 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.556 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.5 p30 -120.68 162.8 19.07 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.43 0.633 . . . . 0.0 110.407 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . 0.43 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 25.2 m -58.8 -33.53 70.45 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.407 -0.808 . . . . 0.0 110.927 -163.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 49.9 p -100.75 12.17 38.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.466 -0.771 . . . . 0.0 112.018 -163.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 30.4 p -94.54 118.1 31.15 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.03 -1.043 . . . . 0.0 110.742 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.2 t -63.2 139.78 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.431 -0.793 . . . . 0.0 110.393 -171.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.83 -5.28 58.08 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.08 -99.78 0.88 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 171.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . 0.43 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.7 mmm -62.71 -31.53 72.46 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.773 -0.84 . . . . 0.0 110.308 178.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.3 p30 44.47 49.32 8.3 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 174.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 21.3 mtt180 54.79 31.71 16.1 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.331 -0.855 . . . . 0.0 111.179 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . 0.417 ' O ' HG23 ' A' ' 282' ' ' ILE . 75.5 mtt180 -119.31 104.96 45.04 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.508 -0.745 . . . . 0.0 110.07 174.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -59.98 145.26 98.79 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 O-C-N 123.162 1.085 . . . . 0.0 110.466 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.638 HG22 ' HA ' ' A' ' 192' ' ' TYR . 46.5 pt -131.98 176.38 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.874 0.845 . . . . 0.0 111.186 -174.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 302' ' ' GLU . 29.4 mt -124.37 149.86 46.18 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.704 HD12 ' CE1' ' A' ' 301' ' ' PHE . 79.0 mt -115.66 130.11 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.595 -0.69 . . . . 0.0 109.174 178.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.592 HG23 ' SG ' ' A' ' 300' ' ' CYS . 79.0 mt -109.86 126.06 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -176.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 57.8 t -118.86 126.93 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.426 HG22 ' HG2' ' A' ' 298' ' ' ARG . 45.2 p -125.27 152.91 44.01 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.592 -0.692 . . . . 0.0 110.614 -173.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.765 HD21 ' HB3' ' A' ' 180' ' ' PRO . 23.2 tp -103.54 126.68 50.83 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.754 -0.591 . . . . 0.0 109.434 168.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.54 ' OE2' HG13 ' A' ' 295' ' ' VAL . 72.6 mm-40 -130.52 152.03 50.34 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.892 -0.505 . . . . 0.0 109.876 -173.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.818 HG22 HD11 ' A' ' 296' ' ' LEU . 68.6 p -89.83 159.91 16.76 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.699 -0.625 . . . . 0.0 109.735 176.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -55.97 -26.1 46.76 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.515 -0.741 . . . . 0.0 110.772 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -86.96 9.18 20.27 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.521 -0.737 . . . . 0.0 111.845 -174.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 86.6 20.16 54.84 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 120.183 -1.008 . . . . 0.0 110.766 170.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -107.55 140.24 40.84 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.282 -1.128 . . . . 0.0 110.196 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.54 HG13 ' OE2' ' A' ' 289' ' ' GLU . 61.5 t -86.21 132.9 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.656 -0.653 . . . . 0.0 110.091 -174.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.818 HD11 HG22 ' A' ' 290' ' ' THR . 80.3 mt -99.89 -40.1 7.85 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.722 -0.611 . . . . 0.0 110.424 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -165.27 153.28 23.3 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.426 ' HG2' HG22 ' A' ' 287' ' ' THR . 79.3 mtm180 -133.49 136.46 45.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.686 -0.891 . . . . 0.0 110.751 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -135.59 158.29 44.74 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.634 -0.666 . . . . 0.0 109.862 172.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . 0.592 ' SG ' HG23 ' A' ' 285' ' ' ILE . 95.0 m -143.0 155.1 44.59 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.34 -0.85 . . . . 0.0 110.772 -175.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.704 ' CE1' HD12 ' A' ' 284' ' ' ILE . 49.4 p90 -144.97 162.76 36.11 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.734 -0.604 . . . . 0.0 110.052 175.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.436 ' HA ' HD23 ' A' ' 283' ' ' LEU . 82.0 tt0 -104.75 135.06 46.83 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.544 -0.723 . . . . 0.0 110.217 -177.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -122.84 143.18 50.03 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.701 -169.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -138.3 139.2 39.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.74 -0.6 . . . . 0.0 109.704 173.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.683 HD13 ' O ' ' A' ' 269' ' ' CYS . 70.5 mt -108.02 122.8 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.537 -0.727 . . . . 0.0 109.605 176.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.9 p -145.27 169.34 18.43 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.629 -0.67 . . . . 0.0 110.676 -171.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -71.32 -40.1 70.98 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.631 -0.668 . . . . 0.0 110.64 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.9 t -127.5 86.05 59.42 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.468 -0.77 . . . . 0.0 110.47 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -55.87 -28.36 67.41 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 O-C-N 123.122 1.064 . . . . 0.0 110.812 174.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -67.59 -36.73 88.62 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -73.35 -39.83 64.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.72 -0.871 . . . . 0.0 109.822 -173.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -69.56 -40.94 76.51 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.137 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -61.88 -43.46 98.81 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.477 -0.765 . . . . 0.0 110.24 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -64.79 -39.06 92.97 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.532 -0.73 . . . . 0.0 110.478 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.2 -50.5 72.88 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.439 -0.788 . . . . 0.0 110.427 -173.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -61.42 -37.72 84.52 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.455 -0.778 . . . . 0.0 110.1 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -61.56 -40.68 95.59 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.601 -0.687 . . . . 0.0 110.132 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -62.34 -35.18 78.3 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.646 -0.659 . . . . 0.0 109.938 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 23.1 m -62.27 -33.74 75.22 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.665 -0.647 . . . . 0.0 110.223 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 83.6 mt -78.12 -43.08 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.692 -0.63 . . . . 0.0 109.953 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -58.64 -39.82 81.64 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.576 -0.702 . . . . 0.0 110.544 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -60.99 -42.14 97.85 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.672 -0.643 . . . . 0.0 110.131 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -61.59 -34.55 75.81 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.643 -0.661 . . . . 0.0 110.15 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -97.66 125.13 42.26 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.716 -0.615 . . . . 0.0 110.355 -176.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 62.2 t -110.86 130.08 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.698 -0.626 . . . . 0.0 109.849 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 50.1 m -95.1 140.19 30.39 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.683 -0.636 . . . . 0.0 110.265 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -68.49 144.88 54.49 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.76 -0.587 . . . . 0.0 110.142 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 55.0 p -68.65 162.34 26.21 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.665 -0.647 . . . . 0.0 110.152 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 71.6 p -92.82 -24.1 18.62 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.648 -0.658 . . . . 0.0 110.465 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -60.14 -36.15 76.89 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.452 -0.78 . . . . 0.0 110.254 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -110.04 137.65 47.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.652 -0.655 . . . . 0.0 110.218 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -84.15 -177.55 51.42 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -75.46 128.14 34.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.609 -0.936 . . . . 0.0 110.254 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -146.42 155.03 42.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.64 -0.662 . . . . 0.0 110.325 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -139.77 166.16 25.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.577 -0.702 . . . . 0.0 110.35 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 56.84 -84.4 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.745 -0.597 . . . . 0.0 111.052 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -57.31 -37.35 72.34 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.151 -0.968 . . . . 0.0 110.681 -174.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -104.91 137.04 43.29 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.67 -0.644 . . . . 0.0 110.274 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . 0.43 HG22 ' H ' ' A' ' 341' ' ' GLY . 52.4 m -121.31 144.78 48.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.65 -0.656 . . . . 0.0 110.292 -178.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -57.23 -34.81 68.96 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.632 -0.668 . . . . 0.0 110.587 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . 0.43 ' H ' HG22 ' A' ' 339' ' ' THR . . . 101.72 -24.35 31.77 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.416 HG22 ' H ' ' A' ' 342' ' ' ILE . 16.3 tt -92.37 150.18 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.452 -1.028 . . . . 0.0 110.324 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -92.2 127.3 37.62 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.653 -0.654 . . . . 0.0 110.241 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 93.4 mmm -59.93 -35.49 75.03 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.697 -0.627 . . . . 0.0 110.329 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . 0.566 HG22 ' O ' ' A' ' 345' ' ' THR . 25.0 m . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.205 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 31.5 m -80.79 -30.97 35.88 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.656 -0.908 . . . . 0.0 110.249 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.6 m -59.95 -36.97 78.24 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.606 -0.684 . . . . 0.0 110.345 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 64.1 p -67.29 -29.65 69.3 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.649 -0.657 . . . . 0.0 110.157 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -59.71 -43.21 94.22 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.596 -0.69 . . . . 0.0 110.433 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -86.94 6.59 31.36 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.659 -0.65 . . . . 0.0 111.438 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 50.02 -161.04 0.06 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.084 -1.01 . . . . 0.0 111.267 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.463 ' O ' HD23 ' A' ' 120' ' ' LEU . 7.4 tt 51.69 91.13 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.491 -0.756 . . . . 0.0 111.153 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 27.0 m -127.87 164.24 38.13 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.666 -0.646 . . . . 0.0 110.269 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -61.04 153.67 62.49 Favored 'Trans proline' 0 N--CA 1.488 1.161 0 O-C-N 123.302 1.159 . . . . 0.0 110.289 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.9 m -81.53 136.35 48.88 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.645 -0.66 . . . . 0.0 110.138 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.604 ' HB3' HG22 ' A' ' 242' ' ' THR . 23.2 Cg_endo -65.97 148.11 85.45 Favored 'Trans proline' 0 N--CA 1.487 1.126 0 O-C-N 123.11 1.058 . . . . 0.0 110.426 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.91 139.49 41.65 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.653 -0.654 . . . . 0.0 110.026 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.524 HD11 HG22 ' A' ' 199' ' ' THR . 50.7 mm -126.05 99.96 30.88 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.648 -0.658 . . . . 0.0 110.128 -177.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -61.64 154.89 56.9 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 O-C-N 123.248 1.13 . . . . 0.0 110.437 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 32.4 t -108.89 150.6 27.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.64 -0.662 . . . . 0.0 110.274 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -92.8 21.2 5.78 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.675 -0.641 . . . . 0.0 111.004 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 54.9 m -72.07 125.11 26.44 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.371 -0.831 . . . . 0.0 110.223 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -69.99 144.89 52.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.679 -0.638 . . . . 0.0 110.558 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -153.64 102.41 2.53 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.744 -0.597 . . . . 0.0 110.182 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -58.53 -39.95 78.56 Favored 'Trans proline' 0 N--CA 1.487 1.142 0 O-C-N 123.096 1.051 . . . . 0.0 110.922 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.43 -155.13 45.04 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -74.69 -46.12 0.27 Allowed 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.366 1.193 . . . . 0.0 111.007 -173.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -89.66 12.12 17.78 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.557 -0.715 . . . . 0.0 111.285 -172.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.5 60.93 3.38 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.017 -1.052 . . . . 0.0 110.709 -176.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.666 ' HA ' HG12 ' A' ' 176' ' ' VAL . 43.8 t80 -77.82 118.32 20.05 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.643 -0.661 . . . . 0.0 109.73 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.403 ' HA ' ' HG3' ' A' ' 299' ' ' ARG . 22.6 t70 -129.98 159.94 35.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.784 -0.573 . . . . 0.0 110.196 -177.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 64.3 t -125.76 146.75 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.802 -0.561 . . . . 0.0 109.716 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.2 p -155.27 162.43 40.89 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.276 0.56 . . . . 0.0 110.108 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.501 ' CD2' ' CE2' ' A' ' 155' ' ' TYR . 72.7 m-85 -126.67 125.2 41.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.837 -0.54 . . . . 0.0 109.708 -177.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -57.08 145.31 31.29 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.59 -0.694 . . . . 0.0 110.527 -174.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -99.04 135.8 39.92 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.675 -0.641 . . . . 0.0 110.413 -175.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 49.5 m -125.68 154.72 41.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.675 -0.641 . . . . 0.0 110.029 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.0 m -59.23 157.36 10.79 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.504 -0.747 . . . . 0.0 110.264 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.462 HG22 ' HD3' ' A' ' 313' ' ' ARG . 64.6 p -68.22 75.83 0.24 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.729 -0.607 . . . . 0.0 110.148 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.07 156.72 18.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.537 -0.727 . . . . 0.0 110.264 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -76.59 156.92 32.39 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.619 -0.676 . . . . 0.0 110.087 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.9 p 50.99 31.1 5.89 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.571 -0.706 . . . . 0.0 111.277 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.02 131.37 49.39 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.608 -0.683 . . . . 0.0 110.036 176.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.405 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 75.5 p -60.11 -34.05 72.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.768 -0.583 . . . . 0.0 109.96 176.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.431 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -171.65 143.66 1.75 Allowed 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.497 0.665 . . . . 0.0 110.489 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 9.9 t -142.16 142.53 32.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.817 -0.552 . . . . 0.0 110.042 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.501 ' CE2' ' CD2' ' A' ' 142' ' ' PHE . 43.8 t80 -125.47 140.09 53.07 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.534 -0.729 . . . . 0.0 110.529 -173.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 30.6 t -111.47 125.66 54.13 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 120.431 -0.507 . . . . 0.0 109.871 176.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 59.4 m -70.78 -37.08 73.3 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.866 -0.521 . . . . 0.0 110.469 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -59.51 -32.99 70.8 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.601 -0.687 . . . . 0.0 110.36 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.543 HD11 ' OD1' ' A' ' 316' ' ' ASP . 55.9 mt -104.74 -12.15 16.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.771 -0.58 . . . . 0.0 110.806 -175.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.1 ttpt 59.81 47.23 10.46 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.025 -1.047 . . . . 0.0 109.693 176.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -148.31 153.26 38.41 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.786 -172.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.504 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.5 137.87 53.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.799 -0.563 . . . . 0.0 110.246 -173.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -114.83 132.84 56.36 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 174.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.32 158.38 44.39 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 120.109 -0.636 . . . . 0.0 111.024 -175.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.412 ' HG3' ' HD3' ' A' ' 309' ' ' PRO . 37.2 mt-30 -104.55 143.6 32.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.553 -0.717 . . . . 0.0 110.481 173.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.43 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.7 tt -53.69 146.58 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 CA-C-O 121.586 0.708 . . . . 0.0 111.687 -173.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.27 10.0 5.26 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.601 -0.687 . . . . 0.0 112.448 176.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.404 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 20.0 mmtp -95.19 154.99 16.92 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.964 -1.085 . . . . 0.0 110.666 175.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 87.4 m -83.1 126.17 32.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.728 -0.607 . . . . 0.0 110.523 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . 0.504 ' SG ' HD21 ' A' ' 162' ' ' LEU . 49.5 t -114.33 90.08 19.58 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.635 -0.666 . . . . 0.0 110.041 172.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.431 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 21.7 Cg_exo -62.2 129.48 27.19 Favored 'Trans proline' 0 C--N 1.316 -1.158 0 O-C-N 123.225 1.119 . . . . 0.0 110.562 173.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.416 HG12 ' CE1' ' A' ' 142' ' ' PHE . 97.3 mt -124.39 141.96 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 176.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -109.69 135.45 50.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.443 -0.785 . . . . 0.0 110.789 -175.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.3 mm -95.22 134.99 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.68 -0.638 . . . . 0.0 109.669 169.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -116.54 129.03 55.96 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.618 -0.676 . . . . 0.0 110.455 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.666 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.1 m -136.77 159.78 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.566 -0.709 . . . . 0.0 109.868 174.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 81.3 mmm -78.22 -42.45 31.27 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.738 -0.601 . . . . 0.0 110.148 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.2 p -131.7 143.2 48.14 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.799 -0.563 . . . . 0.0 109.702 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.8 Cg_exo -55.55 139.8 82.81 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 O-C-N 123.181 1.095 . . . . 0.0 110.876 -171.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.609 ' HB3' HD21 ' A' ' 288' ' ' LEU . 35.3 Cg_endo -67.6 170.03 14.63 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 O-C-N 123.168 1.088 . . . . 0.0 110.627 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -60.81 157.11 39.53 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 123.419 1.22 . . . . 0.0 110.514 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -78.73 139.13 38.5 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.647 -0.658 . . . . 0.0 110.024 175.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.06 -25.05 29.76 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -174.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -49.98 150.44 2.28 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.334 -1.098 . . . . 0.0 111.443 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.76 155.99 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.794 -0.566 . . . . 0.0 109.736 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.721 HD11 ' HD2' ' A' ' 251' ' ' TYR . 79.7 mt -108.27 137.1 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.667 -0.646 . . . . 0.0 109.437 176.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.743 ' HG2' HD22 ' A' ' 248' ' ' LEU . 61.6 mtt180 -114.99 143.09 45.72 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -176.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.652 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -137.35 127.25 25.7 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.46 -0.775 . . . . 0.0 110.28 176.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.407 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 23.9 ttm -137.22 139.91 29.41 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.787 -0.571 . . . . 0.0 111.086 -176.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.61 ' HD3' HD12 ' A' ' 226' ' ' ILE . 72.1 Cg_endo -91.97 138.22 1.94 Allowed 'Trans proline' 0 C--N 1.319 -0.992 0 C-N-CA 121.051 1.167 . . . . 0.0 110.643 177.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.416 HG13 ' C ' ' A' ' 190' ' ' PRO . 34.9 m -146.52 154.9 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.548 -0.72 . . . . 0.0 110.093 174.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.554 ' HA ' HG22 ' A' ' 282' ' ' ILE . 86.1 m-85 -63.56 159.39 18.86 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.483 -0.761 . . . . 0.0 110.578 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.454 ' HA ' HD12 ' A' ' 283' ' ' LEU . 40.7 ttpt -75.39 -56.6 4.55 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.709 -0.619 . . . . 0.0 110.697 -175.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -79.98 147.61 31.5 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.554 -0.716 . . . . 0.0 110.29 -174.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.448 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.54 -38.51 71.97 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.38 -0.825 . . . . 0.0 110.716 -175.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 20.2 mp0 -56.55 -25.16 51.33 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.441 -0.787 . . . . 0.0 110.55 -176.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.409 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 77.4 m80 -109.84 -20.54 12.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.528 -0.733 . . . . 0.0 111.19 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.448 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -67.29 -20.24 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.202 -0.936 . . . . 0.0 110.527 -175.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.524 HG22 HD11 ' A' ' 126' ' ' ILE . 71.3 p -79.43 -16.87 55.43 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.551 -0.718 . . . . 0.0 110.578 175.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -88.38 137.77 32.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.316 -0.865 . . . . 0.0 110.027 172.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.1 t -72.98 144.35 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.651 -0.656 . . . . 0.0 110.184 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.441 HG22 ' CE2' ' A' ' 192' ' ' TYR . 61.8 t -84.91 138.89 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.569 -0.707 . . . . 0.0 109.175 173.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -134.87 -170.37 2.55 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.401 -0.812 . . . . 0.0 111.326 -167.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -95.37 159.13 15.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.818 -0.551 . . . . 0.0 110.617 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 60.7 m -78.82 160.92 70.74 Favored Pre-proline 0 N--CA 1.497 1.9 0 O-C-N 121.605 -0.684 . . . . 0.0 109.324 174.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -64.09 -47.39 6.5 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 O-C-N 123.17 1.089 . . . . 0.0 109.929 177.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.441 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.3 p-10 -65.44 -43.86 89.11 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.577 -0.702 . . . . 0.0 111.106 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . 0.441 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 55.5 m170 -80.43 -27.71 37.91 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.54 -0.725 . . . . 0.0 111.363 -175.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -69.06 -42.08 76.73 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.447 -0.783 . . . . 0.0 110.177 174.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 22.7 tp -60.56 -39.98 89.95 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.627 -0.67 . . . . 0.0 110.289 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 28.6 t -48.45 138.44 10.25 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.512 -0.742 . . . . 0.0 111.225 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -121.7 130.23 53.3 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.661 -0.649 . . . . 0.0 110.298 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -100.68 24.33 9.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.624 -0.673 . . . . 0.0 110.343 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 52.48 75.05 0.24 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.445 -0.784 . . . . 0.0 110.747 -176.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -66.01 -10.3 38.5 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.685 -0.634 . . . . 0.0 111.365 -174.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -59.29 118.64 6.17 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.165 -0.959 . . . . 0.0 110.366 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 79.31 20.06 70.37 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -114.67 140.65 48.67 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.321 -1.105 . . . . 0.0 110.426 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.1 mt -84.92 -25.06 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.633 -0.667 . . . . 0.0 110.557 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.523 ' HB1' ' HB3' ' A' ' 227' ' ' ARG . . . -124.94 90.01 51.71 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.37 -0.831 . . . . 0.0 110.49 -174.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.437 ' HD2' ' CE2' ' A' ' 236' ' ' TYR . 17.7 Cg_endo -65.06 141.38 69.83 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.283 1.149 . . . . 0.0 110.642 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -61.14 -17.5 52.64 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 O-C-N 123.136 1.072 . . . . 0.0 111.392 -177.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 88.1 p -54.35 -22.25 11.67 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.152 -0.968 . . . . 0.0 111.251 -176.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . 0.422 ' CD2' ' HB3' ' A' ' 236' ' ' TYR . 76.3 m80 -103.58 131.73 50.45 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.441 -0.787 . . . . 0.0 110.252 178.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.775 HD21 ' CE ' ' A' ' 277' ' ' MET . 43.3 tp -60.43 -38.0 82.7 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.637 -0.665 . . . . 0.0 110.306 -178.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.61 HD12 ' HD3' ' A' ' 190' ' ' PRO . 83.7 mt -102.82 136.79 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.785 -0.572 . . . . 0.0 109.744 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.523 ' HB3' ' HB1' ' A' ' 220' ' ' ALA . 79.3 mtm180 -134.05 159.84 39.58 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.749 -0.594 . . . . 0.0 110.187 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.505 HG23 HG21 ' A' ' 247' ' ' VAL . 97.2 t -105.72 146.71 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.71 -0.618 . . . . 0.0 110.09 178.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -118.08 123.91 46.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.738 -0.601 . . . . 0.0 110.444 172.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 95.71 24.05 16.72 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 167.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 33.5 t-20 -135.34 107.61 7.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.323 -1.104 . . . . 0.0 110.057 174.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 32.5 t -62.94 -15.14 54.56 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.677 -0.639 . . . . 0.0 111.309 -177.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -99.98 7.06 45.05 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.196 -0.94 . . . . 0.0 111.591 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.35 128.33 35.84 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.036 -1.04 . . . . 0.0 110.236 177.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -139.73 156.71 46.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.794 -0.566 . . . . 0.0 109.656 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.437 ' CE2' ' HD2' ' A' ' 221' ' ' PRO . 82.1 m-85 -118.72 150.76 39.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.601 -0.687 . . . . 0.0 110.685 -176.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.13 159.92 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.717 -0.614 . . . . 0.0 110.334 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -120.82 130.09 53.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.761 -0.587 . . . . 0.0 110.133 176.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -62.48 122.96 76.87 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.678 -0.639 . . . . 0.0 109.71 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.89 -28.08 67.09 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 O-C-N 123.047 1.025 . . . . 0.0 110.812 -173.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.7 mt -103.9 -50.25 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.469 -0.769 . . . . 0.0 110.899 -170.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.604 HG22 ' HB3' ' A' ' 124' ' ' PRO . 5.6 p -105.34 12.23 31.89 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.364 -0.835 . . . . 0.0 112.014 -170.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 81.09 -21.32 5.89 Favored Glycine 0 N--CA 1.497 2.72 0 O-C-N 121.004 -1.06 . . . . 0.0 111.795 170.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 -45.95 142.05 2.83 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-N 118.673 1.236 . . . . 0.0 112.429 -169.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -108.66 145.45 34.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.575 -0.703 . . . . 0.0 110.151 174.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.9 p -154.85 159.88 40.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.655 -0.653 . . . . 0.0 110.598 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.505 HG21 HG23 ' A' ' 228' ' ' VAL . 8.6 p -122.95 148.28 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.791 -0.568 . . . . 0.0 109.657 177.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.743 HD22 ' HG2' ' A' ' 187' ' ' ARG . 81.2 mt -129.58 154.61 46.9 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.829 -175.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.434 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.8 m -150.85 151.69 30.53 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.851 -0.531 . . . . 0.0 110.02 175.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -71.19 138.74 33.95 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 O-C-N 123.385 1.203 . . . . 0.0 109.988 176.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.721 ' HD2' HD11 ' A' ' 186' ' ' ILE . 60.9 t80 -75.0 127.31 32.94 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.487 -0.758 . . . . 0.0 110.224 174.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -100.0 160.12 28.05 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.738 -0.601 . . . . 0.0 109.983 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.94 157.81 27.46 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.266 1.14 . . . . 0.0 110.432 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.02 149.96 76.16 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 O-C-N 123.218 1.115 . . . . 0.0 110.499 -177.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -61.62 148.63 41.8 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.718 -0.614 . . . . 0.0 110.108 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.84 127.23 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.502 -0.749 . . . . 0.0 110.208 -170.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.16 -10.16 56.65 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.404 HG21 ' CE2' ' A' ' 260' ' ' PHE . 10.0 t -144.86 174.23 11.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.185 -1.185 . . . . 0.0 110.527 175.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -109.34 13.18 24.36 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.489 -0.757 . . . . 0.0 111.923 -166.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.404 ' CE2' HG21 ' A' ' 258' ' ' THR . 46.2 p90 -120.0 168.06 11.54 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.113 -0.992 . . . . 0.0 111.219 -175.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 83.1 m -117.7 145.62 44.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.793 -0.567 . . . . 0.0 109.87 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 41.5 m -116.92 135.43 53.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.622 -0.674 . . . . 0.0 110.88 -175.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 60.3 t -131.54 137.31 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 173.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 171' ' ' PRO . 75.0 mt -104.6 121.07 42.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.533 -0.729 . . . . 0.0 109.953 -171.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.652 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 5.4 m-30 -105.39 153.02 22.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.661 -0.649 . . . . 0.0 110.789 -177.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -136.55 142.95 43.44 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 177.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -113.58 131.87 55.94 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.536 -0.728 . . . . 0.0 110.388 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' MET . . . . . 0.436 ' HG3' HD12 ' A' ' 225' ' ' LEU . 5.4 ppp? -101.01 9.06 42.65 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.624 -0.672 . . . . 0.0 112.011 -175.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . 0.636 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.7 OUTLIER -144.7 164.99 29.32 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.079 -1.013 . . . . 0.0 110.146 172.25 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.611 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.3 p30 -123.06 163.98 19.47 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.391 0.615 . . . . 0.0 110.547 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . 0.428 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 23.9 m -57.82 -33.93 69.13 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.479 -0.763 . . . . 0.0 111.104 -164.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 50.0 p -102.18 13.05 35.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.395 -0.816 . . . . 0.0 112.029 -163.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 29.9 p -96.03 118.04 31.86 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.066 -1.021 . . . . 0.0 110.735 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.75 139.82 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.519 -0.738 . . . . 0.0 110.319 -171.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.04 -5.2 59.28 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.07 -96.75 0.78 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 170.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . 0.775 ' CE ' HD21 ' A' ' 225' ' ' LEU . 15.7 mmt -64.33 -35.23 80.18 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.673 -0.898 . . . . 0.0 110.475 177.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.3 p30 42.63 50.66 4.96 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 33.3 mtp180 54.8 29.5 11.97 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.402 -0.811 . . . . 0.0 111.193 176.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -120.0 104.93 43.35 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.599 -0.688 . . . . 0.0 110.177 175.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -60.39 148.82 89.14 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 O-C-N 123.131 1.069 . . . . 0.0 110.518 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.554 HG22 ' HA ' ' A' ' 192' ' ' TYR . 45.8 pt -131.88 177.42 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.788 0.804 . . . . 0.0 111.087 -176.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 193' ' ' LYS . 21.7 mt -124.44 149.89 46.28 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.699 HD12 ' CE1' ' A' ' 301' ' ' PHE . 82.0 mt -117.98 129.71 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.353 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.579 HG23 ' SG ' ' A' ' 300' ' ' CYS . 81.0 mt -109.81 126.91 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -176.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 57.3 t -118.91 126.81 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.63 HG22 ' HG2' ' A' ' 298' ' ' ARG . 45.6 p -125.28 152.79 44.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.596 -0.69 . . . . 0.0 110.659 -174.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.609 HD21 ' HB3' ' A' ' 180' ' ' PRO . 24.0 tp -102.22 126.16 49.12 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.748 -0.595 . . . . 0.0 109.473 169.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -130.43 150.1 51.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.875 -0.516 . . . . 0.0 109.855 -173.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.825 ' CG2' HD11 ' A' ' 296' ' ' LEU . 22.1 p -89.85 160.89 16.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.619 -0.676 . . . . 0.0 109.897 176.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -55.84 -26.21 45.62 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.574 -0.704 . . . . 0.0 111.03 -176.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 45.3 p30 -90.59 9.7 28.51 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.491 -0.756 . . . . 0.0 111.937 -173.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.87 20.18 44.44 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 120.163 -1.018 . . . . 0.0 110.799 170.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -106.98 140.22 40.14 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.238 -1.154 . . . . 0.0 110.106 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 64.1 t -86.55 131.61 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.641 -0.662 . . . . 0.0 110.226 -173.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.825 HD11 ' CG2' ' A' ' 290' ' ' THR . 96.3 mt -99.97 -40.08 7.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.724 -0.61 . . . . 0.0 110.694 177.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -164.14 153.5 23.87 Favored Glycine 0 N--CA 1.497 2.736 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.298 -177.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.63 ' HG2' HG22 ' A' ' 287' ' ' THR . 95.1 mtt180 -135.2 136.44 41.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.749 -0.853 . . . . 0.0 110.719 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . 0.403 ' HG3' ' HA ' ' A' ' 139' ' ' ASP . 28.2 mmt180 -139.38 156.91 46.69 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.622 -0.674 . . . . 0.0 110.001 169.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . 0.579 ' SG ' HG23 ' A' ' 285' ' ' ILE . 80.6 m -141.8 157.23 45.26 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.459 -0.776 . . . . 0.0 110.622 -174.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.699 ' CE1' HD12 ' A' ' 284' ' ' ILE . 49.6 p90 -144.94 162.31 37.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.637 -0.664 . . . . 0.0 110.144 176.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.421 ' HA ' HD23 ' A' ' 283' ' ' LEU . 34.9 tt0 -104.88 134.97 47.11 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.596 -0.69 . . . . 0.0 110.184 -177.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -121.05 142.79 49.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.578 -0.702 . . . . 0.0 110.867 -169.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -137.06 138.95 40.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.792 -0.567 . . . . 0.0 109.622 172.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.636 HD13 ' O ' ' A' ' 269' ' ' CYS . 77.0 mt -108.28 122.81 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.549 -0.719 . . . . 0.0 109.763 177.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.1 p -145.29 168.88 19.38 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.64 -0.662 . . . . 0.0 110.615 -171.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -71.53 -40.07 70.32 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.695 -0.628 . . . . 0.0 110.664 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.8 t -127.25 85.34 61.2 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.532 -0.73 . . . . 0.0 110.568 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . 0.412 ' HD3' ' HG3' ' A' ' 165' ' ' GLN . 47.9 Cg_exo -55.39 -27.23 57.2 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 O-C-N 123.224 1.118 . . . . 0.0 110.728 174.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -68.39 -37.72 86.26 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -71.14 -38.36 72.26 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.605 -0.938 . . . . 0.0 109.74 -174.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -69.36 -35.39 75.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.68 -0.637 . . . . 0.0 110.11 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.462 ' HD3' HG22 ' A' ' 147' ' ' THR . 47.3 ttt180 -58.52 -46.25 87.14 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.55 -0.719 . . . . 0.0 110.43 174.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -64.53 -38.01 89.52 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.647 -0.658 . . . . 0.0 110.345 178.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -62.65 -51.79 65.89 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.484 -0.76 . . . . 0.0 110.578 -173.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . 0.543 ' OD1' HD11 ' A' ' 159' ' ' LEU . 3.8 p30 -61.44 -37.74 84.66 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.457 -0.777 . . . . 0.0 110.031 -176.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -64.67 -41.1 96.32 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.236 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -62.47 -35.08 78.2 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.693 -0.63 . . . . 0.0 110.058 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 24.3 m -62.76 -32.62 73.81 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.742 -0.599 . . . . 0.0 110.209 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 83.4 mt -78.46 -46.5 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.72 -0.612 . . . . 0.0 109.919 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -59.49 -42.41 92.08 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.621 -0.674 . . . . 0.0 110.459 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -66.3 -47.07 74.78 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.689 -0.632 . . . . 0.0 110.201 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -63.62 -36.65 84.53 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.727 -0.608 . . . . 0.0 110.295 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -104.95 124.99 50.46 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.64 -0.663 . . . . 0.0 110.492 -175.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 62.6 t -121.14 130.11 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.678 -0.639 . . . . 0.0 109.793 177.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 30.4 t -95.09 138.18 33.16 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.608 -0.682 . . . . 0.0 110.263 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -87.98 115.46 25.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.673 -0.642 . . . . 0.0 110.177 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 51.2 m -80.06 150.92 30.16 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.59 -0.694 . . . . 0.0 110.186 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 331' ' ' ASN . 9.7 t -143.29 152.31 41.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.663 -0.648 . . . . 0.0 110.386 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -60.83 -40.4 92.65 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.693 -0.629 . . . . 0.0 110.584 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . 0.562 ' O ' HG23 ' A' ' 329' ' ' THR . 88.3 m-20 -107.92 145.72 33.39 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.653 -0.654 . . . . 0.0 110.271 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -59.07 -36.8 90.12 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . 0.401 ' OD2' ' CZ ' ' A' ' 335' ' ' PHE . 18.4 t70 -87.07 114.51 23.75 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.61 -0.935 . . . . 0.0 110.123 177.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -109.4 146.6 34.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.536 -0.728 . . . . 0.0 110.364 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.401 ' CZ ' ' OD2' ' A' ' 333' ' ' ASP . 99.2 m-85 -115.49 146.64 41.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.726 -0.609 . . . . 0.0 110.146 177.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 51.78 -166.7 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.422 -0.799 . . . . 0.0 110.968 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -142.37 159.14 42.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.685 -0.635 . . . . 0.0 110.448 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -91.92 13.51 18.35 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.689 -0.632 . . . . 0.0 111.151 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 41.5 m -59.77 -37.03 77.9 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.319 -0.863 . . . . 0.0 110.342 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 83.5 t60 52.79 26.07 4.28 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.475 -0.766 . . . . 0.0 111.074 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 94.72 -44.2 2.25 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 178.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.437 HG22 ' O ' ' A' ' 344' ' ' MET . 82.2 mt -94.31 129.82 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.574 -0.956 . . . . 0.0 110.124 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -85.02 -30.06 24.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.682 -0.636 . . . . 0.0 110.196 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . 0.437 ' O ' HG22 ' A' ' 342' ' ' ILE . 10.9 tpt -98.01 135.43 39.73 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.658 -0.651 . . . . 0.0 110.281 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.225 -179.973 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 76.7 p -156.17 164.51 38.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.595 -0.944 . . . . 0.0 110.247 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 29.5 t -119.74 141.5 49.37 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.648 -0.657 . . . . 0.0 110.225 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.8 p -124.25 163.32 21.86 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.655 -0.653 . . . . 0.0 110.139 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -131.97 156.55 45.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.662 -0.648 . . . . 0.0 110.294 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -85.81 143.83 28.07 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.655 -0.653 . . . . 0.0 110.362 -178.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 50.69 -158.73 0.09 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.473 -0.767 . . . . 0.0 111.167 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 26.3 tp 56.77 158.93 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.67 -0.644 . . . . 0.0 110.831 -175.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.3 m -82.9 171.86 10.76 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.534 -0.729 . . . . 0.0 110.27 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -66.68 152.22 82.49 Favored 'Cis proline' 0 N--CA 1.496 1.635 0 C-N-CA 123.128 -1.613 . . . . 0.0 110.501 -13.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.403 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . 49.3 m -81.59 146.82 57.81 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.651 -0.656 . . . . 0.0 110.127 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 123' ' ' SER . 24.3 Cg_exo -59.83 145.01 99.34 Favored 'Trans proline' 0 N--CA 1.487 1.128 0 O-C-N 123.194 1.102 . . . . 0.0 110.569 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.97 145.59 40.21 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.597 -0.689 . . . . 0.0 110.202 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 50.4 mm -120.0 139.99 29.12 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.632 -0.667 . . . . 0.0 109.909 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -61.72 149.83 88.31 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 O-C-N 123.134 1.071 . . . . 0.0 110.353 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.8 t -114.24 143.07 45.44 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.629 -0.669 . . . . 0.0 110.275 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -101.42 25.8 7.95 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.617 -0.677 . . . . 0.0 110.634 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 54.4 m -78.85 125.22 29.08 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.554 -0.716 . . . . 0.0 110.231 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -70.33 144.86 51.55 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.632 -0.667 . . . . 0.0 110.396 -178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -158.37 101.21 1.71 Allowed Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.684 -0.635 . . . . 0.0 110.182 178.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -58.76 -39.96 77.12 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 O-C-N 123.086 1.045 . . . . 0.0 110.844 -175.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.82 -155.08 40.49 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -73.11 -49.05 0.24 Allowed 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.308 1.162 . . . . 0.0 110.911 -174.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -85.43 6.99 24.32 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.617 -0.677 . . . . 0.0 111.425 -175.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.97 61.92 2.84 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.949 -1.095 . . . . 0.0 110.608 -176.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.728 ' HA ' HG12 ' A' ' 176' ' ' VAL . 60.2 t80 -77.97 120.48 22.88 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.525 -0.735 . . . . 0.0 109.983 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -129.79 159.92 35.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.835 -0.541 . . . . 0.0 110.124 -176.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.2 t -124.96 145.8 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.792 -0.568 . . . . 0.0 109.889 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.9 p -155.01 162.25 41.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.81 -0.556 . . . . 0.0 109.92 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.472 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 75.3 m-85 -126.66 125.23 41.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.808 -0.558 . . . . 0.0 109.799 -175.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -58.06 144.6 39.37 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.655 -0.653 . . . . 0.0 110.394 -174.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -93.61 138.96 31.32 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.617 -0.677 . . . . 0.0 110.35 -175.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 28.5 t -131.06 148.34 52.73 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.754 -0.591 . . . . 0.0 110.09 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 41.7 m -60.58 158.43 12.42 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.609 -0.682 . . . . 0.0 110.133 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 147' ' ' THR . 7.7 t -70.91 67.51 0.4 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.734 -0.604 . . . . 0.0 110.283 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -78.13 149.61 33.8 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.605 -0.684 . . . . 0.0 110.161 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -58.59 145.14 40.56 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.62 -0.675 . . . . 0.0 110.473 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.8 p 50.8 49.1 21.69 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.581 -0.699 . . . . 0.0 111.315 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.74 130.74 43.7 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.676 -0.64 . . . . 0.0 110.026 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 82.3 p -60.02 -34.05 72.84 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.751 -0.593 . . . . 0.0 109.944 176.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.435 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -172.04 144.02 1.63 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.763 -0.585 . . . . 0.0 110.164 178.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 13.3 t -142.17 142.57 32.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.84 -0.538 . . . . 0.0 109.947 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.472 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 63.7 t80 -125.56 140.06 53.06 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.548 -0.72 . . . . 0.0 110.553 -172.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.9 t -110.23 124.26 51.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.837 -0.539 . . . . 0.0 109.827 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 58.5 m -70.66 -37.03 73.67 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.772 -0.58 . . . . 0.0 110.481 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -59.66 -34.7 73.16 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.553 -0.717 . . . . 0.0 110.43 -177.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.705 HD21 HD11 ' A' ' 320' ' ' ILE . 57.5 mt -104.86 -11.75 16.6 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.662 -0.649 . . . . 0.0 110.864 -175.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 26.2 tttp 59.83 52.03 5.69 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.02 -1.05 . . . . 0.0 109.715 178.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -144.96 152.77 40.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.74 -0.6 . . . . 0.0 110.587 -175.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.627 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.5 tp -126.61 137.81 53.36 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.758 -0.589 . . . . 0.0 110.338 -176.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -115.18 135.45 54.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.616 -0.677 . . . . 0.0 109.243 173.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.8 p -138.28 158.38 44.41 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.922 -175.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.416 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 52.9 mt-30 -104.53 143.02 33.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.593 -0.692 . . . . 0.0 110.131 173.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.432 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 16.8 tt -52.54 146.28 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.499 -0.751 . . . . 0.0 111.895 -173.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.81 10.04 5.78 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.579 -0.7 . . . . 0.0 112.471 176.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.416 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 53.4 mmtt -95.64 155.08 16.89 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.961 -1.087 . . . . 0.0 110.897 174.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 90.5 m -82.94 126.17 32.21 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.628 -0.67 . . . . 0.0 110.689 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . 0.627 ' SG ' HD21 ' A' ' 162' ' ' LEU . 43.6 t -114.23 90.09 19.29 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.657 -0.652 . . . . 0.0 110.108 172.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.435 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 17.4 Cg_exo -63.79 129.41 24.7 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 123.248 1.13 . . . . 0.0 110.581 173.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.404 HG12 ' CE2' ' A' ' 142' ' ' PHE . 97.5 mt -123.12 141.35 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 175.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -108.13 136.39 47.89 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.476 -0.765 . . . . 0.0 110.737 -175.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.443 HG21 ' CE1' ' A' ' 138' ' ' PHE . 48.6 mm -95.37 135.02 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.719 -0.613 . . . . 0.0 109.633 170.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -117.18 129.31 55.86 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.662 -0.649 . . . . 0.0 110.426 176.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.728 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.0 m -136.63 159.77 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.478 -0.764 . . . . 0.0 110.047 175.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 80.8 mmm -77.59 -40.24 42.85 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.745 -0.597 . . . . 0.0 110.007 177.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.9 p -135.51 143.28 44.45 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.832 -0.542 . . . . 0.0 109.675 177.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.6 Cg_exo -55.57 139.89 83.04 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 O-C-N 123.14 1.074 . . . . 0.0 110.887 -172.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.77 ' HB3' HD21 ' A' ' 288' ' ' LEU . 31.3 Cg_endo -67.35 170.04 14.26 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 O-C-N 123.25 1.132 . . . . 0.0 110.633 177.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -60.45 154.98 49.75 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.431 1.227 . . . . 0.0 110.546 -178.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -77.43 140.08 39.8 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.581 -0.699 . . . . 0.0 109.95 175.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.73 -25.06 28.96 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -174.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.22 153.08 1.56 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.363 -1.08 . . . . 0.0 111.41 178.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 33.9 m -129.66 155.93 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.661 -0.649 . . . . 0.0 109.686 176.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.705 HD11 ' HD2' ' A' ' 251' ' ' TYR . 82.6 mt -107.85 137.21 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.688 -0.633 . . . . 0.0 109.462 175.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.748 ' HG2' HD22 ' A' ' 248' ' ' LEU . 32.1 mtm180 -115.06 143.37 45.29 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 -176.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.664 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -136.62 126.48 25.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.568 -0.707 . . . . 0.0 110.235 175.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 23.8 ttp -137.24 137.14 21.8 Favored Pre-proline 0 N--CA 1.497 1.884 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.934 -176.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.643 ' HD3' HD12 ' A' ' 226' ' ' ILE . 72.7 Cg_endo -90.74 138.21 2.47 Favored 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 123.169 1.089 . . . . 0.0 110.706 177.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.427 HG13 ' C ' ' A' ' 190' ' ' PRO . 34.9 m -147.48 154.84 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.467 -0.771 . . . . 0.0 110.191 174.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.658 ' HA ' HG22 ' A' ' 282' ' ' ILE . 79.4 m-85 -63.8 162.81 12.82 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.546 -0.721 . . . . 0.0 110.487 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -79.35 -60.04 2.52 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.669 -0.644 . . . . 0.0 110.905 -173.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -80.11 150.66 30.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.574 -0.704 . . . . 0.0 110.281 -174.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.457 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.58 -38.12 71.53 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.424 -0.797 . . . . 0.0 110.686 -175.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -56.77 -24.91 53.54 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.494 -0.754 . . . . 0.0 110.565 -176.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.4 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 81.0 m-70 -109.68 -20.55 12.79 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.954 -0.699 . . . . 0.0 111.102 -178.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -67.71 -20.25 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.223 -0.923 . . . . 0.0 110.447 -176.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 67.2 p -79.37 -17.12 55.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.496 -0.752 . . . . 0.0 110.7 175.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -88.25 134.17 33.86 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.336 -0.853 . . . . 0.0 109.945 172.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.0 t -72.84 141.84 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.63 -0.669 . . . . 0.0 110.211 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.626 HG22 ' CZ ' ' A' ' 192' ' ' TYR . 58.4 t -84.86 140.05 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.571 -0.706 . . . . 0.0 109.153 171.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -134.71 -170.57 2.58 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.471 -0.768 . . . . 0.0 111.054 -170.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 13.6 mmp_? -95.62 157.35 15.94 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.732 -0.605 . . . . 0.0 110.106 178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 49.8 m -75.15 154.72 86.41 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.539 -0.726 . . . . 0.0 109.263 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.403 ' HD3' ' HA3' ' A' ' 275' ' ' GLY . 17.6 Cg_exo -62.74 -47.44 8.96 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 O-C-N 123.181 1.095 . . . . 0.0 110.067 177.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.442 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.7 p-10 -65.46 -44.45 87.17 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.573 -0.705 . . . . 0.0 111.232 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . 0.442 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 53.9 m170 -81.04 -27.83 35.6 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.413 -0.805 . . . . 0.0 111.346 -174.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -69.13 -42.07 76.51 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.429 -0.794 . . . . 0.0 110.027 171.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 27.3 tp -70.05 -32.79 71.08 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.666 -0.646 . . . . 0.0 110.373 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.4 t -48.46 -33.03 8.66 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.671 -0.643 . . . . 0.0 111.75 -176.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -116.35 125.46 52.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.575 -0.703 . . . . 0.0 110.209 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -127.38 164.07 22.63 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.727 -0.608 . . . . 0.0 110.394 -177.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 53.17 75.13 0.26 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.42 -0.8 . . . . 0.0 110.854 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -83.32 8.1 14.56 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.597 -0.689 . . . . 0.0 111.358 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -60.21 122.86 15.5 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.037 -1.039 . . . . 0.0 110.11 173.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 95.01 2.28 62.57 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -177.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -114.56 146.41 40.8 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.05 -1.265 . . . . 0.0 110.404 175.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.4 mt -84.87 -24.33 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.706 -0.621 . . . . 0.0 110.764 -174.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.627 ' HB1' ' HD2' ' A' ' 227' ' ' ARG . . . -124.8 94.47 44.2 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.335 -0.853 . . . . 0.0 110.622 -173.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.445 ' HD2' ' CE2' ' A' ' 236' ' ' TYR . 17.3 Cg_exo -63.52 139.17 68.92 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 O-C-N 123.335 1.176 . . . . 0.0 110.514 -178.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -60.79 -18.38 55.87 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 O-C-N 123.035 1.018 . . . . 0.0 111.23 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 86.5 p -56.19 -21.22 21.7 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.282 -0.886 . . . . 0.0 111.216 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . 0.432 ' CE1' ' HB3' ' A' ' 236' ' ' TYR . 98.5 m-70 -107.08 130.21 54.71 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.479 -0.763 . . . . 0.0 110.496 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 48.8 tp -61.6 -38.04 86.12 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.731 -0.606 . . . . 0.0 110.253 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.643 HD12 ' HD3' ' A' ' 190' ' ' PRO . 86.2 mt -101.39 136.75 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.803 -0.561 . . . . 0.0 109.889 -175.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.627 ' HD2' ' HB1' ' A' ' 220' ' ' ALA . 79.1 mtm180 -135.18 159.72 40.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.71 -0.619 . . . . 0.0 110.317 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.493 HG23 HG21 ' A' ' 247' ' ' VAL . 94.6 t -105.18 146.82 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.704 -0.622 . . . . 0.0 110.138 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -120.99 124.51 45.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.777 -0.577 . . . . 0.0 110.27 172.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.78 24.16 11.09 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 169.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 -140.6 106.42 5.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.397 -1.06 . . . . 0.0 109.976 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 43.2 m -63.19 -15.28 56.46 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.519 -0.738 . . . . 0.0 111.341 -175.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -99.98 7.53 44.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 111.675 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.74 130.64 46.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.192 -0.942 . . . . 0.0 110.172 177.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -139.79 158.0 44.81 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.784 -0.572 . . . . 0.0 109.715 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.445 ' CE2' ' HD2' ' A' ' 221' ' ' PRO . 80.4 m-85 -116.03 150.66 36.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.569 -0.707 . . . . 0.0 110.435 -177.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.16 159.88 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.79 -0.569 . . . . 0.0 110.26 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -123.43 128.25 49.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.73 -0.607 . . . . 0.0 110.08 174.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -65.12 130.05 94.68 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.669 -0.644 . . . . 0.0 109.85 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -67.07 -27.4 42.22 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 O-C-N 123.128 1.067 . . . . 0.0 111.008 -173.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 84.2 mt -100.57 -50.35 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.369 -0.832 . . . . 0.0 110.923 -168.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.3 p -105.28 12.13 32.12 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.338 -0.852 . . . . 0.0 111.831 -174.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.92 -5.43 12.82 Favored Glycine 0 N--CA 1.497 2.709 0 O-C-N 121.137 -0.977 . . . . 0.0 111.909 173.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 68.3 mmt-85 -46.04 142.0 2.94 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-N 119.192 1.496 . . . . 0.0 112.296 -175.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -109.24 140.8 42.4 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.682 -0.636 . . . . 0.0 110.037 172.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 78.5 p -154.75 159.99 41.02 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.591 -0.693 . . . . 0.0 110.689 178.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.493 HG21 HG23 ' A' ' 228' ' ' VAL . 8.2 p -124.17 148.32 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.798 -0.564 . . . . 0.0 109.657 176.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.748 HD22 ' HG2' ' A' ' 187' ' ' ARG . 84.4 mt -129.57 154.58 46.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.638 -0.664 . . . . 0.0 109.963 -175.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.446 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.9 m -151.28 151.71 29.72 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.794 -0.566 . . . . 0.0 109.947 176.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -71.08 138.95 34.7 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 O-C-N 123.275 1.145 . . . . 0.0 110.15 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.705 ' HD2' HD11 ' A' ' 186' ' ' ILE . 58.3 t80 -74.88 126.06 30.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.525 -0.734 . . . . 0.0 110.233 175.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -99.99 160.07 28.17 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.683 -0.635 . . . . 0.0 109.993 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.83 159.02 22.34 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 O-C-N 123.211 1.111 . . . . 0.0 110.529 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.38 149.98 77.93 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 O-C-N 123.251 1.132 . . . . 0.0 110.471 -178.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -61.31 146.94 46.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.737 -0.602 . . . . 0.0 110.233 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.94 127.25 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.517 -0.74 . . . . 0.0 110.164 -171.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.03 -10.15 55.25 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 10.0 t -144.0 173.44 11.71 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.168 -1.195 . . . . 0.0 110.625 175.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -106.83 13.15 28.19 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.612 -0.68 . . . . 0.0 111.756 -168.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -119.93 167.96 11.61 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.227 -0.921 . . . . 0.0 111.192 -175.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 94.1 m -117.75 146.31 43.87 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.762 -0.586 . . . . 0.0 109.868 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 39.7 m -116.74 135.77 53.5 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.577 -0.702 . . . . 0.0 110.941 -175.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.0 t -130.78 137.19 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 172.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 69.8 mt -104.53 121.6 43.82 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.49 -0.756 . . . . 0.0 109.94 -172.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.664 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 4.7 m-30 -106.56 154.84 20.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.65 -0.656 . . . . 0.0 110.824 -177.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -136.19 142.94 44.17 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -112.86 127.2 56.12 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.737 -0.602 . . . . 0.0 110.057 176.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 4.5 ppp? -95.74 7.3 46.7 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.705 -0.622 . . . . 0.0 111.898 -176.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . 0.672 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.8 OUTLIER -144.87 164.98 29.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.12 -0.987 . . . . 0.0 109.883 174.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.575 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.3 p30 -120.37 160.82 22.29 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.722 -0.611 . . . . 0.0 110.236 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . 0.419 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 24.0 m -58.99 -31.72 69.03 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.458 -0.776 . . . . 0.0 110.908 -163.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 72.9 m -94.99 8.93 41.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.602 -0.686 . . . . 0.0 112.098 -164.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 31.9 p -95.42 118.18 31.69 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.03 -1.044 . . . . 0.0 110.869 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.11 141.05 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.467 -0.771 . . . . 0.0 110.324 -172.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . 0.403 ' HA3' ' HD3' ' A' ' 206' ' ' PRO . . . 100.78 -5.22 56.56 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.0 -105.39 1.13 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 169.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . 0.431 ' SD ' HD13 ' A' ' 282' ' ' ILE . 97.0 mmm -61.35 -36.93 81.57 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.691 -0.888 . . . . 0.0 110.15 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 40.45 55.04 2.9 Favored 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 121.42 0.629 . . . . 0.0 112.664 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 55.62 34.09 22.53 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.456 -0.777 . . . . 0.0 111.523 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . 0.444 ' NH2' ' CZ ' ' A' ' 192' ' ' TYR . 35.6 mtm180 -120.12 106.09 41.44 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.295 -0.878 . . . . 0.0 110.161 165.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -60.7 147.98 93.13 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 O-C-N 123.073 1.039 . . . . 0.0 110.416 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.658 HG22 ' HA ' ' A' ' 192' ' ' TYR . 43.9 pt -131.94 179.52 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-O 121.798 0.808 . . . . 0.0 111.001 -176.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.479 HD23 ' HA ' ' A' ' 302' ' ' GLU . 33.0 mt -124.4 149.93 46.16 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.686 HD12 ' CE1' ' A' ' 301' ' ' PHE . 82.6 mt -115.17 129.9 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.609 HG23 ' SG ' ' A' ' 300' ' ' CYS . 77.7 mt -109.76 126.9 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -176.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 57.6 t -118.93 126.66 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.461 HG22 ' HG2' ' A' ' 298' ' ' ARG . 45.0 p -125.21 152.95 43.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.618 -0.676 . . . . 0.0 110.692 -174.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.77 HD21 ' HB3' ' A' ' 180' ' ' PRO . 26.3 tp -101.52 126.94 48.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.66 -0.65 . . . . 0.0 109.483 168.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.623 ' OE2' HG13 ' A' ' 295' ' ' VAL . 72.1 mm-40 -131.61 150.88 52.0 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -173.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.731 HG22 HD11 ' A' ' 296' ' ' LEU . 80.0 p -89.92 159.4 16.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.623 -0.673 . . . . 0.0 109.726 177.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 68.4 ttp85 -55.96 -26.02 46.31 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.619 -0.676 . . . . 0.0 110.796 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -87.62 9.72 20.36 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.5 -0.75 . . . . 0.0 111.841 -174.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 87.31 20.13 53.15 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 120.159 -1.02 . . . . 0.0 110.779 170.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -107.22 140.19 40.48 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.364 -1.08 . . . . 0.0 110.238 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.623 HG13 ' OE2' ' A' ' 289' ' ' GLU . 60.7 t -88.1 132.33 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.619 -0.676 . . . . 0.0 110.194 -174.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.731 HD11 HG22 ' A' ' 290' ' ' THR . 95.8 mt -99.94 -40.18 7.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.635 -0.666 . . . . 0.0 110.5 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -165.25 153.45 23.58 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.461 ' HG2' HG22 ' A' ' 287' ' ' THR . 78.5 mtm180 -134.72 136.24 42.55 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.672 -0.899 . . . . 0.0 110.908 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -134.0 158.5 43.37 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.572 -0.705 . . . . 0.0 109.77 170.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . 0.609 ' SG ' HG23 ' A' ' 285' ' ' ILE . 93.6 m -142.91 154.2 43.86 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.444 -0.785 . . . . 0.0 110.772 -175.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.686 ' CE1' HD12 ' A' ' 284' ' ' ILE . 46.0 p90 -145.0 162.1 37.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.702 -0.624 . . . . 0.0 110.017 175.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.479 ' HA ' HD23 ' A' ' 283' ' ' LEU . 57.1 tt0 -104.93 136.15 44.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.537 -0.727 . . . . 0.0 110.116 -178.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -122.55 144.05 49.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.647 -0.658 . . . . 0.0 110.769 -169.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -138.52 137.14 36.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.832 -0.543 . . . . 0.0 109.757 173.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.672 HD13 ' O ' ' A' ' 269' ' ' CYS . 67.5 mt -105.88 122.84 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.582 -0.699 . . . . 0.0 109.423 175.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.1 p -145.14 169.45 18.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.559 -0.713 . . . . 0.0 111.038 -169.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -69.63 -40.02 76.82 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.673 -0.642 . . . . 0.0 110.626 -178.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 4.2 t -131.39 88.34 44.22 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.578 -0.702 . . . . 0.0 110.5 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -55.25 -29.45 67.07 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 O-C-N 123.207 1.109 . . . . 0.0 111.023 174.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.43 -37.91 93.1 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.4 ttm-85 -73.47 -40.28 64.26 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.684 -0.892 . . . . 0.0 109.795 -173.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -69.43 -40.45 77.24 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.077 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -61.27 -44.54 97.07 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.271 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 28.9 tttp -64.01 -40.45 96.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.552 -0.717 . . . . 0.0 110.498 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.55 -50.6 71.99 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.487 -0.758 . . . . 0.0 110.476 -173.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -61.57 -37.83 85.27 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.449 -0.782 . . . . 0.0 110.127 -177.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -63.72 -40.56 97.07 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.646 -0.659 . . . . 0.0 110.178 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -62.61 -35.25 78.97 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.678 -0.639 . . . . 0.0 109.967 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 22.8 t -63.1 -32.51 73.9 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.647 -0.658 . . . . 0.0 110.206 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.705 HD11 HD21 ' A' ' 159' ' ' LEU . 83.8 mt -79.51 -44.07 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.647 -0.658 . . . . 0.0 109.894 -177.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.406 ' HA ' ' HG2' ' A' ' 324' ' ' GLN . 69.7 ttt180 -58.4 -41.3 84.61 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.657 -0.652 . . . . 0.0 110.537 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -63.05 -41.91 99.58 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.631 -0.668 . . . . 0.0 110.257 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -63.77 -32.6 74.15 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.645 -0.659 . . . . 0.0 110.273 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.406 ' HG2' ' HA ' ' A' ' 321' ' ' ARG . 14.7 pt20 -105.15 125.14 50.65 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.665 -0.647 . . . . 0.0 110.637 -175.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 61.6 t -109.02 130.09 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.6 -0.688 . . . . 0.0 109.766 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 53.1 p -80.91 140.01 35.56 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.67 -0.644 . . . . 0.0 110.417 -177.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -117.6 141.8 47.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.632 -0.667 . . . . 0.0 110.216 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 54.3 p -65.1 160.45 21.07 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.669 -0.644 . . . . 0.0 110.214 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 77.1 p -138.72 28.2 2.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.696 -0.627 . . . . 0.0 110.297 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -83.08 146.56 28.63 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.672 -0.642 . . . . 0.0 110.173 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -87.47 10.67 16.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.664 -0.647 . . . . 0.0 111.278 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -84.23 -178.71 51.58 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -84.47 119.21 24.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.698 -0.884 . . . . 0.0 110.217 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -92.69 138.6 31.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.634 -0.666 . . . . 0.0 110.207 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -60.54 -38.69 85.29 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.676 -0.64 . . . . 0.0 110.303 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 51.37 90.54 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.362 -0.836 . . . . 0.0 111.128 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -60.66 -34.85 74.92 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.617 -0.677 . . . . 0.0 110.239 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -105.45 142.71 34.74 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.672 -0.643 . . . . 0.0 110.22 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 75.4 p -101.2 24.02 10.06 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.599 -0.688 . . . . 0.0 110.672 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -119.79 131.72 55.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.486 -0.759 . . . . 0.0 110.254 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -85.33 -176.69 50.6 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 26.9 pt -96.7 151.78 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.657 -0.908 . . . . 0.0 110.364 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -91.35 143.81 26.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.627 -0.671 . . . . 0.0 110.267 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 88.3 mtp -60.1 -35.21 74.71 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.592 -0.693 . . . . 0.0 110.344 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 10.3 m . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.288 -179.889 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 29.1 t -156.43 150.02 24.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.643 -0.916 . . . . 0.0 110.215 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 45.1 m -62.11 157.12 19.8 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.673 -0.642 . . . . 0.0 110.106 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.551 HG23 ' H ' ' A' ' 119' ' ' ALA . 6.2 t -64.93 146.79 54.48 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.687 -0.633 . . . . 0.0 110.343 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -63.5 -43.06 98.35 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.716 -0.615 . . . . 0.0 110.553 -177.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -78.93 -36.05 42.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.631 -0.668 . . . . 0.0 110.284 -174.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.551 ' H ' HG23 ' A' ' 116' ' ' THR . . . 57.01 -84.59 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.664 -0.648 . . . . 0.0 110.761 -176.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.721 HD13 ' N ' ' A' ' 121' ' ' SER . 0.5 OUTLIER -85.36 134.23 34.1 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.255 -0.903 . . . . 0.0 110.051 -178.405 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.721 ' N ' HD13 ' A' ' 120' ' ' LEU . 3.9 m -76.15 110.56 11.49 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.678 -0.639 . . . . 0.0 110.17 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 121' ' ' SER . 14.3 Cg_endo -61.02 151.99 74.42 Favored 'Trans proline' 0 N--CA 1.488 1.149 0 O-C-N 123.072 1.038 . . . . 0.0 110.432 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.0 m -81.71 150.95 67.24 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.62 -0.675 . . . . 0.0 110.163 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.494 ' HB3' HG22 ' A' ' 242' ' ' THR . 15.2 Cg_endo -61.65 147.79 94.53 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.334 1.176 . . . . 0.0 110.385 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.6 142.54 42.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.672 -0.642 . . . . 0.0 110.152 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.54 HD11 HG22 ' A' ' 199' ' ' THR . 50.8 mm -122.76 100.03 41.16 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.667 -0.645 . . . . 0.0 109.953 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -60.79 151.0 80.06 Favored 'Trans proline' 0 C--N 1.317 -1.122 0 O-C-N 123.213 1.112 . . . . 0.0 110.53 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.0 t -114.57 148.03 38.6 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.631 -0.668 . . . . 0.0 110.261 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.5 p-10 -95.15 24.63 4.8 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.655 -0.653 . . . . 0.0 110.794 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 50.4 m -73.33 125.17 27.22 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.573 -0.705 . . . . 0.0 110.263 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -72.67 145.05 47.5 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.614 -0.679 . . . . 0.0 110.346 -178.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -154.8 101.41 2.34 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.747 -0.596 . . . . 0.0 110.24 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -58.92 -39.97 76.14 Favored 'Trans proline' 0 N--CA 1.488 1.18 0 O-C-N 123.151 1.079 . . . . 0.0 110.803 -177.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.31 -155.12 48.52 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -72.78 -46.88 0.38 Allowed 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 123.399 1.21 . . . . 0.0 111.066 -173.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -87.59 9.83 19.93 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.523 -0.736 . . . . 0.0 111.396 -173.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.81 59.69 4.13 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.983 -1.073 . . . . 0.0 110.58 -175.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.679 ' HA ' HG12 ' A' ' 176' ' ' VAL . 67.8 t80 -77.83 118.36 20.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.714 -0.616 . . . . 0.0 109.861 -179.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.407 ' HA ' ' HG3' ' A' ' 299' ' ' ARG . 18.4 t70 -130.02 159.89 35.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.781 -0.575 . . . . 0.0 110.193 -177.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 70.9 t -124.22 147.34 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.704 -0.622 . . . . 0.0 109.857 174.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 76.5 p -154.91 162.76 40.99 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 120.378 -0.529 . . . . 0.0 109.956 177.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.49 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 74.9 m-85 -126.66 125.27 41.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.81 -0.556 . . . . 0.0 109.897 -175.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -56.83 140.81 46.86 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.618 -0.676 . . . . 0.0 110.554 -174.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -101.83 130.0 48.18 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.727 -0.608 . . . . 0.0 110.45 -175.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 51.1 m -122.03 150.68 41.76 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.677 -0.64 . . . . 0.0 110.153 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.9 m -60.55 160.76 8.52 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.604 -0.685 . . . . 0.0 110.164 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.667 HG22 ' HD3' ' A' ' 313' ' ' ARG . 68.8 p -62.35 86.49 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.716 -0.615 . . . . 0.0 110.231 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.02 158.38 17.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.687 -0.633 . . . . 0.0 110.266 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -78.51 142.37 37.47 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.647 -0.658 . . . . 0.0 110.042 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.76 55.29 9.22 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.332 -0.855 . . . . 0.0 110.942 -178.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.7 129.88 35.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.6 -0.688 . . . . 0.0 110.137 177.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.468 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 73.1 p -60.13 -33.76 72.59 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.678 -0.639 . . . . 0.0 109.974 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.468 ' HD1' ' HG1' ' A' ' 152' ' ' THR . 68.6 p-90 -171.03 144.68 2.16 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.356 0.598 . . . . 0.0 110.289 178.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 9.5 t -142.2 142.65 32.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.846 -0.534 . . . . 0.0 110.064 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.49 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 62.7 t80 -125.42 140.02 53.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.522 -0.736 . . . . 0.0 110.483 -172.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.4 t -110.09 124.94 52.41 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 120.386 -0.526 . . . . 0.0 109.872 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 49.5 m -70.73 -37.05 73.46 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.391 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -60.28 -32.27 71.03 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.635 -0.666 . . . . 0.0 110.323 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.442 HD11 ' HB2' ' A' ' 316' ' ' ASP . 59.2 mt -104.76 -12.12 16.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.73 -0.606 . . . . 0.0 110.835 -174.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 71.4 tttt 59.78 47.47 10.27 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.019 -1.051 . . . . 0.0 109.58 177.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 47.7 tttp -146.68 153.15 39.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.706 -0.621 . . . . 0.0 110.666 -172.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.641 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.41 137.79 53.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.776 -0.577 . . . . 0.0 110.307 -176.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -114.92 131.62 56.82 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 175.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.3 158.48 44.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.69 -0.631 . . . . 0.0 110.941 -173.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.406 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 39.3 mt-30 -104.69 141.47 36.4 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.47 0.652 . . . . 0.0 110.351 172.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.435 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 16.7 tt -52.19 148.06 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 121.622 0.725 . . . . 0.0 111.857 -174.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.29 10.01 5.29 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.558 -0.714 . . . . 0.0 112.516 177.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.406 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 54.9 mmtt -96.65 155.08 16.92 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.892 -1.13 . . . . 0.0 110.889 174.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 86.8 m -83.5 126.2 32.54 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.73 -0.606 . . . . 0.0 110.602 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . 0.641 ' SG ' HD21 ' A' ' 162' ' ' LEU . 44.4 t -114.85 90.1 21.44 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.55 -0.719 . . . . 0.0 110.222 173.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.439 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 19.3 Cg_exo -63.27 130.09 27.54 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 O-C-N 123.228 1.12 . . . . 0.0 110.753 173.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.405 HG12 ' CE2' ' A' ' 142' ' ' PHE . 97.0 mt -123.52 143.35 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.664 -0.647 . . . . 0.0 109.317 173.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -109.35 135.48 50.35 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.491 -0.756 . . . . 0.0 110.824 -175.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 48.9 mm -95.29 135.03 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.685 -0.634 . . . . 0.0 109.65 169.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 44.5 tttm -116.43 129.53 56.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.62 -0.675 . . . . 0.0 110.482 176.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.679 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.5 m -136.69 159.76 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.552 -0.718 . . . . 0.0 109.873 174.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.4 mmm -78.44 -41.63 32.33 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.692 -0.63 . . . . 0.0 110.15 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.417 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 76.9 p -133.81 143.2 46.58 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.773 -0.579 . . . . 0.0 109.634 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 34.6 Cg_exo -55.21 139.79 80.94 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 O-C-N 123.191 1.101 . . . . 0.0 110.925 -171.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.729 ' HB3' HD21 ' A' ' 288' ' ' LEU . 30.7 Cg_endo -66.81 170.1 13.39 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.17 1.09 . . . . 0.0 110.588 177.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -60.65 155.06 50.45 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.363 1.191 . . . . 0.0 110.537 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -78.08 140.59 39.09 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.619 -0.676 . . . . 0.0 109.91 175.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.83 -24.92 29.6 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -174.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.2 152.06 1.86 Allowed 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.348 -1.09 . . . . 0.0 111.436 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.79 156.3 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.814 -0.554 . . . . 0.0 109.805 176.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.671 HD11 ' HD2' ' A' ' 251' ' ' TYR . 52.4 mt -109.75 135.56 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.745 ' HG2' HD22 ' A' ' 248' ' ' LEU . 71.1 mtt180 -114.97 145.48 42.2 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -174.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.68 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -139.74 126.58 20.75 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.509 -0.744 . . . . 0.0 110.332 173.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 37.5 ttp -137.39 138.55 25.17 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.78 -0.575 . . . . 0.0 111.093 -176.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.508 ' HD3' HD12 ' A' ' 226' ' ' ILE . 73.9 Cg_endo -90.75 138.15 2.45 Favored 'Trans proline' 0 C--N 1.32 -0.941 0 O-C-N 123.207 1.109 . . . . 0.0 110.808 176.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.456 HG12 ' CZ ' ' A' ' 244' ' ' ARG . 34.8 m -147.31 154.78 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.487 -0.758 . . . . 0.0 110.109 173.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.645 ' HA ' HG22 ' A' ' 282' ' ' ILE . 90.4 m-85 -62.18 166.43 4.85 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.41 -0.806 . . . . 0.0 110.477 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -83.09 -60.04 2.28 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.671 -0.643 . . . . 0.0 110.824 -175.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 39.6 mttp -80.06 151.14 30.06 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.609 -0.682 . . . . 0.0 110.328 -175.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.456 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.55 -38.07 71.41 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.404 -0.81 . . . . 0.0 110.802 -175.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -56.75 -24.92 53.37 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.556 -0.715 . . . . 0.0 110.599 -176.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -109.7 -20.53 12.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.519 -0.738 . . . . 0.0 111.144 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.456 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.1 p -67.73 -20.23 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.181 -0.95 . . . . 0.0 110.518 -176.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.54 HG22 HD11 ' A' ' 126' ' ' ILE . 78.5 p -79.43 -17.01 55.19 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.779 175.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -88.28 137.86 31.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.367 -0.833 . . . . 0.0 110.089 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.7 t -73.13 140.89 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.614 -0.679 . . . . 0.0 110.295 177.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.551 HG22 ' CE1' ' A' ' 192' ' ' TYR . 62.0 t -85.0 138.57 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.552 -0.718 . . . . 0.0 109.345 170.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 14.2 pttt -134.92 -170.26 2.53 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.575 -0.703 . . . . 0.0 111.01 -171.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 84.7 mtm-85 -95.27 157.49 15.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.747 -0.596 . . . . 0.0 110.212 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 53.4 m -73.74 156.37 88.4 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.677 -0.64 . . . . 0.0 109.558 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -62.95 -47.34 8.7 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.201 1.106 . . . . 0.0 110.074 176.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.443 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.4 p-10 -65.45 -44.05 88.49 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.541 -0.724 . . . . 0.0 111.149 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . 0.443 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 55.0 m170 -81.24 -27.93 35.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.342 -0.849 . . . . 0.0 111.18 -175.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -69.01 -41.96 77.08 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.441 -0.787 . . . . 0.0 110.263 172.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 27.3 tp -59.15 -34.65 72.33 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.547 -0.721 . . . . 0.0 110.518 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 29.4 t -48.3 145.29 3.4 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.526 -0.734 . . . . 0.0 111.424 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 62.9 mtm180 -59.79 143.72 50.32 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.612 -0.68 . . . . 0.0 110.385 -177.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -61.24 -37.26 82.42 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.72 -0.613 . . . . 0.0 110.403 -176.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 52.28 50.15 18.99 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.431 -0.793 . . . . 0.0 110.916 -176.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -74.27 -10.18 59.34 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.64 -0.662 . . . . 0.0 111.174 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -59.49 118.89 6.56 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.167 -0.958 . . . . 0.0 110.48 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 75.01 19.96 79.67 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 176.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -114.74 139.93 49.3 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.276 -1.132 . . . . 0.0 110.396 178.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 85.3 mt -84.92 -25.22 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.619 -0.675 . . . . 0.0 110.338 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.582 ' HB1' ' OH ' ' A' ' 236' ' ' TYR . . . -130.94 129.96 22.71 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.515 -0.741 . . . . 0.0 110.199 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.425 ' HD2' ' CE2' ' A' ' 236' ' ' TYR . 44.1 Cg_endo -74.55 138.36 24.11 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 O-C-N 123.101 1.053 . . . . 0.0 110.748 -177.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 221' ' ' PRO . 26.0 Cg_exo -58.96 -18.33 42.21 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 O-C-N 123.036 1.019 . . . . 0.0 111.413 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 30.7 m -50.73 -24.27 3.29 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.248 -0.907 . . . . 0.0 111.587 -177.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -104.06 133.75 48.48 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.454 -0.779 . . . . 0.0 110.4 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.41 ' HA ' ' CG ' ' A' ' 268' ' ' MET . 54.9 tp -59.7 -39.7 85.47 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.626 -0.671 . . . . 0.0 110.324 -178.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.508 HD12 ' HD3' ' A' ' 190' ' ' PRO . 83.0 mt -105.51 136.8 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.747 -0.596 . . . . 0.0 109.735 177.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -132.35 157.13 45.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.677 -0.639 . . . . 0.0 110.264 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.473 HG23 HG21 ' A' ' 247' ' ' VAL . 75.2 t -102.52 146.58 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.727 -0.608 . . . . 0.0 110.022 176.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -117.83 130.08 56.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.7 -0.625 . . . . 0.0 110.386 170.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 95.65 20.71 25.97 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.559 -1.017 . . . . 0.0 110.559 168.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -138.84 105.88 5.45 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -1.119 . . . . 0.0 110.005 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 43.2 m -63.21 -15.23 56.32 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.596 -0.69 . . . . 0.0 111.285 -177.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -100.0 8.9 43.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.19 -0.944 . . . . 0.0 111.53 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.37 131.42 50.21 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.072 -1.018 . . . . 0.0 110.196 176.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -139.76 158.06 44.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.752 -0.592 . . . . 0.0 109.805 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.582 ' OH ' ' HB1' ' A' ' 220' ' ' ALA . 72.7 m-85 -111.69 150.63 29.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.614 -0.679 . . . . 0.0 110.484 -177.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.17 159.92 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.732 -0.605 . . . . 0.0 110.216 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -121.03 130.1 53.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.813 -0.555 . . . . 0.0 110.154 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -63.23 130.0 93.89 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.664 -0.648 . . . . 0.0 109.853 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -65.23 -28.63 55.74 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 O-C-N 123.186 1.098 . . . . 0.0 110.968 -170.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.6 mt -102.15 -50.47 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.467 -0.77 . . . . 0.0 111.07 -168.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.494 HG22 ' HB3' ' A' ' 124' ' ' PRO . 14.1 p -105.3 12.18 32.04 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.392 -0.818 . . . . 0.0 111.942 -174.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 72.56 -4.89 18.57 Favored Glycine 0 N--CA 1.496 2.669 0 O-C-N 120.988 -1.07 . . . . 0.0 111.955 172.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.456 ' CZ ' HG12 ' A' ' 191' ' ' VAL . 21.4 mmt180 -45.92 142.02 2.83 Favored 'General case' 0 N--CA 1.506 2.328 0 CA-C-N 119.101 1.451 . . . . 0.0 112.339 -175.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -103.94 141.72 35.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.616 -0.678 . . . . 0.0 110.219 176.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.4 p -154.73 159.95 41.02 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.623 -0.673 . . . . 0.0 110.299 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.473 HG21 HG23 ' A' ' 228' ' ' VAL . 8.3 p -122.95 148.08 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.674 -0.641 . . . . 0.0 109.796 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.745 HD22 ' HG2' ' A' ' 187' ' ' ARG . 80.1 mt -129.63 154.62 46.93 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.816 -175.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.437 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.8 m -150.98 151.76 30.34 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.808 -0.558 . . . . 0.0 109.907 175.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -71.01 140.5 38.11 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 O-C-N 123.251 1.132 . . . . 0.0 110.003 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.671 ' HD2' HD11 ' A' ' 186' ' ' ILE . 60.6 t80 -76.06 125.41 29.08 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.459 -0.775 . . . . 0.0 110.155 177.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -100.05 160.14 27.96 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.739 -0.6 . . . . 0.0 109.998 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -59.0 159.13 22.58 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 O-C-N 123.284 1.149 . . . . 0.0 110.445 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -59.11 149.93 76.79 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 O-C-N 123.248 1.131 . . . . 0.0 110.515 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -60.36 147.45 40.6 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.627 -0.671 . . . . 0.0 110.319 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.7 t -69.83 127.25 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.619 -0.675 . . . . 0.0 110.22 -170.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.99 -10.09 55.33 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 9.6 t -144.35 173.27 11.92 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.224 -1.162 . . . . 0.0 110.558 175.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -106.92 13.21 27.95 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.651 -0.656 . . . . 0.0 111.804 -168.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -120.03 168.05 11.57 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.115 -0.991 . . . . 0.0 111.152 -175.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 82.3 m -117.75 146.25 43.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.729 -0.607 . . . . 0.0 109.788 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 35.6 m -116.72 136.61 52.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.636 -0.665 . . . . 0.0 110.917 -175.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 59.3 t -128.56 137.13 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 66.4 mt -104.78 119.49 39.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.497 -0.752 . . . . 0.0 109.831 -173.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.68 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 6.5 m-30 -105.69 151.06 24.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.62 -0.675 . . . . 0.0 110.718 -177.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -136.53 143.01 43.49 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -115.0 131.97 56.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.527 -0.733 . . . . 0.0 110.501 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' MET . . . . . 0.41 ' CG ' ' HA ' ' A' ' 225' ' ' LEU . 5.2 ppp? -100.24 1.16 41.57 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.654 -0.654 . . . . 0.0 111.9 -177.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.65 159.6 42.55 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.085 -1.009 . . . . 0.0 109.982 173.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.586 ' HA ' HD13 ' A' ' 305' ' ' ILE . 27.2 p30 -115.13 153.89 29.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.74 -0.6 . . . . 0.0 110.161 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . 0.444 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 92.7 p -56.64 -26.7 56.76 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.404 -0.81 . . . . 0.0 111.155 -167.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 46.0 p -95.04 8.19 43.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.387 -0.821 . . . . 0.0 112.086 -165.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 28.9 p -93.96 117.96 30.82 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.98 -1.075 . . . . 0.0 110.727 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . 0.447 HG22 ' NH1' ' A' ' 279' ' ' ARG . 60.2 t -69.68 143.34 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.561 -0.712 . . . . 0.0 110.533 -167.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 99.53 -5.28 58.55 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.04 -95.35 0.74 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 169.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . 0.444 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 95.2 mmm -64.78 -28.61 69.69 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.74 -0.859 . . . . 0.0 110.386 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.9 p30 44.95 51.56 8.6 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 121.325 0.583 . . . . 0.0 112.507 172.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.447 ' NH1' HG22 ' A' ' 274' ' ' VAL . 37.9 mtt180 54.7 33.4 19.35 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.321 -0.862 . . . . 0.0 111.289 174.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . 0.434 ' O ' HG23 ' A' ' 282' ' ' ILE . 89.6 mtt180 -114.89 105.01 53.74 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.499 -0.751 . . . . 0.0 110.092 173.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 280' ' ' ARG . 13.2 Cg_endo -60.8 144.97 99.65 Favored 'Trans proline' 0 N--CA 1.488 1.175 0 O-C-N 123.138 1.073 . . . . 0.0 110.371 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.645 HG22 ' HA ' ' A' ' 192' ' ' TYR . 43.6 pt -132.58 177.84 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 121.943 0.878 . . . . 0.0 111.253 -174.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 302' ' ' GLU . 35.0 mt -124.34 149.9 46.09 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 177.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.669 HD12 ' CE1' ' A' ' 301' ' ' PHE . 80.8 mt -114.21 130.51 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.63 -0.669 . . . . 0.0 109.312 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.504 HG23 ' SG ' ' A' ' 300' ' ' CYS . 81.0 mt -109.78 125.91 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -176.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 75.8 t -118.98 126.71 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.7 p -125.28 153.01 43.89 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.717 -0.614 . . . . 0.0 110.72 -174.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.729 HD21 ' HB3' ' A' ' 180' ' ' PRO . 19.1 tp -100.29 126.95 46.68 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 166.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.696 ' OE2' HG13 ' A' ' 295' ' ' VAL . 74.5 mm-40 -132.69 149.72 52.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.756 -0.59 . . . . 0.0 110.01 -172.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.778 ' CG2' HD11 ' A' ' 296' ' ' LEU . 77.2 p -89.93 158.28 17.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.667 -0.646 . . . . 0.0 110.013 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -55.98 -26.16 47.19 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.559 -0.713 . . . . 0.0 111.009 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -92.93 12.86 22.37 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.47 -0.769 . . . . 0.0 111.697 -173.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.94 20.18 44.17 Favored Glycine 0 N--CA 1.494 2.539 0 C-N-CA 120.118 -1.039 . . . . 0.0 110.962 167.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -107.43 140.14 40.83 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.216 -1.167 . . . . 0.0 110.18 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.696 HG13 ' OE2' ' A' ' 289' ' ' GLU . 58.7 t -90.1 130.9 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.626 -0.671 . . . . 0.0 110.054 -175.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.778 HD11 ' CG2' ' A' ' 290' ' ' THR . 96.3 mt -99.97 -40.07 7.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.716 -0.615 . . . . 0.0 110.569 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -160.35 149.36 18.66 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.504 ' HD2' HG11 ' A' ' 295' ' ' VAL . 48.7 mtp180 -135.19 136.24 41.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.678 -0.895 . . . . 0.0 110.575 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . 0.407 ' HG3' ' HA ' ' A' ' 139' ' ' ASP . 0.4 OUTLIER -138.13 157.82 45.55 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.608 -0.682 . . . . 0.0 110.301 170.021 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . 0.504 ' SG ' HG23 ' A' ' 285' ' ' ILE . 82.2 m -141.88 154.96 45.5 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.493 -0.754 . . . . 0.0 110.643 -175.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.669 ' CE1' HD12 ' A' ' 284' ' ' ILE . 47.3 p90 -144.95 160.97 40.49 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.703 -0.623 . . . . 0.0 110.194 175.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.474 ' HA ' HD23 ' A' ' 283' ' ' LEU . 82.3 tt0 -104.93 136.89 43.56 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.571 -0.706 . . . . 0.0 110.125 -178.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -117.94 143.73 46.1 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.821 -169.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -137.1 138.57 40.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.822 -0.549 . . . . 0.0 109.713 172.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.586 HD13 ' HA ' ' A' ' 270' ' ' ASN . 56.2 mt -112.7 122.86 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.512 -0.743 . . . . 0.0 109.757 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.2 p -145.32 170.56 16.08 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.642 -0.662 . . . . 0.0 110.664 -171.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -71.97 -40.11 68.86 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.694 -0.629 . . . . 0.0 110.641 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.8 t -127.12 86.51 58.66 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.59 -0.694 . . . . 0.0 110.506 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . 0.403 ' HD3' ' HG3' ' A' ' 165' ' ' GLN . 37.5 Cg_exo -56.24 -28.2 70.14 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.169 1.089 . . . . 0.0 110.533 173.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -67.53 -37.57 89.86 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -70.5 -38.33 74.3 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.643 -0.916 . . . . 0.0 109.749 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -69.45 -35.42 75.64 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.085 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.667 ' HD3' HG22 ' A' ' 147' ' ' THR . 37.7 ttt85 -57.16 -47.3 81.55 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.533 -0.73 . . . . 0.0 110.593 174.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -64.56 -39.02 92.98 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.575 -0.703 . . . . 0.0 110.401 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -62.44 -51.41 67.62 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.529 -0.732 . . . . 0.0 110.56 -173.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . 0.442 ' HB2' HD11 ' A' ' 159' ' ' LEU . 3.5 p30 -61.16 -37.77 84.08 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.472 -0.767 . . . . 0.0 110.096 -176.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -66.06 -40.58 91.03 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.257 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -62.86 -35.22 79.28 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.568 -0.707 . . . . 0.0 110.136 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 59.8 p -64.59 -29.66 70.68 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.679 -0.638 . . . . 0.0 110.097 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 83.9 mt -81.26 -45.82 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.641 -0.662 . . . . 0.0 110.047 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -59.47 -39.56 84.09 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.686 -0.633 . . . . 0.0 110.546 -177.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -63.57 -43.13 97.89 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.574 -0.704 . . . . 0.0 110.224 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -66.15 -35.8 81.43 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.669 -0.644 . . . . 0.0 110.339 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -105.07 125.06 50.57 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.647 -0.658 . . . . 0.0 110.952 -174.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 61.8 t -105.5 130.08 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.487 -0.758 . . . . 0.0 109.706 176.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 49.6 m -95.16 140.11 30.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.63 -0.669 . . . . 0.0 110.476 -176.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -80.0 150.05 30.55 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.678 -0.638 . . . . 0.0 110.192 176.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 30.9 t -75.81 137.97 40.86 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.693 -0.629 . . . . 0.0 110.266 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 40.1 m -94.92 -25.53 16.51 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.657 -0.652 . . . . 0.0 110.543 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -58.58 -34.52 71.18 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.503 -0.748 . . . . 0.0 110.567 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -89.07 107.57 19.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.615 -0.678 . . . . 0.0 110.238 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -61.29 -33.69 85.38 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -147.97 160.04 43.24 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.571 -0.959 . . . . 0.0 110.358 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -139.95 159.69 41.61 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.598 -0.689 . . . . 0.0 110.294 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -104.73 139.82 38.98 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.669 -0.644 . . . . 0.0 110.216 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 52.58 -166.59 0.06 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.424 -0.797 . . . . 0.0 110.787 -178.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -97.75 129.07 44.8 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.668 -0.645 . . . . 0.0 110.306 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -116.75 130.47 56.74 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.737 -0.602 . . . . 0.0 110.177 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 66.5 p -119.31 158.22 26.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.696 -0.627 . . . . 0.0 110.262 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -131.72 154.51 48.94 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.699 -0.626 . . . . 0.0 110.318 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 78.67 30.07 49.9 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 27.2 pt -96.37 147.5 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.628 -0.925 . . . . 0.0 110.389 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -143.95 160.67 40.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.586 -0.696 . . . . 0.0 110.055 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 64.6 mtt 52.67 26.55 4.49 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.414 -0.804 . . . . 0.0 110.967 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 117.957 -1.021 . . . . 0.0 110.279 -179.885 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 29.7 t -86.96 144.17 27.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.621 -0.929 . . . . 0.0 110.28 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 86.3 p -61.65 -28.77 69.62 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.659 -0.651 . . . . 0.0 110.247 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 49.6 m -122.49 139.04 54.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.65 -0.656 . . . . 0.0 110.284 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -103.56 134.13 47.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.668 -0.645 . . . . 0.0 110.21 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -155.97 94.34 1.53 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.737 -0.602 . . . . 0.0 110.269 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.12 -28.73 62.43 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.682 -0.636 . . . . 0.0 110.317 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 29.7 tp 56.77 -85.81 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.72 -0.613 . . . . 0.0 110.739 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 21.0 p -70.52 159.5 84.75 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.169 -0.957 . . . . 0.0 110.198 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -66.47 153.04 82.26 Favored 'Cis proline' 0 N--CA 1.496 1.626 0 C-N-CA 123.147 -1.606 . . . . 0.0 110.509 -15.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.7 m -82.13 161.72 59.23 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.691 -0.631 . . . . 0.0 110.219 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -60.69 147.31 95.29 Favored 'Trans proline' 0 C--N 1.316 -1.147 0 O-C-N 123.316 1.166 . . . . 0.0 110.494 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.82 142.32 42.26 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.641 -0.662 . . . . 0.0 110.25 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.574 HD11 HG22 ' A' ' 199' ' ' THR . 49.4 mm -119.96 107.8 39.51 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.676 -0.64 . . . . 0.0 109.885 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 126' ' ' ILE . 11.8 Cg_endo -59.7 150.54 76.17 Favored 'Trans proline' 0 N--CA 1.487 1.136 0 O-C-N 123.117 1.062 . . . . 0.0 110.597 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.5 t -114.43 148.3 37.95 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.632 -0.668 . . . . 0.0 110.252 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -94.65 24.25 4.77 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.691 -0.63 . . . . 0.0 110.878 -178.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 50.9 m -72.33 125.18 26.72 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.496 -0.753 . . . . 0.0 110.148 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -68.5 144.94 54.45 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.614 -0.679 . . . . 0.0 110.388 -176.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -155.55 101.65 2.2 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.802 -0.561 . . . . 0.0 110.058 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -59.54 -39.87 71.25 Favored 'Trans proline' 0 N--CA 1.489 1.222 0 O-C-N 123.152 1.08 . . . . 0.0 110.677 -175.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.04 -155.17 42.1 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -73.29 -43.86 0.64 Allowed 'Trans proline' 0 C--N 1.316 -1.142 0 O-C-N 123.422 1.222 . . . . 0.0 110.89 -175.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -89.28 5.64 44.01 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.543 -0.723 . . . . 0.0 111.497 -174.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 t 53.99 59.43 4.26 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.978 -1.076 . . . . 0.0 110.729 -176.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.725 ' HA ' HG12 ' A' ' 176' ' ' VAL . 64.6 t80 -78.15 118.78 20.72 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.571 -0.706 . . . . 0.0 110.019 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -130.06 160.02 34.98 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.34 0.591 . . . . 0.0 110.321 -176.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.0 t -124.83 148.42 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.692 -0.63 . . . . 0.0 109.87 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.6 p -155.87 166.9 32.09 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.313 0.578 . . . . 0.0 110.088 176.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.496 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 66.3 m-85 -126.58 125.16 41.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.782 -0.574 . . . . 0.0 109.84 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -56.77 141.88 42.65 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.603 -0.686 . . . . 0.0 110.44 -175.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -95.81 125.77 40.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.646 -0.658 . . . . 0.0 110.542 -173.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 49.7 m -122.97 149.22 44.56 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.703 -0.623 . . . . 0.0 110.101 177.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 42.4 m -61.18 160.24 10.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.622 -0.674 . . . . 0.0 110.197 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 147' ' ' THR . 6.7 t -67.77 75.42 0.19 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.66 -0.65 . . . . 0.0 110.237 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.7 162.01 25.45 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.632 -0.668 . . . . 0.0 110.205 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -75.48 143.58 42.51 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.6 -0.687 . . . . 0.0 110.031 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.81 56.05 8.14 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.409 -0.807 . . . . 0.0 110.914 -177.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -79.88 129.25 34.34 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.634 -0.666 . . . . 0.0 110.194 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 42.5 p -60.09 -34.08 72.98 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.643 -0.661 . . . . 0.0 110.094 176.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.442 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.8 p-90 -171.22 144.27 2.02 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.331 0.586 . . . . 0.0 110.224 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.0 t -142.09 142.6 32.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.897 -0.502 . . . . 0.0 109.985 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.496 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 64.7 t80 -125.61 139.98 53.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.486 -0.759 . . . . 0.0 110.775 -171.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.0 t -111.96 123.85 51.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.851 -0.531 . . . . 0.0 109.92 177.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 59.0 m -70.93 -37.01 72.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.806 -0.559 . . . . 0.0 110.568 -176.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -59.21 -35.36 73.48 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.505 -0.747 . . . . 0.0 110.522 -177.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.2 mt -104.86 -11.05 16.94 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.683 -0.636 . . . . 0.0 110.981 -176.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt 59.76 52.64 5.34 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.14 -0.975 . . . . 0.0 109.743 177.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -145.25 153.07 40.92 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.779 -0.576 . . . . 0.0 110.625 -175.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.618 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.58 137.76 53.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.758 -0.588 . . . . 0.0 110.206 -175.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -116.04 135.89 53.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.63 -0.669 . . . . 0.0 109.381 173.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.1 p -138.49 158.49 44.17 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.68 -0.638 . . . . 0.0 110.767 -177.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.431 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 55.4 mt-30 -104.61 144.49 31.64 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.505 -0.747 . . . . 0.0 109.882 171.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.418 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 16.3 tt -51.71 147.48 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.502 -0.749 . . . . 0.0 111.95 -174.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 65.11 10.0 5.99 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.637 -0.665 . . . . 0.0 112.702 174.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.431 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 20.3 mmtp -96.12 155.11 16.9 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.955 -1.091 . . . . 0.0 111.074 172.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 91.3 m -80.33 126.18 30.83 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.719 -0.613 . . . . 0.0 110.569 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . 0.618 ' SG ' HD21 ' A' ' 162' ' ' LEU . 48.6 t -116.32 90.03 28.34 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.604 -0.685 . . . . 0.0 110.126 174.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.442 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 15.2 Cg_exo -65.78 131.08 26.39 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 O-C-N 123.264 1.139 . . . . 0.0 110.756 174.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.635 HD12 ' CD2' ' A' ' 265' ' ' TYR . 78.2 mt -123.91 144.69 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.596 -0.69 . . . . 0.0 109.496 172.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.405 ' OE1' ' CD1' ' A' ' 260' ' ' PHE . 70.5 mm-40 -108.42 133.05 53.12 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.52 -0.738 . . . . 0.0 110.361 -173.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.59 HG21 ' CE1' ' A' ' 138' ' ' PHE . 49.0 mm -95.35 135.0 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.652 -0.655 . . . . 0.0 109.657 170.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.0 tttp -119.3 130.28 55.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.531 -0.73 . . . . 0.0 110.529 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.725 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.4 m -136.2 159.73 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.605 -0.684 . . . . 0.0 109.905 175.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 81.6 mmm -77.13 -40.3 46.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.695 -0.628 . . . . 0.0 110.045 177.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.3 p -135.87 143.27 43.72 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.764 -0.585 . . . . 0.0 109.795 177.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.7 Cg_exo -55.69 139.89 83.68 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 O-C-N 123.217 1.114 . . . . 0.0 110.886 -172.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.742 ' HB3' HD21 ' A' ' 288' ' ' LEU . 23.4 Cg_endo -64.28 169.71 10.45 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.238 1.125 . . . . 0.0 110.69 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -61.06 156.54 44.02 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.35 1.184 . . . . 0.0 110.497 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -77.06 139.61 40.07 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.629 -0.669 . . . . 0.0 109.908 175.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.9 -25.02 29.24 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -175.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.12 152.97 1.53 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.296 -1.12 . . . . 0.0 111.325 176.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.77 155.98 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.748 -0.595 . . . . 0.0 109.774 176.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.641 HD11 ' CD2' ' A' ' 251' ' ' TYR . 72.4 mt -106.13 133.7 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 177.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.758 ' HG2' HD22 ' A' ' 248' ' ' LEU . 65.0 mtt180 -115.01 140.94 48.64 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -174.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -138.52 124.47 20.02 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.49 -0.757 . . . . 0.0 110.53 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 20.3 ttm -137.35 139.31 27.32 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.808 -0.558 . . . . 0.0 111.145 -175.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.718 ' HD3' HD12 ' A' ' 226' ' ' ILE . 71.2 Cg_endo -90.29 138.13 2.69 Favored 'Trans proline' 0 C--N 1.32 -0.948 0 O-C-N 123.185 1.097 . . . . 0.0 110.519 175.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.428 HG13 ' C ' ' A' ' 190' ' ' PRO . 34.8 m -147.07 154.92 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.577 -0.702 . . . . 0.0 110.211 174.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.647 ' HA ' HG22 ' A' ' 282' ' ' ILE . 82.3 m-85 -60.97 161.1 8.76 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.477 -0.764 . . . . 0.0 110.348 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -78.46 -60.04 2.53 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.635 -0.666 . . . . 0.0 110.812 -173.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -80.02 151.88 29.73 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.605 -0.685 . . . . 0.0 110.447 -174.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.447 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.41 -38.94 72.23 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.353 -0.842 . . . . 0.0 110.74 -176.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -56.37 -24.57 45.25 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.533 -0.73 . . . . 0.0 110.624 -176.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.412 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 60.4 m170 -110.01 -20.56 12.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.509 -0.744 . . . . 0.0 111.101 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.447 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.1 p -66.88 -20.34 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.111 -0.993 . . . . 0.0 110.639 -176.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.574 HG22 HD11 ' A' ' 126' ' ' ILE . 73.7 p -79.3 -16.96 55.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.522 -0.736 . . . . 0.0 110.78 175.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -88.41 134.62 33.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.338 -0.851 . . . . 0.0 110.064 173.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.3 t -73.16 143.69 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.612 -0.68 . . . . 0.0 110.269 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 78.9 t -84.9 139.56 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.527 -0.733 . . . . 0.0 109.326 170.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 9.3 pttt -134.9 -170.06 2.49 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.477 -0.765 . . . . 0.0 111.035 -167.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -95.07 154.2 17.28 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.712 -0.617 . . . . 0.0 110.317 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 56.3 m -76.04 157.29 83.55 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.647 -0.658 . . . . 0.0 109.249 174.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -63.11 -47.31 8.44 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 O-C-N 123.088 1.046 . . . . 0.0 110.023 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.415 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.6 p-10 -65.48 -44.36 87.36 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.639 -0.663 . . . . 0.0 111.169 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . 0.415 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 51.9 m170 -81.93 -28.04 33.01 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.461 -0.775 . . . . 0.0 111.279 -174.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -69.05 -38.78 79.3 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.323 -0.861 . . . . 0.0 110.314 172.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 25.3 tp -57.38 -31.97 66.33 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.62 -0.675 . . . . 0.0 110.786 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 31.3 t -48.41 138.23 10.4 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.532 -0.73 . . . . 0.0 111.442 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 34.8 ptt-85 -58.82 126.16 26.53 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.668 -0.645 . . . . 0.0 110.572 -175.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -75.51 -54.67 6.64 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.557 -0.715 . . . . 0.0 110.599 -175.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 51.46 54.55 10.87 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.442 -0.786 . . . . 0.0 111.208 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -69.23 -10.36 57.39 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.619 -0.675 . . . . 0.0 111.001 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -61.29 121.12 11.78 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.264 -0.897 . . . . 0.0 110.162 175.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 78.17 20.02 73.46 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -138.36 139.85 39.2 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.251 -1.146 . . . . 0.0 110.004 177.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.582 HD13 ' HA ' ' A' ' 232' ' ' SER . 81.8 mt -85.59 -25.18 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.705 -0.622 . . . . 0.0 110.522 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.802 ' HB1' ' HB3' ' A' ' 227' ' ' ARG . . . -124.94 89.9 51.87 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.483 -0.761 . . . . 0.0 110.592 -173.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.438 ' HD2' ' CE2' ' A' ' 236' ' ' TYR . 35.5 Cg_endo -70.67 145.72 52.64 Favored 'Trans proline' 0 N--CA 1.487 1.124 0 O-C-N 123.278 1.146 . . . . 0.0 110.673 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -59.4 -17.94 43.22 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 O-C-N 123.222 1.117 . . . . 0.0 111.454 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 27.3 t -51.81 -23.95 5.4 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.163 -0.96 . . . . 0.0 111.393 -178.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . 0.43 ' CE1' ' HB3' ' A' ' 236' ' ' TYR . 99.2 m-70 -104.32 132.4 50.61 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.441 -0.787 . . . . 0.0 110.245 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.401 ' HA ' ' HG3' ' A' ' 268' ' ' MET . 45.8 tp -60.27 -40.31 89.94 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.55 -0.719 . . . . 0.0 110.089 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.718 HD12 ' HD3' ' A' ' 190' ' ' PRO . 79.3 mt -99.21 136.79 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.836 -0.54 . . . . 0.0 109.659 175.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.802 ' HB3' ' HB1' ' A' ' 220' ' ' ALA . 79.1 mtm180 -135.05 157.61 46.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.737 -0.602 . . . . 0.0 109.971 176.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.463 HG23 HG21 ' A' ' 247' ' ' VAL . 72.6 t -103.52 146.65 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.712 -0.618 . . . . 0.0 110.161 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -122.06 130.01 52.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.746 -0.596 . . . . 0.0 110.285 170.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 99.12 19.51 21.19 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 170.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -140.7 104.52 4.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.267 -1.137 . . . . 0.0 110.028 174.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . 0.582 ' HA ' HD13 ' A' ' 219' ' ' ILE . 45.8 m -63.42 -15.31 57.27 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.666 -0.646 . . . . 0.0 111.276 -176.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -100.01 7.63 44.59 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.22 -0.925 . . . . 0.0 111.55 -177.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.61 133.37 55.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.088 -1.007 . . . . 0.0 110.21 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -139.83 157.98 44.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.735 -0.603 . . . . 0.0 109.809 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.438 ' CE2' ' HD2' ' A' ' 221' ' ' PRO . 84.3 m-85 -114.37 150.65 34.27 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.552 -0.717 . . . . 0.0 110.497 -178.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.22 159.92 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.76 -0.588 . . . . 0.0 110.266 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -119.22 130.04 55.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.769 -0.582 . . . . 0.0 110.163 175.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -65.09 130.11 94.72 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.676 -0.64 . . . . 0.0 109.838 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -66.36 -27.66 47.37 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 O-C-N 123.172 1.09 . . . . 0.0 111.021 -171.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 82.6 mt -100.49 -50.54 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.399 -0.813 . . . . 0.0 110.942 -167.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.3 p -105.3 12.04 32.21 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.322 -0.861 . . . . 0.0 111.887 -175.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.88 -5.11 13.57 Favored Glycine 0 N--CA 1.495 2.582 0 O-C-N 121.08 -1.012 . . . . 0.0 111.916 173.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 22.2 mmt85 -46.14 142.02 3.02 Favored 'General case' 0 N--CA 1.505 2.276 0 CA-C-N 119.108 1.454 . . . . 0.0 112.321 -174.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -106.27 139.91 40.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.628 -0.67 . . . . 0.0 110.123 175.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 78.7 p -154.74 159.98 41.03 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.635 -0.665 . . . . 0.0 110.518 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.463 HG21 HG23 ' A' ' 228' ' ' VAL . 8.3 p -122.96 148.17 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.78 -0.575 . . . . 0.0 109.666 177.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.758 HD22 ' HG2' ' A' ' 187' ' ' ARG . 83.0 mt -129.64 154.52 47.04 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.045 -175.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.443 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.4 m -151.12 151.76 30.09 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.812 -0.555 . . . . 0.0 109.84 175.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -70.57 137.16 32.5 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 O-C-N 123.237 1.125 . . . . 0.0 109.979 177.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.641 ' CD2' HD11 ' A' ' 186' ' ' ILE . 13.9 t80 -77.23 124.29 27.63 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.572 -0.705 . . . . 0.0 110.201 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -100.01 160.06 28.2 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.719 -0.613 . . . . 0.0 110.177 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -59.26 159.99 20.9 Favored 'Trans proline' 0 C--N 1.316 -1.163 0 O-C-N 123.244 1.129 . . . . 0.0 110.434 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.88 150.22 73.3 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 O-C-N 123.194 1.102 . . . . 0.0 110.567 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -60.02 148.11 36.72 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.575 -0.703 . . . . 0.0 110.323 -178.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.84 127.25 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.457 -0.777 . . . . 0.0 110.068 -170.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.92 -10.12 55.46 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 9.5 t -144.68 173.71 11.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.163 -1.198 . . . . 0.0 110.601 175.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -106.94 13.18 27.96 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.66 -0.65 . . . . 0.0 111.768 -168.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.405 ' CD1' ' OE1' ' A' ' 173' ' ' GLN . 13.8 p90 -119.94 168.02 11.56 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.212 -0.93 . . . . 0.0 111.233 -175.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 86.4 m -117.86 147.78 42.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.768 -0.583 . . . . 0.0 109.841 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 40.6 m -115.95 137.54 52.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.553 -0.717 . . . . 0.0 110.91 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 57.9 t -128.62 136.87 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 170.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 64.7 mt -104.87 120.12 40.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.494 -0.754 . . . . 0.0 109.815 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.635 ' CD2' HD12 ' A' ' 172' ' ' ILE . 3.3 m-85 -99.19 156.4 16.98 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.796 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -136.42 142.99 43.7 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 171.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -113.41 129.58 56.51 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.61 -0.681 . . . . 0.0 110.163 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' MET . . . . . 0.401 ' HG3' ' HA ' ' A' ' 225' ' ' LEU . 0.0 OUTLIER -98.98 5.85 46.98 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.636 -0.665 . . . . 0.0 111.724 -176.308 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . 0.528 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.8 OUTLIER -144.78 161.33 39.52 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.141 -0.975 . . . . 0.0 110.069 173.636 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.662 ' HA ' HG21 ' A' ' 305' ' ' ILE . 26.9 p30 -116.27 158.71 22.95 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.731 -0.605 . . . . 0.0 109.822 176.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . 0.405 ' HA ' ' HB3' ' A' ' 277' ' ' MET . 19.2 m -58.6 -32.65 69.19 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.376 -0.827 . . . . 0.0 110.947 -163.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 73.1 m -93.93 10.7 32.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.601 -0.687 . . . . 0.0 111.986 -165.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 31.7 p -93.8 118.19 31.1 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.069 -1.019 . . . . 0.0 110.593 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.3 t -61.34 139.9 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.389 -0.819 . . . . 0.0 110.218 -171.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 101.0 -5.11 56.16 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -124.89 -115.87 2.12 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 170.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . 0.405 ' HB3' ' HA ' ' A' ' 271' ' ' SER . 26.9 ttt -60.27 -24.94 65.32 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.613 -0.934 . . . . 0.0 110.409 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 43.87 55.07 5.41 Favored 'General case' 0 N--CA 1.504 2.241 0 CA-C-O 121.434 0.635 . . . . 0.0 112.584 172.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 54.94 30.36 13.87 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.401 -0.812 . . . . 0.0 111.317 175.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -116.81 116.42 38.35 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.468 -0.77 . . . . 0.0 110.128 170.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . 0.404 ' HA ' ' CE ' ' A' ' 277' ' ' MET . 12.0 Cg_endo -59.68 145.66 97.54 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 O-C-N 123.042 1.022 . . . . 0.0 110.495 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.647 HG22 ' HA ' ' A' ' 192' ' ' TYR . 45.4 pt -131.97 175.73 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 121.762 0.791 . . . . 0.0 110.89 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.48 HD23 ' HA ' ' A' ' 302' ' ' GLU . 32.0 mt -124.42 149.92 46.21 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.512 HD12 ' CE1' ' A' ' 301' ' ' PHE . 79.1 mt -112.58 127.95 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.057 176.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.686 HG23 ' SG ' ' A' ' 300' ' ' CYS . 76.5 mt -109.85 126.34 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.436 -175.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 59.1 t -118.92 126.55 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.3 p -125.4 153.93 42.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.643 -0.661 . . . . 0.0 110.536 -174.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.742 HD21 ' HB3' ' A' ' 180' ' ' PRO . 24.3 tp -103.55 126.57 50.78 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 169.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.562 ' OE2' HG13 ' A' ' 295' ' ' VAL . 75.1 mm-40 -132.15 150.24 52.2 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.996 -173.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.759 ' CG2' HD11 ' A' ' 296' ' ' LEU . 76.5 p -89.96 159.21 17.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.732 -0.605 . . . . 0.0 109.907 178.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -55.95 -26.16 46.8 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.534 -0.729 . . . . 0.0 110.905 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -93.07 12.95 22.33 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.479 -0.763 . . . . 0.0 111.697 -174.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.41 20.16 46.22 Favored Glycine 0 N--CA 1.495 2.62 0 C-N-CA 120.132 -1.033 . . . . 0.0 110.972 167.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -105.64 140.16 39.13 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.203 -1.175 . . . . 0.0 110.231 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.562 HG13 ' OE2' ' A' ' 289' ' ' GLU . 59.4 t -87.52 131.32 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.678 -0.639 . . . . 0.0 110.008 -176.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.759 HD11 ' CG2' ' A' ' 290' ' ' THR . 96.9 mt -99.87 -40.11 7.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.718 -0.614 . . . . 0.0 110.484 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -162.7 151.6 21.48 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.434 ' HD2' HG11 ' A' ' 295' ' ' VAL . 46.3 mtp180 -135.01 134.35 40.36 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.719 -0.871 . . . . 0.0 110.469 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -136.3 152.81 51.09 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.558 -0.713 . . . . 0.0 110.236 172.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . 0.686 ' SG ' HG23 ' A' ' 285' ' ' ILE . 90.7 m -142.49 153.18 43.41 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.415 -0.803 . . . . 0.0 110.772 -175.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.512 ' CE1' HD12 ' A' ' 284' ' ' ILE . 51.1 p90 -145.82 166.77 24.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.671 -0.643 . . . . 0.0 109.97 174.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.48 ' HA ' HD23 ' A' ' 283' ' ' LEU . 58.0 tt0 -104.84 136.91 43.45 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.527 -0.733 . . . . 0.0 110.225 -177.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -119.4 145.47 46.19 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.626 -171.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 40.0 tpt85 -138.09 134.01 34.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.71 -0.619 . . . . 0.0 109.699 174.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.662 HG21 ' HA ' ' A' ' 270' ' ' ASN . 80.5 mt -105.75 122.87 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.504 -0.748 . . . . 0.0 109.583 176.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.4 p -145.21 173.23 12.12 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.535 -0.728 . . . . 0.0 110.648 -171.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -72.46 -40.13 67.23 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.704 -0.623 . . . . 0.0 110.582 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.7 t -131.04 89.37 42.52 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.544 -0.722 . . . . 0.0 110.467 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . 0.408 ' CG ' ' HG3' ' A' ' 165' ' ' GLN . 50.7 Cg_exo -54.13 -30.52 60.99 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 O-C-N 123.188 1.099 . . . . 0.0 111.03 172.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -65.4 -37.15 93.51 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -73.26 -40.44 64.63 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.669 -0.901 . . . . 0.0 109.802 -173.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -69.52 -41.33 76.15 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 120.084 -0.647 . . . . 0.0 110.092 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 72.4 ttt-85 -61.21 -41.8 97.48 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.564 -0.71 . . . . 0.0 110.346 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -64.17 -38.61 91.66 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.49 -0.757 . . . . 0.0 110.451 178.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -62.7 -52.85 61.68 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.486 -0.759 . . . . 0.0 110.541 -173.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -61.39 -37.79 84.71 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.464 -0.773 . . . . 0.0 110.158 -176.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -65.94 -39.6 90.64 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.687 -0.633 . . . . 0.0 110.227 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -62.49 -35.3 78.91 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.583 -0.698 . . . . 0.0 109.969 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 23.4 m -62.16 -33.35 74.33 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.615 -0.678 . . . . 0.0 110.198 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 83.7 mt -79.19 -44.57 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.578 -0.701 . . . . 0.0 109.993 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 55.4 ttt85 -58.85 -39.94 82.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.596 -0.69 . . . . 0.0 110.546 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 49.9 mttt -66.16 -46.86 75.95 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.633 -0.667 . . . . 0.0 110.178 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -69.04 -42.04 76.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.669 -0.644 . . . . 0.0 110.238 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -105.12 125.03 50.53 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.722 -0.611 . . . . 0.0 110.479 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.12 128.51 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.581 -0.699 . . . . 0.0 109.916 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 65.9 p -95.12 140.14 30.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.608 -0.683 . . . . 0.0 110.186 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -89.24 112.89 24.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.598 -0.689 . . . . 0.0 110.199 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 50.4 m -71.88 149.66 44.96 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.575 -0.703 . . . . 0.0 110.096 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 331' ' ' ASN . 74.2 m -104.0 117.2 33.72 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.668 -0.645 . . . . 0.0 110.304 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 64.3 mttt -68.58 -40.4 80.56 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.66 -0.65 . . . . 0.0 110.31 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . 0.425 ' O ' HG22 ' A' ' 329' ' ' THR . 42.8 p-10 -152.72 -164.66 2.0 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.626 -0.671 . . . . 0.0 110.386 -177.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -60.17 145.62 46.31 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -82.8 117.38 22.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.645 -0.915 . . . . 0.0 110.31 -176.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -147.14 149.7 33.52 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.775 -0.578 . . . . 0.0 110.066 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 52.91 26.53 4.73 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.438 -0.789 . . . . 0.0 110.872 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 52.88 26.56 4.72 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.469 -0.769 . . . . 0.0 110.938 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 53.73 40.54 31.61 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.532 -0.73 . . . . 0.0 110.836 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 53.22 42.11 32.13 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.44 -0.787 . . . . 0.0 110.887 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 48.3 m -124.1 137.09 54.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.577 -0.702 . . . . 0.0 110.365 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -60.76 -40.84 94.01 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.697 -0.627 . . . . 0.0 110.255 178.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 99.63 123.91 5.11 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 15.8 tt -147.45 147.32 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.652 -0.911 . . . . 0.0 110.202 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -92.39 127.77 38.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.631 -0.668 . . . . 0.0 110.266 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 88.4 mtp -59.86 -35.43 74.77 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.62 -0.675 . . . . 0.0 110.384 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.352 179.803 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 60.3 p -84.38 161.23 20.45 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.687 -0.89 . . . . 0.0 110.233 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 29.4 t -118.03 143.37 46.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.611 -0.68 . . . . 0.0 110.251 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 67.4 p -122.6 161.96 22.75 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.689 -0.632 . . . . 0.0 110.272 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -102.03 133.52 46.72 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.654 -0.653 . . . . 0.0 110.26 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -157.73 163.44 38.13 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.61 -0.681 . . . . 0.0 110.308 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 51.43 -169.87 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.474 -0.767 . . . . 0.0 111.104 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.597 ' N ' HD12 ' A' ' 120' ' ' LEU . 8.1 mp 52.64 -171.08 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.512 -0.742 . . . . 0.0 111.0 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.1 t -108.21 165.34 12.9 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.658 -0.651 . . . . 0.0 110.162 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -63.37 151.7 70.01 Favored 'Cis proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.138 -1.609 . . . . 0.0 110.505 -18.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 2.2 m -81.66 149.58 64.56 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.621 -0.675 . . . . 0.0 110.241 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -61.73 150.46 85.69 Favored 'Trans proline' 0 C--N 1.316 -1.155 0 O-C-N 123.393 1.207 . . . . 0.0 110.384 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.07 143.41 43.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.614 -0.678 . . . . 0.0 110.102 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.515 HD11 HG22 ' A' ' 199' ' ' THR . 51.5 mm -121.93 100.09 43.5 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.668 -0.645 . . . . 0.0 109.96 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -60.22 149.39 85.57 Favored 'Trans proline' 0 N--CA 1.487 1.118 0 O-C-N 123.232 1.122 . . . . 0.0 110.66 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.3 t -114.58 147.31 39.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.691 -0.631 . . . . 0.0 110.306 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 p-10 -95.58 25.17 4.68 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.664 -0.647 . . . . 0.0 110.775 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 55.1 m -72.3 125.25 26.88 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.511 -0.743 . . . . 0.0 110.242 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -72.3 144.88 48.18 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.705 -0.622 . . . . 0.0 110.437 -178.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.429 ' CE1' ' HA2' ' A' ' 134' ' ' GLY . 65.0 t80 -159.64 100.62 1.5 Allowed Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.671 -0.643 . . . . 0.0 110.129 178.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -58.72 -39.93 77.61 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 O-C-N 123.182 1.096 . . . . 0.0 110.818 -176.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.429 ' HA2' ' CE1' ' A' ' 132' ' ' TYR . . . 79.95 -155.16 38.37 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -73.3 -48.31 0.27 Allowed 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.385 1.203 . . . . 0.0 110.901 -174.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -85.05 6.28 26.02 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.557 -0.714 . . . . 0.0 111.341 -174.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.92 59.79 4.04 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.983 -1.073 . . . . 0.0 110.669 -176.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.733 ' HA ' HG12 ' A' ' 176' ' ' VAL . 64.5 t80 -78.35 118.75 20.83 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.54 -0.725 . . . . 0.0 109.959 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -130.1 159.98 35.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.811 -0.556 . . . . 0.0 110.289 -175.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 66.7 t -124.01 146.29 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 121.272 0.558 . . . . 0.0 110.087 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.0 p -156.95 169.09 25.59 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.218 0.532 . . . . 0.0 109.757 174.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.43 ' CE2' HG12 ' A' ' 172' ' ' ILE . 36.4 m-85 -126.6 125.09 41.38 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.7 -0.625 . . . . 0.0 109.792 -177.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -59.18 140.13 56.22 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.541 -0.724 . . . . 0.0 110.178 -178.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -105.8 152.14 23.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.55 -0.719 . . . . 0.0 110.853 -166.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 82.9 p -146.05 166.86 24.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.742 -0.599 . . . . 0.0 109.901 176.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 56.3 p -63.77 164.18 10.43 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.578 -0.701 . . . . 0.0 110.108 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 147' ' ' THR . 6.8 t -71.2 65.02 0.38 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.56 -0.713 . . . . 0.0 110.297 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.13 152.04 46.48 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.596 -0.69 . . . . 0.0 110.132 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -73.31 155.7 39.18 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.667 -0.646 . . . . 0.0 110.046 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.6 t 53.23 29.62 8.72 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.432 -0.793 . . . . 0.0 110.91 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -60.16 129.98 44.43 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.568 -0.707 . . . . 0.0 110.245 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 46.6 p -60.12 -34.05 72.98 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.698 -0.626 . . . . 0.0 110.117 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.585 ' CE3' HD11 ' A' ' 162' ' ' LEU . 64.3 p-90 -170.54 148.0 3.01 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.817 -0.552 . . . . 0.0 109.867 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 15.1 t -142.12 142.41 32.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.777 -0.577 . . . . 0.0 110.063 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.443 ' HB2' HD12 ' A' ' 162' ' ' LEU . 61.0 t80 -125.52 140.08 53.07 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.487 -0.758 . . . . 0.0 110.538 -172.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.2 t -110.01 123.09 49.04 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.863 176.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 61.6 m -70.58 -37.11 73.89 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.763 -0.586 . . . . 0.0 110.503 -176.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -59.28 -34.23 72.03 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.516 -0.74 . . . . 0.0 110.533 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.6 mt -104.75 -11.02 17.04 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.628 -0.67 . . . . 0.0 110.889 -175.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 62.8 tttt 59.86 52.52 5.32 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.063 -1.023 . . . . 0.0 109.735 177.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -145.72 152.99 40.48 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.632 -175.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.679 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.61 137.73 53.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.744 -0.598 . . . . 0.0 110.203 -176.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -117.27 132.81 56.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.54 -0.725 . . . . 0.0 109.283 175.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.1 p -138.31 158.47 44.22 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.983 -175.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -104.53 142.77 34.03 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.456 0.646 . . . . 0.0 110.11 172.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.433 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.2 tt -51.28 147.48 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 CA-C-O 121.655 0.74 . . . . 0.0 112.117 -173.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.47 9.89 5.36 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.543 -0.723 . . . . 0.0 112.481 177.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -96.51 155.12 16.9 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.996 -1.065 . . . . 0.0 110.93 175.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 84.1 m -84.03 126.19 32.81 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.646 -0.659 . . . . 0.0 110.841 -176.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . 0.679 ' SG ' HD21 ' A' ' 162' ' ' LEU . 42.8 t -113.38 90.23 16.68 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.603 -0.685 . . . . 0.0 110.137 174.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.432 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 15.3 Cg_exo -65.9 130.81 25.46 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.298 1.157 . . . . 0.0 110.449 177.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.43 HG12 ' CE2' ' A' ' 142' ' ' PHE . 93.8 mt -124.21 139.39 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.696 -0.628 . . . . 0.0 109.408 176.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 10.3 mp0 -108.95 134.35 51.74 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.613 -0.68 . . . . 0.0 110.664 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.607 HG21 ' CE1' ' A' ' 138' ' ' PHE . 49.6 mm -95.3 135.14 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.637 -0.664 . . . . 0.0 109.612 172.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -118.62 130.36 55.83 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.461 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.733 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.5 m -136.36 159.72 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.523 -0.736 . . . . 0.0 109.971 175.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 80.7 mmm -77.23 -40.21 45.75 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.751 -0.593 . . . . 0.0 110.054 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.5 p -135.15 143.26 45.05 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.79 -0.569 . . . . 0.0 109.826 177.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.9 Cg_exo -55.58 139.92 83.08 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 O-C-N 123.145 1.076 . . . . 0.0 110.859 -172.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.614 ' HB3' HD21 ' A' ' 288' ' ' LEU . 25.5 Cg_endo -64.88 169.16 12.17 Favored 'Trans proline' 0 N--CA 1.487 1.095 0 O-C-N 123.127 1.067 . . . . 0.0 110.687 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -61.12 155.85 48.43 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 O-C-N 123.379 1.199 . . . . 0.0 110.496 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -75.3 139.4 42.46 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.656 -0.652 . . . . 0.0 109.931 175.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.76 -25.05 28.99 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 -175.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.14 150.81 2.24 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.355 -1.085 . . . . 0.0 111.391 178.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.79 155.92 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.665 -0.647 . . . . 0.0 109.897 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.652 HD11 ' CD2' ' A' ' 251' ' ' TYR . 74.0 mt -108.78 135.25 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.727 ' HG2' HD22 ' A' ' 248' ' ' LEU . 54.1 mtt180 -114.97 147.71 39.7 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -174.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.64 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -141.36 128.14 20.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.386 -0.821 . . . . 0.0 110.405 173.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.402 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 31.6 ttp -137.23 140.25 30.4 Favored Pre-proline 0 N--CA 1.496 1.864 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.062 -177.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.562 ' HD3' HD12 ' A' ' 226' ' ' ILE . 72.9 Cg_endo -91.5 138.2 2.13 Favored 'Trans proline' 0 C--N 1.32 -0.957 0 C-N-CA 121.08 1.187 . . . . 0.0 110.858 177.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.461 HG12 ' CZ ' ' A' ' 244' ' ' ARG . 35.0 m -147.91 154.9 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.546 -0.721 . . . . 0.0 109.924 174.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.626 ' HA ' HG22 ' A' ' 282' ' ' ILE . 82.5 m-85 -60.4 168.52 2.05 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.395 -0.816 . . . . 0.0 110.513 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.46 ' HA ' HD12 ' A' ' 283' ' ' LEU . 68.8 tttt -84.08 -60.11 2.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.588 -0.695 . . . . 0.0 110.76 -175.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 43.1 mttp -80.16 151.68 29.62 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.54 -0.725 . . . . 0.0 110.305 -175.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.451 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.76 -38.36 72.34 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.384 -0.823 . . . . 0.0 110.633 -176.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -56.39 -24.52 45.22 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.386 -0.821 . . . . 0.0 110.584 -177.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.419 ' HB3' ' CG ' ' A' ' 192' ' ' TYR . 96.6 m-70 -109.97 -20.52 12.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.466 -0.771 . . . . 0.0 111.21 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.451 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -67.41 -20.2 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.194 -0.941 . . . . 0.0 110.595 -176.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.515 HG22 HD11 ' A' ' 126' ' ' ILE . 74.4 p -79.38 -16.92 55.46 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.524 -0.735 . . . . 0.0 110.767 175.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.45 135.1 33.64 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.348 -0.845 . . . . 0.0 110.064 173.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.414 HG21 ' O ' ' A' ' 242' ' ' THR . 62.0 t -73.38 140.97 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.564 -0.71 . . . . 0.0 110.348 178.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.523 HG22 ' CE1' ' A' ' 192' ' ' TYR . 65.7 t -84.89 140.05 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.594 -0.691 . . . . 0.0 109.506 172.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -134.91 -170.28 2.53 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.53 -0.731 . . . . 0.0 110.99 -169.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 81.3 mtm-85 -95.36 157.06 16.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.842 -0.536 . . . . 0.0 110.424 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 58.8 m -75.39 159.4 82.09 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.651 -0.656 . . . . 0.0 109.475 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.4 ' HD3' ' HA3' ' A' ' 275' ' ' GLY . 16.7 Cg_exo -64.0 -47.36 6.7 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 O-C-N 123.146 1.077 . . . . 0.0 109.985 176.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.438 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.1 p-10 -65.39 -43.4 90.79 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.575 -0.703 . . . . 0.0 111.045 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . 0.438 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 55.1 m170 -81.12 -27.85 35.39 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.49 -0.757 . . . . 0.0 111.245 -175.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -69.07 -38.76 79.23 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.387 -0.82 . . . . 0.0 110.321 172.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 23.5 tp -56.5 -36.13 68.8 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.504 -0.747 . . . . 0.0 110.785 -176.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 29.6 t -48.35 138.9 9.42 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.558 -0.714 . . . . 0.0 111.306 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 214' ' ' PHE . 27.1 mmt85 -61.04 145.84 49.35 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.61 -0.682 . . . . 0.0 110.18 -177.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -64.42 -32.69 74.42 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.691 -0.631 . . . . 0.0 110.454 -177.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 212' ' ' ARG . 63.0 m-85 51.78 46.73 26.09 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.461 -0.774 . . . . 0.0 110.883 -176.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -75.7 -10.21 59.25 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.14 -177.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -61.14 117.9 6.13 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.132 -0.98 . . . . 0.0 110.255 177.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 77.18 20.1 75.96 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -139.64 140.03 36.84 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.316 -1.108 . . . . 0.0 110.057 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 86.5 mt -84.95 -25.06 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.728 -0.607 . . . . 0.0 110.587 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.61 ' HB3' ' NH2' ' A' ' 227' ' ' ARG . . . -124.85 98.16 37.22 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.362 -0.836 . . . . 0.0 110.644 -172.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -70.58 153.26 65.28 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.346 1.182 . . . . 0.0 110.591 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -60.69 -16.29 42.53 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 O-C-N 123.236 1.124 . . . . 0.0 111.419 -177.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 32.0 m -50.42 -23.96 2.76 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.127 -0.983 . . . . 0.0 111.333 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . 0.444 ' CE1' ' CB ' ' A' ' 236' ' ' TYR . 98.7 m-70 -100.71 128.37 46.79 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.545 -0.722 . . . . 0.0 110.141 176.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.816 HD21 ' CE ' ' A' ' 277' ' ' MET . 61.9 tp -60.25 -39.15 85.73 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.606 -0.684 . . . . 0.0 110.235 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.562 HD12 ' HD3' ' A' ' 190' ' ' PRO . 82.2 mt -102.21 136.75 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 120.329 -0.548 . . . . 0.0 109.685 177.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.61 ' NH2' ' HB3' ' A' ' 220' ' ' ALA . 22.2 mtp-105 -131.75 157.23 44.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.758 -0.589 . . . . 0.0 110.157 -178.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.486 HG23 HG21 ' A' ' 247' ' ' VAL . 99.3 t -104.8 146.5 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.737 -0.602 . . . . 0.0 110.042 176.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -118.9 123.65 45.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.768 -0.583 . . . . 0.0 110.473 172.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 96.31 23.32 17.1 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 168.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -135.0 108.82 8.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.369 -1.077 . . . . 0.0 110.142 174.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 27.3 t -62.88 -15.14 53.73 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.609 -0.682 . . . . 0.0 111.318 -177.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -99.35 9.91 42.42 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.29 -0.881 . . . . 0.0 111.552 -177.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.46 124.49 20.51 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.092 -1.005 . . . . 0.0 110.235 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -139.78 158.05 44.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.794 -0.566 . . . . 0.0 109.678 177.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.474 ' OH ' ' HB1' ' A' ' 220' ' ' ALA . 97.4 m-85 -117.98 150.72 38.79 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.546 -0.721 . . . . 0.0 110.793 -175.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.07 159.95 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.819 -0.551 . . . . 0.0 110.108 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -120.0 130.03 54.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.792 -0.567 . . . . 0.0 110.299 177.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -63.77 130.07 94.18 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.653 -0.655 . . . . 0.0 109.784 178.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -65.97 -28.35 49.94 Favored 'Trans proline' 0 C--N 1.316 -1.168 0 O-C-N 123.042 1.022 . . . . 0.0 110.97 -170.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.8 mt -101.14 -50.5 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.465 -0.772 . . . . 0.0 111.019 -168.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.414 ' O ' HG21 ' A' ' 201' ' ' VAL . 13.0 p -105.34 12.15 32.0 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.338 -0.851 . . . . 0.0 111.872 -175.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 72.37 -4.92 17.22 Favored Glycine 0 N--CA 1.496 2.667 0 O-C-N 121.013 -1.055 . . . . 0.0 111.968 172.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.461 ' CZ ' HG12 ' A' ' 191' ' ' VAL . 22.1 mmt180 -46.0 142.07 2.87 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 119.163 1.482 . . . . 0.0 112.389 -175.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -104.25 143.35 33.08 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.674 -0.641 . . . . 0.0 110.204 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.1 p -154.71 160.04 41.1 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.608 -0.682 . . . . 0.0 110.213 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.486 HG21 HG23 ' A' ' 228' ' ' VAL . 8.5 p -123.01 148.19 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.707 -0.621 . . . . 0.0 109.779 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.727 HD22 ' HG2' ' A' ' 187' ' ' ARG . 83.0 mt -129.82 154.69 47.0 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 120.204 -0.599 . . . . 0.0 109.931 -174.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.43 HG13 ' C ' ' A' ' 248' ' ' LEU . 32.1 m -150.69 151.81 31.15 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.783 -0.573 . . . . 0.0 109.816 174.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -70.94 139.46 36.19 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 O-C-N 123.267 1.141 . . . . 0.0 110.029 177.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.652 ' CD2' HD11 ' A' ' 186' ' ' ILE . 10.2 t80 -79.59 122.16 26.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.519 -0.738 . . . . 0.0 110.07 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -100.08 160.09 28.08 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.706 -0.621 . . . . 0.0 110.184 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -58.95 160.08 19.46 Favored 'Trans proline' 0 N--CA 1.488 1.174 0 O-C-N 123.285 1.15 . . . . 0.0 110.457 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.17 150.05 76.32 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 O-C-N 123.276 1.145 . . . . 0.0 110.613 -177.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -60.95 149.56 36.15 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.609 -0.682 . . . . 0.0 110.189 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.84 127.21 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.496 -0.752 . . . . 0.0 110.148 -170.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.29 -10.18 56.46 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 9.4 t -145.41 175.39 10.35 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.25 -1.147 . . . . 0.0 110.619 175.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -110.03 13.09 23.42 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.617 -0.677 . . . . 0.0 111.883 -167.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -120.84 168.03 11.89 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.141 -0.974 . . . . 0.0 111.177 -177.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 93.4 m -117.87 147.56 42.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.793 -0.567 . . . . 0.0 109.837 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 32.7 m -117.78 136.14 53.59 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.567 -0.708 . . . . 0.0 110.945 -175.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 57.9 t -130.44 137.18 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 171.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 74.0 mt -104.88 120.94 42.63 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.512 -0.742 . . . . 0.0 110.004 -173.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.64 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 5.9 m-30 -105.55 150.62 25.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.688 -0.633 . . . . 0.0 110.662 -177.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -136.56 142.99 43.42 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -113.31 131.93 55.76 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.584 -0.697 . . . . 0.0 110.48 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' MET . . . . . 0.436 ' HG3' HD12 ' A' ' 225' ' ' LEU . 5.0 ppp? -101.28 9.43 41.75 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.657 -0.652 . . . . 0.0 111.963 -176.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . 0.549 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.8 OUTLIER -144.6 163.45 33.88 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.115 -0.991 . . . . 0.0 110.076 171.417 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.654 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.9 p30 -121.34 163.97 17.8 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.442 0.639 . . . . 0.0 110.434 -177.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . 0.426 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 50.4 m -58.22 -34.07 70.0 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.44 -0.788 . . . . 0.0 111.058 -163.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 49.6 p -103.62 15.05 29.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.39 -0.819 . . . . 0.0 111.844 -163.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 30.5 p -94.86 118.09 31.21 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.11 -0.994 . . . . 0.0 110.585 177.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 60.1 t -64.24 139.9 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.42 -0.8 . . . . 0.0 110.332 -169.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . 0.4 ' HA3' ' HD3' ' A' ' 206' ' ' PRO . . . 99.22 -5.17 58.98 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 177.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.0 -95.6 0.75 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 172.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . 0.816 ' CE ' HD21 ' A' ' 225' ' ' LEU . 15.9 mmt -63.04 -34.12 76.89 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.699 -0.883 . . . . 0.0 110.304 177.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.4 p30 43.38 48.1 5.92 Favored 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 176.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 36.2 mtt180 54.73 29.46 11.76 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.356 -0.84 . . . . 0.0 111.2 175.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -120.07 105.06 43.0 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.58 -0.7 . . . . 0.0 110.078 175.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.77 147.6 91.62 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 O-C-N 123.128 1.067 . . . . 0.0 110.481 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.626 HG22 ' HA ' ' A' ' 192' ' ' TYR . 45.4 pt -132.02 178.0 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.779 0.8 . . . . 0.0 111.011 -175.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 193' ' ' LYS . 30.4 mt -124.42 149.88 46.26 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.698 HD12 ' CE1' ' A' ' 301' ' ' PHE . 79.9 mt -115.33 130.1 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.245 177.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.519 HG23 ' SG ' ' A' ' 300' ' ' CYS . 80.9 mt -109.76 126.39 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -176.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 57.5 t -118.86 126.78 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.6 p -125.25 153.71 42.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.603 -0.686 . . . . 0.0 110.579 -173.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.614 HD21 ' HB3' ' A' ' 180' ' ' PRO . 25.0 tp -103.97 125.87 50.67 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 169.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.661 ' OE2' HG13 ' A' ' 295' ' ' VAL . 73.9 mm-40 -131.24 149.92 52.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.885 -0.509 . . . . 0.0 109.882 -173.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.728 ' CG2' HD11 ' A' ' 296' ' ' LEU . 74.4 p -89.86 159.36 17.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.629 -0.669 . . . . 0.0 109.774 177.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -55.96 -26.07 46.53 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.582 -0.699 . . . . 0.0 110.823 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -87.27 9.68 19.53 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.519 -0.738 . . . . 0.0 111.783 -174.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 87.51 20.19 52.32 Favored Glycine 0 N--CA 1.495 2.606 0 O-C-N 121.089 -1.007 . . . . 0.0 110.731 170.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -108.02 140.26 41.44 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.283 -1.127 . . . . 0.0 110.175 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.661 HG13 ' OE2' ' A' ' 289' ' ' GLU . 60.0 t -89.55 132.56 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.587 -0.696 . . . . 0.0 110.067 -174.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.728 HD11 ' CG2' ' A' ' 290' ' ' THR . 96.2 mt -99.97 -40.1 7.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.671 -0.643 . . . . 0.0 110.489 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -161.67 154.83 25.91 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -178.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 47.7 mtp180 -134.9 135.15 41.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.669 -0.9 . . . . 0.0 110.746 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 -135.18 158.03 45.4 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.609 -0.682 . . . . 0.0 109.958 172.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . 0.519 ' SG ' HG23 ' A' ' 285' ' ' ILE . 85.9 m -144.29 153.83 42.43 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.504 -0.747 . . . . 0.0 110.745 -176.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.698 ' CE1' HD12 ' A' ' 284' ' ' ILE . 49.3 p90 -144.96 162.17 37.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.705 -0.622 . . . . 0.0 110.05 174.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.45 ' HA ' HD23 ' A' ' 283' ' ' LEU . 82.1 tt0 -104.84 135.36 46.35 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.479 -0.763 . . . . 0.0 110.198 -176.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -120.06 142.93 48.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.626 -0.671 . . . . 0.0 110.687 -170.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -138.49 138.82 38.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.795 -0.565 . . . . 0.0 109.795 173.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.654 HG21 ' HA ' ' A' ' 270' ' ' ASN . 78.7 mt -108.75 122.89 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.544 -0.723 . . . . 0.0 109.619 177.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.9 p -145.36 170.56 16.1 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.66 -0.65 . . . . 0.0 110.69 -171.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -72.52 -40.12 67.05 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.613 -0.68 . . . . 0.0 110.708 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.8 t -127.95 86.43 58.17 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.591 -0.693 . . . . 0.0 110.484 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -55.91 -29.21 71.97 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 O-C-N 123.134 1.07 . . . . 0.0 110.899 174.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.48 -37.98 93.09 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.014 -1.635 . . . . 0.0 109.014 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -73.28 -40.02 64.9 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.748 -0.854 . . . . 0.0 109.751 -173.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -69.44 -39.78 77.6 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.163 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -61.86 -45.56 93.23 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.306 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 23.7 ttpt -64.11 -39.22 93.58 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.585 -0.697 . . . . 0.0 110.47 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.66 -50.71 71.4 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.495 -0.753 . . . . 0.0 110.426 -174.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -61.56 -37.77 85.05 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.45 -0.781 . . . . 0.0 110.105 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -62.3 -40.13 95.27 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.635 -0.665 . . . . 0.0 110.016 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -62.39 -35.18 78.39 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.619 -0.676 . . . . 0.0 109.957 178.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 22.6 t -62.76 -32.06 73.14 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.658 -0.651 . . . . 0.0 110.32 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 51.3 mm -78.38 -45.98 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.593 -0.692 . . . . 0.0 109.964 -177.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -59.09 -42.08 89.6 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.629 -0.669 . . . . 0.0 110.536 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -65.63 -46.29 79.78 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.628 -0.67 . . . . 0.0 110.339 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -66.11 -36.28 82.74 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.68 -0.638 . . . . 0.0 110.349 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -105.03 125.08 50.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.629 -0.669 . . . . 0.0 110.474 -175.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 62.5 t -122.1 130.04 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.586 -0.696 . . . . 0.0 109.789 176.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 48.9 m -95.18 140.05 30.65 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.575 -0.703 . . . . 0.0 110.342 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -106.37 144.25 33.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.693 -0.629 . . . . 0.0 110.15 177.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 50.4 m -65.99 148.51 51.69 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.638 -0.664 . . . . 0.0 110.147 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 74.1 p -96.21 -26.74 15.32 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.687 -0.633 . . . . 0.0 110.497 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -60.35 -41.04 92.8 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.501 -0.75 . . . . 0.0 110.395 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -60.31 -36.08 77.08 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.635 -0.666 . . . . 0.0 110.362 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -92.97 134.27 12.1 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -147.57 82.35 1.53 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.67 -0.9 . . . . 0.0 110.155 178.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.604 ' HB1' ' CD ' ' A' ' 337' ' ' GLN . . . -152.53 149.35 28.42 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.693 -0.629 . . . . 0.0 110.201 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -125.59 153.86 43.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.553 -0.717 . . . . 0.0 110.469 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 53.23 46.0 27.4 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.473 -0.767 . . . . 0.0 111.282 175.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' GLN . . . . . 0.604 ' CD ' ' HB1' ' A' ' 334' ' ' ALA . 95.0 mt-30 -117.77 139.09 51.55 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.55 -0.719 . . . . 0.0 110.288 173.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -119.44 136.85 54.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.666 -0.646 . . . . 0.0 110.245 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 9.8 t -134.33 152.74 51.98 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.69 -0.631 . . . . 0.0 110.44 178.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -60.99 -41.94 97.46 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.704 -0.622 . . . . 0.0 110.212 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 84.58 -170.52 46.37 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 82.4 mt -94.0 133.81 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.634 -0.921 . . . . 0.0 109.97 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -154.12 -50.21 0.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.704 -0.622 . . . . 0.0 110.27 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 65.0 mtt -59.86 -35.44 74.79 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.679 -0.638 . . . . 0.0 110.365 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 7.4 t . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 118.035 -0.984 . . . . 0.0 110.364 179.954 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 75.2 m -86.77 10.37 16.11 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.703 -0.881 . . . . 0.0 111.363 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 86.6 p -61.52 -29.88 70.27 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.135 -0.978 . . . . 0.0 110.263 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 43.4 m -61.13 -38.69 87.26 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.611 -0.681 . . . . 0.0 110.566 -177.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -59.19 -40.95 87.35 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.595 -0.69 . . . . 0.0 110.585 -175.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -85.7 -162.56 0.74 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.644 -0.66 . . . . 0.0 110.336 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 54.61 28.0 9.31 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.325 -0.859 . . . . 0.0 110.798 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 88.4 mt 51.76 32.07 9.01 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.374 -0.829 . . . . 0.0 111.194 176.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.2 m -117.79 154.82 51.21 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.625 -0.672 . . . . 0.0 110.079 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -58.36 150.45 36.99 Favored 'Cis proline' 0 N--CA 1.496 1.623 0 C-N-CA 123.066 -1.639 . . . . 0.0 110.258 -23.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 66.3 m -81.69 141.14 47.88 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.583 -0.698 . . . . 0.0 110.296 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.639 ' HB3' HG22 ' A' ' 242' ' ' THR . 29.7 Cg_endo -68.04 152.61 76.46 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 O-C-N 123.207 1.109 . . . . 0.0 110.552 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.94 144.49 43.2 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.652 -0.655 . . . . 0.0 109.996 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.715 HD11 HG22 ' A' ' 199' ' ' THR . 50.1 mm -121.19 100.85 45.01 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.663 -0.648 . . . . 0.0 110.186 -176.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -61.25 154.01 61.11 Favored 'Trans proline' 0 N--CA 1.487 1.118 0 O-C-N 123.189 1.099 . . . . 0.0 110.364 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.4 t -109.97 146.88 34.49 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.67 -0.644 . . . . 0.0 110.43 -177.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -95.42 24.39 5.17 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.68 -0.637 . . . . 0.0 110.64 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 54.6 m -72.71 125.18 26.88 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.567 -0.708 . . . . 0.0 110.337 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -70.97 144.98 50.33 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.723 -0.611 . . . . 0.0 110.291 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -158.28 102.07 1.71 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.603 -0.686 . . . . 0.0 110.164 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -58.77 -39.96 77.1 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 O-C-N 123.177 1.093 . . . . 0.0 110.691 -178.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.12 -155.15 45.6 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 177.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -72.75 -45.93 0.47 Allowed 'Trans proline' 0 N--CA 1.486 1.067 0 O-C-N 123.33 1.174 . . . . 0.0 111.004 -174.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -89.1 9.1 26.65 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.615 -0.678 . . . . 0.0 111.453 -172.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.71 61.63 3.01 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.975 -1.078 . . . . 0.0 110.732 -176.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.619 ' HA ' HG12 ' A' ' 176' ' ' VAL . 46.6 t80 -77.92 118.2 20.0 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.648 -0.657 . . . . 0.0 109.83 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -130.04 160.04 34.9 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.312 0.577 . . . . 0.0 110.178 -177.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 78.6 t -124.31 148.78 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.69 -0.631 . . . . 0.0 109.775 176.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.4 p -157.1 171.02 21.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.813 -0.554 . . . . 0.0 109.928 176.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.422 ' CE1' HG12 ' A' ' 172' ' ' ILE . 64.8 m-85 -126.36 125.14 41.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.821 -0.549 . . . . 0.0 109.64 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -57.28 142.04 44.65 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.574 -0.704 . . . . 0.0 110.497 -175.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -76.33 144.97 39.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.589 -0.695 . . . . 0.0 110.687 -169.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 83.1 p -145.44 162.63 36.86 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.74 -0.6 . . . . 0.0 110.027 176.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 24.1 t -77.2 157.03 31.11 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.53 -0.731 . . . . 0.0 110.123 179.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 66.6 p -79.12 59.49 2.75 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.682 -0.636 . . . . 0.0 110.145 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.92 158.88 32.58 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.663 -0.648 . . . . 0.0 110.242 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 68.3 mttt -75.22 162.25 28.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.62 -0.675 . . . . 0.0 110.162 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 27.7 t 53.18 25.97 4.69 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.494 -0.754 . . . . 0.0 111.054 -177.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.68 134.32 56.14 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.602 -0.686 . . . . 0.0 110.158 177.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.4 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 76.1 p -60.06 -33.88 72.67 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.668 -0.645 . . . . 0.0 109.928 174.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.425 ' CE3' HD11 ' A' ' 162' ' ' LEU . 67.5 p-90 -170.06 148.02 3.33 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.964 -0.46 . . . . 0.0 109.784 178.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.9 t -142.04 142.37 32.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.789 -0.57 . . . . 0.0 109.974 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.414 ' HB2' HD12 ' A' ' 162' ' ' LEU . 62.9 t80 -125.76 140.12 52.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.513 -0.742 . . . . 0.0 110.559 -172.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 31.2 t -110.43 121.07 44.41 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.727 174.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 69.4 m -71.42 -36.45 71.31 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.702 -0.624 . . . . 0.0 110.489 -176.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -58.76 -33.83 70.72 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.586 -0.696 . . . . 0.0 110.526 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 53.9 mt -104.82 -11.33 16.84 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.734 -0.604 . . . . 0.0 110.851 -176.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt 59.87 51.84 5.76 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.045 -1.034 . . . . 0.0 109.825 176.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -147.14 152.86 39.13 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.696 -0.628 . . . . 0.0 110.714 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.425 HD11 ' CE3' ' A' ' 153' ' ' TRP . 14.6 tp -126.65 137.88 53.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.793 -0.567 . . . . 0.0 110.375 -173.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -117.54 133.32 56.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.537 -0.727 . . . . 0.0 109.462 175.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.1 p -138.3 158.31 44.54 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 120.111 -0.636 . . . . 0.0 111.104 -175.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -104.69 141.59 36.19 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.588 -0.695 . . . . 0.0 110.33 172.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.437 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 18.0 tt -54.6 149.43 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.529 -0.732 . . . . 0.0 111.552 -173.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.22 10.01 5.22 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.593 -0.692 . . . . 0.0 112.515 178.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -96.4 155.13 16.89 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.958 -1.089 . . . . 0.0 110.784 174.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 70.2 m -79.96 126.09 30.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.702 -0.624 . . . . 0.0 110.61 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 42.3 t -115.43 90.23 24.54 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.624 -0.673 . . . . 0.0 110.22 174.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -69.99 125.41 11.99 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.266 1.14 . . . . 0.0 110.521 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.643 HD12 ' CD2' ' A' ' 265' ' ' TYR . 86.4 mt -122.22 143.43 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.594 -0.692 . . . . 0.0 109.575 173.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.422 ' NE2' ' CE1' ' A' ' 260' ' ' PHE . 95.4 mt-30 -109.14 136.64 48.3 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.611 -0.681 . . . . 0.0 110.707 -175.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.3 mm -95.23 135.02 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.674 -0.641 . . . . 0.0 109.744 169.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 35.2 tttm -117.05 130.27 56.55 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.509 -0.745 . . . . 0.0 110.581 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.619 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.0 m -136.01 159.8 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.63 -0.669 . . . . 0.0 109.797 174.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 79.0 mmm -81.3 -45.4 16.27 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.62 -0.675 . . . . 0.0 110.151 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.417 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.0 p -126.52 143.18 45.37 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.724 -0.61 . . . . 0.0 109.684 177.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.5 Cg_exo -55.5 139.74 82.54 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 O-C-N 123.205 1.108 . . . . 0.0 110.902 -171.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.745 ' HB3' HD21 ' A' ' 288' ' ' LEU . 36.0 Cg_endo -67.51 170.01 14.53 Favored 'Trans proline' 0 N--CA 1.487 1.128 0 O-C-N 123.226 1.119 . . . . 0.0 110.542 177.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -60.26 155.77 44.2 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 123.326 1.172 . . . . 0.0 110.622 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -78.16 138.26 38.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.599 -0.688 . . . . 0.0 109.931 175.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.24 -24.97 30.08 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -174.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.13 151.2 2.09 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.381 -1.07 . . . . 0.0 111.48 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 35.4 m -129.75 156.03 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.777 -0.577 . . . . 0.0 109.853 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.693 HD11 ' HD2' ' A' ' 251' ' ' TYR . 53.7 mt -107.34 134.9 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 178.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.736 ' HG2' HD22 ' A' ' 248' ' ' LEU . 70.8 mtt180 -114.94 141.34 48.09 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -174.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.42 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -138.51 123.72 19.21 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.456 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 44.5 ttp -137.34 140.61 31.22 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.773 -0.579 . . . . 0.0 111.222 -175.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.637 ' HD3' HD12 ' A' ' 226' ' ' ILE . 71.7 Cg_endo -90.98 138.22 2.34 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 O-C-N 123.243 1.128 . . . . 0.0 110.717 176.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.434 HG13 ' C ' ' A' ' 190' ' ' PRO . 34.7 m -147.48 154.84 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.51 -0.744 . . . . 0.0 110.134 173.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.636 ' HA ' HG22 ' A' ' 282' ' ' ILE . 88.3 m-85 -61.33 166.67 3.71 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.488 -0.758 . . . . 0.0 110.429 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -84.67 -59.96 2.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.678 -0.639 . . . . 0.0 110.849 -175.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -80.08 152.24 29.44 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.656 -0.653 . . . . 0.0 110.319 -175.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.455 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.81 -38.58 72.78 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.333 -0.854 . . . . 0.0 110.72 -175.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -56.58 -24.57 48.28 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.539 -0.726 . . . . 0.0 110.567 -177.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.433 ' HB3' ' CD1' ' A' ' 192' ' ' TYR . 47.8 m80 -109.89 -20.46 12.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.565 -0.71 . . . . 0.0 111.116 -178.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.1 p -67.56 -20.19 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.145 -0.972 . . . . 0.0 110.606 -176.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.715 HG22 HD11 ' A' ' 126' ' ' ILE . 69.2 p -79.35 -17.01 55.37 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.535 -0.728 . . . . 0.0 110.678 174.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.41 136.93 32.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.357 -0.84 . . . . 0.0 110.029 174.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.8 t -73.02 146.03 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.623 -0.673 . . . . 0.0 110.228 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.581 HG23 HH12 ' A' ' 244' ' ' ARG . 60.8 t -84.95 136.16 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.595 -0.69 . . . . 0.0 109.191 172.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.0 pttp -134.95 -170.18 2.51 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.508 -0.745 . . . . 0.0 111.073 -167.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -95.1 159.32 15.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.75 -0.594 . . . . 0.0 110.501 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 59.9 m -80.05 160.48 68.44 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.627 -0.67 . . . . 0.0 109.281 175.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -64.14 -47.33 6.5 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.171 1.09 . . . . 0.0 109.841 176.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.442 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.5 p-10 -65.42 -44.38 87.57 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.556 -0.715 . . . . 0.0 111.162 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . 0.442 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 55.0 m170 -81.42 -27.96 34.48 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.438 -0.789 . . . . 0.0 111.391 -174.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -69.13 -41.35 77.45 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.387 -0.821 . . . . 0.0 110.243 172.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 26.4 tp -58.48 -34.1 70.52 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.58 -0.7 . . . . 0.0 110.695 -178.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 29.1 t -48.37 142.81 5.28 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.549 -0.719 . . . . 0.0 111.404 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -62.83 130.62 45.64 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.634 -0.666 . . . . 0.0 110.163 -176.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -63.68 -34.89 78.86 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.718 -0.614 . . . . 0.0 110.206 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.406 ' CD2' ' O ' ' A' ' 214' ' ' PHE . 56.6 t80 52.64 50.48 18.06 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.381 -0.824 . . . . 0.0 110.772 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -72.49 -10.09 59.36 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.691 -0.63 . . . . 0.0 111.264 -177.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -59.81 119.63 8.05 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.136 -0.978 . . . . 0.0 110.434 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 75.73 20.0 78.53 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 177.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -114.85 140.45 48.94 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.284 -1.127 . . . . 0.0 110.362 178.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.2 mt -84.86 -25.16 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.602 -0.686 . . . . 0.0 110.401 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.544 ' HB1' ' OH ' ' A' ' 236' ' ' TYR . . . -127.56 127.57 24.07 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.476 -0.765 . . . . 0.0 110.33 -178.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.439 ' HG2' ' CE1' ' A' ' 224' ' ' HIS . 21.0 Cg_endo -66.6 123.32 10.94 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 O-C-N 123.082 1.043 . . . . 0.0 110.479 178.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -59.18 -19.35 49.18 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 O-C-N 122.977 0.988 . . . . 0.0 111.424 -176.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 86.9 p -54.35 -22.32 11.86 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.257 -0.902 . . . . 0.0 111.35 -175.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . 0.439 ' CE1' ' HG2' ' A' ' 221' ' ' PRO . 80.2 m80 -84.08 133.42 34.64 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.414 -0.803 . . . . 0.0 110.226 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.405 ' HA ' ' CG ' ' A' ' 268' ' ' MET . 55.9 tp -59.52 -39.21 83.16 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.563 -0.711 . . . . 0.0 110.325 -177.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.637 HD12 ' HD3' ' A' ' 190' ' ' PRO . 80.9 mt -104.17 136.75 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.821 -0.549 . . . . 0.0 109.818 178.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -132.56 159.17 40.23 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.716 -0.615 . . . . 0.0 110.111 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.589 HG23 HG21 ' A' ' 247' ' ' VAL . 70.5 t -105.59 146.74 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.663 -0.648 . . . . 0.0 110.144 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -121.78 130.05 53.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.715 -0.616 . . . . 0.0 110.303 171.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.8 20.58 21.19 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.526 -1.029 . . . . 0.0 110.526 170.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -141.27 105.16 4.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.307 -1.114 . . . . 0.0 109.988 174.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 93.1 p -63.6 -15.13 57.3 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.603 -0.686 . . . . 0.0 111.224 -177.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -97.24 9.96 40.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.303 -0.873 . . . . 0.0 111.187 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.97 130.35 45.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.205 -0.934 . . . . 0.0 110.081 176.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -139.77 156.25 46.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.774 -0.579 . . . . 0.0 109.719 177.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.544 ' OH ' ' HB1' ' A' ' 220' ' ' ALA . 90.4 m-85 -117.96 150.66 38.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.513 -0.742 . . . . 0.0 110.617 -176.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.08 159.89 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.902 -0.499 . . . . 0.0 110.224 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -119.65 130.08 54.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.771 -0.581 . . . . 0.0 110.113 176.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -61.72 126.04 86.09 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.657 -0.652 . . . . 0.0 109.754 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -65.01 -29.15 57.27 Favored 'Trans proline' 0 C--N 1.317 -1.123 0 O-C-N 123.201 1.106 . . . . 0.0 110.782 -172.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.9 mt -104.15 -50.25 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.553 -0.717 . . . . 0.0 110.943 -170.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.639 HG22 ' HB3' ' A' ' 124' ' ' PRO . 20.3 p -105.26 12.25 32.02 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.372 -0.83 . . . . 0.0 111.945 -170.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 82.31 -23.24 5.55 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 120.97 -1.081 . . . . 0.0 111.85 168.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.581 HH12 HG23 ' A' ' 202' ' ' VAL . 25.9 mmt180 -45.79 142.07 2.69 Favored 'General case' 0 N--CA 1.505 2.325 0 CA-C-N 118.572 1.186 . . . . 0.0 112.569 -168.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -105.12 146.17 29.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.637 -0.664 . . . . 0.0 110.093 174.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 78.8 p -154.79 159.92 40.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.584 -0.698 . . . . 0.0 110.404 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.589 HG21 HG23 ' A' ' 228' ' ' VAL . 8.3 p -122.95 148.1 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.746 -0.596 . . . . 0.0 109.69 178.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.736 HD22 ' HG2' ' A' ' 187' ' ' ARG . 81.6 mt -129.69 154.58 47.02 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.797 -175.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.443 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.4 m -151.07 151.75 30.14 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.822 -0.549 . . . . 0.0 110.008 175.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -71.09 139.08 34.9 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 O-C-N 123.237 1.125 . . . . 0.0 109.999 177.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.693 ' HD2' HD11 ' A' ' 186' ' ' ILE . 61.8 t80 -76.04 123.9 26.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.488 -0.758 . . . . 0.0 110.219 176.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -99.95 160.09 28.15 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.668 -0.645 . . . . 0.0 110.029 176.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -58.76 159.72 19.96 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 O-C-N 123.154 1.081 . . . . 0.0 110.42 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.03 149.98 76.06 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 O-C-N 123.26 1.137 . . . . 0.0 110.522 -176.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -61.71 148.2 43.56 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.648 -0.658 . . . . 0.0 110.138 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.9 t -69.81 127.18 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.586 -0.696 . . . . 0.0 110.233 -170.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.93 -10.13 55.45 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 10.2 t -144.63 174.42 10.98 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.148 -1.207 . . . . 0.0 110.648 175.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -108.27 13.14 25.97 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.613 -0.679 . . . . 0.0 111.83 -167.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.422 ' CE1' ' NE2' ' A' ' 173' ' ' GLN . 40.2 p90 -123.88 168.17 13.13 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.096 -1.003 . . . . 0.0 111.148 -175.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 71.9 m -117.73 145.23 44.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.799 -0.563 . . . . 0.0 109.75 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 28.4 m -115.28 137.41 52.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.615 -0.678 . . . . 0.0 110.882 -174.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 57.8 t -128.78 136.99 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 172.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 63.9 mt -104.73 120.47 41.43 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.534 -0.729 . . . . 0.0 109.873 -174.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.643 ' CD2' HD12 ' A' ' 172' ' ' ILE . 3.8 m-85 -98.41 156.19 16.87 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.627 -0.67 . . . . 0.0 110.842 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -136.49 142.89 43.56 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 171.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -111.89 132.02 54.99 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.61 -0.681 . . . . 0.0 110.397 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' MET . . . . . 0.405 ' CG ' ' HA ' ' A' ' 225' ' ' LEU . 5.2 ppp? -102.73 6.77 39.63 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.659 -0.651 . . . . 0.0 111.874 -177.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . 0.661 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.6 OUTLIER -144.73 160.45 41.2 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.985 -1.072 . . . . 0.0 109.908 171.822 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.522 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.3 p30 -119.77 163.49 17.38 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.459 0.647 . . . . 0.0 110.506 -178.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . 0.426 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 50.1 m -58.63 -33.09 69.66 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.482 -0.761 . . . . 0.0 111.028 -163.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 50.0 p -100.77 12.68 37.03 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.431 -0.793 . . . . 0.0 111.954 -163.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 29.6 p -94.69 117.99 31.02 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.091 -1.006 . . . . 0.0 110.625 177.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.4 t -64.42 139.78 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.561 -0.712 . . . . 0.0 110.356 -169.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.37 -5.02 60.5 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -125.06 -100.33 1.28 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 170.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . 0.426 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.4 mmm -64.87 -31.44 72.67 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.693 -0.887 . . . . 0.0 110.355 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.8 p30 43.1 52.11 5.45 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 175.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 54.85 27.0 8.37 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.328 -0.858 . . . . 0.0 111.182 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 36.6 mtt180 -118.77 106.36 44.08 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.56 -0.712 . . . . 0.0 110.046 175.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.38 149.19 82.9 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 O-C-N 123.015 1.008 . . . . 0.0 110.691 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.636 HG22 ' HA ' ' A' ' 192' ' ' TYR . 44.6 pt -131.93 -179.7 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-O 121.752 0.786 . . . . 0.0 110.742 -177.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 302' ' ' GLU . 34.7 mt -124.33 149.93 46.03 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.56 HD12 ' CE1' ' A' ' 301' ' ' PHE . 77.7 mt -113.83 128.75 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.125 176.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.627 HG23 ' SG ' ' A' ' 300' ' ' CYS . 80.0 mt -109.84 126.46 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -175.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 59.2 t -118.88 126.69 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.2 p -125.36 154.7 41.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.683 -0.635 . . . . 0.0 110.516 -175.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.745 HD21 ' HB3' ' A' ' 180' ' ' PRO . 28.8 tp -102.61 126.42 49.68 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 168.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.746 ' OE2' HG13 ' A' ' 295' ' ' VAL . 74.1 mm-40 -131.61 150.3 52.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.845 -0.534 . . . . 0.0 109.937 -171.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.696 ' CG2' HD11 ' A' ' 296' ' ' LEU . 76.8 p -90.03 157.43 17.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.67 -0.644 . . . . 0.0 109.909 177.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -56.08 -26.1 48.12 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.587 -0.696 . . . . 0.0 110.932 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -91.03 11.86 21.65 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.451 -0.78 . . . . 0.0 111.745 -174.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 90.25 20.15 43.15 Favored Glycine 0 N--CA 1.494 2.541 0 C-N-CA 120.139 -1.029 . . . . 0.0 110.922 168.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -109.15 140.17 43.09 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.3 -1.118 . . . . 0.0 110.062 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.746 HG13 ' OE2' ' A' ' 289' ' ' GLU . 59.2 t -91.64 133.39 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.558 -0.714 . . . . 0.0 110.234 -174.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.696 HD11 ' CG2' ' A' ' 290' ' ' THR . 93.9 mt -99.97 -40.0 7.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.757 -0.589 . . . . 0.0 110.586 -179.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -159.29 155.41 26.5 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.698 ' CZ ' HG11 ' A' ' 295' ' ' VAL . 57.2 mtt85 -135.06 136.28 41.91 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.764 -0.845 . . . . 0.0 110.349 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -136.58 153.99 50.81 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.44 -0.787 . . . . 0.0 110.19 168.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . 0.627 ' SG ' HG23 ' A' ' 285' ' ' ILE . 95.8 m -143.29 154.01 43.35 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.545 -0.722 . . . . 0.0 110.626 -175.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.56 ' CE1' HD12 ' A' ' 284' ' ' ILE . 51.7 p90 -145.77 166.8 24.82 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.647 -0.658 . . . . 0.0 109.962 173.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.474 ' HA ' HD23 ' A' ' 283' ' ' LEU . 82.0 tt0 -104.92 135.62 45.93 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.421 -0.8 . . . . 0.0 110.193 -177.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -122.67 144.26 49.25 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.722 -169.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -138.08 138.94 39.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.747 -0.596 . . . . 0.0 109.694 173.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.661 HD13 ' O ' ' A' ' 269' ' ' CYS . 74.0 mt -107.42 122.83 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.548 -0.72 . . . . 0.0 109.735 176.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.8 p -145.27 169.71 17.7 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.7 -0.625 . . . . 0.0 110.647 -172.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -71.55 -40.11 70.24 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.626 -0.671 . . . . 0.0 110.648 -178.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.7 t -127.16 86.07 59.61 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.476 -0.765 . . . . 0.0 110.468 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -55.94 -28.16 67.15 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 O-C-N 123.251 1.132 . . . . 0.0 110.766 174.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -67.05 -37.8 92.11 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 177.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -72.76 -40.84 65.69 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.737 -0.86 . . . . 0.0 109.845 -173.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -69.5 -38.91 77.82 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.162 -178.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -61.81 -43.22 99.28 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.195 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 21.0 ttpp -64.18 -38.53 91.39 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.582 -0.699 . . . . 0.0 110.446 178.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -60.74 -50.52 73.13 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.507 -0.746 . . . . 0.0 110.46 -173.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -61.55 -37.81 85.15 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.482 -0.761 . . . . 0.0 110.087 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -62.07 -39.56 92.84 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.634 -0.666 . . . . 0.0 110.137 177.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -62.38 -35.17 78.34 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.601 -0.687 . . . . 0.0 109.926 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 24.5 m -62.57 -32.49 73.48 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.728 -0.608 . . . . 0.0 110.176 178.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 51.4 mm -77.56 -45.32 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.686 -0.634 . . . . 0.0 109.943 -178.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -59.11 -40.33 85.03 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.637 -0.664 . . . . 0.0 110.541 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -65.17 -43.3 92.19 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.645 -0.659 . . . . 0.0 110.07 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -65.65 -38.34 89.05 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.708 -0.62 . . . . 0.0 110.377 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -105.15 125.04 50.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.619 -0.675 . . . . 0.0 110.484 -175.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 62.9 t -116.41 130.07 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.6 -0.687 . . . . 0.0 109.834 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 29.3 t -95.11 137.13 34.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.624 -0.673 . . . . 0.0 110.332 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -114.43 116.74 29.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.649 -0.657 . . . . 0.0 110.228 177.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 49.4 m -94.09 142.63 27.17 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.595 -0.691 . . . . 0.0 110.301 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 67.9 p -135.68 157.33 47.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.624 -0.673 . . . . 0.0 109.994 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -61.29 -46.86 88.57 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.58 -0.7 . . . . 0.0 110.285 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -67.42 -46.85 71.97 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.555 -0.716 . . . . 0.0 110.291 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 96.1 -26.77 19.43 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . 0.407 ' O ' ' HB3' ' A' ' 334' ' ' ALA . 79.0 m-20 -101.48 160.06 14.76 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.521 -0.988 . . . . 0.0 110.44 -177.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 333' ' ' ASP . . . 57.59 109.69 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.585 -0.697 . . . . 0.0 110.711 -177.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -58.45 -45.95 87.53 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.608 -0.682 . . . . 0.0 110.379 -178.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 55.2 mmm-85 51.41 58.91 5.0 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.43 -0.794 . . . . 0.0 111.048 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -58.72 -41.51 86.56 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.561 -0.712 . . . . 0.0 110.384 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 27.7 t30 52.43 42.77 31.3 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.428 -0.795 . . . . 0.0 111.064 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 28.2 m -125.57 138.16 53.94 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.576 -0.702 . . . . 0.0 110.261 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -58.78 -38.97 79.7 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.574 -0.704 . . . . 0.0 110.489 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -148.01 -173.71 19.21 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 51.6 mm -91.96 132.43 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.601 -0.94 . . . . 0.0 110.075 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -93.09 148.66 21.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.625 -0.672 . . . . 0.0 110.348 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 93.3 mmm -59.96 -34.86 73.84 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.59 -0.694 . . . . 0.0 110.333 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 59.1 m . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.25 179.9 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 35.9 m -80.77 -29.28 36.2 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.676 -0.896 . . . . 0.0 110.18 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 57.6 p -71.77 163.26 28.12 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.649 -0.657 . . . . 0.0 110.181 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.813 HG23 ' H ' ' A' ' 119' ' ' ALA . 8.7 t -130.86 153.93 48.6 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.598 -0.689 . . . . 0.0 110.513 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -62.94 -37.68 88.02 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.671 -0.643 . . . . 0.0 110.696 -175.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -78.94 -31.91 45.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.504 -0.748 . . . . 0.0 110.226 -175.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.813 ' H ' HG23 ' A' ' 116' ' ' THR . . . 49.72 70.48 0.49 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.456 -0.777 . . . . 0.0 111.272 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.3 mt 55.75 -85.43 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.757 -0.589 . . . . 0.0 111.063 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 74.3 p -105.16 164.93 14.1 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.204 -0.935 . . . . 0.0 110.174 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -63.26 152.35 70.14 Favored 'Cis proline' 0 N--CA 1.495 1.563 0 C-N-CA 123.194 -1.586 . . . . 0.0 110.44 -18.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.9 m -82.01 158.97 66.62 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.638 -0.664 . . . . 0.0 110.274 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.517 ' HB3' HG22 ' A' ' 242' ' ' THR . 26.0 Cg_exo -59.04 147.11 91.79 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.333 1.175 . . . . 0.0 110.643 -178.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.59 144.02 42.03 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.666 -0.646 . . . . 0.0 110.136 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.619 HD11 HG22 ' A' ' 199' ' ' THR . 50.7 mm -121.88 100.02 43.7 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.711 -0.618 . . . . 0.0 109.998 -178.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 126' ' ' ILE . 12.6 Cg_endo -60.34 151.21 75.8 Favored 'Trans proline' 0 N--CA 1.487 1.147 0 O-C-N 123.185 1.097 . . . . 0.0 110.623 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.7 t -112.3 149.77 31.93 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.641 -0.662 . . . . 0.0 110.219 -178.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.7 p-10 -94.31 23.54 5.07 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.658 -0.651 . . . . 0.0 110.885 -178.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 54.0 m -72.35 125.15 26.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.471 -0.768 . . . . 0.0 110.212 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -70.53 144.92 51.17 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.602 -0.686 . . . . 0.0 110.401 -177.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.426 ' CE1' ' HA2' ' A' ' 134' ' ' GLY . 52.6 t80 -157.33 101.22 1.89 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.618 -0.676 . . . . 0.0 110.101 178.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.51 -39.94 78.76 Favored 'Trans proline' 0 N--CA 1.488 1.204 0 O-C-N 123.153 1.081 . . . . 0.0 110.952 -174.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.426 ' HA2' ' CE1' ' A' ' 132' ' ' TYR . . . 79.84 -155.11 38.52 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -74.18 -47.61 0.24 Allowed 'Trans proline' 0 C--N 1.317 -1.085 0 O-C-N 123.313 1.165 . . . . 0.0 110.846 -175.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -84.19 5.16 27.45 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.525 -0.734 . . . . 0.0 111.431 -175.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 54.01 59.97 3.92 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.898 -1.126 . . . . 0.0 110.681 -176.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.728 ' HA ' HG12 ' A' ' 176' ' ' VAL . 64.6 t80 -77.96 118.94 20.74 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.57 -0.706 . . . . 0.0 110.008 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -129.96 159.92 35.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.785 -0.572 . . . . 0.0 110.215 -175.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 71.9 t -123.65 146.66 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-O 121.443 0.639 . . . . 0.0 110.174 177.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 76.8 p -157.06 171.16 20.95 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 175.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.422 ' CE2' HG12 ' A' ' 172' ' ' ILE . 64.8 m-85 -126.57 125.08 41.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.706 -0.622 . . . . 0.0 109.916 -177.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -57.15 150.1 18.19 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.614 -0.679 . . . . 0.0 110.537 -177.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -69.99 133.56 47.39 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.652 -0.655 . . . . 0.0 110.542 -170.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.8 t -128.83 147.44 50.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.761 -0.587 . . . . 0.0 110.043 178.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 56.3 p -67.06 162.92 21.13 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.631 -0.668 . . . . 0.0 110.307 -178.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 73.3 p -101.84 26.31 7.63 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.682 -0.636 . . . . 0.0 110.178 178.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . -75.02 162.06 28.9 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.601 -0.687 . . . . 0.0 110.208 -177.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -55.51 170.55 0.24 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.577 -0.702 . . . . 0.0 110.724 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 68.0 m 52.83 26.38 4.54 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.548 -0.72 . . . . 0.0 111.091 -178.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 148' ' ' ALA . . . -77.26 120.63 22.56 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.594 -0.691 . . . . 0.0 109.943 176.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 57.9 p -60.15 -34.09 73.07 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.773 -0.579 . . . . 0.0 110.118 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.547 ' CE3' HD11 ' A' ' 162' ' ' LEU . 66.9 p-90 -170.46 148.14 3.09 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.636 -0.665 . . . . 0.0 109.752 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 13.7 t -141.52 142.36 33.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.717 -0.614 . . . . 0.0 110.031 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -125.65 140.04 53.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.482 -0.761 . . . . 0.0 110.532 -172.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 32.8 t -109.82 122.31 47.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.783 -0.573 . . . . 0.0 109.785 175.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 65.1 m -70.66 -36.8 73.56 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.689 -0.632 . . . . 0.0 110.482 -177.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -58.79 -34.28 71.29 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.615 -0.678 . . . . 0.0 110.582 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 53.8 mt -104.8 -11.71 16.66 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.61 -0.681 . . . . 0.0 110.804 -176.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.0 tttm 59.82 52.18 5.59 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.14 -0.975 . . . . 0.0 109.732 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -145.86 152.88 40.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.714 -0.616 . . . . 0.0 110.562 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.669 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.5 tp -126.66 137.83 53.34 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.863 -0.523 . . . . 0.0 110.256 -175.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -116.96 133.86 55.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.557 -0.714 . . . . 0.0 109.319 174.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.9 p -138.29 158.46 44.25 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 120.036 -0.665 . . . . 0.0 110.979 -174.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -104.52 143.9 32.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.62 -0.675 . . . . 0.0 110.398 172.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 16.9 tt -52.47 147.77 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 CA-C-O 121.64 0.733 . . . . 0.0 111.841 -173.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.16 10.01 5.18 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.628 -0.67 . . . . 0.0 112.539 177.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 32.3 mmtt -96.52 155.13 16.9 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.04 -1.037 . . . . 0.0 110.788 175.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 85.6 m -84.31 126.21 32.98 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.666 -0.646 . . . . 0.0 110.676 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . 0.669 ' SG ' HD21 ' A' ' 162' ' ' LEU . 42.6 t -112.63 90.31 14.67 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.514 -0.741 . . . . 0.0 110.082 173.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -64.75 129.28 23.03 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 123.339 1.179 . . . . 0.0 110.445 176.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.422 HG12 ' CE2' ' A' ' 142' ' ' PHE . 95.4 mt -123.17 138.67 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.665 -0.647 . . . . 0.0 109.36 176.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -108.72 133.97 52.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.546 -0.722 . . . . 0.0 110.637 -176.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.59 HG21 ' CE1' ' A' ' 138' ' ' PHE . 49.5 mm -95.37 135.07 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.641 -0.662 . . . . 0.0 109.674 172.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -118.08 129.93 55.85 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.583 -0.698 . . . . 0.0 110.597 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.728 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.3 m -136.3 159.74 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.475 -0.766 . . . . 0.0 109.957 175.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 79.7 mmm -77.46 -40.37 43.43 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.745 -0.597 . . . . 0.0 110.018 177.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.0 p -134.1 143.21 46.22 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.78 -0.575 . . . . 0.0 109.793 177.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 33.2 Cg_exo -55.67 139.88 83.6 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 O-C-N 123.2 1.105 . . . . 0.0 110.86 -173.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.616 ' HB3' HD21 ' A' ' 288' ' ' LEU . 23.5 Cg_endo -64.5 168.18 13.54 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 O-C-N 123.23 1.121 . . . . 0.0 110.635 178.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -61.53 158.21 37.72 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 O-C-N 123.353 1.186 . . . . 0.0 110.413 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -77.76 137.9 38.71 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.667 -0.645 . . . . 0.0 109.889 175.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.53 -24.97 30.08 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -174.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.1 149.98 2.58 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.367 -1.078 . . . . 0.0 111.373 177.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.71 155.99 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.654 -0.654 . . . . 0.0 109.816 176.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.656 HD11 ' CD2' ' A' ' 251' ' ' TYR . 69.8 mt -108.46 136.21 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.745 ' HG2' HD22 ' A' ' 248' ' ' LEU . 36.5 mtp180 -114.89 146.11 41.46 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -175.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.629 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -140.6 127.56 20.68 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.439 -0.788 . . . . 0.0 110.337 172.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.405 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 25.0 ttm -137.2 139.36 27.87 Favored Pre-proline 0 N--CA 1.495 1.811 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.031 -177.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.503 ' HD3' HD12 ' A' ' 226' ' ' ILE . 72.6 Cg_endo -91.34 138.29 2.21 Favored 'Trans proline' 0 C--N 1.32 -0.972 0 O-C-N 123.288 1.152 . . . . 0.0 110.772 177.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.428 HG13 ' C ' ' A' ' 190' ' ' PRO . 34.7 m -147.24 154.89 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.518 -0.739 . . . . 0.0 110.059 174.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.631 ' HA ' HG22 ' A' ' 282' ' ' ILE . 77.3 m-85 -61.6 164.78 5.58 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.47 -0.769 . . . . 0.0 110.545 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.437 ' HA ' HD12 ' A' ' 283' ' ' LEU . 48.7 tttp -80.33 -60.02 2.48 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.625 -0.672 . . . . 0.0 110.843 -174.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -80.04 151.2 30.06 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.601 -0.687 . . . . 0.0 110.372 -175.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.453 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.44 -38.52 71.74 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.368 -0.832 . . . . 0.0 110.736 -175.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -56.49 -24.92 49.34 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.525 -0.735 . . . . 0.0 110.58 -176.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.42 ' HB3' ' CG ' ' A' ' 192' ' ' TYR . 63.2 m170 -110.05 -20.49 12.69 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.094 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.453 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -67.14 -20.22 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.157 -0.964 . . . . 0.0 110.564 -176.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.619 HG22 HD11 ' A' ' 126' ' ' ILE . 81.3 p -79.35 -17.08 55.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.502 -0.749 . . . . 0.0 110.777 175.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.25 135.65 33.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.342 -0.849 . . . . 0.0 110.09 173.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.99 142.97 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.682 -0.636 . . . . 0.0 110.22 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 60.2 t -84.93 138.82 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.529 -0.732 . . . . 0.0 109.257 172.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 14.0 pttt -134.77 -170.29 2.53 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.412 -0.805 . . . . 0.0 111.345 -168.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 74.4 mtm-85 -95.3 156.05 16.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.807 -0.558 . . . . 0.0 110.319 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 48.7 m -75.64 154.75 85.48 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.571 -0.706 . . . . 0.0 109.237 173.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.4 ' HD3' ' HA3' ' A' ' 275' ' ' GLY . 17.4 Cg_exo -62.83 -47.35 8.95 Favored 'Trans proline' 0 C--N 1.315 -1.231 0 O-C-N 123.147 1.077 . . . . 0.0 110.056 176.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.412 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.7 p-10 -65.44 -44.1 88.37 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.566 -0.709 . . . . 0.0 111.245 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . 0.412 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 51.2 m170 -82.06 -28.27 32.52 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.411 -0.805 . . . . 0.0 111.171 -174.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 59.4 tt0 -69.2 -37.8 78.3 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.424 -0.798 . . . . 0.0 110.313 172.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 27.1 tp -55.62 -34.56 64.99 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.509 -0.745 . . . . 0.0 110.946 -175.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 28.6 t -48.4 137.51 11.25 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.477 -0.764 . . . . 0.0 111.392 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.442 ' HB2' ' CE2' ' A' ' 214' ' ' PHE . 88.7 mtt180 -60.52 144.26 51.81 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.667 -0.646 . . . . 0.0 110.336 -176.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -63.69 -37.34 86.99 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.727 -0.608 . . . . 0.0 110.328 -178.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.442 ' CE2' ' HB2' ' A' ' 212' ' ' ARG . 8.1 m-85 51.36 50.74 18.29 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.394 -0.816 . . . . 0.0 110.967 -177.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -67.67 -10.39 51.89 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.605 -0.684 . . . . 0.0 111.161 -176.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.63 119.73 9.24 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.202 -0.936 . . . . 0.0 110.208 177.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 74.15 20.12 79.71 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -140.56 153.48 46.15 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.314 -1.11 . . . . 0.0 110.024 -177.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.2 mt -114.97 -8.65 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.678 -0.639 . . . . 0.0 111.143 -177.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -124.94 93.15 46.4 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.18 -0.95 . . . . 0.0 110.474 -173.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.426 ' HD2' ' CE2' ' A' ' 236' ' ' TYR . 28.7 Cg_endo -67.96 150.92 78.27 Favored 'Trans proline' 0 C--N 1.316 -1.168 0 O-C-N 123.355 1.187 . . . . 0.0 110.608 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -60.37 -16.77 43.42 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 O-C-N 123.183 1.097 . . . . 0.0 111.432 -176.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 26.3 m -51.77 -27.1 11.11 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.173 -0.954 . . . . 0.0 111.303 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . 0.407 ' CD2' ' HB3' ' A' ' 245' ' ' GLN . 12.9 t-80 -109.64 129.28 55.61 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.497 -0.752 . . . . 0.0 110.46 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.515 HD12 ' HG3' ' A' ' 268' ' ' MET . 41.3 tp -60.53 -36.43 78.39 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.617 -0.677 . . . . 0.0 110.341 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.503 HD12 ' HD3' ' A' ' 190' ' ' PRO . 84.3 mt -101.81 136.75 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.767 -0.583 . . . . 0.0 110.034 -176.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -125.65 158.11 35.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.692 -0.63 . . . . 0.0 110.135 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.462 HG23 HG21 ' A' ' 247' ' ' VAL . 90.3 t -104.44 146.6 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.701 -0.625 . . . . 0.0 109.844 172.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -118.74 128.13 54.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.629 -0.67 . . . . 0.0 110.4 170.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.11 20.93 21.99 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 168.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -139.37 105.05 5.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.313 -1.11 . . . . 0.0 110.034 174.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 44.2 m -63.49 -15.21 57.2 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.547 -0.721 . . . . 0.0 111.24 -176.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -100.01 8.02 44.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.223 -0.923 . . . . 0.0 111.621 -177.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.68 133.22 55.33 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.108 -0.995 . . . . 0.0 110.175 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -139.8 158.06 44.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.756 -0.59 . . . . 0.0 109.83 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.426 ' CE2' ' HD2' ' A' ' 221' ' ' PRO . 90.4 m-85 -113.87 150.6 33.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.596 -0.69 . . . . 0.0 110.556 -177.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.06 159.98 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.771 -0.58 . . . . 0.0 110.233 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -122.7 130.05 52.51 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.743 -0.598 . . . . 0.0 110.201 177.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -65.04 112.36 7.99 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.672 -0.643 . . . . 0.0 109.714 177.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -60.23 -25.55 80.37 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.107 1.056 . . . . 0.0 110.998 -172.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.8 mt -101.14 -50.32 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.368 -0.832 . . . . 0.0 110.824 -171.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.517 HG22 ' HB3' ' A' ' 124' ' ' PRO . 6.6 p -105.33 12.16 31.99 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.341 -0.85 . . . . 0.0 111.998 -172.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 82.29 -24.85 4.58 Favored Glycine 0 N--CA 1.497 2.742 0 O-C-N 121.007 -1.058 . . . . 0.0 111.813 170.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 23.8 mmt85 -45.81 142.13 2.67 Favored 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 118.54 1.17 . . . . 0.0 112.544 -168.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.407 ' HB3' ' CD2' ' A' ' 224' ' ' HIS . 18.2 mp0 -108.51 145.08 35.28 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.626 -0.671 . . . . 0.0 110.047 174.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 77.3 p -154.84 159.91 40.87 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.572 -0.705 . . . . 0.0 110.487 178.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.462 HG21 HG23 ' A' ' 228' ' ' VAL . 8.5 p -123.01 148.07 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.77 -0.581 . . . . 0.0 109.655 178.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.745 HD22 ' HG2' ' A' ' 187' ' ' ARG . 78.8 mt -129.69 154.62 46.97 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.872 -173.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.438 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.9 m -150.69 151.82 31.16 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.819 -0.55 . . . . 0.0 109.858 174.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -71.02 139.49 35.99 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.173 1.091 . . . . 0.0 110.012 177.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.656 ' CD2' HD11 ' A' ' 186' ' ' ILE . 9.4 t80 -79.82 123.37 27.66 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.463 -0.773 . . . . 0.0 110.05 178.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -100.1 160.05 28.19 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.677 -0.64 . . . . 0.0 110.095 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -58.91 159.97 19.7 Favored 'Trans proline' 0 N--CA 1.487 1.118 0 O-C-N 123.298 1.157 . . . . 0.0 110.425 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -59.15 149.95 76.85 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.245 1.129 . . . . 0.0 110.614 -176.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -61.21 148.94 39.19 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.692 -0.63 . . . . 0.0 110.166 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.78 127.22 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.469 -0.769 . . . . 0.0 110.158 -170.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.92 -10.11 55.46 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 9.9 t -145.02 173.33 11.98 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.245 -1.15 . . . . 0.0 110.607 175.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -107.35 13.14 27.35 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.586 -0.696 . . . . 0.0 111.743 -168.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -120.01 168.0 11.61 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.167 -0.958 . . . . 0.0 111.164 -175.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 93.2 m -117.71 147.01 43.34 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.781 -0.574 . . . . 0.0 109.859 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 38.5 m -116.83 135.0 54.08 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.541 -0.724 . . . . 0.0 110.927 -175.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.4 t -129.66 137.12 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 171.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 70.1 mt -104.83 122.09 45.03 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.582 -0.699 . . . . 0.0 109.903 -173.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.629 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 6.6 m-30 -106.92 149.4 27.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.637 -0.664 . . . . 0.0 110.633 -178.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -136.63 142.95 43.27 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -111.04 131.55 54.97 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.575 -0.703 . . . . 0.0 110.499 -176.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' MET . . . . . 0.515 ' HG3' HD12 ' A' ' 225' ' ' LEU . 3.9 ppp? -96.79 2.87 52.38 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.708 -0.62 . . . . 0.0 112.119 -176.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . 0.656 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.8 OUTLIER -144.67 165.03 29.2 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.055 -1.028 . . . . 0.0 110.11 174.704 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.596 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.6 p30 -119.86 162.37 19.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.72 -0.612 . . . . 0.0 110.303 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . 0.423 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 23.1 m -58.29 -33.47 69.49 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.468 -0.77 . . . . 0.0 110.983 -163.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 49.2 p -97.9 9.88 41.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.458 -0.776 . . . . 0.0 112.07 -163.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 31.2 p -93.79 118.07 30.94 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.09 -1.006 . . . . 0.0 110.691 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 60.4 t -64.42 140.52 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.442 -0.786 . . . . 0.0 110.305 -170.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . 0.4 ' HA3' ' HD3' ' A' ' 206' ' ' PRO . . . 100.74 -5.21 56.62 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 177.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.62 -99.16 0.88 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 170.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . 0.423 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.2 mmm -63.85 -31.59 72.82 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.639 -0.918 . . . . 0.0 110.3 178.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.5 p30 43.84 50.56 6.92 Favored 'General case' 0 N--CA 1.504 2.234 0 CA-C-O 121.286 0.565 . . . . 0.0 112.521 175.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 22.0 mtt180 54.81 29.67 12.31 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.29 -0.881 . . . . 0.0 111.17 175.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -119.28 104.97 45.08 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.517 -0.739 . . . . 0.0 110.149 175.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.85 145.95 96.96 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 123.077 1.04 . . . . 0.0 110.522 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.631 HG22 ' HA ' ' A' ' 192' ' ' TYR . 45.6 pt -131.98 177.59 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 121.79 0.805 . . . . 0.0 111.132 -175.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 302' ' ' GLU . 30.1 mt -124.34 149.9 46.1 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.702 HD12 ' CE1' ' A' ' 301' ' ' PHE . 77.6 mt -115.03 129.91 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.213 177.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.526 HG23 ' SG ' ' A' ' 300' ' ' CYS . 82.3 mt -109.71 127.17 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -176.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 58.7 t -118.83 126.73 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.634 HG22 ' HG2' ' A' ' 298' ' ' ARG . 45.5 p -125.21 153.8 42.57 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.466 -174.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.616 HD21 ' HB3' ' A' ' 180' ' ' PRO . 27.1 tp -105.32 126.08 51.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.73 -0.606 . . . . 0.0 109.535 169.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.566 ' OE2' HG13 ' A' ' 295' ' ' VAL . 71.0 mm-40 -131.79 148.86 52.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.955 -0.466 . . . . 0.0 109.768 -174.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.81 ' CG2' HD11 ' A' ' 296' ' ' LEU . 54.4 p -89.88 161.68 15.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.641 -0.662 . . . . 0.0 109.98 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -55.99 -26.09 46.89 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.544 -0.723 . . . . 0.0 111.112 -174.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 40.8 p30 -91.6 10.25 28.85 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.379 -0.826 . . . . 0.0 111.923 -173.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.85 20.19 44.47 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 120.14 -1.028 . . . . 0.0 110.725 171.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -106.0 140.15 39.44 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.256 -1.144 . . . . 0.0 110.001 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.566 HG13 ' OE2' ' A' ' 289' ' ' GLU . 58.5 t -89.21 132.09 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.634 -0.666 . . . . 0.0 110.282 -172.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.81 HD11 ' CG2' ' A' ' 290' ' ' THR . 95.9 mt -99.92 -40.2 7.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.682 -0.636 . . . . 0.0 110.694 178.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -169.34 158.54 31.01 Favored Glycine 0 N--CA 1.496 2.686 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.612 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.634 ' HG2' HG22 ' A' ' 287' ' ' THR . 94.1 mtt180 -134.6 138.89 44.93 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.619 -0.93 . . . . 0.0 110.957 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -132.76 159.27 40.21 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.639 -0.663 . . . . 0.0 109.727 169.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . 0.526 ' SG ' HG23 ' A' ' 285' ' ' ILE . 87.6 m -144.06 154.38 43.16 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.409 -0.807 . . . . 0.0 110.76 -176.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.702 ' CE1' HD12 ' A' ' 284' ' ' ILE . 48.7 p90 -145.78 161.86 38.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.614 -0.679 . . . . 0.0 110.087 174.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.462 ' HA ' HD23 ' A' ' 283' ' ' LEU . 82.4 tt0 -104.83 136.81 43.64 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.619 -0.676 . . . . 0.0 110.224 -176.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -124.3 142.75 51.01 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.779 -170.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -138.11 140.91 40.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.793 -0.567 . . . . 0.0 109.684 172.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.656 HD13 ' O ' ' A' ' 269' ' ' CYS . 74.5 mt -108.29 122.78 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.462 -0.774 . . . . 0.0 109.688 176.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.0 p -145.31 170.28 16.61 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.605 -0.684 . . . . 0.0 110.676 -171.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -72.47 -40.18 67.17 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.662 -0.649 . . . . 0.0 110.648 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.7 t -126.83 85.75 60.18 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.471 -0.768 . . . . 0.0 110.485 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -55.69 -28.19 64.91 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 O-C-N 123.121 1.064 . . . . 0.0 110.856 174.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.95 -38.18 92.66 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 177.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 57.5 ttt85 -72.61 -40.37 66.54 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.621 -0.929 . . . . 0.0 109.875 -173.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -69.53 -38.91 77.71 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.137 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.401 ' HA ' ' OD2' ' A' ' 316' ' ' ASP . 70.3 ttt180 -61.25 -43.28 99.13 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.52 -0.738 . . . . 0.0 110.251 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -64.51 -40.82 96.34 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.567 -0.708 . . . . 0.0 110.604 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -60.73 -49.88 75.71 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.478 -0.764 . . . . 0.0 110.559 -173.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . 0.401 ' OD2' ' HA ' ' A' ' 313' ' ' ARG . 2.9 p30 -61.27 -37.72 84.16 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.418 -0.802 . . . . 0.0 110.045 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -61.31 -40.57 94.69 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.557 -0.714 . . . . 0.0 110.171 177.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -63.05 -35.28 79.73 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.671 -0.643 . . . . 0.0 110.249 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 37.0 p -66.65 -28.58 68.59 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.661 -0.65 . . . . 0.0 110.318 -178.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 50.9 mm -78.85 -44.37 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.61 -0.681 . . . . 0.0 109.956 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -59.14 -39.76 83.4 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.626 -0.671 . . . . 0.0 110.452 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 20.0 mtpp -61.79 -42.43 98.99 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.186 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -64.49 -32.95 74.8 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.63 -0.669 . . . . 0.0 110.276 178.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -84.55 125.02 32.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.669 -0.644 . . . . 0.0 110.396 -176.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 61.8 t -117.26 130.15 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.587 -0.696 . . . . 0.0 109.787 178.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 28.9 t -60.19 140.05 57.19 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.63 -0.669 . . . . 0.0 110.277 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -72.38 143.46 48.57 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.701 -0.625 . . . . 0.0 110.244 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 63.7 m -94.05 159.22 15.26 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.674 -0.641 . . . . 0.0 110.173 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 4.6 m -139.85 27.45 2.21 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.591 -0.693 . . . . 0.0 110.401 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -96.22 21.68 8.63 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.54 -0.725 . . . . 0.0 110.624 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 41.5 p-10 -84.83 -165.65 1.25 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.456 -0.777 . . . . 0.0 110.453 -178.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 92.63 -161.68 26.19 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -80.18 121.21 25.3 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.672 -0.899 . . . . 0.0 110.269 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.409 ' HB3' ' NE2' ' A' ' 337' ' ' GLN . . . -140.01 157.37 45.77 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.689 -0.632 . . . . 0.0 110.18 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -120.94 160.71 22.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.681 -0.637 . . . . 0.0 110.46 -177.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 56.45 -85.39 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.766 -0.584 . . . . 0.0 111.146 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' GLN . . . . . 0.409 ' NE2' ' HB3' ' A' ' 334' ' ' ALA . 87.9 mt-30 53.16 48.07 23.03 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.122 -0.986 . . . . 0.0 110.878 -176.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -58.1 -36.76 73.35 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.58 -0.7 . . . . 0.0 110.535 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 68.5 p -123.59 158.54 31.2 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.664 -0.647 . . . . 0.0 110.19 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -128.98 145.86 51.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.609 -0.682 . . . . 0.0 110.286 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -97.67 27.24 19.74 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.632 HG22 ' H ' ' A' ' 344' ' ' MET . 82.3 mt -93.77 135.27 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.556 -0.967 . . . . 0.0 109.866 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -90.72 16.5 9.1 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.648 -0.658 . . . . 0.0 111.148 -177.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . 0.632 ' H ' HG22 ' A' ' 342' ' ' ILE . 70.1 mtm -125.8 157.03 38.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.276 -0.89 . . . . 0.0 110.236 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.236 -179.992 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 74.9 m -86.09 9.22 17.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.689 -0.889 . . . . 0.0 111.332 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.6 m -120.02 147.05 45.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.183 -0.948 . . . . 0.0 110.294 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 49.1 m -123.66 140.9 52.53 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.733 -0.605 . . . . 0.0 110.238 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -115.62 148.57 39.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.618 -0.677 . . . . 0.0 110.242 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -80.36 -31.97 37.79 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.659 -0.651 . . . . 0.0 110.215 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 56.45 -84.69 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.646 -0.659 . . . . 0.0 110.843 -176.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 30.3 tp 55.85 -86.66 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.23 -0.919 . . . . 0.0 110.857 -177.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.9 p -131.55 162.58 55.26 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.132 -0.98 . . . . 0.0 110.305 -177.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -64.84 151.48 75.4 Favored 'Cis proline' 0 N--CA 1.496 1.618 0 C-N-CA 123.101 -1.625 . . . . 0.0 110.31 -17.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.8 t -81.27 144.06 53.29 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.631 -0.668 . . . . 0.0 110.153 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -64.23 146.78 90.85 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.297 1.156 . . . . 0.0 110.362 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.5 149.01 38.53 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.663 -0.648 . . . . 0.0 109.991 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.681 HD11 HG22 ' A' ' 199' ' ' THR . 49.9 mm -119.99 138.34 26.86 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.573 -0.705 . . . . 0.0 109.982 -178.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -65.61 154.47 73.64 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 123.141 1.074 . . . . 0.0 110.418 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 27.5 t -114.22 142.88 45.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.612 -0.68 . . . . 0.0 110.238 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.4 p-10 -101.89 25.22 8.91 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.586 -0.696 . . . . 0.0 110.699 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 49.1 m -79.17 125.23 29.17 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.617 -0.677 . . . . 0.0 110.262 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -68.86 144.93 54.1 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.696 -0.628 . . . . 0.0 110.418 -177.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -154.3 99.81 2.48 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.76 -0.587 . . . . 0.0 110.038 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.47 -39.99 78.58 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 O-C-N 123.181 1.095 . . . . 0.0 110.823 -175.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.94 -155.19 47.65 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -73.72 -46.31 0.34 Allowed 'Trans proline' 0 C--N 1.316 -1.155 0 O-C-N 123.354 1.186 . . . . 0.0 110.959 -173.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -87.38 9.08 21.76 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.509 -0.745 . . . . 0.0 111.376 -173.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.61 61.28 3.18 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.991 -1.068 . . . . 0.0 110.727 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.677 ' HA ' HG12 ' A' ' 176' ' ' VAL . 46.3 t80 -77.86 119.22 21.03 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.587 -0.696 . . . . 0.0 109.869 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -130.08 160.43 33.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.829 -0.545 . . . . 0.0 110.154 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 63.2 t -125.76 145.57 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.82 -0.55 . . . . 0.0 109.767 177.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 78.4 p -155.46 160.51 40.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.734 -0.603 . . . . 0.0 110.067 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.434 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 67.8 m-85 -126.75 125.23 41.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.854 -0.529 . . . . 0.0 109.788 -176.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -58.1 137.48 56.9 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.623 -0.673 . . . . 0.0 110.287 -175.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -120.14 155.54 32.86 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.683 -0.635 . . . . 0.0 110.517 -176.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 23.2 t -149.29 171.74 16.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.697 -0.627 . . . . 0.0 110.05 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 43.9 m -59.62 156.33 13.81 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.58 -0.7 . . . . 0.0 110.179 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.1 p -59.11 98.93 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.619 -0.676 . . . . 0.0 110.351 -176.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.12 149.08 22.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.735 -0.603 . . . . 0.0 110.224 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -69.4 133.58 47.95 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.583 -0.698 . . . . 0.0 109.961 178.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.0 t 52.49 74.93 0.25 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.411 -0.806 . . . . 0.0 110.87 -177.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -93.31 132.52 37.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.589 -0.694 . . . . 0.0 110.149 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.441 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 75.8 p -60.09 -33.09 71.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.716 -0.615 . . . . 0.0 109.932 176.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.441 ' HD1' ' HG1' ' A' ' 152' ' ' THR . 68.6 p-90 -170.95 142.6 1.88 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.309 0.576 . . . . 0.0 110.026 178.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 13.2 t -142.2 142.57 32.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.942 -0.474 . . . . 0.0 109.952 -176.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.434 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 64.1 t80 -125.51 140.03 53.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.523 -0.736 . . . . 0.0 110.544 -172.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 28.5 t -110.24 124.41 51.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.861 -0.525 . . . . 0.0 109.845 176.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 58.6 m -70.76 -36.94 73.33 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.789 -0.569 . . . . 0.0 110.556 -177.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -59.43 -34.66 72.77 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.561 -0.712 . . . . 0.0 110.464 -177.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 57.4 mt -104.88 -11.98 16.47 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.672 -0.642 . . . . 0.0 110.88 -175.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 59.8 tttt 59.79 52.01 5.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.065 -1.022 . . . . 0.0 109.746 178.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -145.35 152.99 40.74 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.707 -0.621 . . . . 0.0 110.556 -175.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.656 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.55 137.79 53.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.69 -0.631 . . . . 0.0 110.344 -176.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -116.19 134.2 55.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.675 -0.641 . . . . 0.0 109.382 174.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.3 158.39 44.39 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.939 -175.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -104.61 143.38 33.15 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.469 0.652 . . . . 0.0 110.396 173.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.439 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 16.7 tt -52.0 146.51 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.608 -0.682 . . . . 0.0 111.813 -175.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 65.2 10.01 6.06 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.665 -0.647 . . . . 0.0 112.415 177.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -96.63 155.13 16.9 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.068 -1.02 . . . . 0.0 110.832 174.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 62.3 m -88.53 126.22 35.15 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.662 -0.648 . . . . 0.0 110.669 -177.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . 0.656 ' SG ' HD21 ' A' ' 162' ' ' LEU . 44.2 t -113.71 90.08 17.45 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.59 -0.694 . . . . 0.0 110.19 175.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.439 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 23.7 Cg_exo -60.75 130.26 32.45 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 O-C-N 123.268 1.141 . . . . 0.0 110.678 172.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.402 HG12 ' CE2' ' A' ' 142' ' ' PHE . 97.5 mt -124.9 141.66 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 176.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -109.5 135.43 50.51 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.464 -0.772 . . . . 0.0 110.879 -175.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.408 HG23 ' CE1' ' A' ' 138' ' ' PHE . 50.5 mm -95.29 133.58 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.713 -0.617 . . . . 0.0 109.624 169.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 40.2 tttp -114.49 128.77 56.51 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.579 -0.701 . . . . 0.0 110.449 176.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.677 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.1 m -136.72 159.88 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.588 -0.695 . . . . 0.0 109.86 175.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.7 mmm -76.57 -41.4 46.53 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.666 -0.646 . . . . 0.0 110.1 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.0 p -134.78 143.27 45.65 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.763 -0.586 . . . . 0.0 109.695 178.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.9 Cg_exo -55.45 139.74 82.24 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 O-C-N 123.156 1.082 . . . . 0.0 110.889 -171.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.683 ' HB3' HD21 ' A' ' 288' ' ' LEU . 34.9 Cg_endo -67.63 169.99 14.76 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 O-C-N 123.157 1.082 . . . . 0.0 110.608 177.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -60.81 155.28 50.05 Favored 'Trans proline' 0 C--N 1.316 -1.152 0 O-C-N 123.327 1.172 . . . . 0.0 110.521 -178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -77.46 141.09 39.88 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.519 -0.738 . . . . 0.0 109.879 174.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.8 -24.88 29.76 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -174.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.19 150.74 2.31 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.412 -1.052 . . . . 0.0 111.4 177.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.7 156.04 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.762 -0.586 . . . . 0.0 109.688 176.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.742 HD11 ' HD2' ' A' ' 251' ' ' TYR . 84.2 mt -109.16 141.49 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.752 -0.592 . . . . 0.0 109.599 177.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.68 ' HG2' HD22 ' A' ' 248' ' ' LEU . 70.6 mtp180 -114.78 145.2 42.37 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -176.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.638 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -140.03 126.29 19.98 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.339 173.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.407 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 41.9 ttm -137.24 139.9 29.37 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.81 -0.557 . . . . 0.0 111.059 -176.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.494 ' HD3' HD12 ' A' ' 226' ' ' ILE . 73.9 Cg_endo -91.19 138.23 2.26 Favored 'Trans proline' 0 C--N 1.32 -0.964 0 O-C-N 123.3 1.158 . . . . 0.0 110.812 177.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.438 HG13 ' C ' ' A' ' 190' ' ' PRO . 34.8 m -147.7 154.9 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.574 -0.704 . . . . 0.0 109.988 173.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.6 ' HA ' HG22 ' A' ' 282' ' ' ILE . 87.2 m-85 -61.49 165.76 4.59 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.462 -0.774 . . . . 0.0 110.447 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.486 ' HA ' HD12 ' A' ' 283' ' ' LEU . 33.2 ttmt -83.99 -60.05 2.22 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.626 -0.671 . . . . 0.0 110.799 -173.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 48.3 mttt -80.04 152.49 29.37 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.639 -0.663 . . . . 0.0 110.332 -175.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.452 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.56 -38.75 72.36 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.462 -0.774 . . . . 0.0 110.698 -175.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -56.48 -24.91 49.25 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.519 -0.738 . . . . 0.0 110.621 -176.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.413 ' HB3' ' CG ' ' A' ' 192' ' ' TYR . 77.8 m80 -109.7 -20.5 12.8 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.137 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -67.6 -20.23 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.123 -0.986 . . . . 0.0 110.576 -175.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.681 HG22 HD11 ' A' ' 126' ' ' ILE . 71.7 p -79.48 -16.91 55.25 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.763 174.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -88.37 134.93 33.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.359 -0.838 . . . . 0.0 110.1 173.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 242' ' ' THR . 60.9 t -72.97 145.91 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.615 -0.678 . . . . 0.0 110.27 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 60.6 t -84.72 139.79 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.564 -0.71 . . . . 0.0 109.223 172.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.8 pttp -134.85 -170.16 2.51 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.422 -0.799 . . . . 0.0 111.295 -166.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -95.21 152.59 18.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.789 -0.57 . . . . 0.0 110.102 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 36.5 m -73.5 152.16 89.67 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.471 -0.768 . . . . 0.0 109.025 173.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.408 ' HD3' ' HA3' ' A' ' 275' ' ' GLY . 19.6 Cg_exo -61.8 -47.31 11.25 Favored 'Trans proline' 0 C--N 1.315 -1.231 0 O-C-N 123.071 1.037 . . . . 0.0 110.243 177.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.408 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.6 p-10 -65.38 -44.1 88.64 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.615 -0.678 . . . . 0.0 111.236 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . 0.408 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 52.0 m170 -82.82 -27.93 30.56 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.442 -0.786 . . . . 0.0 111.191 -174.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -69.05 -39.24 79.26 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.341 -0.849 . . . . 0.0 110.302 174.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 25.9 tp -57.11 -35.93 70.02 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.493 -0.755 . . . . 0.0 110.75 -177.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 30.6 t -48.28 141.03 6.87 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.504 -0.748 . . . . 0.0 111.376 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -60.76 141.54 56.84 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.595 -0.691 . . . . 0.0 110.248 -177.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -64.04 -37.06 86.06 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.736 -0.603 . . . . 0.0 110.143 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.406 ' CD2' ' O ' ' A' ' 214' ' ' PHE . 59.1 t80 51.21 51.32 17.2 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.521 -0.737 . . . . 0.0 111.038 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -73.34 -10.22 59.52 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.711 -0.618 . . . . 0.0 111.16 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -60.41 118.55 6.6 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.254 -0.904 . . . . 0.0 110.326 177.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 78.0 20.04 73.86 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 177.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -139.52 140.02 37.06 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.292 -1.122 . . . . 0.0 110.139 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.1 mt -84.91 -24.89 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.689 -0.632 . . . . 0.0 110.529 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -124.83 99.35 35.32 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.429 -0.794 . . . . 0.0 110.482 -173.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 222' ' ' PRO . 22.2 Cg_endo -66.08 149.49 85.78 Favored 'Trans proline' 0 C--N 1.316 -1.132 0 O-C-N 123.211 1.111 . . . . 0.0 110.645 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 221' ' ' PRO . 33.0 Cg_exo -57.5 -19.57 37.07 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 O-C-N 123.285 1.15 . . . . 0.0 111.484 -178.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 25.9 m -51.14 -27.06 7.62 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.153 -0.967 . . . . 0.0 111.467 -177.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -101.92 129.93 48.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.517 -0.739 . . . . 0.0 110.433 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.72 -39.42 88.54 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.69 -0.631 . . . . 0.0 110.202 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.494 HD12 ' HD3' ' A' ' 190' ' ' PRO . 83.7 mt -104.94 136.81 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.834 -0.541 . . . . 0.0 109.801 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -132.47 157.82 43.65 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.797 -0.564 . . . . 0.0 110.292 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.461 HG23 HG21 ' A' ' 247' ' ' VAL . 94.1 t -102.67 146.56 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.722 -0.611 . . . . 0.0 109.909 175.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -117.26 124.14 48.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.722 -0.611 . . . . 0.0 110.428 172.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 95.79 24.33 15.77 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 167.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -137.27 107.07 6.23 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.5 -1.0 . . . . 0.0 110.015 174.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 28.0 t -63.03 -15.2 55.66 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.611 -0.68 . . . . 0.0 111.203 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -100.0 9.34 43.06 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.289 -0.882 . . . . 0.0 111.588 -177.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.37 127.91 33.77 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.129 -0.982 . . . . 0.0 110.179 176.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -139.75 158.01 44.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.707 -0.62 . . . . 0.0 109.868 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -114.67 150.66 34.85 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.604 -0.685 . . . . 0.0 110.576 -176.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.13 160.0 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.742 -0.599 . . . . 0.0 110.173 177.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -119.17 130.06 55.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.703 -0.623 . . . . 0.0 110.227 176.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -64.18 130.04 94.36 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.66 -0.65 . . . . 0.0 109.833 178.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -65.41 -28.34 54.39 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.187 1.098 . . . . 0.0 111.024 -170.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.8 mt -101.74 -50.5 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.425 -0.797 . . . . 0.0 111.051 -167.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.445 ' O ' HG21 ' A' ' 201' ' ' VAL . 11.1 p -105.4 12.18 31.86 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.446 -0.784 . . . . 0.0 111.843 -174.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 72.3 -5.01 16.43 Favored Glycine 0 N--CA 1.496 2.688 0 O-C-N 121.102 -0.999 . . . . 0.0 112.007 173.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.419 ' CZ ' HG12 ' A' ' 191' ' ' VAL . 23.4 mmt180 -45.91 142.05 2.8 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-N 119.134 1.467 . . . . 0.0 112.36 -174.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -103.61 143.43 32.77 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.715 -0.616 . . . . 0.0 110.117 175.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 76.5 p -154.74 159.95 41.0 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.637 -0.664 . . . . 0.0 110.332 177.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.461 HG21 HG23 ' A' ' 228' ' ' VAL . 8.2 p -123.0 148.2 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.789 -0.569 . . . . 0.0 109.699 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.68 HD22 ' HG2' ' A' ' 187' ' ' ARG . 79.9 mt -129.51 154.56 46.9 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.615 -175.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.439 HG13 ' C ' ' A' ' 248' ' ' LEU . 32.5 m -151.13 151.78 30.09 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.776 -0.577 . . . . 0.0 109.955 175.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -71.14 139.59 35.81 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 O-C-N 123.333 1.175 . . . . 0.0 110.009 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.742 ' HD2' HD11 ' A' ' 186' ' ' ILE . 59.2 t80 -75.76 127.22 32.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.539 -0.726 . . . . 0.0 110.123 175.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -100.11 160.09 28.06 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.765 -0.584 . . . . 0.0 109.979 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -58.77 158.34 24.71 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.213 1.112 . . . . 0.0 110.496 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.25 149.95 77.43 Favored 'Trans proline' 0 N--CA 1.487 1.145 0 O-C-N 123.206 1.109 . . . . 0.0 110.549 -177.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -61.87 147.73 45.69 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.603 -0.686 . . . . 0.0 110.146 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.92 127.25 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.537 -0.727 . . . . 0.0 110.161 -170.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.95 -10.17 55.43 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.431 HG21 ' CE2' ' A' ' 260' ' ' PHE . 9.2 t -144.46 174.14 11.19 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.253 -1.145 . . . . 0.0 110.566 175.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -108.08 13.22 26.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.622 -0.674 . . . . 0.0 111.839 -167.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 258' ' ' THR . 38.6 p90 -120.0 168.09 11.51 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.15 -0.969 . . . . 0.0 111.101 -175.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 76.9 m -117.75 145.87 44.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.756 -0.59 . . . . 0.0 109.836 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 55.8 m -116.64 134.81 54.37 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.478 0.656 . . . . 0.0 110.91 -174.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 64.0 t -130.35 137.32 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 172.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 171' ' ' PRO . 76.1 mt -104.73 120.47 41.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.518 -0.739 . . . . 0.0 109.89 -171.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.638 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 6.0 m-30 -106.51 151.67 24.68 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.693 -0.63 . . . . 0.0 110.486 -177.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -136.54 142.89 43.46 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -113.48 131.73 55.93 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.6 -0.688 . . . . 0.0 110.259 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -104.17 9.68 36.11 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.582 -0.699 . . . . 0.0 111.897 -175.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . 0.574 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.7 OUTLIER -144.62 160.37 41.29 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.035 -1.041 . . . . 0.0 109.861 170.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.646 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.5 p30 -117.49 162.43 17.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.682 -0.636 . . . . 0.0 110.31 -177.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . 0.427 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 20.1 m -58.78 -32.28 69.15 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.582 -0.699 . . . . 0.0 110.925 -163.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 48.0 p -99.79 12.89 35.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.507 -0.746 . . . . 0.0 111.962 -164.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 32.0 p -94.54 118.15 31.24 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.552 177.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 60.1 t -64.02 139.54 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.46 -0.775 . . . . 0.0 110.399 -167.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . 0.408 ' HA3' ' HD3' ' A' ' 206' ' ' PRO . . . 99.56 -5.16 58.44 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 176.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -124.46 -100.05 1.33 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 170.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . 0.427 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.2 mmm -63.96 -31.98 73.36 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.654 -0.909 . . . . 0.0 110.207 176.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.5 p30 43.53 51.15 6.31 Favored 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 175.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 54.78 27.42 8.85 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.394 -0.816 . . . . 0.0 111.163 175.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 77.2 mtt180 -117.67 106.42 46.23 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.476 -0.765 . . . . 0.0 110.09 175.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.56 146.71 94.43 Favored 'Trans proline' 0 N--CA 1.488 1.171 0 O-C-N 123.137 1.072 . . . . 0.0 110.577 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.6 HG22 ' HA ' ' A' ' 192' ' ' TYR . 45.4 pt -131.96 178.34 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.761 0.791 . . . . 0.0 110.773 -176.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' ' 193' ' ' LYS . 28.0 mt -124.41 149.84 46.28 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.69 HD12 ' CE1' ' A' ' 301' ' ' PHE . 80.3 mt -115.82 130.44 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.617 -0.677 . . . . 0.0 109.239 177.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.647 HG23 ' SG ' ' A' ' 300' ' ' CYS . 85.3 mt -109.79 126.22 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -176.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 58.5 t -118.91 126.7 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.4 p -125.25 154.69 41.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.673 -0.642 . . . . 0.0 110.795 -175.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.683 HD21 ' HB3' ' A' ' 180' ' ' PRO . 23.6 tp -104.82 126.83 52.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.816 -0.553 . . . . 0.0 109.575 170.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.743 ' OE2' HG13 ' A' ' 295' ' ' VAL . 72.0 mm-40 -132.44 149.83 52.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.897 -0.502 . . . . 0.0 109.912 -172.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.834 ' CG2' HD11 ' A' ' 296' ' ' LEU . 26.1 p -90.42 160.88 15.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.639 -0.663 . . . . 0.0 110.015 177.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -55.95 -26.14 46.7 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.506 -0.746 . . . . 0.0 111.002 -175.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 44.8 p30 -89.72 9.77 25.88 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.414 -0.804 . . . . 0.0 111.9 -172.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.7 20.17 45.08 Favored Glycine 0 N--CA 1.495 2.6 0 C-N-CA 120.143 -1.027 . . . . 0.0 110.677 171.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -108.98 140.13 42.91 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.32 -1.106 . . . . 0.0 109.921 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.743 HG13 ' OE2' ' A' ' 289' ' ' GLU . 60.3 t -91.83 133.3 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.527 -0.733 . . . . 0.0 110.217 -172.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.834 HD11 ' CG2' ' A' ' 290' ' ' THR . 71.6 mt -99.87 -40.24 7.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.792 -0.567 . . . . 0.0 110.59 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -158.36 154.87 25.93 Favored Glycine 0 N--CA 1.496 2.697 0 C-N-CA 119.917 -1.135 . . . . 0.0 110.516 -177.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.713 ' CZ ' HG11 ' A' ' 295' ' ' VAL . 55.5 mtt85 -135.03 136.32 42.0 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.722 -0.869 . . . . 0.0 110.211 178.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -140.69 157.26 45.69 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.487 -0.758 . . . . 0.0 110.152 169.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . 0.647 ' SG ' HG23 ' A' ' 285' ' ' ILE . 95.3 m -142.52 156.63 45.15 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.512 -0.743 . . . . 0.0 110.632 -175.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.69 ' CE1' HD12 ' A' ' 284' ' ' ILE . 48.5 p90 -145.0 162.88 35.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.681 -0.637 . . . . 0.0 110.199 176.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.417 ' HA ' HD23 ' A' ' 283' ' ' LEU . 81.8 tt0 -104.96 136.15 44.97 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.526 -0.734 . . . . 0.0 110.11 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -121.66 144.21 48.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.614 -0.679 . . . . 0.0 110.814 -169.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -139.23 139.51 37.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.857 -0.527 . . . . 0.0 109.744 172.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.646 HG21 ' HA ' ' A' ' 270' ' ' ASN . 82.6 mt -108.71 122.84 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.465 -0.772 . . . . 0.0 109.726 176.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.8 p -145.31 171.02 15.17 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.609 -0.682 . . . . 0.0 110.606 -172.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -73.2 -40.09 65.02 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.589 -0.694 . . . . 0.0 110.7 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.7 t -127.12 85.66 60.55 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.524 -0.735 . . . . 0.0 110.49 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -55.88 -27.85 64.95 Favored 'Trans proline' 0 C--N 1.314 -1.259 0 O-C-N 123.226 1.119 . . . . 0.0 110.772 174.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -67.6 -38.1 89.99 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -72.89 -40.46 65.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.674 -0.897 . . . . 0.0 109.803 -173.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -69.59 -39.35 77.35 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.061 -178.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -61.38 -44.66 96.78 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.219 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -64.04 -40.16 95.7 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.606 -0.684 . . . . 0.0 110.459 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.6 -50.73 71.43 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.548 -0.72 . . . . 0.0 110.419 -173.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -61.62 -37.76 85.12 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.509 -0.744 . . . . 0.0 110.107 -178.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -62.93 -39.61 95.11 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.646 -0.659 . . . . 0.0 110.138 178.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -62.25 -35.22 78.28 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.647 -0.658 . . . . 0.0 109.949 178.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 23.9 m -63.13 -33.38 75.34 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.686 -0.634 . . . . 0.0 110.322 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.48 HG22 HE21 ' A' ' 324' ' ' GLN . 51.0 mm -77.82 -43.51 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.61 -0.681 . . . . 0.0 110.012 -177.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -58.73 -41.17 85.79 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.639 -0.663 . . . . 0.0 110.444 178.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 32.4 tttp -61.76 -41.75 98.09 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.652 -0.655 . . . . 0.0 110.088 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -61.38 -33.8 74.27 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.63 -0.669 . . . . 0.0 110.136 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.48 HE21 HG22 ' A' ' 320' ' ' ILE . 50.6 mt-30 -85.97 125.03 33.08 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.699 -0.626 . . . . 0.0 110.397 -177.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 62.3 t -118.6 130.17 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.699 -0.626 . . . . 0.0 109.803 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 29.4 t -95.09 139.98 30.67 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.669 -0.645 . . . . 0.0 110.239 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -106.55 150.09 26.5 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.682 -0.636 . . . . 0.0 110.442 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 29.7 t -94.05 146.05 24.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.646 -0.659 . . . . 0.0 110.238 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 48.6 m -97.89 134.39 41.09 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.689 -0.632 . . . . 0.0 110.267 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -100.02 146.29 26.91 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.687 -0.633 . . . . 0.0 110.245 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -59.26 -33.2 70.76 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.625 -0.672 . . . . 0.0 110.298 178.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -142.3 179.96 19.7 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 46.8 p30 -146.19 160.02 42.52 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.698 -0.883 . . . . 0.0 110.475 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -147.17 155.88 42.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.674 -0.641 . . . . 0.0 110.278 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.444 ' CD2' ' NE2' ' A' ' 337' ' ' GLN . 66.1 t80 -59.32 -38.51 80.48 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.671 -0.643 . . . . 0.0 110.365 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 53.3 99.35 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.51 -0.744 . . . . 0.0 110.994 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' GLN . . . . . 0.444 ' NE2' ' CD2' ' A' ' 335' ' ' PHE . 98.8 mm-40 -60.2 -33.24 71.97 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.598 -0.689 . . . . 0.0 110.3 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . 0.402 ' OD1' ' CE1' ' A' ' 340' ' ' HIS . 22.7 t-20 -89.13 128.02 35.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.603 -0.686 . . . . 0.0 110.264 -178.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 51.2 m -118.32 141.99 47.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.626 -0.671 . . . . 0.0 110.286 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . 0.402 ' CE1' ' OD1' ' A' ' 338' ' ' ASN . 99.4 m-70 -116.6 144.41 44.41 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.558 -0.714 . . . . 0.0 110.282 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -59.46 -30.43 68.23 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.608 HD12 ' O ' ' A' ' 344' ' ' MET . 26.4 pt -94.33 147.67 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.637 -0.919 . . . . 0.0 110.322 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -83.54 -34.74 25.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.673 -0.642 . . . . 0.0 110.186 -179.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . 0.608 ' O ' HD12 ' A' ' 342' ' ' ILE . 70.3 mtm -120.37 152.44 37.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.622 -0.674 . . . . 0.0 110.256 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 7.4 t . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.315 -179.92 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 29.4 t -156.24 148.19 23.11 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.644 -0.915 . . . . 0.0 110.289 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 29.0 t -119.86 142.9 48.24 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.619 -0.676 . . . . 0.0 110.243 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 49.6 m -121.69 140.11 52.72 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.562 -0.711 . . . . 0.0 110.295 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -118.76 153.04 35.06 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.714 -0.617 . . . . 0.0 110.207 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -80.15 -30.44 38.95 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.667 -0.646 . . . . 0.0 110.119 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 50.78 -165.57 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.368 -0.832 . . . . 0.0 111.159 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.4 mt 52.75 -165.56 0.07 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.434 -0.791 . . . . 0.0 110.922 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.82 174.45 2.39 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.638 -0.664 . . . . 0.0 110.081 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -64.27 152.55 73.91 Favored 'Cis proline' 0 N--CA 1.496 1.623 0 C-N-CA 123.304 -1.54 . . . . 0.0 110.493 -14.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.0 156.48 69.64 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.682 -0.636 . . . . 0.0 110.213 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -59.08 145.04 98.99 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 O-C-N 123.28 1.147 . . . . 0.0 110.666 -178.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.86 150.09 37.69 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.776 -0.578 . . . . 0.0 110.121 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 50.0 mm -119.94 139.52 28.35 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.579 -0.701 . . . . 0.0 109.845 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -61.56 150.04 87.12 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 O-C-N 123.134 1.071 . . . . 0.0 110.383 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.2 t -114.8 143.42 45.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.731 -0.606 . . . . 0.0 110.219 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 p-10 -96.33 24.34 5.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.637 -0.664 . . . . 0.0 110.721 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 49.9 m -77.8 125.16 28.92 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.577 -0.702 . . . . 0.0 110.274 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -71.16 144.96 50.03 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.686 -0.634 . . . . 0.0 110.414 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -157.78 101.48 1.8 Allowed Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.746 -0.596 . . . . 0.0 110.077 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -59.73 -39.87 69.46 Favored 'Trans proline' 0 N--CA 1.488 1.167 0 O-C-N 123.179 1.094 . . . . 0.0 110.681 -175.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.08 -155.12 43.9 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -73.6 -44.85 0.46 Allowed 'Trans proline' 0 C--N 1.317 -1.09 0 O-C-N 123.344 1.181 . . . . 0.0 110.855 -175.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -86.92 4.34 41.93 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.585 -0.697 . . . . 0.0 111.498 -174.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.82 61.6 3.01 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.888 -1.133 . . . . 0.0 110.716 -176.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.727 ' HA ' HG12 ' A' ' 176' ' ' VAL . 63.1 t80 -78.04 120.46 22.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.643 -0.661 . . . . 0.0 110.106 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -129.98 159.97 35.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.763 -0.586 . . . . 0.0 110.261 -177.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 64.5 t -126.28 146.3 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.789 -0.57 . . . . 0.0 109.831 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.9 p -154.98 162.75 41.0 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.947 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.419 ' CE2' HG12 ' A' ' 172' ' ' ILE . 76.2 m-85 -126.66 125.26 41.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.771 -0.581 . . . . 0.0 109.944 -175.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -57.11 145.97 29.27 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.568 -0.708 . . . . 0.0 110.516 -174.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -106.61 148.28 28.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.598 -0.688 . . . . 0.0 110.466 -175.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 83.8 p -143.37 163.44 33.04 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.702 -0.624 . . . . 0.0 110.049 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 44.8 m -61.24 154.85 22.45 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.569 -0.707 . . . . 0.0 110.121 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 73.9 p -67.78 78.4 0.2 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.616 -0.677 . . . . 0.0 110.033 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.11 142.23 27.91 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.692 -0.63 . . . . 0.0 110.25 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -60.02 157.85 12.08 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.629 -0.67 . . . . 0.0 110.464 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 66.1 m 52.31 31.77 9.93 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.426 -0.796 . . . . 0.0 111.093 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.2 129.62 41.61 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.628 -0.67 . . . . 0.0 110.049 177.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.425 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 65.4 p -60.1 -34.08 72.98 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.613 -0.68 . . . . 0.0 110.055 176.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.425 ' HD1' ' HG1' ' A' ' 152' ' ' THR . 68.7 p-90 -171.83 144.15 1.74 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.43 0.633 . . . . 0.0 110.158 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.3 t -142.11 142.59 32.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.788 -0.57 . . . . 0.0 109.943 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -125.52 140.07 53.07 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.532 -0.73 . . . . 0.0 110.579 -172.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.7 t -110.43 123.56 50.11 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 120.366 -0.533 . . . . 0.0 109.641 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 63.1 m -70.82 -37.11 73.21 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.755 -0.591 . . . . 0.0 110.42 -177.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -58.94 -32.76 69.88 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.582 -0.699 . . . . 0.0 110.275 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.507 HD11 ' OD1' ' A' ' 316' ' ' ASP . 37.7 mt -104.8 -12.11 16.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.71 -0.619 . . . . 0.0 110.712 -175.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 31.6 tttm 59.68 47.92 9.97 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.971 -1.08 . . . . 0.0 109.761 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.444 ' HE3' ' CZ ' ' A' ' 163' ' ' TYR . 33.9 ttpt -147.19 153.16 39.5 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 120.114 -0.635 . . . . 0.0 110.725 -174.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.58 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.6 138.18 53.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.763 -0.585 . . . . 0.0 110.374 -173.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.444 ' CZ ' ' HE3' ' A' ' 161' ' ' LYS . 52.3 m-85 -114.7 135.04 54.59 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 174.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.9 p -138.33 158.4 44.36 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.034 -176.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.416 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 57.0 mt-30 -104.55 142.86 33.89 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.611 -0.681 . . . . 0.0 110.211 173.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.428 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.2 tt -52.41 147.42 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.461 -0.774 . . . . 0.0 111.837 -174.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.89 9.97 5.78 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.539 -0.726 . . . . 0.0 112.487 176.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.416 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 72.2 mmtt -95.68 155.09 16.89 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.994 -1.067 . . . . 0.0 110.906 174.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 88.2 m -84.49 126.17 33.04 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.725 -0.609 . . . . 0.0 110.59 -178.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . 0.58 ' SG ' HD21 ' A' ' 162' ' ' LEU . 48.9 t -114.22 90.32 19.91 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.59 -0.694 . . . . 0.0 110.18 175.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.406 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 21.3 Cg_endo -65.94 129.65 22.52 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 O-C-N 123.261 1.137 . . . . 0.0 110.59 176.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.419 HG12 ' CE2' ' A' ' 142' ' ' PHE . 93.9 mt -123.15 141.69 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.62 -0.675 . . . . 0.0 109.329 176.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -109.06 135.35 50.37 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.519 -0.738 . . . . 0.0 110.761 -175.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.424 HG21 ' CE1' ' A' ' 138' ' ' PHE . 48.3 mm -95.24 135.03 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.652 -0.655 . . . . 0.0 109.642 170.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -117.84 128.84 55.24 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.42 175.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.727 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.1 m -136.47 159.75 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.532 -0.73 . . . . 0.0 109.949 175.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.0 mmm -77.07 -40.47 46.04 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.683 -0.635 . . . . 0.0 110.113 178.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.415 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.4 p -135.3 143.18 44.43 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.746 -0.596 . . . . 0.0 109.849 178.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.5 Cg_exo -55.94 139.87 85.09 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 O-C-N 123.181 1.095 . . . . 0.0 110.828 -173.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.771 ' HB3' HD21 ' A' ' 288' ' ' LEU . 20.8 Cg_endo -63.49 169.1 10.25 Favored 'Trans proline' 0 N--CA 1.488 1.18 0 O-C-N 123.204 1.107 . . . . 0.0 110.728 176.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -61.16 157.5 39.42 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.376 1.198 . . . . 0.0 110.482 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -76.61 137.45 39.49 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.635 -0.666 . . . . 0.0 109.898 175.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.51 -25.09 29.62 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -174.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.08 151.98 1.81 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.335 -1.097 . . . . 0.0 111.396 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.77 155.95 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.698 -0.627 . . . . 0.0 109.935 177.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.667 HD11 ' CD2' ' A' ' 251' ' ' TYR . 72.4 mt -108.47 135.51 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.728 ' HG2' HD22 ' A' ' 248' ' ' LEU . 61.8 mtt180 -115.05 147.13 40.54 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.702 -0.623 . . . . 0.0 109.376 -175.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.647 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -140.12 128.7 22.93 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.536 -0.728 . . . . 0.0 110.138 172.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.413 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 22.6 ttp -137.29 137.18 21.82 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.796 -0.565 . . . . 0.0 111.083 -176.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.493 ' HD3' HD12 ' A' ' 226' ' ' ILE . 71.8 Cg_endo -91.43 138.19 2.15 Favored 'Trans proline' 0 C--N 1.32 -0.959 0 C-N-CA 121.038 1.159 . . . . 0.0 110.773 177.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.423 HG13 ' C ' ' A' ' 190' ' ' PRO . 35.0 m -146.99 154.86 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.486 -0.759 . . . . 0.0 110.022 173.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.624 ' HA ' HG22 ' A' ' 282' ' ' ILE . 87.6 m-85 -61.48 160.02 11.85 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.464 -0.773 . . . . 0.0 110.397 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.444 ' HA ' HD12 ' A' ' 283' ' ' LEU . 85.7 tttt -76.21 -60.04 2.5 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.664 -0.647 . . . . 0.0 110.832 -173.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -80.01 150.7 30.32 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.58 -0.7 . . . . 0.0 110.356 -174.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.45 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.44 -38.86 72.2 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.385 -0.822 . . . . 0.0 110.728 -175.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -56.33 -25.04 47.58 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.555 -0.716 . . . . 0.0 110.668 -176.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.408 ' O ' ' CD2' ' A' ' 192' ' ' TYR . 97.3 m-70 -110.03 -20.57 12.67 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.934 -0.706 . . . . 0.0 111.147 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.1 p -66.78 -20.25 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.154 -0.966 . . . . 0.0 110.573 -175.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 68.1 p -79.35 -17.05 55.29 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.713 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -88.27 136.39 33.0 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.353 -0.842 . . . . 0.0 109.951 172.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 56.9 t -73.02 146.48 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.61 -0.681 . . . . 0.0 110.133 178.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 79.5 t -84.92 139.65 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.598 -0.689 . . . . 0.0 109.261 172.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.7 pttp -134.82 -170.07 2.48 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.557 -0.715 . . . . 0.0 111.038 -166.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.46 ' HG2' ' HE3' ' A' ' 268' ' ' MET . 79.9 mtp180 -95.12 154.04 17.37 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.744 -0.597 . . . . 0.0 110.442 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 58.7 m -74.86 159.42 83.07 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.641 -0.662 . . . . 0.0 109.272 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -63.74 -47.41 7.12 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.179 1.094 . . . . 0.0 109.851 176.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.423 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.4 p-10 -65.46 -44.09 88.26 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.549 -0.719 . . . . 0.0 111.165 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . 0.423 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 52.8 m170 -81.84 -29.41 32.59 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.431 -0.793 . . . . 0.0 111.437 -174.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -69.19 -36.15 77.0 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.309 -0.869 . . . . 0.0 110.392 172.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 26.3 tp -54.32 -34.41 60.94 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.591 -0.693 . . . . 0.0 111.087 -175.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 29.1 t -48.38 142.96 5.15 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.437 -0.789 . . . . 0.0 111.252 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -59.24 143.9 47.79 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.655 -0.653 . . . . 0.0 110.445 -175.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -60.57 -41.95 95.64 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.716 -0.615 . . . . 0.0 110.128 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 20.1 t80 50.56 50.52 18.7 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.467 -0.77 . . . . 0.0 111.017 177.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -80.2 -10.1 59.75 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.586 -0.696 . . . . 0.0 111.31 -177.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -59.33 115.25 3.11 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.114 -0.991 . . . . 0.0 110.698 -177.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 73.13 20.16 79.86 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 173.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -114.89 140.04 49.29 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.284 -1.127 . . . . 0.0 110.47 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.2 mt -84.98 -25.09 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.686 -0.633 . . . . 0.0 110.411 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -124.96 92.87 46.87 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.499 -0.75 . . . . 0.0 110.485 -175.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -64.49 145.46 87.65 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 O-C-N 123.362 1.19 . . . . 0.0 110.543 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -59.75 -18.4 48.36 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 O-C-N 123.238 1.125 . . . . 0.0 111.586 -174.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 85.9 p -55.28 -22.94 20.54 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.161 -0.962 . . . . 0.0 111.276 -176.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . 0.423 ' CE1' ' CB ' ' A' ' 236' ' ' TYR . 55.2 m80 -102.05 130.9 48.74 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.339 -0.851 . . . . 0.0 110.614 -177.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.519 HD12 ' HG3' ' A' ' 268' ' ' MET . 59.5 tp -62.18 -36.76 82.87 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.695 -0.628 . . . . 0.0 110.338 177.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.493 HD12 ' HD3' ' A' ' 190' ' ' PRO . 83.4 mt -103.97 136.79 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.729 -0.607 . . . . 0.0 109.949 -178.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -127.26 157.54 39.56 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.748 -0.595 . . . . 0.0 110.176 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.521 HG23 HG21 ' A' ' 247' ' ' VAL . 90.7 t -102.32 146.6 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.787 -0.571 . . . . 0.0 109.81 173.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -118.59 129.97 55.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.698 -0.626 . . . . 0.0 110.4 170.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.96 21.08 26.56 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 168.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 35.7 t-20 -138.45 105.65 5.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.305 -1.115 . . . . 0.0 110.054 174.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 43.7 m -63.28 -15.33 56.87 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.656 -0.653 . . . . 0.0 111.306 -176.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -99.92 7.58 44.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.214 -0.929 . . . . 0.0 111.597 -177.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.64 132.27 52.73 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.114 -0.991 . . . . 0.0 110.24 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -139.76 157.97 44.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.79 -0.569 . . . . 0.0 109.674 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.423 ' CB ' ' CE1' ' A' ' 224' ' ' HIS . 75.3 m-85 -116.36 150.64 37.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.542 -0.724 . . . . 0.0 110.573 -177.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.19 159.89 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.824 -0.548 . . . . 0.0 110.24 177.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -123.71 128.21 49.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.76 -0.587 . . . . 0.0 110.05 174.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -65.09 130.05 94.69 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.678 -0.639 . . . . 0.0 109.893 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -66.8 -26.48 44.93 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 O-C-N 123.036 1.019 . . . . 0.0 111.029 -172.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.2 mt -99.06 -50.45 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.371 -0.831 . . . . 0.0 110.916 -168.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.0 p -105.33 12.07 32.11 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.406 -0.809 . . . . 0.0 111.835 -175.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.89 -5.08 13.77 Favored Glycine 0 N--CA 1.496 2.691 0 O-C-N 121.058 -1.027 . . . . 0.0 111.709 174.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 69.5 mmt-85 -46.18 141.98 3.07 Favored 'General case' 0 N--CA 1.505 2.278 0 CA-C-N 119.07 1.435 . . . . 0.0 112.363 -172.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -108.13 139.55 42.63 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.651 -0.655 . . . . 0.0 110.091 174.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 77.8 p -154.76 159.94 40.98 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.569 -0.707 . . . . 0.0 110.619 177.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.521 HG21 HG23 ' A' ' 228' ' ' VAL . 8.4 p -123.67 148.1 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.706 -0.621 . . . . 0.0 109.713 177.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.728 HD22 ' HG2' ' A' ' 187' ' ' ARG . 83.0 mt -129.67 154.71 46.86 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.032 -174.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.442 HG13 ' C ' ' A' ' 248' ' ' LEU . 36.0 m -150.77 151.76 30.87 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.855 -0.528 . . . . 0.0 109.878 175.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -70.6 139.4 37.22 Favored 'Trans proline' 0 C--N 1.315 -1.184 0 O-C-N 123.292 1.154 . . . . 0.0 110.055 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.667 ' CD2' HD11 ' A' ' 186' ' ' ILE . 10.0 t80 -79.66 123.29 27.5 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.539 -0.726 . . . . 0.0 110.16 178.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -100.04 160.1 28.07 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.693 -0.629 . . . . 0.0 110.19 178.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -59.08 160.05 20.05 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.362 1.191 . . . . 0.0 110.472 178.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.87 150.01 74.63 Favored 'Trans proline' 0 N--CA 1.489 1.244 0 O-C-N 123.293 1.154 . . . . 0.0 110.501 -177.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -60.91 147.94 41.41 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.626 -0.671 . . . . 0.0 110.184 -178.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.85 127.24 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.557 -0.715 . . . . 0.0 110.168 -170.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.88 -10.23 55.59 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 10.2 t -144.62 174.42 10.98 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.187 -1.184 . . . . 0.0 110.613 175.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -108.71 13.06 25.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.57 -0.706 . . . . 0.0 111.85 -167.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -122.41 168.07 12.54 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.125 -0.984 . . . . 0.0 111.149 -176.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 87.2 m -117.69 145.56 44.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.748 -0.595 . . . . 0.0 109.849 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 38.6 m -116.22 135.73 53.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.557 -0.715 . . . . 0.0 110.939 -175.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 57.6 t -129.03 137.29 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 172.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 62.7 mt -104.72 119.97 40.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.525 -0.734 . . . . 0.0 109.793 -172.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.647 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 6.7 m-30 -106.67 150.97 25.7 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.63 -0.669 . . . . 0.0 110.664 -178.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -136.47 142.91 43.59 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -113.15 132.67 55.37 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.56 -0.713 . . . . 0.0 110.48 -176.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' MET . . . . . 0.519 ' HG3' HD12 ' A' ' 225' ' ' LEU . 0.1 OUTLIER -103.21 8.52 38.46 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.711 -0.618 . . . . 0.0 112.172 -175.135 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . 0.681 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.6 OUTLIER -144.68 165.1 29.0 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.045 -1.034 . . . . 0.0 109.906 171.259 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.614 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.9 p30 -121.68 161.61 22.21 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.394 0.616 . . . . 0.0 110.38 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . 0.426 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 26.7 m -58.36 -33.56 69.7 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.465 -0.772 . . . . 0.0 111.09 -163.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 70.6 m -97.56 10.54 39.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.494 -0.754 . . . . 0.0 112.089 -164.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 30.5 p -93.9 118.1 31.0 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.027 -1.045 . . . . 0.0 110.644 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.81 139.87 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.505 -0.747 . . . . 0.0 110.349 -169.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.57 -5.13 60.16 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 178.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -125.18 -100.2 1.26 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 170.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . 0.426 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.4 mmm -65.55 -32.77 74.54 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.614 -0.933 . . . . 0.0 110.419 176.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.6 p30 42.47 53.11 4.7 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 176.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 54.8 27.44 8.9 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.328 -0.858 . . . . 0.0 111.184 176.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -119.12 105.15 45.21 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.484 -0.76 . . . . 0.0 110.098 175.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -59.45 151.02 71.73 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 O-C-N 123.135 1.071 . . . . 0.0 110.686 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.624 HG22 ' HA ' ' A' ' 192' ' ' TYR . 46.3 pt -131.81 177.63 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.766 0.793 . . . . 0.0 110.922 -177.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 193' ' ' LYS . 24.4 mt -124.33 149.81 46.17 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.692 HD12 ' CE1' ' A' ' 301' ' ' PHE . 80.2 mt -118.1 129.12 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.232 178.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.642 HG23 ' SG ' ' A' ' 300' ' ' CYS . 84.7 mt -109.79 127.55 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 120.251 -0.579 . . . . 0.0 109.448 -175.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 59.5 t -118.87 126.79 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.4 p -125.23 153.66 42.81 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 120.136 -0.625 . . . . 0.0 110.55 -174.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.771 HD21 ' HB3' ' A' ' 180' ' ' PRO . 20.7 tp -104.09 125.59 50.55 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 168.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.652 ' OE2' HG13 ' A' ' 295' ' ' VAL . 73.5 mm-40 -131.8 150.43 52.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.855 -0.528 . . . . 0.0 109.851 -171.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.807 HG22 HD11 ' A' ' 296' ' ' LEU . 68.4 p -89.86 159.54 16.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.632 -0.668 . . . . 0.0 109.708 177.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 28.7 tpt180 -56.03 -25.98 46.96 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.521 -0.737 . . . . 0.0 110.761 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -86.65 8.96 20.18 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.482 -0.762 . . . . 0.0 111.706 -174.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 86.95 20.13 54.22 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 120.186 -1.007 . . . . 0.0 110.673 170.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -107.86 140.12 41.44 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.214 -1.168 . . . . 0.0 110.252 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.652 HG13 ' OE2' ' A' ' 289' ' ' GLU . 60.5 t -88.86 131.4 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.683 -0.635 . . . . 0.0 110.133 -174.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.807 HD11 HG22 ' A' ' 290' ' ' THR . 76.8 mt -99.78 -40.18 7.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.753 -0.592 . . . . 0.0 110.504 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -159.68 151.77 22.58 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.453 ' HD2' HG11 ' A' ' 295' ' ' VAL . 46.3 mtp180 -135.08 134.29 40.16 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.643 -0.916 . . . . 0.0 110.606 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -136.76 157.88 45.73 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.568 -0.707 . . . . 0.0 109.848 172.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . 0.642 ' SG ' HG23 ' A' ' 285' ' ' ILE . 94.7 m -143.18 156.69 44.83 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.358 -0.838 . . . . 0.0 110.846 -175.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.692 ' CE1' HD12 ' A' ' 284' ' ' ILE . 47.1 p90 -145.21 162.17 37.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.653 -0.654 . . . . 0.0 110.12 175.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.402 ' HA ' HD23 ' A' ' 283' ' ' LEU . 82.3 tt0 -104.85 135.36 46.36 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.515 -0.741 . . . . 0.0 110.16 -178.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -123.6 142.99 50.5 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.736 -170.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 53.4 ttt85 -139.04 140.33 38.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.853 -0.53 . . . . 0.0 109.769 173.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.681 HD13 ' O ' ' A' ' 269' ' ' CYS . 73.6 mt -107.78 123.0 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.611 -0.68 . . . . 0.0 109.602 176.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.9 p -145.13 167.56 22.45 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.592 -0.692 . . . . 0.0 110.929 -170.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -67.8 -40.07 83.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.633 -0.667 . . . . 0.0 110.628 -177.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 3.9 t -132.09 89.49 37.77 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.592 -0.693 . . . . 0.0 110.448 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.54 -29.86 71.57 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 O-C-N 123.089 1.047 . . . . 0.0 110.853 174.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.26 -37.28 92.76 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -73.25 -40.37 64.69 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.752 -0.852 . . . . 0.0 109.779 -173.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -69.53 -40.14 77.07 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.183 -178.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -61.72 -43.19 99.34 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.301 178.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -65.06 -39.74 93.7 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.494 -0.754 . . . . 0.0 110.445 177.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.37 -49.86 75.21 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.515 -0.74 . . . . 0.0 110.551 -173.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . 0.507 ' OD1' HD11 ' A' ' 159' ' ' LEU . 3.2 p30 -61.39 -37.66 84.22 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.389 -0.82 . . . . 0.0 110.09 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -62.3 -41.27 98.38 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.59 -0.694 . . . . 0.0 110.026 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -62.48 -35.2 78.61 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.7 -0.625 . . . . 0.0 109.917 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 24.6 m -62.14 -32.62 73.24 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.726 -0.609 . . . . 0.0 110.113 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 84.0 mt -78.95 -42.8 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.714 -0.616 . . . . 0.0 109.925 -177.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -58.48 -41.62 85.69 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.683 -0.636 . . . . 0.0 110.53 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -62.58 -42.69 99.71 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.687 -0.633 . . . . 0.0 110.249 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -63.85 -33.64 76.15 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.646 -0.659 . . . . 0.0 110.275 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -96.9 125.04 41.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.714 -0.616 . . . . 0.0 110.367 -177.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 61.5 t -121.45 130.08 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.643 -0.66 . . . . 0.0 109.849 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 49.5 m -95.11 140.01 30.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.696 -0.627 . . . . 0.0 110.329 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -82.04 136.85 35.18 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.694 -0.629 . . . . 0.0 110.29 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 52.1 m -94.08 151.3 19.61 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.642 -0.661 . . . . 0.0 110.403 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . 0.695 HG22 ' HG3' ' A' ' 330' ' ' LYS . 99.5 m 55.57 -87.02 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.695 -0.628 . . . . 0.0 110.957 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . 0.695 ' HG3' HG22 ' A' ' 329' ' ' THR . 34.9 mttm -91.94 147.35 23.03 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.058 -1.026 . . . . 0.0 110.271 -176.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -58.69 -38.39 78.13 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.64 -0.663 . . . . 0.0 110.421 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -149.87 166.69 29.87 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -101.95 147.63 26.31 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.698 -0.884 . . . . 0.0 110.188 178.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -144.91 150.7 37.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.653 -0.655 . . . . 0.0 110.323 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.402 ' O ' ' CD2' ' A' ' 335' ' ' PHE . 64.2 t80 -168.3 32.99 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.629 -0.67 . . . . 0.0 110.089 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 55.55 -85.83 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.689 -0.632 . . . . 0.0 111.086 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -58.85 -37.48 76.59 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.146 -0.971 . . . . 0.0 110.481 -176.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -105.03 140.38 38.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.581 -0.699 . . . . 0.0 110.235 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 66.7 p -121.86 162.08 21.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.679 -0.638 . . . . 0.0 110.316 -179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -60.08 -35.38 75.05 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.613 -0.68 . . . . 0.0 110.364 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -58.66 -33.32 71.94 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -177.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 82.1 mt -92.95 128.57 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.675 -0.897 . . . . 0.0 109.96 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -84.98 -36.39 21.37 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.615 -0.678 . . . . 0.0 110.138 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 59.9 ttp -122.43 147.38 46.38 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.631 -0.668 . . . . 0.0 110.294 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.319 179.886 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.9 t -156.31 148.51 23.32 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.627 -0.925 . . . . 0.0 110.24 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 90.7 p -123.41 155.99 36.34 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.714 -0.616 . . . . 0.0 110.215 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 45.0 m -59.51 -40.37 86.85 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.576 -0.703 . . . . 0.0 110.358 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -119.26 125.1 48.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.65 -0.656 . . . . 0.0 110.285 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -88.32 113.57 24.06 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.591 -0.693 . . . . 0.0 110.313 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 50.85 32.43 7.23 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.469 -0.769 . . . . 0.0 111.168 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.59 ' N ' HD12 ' A' ' 120' ' ' LEU . 7.9 mp 55.44 -85.24 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.726 -0.609 . . . . 0.0 110.991 -177.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.3 m -116.63 159.67 39.46 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.176 -0.952 . . . . 0.0 110.174 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -64.42 159.63 69.46 Favored 'Cis proline' 0 N--CA 1.495 1.601 0 C-N-CA 123.194 -1.586 . . . . 0.0 110.461 -17.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.8 m -80.89 156.08 72.63 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.588 -0.695 . . . . 0.0 110.273 -177.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -59.25 148.21 87.21 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.328 1.173 . . . . 0.0 110.751 -177.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.32 150.05 38.57 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.761 -0.587 . . . . 0.0 110.187 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.438 HG23 ' HD2' ' A' ' 127' ' ' PRO . 49.5 mm -119.83 143.59 35.45 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.682 -0.636 . . . . 0.0 109.827 -178.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.438 ' HD2' HG23 ' A' ' 126' ' ' ILE . 19.1 Cg_endo -63.25 153.05 76.66 Favored 'Trans proline' 0 N--CA 1.486 1.07 0 O-C-N 123.221 1.116 . . . . 0.0 110.513 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.0 t -111.86 144.29 41.41 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.616 -0.678 . . . . 0.0 110.169 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.5 p-10 -94.38 23.2 5.35 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.713 -0.617 . . . . 0.0 110.845 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 50.5 m -75.47 125.1 28.33 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.454 -0.779 . . . . 0.0 110.171 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -70.44 144.88 51.33 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.584 -0.697 . . . . 0.0 110.43 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.43 ' CE2' ' HA2' ' A' ' 134' ' ' GLY . 65.4 t80 -155.92 102.51 2.12 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.635 -0.666 . . . . 0.0 110.055 178.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -58.95 -39.87 76.84 Favored 'Trans proline' 0 N--CA 1.488 1.161 0 O-C-N 123.129 1.068 . . . . 0.0 110.792 -174.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.43 ' HA2' ' CE2' ' A' ' 132' ' ' TYR . . . 81.13 -155.14 36.05 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 178.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -73.04 -49.92 0.22 Allowed 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.361 1.19 . . . . 0.0 110.914 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -87.88 9.89 20.53 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.55 -0.719 . . . . 0.0 111.36 -173.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.71 61.51 3.06 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.922 -1.111 . . . . 0.0 110.705 -177.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.723 ' HA ' HG12 ' A' ' 176' ' ' VAL . 64.3 t80 -79.85 118.81 21.97 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.663 -0.648 . . . . 0.0 110.07 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -130.01 160.04 34.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.787 -0.571 . . . . 0.0 110.316 -175.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 72.3 t -123.99 147.09 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.751 -0.593 . . . . 0.0 109.764 177.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.9 p -155.17 163.65 39.93 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.251 0.548 . . . . 0.0 109.932 176.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.494 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 67.3 m-85 -126.69 125.13 41.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.723 -0.611 . . . . 0.0 109.844 -176.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -57.88 144.29 39.5 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.571 -0.706 . . . . 0.0 110.34 -176.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -120.13 156.38 31.16 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.61 -0.681 . . . . 0.0 110.656 -175.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.6 p -149.29 171.89 15.76 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.681 -0.637 . . . . 0.0 110.075 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 54.2 p -61.63 162.34 8.56 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.633 -0.667 . . . . 0.0 110.056 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 80.9 p -59.12 95.15 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.593 -0.692 . . . . 0.0 110.322 -177.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.07 150.66 21.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.767 -0.583 . . . . 0.0 110.211 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -81.23 145.92 30.71 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.569 -0.707 . . . . 0.0 110.056 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.8 p 50.14 37.43 14.54 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.592 -0.693 . . . . 0.0 111.253 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.3 134.76 57.31 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.637 -0.664 . . . . 0.0 110.182 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.501 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 61.6 p -60.09 -33.22 71.79 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.753 -0.592 . . . . 0.0 110.005 175.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.501 ' HD1' ' HG1' ' A' ' 152' ' ' THR . 68.5 p-90 -171.28 143.48 1.88 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.784 -0.572 . . . . 0.0 110.063 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.5 t -142.03 142.54 32.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.83 -0.544 . . . . 0.0 110.011 -177.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.494 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 64.9 t80 -125.62 140.03 53.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.534 -0.729 . . . . 0.0 110.646 -172.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 40.6 t -109.59 124.46 51.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.863 -0.523 . . . . 0.0 109.944 176.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 56.1 m -71.12 -37.1 72.35 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.794 -0.566 . . . . 0.0 110.513 -177.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -59.9 -34.29 72.99 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.604 -0.685 . . . . 0.0 110.364 -178.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 58.0 mt -104.82 -11.99 16.51 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.656 -0.653 . . . . 0.0 110.871 -175.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.6 tttp 59.81 51.31 6.21 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.112 -0.992 . . . . 0.0 109.734 177.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -145.71 153.06 40.57 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.562 -174.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.67 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.5 tp -126.65 137.8 53.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.772 -0.58 . . . . 0.0 110.416 -175.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -117.15 134.28 54.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.683 -0.635 . . . . 0.0 109.414 174.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.28 158.37 44.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.615 -0.678 . . . . 0.0 111.0 -174.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.404 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 38.3 mt-30 -104.56 144.9 31.06 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.568 0.699 . . . . 0.0 110.491 173.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.417 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 16.8 tt -52.1 146.25 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.551 -0.718 . . . . 0.0 111.894 -174.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 63.96 10.17 5.11 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.629 -0.67 . . . . 0.0 112.448 176.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.404 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 74.5 mmtt -96.12 155.04 16.93 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.987 -1.071 . . . . 0.0 110.705 175.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 90.5 m -84.63 126.18 33.13 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.709 -0.619 . . . . 0.0 110.537 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . 0.67 ' SG ' HD21 ' A' ' 162' ' ' LEU . 42.9 t -114.3 90.08 19.49 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.627 -0.671 . . . . 0.0 110.046 172.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.436 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 22.6 Cg_exo -61.78 129.29 27.12 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 O-C-N 123.334 1.176 . . . . 0.0 110.548 172.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.416 HG12 ' CE2' ' A' ' 142' ' ' PHE . 95.2 mt -123.26 139.38 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 175.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -106.77 135.92 47.49 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.559 -0.713 . . . . 0.0 110.753 -175.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.629 HG21 ' CE1' ' A' ' 138' ' ' PHE . 49.8 mm -95.3 135.01 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.75 -0.594 . . . . 0.0 109.715 171.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 31.7 tptt -117.21 130.57 56.67 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.679 -0.638 . . . . 0.0 110.518 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.723 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.5 m -136.87 159.78 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.518 -0.739 . . . . 0.0 109.977 175.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 80.3 mmm -78.4 -40.29 36.47 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.716 -0.615 . . . . 0.0 110.008 177.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.416 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 76.7 p -135.09 143.21 44.95 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.805 -0.559 . . . . 0.0 109.686 177.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.4 Cg_exo -55.51 139.79 82.6 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 O-C-N 123.177 1.093 . . . . 0.0 110.92 -172.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.66 ' HB3' HD21 ' A' ' 288' ' ' LEU . 34.2 Cg_endo -68.12 169.99 15.46 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.211 1.111 . . . . 0.0 110.616 177.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -60.28 157.92 33.25 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 O-C-N 123.317 1.167 . . . . 0.0 110.685 -178.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -80.21 139.2 36.84 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.663 -0.648 . . . . 0.0 110.034 175.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.04 -24.94 30.22 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 -174.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.07 152.64 1.61 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.365 -1.08 . . . . 0.0 111.429 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.73 155.95 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.686 -0.634 . . . . 0.0 109.841 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.739 HD11 ' HD2' ' A' ' 251' ' ' TYR . 86.7 mt -109.04 137.97 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.629 -0.669 . . . . 0.0 109.539 176.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.733 ' HG2' HD22 ' A' ' 248' ' ' LEU . 58.3 mtt180 -115.03 146.24 41.47 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -176.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.678 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -139.97 127.94 22.16 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.454 -0.779 . . . . 0.0 110.327 174.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.405 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 30.6 ttp -137.26 139.95 29.45 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.752 -0.593 . . . . 0.0 111.19 -176.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.654 ' HD3' HD12 ' A' ' 226' ' ' ILE . 75.2 Cg_endo -92.46 138.14 1.73 Allowed 'Trans proline' 0 C--N 1.32 -0.961 0 C-N-CA 121.15 1.233 . . . . 0.0 110.702 177.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.44 HG13 ' C ' ' A' ' 190' ' ' PRO . 35.0 m -148.05 154.9 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.507 -0.746 . . . . 0.0 110.133 174.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.629 ' HA ' HG22 ' A' ' 282' ' ' ILE . 71.2 m-85 -60.3 164.96 3.84 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.529 -0.732 . . . . 0.0 110.487 178.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.422 ' HA ' HD12 ' A' ' 283' ' ' LEU . 36.8 tttt -79.86 -60.03 2.5 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.607 -0.683 . . . . 0.0 110.805 -174.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -80.1 150.73 30.16 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.525 -0.734 . . . . 0.0 110.293 -174.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.44 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.5 -38.68 72.12 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.334 -0.854 . . . . 0.0 110.749 -174.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -56.31 -25.12 47.51 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.487 -0.758 . . . . 0.0 110.633 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -110.01 -20.52 12.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.605 -0.684 . . . . 0.0 111.218 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.1 p -66.78 -20.24 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.153 -0.967 . . . . 0.0 110.604 -176.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 71.0 p -79.43 -15.44 57.81 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.577 -0.702 . . . . 0.0 110.813 175.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.22 135.18 33.56 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.355 -0.84 . . . . 0.0 110.031 173.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.9 t -72.89 143.98 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.661 -0.65 . . . . 0.0 110.221 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 63.1 t -84.97 136.31 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.583 -0.698 . . . . 0.0 109.318 171.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 9.2 pttt -134.91 -170.14 2.5 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.464 -0.773 . . . . 0.0 111.067 -166.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.448 ' NE ' ' HE3' ' A' ' 268' ' ' MET . 78.6 mtp180 -95.15 159.34 15.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.715 -0.616 . . . . 0.0 110.426 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 59.6 m -80.18 160.53 67.97 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.644 -0.66 . . . . 0.0 109.425 176.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -63.86 -47.36 6.98 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 O-C-N 123.176 1.093 . . . . 0.0 109.88 176.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.445 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.6 p-10 -65.51 -44.26 87.51 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.733 -0.604 . . . . 0.0 111.23 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . 0.445 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 55.3 m170 -81.34 -27.93 34.73 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.407 -0.808 . . . . 0.0 111.319 -174.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -69.1 -42.02 76.68 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.367 -0.833 . . . . 0.0 110.146 171.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 26.9 tp -60.24 -28.94 68.43 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.707 -0.621 . . . . 0.0 110.575 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.1 t -48.33 -38.22 18.55 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.564 -0.71 . . . . 0.0 111.721 -177.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 53.19 102.68 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.588 -0.695 . . . . 0.0 111.305 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -92.17 22.15 4.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.535 -0.728 . . . . 0.0 110.931 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 53.59 75.13 0.28 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.044 -1.035 . . . . 0.0 110.836 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -66.06 -10.35 39.4 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.55 -0.719 . . . . 0.0 111.33 -177.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -60.03 119.21 7.35 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.157 -0.964 . . . . 0.0 110.391 176.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 78.22 20.01 73.36 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -114.61 145.51 41.9 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.3 -1.118 . . . . 0.0 110.528 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.3 mt -84.8 -25.08 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.661 -0.649 . . . . 0.0 110.5 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -124.91 92.88 46.91 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.445 -0.784 . . . . 0.0 110.419 -176.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.45 ' HD2' ' CE1' ' A' ' 236' ' ' TYR . 21.1 Cg_exo -62.41 137.24 63.94 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.299 1.157 . . . . 0.0 110.461 -178.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -60.5 -17.98 51.37 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 O-C-N 123.024 1.012 . . . . 0.0 111.318 -178.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.422 ' HA ' ' HD2' ' A' ' 204' ' ' ARG . 24.0 t -53.47 -26.33 19.98 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.24 -0.912 . . . . 0.0 111.186 -177.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -103.1 130.7 50.34 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.538 -0.726 . . . . 0.0 110.375 -178.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.449 HD12 ' HG3' ' A' ' 268' ' ' MET . 30.7 tp -61.27 -36.85 81.15 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.662 -0.649 . . . . 0.0 110.257 -178.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.654 HD12 ' HD3' ' A' ' 190' ' ' PRO . 80.8 mt -98.96 136.78 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.757 -0.59 . . . . 0.0 109.867 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -132.53 158.01 43.23 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.704 -0.622 . . . . 0.0 110.381 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.574 HG23 HG21 ' A' ' 247' ' ' VAL . 86.3 t -103.45 146.68 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.694 -0.629 . . . . 0.0 110.034 177.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -118.79 129.62 55.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.727 -0.608 . . . . 0.0 110.329 170.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.12 24.18 20.32 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 167.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -139.7 107.29 5.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.427 -1.043 . . . . 0.0 110.104 174.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 93.5 p -63.36 -15.12 56.51 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.641 -0.662 . . . . 0.0 111.197 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -97.02 9.99 40.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.266 -0.896 . . . . 0.0 111.265 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.87 126.2 26.52 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.185 -0.947 . . . . 0.0 110.112 176.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -139.69 155.2 47.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.794 -0.566 . . . . 0.0 109.759 176.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.45 ' CE1' ' HD2' ' A' ' 221' ' ' PRO . 77.2 m-85 -118.77 150.67 39.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.506 -0.746 . . . . 0.0 110.558 -176.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.19 159.88 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.817 -0.552 . . . . 0.0 110.3 178.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -120.1 129.78 54.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.667 -0.645 . . . . 0.0 110.063 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -65.01 130.01 94.71 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.626 -0.671 . . . . 0.0 109.886 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -66.36 -27.66 47.4 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.164 1.086 . . . . 0.0 111.111 -171.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.5 mt -100.35 -50.49 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.377 -0.827 . . . . 0.0 110.978 -168.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.7 p -105.38 12.16 31.91 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.37 -0.831 . . . . 0.0 111.846 -175.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.87 -5.16 13.4 Favored Glycine 0 N--CA 1.497 2.736 0 O-C-N 121.055 -1.028 . . . . 0.0 111.898 173.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 23.1 mmt85 -46.19 142.12 3.01 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-N 119.125 1.462 . . . . 0.0 112.265 -174.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -107.29 141.67 38.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.637 -0.664 . . . . 0.0 110.143 175.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 80.0 p -154.77 159.89 40.94 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.547 -0.721 . . . . 0.0 110.609 177.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.574 HG21 HG23 ' A' ' 228' ' ' VAL . 8.4 p -123.28 148.25 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.739 -0.601 . . . . 0.0 109.696 178.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.733 HD22 ' HG2' ' A' ' 187' ' ' ARG . 82.4 mt -129.57 154.58 46.92 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.878 -175.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.443 HG13 ' C ' ' A' ' 248' ' ' LEU . 34.7 m -151.15 151.73 29.97 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.823 -0.548 . . . . 0.0 109.943 175.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -71.07 140.11 37.1 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 123.303 1.159 . . . . 0.0 110.084 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.739 ' HD2' HD11 ' A' ' 186' ' ' ILE . 58.9 t80 -76.6 125.0 28.47 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.435 -0.791 . . . . 0.0 110.168 174.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -100.0 160.16 27.94 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.795 -0.565 . . . . 0.0 109.907 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -58.68 159.8 19.47 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 O-C-N 123.305 1.161 . . . . 0.0 110.48 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.02 149.92 76.42 Favored 'Trans proline' 0 N--CA 1.487 1.126 0 O-C-N 123.218 1.115 . . . . 0.0 110.539 -177.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -61.98 148.1 44.92 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.689 -0.632 . . . . 0.0 110.21 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.5 t -69.9 127.24 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.496 -0.752 . . . . 0.0 110.124 -170.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.01 -10.1 55.27 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 9.9 t -144.59 173.12 12.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.177 -1.19 . . . . 0.0 110.604 174.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -106.88 13.05 28.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.657 -0.652 . . . . 0.0 111.728 -168.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -119.95 168.02 11.56 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.149 -0.969 . . . . 0.0 111.136 -175.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 92.4 m -117.8 146.89 43.52 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.768 -0.583 . . . . 0.0 109.861 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 47.5 m -117.73 134.9 54.42 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.599 -0.688 . . . . 0.0 110.942 -175.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 59.6 t -131.02 137.36 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 71.9 mt -104.7 121.88 44.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.422 -0.799 . . . . 0.0 109.958 -171.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.678 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 5.8 m-30 -106.38 151.8 24.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.709 -0.619 . . . . 0.0 110.616 -177.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -136.61 142.93 43.31 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -111.26 130.02 55.79 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.54 -0.725 . . . . 0.0 110.426 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' MET . . . . . 0.449 ' HG3' HD12 ' A' ' 225' ' ' LEU . 5.2 ppp? -96.85 3.85 51.98 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.682 -0.636 . . . . 0.0 112.052 -175.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . 0.647 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.5 OUTLIER -144.79 165.02 29.27 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.053 -1.03 . . . . 0.0 109.961 174.067 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.617 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.7 p30 -119.43 159.82 23.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.643 -0.661 . . . . 0.0 110.187 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . 0.401 ' HA ' ' HB3' ' A' ' 277' ' ' MET . 29.5 m -59.31 -32.39 70.01 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.356 -0.84 . . . . 0.0 110.912 -163.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 47.1 p -97.58 11.47 36.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.405 -0.809 . . . . 0.0 111.978 -164.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 30.0 p -95.07 118.07 31.26 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.116 -0.99 . . . . 0.0 110.631 178.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.15 139.16 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.462 -0.774 . . . . 0.0 110.189 -172.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 100.87 -5.12 56.38 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -123.74 -113.98 2.1 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 170.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . 0.403 ' CE ' ' HA ' ' A' ' 281' ' ' PRO . 26.6 ttt -64.16 -23.71 67.42 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.62 -0.93 . . . . 0.0 110.489 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 10.2 p30 44.52 54.46 6.39 Favored 'General case' 0 N--CA 1.504 2.273 0 CA-C-O 121.331 0.586 . . . . 0.0 112.58 172.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 22.8 mtp85 54.74 26.93 8.11 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.312 -0.867 . . . . 0.0 111.365 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . 0.401 ' HA ' ' HD2' ' A' ' 281' ' ' PRO . 82.0 mtt-85 -115.02 114.6 43.62 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.388 -0.82 . . . . 0.0 109.956 173.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . 0.403 ' HA ' ' CE ' ' A' ' 277' ' ' MET . 11.9 Cg_endo -59.45 145.39 98.09 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 O-C-N 122.969 0.984 . . . . 0.0 110.614 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.629 HG22 ' HA ' ' A' ' 192' ' ' TYR . 44.9 pt -131.92 174.72 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-O 121.758 0.79 . . . . 0.0 110.862 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 193' ' ' LYS . 29.2 mt -124.44 149.88 46.28 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . . . . . . . . . 81.3 mt -118.33 128.68 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.218 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.628 HG23 ' SG ' ' A' ' 300' ' ' CYS . 85.4 mt -109.72 127.38 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -174.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 61.8 t -119.0 126.79 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.6 p -125.26 154.07 42.23 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.664 -0.647 . . . . 0.0 110.624 -173.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.66 HD21 ' HB3' ' A' ' 180' ' ' PRO . 29.7 tp -105.19 126.16 51.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.697 -0.627 . . . . 0.0 109.503 169.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.634 ' OE2' HG13 ' A' ' 295' ' ' VAL . 72.5 mm-40 -130.96 149.62 52.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.916 -0.49 . . . . 0.0 109.681 -173.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.799 ' CG2' HD11 ' A' ' 296' ' ' LEU . 23.4 p -89.93 160.37 16.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.6 -0.688 . . . . 0.0 109.999 178.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -55.89 -26.15 45.94 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.568 -0.707 . . . . 0.0 111.082 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 45.4 p30 -90.14 9.52 27.99 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.467 -0.771 . . . . 0.0 111.931 -173.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.61 20.21 45.27 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 120.182 -1.008 . . . . 0.0 110.755 171.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -107.93 140.21 41.4 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.274 -1.133 . . . . 0.0 110.002 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.634 HG13 ' OE2' ' A' ' 289' ' ' GLU . 61.1 t -87.63 133.12 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.551 -0.718 . . . . 0.0 110.278 -172.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.799 HD11 ' CG2' ' A' ' 290' ' ' THR . 96.1 mt -99.86 -40.19 7.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.697 -0.627 . . . . 0.0 110.522 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -167.54 154.97 25.57 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -133.86 136.9 44.68 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.616 -0.932 . . . . 0.0 110.791 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -135.01 155.84 50.07 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.661 -0.65 . . . . 0.0 109.874 172.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . 0.628 ' SG ' HG23 ' A' ' 285' ' ' ILE . 98.1 m -142.52 153.18 43.38 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.399 -0.813 . . . . 0.0 110.781 -175.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -145.02 164.15 32.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.608 -0.683 . . . . 0.0 110.071 176.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.418 ' HA ' HD23 ' A' ' 283' ' ' LEU . 82.1 tt0 -104.84 136.1 44.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.609 -0.682 . . . . 0.0 110.173 -177.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -124.48 143.84 50.42 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.715 -169.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 61.8 ttm-85 -138.13 141.88 40.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.712 -0.617 . . . . 0.0 109.744 173.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.647 HD13 ' O ' ' A' ' 269' ' ' CYS . 77.2 mt -108.74 122.94 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.577 -0.702 . . . . 0.0 109.671 175.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.8 p -145.39 168.89 19.43 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.53 -0.731 . . . . 0.0 110.645 -172.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -71.28 -40.05 71.14 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.674 -0.642 . . . . 0.0 110.77 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.8 t -127.14 85.37 61.19 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.454 -0.779 . . . . 0.0 110.514 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . 0.4 ' HD3' ' HG3' ' A' ' 165' ' ' GLN . 43.7 Cg_exo -56.03 -27.79 66.15 Favored 'Trans proline' 0 N--CA 1.489 1.257 0 O-C-N 123.231 1.122 . . . . 0.0 110.674 174.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -68.14 -37.06 86.62 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.126 -1.589 . . . . 0.0 109.126 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -72.85 -39.92 66.14 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.647 -0.913 . . . . 0.0 109.749 -173.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -69.49 -40.51 77.0 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 120.067 -0.653 . . . . 0.0 109.934 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -62.06 -42.83 99.6 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.557 -0.715 . . . . 0.0 110.122 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -63.87 -40.27 96.15 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.599 -0.688 . . . . 0.0 110.563 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.19 -51.97 66.79 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.503 -0.748 . . . . 0.0 110.392 -174.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -61.66 -37.78 85.31 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.458 -0.776 . . . . 0.0 110.029 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -63.26 -39.88 95.84 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.651 -0.655 . . . . 0.0 110.278 178.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -62.15 -35.27 78.28 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.526 -0.733 . . . . 0.0 109.925 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 22.7 t -63.82 -33.42 75.64 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.782 -0.574 . . . . 0.0 110.237 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 83.7 mt -78.32 -47.62 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.641 -0.662 . . . . 0.0 110.056 -176.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -60.72 -37.7 82.62 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.712 -0.618 . . . . 0.0 110.392 -177.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 35.7 tttt -61.52 -47.58 84.93 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.567 -0.708 . . . . 0.0 110.199 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -70.21 -37.99 75.19 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.707 -0.62 . . . . 0.0 110.469 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -105.02 125.08 50.59 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.667 -0.646 . . . . 0.0 110.553 -174.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.483 HG13 HG21 ' A' ' 345' ' ' THR . 61.8 t -101.37 130.07 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.637 -0.664 . . . . 0.0 109.843 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 50.9 m -63.45 140.15 58.84 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.71 -0.619 . . . . 0.0 110.31 -178.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 46.9 p-10 -78.94 150.01 32.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.626 -0.672 . . . . 0.0 110.295 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 44.8 m -62.5 153.78 30.62 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.607 -0.683 . . . . 0.0 110.209 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 72.0 p -93.71 -21.77 19.14 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.631 -0.668 . . . . 0.0 110.638 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 40.0 mttp -59.27 -31.51 69.18 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.413 -0.804 . . . . 0.0 110.426 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 54.4 46.04 25.87 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.542 -0.724 . . . . 0.0 110.732 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -141.06 -172.54 13.11 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -80.18 118.75 22.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.636 -0.92 . . . . 0.0 110.249 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -61.64 147.95 44.14 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.731 -0.606 . . . . 0.0 110.232 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -132.04 162.57 30.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.615 -0.678 . . . . 0.0 110.306 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 53.35 32.22 13.34 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.499 -0.751 . . . . 0.0 110.793 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -107.24 128.67 54.64 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.582 -0.699 . . . . 0.0 110.145 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -59.14 -36.79 75.85 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.598 -0.688 . . . . 0.0 110.475 -178.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 67.3 p -126.86 162.18 26.5 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.616 -0.677 . . . . 0.0 110.248 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -60.07 -39.51 86.3 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.602 -0.686 . . . . 0.0 110.263 178.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -163.29 -178.21 36.84 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 16.4 tt -147.87 151.94 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.609 -0.936 . . . . 0.0 110.229 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -83.99 -36.4 23.22 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.634 -0.666 . . . . 0.0 110.216 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 64.7 mtt -104.87 145.94 29.7 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.598 -0.688 . . . . 0.0 110.274 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . 0.483 HG21 HG13 ' A' ' 325' ' ' VAL . 67.3 p . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.2 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.455 ' O ' HG23 ' A' ' 241' ' ' ILE . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.0 m -80.57 -30.16 36.97 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.683 -0.892 . . . . 0.0 110.155 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.7 m -120.31 147.37 45.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.622 -0.674 . . . . 0.0 110.248 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.4 t -167.21 46.05 0.06 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.596 -0.69 . . . . 0.0 110.312 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -60.2 -39.47 86.67 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.634 -0.666 . . . . 0.0 110.346 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -158.0 84.01 0.87 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.672 -0.643 . . . . 0.0 110.28 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 50.15 -159.4 0.07 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.494 -0.754 . . . . 0.0 111.242 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.8 mt 52.61 34.54 15.98 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.45 -0.781 . . . . 0.0 111.007 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 68.3 p -123.05 163.11 35.5 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.638 -0.664 . . . . 0.0 110.237 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -59.38 151.28 69.39 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 O-C-N 123.243 1.128 . . . . 0.0 110.59 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.409 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . 96.0 p -81.63 146.51 56.99 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.63 -0.669 . . . . 0.0 110.179 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 123' ' ' SER . 23.6 Cg_exo -60.3 152.22 68.32 Favored 'Trans proline' 0 N--CA 1.487 1.145 0 O-C-N 123.263 1.139 . . . . 0.0 110.507 178.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.69 142.65 44.42 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.622 -0.674 . . . . 0.0 110.12 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.811 HD11 HG22 ' A' ' 199' ' ' THR . 51.5 mm -121.44 99.95 45.03 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.715 -0.615 . . . . 0.0 109.998 -177.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 126' ' ' ILE . 13.3 Cg_endo -60.77 152.09 72.22 Favored 'Trans proline' 0 N--CA 1.487 1.134 0 O-C-N 123.237 1.125 . . . . 0.0 110.583 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.6 t -113.42 150.6 32.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.637 -0.665 . . . . 0.0 110.342 -178.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.9 p-10 -94.97 24.95 4.43 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.644 -0.66 . . . . 0.0 110.797 -178.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 52.1 m -72.09 125.21 26.71 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.593 -0.692 . . . . 0.0 110.248 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -71.09 144.9 50.16 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.754 -0.591 . . . . 0.0 110.538 -177.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -152.18 101.02 2.81 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.732 -0.605 . . . . 0.0 110.134 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -59.07 -39.96 75.11 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.042 1.022 . . . . 0.0 110.792 -174.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.42 -155.12 46.75 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -76.36 -44.0 0.27 Allowed 'Trans proline' 0 C--N 1.317 -1.08 0 O-C-N 123.38 1.2 . . . . 0.0 110.991 -174.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -86.91 8.84 21.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.503 -0.748 . . . . 0.0 111.425 -173.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 t 53.62 60.54 3.62 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.956 -1.09 . . . . 0.0 110.772 -176.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.67 ' HA ' HG12 ' A' ' 176' ' ' VAL . 37.3 t80 -77.84 118.41 20.14 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.585 -0.697 . . . . 0.0 109.871 -178.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -130.03 159.99 35.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.862 -0.523 . . . . 0.0 110.124 -178.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.8 t -125.98 146.07 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.797 -0.564 . . . . 0.0 109.726 177.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.8 p -155.31 161.12 41.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.772 -0.58 . . . . 0.0 110.03 177.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.406 ' CE2' HG12 ' A' ' 172' ' ' ILE . 71.5 m-85 -126.71 125.24 41.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.769 -0.582 . . . . 0.0 109.772 -176.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -56.95 140.99 46.91 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.573 -0.704 . . . . 0.0 110.511 -174.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -101.21 131.46 47.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.686 -0.634 . . . . 0.0 110.392 -175.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 91.0 p -126.85 158.68 36.05 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.641 -0.662 . . . . 0.0 110.09 178.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 54.6 p -64.17 163.26 12.94 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.671 -0.643 . . . . 0.0 110.102 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 147' ' ' THR . 7.7 t -71.89 64.35 0.5 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.578 -0.701 . . . . 0.0 110.219 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.96 147.6 45.07 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.666 -0.646 . . . . 0.0 110.202 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 50.8 pttt -59.4 149.35 29.56 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.618 -0.677 . . . . 0.0 110.487 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.5 m 53.07 51.1 16.42 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.37 -0.831 . . . . 0.0 110.955 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.88 123.12 26.92 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.71 -0.619 . . . . 0.0 110.103 177.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.425 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 44.9 p -60.07 -34.12 73.01 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.7 -0.625 . . . . 0.0 110.243 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.438 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -170.87 144.35 2.2 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.435 0.636 . . . . 0.0 110.237 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.4 t -142.09 142.66 32.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.863 -0.523 . . . . 0.0 109.971 -176.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -125.44 140.12 53.06 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.499 -0.751 . . . . 0.0 110.553 -172.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.2 t -110.69 124.5 52.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.852 -0.53 . . . . 0.0 109.773 176.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 60.6 m -70.63 -36.99 73.73 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.808 -0.558 . . . . 0.0 110.417 -177.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -59.54 -33.59 71.59 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.587 -0.695 . . . . 0.0 110.43 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.429 HD11 ' OD1' ' A' ' 316' ' ' ASP . 57.0 mt -104.85 -12.06 16.45 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.711 -0.618 . . . . 0.0 110.826 -175.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 78.8 tttt 59.84 50.25 7.14 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.126 -0.984 . . . . 0.0 109.678 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -145.84 153.1 40.51 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.571 -174.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.607 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.5 tp -126.5 137.83 53.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.739 -0.601 . . . . 0.0 110.25 -176.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -115.81 134.51 54.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.668 -0.645 . . . . 0.0 109.33 175.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.47 158.57 44.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.646 -0.659 . . . . 0.0 110.808 -176.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.434 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 54.5 mt-30 -104.54 144.56 31.52 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.668 171.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.413 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.2 tt -51.46 147.43 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 CA-C-O 121.572 0.701 . . . . 0.0 112.107 -173.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.99 9.99 5.89 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.555 -0.715 . . . . 0.0 112.734 174.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.434 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 59.3 mmtt -94.22 155.15 17.19 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.951 -1.093 . . . . 0.0 111.045 173.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 87.3 m -81.28 126.22 31.28 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.767 -0.583 . . . . 0.0 110.596 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . 0.607 ' SG ' HD21 ' A' ' 162' ' ' LEU . 43.9 t -114.13 90.04 18.8 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.602 -0.686 . . . . 0.0 110.175 173.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.438 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 18.4 Cg_exo -63.38 128.83 23.55 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 O-C-N 123.281 1.148 . . . . 0.0 110.598 173.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.406 HG12 ' CE2' ' A' ' 142' ' ' PHE . 97.5 mt -123.34 143.43 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.597 -0.689 . . . . 0.0 109.36 175.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -110.47 134.82 51.99 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.453 -0.779 . . . . 0.0 110.857 -175.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.5 mm -95.26 135.03 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.644 -0.66 . . . . 0.0 109.7 169.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.9 tttt -115.21 128.29 56.06 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.466 175.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.67 HG12 ' HA ' ' A' ' 138' ' ' PHE . 15.9 m -136.64 159.71 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.69 -0.631 . . . . 0.0 109.832 174.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.7 mmm -75.22 -40.51 59.04 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.771 -0.581 . . . . 0.0 110.166 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 76.8 p -135.71 143.25 43.96 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.834 -0.541 . . . . 0.0 109.725 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 33.5 Cg_exo -55.31 139.85 81.55 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 O-C-N 123.106 1.056 . . . . 0.0 110.921 -172.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.691 ' HB3' HD21 ' A' ' 288' ' ' LEU . 19.6 Cg_endo -63.05 167.85 11.67 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.226 1.119 . . . . 0.0 110.637 178.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -61.04 156.71 42.95 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 O-C-N 123.395 1.208 . . . . 0.0 110.509 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -74.5 139.01 43.55 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.672 -0.642 . . . . 0.0 109.858 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.69 -24.97 29.29 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 -175.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.2 150.36 2.49 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.317 -1.107 . . . . 0.0 111.323 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 33.6 m -129.79 155.92 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.765 -0.585 . . . . 0.0 109.664 176.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.601 HD11 ' HD2' ' A' ' 251' ' ' TYR . 83.3 mt -106.93 138.31 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.747 -0.595 . . . . 0.0 109.435 175.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.758 ' HG2' HD22 ' A' ' 248' ' ' LEU . 56.6 mtp85 -114.95 144.99 42.71 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -176.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.68 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -137.8 128.03 26.11 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.426 -0.796 . . . . 0.0 110.324 174.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 1.6 ttp -137.3 135.84 19.97 Favored Pre-proline 0 N--CA 1.495 1.816 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.957 -175.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.633 ' HD3' HD12 ' A' ' 226' ' ' ILE . 73.3 Cg_endo -91.19 138.18 2.25 Favored 'Trans proline' 0 C--N 1.32 -0.951 0 O-C-N 123.196 1.103 . . . . 0.0 110.777 177.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.432 HG13 ' C ' ' A' ' 190' ' ' PRO . 35.5 m -148.21 154.95 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.578 -0.702 . . . . 0.0 109.904 173.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.677 ' HA ' HG22 ' A' ' 282' ' ' ILE . 89.6 m-85 -60.91 163.24 5.98 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.379 -0.826 . . . . 0.0 110.385 -178.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.469 ' HA ' HD12 ' A' ' 283' ' ' LEU . 39.6 tttm -78.64 -60.02 2.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.622 -0.674 . . . . 0.0 110.71 -175.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -80.05 150.33 30.38 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.597 -0.69 . . . . 0.0 110.356 -175.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.455 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.42 -37.88 70.8 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.404 -0.81 . . . . 0.0 110.713 -175.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -56.37 -25.24 48.79 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.562 -0.711 . . . . 0.0 110.56 -175.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.441 ' CD2' ' NH1' ' A' ' 280' ' ' ARG . 62.9 m170 -109.94 -20.64 12.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.577 -0.702 . . . . 0.0 111.112 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -67.05 -20.2 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.244 -0.91 . . . . 0.0 110.62 -176.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.811 HG22 HD11 ' A' ' 126' ' ' ILE . 82.3 p -79.42 -16.96 55.3 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.55 -0.719 . . . . 0.0 110.705 175.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -88.3 138.52 31.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.359 -0.838 . . . . 0.0 110.058 173.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.9 t -72.87 139.85 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.606 -0.684 . . . . 0.0 110.428 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.561 HG22 ' CE2' ' A' ' 192' ' ' TYR . 63.9 t -84.93 138.92 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.561 -0.712 . . . . 0.0 109.421 170.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 10.6 pttt -134.9 -170.45 2.57 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.463 -0.773 . . . . 0.0 110.993 -171.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -95.47 156.82 16.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.77 -0.581 . . . . 0.0 110.321 174.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 60.7 m -68.46 163.99 48.35 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 121.554 -0.716 . . . . 0.0 109.07 171.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -63.54 -47.47 7.37 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 O-C-N 123.022 1.012 . . . . 0.0 109.964 177.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.433 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.3 p-10 -65.55 -43.88 88.52 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.579 -0.701 . . . . 0.0 111.118 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . 0.433 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 52.5 m170 -80.06 -27.93 39.29 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.482 -0.762 . . . . 0.0 111.186 -174.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -68.97 -37.87 79.05 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.504 -0.747 . . . . 0.0 110.345 175.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 27.6 tp -54.14 -31.02 51.26 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.464 -0.772 . . . . 0.0 110.948 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 26.1 t -48.24 -27.57 2.54 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.435 -0.791 . . . . 0.0 111.639 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 37.6 ptt85 -55.69 -28.05 53.56 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.53 -0.731 . . . . 0.0 110.886 -178.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -57.68 146.41 30.96 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.593 -0.692 . . . . 0.0 110.541 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 33.2 t80 54.09 64.01 1.98 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.512 -0.742 . . . . 0.0 110.643 -177.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -75.67 -10.16 59.21 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.561 -0.712 . . . . 0.0 111.114 178.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -58.63 125.06 21.82 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.103 -0.998 . . . . 0.0 110.424 175.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 95.01 -1.68 65.38 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -114.66 139.84 49.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.021 -1.281 . . . . 0.0 110.387 174.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.6 mt -84.94 -25.13 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.728 -0.608 . . . . 0.0 110.544 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.543 ' HB1' ' HD2' ' A' ' 227' ' ' ARG . . . -124.82 103.66 30.86 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.495 -0.753 . . . . 0.0 110.267 -173.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.426 ' HD2' ' CE2' ' A' ' 236' ' ' TYR . 29.4 Cg_exo -58.72 115.42 2.54 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 O-C-N 123.167 1.088 . . . . 0.0 110.762 -178.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.67 -19.86 39.72 Favored 'Trans proline' 0 N--CA 1.49 1.299 0 O-C-N 122.937 0.967 . . . . 0.0 111.425 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 25.2 t -51.65 -23.53 4.49 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.23 -0.919 . . . . 0.0 111.415 -177.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -106.86 132.82 52.38 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.426 -0.796 . . . . 0.0 110.21 177.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.475 HD12 ' HG3' ' A' ' 268' ' ' MET . 58.6 tp -59.48 -39.63 84.37 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.588 -0.695 . . . . 0.0 110.352 -177.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.633 HD12 ' HD3' ' A' ' 190' ' ' PRO . 83.0 mt -102.85 136.76 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.85 -0.531 . . . . 0.0 109.642 177.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.543 ' HD2' ' HB1' ' A' ' 220' ' ' ALA . 84.0 mtm180 -136.95 162.96 31.84 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.746 -0.596 . . . . 0.0 110.341 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.478 HG23 HG21 ' A' ' 247' ' ' VAL . 94.5 t -109.09 146.79 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.826 -0.546 . . . . 0.0 110.129 -178.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -120.81 121.54 38.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.809 -0.557 . . . . 0.0 110.348 174.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.98 24.09 10.88 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 169.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -137.23 106.74 6.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.413 -1.051 . . . . 0.0 109.988 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 46.0 m -63.16 -15.34 56.54 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.582 -0.699 . . . . 0.0 111.325 -176.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -99.94 5.59 45.25 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.275 -0.89 . . . . 0.0 111.608 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.94 131.4 49.58 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.039 -1.038 . . . . 0.0 110.16 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -139.72 158.07 44.71 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.797 -0.565 . . . . 0.0 109.811 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.426 ' CE2' ' HD2' ' A' ' 221' ' ' PRO . 72.6 m-85 -112.35 150.64 30.78 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.618 -0.677 . . . . 0.0 110.361 -178.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.26 159.91 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.737 -0.602 . . . . 0.0 110.174 176.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -122.62 129.96 52.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.787 -0.57 . . . . 0.0 110.094 175.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -64.96 130.07 94.72 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.654 -0.654 . . . . 0.0 109.87 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -66.42 -27.92 46.67 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 O-C-N 123.193 1.102 . . . . 0.0 111.049 -170.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.455 HG23 ' O ' ' A' ' 113' ' ' GLY . 83.0 mt -100.51 -50.46 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.423 -0.798 . . . . 0.0 110.879 -168.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.1 p -105.32 12.06 32.14 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.396 -0.815 . . . . 0.0 111.875 -175.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.9 -6.23 10.29 Favored Glycine 0 N--CA 1.496 2.69 0 O-C-N 121.034 -1.041 . . . . 0.0 111.941 172.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -46.12 142.03 3.0 Favored 'General case' 0 N--CA 1.506 2.327 0 CA-C-N 119.081 1.441 . . . . 0.0 112.258 -173.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -104.7 141.57 36.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.559 -0.713 . . . . 0.0 110.218 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 72.4 p -154.76 159.93 40.97 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.61 -0.682 . . . . 0.0 110.476 176.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.478 HG21 HG23 ' A' ' 228' ' ' VAL . 8.2 p -125.31 148.21 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.788 -0.57 . . . . 0.0 109.643 177.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.758 HD22 ' HG2' ' A' ' 187' ' ' ARG . 71.4 mt -129.5 154.7 46.75 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.633 -174.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.446 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.8 m -150.86 151.7 30.52 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.769 -0.582 . . . . 0.0 110.042 176.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -71.09 137.99 32.7 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 O-C-N 123.298 1.157 . . . . 0.0 109.994 177.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.601 ' HD2' HD11 ' A' ' 186' ' ' ILE . 10.5 t80 -76.54 126.02 30.25 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.573 -0.704 . . . . 0.0 110.221 176.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -100.01 160.07 28.16 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.771 -0.581 . . . . 0.0 109.979 176.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.88 159.11 22.25 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.199 1.105 . . . . 0.0 110.419 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.01 150.04 75.59 Favored 'Trans proline' 0 N--CA 1.488 1.187 0 O-C-N 123.26 1.137 . . . . 0.0 110.525 -177.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -61.16 147.46 44.05 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.669 -0.645 . . . . 0.0 110.139 -178.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.7 t -69.9 127.14 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.485 -0.759 . . . . 0.0 110.168 -170.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.53 -10.11 56.05 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 9.8 t -144.36 174.34 11.0 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.147 -1.208 . . . . 0.0 110.6 176.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -109.21 13.09 24.59 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.527 -0.733 . . . . 0.0 111.918 -166.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -120.95 168.06 11.89 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.081 -1.012 . . . . 0.0 111.193 -176.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 76.2 m -117.68 144.3 45.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.797 -0.564 . . . . 0.0 109.865 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 35.7 m -115.71 135.59 53.89 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.612 -0.68 . . . . 0.0 110.867 -175.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 62.9 t -131.18 137.28 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 174.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 72.4 mt -104.63 120.34 41.08 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.42 -0.8 . . . . 0.0 109.908 -171.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.68 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 4.6 m-30 -105.03 155.39 19.02 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.741 -0.599 . . . . 0.0 110.825 -176.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -136.32 142.9 43.89 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -114.89 128.97 56.6 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.616 -0.677 . . . . 0.0 110.266 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' MET . . . . . 0.475 ' HG3' HD12 ' A' ' 225' ' ' LEU . 5.0 ppp? -98.57 9.27 43.61 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.712 -0.617 . . . . 0.0 111.982 -175.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . 0.569 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.8 OUTLIER -144.58 161.32 39.43 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.178 -0.951 . . . . 0.0 110.112 173.662 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.693 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.1 p30 -119.91 164.06 16.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.786 -0.571 . . . . 0.0 110.286 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . 0.424 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 27.6 m -57.6 -33.93 68.73 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.449 -0.782 . . . . 0.0 110.983 -164.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 67.6 m -105.21 14.95 28.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.497 -0.752 . . . . 0.0 112.042 -164.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 30.1 p -95.17 118.06 31.31 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.103 -0.998 . . . . 0.0 110.677 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 51.9 t -63.19 138.86 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.482 -0.761 . . . . 0.0 110.203 -171.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.76 -5.13 59.78 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 178.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.12 -99.3 0.86 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 172.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . 0.424 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.4 mmm -63.29 -32.59 74.04 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.796 -0.826 . . . . 0.0 110.328 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.4 p30 44.05 48.75 7.45 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 175.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 54.95 29.97 13.17 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.392 -0.818 . . . . 0.0 111.146 175.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . 0.441 ' NH1' ' CD2' ' A' ' 197' ' ' HIS . 74.0 mtt180 -119.96 105.0 43.36 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.475 -0.766 . . . . 0.0 110.208 175.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -60.53 145.78 98.15 Favored 'Trans proline' 0 N--CA 1.487 1.115 0 O-C-N 123.094 1.049 . . . . 0.0 110.402 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.677 HG22 ' HA ' ' A' ' 192' ' ' TYR . 46.2 pt -131.95 177.63 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.856 0.836 . . . . 0.0 111.249 -175.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' A' ' 193' ' ' LYS . 24.8 mt -124.5 149.91 46.36 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.678 HD12 ' CE1' ' A' ' 301' ' ' PHE . 81.2 mt -117.83 130.33 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.318 179.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.512 HG23 ' SG ' ' A' ' 300' ' ' CYS . 80.8 mt -109.79 127.38 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -176.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 57.5 t -118.94 126.83 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.634 HG22 ' HG2' ' A' ' 298' ' ' ARG . 45.4 p -125.33 153.1 43.83 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.745 . . . . 0.0 110.632 -173.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.691 HD21 ' HB3' ' A' ' 180' ' ' PRO . 21.7 tp -104.5 124.39 49.19 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.726 -0.609 . . . . 0.0 109.468 169.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.597 ' OE2' HG13 ' A' ' 295' ' ' VAL . 70.1 mm-40 -132.16 151.72 51.64 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.87 -0.519 . . . . 0.0 109.806 -173.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.715 ' CG2' HD11 ' A' ' 296' ' ' LEU . 77.8 p -89.88 159.58 16.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.558 -0.714 . . . . 0.0 109.768 177.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -55.94 -26.11 46.43 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.564 -0.71 . . . . 0.0 110.789 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -88.34 9.76 22.19 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.552 -0.717 . . . . 0.0 111.808 -174.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 87.25 20.22 53.07 Favored Glycine 0 N--CA 1.495 2.583 0 O-C-N 121.083 -1.011 . . . . 0.0 110.687 170.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -106.21 140.15 39.61 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.218 -1.166 . . . . 0.0 110.231 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.597 HG13 ' OE2' ' A' ' 289' ' ' GLU . 59.1 t -89.59 130.97 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.592 -0.692 . . . . 0.0 110.29 -173.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.715 HD11 ' CG2' ' A' ' 290' ' ' THR . 95.6 mt -100.11 -40.08 7.77 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.781 -0.574 . . . . 0.0 110.528 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -166.25 154.67 25.38 Favored Glycine 0 N--CA 1.497 2.719 0 C-N-CA 119.898 -1.144 . . . . 0.0 110.391 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.634 ' HG2' HG22 ' A' ' 287' ' ' THR . 91.1 mtt180 -135.09 137.46 42.87 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.692 -0.887 . . . . 0.0 110.667 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -137.67 157.82 45.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.684 -0.635 . . . . 0.0 109.963 170.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . 0.512 ' SG ' HG23 ' A' ' 285' ' ' ILE . 78.7 m -141.33 156.81 45.8 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.43 -0.794 . . . . 0.0 110.684 -175.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.678 ' CE1' HD12 ' A' ' 284' ' ' ILE . 47.8 p90 -144.91 162.14 37.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.681 -0.637 . . . . 0.0 110.164 175.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.408 ' HA ' HD23 ' A' ' 283' ' ' LEU . 56.7 tt0 -104.94 134.5 47.95 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.501 -0.749 . . . . 0.0 110.051 -177.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -118.78 143.99 46.57 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.728 -169.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 55.7 ttt85 -138.3 136.79 36.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.766 -0.584 . . . . 0.0 109.792 172.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.693 HG21 ' HA ' ' A' ' 270' ' ' ASN . 78.9 mt -108.27 123.0 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.608 -0.682 . . . . 0.0 109.542 177.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.4 p -145.07 172.82 12.53 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.571 -0.706 . . . . 0.0 110.769 -171.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -72.21 -40.09 68.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.676 -0.64 . . . . 0.0 110.566 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.8 t -131.26 89.08 42.45 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.627 -0.671 . . . . 0.0 110.53 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . 0.407 ' CG ' ' HG3' ' A' ' 165' ' ' GLN . 51.2 Cg_exo -54.3 -29.57 58.2 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 O-C-N 123.162 1.085 . . . . 0.0 110.996 173.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -65.95 -37.81 93.57 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -72.5 -41.04 66.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.758 -0.848 . . . . 0.0 109.829 -173.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -69.45 -39.61 77.68 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 120.056 -0.657 . . . . 0.0 110.076 -178.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -61.6 -43.23 99.25 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.284 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -64.27 -40.12 95.32 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.613 -0.679 . . . . 0.0 110.503 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.64 -50.95 70.49 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.502 -0.749 . . . . 0.0 110.512 -173.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . 0.429 ' OD1' HD11 ' A' ' 159' ' ' LEU . 3.4 p30 -61.38 -37.77 84.62 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.507 -0.746 . . . . 0.0 110.142 -177.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -64.96 -40.7 95.4 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.593 -0.692 . . . . 0.0 110.247 178.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -62.78 -35.16 78.93 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.552 -0.718 . . . . 0.0 110.2 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 54.7 p -66.11 -29.31 69.61 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.64 -0.662 . . . . 0.0 110.294 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 83.9 mt -79.71 -45.74 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.638 -0.664 . . . . 0.0 109.919 -178.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -59.17 -41.71 89.09 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.588 -0.695 . . . . 0.0 110.516 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -61.42 -45.47 94.18 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.578 -0.701 . . . . 0.0 110.219 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -64.73 -33.79 76.79 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.682 -0.636 . . . . 0.0 110.304 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -94.89 125.06 39.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.63 -0.669 . . . . 0.0 110.529 -175.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 62.3 t -120.29 130.09 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.653 -0.654 . . . . 0.0 109.694 176.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 30.7 t -95.07 132.86 39.51 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.646 -0.658 . . . . 0.0 110.401 -177.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -92.29 123.12 35.38 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.699 -0.626 . . . . 0.0 110.167 177.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 30.4 t -86.16 133.0 33.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.576 -0.703 . . . . 0.0 110.2 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 40.9 m -96.03 -26.15 15.64 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.655 -0.653 . . . . 0.0 110.606 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -70.78 135.71 48.35 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.484 -0.76 . . . . 0.0 110.269 -178.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 54.38 44.89 28.24 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.511 -0.743 . . . . 0.0 110.826 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -171.81 179.25 43.62 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -86.08 123.93 31.93 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.662 -0.905 . . . . 0.0 110.256 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -60.18 143.7 51.79 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.582 -0.699 . . . . 0.0 110.261 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -65.25 -29.84 70.66 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.639 -0.663 . . . . 0.0 110.407 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 55.46 -85.02 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.704 -0.622 . . . . 0.0 110.884 -176.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -90.52 136.69 32.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.097 -1.002 . . . . 0.0 110.108 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -87.57 108.23 18.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.664 -0.647 . . . . 0.0 110.324 -177.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 76.8 p -114.93 25.48 10.89 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.716 -0.615 . . . . 0.0 110.374 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -114.5 143.79 44.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.543 -0.723 . . . . 0.0 110.375 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 151.9 45.43 0.02 OUTLIER Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.528 HD11 ' OXT' ' A' ' 345' ' ' THR . 16.9 tt -145.37 137.22 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.633 -0.922 . . . . 0.0 110.152 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -89.37 -62.58 1.45 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.616 -0.677 . . . . 0.0 110.215 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 87.4 mtp -122.64 -39.87 2.5 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.665 -0.647 . . . . 0.0 110.234 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . 0.528 ' OXT' HD11 ' A' ' 342' ' ' ILE . 12.3 p . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.264 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 67.4 m -154.79 158.04 38.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.588 -0.948 . . . . 0.0 110.175 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.1 m -119.91 149.28 42.36 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.703 -0.623 . . . . 0.0 110.279 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 71.2 p -99.93 162.59 12.9 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.638 -0.664 . . . . 0.0 110.185 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 53.64 27.0 6.27 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.532 -0.73 . . . . 0.0 110.745 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -84.99 171.88 11.76 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.683 -0.636 . . . . 0.0 110.565 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 51.99 24.07 2.47 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.455 -0.778 . . . . 0.0 111.251 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.2 mt 55.18 -86.15 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.656 -0.653 . . . . 0.0 111.159 -178.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.1 p -69.84 164.25 53.04 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.115 -0.991 . . . . 0.0 110.164 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -63.77 151.21 71.14 Favored 'Cis proline' 0 N--CA 1.495 1.615 0 C-N-CA 123.161 -1.6 . . . . 0.0 110.41 -18.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.1 p -81.37 144.59 53.86 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.651 -0.656 . . . . 0.0 110.059 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.409 ' HB3' HG22 ' A' ' 242' ' ' THR . 23.3 Cg_exo -60.25 145.72 97.96 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 O-C-N 123.188 1.099 . . . . 0.0 110.61 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.58 144.69 41.7 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.617 -0.677 . . . . 0.0 110.082 177.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.923 HD11 HG22 ' A' ' 199' ' ' THR . 49.0 mm -122.63 99.84 41.73 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.585 -0.697 . . . . 0.0 110.096 -177.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.45 154.36 64.79 Favored 'Trans proline' 0 C--N 1.316 -1.168 0 O-C-N 123.261 1.137 . . . . 0.0 110.586 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 30.4 t -112.29 145.32 40.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.681 -0.637 . . . . 0.0 110.31 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 p-10 -96.31 26.06 4.56 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.636 -0.665 . . . . 0.0 110.598 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 47.6 m -73.94 125.13 27.52 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.575 -0.703 . . . . 0.0 110.395 -178.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -73.36 144.98 46.25 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.689 -0.632 . . . . 0.0 110.462 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.422 ' CE2' ' HA2' ' A' ' 134' ' ' GLY . 62.8 t80 -157.01 101.78 1.94 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.7 -0.625 . . . . 0.0 110.137 178.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -58.64 -39.9 78.42 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 O-C-N 123.094 1.049 . . . . 0.0 110.948 -175.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.422 ' HA2' ' CE2' ' A' ' 132' ' ' TYR . . . 78.76 -155.12 40.66 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 178.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -73.14 -49.1 0.24 Allowed 'Trans proline' 0 C--N 1.317 -1.116 0 O-C-N 123.337 1.177 . . . . 0.0 110.874 -174.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -85.18 6.67 24.88 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.626 -0.672 . . . . 0.0 111.432 -174.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 t 54.17 62.09 2.75 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.964 -1.085 . . . . 0.0 110.675 -176.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.724 ' HA ' HG12 ' A' ' 176' ' ' VAL . 59.3 t80 -77.87 120.86 23.34 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.655 -0.653 . . . . 0.0 109.993 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -130.06 159.95 35.19 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.309 0.576 . . . . 0.0 110.134 -177.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 64.8 t -124.97 145.23 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.76 -0.588 . . . . 0.0 109.897 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 80.0 p -155.41 160.94 41.05 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.345 0.593 . . . . 0.0 109.937 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.49 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 59.8 m-85 -126.64 125.21 41.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.728 -0.608 . . . . 0.0 109.848 -176.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -58.03 143.23 44.08 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.545 -0.722 . . . . 0.0 110.34 -175.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -120.12 158.04 27.72 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.573 -0.705 . . . . 0.0 110.566 -175.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.7 p -147.74 170.87 16.65 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.773 -0.58 . . . . 0.0 110.019 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 39.7 m -59.89 157.86 11.7 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.586 -0.696 . . . . 0.0 110.209 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 33.9 p -59.7 90.91 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.616 -0.678 . . . . 0.0 110.388 -177.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.02 152.49 21.15 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.725 -0.61 . . . . 0.0 110.241 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -79.9 149.37 30.93 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.734 -0.604 . . . . 0.0 110.009 177.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.2 p 50.6 35.59 11.89 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.534 -0.729 . . . . 0.0 111.247 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.9 132.23 52.33 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.6 -0.687 . . . . 0.0 110.068 177.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.501 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 82.1 p -60.06 -33.99 72.81 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.689 -0.632 . . . . 0.0 109.933 176.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.501 ' HD1' ' HG1' ' A' ' 152' ' ' THR . 68.8 p-90 -170.74 143.5 2.14 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.366 0.603 . . . . 0.0 110.238 177.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.6 t -142.11 142.58 32.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.9 -0.5 . . . . 0.0 109.978 -176.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.49 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 60.9 t80 -125.58 140.01 53.11 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.496 -0.753 . . . . 0.0 110.771 -172.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 31.5 t -112.2 125.02 53.69 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.007 177.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 54.1 m -70.81 -37.12 73.22 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.724 -0.61 . . . . 0.0 110.534 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -59.25 -34.55 72.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.618 -0.676 . . . . 0.0 110.502 -177.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.668 HD21 HD11 ' A' ' 320' ' ' ILE . 56.1 mt -104.84 -12.0 16.49 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.933 -175.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 49.7 tttt 59.83 51.37 6.14 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.991 -1.068 . . . . 0.0 109.637 178.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -145.15 153.13 41.05 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.571 -173.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.57 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.9 tp -126.54 137.71 53.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.788 -0.57 . . . . 0.0 110.208 -176.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -115.59 134.42 55.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.64 -0.662 . . . . 0.0 109.292 173.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.43 158.62 43.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.736 -0.602 . . . . 0.0 110.85 -177.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.419 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 53.0 mt-30 -104.42 143.08 33.49 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.553 -0.717 . . . . 0.0 109.795 171.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.45 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.3 tt -52.44 148.45 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.538 -0.727 . . . . 0.0 111.851 -173.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 66.38 9.13 6.2 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.624 -0.672 . . . . 0.0 112.596 175.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.419 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 74.9 mmtt -94.41 155.13 17.11 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.933 -1.105 . . . . 0.0 110.983 172.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 88.5 m -84.07 126.21 32.85 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.719 -0.613 . . . . 0.0 110.433 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . 0.57 ' SG ' HD21 ' A' ' 162' ' ' LEU . 48.5 t -113.09 90.19 15.58 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.658 -0.652 . . . . 0.0 110.075 174.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.437 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 22.5 Cg_exo -61.33 130.52 32.4 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.276 1.145 . . . . 0.0 110.704 173.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.416 HG12 ' CE2' ' A' ' 142' ' ' PHE . 94.5 mt -124.61 141.91 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.639 -0.663 . . . . 0.0 109.28 175.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.436 ' NE2' ' CE1' ' A' ' 260' ' ' PHE . 98.4 mt-30 -108.9 136.45 48.43 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.524 -0.735 . . . . 0.0 110.826 -175.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.433 ' CG2' ' CE2' ' A' ' 138' ' ' PHE . 48.5 mm -95.24 135.06 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.694 -0.629 . . . . 0.0 109.64 169.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -117.65 129.37 55.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.606 -0.684 . . . . 0.0 110.405 176.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.724 HG12 ' HA ' ' A' ' 138' ' ' PHE . 17.1 m -136.67 159.75 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.538 -0.726 . . . . 0.0 110.057 175.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 80.7 mmm -77.46 -40.3 43.64 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.703 -0.623 . . . . 0.0 110.122 177.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.417 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 75.6 p -135.48 143.24 44.37 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.744 -0.597 . . . . 0.0 109.693 177.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.7 Cg_exo -55.49 139.89 82.56 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 O-C-N 123.114 1.06 . . . . 0.0 110.911 -172.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.763 ' HB3' HD21 ' A' ' 288' ' ' LEU . 32.1 Cg_endo -67.67 169.98 14.84 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 O-C-N 123.211 1.111 . . . . 0.0 110.565 177.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -60.49 155.32 47.98 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.35 1.184 . . . . 0.0 110.551 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -77.8 140.61 39.43 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.591 -0.693 . . . . 0.0 109.925 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.65 -24.93 29.47 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -174.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.16 152.78 1.61 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.337 -1.096 . . . . 0.0 111.404 178.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.8 155.89 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.713 -0.617 . . . . 0.0 109.765 176.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.726 HD11 ' HD2' ' A' ' 251' ' ' TYR . 81.1 mt -108.89 138.17 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.645 -0.659 . . . . 0.0 109.49 176.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.729 ' HG2' HD22 ' A' ' 248' ' ' LEU . 61.9 mtt180 -115.08 146.05 41.7 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -175.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.684 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -139.03 128.48 24.34 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.535 -0.728 . . . . 0.0 110.226 174.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.412 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 26.3 ttp -137.27 136.37 20.64 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.788 -0.57 . . . . 0.0 110.905 -176.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.504 ' HB3' HD11 ' A' ' 226' ' ' ILE . 74.1 Cg_endo -91.86 138.08 1.96 Allowed 'Trans proline' 0 C--N 1.32 -0.953 0 O-C-N 123.164 1.086 . . . . 0.0 110.643 177.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.439 HG13 ' C ' ' A' ' 190' ' ' PRO . 35.2 m -148.42 154.95 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.528 -0.733 . . . . 0.0 109.907 174.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.695 ' HA ' HG22 ' A' ' 282' ' ' ILE . 91.3 m-85 -60.6 163.92 5.01 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.447 -0.783 . . . . 0.0 110.413 -178.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.465 ' HA ' HD12 ' A' ' 283' ' ' LEU . 78.8 tttt -79.93 -59.99 2.51 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.661 -0.65 . . . . 0.0 110.785 -174.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 35.0 mttm -80.03 150.68 30.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.628 -0.67 . . . . 0.0 110.395 -175.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.454 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.43 -38.3 71.39 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.435 -0.791 . . . . 0.0 110.718 -175.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -56.49 -25.04 49.96 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.518 -0.739 . . . . 0.0 110.594 -175.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -110.01 -20.56 12.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.58 -0.7 . . . . 0.0 111.088 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.454 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.1 p -67.02 -20.27 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.137 -0.977 . . . . 0.0 110.592 -176.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.923 HG22 HD11 ' A' ' 126' ' ' ILE . 81.6 p -79.34 -17.06 55.29 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.545 -0.722 . . . . 0.0 110.753 175.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -88.39 138.79 31.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.38 -0.825 . . . . 0.0 110.041 173.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 57.6 t -73.24 142.73 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.585 -0.697 . . . . 0.0 110.156 176.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.541 HG22 ' CE2' ' A' ' 192' ' ' TYR . 77.8 t -84.9 140.15 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.552 -0.718 . . . . 0.0 109.443 171.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.2 pttp -134.84 -170.27 2.53 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.539 -0.726 . . . . 0.0 110.873 -169.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.439 ' HD2' ' HA ' ' A' ' 223' ' ' SER . 73.9 mtp180 -95.28 156.38 16.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.735 -0.603 . . . . 0.0 110.52 178.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 60.1 m -72.86 163.59 67.12 Favored Pre-proline 0 N--CA 1.497 1.887 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 172.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -64.23 -47.58 5.99 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.031 1.016 . . . . 0.0 109.927 178.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.435 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.4 p-10 -65.42 -43.57 90.12 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.602 -0.686 . . . . 0.0 111.149 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . 0.435 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 54.2 m170 -80.32 -27.88 38.29 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.455 -0.778 . . . . 0.0 111.264 -175.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -67.76 -34.96 77.84 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.405 -0.809 . . . . 0.0 110.223 174.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 26.5 tp -53.81 -33.19 55.34 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.435 -0.791 . . . . 0.0 110.751 177.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 29.9 t -48.45 -27.04 2.41 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.503 -0.748 . . . . 0.0 111.373 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -53.47 -35.22 60.32 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.495 -0.753 . . . . 0.0 110.918 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . 0.441 ' HG3' ' CD2' ' A' ' 214' ' ' PHE . 25.0 tp10 -60.27 151.74 26.7 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.679 -0.638 . . . . 0.0 110.196 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.441 ' CD2' ' HG3' ' A' ' 213' ' ' GLU . 95.9 m-85 53.09 57.37 6.38 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.515 -0.741 . . . . 0.0 110.98 -177.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -66.09 -10.2 38.28 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.508 -0.745 . . . . 0.0 110.966 176.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -58.04 125.16 21.96 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.17 -0.956 . . . . 0.0 110.319 173.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 95.13 2.57 62.23 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 120.362 -0.923 . . . . 0.0 110.931 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -114.63 139.91 49.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.023 -1.281 . . . . 0.0 110.259 170.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.1 mt -89.73 -25.2 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.617 -0.677 . . . . 0.0 110.589 -176.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.522 ' HB1' ' HD2' ' A' ' 227' ' ' ARG . . . -124.88 130.05 24.36 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.417 -0.802 . . . . 0.0 110.29 -175.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.451 ' CG ' ' CE2' ' A' ' 236' ' ' TYR . 23.4 Cg_endo -65.76 109.88 1.55 Allowed 'Trans proline' 0 N--CA 1.487 1.128 0 O-C-N 123.061 1.032 . . . . 0.0 110.628 -173.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -60.14 -15.88 36.68 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 O-C-N 123.07 1.037 . . . . 0.0 111.438 -178.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' A' ' 204' ' ' ARG . 25.4 m -49.41 -28.56 5.28 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.143 -0.973 . . . . 0.0 111.681 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . 0.402 ' CD2' ' O ' ' A' ' 226' ' ' ILE . 5.6 t60 -107.76 139.78 41.81 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.454 -0.779 . . . . 0.0 110.482 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.4 ' CD1' ' HB2' ' A' ' 269' ' ' CYS . 40.7 tp -58.29 -38.61 77.36 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.648 -0.657 . . . . 0.0 110.566 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.504 HD11 ' HB3' ' A' ' 190' ' ' PRO . 91.3 mt -107.67 136.77 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 121.159 0.504 . . . . 0.0 110.111 -176.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.522 ' HD2' ' HB1' ' A' ' 220' ' ' ALA . 71.9 mtm-85 -140.53 167.92 21.02 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.638 -0.664 . . . . 0.0 110.1 177.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.489 HG23 HG21 ' A' ' 247' ' ' VAL . 82.9 t -105.28 146.73 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.37 0.605 . . . . 0.0 110.211 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -116.39 130.0 56.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.729 -0.607 . . . . 0.0 110.356 169.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.36 25.26 16.65 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 167.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -140.9 107.45 5.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.443 -1.034 . . . . 0.0 110.061 175.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 27.2 t -62.89 -15.26 54.4 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.588 -0.695 . . . . 0.0 111.329 -177.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 63.1 m170 -99.77 6.38 45.47 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.21 -0.931 . . . . 0.0 111.612 -177.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.32 128.51 36.71 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.081 -1.012 . . . . 0.0 110.241 176.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -139.75 158.05 44.74 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.785 -0.572 . . . . 0.0 109.681 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.451 ' CE2' ' CG ' ' A' ' 221' ' ' PRO . 93.4 m-85 -116.86 150.6 38.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.574 -0.704 . . . . 0.0 110.686 -176.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.14 159.94 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.81 -0.556 . . . . 0.0 110.167 177.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -120.59 130.0 54.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.775 -0.578 . . . . 0.0 110.193 176.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -65.09 130.1 94.71 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.706 -0.621 . . . . 0.0 109.878 177.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -66.37 -27.62 47.35 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 O-C-N 123.128 1.068 . . . . 0.0 111.038 -171.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 82.9 mt -100.43 -50.41 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.292 -0.88 . . . . 0.0 111.013 -167.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.409 HG22 ' HB3' ' A' ' 124' ' ' PRO . 3.7 p -105.38 12.14 31.93 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.326 -0.859 . . . . 0.0 111.828 -175.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.86 -5.63 11.93 Favored Glycine 0 N--CA 1.496 2.678 0 O-C-N 121.131 -0.981 . . . . 0.0 111.832 174.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 22.9 mmt85 -46.09 142.0 2.99 Favored 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 119.194 1.497 . . . . 0.0 112.23 -173.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -105.59 145.43 30.99 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.607 -0.683 . . . . 0.0 110.091 175.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.0 p -154.74 159.92 40.99 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.623 -0.673 . . . . 0.0 110.534 176.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.489 HG21 HG23 ' A' ' 228' ' ' VAL . 8.2 p -123.82 148.1 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.731 -0.606 . . . . 0.0 109.695 178.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.729 HD22 ' HG2' ' A' ' 187' ' ' ARG . 81.7 mt -129.76 154.57 47.07 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.867 -176.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.441 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.7 m -150.69 151.67 30.89 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.813 -0.554 . . . . 0.0 109.986 174.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -71.1 140.03 36.85 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 O-C-N 123.329 1.173 . . . . 0.0 110.085 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.726 ' HD2' HD11 ' A' ' 186' ' ' ILE . 58.7 t80 -76.6 126.1 30.39 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.505 -0.747 . . . . 0.0 110.194 174.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -100.08 160.09 28.09 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.687 -0.633 . . . . 0.0 109.887 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.88 159.84 20.01 Favored 'Trans proline' 0 N--CA 1.488 1.188 0 O-C-N 123.204 1.107 . . . . 0.0 110.403 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.07 150.03 75.97 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 O-C-N 123.274 1.144 . . . . 0.0 110.501 -177.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -61.6 146.76 47.88 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.674 -0.641 . . . . 0.0 110.123 -178.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.84 127.2 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.517 -0.739 . . . . 0.0 110.145 -170.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.02 -10.2 55.32 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 9.8 t -144.23 174.39 10.93 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.105 -1.233 . . . . 0.0 110.641 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -108.84 13.13 25.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.595 -0.691 . . . . 0.0 111.948 -167.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.436 ' CE1' ' NE2' ' A' ' 173' ' ' GLN . 46.6 p90 -121.76 168.11 12.2 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.155 -0.965 . . . . 0.0 111.122 -176.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 85.5 m -117.77 145.86 44.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.778 -0.576 . . . . 0.0 109.87 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 55.3 m -116.02 135.58 53.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.633 -0.667 . . . . 0.0 110.903 -174.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.9 t -131.77 137.27 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 173.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 77.2 mt -104.69 121.6 43.91 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.477 -0.764 . . . . 0.0 110.005 -170.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.684 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 4.1 m-30 -107.94 149.24 28.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.705 -0.622 . . . . 0.0 110.556 -176.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -136.55 143.01 43.45 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.674 -0.642 . . . . 0.0 109.545 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -120.2 136.99 54.45 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.638 -0.664 . . . . 0.0 110.452 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' MET . . . . . 0.457 ' HE3' ' HB2' ' A' ' 269' ' ' CYS . 0.0 OUTLIER -105.43 12.53 31.41 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 120.179 -0.608 . . . . 0.0 112.195 -176.147 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . 0.676 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.6 OUTLIER -144.6 159.16 43.26 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.075 -1.016 . . . . 0.0 109.838 176.091 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.611 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.2 p30 -120.31 163.42 17.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.651 -0.656 . . . . 0.0 110.401 -177.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . 0.417 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 43.4 m -57.11 -34.18 68.1 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.46 -0.775 . . . . 0.0 111.1 -165.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 65.5 m -104.6 15.02 28.84 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.411 -0.806 . . . . 0.0 111.967 -164.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 30.3 p -93.61 118.03 30.85 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.088 -1.007 . . . . 0.0 110.581 178.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 59.2 t -63.58 139.45 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.442 -0.786 . . . . 0.0 110.419 -169.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.47 -5.09 60.35 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.97 -99.33 0.87 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 173.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . 0.417 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.5 mmm -61.42 -31.87 71.81 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.614 -0.933 . . . . 0.0 110.109 177.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 23.6 p30 42.25 47.02 4.02 Favored 'General case' 0 N--CA 1.507 2.38 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 174.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 22.9 mtt180 54.87 31.58 16.04 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.274 -0.891 . . . . 0.0 111.207 176.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 -120.1 104.94 43.11 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.458 -0.776 . . . . 0.0 110.056 173.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -59.99 148.24 89.75 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 O-C-N 123.094 1.049 . . . . 0.0 110.468 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.695 HG22 ' HA ' ' A' ' 192' ' ' TYR . 46.7 pt -131.86 176.74 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.806 0.812 . . . . 0.0 111.118 -175.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 193' ' ' LYS . 27.5 mt -124.37 149.83 46.23 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.686 HD12 ' CE1' ' A' ' 301' ' ' PHE . 81.4 mt -116.89 130.76 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.21 178.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.476 HG23 ' SG ' ' A' ' 300' ' ' CYS . 79.4 mt -109.8 126.37 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -177.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 58.7 t -118.92 126.75 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 46.1 p -125.21 153.54 42.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.554 -0.716 . . . . 0.0 110.721 -173.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.763 HD21 ' HB3' ' A' ' 180' ' ' PRO . 26.3 tp -104.08 126.42 51.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.785 -0.572 . . . . 0.0 109.5 169.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.502 ' OE2' HG22 ' A' ' 295' ' ' VAL . 72.9 mm-40 -130.44 150.25 51.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.91 -0.494 . . . . 0.0 109.861 -173.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.824 ' CG2' HD11 ' A' ' 296' ' ' LEU . 22.8 p -89.87 161.73 15.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.687 -0.633 . . . . 0.0 109.928 177.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -55.89 -26.15 45.96 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.641 -0.662 . . . . 0.0 111.042 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 45.6 p30 -89.87 9.19 28.53 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.408 -0.807 . . . . 0.0 112.004 -173.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.61 20.19 45.36 Favored Glycine 0 N--CA 1.494 2.522 0 O-C-N 121.09 -1.006 . . . . 0.0 110.725 171.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -107.03 140.21 40.2 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.295 -1.121 . . . . 0.0 110.163 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.502 HG22 ' OE2' ' A' ' 289' ' ' GLU . 72.1 t -85.24 132.79 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.588 -0.695 . . . . 0.0 110.228 -174.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.824 HD11 ' CG2' ' A' ' 290' ' ' THR . 95.2 mt -100.01 -40.15 7.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.621 -0.674 . . . . 0.0 110.399 176.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -163.64 153.44 23.88 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -133.87 136.19 44.18 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.609 -0.936 . . . . 0.0 110.648 -178.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -134.73 157.81 45.75 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.611 -0.681 . . . . 0.0 110.026 172.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . 0.476 ' SG ' HG23 ' A' ' 285' ' ' ILE . 95.3 m -143.02 153.25 42.78 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.474 -0.766 . . . . 0.0 110.629 -176.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.686 ' CE1' HD12 ' A' ' 284' ' ' ILE . 47.8 p90 -145.01 162.38 37.06 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.631 -0.668 . . . . 0.0 110.174 176.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.413 ' HA ' HD23 ' A' ' 283' ' ' LEU . 81.9 tt0 -104.86 135.11 46.82 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.543 -0.723 . . . . 0.0 110.238 -176.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -120.09 143.61 48.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.62 -0.675 . . . . 0.0 110.737 -170.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -138.28 138.29 38.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.786 -0.571 . . . . 0.0 109.74 173.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.676 HD13 ' O ' ' A' ' 269' ' ' CYS . 73.9 mt -109.01 122.96 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.541 -0.724 . . . . 0.0 109.667 176.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.3 p -145.17 171.56 14.35 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.625 -0.672 . . . . 0.0 110.657 -172.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -70.89 -40.11 72.4 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.658 -0.651 . . . . 0.0 110.494 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.8 t -130.44 89.11 45.23 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.524 -0.735 . . . . 0.0 110.467 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . 0.406 ' CG ' ' HG3' ' A' ' 165' ' ' GLN . 50.6 Cg_exo -54.25 -29.27 56.34 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 O-C-N 123.146 1.077 . . . . 0.0 111.025 173.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -65.63 -37.81 93.96 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 177.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 37.6 ttp180 -72.82 -42.1 64.18 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.714 -0.874 . . . . 0.0 109.938 -173.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -69.53 -40.47 76.89 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.172 -178.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 73.2 ttt-85 -60.23 -43.38 96.1 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.449 -0.782 . . . . 0.0 110.351 178.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -64.42 -41.02 96.84 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.585 -0.697 . . . . 0.0 110.522 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -60.94 -50.14 74.62 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.506 -0.746 . . . . 0.0 110.462 -173.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -61.92 -37.77 85.88 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.433 -0.792 . . . . 0.0 110.06 -178.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -62.04 -41.27 97.95 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.631 -0.668 . . . . 0.0 110.141 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -62.8 -35.25 79.26 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.565 -0.71 . . . . 0.0 109.925 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 23.4 m -63.81 -33.0 74.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.719 -0.613 . . . . 0.0 110.221 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.668 HD11 HD21 ' A' ' 159' ' ' LEU . 84.2 mt -79.25 -45.09 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.689 -0.632 . . . . 0.0 109.927 -176.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -60.21 -41.49 93.16 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.622 -0.674 . . . . 0.0 110.38 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -64.52 -46.72 81.7 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.598 -0.688 . . . . 0.0 110.252 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -66.92 -35.1 79.23 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.668 -0.645 . . . . 0.0 110.383 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.508 ' OE1' HG22 ' A' ' 320' ' ' ILE . 96.4 mt-30 -97.85 124.98 42.49 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.591 -0.693 . . . . 0.0 110.547 -175.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 62.4 t -113.08 130.12 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.641 -0.662 . . . . 0.0 109.733 177.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 29.4 t -91.16 140.0 30.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.689 -0.632 . . . . 0.0 110.372 -176.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -85.16 122.01 28.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.718 -0.613 . . . . 0.0 110.298 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 29.7 t -67.91 152.88 44.86 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.674 -0.641 . . . . 0.0 110.146 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 70.6 p -92.19 -22.09 20.02 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.643 -0.66 . . . . 0.0 110.619 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -59.71 -34.11 72.49 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.419 -0.8 . . . . 0.0 110.282 177.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -100.9 108.73 20.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.704 -0.622 . . . . 0.0 110.263 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -61.42 -35.39 90.95 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 46.5 p30 -154.93 160.0 40.83 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.648 -0.913 . . . . 0.0 110.419 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -61.43 142.58 56.88 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.685 -0.634 . . . . 0.0 110.198 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -139.54 159.56 41.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.588 -0.695 . . . . 0.0 110.378 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 55.17 -86.03 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.724 -0.61 . . . . 0.0 111.18 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -76.29 133.86 39.93 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.214 -0.929 . . . . 0.0 110.337 -175.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -121.39 153.43 37.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.681 -0.637 . . . . 0.0 110.234 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 9.8 t -132.21 155.52 48.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.652 -0.655 . . . . 0.0 110.433 179.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -125.99 145.37 50.33 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.673 -0.642 . . . . 0.0 110.212 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -84.82 179.61 51.23 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.589 HG22 ' HG3' ' A' ' 343' ' ' GLN . 82.0 mt -95.29 133.73 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.683 -0.892 . . . . 0.0 110.101 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 342' ' ' ILE . 94.9 mt-30 54.9 47.34 22.49 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.469 -0.77 . . . . 0.0 110.952 178.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 64.6 mtt -123.39 156.08 36.13 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.582 -0.699 . . . . 0.0 110.202 176.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 7.4 t . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 118.103 -0.951 . . . . 0.0 110.212 -179.879 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.348 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 60.4 m -85.3 155.76 21.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.576 -0.955 . . . . 0.0 110.325 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 84.2 p -141.09 164.61 29.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.62 -0.675 . . . . 0.0 110.103 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 47.5 m -109.2 130.52 55.49 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.648 -0.657 . . . . 0.0 110.313 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -62.85 -39.24 93.8 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.663 -0.648 . . . . 0.0 110.299 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -83.21 138.98 33.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.631 -0.668 . . . . 0.0 110.386 -176.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 53.2 -156.07 0.19 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.373 -0.83 . . . . 0.0 110.856 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 28.0 tp 54.12 89.43 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.279 -0.888 . . . . 0.0 110.781 -177.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.4 t -60.8 162.41 12.21 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.689 -0.632 . . . . 0.0 110.113 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -67.97 153.86 87.65 Favored 'Cis proline' 0 N--CA 1.496 1.661 0 C-N-CA 123.228 -1.572 . . . . 0.0 110.499 -13.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.0 p -82.68 164.75 45.6 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.651 -0.656 . . . . 0.0 110.163 178.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -58.96 148.1 86.57 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 O-C-N 123.244 1.128 . . . . 0.0 110.668 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.81 143.08 42.08 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.686 -0.633 . . . . 0.0 110.251 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.415 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 49.7 mm -124.22 99.99 36.52 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.641 -0.662 . . . . 0.0 109.984 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 126' ' ' ILE . 12.2 Cg_endo -60.2 151.42 73.45 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 O-C-N 123.194 1.102 . . . . 0.0 110.513 -179.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.6 t -111.25 151.29 28.46 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.589 -0.694 . . . . 0.0 110.313 -177.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -93.85 22.92 5.19 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.614 -0.679 . . . . 0.0 110.893 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 48.2 m -71.67 125.14 26.34 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.542 -0.724 . . . . 0.0 110.226 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -70.74 144.9 50.78 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.715 -0.615 . . . . 0.0 110.461 -177.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.43 ' CE1' ' HA2' ' A' ' 134' ' ' GLY . 64.9 t80 -154.93 101.37 2.32 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.72 -0.613 . . . . 0.0 110.061 178.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -58.79 -39.88 77.67 Favored 'Trans proline' 0 N--CA 1.488 1.153 0 O-C-N 123.115 1.061 . . . . 0.0 110.799 -174.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.43 ' HA2' ' CE1' ' A' ' 132' ' ' TYR . . . 81.64 -155.2 35.22 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 177.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -74.27 -48.89 0.2 Allowed 'Trans proline' 0 C--N 1.316 -1.156 0 O-C-N 123.385 1.203 . . . . 0.0 110.873 -174.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -86.98 9.03 20.76 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.635 -0.665 . . . . 0.0 111.403 -173.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.57 62.11 2.79 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.99 -1.069 . . . . 0.0 110.686 -177.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.721 ' HA ' HG12 ' A' ' 176' ' ' VAL . 65.2 t80 -79.27 119.3 22.15 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.559 -0.713 . . . . 0.0 110.048 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -130.05 159.94 35.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.785 -0.572 . . . . 0.0 110.37 -175.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 59.4 t -125.11 146.54 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.698 -0.626 . . . . 0.0 109.819 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.6 p -155.18 161.55 41.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.736 -0.602 . . . . 0.0 110.024 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.417 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 41.2 m-85 -126.7 125.16 41.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.789 -0.57 . . . . 0.0 109.923 -176.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -60.2 137.31 58.14 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.592 -0.692 . . . . 0.0 110.146 -176.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -109.19 140.14 43.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.602 -0.686 . . . . 0.0 110.495 -174.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 97.1 p -131.19 160.53 34.54 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.8 -0.562 . . . . 0.0 110.115 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 55.8 p -63.84 164.96 9.28 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.586 -0.697 . . . . 0.0 110.161 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 147' ' ' THR . 5.4 t -63.66 84.5 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.728 -0.608 . . . . 0.0 110.329 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -89.97 162.08 15.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.62 -0.675 . . . . 0.0 110.236 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 36.4 mttp -73.29 141.78 47.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.612 -0.68 . . . . 0.0 110.138 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 52.44 63.65 2.16 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.453 -0.78 . . . . 0.0 110.954 -178.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -84.11 121.33 27.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.596 -0.69 . . . . 0.0 110.076 178.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 44.1 p -60.12 -34.09 73.03 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.682 -0.636 . . . . 0.0 110.229 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.448 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.0 p-90 -171.26 144.29 2.0 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.62 -0.675 . . . . 0.0 110.117 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.4 t -142.13 142.7 32.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.882 -0.511 . . . . 0.0 109.992 -176.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.417 ' CG ' ' HB2' ' A' ' 142' ' ' PHE . 63.2 t80 -125.41 140.06 53.12 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.54 -0.725 . . . . 0.0 110.423 -173.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.8 t -110.56 123.96 50.94 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 120.379 -0.529 . . . . 0.0 109.811 176.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 56.1 m -70.71 -37.1 73.53 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.872 -0.518 . . . . 0.0 110.376 -177.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -59.75 -33.28 71.46 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.58 -0.7 . . . . 0.0 110.478 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.47 HD11 ' OD1' ' A' ' 316' ' ' ASP . 57.7 mt -104.81 -11.96 16.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.666 -0.646 . . . . 0.0 110.81 -175.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 79.9 tttt 59.79 49.65 7.81 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.978 -1.076 . . . . 0.0 109.704 177.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -146.58 153.03 39.88 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.8 -174.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.6 tp -126.58 137.84 53.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.841 -0.537 . . . . 0.0 110.413 -175.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -117.66 134.27 55.07 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.645 -0.659 . . . . 0.0 109.487 175.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.35 158.4 44.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.671 -0.643 . . . . 0.0 111.173 -174.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.4 ' HG3' ' HD3' ' A' ' 309' ' ' PRO . 42.1 mt-30 -104.63 141.3 36.67 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.585 -0.697 . . . . 0.0 110.525 172.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.465 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 18.8 tt -55.39 149.9 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.594 -0.691 . . . . 0.0 111.444 -175.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.79 10.08 5.78 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.559 -0.713 . . . . 0.0 112.481 178.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -96.18 155.07 16.91 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.959 -1.088 . . . . 0.0 110.611 172.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 77.4 m -81.16 126.07 31.03 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.631 -0.668 . . . . 0.0 110.325 177.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 43.5 t -115.13 89.64 21.04 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.652 -0.655 . . . . 0.0 110.273 175.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.489 ' HA ' HD23 ' A' ' 264' ' ' LEU . 15.5 Cg_exo -65.8 124.94 13.42 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 O-C-N 123.281 1.148 . . . . 0.0 110.675 173.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.569 HD12 ' CD2' ' A' ' 265' ' ' TYR . 97.3 mt -119.87 140.83 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.634 -0.667 . . . . 0.0 109.246 172.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -106.79 135.46 48.29 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.454 -0.779 . . . . 0.0 110.74 -174.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.586 HG21 ' CE1' ' A' ' 138' ' ' PHE . 49.6 mm -95.27 134.97 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.708 -0.62 . . . . 0.0 109.687 170.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -117.48 130.69 56.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.557 -0.714 . . . . 0.0 110.44 176.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.721 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.6 m -136.67 159.75 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.573 -0.704 . . . . 0.0 109.99 175.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 80.6 mmm -78.75 -40.56 33.03 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.67 -0.644 . . . . 0.0 110.068 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 76.8 p -135.02 143.24 45.22 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.735 -0.603 . . . . 0.0 109.722 177.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 32.4 Cg_exo -55.84 139.89 84.57 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 O-C-N 123.161 1.085 . . . . 0.0 110.855 -172.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.778 ' HB3' HD21 ' A' ' 288' ' ' LEU . 32.5 Cg_endo -67.47 170.03 14.44 Favored 'Trans proline' 0 N--CA 1.487 1.113 0 O-C-N 123.131 1.069 . . . . 0.0 110.619 177.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -60.75 157.39 37.92 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 O-C-N 123.293 1.154 . . . . 0.0 110.53 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -79.8 140.87 36.7 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.574 -0.704 . . . . 0.0 109.949 175.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 97.7 -24.91 29.57 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -174.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.14 153.78 1.34 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.378 -1.072 . . . . 0.0 111.398 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.8 155.95 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.751 -0.593 . . . . 0.0 109.779 176.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.678 HD11 ' HD2' ' A' ' 251' ' ' TYR . 52.4 mt -108.06 135.59 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.739 ' HG2' HD22 ' A' ' 248' ' ' LEU . 27.6 mtm180 -114.78 143.88 44.38 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -176.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -139.47 123.75 18.04 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.598 -0.689 . . . . 0.0 110.408 177.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.41 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 26.8 ttm -137.36 138.05 23.96 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.797 -0.564 . . . . 0.0 111.073 -175.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.551 ' HD3' HD12 ' A' ' 226' ' ' ILE . 62.6 Cg_endo -91.13 138.17 2.27 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 O-C-N 123.187 1.098 . . . . 0.0 110.643 176.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.419 HG13 ' C ' ' A' ' 190' ' ' PRO . 34.8 m -146.79 154.85 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.471 -0.768 . . . . 0.0 110.212 173.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.677 ' HA ' HG22 ' A' ' 282' ' ' ILE . 87.1 m-85 -58.49 167.55 1.4 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.511 -0.743 . . . . 0.0 110.679 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -84.94 -60.08 2.15 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.639 -0.663 . . . . 0.0 110.863 -174.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -80.08 152.11 29.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.544 -0.722 . . . . 0.0 110.286 -175.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.459 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.67 -38.06 71.68 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.332 -0.855 . . . . 0.0 110.713 -176.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.4 mp0 -56.5 -24.81 48.8 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.483 -0.76 . . . . 0.0 110.616 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.426 ' HB3' ' CD1' ' A' ' 192' ' ' TYR . 99.5 m-70 -109.53 -20.51 12.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.586 -0.696 . . . . 0.0 111.14 -178.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -68.05 -20.24 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.119 -0.988 . . . . 0.0 110.628 -176.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 78.8 p -79.45 -17.08 55.02 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.577 -0.702 . . . . 0.0 110.649 175.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -88.35 136.34 33.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.386 -0.821 . . . . 0.0 110.017 173.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 60.5 t -73.07 143.76 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.584 -0.698 . . . . 0.0 110.13 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.509 HG22 ' CE2' ' A' ' 192' ' ' TYR . 84.0 t -84.82 139.13 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.538 -0.726 . . . . 0.0 109.217 171.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -134.76 -170.04 2.48 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.508 -0.745 . . . . 0.0 111.157 -165.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -95.2 152.99 17.88 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.795 -0.565 . . . . 0.0 110.206 -176.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 56.5 m -76.5 157.75 82.07 Favored Pre-proline 0 N--CA 1.497 1.897 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 172.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -63.52 -47.45 7.45 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 O-C-N 123.086 1.045 . . . . 0.0 109.998 177.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.402 ' ND2' ' NE2' ' A' ' 208' ' ' HIS . 28.7 p-10 -65.43 -44.39 87.49 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.578 -0.701 . . . . 0.0 111.261 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . 0.402 ' NE2' ' ND2' ' A' ' 207' ' ' ASN . 51.2 m170 -81.72 -27.77 33.72 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.432 -0.793 . . . . 0.0 111.234 -174.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -68.59 -39.71 80.81 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.395 -0.816 . . . . 0.0 110.075 172.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 25.4 tp -58.14 -30.95 66.74 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.605 -0.684 . . . . 0.0 110.66 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 29.8 t -48.37 142.94 5.14 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.553 -0.717 . . . . 0.0 111.554 -178.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.446 ' NH1' ' CE2' ' A' ' 214' ' ' PHE . 6.1 ptm85 -57.22 136.76 56.48 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.666 -0.646 . . . . 0.0 110.816 -175.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -102.21 -70.03 0.77 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.767 -0.583 . . . . 0.0 110.128 177.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.446 ' CE2' ' NH1' ' A' ' 212' ' ' ARG . 93.6 m-85 51.33 73.53 0.3 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.283 -0.886 . . . . 0.0 111.148 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -67.48 -10.18 49.1 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.632 -0.668 . . . . 0.0 111.032 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -60.03 121.19 11.23 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.195 -0.941 . . . . 0.0 110.236 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 80.6 17.88 72.16 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -143.65 139.92 29.83 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.196 -1.179 . . . . 0.0 109.927 175.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 232' ' ' SER . 82.9 mt -85.15 -25.2 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.662 -0.649 . . . . 0.0 110.52 -178.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.508 ' HB1' ' HB3' ' A' ' 227' ' ' ARG . . . -124.98 89.97 51.79 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.499 -0.751 . . . . 0.0 110.356 -177.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.433 ' HD2' ' CE1' ' A' ' 236' ' ' TYR . 22.6 Cg_endo -67.01 142.06 60.43 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.38 1.2 . . . . 0.0 110.513 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -57.47 -20.79 42.46 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 O-C-N 123.114 1.06 . . . . 0.0 111.46 -176.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 91.2 p -53.79 -22.27 9.14 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.21 -0.931 . . . . 0.0 111.377 -175.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -93.58 131.85 38.46 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.302 -0.874 . . . . 0.0 110.151 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.405 ' HA ' ' HG3' ' A' ' 268' ' ' MET . 57.5 tp -59.69 -40.43 87.85 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.553 -0.717 . . . . 0.0 110.161 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.551 HD12 ' HD3' ' A' ' 190' ' ' PRO . 83.9 mt -106.31 136.65 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.905 -0.497 . . . . 0.0 109.707 176.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.508 ' HB3' ' HB1' ' A' ' 220' ' ' ALA . 40.6 mtm105 -133.52 157.78 44.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.693 -0.629 . . . . 0.0 110.129 176.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.419 HG23 HG21 ' A' ' 247' ' ' VAL . 79.2 t -102.41 146.58 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.649 -0.657 . . . . 0.0 110.098 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -120.76 130.01 53.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.857 -0.527 . . . . 0.0 110.332 171.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.39 20.69 19.29 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 169.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -140.99 107.06 5.18 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.276 -1.132 . . . . 0.0 110.08 174.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . 0.411 ' HA ' HD13 ' A' ' 219' ' ' ILE . 42.8 m -63.3 -15.26 56.7 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.56 -0.712 . . . . 0.0 111.269 -175.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -100.05 8.1 44.21 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.219 -0.925 . . . . 0.0 111.59 -177.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.2 129.4 41.09 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.104 -0.998 . . . . 0.0 110.345 177.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -139.79 158.1 44.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.826 -0.546 . . . . 0.0 109.709 177.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.433 ' CE1' ' HD2' ' A' ' 221' ' ' PRO . 74.4 m-85 -112.16 150.57 30.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.522 -0.736 . . . . 0.0 110.539 -177.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.21 159.9 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.804 -0.56 . . . . 0.0 110.155 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -122.53 130.04 52.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.68 -0.638 . . . . 0.0 110.194 176.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -65.08 130.12 94.72 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.625 -0.672 . . . . 0.0 109.823 178.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -66.48 -27.79 46.34 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 O-C-N 123.155 1.082 . . . . 0.0 111.006 -171.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 82.8 mt -100.55 -50.39 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.471 -0.768 . . . . 0.0 110.99 -167.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.1 p -105.47 12.11 31.82 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.41 -0.806 . . . . 0.0 111.877 -174.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 71.82 -5.11 13.24 Favored Glycine 0 N--CA 1.496 2.638 0 O-C-N 121.128 -0.982 . . . . 0.0 111.9 173.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -46.11 142.02 3.0 Favored 'General case' 0 N--CA 1.504 2.234 0 CA-C-N 119.104 1.452 . . . . 0.0 112.3 -174.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.6 mp0 -106.09 141.62 37.15 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.577 -0.702 . . . . 0.0 110.156 176.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 80.0 p -154.84 159.96 40.9 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.585 -0.697 . . . . 0.0 110.45 177.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.419 HG21 HG23 ' A' ' 228' ' ' VAL . 8.4 p -123.72 148.22 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.735 -0.603 . . . . 0.0 109.793 178.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.739 HD22 ' HG2' ' A' ' 187' ' ' ARG . 82.9 mt -129.57 154.63 46.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.644 -0.66 . . . . 0.0 110.094 -175.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.442 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.9 m -151.51 151.83 29.53 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.781 -0.574 . . . . 0.0 109.934 177.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -71.14 139.33 35.3 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 O-C-N 123.254 1.133 . . . . 0.0 109.993 176.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.678 ' HD2' HD11 ' A' ' 186' ' ' ILE . 60.6 t80 -75.06 124.48 27.07 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.42 -0.8 . . . . 0.0 110.21 176.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -100.04 160.12 28.03 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.665 -0.647 . . . . 0.0 110.072 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -59.53 159.95 22.05 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 O-C-N 123.241 1.127 . . . . 0.0 110.448 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -59.45 149.92 78.63 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 O-C-N 123.243 1.128 . . . . 0.0 110.426 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -60.91 147.63 42.44 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.612 -0.68 . . . . 0.0 110.19 -178.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.9 t -69.87 127.24 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.557 -0.715 . . . . 0.0 110.212 -170.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.97 -10.05 55.35 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 10.1 t -144.42 173.81 11.46 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.078 -1.248 . . . . 0.0 110.664 175.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -107.05 13.21 27.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.662 -0.649 . . . . 0.0 111.764 -168.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -119.98 168.04 11.55 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.154 -0.966 . . . . 0.0 111.118 -175.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 93.3 m -117.79 146.73 43.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.761 -0.587 . . . . 0.0 109.887 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 45.3 m -116.46 136.41 53.01 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.524 -0.735 . . . . 0.0 110.857 -175.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.2 t -128.39 136.02 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 172.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 171' ' ' PRO . 71.3 mt -104.94 120.75 42.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.565 -0.709 . . . . 0.0 110.015 -174.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.569 ' CD2' HD12 ' A' ' 172' ' ' ILE . 2.9 m-30 -95.5 157.37 15.92 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.642 -0.661 . . . . 0.0 110.605 176.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -136.47 142.83 43.59 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 168.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -114.32 133.16 55.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.498 -0.751 . . . . 0.0 110.459 -177.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' MET . . . . . 0.405 ' HG3' ' HA ' ' A' ' 225' ' ' LEU . 0.0 OUTLIER -103.25 3.31 35.38 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.685 -0.634 . . . . 0.0 111.975 -178.104 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . 0.728 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.8 OUTLIER -144.63 159.95 41.97 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.102 -0.999 . . . . 0.0 109.929 174.569 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.442 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.1 p30 -119.78 163.54 17.31 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.435 0.636 . . . . 0.0 110.484 -178.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . 0.429 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 32.4 m -58.22 -32.62 68.48 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.465 -0.772 . . . . 0.0 110.975 -164.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 49.1 p -101.51 13.05 36.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.47 -0.769 . . . . 0.0 111.941 -164.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 30.7 p -94.26 118.08 31.06 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.077 -1.014 . . . . 0.0 110.612 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 61.2 t -63.82 139.92 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.44 -0.788 . . . . 0.0 110.351 -170.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 100.13 -5.11 57.54 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 177.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.81 -99.05 0.87 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 171.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . 0.429 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.3 mmm -62.91 -32.1 73.31 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.7 -0.882 . . . . 0.0 110.287 178.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.3 p30 44.31 49.88 7.89 Favored 'General case' 0 N--CA 1.504 2.243 0 CA-C-O 121.262 0.553 . . . . 0.0 112.449 174.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 21.3 mtt180 54.85 28.64 10.69 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.29 -0.881 . . . . 0.0 111.197 175.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -116.82 106.01 48.67 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.561 -0.712 . . . . 0.0 109.995 174.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.37 147.71 89.92 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 O-C-N 123.029 1.015 . . . . 0.0 110.609 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.677 HG22 ' HA ' ' A' ' 192' ' ' TYR . 45.2 pt -131.87 177.34 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.646 0.736 . . . . 0.0 110.876 -177.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 302' ' ' GLU . 35.3 mt -124.3 149.85 46.08 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.459 HD12 ' HB2' ' A' ' 303' ' ' ALA . 81.2 mt -112.02 129.94 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 79.4 mt -109.81 125.26 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 63.1 t -118.99 126.78 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.436 HG22 ' HG2' ' A' ' 298' ' ' ARG . 45.9 p -125.24 152.16 44.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.631 -0.668 . . . . 0.0 110.594 -173.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.778 HD21 ' HB3' ' A' ' 180' ' ' PRO . 26.2 tp -101.03 127.14 47.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.715 -0.615 . . . . 0.0 109.5 167.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.403 ' OE2' HG22 ' A' ' 295' ' ' VAL . 73.1 mm-40 -130.27 150.32 51.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.856 -0.528 . . . . 0.0 109.926 -173.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.862 HG23 HD11 ' A' ' 296' ' ' LEU . 8.2 p -89.99 161.14 16.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.579 -0.701 . . . . 0.0 109.971 177.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -55.89 -26.14 45.96 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.502 -0.749 . . . . 0.0 111.043 -176.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 49.1 p30 -87.61 8.28 25.99 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.424 -0.797 . . . . 0.0 111.904 -174.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 88.19 20.19 50.17 Favored Glycine 0 N--CA 1.494 2.548 0 O-C-N 121.067 -1.021 . . . . 0.0 110.648 172.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -107.6 140.21 40.96 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.323 -1.104 . . . . 0.0 110.111 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.403 HG22 ' OE2' ' A' ' 289' ' ' GLU . 58.6 t -83.91 133.56 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.563 -0.711 . . . . 0.0 110.15 -174.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.862 HD11 HG23 ' A' ' 290' ' ' THR . 95.7 mt -99.93 -40.15 7.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.711 -0.618 . . . . 0.0 110.283 176.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -167.26 150.41 17.02 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.436 ' HG2' HG22 ' A' ' 287' ' ' THR . 77.5 mtm180 -133.47 137.29 45.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.612 -0.934 . . . . 0.0 110.718 -178.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -130.61 155.21 46.93 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.619 -0.676 . . . . 0.0 110.229 172.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 79.5 m -139.15 146.73 40.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.469 -0.769 . . . . 0.0 110.831 -174.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.424 ' CE2' ' HB ' ' A' ' 284' ' ' ILE . 9.2 p90 -147.76 162.08 39.93 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.782 -0.574 . . . . 0.0 109.979 177.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.444 ' HA ' HD23 ' A' ' 283' ' ' LEU . 81.9 tt0 -104.77 138.44 41.05 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.542 -0.724 . . . . 0.0 110.331 -175.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.459 ' HB2' HD12 ' A' ' 284' ' ' ILE . . . -125.14 143.63 50.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.651 -0.655 . . . . 0.0 110.596 -171.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -138.19 140.77 39.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.75 -0.594 . . . . 0.0 109.755 174.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.728 HD13 ' O ' ' A' ' 269' ' ' CYS . 63.8 mt -108.88 122.87 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.501 -0.749 . . . . 0.0 109.645 176.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 26.9 p -145.24 168.66 19.88 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.636 -0.665 . . . . 0.0 110.657 -172.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -70.03 -40.18 75.33 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.64 -0.663 . . . . 0.0 110.638 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 1.8 t -127.99 86.55 57.87 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.522 -0.736 . . . . 0.0 110.457 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . 0.4 ' HD3' ' HG3' ' A' ' 165' ' ' GLN . 43.7 Cg_exo -56.23 -27.69 67.51 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 O-C-N 123.198 1.104 . . . . 0.0 110.573 174.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -68.47 -36.79 84.63 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -72.18 -39.95 68.29 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.708 -0.877 . . . . 0.0 109.873 -173.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -69.58 -39.26 77.43 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.062 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 -61.61 -44.01 97.8 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.301 178.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -65.12 -39.42 93.05 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.569 -0.707 . . . . 0.0 110.476 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.32 -49.95 74.94 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.599 -0.688 . . . . 0.0 110.44 -173.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . 0.47 ' OD1' HD11 ' A' ' 159' ' ' LEU . 3.1 p30 -61.63 -37.67 84.85 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.487 -0.758 . . . . 0.0 110.02 -178.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -62.0 -41.22 97.82 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.624 -0.673 . . . . 0.0 110.099 177.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -62.59 -35.16 78.63 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.695 -0.628 . . . . 0.0 109.988 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 24.2 m -63.21 -32.68 74.14 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.759 -0.588 . . . . 0.0 110.289 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 83.6 mt -77.3 -46.96 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.63 -0.669 . . . . 0.0 110.02 -177.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -60.7 -41.75 95.83 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.641 -0.662 . . . . 0.0 110.303 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -65.26 -42.56 93.12 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.587 -0.696 . . . . 0.0 110.081 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -60.86 -35.11 75.74 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.748 -0.595 . . . . 0.0 110.161 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -96.3 104.27 16.22 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.672 -0.643 . . . . 0.0 110.314 -178.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 61.8 t -125.07 130.04 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.645 -0.659 . . . . 0.0 109.854 176.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 29.3 t -95.04 131.66 40.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.646 -0.659 . . . . 0.0 110.248 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -91.5 114.66 27.25 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.666 -0.646 . . . . 0.0 110.259 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 27.5 t -94.07 137.68 32.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.622 -0.674 . . . . 0.0 110.227 178.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 30.8 m -137.57 135.03 36.29 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.746 -0.596 . . . . 0.0 110.094 178.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 43.9 mttp -60.55 -37.6 81.77 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.576 -0.703 . . . . 0.0 110.322 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -111.46 147.09 36.04 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.658 -0.651 . . . . 0.0 110.243 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -59.86 -34.62 83.58 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 48.8 p30 -106.35 160.0 15.71 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.674 -0.898 . . . . 0.0 110.306 177.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -142.04 151.91 42.87 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.514 -0.741 . . . . 0.0 110.385 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -60.11 -39.01 84.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.649 -0.657 . . . . 0.0 110.329 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 54.27 101.62 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.456 -0.777 . . . . 0.0 110.872 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -90.55 134.03 34.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.612 -0.68 . . . . 0.0 110.258 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -100.86 139.03 37.12 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.67 -0.644 . . . . 0.0 110.303 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 71.1 p -122.73 166.01 15.62 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.711 -0.618 . . . . 0.0 110.208 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . 0.405 ' CD2' ' O ' ' A' ' 341' ' ' GLY . 57.0 p-80 -59.08 -33.53 70.92 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.575 -0.703 . . . . 0.0 110.462 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . 0.405 ' O ' ' CD2' ' A' ' 340' ' ' HIS . . . 81.74 -163.95 44.5 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 175.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 15.1 tt -147.67 154.21 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.703 -0.881 . . . . 0.0 110.145 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -91.26 124.72 35.67 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.62 -0.675 . . . . 0.0 110.361 -178.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 70.8 mtm 54.86 -86.55 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.687 -0.633 . . . . 0.0 111.053 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 22.4 p . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.237 -177.738 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 75.1 m -86.19 9.24 18.12 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.669 -0.9 . . . . 0.0 111.344 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 57.0 p -73.1 160.82 31.42 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.3 -0.875 . . . . 0.0 110.165 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.569 HG22 ' H ' ' A' ' 118' ' ' ASP . 44.6 m -123.46 139.54 53.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.636 -0.665 . . . . 0.0 110.292 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -66.37 -25.96 67.04 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.603 -0.686 . . . . 0.0 110.416 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.569 ' H ' HG22 ' A' ' 116' ' ' THR . 23.1 t70 -84.65 120.6 26.57 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.592 -0.693 . . . . 0.0 110.187 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 52.13 179.63 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.516 -0.74 . . . . 0.0 111.027 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.4 mt 52.49 28.41 5.93 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.472 -0.767 . . . . 0.0 110.91 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.0 p -123.34 170.45 8.33 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.676 -0.64 . . . . 0.0 110.278 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.4 163.08 10.95 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 O-C-N 123.349 1.184 . . . . 0.0 110.67 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.42 160.66 67.06 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.679 -0.638 . . . . 0.0 110.22 -177.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -58.77 144.93 97.85 Favored 'Trans proline' 0 N--CA 1.488 1.174 0 O-C-N 123.282 1.148 . . . . 0.0 110.773 -176.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.98 148.66 36.15 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.657 -0.652 . . . . 0.0 110.289 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.466 HD11 HG22 ' A' ' 199' ' ' THR . 50.1 mm -119.92 100.04 48.71 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.654 -0.654 . . . . 0.0 109.847 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 126' ' ' ILE . 12.0 Cg_endo -59.66 151.75 67.74 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 O-C-N 123.179 1.094 . . . . 0.0 110.783 -178.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.2 t -113.01 152.49 29.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.696 -0.628 . . . . 0.0 110.281 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -94.69 25.0 4.26 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.611 -0.681 . . . . 0.0 110.824 -178.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 51.0 m -70.06 125.21 26.09 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.613 -0.679 . . . . 0.0 110.249 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -70.06 144.94 52.02 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.616 -0.678 . . . . 0.0 110.432 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.434 ' CE1' ' HA2' ' A' ' 134' ' ' GLY . 43.2 t80 -155.47 101.4 2.22 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.587 -0.696 . . . . 0.0 110.018 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -59.29 -39.97 72.78 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 O-C-N 123.185 1.097 . . . . 0.0 110.762 -173.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.434 ' HA2' ' CE1' ' A' ' 132' ' ' TYR . . . 82.67 -155.1 33.28 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -73.8 -50.01 0.18 Allowed 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.382 1.201 . . . . 0.0 110.881 -174.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -87.75 9.68 20.85 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.576 -0.702 . . . . 0.0 111.337 -173.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 t 53.81 61.69 2.97 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.961 -1.087 . . . . 0.0 110.632 -176.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.718 ' HA ' HG12 ' A' ' 176' ' ' VAL . 64.4 t80 -80.27 118.69 22.15 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.651 -0.656 . . . . 0.0 109.932 -178.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -129.98 163.21 26.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.768 -0.582 . . . . 0.0 110.413 -174.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 62.9 t -125.16 147.73 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.729 -0.607 . . . . 0.0 109.773 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.7 p -155.16 163.32 40.38 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.942 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.438 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 73.1 m-85 -126.68 125.17 41.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.784 -0.573 . . . . 0.0 109.855 -176.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -56.47 143.62 34.38 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.624 -0.672 . . . . 0.0 110.488 -174.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -94.2 130.04 40.58 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.636 -0.665 . . . . 0.0 110.603 -172.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.2 t -125.18 146.62 49.42 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.697 -0.627 . . . . 0.0 110.058 177.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 56.8 p -64.21 165.35 9.49 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.678 -0.639 . . . . 0.0 110.1 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 147' ' ' THR . 7.0 t -71.63 64.74 0.46 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.611 -0.681 . . . . 0.0 110.348 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.32 157.83 35.06 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.598 -0.689 . . . . 0.0 110.144 179.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -73.51 150.55 41.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.605 -0.684 . . . . 0.0 110.01 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.7 m 52.84 48.09 23.23 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.525 -0.734 . . . . 0.0 110.945 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.32 126.58 30.99 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.685 -0.635 . . . . 0.0 110.218 178.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.406 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 44.6 p -60.07 -33.99 72.83 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.674 -0.641 . . . . 0.0 110.204 177.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.42 ' CE2' ' HD2' ' A' ' 171' ' ' PRO . 68.7 p-90 -171.45 145.94 2.17 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.709 -0.62 . . . . 0.0 110.001 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.7 t -142.12 142.65 32.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.8 -0.563 . . . . 0.0 110.082 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.438 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 61.7 t80 -125.57 140.09 53.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.646 -0.659 . . . . 0.0 110.483 -172.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.4 t -109.78 124.07 50.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.842 -0.536 . . . . 0.0 109.785 175.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 48.7 m -71.35 -37.11 71.7 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.357 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -60.75 -31.64 70.97 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.605 -0.684 . . . . 0.0 110.25 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 58.2 mt -104.79 -12.19 16.43 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.612 -0.68 . . . . 0.0 110.786 -174.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 46.5 tttt 59.73 47.56 10.28 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.05 -1.031 . . . . 0.0 109.751 176.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -147.68 153.12 38.91 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.627 -0.671 . . . . 0.0 110.89 -173.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.662 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.6 tp -126.61 137.86 53.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.771 -0.581 . . . . 0.0 110.408 -176.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -115.51 132.94 56.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.646 -0.659 . . . . 0.0 109.231 174.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.0 p -138.37 158.41 44.32 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.659 -0.651 . . . . 0.0 111.134 -173.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.405 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 50.7 mt-30 -104.58 144.08 32.19 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.494 0.664 . . . . 0.0 110.316 173.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.41 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 17.2 tt -52.06 147.22 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.52 -0.737 . . . . 0.0 111.871 -174.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.42 10.0 5.39 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.614 -0.679 . . . . 0.0 112.544 175.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.405 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 68.8 mmtt -95.36 155.08 16.89 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.001 -1.062 . . . . 0.0 110.894 175.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 84.9 m -83.23 126.1 32.29 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.708 -0.62 . . . . 0.0 110.522 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . 0.662 ' SG ' HD21 ' A' ' 162' ' ' LEU . 43.3 t -115.14 90.29 23.34 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.615 -0.678 . . . . 0.0 110.12 174.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.42 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 18.9 Cg_endo -64.41 131.44 29.98 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.239 1.126 . . . . 0.0 110.45 176.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.405 HG12 ' CE2' ' A' ' 142' ' ' PHE . 93.6 mt -123.78 141.56 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.4 ' OE1' ' CD1' ' A' ' 260' ' ' PHE . 67.1 mm-40 -109.17 133.72 52.65 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.566 -0.709 . . . . 0.0 110.408 -173.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.614 HG21 ' CE1' ' A' ' 138' ' ' PHE . 49.4 mm -95.38 135.01 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.574 -0.704 . . . . 0.0 109.725 171.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 32.2 tttt -119.52 131.13 55.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.594 -0.691 . . . . 0.0 110.453 177.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.718 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.7 m -136.83 159.72 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.59 -0.694 . . . . 0.0 110.05 175.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 78.8 mmm -78.32 -40.3 37.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.726 -0.609 . . . . 0.0 110.019 176.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.0 p -134.15 143.21 46.2 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.735 -0.603 . . . . 0.0 109.718 177.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 33.6 Cg_exo -55.3 139.85 81.45 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 O-C-N 123.076 1.04 . . . . 0.0 110.892 -172.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.556 ' HB3' HD21 ' A' ' 288' ' ' LEU . 36.8 Cg_endo -68.56 170.06 15.91 Favored 'Trans proline' 0 N--CA 1.487 1.099 0 O-C-N 123.153 1.081 . . . . 0.0 110.629 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -60.4 155.41 47.04 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.404 1.213 . . . . 0.0 110.602 -178.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -78.69 138.47 38.29 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.58 -0.7 . . . . 0.0 109.981 175.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.28 -24.78 30.85 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -174.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.14 151.91 1.87 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.364 -1.08 . . . . 0.0 111.452 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.0 m -129.71 155.97 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.707 -0.62 . . . . 0.0 109.625 176.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.728 HD11 ' HD2' ' A' ' 251' ' ' TYR . 81.6 mt -108.43 139.3 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.685 -0.635 . . . . 0.0 109.537 176.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.727 ' HG2' HD22 ' A' ' 248' ' ' LEU . 38.9 mtm180 -114.87 146.81 40.69 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -176.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.675 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -140.55 127.61 20.83 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.372 174.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 33.3 ttm -137.34 139.04 26.55 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.805 -0.56 . . . . 0.0 110.938 -177.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.69 ' HD3' HD12 ' A' ' 226' ' ' ILE . 72.1 Cg_endo -91.44 138.15 2.14 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 120.983 1.122 . . . . 0.0 110.702 176.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.449 HG12 ' CZ ' ' A' ' 244' ' ' ARG . 34.9 m -147.22 154.94 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.599 -0.688 . . . . 0.0 110.14 174.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.642 ' HA ' HG22 ' A' ' 282' ' ' ILE . 90.4 m-85 -60.32 165.9 3.31 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.478 -0.764 . . . . 0.0 110.399 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.426 ' HA ' HD12 ' A' ' 283' ' ' LEU . 63.3 tttm -82.99 -60.1 2.27 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.621 -0.675 . . . . 0.0 110.832 -174.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -80.11 151.96 29.55 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.501 -0.749 . . . . 0.0 110.373 -175.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.452 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.67 -38.31 72.05 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.36 -0.838 . . . . 0.0 110.709 -175.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -56.5 -24.92 49.51 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.48 -0.763 . . . . 0.0 110.652 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.418 ' HB3' ' CG ' ' A' ' 192' ' ' TYR . 98.9 m-70 -109.69 -20.49 12.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.53 -0.732 . . . . 0.0 111.167 -178.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.1 p -67.74 -20.3 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.086 -1.008 . . . . 0.0 110.655 -176.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.466 HG22 HD11 ' A' ' 126' ' ' ILE . 67.0 p -79.35 -17.1 55.17 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.537 -0.727 . . . . 0.0 110.742 175.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -88.31 137.24 32.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.292 -0.88 . . . . 0.0 110.097 173.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 54.1 t -74.09 142.01 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.612 -0.68 . . . . 0.0 110.262 177.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.511 HG22 ' CE2' ' A' ' 192' ' ' TYR . 67.8 t -84.84 138.8 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.579 -0.701 . . . . 0.0 109.331 170.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.9 pttp -134.86 -170.16 2.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.482 -0.761 . . . . 0.0 111.185 -168.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -95.27 153.9 17.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.794 -0.567 . . . . 0.0 110.499 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 60.3 m -76.04 160.6 78.0 Favored Pre-proline 0 N--CA 1.497 1.887 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 174.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -64.2 -47.38 6.32 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 O-C-N 123.189 1.099 . . . . 0.0 109.842 176.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.445 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.6 p-10 -65.54 -44.35 87.12 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.626 -0.671 . . . . 0.0 111.223 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . 0.445 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 55.6 m170 -80.76 -27.73 36.69 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.479 -0.763 . . . . 0.0 111.358 -174.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -66.71 -42.06 87.01 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.442 -0.786 . . . . 0.0 109.919 172.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 23.3 tp -70.15 -34.27 72.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.611 -0.681 . . . . 0.0 110.298 174.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.9 t -48.41 -37.46 17.07 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.657 -0.652 . . . . 0.0 111.886 -175.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -128.04 137.51 52.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.55 -0.719 . . . . 0.0 110.291 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . 0.437 ' HG3' ' CD2' ' A' ' 214' ' ' PHE . 17.6 pt-20 -150.86 -160.46 1.17 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.692 -0.63 . . . . 0.0 110.242 -177.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.437 ' CD2' ' HG3' ' A' ' 213' ' ' GLU . 21.5 m-85 54.08 70.5 0.6 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.306 -0.872 . . . . 0.0 110.785 -179.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -69.02 -10.31 56.88 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.672 -0.642 . . . . 0.0 111.114 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -60.16 118.09 5.93 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.196 -0.94 . . . . 0.0 110.358 177.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 80.51 20.01 67.39 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 177.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -114.65 139.95 49.23 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.269 -1.136 . . . . 0.0 110.321 177.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.8 mt -84.95 -25.11 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.704 -0.622 . . . . 0.0 110.445 -178.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.655 ' HB1' ' HD2' ' A' ' 227' ' ' ARG . . . -125.01 90.01 51.72 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.492 -0.755 . . . . 0.0 110.263 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.454 ' HD2' ' CE2' ' A' ' 236' ' ' TYR . 21.4 Cg_exo -62.34 136.01 57.2 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.317 1.167 . . . . 0.0 110.379 -177.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.417 ' O ' ' HE3' ' A' ' 268' ' ' MET . 27.9 Cg_exo -57.46 -22.25 49.65 Favored 'Trans proline' 0 N--CA 1.49 1.278 0 O-C-N 123.054 1.028 . . . . 0.0 111.286 -176.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 25.2 m -52.89 -28.78 24.75 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.33 -0.856 . . . . 0.0 111.422 -174.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . 0.436 ' CE1' ' HB3' ' A' ' 236' ' ' TYR . 95.1 m-70 -100.12 129.39 46.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.436 -0.79 . . . . 0.0 110.601 -174.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.568 HD12 ' HG3' ' A' ' 268' ' ' MET . 55.2 tp -60.97 -37.51 82.68 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.618 -0.676 . . . . 0.0 110.236 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.69 HD12 ' HD3' ' A' ' 190' ' ' PRO . 82.1 mt -101.01 136.75 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.786 -0.571 . . . . 0.0 109.85 -179.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.655 ' HD2' ' HB1' ' A' ' 220' ' ' ALA . 65.1 mtm180 -133.28 158.71 42.26 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.646 -0.659 . . . . 0.0 110.254 178.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.666 HG23 HG21 ' A' ' 247' ' ' VAL . 93.0 t -103.93 146.7 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.725 -0.61 . . . . 0.0 110.137 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -118.5 130.0 55.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.73 -0.606 . . . . 0.0 110.477 170.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 92.42 25.02 22.47 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 167.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -138.86 108.1 6.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.433 -1.04 . . . . 0.0 110.017 174.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 92.6 p -63.35 -15.14 56.51 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.675 -0.641 . . . . 0.0 111.287 -177.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -97.28 9.36 42.46 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.299 -0.876 . . . . 0.0 111.155 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -62.24 125.44 23.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.222 -0.924 . . . . 0.0 110.156 176.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -139.72 154.81 47.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.798 -0.564 . . . . 0.0 109.74 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.454 ' CE2' ' HD2' ' A' ' 221' ' ' PRO . 91.1 m-85 -117.36 150.73 38.36 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.605 -176.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.19 160.03 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.782 -0.574 . . . . 0.0 110.234 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -114.69 130.05 56.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.768 -0.583 . . . . 0.0 110.038 174.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -63.78 130.11 94.21 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.71 -0.619 . . . . 0.0 109.741 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -64.98 -28.69 57.76 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.232 1.122 . . . . 0.0 111.045 -170.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.9 mt -102.16 -50.53 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.387 -0.821 . . . . 0.0 111.041 -167.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 9.3 p -105.5 12.27 31.58 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.327 -0.858 . . . . 0.0 111.917 -176.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 72.14 -5.01 15.46 Favored Glycine 0 N--CA 1.497 2.737 0 O-C-N 121.057 -1.027 . . . . 0.0 112.001 171.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.449 ' CZ ' HG12 ' A' ' 191' ' ' VAL . 22.6 mmt180 -45.82 142.14 2.68 Favored 'General case' 0 N--CA 1.505 2.324 0 CA-C-N 119.137 1.469 . . . . 0.0 112.509 -174.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -96.01 143.55 27.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.551 -0.718 . . . . 0.0 110.099 172.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 77.9 p -154.7 159.87 41.0 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.579 -0.7 . . . . 0.0 110.483 174.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.666 HG21 HG23 ' A' ' 228' ' ' VAL . 8.6 p -125.12 148.33 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.78 -0.575 . . . . 0.0 109.781 179.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.727 HD22 ' HG2' ' A' ' 187' ' ' ARG . 81.6 mt -129.64 154.55 47.0 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.651 -177.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.452 HG13 ' C ' ' A' ' 248' ' ' LEU . 34.1 m -151.53 151.68 29.22 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.789 -0.569 . . . . 0.0 109.985 176.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -71.07 139.04 34.89 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 123.297 1.156 . . . . 0.0 110.018 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.728 ' HD2' HD11 ' A' ' 186' ' ' ILE . 59.9 t80 -75.96 125.61 29.44 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.491 -0.756 . . . . 0.0 110.123 174.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -100.06 160.01 28.3 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.725 -0.609 . . . . 0.0 109.996 177.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -58.94 159.93 19.9 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.268 1.141 . . . . 0.0 110.417 178.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -59.38 149.91 78.32 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 O-C-N 123.187 1.098 . . . . 0.0 110.493 -177.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -61.82 148.48 43.07 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.681 -0.637 . . . . 0.0 110.138 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 62.2 t -69.92 127.2 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.534 -0.729 . . . . 0.0 110.12 -170.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.98 -10.14 55.37 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 9.9 t -144.73 174.11 11.26 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.124 -1.221 . . . . 0.0 110.616 175.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -107.26 13.16 27.47 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.612 -0.68 . . . . 0.0 111.707 -168.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.4 ' CD1' ' OE1' ' A' ' 173' ' ' GLN . 13.5 p90 -119.86 168.08 11.46 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.152 -0.967 . . . . 0.0 111.135 -174.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 88.4 m -117.77 147.49 42.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.741 -0.599 . . . . 0.0 109.905 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 47.0 m -118.14 136.28 53.71 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.56 -0.712 . . . . 0.0 111.048 -174.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.8 t -131.92 137.26 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 172.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 67.8 mt -104.62 120.73 42.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.467 -0.77 . . . . 0.0 109.826 -172.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.675 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 5.0 m-30 -106.29 151.2 25.13 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.678 -0.639 . . . . 0.0 110.604 -177.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -136.58 142.86 43.39 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -112.0 130.08 55.98 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.595 -0.69 . . . . 0.0 110.453 -177.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' MET . . . . . 0.568 ' HG3' HD12 ' A' ' 225' ' ' LEU . 5.0 ppp? -96.16 3.0 53.54 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.633 -0.667 . . . . 0.0 111.973 -176.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . 0.626 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.5 OUTLIER -144.81 165.04 29.24 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.076 -1.015 . . . . 0.0 110.123 175.874 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.635 ' HA ' HG21 ' A' ' 305' ' ' ILE . 27.3 p30 -121.7 163.4 19.1 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.646 -0.659 . . . . 0.0 110.417 -178.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . 0.423 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 29.6 m -58.42 -35.14 71.62 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.427 -0.796 . . . . 0.0 110.986 -163.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 51.3 p -103.46 15.0 30.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.409 -0.807 . . . . 0.0 111.949 -163.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 29.7 p -93.96 118.05 30.95 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.063 -1.023 . . . . 0.0 110.712 178.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 60.0 t -62.75 138.82 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.519 -0.738 . . . . 0.0 110.352 -171.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.08 -5.21 61.2 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 178.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.13 -101.66 0.95 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 172.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . 0.423 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.4 mmm -60.93 -29.95 69.91 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.657 -0.908 . . . . 0.0 110.124 178.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 22.6 p30 42.86 44.74 4.03 Favored 'General case' 0 N--CA 1.505 2.312 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 173.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 55.02 34.66 22.96 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.355 -0.841 . . . . 0.0 111.11 175.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . 0.468 ' O ' HG23 ' A' ' 282' ' ' ILE . 88.5 mtt180 -120.04 105.74 42.12 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.54 -0.725 . . . . 0.0 109.98 172.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 280' ' ' ARG . 11.3 Cg_endo -58.93 144.94 98.74 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 O-C-N 123.112 1.059 . . . . 0.0 110.573 -178.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.642 HG22 ' HA ' ' A' ' 192' ' ' TYR . 46.2 pt -131.97 175.36 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 122.006 0.908 . . . . 0.0 111.244 -173.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 302' ' ' GLU . 26.0 mt -124.44 149.84 46.34 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.699 HD12 ' CE1' ' A' ' 301' ' ' PHE . 82.4 mt -115.83 129.63 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.173 178.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.61 HG23 ' SG ' ' A' ' 300' ' ' CYS . 82.1 mt -109.74 125.52 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 -176.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 60.4 t -118.9 126.76 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.5 p -125.29 155.0 40.88 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.655 -0.653 . . . . 0.0 110.614 -172.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.575 HD22 ' CD1' ' A' ' 138' ' ' PHE . 30.5 tp -107.02 126.13 51.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.803 -0.561 . . . . 0.0 109.564 170.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.593 ' OE2' HG13 ' A' ' 295' ' ' VAL . 69.4 mm-40 -131.77 151.41 51.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.855 -0.528 . . . . 0.0 109.853 -174.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.645 HG22 HD11 ' A' ' 296' ' ' LEU . 71.4 p -89.9 157.8 17.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.605 -0.684 . . . . 0.0 109.779 178.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -56.12 -26.02 48.36 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.506 -0.746 . . . . 0.0 110.739 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -87.14 9.55 19.61 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.55 -0.719 . . . . 0.0 111.789 -174.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 87.63 20.09 52.26 Favored Glycine 0 N--CA 1.493 2.49 0 O-C-N 121.068 -1.02 . . . . 0.0 110.76 170.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -108.53 140.22 42.17 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.294 -1.121 . . . . 0.0 110.208 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.618 HG11 ' HE ' ' A' ' 298' ' ' ARG . 59.5 t -86.76 134.98 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.571 -0.706 . . . . 0.0 110.043 -173.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.645 HD11 HG22 ' A' ' 290' ' ' THR . 96.4 mt -99.87 -40.14 7.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.658 -0.651 . . . . 0.0 110.457 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -175.35 162.42 31.92 Favored Glycine 0 N--CA 1.496 2.674 0 C-N-CA 119.922 -1.132 . . . . 0.0 110.384 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.618 ' HE ' HG11 ' A' ' 295' ' ' VAL . 84.2 mtt180 -130.73 139.83 50.3 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.672 -0.899 . . . . 0.0 110.567 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -136.59 155.07 50.42 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.479 -0.763 . . . . 0.0 109.869 170.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . 0.61 ' SG ' HG23 ' A' ' 285' ' ' ILE . 89.1 m -143.56 154.76 43.92 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.327 -0.858 . . . . 0.0 110.874 -175.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.699 ' CE1' HD12 ' A' ' 284' ' ' ILE . 48.7 p90 -145.72 163.91 33.44 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.717 -0.614 . . . . 0.0 110.108 176.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.429 ' HA ' HD23 ' A' ' 283' ' ' LEU . 56.6 tt0 -104.89 135.84 45.5 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.457 -0.777 . . . . 0.0 110.325 -177.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -123.84 144.42 49.74 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.633 -0.667 . . . . 0.0 110.729 -170.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -138.67 137.0 36.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.815 -0.553 . . . . 0.0 109.812 173.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.635 HG21 ' HA ' ' A' ' 270' ' ' ASN . 75.0 mt -105.8 123.56 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.58 -0.7 . . . . 0.0 109.584 176.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.2 p -145.15 164.9 29.87 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.569 -0.707 . . . . 0.0 110.948 -169.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -66.43 -39.92 89.2 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.671 -0.643 . . . . 0.0 110.615 -177.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 2.9 t -131.31 89.06 42.31 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.534 -0.729 . . . . 0.0 110.576 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -56.71 -29.3 79.67 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 123.136 1.072 . . . . 0.0 110.477 173.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.15 -37.93 93.46 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 176.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -70.23 -38.41 75.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.536 -0.979 . . . . 0.0 109.779 -175.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -69.4 -36.13 76.45 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.986 178.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 47.7 ttt-85 -57.04 -48.39 78.63 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.529 -0.732 . . . . 0.0 110.57 175.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -64.99 -38.54 91.28 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.72 -0.613 . . . . 0.0 110.448 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.85 -52.16 65.26 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.501 -0.749 . . . . 0.0 110.475 -173.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -61.39 -37.68 84.29 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.434 -0.791 . . . . 0.0 110.155 -177.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -66.29 -38.95 88.96 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.67 -0.644 . . . . 0.0 110.301 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -62.15 -35.11 77.78 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.597 -0.689 . . . . 0.0 110.038 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 24.5 m -61.72 -34.1 75.21 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.651 -0.656 . . . . 0.0 110.102 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 84.4 mt -79.74 -44.7 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.634 -0.666 . . . . 0.0 110.049 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -58.98 -38.13 78.42 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.667 -0.646 . . . . 0.0 110.602 -178.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -60.98 -48.3 82.47 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.538 -0.726 . . . . 0.0 110.181 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -73.54 -43.27 60.33 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.632 -0.667 . . . . 0.0 110.26 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -105.03 125.07 50.57 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.675 -0.641 . . . . 0.0 110.552 -175.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 61.9 t -108.32 129.97 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.682 -0.636 . . . . 0.0 109.806 178.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 49.3 m -95.05 140.07 30.51 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.681 -0.637 . . . . 0.0 110.456 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -91.84 125.14 36.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.648 -0.658 . . . . 0.0 110.143 176.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 53.7 p -61.54 157.08 18.02 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.635 -0.665 . . . . 0.0 110.082 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 49.1 m -103.65 133.58 48.42 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.652 -0.655 . . . . 0.0 110.471 -177.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 49.3 tttt -100.07 150.18 22.74 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.68 -0.637 . . . . 0.0 109.995 175.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -60.82 101.94 0.17 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.639 -0.663 . . . . 0.0 110.168 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 86.68 178.14 49.32 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -178.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . 0.402 ' O ' ' CE2' ' A' ' 335' ' ' PHE . 67.9 m-20 59.47 79.94 0.21 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.5 -1.0 . . . . 0.0 110.229 175.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -66.55 145.88 55.13 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.573 -0.704 . . . . 0.0 110.223 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.402 ' CE2' ' O ' ' A' ' 333' ' ' ASP . 96.6 m-85 -118.8 155.91 30.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.643 -0.661 . . . . 0.0 110.338 179.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 55.71 -86.31 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.763 -0.585 . . . . 0.0 111.11 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 54.89 -86.31 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.318 -0.864 . . . . 0.0 110.88 -175.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -114.52 110.52 19.95 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.178 -0.951 . . . . 0.0 110.212 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 67.3 p -124.74 156.93 36.87 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.631 -0.668 . . . . 0.0 110.256 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -141.81 145.45 34.74 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.677 -0.639 . . . . 0.0 110.212 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 77.62 41.53 19.71 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 177.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 16.1 tt -142.63 136.24 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.609 -0.936 . . . . 0.0 110.095 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -93.95 145.74 24.42 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.663 -0.648 . . . . 0.0 110.283 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 87.8 mtp 51.79 91.61 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.503 -0.748 . . . . 0.0 111.014 178.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 9.0 m . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.255 179.865 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 30.0 t -87.12 144.28 26.93 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.649 -0.912 . . . . 0.0 110.273 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.5 t 51.64 89.97 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.463 -0.773 . . . . 0.0 111.078 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 70.5 p -69.59 -27.38 65.06 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.679 -0.638 . . . . 0.0 110.293 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -108.65 137.16 47.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.595 -0.691 . . . . 0.0 110.255 178.206 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -158.11 155.56 29.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.694 -0.629 . . . . 0.0 110.238 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 50.62 -169.58 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.411 -0.805 . . . . 0.0 111.189 178.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 25.1 tp 56.72 159.07 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.631 -0.668 . . . . 0.0 110.808 -175.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 9.6 t -87.09 160.14 49.73 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.553 -0.717 . . . . 0.0 110.171 179.084 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -65.26 152.16 77.26 Favored 'Cis proline' 0 N--CA 1.495 1.599 0 C-N-CA 123.166 -1.598 . . . . 0.0 110.391 -16.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 79.8 p -81.63 145.31 54.32 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.654 -0.654 . . . . 0.0 110.167 -179.029 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.4 ' HB3' ' CG2' ' A' ' 242' ' ' THR . 24.0 Cg_exo -59.92 150.31 78.8 Favored 'Trans proline' 0 N--CA 1.487 1.147 0 O-C-N 123.239 1.126 . . . . 0.0 110.553 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.83 150.02 39.42 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.624 -0.673 . . . . 0.0 110.004 178.492 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.408 HD11 HG22 ' A' ' 199' ' ' THR . 50.3 mm -119.93 139.56 28.41 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.663 -0.648 . . . . 0.0 109.936 -177.55 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.91 151.91 83.11 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.153 1.081 . . . . 0.0 110.431 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 27.8 t -113.17 142.52 45.68 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.673 -0.642 . . . . 0.0 110.211 179.387 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.9 p-10 -96.33 24.62 5.61 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.722 -0.611 . . . . 0.0 110.681 -179.227 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 51.6 m -76.63 125.17 28.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.54 -0.725 . . . . 0.0 110.279 -179.403 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -70.14 144.91 51.89 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.672 -0.642 . . . . 0.0 110.41 -177.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -154.25 99.41 2.5 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.774 -0.579 . . . . 0.0 110.153 178.6 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -58.8 -39.91 77.37 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 O-C-N 123.202 1.106 . . . . 0.0 110.774 -176.651 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.69 -155.11 47.93 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 178.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -73.29 -46.19 0.38 Allowed 'Trans proline' 0 C--N 1.316 -1.176 0 O-C-N 123.363 1.191 . . . . 0.0 110.922 -174.442 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -85.9 6.7 27.22 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.531 -0.731 . . . . 0.0 111.382 -173.679 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t 53.72 61.18 3.22 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.853 -1.154 . . . . 0.0 110.656 -175.519 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.689 ' HA ' HG12 ' A' ' 176' ' ' VAL . 54.6 t80 -77.82 119.29 21.1 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.64 -0.662 . . . . 0.0 109.852 -178.678 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -130.07 159.93 35.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.826 -0.546 . . . . 0.0 110.189 -178.419 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 68.5 t -124.57 147.65 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.694 -0.629 . . . . 0.0 109.902 176.131 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.9 p -155.04 164.23 39.17 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.075 177.132 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.486 ' CD1' ' CE2' ' A' ' 155' ' ' TYR . 88.0 m-85 -126.64 125.25 41.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.84 -0.537 . . . . 0.0 109.894 -176.532 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -56.58 147.76 21.45 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.705 -0.622 . . . . 0.0 110.684 -173.217 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -104.06 146.68 28.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.69 -0.631 . . . . 0.0 110.421 -175.096 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 84.0 p -145.09 160.61 41.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.704 -0.623 . . . . 0.0 110.114 177.32 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 45.4 m -61.82 155.77 22.27 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.651 -0.655 . . . . 0.0 110.083 179.212 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 77.0 p -60.82 91.76 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.692 -0.63 . . . . 0.0 110.158 -179.254 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.05 147.56 23.58 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.704 -0.623 . . . . 0.0 110.348 -178.588 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -71.88 139.3 48.75 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.698 -0.626 . . . . 0.0 110.152 178.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 34.5 m 52.78 43.23 31.69 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.404 -0.81 . . . . 0.0 110.976 -179.281 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.43 136.32 57.85 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.643 -0.66 . . . . 0.0 110.198 177.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.497 ' HG1' ' HD1' ' A' ' 153' ' ' TRP . 80.9 p -59.99 -32.49 70.9 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.641 -0.662 . . . . 0.0 109.868 174.197 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.497 ' HD1' ' HG1' ' A' ' 152' ' ' THR . 68.7 p-90 -171.34 142.8 1.75 Allowed 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.319 0.581 . . . . 0.0 110.253 176.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.7 t -142.12 142.72 32.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.935 -0.478 . . . . 0.0 109.997 -177.318 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.486 ' CE2' ' CD1' ' A' ' 142' ' ' PHE . 52.0 t80 -125.52 140.06 53.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.545 -0.722 . . . . 0.0 110.524 -172.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.5 t -111.84 124.31 52.08 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 120.401 -0.52 . . . . 0.0 109.789 176.118 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 62.3 m -70.58 -37.05 73.9 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.771 -0.581 . . . . 0.0 110.45 -177.658 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -59.1 -33.03 70.36 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.529 -0.732 . . . . 0.0 110.53 -178.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.469 HD11 ' OD1' ' A' ' 316' ' ' ASP . 56.1 mt -104.84 -11.99 16.5 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.688 -0.632 . . . . 0.0 110.787 -175.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 70.7 tttt 59.74 49.54 8.03 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.046 -1.034 . . . . 0.0 109.653 177.703 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 40.5 tttt -146.56 153.11 39.98 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.754 -0.591 . . . . 0.0 110.668 -174.054 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.604 HD21 ' SG ' ' A' ' 170' ' ' CYS . 14.5 tp -126.52 137.76 53.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.805 -0.559 . . . . 0.0 110.171 -177.333 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -115.16 134.78 54.85 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.8 p -138.42 158.61 43.95 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 120.114 -0.635 . . . . 0.0 111.114 -174.029 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.428 ' HB2' ' HG3' ' A' ' 168' ' ' LYS . 52.4 mt-30 -104.42 141.99 35.38 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.557 -0.714 . . . . 0.0 110.209 173.645 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.439 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 18.3 tt -54.85 146.23 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.562 -0.712 . . . . 0.0 111.561 -171.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 166' ' ' ILE . . . 64.36 9.98 5.33 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.552 -0.718 . . . . 0.0 112.479 177.017 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.428 ' HG3' ' HB2' ' A' ' 165' ' ' GLN . 67.5 mmtt -96.13 155.08 16.91 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.896 -1.128 . . . . 0.0 110.747 175.114 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 86.7 m -81.12 126.2 31.17 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.738 -0.601 . . . . 0.0 110.634 -177.581 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . 0.604 ' SG ' HD21 ' A' ' 162' ' ' LEU . 46.9 t -115.53 90.23 25.07 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.702 -0.624 . . . . 0.0 110.11 172.722 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.441 ' HD2' ' CE2' ' A' ' 153' ' ' TRP . 22.0 Cg_exo -62.37 130.89 31.78 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 O-C-N 123.276 1.145 . . . . 0.0 110.624 174.079 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.413 HG12 ' CE2' ' A' ' 142' ' ' PHE . 94.5 mt -125.41 142.92 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.655 -0.653 . . . . 0.0 109.299 175.593 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -108.44 136.21 48.45 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.517 -0.739 . . . . 0.0 110.739 -176.209 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.419 HG23 ' CE1' ' A' ' 138' ' ' PHE . 48.5 mm -95.27 131.55 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.724 -0.61 . . . . 0.0 109.613 169.241 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -112.99 128.28 56.45 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.607 -0.683 . . . . 0.0 110.447 176.28 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.689 HG12 ' HA ' ' A' ' 138' ' ' PHE . 16.2 m -136.59 159.79 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.594 -0.691 . . . . 0.0 109.903 175.104 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 82.5 mmm -76.47 -40.81 49.35 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.632 -0.668 . . . . 0.0 110.104 178.647 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.411 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 77.5 p -135.44 143.15 44.05 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.782 -0.574 . . . . 0.0 109.65 178.356 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 178' ' ' THR . 34.1 Cg_exo -55.22 139.8 81.02 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 O-C-N 123.142 1.075 . . . . 0.0 110.841 -171.648 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.804 ' HB3' HD21 ' A' ' 288' ' ' LEU . 29.8 Cg_endo -66.58 170.0 13.25 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 O-C-N 123.212 1.111 . . . . 0.0 110.618 178.411 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -60.85 156.25 44.68 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.358 1.189 . . . . 0.0 110.5 -178.293 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -79.1 139.32 38.1 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.651 -0.656 . . . . 0.0 109.954 176.118 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 98.53 -24.94 29.94 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -174.167 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.18 152.35 1.76 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.359 -1.083 . . . . 0.0 111.426 177.684 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 33.8 m -129.78 155.95 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.766 -0.584 . . . . 0.0 109.649 176.293 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.712 HD11 ' HD2' ' A' ' 251' ' ' TYR . 80.4 mt -109.17 138.78 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.676 -0.64 . . . . 0.0 109.51 176.626 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.721 ' HG2' HD22 ' A' ' 248' ' ' LEU . 30.8 mtm180 -114.9 147.27 40.18 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -175.763 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.718 ' HB2' ' OH ' ' A' ' 265' ' ' TYR . . . -140.13 127.18 20.89 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.501 -0.749 . . . . 0.0 110.259 173.456 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.413 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 3.2 ttp -137.24 138.33 24.93 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.777 -0.577 . . . . 0.0 110.926 -176.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.689 ' HD3' HD12 ' A' ' 226' ' ' ILE . 71.9 Cg_endo -91.9 138.09 1.95 Allowed 'Trans proline' 0 C--N 1.32 -0.949 0 C-N-CA 121.023 1.149 . . . . 0.0 110.771 177.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.431 HG13 ' C ' ' A' ' 190' ' ' PRO . 34.7 m -147.43 154.82 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.505 -0.747 . . . . 0.0 110.101 174.089 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.676 ' HA ' HG22 ' A' ' 282' ' ' ILE . 63.3 m-85 -60.05 162.06 6.12 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.409 -0.807 . . . . 0.0 110.55 -179.155 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.5 ' HA ' HD12 ' A' ' 283' ' ' LEU . 29.0 tttp -79.19 -60.02 2.54 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.665 -0.647 . . . . 0.0 110.878 -173.092 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -80.15 152.04 29.44 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.587 -0.695 . . . . 0.0 110.425 -175.373 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.457 ' HA ' HG12 ' A' ' 198' ' ' VAL . . . -56.52 -37.95 71.16 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.376 -0.827 . . . . 0.0 110.674 -177.084 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -56.86 -25.02 55.67 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.548 -0.72 . . . . 0.0 110.572 -177.438 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.411 ' HB3' ' CG ' ' A' ' 192' ' ' TYR . 65.0 m170 -108.81 -20.58 13.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.598 -0.689 . . . . 0.0 111.116 -178.816 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 195' ' ' ALA . 3.2 p -68.45 -20.28 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.148 -0.97 . . . . 0.0 110.581 -175.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.408 HG22 HD11 ' A' ' 126' ' ' ILE . 67.3 p -79.42 -17.03 55.18 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.516 -0.74 . . . . 0.0 110.678 174.37 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.39 136.54 32.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.366 -0.834 . . . . 0.0 110.025 173.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 242' ' ' THR . 61.9 t -72.92 145.08 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.569 -0.707 . . . . 0.0 110.269 178.354 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.631 HG23 HH12 ' A' ' 244' ' ' ARG . 57.8 t -84.88 139.9 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 170.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 11.9 pttt -134.72 -170.46 2.56 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.509 -0.744 . . . . 0.0 111.195 -169.34 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 63.8 mmt-85 -95.37 150.92 19.75 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.827 -0.546 . . . . 0.0 110.423 -176.23 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 60.9 m -73.06 163.16 70.61 Favored Pre-proline 0 N--CA 1.497 1.894 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 169.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -63.96 -47.66 6.34 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 123.044 1.023 . . . . 0.0 109.903 177.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.41 ' ND2' ' CD2' ' A' ' 208' ' ' HIS . 28.4 p-10 -65.56 -44.06 87.93 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.627 -0.671 . . . . 0.0 111.124 178.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . 0.41 ' CD2' ' ND2' ' A' ' 207' ' ' ASN . 51.4 m170 -80.68 -27.79 36.97 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.414 -0.804 . . . . 0.0 111.394 -174.527 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -66.14 -36.73 83.91 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.385 -0.822 . . . . 0.0 110.172 174.028 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 23.3 tp -55.23 -35.19 64.67 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.482 -0.762 . . . . 0.0 110.772 177.458 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 24.5 t -48.39 -27.73 2.79 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.448 -0.783 . . . . 0.0 111.548 178.029 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -54.45 -26.16 29.31 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.545 -0.722 . . . . 0.0 111.175 -177.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -54.88 149.41 11.54 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.418 -0.801 . . . . 0.0 110.955 -176.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 40.2 t80 53.78 70.78 0.56 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.388 -0.82 . . . . 0.0 110.844 179.307 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -83.39 -10.13 58.62 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.607 -0.683 . . . . 0.0 111.155 176.147 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -59.88 125.1 22.33 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.174 -0.954 . . . . 0.0 110.337 176.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 95.14 -1.46 64.91 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 120.447 -0.882 . . . . 0.0 110.928 179.035 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -114.67 139.77 49.38 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.012 -1.287 . . . . 0.0 110.401 173.602 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.9 mt -88.07 -25.08 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.722 -0.611 . . . . 0.0 110.444 -179.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.538 ' HB1' ' HD2' ' A' ' 227' ' ' ARG . . . -124.91 95.14 42.78 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.527 -0.733 . . . . 0.0 110.173 -177.506 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -64.96 144.04 81.25 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.275 1.145 . . . . 0.0 110.612 -175.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.91 -19.59 40.42 Favored 'Trans proline' 0 N--CA 1.489 1.212 0 O-C-N 123.107 1.056 . . . . 0.0 111.321 -179.544 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 96.6 p -53.89 -22.12 9.27 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.178 -0.952 . . . . 0.0 111.211 -177.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . 0.467 ' CE1' ' CG ' ' A' ' 236' ' ' TYR . 41.0 m80 -104.33 128.71 52.17 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.471 -0.768 . . . . 0.0 110.203 177.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.564 HD12 ' HG3' ' A' ' 268' ' ' MET . 57.2 tp -66.66 -38.37 86.71 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.577 -0.702 . . . . 0.0 110.113 -177.603 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.689 HD12 ' HD3' ' A' ' 190' ' ' PRO . 85.5 mt -104.7 136.72 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.589 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.538 ' HD2' ' HB1' ' A' ' 220' ' ' ALA . 78.7 mtm180 -134.57 159.52 40.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.701 -0.624 . . . . 0.0 110.189 -178.401 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.596 HG23 HG21 ' A' ' 247' ' ' VAL . 91.2 t -104.46 146.74 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.766 -0.584 . . . . 0.0 110.103 178.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -118.1 124.4 47.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.732 -0.605 . . . . 0.0 110.361 172.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.05 23.82 14.15 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 168.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -137.17 107.6 6.48 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.464 -1.021 . . . . 0.0 110.028 174.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 26.3 t -62.89 -15.18 53.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.67 -0.643 . . . . 0.0 111.322 -178.001 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -100.02 7.98 44.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.246 -0.909 . . . . 0.0 111.524 -177.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.06 130.76 47.99 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.191 -0.943 . . . . 0.0 110.213 176.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -139.76 157.95 44.9 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.75 -0.594 . . . . 0.0 109.807 177.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.467 ' CG ' ' CE1' ' A' ' 224' ' ' HIS . 78.6 m-85 -115.01 150.73 35.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.596 -0.69 . . . . 0.0 110.658 -176.394 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.16 159.93 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.827 -0.546 . . . . 0.0 110.081 176.38 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -121.46 130.11 53.38 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.69 -0.631 . . . . 0.0 110.344 178.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -64.74 110.34 3.97 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.636 -0.665 . . . . 0.0 109.697 176.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -59.76 -25.11 78.2 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.141 1.074 . . . . 0.0 111.078 -171.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 83.8 mt -100.72 -50.41 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.409 -0.807 . . . . 0.0 110.853 -171.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.422 ' O ' HG22 ' A' ' 201' ' ' VAL . 17.4 p -105.43 12.16 31.83 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.41 -0.807 . . . . 0.0 111.96 -173.211 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 82.32 -25.07 4.48 Favored Glycine 0 N--CA 1.498 2.781 0 O-C-N 120.997 -1.064 . . . . 0.0 111.885 169.169 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.631 HH12 HG23 ' A' ' 202' ' ' VAL . 29.7 mmt180 -45.83 142.14 2.69 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-N 118.652 1.226 . . . . 0.0 112.678 -168.445 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -104.41 146.08 29.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.7 -0.625 . . . . 0.0 109.93 173.681 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 77.9 p -154.74 159.98 41.03 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.609 -0.682 . . . . 0.0 110.39 178.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.596 HG21 HG23 ' A' ' 228' ' ' VAL . 8.6 p -123.23 148.25 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.75 -0.593 . . . . 0.0 109.816 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.721 HD22 ' HG2' ' A' ' 187' ' ' ARG . 83.9 mt -129.57 154.62 46.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.653 -0.655 . . . . 0.0 109.662 -176.506 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.442 HG13 ' C ' ' A' ' 248' ' ' LEU . 35.1 m -151.35 151.73 29.63 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.769 -0.582 . . . . 0.0 110.045 175.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -71.1 138.6 33.92 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 O-C-N 123.232 1.122 . . . . 0.0 109.991 177.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.712 ' HD2' HD11 ' A' ' 186' ' ' ILE . 57.1 t80 -74.07 127.16 32.2 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.53 -0.731 . . . . 0.0 110.194 175.376 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -99.95 160.09 28.13 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.697 -0.627 . . . . 0.0 109.974 175.111 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -58.55 157.86 25.61 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 O-C-N 123.291 1.153 . . . . 0.0 110.518 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.15 149.92 77.06 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 O-C-N 123.203 1.107 . . . . 0.0 110.514 -177.732 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -60.64 147.65 41.17 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.569 -0.707 . . . . 0.0 110.254 -178.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.87 127.2 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.508 -0.745 . . . . 0.0 110.219 -170.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.06 -10.27 55.18 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.405 ' OG1' ' CE2' ' A' ' 260' ' ' PHE . 10.1 t -144.12 174.12 11.15 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.115 -1.227 . . . . 0.0 110.676 176.027 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -107.39 13.17 27.27 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.647 -0.658 . . . . 0.0 111.812 -168.325 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.405 ' CE2' ' OG1' ' A' ' 258' ' ' THR . 14.6 p90 -119.92 168.01 11.56 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.116 -0.99 . . . . 0.0 111.155 -175.184 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 82.2 m -117.77 145.75 44.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.791 -0.568 . . . . 0.0 109.854 179.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 42.2 m -116.62 135.93 53.39 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.582 -0.699 . . . . 0.0 110.78 -176.55 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.9 t -132.31 137.33 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 175.094 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 76.6 mt -104.59 120.92 42.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.493 -0.755 . . . . 0.0 109.991 -170.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.718 ' OH ' ' HB2' ' A' ' 188' ' ' ALA . 4.8 m-30 -105.29 153.64 21.33 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.672 -0.643 . . . . 0.0 110.823 -176.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -136.54 142.92 43.46 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -114.99 133.82 55.71 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.463 -0.773 . . . . 0.0 110.47 -179.414 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 268' ' ' MET . . . . . 0.564 ' HG3' HD12 ' A' ' 225' ' ' LEU . 5.0 ppp? -102.44 9.42 39.66 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.606 -0.684 . . . . 0.0 112.053 -175.683 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . 0.811 ' O ' HD13 ' A' ' 305' ' ' ILE . 0.7 OUTLIER -144.61 159.05 43.44 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.083 -1.011 . . . . 0.0 110.108 173.06 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.455 ' HA ' HG21 ' A' ' 305' ' ' ILE . 26.9 p30 -119.27 163.11 17.62 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.752 -0.593 . . . . 0.0 110.423 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . 0.419 ' HA ' ' CB ' ' A' ' 277' ' ' MET . 25.1 m -57.95 -31.48 66.88 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.44 -0.788 . . . . 0.0 110.843 -166.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 51.1 p -105.72 14.95 27.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.352 -0.843 . . . . 0.0 111.965 -165.222 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 29.6 p -94.18 118.1 31.07 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.139 -0.975 . . . . 0.0 110.539 177.571 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.89 139.23 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.436 -0.79 . . . . 0.0 110.177 -170.5 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.6 -5.13 60.12 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 178.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.05 -97.69 0.81 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 173.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . 0.419 ' CB ' ' HA ' ' A' ' 271' ' ' SER . 93.0 mmm -64.03 -33.76 76.46 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.74 -0.859 . . . . 0.0 110.41 178.589 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.1 p30 43.72 50.77 6.69 Favored 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 175.486 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 54.86 31.86 16.6 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.294 -0.879 . . . . 0.0 111.188 176.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -120.02 104.94 43.3 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.498 -0.751 . . . . 0.0 110.148 174.247 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -60.37 148.16 91.42 Favored 'Trans proline' 0 N--CA 1.487 1.139 0 O-C-N 123.104 1.055 . . . . 0.0 110.528 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.676 HG22 ' HA ' ' A' ' 192' ' ' TYR . 45.5 pt -131.99 177.42 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 CA-C-O 121.79 0.805 . . . . 0.0 111.037 -176.811 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.5 HD12 ' HA ' ' A' ' 193' ' ' LYS . 28.1 mt -124.34 149.9 46.09 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.613 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.677 HD12 ' CE1' ' A' ' 301' ' ' PHE . 81.4 mt -115.79 130.19 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.931 -0.707 . . . . 0.0 109.315 177.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.603 HG23 ' SG ' ' A' ' 300' ' ' CYS . 83.3 mt -109.88 126.19 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.483 -177.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 187' ' ' ARG . 57.8 t -118.96 126.84 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.696 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 45.5 p -125.24 151.61 45.68 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.581 -0.7 . . . . 0.0 110.736 -173.467 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.804 HD21 ' HB3' ' A' ' 180' ' ' PRO . 21.8 tp -101.3 125.67 47.96 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 167.427 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.522 ' OE2' HG13 ' A' ' 295' ' ' VAL . 73.5 mm-40 -130.58 150.54 51.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.845 -0.534 . . . . 0.0 110.005 -172.566 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.837 ' CG2' HD11 ' A' ' 296' ' ' LEU . 17.1 p -89.96 161.13 16.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.678 -0.639 . . . . 0.0 109.967 177.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -55.95 -26.07 46.33 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.579 -0.701 . . . . 0.0 110.98 -176.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 47.0 p30 -90.36 9.36 29.23 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.373 -0.829 . . . . 0.0 111.908 -173.567 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 89.41 20.15 46.23 Favored Glycine 0 N--CA 1.494 2.546 0 C-N-CA 120.169 -1.015 . . . . 0.0 110.841 171.055 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -107.58 140.16 41.01 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.357 -1.084 . . . . 0.0 110.075 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.522 HG13 ' OE2' ' A' ' 289' ' ' GLU . 59.8 t -87.68 132.14 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.543 -0.723 . . . . 0.0 110.164 -173.35 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.837 HD11 ' CG2' ' A' ' 290' ' ' THR . 96.1 mt -99.97 -40.2 7.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.667 -0.646 . . . . 0.0 110.44 178.15 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -159.97 148.62 17.35 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -178.14 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.495 ' HD3' HG11 ' A' ' 295' ' ' VAL . 79.1 mtm180 -135.09 133.14 38.97 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.73 -0.864 . . . . 0.0 110.566 -178.61 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -135.03 156.17 49.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.705 -0.622 . . . . 0.0 109.976 172.32 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . 0.603 ' SG ' HG23 ' A' ' 285' ' ' ILE . 83.0 m -141.77 154.21 45.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.431 -0.793 . . . . 0.0 110.541 -176.269 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.677 ' CE1' HD12 ' A' ' 284' ' ' ILE . 49.3 p90 -144.96 164.62 30.57 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.694 -0.628 . . . . 0.0 110.247 177.14 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.428 ' HA ' HD23 ' A' ' 283' ' ' LEU . 83.7 tt0 -104.87 134.58 47.76 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.548 -0.72 . . . . 0.0 110.048 -177.137 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -121.77 143.68 49.24 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.704 -169.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 64.5 ttt-85 -139.82 134.86 32.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.761 -0.587 . . . . 0.0 109.633 173.585 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.811 HD13 ' O ' ' A' ' 269' ' ' CYS . 33.5 mt -106.79 122.86 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.585 -0.697 . . . . 0.0 109.67 178.627 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 27.2 p -145.12 170.92 15.29 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.594 -0.691 . . . . 0.0 110.975 -169.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -70.23 -40.05 74.72 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.752 -0.593 . . . . 0.0 110.604 -178.481 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 308' ' ' CYS . . . . . . . . . . . . . 3.7 t -131.15 88.85 43.65 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.591 -0.693 . . . . 0.0 110.422 179.139 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -55.85 -29.04 70.72 Favored 'Trans proline' 0 N--CA 1.488 1.187 0 O-C-N 123.176 1.092 . . . . 0.0 110.82 174.48 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -66.6 -37.83 92.83 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 177.136 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 72.2 ttt-85 -72.4 -40.49 67.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.67 -0.9 . . . . 0.0 109.77 -173.327 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -69.43 -38.35 77.8 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.256 -178.347 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -61.23 -43.7 98.46 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.467 -0.77 . . . . 0.0 110.226 178.227 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 52.5 tttt -64.9 -39.41 93.48 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.509 -0.744 . . . . 0.0 110.469 177.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.44 -49.82 75.27 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.515 -0.74 . . . . 0.0 110.573 -173.342 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . 0.469 ' OD1' HD11 ' A' ' 159' ' ' LEU . 3.1 p30 -61.61 -37.67 84.81 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.564 -0.71 . . . . 0.0 110.075 -178.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -61.79 -41.27 97.52 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.59 -0.694 . . . . 0.0 110.041 177.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -62.8 -35.04 78.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.665 -0.647 . . . . 0.0 109.995 178.353 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 22.8 t -63.3 -32.76 74.26 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.676 -0.64 . . . . 0.0 110.219 -179.698 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 83.2 mt -77.19 -45.67 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.605 -0.684 . . . . 0.0 110.037 -177.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -60.3 -40.04 89.07 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.61 -0.681 . . . . 0.0 110.374 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -61.8 -41.29 97.56 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.674 -0.641 . . . . 0.0 110.057 178.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -60.8 -33.98 73.82 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.677 -0.639 . . . . 0.0 110.111 177.561 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -97.38 125.02 41.75 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.7 -0.625 . . . . 0.0 110.387 -178.233 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 61.6 t -121.11 129.94 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.636 -0.665 . . . . 0.0 109.959 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 50.3 m -65.34 140.14 58.64 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.702 -0.623 . . . . 0.0 110.168 179.287 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -83.07 116.42 22.3 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.712 -0.617 . . . . 0.0 110.187 179.647 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 53.4 m -94.07 152.06 19.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.69 -0.631 . . . . 0.0 110.313 -179.184 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 73.3 p -94.26 -19.27 20.86 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.727 -0.608 . . . . 0.0 110.761 179.014 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 25.3 tttp -58.56 -33.36 69.84 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.332 -0.855 . . . . 0.0 110.464 179.2 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -57.52 -33.87 68.52 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.524 -0.735 . . . . 0.0 110.511 -178.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 66.09 -120.85 17.13 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.025 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . 0.401 ' O ' ' CE1' ' A' ' 335' ' ' PHE . 31.5 t0 -80.9 118.94 22.83 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.687 -0.89 . . . . 0.0 110.222 -179.142 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -64.22 147.72 51.73 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.661 -0.649 . . . . 0.0 110.205 -179.311 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.401 ' CE1' ' O ' ' A' ' 333' ' ' ASP . 96.0 m-85 -117.67 156.16 28.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.629 -0.669 . . . . 0.0 110.166 179.131 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 55.65 -84.23 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.817 -0.552 . . . . 0.0 111.05 -177.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 337' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -136.22 161.87 34.55 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.245 -0.909 . . . . 0.0 110.386 -178.027 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 41.5 p-10 -88.63 13.34 12.43 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.63 -0.668 . . . . 0.0 111.371 -176.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 46.4 m -83.5 137.23 33.97 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.204 -0.935 . . . . 0.0 110.144 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -117.51 139.64 50.67 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.649 -0.657 . . . . 0.0 110.375 -179.17 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 171.24 -126.71 1.34 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 26.5 pt -95.69 149.63 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.651 -0.911 . . . . 0.0 110.397 179.406 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -91.49 126.26 36.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.598 -0.689 . . . . 0.0 110.221 -179.52 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 50.9 ttm -100.17 134.89 42.43 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.609 -0.682 . . . . 0.0 110.248 -179.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 118.045 -0.978 . . . . 0.0 110.348 -179.968 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_